data_1zwo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zwo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.275 -1.53 . . . . 0.01 109.275 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -148.45 136.78 21.24 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.128 -1.219 . . . . 0.02 110.337 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.73 140.94 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.17 -0.678 . . . . 0.02 109.17 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -121.5 130.25 53.43 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.396 -0.815 . . . . 0.39 110.089 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 m-85 -110.18 140.14 44.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.598 -0.689 . . . . 0.02 109.27 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.54 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.0 m-85 -122.04 138.21 54.52 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.155 -0.965 . . . . 0.02 109.58 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -69.62 -27.37 65.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 0.03 111.788 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.0 m-20 -113.89 169.44 8.99 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.85 -1.156 . . . . 0.03 110.091 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.15 158.3 33.26 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.606 0.717 . . . . 0.03 110.095 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 0.8 OUTLIER 66.05 35.07 6.52 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.745 0.784 . . . . 0.74 110.76 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.5 p90 49.82 44.31 25.01 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.606 -0.724 . . . . 0.02 111.19 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -112.71 166.05 11.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.95 -167.58 34.8 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 120.736 -1.228 . . . . 0.03 110.415 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -69.36 142.68 53.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -1.024 . . . . 2.76 109.036 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -122.06 150.13 42.56 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.521 -0.737 . . . . 1.89 110.065 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -135.93 132.88 37.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.749 -0.594 . . . . 0.02 109.516 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -110.25 135.96 50.19 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.398 -0.814 . . . . 1.12 109.118 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 43.6 t -128.43 138.49 52.34 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.524 -0.735 . . . . 0.02 109.411 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 34.2 p-10 -119.16 11.88 12.48 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.624 -0.672 . . . . 0.2 110.392 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 4.3 p -159.42 173.45 16.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.765 -1.209 . . . . 1.23 109.05 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 13.2 p-10 -63.15 145.98 54.32 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.693 -1.254 . . . . 0.02 110.612 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.561 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 45.0 t -134.95 118.54 16.98 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.144 -0.687 . . . . 0.02 109.144 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.4 -21.62 52.87 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.53 -0.731 . . . . 0.24 111.605 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -154.49 105.06 2.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.845 -1.159 . . . . 1.14 109.506 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.4 OUTLIER -101.84 8.88 41.16 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.427 -0.796 . . . . 6.37 109.875 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.46 -28.55 68.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.435 -0.79 . . . . 3.11 112.033 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 m -76.83 -17.32 59.07 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.35 -1.469 . . . . 0.88 111.235 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 27.8 m-85 -107.22 -20.48 13.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.381 -0.824 . . . . 0.02 110.393 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tp -148.93 127.15 12.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.026 -1.046 . . . . 3.32 109.51 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.8 p -87.1 -12.26 47.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.558 -0.714 . . . . 0.02 111.329 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -172.02 161.98 5.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.807 -1.183 . . . . 0.02 108.283 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.8 t -143.52 116.61 8.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.96 -1.088 . . . . 0.02 108.984 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.518 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -109.7 0.5 18.98 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.792 -1.193 . . . . 0.03 111.714 -178.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 m -156.09 153.84 30.01 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.276 -1.009 . . . . 0.02 108.276 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mt -146.24 146.9 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.946 -1.096 . . . . 0.02 110.715 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -123.79 124.62 43.08 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.485 -1.302 . . . . 0.02 107.485 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.21 114.39 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.843 -1.54 . . . . 0.02 106.843 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -84.94 -34.85 22.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.565 -0.71 . . . . 3.81 109.906 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.61 149.34 17.22 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.497 -1.811 . . . . 0.02 110.976 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.1 171.84 48.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.386 -1.086 . . . . 0.01 110.386 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.1 m -118.02 134.03 55.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.554 -1.276 . . . . 1.48 107.554 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.1 m95 -128.27 155.69 44.19 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 122.636 1.208 . . . . 0.02 112.27 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.83 134.0 52.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.493 -2.04 . . . . 0.24 105.493 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.08 142.45 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.936 -0.764 . . . . 0.65 108.936 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -120.83 144.98 48.07 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.386 1.089 . . . . 0.02 110.092 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -66.17 -34.0 77.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.721 -0.672 . . . . 0.02 111.472 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -124.44 157.9 63.44 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 121.097 -1.002 . . . . 0.02 109.449 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.56 166.47 1.25 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.766 1.644 . . . . 0.02 112.783 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 m-20 63.71 36.36 10.75 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.366 -0.834 . . . . 0.02 111.15 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.444 ' H ' ' HG ' ' A' ' 81' ' ' SER . 5.1 m-85 45.67 51.74 9.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.567 0.699 . . . . 3.39 110.732 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 p -126.23 163.74 22.51 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.203 0.525 . . . . 2.33 109.993 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.38 -161.56 31.39 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.748 -1.341 . . . . 0.02 109.748 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -64.54 138.79 58.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.936 -1.332 . . . . 0.02 110.042 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 21.2 ptm -119.61 137.49 53.83 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.208 0.528 . . . . 5.01 109.736 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.551 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 95.1 m-85 -134.61 139.67 45.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.434 -0.791 . . . . 0.02 110.127 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 mm -93.79 130.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.736 -0.838 . . . . 1.72 108.736 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.483 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -120.91 110.48 34.91 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.425 -0.797 . . . . 0.02 110.63 -178.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -78.09 169.76 19.85 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 119.767 0.953 . . . . 1.47 110.17 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -53.55 140.84 27.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.818 -1.176 . . . . 4.25 110.496 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.55 -177.37 32.74 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.462 -1.352 . . . . 0.02 110.611 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -119.3 130.42 55.38 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.402 -1.058 . . . . 0.96 109.708 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.483 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 32.1 m-85 -122.94 91.92 49.49 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.296 -1.002 . . . . 0.02 108.296 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -65.95 -2.83 7.28 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.115 1.21 . . . . 0.02 113.739 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -156.93 151.05 24.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.335 -1.478 . . . . 2.02 107.88 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -59.59 -38.94 82.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.662 -0.649 . . . . 0.02 112.538 -176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -60.36 -23.47 64.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.026 -1.046 . . . . 0.02 111.079 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -73.13 -15.54 61.47 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.79 -1.164 . . . . 3.42 108.752 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.559 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 0.6 OUTLIER -107.63 9.35 29.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.3 -1.37 . . . . 0.02 107.3 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.0 mtm 62.11 22.91 13.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.685 -0.635 . . . . 0.02 110.923 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.21 145.05 46.85 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.748 -1.341 . . . . 0.02 109.748 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.76 -31.7 35.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -1.209 . . . . 0.98 107.949 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.655 HD21 ' H ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -157.28 -172.27 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.467 -1.679 . . . . 0.02 106.467 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.29 27.65 4.55 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.768 -1.208 . . . . 0.02 110.654 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.655 ' H ' HD21 ' A' ' 76' ' ' ASN . 68.7 mtm180 -96.34 122.52 39.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.881 -1.137 . . . . 3.2 110.864 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.5 mt -142.44 119.06 11.04 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.771 -1.196 . . . . 2.61 107.771 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.1 -18.28 10.03 Favored Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.138 -0.976 . . . . 0.02 112.511 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.444 ' HG ' ' H ' ' A' ' 54' ' ' PHE . 60.5 p -156.12 156.52 34.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.255 -1.732 . . . . 0.02 110.394 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.4 m -145.47 148.23 33.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.719 -0.613 . . . . 0.02 109.841 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.44 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 54.6 mtm180 -137.39 141.97 41.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.331 -0.855 . . . . 0.01 109.311 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 132.79 36.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.213 -0.93 . . . . 0.43 109.496 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.74 124.03 42.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.242 -1.021 . . . . 1.25 108.242 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -91.31 134.57 34.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.823 -1.173 . . . . 1.77 108.507 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.61 135.41 40.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.841 -1.17 . . . . 1.63 107.841 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.51 ' HG ' ' HG1' ' A' ' 135' ' ' THR . 92.7 p -109.37 127.63 54.5 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.763 -0.828 . . . . 1.08 108.763 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -105.19 -153.78 0.5 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 106.314 -1.736 . . . . 1.26 106.314 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.59 -50.63 0.86 Allowed Glycine 0 N--CA 1.499 2.849 0 O-C-N 120.528 -1.358 . . . . 0.01 111.846 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.73 -100.73 0.15 Allowed Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.867 -1.635 . . . . 0.01 111.402 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -119.61 118.11 30.12 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.185 -1.185 . . . . 4.43 110.243 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.19 136.69 56.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.385 -0.598 . . . . 2.99 109.385 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -134.38 130.4 36.83 Favored 'General case' 0 N--CA 1.519 2.988 0 O-C-N 121.06 -1.025 . . . . 6.36 113.048 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.17 143.49 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 115.63 -0.713 . . . . 1.09 110.591 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.488 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.9 pt20 -124.89 139.71 53.58 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.771 -1.196 . . . . 2.05 107.771 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.22 145.69 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 120.652 -1.28 . . . . 1.1 111.189 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 27.8 m-85 -120.4 140.19 51.71 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.956 0.884 . . . . 0.73 110.847 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -68.55 -32.41 72.32 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.784 -0.644 . . . . 0.02 112.178 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -114.82 165.74 12.51 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.956 -1.09 . . . . 3.18 110.212 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.18 163.41 45.44 Favored Glycine 0 N--CA 1.492 2.38 0 CA-C-O 121.958 0.755 . . . . 0.01 111.278 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 57.15 39.17 29.13 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.578 0.704 . . . . 0.01 111.026 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 52.66 55.91 8.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.624 -0.672 . . . . 0.01 111.112 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -128.42 164.87 21.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.281 -1.007 . . . . 3.15 108.281 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.65 -163.05 28.25 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.092 -1.603 . . . . 0.01 109.092 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -75.62 142.04 42.72 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.878 -1.366 . . . . 0.01 108.959 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 33.9 ttp -116.73 143.27 45.85 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.538 0.685 . . . . 0.01 109.533 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.98 136.41 47.28 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.173 -1.047 . . . . 2.48 108.173 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -115.96 134.09 55.34 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.715 -0.616 . . . . 0.01 109.7 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.1 t -149.31 147.93 28.93 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.515 1.15 . . . . 1.69 111.474 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -114.54 7.63 16.19 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.894 -1.048 . . . . 0.01 109.875 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -121.96 163.56 19.11 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.393 -0.817 . . . . 3.21 111.008 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.4 154.82 41.43 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.358 -0.839 . . . . 0.01 109.379 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.8 t -126.64 114.98 22.77 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.911 -0.774 . . . . 0.01 108.911 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.23 -32.59 5.01 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 120.323 1.151 . . . . 0.01 111.447 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 m -142.31 108.26 5.18 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.847 0.832 . . . . 0.02 108.947 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.29 -39.9 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.776 -0.577 . . . . 1.83 110.97 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 32.7 ttp -66.89 -37.4 84.31 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.026 -1.069 . . . . 1.34 109.812 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -70.22 -38.62 75.29 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.524 -1.36 . . . . 2.11 109.761 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.51 ' NE2' ' CE1' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -80.14 -47.49 14.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.253 -0.904 . . . . 2.08 112.203 -176.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.51 ' CE1' ' NE2' ' A' ' 120' ' ' GLN . 92.1 m-85 -110.82 -0.44 16.93 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.378 -0.826 . . . . 0.02 112.699 -176.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 59.93 33.2 21.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.659 -1.276 . . . . 0.02 109.595 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mt -112.69 135.85 52.95 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 108.764 -0.828 . . . . 0.02 108.764 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -91.73 -22.89 19.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -0.822 . . . . 5.32 110.358 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -149.36 164.03 36.07 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.09 -1.006 . . . . 0.02 110.019 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.414 HD12 HG23 ' A' ' 126' ' ' ILE . 54.8 mt -131.7 129.57 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.375 -1.343 . . . . 2.17 107.375 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -107.77 -12.92 15.12 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.134 -0.979 . . . . 0.02 113.18 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.6 OUTLIER -153.52 151.35 29.71 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.489 -1.382 . . . . 0.01 108.278 178.321 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 13.7 t -160.92 145.03 13.6 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.261 -1.524 . . . . 1.22 109.935 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -121.8 110.22 15.64 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.43 1.109 . . . . 1.41 109.156 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 t -107.55 120.34 58.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 105.851 -1.907 . . . . 0.01 105.851 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.0 t -146.27 68.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 118.453 -1.299 . . . . 1.98 108.369 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 172.65 107.22 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.443 -1.688 . . . . 0.01 106.443 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.66 -174.07 43.1 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.554 -1.418 . . . . 0.01 109.554 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.51 ' HG1' ' HG ' ' A' ' 88' ' ' SER . 13.2 m -111.41 144.3 40.84 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.387 -1.066 . . . . 2.3 109.216 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -129.15 146.03 51.18 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.643 -0.66 . . . . 0.01 110.377 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.1 mt -117.36 141.71 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 107.642 -1.244 . . . . 1.69 107.642 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -113.97 143.42 44.76 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 107.453 -1.314 . . . . 2.49 107.453 177.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 16.0 m-85 -122.77 144.17 49.35 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.291 -0.633 . . . . 0.02 109.291 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.5 -29.86 62.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.737 -0.602 . . . . 0.02 111.964 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.47 153.87 47.69 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 120.679 -1.263 . . . . 1.48 109.26 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -54.48 166.13 1.98 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.229 1.286 . . . . 0.02 112.658 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 15.3 t-20 59.79 31.76 20.97 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.145 -0.934 . . . . 0.75 111.136 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.504 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.8 m-85 57.43 51.45 9.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.54 -0.725 . . . . 0.02 110.827 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -124.55 163.43 21.93 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.541 -0.724 . . . . 0.02 109.659 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.45 -165.34 32.42 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.83 -1.308 . . . . 0.02 109.83 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -67.89 141.48 56.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.991 . . . . 0.02 109.011 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.676 ' H ' ' NE2' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -118.87 149.01 42.27 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.284 -0.635 . . . . 0.02 109.284 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.68 142.4 51.03 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.181 -0.674 . . . . 0.01 109.181 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 150' ' ' LEU . 3.4 mp -95.43 121.11 36.76 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.462 -0.774 . . . . 0.01 109.336 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.42 135.25 47.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.44 -0.788 . . . . 0.01 110.674 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 154' ' ' LYS . 2.8 m-20 -110.31 175.63 5.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.187 -1.042 . . . . 2.27 108.187 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -57.85 84.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.905 -1.122 . . . . 1.84 108.638 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 152' ' ' ASP . 73.6 tttt -137.14 165.38 26.21 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.256 -0.903 . . . . 2.28 111.654 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 6.7 pt-20 -111.8 113.66 26.15 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.061 -1.088 . . . . 0.01 108.061 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.44 115.28 30.25 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.933 -1.104 . . . . 0.01 110.29 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.445 ' O ' ' OG ' ' A' ' 128' ' ' SER . 3.7 ptp180 -92.18 -25.82 18.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.01 111.347 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -125.67 153.17 72.97 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 121.017 -1.052 . . . . 2.54 108.643 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -60.7 -42.08 41.85 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 CA-C-N 119.27 0.775 . . . . 0.7 110.524 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.1 t -60.38 -20.43 20.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.745 -1.222 . . . . 0.86 108.612 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -65.91 -16.19 63.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.989 -1.069 . . . . 0.02 109.605 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.406 ' CZ3' ' CD1' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -94.73 9.3 39.48 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.763 -1.199 . . . . 0.02 107.763 179.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.15 10.32 86.32 Favored Glycine 0 N--CA 1.486 2.024 0 C-N-CA 119.214 -1.47 . . . . 0.02 109.617 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.5 142.03 31.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.45 -1.03 . . . . 0.02 110.091 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.1 -8.33 59.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.677 -0.64 . . . . 0.59 109.828 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.559 ' HG ' ' H ' ' A' ' 168' ' ' ALA . 10.5 p -144.66 150.86 48.47 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.857 -1.152 . . . . 0.87 108.702 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.83 21.03 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 120.816 1.011 . . . . 0.38 112.355 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.559 ' H ' ' HG ' ' A' ' 166' ' ' SER . . . -82.87 124.13 30.03 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.464 1.126 . . . . 0.18 111.708 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.406 ' CD1' ' CZ3' ' A' ' 162' ' ' TRP . 16.4 mt -146.47 126.9 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 106.78 -1.563 . . . . 3.99 106.78 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -112.02 -20.53 11.93 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.098 -1.001 . . . . 5.17 112.783 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.6 p -158.0 160.63 37.68 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 119.269 -2.144 . . . . 0.02 110.141 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -152.48 154.03 34.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.129 -0.982 . . . . 2.02 110.26 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.504 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -144.51 151.97 39.9 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.195 -0.941 . . . . 0.01 110.449 -179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -88.24 143.02 27.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.496 -0.753 . . . . 0.01 109.412 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -93.25 128.66 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.17 -0.956 . . . . 3.04 109.053 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.8 t -136.0 146.4 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.224 -0.923 . . . . 1.89 109.384 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 4.89 109.517 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.642 -1.383 . . . . 0.01 109.642 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -152.83 138.29 17.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.264 -1.139 . . . . 0.02 109.586 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -130.31 140.87 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.373 -0.603 . . . . 0.02 109.373 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -121.13 129.95 53.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.469 -0.77 . . . . 0.39 110.143 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -109.02 139.32 44.05 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.549 -0.719 . . . . 0.02 109.147 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.3 m-85 -121.98 137.73 54.69 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.361 -0.837 . . . . 0.02 109.276 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.78 -27.4 64.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.013 -1.054 . . . . 0.03 111.88 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.9 m-20 -114.2 170.2 8.46 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.87 -1.144 . . . . 0.03 110.366 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -75.25 157.91 33.72 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.599 0.714 . . . . 0.03 110.136 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 10.4 t30 65.85 35.11 6.85 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.803 0.811 . . . . 0.74 110.8 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.96 44.83 25.5 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.487 -0.779 . . . . 0.02 111.368 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -112.28 165.87 11.79 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.032 -1.099 . . . . 0.02 108.032 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -167.88 34.44 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 120.847 -1.158 . . . . 0.03 110.619 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -69.19 143.1 54.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -1.04 . . . . 2.76 108.922 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -123.22 149.92 44.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.518 -0.739 . . . . 1.89 110.211 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -136.25 133.4 36.96 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 109.317 -0.623 . . . . 0.02 109.317 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.0 136.16 48.99 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.688 -0.856 . . . . 1.12 108.688 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.476 ' SG ' ' CZ ' ' A' ' 29' ' ' PHE . 1.9 m -126.94 137.31 53.1 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.637 -0.664 . . . . 0.02 109.541 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -118.95 10.74 12.31 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.572 -0.705 . . . . 0.2 110.233 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 14.9 t -159.61 173.19 16.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.79 -1.194 . . . . 1.23 109.063 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.416 ' OD1' ' SG ' ' A' ' 24' ' ' CYS . 5.5 p-10 -63.22 146.28 53.72 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.683 -1.26 . . . . 0.02 110.721 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.88 119.22 17.81 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.061 -0.718 . . . . 0.02 109.061 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -20.84 51.33 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.504 -0.748 . . . . 0.24 112.037 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -153.73 106.02 2.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.729 -1.232 . . . . 1.14 109.762 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.476 ' CZ ' ' SG ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -102.66 6.7 39.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.353 -0.842 . . . . 6.37 110.399 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -61.17 -29.5 69.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 3.11 111.898 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.4 t -77.06 -17.56 58.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.505 -1.372 . . . . 0.88 110.948 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -106.14 -21.42 13.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.388 -0.82 . . . . 0.02 110.624 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.13 127.39 12.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.145 -0.972 . . . . 3.32 109.472 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.6 t -87.29 -12.48 46.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.516 -0.74 . . . . 0.02 110.976 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -172.56 161.99 5.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.847 -1.158 . . . . 0.02 108.378 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 p -142.63 115.04 8.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.99 -1.069 . . . . 0.02 108.735 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -107.04 -2.71 20.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.836 -1.165 . . . . 0.03 111.289 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -152.96 153.65 33.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.118 -1.067 . . . . 0.02 108.118 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.7 mt -146.83 147.44 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.045 -1.034 . . . . 0.02 110.438 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -124.91 125.66 44.29 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.899 -1.148 . . . . 0.02 107.899 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.6 114.11 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 106.773 -1.566 . . . . 0.02 106.773 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.94 -34.61 22.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.609 -0.682 . . . . 3.81 110.184 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.24 149.99 18.24 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 118.358 -1.877 . . . . 0.02 110.758 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.12 172.42 49.11 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.174 -1.171 . . . . 0.01 110.174 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 m -118.35 134.19 55.26 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.484 -1.302 . . . . 1.48 107.484 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -126.38 154.86 43.0 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.626 1.203 . . . . 0.02 112.326 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.72 133.99 52.51 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.189 -2.152 . . . . 0.24 105.189 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.22 142.63 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.514 -0.741 . . . . 0.65 109.319 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -120.88 143.19 49.05 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 122.053 0.93 . . . . 0.02 109.535 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.08 -33.62 76.47 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.498 -0.774 . . . . 0.02 111.641 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -124.46 157.7 64.19 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 121.098 -1.001 . . . . 0.02 109.467 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.13 166.94 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.656 1.57 . . . . 0.02 112.726 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.07 36.5 12.24 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.331 -0.849 . . . . 0.02 111.108 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.49 ' H ' ' HG ' ' A' ' 81' ' ' SER . 2.8 m-85 45.56 51.54 9.84 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.601 0.715 . . . . 3.39 110.864 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 p -125.78 163.55 22.62 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.384 0.612 . . . . 2.33 109.904 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.49 -161.45 31.17 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.799 -1.32 . . . . 0.02 109.799 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -65.3 139.35 58.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.027 -1.278 . . . . 0.02 110.163 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 18.4 ptm -118.91 137.05 53.73 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.245 0.545 . . . . 5.01 109.61 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.405 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.9 m-85 -134.19 138.82 45.4 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.459 -0.776 . . . . 0.02 109.925 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.7 mm -95.2 130.62 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.49 -0.756 . . . . 1.72 109.031 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 mt -121.44 111.2 33.49 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 121.326 -0.859 . . . . 0.02 110.653 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -77.66 169.77 20.29 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 CA-C-N 119.85 0.982 . . . . 1.47 110.415 177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -53.53 141.26 25.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.902 -1.124 . . . . 4.25 110.603 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.45 -177.4 31.83 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.502 -1.333 . . . . 0.02 110.693 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -118.45 130.42 55.95 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.354 -1.086 . . . . 0.96 109.787 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -120.37 97.05 49.08 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 107.861 -1.163 . . . . 0.02 107.861 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -69.48 -4.49 13.94 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 120.752 0.968 . . . . 0.02 113.583 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -157.27 154.53 29.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.623 -1.298 . . . . 2.02 108.144 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -59.95 -38.6 82.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.408 -0.808 . . . . 0.02 111.773 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -59.82 -24.44 64.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.02 110.226 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -70.09 -18.72 63.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.41 -0.806 . . . . 3.42 108.879 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.46 10.12 27.42 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.628 -1.249 . . . . 0.02 107.628 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.9 mmt 60.81 22.32 12.37 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.48 0.657 . . . . 0.02 110.598 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.43 144.17 45.8 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.367 -1.493 . . . . 0.02 109.367 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.1 tp -78.93 -30.93 44.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.553 -1.276 . . . . 0.98 107.553 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -157.42 -171.82 3.74 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.544 -1.651 . . . . 0.02 106.544 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -98.25 28.63 3.96 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.603 -1.31 . . . . 0.02 110.775 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -97.82 122.72 41.26 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.933 -1.105 . . . . 3.2 111.324 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 mt -142.36 119.51 11.43 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.317 -1.364 . . . . 2.61 107.317 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.99 -18.55 10.41 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 121.282 -0.886 . . . . 0.02 112.065 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.49 ' HG ' ' H ' ' A' ' 54' ' ' PHE . 6.4 p -155.45 155.63 33.86 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 119.531 1.666 . . . . 0.02 110.695 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.5 p -145.17 147.82 32.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.403 -0.811 . . . . 0.02 110.283 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -137.17 141.87 42.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.442 -0.786 . . . . 0.01 109.109 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.58 132.36 37.11 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.203 -0.935 . . . . 0.43 109.28 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.3 123.95 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.653 -0.869 . . . . 1.25 108.653 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -92.01 132.34 36.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.956 -1.09 . . . . 1.77 108.552 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.83 138.12 34.87 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.139 -1.06 . . . . 1.63 108.139 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.9 p -110.21 126.38 54.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 1.08 108.682 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.2 t -102.85 -155.1 0.51 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.205 -1.776 . . . . 1.26 106.205 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.59 -50.41 0.84 Allowed Glycine 0 N--CA 1.497 2.743 0 O-C-N 120.521 -1.362 . . . . 0.01 111.986 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.6 -99.77 0.13 Allowed Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.816 -1.659 . . . . 0.01 111.709 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -119.34 119.45 34.01 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.117 -1.225 . . . . 4.43 110.311 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.35 137.32 56.82 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.344 -0.613 . . . . 2.99 109.344 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.406 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 7.5 ttpm? -136.45 130.7 33.03 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-O 122.273 1.035 . . . . 6.36 113.015 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 tt -131.72 141.51 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 115.397 -0.82 . . . . 1.09 110.286 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.504 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 6.3 pt20 -124.33 140.2 53.18 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 107.597 -1.26 . . . . 2.05 107.597 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 m -124.24 146.29 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.685 -1.259 . . . . 1.1 111.189 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 26.2 m-85 -120.4 140.24 51.64 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 122.224 1.011 . . . . 0.73 110.745 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.84 -32.44 72.97 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.709 -0.678 . . . . 0.02 111.907 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -114.47 165.7 12.47 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 120.948 -1.095 . . . . 3.18 110.446 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.9 163.69 47.24 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 111.038 -0.825 . . . . 0.01 111.038 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 57.62 38.86 27.88 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.578 0.704 . . . . 0.01 110.946 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 52.44 56.91 7.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.537 -0.727 . . . . 0.01 111.035 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -129.48 165.34 21.82 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.166 -1.05 . . . . 3.15 108.166 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.4 -162.77 28.38 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.13 -1.588 . . . . 0.01 109.13 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.471 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 54.6 tt0 -75.81 142.0 42.37 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.016 -1.285 . . . . 0.01 108.76 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.7 ttp -116.55 143.05 46.09 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.513 0.673 . . . . 0.01 109.563 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.471 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 55.9 m-85 -131.89 135.91 47.01 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.198 -1.038 . . . . 2.48 108.198 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -116.52 134.37 54.92 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.722 -0.611 . . . . 0.01 109.669 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t -149.23 148.02 29.09 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.528 1.156 . . . . 1.69 111.367 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.501 ' HG1' ' CD ' ' A' ' 112' ' ' GLU . 15.3 p -114.95 7.67 15.67 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.949 -1.023 . . . . 0.01 109.934 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.501 ' CD ' ' HG1' ' A' ' 111' ' ' THR . 21.8 mp0 -122.03 163.78 18.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.408 -0.808 . . . . 3.21 111.181 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.59 153.89 42.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.384 -0.823 . . . . 0.01 109.46 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 46.0 t -126.98 114.95 22.03 Favored Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 108.971 -0.752 . . . . 0.01 108.971 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -75.1 -32.94 4.86 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 120.387 1.174 . . . . 0.01 111.612 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -142.05 108.49 5.3 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.834 0.826 . . . . 0.02 109.198 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 117' ' ' ILE . 96.4 mt -64.36 -39.75 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.844 -0.535 . . . . 1.83 111.02 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.6 ttt -66.57 -38.17 86.5 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.169 -1.012 . . . . 1.34 109.865 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.62 -38.46 77.23 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.506 -1.371 . . . . 2.11 109.858 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -80.78 -47.25 14.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.29 -0.881 . . . . 2.08 112.462 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -111.21 -0.78 16.36 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.252 -0.905 . . . . 0.02 112.719 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 59.88 33.43 21.57 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.812 -1.18 . . . . 0.02 109.384 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.27 135.7 52.61 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 108.699 -0.852 . . . . 0.02 108.699 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -92.66 -23.43 18.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 5.32 110.65 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -149.11 163.66 36.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.084 -1.01 . . . . 0.02 110.095 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 126' ' ' ILE . 48.2 mt -131.63 129.4 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 107.348 -1.353 . . . . 2.17 107.348 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -107.18 -13.32 15.18 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.144 -0.973 . . . . 0.02 113.06 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.38 153.06 29.85 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.277 -1.514 . . . . 0.01 108.255 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 6.8 t -162.86 143.81 9.75 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.375 -1.453 . . . . 1.22 109.665 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -122.37 112.87 18.62 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.001 0.905 . . . . 1.41 108.77 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 t -109.03 123.4 64.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.061 -1.829 . . . . 0.01 106.061 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -146.41 66.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 C-N-CA 117.951 -1.5 . . . . 1.98 109.061 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.406 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.1 tp10 176.28 108.72 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.32 -1.733 . . . . 0.01 106.32 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.674 ' H ' ' HZ2' ' A' ' 153' ' ' LYS . . . 70.99 -174.44 40.39 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.476 -1.45 . . . . 0.01 109.476 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -112.05 146.57 37.7 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.423 -1.045 . . . . 2.3 109.43 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -130.35 146.19 51.89 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.502 -0.749 . . . . 0.01 110.284 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mt -117.13 141.56 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 107.566 -1.272 . . . . 1.69 107.566 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.33 143.79 44.32 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.688 -1.227 . . . . 2.49 107.688 177.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 7.5 m-85 -122.58 144.7 48.94 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.994 -0.743 . . . . 0.02 108.994 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 76.5 tt0 -74.06 -29.78 62.06 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.669 -0.644 . . . . 0.02 112.08 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.5 mt -115.24 153.5 47.39 Favored Pre-proline 0 N--CA 1.506 2.369 0 O-C-N 120.676 -1.265 . . . . 1.48 109.208 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.41 167.08 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.129 1.219 . . . . 0.02 112.565 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 59.31 31.08 20.88 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.065 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.76 51.12 9.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 0.02 111.124 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -123.99 163.33 21.6 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.569 -0.707 . . . . 0.02 109.528 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.2 -165.79 31.74 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.873 -1.291 . . . . 0.02 109.873 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -68.2 142.28 55.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.477 -1.014 . . . . 0.02 109.03 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -118.01 148.46 42.21 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.451 -0.574 . . . . 0.02 109.451 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.463 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -128.64 142.73 50.94 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.563 -0.71 . . . . 0.01 109.113 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.64 119.8 34.77 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.48 -0.763 . . . . 0.01 109.465 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.5 mt -106.21 131.95 52.84 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.422 -0.798 . . . . 0.01 110.363 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 154' ' ' LYS . 11.9 p-10 -109.84 176.77 4.94 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.454 -0.943 . . . . 2.27 108.454 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.674 ' HZ2' ' H ' ' A' ' 134' ' ' GLY . 48.7 mttm -55.54 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.066 -1.021 . . . . 1.84 108.489 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 152' ' ' ASP . 53.4 mmtt -136.74 166.86 22.6 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.189 -0.945 . . . . 2.28 111.593 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 15.0 mp0 -113.82 106.4 14.42 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.76 -1.2 . . . . 0.01 107.76 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.56 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 90.9 m-85 -99.03 114.16 26.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.965 -1.085 . . . . 0.01 110.201 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -92.41 -25.67 18.37 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.19 -0.943 . . . . 0.01 111.144 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -125.18 153.88 71.74 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.079 -1.013 . . . . 2.54 108.392 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -61.3 -41.43 42.04 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 120.442 0.761 . . . . 0.7 110.651 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.33 -20.1 21.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.657 -1.277 . . . . 0.86 108.769 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -65.57 -16.11 63.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.025 -1.047 . . . . 0.02 109.758 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.56 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 1.1 m0 -96.11 10.88 36.2 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.999 -1.112 . . . . 0.02 107.999 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.57 11.34 85.56 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.414 -1.374 . . . . 0.02 110.159 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.73 141.94 31.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.293 -1.122 . . . . 0.02 110.209 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.29 -8.22 59.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.613 -0.679 . . . . 0.59 109.817 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.4 p -144.31 150.87 49.78 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.806 -1.184 . . . . 0.87 108.728 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.6 20.85 0.5 Allowed 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 120.701 0.934 . . . . 0.38 112.341 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.28 122.14 27.56 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.467 1.127 . . . . 0.18 111.45 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.8 mm -142.74 125.39 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.009 -1.848 . . . . 3.99 106.009 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.526 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 12.3 mp0 -112.33 -20.82 11.69 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.088 -1.008 . . . . 5.17 112.615 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.5 p -157.41 160.92 38.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.384 -2.072 . . . . 0.02 109.954 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -153.53 154.59 34.6 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.182 -0.949 . . . . 2.02 110.578 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -144.46 151.39 39.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.35 -0.843 . . . . 0.01 110.442 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -87.66 142.64 27.68 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.054 -0.721 . . . . 0.01 109.054 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.8 mt -93.12 128.45 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.037 -1.039 . . . . 3.04 109.206 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 44.9 t -136.07 146.71 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.294 -0.879 . . . . 1.89 109.564 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.86 . . . . 4.89 109.483 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.39 -1.484 . . . . 0.01 109.39 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -152.83 138.28 17.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.245 -1.15 . . . . 0.02 109.841 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -130.32 141.03 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.475 -0.565 . . . . 0.02 109.475 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.422 ' OG ' ' NE ' ' A' ' 19' ' ' ARG . 1.6 t -122.26 130.76 53.47 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.308 -0.87 . . . . 0.39 110.091 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.0 OUTLIER -111.11 140.71 45.43 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.768 -0.582 . . . . 0.02 109.444 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.4 m-85 -121.85 138.45 54.38 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.353 -0.842 . . . . 0.02 109.573 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -68.86 -27.4 65.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.99 -1.069 . . . . 0.03 111.504 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.7 m-20 -114.53 170.72 8.1 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.858 -1.151 . . . . 0.03 110.009 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -75.81 162.06 28.49 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.705 0.764 . . . . 0.03 110.313 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.9 t30 62.46 33.28 16.25 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.113 0.959 . . . . 0.74 110.742 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.1 40.29 31.81 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.733 -0.667 . . . . 0.02 110.834 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -109.97 165.42 11.74 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.196 -1.038 . . . . 0.02 108.196 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.54 -168.04 34.38 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.888 -1.149 . . . . 0.03 110.557 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -68.83 143.53 54.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -1.058 . . . . 2.76 108.887 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.533 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 51.4 ttt180 -122.03 149.95 42.78 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.62 -0.675 . . . . 1.89 109.916 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.24 134.5 34.51 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.637 -0.664 . . . . 0.02 109.466 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.31 136.92 48.75 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.385 -0.822 . . . . 1.12 109.384 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.428 ' HG ' ' HG ' ' A' ' 26' ' ' CYS . 11.7 t -127.99 138.3 52.55 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.594 -0.691 . . . . 0.02 109.488 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -118.74 11.98 12.87 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.59 -0.694 . . . . 0.2 110.554 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.2 t -159.46 173.84 15.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.706 -1.246 . . . . 1.23 109.091 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 17.8 p30 -63.11 146.67 52.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.747 -1.221 . . . . 0.02 110.527 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 15.4 m -133.7 117.64 17.21 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.127 -0.694 . . . . 0.02 109.127 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.75 -23.21 45.53 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.284 -0.885 . . . . 0.24 111.471 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -151.77 103.77 2.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.974 -1.079 . . . . 1.14 109.056 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.16 6.81 33.39 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.588 0.709 . . . . 6.37 110.231 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -59.93 -27.63 66.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 3.11 111.691 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.4 p -76.6 -16.08 59.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.611 -1.306 . . . . 0.88 110.803 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.57 -21.96 12.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.44 -0.787 . . . . 0.02 110.422 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tp -149.08 127.33 12.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.04 -1.037 . . . . 3.32 109.436 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.2 t -87.02 -12.16 48.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.64 -0.662 . . . . 0.02 111.051 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.483 ' HE ' HD22 ' A' ' 37' ' ' ASN . 14.9 ptm180 -172.84 162.13 4.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.93 -1.106 . . . . 0.02 108.417 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -142.7 115.79 8.87 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.047 -1.033 . . . . 0.02 108.649 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.483 HD22 ' HE ' ' A' ' 35' ' ' ARG . 1.6 m-80 -107.71 -1.0 21.43 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.803 -1.186 . . . . 0.03 110.987 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.498 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 4.4 t -155.52 152.88 29.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.498 ' N ' ' HG ' ' A' ' 38' ' ' SER . 91.6 mt -145.33 148.46 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.091 -1.006 . . . . 0.02 109.887 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -124.46 124.55 42.56 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.5 -1.296 . . . . 0.02 107.5 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -105.03 113.87 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.704 -1.591 . . . . 0.02 106.704 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -83.81 -34.83 24.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.576 -0.703 . . . . 3.81 109.971 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 151.27 20.64 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 118.392 -1.861 . . . . 0.02 110.535 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.79 171.89 48.61 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.318 -1.113 . . . . 0.01 110.318 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.9 m -117.76 133.74 55.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.429 -1.323 . . . . 1.48 107.429 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -126.21 154.23 43.59 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.6 1.19 . . . . 0.02 112.16 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.03 133.72 52.61 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.419 -2.067 . . . . 0.24 105.419 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.3 m -117.62 142.87 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.569 -0.707 . . . . 0.65 109.249 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -120.62 144.87 47.91 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.112 0.958 . . . . 0.02 109.997 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.472 ' OE2' ' NH2' ' A' ' 78' ' ' ARG . 33.5 tt0 -66.16 -33.69 76.34 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.875 -0.602 . . . . 0.02 111.582 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 51' ' ' ARG . 0.4 OUTLIER -124.64 157.88 64.07 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.006 -1.059 . . . . 0.02 109.486 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.09 166.44 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.637 1.558 . . . . 0.02 112.763 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m120 63.67 36.39 10.84 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.36 -0.836 . . . . 0.02 111.153 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 8.0 m-85 45.29 51.51 9.32 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.654 0.74 . . . . 3.39 110.812 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -125.75 163.44 22.84 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.143 0.497 . . . . 2.33 109.882 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.83 31.38 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.447 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 21.1 m-70 -64.35 138.48 58.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.981 -1.305 . . . . 0.02 109.989 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.8 ppp? -119.37 137.45 53.72 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.283 0.564 . . . . 5.01 109.58 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.563 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.7 m-85 -134.99 139.95 45.29 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.492 -0.755 . . . . 0.02 110.238 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.7 mm -94.16 130.45 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 108.656 -0.868 . . . . 1.72 108.656 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.03 110.32 36.53 Favored Pre-proline 0 N--CA 1.505 2.324 0 O-C-N 121.439 -0.788 . . . . 0.02 110.597 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.69 168.65 22.13 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 CA-C-N 119.935 1.012 . . . . 1.47 110.311 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -53.75 140.79 28.67 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.84 -1.163 . . . . 4.25 110.524 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.77 32.68 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.489 -1.338 . . . . 0.02 110.598 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -118.76 130.09 55.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.251 -1.146 . . . . 0.96 109.622 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.574 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 71.8 m-85 -121.1 98.91 46.88 Favored Pre-proline 0 N--CA 1.492 1.667 0 N-CA-C 107.852 -1.166 . . . . 0.02 107.852 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -71.3 -3.73 13.53 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 120.637 0.892 . . . . 0.02 113.836 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -157.52 155.04 29.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.64 -1.288 . . . . 2.02 108.274 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -59.85 -39.08 84.0 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.62 -0.675 . . . . 0.02 111.787 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -59.94 -23.99 64.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.917 . . . . 0.02 110.256 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -70.32 -18.75 63.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.791 0.805 . . . . 3.42 108.921 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.563 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -108.4 10.53 27.46 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.455 -1.313 . . . . 0.02 107.455 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.0 mtt 61.34 22.56 12.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.619 -0.676 . . . . 0.02 110.714 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.14 144.55 46.92 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.648 -1.381 . . . . 0.02 109.648 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.71 -30.75 41.06 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.725 -1.213 . . . . 0.98 107.725 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -157.38 -171.52 3.63 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.374 -1.713 . . . . 0.02 106.374 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -98.93 28.3 4.45 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.607 -1.308 . . . . 0.02 110.72 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.472 ' NH2' ' OE2' ' A' ' 50' ' ' GLU . 80.1 mtm180 -96.44 122.56 39.47 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.916 -1.115 . . . . 3.2 111.011 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.5 mt -142.71 119.49 11.18 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.791 -1.189 . . . . 2.61 107.791 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.4 -17.79 10.32 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 121.167 -0.958 . . . . 0.02 112.416 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 92.9 p -156.19 156.15 33.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.165 -1.786 . . . . 0.02 110.495 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.8 p -145.26 148.43 33.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.693 -0.629 . . . . 0.02 109.706 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.465 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.9 mtp180 -137.06 141.42 42.42 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.286 -0.884 . . . . 0.01 109.281 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.67 133.03 37.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.843 . . . . 0.43 109.387 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 t -91.72 124.66 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.02 -0.733 . . . . 1.25 109.02 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -91.09 132.11 36.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.852 -1.155 . . . . 1.77 108.202 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -99.09 140.23 33.56 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.775 -0.824 . . . . 1.63 108.775 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.5 m -111.01 123.51 50.34 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.097 -1.075 . . . . 1.08 108.097 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.8 p -114.62 131.96 56.53 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.611 -1.255 . . . . 1.26 107.611 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.9 -48.76 0.01 OUTLIER Glycine 0 N--CA 1.502 3.078 0 C-N-CA 117.698 -2.191 . . . . 0.01 113.329 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.44 -103.79 0.17 Allowed Glycine 0 N--CA 1.485 1.956 0 CA-C-N 119.95 1.875 . . . . 0.01 110.939 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.404 HE22 HH12 ' A' ' 174' ' ' ARG . 64.5 tp60 -119.17 118.94 32.7 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.244 -1.15 . . . . 4.43 110.229 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.39 135.11 53.85 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.234 -0.586 . . . . 2.99 109.532 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -133.73 129.98 37.46 Favored 'General case' 0 N--CA 1.52 3.042 0 CA-C-O 122.224 1.011 . . . . 6.36 113.067 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -130.07 141.26 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-N 115.511 -0.768 . . . . 1.09 110.406 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.64 138.74 54.48 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 107.637 -1.245 . . . . 2.05 107.637 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 m -123.98 145.62 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 O-C-N 120.664 -1.272 . . . . 1.1 111.032 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -120.27 139.61 52.44 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.958 0.885 . . . . 0.73 110.652 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 3.9 tm-20 -69.16 -33.04 72.78 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.766 -0.652 . . . . 0.02 112.073 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.457 ' O ' ' OG ' ' A' ' 128' ' ' SER . 49.4 mttp -114.22 165.57 12.54 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.902 -1.124 . . . . 3.18 110.229 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.38 163.07 46.43 Favored Glycine 0 N--CA 1.492 2.375 0 CA-C-O 122.007 0.781 . . . . 0.01 111.308 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.59 39.51 27.58 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.532 0.682 . . . . 0.01 111.102 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 52.29 56.04 8.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.727 -0.608 . . . . 0.01 111.003 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.617 ' ND2' ' H ' ' A' ' 105' ' ' GLY . 4.9 t-20 -129.08 164.87 22.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.001 -1.111 . . . . 3.15 108.001 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.617 ' H ' ' ND2' ' A' ' 104' ' ' ASN . . . 91.38 -162.64 28.32 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.081 -1.607 . . . . 0.01 109.081 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -75.51 141.79 42.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.919 -1.342 . . . . 0.01 109.126 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 107' ' ' MET . 9.7 tmm? -116.08 142.79 46.34 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.448 0.642 . . . . 0.01 109.546 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -132.08 135.65 46.61 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.166 -1.05 . . . . 2.48 108.166 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.72 133.93 55.42 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.754 -0.592 . . . . 0.01 109.808 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -148.95 148.25 29.57 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.511 1.148 . . . . 1.69 111.365 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.2 p -114.62 7.84 16.14 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.99 -1.005 . . . . 0.01 109.936 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.82 163.48 19.09 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.429 -0.794 . . . . 3.21 111.183 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.04 154.34 42.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.357 -0.839 . . . . 0.01 109.436 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.463 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 51.0 t -126.98 114.6 22.02 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 108.806 -0.812 . . . . 0.01 108.806 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.58 -31.97 5.1 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 120.241 1.122 . . . . 0.01 111.51 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.4 t -142.48 107.67 4.98 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.825 0.822 . . . . 0.02 108.992 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 117' ' ' ILE . 96.7 mt -63.84 -39.31 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.843 -0.535 . . . . 1.83 111.141 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 42.7 ttp -67.37 -37.54 83.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.202 -0.999 . . . . 1.34 110.014 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -69.88 -38.98 76.53 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.504 -1.372 . . . . 2.11 109.852 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.463 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.9 tt0 -79.82 -47.08 15.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.233 -0.917 . . . . 2.08 112.455 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -110.76 -0.13 17.14 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.365 -0.834 . . . . 0.02 112.655 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 m80 59.33 33.06 22.33 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.738 -1.226 . . . . 0.02 109.272 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.27 135.59 52.76 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 108.652 -0.869 . . . . 0.02 108.652 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -92.56 -23.48 19.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 5.32 110.501 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -149.51 163.78 36.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.207 -0.933 . . . . 0.02 110.028 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.1 mt -131.79 129.68 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 107.427 -1.324 . . . . 2.17 107.427 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -106.07 -13.89 15.32 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.105 -0.997 . . . . 0.02 113.098 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 2.2 p -157.63 156.29 31.57 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.486 -1.384 . . . . 0.01 108.242 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.612 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 18.4 p -164.0 146.91 9.52 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.446 -1.409 . . . . 1.22 109.663 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -121.51 111.48 17.31 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.153 0.977 . . . . 1.41 108.532 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.51 122.9 64.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.054 -1.832 . . . . 0.01 106.054 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.98 69.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 118.12 -1.432 . . . . 1.98 108.391 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.37 108.32 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 106.852 -1.536 . . . . 0.01 106.852 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.68 -174.27 45.95 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.876 -1.29 . . . . 0.01 109.876 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 m -110.47 145.6 37.39 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.364 -1.08 . . . . 2.3 108.901 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -131.54 145.35 51.69 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.48 -0.762 . . . . 0.01 110.58 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.8 141.88 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 107.519 -1.289 . . . . 1.69 107.519 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.18 143.62 44.52 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 107.657 -1.238 . . . . 2.49 107.657 177.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.1 m-85 -121.51 143.9 49.01 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.79 -0.819 . . . . 0.02 108.79 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.432 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 3.0 tm-20 -73.86 -29.9 62.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.705 -0.622 . . . . 0.02 111.525 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.42 152.84 47.42 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 120.666 -1.272 . . . . 1.48 108.989 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.07 170.61 0.47 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.213 1.276 . . . . 0.02 112.502 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.632 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER 57.93 31.13 20.17 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.18 -0.918 . . . . 0.75 110.996 178.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 56.54 47.64 18.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.608 -0.682 . . . . 0.02 110.501 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -120.93 163.46 18.2 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.578 -0.702 . . . . 0.02 109.848 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.39 -165.77 31.49 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.971 -1.251 . . . . 0.02 109.971 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -68.06 142.57 55.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.551 -0.97 . . . . 0.02 109.14 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -118.26 148.43 42.43 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.43 -0.582 . . . . 0.02 109.43 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -129.41 142.43 50.8 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.7 tt -97.41 121.33 39.18 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.384 -0.823 . . . . 0.01 109.333 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.584 ' CD1' ' HE1' ' A' ' 162' ' ' TRP . 17.0 mt -107.06 138.01 44.04 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.563 -0.711 . . . . 0.01 110.957 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 154' ' ' LYS . 31.8 t70 -110.21 168.98 9.04 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.174 -1.047 . . . . 2.27 108.174 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -53.02 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.845 -1.159 . . . . 1.84 108.834 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 152' ' ' ASP . 92.6 mttt -136.57 168.53 19.31 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.114 0.959 . . . . 2.28 111.584 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -113.1 109.03 18.13 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.152 -1.055 . . . . 0.01 108.152 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.55 114.45 28.1 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.11 -0.994 . . . . 0.01 110.253 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -92.48 -25.99 18.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.199 -0.938 . . . . 0.01 111.319 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -125.75 152.96 73.1 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 120.956 -1.09 . . . . 2.54 108.583 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -60.27 -42.2 44.26 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 CA-C-N 119.377 0.813 . . . . 0.7 110.408 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.7 t -60.28 -21.24 22.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.625 -1.297 . . . . 0.86 108.443 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 43.1 t0 -66.24 -16.04 63.68 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.143 -1.023 . . . . 0.02 109.255 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.612 ' CZ2' ' SG ' ' A' ' 129' ' ' CYS . 0.0 OUTLIER -92.97 7.33 44.46 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.892 -1.151 . . . . 0.02 107.892 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.4 9.42 85.89 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.417 -1.473 . . . . 0.02 109.417 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.3 142.43 30.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.63 -0.923 . . . . 0.02 110.142 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.26 -8.23 59.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.708 -0.62 . . . . 0.59 109.553 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.473 ' HG ' ' H ' ' A' ' 168' ' ' ALA . 2.0 t -144.41 151.15 50.27 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.969 -1.082 . . . . 0.87 108.289 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.55 22.11 0.46 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 120.774 0.982 . . . . 0.38 112.369 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.473 ' H ' ' HG ' ' A' ' 166' ' ' SER . . . -83.73 122.23 28.36 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.488 1.137 . . . . 0.18 111.79 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.5 mm -142.15 125.67 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 106.004 -1.85 . . . . 3.99 106.004 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 13.5 mp0 -112.66 -22.14 10.9 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.958 -1.089 . . . . 5.17 112.852 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 34.1 t -156.45 159.65 38.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.327 -2.108 . . . . 0.02 110.044 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.404 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.3 p90 -152.85 153.97 34.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.031 -1.043 . . . . 2.02 110.778 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -145.52 152.05 39.13 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.226 -0.921 . . . . 0.01 110.458 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.404 HH12 HE22 ' A' ' 92' ' ' GLN . 32.2 ptt180 -88.04 142.82 27.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.6 -0.688 . . . . 0.01 109.397 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.28 128.62 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.215 -0.928 . . . . 3.04 108.999 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.01 146.35 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.244 -0.91 . . . . 1.89 109.545 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 4.89 109.654 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 109.412 -1.475 . . . . 0.01 109.412 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -153.85 138.48 16.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.239 -1.154 . . . . 0.02 109.605 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -130.06 140.54 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 109.473 -0.566 . . . . 0.02 109.473 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.2 130.14 53.55 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.482 -0.761 . . . . 0.39 109.993 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -110.32 140.27 44.67 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.645 -0.659 . . . . 0.02 109.384 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.5 m-85 -121.93 138.14 54.52 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.162 -0.961 . . . . 0.02 109.617 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 66.6 mt-10 -69.51 -27.6 65.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.054 . . . . 0.03 111.814 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 12.4 t70 -113.93 169.86 8.7 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.829 -1.169 . . . . 0.03 110.115 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.451 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 24.8 mtp180 -75.36 158.12 33.24 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.542 0.687 . . . . 0.03 110.13 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.7 m120 66.23 35.01 6.22 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.774 0.797 . . . . 0.74 110.905 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.3 p90 49.85 44.65 25.16 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.688 0.756 . . . . 0.02 111.316 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -112.86 165.89 11.9 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.064 -1.088 . . . . 0.02 108.064 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.9 -167.47 34.79 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.808 -1.187 . . . . 0.03 110.684 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -68.69 141.92 55.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.515 -0.991 . . . . 2.76 109.152 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -122.95 150.16 43.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.535 -0.728 . . . . 1.89 110.212 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -136.62 133.47 36.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.776 -0.577 . . . . 0.02 109.473 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -109.48 135.91 49.74 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.882 -0.785 . . . . 1.12 108.882 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 45.9 t -127.85 138.43 52.69 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.582 -0.699 . . . . 0.02 109.778 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 14.8 p30 -119.2 11.66 12.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.572 -0.705 . . . . 0.2 110.372 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 21.3 p -159.58 173.58 15.91 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.797 -1.189 . . . . 1.23 109.097 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 9.0 p30 -62.91 145.92 54.09 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.766 -1.208 . . . . 0.02 110.748 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.562 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 19.4 t -134.54 118.68 17.55 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.096 -0.705 . . . . 0.02 109.096 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.19 -21.79 53.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.85 . . . . 0.24 111.697 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -153.82 105.86 2.81 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.893 -1.129 . . . . 1.14 109.82 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.562 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -102.69 8.07 39.64 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.267 -0.896 . . . . 6.37 110.272 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -60.14 -27.69 67.27 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -0.83 . . . . 3.11 111.829 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.0 p -76.32 -16.82 59.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.512 -1.368 . . . . 0.88 111.153 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -106.81 -21.07 13.14 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.287 -0.883 . . . . 0.02 110.644 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 mt -148.77 127.81 12.77 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.959 -1.088 . . . . 3.32 109.399 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.0 t -86.77 -11.8 49.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.647 -0.658 . . . . 0.02 110.582 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -172.03 161.8 5.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.012 -1.055 . . . . 0.02 108.265 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 p -143.79 116.38 8.65 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.044 -1.035 . . . . 0.02 108.835 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.661 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -108.11 -0.77 20.9 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.708 -1.245 . . . . 0.03 111.645 -178.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -154.88 154.04 32.06 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.727 -1.212 . . . . 0.02 107.727 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.2 mt -146.89 147.65 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.902 -1.124 . . . . 0.02 110.728 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.525 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 29.2 ttp180 -123.88 124.69 43.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.119 -1.067 . . . . 0.02 108.119 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.67 113.94 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 106.681 -1.6 . . . . 0.02 106.681 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 69.6 mm-40 -84.75 -34.72 22.79 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.18 -0.608 . . . . 3.81 110.414 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.49 150.55 19.34 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.633 -1.746 . . . . 0.02 110.591 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.74 172.13 48.82 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.25 -1.14 . . . . 0.01 110.25 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 m -118.25 133.86 55.52 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.573 -1.269 . . . . 1.48 107.573 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -126.23 154.61 43.08 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.849 1.309 . . . . 0.02 112.235 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.22 133.76 52.62 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.292 -2.114 . . . . 0.24 105.292 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.88 141.52 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.467 -0.771 . . . . 0.65 109.241 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -120.21 142.59 48.86 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.028 0.918 . . . . 0.02 109.467 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' ND1' ' A' ' 57' ' ' HIS . 35.6 tt0 -65.54 -33.66 76.43 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.62 -0.718 . . . . 0.02 111.915 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 51' ' ' ARG . 0.6 OUTLIER -124.43 157.59 64.45 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 120.926 -1.109 . . . . 0.02 109.383 -178.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.03 166.08 1.06 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.667 1.578 . . . . 0.02 112.728 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 m120 63.66 36.77 10.6 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.362 -0.835 . . . . 0.02 111.12 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.487 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.4 m-85 45.06 51.32 8.94 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.636 0.732 . . . . 3.39 110.747 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 97.1 p -125.54 163.41 22.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.275 0.559 . . . . 2.33 109.837 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.4 -161.41 31.26 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.756 -1.338 . . . . 0.02 109.756 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.516 ' ND1' ' OE1' ' A' ' 50' ' ' GLU . 7.2 m170 -64.43 138.54 58.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.006 -1.291 . . . . 0.02 110.259 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.1 ppp? -119.27 137.44 53.67 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.294 0.569 . . . . 5.01 109.5 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -135.32 139.68 44.51 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.421 -0.799 . . . . 0.02 109.821 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.7 mm -94.27 130.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.831 -0.803 . . . . 1.72 108.831 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.6 110.75 35.2 Favored Pre-proline 0 N--CA 1.506 2.332 0 O-C-N 121.349 -0.844 . . . . 0.02 110.675 -178.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -78.11 169.42 20.37 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 119.869 0.989 . . . . 1.47 110.442 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.53 141.6 24.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.934 -1.104 . . . . 4.25 110.607 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.06 -178.0 31.19 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 119.608 -1.282 . . . . 0.02 110.967 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -119.83 131.4 55.28 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.601 -0.94 . . . . 0.96 109.712 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 50.2 m-85 -121.8 94.84 48.16 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.974 -1.121 . . . . 0.02 107.974 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.84 -4.31 11.03 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 120.908 1.072 . . . . 0.02 113.678 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -157.16 153.96 28.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.611 -1.305 . . . . 2.02 108.143 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -59.53 -38.94 82.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.526 -0.734 . . . . 0.02 111.98 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -59.87 -23.95 63.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.107 -0.995 . . . . 0.02 110.475 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -70.59 -18.69 62.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.883 -0.784 . . . . 3.42 108.883 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.565 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.7 t90 -108.1 10.59 28.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.528 -1.286 . . . . 0.02 107.528 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 73' ' ' MET . 1.5 mpt? 59.34 22.85 11.26 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.502 0.668 . . . . 0.02 110.456 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.34 144.72 45.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.34 -1.504 . . . . 0.02 109.34 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.9 tp -79.31 -30.52 42.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.026 -1.279 . . . . 0.98 107.745 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -157.35 -171.81 3.75 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.475 -1.676 . . . . 0.02 106.475 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.425 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 78.5 m-20 -98.15 28.21 4.16 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.708 -1.245 . . . . 0.02 110.718 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -98.27 123.35 42.31 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.08 -1.013 . . . . 3.2 111.598 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -142.64 120.07 11.66 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.26 -1.385 . . . . 2.61 107.26 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.67 -18.04 10.55 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 121.208 -0.932 . . . . 0.02 112.392 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.538 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 39.6 t -155.63 156.27 34.72 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-N 119.722 1.761 . . . . 0.02 110.816 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.538 ' N ' ' HG ' ' A' ' 81' ' ' SER . 29.0 p -145.49 147.63 32.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.553 -0.717 . . . . 0.02 110.178 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.413 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.5 mtp180 -136.88 141.72 42.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.542 -0.724 . . . . 0.01 109.116 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 132.71 37.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.074 -1.016 . . . . 0.43 109.254 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -91.35 124.58 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.922 -0.77 . . . . 1.25 108.922 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -91.98 130.9 37.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.817 -1.177 . . . . 1.77 108.402 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mt -96.11 138.84 33.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.92 -1.141 . . . . 1.63 107.92 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.0 t -110.41 126.05 53.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.375 -0.828 . . . . 1.08 108.774 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.7 t -102.37 -154.79 0.5 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 106.109 -1.812 . . . . 1.26 106.109 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.69 -50.66 0.84 Allowed Glycine 0 N--CA 1.497 2.746 0 O-C-N 120.486 -1.383 . . . . 0.01 111.977 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.18 -99.59 0.13 Allowed Glycine 0 N--CA 1.488 2.154 0 C-N-CA 118.662 -1.732 . . . . 0.01 112.172 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -120.08 119.89 34.66 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.298 -1.119 . . . . 4.43 110.707 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.16 137.95 57.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.835 -0.541 . . . . 2.99 109.559 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.405 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 19.7 ttpp -136.88 130.16 31.29 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 120.915 -1.115 . . . . 6.36 112.973 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.53 141.79 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.535 -0.757 . . . . 1.09 110.35 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 1.3 pt20 -124.69 139.77 53.55 Favored 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 107.666 -1.235 . . . . 2.05 107.666 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.49 146.08 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 O-C-N 120.586 -1.321 . . . . 1.1 111.123 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -120.48 139.99 52.07 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 122.259 1.028 . . . . 0.73 110.855 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -68.08 -32.35 72.62 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.731 -0.668 . . . . 0.02 111.73 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -114.26 167.38 10.75 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.032 -1.042 . . . . 3.18 110.347 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.36 163.81 52.72 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.857 -0.897 . . . . 0.01 110.857 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 58.05 38.29 26.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.986 -0.714 . . . . 0.01 111.618 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 14.9 m-85 52.63 54.76 10.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.417 -0.802 . . . . 0.01 111.234 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -128.1 164.87 21.48 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.957 -1.127 . . . . 3.15 107.957 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.3 -162.21 29.39 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.146 -1.582 . . . . 0.01 109.146 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -75.93 141.37 42.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.817 -1.402 . . . . 0.01 109.179 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.1 tmm? -116.38 143.13 45.95 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.519 0.676 . . . . 0.01 109.566 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -132.23 135.9 46.62 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.315 -0.994 . . . . 2.48 108.315 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -117.01 134.15 55.11 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.68 -0.638 . . . . 0.01 109.715 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -149.11 148.8 30.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.87 -1.144 . . . . 1.69 111.318 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 p -114.88 7.79 15.79 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.1 -0.955 . . . . 0.01 109.829 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -122.26 163.12 20.2 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.614 -0.679 . . . . 3.21 111.227 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.88 155.78 40.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.405 -0.809 . . . . 0.01 109.823 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.494 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 63.3 m -129.55 116.72 18.46 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 109.043 -0.725 . . . . 0.01 109.043 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.83 -30.74 7.16 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.343 1.158 . . . . 0.01 111.49 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.6 m -142.83 108.68 5.15 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.856 0.836 . . . . 0.02 109.195 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.98 -39.96 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.873 -0.517 . . . . 1.83 111.057 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.7 ttp -66.38 -37.89 86.3 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.198 -1.001 . . . . 1.34 109.808 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.77 -38.42 76.71 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.537 -1.352 . . . . 2.11 109.696 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.427 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 9.2 tt0 -80.11 -47.64 14.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.91 . . . . 2.08 112.415 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.427 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 80.6 m-85 -111.06 -0.41 16.64 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.354 -0.841 . . . . 0.02 112.848 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 m80 59.68 33.61 21.95 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.799 -1.188 . . . . 0.02 109.463 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 mt -112.46 135.35 53.26 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.579 -0.897 . . . . 0.02 108.579 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -92.68 -23.18 19.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -0.901 . . . . 5.32 110.557 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -148.93 163.37 37.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.163 -0.96 . . . . 0.02 109.949 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 126' ' ' ILE . 53.8 mt -131.56 129.33 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 107.523 -1.288 . . . . 2.17 107.523 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -107.11 -13.11 15.25 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.177 -0.952 . . . . 0.02 112.971 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.518 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.88 153.5 29.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.339 -1.476 . . . . 0.01 108.297 178.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.1 t -163.36 145.43 9.82 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.317 -1.49 . . . . 1.22 109.757 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -122.45 112.73 18.42 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.248 1.023 . . . . 1.41 109.061 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.63 122.63 63.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 105.924 -1.88 . . . . 0.01 105.924 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 t -146.02 64.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 117.974 -1.491 . . . . 1.98 108.971 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.405 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.2 tp10 176.14 108.83 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.641 -1.615 . . . . 0.01 106.641 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.721 ' H ' ' HZ3' ' A' ' 153' ' ' LYS . . . 72.55 -173.1 47.38 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.115 -1.194 . . . . 0.01 110.115 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.413 ' H ' ' HG1' ' A' ' 135' ' ' THR . 1.0 OUTLIER -111.25 142.94 42.8 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.318 -1.107 . . . . 2.3 109.043 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -129.42 145.17 51.45 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.458 -0.776 . . . . 0.01 109.849 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.9 mt -118.46 142.78 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.892 -1.151 . . . . 1.69 107.892 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.84 144.14 43.99 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 107.542 -1.281 . . . . 2.49 107.542 177.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 8.0 m-85 -123.11 145.2 48.77 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.069 -0.715 . . . . 0.02 109.069 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -73.72 -30.06 62.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.628 -0.67 . . . . 0.02 112.043 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.33 153.83 47.51 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 120.644 -1.285 . . . . 1.48 109.031 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.35 166.52 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.236 1.291 . . . . 0.02 112.742 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.655 HD21 ' HE ' ' A' ' 145' ' ' ARG . 23.9 t30 59.23 31.86 21.54 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.185 -0.916 . . . . 0.75 111.063 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.404 ' CE1' ' CG ' ' A' ' 173' ' ' ARG . 2.0 m-85 57.42 52.42 8.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.02 111.294 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.655 ' HE ' HD21 ' A' ' 143' ' ' ASN . 94.4 mtt180 -124.88 163.19 22.76 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.424 -0.797 . . . . 0.02 109.706 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.46 -165.29 32.38 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.835 -1.306 . . . . 0.02 109.835 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -67.99 141.47 56.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.531 -0.982 . . . . 0.02 108.863 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -118.2 148.37 42.44 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.379 -0.6 . . . . 0.02 109.379 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.49 142.76 50.7 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.804 -0.813 . . . . 0.01 108.804 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tt -98.18 122.26 41.11 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.268 -0.895 . . . . 0.01 109.245 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.6 mt -105.14 134.21 48.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.435 -0.791 . . . . 0.01 110.141 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 2.6 m-20 -108.35 176.95 4.94 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.504 -0.925 . . . . 2.27 108.504 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.721 ' HZ3' ' H ' ' A' ' 134' ' ' GLY . 45.0 mttm -57.73 83.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 1.84 108.456 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 55.3 mmtt -136.51 167.7 20.86 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.971 0.891 . . . . 2.28 111.659 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -112.92 107.33 15.86 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.7 -1.222 . . . . 0.01 107.7 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.585 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 93.1 m-85 -99.09 115.09 28.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.175 -0.953 . . . . 0.01 110.383 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -93.14 -25.21 17.97 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.263 -0.898 . . . . 0.01 111.356 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -125.87 153.81 73.53 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.047 -1.033 . . . . 2.54 108.701 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.38 -42.04 37.12 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 120.436 0.757 . . . . 0.7 110.645 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.04 -20.12 21.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.666 -1.271 . . . . 0.86 108.869 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -65.34 -15.83 62.96 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.926 -1.109 . . . . 0.02 109.705 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.585 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 1.7 m0 -96.85 11.22 36.55 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.73 85.26 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.489 -1.338 . . . . 0.02 110.249 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.7 141.79 32.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.3 -1.118 . . . . 0.02 110.243 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.34 -8.7 58.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.718 -0.614 . . . . 0.59 109.95 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 t -144.22 150.64 49.27 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.934 -1.104 . . . . 0.87 108.651 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.63 21.21 0.49 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 120.717 0.945 . . . . 0.38 112.484 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.64 121.94 27.48 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.466 1.127 . . . . 0.18 111.393 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.2 mm -143.48 125.66 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 106.048 -1.834 . . . . 3.99 106.048 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -110.94 -20.1 12.56 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.983 -1.073 . . . . 5.17 112.716 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.7 p -158.46 161.97 37.48 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 119.558 -1.964 . . . . 0.02 110.075 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.494 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 8.9 p90 -152.48 153.13 32.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 2.02 110.278 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.404 ' CG ' ' CE1' ' A' ' 144' ' ' TYR . 7.2 mmm180 -143.0 150.08 39.14 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.63 0.729 . . . . 0.01 110.035 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -87.79 142.71 27.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.538 -0.727 . . . . 0.01 109.319 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.1 mt -92.59 128.03 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.065 -1.022 . . . . 3.04 109.021 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.07 146.39 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.247 -0.908 . . . . 1.89 109.546 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 4.89 109.402 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.493 -1.443 . . . . 0.01 109.493 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' NZ ' ' CB ' ' A' ' 6' ' ' LYS . 5.5 ttpm? -152.3 137.61 17.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.18 -1.188 . . . . 0.02 109.978 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.6 139.95 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.302 -0.629 . . . . 0.02 109.302 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -121.04 130.41 53.77 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.484 -0.76 . . . . 0.39 110.183 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.8 m-85 -110.63 140.15 45.23 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.603 -0.686 . . . . 0.02 109.498 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.3 m-85 -122.98 138.7 54.62 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.182 -0.949 . . . . 0.02 109.921 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 41.9 mm-40 -68.54 -28.13 66.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.047 . . . . 0.03 111.742 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -114.49 170.01 8.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.917 -1.114 . . . . 0.03 110.214 -179.514 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -75.5 158.54 32.43 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.574 0.702 . . . . 0.03 110.051 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.604 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.4 m120 66.06 35.02 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.919 0.866 . . . . 0.74 110.88 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.604 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.9 p90 49.93 44.67 25.4 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.502 -0.772 . . . . 0.02 111.47 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -112.26 166.16 11.53 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.005 -1.109 . . . . 0.02 108.005 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.28 -167.81 36.19 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.792 -1.194 . . . . 0.03 110.478 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -68.43 142.5 55.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.41 -1.053 . . . . 2.76 109.142 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -121.99 149.5 43.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.596 -0.69 . . . . 1.89 110.115 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -135.81 132.24 36.43 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.372 -0.603 . . . . 0.02 109.372 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.07 135.83 49.59 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.859 -0.793 . . . . 1.12 108.859 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 48.2 t -127.34 138.02 52.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.603 -0.686 . . . . 0.02 109.704 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.496 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 23.4 t0 -119.37 11.31 12.17 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.622 -0.674 . . . . 0.2 110.552 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.7 m -158.99 173.51 16.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.791 -1.193 . . . . 1.23 109.002 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.06 146.27 53.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.74 -1.225 . . . . 0.02 110.706 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.548 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 12.2 t -134.52 118.46 17.33 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.018 -0.734 . . . . 0.02 109.018 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.18 -21.44 53.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.814 . . . . 0.24 111.682 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -154.51 106.17 2.71 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.876 -1.14 . . . . 1.14 109.727 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.548 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.83 8.2 41.41 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.336 -0.853 . . . . 6.37 110.105 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -60.45 -28.66 68.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 3.11 112.046 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 p -76.22 -17.7 59.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.404 -1.435 . . . . 0.88 111.176 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -106.94 -21.08 13.13 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.309 -0.869 . . . . 0.02 110.268 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -147.32 126.42 12.91 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.217 -0.927 . . . . 3.32 108.909 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t -86.65 -11.33 51.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.658 -0.652 . . . . 0.02 110.374 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 33.2 ttt180 -171.47 161.67 6.38 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.057 -1.09 . . . . 0.02 108.057 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -144.15 116.59 8.57 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.764 -1.21 . . . . 0.02 108.886 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 -110.12 0.19 18.21 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.767 -1.208 . . . . 0.03 112.132 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.4 t -155.64 153.75 30.54 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.047 -1.094 . . . . 0.02 108.047 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.47 146.81 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.274 1.035 . . . . 0.02 111.049 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -122.86 123.93 42.11 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.535 -1.283 . . . . 0.02 107.535 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.1 t -105.25 113.87 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.777 -1.564 . . . . 0.02 106.777 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -84.66 -35.43 22.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.69 -0.631 . . . . 3.81 110.174 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.54 150.96 20.63 Favored Glycine 0 N--CA 1.487 2.086 0 C-N-CA 118.447 -1.835 . . . . 0.02 110.701 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.7 172.06 48.74 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.347 -1.101 . . . . 0.01 110.347 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.9 m -117.55 133.67 55.71 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.552 -1.277 . . . . 1.48 107.552 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -126.29 154.57 43.24 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.724 1.249 . . . . 0.02 112.223 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.3 133.79 52.61 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.337 -2.097 . . . . 0.24 105.337 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.92 141.16 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.519 -0.738 . . . . 0.65 109.34 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.538 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 27.5 m-85 -120.08 142.62 48.71 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.064 0.935 . . . . 0.02 109.556 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.41 -33.93 77.11 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.526 -0.761 . . . . 0.02 111.855 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -124.85 157.86 64.79 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.92 -1.113 . . . . 0.02 109.58 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.38 166.96 0.96 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.633 1.556 . . . . 0.02 112.824 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 63.28 36.52 11.71 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.258 -0.883 . . . . 0.02 111.084 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.7 m-85 45.31 51.48 9.36 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.71 0.767 . . . . 3.39 110.788 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 p -125.94 163.6 22.62 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.287 0.565 . . . . 2.33 109.954 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.64 -161.79 31.21 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.788 -1.325 . . . . 0.02 109.788 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -64.57 138.62 58.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.257 . . . . 0.02 110.299 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.538 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 47.5 ttp -119.43 137.01 54.04 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.229 0.538 . . . . 5.01 109.635 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 84.4 m-85 -135.0 140.15 45.43 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.483 -0.761 . . . . 0.02 109.862 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -94.49 130.58 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.773 -0.825 . . . . 1.72 108.773 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.548 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -121.08 111.07 34.16 Favored Pre-proline 0 N--CA 1.506 2.372 0 O-C-N 121.37 -0.832 . . . . 0.02 110.744 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -77.86 169.44 20.63 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 CA-C-N 119.81 0.968 . . . . 1.47 110.557 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -53.6 141.04 26.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.95 -1.094 . . . . 4.25 110.618 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.91 -177.39 32.21 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.447 -1.359 . . . . 0.02 110.834 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -119.41 131.02 55.58 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.516 -0.99 . . . . 0.96 109.668 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.548 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 74.9 m-85 -121.54 97.42 46.93 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.814 -1.18 . . . . 0.02 107.814 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -69.93 -3.62 12.5 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 120.76 0.973 . . . . 0.02 113.766 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -157.28 154.17 28.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.523 -1.36 . . . . 2.02 108.043 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -59.83 -38.72 82.85 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.617 -0.677 . . . . 0.02 111.755 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.62 -24.65 65.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -0.967 . . . . 0.02 110.258 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -68.54 -17.9 64.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.276 -0.89 . . . . 3.42 109.067 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.562 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.5 11.66 26.68 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.754 -1.202 . . . . 0.02 107.754 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 mtp 60.91 22.2 12.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.491 -0.756 . . . . 0.02 110.313 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.14 144.9 46.79 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.615 -1.394 . . . . 0.02 109.615 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.86 -30.63 40.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.134 -1.215 . . . . 0.98 107.843 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -156.96 -171.66 3.74 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.478 -1.675 . . . . 0.02 106.478 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -98.54 28.06 4.42 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.752 -1.218 . . . . 0.02 110.671 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -96.61 122.92 40.06 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.816 -1.178 . . . . 3.2 111.229 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.8 mt -142.5 119.88 11.62 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.931 -1.137 . . . . 2.61 107.931 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.86 -18.37 8.94 Favored Glycine 0 N--CA 1.5 2.911 0 O-C-N 121.193 -0.942 . . . . 0.02 112.627 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.442 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 13.2 t -155.75 156.19 34.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.038 -1.86 . . . . 0.02 111.091 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.1 p -146.04 147.99 32.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.514 -0.741 . . . . 0.02 110.335 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.422 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 47.8 mtm180 -136.97 142.02 42.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.482 -0.761 . . . . 0.01 109.13 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.7 131.97 36.82 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.128 -0.983 . . . . 0.43 109.307 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 t -90.66 124.63 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.882 -0.784 . . . . 1.25 108.882 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -92.33 131.35 37.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.893 -1.129 . . . . 1.77 108.583 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -96.4 139.08 33.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.158 -1.053 . . . . 1.63 108.158 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.1 t -110.83 126.61 54.83 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 1.08 108.906 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 m -103.02 -154.62 0.5 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.207 -1.775 . . . . 1.26 106.207 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.43 -50.68 0.83 Allowed Glycine 0 N--CA 1.498 2.774 0 O-C-N 120.454 -1.404 . . . . 0.01 112.213 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.53 -99.75 0.13 Allowed Glycine 0 N--CA 1.487 2.088 0 C-N-CA 118.79 -1.671 . . . . 0.01 112.076 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -119.99 119.59 33.88 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.142 -1.211 . . . . 4.43 110.642 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.26 135.56 54.62 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.253 -0.579 . . . . 2.99 109.541 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.504 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 52.5 tttp -135.33 131.23 36.18 Favored 'General case' 0 N--CA 1.519 2.985 0 CA-C-O 122.136 0.969 . . . . 6.36 113.066 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.39 142.78 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.737 0.779 . . . . 1.09 110.642 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.495 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.0 pt20 -124.68 139.76 53.56 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 107.581 -1.266 . . . . 2.05 107.581 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.33 146.29 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 O-C-N 120.596 -1.315 . . . . 1.1 111.182 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 24.9 m-85 -120.42 139.79 52.31 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.97 0.89 . . . . 0.73 110.769 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -68.02 -32.49 72.91 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.694 -0.684 . . . . 0.02 112.145 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -114.85 166.24 11.99 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.054 -1.029 . . . . 3.18 110.403 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.48 163.58 46.11 Favored Glycine 0 N--CA 1.492 2.382 0 CA-C-O 122.072 0.818 . . . . 0.01 111.243 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.3 m-20 57.15 39.33 29.02 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.636 0.732 . . . . 0.01 111.071 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 52.38 56.39 7.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.555 -0.715 . . . . 0.01 110.971 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -129.5 165.57 21.38 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.02 -1.104 . . . . 3.15 108.02 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.3 -162.91 28.6 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.222 -1.551 . . . . 0.01 109.222 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -76.04 142.14 41.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.927 -1.337 . . . . 0.01 108.947 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.54 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.4 ttp -116.64 143.34 45.75 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.626 0.727 . . . . 0.01 109.694 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -131.74 136.22 47.43 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.138 -1.06 . . . . 2.48 108.138 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.504 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 44.7 tt0 -115.89 134.05 55.39 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.695 -0.628 . . . . 0.01 109.62 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.57 148.7 28.99 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.519 1.152 . . . . 1.69 111.525 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.8 p -115.24 8.14 15.43 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.863 -1.062 . . . . 0.01 110.295 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -121.97 163.26 19.64 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.359 -0.838 . . . . 3.21 111.308 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.01 155.05 41.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.501 -0.749 . . . . 0.01 109.414 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 32.8 m -128.87 116.93 19.25 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.589 -0.694 . . . . 0.01 109.156 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -74.96 -31.47 6.26 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 CA-C-N 120.386 1.173 . . . . 0.01 111.424 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.0 t -142.65 108.76 5.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.361 -0.837 . . . . 0.02 109.298 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.63 -39.51 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.795 -0.565 . . . . 1.83 110.731 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.81 -37.77 85.17 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.265 -0.974 . . . . 1.34 109.936 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -69.76 -38.65 76.83 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.595 -1.316 . . . . 2.11 109.778 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -79.93 -47.4 15.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.228 -0.92 . . . . 2.08 112.456 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -111.03 -0.29 16.7 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.396 -0.815 . . . . 0.02 112.662 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.488 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.7 m-70 59.77 33.14 21.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.79 -1.194 . . . . 0.02 109.464 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 mt -112.33 135.59 52.83 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.684 -0.858 . . . . 0.02 108.684 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -91.7 -22.83 20.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 5.32 110.473 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -149.44 164.06 36.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.152 -0.968 . . . . 0.02 109.858 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 126' ' ' ILE . 55.9 mt -131.54 129.27 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 107.289 -1.374 . . . . 2.17 107.289 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -107.71 -13.52 15.01 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.243 -0.911 . . . . 0.02 113.184 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -154.5 152.1 29.71 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.47 -1.394 . . . . 0.01 108.19 178.234 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.6 t -161.52 145.14 12.68 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.286 -1.509 . . . . 1.22 109.849 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -119.56 108.53 14.61 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.155 0.979 . . . . 1.41 108.486 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 t -107.5 120.49 58.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 105.797 -1.927 . . . . 0.01 105.797 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.41 68.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 C-N-CA 118.199 -1.401 . . . . 1.98 108.384 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.64 108.18 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.501 -1.666 . . . . 0.01 106.501 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.87 -174.03 43.8 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.899 -1.28 . . . . 0.01 109.899 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.5 m -111.69 145.51 39.14 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.335 -1.097 . . . . 2.3 109.191 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -130.6 146.27 52.07 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.492 -0.755 . . . . 0.01 110.492 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.6 mt -118.46 142.17 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 107.83 -1.174 . . . . 1.69 107.83 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -115.06 144.41 43.68 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 107.647 -1.242 . . . . 2.49 107.647 177.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.4 m-85 -122.42 145.08 48.62 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.657 -0.868 . . . . 0.02 108.657 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.29 -29.47 61.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.685 -0.634 . . . . 0.02 112.137 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.24 153.79 47.39 Favored Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 120.703 -1.248 . . . . 1.48 109.216 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.37 166.67 1.64 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.132 1.221 . . . . 0.02 112.47 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.4 m120 59.72 31.15 20.69 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.172 -0.922 . . . . 0.75 111.127 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 57.85 51.47 9.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.576 -0.703 . . . . 0.02 111.083 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -124.83 163.63 21.75 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.496 -0.753 . . . . 0.02 109.908 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.03 -165.51 31.79 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.91 -1.276 . . . . 0.02 109.91 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -67.67 141.66 56.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.435 -1.038 . . . . 0.02 108.846 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -117.98 148.18 42.46 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.375 -0.602 . . . . 0.02 109.375 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.456 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.5 t80 -129.69 143.72 50.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.057 -0.72 . . . . 0.01 109.057 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.1 tt -98.11 121.46 40.06 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.183 -0.948 . . . . 0.01 109.294 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.4 mt -105.35 136.43 44.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.01 110.319 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 154' ' ' LYS . 52.4 m-20 -108.19 171.29 7.49 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.702 -0.851 . . . . 2.27 108.702 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -57.69 83.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 1.84 108.748 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 152' ' ' ASP . 5.2 tptm -138.08 168.51 19.58 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.166 -0.959 . . . . 2.28 111.356 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -110.18 110.6 21.51 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.081 -1.081 . . . . 0.01 108.081 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.616 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 97.2 m-85 -100.44 116.35 32.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.134 -0.979 . . . . 0.01 110.089 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 7.5 ptp180 -92.05 -26.19 18.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.305 -0.872 . . . . 0.01 111.579 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -125.42 155.53 71.63 Favored Pre-proline 0 N--CA 1.504 2.245 0 O-C-N 120.741 -1.225 . . . . 2.54 107.866 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -62.79 -40.58 35.22 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.554 0.836 . . . . 0.7 110.473 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.75 -20.3 21.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.823 -1.173 . . . . 0.86 108.931 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 161' ' ' ASP . 4.9 m-20 -65.46 -16.02 63.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.953 -1.092 . . . . 0.02 109.804 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.616 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 2.7 m0 -96.72 10.83 37.57 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.164 -1.05 . . . . 0.02 108.164 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.64 12.08 84.73 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.271 -1.442 . . . . 0.02 109.959 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.42 142.01 32.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.467 -1.019 . . . . 0.02 110.159 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.59 -8.4 58.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.747 -0.596 . . . . 0.59 110.098 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 25.1 p -144.53 150.67 48.29 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.754 -1.216 . . . . 0.87 108.813 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.1 21.35 0.52 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 120.741 0.961 . . . . 0.38 112.19 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.69 123.98 29.79 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.595 1.188 . . . . 0.18 111.57 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 10.3 mm -143.63 124.69 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.463 -1.68 . . . . 3.99 106.463 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -110.33 -22.02 11.92 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.95 -1.094 . . . . 5.17 112.369 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.6 p -157.4 160.17 38.13 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 119.501 -2.0 . . . . 0.02 109.856 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.439 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 23.5 p90 -153.61 155.26 35.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.08 -1.013 . . . . 2.02 110.696 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -145.42 151.95 39.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.239 -0.913 . . . . 0.01 110.62 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -87.85 143.16 27.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.648 -0.658 . . . . 0.01 109.357 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.1 mt -93.42 128.6 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.071 -1.018 . . . . 3.04 108.882 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.95 146.66 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.314 -0.866 . . . . 1.89 109.525 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 4.89 109.493 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 110.495 -1.042 . . . . 0.01 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -153.23 138.6 17.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.483 -1.01 . . . . 0.02 109.603 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tt -130.05 140.56 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.186 0.517 . . . . 0.02 109.632 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -121.84 130.25 53.24 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.332 -0.855 . . . . 0.39 110.247 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.7 m-85 -111.19 140.39 45.79 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.501 -0.75 . . . . 0.02 109.75 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.2 m-85 -122.33 138.54 54.48 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.121 -0.987 . . . . 0.02 109.88 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -69.35 -27.5 65.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.03 111.865 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' O ' ' OG ' ' A' ' 38' ' ' SER . 17.2 t70 -113.82 169.43 9.0 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.818 -1.176 . . . . 0.03 110.23 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -75.6 158.32 32.61 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.695 0.76 . . . . 0.03 110.101 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 66.36 33.31 7.08 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.025 0.917 . . . . 0.74 110.956 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 55.23 41.54 31.32 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.023 -0.535 . . . . 0.02 111.273 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -112.37 165.45 12.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.122 -1.066 . . . . 0.02 108.122 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.13 -167.7 34.64 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.888 -1.148 . . . . 0.03 110.289 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -69.1 143.65 54.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.328 -1.101 . . . . 2.76 109.109 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -120.52 150.05 41.45 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.473 0.654 . . . . 1.89 109.719 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -136.36 131.59 34.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.642 -0.661 . . . . 0.02 109.549 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -109.42 134.91 51.27 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.403 -0.811 . . . . 1.12 108.907 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.2 t -127.35 137.55 52.81 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.126 -0.694 . . . . 0.02 109.126 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.95 11.87 12.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.583 -0.698 . . . . 0.2 110.552 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 p -159.93 173.59 15.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.75 -1.219 . . . . 1.23 109.303 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -63.55 146.41 53.74 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.84 -1.163 . . . . 0.02 110.842 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.43 116.92 16.61 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.922 -0.77 . . . . 0.02 108.922 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.13 -22.23 49.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.206 -0.934 . . . . 0.24 111.373 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 28.2 p-10 -149.58 103.18 3.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.194 -1.039 . . . . 1.14 108.194 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -105.01 3.46 30.61 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.188 0.994 . . . . 6.37 110.866 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -61.13 -25.46 67.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 3.11 112.232 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 t -77.53 -15.01 59.52 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.366 -1.459 . . . . 0.88 111.342 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -105.31 -20.17 13.58 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.199 -0.938 . . . . 0.02 110.442 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 tp -151.29 131.84 13.89 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.07 -1.019 . . . . 3.32 109.64 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.9 m -86.8 -11.89 49.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.66 -0.65 . . . . 0.02 111.021 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -172.91 162.12 4.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.787 -1.196 . . . . 0.02 108.575 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.29 116.68 9.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.177 -0.952 . . . . 0.02 108.681 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -108.65 -0.64 20.06 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.65 -1.281 . . . . 0.03 111.474 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 2.8 p -155.43 153.61 30.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.597 -1.26 . . . . 0.02 107.597 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -147.03 148.56 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.187 -0.946 . . . . 0.02 110.619 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.506 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 60.7 ttt180 -125.41 125.48 43.46 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.94 -1.133 . . . . 0.02 107.94 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 t -105.29 114.79 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.71 -1.589 . . . . 0.02 106.71 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 53.8 mm-40 -84.56 -34.53 23.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.491 -0.756 . . . . 3.81 109.991 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.23 151.29 20.44 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 118.451 -1.833 . . . . 0.02 110.807 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.93 171.45 48.26 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.227 -1.149 . . . . 0.01 110.227 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -118.05 133.73 55.64 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.403 -1.332 . . . . 1.48 107.403 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 39.7 m95 -126.96 154.82 44.06 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.622 1.201 . . . . 0.02 112.19 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.17 133.8 52.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.423 -2.066 . . . . 0.24 105.423 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.95 141.3 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.623 -0.673 . . . . 0.65 109.227 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -120.43 143.0 48.71 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.999 0.904 . . . . 0.02 109.651 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.22 -34.39 78.26 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.599 -0.728 . . . . 0.02 111.826 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -124.84 158.27 63.27 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 120.893 -1.129 . . . . 0.02 109.36 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.54 166.77 1.12 Allowed 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.724 1.616 . . . . 0.02 112.867 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 63.08 37.31 11.66 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.21 -0.905 . . . . 0.02 111.143 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.435 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.0 m-85 44.9 51.92 8.35 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.664 0.745 . . . . 3.39 110.79 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.4 m -125.87 163.5 22.79 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.259 0.552 . . . . 2.33 109.898 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.28 -161.72 31.63 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.842 -1.303 . . . . 0.02 109.842 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 13.0 m170 -64.86 138.46 58.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.061 -1.258 . . . . 0.02 110.227 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.2 ptm -119.23 136.84 54.02 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.24 0.543 . . . . 5.01 109.567 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -134.48 139.68 45.66 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.551 -0.718 . . . . 0.02 109.937 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.2 mm -94.43 130.5 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.932 -0.766 . . . . 1.72 108.932 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.559 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.56 110.69 35.31 Favored Pre-proline 0 N--CA 1.505 2.314 0 O-C-N 121.409 -0.807 . . . . 0.02 110.781 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -78.14 169.21 20.68 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 CA-C-N 119.898 0.999 . . . . 1.47 110.531 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -54.77 140.23 36.84 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.92 -1.112 . . . . 4.25 110.716 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.81 -176.97 33.16 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.506 -1.331 . . . . 0.02 110.517 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -119.29 130.7 55.53 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.287 -1.125 . . . . 0.96 109.853 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.559 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 83.3 m-85 -121.07 96.98 48.26 Favored Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 107.991 -1.114 . . . . 0.02 107.991 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.17 -4.14 13.04 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.76 0.973 . . . . 0.02 113.621 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -157.45 154.62 29.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.705 -1.247 . . . . 2.02 108.114 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -59.61 -39.05 82.98 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.448 -0.783 . . . . 0.02 111.868 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -59.99 -23.76 63.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.061 -1.025 . . . . 0.02 110.44 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -70.74 -18.55 62.78 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.777 0.798 . . . . 3.42 108.918 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.55 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.11 10.18 28.13 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.421 -1.325 . . . . 0.02 107.421 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 mtt 60.83 22.39 12.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.563 -0.711 . . . . 0.02 110.464 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.08 144.76 46.72 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.512 -1.435 . . . . 0.02 109.512 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.493 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 11.9 tp -79.55 -31.08 41.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -1.19 . . . . 0.98 107.888 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 75' ' ' LEU . 16.2 m-80 -157.48 -171.93 3.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.553 -1.647 . . . . 0.02 106.553 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.05 28.31 4.06 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.658 -1.276 . . . . 0.02 110.596 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -97.74 122.75 41.21 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.978 -1.076 . . . . 3.2 111.201 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.9 mt -142.09 119.91 11.92 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.444 -1.317 . . . . 2.61 107.444 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.79 -18.59 9.9 Favored Glycine 0 N--CA 1.498 2.823 0 O-C-N 121.233 -0.917 . . . . 0.02 112.231 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.435 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 17.2 t -155.68 155.97 34.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.112 -1.817 . . . . 0.02 110.68 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.8 p -145.95 148.1 32.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.446 -0.784 . . . . 0.02 110.254 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.417 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 22.2 mtp180 -137.67 142.35 41.13 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.504 -0.747 . . . . 0.01 109.111 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.14 131.75 36.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.207 -0.933 . . . . 0.43 109.478 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -90.49 124.83 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.698 -0.852 . . . . 1.25 108.698 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -91.26 132.25 36.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.969 -1.082 . . . . 1.77 108.319 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mt -99.14 140.47 33.25 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.708 -0.849 . . . . 1.63 108.708 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.6 p -111.18 123.5 50.32 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.096 -1.076 . . . . 1.08 108.096 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 t -114.8 132.62 56.41 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.766 -1.209 . . . . 1.26 107.806 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.48 -47.9 0.01 OUTLIER Glycine 0 N--CA 1.503 3.124 0 C-N-CA 117.754 -2.165 . . . . 0.01 113.465 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.9 -103.38 0.17 Allowed Glycine 0 N--CA 1.486 2.03 0 CA-C-N 120.005 1.902 . . . . 0.01 110.908 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -118.92 118.12 30.66 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.178 -1.19 . . . . 4.43 110.021 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.02 54.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 120.132 -0.627 . . . . 2.99 109.528 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -134.12 130.57 37.57 Favored 'General case' 0 N--CA 1.517 2.905 0 CA-C-O 122.175 0.988 . . . . 6.36 113.115 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -130.46 141.23 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 115.51 -0.768 . . . . 1.09 110.276 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.536 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 10.9 pt20 -124.09 137.73 54.53 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 107.501 -1.296 . . . . 2.05 107.501 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.4 m -123.69 146.6 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.602 0 O-C-N 120.489 -1.382 . . . . 1.1 111.406 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.52 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 64.6 m-85 -119.4 139.17 52.45 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.137 0.97 . . . . 0.73 110.709 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.37 -32.09 71.93 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 115.853 -0.612 . . . . 0.02 111.797 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -114.78 167.52 10.7 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.964 -1.085 . . . . 3.18 110.485 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.27 164.18 52.39 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 111.057 -0.817 . . . . 0.01 111.057 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 t70 57.6 38.36 27.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.968 -0.725 . . . . 0.01 111.479 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.433 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 14.7 m-85 53.09 54.88 9.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.01 111.352 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -129.13 165.02 22.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.253 -1.018 . . . . 3.15 108.253 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.15 -163.21 28.97 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.24 -1.544 . . . . 0.01 109.24 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.428 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 55.0 tt0 -75.86 142.95 42.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.925 -1.338 . . . . 0.01 109.314 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.52 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.9 ttp -117.4 143.35 46.09 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.505 0.669 . . . . 0.01 109.754 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.428 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 54.2 m-85 -131.91 136.31 47.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.222 -1.029 . . . . 2.48 108.222 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -116.7 134.65 54.55 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.737 -0.602 . . . . 0.01 109.849 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -149.54 147.87 28.69 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.39 1.091 . . . . 1.69 111.272 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.6 p -114.3 7.94 16.58 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.049 -0.978 . . . . 0.01 109.996 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -122.18 163.44 19.54 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.439 -0.788 . . . . 3.21 111.186 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 6.7 p30 -69.19 154.81 41.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.01 109.396 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.403 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 51.2 t -126.64 115.18 22.78 Favored Pre-proline 0 N--CA 1.499 2.025 0 N-CA-C 109.009 -0.737 . . . . 0.01 109.009 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -75.41 -32.41 4.96 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 CA-C-N 120.302 1.143 . . . . 0.01 111.406 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -142.45 107.79 5.02 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.842 0.829 . . . . 0.02 108.995 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.416 HD13 HG23 ' A' ' 117' ' ' ILE . 96.8 mt -64.43 -39.43 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.791 -0.568 . . . . 1.83 111.061 -178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.9 ttt -66.78 -37.21 84.13 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.04 -1.064 . . . . 1.34 109.873 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -70.16 -38.7 75.5 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.673 -1.267 . . . . 2.11 109.871 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -80.14 -47.45 14.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.283 -0.886 . . . . 2.08 112.469 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -110.56 -0.42 17.32 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.337 -0.852 . . . . 0.02 112.675 -176.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.574 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.2 m-70 59.78 32.64 21.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.836 -1.165 . . . . 0.02 109.504 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.2 135.75 52.47 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 108.756 -0.831 . . . . 0.02 108.756 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -92.11 -22.92 19.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 5.32 110.425 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -149.55 163.62 37.35 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.132 -0.98 . . . . 0.02 110.134 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.406 HD11 HG23 ' A' ' 126' ' ' ILE . 52.0 mt -131.76 129.48 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 107.125 -1.435 . . . . 2.17 107.125 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.0 -13.07 15.28 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.193 -0.942 . . . . 0.02 113.015 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.433 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -155.82 153.97 30.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.483 -1.386 . . . . 0.01 108.146 177.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 5.0 t -163.07 145.62 10.36 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.181 -1.574 . . . . 1.22 109.683 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -122.29 110.49 15.75 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.423 1.106 . . . . 1.41 108.767 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.81 122.86 64.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.127 -1.805 . . . . 0.01 106.127 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t -146.63 69.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 118.051 -1.46 . . . . 1.98 108.405 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.1 108.94 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.862 -1.533 . . . . 0.01 106.862 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.88 -174.63 46.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.003 -1.239 . . . . 0.01 110.003 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.1 m -111.33 144.98 39.64 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.528 -0.984 . . . . 2.3 109.234 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -131.62 146.84 52.4 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.436 -0.79 . . . . 0.01 110.907 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.4 mt -118.76 141.28 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 107.279 -1.378 . . . . 1.69 107.279 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.6 142.38 46.04 Favored 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 107.549 -1.278 . . . . 2.49 107.549 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 16.7 m-85 -122.94 145.14 48.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.452 -0.78 . . . . 0.02 109.213 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -74.69 -29.7 61.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.643 -0.66 . . . . 0.02 112.08 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.29 153.41 47.45 Favored Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 120.639 -1.288 . . . . 1.48 109.074 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -54.24 166.85 1.47 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.315 1.344 . . . . 0.02 112.41 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.584 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.0 OUTLIER 59.43 31.24 20.92 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.062 -0.972 . . . . 0.75 111.081 178.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.3 m-85 58.1 51.38 8.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.548 -0.72 . . . . 0.02 110.981 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.93 164.01 21.02 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.47 -0.769 . . . . 0.02 109.896 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.37 -165.41 32.57 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.975 -1.25 . . . . 0.02 109.975 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -67.73 141.6 56.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.549 -0.971 . . . . 0.02 108.78 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.1 mp0 -118.52 148.46 42.61 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.219 0.533 . . . . 0.02 109.606 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.95 142.19 51.32 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.61 -0.885 . . . . 0.01 108.61 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.9 tt -96.28 119.79 35.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.117 -0.99 . . . . 0.01 108.678 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.8 mt -104.29 135.23 46.14 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.527 -0.733 . . . . 0.01 109.985 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 154' ' ' LYS . 1.9 m-20 -110.91 172.8 6.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.356 -0.84 . . . . 2.27 108.867 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -55.04 85.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.161 -0.962 . . . . 1.84 108.635 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 152' ' ' ASP . 19.5 mmtp -137.16 166.48 23.62 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 2.28 111.594 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 6.6 mp0 -112.35 107.47 16.31 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.51 -1.293 . . . . 0.01 107.51 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.625 ' CE2' ' NE1' ' A' ' 162' ' ' TRP . 94.2 m-85 -99.54 113.42 25.81 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.0 -1.063 . . . . 0.01 110.581 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -91.62 -28.18 17.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.329 -0.857 . . . . 0.01 111.392 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 158' ' ' LYS . 8.0 mtmp? -126.46 151.42 72.71 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 120.819 -1.175 . . . . 2.54 108.384 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -58.62 -45.62 28.69 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.352 0.804 . . . . 0.7 111.346 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 t -61.21 -22.56 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.726 -1.234 . . . . 0.86 109.696 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -65.57 -15.69 62.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.723 -1.236 . . . . 0.02 109.928 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.625 ' NE1' ' CE2' ' A' ' 156' ' ' TYR . 0.0 OUTLIER -97.46 11.36 37.02 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.618 -0.882 . . . . 0.02 108.618 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.95 9.27 87.05 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.555 -1.307 . . . . 0.02 110.421 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.2 142.34 30.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.396 -1.061 . . . . 0.02 110.075 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.36 -9.69 57.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.752 -0.592 . . . . 0.59 110.168 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 42.1 m -146.08 150.76 43.0 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 120.648 -1.283 . . . . 0.87 108.928 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.59 21.74 0.55 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.903 1.069 . . . . 0.38 112.397 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.93 125.56 31.52 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.556 1.169 . . . . 0.18 112.063 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.0 mt -145.94 125.74 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.778 -1.564 . . . . 3.99 106.778 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -112.16 -21.78 11.3 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.969 -1.082 . . . . 5.17 112.823 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 p -157.16 159.9 38.23 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.427 -2.046 . . . . 0.02 109.749 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.403 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.1 p90 -152.63 154.2 34.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.93 -1.106 . . . . 2.02 110.71 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 25.0 mtp180 -144.17 150.9 38.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.381 -0.824 . . . . 0.01 110.29 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -88.07 142.36 27.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.726 . . . . 0.01 109.313 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.73 128.5 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.106 -0.996 . . . . 3.04 109.051 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.9 t -136.39 146.87 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.152 -0.967 . . . . 1.89 109.676 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 4.89 109.417 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.441 -1.064 . . . . 0.01 110.441 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -152.65 139.12 18.6 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.365 -1.079 . . . . 0.02 109.887 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 tt -130.63 139.6 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.691 -0.631 . . . . 0.02 109.412 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -121.28 130.31 53.59 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.545 -0.722 . . . . 0.39 109.938 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.5 m-85 -110.49 139.65 45.52 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.652 -0.655 . . . . 0.02 109.578 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.9 m-85 -121.41 137.88 54.51 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.237 -0.914 . . . . 0.02 109.531 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.56 -27.42 65.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.843 -1.16 . . . . 0.03 111.731 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -113.78 169.73 8.77 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.821 -1.174 . . . . 0.03 110.114 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -75.7 158.06 32.81 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.63 0.729 . . . . 0.03 110.13 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 1.1 m120 66.44 33.34 6.91 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.96 0.886 . . . . 0.74 111.046 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.411 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.69 41.66 30.19 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.271 0.557 . . . . 0.02 111.259 177.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -113.31 165.51 12.36 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.376 -0.972 . . . . 0.02 108.376 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.25 -167.62 34.39 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.898 -1.144 . . . . 0.03 110.554 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -69.02 142.68 54.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.46 -1.023 . . . . 2.76 108.941 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -122.53 150.24 42.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.587 -0.695 . . . . 1.89 110.079 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -136.43 133.08 36.26 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.131 -0.692 . . . . 0.02 109.131 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -109.45 135.79 49.9 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.507 -0.923 . . . . 1.12 108.507 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.6 t -127.82 138.04 52.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.635 -0.665 . . . . 0.02 109.348 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -118.45 12.32 13.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.654 -0.654 . . . . 0.2 110.128 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.6 t -159.81 173.77 15.48 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.888 -1.133 . . . . 1.23 109.164 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -62.79 146.09 53.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.807 -1.183 . . . . 0.02 110.708 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.1 m -133.36 117.33 17.16 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.84 -0.8 . . . . 0.02 108.84 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.79 -20.91 48.66 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.271 -0.893 . . . . 0.24 111.758 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -151.82 105.36 3.11 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.804 -1.185 . . . . 1.14 109.342 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.15 5.82 42.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.402 -0.811 . . . . 6.37 110.291 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -62.75 -29.36 70.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.373 -0.83 . . . . 3.11 112.708 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.6 p -77.49 -18.66 56.87 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.198 -1.564 . . . . 0.88 111.605 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -107.33 -19.29 13.63 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.315 -0.866 . . . . 0.02 110.089 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -148.94 127.08 12.04 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.046 . . . . 3.32 109.258 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 p -87.72 -12.45 45.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.453 -0.779 . . . . 0.02 111.389 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -171.49 160.84 6.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.793 -1.192 . . . . 0.02 108.446 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.78 116.35 8.64 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.031 -1.043 . . . . 0.02 108.97 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 -109.83 0.49 18.78 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.856 -1.153 . . . . 0.03 111.987 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 t -156.2 154.45 30.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.325 -0.991 . . . . 0.02 108.325 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mt -146.57 146.95 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.02 -1.05 . . . . 0.02 111.001 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -122.84 124.07 42.45 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.487 -1.301 . . . . 0.02 107.487 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.35 114.15 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.774 -1.565 . . . . 0.02 106.774 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -84.16 -34.05 24.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.574 -0.704 . . . . 3.81 110.552 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.22 150.74 19.87 Favored Glycine 0 N--CA 1.484 1.897 0 C-N-CA 118.977 -1.583 . . . . 0.02 110.775 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.4 172.22 48.81 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 119.988 -1.101 . . . . 0.01 110.488 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -118.16 134.47 54.98 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.631 -1.248 . . . . 1.48 107.631 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -127.29 154.52 44.81 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 122.508 1.147 . . . . 0.02 112.112 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.38 134.45 51.81 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 105.625 -1.991 . . . . 0.24 105.625 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.94 142.1 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -0.762 . . . . 0.65 109.316 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -121.08 143.61 48.99 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.032 0.92 . . . . 0.02 109.688 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.432 ' OE1' ' CD2' ' A' ' 57' ' ' HIS . 43.5 tt0 -65.13 -34.04 77.46 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.604 -0.725 . . . . 0.02 111.791 -177.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -124.43 157.78 63.8 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 121.001 -1.062 . . . . 0.02 109.51 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.38 166.87 0.99 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.613 1.542 . . . . 0.02 112.814 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 63.65 36.73 10.64 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.243 -0.89 . . . . 0.02 111.039 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 45.03 51.46 8.8 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.667 0.746 . . . . 3.39 110.617 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.7 m -125.9 163.65 22.49 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.184 0.516 . . . . 2.33 109.898 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.65 -161.95 31.32 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.821 -1.311 . . . . 0.02 109.821 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.432 ' CD2' ' OE1' ' A' ' 50' ' ' GLU . 13.4 m-70 -64.9 138.78 58.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.999 -1.295 . . . . 0.02 110.103 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.7 ppp? -119.89 137.6 53.92 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.773 -0.579 . . . . 5.01 109.817 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 85.4 m-85 -134.87 140.19 45.6 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.408 -0.808 . . . . 0.02 109.944 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mm -95.18 130.72 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.972 -0.751 . . . . 1.72 108.972 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.4 mt -121.86 111.66 32.52 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.374 -0.829 . . . . 0.02 110.802 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.67 170.35 19.29 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 119.859 0.985 . . . . 1.47 110.329 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -52.59 141.01 21.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.904 -1.123 . . . . 4.25 110.357 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.19 -177.54 32.35 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.41 -1.376 . . . . 0.02 110.785 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -120.1 131.33 55.02 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.408 -1.054 . . . . 0.96 109.878 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -122.21 94.79 47.74 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.931 -1.137 . . . . 0.02 107.931 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.88 -3.98 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.078 1.185 . . . . 0.02 113.855 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -157.58 154.55 28.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.608 -1.308 . . . . 2.02 108.213 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.621 ' HH ' HE21 ' A' ' 70' ' ' GLN . 39.1 p90 -59.49 -39.35 83.46 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.409 -0.807 . . . . 0.02 111.935 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.621 HE21 ' HH ' ' A' ' 69' ' ' TYR . 73.1 mt-30 -60.04 -24.02 64.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.081 -1.012 . . . . 0.02 110.573 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -70.37 -18.32 63.05 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.936 0.874 . . . . 3.42 108.828 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -107.49 11.17 29.06 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.324 -1.362 . . . . 0.02 107.324 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.1 mmt 60.41 22.28 11.87 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.51 0.671 . . . . 0.02 110.286 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.49 144.26 45.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.505 -1.438 . . . . 0.02 109.505 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.5 tp -79.13 -30.18 43.57 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.699 -1.223 . . . . 0.98 107.699 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.434 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 15.0 t-20 -157.2 -171.9 3.8 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.47 -1.678 . . . . 0.02 106.47 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 84.4 m-20 -98.81 28.21 4.45 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.789 -1.195 . . . . 0.02 110.639 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -96.52 123.05 40.06 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.971 -1.081 . . . . 3.2 111.1 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.2 mt -141.57 119.28 11.76 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.772 -1.196 . . . . 2.61 107.772 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.51 -18.94 9.14 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 121.144 -0.973 . . . . 0.02 112.389 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 p -156.08 156.2 33.93 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 119.738 1.769 . . . . 0.02 110.793 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.78 147.95 32.43 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.471 -0.768 . . . . 0.02 110.327 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -137.38 142.16 41.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.423 -0.798 . . . . 0.01 109.267 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.29 132.46 36.47 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.145 -0.972 . . . . 0.43 109.583 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.16 124.89 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.806 -0.813 . . . . 1.25 108.806 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.519 ' N ' ' HD1' ' A' ' 86' ' ' HIS . 1.6 m80 -91.11 132.81 35.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.919 -1.113 . . . . 1.77 108.424 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 mt -99.36 139.61 34.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.838 -0.801 . . . . 1.63 108.838 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.6 t -110.85 123.79 50.79 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.969 -1.123 . . . . 1.08 107.969 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.9 p -114.79 132.1 56.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.654 -1.279 . . . . 1.26 107.689 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.76 -48.97 0.01 OUTLIER Glycine 0 N--CA 1.503 3.129 0 C-N-CA 117.652 -2.214 . . . . 0.01 113.299 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.17 -103.93 0.17 Allowed Glycine 0 N--CA 1.488 2.105 0 CA-C-N 119.82 1.81 . . . . 0.01 110.963 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -118.99 118.41 31.41 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.244 -1.15 . . . . 4.43 110.184 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.87 135.07 54.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.811 -0.556 . . . . 2.99 109.527 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -133.68 129.97 37.54 Favored 'General case' 0 N--CA 1.519 2.994 0 CA-C-O 122.187 0.994 . . . . 6.36 113.055 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -131.84 141.46 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 115.505 -0.77 . . . . 1.09 110.248 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.504 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.3 pt20 -124.41 139.53 53.81 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 107.399 -1.334 . . . . 2.05 107.399 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.76 145.84 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 120.657 -1.277 . . . . 1.1 110.917 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -120.42 139.67 52.48 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.084 0.945 . . . . 0.73 110.929 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -68.31 -32.24 72.24 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.712 -0.676 . . . . 0.02 111.895 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -114.68 167.7 10.53 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.976 -1.077 . . . . 3.18 110.181 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.36 163.7 52.79 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.741 -0.943 . . . . 0.01 110.741 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 58.12 37.79 26.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.821 -0.811 . . . . 0.01 111.604 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.527 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 28.6 m-85 53.33 54.69 9.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.01 111.253 177.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -128.15 164.3 22.78 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.079 -1.082 . . . . 3.15 108.079 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.32 -162.4 29.49 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.913 -1.675 . . . . 0.01 108.913 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -75.82 141.67 42.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.958 -1.319 . . . . 0.01 109.28 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.1 tmm? -116.54 143.23 45.86 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.518 0.675 . . . . 0.01 109.304 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -132.48 136.36 46.64 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.337 -0.986 . . . . 2.48 108.337 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -116.38 134.23 55.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.704 -0.622 . . . . 0.01 109.814 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.9 t -149.35 147.57 28.48 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.901 -1.125 . . . . 1.69 111.336 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.9 p -115.03 7.61 15.54 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.996 -1.002 . . . . 0.01 110.19 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -121.77 163.22 19.47 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.411 -0.806 . . . . 3.21 111.109 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -69.44 154.78 41.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.351 -0.843 . . . . 0.01 109.491 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.608 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 20.5 p -126.53 119.77 23.11 Favored Pre-proline 0 N--CA 1.502 2.126 0 N-CA-C 109.22 -0.659 . . . . 0.01 109.22 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -77.01 -33.11 2.88 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 120.341 1.158 . . . . 0.01 110.638 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 t -143.24 108.8 5.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.438 -0.789 . . . . 0.02 109.103 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.99 -39.31 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.731 -0.606 . . . . 1.83 110.823 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.7 ttp -67.18 -36.74 82.43 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.174 -1.01 . . . . 1.34 109.881 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.95 -38.79 76.23 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.575 -1.328 . . . . 2.11 109.668 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.415 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 8.3 tt0 -80.34 -46.6 15.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.345 -0.847 . . . . 2.08 112.509 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.415 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 53.1 m-85 -110.29 -0.45 17.7 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.281 -0.887 . . . . 0.02 112.623 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.7 m80 59.65 33.01 21.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.738 -1.226 . . . . 0.02 109.495 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.0 mt -112.45 135.71 52.83 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 108.71 -0.848 . . . . 0.02 108.71 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -92.4 -22.9 19.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 5.32 110.581 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -149.02 163.33 37.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.184 -0.948 . . . . 0.02 109.947 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 126' ' ' ILE . 53.6 mt -131.75 129.19 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.452 -1.314 . . . . 2.17 107.452 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -106.81 -13.4 15.26 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.2 -0.938 . . . . 0.02 113.172 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.32 153.58 30.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.333 -1.479 . . . . 0.01 108.186 178.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 8.6 t -160.52 147.01 15.42 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.318 -1.489 . . . . 1.22 109.904 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -121.79 108.28 13.31 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.029 0.919 . . . . 1.41 108.623 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.15 121.06 60.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.068 -1.827 . . . . 0.01 106.068 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t -146.83 69.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 118.182 -1.407 . . . . 1.98 108.42 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.66 109.04 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.634 -1.617 . . . . 0.01 106.634 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.35 -174.1 45.2 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.819 -1.312 . . . . 0.01 109.819 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.5 m -111.4 143.62 41.93 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.526 -0.984 . . . . 2.3 109.147 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -129.92 144.97 51.6 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.403 -0.811 . . . . 0.01 110.481 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.7 mt -117.61 141.36 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.504 -1.295 . . . . 1.69 107.504 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.31 143.55 44.69 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 107.528 -1.286 . . . . 2.49 107.528 177.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 9.4 m-85 -122.46 144.88 48.78 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.903 -0.777 . . . . 0.02 108.903 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -74.33 -29.82 61.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.729 -0.607 . . . . 0.02 112.119 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.56 153.54 47.78 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 120.805 -1.184 . . . . 1.48 109.083 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.23 166.86 1.46 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.232 1.288 . . . . 0.02 112.7 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 59.54 30.9 20.58 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.235 -0.893 . . . . 0.75 111.029 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.77 51.57 9.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.574 -0.704 . . . . 0.02 110.924 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -124.58 163.66 21.47 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.55 -0.719 . . . . 0.02 109.732 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.52 -165.17 32.22 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.843 -1.303 . . . . 0.02 109.843 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -67.92 141.77 56.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.607 -0.937 . . . . 0.02 108.921 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -118.26 149.03 41.81 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.155 -0.683 . . . . 0.02 109.155 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -129.5 142.54 50.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.486 -0.759 . . . . 0.01 109.049 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.96 121.45 38.85 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.217 -0.927 . . . . 0.01 109.079 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.8 mt -105.8 135.32 47.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.545 -0.722 . . . . 0.01 110.71 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 154' ' ' LYS . 29.4 t70 -108.68 172.71 6.68 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.015 -1.106 . . . . 2.27 108.015 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -57.08 85.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.964 -1.085 . . . . 1.84 108.483 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 152' ' ' ASP . 52.2 tttp -135.79 167.04 21.9 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.303 1.049 . . . . 2.28 111.428 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.414 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 29.5 mt-10 -110.92 108.29 18.02 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.209 -1.034 . . . . 0.01 108.209 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.83 114.36 26.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.063 -1.023 . . . . 0.01 110.272 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -91.46 -27.12 18.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.101 -0.999 . . . . 0.01 111.506 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -125.82 153.77 73.39 Favored Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.027 -1.046 . . . . 2.54 108.692 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.58 -42.91 36.25 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 CA-C-N 119.171 0.74 . . . . 0.7 110.745 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.9 t -60.63 -20.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.648 -1.282 . . . . 0.86 108.642 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -65.44 -15.96 63.16 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.908 -1.12 . . . . 0.02 109.432 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.17 9.76 38.45 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.939 -1.134 . . . . 0.02 107.939 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.87 10.48 86.1 Favored Glycine 0 N--CA 1.485 1.963 0 C-N-CA 119.3 -1.429 . . . . 0.02 109.813 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.41 142.23 31.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.547 -0.972 . . . . 0.02 110.164 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.63 -8.37 58.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.682 -0.636 . . . . 0.59 109.783 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 t -144.66 150.71 47.94 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.758 -1.214 . . . . 0.87 108.696 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.84 21.54 0.5 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 120.735 0.957 . . . . 0.38 112.322 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.15 123.76 29.85 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.508 1.147 . . . . 0.18 111.649 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.6 mt -146.4 126.77 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.663 -1.606 . . . . 3.99 106.663 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -112.45 -20.15 11.88 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.04 -1.038 . . . . 5.17 112.982 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 11.9 p -157.69 160.83 38.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 119.353 -2.092 . . . . 0.02 110.19 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.608 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 5.2 p90 -152.46 154.28 35.22 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.149 -0.969 . . . . 2.02 110.784 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -144.79 151.85 39.45 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.105 -0.997 . . . . 0.01 110.708 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -88.21 143.75 26.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.68 -0.638 . . . . 0.01 109.33 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.17 129.26 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.137 -0.977 . . . . 3.04 109.083 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.5 t -136.14 146.57 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.269 -0.895 . . . . 1.89 109.62 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.295 -0.878 . . . . 4.89 109.434 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 110.406 -1.078 . . . . 0.01 110.406 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -152.57 138.56 18.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.421 -1.047 . . . . 0.02 109.879 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.05 139.24 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.215 -0.661 . . . . 0.02 109.215 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -121.85 130.94 53.77 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.459 -0.776 . . . . 0.39 109.861 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 m-85 -110.89 140.41 45.39 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.656 -0.653 . . . . 0.02 109.633 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 4.8 m-85 -122.07 138.41 54.45 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.317 -0.865 . . . . 0.02 109.402 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -69.27 -27.43 65.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.144 . . . . 0.03 111.869 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -114.08 169.97 8.62 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.852 -1.155 . . . . 0.03 110.257 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -75.41 158.48 32.64 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.535 0.684 . . . . 0.03 109.986 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.1 t30 65.7 35.05 7.14 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.891 0.853 . . . . 0.74 110.75 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.4 p90 50.03 44.78 25.7 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.681 0.753 . . . . 0.02 111.342 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -112.16 165.73 11.89 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.986 -1.116 . . . . 0.02 107.986 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.21 -167.74 34.57 Favored Glycine 0 N--CA 1.494 2.567 0 C-N-CA 119.87 -1.157 . . . . 0.03 110.559 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -68.95 143.18 54.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -1.108 . . . . 2.76 108.861 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.515 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 50.1 ttt180 -122.19 149.26 43.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.564 -0.71 . . . . 1.89 110.225 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -135.91 132.2 36.18 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.18 -0.674 . . . . 0.02 109.18 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -109.65 136.57 48.81 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.396 -0.815 . . . . 1.12 108.928 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 t -128.03 137.85 52.35 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.553 -0.717 . . . . 0.02 109.593 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.39 11.85 13.15 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.661 -0.649 . . . . 0.2 110.139 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.543 ' HG ' ' H ' ' A' ' 25' ' ' ASP . 36.7 t -159.53 174.15 15.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.896 -1.128 . . . . 1.23 108.913 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.543 ' H ' ' HG ' ' A' ' 24' ' ' CYS . 1.4 p30 -62.85 145.86 54.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.63 -1.294 . . . . 0.02 110.599 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.519 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 12.7 p -134.93 119.36 17.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.5 -0.75 . . . . 0.02 109.152 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.0 -21.08 47.53 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.289 -0.882 . . . . 0.24 112.376 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -152.41 107.02 3.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.67 -1.269 . . . . 1.14 110.14 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.48 5.95 39.79 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.375 -0.828 . . . . 6.37 110.442 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -61.42 -30.25 70.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 3.11 112.186 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.7 t -76.94 -17.31 58.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.389 -1.444 . . . . 0.88 111.124 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -106.99 -20.84 13.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.403 -0.811 . . . . 0.02 110.755 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.07 127.2 12.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.979 -1.076 . . . . 3.32 109.663 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 t -87.01 -12.39 47.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.57 -0.706 . . . . 0.02 111.032 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -172.8 161.72 4.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.781 -1.199 . . . . 0.02 108.467 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.4 p -143.49 116.55 8.9 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.1 -1.0 . . . . 0.02 108.876 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -108.28 -0.04 21.04 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.813 -1.179 . . . . 0.03 111.287 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 t -156.46 154.34 30.26 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.965 -1.124 . . . . 0.02 107.965 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.0 mt -146.96 148.13 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.057 -1.027 . . . . 0.02 110.554 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -123.54 124.81 43.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.2 -1.037 . . . . 0.02 108.2 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.66 114.31 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 106.768 -1.567 . . . . 0.02 106.768 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -83.99 -34.1 24.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.717 -0.614 . . . . 3.81 110.629 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.54 151.19 20.58 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.019 -1.563 . . . . 0.02 110.688 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.09 172.41 49.12 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.934 -1.127 . . . . 0.01 110.496 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -118.15 133.98 55.42 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.548 -1.278 . . . . 1.48 107.548 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -126.36 154.74 43.13 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.685 -1.26 . . . . 0.02 112.196 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.61 133.93 52.53 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.543 -2.021 . . . . 0.24 105.543 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.86 142.6 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.565 -0.709 . . . . 0.65 109.451 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -120.7 142.74 49.21 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.053 0.93 . . . . 0.02 109.596 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.433 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 38.0 tt0 -65.11 -33.54 76.27 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.593 -0.73 . . . . 0.02 111.786 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -124.45 157.71 64.1 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 120.988 -1.07 . . . . 0.02 109.444 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.23 166.63 0.99 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.61 1.54 . . . . 0.02 112.71 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m120 63.44 36.42 11.39 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 115.355 -0.839 . . . . 0.02 111.016 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.527 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.3 m-85 45.37 51.41 9.53 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.528 0.68 . . . . 3.39 110.742 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 p -125.75 163.7 22.27 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.27 0.557 . . . . 2.33 109.948 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.46 -161.54 31.26 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.882 -1.287 . . . . 0.02 109.882 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 13.8 m80 -64.25 138.79 58.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.045 -1.268 . . . . 0.02 110.161 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.1 ppp? -119.09 137.17 53.75 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.397 0.618 . . . . 5.01 109.65 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 88.3 m-85 -135.27 139.29 44.29 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.419 -0.801 . . . . 0.02 109.765 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 mm -96.25 131.03 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.715 -0.846 . . . . 1.72 108.715 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mt -121.69 111.9 32.67 Favored Pre-proline 0 N--CA 1.505 2.305 0 O-C-N 121.344 -0.848 . . . . 0.02 110.757 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.46 170.1 19.93 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 119.892 0.997 . . . . 1.47 110.325 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -52.63 141.09 21.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.991 -1.068 . . . . 4.25 110.42 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.71 -177.9 31.76 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.437 -1.363 . . . . 0.02 110.782 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -120.04 131.57 55.16 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.401 -1.058 . . . . 0.96 109.659 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -121.32 97.95 47.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.941 -1.133 . . . . 0.02 107.941 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -70.17 -3.88 13.18 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.678 0.919 . . . . 0.02 113.6 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -157.39 154.2 28.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.549 -1.344 . . . . 2.02 107.989 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -59.83 -38.49 82.2 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.432 -0.792 . . . . 0.02 111.872 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -59.71 -24.38 63.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.051 . . . . 0.02 110.433 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -70.22 -18.81 63.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.863 0.84 . . . . 3.42 108.978 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.55 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.6 t90 -108.25 10.08 27.87 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.493 -1.299 . . . . 0.02 107.493 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.3 mtm 60.84 21.84 11.95 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.484 0.659 . . . . 0.02 110.535 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.61 144.3 46.06 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.388 -1.485 . . . . 0.02 109.388 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 mt -78.84 -30.57 45.27 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.687 -1.227 . . . . 0.98 107.687 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -157.32 -171.31 3.56 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.335 -1.728 . . . . 0.02 106.335 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -98.32 29.06 3.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.639 -1.288 . . . . 0.02 110.595 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -97.94 122.65 41.31 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.899 -1.126 . . . . 3.2 111.448 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.1 mt -142.76 119.78 11.36 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.45 -1.315 . . . . 2.61 107.45 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.94 -17.89 10.53 Favored Glycine 0 N--CA 1.497 2.762 0 O-C-N 121.296 -0.878 . . . . 0.02 112.25 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.577 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 31.2 t -155.17 155.83 34.64 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.189 -1.771 . . . . 0.02 110.856 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.577 ' N ' ' HG ' ' A' ' 81' ' ' SER . 47.8 t -145.42 148.17 33.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.463 -0.773 . . . . 0.02 110.233 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -137.52 141.67 41.44 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.482 -0.761 . . . . 0.01 109.038 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.06 133.73 36.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.43 109.405 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 t -91.92 124.58 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.98 -0.748 . . . . 1.25 108.98 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -92.75 131.96 37.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.958 -1.089 . . . . 1.77 108.507 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.15 138.8 33.23 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.134 -1.061 . . . . 1.63 108.134 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 t -110.84 126.67 54.9 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.758 -0.83 . . . . 1.08 108.758 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.4 m -103.22 -154.49 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.23 -1.767 . . . . 1.26 106.23 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.06 -50.55 0.84 Allowed Glycine 0 N--CA 1.497 2.723 0 O-C-N 120.527 -1.358 . . . . 0.01 112.09 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.67 -100.2 0.14 Allowed Glycine 0 N--CA 1.487 2.076 0 C-N-CA 118.76 -1.686 . . . . 0.01 111.995 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -120.03 119.73 34.23 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.164 -1.198 . . . . 4.43 110.523 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.44 136.45 55.74 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.177 -0.609 . . . . 2.99 109.463 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -134.7 130.57 36.49 Favored 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 122.163 0.982 . . . . 6.36 112.942 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -132.08 142.07 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.675 0.75 . . . . 1.09 110.532 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.9 pt20 -124.82 139.83 53.48 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 107.686 -1.228 . . . . 2.05 107.686 176.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -124.07 145.71 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.495 0 O-C-N 120.607 -1.308 . . . . 1.1 111.121 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -120.47 140.17 51.8 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 122.081 0.943 . . . . 0.73 110.852 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -68.66 -32.58 72.51 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.652 -0.704 . . . . 0.02 111.929 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -114.57 165.47 12.73 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.978 -1.076 . . . . 3.18 110.228 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 163.39 45.42 Favored Glycine 0 N--CA 1.494 2.532 0 CA-C-O 122.022 0.79 . . . . 0.01 111.264 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 t70 57.01 39.4 29.37 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.595 0.712 . . . . 0.01 111.1 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 52.15 56.2 8.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.509 -0.744 . . . . 0.01 111.03 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -129.23 165.03 22.17 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.839 -1.171 . . . . 3.15 107.839 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.07 -162.78 28.8 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 108.963 -1.655 . . . . 0.01 108.963 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -75.33 141.24 43.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.775 -1.426 . . . . 0.01 109.001 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.1 tmm? -116.3 143.37 45.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.604 0.716 . . . . 0.01 109.526 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -132.41 136.65 46.92 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.309 -0.997 . . . . 2.48 108.309 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -116.21 134.42 54.94 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.632 -0.668 . . . . 0.01 109.635 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -149.68 148.08 28.85 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.532 1.158 . . . . 1.69 111.437 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 p -115.09 7.88 15.55 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.936 -1.029 . . . . 0.01 109.985 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -122.16 163.26 19.85 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.437 -0.79 . . . . 3.21 111.236 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.55 154.31 42.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.01 109.471 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.429 ' O ' ' OG ' ' A' ' 171' ' ' SER . 44.2 t -127.07 115.99 21.9 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 109.096 -0.705 . . . . 0.01 109.096 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.45 -32.95 4.51 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.324 1.151 . . . . 0.01 111.604 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.7 m -142.07 108.59 5.32 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.379 -0.826 . . . . 0.02 109.237 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.37 -40.02 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.787 -0.571 . . . . 1.83 111.019 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.0 ttp -66.76 -37.6 84.94 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.021 -1.071 . . . . 1.34 109.76 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -69.81 -38.53 76.62 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.538 -1.351 . . . . 2.11 109.817 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.526 ' OE1' ' CG ' ' A' ' 121' ' ' PHE . 7.9 tm0? -80.49 -47.61 14.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.281 -0.887 . . . . 2.08 112.282 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.526 ' CG ' ' OE1' ' A' ' 120' ' ' GLN . 92.1 m-85 -110.72 -0.85 16.93 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.389 -0.819 . . . . 0.02 112.748 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.9 m80 60.1 33.24 21.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.748 -1.22 . . . . 0.02 109.483 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 mt -112.42 135.67 52.84 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.802 -0.814 . . . . 0.02 108.802 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -92.3 -23.14 19.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.313 -0.867 . . . . 5.32 110.365 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -148.92 163.57 37.08 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.151 -0.968 . . . . 0.02 109.957 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.423 HD12 HG21 ' A' ' 126' ' ' ILE . 52.2 mt -131.6 129.43 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 107.473 -1.306 . . . . 2.17 107.473 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -107.82 -13.26 15.04 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.25 -0.906 . . . . 0.02 113.171 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.5 OUTLIER -153.87 152.1 30.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.355 -1.466 . . . . 0.01 108.206 178.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.2 t -160.72 145.04 13.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.29 -1.506 . . . . 1.22 109.651 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -120.86 108.82 14.38 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.099 0.952 . . . . 1.41 108.714 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.12 120.68 59.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 105.771 -1.937 . . . . 0.01 105.771 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 t -146.43 68.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 118.209 -1.397 . . . . 1.98 108.341 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.62 108.75 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.563 -1.643 . . . . 0.01 106.563 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.89 -174.16 40.52 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.693 -1.363 . . . . 0.01 109.693 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 m -111.62 144.88 40.16 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.37 -1.076 . . . . 2.3 109.12 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -129.69 146.47 51.46 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.537 -0.727 . . . . 0.01 110.263 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.2 mt -118.0 141.3 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.583 -1.266 . . . . 1.69 107.583 177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.1 143.66 44.43 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.77 -1.196 . . . . 2.49 107.77 177.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.5 m-85 -122.63 143.75 49.56 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.535 -0.728 . . . . 0.02 109.052 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -73.21 -29.61 62.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.514 -0.741 . . . . 0.02 111.98 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.31 153.54 47.48 Favored Pre-proline 0 N--CA 1.505 2.318 0 O-C-N 120.69 -1.256 . . . . 1.48 109.112 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.46 167.24 1.44 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.376 1.384 . . . . 0.02 112.565 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.34 31.14 20.91 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.246 -0.888 . . . . 0.75 111.058 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.65 51.65 9.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.641 -0.662 . . . . 0.02 110.943 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -125.02 163.8 21.55 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.567 -0.708 . . . . 0.02 109.809 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.83 -165.55 32.07 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.878 -1.289 . . . . 0.02 109.878 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -67.7 141.77 56.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.555 -0.968 . . . . 0.02 108.784 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -118.15 148.75 42.03 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.308 -0.627 . . . . 0.02 109.308 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.95 142.45 50.93 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.477 -0.764 . . . . 0.01 109.007 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.37 121.37 38.1 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.302 -0.874 . . . . 0.01 109.297 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.1 mt -105.27 136.62 44.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.37 -0.831 . . . . 0.01 110.616 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 154' ' ' LYS . 48.1 t0 -109.88 171.99 7.12 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.127 -1.064 . . . . 2.27 108.127 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -57.87 84.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.994 -1.066 . . . . 1.84 108.796 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 152' ' ' ASP . 53.8 mttm -136.19 168.78 18.76 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.245 -0.909 . . . . 2.28 111.62 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -112.88 110.61 20.8 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.001 -1.111 . . . . 0.01 108.001 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -100.72 116.52 32.81 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.069 -1.019 . . . . 0.01 110.171 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.457 ' O ' ' OG ' ' A' ' 128' ' ' SER . 25.4 ptt180 -92.44 -25.21 18.57 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.251 -0.906 . . . . 0.01 111.525 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -126.32 153.38 74.68 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 120.845 -1.159 . . . . 2.54 108.658 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -60.71 -42.19 40.98 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 119.265 0.773 . . . . 0.7 110.446 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.36 -20.43 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.696 -1.253 . . . . 0.86 108.571 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -65.75 -16.46 63.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.92 -1.113 . . . . 0.02 109.561 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -94.88 9.76 37.96 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.873 -1.158 . . . . 0.02 107.873 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.64 10.73 85.76 Favored Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.341 -1.409 . . . . 0.02 109.761 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.06 142.23 31.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.463 -1.022 . . . . 0.02 110.194 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.38 -8.23 59.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.773 -0.579 . . . . 0.59 109.856 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.4 m -144.68 150.91 48.55 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 120.88 -1.137 . . . . 0.87 108.708 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.19 21.67 0.52 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.708 0.939 . . . . 0.38 112.233 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.02 123.91 29.91 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.455 1.122 . . . . 0.18 111.702 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.5 mt -146.47 126.24 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.799 -1.556 . . . . 3.99 106.799 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -112.24 -19.87 12.08 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.074 -1.016 . . . . 5.17 112.896 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 28.4 t -157.29 160.0 38.14 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 119.174 -2.204 . . . . 0.02 110.357 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.425 ' N ' ' HG ' ' A' ' 171' ' ' SER . 11.5 p90 -153.01 154.25 34.56 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 2.02 110.589 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -144.44 151.19 38.86 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.169 -0.957 . . . . 0.01 110.566 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -87.95 143.46 27.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.409 -0.807 . . . . 0.01 109.232 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.0 mt -93.73 128.65 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.052 -1.03 . . . . 3.04 109.221 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.86 146.69 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.42 -0.8 . . . . 1.89 109.535 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 4.89 109.528 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 110.42 -1.072 . . . . 0.01 110.42 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -152.62 137.44 17.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.586 -0.949 . . . . 0.02 109.488 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.2 tt -130.27 141.12 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.223 0.535 . . . . 0.02 109.828 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t -121.75 130.27 53.3 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.39 -0.819 . . . . 0.39 109.972 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 m-85 -110.25 139.6 45.25 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.543 -0.723 . . . . 0.02 109.378 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.2 m-85 -121.76 137.94 54.57 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.282 -0.886 . . . . 0.02 109.557 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -69.58 -27.53 65.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -0.999 . . . . 0.03 111.733 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.4 170.68 8.12 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.848 -1.158 . . . . 0.03 110.087 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -74.93 161.16 29.76 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.749 0.785 . . . . 0.03 110.26 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 12.9 t-20 62.4 35.06 15.14 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.894 0.854 . . . . 0.74 110.551 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 19.6 p90 49.41 43.39 23.42 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.381 -0.827 . . . . 0.02 110.906 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -109.39 165.48 11.61 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.698 -1.223 . . . . 0.02 107.698 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.8 -167.61 33.62 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.785 -1.198 . . . . 0.03 110.63 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -69.47 143.81 53.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.361 -1.082 . . . . 2.76 109.032 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -122.96 150.51 42.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.63 -0.669 . . . . 1.89 110.164 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -137.18 134.05 35.89 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.367 -0.605 . . . . 0.02 109.367 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -109.53 135.57 50.31 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.961 -0.755 . . . . 1.12 108.961 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.7 t -127.73 137.65 52.52 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.588 -0.695 . . . . 0.02 109.327 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -118.84 11.99 12.79 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.64 -0.662 . . . . 0.2 110.377 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 46.3 t -159.85 173.62 15.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.77 -1.206 . . . . 1.23 109.186 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.562 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.9 p30 -63.35 146.26 53.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.794 -1.191 . . . . 0.02 110.829 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.6 m -134.01 117.48 16.73 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.691 -0.855 . . . . 0.02 108.691 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.484 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.19 -20.46 55.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.466 -0.771 . . . . 0.24 111.793 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.57 105.87 3.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.901 -1.124 . . . . 1.14 109.25 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.68 5.23 43.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 6.37 110.243 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -62.15 -29.6 70.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.448 -0.782 . . . . 3.11 112.495 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -77.34 -18.59 57.29 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.224 -1.548 . . . . 0.88 111.687 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -106.43 -19.96 13.52 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.305 -0.872 . . . . 0.02 110.423 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -149.05 127.44 12.23 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.019 -1.051 . . . . 3.32 109.457 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -87.27 -12.97 45.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.549 -0.72 . . . . 0.02 111.004 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -172.8 162.08 4.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.02 108.477 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.4 p -142.61 115.21 8.57 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.021 -1.05 . . . . 0.02 108.851 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.433 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.7 m-80 -106.8 -2.77 21.11 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.737 -1.227 . . . . 0.03 111.44 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 t -152.98 153.51 33.09 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.884 -1.154 . . . . 0.02 107.884 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -147.01 147.35 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.858 -1.151 . . . . 0.02 110.725 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -125.12 125.55 43.92 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.972 -1.122 . . . . 0.02 107.972 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -105.9 114.95 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.643 -1.614 . . . . 0.02 106.643 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -85.57 -34.31 21.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 3.81 109.968 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.37 150.52 19.33 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.512 -1.804 . . . . 0.02 110.696 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.68 171.78 48.34 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.486 -1.046 . . . . 0.01 110.486 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.5 m -118.16 133.35 55.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.579 -1.267 . . . . 1.48 107.579 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 43.8 m95 -126.3 154.68 43.11 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.812 -1.18 . . . . 0.02 112.14 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.24 133.96 52.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.253 -2.129 . . . . 0.24 105.253 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.21 144.0 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.656 -0.653 . . . . 0.65 109.405 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.555 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 43.6 m-85 -120.93 145.15 48.0 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.095 0.95 . . . . 0.02 109.887 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -66.97 -33.35 75.38 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.975 -0.557 . . . . 0.02 111.914 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -123.7 158.2 60.24 Favored Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 120.978 -1.076 . . . . 0.02 109.598 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.36 164.98 1.69 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.591 1.527 . . . . 0.02 112.764 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 64.07 37.17 9.3 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.452 -0.795 . . . . 0.02 111.189 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 44.88 51.26 8.64 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.559 0.695 . . . . 3.39 110.738 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.5 t -125.93 163.59 22.63 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.179 0.514 . . . . 2.33 109.745 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.92 -161.74 30.8 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.877 -1.289 . . . . 0.02 109.877 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -65.84 140.6 58.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.081 -1.246 . . . . 0.02 110.348 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.555 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 52.4 ttp -118.65 138.3 52.7 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.639 -0.663 . . . . 5.01 109.956 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.508 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 48.3 m-85 -134.45 137.39 43.93 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.409 -0.807 . . . . 0.02 109.748 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.0 mm -95.28 131.25 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.579 -0.897 . . . . 1.72 108.579 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.9 mt -120.5 111.52 34.78 Favored Pre-proline 0 N--CA 1.504 2.266 0 O-C-N 121.31 -0.869 . . . . 0.02 110.985 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.02 168.97 21.22 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 119.853 0.983 . . . . 1.47 110.117 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -53.67 140.7 28.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.774 -1.204 . . . . 4.25 110.502 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.37 -177.21 32.67 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.586 -1.293 . . . . 0.02 110.636 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -118.95 130.63 55.81 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.352 -1.087 . . . . 0.96 109.808 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -120.64 97.11 48.73 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.004 -1.11 . . . . 0.02 108.004 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.45 -3.94 12.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 120.708 0.939 . . . . 0.02 113.52 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -157.38 153.96 28.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.651 -1.28 . . . . 2.02 107.988 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -59.76 -38.17 81.07 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.456 -0.777 . . . . 0.02 111.787 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -60.78 -23.85 65.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.061 -1.025 . . . . 0.02 110.433 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -70.1 -18.28 63.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.339 -0.851 . . . . 3.42 108.89 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.546 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.55 10.46 27.15 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.482 -1.303 . . . . 0.02 107.482 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.1 mtt 61.13 21.55 11.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.621 -0.674 . . . . 0.02 110.539 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.45 144.49 45.63 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.307 -1.517 . . . . 0.02 109.307 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.45 -31.1 42.45 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.743 -1.206 . . . . 0.98 107.743 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -157.48 -172.21 3.89 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.443 -1.688 . . . . 0.02 106.443 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 3.7 p-10 -98.1 28.49 3.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.708 -1.245 . . . . 0.02 110.672 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HG3' HH11 ' A' ' 78' ' ' ARG . 26.5 ttm-85 -97.84 122.48 41.0 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.851 -1.156 . . . . 3.2 111.142 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.5 mt -142.34 120.13 11.91 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.652 -1.24 . . . . 2.61 107.652 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.32 -18.1 10.72 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 121.309 -0.87 . . . . 0.02 112.183 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.6 m -155.67 155.67 33.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.212 -1.758 . . . . 0.02 110.505 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.4 p -145.23 147.67 32.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.807 -0.558 . . . . 0.02 109.74 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -137.64 142.09 41.19 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.39 -0.819 . . . . 0.01 109.159 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.94 133.13 36.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.13 -0.981 . . . . 0.43 109.391 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.03 124.41 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.89 -0.781 . . . . 1.25 108.89 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -92.4 131.54 37.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.859 -1.15 . . . . 1.77 108.582 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.55 138.98 33.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.183 -1.043 . . . . 1.63 108.183 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.8 p -111.05 126.56 54.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.351 -0.843 . . . . 1.08 108.878 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.2 t -103.32 -154.33 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.184 -1.784 . . . . 1.26 106.184 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.19 -50.96 0.83 Allowed Glycine 0 N--CA 1.499 2.88 0 O-C-N 120.49 -1.381 . . . . 0.01 112.214 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.74 -100.14 0.14 Allowed Glycine 0 N--CA 1.487 2.091 0 C-N-CA 118.845 -1.645 . . . . 0.01 111.905 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -120.26 119.53 33.46 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.23 -1.159 . . . . 4.43 110.386 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.61 136.93 56.31 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.226 -0.59 . . . . 2.99 109.586 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -136.01 131.16 34.64 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-O 122.205 1.003 . . . . 6.36 112.93 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.1 143.35 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-N 115.584 -0.734 . . . . 1.09 110.365 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.507 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 1.3 pt20 -124.8 139.52 53.76 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 107.493 -1.299 . . . . 2.05 107.493 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.0 m -123.99 145.86 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.548 -1.345 . . . . 1.1 110.971 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -120.68 140.16 52.0 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.302 1.049 . . . . 0.73 110.876 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.2 tm-20 -68.36 -32.54 72.69 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.587 -0.733 . . . . 0.02 111.81 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -114.0 167.46 10.64 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.043 -1.035 . . . . 3.18 110.306 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.24 163.52 52.67 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.815 -0.914 . . . . 0.01 110.815 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 58.2 38.51 26.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.98 -0.718 . . . . 0.01 111.567 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 52.16 55.41 9.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.01 111.245 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -128.51 164.53 22.59 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.93 -1.137 . . . . 3.15 107.93 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.67 -162.39 29.05 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.013 -1.635 . . . . 0.01 109.013 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.405 ' OE1' ' OH ' ' A' ' 108' ' ' TYR . 9.4 tt0 -75.54 141.18 43.04 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.842 -1.387 . . . . 0.01 109.154 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 107' ' ' MET . 0.8 OUTLIER -116.26 143.07 46.0 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.48 0.657 . . . . 0.01 109.42 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.405 ' OH ' ' OE1' ' A' ' 106' ' ' GLN . 53.6 m-85 -132.36 136.16 46.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.22 -1.03 . . . . 2.48 108.22 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.482 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.2 tm-20 -116.4 134.1 55.26 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.735 -0.603 . . . . 0.01 109.5 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.482 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 11.9 t -149.3 148.04 29.07 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.491 1.138 . . . . 1.69 111.216 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.5 p -115.09 7.56 15.46 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.017 -0.992 . . . . 0.01 109.924 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -121.97 163.31 19.55 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.504 -0.747 . . . . 3.21 111.194 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -70.25 155.05 41.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.833 . . . . 0.01 109.78 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.402 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 34.9 t -126.49 115.17 23.09 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 121.532 -0.73 . . . . 0.01 109.195 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.05 -33.13 4.76 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 120.339 1.157 . . . . 0.01 111.113 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.8 t -141.8 107.67 5.15 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.968 0.889 . . . . 0.02 108.832 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.09 -39.93 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.585 -0.697 . . . . 1.83 111.176 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.8 ttt -66.39 -37.47 85.31 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.078 -1.049 . . . . 1.34 109.593 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.59 -38.46 77.35 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.572 -1.33 . . . . 2.11 109.709 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -80.44 -47.24 14.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -0.906 . . . . 2.08 112.476 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -111.41 -0.7 16.2 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.235 -0.915 . . . . 0.02 112.653 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 60.08 33.41 21.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.755 -1.216 . . . . 0.02 109.648 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.42 135.51 53.03 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.793 -0.817 . . . . 0.02 108.793 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -92.71 -23.16 19.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.334 -0.854 . . . . 5.32 110.766 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -148.91 163.42 37.49 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.226 -0.922 . . . . 0.02 109.965 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.435 HD13 HG23 ' A' ' 126' ' ' ILE . 59.2 mt -131.97 129.72 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 107.576 -1.268 . . . . 2.17 107.576 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -107.72 -13.53 15.0 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.21 -0.931 . . . . 0.02 113.243 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.95 153.52 31.18 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.277 -1.515 . . . . 0.01 108.24 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 7.4 t -161.35 147.39 14.24 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.286 -1.509 . . . . 1.22 109.9 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -121.76 108.66 13.77 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.989 0.9 . . . . 1.41 108.627 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 t -107.59 120.41 58.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 105.941 -1.874 . . . . 0.01 105.941 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 t -146.49 68.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 118.189 -1.404 . . . . 1.98 108.454 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.39 108.75 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 106.715 -1.587 . . . . 0.01 106.715 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.21 -173.27 43.1 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.978 -1.249 . . . . 0.01 109.978 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.2 m -112.02 143.73 42.54 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.283 -1.128 . . . . 2.3 109.221 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -129.69 145.72 51.51 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.461 -0.774 . . . . 0.01 110.336 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.0 mt -117.8 141.35 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 107.708 -1.219 . . . . 1.69 107.708 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.54 141.45 47.14 Favored 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 107.019 -1.474 . . . . 2.49 107.019 178.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 7.7 m-85 -122.73 145.71 48.16 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.437 -0.789 . . . . 0.02 109.197 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -74.12 -29.92 62.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.02 112.007 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.68 153.18 47.91 Favored Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 120.753 -1.217 . . . . 1.48 109.118 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.419 ' O ' ' NH1' ' A' ' 145' ' ' ARG . 1.2 Cg_endo -54.24 166.72 1.54 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.25 1.3 . . . . 0.02 112.791 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.2 t30 58.67 32.15 21.87 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.205 -0.907 . . . . 0.75 111.099 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 144' ' ' TYR . 1.0 OUTLIER 57.51 52.25 8.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.564 -0.71 . . . . 0.02 111.473 178.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.454 ' HG3' HH11 ' A' ' 145' ' ' ARG . 10.8 mtm-85 -124.5 163.14 22.49 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.52 -0.737 . . . . 0.02 109.597 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.2 -164.95 32.48 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.923 -1.271 . . . . 0.02 109.923 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -68.04 141.13 56.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.583 -0.951 . . . . 0.02 108.862 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -118.32 148.42 42.49 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.361 0.601 . . . . 0.02 109.438 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.5 141.97 51.22 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.465 -0.772 . . . . 0.01 108.977 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.0 tt -97.15 121.57 39.18 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.263 -0.898 . . . . 0.01 109.288 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.1 mt -105.22 133.91 49.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.426 -0.797 . . . . 0.01 110.536 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 32.2 t70 -109.41 175.76 5.33 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.346 -0.983 . . . . 2.27 108.346 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.18 84.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.974 -1.079 . . . . 1.84 108.528 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 48.6 tttp -136.61 165.45 25.85 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.343 -0.848 . . . . 2.28 111.461 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.484 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 27.1 mt-10 -111.1 108.4 18.09 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.033 -1.099 . . . . 0.01 108.033 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -98.93 114.82 27.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.002 -1.061 . . . . 0.01 110.241 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -93.26 -26.05 17.51 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.145 -0.972 . . . . 0.01 111.34 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -125.56 153.75 72.7 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 120.94 -1.1 . . . . 2.54 108.738 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.67 -43.35 32.79 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 119.145 0.73 . . . . 0.7 110.724 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.34 -20.72 21.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.728 -1.233 . . . . 0.86 108.632 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -65.67 -16.2 63.51 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.044 -1.035 . . . . 0.02 109.568 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.42 ' CZ3' ' CD1' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -94.91 9.76 38.06 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.026 -1.101 . . . . 0.02 108.026 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.02 10.43 86.26 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.259 -1.448 . . . . 0.02 109.693 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.56 142.22 31.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.482 -1.011 . . . . 0.02 110.145 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.46 -8.48 58.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.7 -0.625 . . . . 0.59 109.819 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 32.2 m -144.5 151.05 49.66 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.888 -1.133 . . . . 0.87 108.602 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.8 21.3 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 120.786 0.991 . . . . 0.38 112.294 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.06 122.69 28.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.525 1.155 . . . . 0.18 111.476 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.42 ' CD1' ' CZ3' ' A' ' 162' ' ' TRP . 56.4 mt -145.76 125.35 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.183 -1.784 . . . . 3.99 106.183 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -111.65 -19.34 12.52 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.024 -1.048 . . . . 5.17 113.094 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.2 t -157.05 160.49 38.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.328 -2.108 . . . . 0.02 110.2 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.402 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 11.6 p90 -151.55 152.25 32.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.116 -0.99 . . . . 2.02 110.272 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.419 ' CG ' ' CE1' ' A' ' 144' ' ' TYR . 7.1 mmm180 -143.34 149.81 38.29 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.388 -0.82 . . . . 0.01 110.033 -178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -88.56 143.46 26.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.464 -0.772 . . . . 0.01 109.566 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.11 128.25 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.136 -0.977 . . . . 3.04 109.123 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.9 t -136.01 146.48 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.223 -0.923 . . . . 1.89 109.496 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 4.89 109.508 179.995 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.429 -1.468 . . . . 0.01 109.429 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -151.28 138.2 19.02 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.214 -1.168 . . . . 0.02 110.355 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 tt -130.13 138.33 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.055 -0.72 . . . . 0.02 109.055 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.532 ' HG ' ' HE ' ' A' ' 19' ' ' ARG . 5.5 t -120.72 130.59 54.13 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.468 -0.77 . . . . 0.39 110.058 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.6 m-85 -110.86 140.09 45.62 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.695 -0.628 . . . . 0.02 109.548 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.8 m-85 -122.51 138.61 54.51 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.219 -0.926 . . . . 0.02 109.362 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.41 -27.13 65.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.126 -0.984 . . . . 0.03 111.781 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -114.18 169.88 8.7 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.926 -1.109 . . . . 0.03 110.15 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -75.61 158.25 32.68 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.626 0.727 . . . . 0.03 110.074 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 66.22 33.18 7.46 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.899 0.857 . . . . 0.74 111.029 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.47 41.58 30.74 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.235 0.541 . . . . 0.02 111.212 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -113.02 166.09 11.74 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.321 -0.992 . . . . 0.02 108.321 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.48 -167.71 35.75 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.965 -1.112 . . . . 0.03 110.446 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -68.71 142.15 55.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.229 -1.159 . . . . 2.76 108.771 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.532 ' HE ' ' HG ' ' A' ' 8' ' ' SER . 1.6 tmt_? -122.75 149.37 44.19 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.653 -0.654 . . . . 1.89 110.013 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -135.93 133.02 37.19 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.685 -0.634 . . . . 0.02 109.656 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 2.2 p-10 -109.64 136.46 48.96 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.526 -0.733 . . . . 1.12 109.07 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 54.1 t -128.2 138.08 52.31 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.554 -0.716 . . . . 0.02 109.618 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -119.24 11.14 12.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.62 -0.675 . . . . 0.2 110.645 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 30.4 p -159.27 173.67 15.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.779 -1.201 . . . . 1.23 109.124 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.69 145.73 53.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.612 -1.305 . . . . 0.02 110.694 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.561 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 21.6 t -134.6 118.42 17.21 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.09 -0.708 . . . . 0.02 109.09 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.23 -20.95 54.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.373 -0.829 . . . . 0.24 111.444 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -155.31 105.68 2.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.797 -1.189 . . . . 1.14 109.707 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.63 8.81 41.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.388 -0.82 . . . . 6.37 109.922 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -60.55 -29.13 68.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -0.841 . . . . 3.11 111.978 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.8 m -76.45 -17.61 59.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.466 -1.396 . . . . 0.88 111.347 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -107.32 -20.24 13.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.374 -0.829 . . . . 0.02 110.539 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 tp -148.83 127.02 12.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.89 -1.131 . . . . 3.32 109.631 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.9 t -87.14 -12.58 46.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.615 -0.678 . . . . 0.02 111.37 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -171.82 161.91 6.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.73 -1.231 . . . . 0.02 108.364 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.91 116.62 8.71 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.972 -1.08 . . . . 0.02 109.043 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 1.9 m120 -109.41 0.41 19.37 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.671 -1.268 . . . . 0.03 111.862 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.1 t -156.39 154.38 30.41 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.274 -1.01 . . . . 0.02 108.274 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -146.14 146.91 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 122.328 1.061 . . . . 0.02 111.092 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -122.77 124.24 42.89 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.706 -1.22 . . . . 0.02 107.706 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -106.67 114.33 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 106.716 -1.587 . . . . 0.02 106.716 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.26 -34.38 23.84 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.348 -0.541 . . . . 3.81 110.554 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.19 149.99 18.26 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.102 -1.523 . . . . 0.02 110.682 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.31 172.54 49.13 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.374 -1.09 . . . . 0.01 110.374 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -118.24 134.05 55.36 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 107.81 -1.181 . . . . 1.48 107.81 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -126.47 154.89 43.11 Favored 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 122.587 1.184 . . . . 0.02 112.274 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.08 52.27 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.681 -1.97 . . . . 0.24 105.681 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.36 141.64 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -0.758 . . . . 0.65 109.298 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -120.52 143.07 48.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.158 0.98 . . . . 0.02 109.536 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' CD ' HH21 ' A' ' 78' ' ' ARG . 31.2 tt0 -65.35 -34.07 77.46 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.52 -0.764 . . . . 0.02 111.794 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -124.65 157.95 63.86 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.095 -1.003 . . . . 0.02 109.323 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.56 167.05 1.03 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.67 1.58 . . . . 0.02 112.623 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.1 t30 62.82 36.44 13.04 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.238 -0.892 . . . . 0.02 111.007 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.494 ' H ' ' HG ' ' A' ' 81' ' ' SER . 4.5 m-85 45.21 51.53 9.13 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.728 0.775 . . . . 3.39 110.72 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -125.37 163.26 22.98 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.234 0.54 . . . . 2.33 109.818 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.32 -161.34 31.31 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.426 ' ND1' ' OE1' ' A' ' 50' ' ' GLU . 10.9 m80 -65.35 138.54 58.23 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.89 -1.359 . . . . 0.02 110.251 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -119.58 137.16 54.02 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.773 -0.579 . . . . 5.01 109.505 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.486 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.4 m-85 -134.75 140.38 45.88 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.437 -0.789 . . . . 0.02 109.978 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.8 mm -94.49 130.74 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.863 -0.791 . . . . 1.72 108.863 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -121.22 110.95 34.02 Favored Pre-proline 0 N--CA 1.505 2.287 0 O-C-N 121.353 -0.842 . . . . 0.02 110.702 -178.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.67 169.79 20.25 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 CA-C-N 119.819 0.971 . . . . 1.47 110.423 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -53.19 141.7 22.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.023 -1.048 . . . . 4.25 110.413 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.92 -177.83 31.17 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.41 -1.376 . . . . 0.02 111.012 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -119.55 131.32 55.5 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.453 -1.028 . . . . 0.96 109.749 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 53.3 m-85 -122.42 96.03 46.37 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 107.823 -1.176 . . . . 0.02 107.823 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.52 -3.43 11.05 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.831 1.021 . . . . 0.02 113.876 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -157.39 154.22 28.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.548 -1.345 . . . . 2.02 108.098 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -59.7 -38.98 83.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.02 112.016 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -60.16 -23.76 64.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.149 -0.969 . . . . 0.02 110.417 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -70.18 -18.26 63.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 3.42 108.755 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.552 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.0 OUTLIER -108.26 10.78 27.69 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.56 -1.274 . . . . 0.02 107.56 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.6 mtt 61.65 22.73 13.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.02 110.546 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.12 144.57 48.64 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.81 -1.316 . . . . 0.02 109.81 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.05 -30.28 39.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -1.219 . . . . 0.98 107.88 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -157.03 -171.48 3.66 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.666 -1.605 . . . . 0.02 106.666 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.498 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 65.9 m-20 -98.66 28.34 4.3 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.64 -1.288 . . . . 0.02 110.847 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.49 HH21 ' CD ' ' A' ' 50' ' ' GLU . 27.7 mtm-85 -96.77 122.82 40.13 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.833 -1.167 . . . . 3.2 111.351 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.05 119.3 11.47 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 107.618 -1.253 . . . . 2.61 107.618 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.86 -18.53 9.32 Favored Glycine 0 N--CA 1.499 2.889 0 O-C-N 121.12 -0.988 . . . . 0.02 112.638 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 54' ' ' PHE . 6.4 p -156.16 156.69 34.66 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 119.628 1.714 . . . . 0.02 110.841 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 57.0 m -145.91 148.42 32.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.366 -0.834 . . . . 0.02 110.361 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -137.05 141.89 42.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.435 -0.791 . . . . 0.01 109.284 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 132.18 36.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.048 -1.033 . . . . 0.43 109.443 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 t -91.49 124.58 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.874 -0.787 . . . . 1.25 108.874 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -92.58 131.3 37.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.942 -1.099 . . . . 1.77 108.569 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mt -95.87 139.69 31.72 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.233 -1.025 . . . . 1.63 108.233 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.6 t -110.89 126.12 54.36 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.643 -0.873 . . . . 1.08 108.643 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.0 m -102.58 -154.91 0.5 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.069 -1.826 . . . . 1.26 106.069 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.23 -51.01 0.82 Allowed Glycine 0 N--CA 1.498 2.778 0 O-C-N 120.522 -1.361 . . . . 0.01 112.029 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.56 -99.85 0.13 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 118.683 -1.722 . . . . 0.01 112.121 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -120.17 120.37 35.97 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.202 -1.175 . . . . 4.43 110.723 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.2 137.58 57.09 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.362 -0.607 . . . . 2.99 109.362 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 32.6 ttmt -136.53 130.44 32.46 Favored 'General case' 0 N--CA 1.516 2.856 0 CA-C-O 122.155 0.979 . . . . 6.36 113.031 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -131.81 141.37 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-N 115.51 -0.768 . . . . 1.09 110.524 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 pt20 -124.45 139.78 53.57 Favored 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 107.485 -1.302 . . . . 2.05 107.485 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.83 146.07 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 O-C-N 120.734 -1.229 . . . . 1.1 111.038 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -120.73 139.96 52.34 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.046 0.927 . . . . 0.73 110.817 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -68.6 -32.47 72.38 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.688 -0.687 . . . . 0.02 112.025 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -114.27 165.35 12.78 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.855 -1.153 . . . . 3.18 110.087 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.29 163.41 45.75 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.973 -0.851 . . . . 0.01 110.973 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.428 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 9.5 m-20 57.29 38.86 28.8 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.541 0.686 . . . . 0.01 111.069 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.451 ' C ' HD21 ' A' ' 104' ' ' ASN . 19.8 m-85 52.65 56.23 7.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.534 -0.729 . . . . 0.01 111.087 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.451 HD21 ' C ' ' A' ' 103' ' ' PHE . 1.8 m-80 -128.59 164.93 21.78 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.998 -1.112 . . . . 3.15 107.998 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.93 -162.6 28.86 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.04 -1.624 . . . . 0.01 109.04 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -75.34 141.57 43.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.839 -1.389 . . . . 0.01 108.963 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' A' ' 107' ' ' MET . 9.3 tmm? -116.33 142.94 46.18 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.482 0.658 . . . . 0.01 109.431 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -132.44 136.55 46.81 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.348 -0.982 . . . . 2.48 108.348 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -116.35 134.15 55.22 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.713 -0.617 . . . . 0.01 109.615 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -149.1 147.92 29.07 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.522 1.153 . . . . 1.69 111.358 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.4 p -114.53 7.66 16.2 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.972 -1.013 . . . . 0.01 109.901 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -122.14 163.34 19.68 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.443 -0.786 . . . . 3.21 111.264 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 4.9 p30 -69.57 154.6 41.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.01 109.568 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.5 t -126.79 115.33 22.45 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.487 -0.758 . . . . 0.01 108.976 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.03 -32.69 5.14 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 120.4 1.179 . . . . 0.01 111.346 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.0 m -142.12 108.38 5.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.368 -0.833 . . . . 0.02 109.203 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.412 HD12 HG21 ' A' ' 117' ' ' ILE . 96.0 mt -64.22 -39.66 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.769 -0.582 . . . . 1.83 111.03 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.3 ttt -67.04 -37.79 84.72 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.141 -1.024 . . . . 1.34 109.835 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -69.59 -38.5 77.34 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.622 -1.299 . . . . 2.11 109.724 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -80.62 -47.4 14.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -0.919 . . . . 2.08 112.531 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -111.0 -0.72 16.58 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.291 -0.881 . . . . 0.02 112.727 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.3 m170 59.96 33.51 21.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.738 -1.226 . . . . 0.02 109.436 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.53 135.38 53.31 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.73 -0.841 . . . . 0.02 108.73 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -92.42 -23.03 19.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.288 -0.883 . . . . 5.32 110.605 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -148.8 163.64 36.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.163 -0.96 . . . . 0.02 109.934 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.432 HD13 HG22 ' A' ' 126' ' ' ILE . 55.4 mt -131.57 129.46 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 107.454 -1.313 . . . . 2.17 107.454 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -107.86 -13.21 15.04 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.216 -0.927 . . . . 0.02 113.142 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -154.1 152.11 30.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.432 -1.418 . . . . 0.01 108.251 178.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 7.3 t -161.77 145.12 12.25 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.212 -1.555 . . . . 1.22 109.56 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.447 ' HZ1' ' CB ' ' A' ' 155' ' ' GLU . 10.5 tttp -122.02 111.03 16.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.191 0.996 . . . . 1.41 108.861 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.14 121.96 63.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 105.733 -1.951 . . . . 0.01 105.733 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.7 t -146.27 64.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 117.996 -1.482 . . . . 1.98 108.955 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.2 tp10 176.67 109.67 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.485 -1.672 . . . . 0.01 106.485 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.16 -173.41 45.71 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.214 -1.154 . . . . 0.01 110.214 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.42 142.95 41.43 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.491 -1.006 . . . . 2.3 108.93 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -129.2 145.21 51.37 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.513 -0.742 . . . . 0.01 109.958 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.0 mt -118.2 142.09 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 107.743 -1.206 . . . . 1.69 107.743 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.2 143.25 45.13 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 107.515 -1.291 . . . . 2.49 107.515 177.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -122.56 143.65 49.6 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.107 -0.701 . . . . 0.02 109.107 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.45 -29.95 62.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.614 -0.679 . . . . 0.02 112.19 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.26 153.58 47.42 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 120.674 -1.266 . . . . 1.48 109.128 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.35 166.59 1.67 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.237 1.291 . . . . 0.02 112.492 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 59.67 31.54 20.95 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.166 -0.925 . . . . 0.75 111.127 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.482 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.8 m-85 57.62 51.51 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.513 -0.742 . . . . 0.02 111.066 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -124.97 163.81 21.49 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.484 -0.76 . . . . 0.02 109.886 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.68 -165.36 32.14 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.838 -1.305 . . . . 0.02 109.838 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -67.71 141.41 56.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.979 . . . . 0.02 108.81 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.63 148.37 42.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.246 -0.65 . . . . 0.02 109.246 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.442 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.04 143.07 50.75 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.808 -0.812 . . . . 0.01 108.808 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 tt -97.51 121.99 40.05 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.385 -0.822 . . . . 0.01 109.127 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.9 mt -104.3 135.63 45.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.01 110.311 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 154' ' ' LYS . 13.2 m-20 -108.05 173.36 6.36 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -58.68 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.992 -1.068 . . . . 1.84 108.614 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 152' ' ' ASP . 40.8 tttm -137.04 168.75 19.0 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.362 -0.836 . . . . 2.28 111.483 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 1.6 pm0 -112.61 111.37 22.13 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.213 -1.032 . . . . 0.01 108.213 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -100.68 116.03 31.62 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.053 -1.029 . . . . 0.01 110.059 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.448 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.9 ptm180 -92.78 -25.6 18.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.101 -0.999 . . . . 0.01 111.49 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -125.96 153.08 73.73 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.78 -1.2 . . . . 2.54 108.716 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.72 -42.2 40.75 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 119.271 0.775 . . . . 0.7 110.62 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.78 -20.22 21.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.706 -1.246 . . . . 0.86 108.508 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -65.65 -16.16 63.47 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.941 -1.099 . . . . 0.02 109.494 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.442 ' O ' ' CE2' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -95.11 9.68 38.67 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.881 -1.155 . . . . 0.02 107.881 178.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.53 11.07 85.5 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 119.295 -1.431 . . . . 0.02 109.659 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.96 142.24 31.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.44 -1.035 . . . . 0.02 110.174 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.44 -8.28 59.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.736 -0.603 . . . . 0.59 109.987 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.0 p -144.48 150.85 49.05 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.709 -1.244 . . . . 0.87 108.771 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -76.05 21.31 0.52 Allowed 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 120.818 1.012 . . . . 0.38 112.248 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.63 123.99 29.76 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.572 1.177 . . . . 0.18 111.739 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.2 mt -147.05 126.71 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 106.925 -1.509 . . . . 3.99 106.925 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -112.66 -19.52 12.02 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.132 -0.98 . . . . 5.17 112.826 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.1 p -158.4 161.44 37.53 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 119.242 -2.161 . . . . 0.02 110.216 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -153.03 154.6 35.24 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.182 -0.948 . . . . 2.02 110.576 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.482 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 25.5 mtp180 -143.84 150.54 38.63 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.086 -1.009 . . . . 0.01 110.314 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -87.74 142.72 27.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.622 -0.674 . . . . 0.01 109.268 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.5 mt -93.14 128.19 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.089 -1.007 . . . . 3.04 109.033 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.4 m -135.89 146.31 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.116 -0.99 . . . . 1.89 109.558 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 4.89 109.389 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 110.322 -1.111 . . . . 0.01 110.322 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -152.37 138.59 18.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.354 -1.086 . . . . 0.02 109.769 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.4 139.52 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.194 -0.669 . . . . 0.02 109.194 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 t -122.08 130.96 53.72 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.464 -0.773 . . . . 0.39 110.301 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 m-85 -111.16 140.31 45.81 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.617 -0.677 . . . . 0.02 109.623 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.7 m-85 -121.8 138.54 54.33 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.296 -0.877 . . . . 0.02 109.368 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -68.99 -27.33 65.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.905 -1.122 . . . . 0.03 111.767 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -114.47 170.35 8.37 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.864 -1.147 . . . . 0.03 110.111 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -74.99 161.59 29.33 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.673 0.749 . . . . 0.03 110.137 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.608 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 6.0 t-20 62.42 34.97 15.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.907 0.86 . . . . 0.74 110.634 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.608 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 19.5 p90 49.68 43.31 24.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.307 -0.861 . . . . 0.02 111.057 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -109.43 165.71 11.43 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.73 -1.211 . . . . 0.02 107.73 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.41 -167.86 34.4 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 120.775 -1.203 . . . . 0.03 110.688 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -68.84 143.66 54.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.382 -1.069 . . . . 2.76 108.883 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.532 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 48.9 ttt180 -122.1 149.94 42.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.615 -0.678 . . . . 1.89 110.039 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -136.91 132.63 34.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.653 -0.654 . . . . 0.02 109.303 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -109.75 136.14 49.55 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.435 -0.79 . . . . 1.12 109.046 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.1 t -127.86 137.71 52.43 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.522 -0.736 . . . . 0.02 109.42 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.492 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -118.41 11.98 13.18 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.2 110.15 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 29.3 m -159.17 173.77 15.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.849 -1.157 . . . . 1.23 108.826 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 33.4 p30 -62.87 145.8 54.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.856 -1.152 . . . . 0.02 110.324 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 10.8 p -134.89 119.2 17.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.497 -0.752 . . . . 0.02 109.16 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.2 -20.97 47.02 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.257 -0.902 . . . . 0.24 112.297 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.48 106.28 3.1 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.702 -1.249 . . . . 1.14 110.175 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.512 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.1 6.46 40.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.341 -0.849 . . . . 6.37 110.046 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -61.21 -30.37 70.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 3.11 112.097 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.1 m -77.1 -17.52 58.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.308 -1.495 . . . . 0.88 110.965 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -106.66 -21.19 13.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.453 -0.78 . . . . 0.02 110.64 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -149.01 127.18 12.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.98 -1.075 . . . . 3.32 109.599 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.9 t -86.66 -12.2 49.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.531 -0.731 . . . . 0.02 111.176 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -172.0 161.73 5.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.867 -1.146 . . . . 0.02 108.357 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.5 t -143.19 116.59 9.07 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.914 -1.116 . . . . 0.02 108.936 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -109.33 0.29 19.43 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.831 -1.168 . . . . 0.03 111.608 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 66' ' ' TYR . 31.1 t -156.92 154.72 30.2 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.508 -0.923 . . . . 0.02 108.508 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.1 147.0 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 122.232 1.015 . . . . 0.02 110.79 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -122.21 123.67 42.03 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.847 -1.168 . . . . 0.02 107.847 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 t -106.52 113.75 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 106.746 -1.576 . . . . 0.02 106.746 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -83.95 -34.12 24.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.17 -0.612 . . . . 3.81 110.412 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.94 150.63 19.76 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 119.052 -1.546 . . . . 0.02 110.525 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.32 172.08 48.72 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.871 -1.157 . . . . 0.01 110.502 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.7 m -118.48 134.72 54.85 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.69 -1.226 . . . . 1.48 107.69 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.0 m95 -127.58 155.01 44.51 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.601 1.191 . . . . 0.02 112.118 -176.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.38 134.26 52.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 105.518 -2.03 . . . . 0.24 105.518 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.02 143.48 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.523 -0.736 . . . . 0.65 109.374 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -120.69 144.67 48.09 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.165 0.983 . . . . 0.02 110.06 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' OE2' ' ND1' ' A' ' 57' ' ' HIS . 21.0 tt0 -65.95 -33.09 75.02 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.798 -0.637 . . . . 0.02 111.505 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -124.62 158.1 63.25 Favored Pre-proline 0 N--CA 1.503 2.219 0 O-C-N 120.993 -1.067 . . . . 0.02 109.419 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.61 166.68 1.19 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.692 1.595 . . . . 0.02 112.772 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.56 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 63.31 36.62 11.57 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.464 -0.789 . . . . 0.02 110.934 178.211 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.46 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 6.5 m-85 45.23 51.74 9.05 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.612 0.72 . . . . 3.39 110.749 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.53 ' HG ' ' N ' ' A' ' 56' ' ' GLY . 27.1 t -125.99 163.61 22.63 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.208 0.528 . . . . 2.33 109.883 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.53 ' N ' ' HG ' ' A' ' 55' ' ' SER . . . 88.7 -161.9 31.21 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.705 -1.358 . . . . 0.02 109.705 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.457 ' ND1' ' OE2' ' A' ' 50' ' ' GLU . 14.0 m80 -64.34 138.87 58.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.922 -1.34 . . . . 0.02 110.122 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -118.77 137.16 53.56 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.337 0.589 . . . . 5.01 109.609 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.556 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.5 m-85 -134.73 139.34 45.11 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.459 -0.776 . . . . 0.02 109.912 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 60' ' ' ILE . 25.7 mm -95.51 130.97 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.11 -0.7 . . . . 1.72 109.11 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.5 mt -122.33 112.01 31.59 Favored Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.261 -0.9 . . . . 0.02 110.835 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.38 170.84 18.7 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 119.754 0.948 . . . . 1.47 110.03 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -52.28 140.79 20.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 4.25 110.243 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.39 -177.46 32.55 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.4 -1.381 . . . . 0.02 110.769 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -121.02 131.94 54.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.381 -1.07 . . . . 0.96 109.878 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.407 ' O ' ' OG ' ' A' ' 38' ' ' SER . 96.6 m-85 -122.27 97.79 44.89 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 107.768 -1.197 . . . . 0.02 107.768 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.08 -2.23 10.78 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.79 0.994 . . . . 0.02 113.694 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -157.32 153.94 28.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.734 -1.228 . . . . 2.02 108.156 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -59.96 -39.68 86.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.478 -0.764 . . . . 0.02 111.778 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -59.73 -23.88 63.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.02 110.35 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -70.87 -18.49 62.69 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.926 0.869 . . . . 3.42 108.937 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.556 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.72 10.08 28.97 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.376 -1.342 . . . . 0.02 107.376 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.6 mtt 61.04 22.4 12.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.593 -0.692 . . . . 0.02 110.518 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.93 144.45 46.56 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.571 -1.412 . . . . 0.02 109.571 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -79.42 -30.8 42.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.699 -1.222 . . . . 0.98 107.699 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 11.7 p-10 -157.03 -171.65 3.72 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.35 -1.722 . . . . 0.02 106.35 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -98.61 28.74 4.04 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.652 -1.28 . . . . 0.02 110.591 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' ' 78' ' ' ARG . 25.5 ttm-85 -96.77 122.23 39.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.817 -1.177 . . . . 3.2 111.005 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.4 mt -141.9 119.37 11.62 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.606 -1.257 . . . . 2.61 107.606 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.4 -18.34 9.78 Favored Glycine 0 N--CA 1.501 3.026 0 O-C-N 121.129 -0.982 . . . . 0.02 112.579 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.1 p -156.48 156.81 34.37 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 119.502 1.651 . . . . 0.02 110.451 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.4 m -145.38 148.26 33.17 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.623 -0.673 . . . . 0.02 109.846 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.46 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 51.1 mtp180 -137.48 141.98 41.52 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.193 -0.942 . . . . 0.01 109.283 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 133.18 36.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.237 -0.915 . . . . 0.43 109.679 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.74 123.66 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.112 -1.07 . . . . 1.25 108.112 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -94.92 133.29 38.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.131 . . . . 1.77 108.956 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.57 134.14 37.44 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.714 -1.217 . . . . 1.63 107.714 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m -106.79 130.27 54.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.501 -0.749 . . . . 1.08 109.988 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.4 p -115.3 100.53 8.19 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 102.749 -3.056 . . . . 1.26 102.749 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -119.74 -60.84 0.26 Allowed Glycine 0 N--CA 1.51 3.623 0 N-CA-C 110.069 -1.212 . . . . 0.01 110.069 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.13 -107.82 1.32 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.353 -1.499 . . . . 0.01 109.353 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.4 ' CG ' ' H ' ' A' ' 93' ' ' ALA . 9.2 tt0 -120.55 -141.01 0.34 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.679 -0.895 . . . . 4.43 109.213 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.4 ' H ' ' CG ' ' A' ' 92' ' ' GLN . . . -126.5 119.73 27.91 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.23 -1.026 . . . . 2.99 108.23 177.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -144.1 121.98 12.0 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.416 -1.427 . . . . 6.36 113.28 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.3 tt -130.71 138.09 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.435 0.636 . . . . 1.09 109.681 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.483 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.6 pt20 -123.84 138.76 54.44 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.418 -1.327 . . . . 2.05 107.418 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.61 146.21 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.687 -1.258 . . . . 1.1 110.658 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -119.77 141.7 49.23 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.215 1.007 . . . . 0.73 111.385 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.32 -33.02 72.5 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.783 -0.644 . . . . 0.02 111.358 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.8 mmmt -114.38 167.91 10.31 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.122 -0.986 . . . . 3.18 109.66 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.68 168.89 45.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 111.169 -0.772 . . . . 0.01 111.169 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 53.53 39.51 30.14 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.511 0.672 . . . . 0.01 111.598 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 52.48 48.45 22.56 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.707 -0.621 . . . . 0.01 110.934 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -121.67 164.22 17.7 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.332 -0.988 . . . . 3.15 108.332 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.69 -163.09 29.48 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.042 -1.623 . . . . 0.01 109.042 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.5 141.58 43.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.798 -1.413 . . . . 0.01 109.199 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.458 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.6 tmm? -116.24 143.79 45.06 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.479 0.657 . . . . 0.01 109.595 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.44 136.44 46.73 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.387 -0.968 . . . . 2.48 108.387 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -117.36 133.94 55.4 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.576 -0.703 . . . . 0.01 109.771 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.428 ' HG1' ' N ' ' A' ' 111' ' ' THR . 8.4 t -149.58 149.2 30.33 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.481 1.134 . . . . 1.69 111.329 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.428 ' N ' ' HG1' ' A' ' 110' ' ' THR . 28.7 p -114.74 7.96 16.01 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.057 -0.974 . . . . 0.01 110.334 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 23.9 mp0 -121.62 163.16 19.41 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.345 -0.847 . . . . 3.21 111.018 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.6 p30 -69.46 154.91 41.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.479 -0.763 . . . . 0.01 109.451 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.4 t -127.31 115.17 21.5 Favored Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 109.13 -0.692 . . . . 0.01 109.13 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.4 -31.44 5.72 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 120.295 1.141 . . . . 0.01 111.429 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.3 m -142.46 107.86 5.03 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.385 -0.822 . . . . 0.02 108.989 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.07 -39.92 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.783 -0.573 . . . . 1.83 111.066 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.44 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 15.1 tpt -66.43 -37.4 85.11 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.167 -1.013 . . . . 1.34 109.766 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -70.15 -38.42 75.47 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.584 -1.322 . . . . 2.11 109.791 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -80.56 -47.4 14.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.179 -0.951 . . . . 2.08 112.354 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -111.04 -0.81 16.52 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.329 -0.857 . . . . 0.02 112.852 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.3 m80 59.6 33.53 22.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.732 -1.23 . . . . 0.02 109.525 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.44 ' C ' ' SD ' ' A' ' 118' ' ' MET . 6.4 mt -112.4 135.45 53.08 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 108.703 -0.851 . . . . 0.02 108.703 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -92.12 -23.01 19.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 5.32 110.633 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -149.15 163.6 37.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.078 -1.014 . . . . 0.02 110.101 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 126' ' ' ILE . 57.5 mt -132.25 129.55 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 107.475 -1.305 . . . . 2.17 107.475 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -107.65 -12.12 15.31 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.159 -0.963 . . . . 0.02 113.13 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -156.7 154.12 29.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.467 -1.396 . . . . 0.01 107.759 178.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.9 t -161.48 146.0 13.24 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.877 -1.139 . . . . 1.22 109.639 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -121.86 109.56 14.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.374 1.083 . . . . 1.41 108.949 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.53 122.18 64.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 106.408 -1.701 . . . . 0.01 106.408 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.63 68.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 118.639 -1.225 . . . . 1.98 107.802 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 174.13 105.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.705 -1.591 . . . . 0.01 106.705 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.11 -177.07 46.04 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.548 -1.421 . . . . 0.01 109.548 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.8 m -109.55 143.73 38.82 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.442 -1.034 . . . . 2.3 108.659 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -128.56 145.34 51.16 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.474 -0.767 . . . . 0.01 110.49 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.4 mt -116.56 140.29 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 107.504 -1.295 . . . . 1.69 107.504 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -112.89 141.7 46.42 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 107.577 -1.268 . . . . 2.49 107.577 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 15.3 m-85 -121.99 143.54 49.42 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.008 -0.738 . . . . 0.02 109.008 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 140' ' ' GLU . 3.2 tm-20 -73.32 -29.74 62.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.02 112.001 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -114.76 153.92 46.86 Favored Pre-proline 0 N--CA 1.508 2.457 0 O-C-N 120.593 -1.317 . . . . 1.48 109.332 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.47 166.27 1.91 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.13 1.22 . . . . 0.02 112.44 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 59.97 31.1 20.51 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.178 -0.919 . . . . 0.75 111.138 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 58.0 51.53 8.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.553 -0.717 . . . . 0.02 111.044 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -124.95 163.69 21.74 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.551 -0.718 . . . . 0.02 109.76 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.93 -165.28 31.76 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.804 -1.318 . . . . 0.02 109.804 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -67.86 141.97 56.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -1.004 . . . . 0.02 108.831 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.462 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.3 mp0 -118.57 149.42 41.37 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.509 -0.552 . . . . 0.02 109.509 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.49 141.89 51.25 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.536 -0.727 . . . . 0.01 109.263 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.7 tp -94.61 119.91 34.01 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.826 -0.805 . . . . 0.01 108.826 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.7 mt -106.67 136.22 46.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.44 -0.788 . . . . 0.01 110.781 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 154' ' ' LYS . 16.3 t0 -110.42 171.35 7.51 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.21 -1.033 . . . . 2.27 108.21 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 pttm -55.74 86.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.0 -1.063 . . . . 1.84 108.605 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 152' ' ' ASP . 56.0 mttp -136.27 168.6 19.11 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.096 -1.003 . . . . 2.28 111.423 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 18.9 mp0 -112.99 109.7 19.28 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.129 -1.063 . . . . 0.01 108.129 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -101.05 115.05 29.57 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.019 -1.05 . . . . 0.01 110.448 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -92.19 -25.65 18.57 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.083 -1.011 . . . . 0.01 111.324 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -126.2 153.53 74.36 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.797 -1.189 . . . . 2.54 108.54 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.04 -42.61 35.33 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 CA-C-N 119.313 0.791 . . . . 0.7 110.644 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.6 t -60.24 -20.71 20.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.637 -1.29 . . . . 0.86 108.669 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -65.87 -15.95 63.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.888 -1.132 . . . . 0.02 109.609 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.83 9.55 38.69 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.08 10.56 86.2 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.349 -1.405 . . . . 0.02 109.784 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.54 142.13 31.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.455 -1.027 . . . . 0.02 110.194 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.62 -8.41 58.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.66 -0.65 . . . . 0.59 109.767 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.9 p -144.49 150.98 49.52 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.947 -1.095 . . . . 0.87 108.544 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -76.15 21.56 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.738 0.958 . . . . 0.38 112.4 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.14 123.89 29.97 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.592 1.187 . . . . 0.18 111.92 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.0 mt -146.08 125.22 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 106.38 -1.711 . . . . 3.99 106.38 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -111.21 -20.26 12.39 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.154 -0.966 . . . . 5.17 112.988 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.7 p -157.89 160.17 37.36 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 119.423 -2.048 . . . . 0.02 109.871 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -152.81 154.59 35.47 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.095 -1.003 . . . . 2.02 110.426 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -144.33 151.63 39.61 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.25 -0.906 . . . . 0.01 110.712 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -88.27 144.88 26.16 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.168 -0.679 . . . . 0.01 109.168 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -95.63 128.58 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.165 -0.959 . . . . 3.04 109.403 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 177' ' ' GLU . 17.4 m -136.81 146.6 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.229 -0.92 . . . . 1.89 109.304 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 176' ' ' VAL . 16.1 pt-20 . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.891 -0.506 . . . . 4.89 110.808 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.107 -1.597 . . . . 0.01 109.107 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -149.06 136.99 20.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.015 -1.285 . . . . 0.02 110.255 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 tt -130.43 140.67 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.136 -0.69 . . . . 0.02 109.136 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 t -121.47 130.23 53.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.427 -0.795 . . . . 0.39 110.146 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.51 140.42 44.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.647 -0.658 . . . . 0.02 109.361 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -121.92 138.26 54.48 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.189 -0.944 . . . . 0.02 109.493 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -69.47 -27.42 65.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.892 -1.13 . . . . 0.03 111.672 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -113.89 169.86 8.69 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.801 -1.187 . . . . 0.03 110.241 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -75.62 158.42 32.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.509 0.671 . . . . 0.03 110.174 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 43.8 t30 65.78 35.37 6.83 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.883 0.849 . . . . 0.74 110.759 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.602 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.99 44.62 25.57 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.682 0.754 . . . . 0.02 111.26 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -112.58 165.67 12.04 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.975 -1.12 . . . . 0.02 107.975 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.09 -167.57 34.57 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.789 -1.196 . . . . 0.03 110.563 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -69.14 142.64 54.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -1.06 . . . . 2.76 109.073 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -122.3 150.13 42.77 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.455 -0.778 . . . . 1.89 110.152 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -136.53 133.12 36.14 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.665 -0.647 . . . . 0.02 109.351 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -109.37 135.74 49.93 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.772 -0.825 . . . . 1.12 108.772 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -127.44 138.02 52.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.588 -0.695 . . . . 0.02 109.516 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -118.81 12.14 12.86 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.598 -0.689 . . . . 0.2 110.305 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 39.0 t -159.94 173.79 15.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.771 -1.206 . . . . 1.23 109.079 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.423 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 4.9 p-10 -63.29 146.36 53.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.805 -1.184 . . . . 0.02 110.652 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.9 m -133.45 117.34 17.09 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.725 -0.843 . . . . 0.02 108.725 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.3 -20.26 55.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.477 -0.764 . . . . 0.24 111.806 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 25.4 p-10 -152.85 106.28 3.04 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.887 -1.133 . . . . 1.14 109.287 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.76 5.21 41.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.473 -0.767 . . . . 6.37 110.427 -178.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -62.46 -29.42 70.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 3.11 112.65 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -77.05 -18.42 58.09 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.159 -1.588 . . . . 0.88 111.797 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -107.25 -19.52 13.57 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.313 -0.867 . . . . 0.02 110.438 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.4 tp -148.73 126.91 12.1 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.927 -1.108 . . . . 3.32 109.467 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 t -87.43 -13.07 44.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.538 -0.726 . . . . 0.02 111.362 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -172.55 161.73 5.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.819 -1.176 . . . . 0.02 108.5 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.6 p -143.86 116.59 8.72 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.194 -0.941 . . . . 0.02 108.85 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.553 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.0 OUTLIER -108.38 -0.06 20.85 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.744 -1.223 . . . . 0.03 111.314 -178.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 t -155.9 153.85 30.31 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.723 -1.214 . . . . 0.02 107.723 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.1 mt -146.81 147.97 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.253 1.025 . . . . 0.02 110.727 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -123.49 125.04 44.2 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.95 -1.13 . . . . 0.02 107.95 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.59 114.02 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 106.663 -1.606 . . . . 0.02 106.663 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -85.36 -34.72 21.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.628 -0.67 . . . . 3.81 110.277 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.31 148.9 16.52 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.52 -1.8 . . . . 0.02 110.72 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.89 172.33 48.7 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.284 -1.126 . . . . 0.01 110.284 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.3 m -118.58 134.95 54.71 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.529 -1.285 . . . . 1.48 107.529 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -127.17 154.28 44.99 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.703 1.239 . . . . 0.02 112.305 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.95 134.28 51.82 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 105.176 -2.157 . . . . 0.24 105.176 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.16 144.32 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.578 -0.701 . . . . 0.65 109.512 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -120.78 144.68 48.17 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.083 0.944 . . . . 0.02 109.976 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.61 -33.45 75.69 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.833 -0.621 . . . . 0.02 111.925 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -123.75 158.12 60.63 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.069 -1.019 . . . . 0.02 109.521 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -52.9 164.7 1.48 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.503 1.468 . . . . 0.02 112.669 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 64.1 37.29 9.15 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.722 0.772 . . . . 0.02 111.299 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 45.1 51.6 8.87 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.689 0.757 . . . . 3.39 110.764 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -125.92 163.59 22.63 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.185 0.517 . . . . 2.33 109.811 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.71 -161.72 31.06 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.729 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -64.46 139.43 58.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.997 -1.296 . . . . 0.02 110.275 -178.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.3 ppp? -119.0 137.16 53.72 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.769 -0.582 . . . . 5.01 109.663 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.474 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.8 m-85 -134.92 139.32 44.87 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.434 -0.791 . . . . 0.02 110.197 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.6 mm -94.21 130.56 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.953 -0.758 . . . . 1.72 108.953 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 mt -120.95 111.13 34.35 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 121.251 -0.905 . . . . 0.02 110.887 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.15 169.86 19.62 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 CA-C-N 119.742 0.943 . . . . 1.47 110.184 177.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -52.94 141.03 23.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.894 -1.129 . . . . 4.25 110.388 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.82 -177.59 32.02 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.551 -1.309 . . . . 0.02 110.929 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -120.06 131.39 55.08 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.56 -0.964 . . . . 0.96 109.91 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -121.94 92.93 48.81 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 107.928 -1.138 . . . . 0.02 107.928 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.85 -4.13 6.83 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.003 1.135 . . . . 0.02 113.863 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -157.62 154.85 29.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.621 -1.299 . . . . 2.02 108.201 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -59.5 -39.37 83.59 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.445 -0.784 . . . . 0.02 112.092 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -59.81 -23.97 63.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.02 110.366 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.71 -18.68 62.81 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.75 0.785 . . . . 3.42 109.013 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.1 t90 -107.92 9.91 28.58 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.439 -1.319 . . . . 0.02 107.439 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.3 mtt 60.79 22.25 12.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.572 -0.705 . . . . 0.02 110.485 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.25 144.4 45.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.344 -1.502 . . . . 0.02 109.344 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.2 tp -78.74 -31.06 46.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.492 -1.299 . . . . 0.98 107.492 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.514 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 55.6 t30 -157.07 -171.16 3.53 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.389 -1.708 . . . . 0.02 106.389 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.514 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 2.9 p-10 -98.6 28.76 4.03 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.59 -1.319 . . . . 0.02 110.468 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -97.95 123.02 41.75 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.953 -1.092 . . . . 3.2 111.175 -178.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.8 mt -142.79 119.97 11.48 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.404 -1.332 . . . . 2.61 107.404 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.15 -17.91 11.04 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 121.123 -0.986 . . . . 0.02 112.17 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.5 m -155.77 155.99 34.03 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.271 -1.723 . . . . 0.02 110.598 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.7 m -145.17 147.77 32.84 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.304 0.573 . . . . 0.02 109.58 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -137.44 142.15 41.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.416 -0.802 . . . . 0.01 109.173 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.31 132.97 36.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.212 -0.93 . . . . 0.43 109.314 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -89.68 123.79 42.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.282 -1.006 . . . . 1.25 108.282 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -91.19 131.5 36.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.751 -1.218 . . . . 1.77 108.004 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -96.77 137.48 35.79 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.005 -1.109 . . . . 1.63 108.005 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.2 t -109.91 126.58 54.02 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.479 -0.934 . . . . 1.08 108.479 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 t -103.15 -154.87 0.51 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.046 -1.835 . . . . 1.26 106.046 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.9 -49.62 0.89 Allowed Glycine 0 N--CA 1.497 2.734 0 O-C-N 120.658 -1.276 . . . . 0.01 111.812 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.85 -99.21 0.12 Allowed Glycine 0 N--CA 1.487 2.069 0 C-N-CA 118.77 -1.681 . . . . 0.01 111.897 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -120.91 119.92 34.02 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.279 -1.13 . . . . 4.43 110.619 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.49 137.09 56.57 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.325 -0.62 . . . . 2.99 109.325 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.548 ' HZ3' ' CG2' ' A' ' 111' ' ' THR . 15.6 ttmm -134.79 130.96 36.91 Favored 'General case' 0 N--CA 1.518 2.957 0 CA-C-O 122.195 0.997 . . . . 6.36 112.996 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -131.71 142.38 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 115.598 -0.728 . . . . 1.09 110.2 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.48 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.7 pt20 -124.22 139.67 53.7 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.818 -1.179 . . . . 2.05 107.818 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.5 m -123.59 144.71 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 O-C-N 120.73 -1.231 . . . . 1.1 110.942 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -120.55 140.43 51.51 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.155 0.978 . . . . 0.73 111.13 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.46 ' OE2' ' CD2' ' A' ' 123' ' ' LEU . 7.2 tp10 -68.38 -33.4 74.18 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.934 -0.576 . . . . 0.02 111.474 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -114.84 168.59 9.77 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.933 -1.104 . . . . 3.18 110.168 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.01 169.16 46.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.916 -0.873 . . . . 0.01 110.916 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 53.34 39.19 29.46 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.58 0.705 . . . . 0.01 111.686 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.408 ' C ' HD21 ' A' ' 104' ' ' ASN . 11.7 m-85 52.69 48.21 23.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.56 -0.712 . . . . 0.01 111.075 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.408 HD21 ' C ' ' A' ' 103' ' ' PHE . 4.0 m120 -121.01 164.21 17.09 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.384 -0.969 . . . . 3.15 108.384 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.69 -162.91 29.37 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.97 -1.652 . . . . 0.01 108.97 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.482 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 56.6 tt0 -75.94 141.69 42.2 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.945 -1.327 . . . . 0.01 109.214 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.2 tmm? -116.09 143.4 45.52 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.596 0.712 . . . . 0.01 109.465 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.482 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 54.6 m-85 -132.56 136.13 46.39 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.278 -1.008 . . . . 2.48 108.278 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.467 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.9 tm-20 -116.63 134.16 55.15 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.639 -0.663 . . . . 0.01 109.576 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.467 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 8.8 t -148.88 148.35 29.76 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.383 1.087 . . . . 1.69 111.302 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.548 ' CG2' ' HZ3' ' A' ' 94' ' ' LYS . 18.2 p -115.01 7.67 15.59 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.213 -0.903 . . . . 0.01 110.051 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -122.09 163.2 19.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.401 -0.812 . . . . 3.21 111.24 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -69.7 154.75 41.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.01 109.419 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.497 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 53.1 m -127.78 115.53 20.79 Favored Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 109.049 -0.723 . . . . 0.01 109.049 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.43 -32.5 4.87 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 CA-C-N 120.198 1.107 . . . . 0.01 111.308 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 t -141.83 107.37 5.06 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.833 0.825 . . . . 0.02 108.888 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.4 mt -64.83 -39.17 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.864 -0.523 . . . . 1.83 111.036 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 37.1 ttp -67.41 -37.39 83.01 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.148 -1.021 . . . . 1.34 109.79 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.73 -38.72 76.98 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.588 -1.32 . . . . 2.11 109.709 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -79.42 -46.84 16.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.346 -0.846 . . . . 2.08 112.317 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.81 0.45 17.28 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.384 -0.822 . . . . 0.02 112.769 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 59.82 33.07 21.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.68 -1.262 . . . . 0.02 109.39 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.46 ' CD2' ' OE2' ' A' ' 99' ' ' GLU . 10.6 mt -111.89 135.08 52.98 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.64 -0.874 . . . . 0.02 108.64 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -92.58 -23.76 18.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 5.32 110.409 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -148.89 162.96 38.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.146 -0.971 . . . . 0.02 110.023 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.424 HD12 HG22 ' A' ' 126' ' ' ILE . 51.6 mt -131.96 129.44 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.223 -1.399 . . . . 2.17 107.223 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -105.54 -12.32 16.02 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.087 -1.008 . . . . 0.02 112.64 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -155.05 153.15 30.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.524 -1.36 . . . . 0.01 108.156 178.06 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 12.8 t -160.63 144.45 13.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.446 -1.408 . . . . 1.22 109.775 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -122.07 113.4 19.48 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.267 1.032 . . . . 1.41 109.457 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.06 120.23 60.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 105.554 -2.017 . . . . 0.01 105.554 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -145.76 67.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 118.34 -1.344 . . . . 1.98 108.398 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 172.14 108.32 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.586 -1.635 . . . . 0.01 106.586 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.38 -172.56 47.65 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.999 -1.24 . . . . 0.01 109.999 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -110.93 144.22 40.35 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.483 -1.01 . . . . 2.3 108.845 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -131.32 147.2 52.55 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.446 -0.784 . . . . 0.01 110.641 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.4 mt -119.1 140.29 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 107.956 -1.128 . . . . 1.69 107.956 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -112.81 141.73 46.28 Favored 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 107.408 -1.331 . . . . 2.49 107.408 177.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 12.9 m-85 -122.46 145.04 48.67 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.55 -0.719 . . . . 0.02 109.264 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -74.55 -30.29 61.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.579 -0.701 . . . . 0.02 112.275 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -114.89 153.79 46.99 Favored Pre-proline 0 N--CA 1.506 2.362 0 O-C-N 120.622 -1.299 . . . . 1.48 109.139 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.51 166.34 1.89 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 120.991 1.127 . . . . 0.02 112.462 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 59.79 31.21 20.68 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.221 -0.9 . . . . 0.75 111.253 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.497 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 58.38 51.97 7.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.02 111.13 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -124.91 163.34 22.46 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.666 -0.646 . . . . 0.02 109.937 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.65 -165.61 32.35 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.159 -1.177 . . . . 0.02 110.159 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -67.85 141.62 56.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.614 -0.933 . . . . 0.02 108.957 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.11 149.07 41.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.582 -0.525 . . . . 0.02 109.582 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.67 141.43 51.61 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 109.125 -0.695 . . . . 0.01 109.125 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.25 120.87 36.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.334 -0.854 . . . . 0.01 109.282 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.646 ' CD2' ' HE1' ' A' ' 162' ' ' TRP . 6.7 mt -104.3 135.14 46.31 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.344 -0.848 . . . . 0.01 110.321 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 154' ' ' LYS . 38.9 t70 -110.78 178.23 4.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.399 -1.334 . . . . 2.27 107.399 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -59.3 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.747 -1.221 . . . . 1.84 108.519 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 152' ' ' ASP . 68.4 tttt -134.95 163.12 30.56 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 122.106 0.955 . . . . 2.28 111.957 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.406 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 2.7 pt-20 -113.87 112.03 22.7 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.07 -1.085 . . . . 0.01 108.07 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.63 114.92 29.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.023 -1.048 . . . . 0.01 110.18 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.456 ' O ' ' OG ' ' A' ' 128' ' ' SER . 23.5 ptt180 -96.74 -27.12 14.9 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.497 -0.752 . . . . 0.01 112.063 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -125.65 151.33 70.45 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 120.766 -1.209 . . . . 2.54 108.98 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -57.97 -48.8 14.82 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 CA-C-N 119.234 0.762 . . . . 0.7 110.759 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.68 -23.67 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.86 -1.15 . . . . 0.86 109.152 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.61 -15.86 63.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.755 -1.216 . . . . 0.02 109.305 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.646 ' HE1' ' CD2' ' A' ' 151' ' ' LEU . 2.7 t90 -94.78 6.54 48.65 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.607 -0.886 . . . . 0.02 108.607 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 74.79 8.29 81.81 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.565 -1.303 . . . . 0.02 109.917 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.22 143.32 29.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.62 -0.929 . . . . 0.02 110.074 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.13 -9.22 58.76 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.675 -0.641 . . . . 0.59 109.671 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.1 p -147.24 150.9 39.34 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.756 -1.215 . . . . 0.87 108.015 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -75.7 25.48 0.4 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 120.777 0.985 . . . . 0.38 112.464 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.85 124.4 30.92 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.644 1.211 . . . . 0.18 112.534 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.4 mm -142.19 127.82 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 106.382 -1.71 . . . . 3.99 106.382 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -113.65 -23.7 9.59 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.784 -1.198 . . . . 5.17 112.846 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.9 p -157.31 160.26 38.37 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 119.503 -1.998 . . . . 0.02 109.839 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.497 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 11.8 p90 -153.44 153.98 33.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.983 -1.073 . . . . 2.02 110.601 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.497 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 18.9 mtp180 -143.23 151.14 40.25 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.161 -0.962 . . . . 0.01 110.4 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -87.56 141.83 28.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.991 -0.744 . . . . 0.01 108.991 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.0 mt -93.25 128.31 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.005 -1.059 . . . . 3.04 109.078 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.1 t -136.27 146.52 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.254 -0.903 . . . . 1.89 109.553 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 4.89 109.452 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.292 -1.523 . . . . 0.01 109.292 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -147.76 136.69 22.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.012 -1.287 . . . . 0.02 110.641 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 tt -130.78 139.52 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 109.115 -0.698 . . . . 0.02 109.115 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -121.22 130.33 53.64 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.465 -0.772 . . . . 0.39 109.766 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.05 139.77 44.81 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.983 -0.747 . . . . 0.02 108.983 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.6 m-85 -122.16 138.37 54.49 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.213 -0.929 . . . . 0.02 109.545 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -69.57 -27.76 65.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.03 111.652 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.2 m-20 -114.36 169.7 8.85 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.808 -1.182 . . . . 0.03 110.237 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.666 HH12 HD21 ' A' ' 37' ' ' ASN . 3.5 mtt-85 -74.88 157.81 34.43 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.703 0.763 . . . . 0.03 110.078 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 66.26 33.49 7.16 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.958 0.885 . . . . 0.74 111.14 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.25 42.32 30.53 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.212 0.53 . . . . 0.02 111.266 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -113.74 166.0 11.98 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.288 -1.005 . . . . 0.02 108.288 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.95 -167.25 36.2 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.841 -1.171 . . . . 0.03 110.702 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.05 141.59 54.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.976 . . . . 2.76 109.313 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -120.27 148.81 43.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.523 -0.736 . . . . 1.89 110.149 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -132.68 127.39 34.72 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.488 -0.93 . . . . 0.02 108.488 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.62 136.16 51.23 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.414 -0.804 . . . . 1.12 109.565 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -130.52 138.18 50.09 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.502 0.668 . . . . 0.02 109.55 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -117.56 11.16 13.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.737 -0.602 . . . . 0.2 109.655 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.9 p -158.31 173.83 16.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.144 -0.972 . . . . 1.23 108.585 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.62 145.19 55.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.636 -1.29 . . . . 0.02 110.372 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 82' ' ' CYS . 22.0 p -132.99 117.32 17.49 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.407 -0.96 . . . . 0.02 108.407 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.83 -23.5 52.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.24 110.743 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 31.1 p-10 -154.83 101.44 2.29 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.615 -0.883 . . . . 1.14 108.615 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 22.2 p90 -107.08 10.06 30.3 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 122.089 0.947 . . . . 6.37 110.273 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.402 ' HE ' ' CA ' ' A' ' 80' ' ' GLY . 29.4 mmt180 -59.2 -23.19 62.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.544 -0.722 . . . . 3.11 110.676 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -75.23 -16.32 60.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.726 -1.233 . . . . 0.88 110.354 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -103.08 -21.43 13.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.382 -0.824 . . . . 0.02 109.277 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -150.27 129.46 12.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.309 -0.869 . . . . 3.32 109.081 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t -85.5 -10.58 55.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.76 -0.588 . . . . 0.02 110.769 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -170.56 161.97 7.88 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.896 -1.15 . . . . 0.02 107.896 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.32 115.89 8.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.817 -1.177 . . . . 0.02 109.087 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.666 HD21 HH12 ' A' ' 13' ' ' ARG . 4.4 m120 -109.56 0.79 19.33 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.81 -1.181 . . . . 0.03 111.595 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -156.33 154.51 30.71 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.24 -1.022 . . . . 0.02 108.24 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.9 146.72 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.031 -1.043 . . . . 0.02 110.879 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -123.04 124.04 42.23 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.886 -1.153 . . . . 0.02 107.886 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.0 t -106.45 113.91 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 106.751 -1.574 . . . . 0.02 106.751 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 32.1 tp10 -84.27 -34.52 23.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.633 . . . . 3.81 110.435 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.51 149.32 17.24 Favored Glycine 0 N--CA 1.485 1.948 0 C-N-CA 119.029 -1.558 . . . . 0.02 110.525 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.73 172.41 48.83 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.255 -1.138 . . . . 0.01 110.255 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -118.3 134.77 54.75 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.489 -1.3 . . . . 1.48 107.489 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -127.17 154.68 44.48 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.755 -1.216 . . . . 0.02 112.443 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.37 134.1 52.24 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.349 -2.093 . . . . 0.24 105.349 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -118.35 143.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.479 -0.763 . . . . 0.65 109.351 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -120.84 144.42 48.36 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.37 1.081 . . . . 0.02 110.073 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.86 -33.42 75.8 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.665 -0.698 . . . . 0.02 111.47 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -124.38 157.81 63.54 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.034 -1.041 . . . . 0.02 109.491 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.27 166.45 1.08 Allowed 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.702 1.601 . . . . 0.02 112.728 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 t30 63.28 36.65 11.63 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.383 -0.826 . . . . 0.02 111.127 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 45.31 51.22 9.53 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.634 0.73 . . . . 3.39 110.769 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.2 p -125.49 163.28 23.0 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.186 0.517 . . . . 2.33 109.862 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.67 -161.74 31.14 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.722 -1.351 . . . . 0.02 109.722 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -64.32 138.58 58.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.33 . . . . 0.02 110.124 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -119.16 137.29 53.71 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.818 -0.551 . . . . 5.01 109.578 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.582 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 79.4 m-85 -134.76 139.98 45.57 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.5 -0.75 . . . . 0.02 110.067 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.8 mm -95.18 130.43 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.907 -0.775 . . . . 1.72 108.907 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.8 mt -122.54 111.72 31.39 Favored Pre-proline 0 N--CA 1.507 2.39 0 O-C-N 121.338 -0.852 . . . . 0.02 110.654 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.99 170.65 19.39 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 CA-C-N 119.863 0.987 . . . . 1.47 110.13 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 58.1 tt0 -52.16 140.47 20.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.963 -1.086 . . . . 4.25 110.092 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.59 -177.75 32.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.366 -1.397 . . . . 0.02 110.84 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -120.75 131.62 54.6 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.454 -1.027 . . . . 0.96 110.043 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -122.24 95.84 46.83 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.1 Cg_endo -67.79 -3.16 9.88 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.945 1.096 . . . . 0.02 114.125 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 67.6 mt-10 -157.54 154.96 29.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.551 -1.343 . . . . 2.02 108.313 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -60.02 -39.28 85.31 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.498 -0.751 . . . . 0.02 111.734 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -59.56 -24.13 63.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.033 . . . . 0.02 110.202 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -70.49 -18.97 62.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.935 0.874 . . . . 3.42 108.904 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.582 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.3 t90 -108.01 9.78 28.44 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.537 -1.283 . . . . 0.02 107.537 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 mmt 60.97 22.61 12.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.02 110.59 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.16 145.44 46.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.505 -1.438 . . . . 0.02 109.505 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.88 -31.28 40.33 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.601 -1.259 . . . . 0.98 107.601 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -156.92 -171.44 3.65 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.448 -1.686 . . . . 0.02 106.448 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 16.5 p-10 -97.98 28.14 4.12 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.634 -1.291 . . . . 0.02 110.661 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 78' ' ' ARG . 2.5 mtt-85 -96.42 121.93 38.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.009 -1.057 . . . . 3.2 110.563 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.501 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 24.9 mt -144.82 121.4 11.1 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.629 -1.248 . . . . 2.61 107.629 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' CA ' ' HE ' ' A' ' 30' ' ' ARG . . . -112.12 -16.4 9.08 Favored Glycine 0 N--CA 1.508 3.471 0 O-C-N 121.218 -0.926 . . . . 0.02 113.495 -177.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.6 p -155.51 156.87 35.97 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.244 -1.739 . . . . 0.02 110.69 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 14.2 p -145.73 148.32 32.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.695 -0.628 . . . . 0.02 109.903 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -137.23 141.71 42.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.365 -0.834 . . . . 0.01 109.181 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 132.11 36.48 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.166 -0.959 . . . . 0.43 109.436 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -90.06 124.12 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.302 -0.999 . . . . 1.25 108.302 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -92.4 131.98 37.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.819 -1.176 . . . . 1.77 108.408 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -96.39 138.25 34.25 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.082 -1.081 . . . . 1.63 108.082 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 m -109.72 126.74 54.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.671 -0.862 . . . . 1.08 108.671 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.9 t -103.65 -154.94 0.51 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.07 -1.826 . . . . 1.26 106.07 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.89 -49.87 0.88 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 120.552 -1.343 . . . . 0.01 111.879 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.26 -99.7 0.13 Allowed Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.825 -1.655 . . . . 0.01 111.924 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.4 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 38.5 tt0 -120.37 119.5 33.28 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.294 -1.121 . . . . 4.43 110.523 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 136.68 55.87 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.501 -0.555 . . . . 2.99 109.501 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -134.39 130.19 36.5 Favored 'General case' 0 N--CA 1.517 2.912 0 CA-C-O 122.11 0.957 . . . . 6.36 113.029 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.43 141.76 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-N 115.637 -0.711 . . . . 1.09 110.211 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.4 pt20 -124.95 139.7 53.59 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 107.526 -1.287 . . . . 2.05 107.526 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.07 146.85 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 120.646 -1.284 . . . . 1.1 111.08 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -120.84 140.29 51.97 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.256 1.027 . . . . 0.73 111.117 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -67.94 -32.19 72.46 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.644 -0.707 . . . . 0.02 111.934 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -114.76 165.61 12.64 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.078 -1.014 . . . . 3.18 110.43 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.26 163.12 46.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 111.069 -0.812 . . . . 0.01 111.069 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 57.65 39.06 27.8 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.608 0.718 . . . . 0.01 111.004 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 33.2 m-85 52.31 56.33 7.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 0.01 111.052 177.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -128.62 164.92 21.84 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.034 -1.098 . . . . 3.15 108.034 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.39 -162.82 28.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.077 -1.609 . . . . 0.01 109.077 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -75.07 141.81 43.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.874 -1.368 . . . . 0.01 108.864 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.9 tmm? -116.18 143.0 46.08 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.472 0.653 . . . . 0.01 109.451 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -132.07 136.22 47.03 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.206 -1.035 . . . . 2.48 108.206 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -116.76 134.48 54.74 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.711 -0.618 . . . . 0.01 109.756 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -149.7 148.55 29.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.941 -1.099 . . . . 1.69 111.337 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -114.48 7.95 16.35 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.106 -0.952 . . . . 0.01 109.695 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -122.27 163.41 19.71 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.545 -0.722 . . . . 3.21 111.152 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -69.62 154.83 41.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.802 . . . . 0.01 109.591 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.401 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 47.5 t -125.92 114.28 24.39 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.947 -0.76 . . . . 0.01 108.947 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -76.0 -33.64 3.52 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 CA-C-N 120.3 1.143 . . . . 0.01 111.557 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t -141.69 107.2 5.05 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.328 -0.858 . . . . 0.02 108.692 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.21 -39.41 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.715 -0.615 . . . . 1.83 111.198 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.2 ttp -66.26 -38.13 87.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.944 -1.102 . . . . 1.34 109.574 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -69.95 -38.73 76.22 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.63 -1.294 . . . . 2.11 109.74 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.496 ' NE2' ' CE1' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -80.47 -47.95 13.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.188 -0.945 . . . . 2.08 112.207 -176.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.496 ' CE1' ' NE2' ' A' ' 120' ' ' GLN . 94.8 m-85 -111.35 -1.06 16.13 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.474 -0.766 . . . . 0.02 112.884 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.457 ' ND1' ' C ' ' A' ' 121' ' ' PHE . 5.0 m80 60.26 33.7 20.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.716 -1.24 . . . . 0.02 109.707 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.44 135.63 52.91 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.784 -0.821 . . . . 0.02 108.784 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -92.83 -23.69 18.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.334 -0.854 . . . . 5.32 110.788 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -149.21 163.69 36.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.016 -1.053 . . . . 0.02 110.121 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 126' ' ' ILE . 49.2 mt -131.56 129.43 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 107.443 -1.317 . . . . 2.17 107.443 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -107.77 -13.17 15.07 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.123 -0.986 . . . . 0.02 113.033 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.471 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.54 153.08 29.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.412 -1.43 . . . . 0.01 108.261 177.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.9 t -163.53 143.96 8.82 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.287 -1.508 . . . . 1.22 109.697 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -121.82 113.31 19.49 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.062 0.934 . . . . 1.41 108.841 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.96 123.23 63.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 105.694 -1.965 . . . . 0.01 105.694 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.5 t -146.31 68.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 118.186 -1.406 . . . . 1.98 108.271 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER 172.51 107.87 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.537 -1.653 . . . . 0.01 106.537 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.53 -174.1 42.64 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.623 -1.391 . . . . 0.01 109.623 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 m -111.81 143.66 42.38 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.411 -1.053 . . . . 2.3 109.214 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.92 146.17 51.02 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.444 -0.785 . . . . 0.01 110.424 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.11 141.15 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.398 -1.334 . . . . 1.69 107.398 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.506 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.14 143.16 45.26 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 107.329 -1.359 . . . . 2.49 107.329 177.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.42 144.64 49.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.623 -0.673 . . . . 0.02 109.297 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 -30.06 63.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.638 -0.664 . . . . 0.02 112.124 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.5 153.64 47.71 Favored Pre-proline 0 N--CA 1.506 2.356 0 O-C-N 120.637 -1.289 . . . . 1.48 109.223 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.72 166.93 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.344 1.362 . . . . 0.02 112.678 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.8 m120 59.46 31.36 20.99 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.188 -0.915 . . . . 0.75 111.114 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.466 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.2 m-85 57.73 51.52 9.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.55 -0.719 . . . . 0.02 110.961 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -124.7 163.54 21.83 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.487 -0.758 . . . . 0.02 109.857 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.51 -165.28 32.3 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.711 -1.356 . . . . 0.02 109.711 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -67.89 141.3 56.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.437 -1.037 . . . . 0.02 108.894 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -118.22 148.52 42.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.06 -0.718 . . . . 0.02 109.06 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -128.83 142.84 50.84 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.574 -0.704 . . . . 0.01 109.18 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.12 120.0 34.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.367 -0.833 . . . . 0.01 109.492 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.12 133.08 51.4 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.36 -0.837 . . . . 0.01 110.297 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 154' ' ' LYS . 4.4 m-20 -108.79 174.63 5.79 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.356 -0.979 . . . . 2.27 108.356 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -57.12 84.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.077 -1.014 . . . . 1.84 108.627 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 152' ' ' ASP . 90.8 mttt -137.76 169.37 17.9 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 122.0 0.905 . . . . 2.28 111.603 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.39 110.59 20.89 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.389 -0.967 . . . . 0.01 108.389 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.57 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 90.7 m-85 -101.73 114.36 28.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.1 -1.0 . . . . 0.01 109.827 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -91.64 -25.84 18.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.096 -1.003 . . . . 0.01 111.222 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -125.44 154.09 72.43 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.061 -1.024 . . . . 2.54 108.525 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.27 -41.16 44.15 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 120.44 0.76 . . . . 0.7 110.539 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.95 -20.07 21.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.906 -1.121 . . . . 0.86 108.841 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -65.48 -16.17 63.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.003 -1.061 . . . . 0.02 109.787 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.57 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 2.0 m0 -96.94 11.0 37.54 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.065 -1.087 . . . . 0.02 108.065 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.59 11.78 85.14 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.414 -1.374 . . . . 0.02 110.336 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.9 141.83 32.19 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.178 -1.19 . . . . 0.02 110.096 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -8.29 58.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.791 -0.568 . . . . 0.59 109.917 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.6 m -144.37 151.04 50.1 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 120.845 -1.159 . . . . 0.87 108.791 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.43 21.25 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 120.694 0.929 . . . . 0.38 112.368 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.82 122.4 28.64 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.357 1.075 . . . . 0.18 111.602 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.6 mp -149.01 125.94 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.425 -1.694 . . . . 3.99 106.425 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -111.07 -16.44 13.48 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.176 -0.953 . . . . 5.17 113.23 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 86.4 p -158.46 161.14 37.42 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 119.181 -2.199 . . . . 0.02 110.075 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.2 p90 -152.78 155.25 36.79 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.076 -1.015 . . . . 2.02 110.358 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.466 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 22.9 mtp180 -143.54 150.41 38.85 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.158 -0.964 . . . . 0.01 110.293 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -87.35 142.73 27.66 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.072 -0.714 . . . . 0.01 109.072 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.4 mt -93.66 127.9 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.033 -1.042 . . . . 3.04 109.279 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.7 t -136.01 146.5 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.346 -0.846 . . . . 1.89 109.549 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 4.89 109.477 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 109.21 -1.556 . . . . 0.01 109.21 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -148.25 136.31 21.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.898 -1.354 . . . . 0.02 110.29 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 tt -130.38 140.08 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.098 -0.705 . . . . 0.02 109.098 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -121.38 130.46 53.62 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.363 -0.836 . . . . 0.39 110.071 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -110.06 139.7 44.9 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.657 -0.652 . . . . 0.02 109.316 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.543 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.4 m-85 -122.28 138.28 54.56 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.293 -0.879 . . . . 0.02 109.483 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -69.36 -27.3 65.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.956 -1.09 . . . . 0.03 111.875 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -113.92 169.66 8.84 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.796 -1.19 . . . . 0.03 110.143 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.39 158.38 32.81 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.549 0.69 . . . . 0.03 109.647 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.4 m120 66.24 35.05 6.19 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.719 0.771 . . . . 0.74 110.933 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.81 44.89 25.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.669 0.747 . . . . 0.02 111.403 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -112.64 165.84 11.89 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.008 -1.108 . . . . 0.02 108.008 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -167.87 34.44 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.766 -1.207 . . . . 0.03 110.532 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.723 ' HE ' ' H ' ' A' ' 19' ' ' ARG . 9.3 tpm_? -69.33 142.96 53.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -1.088 . . . . 2.76 108.922 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.723 ' H ' ' HE ' ' A' ' 18' ' ' ARG . 18.7 ttm180 -122.44 150.1 42.95 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.38 -0.825 . . . . 1.89 110.331 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -135.9 132.5 36.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.155 -0.683 . . . . 0.02 109.155 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 14.6 p-10 -108.52 136.23 48.48 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.589 -0.893 . . . . 1.12 108.589 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 15.9 t -127.68 137.77 52.6 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.666 -0.646 . . . . 0.02 110.035 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -119.9 11.05 11.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.2 110.754 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.532 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 16.0 t -159.73 173.77 15.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.633 -1.292 . . . . 1.23 109.26 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.464 ' H ' ' HG ' ' A' ' 24' ' ' CYS . 19.5 p-10 -63.41 145.8 54.86 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.416 -1.428 . . . . 0.02 110.931 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.9 m -135.22 119.19 17.41 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.886 -0.783 . . . . 0.02 108.886 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.482 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.79 -20.02 54.0 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.526 -0.734 . . . . 0.24 112.24 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -154.16 106.68 2.82 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.705 -1.247 . . . . 1.14 109.931 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.95 6.63 39.05 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.425 -0.797 . . . . 6.37 110.202 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -61.12 -29.69 69.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 3.11 112.052 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -76.96 -17.41 58.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.405 -1.434 . . . . 0.88 111.005 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -106.34 -21.17 13.17 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.413 -0.804 . . . . 0.02 110.621 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -149.33 127.47 12.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.092 -1.005 . . . . 3.32 109.653 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.5 p -87.2 -12.39 46.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.618 -0.676 . . . . 0.02 111.083 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -172.28 161.94 5.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.743 -1.223 . . . . 0.02 108.479 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 t -143.73 117.06 9.04 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.001 -1.062 . . . . 0.02 109.002 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -109.64 0.12 18.9 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.708 -1.245 . . . . 0.03 111.754 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 18.3 m -155.74 154.05 30.86 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.273 -1.01 . . . . 0.02 108.273 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -145.86 146.31 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 122.32 1.057 . . . . 0.02 110.818 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -122.77 123.68 41.61 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.594 -1.262 . . . . 0.02 107.594 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.1 t -105.64 113.63 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.87 -1.53 . . . . 0.02 106.87 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -85.13 -34.53 22.14 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.133 -0.627 . . . . 3.81 110.07 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.4 149.15 16.96 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.599 -1.763 . . . . 0.02 110.751 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.59 172.19 48.71 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.243 -1.143 . . . . 0.01 110.243 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.5 m -118.3 134.65 54.86 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.644 -1.243 . . . . 1.48 107.644 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -127.06 154.56 44.52 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 122.624 1.202 . . . . 0.02 112.345 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.34 133.77 52.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 105.453 -2.055 . . . . 0.24 105.453 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.1 144.19 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.519 -0.738 . . . . 0.65 109.323 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -120.65 144.95 47.9 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.157 0.979 . . . . 0.02 109.978 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -66.77 -33.8 76.43 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.943 -0.571 . . . . 0.02 111.957 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -123.09 158.27 58.27 Favored Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 121.111 -0.993 . . . . 0.02 109.509 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -53.1 164.64 1.64 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.524 1.482 . . . . 0.02 112.636 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 64.0 37.06 9.55 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.8 0.809 . . . . 0.02 111.363 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.453 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 11.2 m-85 45.54 51.39 9.91 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.681 0.753 . . . . 3.39 110.91 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 t -125.67 163.43 22.81 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.168 0.509 . . . . 2.33 109.827 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.72 -161.69 31.03 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.764 -1.334 . . . . 0.02 109.764 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -64.68 139.17 58.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.932 -1.334 . . . . 0.02 110.216 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.0 ppp? -119.6 138.12 53.43 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.725 -0.609 . . . . 5.01 109.475 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.562 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 63.8 m-85 -135.32 139.93 44.7 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.461 -0.774 . . . . 0.02 110.084 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.1 mm -93.76 130.18 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.311 -0.996 . . . . 1.72 108.311 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -121.48 111.1 33.47 Favored Pre-proline 0 N--CA 1.506 2.337 0 O-C-N 121.291 -0.881 . . . . 0.02 111.008 -178.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.04 169.79 19.85 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.738 0.942 . . . . 1.47 110.542 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -53.03 141.25 22.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.972 -1.08 . . . . 4.25 110.695 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.71 -177.76 31.84 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.47 -1.347 . . . . 0.02 110.955 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -119.68 131.29 55.38 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.367 -1.078 . . . . 0.96 109.782 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 78.8 m-85 -121.93 98.59 44.93 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.034 -1.099 . . . . 0.02 108.034 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.425 ' O ' ' OG ' ' A' ' 38' ' ' SER . 9.8 Cg_endo -71.12 -3.25 12.51 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.82 1.013 . . . . 0.02 113.919 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -157.51 154.54 28.82 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.672 -1.267 . . . . 2.02 108.221 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -59.69 -39.32 84.19 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.462 -0.774 . . . . 0.02 111.886 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -59.85 -23.82 63.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.02 110.303 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -70.49 -18.7 62.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.301 -0.874 . . . . 3.42 108.972 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.562 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -108.22 10.6 27.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.391 -1.337 . . . . 0.02 107.391 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.3 mmt 60.55 22.45 12.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.02 110.401 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.02 145.08 46.41 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.449 -1.46 . . . . 0.02 109.449 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -79.94 -30.53 39.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -1.174 . . . . 0.98 107.9 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.46 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 60.4 t30 -157.16 -171.64 3.71 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.558 -1.645 . . . . 0.02 106.558 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.46 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 1.6 p30 -98.81 28.67 4.17 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.606 -1.309 . . . . 0.02 110.791 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -96.99 123.14 40.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.862 -1.149 . . . . 3.2 111.074 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.5 mt -141.78 119.1 11.47 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.472 -1.307 . . . . 2.61 107.472 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.96 -18.49 9.89 Favored Glycine 0 N--CA 1.502 3.062 0 O-C-N 121.008 -1.058 . . . . 0.02 112.537 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.1 m -156.11 156.52 34.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.303 -1.704 . . . . 0.02 110.387 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.0 m -144.83 147.63 33.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.801 -0.562 . . . . 0.02 109.754 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.453 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 46.6 mtp180 -137.32 141.77 41.86 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.451 -0.781 . . . . 0.01 109.162 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.86 132.13 36.7 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.26 -0.9 . . . . 0.43 109.313 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -90.76 124.4 43.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.634 -0.876 . . . . 1.25 108.634 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -92.13 131.67 37.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.844 -1.16 . . . . 1.77 108.645 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.45 138.83 33.46 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.142 -1.058 . . . . 1.63 108.142 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.1 p -110.73 126.42 54.54 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.783 -0.821 . . . . 1.08 108.783 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.4 p -103.17 -154.99 0.51 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.089 -1.819 . . . . 1.26 106.089 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.7 -49.61 0.88 Allowed Glycine 0 N--CA 1.498 2.814 0 O-C-N 120.482 -1.386 . . . . 0.01 112.069 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.58 -99.7 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 118.758 -1.687 . . . . 0.01 112.091 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -120.76 120.02 34.43 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.204 -1.174 . . . . 4.43 110.601 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.65 135.46 54.12 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.332 -0.547 . . . . 2.99 109.612 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -133.57 130.19 38.07 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 121.103 -0.998 . . . . 6.36 112.924 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 tt -131.75 141.3 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 115.538 -0.756 . . . . 1.09 110.535 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.1 pt20 -124.44 139.19 54.12 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 107.56 -1.274 . . . . 2.05 107.56 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.13 146.64 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 120.644 -1.285 . . . . 1.1 110.942 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -119.34 139.31 52.16 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.897 0.855 . . . . 0.73 110.65 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.5 -32.47 72.47 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.694 -0.684 . . . . 0.02 111.86 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.476 ' O ' ' OG ' ' A' ' 128' ' ' SER . 14.6 mtpp -114.67 168.32 9.98 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.04 -1.038 . . . . 3.18 109.753 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.38 168.83 44.99 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.67 -0.776 . . . . 0.01 111.201 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.45 39.6 30.17 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.667 0.746 . . . . 0.01 111.611 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 52.68 48.8 21.72 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.58 -0.7 . . . . 0.01 111.027 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -121.79 164.35 17.61 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.378 -0.971 . . . . 3.15 108.378 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.63 -163.38 28.47 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.389 -1.484 . . . . 0.01 109.389 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -76.01 142.57 41.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.93 -1.335 . . . . 0.01 109.143 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.458 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.2 tmm? -116.47 143.38 45.65 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.5 0.667 . . . . 0.01 109.771 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.08 136.11 46.94 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.265 -1.013 . . . . 2.48 108.265 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -116.77 134.33 54.92 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.748 -0.595 . . . . 0.01 109.856 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -149.5 148.78 29.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.885 -1.134 . . . . 1.69 111.195 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.5 p -114.87 7.86 15.82 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.103 -0.953 . . . . 0.01 109.685 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -122.15 163.59 19.26 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.536 -0.727 . . . . 3.21 111.031 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 1.5 p30 -69.2 154.36 42.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.456 -0.777 . . . . 0.01 109.535 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.415 ' O ' ' OG ' ' A' ' 171' ' ' SER . 41.7 t -125.8 115.03 24.61 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 108.966 -0.753 . . . . 0.01 108.966 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -75.66 -33.47 3.95 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 CA-C-N 120.404 1.18 . . . . 0.01 111.687 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.4 p -141.91 108.06 5.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.325 -0.859 . . . . 0.02 109.071 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.68 -40.06 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.753 -0.592 . . . . 1.83 110.993 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.4 ttt -66.69 -37.45 84.77 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.005 -1.078 . . . . 1.34 109.749 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -69.74 -38.5 76.87 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.474 -1.391 . . . . 2.11 109.819 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.31 -47.54 14.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.277 -0.889 . . . . 2.08 112.493 -177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.51 -1.36 15.88 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.269 -0.895 . . . . 0.02 112.747 -176.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 61.25 34.01 18.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.789 -1.194 . . . . 0.02 109.697 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.1 mt -113.78 136.52 52.77 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.498 -0.751 . . . . 0.02 109.351 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -91.26 -22.49 20.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.873 . . . . 5.32 111.074 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -148.54 163.94 35.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.907 -1.121 . . . . 0.02 110.254 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mm -127.87 125.5 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.163 -1.421 . . . . 2.17 107.163 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -106.15 -15.41 14.88 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.865 -1.147 . . . . 0.02 113.201 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 1.2 p -157.03 155.51 31.33 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.278 -1.513 . . . . 0.01 107.942 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.6 t -163.15 146.49 10.67 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.442 -1.411 . . . . 1.22 109.737 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.77 111.49 17.22 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.432 1.11 . . . . 1.41 108.601 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.7 t -109.16 122.67 64.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 105.584 -2.006 . . . . 0.01 105.584 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.3 t -146.43 67.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 118.128 -1.429 . . . . 1.98 108.06 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.95 108.83 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.534 -1.654 . . . . 0.01 106.534 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.82 -174.3 40.05 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.659 -1.376 . . . . 0.01 109.659 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 m -112.2 145.1 40.47 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.331 -1.1 . . . . 2.3 109.522 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -130.03 145.87 51.68 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.535 -0.728 . . . . 0.01 110.379 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mt -116.96 141.45 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 107.639 -1.245 . . . . 1.69 107.639 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.525 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -112.36 141.76 45.7 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 107.198 -1.408 . . . . 2.49 107.198 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -122.06 143.78 49.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.09 -0.707 . . . . 0.02 109.09 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.34 -30.3 61.96 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.729 -0.607 . . . . 0.02 111.908 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.53 153.45 47.74 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.667 -1.271 . . . . 1.48 109.018 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.45 167.11 1.47 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.243 1.295 . . . . 0.02 112.665 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 m120 59.21 31.03 20.89 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.141 -0.936 . . . . 0.75 111.079 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.494 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.6 m-85 57.72 52.07 8.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.633 -0.667 . . . . 0.02 111.048 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -125.07 163.72 21.78 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.495 -0.753 . . . . 0.02 109.69 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.17 -165.5 32.89 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -67.81 141.22 56.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.448 -1.031 . . . . 0.02 108.92 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.64 148.48 42.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.25 -0.648 . . . . 0.02 109.25 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.52 142.72 50.98 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.959 -0.756 . . . . 0.01 108.959 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.0 tt -96.69 121.3 38.39 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.277 -0.89 . . . . 0.01 109.131 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.11 135.05 48.26 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.369 -0.832 . . . . 0.01 110.261 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 154' ' ' LYS . 22.8 t70 -108.25 174.82 5.71 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.339 -0.985 . . . . 2.27 108.339 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.455 ' N ' ' CG ' ' A' ' 152' ' ' ASP . 13.2 pttp -58.72 83.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.921 -1.112 . . . . 1.84 108.598 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 152' ' ' ASP . 55.0 mmtt -136.47 170.74 15.55 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.215 -0.928 . . . . 2.28 111.518 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.465 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 14.5 mp0 -113.24 109.49 18.84 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.282 -1.007 . . . . 0.01 108.282 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -100.1 114.77 28.36 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.031 -1.043 . . . . 0.01 110.112 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -93.31 -25.85 17.56 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.156 -0.965 . . . . 0.01 111.643 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -125.75 153.32 73.18 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 120.762 -1.211 . . . . 2.54 108.682 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -61.04 -43.02 32.35 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 120.431 0.754 . . . . 0.7 110.77 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.7 t -60.73 -20.52 21.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.64 -1.288 . . . . 0.86 108.619 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -65.14 -15.99 63.02 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.068 -1.02 . . . . 0.02 109.416 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.407 ' CZ3' ' CD1' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -94.85 9.87 37.51 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.945 -1.132 . . . . 0.02 107.945 178.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.09 11.27 84.95 Favored Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.18 -1.486 . . . . 0.02 109.627 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.59 142.33 31.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.557 -0.966 . . . . 0.02 110.181 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.79 -8.61 58.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.775 -0.578 . . . . 0.59 109.885 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 58.7 m -144.19 150.59 49.22 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 120.862 -1.149 . . . . 0.87 108.687 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -76.09 21.17 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 120.781 0.987 . . . . 0.38 112.541 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 123.23 28.73 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.653 1.216 . . . . 0.18 111.437 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.407 ' CD1' ' CZ3' ' A' ' 162' ' ' TRP . 17.4 mt -147.25 124.51 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.316 -1.735 . . . . 3.99 106.316 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -114.01 -17.79 11.88 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.178 -0.951 . . . . 5.17 113.022 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 40.0 t -157.6 160.27 37.93 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.354 -2.091 . . . . 0.02 110.144 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -153.4 154.55 34.68 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.009 -1.057 . . . . 2.02 110.611 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.494 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 21.8 mtp180 -143.53 150.81 39.45 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 0.01 110.356 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -87.94 142.77 27.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.01 109.173 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.96 128.21 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.121 -0.987 . . . . 3.04 109.081 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.9 146.46 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.293 -0.88 . . . . 1.89 109.708 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 4.89 109.353 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.144 -1.583 . . . . 0.01 109.144 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.514 ' NZ ' ' CB ' ' A' ' 6' ' ' LYS . 5.4 ttpm? -148.8 137.34 21.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.285 . . . . 0.02 110.414 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 tt -130.95 140.52 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 109.206 -0.664 . . . . 0.02 109.206 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -121.41 130.46 53.61 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.403 -0.811 . . . . 0.39 110.054 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.85 140.46 45.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.737 -0.602 . . . . 0.02 109.448 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.3 m-85 -122.24 138.66 54.41 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.184 -0.947 . . . . 0.02 109.603 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.49 -27.27 65.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.08 . . . . 0.03 111.805 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -114.32 170.28 8.42 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.816 -1.178 . . . . 0.03 110.263 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -75.64 158.48 32.34 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.662 0.744 . . . . 0.03 110.18 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 65.99 33.15 7.93 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.006 0.908 . . . . 0.74 111.142 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.22 41.94 30.95 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.923 -0.58 . . . . 0.02 111.21 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -113.16 165.83 12.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.278 -1.008 . . . . 0.02 108.278 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.67 -167.67 35.38 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.882 -1.152 . . . . 0.03 110.464 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -68.97 142.0 54.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -1.096 . . . . 2.76 108.838 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -122.69 151.0 41.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.532 -0.73 . . . . 1.89 109.999 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -137.52 133.87 35.04 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.756 -0.59 . . . . 0.02 109.746 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -109.44 136.08 49.43 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.973 -0.751 . . . . 1.12 108.973 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.0 t -127.63 138.32 52.81 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.577 -0.702 . . . . 0.02 109.535 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 13.1 t70 -119.2 12.19 12.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.619 -0.676 . . . . 0.2 110.494 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.8 p -159.65 173.4 16.15 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.898 -1.126 . . . . 1.23 109.197 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -62.64 146.09 52.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.776 -1.203 . . . . 0.02 110.586 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.7 m -133.73 117.33 16.82 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.801 -0.814 . . . . 0.02 108.801 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.32 52.01 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.314 -0.866 . . . . 0.24 111.641 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -151.06 105.69 3.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.88 -1.137 . . . . 1.14 109.215 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.0 4.85 42.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 6.37 110.097 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -62.1 -29.47 70.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 3.11 112.635 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 m -77.21 -18.22 57.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.152 -1.592 . . . . 0.88 111.647 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -106.95 -19.8 13.52 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.418 -0.801 . . . . 0.02 110.51 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -148.98 127.09 12.02 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.032 -1.042 . . . . 3.32 109.55 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 p -87.44 -13.15 44.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.02 111.301 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -172.38 161.84 5.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.788 -1.195 . . . . 0.02 108.45 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.6 p -143.35 116.24 8.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.117 -0.989 . . . . 0.02 108.851 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -108.1 -0.73 20.95 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.829 -1.169 . . . . 0.03 111.228 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 19.3 m -155.23 153.68 31.04 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.829 -1.174 . . . . 0.02 107.829 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.89 147.53 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 122.158 0.98 . . . . 0.02 110.551 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -123.58 124.96 43.98 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.952 -1.129 . . . . 0.02 107.952 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.27 113.79 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.672 -1.603 . . . . 0.02 106.672 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -84.76 -35.06 22.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.6 -0.687 . . . . 3.81 110.001 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.65 149.45 17.42 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.598 -1.763 . . . . 0.02 110.778 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.75 172.1 48.57 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.237 -1.145 . . . . 0.01 110.237 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -118.48 134.36 55.13 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.592 -1.262 . . . . 1.48 107.592 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -127.03 154.31 44.81 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.704 1.24 . . . . 0.02 112.484 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.88 134.11 52.0 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 105.194 -2.15 . . . . 0.24 105.194 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.38 141.95 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.65 109.453 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -120.48 143.13 48.69 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.192 0.996 . . . . 0.02 109.649 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.84 -34.1 77.37 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.511 -0.768 . . . . 0.02 111.897 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -124.51 157.96 63.43 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.017 -1.052 . . . . 0.02 109.472 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.39 166.4 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.587 1.525 . . . . 0.02 112.769 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.55 36.59 10.99 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.242 -0.89 . . . . 0.02 111.116 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.518 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 6.0 m-85 45.56 51.6 9.81 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.603 0.716 . . . . 3.39 110.679 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.8 m -126.1 163.62 22.68 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.291 0.567 . . . . 2.33 109.77 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.66 31.27 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -64.78 139.21 58.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.036 -1.273 . . . . 0.02 110.268 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 19.9 ptm -119.54 136.96 54.13 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.178 0.513 . . . . 5.01 109.722 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -134.41 139.51 45.62 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.47 -0.768 . . . . 0.02 109.954 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.431 HG22 HD13 ' A' ' 60' ' ' ILE . 29.0 mm -94.1 130.34 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.924 -0.769 . . . . 1.72 108.924 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.546 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.55 110.69 35.32 Favored Pre-proline 0 N--CA 1.505 2.308 0 O-C-N 121.39 -0.819 . . . . 0.02 110.877 -178.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.99 169.32 20.69 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 119.823 0.972 . . . . 1.47 110.388 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -53.97 141.25 28.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.882 -1.136 . . . . 4.25 110.728 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.72 -177.64 31.91 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.509 -1.329 . . . . 0.02 110.748 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -119.42 131.38 55.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.388 -1.066 . . . . 0.96 109.887 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 73.5 m-85 -121.67 98.09 46.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.051 -1.092 . . . . 0.02 108.051 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.423 ' O ' ' OG ' ' A' ' 38' ' ' SER . 7.3 Cg_endo -70.61 -3.82 13.36 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 120.787 0.991 . . . . 0.02 113.576 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -157.33 154.54 29.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.489 -1.382 . . . . 2.02 107.966 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -59.85 -39.07 83.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.434 -0.792 . . . . 0.02 111.722 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -59.75 -24.39 64.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.02 110.496 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -69.95 -18.89 63.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 3.42 109.247 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.554 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.12 10.61 28.02 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.637 -1.245 . . . . 0.02 107.637 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 mtt 60.67 21.97 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.555 0.693 . . . . 0.02 110.359 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.02 144.28 44.98 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.332 -1.507 . . . . 0.02 109.332 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.2 tp -78.64 -30.46 46.38 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.502 -1.296 . . . . 0.98 107.502 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -157.66 -171.39 3.54 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.326 -1.731 . . . . 0.02 106.326 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -98.93 28.56 4.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.62 -1.3 . . . . 0.02 110.433 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -97.84 123.3 41.74 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.026 -1.046 . . . . 3.2 111.36 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.1 mt -142.5 119.6 11.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.259 -1.385 . . . . 2.61 107.259 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.98 -18.07 10.98 Favored Glycine 0 N--CA 1.497 2.703 0 O-C-N 121.249 -0.907 . . . . 0.02 111.949 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.589 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 15.8 t -155.67 155.29 32.95 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.321 -1.693 . . . . 0.02 110.826 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.589 ' N ' ' HG ' ' A' ' 81' ' ' SER . 30.0 p -146.02 148.2 32.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.02 110.19 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.445 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 49.0 mtp180 -137.43 142.05 41.62 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.88 -0.785 . . . . 0.01 108.88 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.65 133.06 37.27 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.175 -0.953 . . . . 0.43 109.276 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.18 123.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.351 -0.981 . . . . 1.25 108.351 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -91.47 131.75 36.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.678 -1.264 . . . . 1.77 107.958 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.52 137.28 35.83 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.145 -1.057 . . . . 1.63 108.145 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 t -109.7 126.47 53.73 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.454 -0.943 . . . . 1.08 108.454 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.3 m -103.47 -154.48 0.5 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.211 -1.774 . . . . 1.26 106.211 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.36 -50.12 0.88 Allowed Glycine 0 N--CA 1.497 2.748 0 O-C-N 120.692 -1.255 . . . . 0.01 111.676 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.87 -99.41 0.13 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.74 -1.695 . . . . 0.01 112.001 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.42 119.2 32.34 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.311 -1.111 . . . . 4.43 110.457 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.79 137.52 56.68 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.765 -0.584 . . . . 2.99 109.472 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -134.55 131.51 38.03 Favored 'General case' 0 N--CA 1.519 2.994 0 O-C-N 121.083 -1.011 . . . . 6.36 113.19 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 tt -131.83 141.96 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 115.525 -0.761 . . . . 1.09 110.237 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.532 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 2.3 pm0 -125.11 140.34 52.97 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 107.743 -1.206 . . . . 2.05 107.743 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.3 145.79 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 O-C-N 120.603 -1.31 . . . . 1.1 111.038 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 27.6 m-85 -119.79 140.05 51.37 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.218 1.009 . . . . 0.73 110.959 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.27 -32.97 73.51 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.801 -0.636 . . . . 0.02 111.48 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -115.02 168.91 9.5 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.213 -0.929 . . . . 3.18 109.953 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.25 169.03 47.31 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 111.011 -0.836 . . . . 0.01 111.011 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.7 t0 53.55 39.11 29.61 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.66 0.743 . . . . 0.01 111.594 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 52.53 48.41 22.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.553 -0.717 . . . . 0.01 110.828 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 24.2 t30 -121.53 164.36 17.35 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.307 -0.997 . . . . 3.15 108.307 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 90.68 -163.13 29.52 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.118 -1.593 . . . . 0.01 109.118 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -75.48 141.82 43.03 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.839 -1.389 . . . . 0.01 109.222 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 41.3 ttp -116.39 143.39 45.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.613 0.721 . . . . 0.01 109.528 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -132.52 136.18 46.46 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.34 -0.985 . . . . 2.48 108.34 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -117.0 134.72 54.38 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.702 -0.624 . . . . 0.01 109.642 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -149.49 148.55 29.54 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.419 1.104 . . . . 1.69 111.353 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 p -115.6 6.91 14.68 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.045 -0.98 . . . . 0.01 110.015 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.56 163.34 19.05 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.505 -0.747 . . . . 3.21 111.107 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -68.31 152.59 45.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.01 109.822 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.1 t -126.52 113.79 23.02 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.901 -0.777 . . . . 0.01 108.901 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -76.1 -33.27 3.66 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 CA-C-N 120.19 1.103 . . . . 0.01 111.658 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.4 p -140.91 106.84 5.16 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.056 0.931 . . . . 0.02 108.645 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.44 -39.36 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.772 -0.58 . . . . 1.83 111.186 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.0 ttt -67.26 -37.24 83.15 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.024 -1.07 . . . . 1.34 109.578 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -69.6 -38.39 77.28 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.64 -1.288 . . . . 2.11 109.858 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.17 -46.51 16.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 2.08 112.265 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -110.11 -0.14 18.09 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.317 -0.864 . . . . 0.02 112.694 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 59.81 33.26 21.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.653 -1.279 . . . . 0.02 109.379 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.76 135.64 53.27 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 108.676 -0.861 . . . . 0.02 108.676 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -92.34 -23.19 19.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 5.32 110.46 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -149.16 163.32 37.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.163 -0.961 . . . . 0.02 110.073 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.408 HD13 HG23 ' A' ' 126' ' ' ILE . 43.4 mt -132.06 129.66 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 107.189 -1.412 . . . . 2.17 107.189 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -105.75 -12.31 15.94 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.381 -0.928 . . . . 0.02 112.59 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.18 152.8 29.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.368 -1.458 . . . . 0.01 108.11 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 12.8 t -162.88 141.86 8.7 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.556 -1.34 . . . . 1.22 109.465 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.405 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 30.5 ttpt -124.04 114.47 19.78 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.643 1.211 . . . . 1.41 109.656 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.39 123.75 61.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 105.614 -1.995 . . . . 0.01 105.614 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.0 t -147.65 71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 C-N-CA 118.404 -1.318 . . . . 1.98 108.205 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 171.35 108.29 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.427 -1.694 . . . . 0.01 106.427 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.75 -172.31 46.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.563 -1.415 . . . . 0.01 109.563 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -110.25 140.89 43.94 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.555 -0.968 . . . . 2.3 108.877 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -129.85 146.69 51.57 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.443 -0.786 . . . . 0.01 110.442 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 61.1 mt -118.36 139.86 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 107.816 -1.179 . . . . 1.69 107.816 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.04 141.96 46.26 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.103 -1.443 . . . . 2.49 107.103 178.057 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 6.7 m-85 -122.55 144.39 49.12 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.593 -0.692 . . . . 0.02 109.155 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -73.92 -30.12 62.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.586 -0.696 . . . . 0.02 112.407 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.3 mt -115.05 153.56 47.17 Favored Pre-proline 0 N--CA 1.506 2.349 0 O-C-N 120.773 -1.204 . . . . 1.48 109.085 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.3 166.67 1.6 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.117 1.211 . . . . 0.02 112.522 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 59.54 30.76 20.43 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.225 -0.898 . . . . 0.75 111.114 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.56 52.21 7.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.424 -0.798 . . . . 0.02 111.272 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -125.78 163.84 21.98 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.532 -0.73 . . . . 0.02 109.959 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.67 -165.56 32.29 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.078 -1.209 . . . . 0.02 110.078 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -68.1 141.69 56.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.543 -0.975 . . . . 0.02 108.941 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -118.15 149.92 40.24 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 116.044 -0.526 . . . . 0.02 109.676 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.56 140.82 51.87 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.221 -0.659 . . . . 0.01 109.221 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.5 tp -95.13 121.69 37.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.414 -0.804 . . . . 0.01 109.191 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.62 ' CD2' ' HE1' ' A' ' 162' ' ' TRP . 5.8 mt -104.62 113.98 27.91 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.384 -0.823 . . . . 0.01 109.677 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 152' ' ' ASP . 5.3 m-20 -113.9 89.83 3.19 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 108.702 -0.851 . . . . 2.27 108.702 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 51.8 tttp 49.37 78.86 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.99 -1.069 . . . . 1.84 108.267 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -131.45 144.4 51.14 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.468 -0.77 . . . . 2.28 111.902 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -112.98 99.79 8.13 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.329 -1.36 . . . . 0.01 107.329 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -98.06 116.72 30.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.096 -1.003 . . . . 0.01 110.853 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -97.72 -27.3 14.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.434 -0.791 . . . . 0.01 110.734 -178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -125.72 152.44 72.28 Favored Pre-proline 0 N--CA 1.502 2.137 0 N-CA-C 108.527 -0.916 . . . . 2.54 108.527 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -57.87 -47.49 20.6 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 CA-C-N 119.313 0.79 . . . . 0.7 110.889 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.58 -23.57 29.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.829 -1.17 . . . . 0.86 109.435 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 11.9 t0 -66.8 -16.22 64.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.777 -1.202 . . . . 0.02 109.492 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.62 ' HE1' ' CD2' ' A' ' 151' ' ' LEU . 2.2 t90 -95.06 7.83 44.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.529 -0.915 . . . . 0.02 108.529 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.98 8.18 84.67 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.904 -1.278 . . . . 0.02 109.904 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.27 142.84 30.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.552 -0.97 . . . . 0.02 110.035 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.31 -8.97 58.85 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.728 -0.608 . . . . 0.59 109.635 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.7 t -146.46 151.38 43.33 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.825 -1.172 . . . . 0.87 108.113 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.22 24.85 0.39 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.768 0.979 . . . . 0.38 112.344 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.27 123.01 30.27 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.87 -1.144 . . . . 0.18 112.803 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.6 mp -146.84 126.92 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.429 -1.693 . . . . 3.99 106.429 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -112.16 -17.88 12.7 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.917 -1.114 . . . . 5.17 113.605 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.8 p -157.79 160.82 38.2 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 119.18 -2.2 . . . . 0.02 110.263 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -153.2 153.74 33.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.054 -1.029 . . . . 2.02 110.766 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -144.72 152.16 39.97 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.205 -0.934 . . . . 0.01 110.908 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -88.31 141.82 28.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.118 -0.697 . . . . 0.01 109.118 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.0 mt -94.42 129.41 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.215 -0.928 . . . . 3.04 109.105 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.29 147.22 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.186 -0.946 . . . . 1.89 109.681 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 4.89 109.366 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.425 -1.47 . . . . 0.01 109.425 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -147.67 136.03 21.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.093 -1.239 . . . . 0.02 110.267 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -130.38 140.32 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.211 -0.663 . . . . 0.02 109.211 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.95 130.9 53.7 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.429 -0.795 . . . . 0.39 110.191 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.9 m-85 -110.98 140.62 45.34 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.546 -0.721 . . . . 0.02 109.487 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -121.89 138.1 54.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.365 -0.834 . . . . 0.02 109.49 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.43 -27.25 65.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.957 -1.09 . . . . 0.03 111.681 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -113.88 169.63 8.85 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.927 -1.108 . . . . 0.03 110.212 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.51 ' NH2' ' OE2' ' A' ' 68' ' ' GLU . 21.8 mtp180 -75.91 158.43 32.05 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.614 0.721 . . . . 0.03 110.159 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 66.39 33.26 7.06 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.05 0.928 . . . . 0.74 111.082 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 55.58 41.8 30.27 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.932 -0.576 . . . . 0.02 111.39 177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -113.44 165.72 12.19 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.357 -0.979 . . . . 0.02 108.357 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.18 -167.94 34.81 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.851 -1.166 . . . . 0.03 110.536 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -69.03 142.84 54.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.443 -1.034 . . . . 2.76 108.955 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -122.2 149.96 42.93 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.614 -0.679 . . . . 1.89 110.053 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -136.59 133.02 35.91 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.329 -0.619 . . . . 0.02 109.329 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 20.6 p-10 -109.22 136.79 48.12 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.761 -0.829 . . . . 1.12 108.761 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 16.0 t -128.21 138.44 52.46 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.556 -0.715 . . . . 0.02 109.891 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -119.74 11.53 11.95 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.647 -0.658 . . . . 0.2 110.776 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.525 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 26.7 p -159.7 173.48 15.99 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.562 -1.336 . . . . 1.23 109.418 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.09 145.89 54.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.404 -1.435 . . . . 0.02 110.688 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.9 m -135.1 119.57 18.01 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.037 -0.727 . . . . 0.02 109.037 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.25 -20.33 55.33 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.425 -0.797 . . . . 0.24 111.918 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -153.96 106.62 2.86 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.838 -1.163 . . . . 1.14 109.792 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.77 5.65 38.93 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.378 -0.826 . . . . 6.37 110.289 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -60.5 -29.21 68.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 3.11 111.976 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 p -76.86 -16.78 59.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.417 -1.427 . . . . 0.88 111.039 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -106.13 -21.63 13.07 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.326 -0.859 . . . . 0.02 110.684 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 tp -149.44 127.67 12.09 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.988 -1.07 . . . . 3.32 109.534 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -87.63 -12.41 45.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.562 -0.711 . . . . 0.02 110.966 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -171.82 160.85 5.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.854 -1.154 . . . . 0.02 108.541 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.38 116.1 8.71 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.975 -1.078 . . . . 0.02 108.846 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -108.6 -0.91 19.98 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.811 -1.18 . . . . 0.03 111.363 -178.331 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 21.1 m -154.73 153.64 31.6 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mt -146.67 147.41 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.296 1.046 . . . . 0.02 110.735 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -123.75 124.53 42.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.052 -1.092 . . . . 0.02 108.052 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 t -105.28 113.88 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.654 -1.609 . . . . 0.02 106.654 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -85.52 -34.9 21.44 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.079 -0.649 . . . . 3.81 110.212 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.56 149.11 16.78 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 118.481 -1.819 . . . . 0.02 110.773 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.75 172.18 48.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.08 -1.208 . . . . 0.01 110.08 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.8 m -118.26 134.37 55.08 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.422 -1.325 . . . . 1.48 107.422 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -126.78 154.49 44.19 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.694 1.235 . . . . 0.02 112.411 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.25 133.97 52.36 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 105.18 -2.155 . . . . 0.24 105.18 176.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.1 m -116.38 142.01 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.494 -0.754 . . . . 0.65 109.268 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -120.85 143.06 49.09 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.104 0.954 . . . . 0.02 109.607 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.88 -33.82 76.93 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.527 -0.761 . . . . 0.02 111.76 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -124.76 158.01 63.98 Favored Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 120.971 -1.081 . . . . 0.02 109.366 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.29 167.14 0.87 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.548 1.499 . . . . 0.02 112.76 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 63.2 36.58 11.88 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.245 -0.888 . . . . 0.02 111.11 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' H ' ' HG ' ' A' ' 81' ' ' SER . 4.1 m-85 45.1 51.59 8.89 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.626 0.727 . . . . 3.39 110.677 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.7 p -125.69 163.33 23.04 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.227 0.537 . . . . 2.33 109.966 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.51 -161.59 31.23 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.58 -1.408 . . . . 0.02 109.58 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -65.27 138.9 58.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.962 -1.317 . . . . 0.02 110.153 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.2 ptm -118.86 137.31 53.52 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.314 0.578 . . . . 5.01 109.717 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -134.27 139.34 45.67 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.52 -0.738 . . . . 0.02 109.818 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.9 mm -94.54 130.5 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.906 -0.775 . . . . 1.72 108.906 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.78 110.84 34.83 Favored Pre-proline 0 N--CA 1.506 2.359 0 O-C-N 121.417 -0.802 . . . . 0.02 110.784 -178.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -78.06 169.61 20.14 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.855 0.984 . . . . 1.47 110.438 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -53.71 141.18 27.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.966 -1.084 . . . . 4.25 110.589 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.66 -177.61 31.88 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.485 -1.341 . . . . 0.02 110.94 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -119.91 131.38 55.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.377 -1.073 . . . . 0.96 109.785 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 76.3 m-85 -121.29 97.74 47.24 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 107.959 -1.126 . . . . 0.02 107.959 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.43 ' O ' ' OG ' ' A' ' 38' ' ' SER . 4.8 Cg_endo -69.38 -4.46 13.82 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 120.731 0.954 . . . . 0.02 113.754 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.51 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 74.6 mt-10 -157.53 154.66 28.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.693 -1.255 . . . . 2.02 107.97 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -59.45 -38.69 81.4 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.473 -0.767 . . . . 0.02 111.978 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -60.36 -23.98 64.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 0.02 110.554 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -70.04 -18.78 63.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.38 -0.825 . . . . 3.42 108.951 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.552 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.69 10.4 26.88 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.562 -1.273 . . . . 0.02 107.562 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 mtt 60.94 22.32 12.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.735 . . . . 0.02 110.457 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.36 144.48 45.46 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.389 -1.484 . . . . 0.02 109.389 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.09 -31.2 44.25 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.494 -1.299 . . . . 0.98 107.494 177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -157.18 -171.82 3.77 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.383 -1.71 . . . . 0.02 106.383 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 92.9 m-20 -98.5 28.1 4.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.784 -1.198 . . . . 0.02 110.718 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -97.64 123.17 41.44 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.085 -1.009 . . . . 3.2 111.422 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.0 mt -142.01 119.56 11.7 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.221 -1.4 . . . . 2.61 107.221 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.22 -18.31 10.55 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.229 -0.92 . . . . 0.02 112.14 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.476 ' HG ' ' H ' ' A' ' 54' ' ' PHE . 3.8 p -155.84 156.01 33.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.371 -1.664 . . . . 0.02 110.583 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.2 p -145.72 148.15 32.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.497 -0.752 . . . . 0.02 110.08 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.412 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 54.3 mtp180 -137.4 142.03 41.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.383 -0.823 . . . . 0.01 109.075 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.8 132.38 36.86 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.259 -0.901 . . . . 0.43 109.394 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 t -89.52 123.75 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.43 -0.952 . . . . 1.25 108.43 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -91.84 131.87 36.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.925 -1.109 . . . . 1.77 108.267 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.99 138.02 35.17 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.16 -1.052 . . . . 1.63 108.16 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 m -110.01 126.79 54.33 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.665 -0.865 . . . . 1.08 108.665 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.4 m -103.34 -154.39 0.5 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.196 -1.779 . . . . 1.26 106.196 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.42 -49.91 0.87 Allowed Glycine 0 N--CA 1.497 2.701 0 O-C-N 120.517 -1.364 . . . . 0.01 111.891 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.28 -99.86 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 118.723 -1.703 . . . . 0.01 111.822 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -119.67 119.35 33.44 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.258 -1.142 . . . . 4.43 110.465 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.12 135.59 54.78 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.304 -0.628 . . . . 2.99 109.304 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -134.69 131.06 37.23 Favored 'General case' 0 N--CA 1.519 3.021 0 O-C-N 121.024 -1.047 . . . . 6.36 113.079 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 tt -131.83 142.04 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 115.467 -0.788 . . . . 1.09 110.384 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.531 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.4 pt20 -124.32 138.44 54.38 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 107.285 -1.376 . . . . 2.05 107.285 176.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -124.55 147.23 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 120.586 -1.321 . . . . 1.1 111.188 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -119.86 141.51 49.49 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 122.385 1.088 . . . . 0.73 111.582 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -69.54 -33.18 72.42 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.738 -0.664 . . . . 0.02 111.135 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 12.0 mptt -113.84 167.73 10.39 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.185 -0.947 . . . . 3.18 109.545 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.38 169.69 46.55 Favored Glycine 0 N--CA 1.492 2.404 0 CA-C-O 122.033 0.796 . . . . 0.01 111.318 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 53.26 40.09 30.75 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.632 0.73 . . . . 0.01 111.605 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 52.58 47.73 24.07 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.523 -0.735 . . . . 0.01 110.785 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -121.47 165.28 15.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.12 -1.066 . . . . 3.15 108.12 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.27 -162.93 29.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.168 -1.573 . . . . 0.01 109.168 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -76.14 141.87 41.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.903 -1.351 . . . . 0.01 108.967 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.456 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.0 tmm? -116.08 143.28 45.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.497 0.665 . . . . 0.01 109.595 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -132.28 136.4 46.91 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.421 -0.955 . . . . 2.48 108.421 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -116.78 134.19 55.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.703 -0.623 . . . . 0.01 109.871 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.2 t -149.13 148.54 29.77 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 122.466 1.126 . . . . 1.69 111.444 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -114.74 7.64 15.93 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.062 -0.972 . . . . 0.01 110.1 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.89 163.35 19.39 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.43 -0.794 . . . . 3.21 111.28 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 154.41 42.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.01 109.379 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 35.0 t -125.8 114.5 24.64 Favored Pre-proline 0 N--CA 1.5 2.025 0 N-CA-C 109.19 -0.671 . . . . 0.01 109.19 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -75.59 -33.81 3.78 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 CA-C-N 120.225 1.116 . . . . 0.01 111.488 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 55.0 m -141.46 107.55 5.2 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.921 0.867 . . . . 0.02 108.84 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.7 mt -65.01 -39.04 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.748 -0.595 . . . . 1.83 111.182 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.6 ttt -66.88 -37.36 84.25 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.936 -1.105 . . . . 1.34 109.577 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -69.81 -38.56 76.64 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.59 -1.319 . . . . 2.11 109.752 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -80.16 -47.58 14.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.314 -0.866 . . . . 2.08 112.491 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.43 -0.65 16.2 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.389 -0.82 . . . . 0.02 112.724 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m170 59.71 33.63 21.9 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.76 -1.213 . . . . 0.02 109.5 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 mt -112.3 135.28 53.17 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.637 -0.875 . . . . 0.02 108.637 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -92.45 -23.44 19.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 5.32 110.664 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -149.34 163.63 37.16 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.218 -0.926 . . . . 0.02 110.12 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 126' ' ' ILE . 57.5 mt -131.89 129.48 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.237 -1.394 . . . . 2.17 107.237 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -106.32 -12.49 15.67 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.109 -0.994 . . . . 0.02 113.068 -176.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 1.5 p -158.9 156.23 29.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.636 -1.29 . . . . 0.01 107.519 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 3.3 t -163.18 147.18 10.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.939 -1.1 . . . . 1.22 109.541 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.75 108.93 15.01 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.132 0.968 . . . . 1.41 108.767 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.49 121.6 61.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 105.886 -1.894 . . . . 0.01 105.886 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.1 t -147.24 69.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 118.072 -1.451 . . . . 1.98 108.289 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.68 107.56 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.238 -1.764 . . . . 0.01 106.238 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.19 -176.46 40.95 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.604 -1.399 . . . . 0.01 109.604 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.6 m -110.74 146.83 35.63 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.413 -1.051 . . . . 2.3 109.103 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -131.54 149.11 52.64 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.491 -0.756 . . . . 0.01 110.693 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 58.8 mt -118.8 140.61 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.66 -1.237 . . . . 1.69 107.66 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.14 141.44 46.93 Favored 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 107.314 -1.365 . . . . 2.49 107.314 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 7.4 m-85 -122.64 145.46 48.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.408 -0.807 . . . . 0.02 109.325 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.79 -30.03 61.3 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.561 -0.712 . . . . 0.02 112.187 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.45 153.33 47.64 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 120.684 -1.26 . . . . 1.48 109.068 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.13 167.06 1.33 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.27 1.313 . . . . 0.02 112.478 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.2 t30 59.22 31.11 20.95 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.051 -0.977 . . . . 0.75 111.027 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.57 51.32 9.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.563 -0.711 . . . . 0.02 111.06 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -124.12 163.31 21.76 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.533 -0.729 . . . . 0.02 109.726 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.53 -165.13 32.18 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.889 -1.284 . . . . 0.02 109.889 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -67.84 141.62 56.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.453 -1.028 . . . . 0.02 108.877 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -117.63 149.09 41.27 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.195 -0.669 . . . . 0.02 109.195 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -128.47 141.85 51.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.5 -0.75 . . . . 0.01 109.346 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.12 118.14 31.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.258 -0.901 . . . . 0.01 108.821 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.58 135.55 47.9 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.454 -0.778 . . . . 0.01 109.519 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 154' ' ' LYS . 14.4 p30 -109.62 172.73 6.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.234 -0.917 . . . . 2.27 109.157 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 83.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.14 -0.975 . . . . 1.84 108.738 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 152' ' ' ASP . 51.3 tttm -136.3 166.46 23.39 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.192 -0.942 . . . . 2.28 111.332 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 1.4 pm0 -110.04 108.48 18.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.805 -1.183 . . . . 0.01 107.805 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.608 ' CE2' ' NE1' ' A' ' 162' ' ' TRP . 94.4 m-85 -99.08 114.27 26.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.026 -1.046 . . . . 0.01 110.314 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -91.98 -27.82 17.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.443 -0.786 . . . . 0.01 111.208 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -126.26 152.23 73.4 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 120.96 -1.088 . . . . 2.54 108.228 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -59.72 -44.25 32.66 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 CA-C-N 119.283 0.78 . . . . 0.7 111.185 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.3 t -61.09 -21.62 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.789 -1.194 . . . . 0.86 109.509 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -65.92 -15.84 63.32 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.748 -1.22 . . . . 0.02 110.057 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.608 ' NE1' ' CE2' ' A' ' 156' ' ' TYR . 0.0 OUTLIER -97.39 11.22 37.4 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.548 -0.908 . . . . 0.02 108.548 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.2 10.0 86.54 Favored Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.633 -1.27 . . . . 0.02 110.346 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.71 142.39 31.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.281 -1.129 . . . . 0.02 110.146 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.2 -9.47 57.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.688 -0.633 . . . . 0.59 110.314 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -145.51 150.49 44.13 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.703 -1.248 . . . . 0.87 108.957 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -76.19 21.23 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 120.888 1.059 . . . . 0.38 112.47 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.6 124.66 30.36 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.454 1.121 . . . . 0.18 111.762 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.3 mt -145.71 125.91 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.526 -1.657 . . . . 3.99 106.526 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -112.06 -20.7 11.86 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.008 -1.057 . . . . 5.17 112.584 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.422 ' HG ' ' N ' ' A' ' 172' ' ' PHE . 48.2 t -156.5 159.67 38.82 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 119.546 -1.971 . . . . 0.02 109.725 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.422 ' N ' ' HG ' ' A' ' 171' ' ' SER . 12.7 p90 -153.13 154.02 33.97 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.008 -1.058 . . . . 2.02 110.649 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -144.52 151.61 39.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.156 -0.965 . . . . 0.01 110.558 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -87.59 142.33 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.952 -0.759 . . . . 0.01 108.952 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.9 mt -93.93 128.8 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.145 -0.972 . . . . 3.04 109.004 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.28 146.9 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.208 -0.932 . . . . 1.89 109.46 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 4.89 109.502 179.876 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.106 -1.598 . . . . 0.01 109.106 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -148.46 136.03 20.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.071 -1.252 . . . . 0.02 110.209 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -130.35 140.59 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.198 -0.668 . . . . 0.02 109.198 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 t -120.86 129.82 53.68 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.544 -0.722 . . . . 0.39 109.908 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 m-85 -109.81 139.47 44.85 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.61 -0.681 . . . . 0.02 109.239 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.515 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.5 m-85 -121.56 137.9 54.54 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.209 -0.932 . . . . 0.02 109.416 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.8 -27.34 64.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.074 -1.016 . . . . 0.03 111.756 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.48 170.66 8.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.843 -1.161 . . . . 0.03 109.95 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.457 ' CZ ' ' OE1' ' A' ' 68' ' ' GLU . 37.4 mtp180 -75.02 161.25 29.62 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.699 0.761 . . . . 0.03 110.245 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.2 m120 62.68 35.03 14.38 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.937 0.875 . . . . 0.74 110.565 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.6 p90 49.49 43.4 23.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.365 -0.834 . . . . 0.02 110.932 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -109.54 165.61 11.53 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.877 -1.157 . . . . 0.02 107.877 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.73 -167.83 33.92 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 120.748 -1.22 . . . . 0.03 110.733 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -69.37 143.71 53.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -1.059 . . . . 2.76 109.071 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -122.85 150.2 43.18 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.529 -0.732 . . . . 1.89 110.24 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -136.05 133.28 37.24 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.245 -0.65 . . . . 0.02 109.245 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -109.22 135.61 50.05 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.708 -0.849 . . . . 1.12 108.708 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.3 t -127.85 138.11 52.58 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.649 -0.657 . . . . 0.02 109.411 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 24.5 p-10 -118.89 12.1 12.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.747 -0.596 . . . . 0.2 110.166 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.8 p -160.18 173.67 15.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.864 -1.148 . . . . 1.23 109.083 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.18 146.07 54.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.838 -1.164 . . . . 0.02 110.657 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 29' ' ' PHE . 5.5 t -133.75 117.92 17.48 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.767 -0.827 . . . . 0.02 108.767 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.53 -21.25 49.07 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.299 -0.876 . . . . 0.24 111.865 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.99 105.79 3.29 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.784 -1.197 . . . . 1.14 109.496 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.581 ' CD2' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -101.32 5.33 42.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.459 -0.776 . . . . 6.37 110.351 -178.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -62.48 -29.78 70.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 3.11 112.669 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.6 p -77.11 -19.04 57.5 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.152 -1.592 . . . . 0.88 111.806 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -106.99 -19.49 13.61 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.303 -0.873 . . . . 0.02 110.152 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -148.73 126.97 12.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.994 -1.066 . . . . 3.32 109.39 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 m -87.43 -12.5 45.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.53 -0.732 . . . . 0.02 111.174 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -172.61 162.0 5.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.807 -1.183 . . . . 0.02 108.43 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 p -142.77 115.2 8.5 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.992 -1.068 . . . . 0.02 108.791 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -107.87 -1.97 20.28 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.858 -1.152 . . . . 0.03 111.441 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.02 153.63 33.3 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -147.23 147.64 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.041 -1.037 . . . . 0.02 110.653 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -125.33 125.94 44.28 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.868 -1.16 . . . . 0.02 107.868 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.5 t -105.39 114.24 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 106.828 -1.545 . . . . 0.02 106.828 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -85.37 -34.83 21.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 3.81 110.131 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.7 149.07 16.6 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 118.38 -1.867 . . . . 0.02 110.797 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.86 172.42 48.78 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.144 -1.182 . . . . 0.01 110.144 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -118.34 134.48 55.01 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.572 -1.27 . . . . 1.48 107.572 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -126.77 154.04 44.76 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.595 1.188 . . . . 0.02 112.382 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.69 133.53 52.66 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.094 -2.187 . . . . 0.24 105.094 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -117.75 143.28 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.546 -0.721 . . . . 0.65 109.279 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.544 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 33.1 m-85 -120.72 145.1 47.84 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.197 0.999 . . . . 0.02 109.917 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.97 -33.66 76.32 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.76 -0.654 . . . . 0.02 111.436 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -124.71 158.01 63.83 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.122 -0.986 . . . . 0.02 109.484 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.7 167.16 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.747 1.631 . . . . 0.02 112.716 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.0 t30 63.29 36.55 11.66 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.309 -0.859 . . . . 0.02 111.015 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.433 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 7.2 m-85 45.59 51.49 9.92 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.619 0.723 . . . . 3.39 110.936 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -126.13 163.63 22.68 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.223 0.535 . . . . 2.33 110.014 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.85 -161.87 30.99 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.895 -1.282 . . . . 0.02 109.895 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -65.16 139.5 58.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.966 -1.314 . . . . 0.02 110.134 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.544 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 49.2 ttp -118.35 137.34 53.16 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.292 0.568 . . . . 5.01 109.827 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.535 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.6 m-85 -134.75 138.81 44.66 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.467 -0.77 . . . . 0.02 109.911 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.2 mm -94.55 130.89 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.003 -0.74 . . . . 1.72 109.003 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -120.36 110.76 35.58 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.396 -0.815 . . . . 0.02 110.631 -178.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -78.25 169.2 20.57 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.876 0.992 . . . . 1.47 110.275 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -53.79 140.64 29.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.831 -1.168 . . . . 4.25 110.558 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.17 -177.56 32.32 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.635 -1.269 . . . . 0.02 110.61 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -118.58 130.41 55.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.454 -1.027 . . . . 0.96 109.735 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 53.2 m-85 -120.61 97.25 48.72 Favored Pre-proline 0 N--CA 1.494 1.763 0 N-CA-C 107.994 -1.113 . . . . 0.02 107.994 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -69.73 -3.72 12.55 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.69 0.926 . . . . 0.02 113.656 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.457 ' OE1' ' CZ ' ' A' ' 13' ' ' ARG . 40.6 mt-10 -157.49 154.17 28.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.579 -1.326 . . . . 2.02 108.138 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -59.63 -38.82 82.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.485 -0.759 . . . . 0.02 111.768 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -60.26 -23.92 64.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.105 -0.997 . . . . 0.02 110.283 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -70.15 -18.58 63.22 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.812 0.815 . . . . 3.42 108.842 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.561 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 0.7 OUTLIER -108.13 11.13 27.8 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.378 -1.342 . . . . 0.02 107.378 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' A' ' 73' ' ' MET . 1.2 mpt? 59.04 22.61 10.66 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.66 0.743 . . . . 0.02 110.435 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.48 145.16 45.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.409 -1.476 . . . . 0.02 109.409 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.38 -31.6 42.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.122 -1.222 . . . . 0.98 107.751 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -157.07 -171.88 3.81 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.501 -1.666 . . . . 0.02 106.501 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -98.05 28.26 4.08 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.738 -1.226 . . . . 0.02 110.612 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -97.7 122.72 41.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.921 -1.112 . . . . 3.2 111.225 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.1 mt -142.24 119.25 11.31 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.372 -1.344 . . . . 2.61 107.372 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.79 -18.22 10.99 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.272 -0.893 . . . . 0.02 112.18 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 76.9 p -155.68 155.62 33.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.335 -1.685 . . . . 0.02 110.169 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.4 p -145.27 148.03 33.02 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.712 -0.618 . . . . 0.02 109.669 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 66.5 mtm180 -137.4 142.2 41.69 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.474 -0.766 . . . . 0.01 109.17 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.97 133.15 36.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.227 -0.92 . . . . 0.43 109.413 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.33 123.91 42.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.593 -0.892 . . . . 1.25 108.593 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -91.75 131.67 36.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.731 -1.231 . . . . 1.77 108.147 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mt -97.12 138.57 34.44 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.194 -1.039 . . . . 1.63 108.194 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.1 m -110.43 126.33 54.2 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.652 -0.87 . . . . 1.08 108.652 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 t -102.96 -154.82 0.5 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.011 -1.848 . . . . 1.26 106.011 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.48 -49.27 0.89 Allowed Glycine 0 N--CA 1.496 2.694 0 O-C-N 120.472 -1.392 . . . . 0.01 111.847 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.08 -99.24 0.12 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 118.77 -1.681 . . . . 0.01 111.897 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -120.59 120.26 35.28 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.321 -1.105 . . . . 4.43 110.595 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.28 135.83 54.98 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.365 -0.606 . . . . 2.99 109.365 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.511 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 2.4 ttmp? -134.5 130.67 37.03 Favored 'General case' 0 N--CA 1.518 2.974 0 CA-C-O 122.258 1.028 . . . . 6.36 113.074 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 tt -131.62 142.2 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.5 -0.773 . . . . 1.09 110.143 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.504 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.5 pt20 -124.53 139.74 53.6 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.611 -1.255 . . . . 2.05 107.611 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.16 145.83 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 120.68 -1.262 . . . . 1.1 111.2 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.525 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 76.1 m-85 -120.2 139.91 51.94 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.045 0.926 . . . . 0.73 110.758 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.31 -32.11 72.01 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.836 -0.62 . . . . 0.02 111.791 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -114.6 167.73 10.49 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.064 -1.022 . . . . 3.18 110.352 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.53 164.35 52.79 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 111.071 -0.812 . . . . 0.01 111.071 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 57.74 38.77 27.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 122.02 -0.694 . . . . 0.01 111.595 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 52.29 54.95 9.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.519 -0.738 . . . . 0.01 111.208 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -128.97 165.46 21.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.041 -1.096 . . . . 3.15 108.041 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.06 -162.99 30.21 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.014 -1.634 . . . . 0.01 109.014 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -75.73 141.6 42.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.879 -1.366 . . . . 0.01 109.193 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.525 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 51.1 ttp -116.48 143.09 46.02 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.645 0.736 . . . . 0.01 109.548 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -131.91 136.13 47.16 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 2.48 108.21 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.406 ' OE2' ' N ' ' A' ' 110' ' ' THR . 3.0 tm-20 -116.71 133.76 55.63 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.658 -0.651 . . . . 0.01 109.687 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.406 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 0.1 OUTLIER -149.09 148.31 29.53 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.429 1.109 . . . . 1.69 111.088 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -115.23 7.62 15.31 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.96 -1.018 . . . . 0.01 110.152 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -122.07 163.59 19.17 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.373 -0.83 . . . . 3.21 111.214 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.56 154.85 41.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.333 -0.855 . . . . 0.01 109.309 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.604 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 20.3 p -127.32 119.79 22.03 Favored Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 109.24 -0.652 . . . . 0.01 109.24 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -76.72 -33.39 3.01 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 120.198 1.107 . . . . 0.01 110.995 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.0 m -143.45 109.05 5.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.443 -0.786 . . . . 0.02 109.304 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.5 mt -64.04 -39.48 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.83 -0.544 . . . . 1.83 110.79 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.1 ttt -66.64 -37.27 84.47 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.102 -1.039 . . . . 1.34 109.79 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -69.98 -38.61 76.09 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.543 -1.348 . . . . 2.11 109.707 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -80.23 -47.06 15.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.356 -0.84 . . . . 2.08 112.39 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -110.69 -0.62 17.06 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.376 -0.827 . . . . 0.02 112.678 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.598 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.1 m-70 59.92 33.3 21.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.749 -1.219 . . . . 0.02 109.483 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.6 135.82 52.87 Favored 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 108.761 -0.829 . . . . 0.02 108.761 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -92.72 -23.15 19.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 5.32 110.6 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -148.89 163.32 37.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.048 -1.033 . . . . 0.02 110.082 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 126' ' ' ILE . 56.0 mt -131.87 129.49 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 107.345 -1.354 . . . . 2.17 107.345 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -107.09 -13.15 15.24 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.183 -0.948 . . . . 0.02 113.073 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.21 153.64 31.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.36 -1.462 . . . . 0.01 108.189 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.6 t -160.88 146.14 14.32 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.218 -1.551 . . . . 1.22 109.963 -178.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -121.82 109.08 14.23 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.143 0.973 . . . . 1.41 108.827 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.9 120.74 59.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.002 -1.851 . . . . 0.01 106.002 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -146.59 69.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 118.326 -1.35 . . . . 1.98 108.437 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.57 108.05 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.48 -1.674 . . . . 0.01 106.48 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.663 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 71.07 -172.84 43.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.658 -1.377 . . . . 0.01 109.658 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.24 146.05 37.64 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.466 -1.02 . . . . 2.3 108.93 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -131.35 145.23 51.76 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.441 -0.787 . . . . 0.01 110.389 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mt -117.69 140.94 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.806 -1.183 . . . . 1.69 107.806 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.27 143.63 44.54 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.58 -1.267 . . . . 2.49 107.58 177.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 11.2 m-85 -122.69 144.04 49.4 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.168 -0.678 . . . . 0.02 109.168 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -73.53 -29.72 62.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.654 -0.654 . . . . 0.02 112.088 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.88 153.78 48.19 Favored Pre-proline 0 N--CA 1.506 2.353 0 O-C-N 120.584 -1.322 . . . . 1.48 109.205 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.49 166.73 1.68 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.248 1.299 . . . . 0.02 112.686 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.3 t30 59.39 31.54 21.16 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.13 -0.941 . . . . 0.75 111.076 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.41 51.38 9.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.515 -0.741 . . . . 0.02 110.962 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -124.44 163.49 21.69 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.493 -0.754 . . . . 0.02 109.77 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' A' ' 148' ' ' GLN . . . 89.58 -165.44 32.31 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.755 -1.338 . . . . 0.02 109.755 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -67.97 141.76 56.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -1.059 . . . . 0.02 108.952 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.448 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -118.5 149.07 41.91 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.109 -0.7 . . . . 0.02 109.109 -178.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.37 142.33 51.15 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.576 -0.703 . . . . 0.01 109.121 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.11 120.68 35.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.505 -0.747 . . . . 0.01 109.27 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.0 mt -105.61 133.91 49.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.01 110.727 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 1.2 m-20 -110.31 176.43 5.05 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.183 -1.043 . . . . 2.27 108.183 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.663 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 37.7 mttm -56.66 85.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.985 -1.072 . . . . 1.84 108.571 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 44.8 mttp -136.47 165.13 26.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.233 -0.917 . . . . 2.28 111.778 -178.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -113.27 109.1 18.19 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.951 -1.129 . . . . 0.01 107.951 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -99.67 114.64 27.86 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.139 -0.975 . . . . 0.01 110.219 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -92.17 -25.86 18.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.17 -0.956 . . . . 0.01 111.151 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -125.47 153.65 72.47 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 121.169 -0.957 . . . . 2.54 108.526 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.67 -42.09 42.01 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 CA-C-N 119.227 0.76 . . . . 0.7 110.628 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.56 -20.38 20.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.731 -1.23 . . . . 0.86 108.535 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 37.5 t0 -65.74 -16.25 63.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.986 -1.071 . . . . 0.02 109.531 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.407 ' CZ3' ' CD1' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -94.86 9.59 38.58 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.847 -1.168 . . . . 0.02 107.847 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.99 10.62 86.16 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.308 -1.425 . . . . 0.02 109.716 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.91 142.11 31.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.491 -1.005 . . . . 0.02 110.162 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.08 -8.13 58.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.711 -0.618 . . . . 0.59 109.847 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 t -143.77 148.6 43.41 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.85 -1.156 . . . . 0.87 108.535 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -74.77 21.57 0.42 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 CA-C-N 119.842 0.979 . . . . 0.38 112.231 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.02 123.77 29.78 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.538 1.161 . . . . 0.18 111.781 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.407 ' CD1' ' CZ3' ' A' ' 162' ' ' TRP . 17.8 mt -146.59 126.63 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.773 -1.566 . . . . 3.99 106.773 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -112.36 -19.62 12.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.071 -1.018 . . . . 5.17 112.909 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 9.6 p -157.85 159.88 37.12 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 119.238 -2.164 . . . . 0.02 110.154 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.604 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 6.1 p90 -152.19 154.68 36.29 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.09 -1.006 . . . . 2.02 110.477 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -144.71 151.79 39.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.192 -0.943 . . . . 0.01 110.586 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -87.77 142.57 27.71 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.018 -0.734 . . . . 0.01 109.018 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.6 mt -93.63 128.88 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.091 -1.006 . . . . 3.04 109.14 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.27 146.88 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.194 -0.941 . . . . 1.89 109.54 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.359 -0.838 . . . . 4.89 109.435 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.365 -1.494 . . . . 0.01 109.365 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -148.23 136.52 21.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.129 -1.218 . . . . 0.02 110.333 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 tt -130.58 140.38 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.111 -0.7 . . . . 0.02 109.111 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.79 130.71 53.61 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.238 -0.914 . . . . 0.39 110.171 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -110.9 140.3 45.49 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.577 -0.702 . . . . 0.02 109.622 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -122.71 138.64 54.55 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.282 -0.886 . . . . 0.02 109.591 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -69.42 -27.28 65.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.01 -1.056 . . . . 0.03 111.76 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.12 169.73 8.8 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.896 -1.128 . . . . 0.03 110.127 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -75.44 158.43 32.67 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.571 0.701 . . . . 0.03 110.196 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 m120 66.19 33.38 7.38 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.907 0.861 . . . . 0.74 111.093 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.32 42.14 30.54 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.223 0.535 . . . . 0.02 111.136 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -113.28 165.75 12.12 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.274 -1.01 . . . . 0.02 108.274 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.08 -167.9 34.9 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.872 -1.156 . . . . 0.03 110.576 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -69.17 142.5 54.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.382 -1.069 . . . . 2.76 108.928 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -122.66 151.21 41.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.586 -0.696 . . . . 1.89 110.181 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -136.83 132.77 35.11 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.193 -0.669 . . . . 0.02 109.193 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 6.6 p30 -108.38 135.93 48.87 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.369 -0.975 . . . . 1.12 108.369 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 13.9 t -127.37 137.5 52.79 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.585 -0.697 . . . . 0.02 109.981 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.75 11.03 11.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.673 -0.642 . . . . 0.2 110.808 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.526 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 25.0 p -159.71 173.43 16.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.574 -1.329 . . . . 1.23 109.34 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -63.1 145.54 55.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.428 -1.42 . . . . 0.02 110.801 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.7 m -135.12 119.21 17.55 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.925 -0.769 . . . . 0.02 108.925 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.98 -20.83 51.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.35 -0.844 . . . . 0.24 112.269 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -153.53 106.64 2.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.748 -1.22 . . . . 1.14 110.034 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.64 6.49 39.7 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.4 -0.813 . . . . 6.37 110.401 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.96 -29.32 69.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 3.11 112.063 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.0 m -77.01 -17.23 58.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.389 -1.445 . . . . 0.88 111.126 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -106.57 -21.09 13.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.454 -0.779 . . . . 0.02 110.555 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -149.28 127.57 12.15 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.966 -1.083 . . . . 3.32 109.62 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.8 t -87.47 -12.58 45.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.461 -0.774 . . . . 0.02 111.267 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -172.23 161.75 5.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.02 108.41 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.8 t -143.78 117.6 9.32 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.974 -1.079 . . . . 0.02 109.201 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.54 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.1 m-80 -109.56 0.0 18.96 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.746 -1.222 . . . . 0.03 111.691 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 22.3 m -155.54 153.97 31.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.005 -1.059 . . . . 0.02 108.475 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mt -145.88 146.56 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.011 -1.055 . . . . 0.02 110.848 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -123.19 124.17 42.43 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.808 -1.182 . . . . 0.02 107.808 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.1 t -105.29 113.72 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.829 -1.545 . . . . 0.02 106.829 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -85.14 -34.66 22.09 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.997 -0.681 . . . . 3.81 110.139 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.44 149.2 17.04 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.602 -1.761 . . . . 0.02 110.824 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.78 172.16 48.61 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.332 -1.107 . . . . 0.01 110.332 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -117.79 134.01 55.36 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.39 -1.337 . . . . 1.48 107.39 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -126.29 154.49 43.35 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.555 1.169 . . . . 0.02 112.495 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.0 133.3 53.17 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.57 -2.011 . . . . 0.24 105.57 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.1 141.31 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.544 -0.723 . . . . 0.65 109.154 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -120.16 143.08 48.41 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.128 0.966 . . . . 0.02 109.651 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.02 -34.09 77.6 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.641 -0.708 . . . . 0.02 111.755 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -124.49 157.78 63.98 Favored Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 120.939 -1.101 . . . . 0.02 109.615 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.26 166.56 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.733 1.622 . . . . 0.02 112.704 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 63.52 36.61 11.04 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.344 -0.843 . . . . 0.02 111.118 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.452 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 4.8 m-85 44.98 51.42 8.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.744 0.783 . . . . 3.39 110.691 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 m -125.4 163.22 23.08 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.206 0.527 . . . . 2.33 109.783 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.95 -162.07 31.0 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.599 -1.4 . . . . 0.02 109.599 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 8.3 t-80 -67.4 139.86 57.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.947 -1.325 . . . . 0.02 110.138 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.453 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 20.4 ptm -119.22 137.86 53.36 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.472 0.653 . . . . 5.01 109.978 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 79.8 m-85 -133.92 139.85 46.42 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.465 -0.772 . . . . 0.02 109.744 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.34 132.29 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 N-CA-C 108.523 -0.917 . . . . 1.72 108.523 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 mt -122.48 112.6 31.06 Favored Pre-proline 0 N--CA 1.506 2.357 0 O-C-N 121.414 -0.804 . . . . 0.02 110.644 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.45 170.73 18.84 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 119.821 0.972 . . . . 1.47 110.415 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -53.12 140.33 26.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.951 -1.093 . . . . 4.25 110.534 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.49 -178.18 32.25 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.38 -1.39 . . . . 0.02 110.8 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -119.72 131.23 55.33 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.362 -1.081 . . . . 0.96 109.896 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -121.5 97.91 46.6 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 107.726 -1.212 . . . . 0.02 107.726 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 38' ' ' SER . 7.9 Cg_endo -70.64 -3.44 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 120.743 0.962 . . . . 0.02 113.761 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -157.38 154.87 29.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.54 -1.35 . . . . 2.02 108.136 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -59.69 -39.4 84.42 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.531 -0.731 . . . . 0.02 111.766 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -59.89 -24.15 64.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.02 110.474 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -70.43 -18.38 63.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.4 -0.812 . . . . 3.42 108.846 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 2.1 t90 -107.78 10.2 28.82 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.535 -1.283 . . . . 0.02 107.535 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 10.0 mmt 60.63 22.66 12.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 0.02 110.322 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.68 144.88 47.91 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.542 -1.423 . . . . 0.02 109.542 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 mt -79.99 -30.54 39.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -1.175 . . . . 0.98 107.946 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -157.05 -171.49 3.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.43 -1.692 . . . . 0.02 106.43 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -99.03 28.78 4.18 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.645 -1.284 . . . . 0.02 110.815 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -96.65 122.82 40.0 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.826 -1.171 . . . . 3.2 111.146 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -141.39 118.8 11.49 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.551 -1.277 . . . . 2.61 107.551 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.55 -18.96 9.09 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 121.193 -0.942 . . . . 0.02 112.474 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 11.2 t -156.09 156.41 34.28 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 119.763 1.782 . . . . 0.02 111.028 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.6 p -145.85 147.83 32.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.421 -0.799 . . . . 0.02 110.501 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.422 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 49.2 mtp180 -137.14 142.04 42.25 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.511 -0.743 . . . . 0.01 109.111 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.29 131.26 36.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.129 -0.982 . . . . 0.43 109.505 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 t -90.4 124.61 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.561 -0.903 . . . . 1.25 108.561 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -92.91 131.58 37.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.071 . . . . 1.77 108.571 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.32 139.57 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.13 -1.063 . . . . 1.63 108.13 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.5 p -110.8 126.09 54.26 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.674 -0.861 . . . . 1.08 108.674 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.0 t -102.66 -154.8 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.029 -1.841 . . . . 1.26 106.029 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.29 -49.36 0.89 Allowed Glycine 0 N--CA 1.497 2.754 0 O-C-N 120.473 -1.392 . . . . 0.01 111.952 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.66 -99.33 0.13 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.64 -1.743 . . . . 0.01 112.085 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -121.05 120.67 36.03 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.262 -1.14 . . . . 4.43 110.702 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.34 135.75 54.81 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.47 -0.567 . . . . 2.99 109.47 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.484 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 2.7 ttmp? -134.54 130.59 36.81 Favored 'General case' 0 N--CA 1.519 2.981 0 CA-C-O 122.187 0.994 . . . . 6.36 112.936 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -132.44 141.61 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 115.62 -0.718 . . . . 1.09 110.627 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.515 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 pm0 -124.56 140.04 53.31 Favored 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 107.568 -1.271 . . . . 2.05 107.568 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.2 m -123.45 146.96 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 O-C-N 120.664 -1.272 . . . . 1.1 111.236 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 24.0 m-85 -120.17 139.72 52.2 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.035 0.922 . . . . 0.73 110.804 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.6 -32.81 71.75 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.77 -0.65 . . . . 0.02 112.304 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' O ' ' OG ' ' A' ' 128' ' ' SER . 41.0 mmtm -113.89 165.14 12.88 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.866 -1.146 . . . . 3.18 110.059 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.93 163.06 45.11 Favored Glycine 0 N--CA 1.492 2.374 0 CA-C-O 122.034 0.797 . . . . 0.01 111.306 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.22 39.58 28.62 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.567 0.698 . . . . 0.01 111.108 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 52.5 55.69 8.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.57 -0.706 . . . . 0.01 111.036 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -128.75 164.89 22.01 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.943 -1.132 . . . . 3.15 107.943 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.23 -162.67 28.53 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.269 -1.532 . . . . 0.01 109.269 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -75.79 142.17 42.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.93 -1.336 . . . . 0.01 109.211 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.529 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.7 ttp -116.69 143.48 45.58 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.593 0.711 . . . . 0.01 109.543 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -132.25 136.33 46.9 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.252 -1.018 . . . . 2.48 108.252 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -116.49 134.32 54.99 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.619 -0.675 . . . . 0.01 109.791 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 t -149.48 148.35 29.3 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.492 1.139 . . . . 1.69 111.578 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.7 p -115.34 7.46 15.13 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.998 -1.001 . . . . 0.01 109.961 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -122.31 163.42 19.73 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.448 -0.783 . . . . 3.21 111.043 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.29 154.86 41.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.439 -0.788 . . . . 0.01 109.624 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.5 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 59.4 m -128.61 115.94 19.55 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.913 -0.773 . . . . 0.01 108.913 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.09 -30.89 6.57 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 CA-C-N 120.316 1.149 . . . . 0.01 111.56 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.7 p -142.61 108.25 5.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.289 -0.882 . . . . 0.02 109.115 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.5 -39.31 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.773 -0.58 . . . . 1.83 111.062 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 15.0 tpt -66.89 -37.76 85.0 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.035 -1.066 . . . . 1.34 109.856 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.69 -38.66 77.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.504 -1.372 . . . . 2.11 109.887 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -80.41 -47.62 14.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.169 -0.957 . . . . 2.08 112.472 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -111.03 -0.82 16.53 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.283 -0.886 . . . . 0.02 112.728 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 59.79 33.73 21.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.822 -1.174 . . . . 0.02 109.487 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' C ' ' SD ' ' A' ' 118' ' ' MET . 6.3 mt -112.69 135.54 53.31 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 108.737 -0.838 . . . . 0.02 108.737 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -92.37 -23.18 19.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.302 -0.874 . . . . 5.32 110.623 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -148.96 163.44 37.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.077 -1.015 . . . . 0.02 110.121 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.411 HD12 HG21 ' A' ' 126' ' ' ILE . 51.6 mt -131.97 129.45 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.55 -1.278 . . . . 2.17 107.55 178.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -106.65 -13.65 15.23 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.206 -0.934 . . . . 0.02 113.185 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -157.04 155.68 31.59 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.35 -1.468 . . . . 0.01 108.237 177.606 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.4 t -164.28 145.86 8.58 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.482 -1.386 . . . . 1.22 109.567 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.43 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 27.6 mtmt -121.35 112.14 18.21 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.443 1.116 . . . . 1.41 108.905 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.2 t -107.41 122.52 61.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 105.372 -2.085 . . . . 0.01 105.372 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -145.9 67.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 118.153 -1.419 . . . . 1.98 108.133 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.01 108.29 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.563 -1.643 . . . . 0.01 106.563 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.86 -174.53 42.95 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.186 -1.165 . . . . 0.01 110.186 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.72 144.12 40.16 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.472 -1.016 . . . . 2.3 109.036 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -129.82 145.59 51.57 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.366 -0.834 . . . . 0.01 110.294 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.7 mt -117.92 141.86 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.667 -1.234 . . . . 1.69 107.667 178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.58 143.45 44.97 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 107.521 -1.289 . . . . 2.49 107.521 177.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 8.4 m-85 -122.59 144.24 49.24 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.005 -0.739 . . . . 0.02 109.005 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.49 -29.85 62.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.722 -0.611 . . . . 0.02 111.905 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.33 153.63 47.5 Favored Pre-proline 0 N--CA 1.505 2.279 0 O-C-N 120.604 -1.31 . . . . 1.48 109.187 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.9 167.03 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.225 1.284 . . . . 0.02 112.481 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 59.64 31.12 20.72 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.119 -0.946 . . . . 0.75 111.052 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.2 m-85 58.16 51.55 8.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.547 -0.72 . . . . 0.02 111.026 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -125.1 163.73 21.76 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.435 -0.791 . . . . 0.02 109.843 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.65 -165.6 32.34 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.951 -1.26 . . . . 0.02 109.951 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -67.7 141.32 56.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.425 -1.044 . . . . 0.02 108.883 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -118.65 147.95 43.24 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.424 -0.584 . . . . 0.02 109.424 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 2.5 t80 -129.9 143.87 51.03 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.836 -0.802 . . . . 0.01 108.836 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 tt -98.3 122.53 41.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.414 -0.804 . . . . 0.01 109.528 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.0 mt -104.29 135.95 44.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.499 -0.75 . . . . 0.01 109.982 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 154' ' ' LYS . 30.0 t70 -108.61 174.47 5.86 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.221 -1.029 . . . . 2.27 108.221 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -59.38 83.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.883 -1.135 . . . . 1.84 108.439 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 152' ' ' ASP . 66.6 mttm -136.53 172.09 13.53 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.257 -0.902 . . . . 2.28 111.696 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -113.62 110.12 19.7 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.423 -0.955 . . . . 0.01 108.423 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.68 114.61 28.48 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.019 -1.051 . . . . 0.01 109.876 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -93.69 -25.07 17.62 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.072 -1.018 . . . . 0.01 111.668 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -126.2 153.5 74.38 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.855 -1.153 . . . . 2.54 108.987 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.15 -42.7 33.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 119.247 0.767 . . . . 0.7 110.713 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.67 -20.58 21.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.732 -1.23 . . . . 0.86 108.557 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -64.95 -15.81 62.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.978 -1.076 . . . . 0.02 109.383 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.529 ' O ' ' CE2' ' A' ' 149' ' ' TYR . 0.5 OUTLIER -95.46 9.97 38.13 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.971 -1.122 . . . . 0.02 107.971 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.73 11.41 84.55 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.173 -1.489 . . . . 0.02 109.648 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.98 142.43 31.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.453 -1.028 . . . . 0.02 110.266 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.62 -8.21 58.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.758 -0.589 . . . . 0.59 110.022 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.3 p -144.9 150.93 47.88 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.726 -1.234 . . . . 0.87 108.819 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.37 21.58 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.833 1.022 . . . . 0.38 112.397 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.85 124.31 30.19 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.612 1.196 . . . . 0.18 111.631 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.1 mt -147.51 127.23 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.796 -1.557 . . . . 3.99 106.796 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -112.38 -19.08 12.31 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.187 -0.945 . . . . 5.17 112.865 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.6 p -158.37 161.28 37.55 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.147 -2.221 . . . . 0.02 110.271 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.5 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 9.5 p90 -152.55 153.69 33.92 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.168 -0.958 . . . . 2.02 110.496 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 21.5 mtp180 -143.58 151.0 39.66 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.267 -0.896 . . . . 0.01 110.412 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -87.64 142.33 27.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.01 109.188 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.1 mt -92.98 128.24 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.133 -0.979 . . . . 3.04 109.019 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.07 146.58 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.257 -0.902 . . . . 1.89 109.592 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 4.89 109.404 179.948 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.273 -1.531 . . . . 0.01 109.273 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -149.23 136.91 20.35 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.095 -1.238 . . . . 0.02 110.168 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -130.23 141.14 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.201 -0.666 . . . . 0.02 109.201 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.8 t -121.3 129.92 53.37 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.523 -0.736 . . . . 0.39 110.0 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -110.36 140.23 44.77 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.159 -0.682 . . . . 0.02 109.159 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.9 m-85 -122.67 138.71 54.52 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.105 -0.997 . . . . 0.02 109.512 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.431 ' OE2' ' NH2' ' A' ' 18' ' ' ARG . 78.5 mt-10 -68.93 -27.27 65.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.075 -1.016 . . . . 0.03 111.693 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.31 170.28 8.41 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.902 -1.124 . . . . 0.03 110.034 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -74.93 161.79 29.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.698 0.761 . . . . 0.03 110.149 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 23.4 t30 62.42 35.06 15.1 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.898 0.856 . . . . 0.74 110.594 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.69 43.2 24.32 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.396 -0.82 . . . . 0.02 111.084 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -109.73 165.82 11.39 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.827 -1.175 . . . . 0.02 107.827 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.29 -168.16 34.84 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.83 -1.176 . . . . 0.03 110.663 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.431 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 25.9 ttp180 -69.16 143.5 54.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -1.102 . . . . 2.76 108.962 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.422 ' NH1' ' OD2' ' A' ' 21' ' ' ASP . 5.3 tmm_? -123.54 151.22 43.09 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.541 -0.725 . . . . 1.89 110.353 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -136.6 133.03 35.89 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.252 -0.647 . . . . 0.02 109.252 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.422 ' OD2' ' NH1' ' A' ' 19' ' ' ARG . 50.8 m-20 -109.64 136.32 49.19 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.911 -0.774 . . . . 1.12 108.911 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.1 t -127.83 137.74 52.47 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.659 -0.65 . . . . 0.02 109.704 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -118.61 11.41 12.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.726 -0.609 . . . . 0.2 110.157 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.5 p -159.68 173.7 15.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.848 -1.158 . . . . 1.23 109.066 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.87 145.63 54.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.842 -1.162 . . . . 0.02 110.629 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.591 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 11.6 p -135.04 119.69 18.21 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 109.004 -0.739 . . . . 0.02 109.004 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.39 -20.68 50.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.261 -0.9 . . . . 0.24 112.275 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -152.89 107.12 3.12 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.812 -1.18 . . . . 1.14 110.049 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.591 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.12 5.63 40.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.315 -0.865 . . . . 6.37 110.309 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -61.22 -30.13 70.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 3.11 112.133 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 p -76.69 -17.72 58.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.466 -1.396 . . . . 0.88 111.062 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -106.79 -21.13 13.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.392 -0.817 . . . . 0.02 110.655 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 tp -148.65 126.61 11.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.901 -1.124 . . . . 3.32 109.556 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.2 t -87.01 -12.83 46.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.519 -0.738 . . . . 0.02 111.053 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -172.72 162.16 4.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.858 -1.151 . . . . 0.02 108.403 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.2 p -143.83 116.52 8.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.068 -1.02 . . . . 0.02 108.824 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.59 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -108.38 -0.42 20.64 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.755 -1.216 . . . . 0.03 111.203 -178.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.414 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 13.0 t -155.36 153.46 30.5 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.856 -1.165 . . . . 0.02 107.856 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.414 ' N ' ' HG ' ' A' ' 38' ' ' SER . 8.8 mt -146.83 148.05 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.102 -0.999 . . . . 0.02 110.49 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -123.92 124.72 43.23 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.02 -1.104 . . . . 0.02 108.02 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.3 t -105.3 114.06 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.691 -1.596 . . . . 0.02 106.691 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -85.41 -34.92 21.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.447 -0.783 . . . . 3.81 110.178 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.49 149.03 16.65 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 118.523 -1.799 . . . . 0.02 110.864 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.7 172.32 48.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.197 -1.161 . . . . 0.01 110.197 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.0 m -117.67 134.09 55.26 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.494 -1.299 . . . . 1.48 107.494 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -126.68 154.52 43.97 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.541 1.162 . . . . 0.02 112.192 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.37 134.06 52.29 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 105.502 -2.036 . . . . 0.24 105.502 176.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.07 141.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.56 -0.712 . . . . 0.65 109.292 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -120.3 142.99 48.6 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.062 0.934 . . . . 0.02 109.624 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -65.21 -34.36 78.2 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.491 -0.777 . . . . 0.02 111.904 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -124.44 158.02 63.02 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.091 -1.006 . . . . 0.02 109.495 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.04 166.55 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.642 1.561 . . . . 0.02 112.806 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 63.11 37.17 11.67 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.373 -0.83 . . . . 0.02 111.135 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.3 m-85 45.1 51.69 8.84 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.62 0.724 . . . . 3.39 110.834 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 t -125.89 163.62 22.55 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.12 0.486 . . . . 2.33 109.95 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.52 -161.89 31.44 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.926 -1.27 . . . . 0.02 109.926 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.437 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 8.5 m80 -64.34 138.51 58.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.996 -1.297 . . . . 0.02 110.224 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 58' ' ' MET . 12.3 tmm? -119.12 137.17 53.77 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.519 -0.549 . . . . 5.01 109.519 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.407 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 86.4 m-85 -135.01 139.84 45.18 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.526 -0.733 . . . . 0.02 109.943 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.8 mm -94.37 130.48 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.903 -0.777 . . . . 1.72 108.903 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.558 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.73 110.86 34.89 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.386 -0.821 . . . . 0.02 110.752 -178.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.9 169.23 20.93 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 CA-C-N 119.793 0.962 . . . . 1.47 110.415 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -53.78 140.64 29.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.959 -1.088 . . . . 4.25 110.767 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.04 -177.46 32.27 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.507 -1.33 . . . . 0.02 110.722 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -119.47 131.09 55.54 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.39 -1.065 . . . . 0.96 109.659 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.558 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 78.0 m-85 -120.99 97.85 47.86 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 107.914 -1.143 . . . . 0.02 107.914 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -69.86 -4.52 14.26 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 120.679 0.919 . . . . 0.02 113.686 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -157.47 154.06 28.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.614 -1.304 . . . . 2.02 107.992 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -59.81 -38.03 80.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.379 -0.826 . . . . 0.02 111.871 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -59.79 -24.46 64.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.02 110.446 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -69.75 -19.0 63.55 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.756 0.789 . . . . 3.42 108.894 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.19 10.38 27.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.601 -1.259 . . . . 0.02 107.601 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.2 mmm 60.52 22.55 12.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.597 -0.689 . . . . 0.02 110.381 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.55 144.94 47.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.534 -1.427 . . . . 0.02 109.534 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.5 mt -79.51 -30.73 42.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -1.215 . . . . 0.98 108.013 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -157.42 -171.4 3.58 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.463 -1.68 . . . . 0.02 106.463 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 14.3 p30 -98.6 28.66 4.08 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.692 -1.255 . . . . 0.02 110.64 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -97.83 122.88 41.46 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.875 -1.141 . . . . 3.2 111.435 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.4 mt -142.66 120.06 11.64 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.298 -1.371 . . . . 2.61 107.298 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.46 -17.99 10.75 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 121.251 -0.905 . . . . 0.02 112.295 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.599 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 22.6 t -155.79 156.15 34.27 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 119.591 1.696 . . . . 0.02 110.845 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.599 ' N ' ' HG ' ' A' ' 81' ' ' SER . 49.5 t -145.65 147.92 32.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.02 110.161 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 17.6 mtp180 -136.88 141.73 42.76 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.461 -0.774 . . . . 0.01 109.023 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.38 131.5 36.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.203 -0.936 . . . . 0.43 109.269 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.54 124.34 43.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.816 -0.809 . . . . 1.25 108.816 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -92.47 131.91 37.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.826 -1.171 . . . . 1.77 108.737 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.36 138.5 33.86 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.127 -1.064 . . . . 1.63 108.127 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.4 p -110.67 126.65 54.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.357 -0.839 . . . . 1.08 108.757 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.511 ' HG ' ' H ' ' A' ' 90' ' ' GLY . 13.1 t -103.15 -154.54 0.5 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 106.114 -1.81 . . . . 1.26 106.114 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.511 ' H ' ' HG ' ' A' ' 89' ' ' SER . . . 135.63 -50.31 0.86 Allowed Glycine 0 N--CA 1.498 2.799 0 O-C-N 120.456 -1.403 . . . . 0.01 112.066 178.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.47 -99.77 0.13 Allowed Glycine 0 N--CA 1.487 2.068 0 C-N-CA 118.683 -1.722 . . . . 0.01 112.212 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -120.51 119.54 33.27 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.261 -1.141 . . . . 4.43 110.635 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.8 136.39 55.38 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.302 -0.559 . . . . 2.99 109.588 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -134.85 130.93 36.76 Favored 'General case' 0 N--CA 1.518 2.942 0 CA-C-O 122.182 0.992 . . . . 6.36 112.65 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.5 141.96 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.527 -0.76 . . . . 1.09 110.409 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.5 pm0 -124.68 140.34 53.03 Favored 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 107.573 -1.269 . . . . 2.05 107.573 176.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.87 146.2 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 O-C-N 120.618 -1.301 . . . . 1.1 110.882 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.537 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 25.4 m-85 -119.93 139.96 51.64 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 122.347 1.07 . . . . 0.73 110.799 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.97 -32.26 72.55 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.639 -0.709 . . . . 0.02 111.694 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -114.5 167.31 10.84 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.109 -0.994 . . . . 3.18 110.321 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.45 164.39 52.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 111.147 -0.781 . . . . 0.01 111.147 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 57.82 38.95 27.36 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.554 0.692 . . . . 0.01 111.641 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 52.27 54.58 10.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.41 -0.806 . . . . 0.01 111.241 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 24.7 t30 -129.6 165.21 22.21 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.992 -1.114 . . . . 3.15 107.992 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 90.94 -162.61 28.85 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.975 -1.65 . . . . 0.01 108.975 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -76.22 141.61 41.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.841 -1.388 . . . . 0.01 109.078 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.537 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.4 ttp -116.66 143.54 45.51 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.553 0.692 . . . . 0.01 109.61 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -132.28 136.23 46.79 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -116.02 134.29 55.12 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.748 -0.595 . . . . 0.01 109.754 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -149.34 148.28 29.33 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.626 1.203 . . . . 1.69 111.501 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -115.44 7.38 14.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.872 -1.058 . . . . 0.01 109.938 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -122.38 163.35 19.94 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.391 -0.818 . . . . 3.21 111.307 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -69.69 154.33 42.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.898 . . . . 0.01 109.665 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.425 ' O ' ' OG ' ' A' ' 171' ' ' SER . 40.8 t -126.74 115.56 22.55 Favored Pre-proline 0 N--CA 1.501 2.104 0 N-CA-C 109.192 -0.67 . . . . 0.01 109.192 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.2 -32.63 5.01 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 120.358 1.164 . . . . 0.01 111.418 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 p -142.35 108.42 5.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.294 -0.879 . . . . 0.02 109.125 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.404 HD11 HG21 ' A' ' 117' ' ' ILE . 95.7 mt -64.44 -39.73 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.825 -0.547 . . . . 1.83 111.099 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.7 ttt -66.95 -37.5 84.4 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.107 -1.037 . . . . 1.34 109.853 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.84 -38.57 76.54 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.559 -1.338 . . . . 2.11 109.792 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -80.2 -47.55 14.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 2.08 112.472 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.36 -0.88 16.19 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.334 -0.854 . . . . 0.02 112.727 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.4 m80 60.28 33.77 20.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.808 -1.182 . . . . 0.02 109.48 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.7 mt -112.53 135.16 53.57 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 108.62 -0.882 . . . . 0.02 108.62 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -92.29 -23.23 19.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.354 -0.841 . . . . 5.32 110.565 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -148.97 163.57 37.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.166 -0.959 . . . . 0.02 110.008 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 126' ' ' ILE . 51.2 mt -131.61 129.11 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 107.417 -1.327 . . . . 2.17 107.417 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -107.16 -13.38 15.17 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.192 -0.943 . . . . 0.02 113.246 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.29 153.35 30.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.306 -1.496 . . . . 0.01 108.287 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.4 t -162.34 145.06 11.28 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.326 -1.484 . . . . 1.22 109.737 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.434 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 27.0 ttmt -122.29 111.53 17.03 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.3 1.048 . . . . 1.41 108.892 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.9 t -107.51 122.62 62.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.661 -1.977 . . . . 0.01 105.661 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -146.58 67.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 118.125 -1.43 . . . . 1.98 108.222 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.69 109.04 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.597 -1.631 . . . . 0.01 106.597 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.7 -174.28 39.64 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.711 -1.356 . . . . 0.01 109.711 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -112.4 144.47 41.78 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.372 -1.076 . . . . 2.3 109.349 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -129.89 146.2 51.61 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.43 -0.794 . . . . 0.01 110.392 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.6 mt -118.06 142.12 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 107.668 -1.234 . . . . 1.69 107.668 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.67 143.92 44.27 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 107.736 -1.209 . . . . 2.49 107.736 177.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.8 m-85 -122.53 143.52 49.67 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.966 -0.753 . . . . 0.02 108.966 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -73.02 -29.52 63.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.575 -0.703 . . . . 0.02 112.005 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.58 153.58 47.8 Favored Pre-proline 0 N--CA 1.505 2.323 0 O-C-N 120.614 -1.304 . . . . 1.48 109.198 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.58 167.05 1.57 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.359 1.372 . . . . 0.02 112.606 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 59.56 31.21 20.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.063 -0.971 . . . . 0.75 110.993 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.61 51.32 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.449 -0.782 . . . . 0.02 111.045 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -124.77 163.78 21.39 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.466 -0.771 . . . . 0.02 109.838 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.77 -165.65 32.22 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.873 -1.291 . . . . 0.02 109.873 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -67.53 141.38 56.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.564 -0.962 . . . . 0.02 109.042 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -117.9 148.4 42.18 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.28 -0.637 . . . . 0.02 109.28 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.64 142.92 50.64 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.041 -0.726 . . . . 0.01 109.041 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.412 ' CD2' ' C ' ' A' ' 150' ' ' LEU . 6.0 tt -97.41 121.84 39.78 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.283 -0.886 . . . . 0.01 109.485 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.5 mt -104.98 133.33 49.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.472 -0.767 . . . . 0.01 110.321 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 5.3 p-10 -107.69 173.19 6.43 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.253 -1.017 . . . . 2.27 108.253 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -57.97 84.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.972 -1.08 . . . . 1.84 108.621 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 11.4 tptp -136.34 168.31 19.67 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.327 -0.858 . . . . 2.28 111.068 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 5.3 mp0 -111.09 109.78 20.02 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.325 -0.991 . . . . 0.01 108.325 178.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.37 115.69 30.58 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.087 -1.008 . . . . 0.01 109.904 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -94.05 -25.49 17.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.99 -1.069 . . . . 0.01 111.375 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -125.85 153.92 73.48 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.958 -1.089 . . . . 2.54 109.008 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.03 -42.66 35.02 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 119.144 0.73 . . . . 0.7 110.64 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.73 -20.42 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.638 -1.289 . . . . 0.86 108.433 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -65.41 -15.75 62.92 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.961 -1.087 . . . . 0.02 109.425 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.436 ' O ' ' CE2' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -95.21 9.72 38.69 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.943 -1.132 . . . . 0.02 107.943 178.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.49 11.04 85.49 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.204 -1.474 . . . . 0.02 109.607 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.94 142.26 31.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.382 -1.07 . . . . 0.02 110.204 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.41 -8.49 58.96 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.728 -0.608 . . . . 0.59 109.886 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 16.5 p -144.46 150.78 48.92 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 120.849 -1.157 . . . . 0.87 108.731 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.16 21.55 0.52 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.73 0.953 . . . . 0.38 112.376 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.78 123.98 29.84 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.5 1.143 . . . . 0.18 111.705 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.0 mt -147.07 126.92 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 106.92 -1.511 . . . . 3.99 106.92 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -113.46 -19.22 11.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.142 -0.974 . . . . 5.17 112.853 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.459 ' HG ' ' N ' ' A' ' 172' ' ' PHE . 32.6 t -157.15 159.88 38.22 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 119.142 -2.224 . . . . 0.02 110.376 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.459 ' N ' ' HG ' ' A' ' 171' ' ' SER . 10.9 p90 -152.92 154.08 34.31 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.044 -1.035 . . . . 2.02 110.7 178.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -144.62 151.69 39.38 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.304 -0.872 . . . . 0.01 110.58 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -87.69 142.94 27.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.564 -0.71 . . . . 0.01 109.254 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.2 128.21 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.998 -1.064 . . . . 3.04 109.099 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -136.07 146.46 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.218 -0.927 . . . . 1.89 109.631 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 4.89 109.446 179.903 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.267 -1.533 . . . . 0.01 109.267 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -147.49 135.98 21.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.133 -1.216 . . . . 0.02 110.039 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.9 tt -130.58 140.09 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.218 -0.66 . . . . 0.02 109.218 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t -121.65 130.28 53.37 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.291 -0.88 . . . . 0.39 110.077 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -110.24 139.62 45.22 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.652 -0.655 . . . . 0.02 109.397 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.3 m-85 -121.42 138.03 54.45 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.209 -0.932 . . . . 0.02 109.698 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.516 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 88.5 mt-10 -69.47 -27.52 65.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.842 -1.162 . . . . 0.03 111.594 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -114.16 169.79 8.76 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.752 -1.217 . . . . 0.03 110.179 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.516 ' NH2' ' OE1' ' A' ' 68' ' ' GLU . 49.9 mtp180 -75.67 158.65 32.09 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.629 0.728 . . . . 0.03 110.121 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.41 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 8.2 t-20 65.75 33.71 8.03 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.016 0.912 . . . . 0.74 111.072 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.52 41.74 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.974 -0.557 . . . . 0.02 111.306 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -113.69 165.57 12.4 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.265 -1.013 . . . . 0.02 108.265 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.8 -167.43 34.92 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.887 -1.149 . . . . 0.03 110.711 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -68.24 141.51 55.9 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.554 -0.968 . . . . 2.76 109.046 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -122.52 150.15 42.95 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.572 -0.705 . . . . 1.89 109.87 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -137.21 133.16 34.83 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.205 -0.665 . . . . 0.02 109.205 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -108.74 136.05 48.96 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.748 -0.834 . . . . 1.12 108.748 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 17.1 t -127.64 137.31 52.49 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.572 -0.705 . . . . 0.02 110.02 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 p30 -119.89 11.57 11.85 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.702 -0.624 . . . . 0.2 110.704 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.527 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 32.4 t -159.64 173.22 16.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.709 -1.245 . . . . 1.23 109.262 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -62.8 145.25 55.38 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.489 -1.382 . . . . 0.02 110.611 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 m -135.23 119.48 17.76 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.51 -0.744 . . . . 0.02 109.035 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.66 -20.52 50.07 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.581 -0.699 . . . . 0.24 112.325 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 8.9 p-10 -153.35 106.39 2.95 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.541 -1.349 . . . . 1.14 110.103 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.8 6.59 36.76 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.242 -0.911 . . . . 6.37 110.461 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -60.58 -28.77 68.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.853 . . . . 3.11 111.891 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.9 p -76.69 -16.77 59.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.465 -1.397 . . . . 0.88 111.021 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -105.89 -21.62 13.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.329 -0.857 . . . . 0.02 110.624 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.9 mt -148.66 127.67 12.76 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.093 -1.005 . . . . 3.32 109.309 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -85.9 -11.01 54.31 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.728 -0.607 . . . . 0.02 110.254 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -171.85 161.85 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.144 -1.058 . . . . 0.02 108.144 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 t -143.24 116.41 8.95 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.0 -1.063 . . . . 0.02 108.566 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.682 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.2 OUTLIER -109.77 -0.82 18.28 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 120.789 -1.194 . . . . 0.03 112.049 -177.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 t -154.93 153.69 31.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.014 -1.053 . . . . 0.02 108.3 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -146.17 147.81 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.104 -0.998 . . . . 0.02 110.716 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -124.86 124.86 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.676 -1.231 . . . . 0.02 107.676 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.1 t -105.69 114.13 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.928 -1.508 . . . . 0.02 106.928 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -85.33 -34.49 21.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.548 -0.72 . . . . 3.81 110.216 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.33 148.97 16.65 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.592 -1.766 . . . . 0.02 110.807 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.67 172.31 48.78 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.287 -1.125 . . . . 0.01 110.287 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.9 m -118.12 134.5 54.94 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.505 -1.295 . . . . 1.48 107.505 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -126.73 154.16 44.54 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.516 1.15 . . . . 0.02 112.33 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.57 133.62 52.45 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.29 -2.115 . . . . 0.24 105.29 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -117.32 142.49 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 0.65 109.173 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.513 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 31.9 m-85 -120.62 144.87 47.9 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.262 1.029 . . . . 0.02 110.024 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.21 -33.61 76.16 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.773 -0.649 . . . . 0.02 111.526 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -124.63 157.96 63.75 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 121.065 -1.022 . . . . 0.02 109.551 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.81 166.9 1.22 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.788 1.659 . . . . 0.02 112.794 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 63.58 36.68 10.87 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.344 -0.844 . . . . 0.02 110.968 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.666 ' H ' ' HG ' ' A' ' 81' ' ' SER . 3.6 m-85 45.11 51.48 8.96 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.562 0.696 . . . . 3.39 110.78 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.3 m -125.91 163.53 22.76 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.206 0.526 . . . . 2.33 109.918 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.78 -162.31 31.38 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.738 -1.345 . . . . 0.02 109.738 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.454 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 18.7 m-70 -64.8 138.48 58.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.35 . . . . 0.02 110.04 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.513 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 60.0 ttp -118.3 137.88 52.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.324 0.583 . . . . 5.01 109.514 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.2 m-85 -134.98 139.33 44.81 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.469 -0.769 . . . . 0.02 109.882 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.3 130.53 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.875 -0.787 . . . . 1.72 108.875 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.91 110.6 34.82 Favored Pre-proline 0 N--CA 1.504 2.265 0 O-C-N 121.43 -0.794 . . . . 0.02 110.876 -178.341 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.54 169.39 21.09 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 CA-C-N 119.722 0.936 . . . . 1.47 110.317 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -53.69 140.78 28.35 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.924 -1.11 . . . . 4.25 110.562 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.42 -177.15 32.76 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.47 -1.348 . . . . 0.02 110.634 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -119.41 130.6 55.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.459 -1.024 . . . . 0.96 109.686 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 71.1 m-85 -121.83 95.15 47.96 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.297 -1.001 . . . . 0.02 108.297 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.31 -3.57 10.19 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 120.978 1.118 . . . . 0.02 114.221 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' NH2' ' A' ' 13' ' ' ARG . 38.2 mt-10 -157.96 155.08 28.85 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.479 -1.388 . . . . 2.02 108.311 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -60.08 -38.78 83.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.594 -0.691 . . . . 0.02 112.035 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -59.7 -23.74 63.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.052 -1.03 . . . . 0.02 110.091 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -70.31 -19.11 63.1 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.774 0.797 . . . . 3.42 108.938 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -108.36 10.75 27.5 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.517 -1.29 . . . . 0.02 107.517 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 73' ' ' MET . 2.1 mpt? 59.65 23.88 12.69 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.478 0.656 . . . . 0.02 110.563 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.0 144.86 46.5 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.785 -1.326 . . . . 0.02 109.785 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.13 -30.73 39.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -1.219 . . . . 0.98 107.875 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -157.16 -171.93 3.82 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.413 -1.699 . . . . 0.02 106.413 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.422 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 78.4 m-20 -97.98 27.92 4.25 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.642 -1.286 . . . . 0.02 110.83 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -96.71 122.54 39.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.805 -1.184 . . . . 3.2 111.102 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.0 mt -141.38 118.42 11.24 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.449 -1.315 . . . . 2.61 107.449 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.49 -18.27 9.79 Favored Glycine 0 N--CA 1.501 2.997 0 O-C-N 120.992 -1.067 . . . . 0.02 112.463 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.666 ' HG ' ' H ' ' A' ' 54' ' ' PHE . 32.8 p -156.25 156.01 33.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.352 -1.675 . . . . 0.02 110.351 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.0 m -145.14 148.28 33.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.749 -0.594 . . . . 0.02 109.923 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -137.15 141.75 42.22 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.456 -0.778 . . . . 0.01 109.304 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.16 132.24 36.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.106 -0.996 . . . . 0.43 109.434 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.87 124.48 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.69 -0.856 . . . . 1.25 108.69 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -90.72 133.2 35.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.868 -1.145 . . . . 1.77 108.287 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.17 139.18 36.21 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.851 -0.796 . . . . 1.63 108.851 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 p -110.58 123.78 50.62 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.072 -1.085 . . . . 1.08 108.072 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.4 p -114.99 132.46 56.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.746 -1.221 . . . . 1.26 107.818 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.73 -47.98 0.01 OUTLIER Glycine 0 N--CA 1.503 3.1 0 C-N-CA 117.704 -2.189 . . . . 0.01 113.44 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.16 -103.39 0.17 Allowed Glycine 0 N--CA 1.488 2.129 0 CA-C-N 120.045 1.923 . . . . 0.01 110.927 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -119.13 118.2 30.73 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.16 -1.2 . . . . 4.43 110.179 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.0 135.92 55.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.769 -0.582 . . . . 2.99 109.491 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -134.86 130.06 35.39 Favored 'General case' 0 N--CA 1.519 2.977 0 O-C-N 121.128 -0.982 . . . . 6.36 112.997 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -131.72 142.39 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-O 121.591 0.71 . . . . 1.09 110.318 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.494 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 2.0 pt20 -124.78 139.27 54.0 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.679 -1.23 . . . . 2.05 107.679 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.65 146.54 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.584 0 O-C-N 120.655 -1.278 . . . . 1.1 110.96 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -121.34 140.96 51.41 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 122.084 0.945 . . . . 0.73 111.482 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -69.09 -33.42 73.49 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.774 -0.648 . . . . 0.02 112.391 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.484 ' O ' ' OG ' ' A' ' 128' ' ' SER . 0.8 OUTLIER -113.67 165.33 12.63 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.815 -1.178 . . . . 3.18 109.584 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.97 163.43 44.78 Favored Glycine 0 N--CA 1.492 2.376 0 CA-C-O 122.07 0.817 . . . . 0.01 111.266 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.7 t0 57.65 39.96 27.01 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.599 0.714 . . . . 0.01 111.077 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.46 55.01 9.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.632 -0.668 . . . . 0.01 111.002 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -127.07 165.72 18.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.219 -1.03 . . . . 3.15 108.219 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.65 -163.0 29.47 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.14 -1.584 . . . . 0.01 109.14 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.492 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 58.7 tt0 -75.2 142.18 43.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.942 -1.328 . . . . 0.01 108.841 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' A' ' 107' ' ' MET . 9.7 tmm? -116.46 143.28 45.78 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.566 0.698 . . . . 0.01 109.433 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.492 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 55.1 m-85 -132.17 136.04 46.79 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.349 -0.982 . . . . 2.48 108.349 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -117.01 134.07 55.21 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.697 -0.627 . . . . 0.01 109.844 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.49 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -149.83 149.1 29.99 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.42 1.105 . . . . 1.69 111.313 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -115.19 7.75 15.39 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.132 -0.94 . . . . 0.01 110.321 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.49 ' H ' ' HG1' ' A' ' 110' ' ' THR . 62.9 mm-40 -121.67 163.28 19.27 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.406 -0.809 . . . . 3.21 111.255 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.21 154.84 41.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.01 109.539 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 35.1 t -126.64 114.53 22.76 Favored Pre-proline 0 N--CA 1.499 2.013 0 N-CA-C 109.049 -0.722 . . . . 0.01 109.049 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.37 -33.57 4.14 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 120.274 1.134 . . . . 0.01 111.218 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 p -141.15 107.15 5.17 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.662 -0.866 . . . . 0.02 108.662 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.82 -39.52 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.721 -0.612 . . . . 1.83 111.23 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.6 ttt -66.77 -37.65 85.01 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.002 -1.079 . . . . 1.34 109.727 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.72 -38.55 76.95 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.58 -1.325 . . . . 2.11 109.693 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -80.18 -47.47 14.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 2.08 112.359 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -111.02 -1.1 16.43 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.413 -0.804 . . . . 0.02 112.84 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 m80 59.97 33.23 21.4 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.621 -1.299 . . . . 0.02 109.503 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.1 mt -111.63 135.02 52.79 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.805 -0.813 . . . . 0.02 108.805 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -93.65 -24.01 18.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.284 -0.885 . . . . 5.32 110.688 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -148.42 162.55 39.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.259 -0.9 . . . . 0.02 109.791 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.434 ' C ' ' HD1' ' A' ' 127' ' ' HIS . 54.5 mt -133.18 130.2 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 107.64 -1.244 . . . . 2.17 107.64 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.434 ' HD1' ' C ' ' A' ' 126' ' ' ILE . 0.7 OUTLIER -106.52 -13.72 15.25 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 113.524 0.935 . . . . 0.02 113.524 -176.346 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -157.45 156.37 32.02 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.256 -1.527 . . . . 0.01 108.396 177.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.4 t -162.11 146.81 12.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.478 -1.389 . . . . 1.22 109.93 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -120.03 108.54 14.42 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.137 0.97 . . . . 1.41 108.445 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 t -107.09 120.35 58.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 105.795 -1.928 . . . . 0.01 105.795 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 t -146.63 68.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 118.043 -1.463 . . . . 1.98 108.304 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.6 108.3 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.505 -1.665 . . . . 0.01 106.505 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.24 -174.31 44.51 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.737 -1.345 . . . . 0.01 109.737 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 m -111.92 145.69 39.11 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.369 -1.077 . . . . 2.3 109.088 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -131.32 145.29 51.8 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.552 -0.718 . . . . 0.01 110.741 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.2 mt -117.7 142.01 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 107.421 -1.325 . . . . 1.69 107.421 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -115.12 143.9 44.49 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 107.499 -1.297 . . . . 2.49 107.499 177.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 18.0 m-85 -122.42 144.67 48.9 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.948 -0.76 . . . . 0.02 108.948 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.01 -30.0 62.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.02 112.06 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.17 153.96 47.32 Favored Pre-proline 0 N--CA 1.506 2.351 0 O-C-N 120.593 -1.317 . . . . 1.48 109.292 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.71 166.27 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.192 1.262 . . . . 0.02 112.615 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 59.84 31.31 20.7 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.149 -0.932 . . . . 0.75 111.186 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 57.74 51.94 8.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.02 110.926 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -125.09 163.67 21.89 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.486 -0.759 . . . . 0.02 109.747 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.51 -165.37 32.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.751 -1.34 . . . . 0.02 109.751 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -67.97 141.72 56.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.629 -0.924 . . . . 0.02 108.949 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.464 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.2 mp0 -118.51 148.41 42.65 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.463 -0.569 . . . . 0.02 109.463 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.516 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.7 t80 -129.33 142.9 50.7 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.013 -0.736 . . . . 0.01 109.013 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.75 121.8 39.0 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.293 -0.88 . . . . 0.01 109.345 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.4 mt -104.66 133.51 49.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.506 -0.746 . . . . 0.01 110.225 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 154' ' ' LYS . 21.1 t0 -108.83 175.39 5.48 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.341 -0.985 . . . . 2.27 108.341 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.402 ' H ' ' CG ' ' A' ' 152' ' ' ASP . 86.9 mttt -57.41 84.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.84 -1.162 . . . . 1.84 108.626 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 152' ' ' ASP . 35.4 mttp -137.73 168.42 19.72 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.191 0.996 . . . . 2.28 111.647 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -113.33 109.82 19.34 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.26 -1.015 . . . . 0.01 108.26 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -99.77 115.87 30.54 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.022 -1.049 . . . . 0.01 109.931 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -93.52 -25.4 17.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.079 -1.013 . . . . 0.01 111.433 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -125.89 153.42 73.56 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 120.786 -1.196 . . . . 2.54 108.613 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.16 -41.7 41.14 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 CA-C-N 119.281 0.779 . . . . 0.7 110.584 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.58 -20.58 21.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.769 -1.207 . . . . 0.86 108.586 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.49 -15.77 62.99 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.029 -1.044 . . . . 0.02 109.625 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.516 ' O ' ' CE2' ' A' ' 149' ' ' TYR . 0.3 OUTLIER -95.34 9.87 38.31 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 107.919 -1.141 . . . . 0.02 107.919 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.38 10.8 85.48 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.205 -1.474 . . . . 0.02 109.588 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.76 142.43 31.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.469 -1.018 . . . . 0.02 110.282 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.63 -8.59 58.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.728 -0.608 . . . . 0.59 110.007 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.3 p -144.68 150.99 48.85 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.737 -1.227 . . . . 0.87 108.789 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.97 21.72 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 120.899 1.066 . . . . 0.38 112.331 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.19 123.89 29.99 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.623 1.201 . . . . 0.18 111.563 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.0 mt -146.66 126.75 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 106.765 -1.569 . . . . 3.99 106.765 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -113.17 -20.34 11.48 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.112 -0.993 . . . . 5.17 112.835 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.1 p -157.76 160.13 37.53 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.172 -2.205 . . . . 0.02 110.233 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -153.04 154.9 35.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.184 -0.948 . . . . 2.02 110.683 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -145.03 151.63 38.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.263 -0.898 . . . . 0.01 110.539 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -87.73 142.08 28.1 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.524 -0.735 . . . . 0.01 109.406 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.3 mt -92.2 128.17 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.137 -0.977 . . . . 3.04 109.241 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.7 t -136.35 146.83 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.151 -0.968 . . . . 1.89 109.487 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 4.89 109.441 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.405 -0.591 . . . . 5.28 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -76.3 64.31 2.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 5.96 109.528 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.6 m -80.91 143.1 32.92 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.32 -0.993 . . . . 2.22 108.32 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.39 -179.72 47.29 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 118.332 -1.889 . . . . 0.81 112.082 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.71 157.7 44.11 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.275 -1.53 . . . . 0.01 109.275 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -148.45 136.78 21.24 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.128 -1.219 . . . . 0.02 110.337 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.73 140.94 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.17 -0.678 . . . . 0.02 109.17 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -121.5 130.25 53.43 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.396 -0.815 . . . . 0.39 110.089 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 m-85 -110.18 140.14 44.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.598 -0.689 . . . . 0.02 109.27 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.54 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.0 m-85 -122.04 138.21 54.52 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.155 -0.965 . . . . 0.02 109.58 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -69.62 -27.37 65.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 0.03 111.788 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.0 m-20 -113.89 169.44 8.99 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.85 -1.156 . . . . 0.03 110.091 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.15 158.3 33.26 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.606 0.717 . . . . 0.03 110.095 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 0.8 OUTLIER 66.05 35.07 6.52 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.745 0.784 . . . . 0.74 110.76 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.5 p90 49.82 44.31 25.01 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.606 -0.724 . . . . 0.02 111.19 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -112.71 166.05 11.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.95 -167.58 34.8 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 120.736 -1.228 . . . . 0.03 110.415 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -69.36 142.68 53.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -1.024 . . . . 2.76 109.036 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -122.06 150.13 42.56 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.521 -0.737 . . . . 1.89 110.065 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -135.93 132.88 37.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.749 -0.594 . . . . 0.02 109.516 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -110.25 135.96 50.19 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.398 -0.814 . . . . 1.12 109.118 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 43.6 t -128.43 138.49 52.34 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.524 -0.735 . . . . 0.02 109.411 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 34.2 p-10 -119.16 11.88 12.48 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.624 -0.672 . . . . 0.2 110.392 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 4.3 p -159.42 173.45 16.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.765 -1.209 . . . . 1.23 109.05 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 13.2 p-10 -63.15 145.98 54.32 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.693 -1.254 . . . . 0.02 110.612 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.561 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 45.0 t -134.95 118.54 16.98 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.144 -0.687 . . . . 0.02 109.144 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.4 -21.62 52.87 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.53 -0.731 . . . . 0.24 111.605 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -154.49 105.06 2.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.845 -1.159 . . . . 1.14 109.506 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.4 OUTLIER -101.84 8.88 41.16 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.427 -0.796 . . . . 6.37 109.875 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.46 -28.55 68.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.435 -0.79 . . . . 3.11 112.033 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 m -76.83 -17.32 59.07 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.35 -1.469 . . . . 0.88 111.235 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 27.8 m-85 -107.22 -20.48 13.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.381 -0.824 . . . . 0.02 110.393 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tp -148.93 127.15 12.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.026 -1.046 . . . . 3.32 109.51 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.8 p -87.1 -12.26 47.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.558 -0.714 . . . . 0.02 111.329 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -172.02 161.98 5.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.807 -1.183 . . . . 0.02 108.283 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.8 t -143.52 116.61 8.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.96 -1.088 . . . . 0.02 108.984 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.518 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -109.7 0.5 18.98 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.792 -1.193 . . . . 0.03 111.714 -178.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 m -156.09 153.84 30.01 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.276 -1.009 . . . . 0.02 108.276 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mt -146.24 146.9 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.946 -1.096 . . . . 0.02 110.715 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -123.79 124.62 43.08 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.485 -1.302 . . . . 0.02 107.485 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.21 114.39 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.843 -1.54 . . . . 0.02 106.843 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -84.94 -34.85 22.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.565 -0.71 . . . . 3.81 109.906 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.61 149.34 17.22 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.497 -1.811 . . . . 0.02 110.976 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.1 171.84 48.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.386 -1.086 . . . . 0.01 110.386 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.1 m -118.02 134.03 55.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.554 -1.276 . . . . 1.48 107.554 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.1 m95 -128.27 155.69 44.19 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 122.636 1.208 . . . . 0.02 112.27 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.83 134.0 52.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.493 -2.04 . . . . 0.24 105.493 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.08 142.45 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.936 -0.764 . . . . 0.65 108.936 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -120.83 144.98 48.07 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.386 1.089 . . . . 0.02 110.092 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -66.17 -34.0 77.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.721 -0.672 . . . . 0.02 111.472 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -124.44 157.9 63.44 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 121.097 -1.002 . . . . 0.02 109.449 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.56 166.47 1.25 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.766 1.644 . . . . 0.02 112.783 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 m-20 63.71 36.36 10.75 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.366 -0.834 . . . . 0.02 111.15 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.444 ' H ' ' HG ' ' A' ' 81' ' ' SER . 5.1 m-85 45.67 51.74 9.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.567 0.699 . . . . 3.39 110.732 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 p -126.23 163.74 22.51 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.203 0.525 . . . . 2.33 109.993 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.38 -161.56 31.39 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.748 -1.341 . . . . 0.02 109.748 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -64.54 138.79 58.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.936 -1.332 . . . . 0.02 110.042 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 21.2 ptm -119.61 137.49 53.83 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.208 0.528 . . . . 5.01 109.736 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.551 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 95.1 m-85 -134.61 139.67 45.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.434 -0.791 . . . . 0.02 110.127 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 mm -93.79 130.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.736 -0.838 . . . . 1.72 108.736 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.483 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -120.91 110.48 34.91 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.425 -0.797 . . . . 0.02 110.63 -178.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -78.09 169.76 19.85 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 119.767 0.953 . . . . 1.47 110.17 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -53.55 140.84 27.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.818 -1.176 . . . . 4.25 110.496 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.55 -177.37 32.74 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.462 -1.352 . . . . 0.02 110.611 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -119.3 130.42 55.38 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.402 -1.058 . . . . 0.96 109.708 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.483 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 32.1 m-85 -122.94 91.92 49.49 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.296 -1.002 . . . . 0.02 108.296 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -65.95 -2.83 7.28 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.115 1.21 . . . . 0.02 113.739 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -156.93 151.05 24.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.335 -1.478 . . . . 2.02 107.88 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -59.59 -38.94 82.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.662 -0.649 . . . . 0.02 112.538 -176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -60.36 -23.47 64.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.026 -1.046 . . . . 0.02 111.079 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -73.13 -15.54 61.47 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.79 -1.164 . . . . 3.42 108.752 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.559 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 0.6 OUTLIER -107.63 9.35 29.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.3 -1.37 . . . . 0.02 107.3 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.0 mtm 62.11 22.91 13.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.685 -0.635 . . . . 0.02 110.923 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.21 145.05 46.85 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.748 -1.341 . . . . 0.02 109.748 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.76 -31.7 35.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -1.209 . . . . 0.98 107.949 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.655 HD21 ' H ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -157.28 -172.27 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.467 -1.679 . . . . 0.02 106.467 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.29 27.65 4.55 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.768 -1.208 . . . . 0.02 110.654 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.655 ' H ' HD21 ' A' ' 76' ' ' ASN . 68.7 mtm180 -96.34 122.52 39.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.881 -1.137 . . . . 3.2 110.864 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.5 mt -142.44 119.06 11.04 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.771 -1.196 . . . . 2.61 107.771 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.1 -18.28 10.03 Favored Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.138 -0.976 . . . . 0.02 112.511 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.444 ' HG ' ' H ' ' A' ' 54' ' ' PHE . 60.5 p -156.12 156.52 34.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.255 -1.732 . . . . 0.02 110.394 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.4 m -145.47 148.23 33.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.719 -0.613 . . . . 0.02 109.841 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.44 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 54.6 mtm180 -137.39 141.97 41.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.331 -0.855 . . . . 0.01 109.311 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 132.79 36.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.213 -0.93 . . . . 0.43 109.496 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.74 124.03 42.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.242 -1.021 . . . . 1.25 108.242 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -91.31 134.57 34.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.823 -1.173 . . . . 1.77 108.507 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.61 135.41 40.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.841 -1.17 . . . . 1.63 107.841 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.51 ' HG ' ' HG1' ' A' ' 135' ' ' THR . 92.7 p -109.37 127.63 54.5 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.763 -0.828 . . . . 1.08 108.763 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -105.19 -153.78 0.5 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 106.314 -1.736 . . . . 1.26 106.314 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.59 -50.63 0.86 Allowed Glycine 0 N--CA 1.499 2.849 0 O-C-N 120.528 -1.358 . . . . 0.01 111.846 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.73 -100.73 0.15 Allowed Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.867 -1.635 . . . . 0.01 111.402 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -119.61 118.11 30.12 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.185 -1.185 . . . . 4.43 110.243 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.19 136.69 56.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.385 -0.598 . . . . 2.99 109.385 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -134.38 130.4 36.83 Favored 'General case' 0 N--CA 1.519 2.988 0 O-C-N 121.06 -1.025 . . . . 6.36 113.048 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.17 143.49 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 115.63 -0.713 . . . . 1.09 110.591 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.488 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.9 pt20 -124.89 139.71 53.58 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.771 -1.196 . . . . 2.05 107.771 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.22 145.69 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 120.652 -1.28 . . . . 1.1 111.189 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 27.8 m-85 -120.4 140.19 51.71 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.956 0.884 . . . . 0.73 110.847 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -68.55 -32.41 72.32 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.784 -0.644 . . . . 0.02 112.178 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -114.82 165.74 12.51 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.956 -1.09 . . . . 3.18 110.212 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.18 163.41 45.44 Favored Glycine 0 N--CA 1.492 2.38 0 CA-C-O 121.958 0.755 . . . . 0.01 111.278 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 57.15 39.17 29.13 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.578 0.704 . . . . 0.01 111.026 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 52.66 55.91 8.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.624 -0.672 . . . . 0.01 111.112 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -128.42 164.87 21.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.281 -1.007 . . . . 3.15 108.281 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.65 -163.05 28.25 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.092 -1.603 . . . . 0.01 109.092 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -75.62 142.04 42.72 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.878 -1.366 . . . . 0.01 108.959 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 33.9 ttp -116.73 143.27 45.85 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.538 0.685 . . . . 0.01 109.533 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.98 136.41 47.28 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.173 -1.047 . . . . 2.48 108.173 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -115.96 134.09 55.34 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.715 -0.616 . . . . 0.01 109.7 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.1 t -149.31 147.93 28.93 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.515 1.15 . . . . 1.69 111.474 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -114.54 7.63 16.19 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.894 -1.048 . . . . 0.01 109.875 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -121.96 163.56 19.11 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.393 -0.817 . . . . 3.21 111.008 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.4 154.82 41.43 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.358 -0.839 . . . . 0.01 109.379 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.8 t -126.64 114.98 22.77 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.911 -0.774 . . . . 0.01 108.911 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.23 -32.59 5.01 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 120.323 1.151 . . . . 0.01 111.447 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 m -142.31 108.26 5.18 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.847 0.832 . . . . 0.02 108.947 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.29 -39.9 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.776 -0.577 . . . . 1.83 110.97 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 32.7 ttp -66.89 -37.4 84.31 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.026 -1.069 . . . . 1.34 109.812 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -70.22 -38.62 75.29 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.524 -1.36 . . . . 2.11 109.761 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.51 ' NE2' ' CE1' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -80.14 -47.49 14.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.253 -0.904 . . . . 2.08 112.203 -176.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.51 ' CE1' ' NE2' ' A' ' 120' ' ' GLN . 92.1 m-85 -110.82 -0.44 16.93 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.378 -0.826 . . . . 0.02 112.699 -176.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 59.93 33.2 21.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.659 -1.276 . . . . 0.02 109.595 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mt -112.69 135.85 52.95 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 108.764 -0.828 . . . . 0.02 108.764 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -91.73 -22.89 19.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -0.822 . . . . 5.32 110.358 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -149.36 164.03 36.07 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.09 -1.006 . . . . 0.02 110.019 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.414 HD12 HG23 ' A' ' 126' ' ' ILE . 54.8 mt -131.7 129.57 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.375 -1.343 . . . . 2.17 107.375 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -107.77 -12.92 15.12 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.134 -0.979 . . . . 0.02 113.18 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.6 OUTLIER -153.52 151.35 29.71 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.489 -1.382 . . . . 0.01 108.278 178.321 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 13.7 t -160.92 145.03 13.6 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.261 -1.524 . . . . 1.22 109.935 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -121.8 110.22 15.64 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.43 1.109 . . . . 1.41 109.156 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 t -107.55 120.34 58.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 105.851 -1.907 . . . . 0.01 105.851 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.0 t -146.27 68.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 118.453 -1.299 . . . . 1.98 108.369 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 172.65 107.22 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.443 -1.688 . . . . 0.01 106.443 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.66 -174.07 43.1 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.554 -1.418 . . . . 0.01 109.554 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.51 ' HG1' ' HG ' ' A' ' 88' ' ' SER . 13.2 m -111.41 144.3 40.84 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.387 -1.066 . . . . 2.3 109.216 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -129.15 146.03 51.18 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.643 -0.66 . . . . 0.01 110.377 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.1 mt -117.36 141.71 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 107.642 -1.244 . . . . 1.69 107.642 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -113.97 143.42 44.76 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 107.453 -1.314 . . . . 2.49 107.453 177.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 16.0 m-85 -122.77 144.17 49.35 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.291 -0.633 . . . . 0.02 109.291 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.5 -29.86 62.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.737 -0.602 . . . . 0.02 111.964 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.47 153.87 47.69 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 120.679 -1.263 . . . . 1.48 109.26 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -54.48 166.13 1.98 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.229 1.286 . . . . 0.02 112.658 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 15.3 t-20 59.79 31.76 20.97 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.145 -0.934 . . . . 0.75 111.136 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.504 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.8 m-85 57.43 51.45 9.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.54 -0.725 . . . . 0.02 110.827 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -124.55 163.43 21.93 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.541 -0.724 . . . . 0.02 109.659 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.45 -165.34 32.42 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.83 -1.308 . . . . 0.02 109.83 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -67.89 141.48 56.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.991 . . . . 0.02 109.011 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.676 ' H ' ' NE2' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -118.87 149.01 42.27 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.284 -0.635 . . . . 0.02 109.284 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.68 142.4 51.03 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.181 -0.674 . . . . 0.01 109.181 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.564 ' CD1' ' N ' ' A' ' 150' ' ' LEU . 3.4 mp -95.43 121.11 36.76 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.462 -0.774 . . . . 0.01 109.336 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.42 135.25 47.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.44 -0.788 . . . . 0.01 110.674 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 154' ' ' LYS . 2.8 m-20 -110.31 175.63 5.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.187 -1.042 . . . . 2.27 108.187 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -57.85 84.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.905 -1.122 . . . . 1.84 108.638 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 152' ' ' ASP . 73.6 tttt -137.14 165.38 26.21 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.256 -0.903 . . . . 2.28 111.654 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 6.7 pt-20 -111.8 113.66 26.15 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.061 -1.088 . . . . 0.01 108.061 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.44 115.28 30.25 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.933 -1.104 . . . . 0.01 110.29 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.445 ' O ' ' OG ' ' A' ' 128' ' ' SER . 3.7 ptp180 -92.18 -25.82 18.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.01 111.347 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -125.67 153.17 72.97 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 121.017 -1.052 . . . . 2.54 108.643 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -60.7 -42.08 41.85 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 CA-C-N 119.27 0.775 . . . . 0.7 110.524 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.1 t -60.38 -20.43 20.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.745 -1.222 . . . . 0.86 108.612 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -65.91 -16.19 63.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.989 -1.069 . . . . 0.02 109.605 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.406 ' CZ3' ' CD1' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -94.73 9.3 39.48 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.763 -1.199 . . . . 0.02 107.763 179.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.15 10.32 86.32 Favored Glycine 0 N--CA 1.486 2.024 0 C-N-CA 119.214 -1.47 . . . . 0.02 109.617 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.5 142.03 31.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.45 -1.03 . . . . 0.02 110.091 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.1 -8.33 59.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.677 -0.64 . . . . 0.59 109.828 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.559 ' HG ' ' H ' ' A' ' 168' ' ' ALA . 10.5 p -144.66 150.86 48.47 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.857 -1.152 . . . . 0.87 108.702 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.83 21.03 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 120.816 1.011 . . . . 0.38 112.355 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.559 ' H ' ' HG ' ' A' ' 166' ' ' SER . . . -82.87 124.13 30.03 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.464 1.126 . . . . 0.18 111.708 -178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.406 ' CD1' ' CZ3' ' A' ' 162' ' ' TRP . 16.4 mt -146.47 126.9 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 106.78 -1.563 . . . . 3.99 106.78 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -112.02 -20.53 11.93 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.098 -1.001 . . . . 5.17 112.783 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.6 p -158.0 160.63 37.68 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 119.269 -2.144 . . . . 0.02 110.141 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -152.48 154.03 34.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.129 -0.982 . . . . 2.02 110.26 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.504 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -144.51 151.97 39.9 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.195 -0.941 . . . . 0.01 110.449 -179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -88.24 143.02 27.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.496 -0.753 . . . . 0.01 109.412 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -93.25 128.66 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.17 -0.956 . . . . 3.04 109.053 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.8 t -136.0 146.4 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.224 -0.923 . . . . 1.89 109.384 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 4.89 109.517 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.581 -0.525 . . . . 5.28 109.581 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.91 -86.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 5.96 109.329 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 t -170.49 169.09 7.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.832 -1.167 . . . . 2.22 109.053 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.08 117.34 3.62 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 106.939 -2.465 . . . . 0.81 106.939 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.08 145.38 33.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.642 -1.383 . . . . 0.01 109.642 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -152.83 138.29 17.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.264 -1.139 . . . . 0.02 109.586 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -130.31 140.87 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.373 -0.603 . . . . 0.02 109.373 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -121.13 129.95 53.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.469 -0.77 . . . . 0.39 110.143 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -109.02 139.32 44.05 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.549 -0.719 . . . . 0.02 109.147 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.3 m-85 -121.98 137.73 54.69 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.361 -0.837 . . . . 0.02 109.276 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.78 -27.4 64.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.013 -1.054 . . . . 0.03 111.88 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.9 m-20 -114.2 170.2 8.46 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.87 -1.144 . . . . 0.03 110.366 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -75.25 157.91 33.72 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.599 0.714 . . . . 0.03 110.136 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 10.4 t30 65.85 35.11 6.85 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.803 0.811 . . . . 0.74 110.8 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.96 44.83 25.5 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.487 -0.779 . . . . 0.02 111.368 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -112.28 165.87 11.79 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.032 -1.099 . . . . 0.02 108.032 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -167.88 34.44 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 120.847 -1.158 . . . . 0.03 110.619 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -69.19 143.1 54.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -1.04 . . . . 2.76 108.922 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -123.22 149.92 44.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.518 -0.739 . . . . 1.89 110.211 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -136.25 133.4 36.96 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 109.317 -0.623 . . . . 0.02 109.317 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.0 136.16 48.99 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.688 -0.856 . . . . 1.12 108.688 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.476 ' SG ' ' CZ ' ' A' ' 29' ' ' PHE . 1.9 m -126.94 137.31 53.1 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.637 -0.664 . . . . 0.02 109.541 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -118.95 10.74 12.31 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.572 -0.705 . . . . 0.2 110.233 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 14.9 t -159.61 173.19 16.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.79 -1.194 . . . . 1.23 109.063 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.416 ' OD1' ' SG ' ' A' ' 24' ' ' CYS . 5.5 p-10 -63.22 146.28 53.72 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.683 -1.26 . . . . 0.02 110.721 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.88 119.22 17.81 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.061 -0.718 . . . . 0.02 109.061 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -20.84 51.33 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.504 -0.748 . . . . 0.24 112.037 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -153.73 106.02 2.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.729 -1.232 . . . . 1.14 109.762 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.476 ' CZ ' ' SG ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -102.66 6.7 39.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.353 -0.842 . . . . 6.37 110.399 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -61.17 -29.5 69.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 3.11 111.898 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.4 t -77.06 -17.56 58.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.505 -1.372 . . . . 0.88 110.948 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -106.14 -21.42 13.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.388 -0.82 . . . . 0.02 110.624 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.13 127.39 12.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.145 -0.972 . . . . 3.32 109.472 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.6 t -87.29 -12.48 46.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.516 -0.74 . . . . 0.02 110.976 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -172.56 161.99 5.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.847 -1.158 . . . . 0.02 108.378 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 p -142.63 115.04 8.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.99 -1.069 . . . . 0.02 108.735 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -107.04 -2.71 20.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.836 -1.165 . . . . 0.03 111.289 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -152.96 153.65 33.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.118 -1.067 . . . . 0.02 108.118 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.7 mt -146.83 147.44 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.045 -1.034 . . . . 0.02 110.438 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -124.91 125.66 44.29 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.899 -1.148 . . . . 0.02 107.899 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.6 114.11 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 106.773 -1.566 . . . . 0.02 106.773 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.94 -34.61 22.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.609 -0.682 . . . . 3.81 110.184 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.24 149.99 18.24 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 118.358 -1.877 . . . . 0.02 110.758 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.12 172.42 49.11 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.174 -1.171 . . . . 0.01 110.174 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 m -118.35 134.19 55.26 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.484 -1.302 . . . . 1.48 107.484 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -126.38 154.86 43.0 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.626 1.203 . . . . 0.02 112.326 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.72 133.99 52.51 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.189 -2.152 . . . . 0.24 105.189 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.22 142.63 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.514 -0.741 . . . . 0.65 109.319 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -120.88 143.19 49.05 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 122.053 0.93 . . . . 0.02 109.535 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.08 -33.62 76.47 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.498 -0.774 . . . . 0.02 111.641 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -124.46 157.7 64.19 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 121.098 -1.001 . . . . 0.02 109.467 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.13 166.94 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.656 1.57 . . . . 0.02 112.726 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.07 36.5 12.24 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.331 -0.849 . . . . 0.02 111.108 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.49 ' H ' ' HG ' ' A' ' 81' ' ' SER . 2.8 m-85 45.56 51.54 9.84 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.601 0.715 . . . . 3.39 110.864 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 p -125.78 163.55 22.62 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.384 0.612 . . . . 2.33 109.904 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.49 -161.45 31.17 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.799 -1.32 . . . . 0.02 109.799 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -65.3 139.35 58.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.027 -1.278 . . . . 0.02 110.163 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 18.4 ptm -118.91 137.05 53.73 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.245 0.545 . . . . 5.01 109.61 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.405 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.9 m-85 -134.19 138.82 45.4 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.459 -0.776 . . . . 0.02 109.925 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.7 mm -95.2 130.62 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.49 -0.756 . . . . 1.72 109.031 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 mt -121.44 111.2 33.49 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 121.326 -0.859 . . . . 0.02 110.653 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -77.66 169.77 20.29 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 CA-C-N 119.85 0.982 . . . . 1.47 110.415 177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -53.53 141.26 25.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.902 -1.124 . . . . 4.25 110.603 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.45 -177.4 31.83 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.502 -1.333 . . . . 0.02 110.693 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -118.45 130.42 55.95 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.354 -1.086 . . . . 0.96 109.787 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -120.37 97.05 49.08 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 107.861 -1.163 . . . . 0.02 107.861 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -69.48 -4.49 13.94 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 120.752 0.968 . . . . 0.02 113.583 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -157.27 154.53 29.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.623 -1.298 . . . . 2.02 108.144 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -59.95 -38.6 82.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.408 -0.808 . . . . 0.02 111.773 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -59.82 -24.44 64.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.02 110.226 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -70.09 -18.72 63.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.41 -0.806 . . . . 3.42 108.879 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.46 10.12 27.42 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.628 -1.249 . . . . 0.02 107.628 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.9 mmt 60.81 22.32 12.37 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.48 0.657 . . . . 0.02 110.598 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.43 144.17 45.8 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.367 -1.493 . . . . 0.02 109.367 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.1 tp -78.93 -30.93 44.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.553 -1.276 . . . . 0.98 107.553 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -157.42 -171.82 3.74 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.544 -1.651 . . . . 0.02 106.544 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -98.25 28.63 3.96 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.603 -1.31 . . . . 0.02 110.775 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -97.82 122.72 41.26 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.933 -1.105 . . . . 3.2 111.324 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 mt -142.36 119.51 11.43 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.317 -1.364 . . . . 2.61 107.317 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.99 -18.55 10.41 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 121.282 -0.886 . . . . 0.02 112.065 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.49 ' HG ' ' H ' ' A' ' 54' ' ' PHE . 6.4 p -155.45 155.63 33.86 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 119.531 1.666 . . . . 0.02 110.695 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.5 p -145.17 147.82 32.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.403 -0.811 . . . . 0.02 110.283 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -137.17 141.87 42.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.442 -0.786 . . . . 0.01 109.109 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.58 132.36 37.11 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.203 -0.935 . . . . 0.43 109.28 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.3 123.95 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.653 -0.869 . . . . 1.25 108.653 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -92.01 132.34 36.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.956 -1.09 . . . . 1.77 108.552 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.83 138.12 34.87 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.139 -1.06 . . . . 1.63 108.139 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.9 p -110.21 126.38 54.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 1.08 108.682 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.2 t -102.85 -155.1 0.51 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.205 -1.776 . . . . 1.26 106.205 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.59 -50.41 0.84 Allowed Glycine 0 N--CA 1.497 2.743 0 O-C-N 120.521 -1.362 . . . . 0.01 111.986 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.6 -99.77 0.13 Allowed Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.816 -1.659 . . . . 0.01 111.709 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -119.34 119.45 34.01 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.117 -1.225 . . . . 4.43 110.311 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.35 137.32 56.82 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.344 -0.613 . . . . 2.99 109.344 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.406 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 7.5 ttpm? -136.45 130.7 33.03 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-O 122.273 1.035 . . . . 6.36 113.015 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 tt -131.72 141.51 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 115.397 -0.82 . . . . 1.09 110.286 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.504 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 6.3 pt20 -124.33 140.2 53.18 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 107.597 -1.26 . . . . 2.05 107.597 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 m -124.24 146.29 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.685 -1.259 . . . . 1.1 111.189 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 26.2 m-85 -120.4 140.24 51.64 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 122.224 1.011 . . . . 0.73 110.745 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.84 -32.44 72.97 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.709 -0.678 . . . . 0.02 111.907 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -114.47 165.7 12.47 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 120.948 -1.095 . . . . 3.18 110.446 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.9 163.69 47.24 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 111.038 -0.825 . . . . 0.01 111.038 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 57.62 38.86 27.88 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.578 0.704 . . . . 0.01 110.946 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 52.44 56.91 7.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.537 -0.727 . . . . 0.01 111.035 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -129.48 165.34 21.82 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.166 -1.05 . . . . 3.15 108.166 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.4 -162.77 28.38 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.13 -1.588 . . . . 0.01 109.13 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.471 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 54.6 tt0 -75.81 142.0 42.37 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.016 -1.285 . . . . 0.01 108.76 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.7 ttp -116.55 143.05 46.09 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.513 0.673 . . . . 0.01 109.563 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.471 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 55.9 m-85 -131.89 135.91 47.01 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.198 -1.038 . . . . 2.48 108.198 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -116.52 134.37 54.92 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.722 -0.611 . . . . 0.01 109.669 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t -149.23 148.02 29.09 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.528 1.156 . . . . 1.69 111.367 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.501 ' HG1' ' CD ' ' A' ' 112' ' ' GLU . 15.3 p -114.95 7.67 15.67 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.949 -1.023 . . . . 0.01 109.934 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.501 ' CD ' ' HG1' ' A' ' 111' ' ' THR . 21.8 mp0 -122.03 163.78 18.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.408 -0.808 . . . . 3.21 111.181 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.59 153.89 42.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.384 -0.823 . . . . 0.01 109.46 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 46.0 t -126.98 114.95 22.03 Favored Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 108.971 -0.752 . . . . 0.01 108.971 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -75.1 -32.94 4.86 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 120.387 1.174 . . . . 0.01 111.612 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -142.05 108.49 5.3 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.834 0.826 . . . . 0.02 109.198 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 117' ' ' ILE . 96.4 mt -64.36 -39.75 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.844 -0.535 . . . . 1.83 111.02 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.6 ttt -66.57 -38.17 86.5 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.169 -1.012 . . . . 1.34 109.865 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.62 -38.46 77.23 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.506 -1.371 . . . . 2.11 109.858 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -80.78 -47.25 14.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.29 -0.881 . . . . 2.08 112.462 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -111.21 -0.78 16.36 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.252 -0.905 . . . . 0.02 112.719 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 59.88 33.43 21.57 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.812 -1.18 . . . . 0.02 109.384 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.27 135.7 52.61 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 108.699 -0.852 . . . . 0.02 108.699 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -92.66 -23.43 18.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 5.32 110.65 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -149.11 163.66 36.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.084 -1.01 . . . . 0.02 110.095 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 126' ' ' ILE . 48.2 mt -131.63 129.4 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 107.348 -1.353 . . . . 2.17 107.348 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -107.18 -13.32 15.18 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.144 -0.973 . . . . 0.02 113.06 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.38 153.06 29.85 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.277 -1.514 . . . . 0.01 108.255 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 6.8 t -162.86 143.81 9.75 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.375 -1.453 . . . . 1.22 109.665 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -122.37 112.87 18.62 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.001 0.905 . . . . 1.41 108.77 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 t -109.03 123.4 64.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.061 -1.829 . . . . 0.01 106.061 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -146.41 66.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 C-N-CA 117.951 -1.5 . . . . 1.98 109.061 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.406 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.1 tp10 176.28 108.72 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.32 -1.733 . . . . 0.01 106.32 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.674 ' H ' ' HZ2' ' A' ' 153' ' ' LYS . . . 70.99 -174.44 40.39 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.476 -1.45 . . . . 0.01 109.476 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -112.05 146.57 37.7 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.423 -1.045 . . . . 2.3 109.43 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -130.35 146.19 51.89 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.502 -0.749 . . . . 0.01 110.284 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mt -117.13 141.56 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 107.566 -1.272 . . . . 1.69 107.566 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.33 143.79 44.32 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.688 -1.227 . . . . 2.49 107.688 177.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 7.5 m-85 -122.58 144.7 48.94 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.994 -0.743 . . . . 0.02 108.994 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 76.5 tt0 -74.06 -29.78 62.06 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.669 -0.644 . . . . 0.02 112.08 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.5 mt -115.24 153.5 47.39 Favored Pre-proline 0 N--CA 1.506 2.369 0 O-C-N 120.676 -1.265 . . . . 1.48 109.208 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.41 167.08 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.129 1.219 . . . . 0.02 112.565 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 59.31 31.08 20.88 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.065 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.76 51.12 9.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 0.02 111.124 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -123.99 163.33 21.6 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.569 -0.707 . . . . 0.02 109.528 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.2 -165.79 31.74 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.873 -1.291 . . . . 0.02 109.873 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -68.2 142.28 55.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.477 -1.014 . . . . 0.02 109.03 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -118.01 148.46 42.21 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.451 -0.574 . . . . 0.02 109.451 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.463 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -128.64 142.73 50.94 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.563 -0.71 . . . . 0.01 109.113 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.64 119.8 34.77 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.48 -0.763 . . . . 0.01 109.465 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.5 mt -106.21 131.95 52.84 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.422 -0.798 . . . . 0.01 110.363 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 154' ' ' LYS . 11.9 p-10 -109.84 176.77 4.94 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.454 -0.943 . . . . 2.27 108.454 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.674 ' HZ2' ' H ' ' A' ' 134' ' ' GLY . 48.7 mttm -55.54 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.066 -1.021 . . . . 1.84 108.489 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 152' ' ' ASP . 53.4 mmtt -136.74 166.86 22.6 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.189 -0.945 . . . . 2.28 111.593 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 15.0 mp0 -113.82 106.4 14.42 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.76 -1.2 . . . . 0.01 107.76 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.56 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 90.9 m-85 -99.03 114.16 26.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.965 -1.085 . . . . 0.01 110.201 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -92.41 -25.67 18.37 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.19 -0.943 . . . . 0.01 111.144 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -125.18 153.88 71.74 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.079 -1.013 . . . . 2.54 108.392 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -61.3 -41.43 42.04 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 120.442 0.761 . . . . 0.7 110.651 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.33 -20.1 21.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.657 -1.277 . . . . 0.86 108.769 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -65.57 -16.11 63.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.025 -1.047 . . . . 0.02 109.758 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.56 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 1.1 m0 -96.11 10.88 36.2 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.999 -1.112 . . . . 0.02 107.999 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.57 11.34 85.56 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.414 -1.374 . . . . 0.02 110.159 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.73 141.94 31.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.293 -1.122 . . . . 0.02 110.209 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.29 -8.22 59.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.613 -0.679 . . . . 0.59 109.817 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.4 p -144.31 150.87 49.78 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.806 -1.184 . . . . 0.87 108.728 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.6 20.85 0.5 Allowed 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 120.701 0.934 . . . . 0.38 112.341 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.28 122.14 27.56 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.467 1.127 . . . . 0.18 111.45 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.8 mm -142.74 125.39 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.009 -1.848 . . . . 3.99 106.009 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.526 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 12.3 mp0 -112.33 -20.82 11.69 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.088 -1.008 . . . . 5.17 112.615 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.5 p -157.41 160.92 38.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.384 -2.072 . . . . 0.02 109.954 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -153.53 154.59 34.6 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.182 -0.949 . . . . 2.02 110.578 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -144.46 151.39 39.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.35 -0.843 . . . . 0.01 110.442 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -87.66 142.64 27.68 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.054 -0.721 . . . . 0.01 109.054 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.8 mt -93.12 128.45 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.037 -1.039 . . . . 3.04 109.206 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 44.9 t -136.07 146.71 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.294 -0.879 . . . . 1.89 109.564 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.86 . . . . 4.89 109.483 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.353 -0.61 . . . . 5.28 109.353 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -151.66 -35.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 5.96 109.442 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 m -55.22 -54.13 47.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.607 -1.308 . . . . 2.22 110.615 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.85 117.77 3.86 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 107.038 -2.425 . . . . 0.81 107.038 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.58 145.27 33.97 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.39 -1.484 . . . . 0.01 109.39 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -152.83 138.28 17.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.245 -1.15 . . . . 0.02 109.841 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -130.32 141.03 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.475 -0.565 . . . . 0.02 109.475 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.422 ' OG ' ' NE ' ' A' ' 19' ' ' ARG . 1.6 t -122.26 130.76 53.47 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.308 -0.87 . . . . 0.39 110.091 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.0 OUTLIER -111.11 140.71 45.43 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.768 -0.582 . . . . 0.02 109.444 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.4 m-85 -121.85 138.45 54.38 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.353 -0.842 . . . . 0.02 109.573 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -68.86 -27.4 65.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.99 -1.069 . . . . 0.03 111.504 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.7 m-20 -114.53 170.72 8.1 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.858 -1.151 . . . . 0.03 110.009 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -75.81 162.06 28.49 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.705 0.764 . . . . 0.03 110.313 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.9 t30 62.46 33.28 16.25 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.113 0.959 . . . . 0.74 110.742 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.1 40.29 31.81 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.733 -0.667 . . . . 0.02 110.834 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -109.97 165.42 11.74 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.196 -1.038 . . . . 0.02 108.196 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.54 -168.04 34.38 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.888 -1.149 . . . . 0.03 110.557 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -68.83 143.53 54.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -1.058 . . . . 2.76 108.887 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.533 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 51.4 ttt180 -122.03 149.95 42.78 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.62 -0.675 . . . . 1.89 109.916 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.24 134.5 34.51 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.637 -0.664 . . . . 0.02 109.466 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.31 136.92 48.75 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.385 -0.822 . . . . 1.12 109.384 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.428 ' HG ' ' HG ' ' A' ' 26' ' ' CYS . 11.7 t -127.99 138.3 52.55 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.594 -0.691 . . . . 0.02 109.488 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -118.74 11.98 12.87 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.59 -0.694 . . . . 0.2 110.554 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.2 t -159.46 173.84 15.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.706 -1.246 . . . . 1.23 109.091 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 17.8 p30 -63.11 146.67 52.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.747 -1.221 . . . . 0.02 110.527 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' HG ' ' HG ' ' A' ' 22' ' ' CYS . 15.4 m -133.7 117.64 17.21 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.127 -0.694 . . . . 0.02 109.127 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.75 -23.21 45.53 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.284 -0.885 . . . . 0.24 111.471 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -151.77 103.77 2.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.974 -1.079 . . . . 1.14 109.056 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.16 6.81 33.39 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.588 0.709 . . . . 6.37 110.231 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -59.93 -27.63 66.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 3.11 111.691 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.4 p -76.6 -16.08 59.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.611 -1.306 . . . . 0.88 110.803 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.57 -21.96 12.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.44 -0.787 . . . . 0.02 110.422 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tp -149.08 127.33 12.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.04 -1.037 . . . . 3.32 109.436 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.2 t -87.02 -12.16 48.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.64 -0.662 . . . . 0.02 111.051 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.483 ' HE ' HD22 ' A' ' 37' ' ' ASN . 14.9 ptm180 -172.84 162.13 4.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.93 -1.106 . . . . 0.02 108.417 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -142.7 115.79 8.87 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.047 -1.033 . . . . 0.02 108.649 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.483 HD22 ' HE ' ' A' ' 35' ' ' ARG . 1.6 m-80 -107.71 -1.0 21.43 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.803 -1.186 . . . . 0.03 110.987 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.498 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 4.4 t -155.52 152.88 29.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.498 ' N ' ' HG ' ' A' ' 38' ' ' SER . 91.6 mt -145.33 148.46 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.091 -1.006 . . . . 0.02 109.887 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -124.46 124.55 42.56 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.5 -1.296 . . . . 0.02 107.5 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -105.03 113.87 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.704 -1.591 . . . . 0.02 106.704 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -83.81 -34.83 24.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.576 -0.703 . . . . 3.81 109.971 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 151.27 20.64 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 118.392 -1.861 . . . . 0.02 110.535 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.79 171.89 48.61 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.318 -1.113 . . . . 0.01 110.318 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.9 m -117.76 133.74 55.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.429 -1.323 . . . . 1.48 107.429 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -126.21 154.23 43.59 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.6 1.19 . . . . 0.02 112.16 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.03 133.72 52.61 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.419 -2.067 . . . . 0.24 105.419 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.3 m -117.62 142.87 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.569 -0.707 . . . . 0.65 109.249 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -120.62 144.87 47.91 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.112 0.958 . . . . 0.02 109.997 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.472 ' OE2' ' NH2' ' A' ' 78' ' ' ARG . 33.5 tt0 -66.16 -33.69 76.34 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.875 -0.602 . . . . 0.02 111.582 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 51' ' ' ARG . 0.4 OUTLIER -124.64 157.88 64.07 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.006 -1.059 . . . . 0.02 109.486 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.09 166.44 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.637 1.558 . . . . 0.02 112.763 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m120 63.67 36.39 10.84 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.36 -0.836 . . . . 0.02 111.153 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 8.0 m-85 45.29 51.51 9.32 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.654 0.74 . . . . 3.39 110.812 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -125.75 163.44 22.84 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.143 0.497 . . . . 2.33 109.882 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.83 31.38 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.447 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 21.1 m-70 -64.35 138.48 58.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.981 -1.305 . . . . 0.02 109.989 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.8 ppp? -119.37 137.45 53.72 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.283 0.564 . . . . 5.01 109.58 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.563 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.7 m-85 -134.99 139.95 45.29 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.492 -0.755 . . . . 0.02 110.238 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.7 mm -94.16 130.45 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 108.656 -0.868 . . . . 1.72 108.656 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.03 110.32 36.53 Favored Pre-proline 0 N--CA 1.505 2.324 0 O-C-N 121.439 -0.788 . . . . 0.02 110.597 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.69 168.65 22.13 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 CA-C-N 119.935 1.012 . . . . 1.47 110.311 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -53.75 140.79 28.67 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.84 -1.163 . . . . 4.25 110.524 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.77 32.68 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.489 -1.338 . . . . 0.02 110.598 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -118.76 130.09 55.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.251 -1.146 . . . . 0.96 109.622 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.574 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 71.8 m-85 -121.1 98.91 46.88 Favored Pre-proline 0 N--CA 1.492 1.667 0 N-CA-C 107.852 -1.166 . . . . 0.02 107.852 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -71.3 -3.73 13.53 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 120.637 0.892 . . . . 0.02 113.836 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -157.52 155.04 29.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.64 -1.288 . . . . 2.02 108.274 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -59.85 -39.08 84.0 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.62 -0.675 . . . . 0.02 111.787 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -59.94 -23.99 64.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.917 . . . . 0.02 110.256 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -70.32 -18.75 63.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.791 0.805 . . . . 3.42 108.921 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.563 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -108.4 10.53 27.46 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.455 -1.313 . . . . 0.02 107.455 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.0 mtt 61.34 22.56 12.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.619 -0.676 . . . . 0.02 110.714 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.14 144.55 46.92 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.648 -1.381 . . . . 0.02 109.648 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.71 -30.75 41.06 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.725 -1.213 . . . . 0.98 107.725 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -157.38 -171.52 3.63 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.374 -1.713 . . . . 0.02 106.374 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -98.93 28.3 4.45 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.607 -1.308 . . . . 0.02 110.72 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' NH2' ' OE2' ' A' ' 50' ' ' GLU . 80.1 mtm180 -96.44 122.56 39.47 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.916 -1.115 . . . . 3.2 111.011 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.5 mt -142.71 119.49 11.18 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.791 -1.189 . . . . 2.61 107.791 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.4 -17.79 10.32 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 121.167 -0.958 . . . . 0.02 112.416 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 92.9 p -156.19 156.15 33.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.165 -1.786 . . . . 0.02 110.495 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.8 p -145.26 148.43 33.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.693 -0.629 . . . . 0.02 109.706 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.465 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.9 mtp180 -137.06 141.42 42.42 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.286 -0.884 . . . . 0.01 109.281 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.67 133.03 37.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.843 . . . . 0.43 109.387 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 t -91.72 124.66 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.02 -0.733 . . . . 1.25 109.02 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -91.09 132.11 36.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.852 -1.155 . . . . 1.77 108.202 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -99.09 140.23 33.56 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.775 -0.824 . . . . 1.63 108.775 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.5 m -111.01 123.51 50.34 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.097 -1.075 . . . . 1.08 108.097 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.8 p -114.62 131.96 56.53 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.611 -1.255 . . . . 1.26 107.611 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.9 -48.76 0.01 OUTLIER Glycine 0 N--CA 1.502 3.078 0 C-N-CA 117.698 -2.191 . . . . 0.01 113.329 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.44 -103.79 0.17 Allowed Glycine 0 N--CA 1.485 1.956 0 CA-C-N 119.95 1.875 . . . . 0.01 110.939 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.404 HE22 HH12 ' A' ' 174' ' ' ARG . 64.5 tp60 -119.17 118.94 32.7 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.244 -1.15 . . . . 4.43 110.229 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.39 135.11 53.85 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.234 -0.586 . . . . 2.99 109.532 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -133.73 129.98 37.46 Favored 'General case' 0 N--CA 1.52 3.042 0 CA-C-O 122.224 1.011 . . . . 6.36 113.067 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -130.07 141.26 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-N 115.511 -0.768 . . . . 1.09 110.406 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.64 138.74 54.48 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 107.637 -1.245 . . . . 2.05 107.637 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 m -123.98 145.62 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 O-C-N 120.664 -1.272 . . . . 1.1 111.032 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -120.27 139.61 52.44 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.958 0.885 . . . . 0.73 110.652 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 3.9 tm-20 -69.16 -33.04 72.78 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.766 -0.652 . . . . 0.02 112.073 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.457 ' O ' ' OG ' ' A' ' 128' ' ' SER . 49.4 mttp -114.22 165.57 12.54 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.902 -1.124 . . . . 3.18 110.229 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.38 163.07 46.43 Favored Glycine 0 N--CA 1.492 2.375 0 CA-C-O 122.007 0.781 . . . . 0.01 111.308 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.59 39.51 27.58 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.532 0.682 . . . . 0.01 111.102 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 52.29 56.04 8.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.727 -0.608 . . . . 0.01 111.003 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.617 ' ND2' ' H ' ' A' ' 105' ' ' GLY . 4.9 t-20 -129.08 164.87 22.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.001 -1.111 . . . . 3.15 108.001 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.617 ' H ' ' ND2' ' A' ' 104' ' ' ASN . . . 91.38 -162.64 28.32 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.081 -1.607 . . . . 0.01 109.081 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -75.51 141.79 42.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.919 -1.342 . . . . 0.01 109.126 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 107' ' ' MET . 9.7 tmm? -116.08 142.79 46.34 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.448 0.642 . . . . 0.01 109.546 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -132.08 135.65 46.61 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.166 -1.05 . . . . 2.48 108.166 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.72 133.93 55.42 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.754 -0.592 . . . . 0.01 109.808 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -148.95 148.25 29.57 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.511 1.148 . . . . 1.69 111.365 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.2 p -114.62 7.84 16.14 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.99 -1.005 . . . . 0.01 109.936 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.82 163.48 19.09 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.429 -0.794 . . . . 3.21 111.183 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.04 154.34 42.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.357 -0.839 . . . . 0.01 109.436 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.463 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 51.0 t -126.98 114.6 22.02 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 108.806 -0.812 . . . . 0.01 108.806 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.58 -31.97 5.1 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 120.241 1.122 . . . . 0.01 111.51 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.4 t -142.48 107.67 4.98 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.825 0.822 . . . . 0.02 108.992 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 117' ' ' ILE . 96.7 mt -63.84 -39.31 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.843 -0.535 . . . . 1.83 111.141 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 42.7 ttp -67.37 -37.54 83.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.202 -0.999 . . . . 1.34 110.014 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -69.88 -38.98 76.53 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.504 -1.372 . . . . 2.11 109.852 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.463 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.9 tt0 -79.82 -47.08 15.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.233 -0.917 . . . . 2.08 112.455 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -110.76 -0.13 17.14 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.365 -0.834 . . . . 0.02 112.655 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 m80 59.33 33.06 22.33 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.738 -1.226 . . . . 0.02 109.272 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.27 135.59 52.76 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 108.652 -0.869 . . . . 0.02 108.652 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -92.56 -23.48 19.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 5.32 110.501 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -149.51 163.78 36.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.207 -0.933 . . . . 0.02 110.028 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.1 mt -131.79 129.68 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 107.427 -1.324 . . . . 2.17 107.427 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -106.07 -13.89 15.32 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.105 -0.997 . . . . 0.02 113.098 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 2.2 p -157.63 156.29 31.57 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.486 -1.384 . . . . 0.01 108.242 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.612 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 18.4 p -164.0 146.91 9.52 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.446 -1.409 . . . . 1.22 109.663 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -121.51 111.48 17.31 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.153 0.977 . . . . 1.41 108.532 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.51 122.9 64.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.054 -1.832 . . . . 0.01 106.054 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.98 69.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 118.12 -1.432 . . . . 1.98 108.391 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.37 108.32 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 106.852 -1.536 . . . . 0.01 106.852 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.68 -174.27 45.95 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.876 -1.29 . . . . 0.01 109.876 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 m -110.47 145.6 37.39 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.364 -1.08 . . . . 2.3 108.901 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -131.54 145.35 51.69 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.48 -0.762 . . . . 0.01 110.58 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.8 141.88 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 107.519 -1.289 . . . . 1.69 107.519 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.18 143.62 44.52 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 107.657 -1.238 . . . . 2.49 107.657 177.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.1 m-85 -121.51 143.9 49.01 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.79 -0.819 . . . . 0.02 108.79 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.432 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 3.0 tm-20 -73.86 -29.9 62.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.705 -0.622 . . . . 0.02 111.525 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.42 152.84 47.42 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 120.666 -1.272 . . . . 1.48 108.989 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.07 170.61 0.47 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.213 1.276 . . . . 0.02 112.502 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.632 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER 57.93 31.13 20.17 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.18 -0.918 . . . . 0.75 110.996 178.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 56.54 47.64 18.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.608 -0.682 . . . . 0.02 110.501 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -120.93 163.46 18.2 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.578 -0.702 . . . . 0.02 109.848 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.39 -165.77 31.49 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.971 -1.251 . . . . 0.02 109.971 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -68.06 142.57 55.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.551 -0.97 . . . . 0.02 109.14 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -118.26 148.43 42.43 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.43 -0.582 . . . . 0.02 109.43 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -129.41 142.43 50.8 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.7 tt -97.41 121.33 39.18 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.384 -0.823 . . . . 0.01 109.333 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.584 ' CD1' ' HE1' ' A' ' 162' ' ' TRP . 17.0 mt -107.06 138.01 44.04 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.563 -0.711 . . . . 0.01 110.957 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 154' ' ' LYS . 31.8 t70 -110.21 168.98 9.04 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.174 -1.047 . . . . 2.27 108.174 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -53.02 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.845 -1.159 . . . . 1.84 108.834 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 152' ' ' ASP . 92.6 mttt -136.57 168.53 19.31 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.114 0.959 . . . . 2.28 111.584 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -113.1 109.03 18.13 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.152 -1.055 . . . . 0.01 108.152 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.55 114.45 28.1 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.11 -0.994 . . . . 0.01 110.253 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -92.48 -25.99 18.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.199 -0.938 . . . . 0.01 111.319 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -125.75 152.96 73.1 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 120.956 -1.09 . . . . 2.54 108.583 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -60.27 -42.2 44.26 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 CA-C-N 119.377 0.813 . . . . 0.7 110.408 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.7 t -60.28 -21.24 22.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.625 -1.297 . . . . 0.86 108.443 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 43.1 t0 -66.24 -16.04 63.68 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.143 -1.023 . . . . 0.02 109.255 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.612 ' CZ2' ' SG ' ' A' ' 129' ' ' CYS . 0.0 OUTLIER -92.97 7.33 44.46 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.892 -1.151 . . . . 0.02 107.892 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.4 9.42 85.89 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.417 -1.473 . . . . 0.02 109.417 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.3 142.43 30.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.63 -0.923 . . . . 0.02 110.142 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.26 -8.23 59.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.708 -0.62 . . . . 0.59 109.553 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.473 ' HG ' ' H ' ' A' ' 168' ' ' ALA . 2.0 t -144.41 151.15 50.27 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.969 -1.082 . . . . 0.87 108.289 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.55 22.11 0.46 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 120.774 0.982 . . . . 0.38 112.369 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.473 ' H ' ' HG ' ' A' ' 166' ' ' SER . . . -83.73 122.23 28.36 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.488 1.137 . . . . 0.18 111.79 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.5 mm -142.15 125.67 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 106.004 -1.85 . . . . 3.99 106.004 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 13.5 mp0 -112.66 -22.14 10.9 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.958 -1.089 . . . . 5.17 112.852 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 34.1 t -156.45 159.65 38.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.327 -2.108 . . . . 0.02 110.044 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.404 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.3 p90 -152.85 153.97 34.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.031 -1.043 . . . . 2.02 110.778 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -145.52 152.05 39.13 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.226 -0.921 . . . . 0.01 110.458 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.404 HH12 HE22 ' A' ' 92' ' ' GLN . 32.2 ptt180 -88.04 142.82 27.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.6 -0.688 . . . . 0.01 109.397 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.28 128.62 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.215 -0.928 . . . . 3.04 108.999 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.01 146.35 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.244 -0.91 . . . . 1.89 109.545 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 4.89 109.654 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 85.0 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.413 -0.588 . . . . 5.28 109.413 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 11.3 mptt -78.89 52.4 1.24 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.15 -0.969 . . . . 5.96 109.282 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -49.39 69.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.118 -0.989 . . . . 2.22 110.718 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.93 119.05 4.2 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 107.122 -2.391 . . . . 0.81 107.122 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.05 145.97 34.27 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.412 -1.475 . . . . 0.01 109.412 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -153.85 138.48 16.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.239 -1.154 . . . . 0.02 109.605 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -130.06 140.54 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 109.473 -0.566 . . . . 0.02 109.473 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.2 130.14 53.55 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.482 -0.761 . . . . 0.39 109.993 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -110.32 140.27 44.67 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.645 -0.659 . . . . 0.02 109.384 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.5 m-85 -121.93 138.14 54.52 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.162 -0.961 . . . . 0.02 109.617 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 66.6 mt-10 -69.51 -27.6 65.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.054 . . . . 0.03 111.814 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 12.4 t70 -113.93 169.86 8.7 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.829 -1.169 . . . . 0.03 110.115 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 24.8 mtp180 -75.36 158.12 33.24 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.542 0.687 . . . . 0.03 110.13 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.7 m120 66.23 35.01 6.22 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.774 0.797 . . . . 0.74 110.905 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.3 p90 49.85 44.65 25.16 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.688 0.756 . . . . 0.02 111.316 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -112.86 165.89 11.9 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.064 -1.088 . . . . 0.02 108.064 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.9 -167.47 34.79 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.808 -1.187 . . . . 0.03 110.684 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -68.69 141.92 55.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.515 -0.991 . . . . 2.76 109.152 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -122.95 150.16 43.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.535 -0.728 . . . . 1.89 110.212 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -136.62 133.47 36.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.776 -0.577 . . . . 0.02 109.473 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -109.48 135.91 49.74 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.882 -0.785 . . . . 1.12 108.882 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 45.9 t -127.85 138.43 52.69 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.582 -0.699 . . . . 0.02 109.778 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 14.8 p30 -119.2 11.66 12.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.572 -0.705 . . . . 0.2 110.372 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 21.3 p -159.58 173.58 15.91 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.797 -1.189 . . . . 1.23 109.097 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 9.0 p30 -62.91 145.92 54.09 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.766 -1.208 . . . . 0.02 110.748 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.562 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 19.4 t -134.54 118.68 17.55 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.096 -0.705 . . . . 0.02 109.096 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.19 -21.79 53.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.85 . . . . 0.24 111.697 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -153.82 105.86 2.81 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.893 -1.129 . . . . 1.14 109.82 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.562 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -102.69 8.07 39.64 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.267 -0.896 . . . . 6.37 110.272 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -60.14 -27.69 67.27 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -0.83 . . . . 3.11 111.829 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.0 p -76.32 -16.82 59.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.512 -1.368 . . . . 0.88 111.153 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -106.81 -21.07 13.14 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.287 -0.883 . . . . 0.02 110.644 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 mt -148.77 127.81 12.77 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.959 -1.088 . . . . 3.32 109.399 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.0 t -86.77 -11.8 49.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.647 -0.658 . . . . 0.02 110.582 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -172.03 161.8 5.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.012 -1.055 . . . . 0.02 108.265 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.1 p -143.79 116.38 8.65 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.044 -1.035 . . . . 0.02 108.835 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.661 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -108.11 -0.77 20.9 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.708 -1.245 . . . . 0.03 111.645 -178.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -154.88 154.04 32.06 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.727 -1.212 . . . . 0.02 107.727 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.2 mt -146.89 147.65 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.902 -1.124 . . . . 0.02 110.728 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.525 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 29.2 ttp180 -123.88 124.69 43.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.119 -1.067 . . . . 0.02 108.119 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.67 113.94 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 106.681 -1.6 . . . . 0.02 106.681 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 69.6 mm-40 -84.75 -34.72 22.79 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.18 -0.608 . . . . 3.81 110.414 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.49 150.55 19.34 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.633 -1.746 . . . . 0.02 110.591 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.74 172.13 48.82 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.25 -1.14 . . . . 0.01 110.25 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 m -118.25 133.86 55.52 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.573 -1.269 . . . . 1.48 107.573 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -126.23 154.61 43.08 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.849 1.309 . . . . 0.02 112.235 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.22 133.76 52.62 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.292 -2.114 . . . . 0.24 105.292 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -115.88 141.52 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.467 -0.771 . . . . 0.65 109.241 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -120.21 142.59 48.86 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.028 0.918 . . . . 0.02 109.467 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' ND1' ' A' ' 57' ' ' HIS . 35.6 tt0 -65.54 -33.66 76.43 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.62 -0.718 . . . . 0.02 111.915 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 51' ' ' ARG . 0.6 OUTLIER -124.43 157.59 64.45 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 120.926 -1.109 . . . . 0.02 109.383 -178.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.03 166.08 1.06 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.667 1.578 . . . . 0.02 112.728 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 m120 63.66 36.77 10.6 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.362 -0.835 . . . . 0.02 111.12 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.4 m-85 45.06 51.32 8.94 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.636 0.732 . . . . 3.39 110.747 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 97.1 p -125.54 163.41 22.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.275 0.559 . . . . 2.33 109.837 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.4 -161.41 31.26 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.756 -1.338 . . . . 0.02 109.756 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.516 ' ND1' ' OE1' ' A' ' 50' ' ' GLU . 7.2 m170 -64.43 138.54 58.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.006 -1.291 . . . . 0.02 110.259 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.1 ppp? -119.27 137.44 53.67 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.294 0.569 . . . . 5.01 109.5 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -135.32 139.68 44.51 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.421 -0.799 . . . . 0.02 109.821 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.7 mm -94.27 130.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.831 -0.803 . . . . 1.72 108.831 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.6 110.75 35.2 Favored Pre-proline 0 N--CA 1.506 2.332 0 O-C-N 121.349 -0.844 . . . . 0.02 110.675 -178.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -78.11 169.42 20.37 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 119.869 0.989 . . . . 1.47 110.442 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.53 141.6 24.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.934 -1.104 . . . . 4.25 110.607 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.06 -178.0 31.19 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 119.608 -1.282 . . . . 0.02 110.967 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -119.83 131.4 55.28 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.601 -0.94 . . . . 0.96 109.712 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 50.2 m-85 -121.8 94.84 48.16 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.974 -1.121 . . . . 0.02 107.974 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.84 -4.31 11.03 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 120.908 1.072 . . . . 0.02 113.678 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -157.16 153.96 28.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.611 -1.305 . . . . 2.02 108.143 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -59.53 -38.94 82.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.526 -0.734 . . . . 0.02 111.98 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -59.87 -23.95 63.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.107 -0.995 . . . . 0.02 110.475 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -70.59 -18.69 62.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.883 -0.784 . . . . 3.42 108.883 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.565 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.7 t90 -108.1 10.59 28.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.528 -1.286 . . . . 0.02 107.528 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 73' ' ' MET . 1.5 mpt? 59.34 22.85 11.26 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.502 0.668 . . . . 0.02 110.456 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.34 144.72 45.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.34 -1.504 . . . . 0.02 109.34 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.9 tp -79.31 -30.52 42.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.026 -1.279 . . . . 0.98 107.745 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -157.35 -171.81 3.75 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.475 -1.676 . . . . 0.02 106.475 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 78.5 m-20 -98.15 28.21 4.16 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.708 -1.245 . . . . 0.02 110.718 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -98.27 123.35 42.31 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.08 -1.013 . . . . 3.2 111.598 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -142.64 120.07 11.66 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.26 -1.385 . . . . 2.61 107.26 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.67 -18.04 10.55 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 121.208 -0.932 . . . . 0.02 112.392 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.538 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 39.6 t -155.63 156.27 34.72 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-N 119.722 1.761 . . . . 0.02 110.816 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.538 ' N ' ' HG ' ' A' ' 81' ' ' SER . 29.0 p -145.49 147.63 32.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.553 -0.717 . . . . 0.02 110.178 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.413 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.5 mtp180 -136.88 141.72 42.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.542 -0.724 . . . . 0.01 109.116 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 132.71 37.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.074 -1.016 . . . . 0.43 109.254 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -91.35 124.58 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.922 -0.77 . . . . 1.25 108.922 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -91.98 130.9 37.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.817 -1.177 . . . . 1.77 108.402 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mt -96.11 138.84 33.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.92 -1.141 . . . . 1.63 107.92 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.0 t -110.41 126.05 53.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.375 -0.828 . . . . 1.08 108.774 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.7 t -102.37 -154.79 0.5 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 106.109 -1.812 . . . . 1.26 106.109 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.69 -50.66 0.84 Allowed Glycine 0 N--CA 1.497 2.746 0 O-C-N 120.486 -1.383 . . . . 0.01 111.977 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.18 -99.59 0.13 Allowed Glycine 0 N--CA 1.488 2.154 0 C-N-CA 118.662 -1.732 . . . . 0.01 112.172 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -120.08 119.89 34.66 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.298 -1.119 . . . . 4.43 110.707 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.16 137.95 57.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.835 -0.541 . . . . 2.99 109.559 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.405 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 19.7 ttpp -136.88 130.16 31.29 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 120.915 -1.115 . . . . 6.36 112.973 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.53 141.79 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.535 -0.757 . . . . 1.09 110.35 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 1.3 pt20 -124.69 139.77 53.55 Favored 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 107.666 -1.235 . . . . 2.05 107.666 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.49 146.08 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 O-C-N 120.586 -1.321 . . . . 1.1 111.123 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -120.48 139.99 52.07 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 122.259 1.028 . . . . 0.73 110.855 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -68.08 -32.35 72.62 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.731 -0.668 . . . . 0.02 111.73 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -114.26 167.38 10.75 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.032 -1.042 . . . . 3.18 110.347 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.36 163.81 52.72 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.857 -0.897 . . . . 0.01 110.857 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 58.05 38.29 26.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.986 -0.714 . . . . 0.01 111.618 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 14.9 m-85 52.63 54.76 10.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.417 -0.802 . . . . 0.01 111.234 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -128.1 164.87 21.48 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.957 -1.127 . . . . 3.15 107.957 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.3 -162.21 29.39 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.146 -1.582 . . . . 0.01 109.146 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -75.93 141.37 42.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.817 -1.402 . . . . 0.01 109.179 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.1 tmm? -116.38 143.13 45.95 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.519 0.676 . . . . 0.01 109.566 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -132.23 135.9 46.62 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.315 -0.994 . . . . 2.48 108.315 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -117.01 134.15 55.11 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.68 -0.638 . . . . 0.01 109.715 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -149.11 148.8 30.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.87 -1.144 . . . . 1.69 111.318 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 p -114.88 7.79 15.79 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.1 -0.955 . . . . 0.01 109.829 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -122.26 163.12 20.2 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.614 -0.679 . . . . 3.21 111.227 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.88 155.78 40.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.405 -0.809 . . . . 0.01 109.823 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.494 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 63.3 m -129.55 116.72 18.46 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 109.043 -0.725 . . . . 0.01 109.043 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.83 -30.74 7.16 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.343 1.158 . . . . 0.01 111.49 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.6 m -142.83 108.68 5.15 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.856 0.836 . . . . 0.02 109.195 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.98 -39.96 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.873 -0.517 . . . . 1.83 111.057 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.7 ttp -66.38 -37.89 86.3 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.198 -1.001 . . . . 1.34 109.808 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.77 -38.42 76.71 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.537 -1.352 . . . . 2.11 109.696 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.427 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 9.2 tt0 -80.11 -47.64 14.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.91 . . . . 2.08 112.415 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.427 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 80.6 m-85 -111.06 -0.41 16.64 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.354 -0.841 . . . . 0.02 112.848 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 m80 59.68 33.61 21.95 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.799 -1.188 . . . . 0.02 109.463 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 mt -112.46 135.35 53.26 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.579 -0.897 . . . . 0.02 108.579 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -92.68 -23.18 19.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -0.901 . . . . 5.32 110.557 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -148.93 163.37 37.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.163 -0.96 . . . . 0.02 109.949 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 126' ' ' ILE . 53.8 mt -131.56 129.33 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 107.523 -1.288 . . . . 2.17 107.523 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -107.11 -13.11 15.25 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.177 -0.952 . . . . 0.02 112.971 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.518 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.88 153.5 29.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.339 -1.476 . . . . 0.01 108.297 178.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.1 t -163.36 145.43 9.82 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.317 -1.49 . . . . 1.22 109.757 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -122.45 112.73 18.42 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.248 1.023 . . . . 1.41 109.061 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.63 122.63 63.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 105.924 -1.88 . . . . 0.01 105.924 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 t -146.02 64.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 117.974 -1.491 . . . . 1.98 108.971 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.405 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.2 tp10 176.14 108.83 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.641 -1.615 . . . . 0.01 106.641 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.721 ' H ' ' HZ3' ' A' ' 153' ' ' LYS . . . 72.55 -173.1 47.38 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.115 -1.194 . . . . 0.01 110.115 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.413 ' H ' ' HG1' ' A' ' 135' ' ' THR . 1.0 OUTLIER -111.25 142.94 42.8 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.318 -1.107 . . . . 2.3 109.043 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -129.42 145.17 51.45 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.458 -0.776 . . . . 0.01 109.849 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.9 mt -118.46 142.78 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.892 -1.151 . . . . 1.69 107.892 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.84 144.14 43.99 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 107.542 -1.281 . . . . 2.49 107.542 177.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 8.0 m-85 -123.11 145.2 48.77 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.069 -0.715 . . . . 0.02 109.069 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -73.72 -30.06 62.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.628 -0.67 . . . . 0.02 112.043 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.33 153.83 47.51 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 120.644 -1.285 . . . . 1.48 109.031 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.35 166.52 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.236 1.291 . . . . 0.02 112.742 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.655 HD21 ' HE ' ' A' ' 145' ' ' ARG . 23.9 t30 59.23 31.86 21.54 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.185 -0.916 . . . . 0.75 111.063 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.404 ' CE1' ' CG ' ' A' ' 173' ' ' ARG . 2.0 m-85 57.42 52.42 8.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.02 111.294 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.655 ' HE ' HD21 ' A' ' 143' ' ' ASN . 94.4 mtt180 -124.88 163.19 22.76 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.424 -0.797 . . . . 0.02 109.706 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.46 -165.29 32.38 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.835 -1.306 . . . . 0.02 109.835 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -67.99 141.47 56.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.531 -0.982 . . . . 0.02 108.863 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -118.2 148.37 42.44 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.379 -0.6 . . . . 0.02 109.379 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.49 142.76 50.7 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.804 -0.813 . . . . 0.01 108.804 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tt -98.18 122.26 41.11 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.268 -0.895 . . . . 0.01 109.245 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.6 mt -105.14 134.21 48.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.435 -0.791 . . . . 0.01 110.141 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 2.6 m-20 -108.35 176.95 4.94 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.504 -0.925 . . . . 2.27 108.504 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.721 ' HZ3' ' H ' ' A' ' 134' ' ' GLY . 45.0 mttm -57.73 83.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 1.84 108.456 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 55.3 mmtt -136.51 167.7 20.86 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.971 0.891 . . . . 2.28 111.659 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -112.92 107.33 15.86 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.7 -1.222 . . . . 0.01 107.7 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.585 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 93.1 m-85 -99.09 115.09 28.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.175 -0.953 . . . . 0.01 110.383 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -93.14 -25.21 17.97 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.263 -0.898 . . . . 0.01 111.356 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -125.87 153.81 73.53 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.047 -1.033 . . . . 2.54 108.701 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.38 -42.04 37.12 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 120.436 0.757 . . . . 0.7 110.645 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.04 -20.12 21.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.666 -1.271 . . . . 0.86 108.869 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -65.34 -15.83 62.96 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.926 -1.109 . . . . 0.02 109.705 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.585 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 1.7 m0 -96.85 11.22 36.55 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.73 85.26 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.489 -1.338 . . . . 0.02 110.249 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.7 141.79 32.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.3 -1.118 . . . . 0.02 110.243 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.34 -8.7 58.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.718 -0.614 . . . . 0.59 109.95 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 t -144.22 150.64 49.27 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.934 -1.104 . . . . 0.87 108.651 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.63 21.21 0.49 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 120.717 0.945 . . . . 0.38 112.484 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.64 121.94 27.48 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.466 1.127 . . . . 0.18 111.393 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.2 mm -143.48 125.66 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 106.048 -1.834 . . . . 3.99 106.048 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -110.94 -20.1 12.56 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.983 -1.073 . . . . 5.17 112.716 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.7 p -158.46 161.97 37.48 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 119.558 -1.964 . . . . 0.02 110.075 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.494 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 8.9 p90 -152.48 153.13 32.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 2.02 110.278 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.404 ' CG ' ' CE1' ' A' ' 144' ' ' TYR . 7.2 mmm180 -143.0 150.08 39.14 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.63 0.729 . . . . 0.01 110.035 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -87.79 142.71 27.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.538 -0.727 . . . . 0.01 109.319 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.1 mt -92.59 128.03 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.065 -1.022 . . . . 3.04 109.021 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.07 146.39 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.247 -0.908 . . . . 1.89 109.546 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 4.89 109.402 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.458 -0.571 . . . . 5.28 109.458 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -78.32 96.87 5.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 5.96 109.498 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.3 p -97.81 40.52 1.16 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.023 -1.048 . . . . 2.22 111.915 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.51 115.18 2.95 Favored Glycine 0 N--CA 1.502 3.071 0 N-CA-C 107.371 -2.292 . . . . 0.81 107.371 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.77 146.39 35.27 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.493 -1.443 . . . . 0.01 109.493 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' NZ ' ' CB ' ' A' ' 6' ' ' LYS . 5.5 ttpm? -152.3 137.61 17.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.18 -1.188 . . . . 0.02 109.978 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.6 139.95 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.302 -0.629 . . . . 0.02 109.302 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -121.04 130.41 53.77 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.484 -0.76 . . . . 0.39 110.183 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.8 m-85 -110.63 140.15 45.23 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.603 -0.686 . . . . 0.02 109.498 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.3 m-85 -122.98 138.7 54.62 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.182 -0.949 . . . . 0.02 109.921 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 41.9 mm-40 -68.54 -28.13 66.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.047 . . . . 0.03 111.742 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -114.49 170.01 8.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.917 -1.114 . . . . 0.03 110.214 -179.514 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -75.5 158.54 32.43 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.574 0.702 . . . . 0.03 110.051 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.604 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.4 m120 66.06 35.02 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.919 0.866 . . . . 0.74 110.88 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.604 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.9 p90 49.93 44.67 25.4 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.502 -0.772 . . . . 0.02 111.47 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -112.26 166.16 11.53 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.005 -1.109 . . . . 0.02 108.005 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.28 -167.81 36.19 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.792 -1.194 . . . . 0.03 110.478 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -68.43 142.5 55.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.41 -1.053 . . . . 2.76 109.142 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -121.99 149.5 43.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.596 -0.69 . . . . 1.89 110.115 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -135.81 132.24 36.43 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.372 -0.603 . . . . 0.02 109.372 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.07 135.83 49.59 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.859 -0.793 . . . . 1.12 108.859 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 48.2 t -127.34 138.02 52.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.603 -0.686 . . . . 0.02 109.704 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.496 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 23.4 t0 -119.37 11.31 12.17 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.622 -0.674 . . . . 0.2 110.552 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.7 m -158.99 173.51 16.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.791 -1.193 . . . . 1.23 109.002 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.06 146.27 53.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.74 -1.225 . . . . 0.02 110.706 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.548 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 12.2 t -134.52 118.46 17.33 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.018 -0.734 . . . . 0.02 109.018 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.18 -21.44 53.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.814 . . . . 0.24 111.682 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -154.51 106.17 2.71 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.876 -1.14 . . . . 1.14 109.727 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.548 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.83 8.2 41.41 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.336 -0.853 . . . . 6.37 110.105 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -60.45 -28.66 68.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 3.11 112.046 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 p -76.22 -17.7 59.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.404 -1.435 . . . . 0.88 111.176 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -106.94 -21.08 13.13 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.309 -0.869 . . . . 0.02 110.268 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -147.32 126.42 12.91 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.217 -0.927 . . . . 3.32 108.909 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t -86.65 -11.33 51.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.658 -0.652 . . . . 0.02 110.374 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 33.2 ttt180 -171.47 161.67 6.38 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.057 -1.09 . . . . 0.02 108.057 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -144.15 116.59 8.57 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.764 -1.21 . . . . 0.02 108.886 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 -110.12 0.19 18.21 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.767 -1.208 . . . . 0.03 112.132 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.4 t -155.64 153.75 30.54 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.047 -1.094 . . . . 0.02 108.047 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.47 146.81 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.274 1.035 . . . . 0.02 111.049 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -122.86 123.93 42.11 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.535 -1.283 . . . . 0.02 107.535 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.1 t -105.25 113.87 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.777 -1.564 . . . . 0.02 106.777 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -84.66 -35.43 22.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.69 -0.631 . . . . 3.81 110.174 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.54 150.96 20.63 Favored Glycine 0 N--CA 1.487 2.086 0 C-N-CA 118.447 -1.835 . . . . 0.02 110.701 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.7 172.06 48.74 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.347 -1.101 . . . . 0.01 110.347 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.9 m -117.55 133.67 55.71 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.552 -1.277 . . . . 1.48 107.552 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -126.29 154.57 43.24 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.724 1.249 . . . . 0.02 112.223 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.3 133.79 52.61 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.337 -2.097 . . . . 0.24 105.337 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.92 141.16 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.519 -0.738 . . . . 0.65 109.34 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.538 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 27.5 m-85 -120.08 142.62 48.71 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.064 0.935 . . . . 0.02 109.556 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.41 -33.93 77.11 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.526 -0.761 . . . . 0.02 111.855 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -124.85 157.86 64.79 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.92 -1.113 . . . . 0.02 109.58 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.38 166.96 0.96 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.633 1.556 . . . . 0.02 112.824 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 63.28 36.52 11.71 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.258 -0.883 . . . . 0.02 111.084 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.7 m-85 45.31 51.48 9.36 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.71 0.767 . . . . 3.39 110.788 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 p -125.94 163.6 22.62 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.287 0.565 . . . . 2.33 109.954 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.64 -161.79 31.21 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.788 -1.325 . . . . 0.02 109.788 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -64.57 138.62 58.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.257 . . . . 0.02 110.299 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.538 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 47.5 ttp -119.43 137.01 54.04 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.229 0.538 . . . . 5.01 109.635 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 84.4 m-85 -135.0 140.15 45.43 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.483 -0.761 . . . . 0.02 109.862 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -94.49 130.58 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.773 -0.825 . . . . 1.72 108.773 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.548 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -121.08 111.07 34.16 Favored Pre-proline 0 N--CA 1.506 2.372 0 O-C-N 121.37 -0.832 . . . . 0.02 110.744 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -77.86 169.44 20.63 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 CA-C-N 119.81 0.968 . . . . 1.47 110.557 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -53.6 141.04 26.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.95 -1.094 . . . . 4.25 110.618 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.91 -177.39 32.21 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.447 -1.359 . . . . 0.02 110.834 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -119.41 131.02 55.58 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.516 -0.99 . . . . 0.96 109.668 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.548 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 74.9 m-85 -121.54 97.42 46.93 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.814 -1.18 . . . . 0.02 107.814 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -69.93 -3.62 12.5 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 120.76 0.973 . . . . 0.02 113.766 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -157.28 154.17 28.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.523 -1.36 . . . . 2.02 108.043 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -59.83 -38.72 82.85 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.617 -0.677 . . . . 0.02 111.755 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.62 -24.65 65.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -0.967 . . . . 0.02 110.258 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -68.54 -17.9 64.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.276 -0.89 . . . . 3.42 109.067 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.562 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.5 11.66 26.68 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.754 -1.202 . . . . 0.02 107.754 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 mtp 60.91 22.2 12.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.491 -0.756 . . . . 0.02 110.313 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.14 144.9 46.79 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.615 -1.394 . . . . 0.02 109.615 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.86 -30.63 40.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.134 -1.215 . . . . 0.98 107.843 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -156.96 -171.66 3.74 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.478 -1.675 . . . . 0.02 106.478 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -98.54 28.06 4.42 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.752 -1.218 . . . . 0.02 110.671 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -96.61 122.92 40.06 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.816 -1.178 . . . . 3.2 111.229 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.8 mt -142.5 119.88 11.62 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.931 -1.137 . . . . 2.61 107.931 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.86 -18.37 8.94 Favored Glycine 0 N--CA 1.5 2.911 0 O-C-N 121.193 -0.942 . . . . 0.02 112.627 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.442 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 13.2 t -155.75 156.19 34.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.038 -1.86 . . . . 0.02 111.091 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.1 p -146.04 147.99 32.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.514 -0.741 . . . . 0.02 110.335 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.422 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 47.8 mtm180 -136.97 142.02 42.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.482 -0.761 . . . . 0.01 109.13 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.7 131.97 36.82 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.128 -0.983 . . . . 0.43 109.307 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 t -90.66 124.63 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.882 -0.784 . . . . 1.25 108.882 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -92.33 131.35 37.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.893 -1.129 . . . . 1.77 108.583 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -96.4 139.08 33.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.158 -1.053 . . . . 1.63 108.158 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.1 t -110.83 126.61 54.83 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 1.08 108.906 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 m -103.02 -154.62 0.5 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.207 -1.775 . . . . 1.26 106.207 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.43 -50.68 0.83 Allowed Glycine 0 N--CA 1.498 2.774 0 O-C-N 120.454 -1.404 . . . . 0.01 112.213 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.53 -99.75 0.13 Allowed Glycine 0 N--CA 1.487 2.088 0 C-N-CA 118.79 -1.671 . . . . 0.01 112.076 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -119.99 119.59 33.88 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.142 -1.211 . . . . 4.43 110.642 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.26 135.56 54.62 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.253 -0.579 . . . . 2.99 109.541 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.504 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 52.5 tttp -135.33 131.23 36.18 Favored 'General case' 0 N--CA 1.519 2.985 0 CA-C-O 122.136 0.969 . . . . 6.36 113.066 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.39 142.78 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.737 0.779 . . . . 1.09 110.642 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.495 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.0 pt20 -124.68 139.76 53.56 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 107.581 -1.266 . . . . 2.05 107.581 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.33 146.29 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 O-C-N 120.596 -1.315 . . . . 1.1 111.182 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 24.9 m-85 -120.42 139.79 52.31 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.97 0.89 . . . . 0.73 110.769 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -68.02 -32.49 72.91 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.694 -0.684 . . . . 0.02 112.145 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -114.85 166.24 11.99 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.054 -1.029 . . . . 3.18 110.403 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.48 163.58 46.11 Favored Glycine 0 N--CA 1.492 2.382 0 CA-C-O 122.072 0.818 . . . . 0.01 111.243 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.3 m-20 57.15 39.33 29.02 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.636 0.732 . . . . 0.01 111.071 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 52.38 56.39 7.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.555 -0.715 . . . . 0.01 110.971 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -129.5 165.57 21.38 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.02 -1.104 . . . . 3.15 108.02 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.3 -162.91 28.6 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.222 -1.551 . . . . 0.01 109.222 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -76.04 142.14 41.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.927 -1.337 . . . . 0.01 108.947 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.54 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.4 ttp -116.64 143.34 45.75 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.626 0.727 . . . . 0.01 109.694 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -131.74 136.22 47.43 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.138 -1.06 . . . . 2.48 108.138 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.504 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 44.7 tt0 -115.89 134.05 55.39 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.695 -0.628 . . . . 0.01 109.62 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.57 148.7 28.99 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.519 1.152 . . . . 1.69 111.525 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.8 p -115.24 8.14 15.43 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.863 -1.062 . . . . 0.01 110.295 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -121.97 163.26 19.64 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.359 -0.838 . . . . 3.21 111.308 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.01 155.05 41.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.501 -0.749 . . . . 0.01 109.414 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 32.8 m -128.87 116.93 19.25 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.589 -0.694 . . . . 0.01 109.156 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -74.96 -31.47 6.26 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 CA-C-N 120.386 1.173 . . . . 0.01 111.424 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.0 t -142.65 108.76 5.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.361 -0.837 . . . . 0.02 109.298 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.9 mt -63.63 -39.51 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.795 -0.565 . . . . 1.83 110.731 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.81 -37.77 85.17 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.265 -0.974 . . . . 1.34 109.936 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -69.76 -38.65 76.83 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.595 -1.316 . . . . 2.11 109.778 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -79.93 -47.4 15.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.228 -0.92 . . . . 2.08 112.456 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -111.03 -0.29 16.7 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.396 -0.815 . . . . 0.02 112.662 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.488 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.7 m-70 59.77 33.14 21.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.79 -1.194 . . . . 0.02 109.464 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 mt -112.33 135.59 52.83 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.684 -0.858 . . . . 0.02 108.684 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -91.7 -22.83 20.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 5.32 110.473 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -149.44 164.06 36.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.152 -0.968 . . . . 0.02 109.858 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 126' ' ' ILE . 55.9 mt -131.54 129.27 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 107.289 -1.374 . . . . 2.17 107.289 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -107.71 -13.52 15.01 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.243 -0.911 . . . . 0.02 113.184 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -154.5 152.1 29.71 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.47 -1.394 . . . . 0.01 108.19 178.234 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.6 t -161.52 145.14 12.68 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.286 -1.509 . . . . 1.22 109.849 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -119.56 108.53 14.61 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.155 0.979 . . . . 1.41 108.486 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 t -107.5 120.49 58.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 105.797 -1.927 . . . . 0.01 105.797 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.41 68.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 C-N-CA 118.199 -1.401 . . . . 1.98 108.384 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.64 108.18 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.501 -1.666 . . . . 0.01 106.501 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.87 -174.03 43.8 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.899 -1.28 . . . . 0.01 109.899 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.5 m -111.69 145.51 39.14 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.335 -1.097 . . . . 2.3 109.191 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -130.6 146.27 52.07 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.492 -0.755 . . . . 0.01 110.492 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.6 mt -118.46 142.17 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 107.83 -1.174 . . . . 1.69 107.83 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -115.06 144.41 43.68 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 107.647 -1.242 . . . . 2.49 107.647 177.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.4 m-85 -122.42 145.08 48.62 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.657 -0.868 . . . . 0.02 108.657 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.29 -29.47 61.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.685 -0.634 . . . . 0.02 112.137 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.24 153.79 47.39 Favored Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 120.703 -1.248 . . . . 1.48 109.216 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.37 166.67 1.64 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.132 1.221 . . . . 0.02 112.47 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.4 m120 59.72 31.15 20.69 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.172 -0.922 . . . . 0.75 111.127 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 57.85 51.47 9.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.576 -0.703 . . . . 0.02 111.083 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -124.83 163.63 21.75 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.496 -0.753 . . . . 0.02 109.908 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.03 -165.51 31.79 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.91 -1.276 . . . . 0.02 109.91 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -67.67 141.66 56.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.435 -1.038 . . . . 0.02 108.846 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -117.98 148.18 42.46 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.375 -0.602 . . . . 0.02 109.375 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.456 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.5 t80 -129.69 143.72 50.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.057 -0.72 . . . . 0.01 109.057 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.1 tt -98.11 121.46 40.06 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.183 -0.948 . . . . 0.01 109.294 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.4 mt -105.35 136.43 44.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.01 110.319 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 154' ' ' LYS . 52.4 m-20 -108.19 171.29 7.49 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.702 -0.851 . . . . 2.27 108.702 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -57.69 83.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 1.84 108.748 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 152' ' ' ASP . 5.2 tptm -138.08 168.51 19.58 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.166 -0.959 . . . . 2.28 111.356 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -110.18 110.6 21.51 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.081 -1.081 . . . . 0.01 108.081 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.616 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 97.2 m-85 -100.44 116.35 32.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.134 -0.979 . . . . 0.01 110.089 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 7.5 ptp180 -92.05 -26.19 18.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.305 -0.872 . . . . 0.01 111.579 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -125.42 155.53 71.63 Favored Pre-proline 0 N--CA 1.504 2.245 0 O-C-N 120.741 -1.225 . . . . 2.54 107.866 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -62.79 -40.58 35.22 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.554 0.836 . . . . 0.7 110.473 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.75 -20.3 21.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.823 -1.173 . . . . 0.86 108.931 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 161' ' ' ASP . 4.9 m-20 -65.46 -16.02 63.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.953 -1.092 . . . . 0.02 109.804 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.616 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 2.7 m0 -96.72 10.83 37.57 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.164 -1.05 . . . . 0.02 108.164 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.64 12.08 84.73 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.271 -1.442 . . . . 0.02 109.959 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.42 142.01 32.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.467 -1.019 . . . . 0.02 110.159 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.59 -8.4 58.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.747 -0.596 . . . . 0.59 110.098 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 25.1 p -144.53 150.67 48.29 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.754 -1.216 . . . . 0.87 108.813 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.1 21.35 0.52 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 120.741 0.961 . . . . 0.38 112.19 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.69 123.98 29.79 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.595 1.188 . . . . 0.18 111.57 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 10.3 mm -143.63 124.69 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.463 -1.68 . . . . 3.99 106.463 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -110.33 -22.02 11.92 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.95 -1.094 . . . . 5.17 112.369 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.6 p -157.4 160.17 38.13 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 119.501 -2.0 . . . . 0.02 109.856 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.439 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 23.5 p90 -153.61 155.26 35.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.08 -1.013 . . . . 2.02 110.696 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -145.42 151.95 39.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.239 -0.913 . . . . 0.01 110.62 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -87.85 143.16 27.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.648 -0.658 . . . . 0.01 109.357 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.1 mt -93.42 128.6 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.071 -1.018 . . . . 3.04 108.882 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.95 146.66 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.314 -0.866 . . . . 1.89 109.525 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 4.89 109.493 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.538 -0.541 . . . . 5.28 109.538 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -74.85 -134.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.837 . . . . 5.96 109.283 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.9 m -98.91 110.76 23.32 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.531 -1.655 . . . . 2.22 106.531 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.4 94.99 0.1 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 106.626 -2.589 . . . . 0.81 106.626 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.78 147.62 33.99 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.495 -1.042 . . . . 0.01 110.495 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -153.23 138.6 17.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.483 -1.01 . . . . 0.02 109.603 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tt -130.05 140.56 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.186 0.517 . . . . 0.02 109.632 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -121.84 130.25 53.24 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.332 -0.855 . . . . 0.39 110.247 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.7 m-85 -111.19 140.39 45.79 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.501 -0.75 . . . . 0.02 109.75 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.2 m-85 -122.33 138.54 54.48 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.121 -0.987 . . . . 0.02 109.88 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -69.35 -27.5 65.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.03 111.865 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' O ' ' OG ' ' A' ' 38' ' ' SER . 17.2 t70 -113.82 169.43 9.0 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.818 -1.176 . . . . 0.03 110.23 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -75.6 158.32 32.61 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.695 0.76 . . . . 0.03 110.101 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 66.36 33.31 7.08 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.025 0.917 . . . . 0.74 110.956 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 55.23 41.54 31.32 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.023 -0.535 . . . . 0.02 111.273 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -112.37 165.45 12.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.122 -1.066 . . . . 0.02 108.122 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.13 -167.7 34.64 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.888 -1.148 . . . . 0.03 110.289 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -69.1 143.65 54.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.328 -1.101 . . . . 2.76 109.109 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -120.52 150.05 41.45 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.473 0.654 . . . . 1.89 109.719 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -136.36 131.59 34.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.642 -0.661 . . . . 0.02 109.549 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -109.42 134.91 51.27 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.403 -0.811 . . . . 1.12 108.907 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.2 t -127.35 137.55 52.81 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.126 -0.694 . . . . 0.02 109.126 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.95 11.87 12.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.583 -0.698 . . . . 0.2 110.552 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 p -159.93 173.59 15.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.75 -1.219 . . . . 1.23 109.303 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -63.55 146.41 53.74 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.84 -1.163 . . . . 0.02 110.842 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.43 116.92 16.61 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.922 -0.77 . . . . 0.02 108.922 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.13 -22.23 49.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.206 -0.934 . . . . 0.24 111.373 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 28.2 p-10 -149.58 103.18 3.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.194 -1.039 . . . . 1.14 108.194 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -105.01 3.46 30.61 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.188 0.994 . . . . 6.37 110.866 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -61.13 -25.46 67.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 3.11 112.232 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 t -77.53 -15.01 59.52 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.366 -1.459 . . . . 0.88 111.342 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -105.31 -20.17 13.58 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.199 -0.938 . . . . 0.02 110.442 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 tp -151.29 131.84 13.89 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.07 -1.019 . . . . 3.32 109.64 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.9 m -86.8 -11.89 49.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.66 -0.65 . . . . 0.02 111.021 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -172.91 162.12 4.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.787 -1.196 . . . . 0.02 108.575 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.29 116.68 9.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.177 -0.952 . . . . 0.02 108.681 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -108.65 -0.64 20.06 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.65 -1.281 . . . . 0.03 111.474 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 2.8 p -155.43 153.61 30.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.597 -1.26 . . . . 0.02 107.597 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -147.03 148.56 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.187 -0.946 . . . . 0.02 110.619 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.506 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 60.7 ttt180 -125.41 125.48 43.46 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.94 -1.133 . . . . 0.02 107.94 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 t -105.29 114.79 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.71 -1.589 . . . . 0.02 106.71 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 53.8 mm-40 -84.56 -34.53 23.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.491 -0.756 . . . . 3.81 109.991 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.23 151.29 20.44 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 118.451 -1.833 . . . . 0.02 110.807 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.93 171.45 48.26 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.227 -1.149 . . . . 0.01 110.227 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -118.05 133.73 55.64 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.403 -1.332 . . . . 1.48 107.403 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 39.7 m95 -126.96 154.82 44.06 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.622 1.201 . . . . 0.02 112.19 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.17 133.8 52.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.423 -2.066 . . . . 0.24 105.423 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.95 141.3 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.623 -0.673 . . . . 0.65 109.227 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -120.43 143.0 48.71 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.999 0.904 . . . . 0.02 109.651 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.22 -34.39 78.26 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.599 -0.728 . . . . 0.02 111.826 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -124.84 158.27 63.27 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 120.893 -1.129 . . . . 0.02 109.36 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.54 166.77 1.12 Allowed 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.724 1.616 . . . . 0.02 112.867 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 63.08 37.31 11.66 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.21 -0.905 . . . . 0.02 111.143 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.435 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.0 m-85 44.9 51.92 8.35 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.664 0.745 . . . . 3.39 110.79 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.4 m -125.87 163.5 22.79 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.259 0.552 . . . . 2.33 109.898 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.28 -161.72 31.63 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.842 -1.303 . . . . 0.02 109.842 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 13.0 m170 -64.86 138.46 58.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.061 -1.258 . . . . 0.02 110.227 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.2 ptm -119.23 136.84 54.02 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.24 0.543 . . . . 5.01 109.567 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -134.48 139.68 45.66 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.551 -0.718 . . . . 0.02 109.937 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.2 mm -94.43 130.5 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.932 -0.766 . . . . 1.72 108.932 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.559 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.56 110.69 35.31 Favored Pre-proline 0 N--CA 1.505 2.314 0 O-C-N 121.409 -0.807 . . . . 0.02 110.781 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -78.14 169.21 20.68 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 CA-C-N 119.898 0.999 . . . . 1.47 110.531 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -54.77 140.23 36.84 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.92 -1.112 . . . . 4.25 110.716 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.81 -176.97 33.16 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.506 -1.331 . . . . 0.02 110.517 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -119.29 130.7 55.53 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.287 -1.125 . . . . 0.96 109.853 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.559 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 83.3 m-85 -121.07 96.98 48.26 Favored Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 107.991 -1.114 . . . . 0.02 107.991 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.17 -4.14 13.04 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.76 0.973 . . . . 0.02 113.621 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -157.45 154.62 29.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.705 -1.247 . . . . 2.02 108.114 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -59.61 -39.05 82.98 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.448 -0.783 . . . . 0.02 111.868 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -59.99 -23.76 63.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.061 -1.025 . . . . 0.02 110.44 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -70.74 -18.55 62.78 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.777 0.798 . . . . 3.42 108.918 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.55 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.11 10.18 28.13 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.421 -1.325 . . . . 0.02 107.421 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 mtt 60.83 22.39 12.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.563 -0.711 . . . . 0.02 110.464 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.08 144.76 46.72 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.512 -1.435 . . . . 0.02 109.512 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.493 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 11.9 tp -79.55 -31.08 41.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -1.19 . . . . 0.98 107.888 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 75' ' ' LEU . 16.2 m-80 -157.48 -171.93 3.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.553 -1.647 . . . . 0.02 106.553 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.05 28.31 4.06 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.658 -1.276 . . . . 0.02 110.596 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -97.74 122.75 41.21 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.978 -1.076 . . . . 3.2 111.201 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.9 mt -142.09 119.91 11.92 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.444 -1.317 . . . . 2.61 107.444 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.79 -18.59 9.9 Favored Glycine 0 N--CA 1.498 2.823 0 O-C-N 121.233 -0.917 . . . . 0.02 112.231 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.435 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 17.2 t -155.68 155.97 34.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.112 -1.817 . . . . 0.02 110.68 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.8 p -145.95 148.1 32.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.446 -0.784 . . . . 0.02 110.254 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.417 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 22.2 mtp180 -137.67 142.35 41.13 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.504 -0.747 . . . . 0.01 109.111 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.14 131.75 36.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.207 -0.933 . . . . 0.43 109.478 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -90.49 124.83 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.698 -0.852 . . . . 1.25 108.698 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -91.26 132.25 36.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.969 -1.082 . . . . 1.77 108.319 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mt -99.14 140.47 33.25 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.708 -0.849 . . . . 1.63 108.708 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.6 p -111.18 123.5 50.32 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.096 -1.076 . . . . 1.08 108.096 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 t -114.8 132.62 56.41 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.766 -1.209 . . . . 1.26 107.806 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.48 -47.9 0.01 OUTLIER Glycine 0 N--CA 1.503 3.124 0 C-N-CA 117.754 -2.165 . . . . 0.01 113.465 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.9 -103.38 0.17 Allowed Glycine 0 N--CA 1.486 2.03 0 CA-C-N 120.005 1.902 . . . . 0.01 110.908 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -118.92 118.12 30.66 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.178 -1.19 . . . . 4.43 110.021 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.02 54.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 120.132 -0.627 . . . . 2.99 109.528 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -134.12 130.57 37.57 Favored 'General case' 0 N--CA 1.517 2.905 0 CA-C-O 122.175 0.988 . . . . 6.36 113.115 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -130.46 141.23 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 115.51 -0.768 . . . . 1.09 110.276 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.536 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 10.9 pt20 -124.09 137.73 54.53 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 107.501 -1.296 . . . . 2.05 107.501 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.4 m -123.69 146.6 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.602 0 O-C-N 120.489 -1.382 . . . . 1.1 111.406 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.52 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 64.6 m-85 -119.4 139.17 52.45 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.137 0.97 . . . . 0.73 110.709 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.37 -32.09 71.93 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 115.853 -0.612 . . . . 0.02 111.797 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -114.78 167.52 10.7 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.964 -1.085 . . . . 3.18 110.485 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.27 164.18 52.39 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 111.057 -0.817 . . . . 0.01 111.057 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 t70 57.6 38.36 27.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.968 -0.725 . . . . 0.01 111.479 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.433 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 14.7 m-85 53.09 54.88 9.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.01 111.352 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -129.13 165.02 22.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.253 -1.018 . . . . 3.15 108.253 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.15 -163.21 28.97 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.24 -1.544 . . . . 0.01 109.24 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.428 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 55.0 tt0 -75.86 142.95 42.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.925 -1.338 . . . . 0.01 109.314 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.52 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.9 ttp -117.4 143.35 46.09 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.505 0.669 . . . . 0.01 109.754 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.428 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 54.2 m-85 -131.91 136.31 47.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.222 -1.029 . . . . 2.48 108.222 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -116.7 134.65 54.55 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.737 -0.602 . . . . 0.01 109.849 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -149.54 147.87 28.69 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.39 1.091 . . . . 1.69 111.272 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.6 p -114.3 7.94 16.58 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.049 -0.978 . . . . 0.01 109.996 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -122.18 163.44 19.54 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.439 -0.788 . . . . 3.21 111.186 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 6.7 p30 -69.19 154.81 41.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.01 109.396 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.403 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 51.2 t -126.64 115.18 22.78 Favored Pre-proline 0 N--CA 1.499 2.025 0 N-CA-C 109.009 -0.737 . . . . 0.01 109.009 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -75.41 -32.41 4.96 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 CA-C-N 120.302 1.143 . . . . 0.01 111.406 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -142.45 107.79 5.02 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.842 0.829 . . . . 0.02 108.995 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.416 HD13 HG23 ' A' ' 117' ' ' ILE . 96.8 mt -64.43 -39.43 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.791 -0.568 . . . . 1.83 111.061 -178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.9 ttt -66.78 -37.21 84.13 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.04 -1.064 . . . . 1.34 109.873 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -70.16 -38.7 75.5 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.673 -1.267 . . . . 2.11 109.871 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -80.14 -47.45 14.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.283 -0.886 . . . . 2.08 112.469 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -110.56 -0.42 17.32 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.337 -0.852 . . . . 0.02 112.675 -176.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.574 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.2 m-70 59.78 32.64 21.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.836 -1.165 . . . . 0.02 109.504 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.2 135.75 52.47 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 108.756 -0.831 . . . . 0.02 108.756 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -92.11 -22.92 19.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 5.32 110.425 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -149.55 163.62 37.35 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.132 -0.98 . . . . 0.02 110.134 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.406 HD11 HG23 ' A' ' 126' ' ' ILE . 52.0 mt -131.76 129.48 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 107.125 -1.435 . . . . 2.17 107.125 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.0 -13.07 15.28 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.193 -0.942 . . . . 0.02 113.015 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.433 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -155.82 153.97 30.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.483 -1.386 . . . . 0.01 108.146 177.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 5.0 t -163.07 145.62 10.36 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.181 -1.574 . . . . 1.22 109.683 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -122.29 110.49 15.75 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.423 1.106 . . . . 1.41 108.767 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.81 122.86 64.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.127 -1.805 . . . . 0.01 106.127 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t -146.63 69.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 118.051 -1.46 . . . . 1.98 108.405 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.1 108.94 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.862 -1.533 . . . . 0.01 106.862 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.88 -174.63 46.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.003 -1.239 . . . . 0.01 110.003 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.1 m -111.33 144.98 39.64 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.528 -0.984 . . . . 2.3 109.234 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -131.62 146.84 52.4 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.436 -0.79 . . . . 0.01 110.907 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.4 mt -118.76 141.28 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 107.279 -1.378 . . . . 1.69 107.279 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.6 142.38 46.04 Favored 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 107.549 -1.278 . . . . 2.49 107.549 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 16.7 m-85 -122.94 145.14 48.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.452 -0.78 . . . . 0.02 109.213 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -74.69 -29.7 61.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.643 -0.66 . . . . 0.02 112.08 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.29 153.41 47.45 Favored Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 120.639 -1.288 . . . . 1.48 109.074 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -54.24 166.85 1.47 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.315 1.344 . . . . 0.02 112.41 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.584 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.0 OUTLIER 59.43 31.24 20.92 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.062 -0.972 . . . . 0.75 111.081 178.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.3 m-85 58.1 51.38 8.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.548 -0.72 . . . . 0.02 110.981 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.93 164.01 21.02 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.47 -0.769 . . . . 0.02 109.896 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.37 -165.41 32.57 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.975 -1.25 . . . . 0.02 109.975 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -67.73 141.6 56.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.549 -0.971 . . . . 0.02 108.78 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.1 mp0 -118.52 148.46 42.61 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.219 0.533 . . . . 0.02 109.606 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.95 142.19 51.32 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.61 -0.885 . . . . 0.01 108.61 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.9 tt -96.28 119.79 35.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.117 -0.99 . . . . 0.01 108.678 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.8 mt -104.29 135.23 46.14 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.527 -0.733 . . . . 0.01 109.985 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 154' ' ' LYS . 1.9 m-20 -110.91 172.8 6.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.356 -0.84 . . . . 2.27 108.867 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -55.04 85.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.161 -0.962 . . . . 1.84 108.635 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 152' ' ' ASP . 19.5 mmtp -137.16 166.48 23.62 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 2.28 111.594 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 6.6 mp0 -112.35 107.47 16.31 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.51 -1.293 . . . . 0.01 107.51 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.625 ' CE2' ' NE1' ' A' ' 162' ' ' TRP . 94.2 m-85 -99.54 113.42 25.81 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.0 -1.063 . . . . 0.01 110.581 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -91.62 -28.18 17.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.329 -0.857 . . . . 0.01 111.392 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 158' ' ' LYS . 8.0 mtmp? -126.46 151.42 72.71 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 120.819 -1.175 . . . . 2.54 108.384 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -58.62 -45.62 28.69 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.352 0.804 . . . . 0.7 111.346 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.3 t -61.21 -22.56 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.726 -1.234 . . . . 0.86 109.696 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -65.57 -15.69 62.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.723 -1.236 . . . . 0.02 109.928 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.625 ' NE1' ' CE2' ' A' ' 156' ' ' TYR . 0.0 OUTLIER -97.46 11.36 37.02 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.618 -0.882 . . . . 0.02 108.618 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.95 9.27 87.05 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.555 -1.307 . . . . 0.02 110.421 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.2 142.34 30.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.396 -1.061 . . . . 0.02 110.075 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.36 -9.69 57.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.752 -0.592 . . . . 0.59 110.168 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 42.1 m -146.08 150.76 43.0 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 120.648 -1.283 . . . . 0.87 108.928 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.59 21.74 0.55 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.903 1.069 . . . . 0.38 112.397 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.93 125.56 31.52 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.556 1.169 . . . . 0.18 112.063 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 22.0 mt -145.94 125.74 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.778 -1.564 . . . . 3.99 106.778 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -112.16 -21.78 11.3 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.969 -1.082 . . . . 5.17 112.823 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 p -157.16 159.9 38.23 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.427 -2.046 . . . . 0.02 109.749 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.403 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.1 p90 -152.63 154.2 34.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.93 -1.106 . . . . 2.02 110.71 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 25.0 mtp180 -144.17 150.9 38.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.381 -0.824 . . . . 0.01 110.29 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -88.07 142.36 27.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.726 . . . . 0.01 109.313 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.73 128.5 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.106 -0.996 . . . . 3.04 109.051 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.9 t -136.39 146.87 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.152 -0.967 . . . . 1.89 109.676 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 4.89 109.417 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.532 -0.544 . . . . 5.28 109.532 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -80.5 -12.05 59.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 5.96 109.714 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.1 m -100.45 110.87 23.08 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.872 -1.529 . . . . 2.22 106.872 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.17 93.89 0.09 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 106.671 -2.572 . . . . 0.81 106.671 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.07 148.01 34.06 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.441 -1.064 . . . . 0.01 110.441 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -152.65 139.12 18.6 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.365 -1.079 . . . . 0.02 109.887 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 tt -130.63 139.6 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.691 -0.631 . . . . 0.02 109.412 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -121.28 130.31 53.59 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.545 -0.722 . . . . 0.39 109.938 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.5 m-85 -110.49 139.65 45.52 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.652 -0.655 . . . . 0.02 109.578 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.9 m-85 -121.41 137.88 54.51 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.237 -0.914 . . . . 0.02 109.531 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.56 -27.42 65.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.843 -1.16 . . . . 0.03 111.731 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -113.78 169.73 8.77 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.821 -1.174 . . . . 0.03 110.114 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -75.7 158.06 32.81 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.63 0.729 . . . . 0.03 110.13 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 1.1 m120 66.44 33.34 6.91 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.96 0.886 . . . . 0.74 111.046 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.411 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.69 41.66 30.19 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.271 0.557 . . . . 0.02 111.259 177.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -113.31 165.51 12.36 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.376 -0.972 . . . . 0.02 108.376 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.25 -167.62 34.39 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.898 -1.144 . . . . 0.03 110.554 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -69.02 142.68 54.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.46 -1.023 . . . . 2.76 108.941 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -122.53 150.24 42.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.587 -0.695 . . . . 1.89 110.079 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -136.43 133.08 36.26 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.131 -0.692 . . . . 0.02 109.131 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -109.45 135.79 49.9 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.507 -0.923 . . . . 1.12 108.507 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.6 t -127.82 138.04 52.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.635 -0.665 . . . . 0.02 109.348 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -118.45 12.32 13.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.654 -0.654 . . . . 0.2 110.128 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.6 t -159.81 173.77 15.48 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.888 -1.133 . . . . 1.23 109.164 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -62.79 146.09 53.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.807 -1.183 . . . . 0.02 110.708 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.1 m -133.36 117.33 17.16 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.84 -0.8 . . . . 0.02 108.84 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.79 -20.91 48.66 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.271 -0.893 . . . . 0.24 111.758 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -151.82 105.36 3.11 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.804 -1.185 . . . . 1.14 109.342 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.15 5.82 42.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.402 -0.811 . . . . 6.37 110.291 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -62.75 -29.36 70.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.373 -0.83 . . . . 3.11 112.708 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.6 p -77.49 -18.66 56.87 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.198 -1.564 . . . . 0.88 111.605 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -107.33 -19.29 13.63 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.315 -0.866 . . . . 0.02 110.089 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -148.94 127.08 12.04 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.046 . . . . 3.32 109.258 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 p -87.72 -12.45 45.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.453 -0.779 . . . . 0.02 111.389 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -171.49 160.84 6.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.793 -1.192 . . . . 0.02 108.446 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.78 116.35 8.64 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.031 -1.043 . . . . 0.02 108.97 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 -109.83 0.49 18.78 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.856 -1.153 . . . . 0.03 111.987 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 t -156.2 154.45 30.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.325 -0.991 . . . . 0.02 108.325 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mt -146.57 146.95 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.02 -1.05 . . . . 0.02 111.001 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -122.84 124.07 42.45 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.487 -1.301 . . . . 0.02 107.487 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.35 114.15 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.774 -1.565 . . . . 0.02 106.774 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -84.16 -34.05 24.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.574 -0.704 . . . . 3.81 110.552 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.22 150.74 19.87 Favored Glycine 0 N--CA 1.484 1.897 0 C-N-CA 118.977 -1.583 . . . . 0.02 110.775 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.4 172.22 48.81 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 119.988 -1.101 . . . . 0.01 110.488 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -118.16 134.47 54.98 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.631 -1.248 . . . . 1.48 107.631 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -127.29 154.52 44.81 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 122.508 1.147 . . . . 0.02 112.112 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.38 134.45 51.81 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 105.625 -1.991 . . . . 0.24 105.625 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.94 142.1 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -0.762 . . . . 0.65 109.316 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -121.08 143.61 48.99 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.032 0.92 . . . . 0.02 109.688 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' OE1' ' CD2' ' A' ' 57' ' ' HIS . 43.5 tt0 -65.13 -34.04 77.46 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.604 -0.725 . . . . 0.02 111.791 -177.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -124.43 157.78 63.8 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 121.001 -1.062 . . . . 0.02 109.51 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.38 166.87 0.99 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.613 1.542 . . . . 0.02 112.814 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 63.65 36.73 10.64 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.243 -0.89 . . . . 0.02 111.039 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 45.03 51.46 8.8 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.667 0.746 . . . . 3.39 110.617 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.7 m -125.9 163.65 22.49 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.184 0.516 . . . . 2.33 109.898 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.65 -161.95 31.32 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.821 -1.311 . . . . 0.02 109.821 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.432 ' CD2' ' OE1' ' A' ' 50' ' ' GLU . 13.4 m-70 -64.9 138.78 58.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.999 -1.295 . . . . 0.02 110.103 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.7 ppp? -119.89 137.6 53.92 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.773 -0.579 . . . . 5.01 109.817 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 85.4 m-85 -134.87 140.19 45.6 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.408 -0.808 . . . . 0.02 109.944 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mm -95.18 130.72 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.972 -0.751 . . . . 1.72 108.972 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.4 mt -121.86 111.66 32.52 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.374 -0.829 . . . . 0.02 110.802 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.67 170.35 19.29 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 119.859 0.985 . . . . 1.47 110.329 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -52.59 141.01 21.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.904 -1.123 . . . . 4.25 110.357 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.19 -177.54 32.35 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.41 -1.376 . . . . 0.02 110.785 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -120.1 131.33 55.02 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.408 -1.054 . . . . 0.96 109.878 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -122.21 94.79 47.74 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.931 -1.137 . . . . 0.02 107.931 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.88 -3.98 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.078 1.185 . . . . 0.02 113.855 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -157.58 154.55 28.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.608 -1.308 . . . . 2.02 108.213 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.621 ' HH ' HE21 ' A' ' 70' ' ' GLN . 39.1 p90 -59.49 -39.35 83.46 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.409 -0.807 . . . . 0.02 111.935 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.621 HE21 ' HH ' ' A' ' 69' ' ' TYR . 73.1 mt-30 -60.04 -24.02 64.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.081 -1.012 . . . . 0.02 110.573 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -70.37 -18.32 63.05 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.936 0.874 . . . . 3.42 108.828 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -107.49 11.17 29.06 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.324 -1.362 . . . . 0.02 107.324 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.1 mmt 60.41 22.28 11.87 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.51 0.671 . . . . 0.02 110.286 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.49 144.26 45.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.505 -1.438 . . . . 0.02 109.505 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.5 tp -79.13 -30.18 43.57 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.699 -1.223 . . . . 0.98 107.699 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.434 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 15.0 t-20 -157.2 -171.9 3.8 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.47 -1.678 . . . . 0.02 106.47 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 84.4 m-20 -98.81 28.21 4.45 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.789 -1.195 . . . . 0.02 110.639 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -96.52 123.05 40.06 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.971 -1.081 . . . . 3.2 111.1 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.2 mt -141.57 119.28 11.76 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.772 -1.196 . . . . 2.61 107.772 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.51 -18.94 9.14 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 121.144 -0.973 . . . . 0.02 112.389 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 p -156.08 156.2 33.93 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 119.738 1.769 . . . . 0.02 110.793 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.78 147.95 32.43 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.471 -0.768 . . . . 0.02 110.327 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -137.38 142.16 41.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.423 -0.798 . . . . 0.01 109.267 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.29 132.46 36.47 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.145 -0.972 . . . . 0.43 109.583 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.16 124.89 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.806 -0.813 . . . . 1.25 108.806 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.519 ' N ' ' HD1' ' A' ' 86' ' ' HIS . 1.6 m80 -91.11 132.81 35.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.919 -1.113 . . . . 1.77 108.424 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 mt -99.36 139.61 34.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.838 -0.801 . . . . 1.63 108.838 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.6 t -110.85 123.79 50.79 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.969 -1.123 . . . . 1.08 107.969 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.9 p -114.79 132.1 56.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.654 -1.279 . . . . 1.26 107.689 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.76 -48.97 0.01 OUTLIER Glycine 0 N--CA 1.503 3.129 0 C-N-CA 117.652 -2.214 . . . . 0.01 113.299 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.17 -103.93 0.17 Allowed Glycine 0 N--CA 1.488 2.105 0 CA-C-N 119.82 1.81 . . . . 0.01 110.963 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -118.99 118.41 31.41 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.244 -1.15 . . . . 4.43 110.184 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.87 135.07 54.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.811 -0.556 . . . . 2.99 109.527 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -133.68 129.97 37.54 Favored 'General case' 0 N--CA 1.519 2.994 0 CA-C-O 122.187 0.994 . . . . 6.36 113.055 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -131.84 141.46 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 115.505 -0.77 . . . . 1.09 110.248 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.504 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.3 pt20 -124.41 139.53 53.81 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 107.399 -1.334 . . . . 2.05 107.399 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.76 145.84 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 120.657 -1.277 . . . . 1.1 110.917 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -120.42 139.67 52.48 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.084 0.945 . . . . 0.73 110.929 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -68.31 -32.24 72.24 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.712 -0.676 . . . . 0.02 111.895 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -114.68 167.7 10.53 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.976 -1.077 . . . . 3.18 110.181 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.36 163.7 52.79 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.741 -0.943 . . . . 0.01 110.741 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 58.12 37.79 26.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.821 -0.811 . . . . 0.01 111.604 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.527 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 28.6 m-85 53.33 54.69 9.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.01 111.253 177.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -128.15 164.3 22.78 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.079 -1.082 . . . . 3.15 108.079 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.32 -162.4 29.49 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.913 -1.675 . . . . 0.01 108.913 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -75.82 141.67 42.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.958 -1.319 . . . . 0.01 109.28 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.1 tmm? -116.54 143.23 45.86 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.518 0.675 . . . . 0.01 109.304 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -132.48 136.36 46.64 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.337 -0.986 . . . . 2.48 108.337 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -116.38 134.23 55.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.704 -0.622 . . . . 0.01 109.814 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.9 t -149.35 147.57 28.48 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.901 -1.125 . . . . 1.69 111.336 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.9 p -115.03 7.61 15.54 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.996 -1.002 . . . . 0.01 110.19 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -121.77 163.22 19.47 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.411 -0.806 . . . . 3.21 111.109 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -69.44 154.78 41.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.351 -0.843 . . . . 0.01 109.491 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.608 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 20.5 p -126.53 119.77 23.11 Favored Pre-proline 0 N--CA 1.502 2.126 0 N-CA-C 109.22 -0.659 . . . . 0.01 109.22 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -77.01 -33.11 2.88 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 120.341 1.158 . . . . 0.01 110.638 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 t -143.24 108.8 5.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.438 -0.789 . . . . 0.02 109.103 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.99 -39.31 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.731 -0.606 . . . . 1.83 110.823 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.7 ttp -67.18 -36.74 82.43 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.174 -1.01 . . . . 1.34 109.881 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.95 -38.79 76.23 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.575 -1.328 . . . . 2.11 109.668 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.415 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 8.3 tt0 -80.34 -46.6 15.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.345 -0.847 . . . . 2.08 112.509 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.415 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 53.1 m-85 -110.29 -0.45 17.7 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.281 -0.887 . . . . 0.02 112.623 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.7 m80 59.65 33.01 21.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.738 -1.226 . . . . 0.02 109.495 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.0 mt -112.45 135.71 52.83 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 108.71 -0.848 . . . . 0.02 108.71 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -92.4 -22.9 19.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 5.32 110.581 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -149.02 163.33 37.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.184 -0.948 . . . . 0.02 109.947 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 126' ' ' ILE . 53.6 mt -131.75 129.19 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.452 -1.314 . . . . 2.17 107.452 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -106.81 -13.4 15.26 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.2 -0.938 . . . . 0.02 113.172 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.32 153.58 30.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.333 -1.479 . . . . 0.01 108.186 178.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 8.6 t -160.52 147.01 15.42 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.318 -1.489 . . . . 1.22 109.904 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -121.79 108.28 13.31 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.029 0.919 . . . . 1.41 108.623 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.15 121.06 60.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.068 -1.827 . . . . 0.01 106.068 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t -146.83 69.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 118.182 -1.407 . . . . 1.98 108.42 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.66 109.04 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.634 -1.617 . . . . 0.01 106.634 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.35 -174.1 45.2 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.819 -1.312 . . . . 0.01 109.819 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.5 m -111.4 143.62 41.93 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.526 -0.984 . . . . 2.3 109.147 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -129.92 144.97 51.6 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.403 -0.811 . . . . 0.01 110.481 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.7 mt -117.61 141.36 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.504 -1.295 . . . . 1.69 107.504 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.31 143.55 44.69 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 107.528 -1.286 . . . . 2.49 107.528 177.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 9.4 m-85 -122.46 144.88 48.78 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.903 -0.777 . . . . 0.02 108.903 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -74.33 -29.82 61.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.729 -0.607 . . . . 0.02 112.119 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.56 153.54 47.78 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 120.805 -1.184 . . . . 1.48 109.083 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.23 166.86 1.46 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.232 1.288 . . . . 0.02 112.7 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 59.54 30.9 20.58 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.235 -0.893 . . . . 0.75 111.029 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.77 51.57 9.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.574 -0.704 . . . . 0.02 110.924 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -124.58 163.66 21.47 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.55 -0.719 . . . . 0.02 109.732 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.52 -165.17 32.22 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.843 -1.303 . . . . 0.02 109.843 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -67.92 141.77 56.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.607 -0.937 . . . . 0.02 108.921 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -118.26 149.03 41.81 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.155 -0.683 . . . . 0.02 109.155 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -129.5 142.54 50.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.486 -0.759 . . . . 0.01 109.049 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.96 121.45 38.85 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.217 -0.927 . . . . 0.01 109.079 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.8 mt -105.8 135.32 47.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.545 -0.722 . . . . 0.01 110.71 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 154' ' ' LYS . 29.4 t70 -108.68 172.71 6.68 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.015 -1.106 . . . . 2.27 108.015 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -57.08 85.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.964 -1.085 . . . . 1.84 108.483 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 152' ' ' ASP . 52.2 tttp -135.79 167.04 21.9 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.303 1.049 . . . . 2.28 111.428 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.414 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 29.5 mt-10 -110.92 108.29 18.02 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.209 -1.034 . . . . 0.01 108.209 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.83 114.36 26.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.063 -1.023 . . . . 0.01 110.272 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -91.46 -27.12 18.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.101 -0.999 . . . . 0.01 111.506 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -125.82 153.77 73.39 Favored Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.027 -1.046 . . . . 2.54 108.692 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.58 -42.91 36.25 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 CA-C-N 119.171 0.74 . . . . 0.7 110.745 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.9 t -60.63 -20.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.648 -1.282 . . . . 0.86 108.642 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -65.44 -15.96 63.16 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.908 -1.12 . . . . 0.02 109.432 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -95.17 9.76 38.45 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.939 -1.134 . . . . 0.02 107.939 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.87 10.48 86.1 Favored Glycine 0 N--CA 1.485 1.963 0 C-N-CA 119.3 -1.429 . . . . 0.02 109.813 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.41 142.23 31.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.547 -0.972 . . . . 0.02 110.164 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.63 -8.37 58.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.682 -0.636 . . . . 0.59 109.783 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 t -144.66 150.71 47.94 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.758 -1.214 . . . . 0.87 108.696 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.84 21.54 0.5 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 120.735 0.957 . . . . 0.38 112.322 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.15 123.76 29.85 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.508 1.147 . . . . 0.18 111.649 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.6 mt -146.4 126.77 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.663 -1.606 . . . . 3.99 106.663 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -112.45 -20.15 11.88 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.04 -1.038 . . . . 5.17 112.982 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 11.9 p -157.69 160.83 38.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 119.353 -2.092 . . . . 0.02 110.19 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.608 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 5.2 p90 -152.46 154.28 35.22 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.149 -0.969 . . . . 2.02 110.784 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -144.79 151.85 39.45 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.105 -0.997 . . . . 0.01 110.708 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -88.21 143.75 26.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.68 -0.638 . . . . 0.01 109.33 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.17 129.26 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.137 -0.977 . . . . 3.04 109.083 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.5 t -136.14 146.57 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.269 -0.895 . . . . 1.89 109.62 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.295 -0.878 . . . . 4.89 109.434 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' LYS . 38.8 m . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.543 -0.54 . . . . 5.28 109.543 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 1' ' ' SER . 44.8 mttp 54.69 103.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 5.96 109.433 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.0 m -99.74 113.31 25.7 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 106.461 -1.681 . . . . 2.22 106.461 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.52 95.33 0.1 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 106.477 -2.649 . . . . 0.81 106.477 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.21 147.93 33.74 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.406 -1.078 . . . . 0.01 110.406 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -152.57 138.56 18.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.421 -1.047 . . . . 0.02 109.879 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.05 139.24 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.215 -0.661 . . . . 0.02 109.215 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -121.85 130.94 53.77 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.459 -0.776 . . . . 0.39 109.861 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 m-85 -110.89 140.41 45.39 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.656 -0.653 . . . . 0.02 109.633 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 4.8 m-85 -122.07 138.41 54.45 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.317 -0.865 . . . . 0.02 109.402 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -69.27 -27.43 65.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.144 . . . . 0.03 111.869 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -114.08 169.97 8.62 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.852 -1.155 . . . . 0.03 110.257 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -75.41 158.48 32.64 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.535 0.684 . . . . 0.03 109.986 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.1 t30 65.7 35.05 7.14 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.891 0.853 . . . . 0.74 110.75 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.4 p90 50.03 44.78 25.7 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.681 0.753 . . . . 0.02 111.342 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -112.16 165.73 11.89 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.986 -1.116 . . . . 0.02 107.986 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.21 -167.74 34.57 Favored Glycine 0 N--CA 1.494 2.567 0 C-N-CA 119.87 -1.157 . . . . 0.03 110.559 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -68.95 143.18 54.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -1.108 . . . . 2.76 108.861 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 50.1 ttt180 -122.19 149.26 43.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.564 -0.71 . . . . 1.89 110.225 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -135.91 132.2 36.18 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.18 -0.674 . . . . 0.02 109.18 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -109.65 136.57 48.81 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.396 -0.815 . . . . 1.12 108.928 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 t -128.03 137.85 52.35 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.553 -0.717 . . . . 0.02 109.593 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.39 11.85 13.15 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.661 -0.649 . . . . 0.2 110.139 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.543 ' HG ' ' H ' ' A' ' 25' ' ' ASP . 36.7 t -159.53 174.15 15.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.896 -1.128 . . . . 1.23 108.913 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.543 ' H ' ' HG ' ' A' ' 24' ' ' CYS . 1.4 p30 -62.85 145.86 54.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.63 -1.294 . . . . 0.02 110.599 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.519 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 12.7 p -134.93 119.36 17.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.5 -0.75 . . . . 0.02 109.152 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.0 -21.08 47.53 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.289 -0.882 . . . . 0.24 112.376 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -152.41 107.02 3.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.67 -1.269 . . . . 1.14 110.14 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.48 5.95 39.79 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.375 -0.828 . . . . 6.37 110.442 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -61.42 -30.25 70.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 3.11 112.186 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.7 t -76.94 -17.31 58.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.389 -1.444 . . . . 0.88 111.124 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -106.99 -20.84 13.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.403 -0.811 . . . . 0.02 110.755 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.07 127.2 12.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.979 -1.076 . . . . 3.32 109.663 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 t -87.01 -12.39 47.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.57 -0.706 . . . . 0.02 111.032 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -172.8 161.72 4.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.781 -1.199 . . . . 0.02 108.467 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.4 p -143.49 116.55 8.9 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.1 -1.0 . . . . 0.02 108.876 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -108.28 -0.04 21.04 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.813 -1.179 . . . . 0.03 111.287 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 t -156.46 154.34 30.26 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.965 -1.124 . . . . 0.02 107.965 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.0 mt -146.96 148.13 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.057 -1.027 . . . . 0.02 110.554 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -123.54 124.81 43.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.2 -1.037 . . . . 0.02 108.2 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.66 114.31 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 106.768 -1.567 . . . . 0.02 106.768 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -83.99 -34.1 24.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.717 -0.614 . . . . 3.81 110.629 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.54 151.19 20.58 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.019 -1.563 . . . . 0.02 110.688 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.09 172.41 49.12 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.934 -1.127 . . . . 0.01 110.496 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -118.15 133.98 55.42 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.548 -1.278 . . . . 1.48 107.548 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -126.36 154.74 43.13 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.685 -1.26 . . . . 0.02 112.196 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.61 133.93 52.53 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.543 -2.021 . . . . 0.24 105.543 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.86 142.6 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.565 -0.709 . . . . 0.65 109.451 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -120.7 142.74 49.21 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.053 0.93 . . . . 0.02 109.596 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.433 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 38.0 tt0 -65.11 -33.54 76.27 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.593 -0.73 . . . . 0.02 111.786 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -124.45 157.71 64.1 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 120.988 -1.07 . . . . 0.02 109.444 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.23 166.63 0.99 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.61 1.54 . . . . 0.02 112.71 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m120 63.44 36.42 11.39 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 115.355 -0.839 . . . . 0.02 111.016 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.527 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.3 m-85 45.37 51.41 9.53 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.528 0.68 . . . . 3.39 110.742 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 p -125.75 163.7 22.27 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.27 0.557 . . . . 2.33 109.948 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.46 -161.54 31.26 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.882 -1.287 . . . . 0.02 109.882 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 13.8 m80 -64.25 138.79 58.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.045 -1.268 . . . . 0.02 110.161 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.1 ppp? -119.09 137.17 53.75 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.397 0.618 . . . . 5.01 109.65 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 88.3 m-85 -135.27 139.29 44.29 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.419 -0.801 . . . . 0.02 109.765 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 mm -96.25 131.03 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.715 -0.846 . . . . 1.72 108.715 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mt -121.69 111.9 32.67 Favored Pre-proline 0 N--CA 1.505 2.305 0 O-C-N 121.344 -0.848 . . . . 0.02 110.757 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.46 170.1 19.93 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 119.892 0.997 . . . . 1.47 110.325 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -52.63 141.09 21.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.991 -1.068 . . . . 4.25 110.42 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.71 -177.9 31.76 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.437 -1.363 . . . . 0.02 110.782 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -120.04 131.57 55.16 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.401 -1.058 . . . . 0.96 109.659 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -121.32 97.95 47.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.941 -1.133 . . . . 0.02 107.941 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -70.17 -3.88 13.18 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.678 0.919 . . . . 0.02 113.6 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -157.39 154.2 28.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.549 -1.344 . . . . 2.02 107.989 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -59.83 -38.49 82.2 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.432 -0.792 . . . . 0.02 111.872 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -59.71 -24.38 63.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.051 . . . . 0.02 110.433 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -70.22 -18.81 63.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.863 0.84 . . . . 3.42 108.978 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.55 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.6 t90 -108.25 10.08 27.87 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.493 -1.299 . . . . 0.02 107.493 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.3 mtm 60.84 21.84 11.95 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.484 0.659 . . . . 0.02 110.535 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.61 144.3 46.06 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.388 -1.485 . . . . 0.02 109.388 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 mt -78.84 -30.57 45.27 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.687 -1.227 . . . . 0.98 107.687 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -157.32 -171.31 3.56 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.335 -1.728 . . . . 0.02 106.335 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -98.32 29.06 3.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.639 -1.288 . . . . 0.02 110.595 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -97.94 122.65 41.31 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.899 -1.126 . . . . 3.2 111.448 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.1 mt -142.76 119.78 11.36 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.45 -1.315 . . . . 2.61 107.45 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.94 -17.89 10.53 Favored Glycine 0 N--CA 1.497 2.762 0 O-C-N 121.296 -0.878 . . . . 0.02 112.25 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.577 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 31.2 t -155.17 155.83 34.64 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.189 -1.771 . . . . 0.02 110.856 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.577 ' N ' ' HG ' ' A' ' 81' ' ' SER . 47.8 t -145.42 148.17 33.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.463 -0.773 . . . . 0.02 110.233 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -137.52 141.67 41.44 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.482 -0.761 . . . . 0.01 109.038 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.06 133.73 36.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.43 109.405 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 t -91.92 124.58 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.98 -0.748 . . . . 1.25 108.98 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -92.75 131.96 37.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.958 -1.089 . . . . 1.77 108.507 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.15 138.8 33.23 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.134 -1.061 . . . . 1.63 108.134 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 t -110.84 126.67 54.9 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.758 -0.83 . . . . 1.08 108.758 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.4 m -103.22 -154.49 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.23 -1.767 . . . . 1.26 106.23 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.06 -50.55 0.84 Allowed Glycine 0 N--CA 1.497 2.723 0 O-C-N 120.527 -1.358 . . . . 0.01 112.09 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.67 -100.2 0.14 Allowed Glycine 0 N--CA 1.487 2.076 0 C-N-CA 118.76 -1.686 . . . . 0.01 111.995 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -120.03 119.73 34.23 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.164 -1.198 . . . . 4.43 110.523 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.44 136.45 55.74 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.177 -0.609 . . . . 2.99 109.463 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -134.7 130.57 36.49 Favored 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 122.163 0.982 . . . . 6.36 112.942 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -132.08 142.07 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.675 0.75 . . . . 1.09 110.532 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.9 pt20 -124.82 139.83 53.48 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 107.686 -1.228 . . . . 2.05 107.686 176.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -124.07 145.71 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.495 0 O-C-N 120.607 -1.308 . . . . 1.1 111.121 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -120.47 140.17 51.8 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 122.081 0.943 . . . . 0.73 110.852 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -68.66 -32.58 72.51 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.652 -0.704 . . . . 0.02 111.929 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -114.57 165.47 12.73 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.978 -1.076 . . . . 3.18 110.228 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 163.39 45.42 Favored Glycine 0 N--CA 1.494 2.532 0 CA-C-O 122.022 0.79 . . . . 0.01 111.264 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 t70 57.01 39.4 29.37 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.595 0.712 . . . . 0.01 111.1 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 52.15 56.2 8.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.509 -0.744 . . . . 0.01 111.03 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -129.23 165.03 22.17 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.839 -1.171 . . . . 3.15 107.839 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.07 -162.78 28.8 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 108.963 -1.655 . . . . 0.01 108.963 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -75.33 141.24 43.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.775 -1.426 . . . . 0.01 109.001 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.1 tmm? -116.3 143.37 45.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.604 0.716 . . . . 0.01 109.526 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -132.41 136.65 46.92 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.309 -0.997 . . . . 2.48 108.309 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -116.21 134.42 54.94 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.632 -0.668 . . . . 0.01 109.635 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -149.68 148.08 28.85 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.532 1.158 . . . . 1.69 111.437 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 p -115.09 7.88 15.55 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.936 -1.029 . . . . 0.01 109.985 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -122.16 163.26 19.85 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.437 -0.79 . . . . 3.21 111.236 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.55 154.31 42.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.01 109.471 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.429 ' O ' ' OG ' ' A' ' 171' ' ' SER . 44.2 t -127.07 115.99 21.9 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 109.096 -0.705 . . . . 0.01 109.096 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.45 -32.95 4.51 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.324 1.151 . . . . 0.01 111.604 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.7 m -142.07 108.59 5.32 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.379 -0.826 . . . . 0.02 109.237 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.37 -40.02 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.787 -0.571 . . . . 1.83 111.019 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.0 ttp -66.76 -37.6 84.94 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.021 -1.071 . . . . 1.34 109.76 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -69.81 -38.53 76.62 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.538 -1.351 . . . . 2.11 109.817 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.526 ' OE1' ' CG ' ' A' ' 121' ' ' PHE . 7.9 tm0? -80.49 -47.61 14.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.281 -0.887 . . . . 2.08 112.282 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.526 ' CG ' ' OE1' ' A' ' 120' ' ' GLN . 92.1 m-85 -110.72 -0.85 16.93 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.389 -0.819 . . . . 0.02 112.748 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.9 m80 60.1 33.24 21.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.748 -1.22 . . . . 0.02 109.483 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 mt -112.42 135.67 52.84 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.802 -0.814 . . . . 0.02 108.802 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -92.3 -23.14 19.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.313 -0.867 . . . . 5.32 110.365 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -148.92 163.57 37.08 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.151 -0.968 . . . . 0.02 109.957 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.423 HD12 HG21 ' A' ' 126' ' ' ILE . 52.2 mt -131.6 129.43 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 107.473 -1.306 . . . . 2.17 107.473 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -107.82 -13.26 15.04 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.25 -0.906 . . . . 0.02 113.171 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.5 OUTLIER -153.87 152.1 30.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.355 -1.466 . . . . 0.01 108.206 178.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.2 t -160.72 145.04 13.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.29 -1.506 . . . . 1.22 109.651 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -120.86 108.82 14.38 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.099 0.952 . . . . 1.41 108.714 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.12 120.68 59.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 105.771 -1.937 . . . . 0.01 105.771 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 t -146.43 68.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 118.209 -1.397 . . . . 1.98 108.341 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.62 108.75 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.563 -1.643 . . . . 0.01 106.563 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.89 -174.16 40.52 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.693 -1.363 . . . . 0.01 109.693 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 m -111.62 144.88 40.16 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.37 -1.076 . . . . 2.3 109.12 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -129.69 146.47 51.46 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.537 -0.727 . . . . 0.01 110.263 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.2 mt -118.0 141.3 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.583 -1.266 . . . . 1.69 107.583 177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.1 143.66 44.43 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.77 -1.196 . . . . 2.49 107.77 177.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.5 m-85 -122.63 143.75 49.56 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.535 -0.728 . . . . 0.02 109.052 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -73.21 -29.61 62.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.514 -0.741 . . . . 0.02 111.98 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.31 153.54 47.48 Favored Pre-proline 0 N--CA 1.505 2.318 0 O-C-N 120.69 -1.256 . . . . 1.48 109.112 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.46 167.24 1.44 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.376 1.384 . . . . 0.02 112.565 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.34 31.14 20.91 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.246 -0.888 . . . . 0.75 111.058 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.65 51.65 9.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.641 -0.662 . . . . 0.02 110.943 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -125.02 163.8 21.55 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.567 -0.708 . . . . 0.02 109.809 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.83 -165.55 32.07 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.878 -1.289 . . . . 0.02 109.878 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -67.7 141.77 56.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.555 -0.968 . . . . 0.02 108.784 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -118.15 148.75 42.03 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.308 -0.627 . . . . 0.02 109.308 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.95 142.45 50.93 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.477 -0.764 . . . . 0.01 109.007 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.37 121.37 38.1 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.302 -0.874 . . . . 0.01 109.297 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.1 mt -105.27 136.62 44.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.37 -0.831 . . . . 0.01 110.616 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 154' ' ' LYS . 48.1 t0 -109.88 171.99 7.12 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.127 -1.064 . . . . 2.27 108.127 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -57.87 84.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.994 -1.066 . . . . 1.84 108.796 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 152' ' ' ASP . 53.8 mttm -136.19 168.78 18.76 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.245 -0.909 . . . . 2.28 111.62 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -112.88 110.61 20.8 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.001 -1.111 . . . . 0.01 108.001 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -100.72 116.52 32.81 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.069 -1.019 . . . . 0.01 110.171 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.457 ' O ' ' OG ' ' A' ' 128' ' ' SER . 25.4 ptt180 -92.44 -25.21 18.57 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.251 -0.906 . . . . 0.01 111.525 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -126.32 153.38 74.68 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 120.845 -1.159 . . . . 2.54 108.658 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -60.71 -42.19 40.98 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 119.265 0.773 . . . . 0.7 110.446 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.36 -20.43 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.696 -1.253 . . . . 0.86 108.571 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -65.75 -16.46 63.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.92 -1.113 . . . . 0.02 109.561 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -94.88 9.76 37.96 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.873 -1.158 . . . . 0.02 107.873 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.64 10.73 85.76 Favored Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.341 -1.409 . . . . 0.02 109.761 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.06 142.23 31.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.463 -1.022 . . . . 0.02 110.194 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.38 -8.23 59.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.773 -0.579 . . . . 0.59 109.856 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.4 m -144.68 150.91 48.55 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 120.88 -1.137 . . . . 0.87 108.708 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.19 21.67 0.52 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.708 0.939 . . . . 0.38 112.233 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.02 123.91 29.91 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.455 1.122 . . . . 0.18 111.702 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.5 mt -146.47 126.24 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.799 -1.556 . . . . 3.99 106.799 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -112.24 -19.87 12.08 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.074 -1.016 . . . . 5.17 112.896 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 28.4 t -157.29 160.0 38.14 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 119.174 -2.204 . . . . 0.02 110.357 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.425 ' N ' ' HG ' ' A' ' 171' ' ' SER . 11.5 p90 -153.01 154.25 34.56 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 2.02 110.589 178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -144.44 151.19 38.86 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.169 -0.957 . . . . 0.01 110.566 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -87.95 143.46 27.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.409 -0.807 . . . . 0.01 109.232 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.0 mt -93.73 128.65 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.052 -1.03 . . . . 3.04 109.221 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.86 146.69 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.42 -0.8 . . . . 1.89 109.535 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 4.89 109.528 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.42 -0.585 . . . . 5.28 109.42 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -66.43 -134.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 5.96 109.206 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.6 p -99.5 111.6 23.93 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.754 -1.573 . . . . 2.22 106.754 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.29 95.53 0.1 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 106.565 -2.614 . . . . 0.81 106.565 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.68 147.47 33.93 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.42 -1.072 . . . . 0.01 110.42 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -152.62 137.44 17.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.586 -0.949 . . . . 0.02 109.488 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.2 tt -130.27 141.12 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.223 0.535 . . . . 0.02 109.828 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t -121.75 130.27 53.3 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.39 -0.819 . . . . 0.39 109.972 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 m-85 -110.25 139.6 45.25 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.543 -0.723 . . . . 0.02 109.378 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.2 m-85 -121.76 137.94 54.57 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.282 -0.886 . . . . 0.02 109.557 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -69.58 -27.53 65.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -0.999 . . . . 0.03 111.733 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.4 170.68 8.12 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.848 -1.158 . . . . 0.03 110.087 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -74.93 161.16 29.76 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.749 0.785 . . . . 0.03 110.26 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 12.9 t-20 62.4 35.06 15.14 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.894 0.854 . . . . 0.74 110.551 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 19.6 p90 49.41 43.39 23.42 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.381 -0.827 . . . . 0.02 110.906 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -109.39 165.48 11.61 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.698 -1.223 . . . . 0.02 107.698 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.8 -167.61 33.62 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.785 -1.198 . . . . 0.03 110.63 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -69.47 143.81 53.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.361 -1.082 . . . . 2.76 109.032 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -122.96 150.51 42.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.63 -0.669 . . . . 1.89 110.164 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -137.18 134.05 35.89 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.367 -0.605 . . . . 0.02 109.367 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -109.53 135.57 50.31 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.961 -0.755 . . . . 1.12 108.961 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.7 t -127.73 137.65 52.52 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.588 -0.695 . . . . 0.02 109.327 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -118.84 11.99 12.79 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.64 -0.662 . . . . 0.2 110.377 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 46.3 t -159.85 173.62 15.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.77 -1.206 . . . . 1.23 109.186 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.562 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.9 p30 -63.35 146.26 53.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.794 -1.191 . . . . 0.02 110.829 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.6 m -134.01 117.48 16.73 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.691 -0.855 . . . . 0.02 108.691 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.484 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.19 -20.46 55.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.466 -0.771 . . . . 0.24 111.793 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.57 105.87 3.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.901 -1.124 . . . . 1.14 109.25 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.68 5.23 43.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 6.37 110.243 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -62.15 -29.6 70.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.448 -0.782 . . . . 3.11 112.495 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -77.34 -18.59 57.29 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.224 -1.548 . . . . 0.88 111.687 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -106.43 -19.96 13.52 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.305 -0.872 . . . . 0.02 110.423 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -149.05 127.44 12.23 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.019 -1.051 . . . . 3.32 109.457 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -87.27 -12.97 45.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.549 -0.72 . . . . 0.02 111.004 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -172.8 162.08 4.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.02 108.477 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.4 p -142.61 115.21 8.57 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.021 -1.05 . . . . 0.02 108.851 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.433 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.7 m-80 -106.8 -2.77 21.11 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.737 -1.227 . . . . 0.03 111.44 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 t -152.98 153.51 33.09 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.884 -1.154 . . . . 0.02 107.884 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -147.01 147.35 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.858 -1.151 . . . . 0.02 110.725 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -125.12 125.55 43.92 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.972 -1.122 . . . . 0.02 107.972 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -105.9 114.95 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.643 -1.614 . . . . 0.02 106.643 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -85.57 -34.31 21.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 3.81 109.968 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.37 150.52 19.33 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.512 -1.804 . . . . 0.02 110.696 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.68 171.78 48.34 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.486 -1.046 . . . . 0.01 110.486 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.5 m -118.16 133.35 55.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.579 -1.267 . . . . 1.48 107.579 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 43.8 m95 -126.3 154.68 43.11 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.812 -1.18 . . . . 0.02 112.14 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.24 133.96 52.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.253 -2.129 . . . . 0.24 105.253 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.21 144.0 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.656 -0.653 . . . . 0.65 109.405 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.555 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 43.6 m-85 -120.93 145.15 48.0 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.095 0.95 . . . . 0.02 109.887 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -66.97 -33.35 75.38 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.975 -0.557 . . . . 0.02 111.914 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -123.7 158.2 60.24 Favored Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 120.978 -1.076 . . . . 0.02 109.598 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.36 164.98 1.69 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.591 1.527 . . . . 0.02 112.764 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 64.07 37.17 9.3 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.452 -0.795 . . . . 0.02 111.189 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 44.88 51.26 8.64 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.559 0.695 . . . . 3.39 110.738 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.5 t -125.93 163.59 22.63 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.179 0.514 . . . . 2.33 109.745 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.92 -161.74 30.8 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.877 -1.289 . . . . 0.02 109.877 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -65.84 140.6 58.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.081 -1.246 . . . . 0.02 110.348 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.555 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 52.4 ttp -118.65 138.3 52.7 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.639 -0.663 . . . . 5.01 109.956 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.508 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 48.3 m-85 -134.45 137.39 43.93 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.409 -0.807 . . . . 0.02 109.748 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.0 mm -95.28 131.25 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.579 -0.897 . . . . 1.72 108.579 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.9 mt -120.5 111.52 34.78 Favored Pre-proline 0 N--CA 1.504 2.266 0 O-C-N 121.31 -0.869 . . . . 0.02 110.985 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.02 168.97 21.22 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 119.853 0.983 . . . . 1.47 110.117 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -53.67 140.7 28.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.774 -1.204 . . . . 4.25 110.502 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.37 -177.21 32.67 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.586 -1.293 . . . . 0.02 110.636 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -118.95 130.63 55.81 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.352 -1.087 . . . . 0.96 109.808 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -120.64 97.11 48.73 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.004 -1.11 . . . . 0.02 108.004 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.45 -3.94 12.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 120.708 0.939 . . . . 0.02 113.52 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -157.38 153.96 28.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.651 -1.28 . . . . 2.02 107.988 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -59.76 -38.17 81.07 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.456 -0.777 . . . . 0.02 111.787 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -60.78 -23.85 65.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.061 -1.025 . . . . 0.02 110.433 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -70.1 -18.28 63.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.339 -0.851 . . . . 3.42 108.89 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.546 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.55 10.46 27.15 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.482 -1.303 . . . . 0.02 107.482 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.1 mtt 61.13 21.55 11.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.621 -0.674 . . . . 0.02 110.539 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.45 144.49 45.63 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.307 -1.517 . . . . 0.02 109.307 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.45 -31.1 42.45 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.743 -1.206 . . . . 0.98 107.743 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -157.48 -172.21 3.89 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.443 -1.688 . . . . 0.02 106.443 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 3.7 p-10 -98.1 28.49 3.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.708 -1.245 . . . . 0.02 110.672 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HG3' HH11 ' A' ' 78' ' ' ARG . 26.5 ttm-85 -97.84 122.48 41.0 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.851 -1.156 . . . . 3.2 111.142 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.5 mt -142.34 120.13 11.91 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.652 -1.24 . . . . 2.61 107.652 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.32 -18.1 10.72 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 121.309 -0.87 . . . . 0.02 112.183 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.6 m -155.67 155.67 33.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.212 -1.758 . . . . 0.02 110.505 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.4 p -145.23 147.67 32.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.807 -0.558 . . . . 0.02 109.74 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -137.64 142.09 41.19 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.39 -0.819 . . . . 0.01 109.159 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.94 133.13 36.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.13 -0.981 . . . . 0.43 109.391 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.03 124.41 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.89 -0.781 . . . . 1.25 108.89 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -92.4 131.54 37.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.859 -1.15 . . . . 1.77 108.582 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.55 138.98 33.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.183 -1.043 . . . . 1.63 108.183 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.8 p -111.05 126.56 54.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.351 -0.843 . . . . 1.08 108.878 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.2 t -103.32 -154.33 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.184 -1.784 . . . . 1.26 106.184 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.19 -50.96 0.83 Allowed Glycine 0 N--CA 1.499 2.88 0 O-C-N 120.49 -1.381 . . . . 0.01 112.214 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.74 -100.14 0.14 Allowed Glycine 0 N--CA 1.487 2.091 0 C-N-CA 118.845 -1.645 . . . . 0.01 111.905 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -120.26 119.53 33.46 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.23 -1.159 . . . . 4.43 110.386 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.61 136.93 56.31 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.226 -0.59 . . . . 2.99 109.586 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -136.01 131.16 34.64 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-O 122.205 1.003 . . . . 6.36 112.93 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.1 143.35 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-N 115.584 -0.734 . . . . 1.09 110.365 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.507 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 1.3 pt20 -124.8 139.52 53.76 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 107.493 -1.299 . . . . 2.05 107.493 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.0 m -123.99 145.86 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.548 -1.345 . . . . 1.1 110.971 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -120.68 140.16 52.0 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.302 1.049 . . . . 0.73 110.876 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.2 tm-20 -68.36 -32.54 72.69 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.587 -0.733 . . . . 0.02 111.81 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -114.0 167.46 10.64 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.043 -1.035 . . . . 3.18 110.306 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.24 163.52 52.67 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.815 -0.914 . . . . 0.01 110.815 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 58.2 38.51 26.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.98 -0.718 . . . . 0.01 111.567 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 52.16 55.41 9.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.01 111.245 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -128.51 164.53 22.59 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.93 -1.137 . . . . 3.15 107.93 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.67 -162.39 29.05 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.013 -1.635 . . . . 0.01 109.013 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.405 ' OE1' ' OH ' ' A' ' 108' ' ' TYR . 9.4 tt0 -75.54 141.18 43.04 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.842 -1.387 . . . . 0.01 109.154 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 107' ' ' MET . 0.8 OUTLIER -116.26 143.07 46.0 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.48 0.657 . . . . 0.01 109.42 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.405 ' OH ' ' OE1' ' A' ' 106' ' ' GLN . 53.6 m-85 -132.36 136.16 46.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.22 -1.03 . . . . 2.48 108.22 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.482 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.2 tm-20 -116.4 134.1 55.26 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.735 -0.603 . . . . 0.01 109.5 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.482 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 11.9 t -149.3 148.04 29.07 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.491 1.138 . . . . 1.69 111.216 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.5 p -115.09 7.56 15.46 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.017 -0.992 . . . . 0.01 109.924 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -121.97 163.31 19.55 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.504 -0.747 . . . . 3.21 111.194 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -70.25 155.05 41.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.833 . . . . 0.01 109.78 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.402 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 34.9 t -126.49 115.17 23.09 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 121.532 -0.73 . . . . 0.01 109.195 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.05 -33.13 4.76 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 120.339 1.157 . . . . 0.01 111.113 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.8 t -141.8 107.67 5.15 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.968 0.889 . . . . 0.02 108.832 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.09 -39.93 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.585 -0.697 . . . . 1.83 111.176 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.8 ttt -66.39 -37.47 85.31 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.078 -1.049 . . . . 1.34 109.593 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.59 -38.46 77.35 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.572 -1.33 . . . . 2.11 109.709 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -80.44 -47.24 14.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -0.906 . . . . 2.08 112.476 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -111.41 -0.7 16.2 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.235 -0.915 . . . . 0.02 112.653 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 60.08 33.41 21.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.755 -1.216 . . . . 0.02 109.648 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.42 135.51 53.03 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.793 -0.817 . . . . 0.02 108.793 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -92.71 -23.16 19.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.334 -0.854 . . . . 5.32 110.766 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -148.91 163.42 37.49 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.226 -0.922 . . . . 0.02 109.965 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.435 HD13 HG23 ' A' ' 126' ' ' ILE . 59.2 mt -131.97 129.72 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 107.576 -1.268 . . . . 2.17 107.576 178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -107.72 -13.53 15.0 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.21 -0.931 . . . . 0.02 113.243 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.95 153.52 31.18 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.277 -1.515 . . . . 0.01 108.24 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 7.4 t -161.35 147.39 14.24 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.286 -1.509 . . . . 1.22 109.9 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -121.76 108.66 13.77 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.989 0.9 . . . . 1.41 108.627 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 t -107.59 120.41 58.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 105.941 -1.874 . . . . 0.01 105.941 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 t -146.49 68.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 118.189 -1.404 . . . . 1.98 108.454 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.39 108.75 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 106.715 -1.587 . . . . 0.01 106.715 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.21 -173.27 43.1 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.978 -1.249 . . . . 0.01 109.978 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.2 m -112.02 143.73 42.54 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.283 -1.128 . . . . 2.3 109.221 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -129.69 145.72 51.51 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.461 -0.774 . . . . 0.01 110.336 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.0 mt -117.8 141.35 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 107.708 -1.219 . . . . 1.69 107.708 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.54 141.45 47.14 Favored 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 107.019 -1.474 . . . . 2.49 107.019 178.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 7.7 m-85 -122.73 145.71 48.16 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.437 -0.789 . . . . 0.02 109.197 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -74.12 -29.92 62.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.02 112.007 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.68 153.18 47.91 Favored Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 120.753 -1.217 . . . . 1.48 109.118 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.419 ' O ' ' NH1' ' A' ' 145' ' ' ARG . 1.2 Cg_endo -54.24 166.72 1.54 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.25 1.3 . . . . 0.02 112.791 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.2 t30 58.67 32.15 21.87 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.205 -0.907 . . . . 0.75 111.099 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 144' ' ' TYR . 1.0 OUTLIER 57.51 52.25 8.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.564 -0.71 . . . . 0.02 111.473 178.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.454 ' HG3' HH11 ' A' ' 145' ' ' ARG . 10.8 mtm-85 -124.5 163.14 22.49 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.52 -0.737 . . . . 0.02 109.597 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.2 -164.95 32.48 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.923 -1.271 . . . . 0.02 109.923 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -68.04 141.13 56.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.583 -0.951 . . . . 0.02 108.862 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -118.32 148.42 42.49 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.361 0.601 . . . . 0.02 109.438 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.5 141.97 51.22 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.465 -0.772 . . . . 0.01 108.977 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.0 tt -97.15 121.57 39.18 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.263 -0.898 . . . . 0.01 109.288 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.1 mt -105.22 133.91 49.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.426 -0.797 . . . . 0.01 110.536 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 32.2 t70 -109.41 175.76 5.33 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.346 -0.983 . . . . 2.27 108.346 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.18 84.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.974 -1.079 . . . . 1.84 108.528 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 48.6 tttp -136.61 165.45 25.85 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.343 -0.848 . . . . 2.28 111.461 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.484 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 27.1 mt-10 -111.1 108.4 18.09 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.033 -1.099 . . . . 0.01 108.033 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -98.93 114.82 27.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.002 -1.061 . . . . 0.01 110.241 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -93.26 -26.05 17.51 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.145 -0.972 . . . . 0.01 111.34 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -125.56 153.75 72.7 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 120.94 -1.1 . . . . 2.54 108.738 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.67 -43.35 32.79 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 119.145 0.73 . . . . 0.7 110.724 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.34 -20.72 21.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.728 -1.233 . . . . 0.86 108.632 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -65.67 -16.2 63.51 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.044 -1.035 . . . . 0.02 109.568 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.42 ' CZ3' ' CD1' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -94.91 9.76 38.06 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.026 -1.101 . . . . 0.02 108.026 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.02 10.43 86.26 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.259 -1.448 . . . . 0.02 109.693 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.56 142.22 31.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.482 -1.011 . . . . 0.02 110.145 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.46 -8.48 58.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.7 -0.625 . . . . 0.59 109.819 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 32.2 m -144.5 151.05 49.66 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.888 -1.133 . . . . 0.87 108.602 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.8 21.3 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 120.786 0.991 . . . . 0.38 112.294 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.06 122.69 28.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.525 1.155 . . . . 0.18 111.476 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.42 ' CD1' ' CZ3' ' A' ' 162' ' ' TRP . 56.4 mt -145.76 125.35 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.183 -1.784 . . . . 3.99 106.183 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -111.65 -19.34 12.52 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.024 -1.048 . . . . 5.17 113.094 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.2 t -157.05 160.49 38.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.328 -2.108 . . . . 0.02 110.2 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.402 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 11.6 p90 -151.55 152.25 32.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.116 -0.99 . . . . 2.02 110.272 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.419 ' CG ' ' CE1' ' A' ' 144' ' ' TYR . 7.1 mmm180 -143.34 149.81 38.29 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.388 -0.82 . . . . 0.01 110.033 -178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -88.56 143.46 26.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.464 -0.772 . . . . 0.01 109.566 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.11 128.25 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.136 -0.977 . . . . 3.04 109.123 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.9 t -136.01 146.48 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.223 -0.923 . . . . 1.89 109.496 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 4.89 109.508 179.995 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' LYS . 70.5 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.505 -0.554 . . . . 5.28 109.505 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 1' ' ' SER . 76.6 mttt 52.4 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 5.96 109.456 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -98.03 40.71 1.16 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.034 -1.041 . . . . 2.22 111.923 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.45 115.36 3.01 Favored Glycine 0 N--CA 1.503 3.139 0 N-CA-C 107.4 -2.28 . . . . 0.81 107.4 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.19 146.37 34.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.429 -1.468 . . . . 0.01 109.429 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -151.28 138.2 19.02 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.214 -1.168 . . . . 0.02 110.355 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 tt -130.13 138.33 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.055 -0.72 . . . . 0.02 109.055 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.532 ' HG ' ' HE ' ' A' ' 19' ' ' ARG . 5.5 t -120.72 130.59 54.13 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.468 -0.77 . . . . 0.39 110.058 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.6 m-85 -110.86 140.09 45.62 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.695 -0.628 . . . . 0.02 109.548 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.8 m-85 -122.51 138.61 54.51 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.219 -0.926 . . . . 0.02 109.362 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.41 -27.13 65.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.126 -0.984 . . . . 0.03 111.781 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -114.18 169.88 8.7 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.926 -1.109 . . . . 0.03 110.15 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -75.61 158.25 32.68 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.626 0.727 . . . . 0.03 110.074 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 66.22 33.18 7.46 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.899 0.857 . . . . 0.74 111.029 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.47 41.58 30.74 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.235 0.541 . . . . 0.02 111.212 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -113.02 166.09 11.74 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.321 -0.992 . . . . 0.02 108.321 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.48 -167.71 35.75 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.965 -1.112 . . . . 0.03 110.446 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -68.71 142.15 55.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.229 -1.159 . . . . 2.76 108.771 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' HE ' ' HG ' ' A' ' 8' ' ' SER . 1.6 tmt_? -122.75 149.37 44.19 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.653 -0.654 . . . . 1.89 110.013 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -135.93 133.02 37.19 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.685 -0.634 . . . . 0.02 109.656 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 2.2 p-10 -109.64 136.46 48.96 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.526 -0.733 . . . . 1.12 109.07 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 54.1 t -128.2 138.08 52.31 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.554 -0.716 . . . . 0.02 109.618 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -119.24 11.14 12.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.62 -0.675 . . . . 0.2 110.645 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 30.4 p -159.27 173.67 15.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.779 -1.201 . . . . 1.23 109.124 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.69 145.73 53.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.612 -1.305 . . . . 0.02 110.694 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.561 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 21.6 t -134.6 118.42 17.21 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.09 -0.708 . . . . 0.02 109.09 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.23 -20.95 54.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.373 -0.829 . . . . 0.24 111.444 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -155.31 105.68 2.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.797 -1.189 . . . . 1.14 109.707 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.63 8.81 41.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.388 -0.82 . . . . 6.37 109.922 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -60.55 -29.13 68.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -0.841 . . . . 3.11 111.978 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.8 m -76.45 -17.61 59.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.466 -1.396 . . . . 0.88 111.347 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -107.32 -20.24 13.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.374 -0.829 . . . . 0.02 110.539 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 tp -148.83 127.02 12.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.89 -1.131 . . . . 3.32 109.631 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.9 t -87.14 -12.58 46.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.615 -0.678 . . . . 0.02 111.37 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -171.82 161.91 6.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.73 -1.231 . . . . 0.02 108.364 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.91 116.62 8.71 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.972 -1.08 . . . . 0.02 109.043 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 1.9 m120 -109.41 0.41 19.37 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.671 -1.268 . . . . 0.03 111.862 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.1 t -156.39 154.38 30.41 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.274 -1.01 . . . . 0.02 108.274 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -146.14 146.91 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 122.328 1.061 . . . . 0.02 111.092 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -122.77 124.24 42.89 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.706 -1.22 . . . . 0.02 107.706 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -106.67 114.33 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 106.716 -1.587 . . . . 0.02 106.716 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.26 -34.38 23.84 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.348 -0.541 . . . . 3.81 110.554 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.19 149.99 18.26 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.102 -1.523 . . . . 0.02 110.682 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.31 172.54 49.13 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.374 -1.09 . . . . 0.01 110.374 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -118.24 134.05 55.36 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 107.81 -1.181 . . . . 1.48 107.81 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -126.47 154.89 43.11 Favored 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 122.587 1.184 . . . . 0.02 112.274 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.08 52.27 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.681 -1.97 . . . . 0.24 105.681 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.36 141.64 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -0.758 . . . . 0.65 109.298 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -120.52 143.07 48.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.158 0.98 . . . . 0.02 109.536 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' CD ' HH21 ' A' ' 78' ' ' ARG . 31.2 tt0 -65.35 -34.07 77.46 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.52 -0.764 . . . . 0.02 111.794 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -124.65 157.95 63.86 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.095 -1.003 . . . . 0.02 109.323 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.56 167.05 1.03 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.67 1.58 . . . . 0.02 112.623 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.1 t30 62.82 36.44 13.04 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.238 -0.892 . . . . 0.02 111.007 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.494 ' H ' ' HG ' ' A' ' 81' ' ' SER . 4.5 m-85 45.21 51.53 9.13 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.728 0.775 . . . . 3.39 110.72 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -125.37 163.26 22.98 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.234 0.54 . . . . 2.33 109.818 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.32 -161.34 31.31 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.426 ' ND1' ' OE1' ' A' ' 50' ' ' GLU . 10.9 m80 -65.35 138.54 58.23 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.89 -1.359 . . . . 0.02 110.251 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -119.58 137.16 54.02 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.773 -0.579 . . . . 5.01 109.505 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.486 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.4 m-85 -134.75 140.38 45.88 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.437 -0.789 . . . . 0.02 109.978 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.8 mm -94.49 130.74 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.863 -0.791 . . . . 1.72 108.863 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -121.22 110.95 34.02 Favored Pre-proline 0 N--CA 1.505 2.287 0 O-C-N 121.353 -0.842 . . . . 0.02 110.702 -178.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.67 169.79 20.25 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 CA-C-N 119.819 0.971 . . . . 1.47 110.423 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -53.19 141.7 22.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.023 -1.048 . . . . 4.25 110.413 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.92 -177.83 31.17 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.41 -1.376 . . . . 0.02 111.012 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -119.55 131.32 55.5 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.453 -1.028 . . . . 0.96 109.749 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 53.3 m-85 -122.42 96.03 46.37 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 107.823 -1.176 . . . . 0.02 107.823 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.52 -3.43 11.05 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.831 1.021 . . . . 0.02 113.876 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -157.39 154.22 28.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.548 -1.345 . . . . 2.02 108.098 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -59.7 -38.98 83.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.02 112.016 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -60.16 -23.76 64.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.149 -0.969 . . . . 0.02 110.417 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -70.18 -18.26 63.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 3.42 108.755 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.552 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.0 OUTLIER -108.26 10.78 27.69 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.56 -1.274 . . . . 0.02 107.56 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.6 mtt 61.65 22.73 13.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.02 110.546 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.12 144.57 48.64 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.81 -1.316 . . . . 0.02 109.81 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.05 -30.28 39.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -1.219 . . . . 0.98 107.88 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -157.03 -171.48 3.66 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.666 -1.605 . . . . 0.02 106.666 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.498 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 65.9 m-20 -98.66 28.34 4.3 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.64 -1.288 . . . . 0.02 110.847 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.49 HH21 ' CD ' ' A' ' 50' ' ' GLU . 27.7 mtm-85 -96.77 122.82 40.13 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.833 -1.167 . . . . 3.2 111.351 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.05 119.3 11.47 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 107.618 -1.253 . . . . 2.61 107.618 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.86 -18.53 9.32 Favored Glycine 0 N--CA 1.499 2.889 0 O-C-N 121.12 -0.988 . . . . 0.02 112.638 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 54' ' ' PHE . 6.4 p -156.16 156.69 34.66 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 119.628 1.714 . . . . 0.02 110.841 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 57.0 m -145.91 148.42 32.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.366 -0.834 . . . . 0.02 110.361 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -137.05 141.89 42.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.435 -0.791 . . . . 0.01 109.284 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 132.18 36.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.048 -1.033 . . . . 0.43 109.443 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 t -91.49 124.58 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.874 -0.787 . . . . 1.25 108.874 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -92.58 131.3 37.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.942 -1.099 . . . . 1.77 108.569 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mt -95.87 139.69 31.72 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.233 -1.025 . . . . 1.63 108.233 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.6 t -110.89 126.12 54.36 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.643 -0.873 . . . . 1.08 108.643 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.0 m -102.58 -154.91 0.5 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.069 -1.826 . . . . 1.26 106.069 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.23 -51.01 0.82 Allowed Glycine 0 N--CA 1.498 2.778 0 O-C-N 120.522 -1.361 . . . . 0.01 112.029 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.56 -99.85 0.13 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 118.683 -1.722 . . . . 0.01 112.121 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -120.17 120.37 35.97 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.202 -1.175 . . . . 4.43 110.723 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.2 137.58 57.09 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.362 -0.607 . . . . 2.99 109.362 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 32.6 ttmt -136.53 130.44 32.46 Favored 'General case' 0 N--CA 1.516 2.856 0 CA-C-O 122.155 0.979 . . . . 6.36 113.031 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -131.81 141.37 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-N 115.51 -0.768 . . . . 1.09 110.524 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 pt20 -124.45 139.78 53.57 Favored 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 107.485 -1.302 . . . . 2.05 107.485 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.83 146.07 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 O-C-N 120.734 -1.229 . . . . 1.1 111.038 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -120.73 139.96 52.34 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.046 0.927 . . . . 0.73 110.817 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -68.6 -32.47 72.38 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.688 -0.687 . . . . 0.02 112.025 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -114.27 165.35 12.78 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.855 -1.153 . . . . 3.18 110.087 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.29 163.41 45.75 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.973 -0.851 . . . . 0.01 110.973 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.428 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 9.5 m-20 57.29 38.86 28.8 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.541 0.686 . . . . 0.01 111.069 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.451 ' C ' HD21 ' A' ' 104' ' ' ASN . 19.8 m-85 52.65 56.23 7.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.534 -0.729 . . . . 0.01 111.087 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.451 HD21 ' C ' ' A' ' 103' ' ' PHE . 1.8 m-80 -128.59 164.93 21.78 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.998 -1.112 . . . . 3.15 107.998 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.93 -162.6 28.86 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.04 -1.624 . . . . 0.01 109.04 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -75.34 141.57 43.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.839 -1.389 . . . . 0.01 108.963 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' A' ' 107' ' ' MET . 9.3 tmm? -116.33 142.94 46.18 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.482 0.658 . . . . 0.01 109.431 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -132.44 136.55 46.81 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.348 -0.982 . . . . 2.48 108.348 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -116.35 134.15 55.22 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.713 -0.617 . . . . 0.01 109.615 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -149.1 147.92 29.07 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.522 1.153 . . . . 1.69 111.358 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.4 p -114.53 7.66 16.2 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.972 -1.013 . . . . 0.01 109.901 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -122.14 163.34 19.68 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.443 -0.786 . . . . 3.21 111.264 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 4.9 p30 -69.57 154.6 41.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.01 109.568 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.5 t -126.79 115.33 22.45 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.487 -0.758 . . . . 0.01 108.976 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.03 -32.69 5.14 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 120.4 1.179 . . . . 0.01 111.346 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.0 m -142.12 108.38 5.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.368 -0.833 . . . . 0.02 109.203 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.412 HD12 HG21 ' A' ' 117' ' ' ILE . 96.0 mt -64.22 -39.66 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.769 -0.582 . . . . 1.83 111.03 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.3 ttt -67.04 -37.79 84.72 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.141 -1.024 . . . . 1.34 109.835 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -69.59 -38.5 77.34 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.622 -1.299 . . . . 2.11 109.724 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -80.62 -47.4 14.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -0.919 . . . . 2.08 112.531 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -111.0 -0.72 16.58 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.291 -0.881 . . . . 0.02 112.727 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.3 m170 59.96 33.51 21.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.738 -1.226 . . . . 0.02 109.436 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.53 135.38 53.31 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.73 -0.841 . . . . 0.02 108.73 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -92.42 -23.03 19.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.288 -0.883 . . . . 5.32 110.605 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -148.8 163.64 36.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.163 -0.96 . . . . 0.02 109.934 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.432 HD13 HG22 ' A' ' 126' ' ' ILE . 55.4 mt -131.57 129.46 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 107.454 -1.313 . . . . 2.17 107.454 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -107.86 -13.21 15.04 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.216 -0.927 . . . . 0.02 113.142 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -154.1 152.11 30.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.432 -1.418 . . . . 0.01 108.251 178.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 7.3 t -161.77 145.12 12.25 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.212 -1.555 . . . . 1.22 109.56 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.447 ' HZ1' ' CB ' ' A' ' 155' ' ' GLU . 10.5 tttp -122.02 111.03 16.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.191 0.996 . . . . 1.41 108.861 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.14 121.96 63.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 105.733 -1.951 . . . . 0.01 105.733 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.7 t -146.27 64.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 117.996 -1.482 . . . . 1.98 108.955 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.2 tp10 176.67 109.67 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.485 -1.672 . . . . 0.01 106.485 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.16 -173.41 45.71 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.214 -1.154 . . . . 0.01 110.214 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.42 142.95 41.43 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.491 -1.006 . . . . 2.3 108.93 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -129.2 145.21 51.37 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.513 -0.742 . . . . 0.01 109.958 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.0 mt -118.2 142.09 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 107.743 -1.206 . . . . 1.69 107.743 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.2 143.25 45.13 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 107.515 -1.291 . . . . 2.49 107.515 177.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -122.56 143.65 49.6 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.107 -0.701 . . . . 0.02 109.107 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.45 -29.95 62.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.614 -0.679 . . . . 0.02 112.19 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.26 153.58 47.42 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 120.674 -1.266 . . . . 1.48 109.128 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.35 166.59 1.67 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.237 1.291 . . . . 0.02 112.492 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 59.67 31.54 20.95 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.166 -0.925 . . . . 0.75 111.127 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.482 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.8 m-85 57.62 51.51 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.513 -0.742 . . . . 0.02 111.066 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -124.97 163.81 21.49 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.484 -0.76 . . . . 0.02 109.886 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.68 -165.36 32.14 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.838 -1.305 . . . . 0.02 109.838 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -67.71 141.41 56.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.979 . . . . 0.02 108.81 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.63 148.37 42.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.246 -0.65 . . . . 0.02 109.246 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.442 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.04 143.07 50.75 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.808 -0.812 . . . . 0.01 108.808 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 tt -97.51 121.99 40.05 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.385 -0.822 . . . . 0.01 109.127 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.9 mt -104.3 135.63 45.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.01 110.311 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 154' ' ' LYS . 13.2 m-20 -108.05 173.36 6.36 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -58.68 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.992 -1.068 . . . . 1.84 108.614 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 152' ' ' ASP . 40.8 tttm -137.04 168.75 19.0 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.362 -0.836 . . . . 2.28 111.483 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 1.6 pm0 -112.61 111.37 22.13 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.213 -1.032 . . . . 0.01 108.213 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -100.68 116.03 31.62 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.053 -1.029 . . . . 0.01 110.059 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.448 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.9 ptm180 -92.78 -25.6 18.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.101 -0.999 . . . . 0.01 111.49 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -125.96 153.08 73.73 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.78 -1.2 . . . . 2.54 108.716 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.72 -42.2 40.75 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 119.271 0.775 . . . . 0.7 110.62 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.78 -20.22 21.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.706 -1.246 . . . . 0.86 108.508 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -65.65 -16.16 63.47 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.941 -1.099 . . . . 0.02 109.494 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.442 ' O ' ' CE2' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -95.11 9.68 38.67 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.881 -1.155 . . . . 0.02 107.881 178.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.53 11.07 85.5 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 119.295 -1.431 . . . . 0.02 109.659 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.96 142.24 31.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.44 -1.035 . . . . 0.02 110.174 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.44 -8.28 59.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.736 -0.603 . . . . 0.59 109.987 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.0 p -144.48 150.85 49.05 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.709 -1.244 . . . . 0.87 108.771 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -76.05 21.31 0.52 Allowed 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 120.818 1.012 . . . . 0.38 112.248 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.63 123.99 29.76 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.572 1.177 . . . . 0.18 111.739 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.2 mt -147.05 126.71 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 106.925 -1.509 . . . . 3.99 106.925 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -112.66 -19.52 12.02 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.132 -0.98 . . . . 5.17 112.826 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.1 p -158.4 161.44 37.53 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 119.242 -2.161 . . . . 0.02 110.216 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -153.03 154.6 35.24 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.182 -0.948 . . . . 2.02 110.576 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.482 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 25.5 mtp180 -143.84 150.54 38.63 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.086 -1.009 . . . . 0.01 110.314 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -87.74 142.72 27.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.622 -0.674 . . . . 0.01 109.268 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.5 mt -93.14 128.19 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.089 -1.007 . . . . 3.04 109.033 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.4 m -135.89 146.31 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.116 -0.99 . . . . 1.89 109.558 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 4.89 109.389 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.475 -0.565 . . . . 5.28 109.475 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.499 ' NZ ' ' CB ' ' A' ' 2' ' ' LYS . 8.9 mtmp? -61.6 103.17 0.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 5.96 109.517 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.2 m -99.07 112.11 24.33 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.288 -1.745 . . . . 2.22 106.288 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.47 95.24 0.1 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 106.57 -2.612 . . . . 0.81 106.57 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.91 147.9 34.14 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.322 -1.111 . . . . 0.01 110.322 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -152.37 138.59 18.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.354 -1.086 . . . . 0.02 109.769 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.4 139.52 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.194 -0.669 . . . . 0.02 109.194 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 t -122.08 130.96 53.72 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.464 -0.773 . . . . 0.39 110.301 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 m-85 -111.16 140.31 45.81 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.617 -0.677 . . . . 0.02 109.623 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.7 m-85 -121.8 138.54 54.33 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.296 -0.877 . . . . 0.02 109.368 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -68.99 -27.33 65.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.905 -1.122 . . . . 0.03 111.767 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -114.47 170.35 8.37 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.864 -1.147 . . . . 0.03 110.111 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -74.99 161.59 29.33 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.673 0.749 . . . . 0.03 110.137 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.608 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 6.0 t-20 62.42 34.97 15.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.907 0.86 . . . . 0.74 110.634 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.608 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 19.5 p90 49.68 43.31 24.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.307 -0.861 . . . . 0.02 111.057 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -109.43 165.71 11.43 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.73 -1.211 . . . . 0.02 107.73 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.41 -167.86 34.4 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 120.775 -1.203 . . . . 0.03 110.688 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -68.84 143.66 54.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.382 -1.069 . . . . 2.76 108.883 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 48.9 ttt180 -122.1 149.94 42.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.615 -0.678 . . . . 1.89 110.039 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -136.91 132.63 34.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.653 -0.654 . . . . 0.02 109.303 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -109.75 136.14 49.55 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.435 -0.79 . . . . 1.12 109.046 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.1 t -127.86 137.71 52.43 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.522 -0.736 . . . . 0.02 109.42 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -118.41 11.98 13.18 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.2 110.15 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 29.3 m -159.17 173.77 15.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.849 -1.157 . . . . 1.23 108.826 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 33.4 p30 -62.87 145.8 54.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.856 -1.152 . . . . 0.02 110.324 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 10.8 p -134.89 119.2 17.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.497 -0.752 . . . . 0.02 109.16 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.2 -20.97 47.02 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.257 -0.902 . . . . 0.24 112.297 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.48 106.28 3.1 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.702 -1.249 . . . . 1.14 110.175 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.512 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.1 6.46 40.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.341 -0.849 . . . . 6.37 110.046 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -61.21 -30.37 70.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 3.11 112.097 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.1 m -77.1 -17.52 58.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.308 -1.495 . . . . 0.88 110.965 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -106.66 -21.19 13.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.453 -0.78 . . . . 0.02 110.64 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -149.01 127.18 12.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.98 -1.075 . . . . 3.32 109.599 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.9 t -86.66 -12.2 49.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.531 -0.731 . . . . 0.02 111.176 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -172.0 161.73 5.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.867 -1.146 . . . . 0.02 108.357 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.5 t -143.19 116.59 9.07 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.914 -1.116 . . . . 0.02 108.936 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -109.33 0.29 19.43 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.831 -1.168 . . . . 0.03 111.608 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 66' ' ' TYR . 31.1 t -156.92 154.72 30.2 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.508 -0.923 . . . . 0.02 108.508 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.1 147.0 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 122.232 1.015 . . . . 0.02 110.79 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -122.21 123.67 42.03 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.847 -1.168 . . . . 0.02 107.847 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 t -106.52 113.75 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 106.746 -1.576 . . . . 0.02 106.746 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -83.95 -34.12 24.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.17 -0.612 . . . . 3.81 110.412 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.94 150.63 19.76 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 119.052 -1.546 . . . . 0.02 110.525 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.32 172.08 48.72 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.871 -1.157 . . . . 0.01 110.502 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.7 m -118.48 134.72 54.85 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.69 -1.226 . . . . 1.48 107.69 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.0 m95 -127.58 155.01 44.51 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.601 1.191 . . . . 0.02 112.118 -176.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.38 134.26 52.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 105.518 -2.03 . . . . 0.24 105.518 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.02 143.48 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.523 -0.736 . . . . 0.65 109.374 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -120.69 144.67 48.09 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.165 0.983 . . . . 0.02 110.06 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' OE2' ' ND1' ' A' ' 57' ' ' HIS . 21.0 tt0 -65.95 -33.09 75.02 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.798 -0.637 . . . . 0.02 111.505 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -124.62 158.1 63.25 Favored Pre-proline 0 N--CA 1.503 2.219 0 O-C-N 120.993 -1.067 . . . . 0.02 109.419 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.61 166.68 1.19 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.692 1.595 . . . . 0.02 112.772 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.56 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 63.31 36.62 11.57 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.464 -0.789 . . . . 0.02 110.934 178.211 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.46 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 6.5 m-85 45.23 51.74 9.05 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.612 0.72 . . . . 3.39 110.749 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.53 ' HG ' ' N ' ' A' ' 56' ' ' GLY . 27.1 t -125.99 163.61 22.63 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.208 0.528 . . . . 2.33 109.883 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.53 ' N ' ' HG ' ' A' ' 55' ' ' SER . . . 88.7 -161.9 31.21 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.705 -1.358 . . . . 0.02 109.705 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.457 ' ND1' ' OE2' ' A' ' 50' ' ' GLU . 14.0 m80 -64.34 138.87 58.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.922 -1.34 . . . . 0.02 110.122 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -118.77 137.16 53.56 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.337 0.589 . . . . 5.01 109.609 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.556 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.5 m-85 -134.73 139.34 45.11 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.459 -0.776 . . . . 0.02 109.912 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 60' ' ' ILE . 25.7 mm -95.51 130.97 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.11 -0.7 . . . . 1.72 109.11 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.5 mt -122.33 112.01 31.59 Favored Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.261 -0.9 . . . . 0.02 110.835 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.38 170.84 18.7 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 119.754 0.948 . . . . 1.47 110.03 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -52.28 140.79 20.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 4.25 110.243 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.39 -177.46 32.55 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.4 -1.381 . . . . 0.02 110.769 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -121.02 131.94 54.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.381 -1.07 . . . . 0.96 109.878 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.407 ' O ' ' OG ' ' A' ' 38' ' ' SER . 96.6 m-85 -122.27 97.79 44.89 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 107.768 -1.197 . . . . 0.02 107.768 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.08 -2.23 10.78 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.79 0.994 . . . . 0.02 113.694 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -157.32 153.94 28.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.734 -1.228 . . . . 2.02 108.156 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -59.96 -39.68 86.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.478 -0.764 . . . . 0.02 111.778 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -59.73 -23.88 63.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.02 110.35 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -70.87 -18.49 62.69 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.926 0.869 . . . . 3.42 108.937 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.556 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.72 10.08 28.97 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.376 -1.342 . . . . 0.02 107.376 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.6 mtt 61.04 22.4 12.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.593 -0.692 . . . . 0.02 110.518 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.93 144.45 46.56 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.571 -1.412 . . . . 0.02 109.571 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -79.42 -30.8 42.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.699 -1.222 . . . . 0.98 107.699 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 11.7 p-10 -157.03 -171.65 3.72 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.35 -1.722 . . . . 0.02 106.35 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -98.61 28.74 4.04 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.652 -1.28 . . . . 0.02 110.591 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' ' 78' ' ' ARG . 25.5 ttm-85 -96.77 122.23 39.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.817 -1.177 . . . . 3.2 111.005 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.4 mt -141.9 119.37 11.62 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.606 -1.257 . . . . 2.61 107.606 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.4 -18.34 9.78 Favored Glycine 0 N--CA 1.501 3.026 0 O-C-N 121.129 -0.982 . . . . 0.02 112.579 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.1 p -156.48 156.81 34.37 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 119.502 1.651 . . . . 0.02 110.451 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.4 m -145.38 148.26 33.17 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.623 -0.673 . . . . 0.02 109.846 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.46 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 51.1 mtp180 -137.48 141.98 41.52 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.193 -0.942 . . . . 0.01 109.283 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 133.18 36.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.237 -0.915 . . . . 0.43 109.679 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.74 123.66 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.112 -1.07 . . . . 1.25 108.112 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -94.92 133.29 38.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.131 . . . . 1.77 108.956 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.57 134.14 37.44 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.714 -1.217 . . . . 1.63 107.714 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m -106.79 130.27 54.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.501 -0.749 . . . . 1.08 109.988 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.4 p -115.3 100.53 8.19 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 102.749 -3.056 . . . . 1.26 102.749 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -119.74 -60.84 0.26 Allowed Glycine 0 N--CA 1.51 3.623 0 N-CA-C 110.069 -1.212 . . . . 0.01 110.069 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.13 -107.82 1.32 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.353 -1.499 . . . . 0.01 109.353 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.4 ' CG ' ' H ' ' A' ' 93' ' ' ALA . 9.2 tt0 -120.55 -141.01 0.34 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.679 -0.895 . . . . 4.43 109.213 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.4 ' H ' ' CG ' ' A' ' 92' ' ' GLN . . . -126.5 119.73 27.91 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.23 -1.026 . . . . 2.99 108.23 177.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -144.1 121.98 12.0 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.416 -1.427 . . . . 6.36 113.28 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.3 tt -130.71 138.09 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.435 0.636 . . . . 1.09 109.681 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.483 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.6 pt20 -123.84 138.76 54.44 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.418 -1.327 . . . . 2.05 107.418 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.61 146.21 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.687 -1.258 . . . . 1.1 110.658 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -119.77 141.7 49.23 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.215 1.007 . . . . 0.73 111.385 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.32 -33.02 72.5 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.783 -0.644 . . . . 0.02 111.358 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.8 mmmt -114.38 167.91 10.31 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.122 -0.986 . . . . 3.18 109.66 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.68 168.89 45.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 111.169 -0.772 . . . . 0.01 111.169 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 53.53 39.51 30.14 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.511 0.672 . . . . 0.01 111.598 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 52.48 48.45 22.56 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.707 -0.621 . . . . 0.01 110.934 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -121.67 164.22 17.7 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.332 -0.988 . . . . 3.15 108.332 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.69 -163.09 29.48 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.042 -1.623 . . . . 0.01 109.042 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.5 141.58 43.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.798 -1.413 . . . . 0.01 109.199 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.458 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.6 tmm? -116.24 143.79 45.06 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.479 0.657 . . . . 0.01 109.595 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.44 136.44 46.73 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.387 -0.968 . . . . 2.48 108.387 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -117.36 133.94 55.4 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.576 -0.703 . . . . 0.01 109.771 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.428 ' HG1' ' N ' ' A' ' 111' ' ' THR . 8.4 t -149.58 149.2 30.33 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.481 1.134 . . . . 1.69 111.329 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.428 ' N ' ' HG1' ' A' ' 110' ' ' THR . 28.7 p -114.74 7.96 16.01 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.057 -0.974 . . . . 0.01 110.334 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 23.9 mp0 -121.62 163.16 19.41 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.345 -0.847 . . . . 3.21 111.018 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.6 p30 -69.46 154.91 41.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.479 -0.763 . . . . 0.01 109.451 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.4 t -127.31 115.17 21.5 Favored Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 109.13 -0.692 . . . . 0.01 109.13 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.4 -31.44 5.72 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 120.295 1.141 . . . . 0.01 111.429 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.3 m -142.46 107.86 5.03 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.385 -0.822 . . . . 0.02 108.989 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.07 -39.92 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.783 -0.573 . . . . 1.83 111.066 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.44 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 15.1 tpt -66.43 -37.4 85.11 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.167 -1.013 . . . . 1.34 109.766 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -70.15 -38.42 75.47 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.584 -1.322 . . . . 2.11 109.791 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -80.56 -47.4 14.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.179 -0.951 . . . . 2.08 112.354 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -111.04 -0.81 16.52 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.329 -0.857 . . . . 0.02 112.852 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.3 m80 59.6 33.53 22.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.732 -1.23 . . . . 0.02 109.525 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.44 ' C ' ' SD ' ' A' ' 118' ' ' MET . 6.4 mt -112.4 135.45 53.08 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 108.703 -0.851 . . . . 0.02 108.703 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -92.12 -23.01 19.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 5.32 110.633 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -149.15 163.6 37.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.078 -1.014 . . . . 0.02 110.101 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 126' ' ' ILE . 57.5 mt -132.25 129.55 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 107.475 -1.305 . . . . 2.17 107.475 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -107.65 -12.12 15.31 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.159 -0.963 . . . . 0.02 113.13 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -156.7 154.12 29.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.467 -1.396 . . . . 0.01 107.759 178.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.9 t -161.48 146.0 13.24 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.877 -1.139 . . . . 1.22 109.639 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -121.86 109.56 14.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.374 1.083 . . . . 1.41 108.949 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.53 122.18 64.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 106.408 -1.701 . . . . 0.01 106.408 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.63 68.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 118.639 -1.225 . . . . 1.98 107.802 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 174.13 105.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.705 -1.591 . . . . 0.01 106.705 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.11 -177.07 46.04 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.548 -1.421 . . . . 0.01 109.548 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.8 m -109.55 143.73 38.82 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.442 -1.034 . . . . 2.3 108.659 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -128.56 145.34 51.16 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.474 -0.767 . . . . 0.01 110.49 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.4 mt -116.56 140.29 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 107.504 -1.295 . . . . 1.69 107.504 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -112.89 141.7 46.42 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 107.577 -1.268 . . . . 2.49 107.577 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 15.3 m-85 -121.99 143.54 49.42 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.008 -0.738 . . . . 0.02 109.008 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 140' ' ' GLU . 3.2 tm-20 -73.32 -29.74 62.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.02 112.001 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -114.76 153.92 46.86 Favored Pre-proline 0 N--CA 1.508 2.457 0 O-C-N 120.593 -1.317 . . . . 1.48 109.332 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.47 166.27 1.91 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.13 1.22 . . . . 0.02 112.44 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 59.97 31.1 20.51 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.178 -0.919 . . . . 0.75 111.138 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 58.0 51.53 8.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.553 -0.717 . . . . 0.02 111.044 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -124.95 163.69 21.74 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.551 -0.718 . . . . 0.02 109.76 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.93 -165.28 31.76 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.804 -1.318 . . . . 0.02 109.804 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -67.86 141.97 56.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -1.004 . . . . 0.02 108.831 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.462 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.3 mp0 -118.57 149.42 41.37 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.509 -0.552 . . . . 0.02 109.509 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.49 141.89 51.25 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.536 -0.727 . . . . 0.01 109.263 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.7 tp -94.61 119.91 34.01 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.826 -0.805 . . . . 0.01 108.826 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.7 mt -106.67 136.22 46.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.44 -0.788 . . . . 0.01 110.781 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 154' ' ' LYS . 16.3 t0 -110.42 171.35 7.51 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.21 -1.033 . . . . 2.27 108.21 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 pttm -55.74 86.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.0 -1.063 . . . . 1.84 108.605 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 152' ' ' ASP . 56.0 mttp -136.27 168.6 19.11 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.096 -1.003 . . . . 2.28 111.423 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 18.9 mp0 -112.99 109.7 19.28 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.129 -1.063 . . . . 0.01 108.129 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -101.05 115.05 29.57 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.019 -1.05 . . . . 0.01 110.448 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -92.19 -25.65 18.57 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.083 -1.011 . . . . 0.01 111.324 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -126.2 153.53 74.36 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.797 -1.189 . . . . 2.54 108.54 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.04 -42.61 35.33 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 CA-C-N 119.313 0.791 . . . . 0.7 110.644 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.6 t -60.24 -20.71 20.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.637 -1.29 . . . . 0.86 108.669 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -65.87 -15.95 63.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.888 -1.132 . . . . 0.02 109.609 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.83 9.55 38.69 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.08 10.56 86.2 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.349 -1.405 . . . . 0.02 109.784 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.54 142.13 31.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.455 -1.027 . . . . 0.02 110.194 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.62 -8.41 58.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.66 -0.65 . . . . 0.59 109.767 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.9 p -144.49 150.98 49.52 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.947 -1.095 . . . . 0.87 108.544 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -76.15 21.56 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.738 0.958 . . . . 0.38 112.4 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.14 123.89 29.97 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.592 1.187 . . . . 0.18 111.92 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.0 mt -146.08 125.22 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 106.38 -1.711 . . . . 3.99 106.38 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -111.21 -20.26 12.39 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.154 -0.966 . . . . 5.17 112.988 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.7 p -157.89 160.17 37.36 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 119.423 -2.048 . . . . 0.02 109.871 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -152.81 154.59 35.47 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.095 -1.003 . . . . 2.02 110.426 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -144.33 151.63 39.61 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.25 -0.906 . . . . 0.01 110.712 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -88.27 144.88 26.16 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.168 -0.679 . . . . 0.01 109.168 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -95.63 128.58 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.165 -0.959 . . . . 3.04 109.403 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 177' ' ' GLU . 17.4 m -136.81 146.6 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.229 -0.92 . . . . 1.89 109.304 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 176' ' ' VAL . 16.1 pt-20 . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.891 -0.506 . . . . 4.89 110.808 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.0 t . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.419 -0.586 . . . . 5.28 109.419 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.466 ' O ' ' OG1' ' A' ' 3' ' ' THR . 43.8 mttm -70.7 62.91 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 5.96 109.424 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 50.2 m -173.88 158.39 3.19 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.824 -1.173 . . . . 2.22 108.265 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.79 177.76 47.62 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 118.619 -1.753 . . . . 0.81 111.806 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.47 156.9 43.58 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.107 -1.597 . . . . 0.01 109.107 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -149.06 136.99 20.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.015 -1.285 . . . . 0.02 110.255 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 tt -130.43 140.67 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.136 -0.69 . . . . 0.02 109.136 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 t -121.47 130.23 53.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.427 -0.795 . . . . 0.39 110.146 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.51 140.42 44.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.647 -0.658 . . . . 0.02 109.361 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -121.92 138.26 54.48 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.189 -0.944 . . . . 0.02 109.493 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -69.47 -27.42 65.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.892 -1.13 . . . . 0.03 111.672 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -113.89 169.86 8.69 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.801 -1.187 . . . . 0.03 110.241 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -75.62 158.42 32.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.509 0.671 . . . . 0.03 110.174 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 43.8 t30 65.78 35.37 6.83 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.883 0.849 . . . . 0.74 110.759 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.602 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.99 44.62 25.57 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.682 0.754 . . . . 0.02 111.26 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -112.58 165.67 12.04 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.975 -1.12 . . . . 0.02 107.975 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.09 -167.57 34.57 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.789 -1.196 . . . . 0.03 110.563 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -69.14 142.64 54.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -1.06 . . . . 2.76 109.073 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -122.3 150.13 42.77 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.455 -0.778 . . . . 1.89 110.152 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -136.53 133.12 36.14 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.665 -0.647 . . . . 0.02 109.351 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -109.37 135.74 49.93 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.772 -0.825 . . . . 1.12 108.772 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -127.44 138.02 52.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.588 -0.695 . . . . 0.02 109.516 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -118.81 12.14 12.86 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.598 -0.689 . . . . 0.2 110.305 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 39.0 t -159.94 173.79 15.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.771 -1.206 . . . . 1.23 109.079 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 4.9 p-10 -63.29 146.36 53.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.805 -1.184 . . . . 0.02 110.652 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.9 m -133.45 117.34 17.09 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.725 -0.843 . . . . 0.02 108.725 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.3 -20.26 55.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.477 -0.764 . . . . 0.24 111.806 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 25.4 p-10 -152.85 106.28 3.04 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.887 -1.133 . . . . 1.14 109.287 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.76 5.21 41.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.473 -0.767 . . . . 6.37 110.427 -178.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -62.46 -29.42 70.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 3.11 112.65 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -77.05 -18.42 58.09 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.159 -1.588 . . . . 0.88 111.797 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -107.25 -19.52 13.57 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.313 -0.867 . . . . 0.02 110.438 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.4 tp -148.73 126.91 12.1 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.927 -1.108 . . . . 3.32 109.467 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 t -87.43 -13.07 44.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.538 -0.726 . . . . 0.02 111.362 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -172.55 161.73 5.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.819 -1.176 . . . . 0.02 108.5 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.6 p -143.86 116.59 8.72 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.194 -0.941 . . . . 0.02 108.85 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.553 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.0 OUTLIER -108.38 -0.06 20.85 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.744 -1.223 . . . . 0.03 111.314 -178.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 t -155.9 153.85 30.31 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.723 -1.214 . . . . 0.02 107.723 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.1 mt -146.81 147.97 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.253 1.025 . . . . 0.02 110.727 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -123.49 125.04 44.2 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.95 -1.13 . . . . 0.02 107.95 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.59 114.02 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 106.663 -1.606 . . . . 0.02 106.663 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -85.36 -34.72 21.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.628 -0.67 . . . . 3.81 110.277 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.31 148.9 16.52 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.52 -1.8 . . . . 0.02 110.72 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.89 172.33 48.7 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.284 -1.126 . . . . 0.01 110.284 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.3 m -118.58 134.95 54.71 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.529 -1.285 . . . . 1.48 107.529 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -127.17 154.28 44.99 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.703 1.239 . . . . 0.02 112.305 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.95 134.28 51.82 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 105.176 -2.157 . . . . 0.24 105.176 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.16 144.32 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.578 -0.701 . . . . 0.65 109.512 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -120.78 144.68 48.17 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.083 0.944 . . . . 0.02 109.976 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.61 -33.45 75.69 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.833 -0.621 . . . . 0.02 111.925 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -123.75 158.12 60.63 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.069 -1.019 . . . . 0.02 109.521 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -52.9 164.7 1.48 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.503 1.468 . . . . 0.02 112.669 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 64.1 37.29 9.15 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.722 0.772 . . . . 0.02 111.299 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 45.1 51.6 8.87 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.689 0.757 . . . . 3.39 110.764 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -125.92 163.59 22.63 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.185 0.517 . . . . 2.33 109.811 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.71 -161.72 31.06 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.729 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -64.46 139.43 58.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.997 -1.296 . . . . 0.02 110.275 -178.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.3 ppp? -119.0 137.16 53.72 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.769 -0.582 . . . . 5.01 109.663 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.474 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.8 m-85 -134.92 139.32 44.87 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.434 -0.791 . . . . 0.02 110.197 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.6 mm -94.21 130.56 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.953 -0.758 . . . . 1.72 108.953 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 mt -120.95 111.13 34.35 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 121.251 -0.905 . . . . 0.02 110.887 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.15 169.86 19.62 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 CA-C-N 119.742 0.943 . . . . 1.47 110.184 177.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -52.94 141.03 23.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.894 -1.129 . . . . 4.25 110.388 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.82 -177.59 32.02 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.551 -1.309 . . . . 0.02 110.929 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -120.06 131.39 55.08 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.56 -0.964 . . . . 0.96 109.91 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -121.94 92.93 48.81 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 107.928 -1.138 . . . . 0.02 107.928 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.85 -4.13 6.83 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.003 1.135 . . . . 0.02 113.863 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -157.62 154.85 29.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.621 -1.299 . . . . 2.02 108.201 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -59.5 -39.37 83.59 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.445 -0.784 . . . . 0.02 112.092 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -59.81 -23.97 63.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.02 110.366 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.71 -18.68 62.81 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.75 0.785 . . . . 3.42 109.013 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.1 t90 -107.92 9.91 28.58 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.439 -1.319 . . . . 0.02 107.439 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.3 mtt 60.79 22.25 12.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.572 -0.705 . . . . 0.02 110.485 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.25 144.4 45.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.344 -1.502 . . . . 0.02 109.344 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.2 tp -78.74 -31.06 46.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.492 -1.299 . . . . 0.98 107.492 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.514 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 55.6 t30 -157.07 -171.16 3.53 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.389 -1.708 . . . . 0.02 106.389 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.514 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 2.9 p-10 -98.6 28.76 4.03 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.59 -1.319 . . . . 0.02 110.468 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -97.95 123.02 41.75 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.953 -1.092 . . . . 3.2 111.175 -178.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.8 mt -142.79 119.97 11.48 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.404 -1.332 . . . . 2.61 107.404 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.15 -17.91 11.04 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 121.123 -0.986 . . . . 0.02 112.17 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.5 m -155.77 155.99 34.03 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.271 -1.723 . . . . 0.02 110.598 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.7 m -145.17 147.77 32.84 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.304 0.573 . . . . 0.02 109.58 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -137.44 142.15 41.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.416 -0.802 . . . . 0.01 109.173 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.31 132.97 36.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.212 -0.93 . . . . 0.43 109.314 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -89.68 123.79 42.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.282 -1.006 . . . . 1.25 108.282 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -91.19 131.5 36.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.751 -1.218 . . . . 1.77 108.004 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -96.77 137.48 35.79 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.005 -1.109 . . . . 1.63 108.005 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.2 t -109.91 126.58 54.02 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.479 -0.934 . . . . 1.08 108.479 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 t -103.15 -154.87 0.51 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.046 -1.835 . . . . 1.26 106.046 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.9 -49.62 0.89 Allowed Glycine 0 N--CA 1.497 2.734 0 O-C-N 120.658 -1.276 . . . . 0.01 111.812 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.85 -99.21 0.12 Allowed Glycine 0 N--CA 1.487 2.069 0 C-N-CA 118.77 -1.681 . . . . 0.01 111.897 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -120.91 119.92 34.02 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.279 -1.13 . . . . 4.43 110.619 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.49 137.09 56.57 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.325 -0.62 . . . . 2.99 109.325 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.548 ' HZ3' ' CG2' ' A' ' 111' ' ' THR . 15.6 ttmm -134.79 130.96 36.91 Favored 'General case' 0 N--CA 1.518 2.957 0 CA-C-O 122.195 0.997 . . . . 6.36 112.996 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -131.71 142.38 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 115.598 -0.728 . . . . 1.09 110.2 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.48 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.7 pt20 -124.22 139.67 53.7 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.818 -1.179 . . . . 2.05 107.818 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.5 m -123.59 144.71 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 O-C-N 120.73 -1.231 . . . . 1.1 110.942 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -120.55 140.43 51.51 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.155 0.978 . . . . 0.73 111.13 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.46 ' OE2' ' CD2' ' A' ' 123' ' ' LEU . 7.2 tp10 -68.38 -33.4 74.18 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.934 -0.576 . . . . 0.02 111.474 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -114.84 168.59 9.77 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.933 -1.104 . . . . 3.18 110.168 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.01 169.16 46.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.916 -0.873 . . . . 0.01 110.916 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 53.34 39.19 29.46 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.58 0.705 . . . . 0.01 111.686 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.408 ' C ' HD21 ' A' ' 104' ' ' ASN . 11.7 m-85 52.69 48.21 23.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.56 -0.712 . . . . 0.01 111.075 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.408 HD21 ' C ' ' A' ' 103' ' ' PHE . 4.0 m120 -121.01 164.21 17.09 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.384 -0.969 . . . . 3.15 108.384 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.69 -162.91 29.37 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.97 -1.652 . . . . 0.01 108.97 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.482 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 56.6 tt0 -75.94 141.69 42.2 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.945 -1.327 . . . . 0.01 109.214 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.2 tmm? -116.09 143.4 45.52 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.596 0.712 . . . . 0.01 109.465 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.482 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 54.6 m-85 -132.56 136.13 46.39 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.278 -1.008 . . . . 2.48 108.278 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.467 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.9 tm-20 -116.63 134.16 55.15 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.639 -0.663 . . . . 0.01 109.576 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.467 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 8.8 t -148.88 148.35 29.76 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.383 1.087 . . . . 1.69 111.302 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.548 ' CG2' ' HZ3' ' A' ' 94' ' ' LYS . 18.2 p -115.01 7.67 15.59 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.213 -0.903 . . . . 0.01 110.051 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -122.09 163.2 19.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.401 -0.812 . . . . 3.21 111.24 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -69.7 154.75 41.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.01 109.419 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.497 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 53.1 m -127.78 115.53 20.79 Favored Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 109.049 -0.723 . . . . 0.01 109.049 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.43 -32.5 4.87 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 CA-C-N 120.198 1.107 . . . . 0.01 111.308 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 t -141.83 107.37 5.06 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.833 0.825 . . . . 0.02 108.888 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.4 mt -64.83 -39.17 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.864 -0.523 . . . . 1.83 111.036 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 37.1 ttp -67.41 -37.39 83.01 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.148 -1.021 . . . . 1.34 109.79 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.73 -38.72 76.98 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.588 -1.32 . . . . 2.11 109.709 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -79.42 -46.84 16.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.346 -0.846 . . . . 2.08 112.317 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.81 0.45 17.28 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.384 -0.822 . . . . 0.02 112.769 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 59.82 33.07 21.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.68 -1.262 . . . . 0.02 109.39 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.46 ' CD2' ' OE2' ' A' ' 99' ' ' GLU . 10.6 mt -111.89 135.08 52.98 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.64 -0.874 . . . . 0.02 108.64 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -92.58 -23.76 18.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 5.32 110.409 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -148.89 162.96 38.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.146 -0.971 . . . . 0.02 110.023 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.424 HD12 HG22 ' A' ' 126' ' ' ILE . 51.6 mt -131.96 129.44 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.223 -1.399 . . . . 2.17 107.223 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -105.54 -12.32 16.02 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.087 -1.008 . . . . 0.02 112.64 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -155.05 153.15 30.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.524 -1.36 . . . . 0.01 108.156 178.06 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 12.8 t -160.63 144.45 13.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.446 -1.408 . . . . 1.22 109.775 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -122.07 113.4 19.48 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.267 1.032 . . . . 1.41 109.457 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.06 120.23 60.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 105.554 -2.017 . . . . 0.01 105.554 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -145.76 67.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 118.34 -1.344 . . . . 1.98 108.398 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 172.14 108.32 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.586 -1.635 . . . . 0.01 106.586 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.38 -172.56 47.65 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.999 -1.24 . . . . 0.01 109.999 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -110.93 144.22 40.35 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.483 -1.01 . . . . 2.3 108.845 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -131.32 147.2 52.55 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.446 -0.784 . . . . 0.01 110.641 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.4 mt -119.1 140.29 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 107.956 -1.128 . . . . 1.69 107.956 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -112.81 141.73 46.28 Favored 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 107.408 -1.331 . . . . 2.49 107.408 177.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 12.9 m-85 -122.46 145.04 48.67 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.55 -0.719 . . . . 0.02 109.264 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -74.55 -30.29 61.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.579 -0.701 . . . . 0.02 112.275 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -114.89 153.79 46.99 Favored Pre-proline 0 N--CA 1.506 2.362 0 O-C-N 120.622 -1.299 . . . . 1.48 109.139 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.51 166.34 1.89 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 120.991 1.127 . . . . 0.02 112.462 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 59.79 31.21 20.68 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.221 -0.9 . . . . 0.75 111.253 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.497 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 58.38 51.97 7.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.02 111.13 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -124.91 163.34 22.46 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.666 -0.646 . . . . 0.02 109.937 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.65 -165.61 32.35 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.159 -1.177 . . . . 0.02 110.159 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -67.85 141.62 56.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.614 -0.933 . . . . 0.02 108.957 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.11 149.07 41.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.582 -0.525 . . . . 0.02 109.582 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.67 141.43 51.61 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 109.125 -0.695 . . . . 0.01 109.125 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.25 120.87 36.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.334 -0.854 . . . . 0.01 109.282 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.646 ' CD2' ' HE1' ' A' ' 162' ' ' TRP . 6.7 mt -104.3 135.14 46.31 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.344 -0.848 . . . . 0.01 110.321 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 154' ' ' LYS . 38.9 t70 -110.78 178.23 4.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.399 -1.334 . . . . 2.27 107.399 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -59.3 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.747 -1.221 . . . . 1.84 108.519 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 152' ' ' ASP . 68.4 tttt -134.95 163.12 30.56 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 122.106 0.955 . . . . 2.28 111.957 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.406 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 2.7 pt-20 -113.87 112.03 22.7 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.07 -1.085 . . . . 0.01 108.07 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.63 114.92 29.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.023 -1.048 . . . . 0.01 110.18 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.456 ' O ' ' OG ' ' A' ' 128' ' ' SER . 23.5 ptt180 -96.74 -27.12 14.9 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.497 -0.752 . . . . 0.01 112.063 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -125.65 151.33 70.45 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 120.766 -1.209 . . . . 2.54 108.98 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -57.97 -48.8 14.82 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 CA-C-N 119.234 0.762 . . . . 0.7 110.759 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.68 -23.67 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.86 -1.15 . . . . 0.86 109.152 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.61 -15.86 63.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.755 -1.216 . . . . 0.02 109.305 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.646 ' HE1' ' CD2' ' A' ' 151' ' ' LEU . 2.7 t90 -94.78 6.54 48.65 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.607 -0.886 . . . . 0.02 108.607 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 74.79 8.29 81.81 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.565 -1.303 . . . . 0.02 109.917 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.22 143.32 29.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.62 -0.929 . . . . 0.02 110.074 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.13 -9.22 58.76 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.675 -0.641 . . . . 0.59 109.671 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.1 p -147.24 150.9 39.34 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.756 -1.215 . . . . 0.87 108.015 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -75.7 25.48 0.4 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 120.777 0.985 . . . . 0.38 112.464 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.85 124.4 30.92 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.644 1.211 . . . . 0.18 112.534 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.4 mm -142.19 127.82 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 106.382 -1.71 . . . . 3.99 106.382 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -113.65 -23.7 9.59 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.784 -1.198 . . . . 5.17 112.846 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.9 p -157.31 160.26 38.37 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 119.503 -1.998 . . . . 0.02 109.839 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.497 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 11.8 p90 -153.44 153.98 33.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.983 -1.073 . . . . 2.02 110.601 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.497 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 18.9 mtp180 -143.23 151.14 40.25 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.161 -0.962 . . . . 0.01 110.4 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -87.56 141.83 28.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.991 -0.744 . . . . 0.01 108.991 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.0 mt -93.25 128.31 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.005 -1.059 . . . . 3.04 109.078 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.1 t -136.27 146.52 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.254 -0.903 . . . . 1.89 109.553 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 4.89 109.452 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.495 -0.557 . . . . 5.28 109.495 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.07 166.99 6.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 5.96 109.429 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.13 141.8 33.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 2.22 108.415 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.54 -179.51 47.52 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 118.317 -1.897 . . . . 0.81 112.005 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.78 157.92 44.24 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.292 -1.523 . . . . 0.01 109.292 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -147.76 136.69 22.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.012 -1.287 . . . . 0.02 110.641 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 tt -130.78 139.52 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 109.115 -0.698 . . . . 0.02 109.115 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -121.22 130.33 53.64 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.465 -0.772 . . . . 0.39 109.766 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.05 139.77 44.81 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.983 -0.747 . . . . 0.02 108.983 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.6 m-85 -122.16 138.37 54.49 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.213 -0.929 . . . . 0.02 109.545 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -69.57 -27.76 65.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.03 111.652 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.2 m-20 -114.36 169.7 8.85 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.808 -1.182 . . . . 0.03 110.237 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.666 HH12 HD21 ' A' ' 37' ' ' ASN . 3.5 mtt-85 -74.88 157.81 34.43 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.703 0.763 . . . . 0.03 110.078 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 66.26 33.49 7.16 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.958 0.885 . . . . 0.74 111.14 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.25 42.32 30.53 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.212 0.53 . . . . 0.02 111.266 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -113.74 166.0 11.98 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.288 -1.005 . . . . 0.02 108.288 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.95 -167.25 36.2 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.841 -1.171 . . . . 0.03 110.702 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.05 141.59 54.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.976 . . . . 2.76 109.313 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -120.27 148.81 43.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.523 -0.736 . . . . 1.89 110.149 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -132.68 127.39 34.72 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.488 -0.93 . . . . 0.02 108.488 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.62 136.16 51.23 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.414 -0.804 . . . . 1.12 109.565 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -130.52 138.18 50.09 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.502 0.668 . . . . 0.02 109.55 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -117.56 11.16 13.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.737 -0.602 . . . . 0.2 109.655 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.9 p -158.31 173.83 16.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.144 -0.972 . . . . 1.23 108.585 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.62 145.19 55.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.636 -1.29 . . . . 0.02 110.372 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 82' ' ' CYS . 22.0 p -132.99 117.32 17.49 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.407 -0.96 . . . . 0.02 108.407 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.83 -23.5 52.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.24 110.743 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 31.1 p-10 -154.83 101.44 2.29 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.615 -0.883 . . . . 1.14 108.615 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 22.2 p90 -107.08 10.06 30.3 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 122.089 0.947 . . . . 6.37 110.273 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' HE ' ' CA ' ' A' ' 80' ' ' GLY . 29.4 mmt180 -59.2 -23.19 62.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.544 -0.722 . . . . 3.11 110.676 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -75.23 -16.32 60.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.726 -1.233 . . . . 0.88 110.354 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -103.08 -21.43 13.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.382 -0.824 . . . . 0.02 109.277 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -150.27 129.46 12.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.309 -0.869 . . . . 3.32 109.081 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t -85.5 -10.58 55.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.76 -0.588 . . . . 0.02 110.769 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -170.56 161.97 7.88 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.896 -1.15 . . . . 0.02 107.896 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.32 115.89 8.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.817 -1.177 . . . . 0.02 109.087 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.666 HD21 HH12 ' A' ' 13' ' ' ARG . 4.4 m120 -109.56 0.79 19.33 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.81 -1.181 . . . . 0.03 111.595 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -156.33 154.51 30.71 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.24 -1.022 . . . . 0.02 108.24 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.9 146.72 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.031 -1.043 . . . . 0.02 110.879 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -123.04 124.04 42.23 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.886 -1.153 . . . . 0.02 107.886 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.0 t -106.45 113.91 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 106.751 -1.574 . . . . 0.02 106.751 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 32.1 tp10 -84.27 -34.52 23.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.633 . . . . 3.81 110.435 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.51 149.32 17.24 Favored Glycine 0 N--CA 1.485 1.948 0 C-N-CA 119.029 -1.558 . . . . 0.02 110.525 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.73 172.41 48.83 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.255 -1.138 . . . . 0.01 110.255 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -118.3 134.77 54.75 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.489 -1.3 . . . . 1.48 107.489 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -127.17 154.68 44.48 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.755 -1.216 . . . . 0.02 112.443 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.37 134.1 52.24 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.349 -2.093 . . . . 0.24 105.349 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.0 m -118.35 143.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.479 -0.763 . . . . 0.65 109.351 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -120.84 144.42 48.36 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.37 1.081 . . . . 0.02 110.073 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.86 -33.42 75.8 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.665 -0.698 . . . . 0.02 111.47 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -124.38 157.81 63.54 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.034 -1.041 . . . . 0.02 109.491 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.27 166.45 1.08 Allowed 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.702 1.601 . . . . 0.02 112.728 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 t30 63.28 36.65 11.63 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.383 -0.826 . . . . 0.02 111.127 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 45.31 51.22 9.53 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.634 0.73 . . . . 3.39 110.769 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.2 p -125.49 163.28 23.0 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.186 0.517 . . . . 2.33 109.862 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.67 -161.74 31.14 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.722 -1.351 . . . . 0.02 109.722 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -64.32 138.58 58.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.33 . . . . 0.02 110.124 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -119.16 137.29 53.71 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.818 -0.551 . . . . 5.01 109.578 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.582 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 79.4 m-85 -134.76 139.98 45.57 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.5 -0.75 . . . . 0.02 110.067 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.8 mm -95.18 130.43 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.907 -0.775 . . . . 1.72 108.907 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.8 mt -122.54 111.72 31.39 Favored Pre-proline 0 N--CA 1.507 2.39 0 O-C-N 121.338 -0.852 . . . . 0.02 110.654 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.99 170.65 19.39 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 CA-C-N 119.863 0.987 . . . . 1.47 110.13 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 58.1 tt0 -52.16 140.47 20.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.963 -1.086 . . . . 4.25 110.092 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.59 -177.75 32.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.366 -1.397 . . . . 0.02 110.84 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -120.75 131.62 54.6 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.454 -1.027 . . . . 0.96 110.043 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -122.24 95.84 46.83 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.1 Cg_endo -67.79 -3.16 9.88 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.945 1.096 . . . . 0.02 114.125 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 67.6 mt-10 -157.54 154.96 29.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.551 -1.343 . . . . 2.02 108.313 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -60.02 -39.28 85.31 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.498 -0.751 . . . . 0.02 111.734 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -59.56 -24.13 63.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.033 . . . . 0.02 110.202 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -70.49 -18.97 62.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.935 0.874 . . . . 3.42 108.904 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.582 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.3 t90 -108.01 9.78 28.44 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.537 -1.283 . . . . 0.02 107.537 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 mmt 60.97 22.61 12.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.02 110.59 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.16 145.44 46.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.505 -1.438 . . . . 0.02 109.505 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.88 -31.28 40.33 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.601 -1.259 . . . . 0.98 107.601 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -156.92 -171.44 3.65 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.448 -1.686 . . . . 0.02 106.448 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 16.5 p-10 -97.98 28.14 4.12 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.634 -1.291 . . . . 0.02 110.661 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 78' ' ' ARG . 2.5 mtt-85 -96.42 121.93 38.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.009 -1.057 . . . . 3.2 110.563 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.501 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 24.9 mt -144.82 121.4 11.1 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.629 -1.248 . . . . 2.61 107.629 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' CA ' ' HE ' ' A' ' 30' ' ' ARG . . . -112.12 -16.4 9.08 Favored Glycine 0 N--CA 1.508 3.471 0 O-C-N 121.218 -0.926 . . . . 0.02 113.495 -177.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.6 p -155.51 156.87 35.97 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.244 -1.739 . . . . 0.02 110.69 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 14.2 p -145.73 148.32 32.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.695 -0.628 . . . . 0.02 109.903 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -137.23 141.71 42.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.365 -0.834 . . . . 0.01 109.181 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 132.11 36.48 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.166 -0.959 . . . . 0.43 109.436 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -90.06 124.12 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.302 -0.999 . . . . 1.25 108.302 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -92.4 131.98 37.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.819 -1.176 . . . . 1.77 108.408 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -96.39 138.25 34.25 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.082 -1.081 . . . . 1.63 108.082 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 m -109.72 126.74 54.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.671 -0.862 . . . . 1.08 108.671 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.9 t -103.65 -154.94 0.51 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.07 -1.826 . . . . 1.26 106.07 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.89 -49.87 0.88 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 120.552 -1.343 . . . . 0.01 111.879 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.26 -99.7 0.13 Allowed Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.825 -1.655 . . . . 0.01 111.924 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.4 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 38.5 tt0 -120.37 119.5 33.28 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.294 -1.121 . . . . 4.43 110.523 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 136.68 55.87 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.501 -0.555 . . . . 2.99 109.501 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -134.39 130.19 36.5 Favored 'General case' 0 N--CA 1.517 2.912 0 CA-C-O 122.11 0.957 . . . . 6.36 113.029 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.43 141.76 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-N 115.637 -0.711 . . . . 1.09 110.211 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.4 pt20 -124.95 139.7 53.59 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 107.526 -1.287 . . . . 2.05 107.526 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.07 146.85 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 120.646 -1.284 . . . . 1.1 111.08 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -120.84 140.29 51.97 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.256 1.027 . . . . 0.73 111.117 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -67.94 -32.19 72.46 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.644 -0.707 . . . . 0.02 111.934 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -114.76 165.61 12.64 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.078 -1.014 . . . . 3.18 110.43 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.26 163.12 46.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 111.069 -0.812 . . . . 0.01 111.069 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 57.65 39.06 27.8 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.608 0.718 . . . . 0.01 111.004 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 33.2 m-85 52.31 56.33 7.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 0.01 111.052 177.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -128.62 164.92 21.84 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.034 -1.098 . . . . 3.15 108.034 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.39 -162.82 28.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.077 -1.609 . . . . 0.01 109.077 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -75.07 141.81 43.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.874 -1.368 . . . . 0.01 108.864 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.9 tmm? -116.18 143.0 46.08 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.472 0.653 . . . . 0.01 109.451 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -132.07 136.22 47.03 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.206 -1.035 . . . . 2.48 108.206 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -116.76 134.48 54.74 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.711 -0.618 . . . . 0.01 109.756 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -149.7 148.55 29.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.941 -1.099 . . . . 1.69 111.337 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -114.48 7.95 16.35 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.106 -0.952 . . . . 0.01 109.695 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -122.27 163.41 19.71 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.545 -0.722 . . . . 3.21 111.152 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -69.62 154.83 41.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.802 . . . . 0.01 109.591 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.401 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 47.5 t -125.92 114.28 24.39 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.947 -0.76 . . . . 0.01 108.947 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -76.0 -33.64 3.52 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 CA-C-N 120.3 1.143 . . . . 0.01 111.557 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t -141.69 107.2 5.05 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.328 -0.858 . . . . 0.02 108.692 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.21 -39.41 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.715 -0.615 . . . . 1.83 111.198 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.2 ttp -66.26 -38.13 87.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.944 -1.102 . . . . 1.34 109.574 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -69.95 -38.73 76.22 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.63 -1.294 . . . . 2.11 109.74 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.496 ' NE2' ' CE1' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -80.47 -47.95 13.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.188 -0.945 . . . . 2.08 112.207 -176.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.496 ' CE1' ' NE2' ' A' ' 120' ' ' GLN . 94.8 m-85 -111.35 -1.06 16.13 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.474 -0.766 . . . . 0.02 112.884 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.457 ' ND1' ' C ' ' A' ' 121' ' ' PHE . 5.0 m80 60.26 33.7 20.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.716 -1.24 . . . . 0.02 109.707 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.44 135.63 52.91 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.784 -0.821 . . . . 0.02 108.784 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -92.83 -23.69 18.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.334 -0.854 . . . . 5.32 110.788 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -149.21 163.69 36.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.016 -1.053 . . . . 0.02 110.121 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 126' ' ' ILE . 49.2 mt -131.56 129.43 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 107.443 -1.317 . . . . 2.17 107.443 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -107.77 -13.17 15.07 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.123 -0.986 . . . . 0.02 113.033 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.471 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.54 153.08 29.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.412 -1.43 . . . . 0.01 108.261 177.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.9 t -163.53 143.96 8.82 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.287 -1.508 . . . . 1.22 109.697 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -121.82 113.31 19.49 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.062 0.934 . . . . 1.41 108.841 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.96 123.23 63.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 105.694 -1.965 . . . . 0.01 105.694 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.5 t -146.31 68.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 118.186 -1.406 . . . . 1.98 108.271 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER 172.51 107.87 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.537 -1.653 . . . . 0.01 106.537 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.53 -174.1 42.64 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.623 -1.391 . . . . 0.01 109.623 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 m -111.81 143.66 42.38 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.411 -1.053 . . . . 2.3 109.214 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.92 146.17 51.02 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.444 -0.785 . . . . 0.01 110.424 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.11 141.15 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.398 -1.334 . . . . 1.69 107.398 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.506 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.14 143.16 45.26 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 107.329 -1.359 . . . . 2.49 107.329 177.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.42 144.64 49.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.623 -0.673 . . . . 0.02 109.297 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 -30.06 63.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.638 -0.664 . . . . 0.02 112.124 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.5 153.64 47.71 Favored Pre-proline 0 N--CA 1.506 2.356 0 O-C-N 120.637 -1.289 . . . . 1.48 109.223 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.72 166.93 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.344 1.362 . . . . 0.02 112.678 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.8 m120 59.46 31.36 20.99 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.188 -0.915 . . . . 0.75 111.114 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.466 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.2 m-85 57.73 51.52 9.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.55 -0.719 . . . . 0.02 110.961 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -124.7 163.54 21.83 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.487 -0.758 . . . . 0.02 109.857 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.51 -165.28 32.3 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.711 -1.356 . . . . 0.02 109.711 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -67.89 141.3 56.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.437 -1.037 . . . . 0.02 108.894 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -118.22 148.52 42.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.06 -0.718 . . . . 0.02 109.06 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -128.83 142.84 50.84 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.574 -0.704 . . . . 0.01 109.18 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.12 120.0 34.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.367 -0.833 . . . . 0.01 109.492 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.12 133.08 51.4 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.36 -0.837 . . . . 0.01 110.297 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 154' ' ' LYS . 4.4 m-20 -108.79 174.63 5.79 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.356 -0.979 . . . . 2.27 108.356 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -57.12 84.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.077 -1.014 . . . . 1.84 108.627 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 152' ' ' ASP . 90.8 mttt -137.76 169.37 17.9 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 122.0 0.905 . . . . 2.28 111.603 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.39 110.59 20.89 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.389 -0.967 . . . . 0.01 108.389 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.57 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 90.7 m-85 -101.73 114.36 28.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.1 -1.0 . . . . 0.01 109.827 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -91.64 -25.84 18.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.096 -1.003 . . . . 0.01 111.222 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -125.44 154.09 72.43 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.061 -1.024 . . . . 2.54 108.525 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.27 -41.16 44.15 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 120.44 0.76 . . . . 0.7 110.539 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.95 -20.07 21.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.906 -1.121 . . . . 0.86 108.841 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -65.48 -16.17 63.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.003 -1.061 . . . . 0.02 109.787 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.57 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 2.0 m0 -96.94 11.0 37.54 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.065 -1.087 . . . . 0.02 108.065 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.59 11.78 85.14 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.414 -1.374 . . . . 0.02 110.336 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.9 141.83 32.19 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.178 -1.19 . . . . 0.02 110.096 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -8.29 58.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.791 -0.568 . . . . 0.59 109.917 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.6 m -144.37 151.04 50.1 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 120.845 -1.159 . . . . 0.87 108.791 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.43 21.25 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 120.694 0.929 . . . . 0.38 112.368 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.82 122.4 28.64 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.357 1.075 . . . . 0.18 111.602 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.6 mp -149.01 125.94 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.425 -1.694 . . . . 3.99 106.425 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -111.07 -16.44 13.48 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.176 -0.953 . . . . 5.17 113.23 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 86.4 p -158.46 161.14 37.42 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 119.181 -2.199 . . . . 0.02 110.075 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.2 p90 -152.78 155.25 36.79 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.076 -1.015 . . . . 2.02 110.358 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.466 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 22.9 mtp180 -143.54 150.41 38.85 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.158 -0.964 . . . . 0.01 110.293 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -87.35 142.73 27.66 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.072 -0.714 . . . . 0.01 109.072 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.4 mt -93.66 127.9 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.033 -1.042 . . . . 3.04 109.279 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.7 t -136.01 146.5 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.346 -0.846 . . . . 1.89 109.549 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 4.89 109.477 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.281 0.563 . . . . 5.28 109.496 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -57.82 156.35 8.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.216 -0.927 . . . . 5.96 109.482 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 t -174.78 158.25 2.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.347 -1.47 . . . . 2.22 108.63 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.31 178.54 47.8 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 118.717 -1.706 . . . . 0.81 111.637 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.57 157.1 43.66 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.21 -1.556 . . . . 0.01 109.21 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -148.25 136.31 21.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.898 -1.354 . . . . 0.02 110.29 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 tt -130.38 140.08 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.098 -0.705 . . . . 0.02 109.098 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -121.38 130.46 53.62 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.363 -0.836 . . . . 0.39 110.071 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -110.06 139.7 44.9 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.657 -0.652 . . . . 0.02 109.316 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.543 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.4 m-85 -122.28 138.28 54.56 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.293 -0.879 . . . . 0.02 109.483 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -69.36 -27.3 65.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.956 -1.09 . . . . 0.03 111.875 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -113.92 169.66 8.84 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.796 -1.19 . . . . 0.03 110.143 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.39 158.38 32.81 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.549 0.69 . . . . 0.03 109.647 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.4 m120 66.24 35.05 6.19 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.719 0.771 . . . . 0.74 110.933 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.81 44.89 25.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.669 0.747 . . . . 0.02 111.403 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -112.64 165.84 11.89 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.008 -1.108 . . . . 0.02 108.008 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -167.87 34.44 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.766 -1.207 . . . . 0.03 110.532 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.723 ' HE ' ' H ' ' A' ' 19' ' ' ARG . 9.3 tpm_? -69.33 142.96 53.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -1.088 . . . . 2.76 108.922 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.723 ' H ' ' HE ' ' A' ' 18' ' ' ARG . 18.7 ttm180 -122.44 150.1 42.95 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.38 -0.825 . . . . 1.89 110.331 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -135.9 132.5 36.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.155 -0.683 . . . . 0.02 109.155 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 14.6 p-10 -108.52 136.23 48.48 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.589 -0.893 . . . . 1.12 108.589 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 15.9 t -127.68 137.77 52.6 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.666 -0.646 . . . . 0.02 110.035 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -119.9 11.05 11.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.2 110.754 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.532 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 16.0 t -159.73 173.77 15.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.633 -1.292 . . . . 1.23 109.26 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.464 ' H ' ' HG ' ' A' ' 24' ' ' CYS . 19.5 p-10 -63.41 145.8 54.86 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.416 -1.428 . . . . 0.02 110.931 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.565 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.9 m -135.22 119.19 17.41 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.886 -0.783 . . . . 0.02 108.886 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.482 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.79 -20.02 54.0 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.526 -0.734 . . . . 0.24 112.24 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -154.16 106.68 2.82 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.705 -1.247 . . . . 1.14 109.931 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.95 6.63 39.05 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.425 -0.797 . . . . 6.37 110.202 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -61.12 -29.69 69.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 3.11 112.052 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -76.96 -17.41 58.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.405 -1.434 . . . . 0.88 111.005 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -106.34 -21.17 13.17 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.413 -0.804 . . . . 0.02 110.621 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -149.33 127.47 12.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.092 -1.005 . . . . 3.32 109.653 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.5 p -87.2 -12.39 46.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.618 -0.676 . . . . 0.02 111.083 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -172.28 161.94 5.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.743 -1.223 . . . . 0.02 108.479 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 t -143.73 117.06 9.04 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.001 -1.062 . . . . 0.02 109.002 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -109.64 0.12 18.9 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.708 -1.245 . . . . 0.03 111.754 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 18.3 m -155.74 154.05 30.86 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.273 -1.01 . . . . 0.02 108.273 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -145.86 146.31 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 122.32 1.057 . . . . 0.02 110.818 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -122.77 123.68 41.61 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.594 -1.262 . . . . 0.02 107.594 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.1 t -105.64 113.63 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.87 -1.53 . . . . 0.02 106.87 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -85.13 -34.53 22.14 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.133 -0.627 . . . . 3.81 110.07 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.4 149.15 16.96 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.599 -1.763 . . . . 0.02 110.751 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.59 172.19 48.71 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.243 -1.143 . . . . 0.01 110.243 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.5 m -118.3 134.65 54.86 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.644 -1.243 . . . . 1.48 107.644 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -127.06 154.56 44.52 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 122.624 1.202 . . . . 0.02 112.345 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.34 133.77 52.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 105.453 -2.055 . . . . 0.24 105.453 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.1 144.19 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.519 -0.738 . . . . 0.65 109.323 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -120.65 144.95 47.9 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.157 0.979 . . . . 0.02 109.978 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -66.77 -33.8 76.43 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.943 -0.571 . . . . 0.02 111.957 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -123.09 158.27 58.27 Favored Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 121.111 -0.993 . . . . 0.02 109.509 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -53.1 164.64 1.64 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.524 1.482 . . . . 0.02 112.636 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 64.0 37.06 9.55 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.8 0.809 . . . . 0.02 111.363 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.453 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 11.2 m-85 45.54 51.39 9.91 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.681 0.753 . . . . 3.39 110.91 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 t -125.67 163.43 22.81 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.168 0.509 . . . . 2.33 109.827 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.72 -161.69 31.03 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.764 -1.334 . . . . 0.02 109.764 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -64.68 139.17 58.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.932 -1.334 . . . . 0.02 110.216 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.0 ppp? -119.6 138.12 53.43 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.725 -0.609 . . . . 5.01 109.475 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.562 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 63.8 m-85 -135.32 139.93 44.7 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.461 -0.774 . . . . 0.02 110.084 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.1 mm -93.76 130.18 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.311 -0.996 . . . . 1.72 108.311 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -121.48 111.1 33.47 Favored Pre-proline 0 N--CA 1.506 2.337 0 O-C-N 121.291 -0.881 . . . . 0.02 111.008 -178.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.04 169.79 19.85 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.738 0.942 . . . . 1.47 110.542 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -53.03 141.25 22.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.972 -1.08 . . . . 4.25 110.695 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.71 -177.76 31.84 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.47 -1.347 . . . . 0.02 110.955 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -119.68 131.29 55.38 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.367 -1.078 . . . . 0.96 109.782 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 78.8 m-85 -121.93 98.59 44.93 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.034 -1.099 . . . . 0.02 108.034 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.425 ' O ' ' OG ' ' A' ' 38' ' ' SER . 9.8 Cg_endo -71.12 -3.25 12.51 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.82 1.013 . . . . 0.02 113.919 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -157.51 154.54 28.82 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.672 -1.267 . . . . 2.02 108.221 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -59.69 -39.32 84.19 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.462 -0.774 . . . . 0.02 111.886 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -59.85 -23.82 63.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.02 110.303 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -70.49 -18.7 62.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.301 -0.874 . . . . 3.42 108.972 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.562 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -108.22 10.6 27.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.391 -1.337 . . . . 0.02 107.391 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.3 mmt 60.55 22.45 12.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.02 110.401 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.02 145.08 46.41 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.449 -1.46 . . . . 0.02 109.449 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -79.94 -30.53 39.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -1.174 . . . . 0.98 107.9 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.46 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 60.4 t30 -157.16 -171.64 3.71 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.558 -1.645 . . . . 0.02 106.558 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 1.6 p30 -98.81 28.67 4.17 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.606 -1.309 . . . . 0.02 110.791 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -96.99 123.14 40.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.862 -1.149 . . . . 3.2 111.074 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.5 mt -141.78 119.1 11.47 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.472 -1.307 . . . . 2.61 107.472 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.96 -18.49 9.89 Favored Glycine 0 N--CA 1.502 3.062 0 O-C-N 121.008 -1.058 . . . . 0.02 112.537 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.1 m -156.11 156.52 34.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.303 -1.704 . . . . 0.02 110.387 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.0 m -144.83 147.63 33.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.801 -0.562 . . . . 0.02 109.754 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.453 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 46.6 mtp180 -137.32 141.77 41.86 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.451 -0.781 . . . . 0.01 109.162 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.86 132.13 36.7 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.26 -0.9 . . . . 0.43 109.313 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -90.76 124.4 43.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.634 -0.876 . . . . 1.25 108.634 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -92.13 131.67 37.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.844 -1.16 . . . . 1.77 108.645 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.45 138.83 33.46 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.142 -1.058 . . . . 1.63 108.142 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.1 p -110.73 126.42 54.54 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.783 -0.821 . . . . 1.08 108.783 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.4 p -103.17 -154.99 0.51 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.089 -1.819 . . . . 1.26 106.089 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.7 -49.61 0.88 Allowed Glycine 0 N--CA 1.498 2.814 0 O-C-N 120.482 -1.386 . . . . 0.01 112.069 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.58 -99.7 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 118.758 -1.687 . . . . 0.01 112.091 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -120.76 120.02 34.43 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.204 -1.174 . . . . 4.43 110.601 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.65 135.46 54.12 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.332 -0.547 . . . . 2.99 109.612 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -133.57 130.19 38.07 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 121.103 -0.998 . . . . 6.36 112.924 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 tt -131.75 141.3 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 115.538 -0.756 . . . . 1.09 110.535 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.1 pt20 -124.44 139.19 54.12 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 107.56 -1.274 . . . . 2.05 107.56 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.13 146.64 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 120.644 -1.285 . . . . 1.1 110.942 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -119.34 139.31 52.16 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.897 0.855 . . . . 0.73 110.65 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.5 -32.47 72.47 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.694 -0.684 . . . . 0.02 111.86 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.476 ' O ' ' OG ' ' A' ' 128' ' ' SER . 14.6 mtpp -114.67 168.32 9.98 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.04 -1.038 . . . . 3.18 109.753 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.38 168.83 44.99 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.67 -0.776 . . . . 0.01 111.201 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.45 39.6 30.17 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.667 0.746 . . . . 0.01 111.611 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 52.68 48.8 21.72 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.58 -0.7 . . . . 0.01 111.027 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -121.79 164.35 17.61 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.378 -0.971 . . . . 3.15 108.378 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.63 -163.38 28.47 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.389 -1.484 . . . . 0.01 109.389 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -76.01 142.57 41.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.93 -1.335 . . . . 0.01 109.143 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.458 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.2 tmm? -116.47 143.38 45.65 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.5 0.667 . . . . 0.01 109.771 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.08 136.11 46.94 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.265 -1.013 . . . . 2.48 108.265 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -116.77 134.33 54.92 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.748 -0.595 . . . . 0.01 109.856 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -149.5 148.78 29.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.885 -1.134 . . . . 1.69 111.195 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.5 p -114.87 7.86 15.82 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.103 -0.953 . . . . 0.01 109.685 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -122.15 163.59 19.26 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.536 -0.727 . . . . 3.21 111.031 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 1.5 p30 -69.2 154.36 42.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.456 -0.777 . . . . 0.01 109.535 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.415 ' O ' ' OG ' ' A' ' 171' ' ' SER . 41.7 t -125.8 115.03 24.61 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 108.966 -0.753 . . . . 0.01 108.966 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -75.66 -33.47 3.95 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 CA-C-N 120.404 1.18 . . . . 0.01 111.687 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.4 p -141.91 108.06 5.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.325 -0.859 . . . . 0.02 109.071 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.68 -40.06 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.753 -0.592 . . . . 1.83 110.993 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.4 ttt -66.69 -37.45 84.77 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.005 -1.078 . . . . 1.34 109.749 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -69.74 -38.5 76.87 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.474 -1.391 . . . . 2.11 109.819 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.31 -47.54 14.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.277 -0.889 . . . . 2.08 112.493 -177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.51 -1.36 15.88 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.269 -0.895 . . . . 0.02 112.747 -176.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 61.25 34.01 18.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.789 -1.194 . . . . 0.02 109.697 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.1 mt -113.78 136.52 52.77 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.498 -0.751 . . . . 0.02 109.351 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -91.26 -22.49 20.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.873 . . . . 5.32 111.074 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -148.54 163.94 35.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.907 -1.121 . . . . 0.02 110.254 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mm -127.87 125.5 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.163 -1.421 . . . . 2.17 107.163 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -106.15 -15.41 14.88 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.865 -1.147 . . . . 0.02 113.201 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 1.2 p -157.03 155.51 31.33 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.278 -1.513 . . . . 0.01 107.942 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.6 t -163.15 146.49 10.67 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.442 -1.411 . . . . 1.22 109.737 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.77 111.49 17.22 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.432 1.11 . . . . 1.41 108.601 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.7 t -109.16 122.67 64.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 105.584 -2.006 . . . . 0.01 105.584 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.3 t -146.43 67.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 118.128 -1.429 . . . . 1.98 108.06 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.95 108.83 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.534 -1.654 . . . . 0.01 106.534 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.82 -174.3 40.05 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.659 -1.376 . . . . 0.01 109.659 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 m -112.2 145.1 40.47 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.331 -1.1 . . . . 2.3 109.522 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -130.03 145.87 51.68 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.535 -0.728 . . . . 0.01 110.379 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mt -116.96 141.45 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 107.639 -1.245 . . . . 1.69 107.639 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.525 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -112.36 141.76 45.7 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 107.198 -1.408 . . . . 2.49 107.198 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -122.06 143.78 49.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.09 -0.707 . . . . 0.02 109.09 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.34 -30.3 61.96 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.729 -0.607 . . . . 0.02 111.908 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.53 153.45 47.74 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.667 -1.271 . . . . 1.48 109.018 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.45 167.11 1.47 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.243 1.295 . . . . 0.02 112.665 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 m120 59.21 31.03 20.89 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.141 -0.936 . . . . 0.75 111.079 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.494 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.6 m-85 57.72 52.07 8.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.633 -0.667 . . . . 0.02 111.048 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -125.07 163.72 21.78 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.495 -0.753 . . . . 0.02 109.69 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.17 -165.5 32.89 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -67.81 141.22 56.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.448 -1.031 . . . . 0.02 108.92 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.64 148.48 42.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.25 -0.648 . . . . 0.02 109.25 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.52 142.72 50.98 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.959 -0.756 . . . . 0.01 108.959 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.0 tt -96.69 121.3 38.39 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.277 -0.89 . . . . 0.01 109.131 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.9 mt -106.11 135.05 48.26 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.369 -0.832 . . . . 0.01 110.261 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 154' ' ' LYS . 22.8 t70 -108.25 174.82 5.71 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.339 -0.985 . . . . 2.27 108.339 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' N ' ' CG ' ' A' ' 152' ' ' ASP . 13.2 pttp -58.72 83.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.921 -1.112 . . . . 1.84 108.598 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 152' ' ' ASP . 55.0 mmtt -136.47 170.74 15.55 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.215 -0.928 . . . . 2.28 111.518 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.465 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 14.5 mp0 -113.24 109.49 18.84 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.282 -1.007 . . . . 0.01 108.282 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -100.1 114.77 28.36 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.031 -1.043 . . . . 0.01 110.112 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -93.31 -25.85 17.56 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.156 -0.965 . . . . 0.01 111.643 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -125.75 153.32 73.18 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 120.762 -1.211 . . . . 2.54 108.682 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -61.04 -43.02 32.35 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 120.431 0.754 . . . . 0.7 110.77 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.7 t -60.73 -20.52 21.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.64 -1.288 . . . . 0.86 108.619 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -65.14 -15.99 63.02 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.068 -1.02 . . . . 0.02 109.416 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.407 ' CZ3' ' CD1' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -94.85 9.87 37.51 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.945 -1.132 . . . . 0.02 107.945 178.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.09 11.27 84.95 Favored Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.18 -1.486 . . . . 0.02 109.627 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.59 142.33 31.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.557 -0.966 . . . . 0.02 110.181 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.79 -8.61 58.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.775 -0.578 . . . . 0.59 109.885 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 58.7 m -144.19 150.59 49.22 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 120.862 -1.149 . . . . 0.87 108.687 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -76.09 21.17 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 120.781 0.987 . . . . 0.38 112.541 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 123.23 28.73 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.653 1.216 . . . . 0.18 111.437 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.407 ' CD1' ' CZ3' ' A' ' 162' ' ' TRP . 17.4 mt -147.25 124.51 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.316 -1.735 . . . . 3.99 106.316 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -114.01 -17.79 11.88 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.178 -0.951 . . . . 5.17 113.022 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 40.0 t -157.6 160.27 37.93 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.354 -2.091 . . . . 0.02 110.144 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -153.4 154.55 34.68 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.009 -1.057 . . . . 2.02 110.611 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.494 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 21.8 mtp180 -143.53 150.81 39.45 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 0.01 110.356 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -87.94 142.77 27.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.01 109.173 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.96 128.21 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.121 -0.987 . . . . 3.04 109.081 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.9 146.46 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.293 -0.88 . . . . 1.89 109.708 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 4.89 109.353 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.482 -0.562 . . . . 5.28 109.482 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.473 ' O ' ' OG1' ' A' ' 3' ' ' THR . 59.0 mttm -72.41 -39.32 68.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 5.96 109.188 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 55.2 m -173.31 156.39 3.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.48 -1.388 . . . . 2.22 108.212 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.9 177.67 47.65 Favored Glycine 0 N--CA 1.491 2.3 0 C-N-CA 118.651 -1.738 . . . . 0.81 111.791 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.14 156.47 43.62 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.144 -1.583 . . . . 0.01 109.144 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.514 ' NZ ' ' CB ' ' A' ' 6' ' ' LYS . 5.4 ttpm? -148.8 137.34 21.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.285 . . . . 0.02 110.414 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 tt -130.95 140.52 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 109.206 -0.664 . . . . 0.02 109.206 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -121.41 130.46 53.61 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.403 -0.811 . . . . 0.39 110.054 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.85 140.46 45.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.737 -0.602 . . . . 0.02 109.448 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.3 m-85 -122.24 138.66 54.41 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.184 -0.947 . . . . 0.02 109.603 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.49 -27.27 65.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.08 . . . . 0.03 111.805 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -114.32 170.28 8.42 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.816 -1.178 . . . . 0.03 110.263 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -75.64 158.48 32.34 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.662 0.744 . . . . 0.03 110.18 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 65.99 33.15 7.93 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.006 0.908 . . . . 0.74 111.142 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.22 41.94 30.95 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.923 -0.58 . . . . 0.02 111.21 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -113.16 165.83 12.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.278 -1.008 . . . . 0.02 108.278 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.67 -167.67 35.38 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.882 -1.152 . . . . 0.03 110.464 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -68.97 142.0 54.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -1.096 . . . . 2.76 108.838 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -122.69 151.0 41.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.532 -0.73 . . . . 1.89 109.999 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -137.52 133.87 35.04 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.756 -0.59 . . . . 0.02 109.746 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -109.44 136.08 49.43 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.973 -0.751 . . . . 1.12 108.973 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.0 t -127.63 138.32 52.81 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.577 -0.702 . . . . 0.02 109.535 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 13.1 t70 -119.2 12.19 12.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.619 -0.676 . . . . 0.2 110.494 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.8 p -159.65 173.4 16.15 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.898 -1.126 . . . . 1.23 109.197 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -62.64 146.09 52.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.776 -1.203 . . . . 0.02 110.586 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.7 m -133.73 117.33 16.82 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.801 -0.814 . . . . 0.02 108.801 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.32 52.01 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.314 -0.866 . . . . 0.24 111.641 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -151.06 105.69 3.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.88 -1.137 . . . . 1.14 109.215 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.0 4.85 42.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 6.37 110.097 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -62.1 -29.47 70.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 3.11 112.635 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 m -77.21 -18.22 57.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.152 -1.592 . . . . 0.88 111.647 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -106.95 -19.8 13.52 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.418 -0.801 . . . . 0.02 110.51 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -148.98 127.09 12.02 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.032 -1.042 . . . . 3.32 109.55 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 p -87.44 -13.15 44.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.02 111.301 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -172.38 161.84 5.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.788 -1.195 . . . . 0.02 108.45 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.6 p -143.35 116.24 8.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.117 -0.989 . . . . 0.02 108.851 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -108.1 -0.73 20.95 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.829 -1.169 . . . . 0.03 111.228 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 19.3 m -155.23 153.68 31.04 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.829 -1.174 . . . . 0.02 107.829 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.89 147.53 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 122.158 0.98 . . . . 0.02 110.551 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -123.58 124.96 43.98 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.952 -1.129 . . . . 0.02 107.952 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.27 113.79 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.672 -1.603 . . . . 0.02 106.672 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -84.76 -35.06 22.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.6 -0.687 . . . . 3.81 110.001 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.65 149.45 17.42 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.598 -1.763 . . . . 0.02 110.778 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.75 172.1 48.57 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.237 -1.145 . . . . 0.01 110.237 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -118.48 134.36 55.13 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.592 -1.262 . . . . 1.48 107.592 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -127.03 154.31 44.81 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.704 1.24 . . . . 0.02 112.484 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.88 134.11 52.0 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 105.194 -2.15 . . . . 0.24 105.194 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.38 141.95 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.65 109.453 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -120.48 143.13 48.69 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.192 0.996 . . . . 0.02 109.649 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.84 -34.1 77.37 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.511 -0.768 . . . . 0.02 111.897 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -124.51 157.96 63.43 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.017 -1.052 . . . . 0.02 109.472 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.39 166.4 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.587 1.525 . . . . 0.02 112.769 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.55 36.59 10.99 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.242 -0.89 . . . . 0.02 111.116 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.518 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 6.0 m-85 45.56 51.6 9.81 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.603 0.716 . . . . 3.39 110.679 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.8 m -126.1 163.62 22.68 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.291 0.567 . . . . 2.33 109.77 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.66 31.27 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -64.78 139.21 58.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.036 -1.273 . . . . 0.02 110.268 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 19.9 ptm -119.54 136.96 54.13 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.178 0.513 . . . . 5.01 109.722 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -134.41 139.51 45.62 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.47 -0.768 . . . . 0.02 109.954 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.431 HG22 HD13 ' A' ' 60' ' ' ILE . 29.0 mm -94.1 130.34 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.924 -0.769 . . . . 1.72 108.924 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.546 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.55 110.69 35.32 Favored Pre-proline 0 N--CA 1.505 2.308 0 O-C-N 121.39 -0.819 . . . . 0.02 110.877 -178.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.99 169.32 20.69 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 119.823 0.972 . . . . 1.47 110.388 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -53.97 141.25 28.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.882 -1.136 . . . . 4.25 110.728 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.72 -177.64 31.91 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.509 -1.329 . . . . 0.02 110.748 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -119.42 131.38 55.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.388 -1.066 . . . . 0.96 109.887 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 73.5 m-85 -121.67 98.09 46.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.051 -1.092 . . . . 0.02 108.051 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.423 ' O ' ' OG ' ' A' ' 38' ' ' SER . 7.3 Cg_endo -70.61 -3.82 13.36 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 120.787 0.991 . . . . 0.02 113.576 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -157.33 154.54 29.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.489 -1.382 . . . . 2.02 107.966 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -59.85 -39.07 83.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.434 -0.792 . . . . 0.02 111.722 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -59.75 -24.39 64.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.02 110.496 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -69.95 -18.89 63.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 3.42 109.247 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.554 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.12 10.61 28.02 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.637 -1.245 . . . . 0.02 107.637 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 mtt 60.67 21.97 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.555 0.693 . . . . 0.02 110.359 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.02 144.28 44.98 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.332 -1.507 . . . . 0.02 109.332 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.2 tp -78.64 -30.46 46.38 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.502 -1.296 . . . . 0.98 107.502 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -157.66 -171.39 3.54 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.326 -1.731 . . . . 0.02 106.326 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -98.93 28.56 4.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.62 -1.3 . . . . 0.02 110.433 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -97.84 123.3 41.74 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.026 -1.046 . . . . 3.2 111.36 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.1 mt -142.5 119.6 11.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.259 -1.385 . . . . 2.61 107.259 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.98 -18.07 10.98 Favored Glycine 0 N--CA 1.497 2.703 0 O-C-N 121.249 -0.907 . . . . 0.02 111.949 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.589 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 15.8 t -155.67 155.29 32.95 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.321 -1.693 . . . . 0.02 110.826 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.589 ' N ' ' HG ' ' A' ' 81' ' ' SER . 30.0 p -146.02 148.2 32.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.02 110.19 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.445 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 49.0 mtp180 -137.43 142.05 41.62 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.88 -0.785 . . . . 0.01 108.88 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.65 133.06 37.27 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.175 -0.953 . . . . 0.43 109.276 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.18 123.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.351 -0.981 . . . . 1.25 108.351 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -91.47 131.75 36.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.678 -1.264 . . . . 1.77 107.958 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.52 137.28 35.83 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.145 -1.057 . . . . 1.63 108.145 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 t -109.7 126.47 53.73 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.454 -0.943 . . . . 1.08 108.454 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.3 m -103.47 -154.48 0.5 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.211 -1.774 . . . . 1.26 106.211 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.36 -50.12 0.88 Allowed Glycine 0 N--CA 1.497 2.748 0 O-C-N 120.692 -1.255 . . . . 0.01 111.676 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.87 -99.41 0.13 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.74 -1.695 . . . . 0.01 112.001 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.42 119.2 32.34 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.311 -1.111 . . . . 4.43 110.457 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.79 137.52 56.68 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.765 -0.584 . . . . 2.99 109.472 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -134.55 131.51 38.03 Favored 'General case' 0 N--CA 1.519 2.994 0 O-C-N 121.083 -1.011 . . . . 6.36 113.19 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 tt -131.83 141.96 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 115.525 -0.761 . . . . 1.09 110.237 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.532 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 2.3 pm0 -125.11 140.34 52.97 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 107.743 -1.206 . . . . 2.05 107.743 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.3 145.79 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 O-C-N 120.603 -1.31 . . . . 1.1 111.038 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 27.6 m-85 -119.79 140.05 51.37 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.218 1.009 . . . . 0.73 110.959 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.27 -32.97 73.51 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.801 -0.636 . . . . 0.02 111.48 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -115.02 168.91 9.5 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.213 -0.929 . . . . 3.18 109.953 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.25 169.03 47.31 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 111.011 -0.836 . . . . 0.01 111.011 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.7 t0 53.55 39.11 29.61 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.66 0.743 . . . . 0.01 111.594 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 52.53 48.41 22.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.553 -0.717 . . . . 0.01 110.828 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 24.2 t30 -121.53 164.36 17.35 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.307 -0.997 . . . . 3.15 108.307 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 90.68 -163.13 29.52 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.118 -1.593 . . . . 0.01 109.118 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -75.48 141.82 43.03 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.839 -1.389 . . . . 0.01 109.222 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 41.3 ttp -116.39 143.39 45.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.613 0.721 . . . . 0.01 109.528 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -132.52 136.18 46.46 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.34 -0.985 . . . . 2.48 108.34 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -117.0 134.72 54.38 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.702 -0.624 . . . . 0.01 109.642 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -149.49 148.55 29.54 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.419 1.104 . . . . 1.69 111.353 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 p -115.6 6.91 14.68 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.045 -0.98 . . . . 0.01 110.015 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.56 163.34 19.05 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.505 -0.747 . . . . 3.21 111.107 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -68.31 152.59 45.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.01 109.822 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.1 t -126.52 113.79 23.02 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.901 -0.777 . . . . 0.01 108.901 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -76.1 -33.27 3.66 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 CA-C-N 120.19 1.103 . . . . 0.01 111.658 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.4 p -140.91 106.84 5.16 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.056 0.931 . . . . 0.02 108.645 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.44 -39.36 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.772 -0.58 . . . . 1.83 111.186 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.0 ttt -67.26 -37.24 83.15 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.024 -1.07 . . . . 1.34 109.578 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -69.6 -38.39 77.28 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.64 -1.288 . . . . 2.11 109.858 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.17 -46.51 16.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 2.08 112.265 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -110.11 -0.14 18.09 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.317 -0.864 . . . . 0.02 112.694 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 59.81 33.26 21.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.653 -1.279 . . . . 0.02 109.379 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.76 135.64 53.27 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 108.676 -0.861 . . . . 0.02 108.676 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -92.34 -23.19 19.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 5.32 110.46 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -149.16 163.32 37.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.163 -0.961 . . . . 0.02 110.073 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.408 HD13 HG23 ' A' ' 126' ' ' ILE . 43.4 mt -132.06 129.66 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 107.189 -1.412 . . . . 2.17 107.189 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -105.75 -12.31 15.94 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.381 -0.928 . . . . 0.02 112.59 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.18 152.8 29.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.368 -1.458 . . . . 0.01 108.11 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 12.8 t -162.88 141.86 8.7 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.556 -1.34 . . . . 1.22 109.465 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.405 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 30.5 ttpt -124.04 114.47 19.78 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.643 1.211 . . . . 1.41 109.656 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.39 123.75 61.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 105.614 -1.995 . . . . 0.01 105.614 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.0 t -147.65 71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 C-N-CA 118.404 -1.318 . . . . 1.98 108.205 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 171.35 108.29 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.427 -1.694 . . . . 0.01 106.427 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.75 -172.31 46.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.563 -1.415 . . . . 0.01 109.563 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -110.25 140.89 43.94 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.555 -0.968 . . . . 2.3 108.877 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -129.85 146.69 51.57 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.443 -0.786 . . . . 0.01 110.442 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 61.1 mt -118.36 139.86 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 107.816 -1.179 . . . . 1.69 107.816 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.04 141.96 46.26 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.103 -1.443 . . . . 2.49 107.103 178.057 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 6.7 m-85 -122.55 144.39 49.12 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.593 -0.692 . . . . 0.02 109.155 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -73.92 -30.12 62.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.586 -0.696 . . . . 0.02 112.407 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.3 mt -115.05 153.56 47.17 Favored Pre-proline 0 N--CA 1.506 2.349 0 O-C-N 120.773 -1.204 . . . . 1.48 109.085 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.3 166.67 1.6 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.117 1.211 . . . . 0.02 112.522 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 59.54 30.76 20.43 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.225 -0.898 . . . . 0.75 111.114 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.56 52.21 7.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.424 -0.798 . . . . 0.02 111.272 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -125.78 163.84 21.98 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.532 -0.73 . . . . 0.02 109.959 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.67 -165.56 32.29 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.078 -1.209 . . . . 0.02 110.078 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -68.1 141.69 56.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.543 -0.975 . . . . 0.02 108.941 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -118.15 149.92 40.24 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 116.044 -0.526 . . . . 0.02 109.676 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.56 140.82 51.87 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.221 -0.659 . . . . 0.01 109.221 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.5 tp -95.13 121.69 37.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.414 -0.804 . . . . 0.01 109.191 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.62 ' CD2' ' HE1' ' A' ' 162' ' ' TRP . 5.8 mt -104.62 113.98 27.91 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.384 -0.823 . . . . 0.01 109.677 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 152' ' ' ASP . 5.3 m-20 -113.9 89.83 3.19 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 108.702 -0.851 . . . . 2.27 108.702 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 51.8 tttp 49.37 78.86 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.99 -1.069 . . . . 1.84 108.267 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -131.45 144.4 51.14 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.468 -0.77 . . . . 2.28 111.902 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -112.98 99.79 8.13 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.329 -1.36 . . . . 0.01 107.329 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -98.06 116.72 30.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.096 -1.003 . . . . 0.01 110.853 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -97.72 -27.3 14.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.434 -0.791 . . . . 0.01 110.734 -178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -125.72 152.44 72.28 Favored Pre-proline 0 N--CA 1.502 2.137 0 N-CA-C 108.527 -0.916 . . . . 2.54 108.527 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -57.87 -47.49 20.6 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 CA-C-N 119.313 0.79 . . . . 0.7 110.889 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.58 -23.57 29.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.829 -1.17 . . . . 0.86 109.435 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 11.9 t0 -66.8 -16.22 64.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.777 -1.202 . . . . 0.02 109.492 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.62 ' HE1' ' CD2' ' A' ' 151' ' ' LEU . 2.2 t90 -95.06 7.83 44.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.529 -0.915 . . . . 0.02 108.529 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.98 8.18 84.67 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.904 -1.278 . . . . 0.02 109.904 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.27 142.84 30.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.552 -0.97 . . . . 0.02 110.035 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.31 -8.97 58.85 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.728 -0.608 . . . . 0.59 109.635 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.7 t -146.46 151.38 43.33 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.825 -1.172 . . . . 0.87 108.113 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.22 24.85 0.39 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.768 0.979 . . . . 0.38 112.344 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.27 123.01 30.27 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.87 -1.144 . . . . 0.18 112.803 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.6 mp -146.84 126.92 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.429 -1.693 . . . . 3.99 106.429 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -112.16 -17.88 12.7 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.917 -1.114 . . . . 5.17 113.605 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.8 p -157.79 160.82 38.2 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 119.18 -2.2 . . . . 0.02 110.263 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -153.2 153.74 33.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.054 -1.029 . . . . 2.02 110.766 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -144.72 152.16 39.97 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.205 -0.934 . . . . 0.01 110.908 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -88.31 141.82 28.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.118 -0.697 . . . . 0.01 109.118 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.0 mt -94.42 129.41 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.215 -0.928 . . . . 3.04 109.105 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.29 147.22 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.186 -0.946 . . . . 1.89 109.681 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 4.89 109.366 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.388 -0.597 . . . . 5.28 109.388 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -55.35 116.69 2.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 5.96 109.463 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 p -89.9 -139.74 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.367 -1.346 . . . . 2.22 107.367 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.67 -174.95 45.81 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 117.421 -2.323 . . . . 0.81 112.9 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.88 160.36 44.77 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.425 -1.47 . . . . 0.01 109.425 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -147.67 136.03 21.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.093 -1.239 . . . . 0.02 110.267 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -130.38 140.32 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.211 -0.663 . . . . 0.02 109.211 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.95 130.9 53.7 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.429 -0.795 . . . . 0.39 110.191 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.9 m-85 -110.98 140.62 45.34 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.546 -0.721 . . . . 0.02 109.487 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -121.89 138.1 54.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.365 -0.834 . . . . 0.02 109.49 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.43 -27.25 65.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.957 -1.09 . . . . 0.03 111.681 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -113.88 169.63 8.85 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.927 -1.108 . . . . 0.03 110.212 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.51 ' NH2' ' OE2' ' A' ' 68' ' ' GLU . 21.8 mtp180 -75.91 158.43 32.05 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.614 0.721 . . . . 0.03 110.159 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 66.39 33.26 7.06 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.05 0.928 . . . . 0.74 111.082 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 55.58 41.8 30.27 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.932 -0.576 . . . . 0.02 111.39 177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -113.44 165.72 12.19 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.357 -0.979 . . . . 0.02 108.357 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.18 -167.94 34.81 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.851 -1.166 . . . . 0.03 110.536 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -69.03 142.84 54.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.443 -1.034 . . . . 2.76 108.955 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -122.2 149.96 42.93 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.614 -0.679 . . . . 1.89 110.053 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -136.59 133.02 35.91 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.329 -0.619 . . . . 0.02 109.329 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 20.6 p-10 -109.22 136.79 48.12 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.761 -0.829 . . . . 1.12 108.761 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 16.0 t -128.21 138.44 52.46 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.556 -0.715 . . . . 0.02 109.891 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -119.74 11.53 11.95 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.647 -0.658 . . . . 0.2 110.776 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.525 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 26.7 p -159.7 173.48 15.99 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.562 -1.336 . . . . 1.23 109.418 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.09 145.89 54.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.404 -1.435 . . . . 0.02 110.688 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.9 m -135.1 119.57 18.01 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.037 -0.727 . . . . 0.02 109.037 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.25 -20.33 55.33 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.425 -0.797 . . . . 0.24 111.918 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -153.96 106.62 2.86 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.838 -1.163 . . . . 1.14 109.792 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.77 5.65 38.93 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.378 -0.826 . . . . 6.37 110.289 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -60.5 -29.21 68.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 3.11 111.976 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 p -76.86 -16.78 59.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.417 -1.427 . . . . 0.88 111.039 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -106.13 -21.63 13.07 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.326 -0.859 . . . . 0.02 110.684 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 tp -149.44 127.67 12.09 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.988 -1.07 . . . . 3.32 109.534 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -87.63 -12.41 45.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.562 -0.711 . . . . 0.02 110.966 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -171.82 160.85 5.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.854 -1.154 . . . . 0.02 108.541 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.38 116.1 8.71 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.975 -1.078 . . . . 0.02 108.846 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -108.6 -0.91 19.98 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.811 -1.18 . . . . 0.03 111.363 -178.331 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 21.1 m -154.73 153.64 31.6 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mt -146.67 147.41 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.296 1.046 . . . . 0.02 110.735 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -123.75 124.53 42.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.052 -1.092 . . . . 0.02 108.052 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 t -105.28 113.88 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.654 -1.609 . . . . 0.02 106.654 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -85.52 -34.9 21.44 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.079 -0.649 . . . . 3.81 110.212 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.56 149.11 16.78 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 118.481 -1.819 . . . . 0.02 110.773 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.75 172.18 48.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.08 -1.208 . . . . 0.01 110.08 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.8 m -118.26 134.37 55.08 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.422 -1.325 . . . . 1.48 107.422 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -126.78 154.49 44.19 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.694 1.235 . . . . 0.02 112.411 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.25 133.97 52.36 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 105.18 -2.155 . . . . 0.24 105.18 176.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.1 m -116.38 142.01 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.494 -0.754 . . . . 0.65 109.268 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -120.85 143.06 49.09 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.104 0.954 . . . . 0.02 109.607 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.88 -33.82 76.93 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.527 -0.761 . . . . 0.02 111.76 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -124.76 158.01 63.98 Favored Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 120.971 -1.081 . . . . 0.02 109.366 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.29 167.14 0.87 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.548 1.499 . . . . 0.02 112.76 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 63.2 36.58 11.88 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.245 -0.888 . . . . 0.02 111.11 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' H ' ' HG ' ' A' ' 81' ' ' SER . 4.1 m-85 45.1 51.59 8.89 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.626 0.727 . . . . 3.39 110.677 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.7 p -125.69 163.33 23.04 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.227 0.537 . . . . 2.33 109.966 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.51 -161.59 31.23 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.58 -1.408 . . . . 0.02 109.58 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -65.27 138.9 58.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.962 -1.317 . . . . 0.02 110.153 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.2 ptm -118.86 137.31 53.52 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.314 0.578 . . . . 5.01 109.717 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -134.27 139.34 45.67 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.52 -0.738 . . . . 0.02 109.818 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.9 mm -94.54 130.5 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.906 -0.775 . . . . 1.72 108.906 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.78 110.84 34.83 Favored Pre-proline 0 N--CA 1.506 2.359 0 O-C-N 121.417 -0.802 . . . . 0.02 110.784 -178.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -78.06 169.61 20.14 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.855 0.984 . . . . 1.47 110.438 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -53.71 141.18 27.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.966 -1.084 . . . . 4.25 110.589 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.66 -177.61 31.88 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.485 -1.341 . . . . 0.02 110.94 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -119.91 131.38 55.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.377 -1.073 . . . . 0.96 109.785 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 76.3 m-85 -121.29 97.74 47.24 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 107.959 -1.126 . . . . 0.02 107.959 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.43 ' O ' ' OG ' ' A' ' 38' ' ' SER . 4.8 Cg_endo -69.38 -4.46 13.82 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 120.731 0.954 . . . . 0.02 113.754 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.51 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 74.6 mt-10 -157.53 154.66 28.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.693 -1.255 . . . . 2.02 107.97 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -59.45 -38.69 81.4 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.473 -0.767 . . . . 0.02 111.978 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -60.36 -23.98 64.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 0.02 110.554 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -70.04 -18.78 63.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.38 -0.825 . . . . 3.42 108.951 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.552 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.69 10.4 26.88 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.562 -1.273 . . . . 0.02 107.562 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 mtt 60.94 22.32 12.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.735 . . . . 0.02 110.457 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.36 144.48 45.46 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.389 -1.484 . . . . 0.02 109.389 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.09 -31.2 44.25 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.494 -1.299 . . . . 0.98 107.494 177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -157.18 -171.82 3.77 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.383 -1.71 . . . . 0.02 106.383 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 92.9 m-20 -98.5 28.1 4.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.784 -1.198 . . . . 0.02 110.718 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -97.64 123.17 41.44 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.085 -1.009 . . . . 3.2 111.422 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.0 mt -142.01 119.56 11.7 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.221 -1.4 . . . . 2.61 107.221 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.22 -18.31 10.55 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.229 -0.92 . . . . 0.02 112.14 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.476 ' HG ' ' H ' ' A' ' 54' ' ' PHE . 3.8 p -155.84 156.01 33.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.371 -1.664 . . . . 0.02 110.583 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.2 p -145.72 148.15 32.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.497 -0.752 . . . . 0.02 110.08 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.412 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 54.3 mtp180 -137.4 142.03 41.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.383 -0.823 . . . . 0.01 109.075 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.8 132.38 36.86 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.259 -0.901 . . . . 0.43 109.394 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 t -89.52 123.75 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.43 -0.952 . . . . 1.25 108.43 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -91.84 131.87 36.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.925 -1.109 . . . . 1.77 108.267 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.99 138.02 35.17 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.16 -1.052 . . . . 1.63 108.16 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 m -110.01 126.79 54.33 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.665 -0.865 . . . . 1.08 108.665 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.4 m -103.34 -154.39 0.5 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.196 -1.779 . . . . 1.26 106.196 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.42 -49.91 0.87 Allowed Glycine 0 N--CA 1.497 2.701 0 O-C-N 120.517 -1.364 . . . . 0.01 111.891 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.28 -99.86 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 118.723 -1.703 . . . . 0.01 111.822 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -119.67 119.35 33.44 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.258 -1.142 . . . . 4.43 110.465 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.12 135.59 54.78 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.304 -0.628 . . . . 2.99 109.304 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -134.69 131.06 37.23 Favored 'General case' 0 N--CA 1.519 3.021 0 O-C-N 121.024 -1.047 . . . . 6.36 113.079 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 tt -131.83 142.04 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 115.467 -0.788 . . . . 1.09 110.384 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.531 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.4 pt20 -124.32 138.44 54.38 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 107.285 -1.376 . . . . 2.05 107.285 176.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -124.55 147.23 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 120.586 -1.321 . . . . 1.1 111.188 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -119.86 141.51 49.49 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 122.385 1.088 . . . . 0.73 111.582 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -69.54 -33.18 72.42 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.738 -0.664 . . . . 0.02 111.135 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 12.0 mptt -113.84 167.73 10.39 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.185 -0.947 . . . . 3.18 109.545 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.38 169.69 46.55 Favored Glycine 0 N--CA 1.492 2.404 0 CA-C-O 122.033 0.796 . . . . 0.01 111.318 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 53.26 40.09 30.75 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.632 0.73 . . . . 0.01 111.605 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 52.58 47.73 24.07 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.523 -0.735 . . . . 0.01 110.785 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -121.47 165.28 15.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.12 -1.066 . . . . 3.15 108.12 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.27 -162.93 29.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.168 -1.573 . . . . 0.01 109.168 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -76.14 141.87 41.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.903 -1.351 . . . . 0.01 108.967 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.456 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.0 tmm? -116.08 143.28 45.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.497 0.665 . . . . 0.01 109.595 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -132.28 136.4 46.91 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.421 -0.955 . . . . 2.48 108.421 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -116.78 134.19 55.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.703 -0.623 . . . . 0.01 109.871 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.2 t -149.13 148.54 29.77 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 122.466 1.126 . . . . 1.69 111.444 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -114.74 7.64 15.93 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.062 -0.972 . . . . 0.01 110.1 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.89 163.35 19.39 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.43 -0.794 . . . . 3.21 111.28 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 154.41 42.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.01 109.379 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 35.0 t -125.8 114.5 24.64 Favored Pre-proline 0 N--CA 1.5 2.025 0 N-CA-C 109.19 -0.671 . . . . 0.01 109.19 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -75.59 -33.81 3.78 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 CA-C-N 120.225 1.116 . . . . 0.01 111.488 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 55.0 m -141.46 107.55 5.2 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.921 0.867 . . . . 0.02 108.84 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.7 mt -65.01 -39.04 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.748 -0.595 . . . . 1.83 111.182 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.6 ttt -66.88 -37.36 84.25 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.936 -1.105 . . . . 1.34 109.577 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -69.81 -38.56 76.64 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.59 -1.319 . . . . 2.11 109.752 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -80.16 -47.58 14.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.314 -0.866 . . . . 2.08 112.491 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.43 -0.65 16.2 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.389 -0.82 . . . . 0.02 112.724 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m170 59.71 33.63 21.9 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.76 -1.213 . . . . 0.02 109.5 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 mt -112.3 135.28 53.17 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.637 -0.875 . . . . 0.02 108.637 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -92.45 -23.44 19.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 5.32 110.664 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -149.34 163.63 37.16 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.218 -0.926 . . . . 0.02 110.12 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 126' ' ' ILE . 57.5 mt -131.89 129.48 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.237 -1.394 . . . . 2.17 107.237 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -106.32 -12.49 15.67 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.109 -0.994 . . . . 0.02 113.068 -176.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 1.5 p -158.9 156.23 29.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.636 -1.29 . . . . 0.01 107.519 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 3.3 t -163.18 147.18 10.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.939 -1.1 . . . . 1.22 109.541 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.75 108.93 15.01 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.132 0.968 . . . . 1.41 108.767 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.49 121.6 61.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 105.886 -1.894 . . . . 0.01 105.886 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.1 t -147.24 69.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 118.072 -1.451 . . . . 1.98 108.289 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.68 107.56 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.238 -1.764 . . . . 0.01 106.238 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.19 -176.46 40.95 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.604 -1.399 . . . . 0.01 109.604 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.6 m -110.74 146.83 35.63 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.413 -1.051 . . . . 2.3 109.103 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -131.54 149.11 52.64 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.491 -0.756 . . . . 0.01 110.693 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 58.8 mt -118.8 140.61 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.66 -1.237 . . . . 1.69 107.66 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.14 141.44 46.93 Favored 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 107.314 -1.365 . . . . 2.49 107.314 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 7.4 m-85 -122.64 145.46 48.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.408 -0.807 . . . . 0.02 109.325 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.79 -30.03 61.3 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.561 -0.712 . . . . 0.02 112.187 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.45 153.33 47.64 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 120.684 -1.26 . . . . 1.48 109.068 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.13 167.06 1.33 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.27 1.313 . . . . 0.02 112.478 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.2 t30 59.22 31.11 20.95 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.051 -0.977 . . . . 0.75 111.027 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.57 51.32 9.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.563 -0.711 . . . . 0.02 111.06 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -124.12 163.31 21.76 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.533 -0.729 . . . . 0.02 109.726 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.53 -165.13 32.18 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.889 -1.284 . . . . 0.02 109.889 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -67.84 141.62 56.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.453 -1.028 . . . . 0.02 108.877 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -117.63 149.09 41.27 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.195 -0.669 . . . . 0.02 109.195 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -128.47 141.85 51.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.5 -0.75 . . . . 0.01 109.346 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.12 118.14 31.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.258 -0.901 . . . . 0.01 108.821 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.58 135.55 47.9 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.454 -0.778 . . . . 0.01 109.519 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 154' ' ' LYS . 14.4 p30 -109.62 172.73 6.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.234 -0.917 . . . . 2.27 109.157 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 83.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.14 -0.975 . . . . 1.84 108.738 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 152' ' ' ASP . 51.3 tttm -136.3 166.46 23.39 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.192 -0.942 . . . . 2.28 111.332 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 1.4 pm0 -110.04 108.48 18.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.805 -1.183 . . . . 0.01 107.805 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.608 ' CE2' ' NE1' ' A' ' 162' ' ' TRP . 94.4 m-85 -99.08 114.27 26.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.026 -1.046 . . . . 0.01 110.314 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -91.98 -27.82 17.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.443 -0.786 . . . . 0.01 111.208 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -126.26 152.23 73.4 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 120.96 -1.088 . . . . 2.54 108.228 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -59.72 -44.25 32.66 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 CA-C-N 119.283 0.78 . . . . 0.7 111.185 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.3 t -61.09 -21.62 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.789 -1.194 . . . . 0.86 109.509 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -65.92 -15.84 63.32 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.748 -1.22 . . . . 0.02 110.057 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.608 ' NE1' ' CE2' ' A' ' 156' ' ' TYR . 0.0 OUTLIER -97.39 11.22 37.4 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.548 -0.908 . . . . 0.02 108.548 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.2 10.0 86.54 Favored Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.633 -1.27 . . . . 0.02 110.346 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.71 142.39 31.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.281 -1.129 . . . . 0.02 110.146 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.2 -9.47 57.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.688 -0.633 . . . . 0.59 110.314 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -145.51 150.49 44.13 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.703 -1.248 . . . . 0.87 108.957 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -76.19 21.23 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 120.888 1.059 . . . . 0.38 112.47 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.6 124.66 30.36 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.454 1.121 . . . . 0.18 111.762 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 42.3 mt -145.71 125.91 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.526 -1.657 . . . . 3.99 106.526 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -112.06 -20.7 11.86 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.008 -1.057 . . . . 5.17 112.584 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.422 ' HG ' ' N ' ' A' ' 172' ' ' PHE . 48.2 t -156.5 159.67 38.82 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 119.546 -1.971 . . . . 0.02 109.725 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.422 ' N ' ' HG ' ' A' ' 171' ' ' SER . 12.7 p90 -153.13 154.02 33.97 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.008 -1.058 . . . . 2.02 110.649 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -144.52 151.61 39.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.156 -0.965 . . . . 0.01 110.558 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -87.59 142.33 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.952 -0.759 . . . . 0.01 108.952 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.9 mt -93.93 128.8 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.145 -0.972 . . . . 3.04 109.004 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.28 146.9 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.208 -0.932 . . . . 1.89 109.46 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 4.89 109.502 179.876 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.313 0.578 . . . . 5.28 109.528 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -68.4 -112.48 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 5.96 109.518 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -175.4 158.82 2.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.242 -1.536 . . . . 2.22 108.653 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.38 178.47 47.8 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.819 -1.658 . . . . 0.81 111.658 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.82 156.08 43.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.106 -1.598 . . . . 0.01 109.106 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -148.46 136.03 20.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.071 -1.252 . . . . 0.02 110.209 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -130.35 140.59 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.198 -0.668 . . . . 0.02 109.198 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 t -120.86 129.82 53.68 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.544 -0.722 . . . . 0.39 109.908 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 m-85 -109.81 139.47 44.85 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.61 -0.681 . . . . 0.02 109.239 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.515 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.5 m-85 -121.56 137.9 54.54 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.209 -0.932 . . . . 0.02 109.416 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.8 -27.34 64.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.074 -1.016 . . . . 0.03 111.756 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.48 170.66 8.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.843 -1.161 . . . . 0.03 109.95 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.457 ' CZ ' ' OE1' ' A' ' 68' ' ' GLU . 37.4 mtp180 -75.02 161.25 29.62 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.699 0.761 . . . . 0.03 110.245 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.2 m120 62.68 35.03 14.38 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.937 0.875 . . . . 0.74 110.565 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.6 p90 49.49 43.4 23.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.365 -0.834 . . . . 0.02 110.932 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -109.54 165.61 11.53 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.877 -1.157 . . . . 0.02 107.877 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.73 -167.83 33.92 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 120.748 -1.22 . . . . 0.03 110.733 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -69.37 143.71 53.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -1.059 . . . . 2.76 109.071 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -122.85 150.2 43.18 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.529 -0.732 . . . . 1.89 110.24 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -136.05 133.28 37.24 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.245 -0.65 . . . . 0.02 109.245 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -109.22 135.61 50.05 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.708 -0.849 . . . . 1.12 108.708 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.3 t -127.85 138.11 52.58 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.649 -0.657 . . . . 0.02 109.411 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 24.5 p-10 -118.89 12.1 12.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.747 -0.596 . . . . 0.2 110.166 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.8 p -160.18 173.67 15.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.864 -1.148 . . . . 1.23 109.083 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.18 146.07 54.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.838 -1.164 . . . . 0.02 110.657 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 29' ' ' PHE . 5.5 t -133.75 117.92 17.48 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.767 -0.827 . . . . 0.02 108.767 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.53 -21.25 49.07 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.299 -0.876 . . . . 0.24 111.865 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.99 105.79 3.29 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.784 -1.197 . . . . 1.14 109.496 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.581 ' CD2' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -101.32 5.33 42.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.459 -0.776 . . . . 6.37 110.351 -178.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -62.48 -29.78 70.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 3.11 112.669 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.6 p -77.11 -19.04 57.5 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.152 -1.592 . . . . 0.88 111.806 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -106.99 -19.49 13.61 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.303 -0.873 . . . . 0.02 110.152 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -148.73 126.97 12.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.994 -1.066 . . . . 3.32 109.39 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 m -87.43 -12.5 45.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.53 -0.732 . . . . 0.02 111.174 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -172.61 162.0 5.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.807 -1.183 . . . . 0.02 108.43 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.9 p -142.77 115.2 8.5 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.992 -1.068 . . . . 0.02 108.791 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -107.87 -1.97 20.28 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.858 -1.152 . . . . 0.03 111.441 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.02 153.63 33.3 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.7 mt -147.23 147.64 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.041 -1.037 . . . . 0.02 110.653 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -125.33 125.94 44.28 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.868 -1.16 . . . . 0.02 107.868 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.5 t -105.39 114.24 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 106.828 -1.545 . . . . 0.02 106.828 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -85.37 -34.83 21.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 3.81 110.131 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.7 149.07 16.6 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 118.38 -1.867 . . . . 0.02 110.797 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.86 172.42 48.78 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.144 -1.182 . . . . 0.01 110.144 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -118.34 134.48 55.01 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.572 -1.27 . . . . 1.48 107.572 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -126.77 154.04 44.76 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.595 1.188 . . . . 0.02 112.382 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.69 133.53 52.66 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.094 -2.187 . . . . 0.24 105.094 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -117.75 143.28 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.546 -0.721 . . . . 0.65 109.279 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.544 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 33.1 m-85 -120.72 145.1 47.84 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.197 0.999 . . . . 0.02 109.917 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.97 -33.66 76.32 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.76 -0.654 . . . . 0.02 111.436 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -124.71 158.01 63.83 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.122 -0.986 . . . . 0.02 109.484 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.7 167.16 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.747 1.631 . . . . 0.02 112.716 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.0 t30 63.29 36.55 11.66 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.309 -0.859 . . . . 0.02 111.015 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.433 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 7.2 m-85 45.59 51.49 9.92 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.619 0.723 . . . . 3.39 110.936 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -126.13 163.63 22.68 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.223 0.535 . . . . 2.33 110.014 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.85 -161.87 30.99 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.895 -1.282 . . . . 0.02 109.895 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -65.16 139.5 58.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.966 -1.314 . . . . 0.02 110.134 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.544 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 49.2 ttp -118.35 137.34 53.16 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.292 0.568 . . . . 5.01 109.827 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.535 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.6 m-85 -134.75 138.81 44.66 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.467 -0.77 . . . . 0.02 109.911 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.2 mm -94.55 130.89 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.003 -0.74 . . . . 1.72 109.003 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -120.36 110.76 35.58 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.396 -0.815 . . . . 0.02 110.631 -178.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -78.25 169.2 20.57 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.876 0.992 . . . . 1.47 110.275 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -53.79 140.64 29.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.831 -1.168 . . . . 4.25 110.558 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.17 -177.56 32.32 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.635 -1.269 . . . . 0.02 110.61 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -118.58 130.41 55.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.454 -1.027 . . . . 0.96 109.735 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 53.2 m-85 -120.61 97.25 48.72 Favored Pre-proline 0 N--CA 1.494 1.763 0 N-CA-C 107.994 -1.113 . . . . 0.02 107.994 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -69.73 -3.72 12.55 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.69 0.926 . . . . 0.02 113.656 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.457 ' OE1' ' CZ ' ' A' ' 13' ' ' ARG . 40.6 mt-10 -157.49 154.17 28.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.579 -1.326 . . . . 2.02 108.138 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -59.63 -38.82 82.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.485 -0.759 . . . . 0.02 111.768 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -60.26 -23.92 64.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.105 -0.997 . . . . 0.02 110.283 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -70.15 -18.58 63.22 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.812 0.815 . . . . 3.42 108.842 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.561 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 0.7 OUTLIER -108.13 11.13 27.8 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.378 -1.342 . . . . 0.02 107.378 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' A' ' 73' ' ' MET . 1.2 mpt? 59.04 22.61 10.66 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.66 0.743 . . . . 0.02 110.435 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.48 145.16 45.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.409 -1.476 . . . . 0.02 109.409 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.38 -31.6 42.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.122 -1.222 . . . . 0.98 107.751 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -157.07 -171.88 3.81 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.501 -1.666 . . . . 0.02 106.501 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -98.05 28.26 4.08 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.738 -1.226 . . . . 0.02 110.612 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -97.7 122.72 41.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.921 -1.112 . . . . 3.2 111.225 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.1 mt -142.24 119.25 11.31 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.372 -1.344 . . . . 2.61 107.372 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.79 -18.22 10.99 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.272 -0.893 . . . . 0.02 112.18 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 76.9 p -155.68 155.62 33.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.335 -1.685 . . . . 0.02 110.169 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.4 p -145.27 148.03 33.02 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.712 -0.618 . . . . 0.02 109.669 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 66.5 mtm180 -137.4 142.2 41.69 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.474 -0.766 . . . . 0.01 109.17 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.97 133.15 36.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.227 -0.92 . . . . 0.43 109.413 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.33 123.91 42.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.593 -0.892 . . . . 1.25 108.593 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -91.75 131.67 36.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.731 -1.231 . . . . 1.77 108.147 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mt -97.12 138.57 34.44 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.194 -1.039 . . . . 1.63 108.194 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.1 m -110.43 126.33 54.2 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.652 -0.87 . . . . 1.08 108.652 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 t -102.96 -154.82 0.5 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.011 -1.848 . . . . 1.26 106.011 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.48 -49.27 0.89 Allowed Glycine 0 N--CA 1.496 2.694 0 O-C-N 120.472 -1.392 . . . . 0.01 111.847 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.08 -99.24 0.12 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 118.77 -1.681 . . . . 0.01 111.897 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -120.59 120.26 35.28 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.321 -1.105 . . . . 4.43 110.595 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.28 135.83 54.98 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.365 -0.606 . . . . 2.99 109.365 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.511 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 2.4 ttmp? -134.5 130.67 37.03 Favored 'General case' 0 N--CA 1.518 2.974 0 CA-C-O 122.258 1.028 . . . . 6.36 113.074 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 tt -131.62 142.2 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.5 -0.773 . . . . 1.09 110.143 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.504 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.5 pt20 -124.53 139.74 53.6 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.611 -1.255 . . . . 2.05 107.611 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.16 145.83 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 120.68 -1.262 . . . . 1.1 111.2 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.525 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 76.1 m-85 -120.2 139.91 51.94 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.045 0.926 . . . . 0.73 110.758 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.31 -32.11 72.01 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.836 -0.62 . . . . 0.02 111.791 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -114.6 167.73 10.49 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.064 -1.022 . . . . 3.18 110.352 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.53 164.35 52.79 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 111.071 -0.812 . . . . 0.01 111.071 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 57.74 38.77 27.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 122.02 -0.694 . . . . 0.01 111.595 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 52.29 54.95 9.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.519 -0.738 . . . . 0.01 111.208 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -128.97 165.46 21.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.041 -1.096 . . . . 3.15 108.041 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.06 -162.99 30.21 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.014 -1.634 . . . . 0.01 109.014 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -75.73 141.6 42.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.879 -1.366 . . . . 0.01 109.193 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.525 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 51.1 ttp -116.48 143.09 46.02 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.645 0.736 . . . . 0.01 109.548 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -131.91 136.13 47.16 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 2.48 108.21 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.406 ' OE2' ' N ' ' A' ' 110' ' ' THR . 3.0 tm-20 -116.71 133.76 55.63 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.658 -0.651 . . . . 0.01 109.687 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.406 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 0.1 OUTLIER -149.09 148.31 29.53 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.429 1.109 . . . . 1.69 111.088 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -115.23 7.62 15.31 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.96 -1.018 . . . . 0.01 110.152 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -122.07 163.59 19.17 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.373 -0.83 . . . . 3.21 111.214 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.56 154.85 41.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.333 -0.855 . . . . 0.01 109.309 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.604 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 20.3 p -127.32 119.79 22.03 Favored Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 109.24 -0.652 . . . . 0.01 109.24 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -76.72 -33.39 3.01 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 120.198 1.107 . . . . 0.01 110.995 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.0 m -143.45 109.05 5.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.443 -0.786 . . . . 0.02 109.304 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.5 mt -64.04 -39.48 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.83 -0.544 . . . . 1.83 110.79 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.1 ttt -66.64 -37.27 84.47 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.102 -1.039 . . . . 1.34 109.79 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -69.98 -38.61 76.09 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.543 -1.348 . . . . 2.11 109.707 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -80.23 -47.06 15.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.356 -0.84 . . . . 2.08 112.39 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -110.69 -0.62 17.06 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.376 -0.827 . . . . 0.02 112.678 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.598 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.1 m-70 59.92 33.3 21.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.749 -1.219 . . . . 0.02 109.483 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.6 135.82 52.87 Favored 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 108.761 -0.829 . . . . 0.02 108.761 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -92.72 -23.15 19.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 5.32 110.6 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -148.89 163.32 37.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.048 -1.033 . . . . 0.02 110.082 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 126' ' ' ILE . 56.0 mt -131.87 129.49 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 107.345 -1.354 . . . . 2.17 107.345 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -107.09 -13.15 15.24 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.183 -0.948 . . . . 0.02 113.073 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.21 153.64 31.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.36 -1.462 . . . . 0.01 108.189 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.6 t -160.88 146.14 14.32 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.218 -1.551 . . . . 1.22 109.963 -178.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -121.82 109.08 14.23 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.143 0.973 . . . . 1.41 108.827 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.9 120.74 59.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.002 -1.851 . . . . 0.01 106.002 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -146.59 69.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 118.326 -1.35 . . . . 1.98 108.437 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.57 108.05 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.48 -1.674 . . . . 0.01 106.48 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.663 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 71.07 -172.84 43.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.658 -1.377 . . . . 0.01 109.658 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.24 146.05 37.64 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.466 -1.02 . . . . 2.3 108.93 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -131.35 145.23 51.76 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.441 -0.787 . . . . 0.01 110.389 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mt -117.69 140.94 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.806 -1.183 . . . . 1.69 107.806 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.27 143.63 44.54 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.58 -1.267 . . . . 2.49 107.58 177.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 11.2 m-85 -122.69 144.04 49.4 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.168 -0.678 . . . . 0.02 109.168 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -73.53 -29.72 62.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.654 -0.654 . . . . 0.02 112.088 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.88 153.78 48.19 Favored Pre-proline 0 N--CA 1.506 2.353 0 O-C-N 120.584 -1.322 . . . . 1.48 109.205 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.49 166.73 1.68 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.248 1.299 . . . . 0.02 112.686 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.3 t30 59.39 31.54 21.16 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.13 -0.941 . . . . 0.75 111.076 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.41 51.38 9.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.515 -0.741 . . . . 0.02 110.962 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -124.44 163.49 21.69 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.493 -0.754 . . . . 0.02 109.77 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' A' ' 148' ' ' GLN . . . 89.58 -165.44 32.31 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.755 -1.338 . . . . 0.02 109.755 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -67.97 141.76 56.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -1.059 . . . . 0.02 108.952 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.448 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -118.5 149.07 41.91 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.109 -0.7 . . . . 0.02 109.109 -178.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.37 142.33 51.15 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.576 -0.703 . . . . 0.01 109.121 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.11 120.68 35.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.505 -0.747 . . . . 0.01 109.27 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.0 mt -105.61 133.91 49.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.01 110.727 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 1.2 m-20 -110.31 176.43 5.05 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.183 -1.043 . . . . 2.27 108.183 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.663 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 37.7 mttm -56.66 85.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.985 -1.072 . . . . 1.84 108.571 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 44.8 mttp -136.47 165.13 26.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.233 -0.917 . . . . 2.28 111.778 -178.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -113.27 109.1 18.19 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.951 -1.129 . . . . 0.01 107.951 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -99.67 114.64 27.86 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.139 -0.975 . . . . 0.01 110.219 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -92.17 -25.86 18.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.17 -0.956 . . . . 0.01 111.151 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -125.47 153.65 72.47 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 121.169 -0.957 . . . . 2.54 108.526 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.67 -42.09 42.01 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 CA-C-N 119.227 0.76 . . . . 0.7 110.628 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.56 -20.38 20.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.731 -1.23 . . . . 0.86 108.535 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 37.5 t0 -65.74 -16.25 63.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.986 -1.071 . . . . 0.02 109.531 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.407 ' CZ3' ' CD1' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -94.86 9.59 38.58 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.847 -1.168 . . . . 0.02 107.847 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.99 10.62 86.16 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.308 -1.425 . . . . 0.02 109.716 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.91 142.11 31.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.491 -1.005 . . . . 0.02 110.162 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.08 -8.13 58.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.711 -0.618 . . . . 0.59 109.847 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 t -143.77 148.6 43.41 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.85 -1.156 . . . . 0.87 108.535 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -74.77 21.57 0.42 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 CA-C-N 119.842 0.979 . . . . 0.38 112.231 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.02 123.77 29.78 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.538 1.161 . . . . 0.18 111.781 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.407 ' CD1' ' CZ3' ' A' ' 162' ' ' TRP . 17.8 mt -146.59 126.63 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.773 -1.566 . . . . 3.99 106.773 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -112.36 -19.62 12.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.071 -1.018 . . . . 5.17 112.909 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 9.6 p -157.85 159.88 37.12 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 119.238 -2.164 . . . . 0.02 110.154 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.604 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 6.1 p90 -152.19 154.68 36.29 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.09 -1.006 . . . . 2.02 110.477 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -144.71 151.79 39.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.192 -0.943 . . . . 0.01 110.586 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -87.77 142.57 27.71 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.018 -0.734 . . . . 0.01 109.018 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.6 mt -93.63 128.88 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.091 -1.006 . . . . 3.04 109.14 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.27 146.88 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.194 -0.941 . . . . 1.89 109.54 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.359 -0.838 . . . . 4.89 109.435 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.507 -0.553 . . . . 5.28 109.507 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -52.78 166.36 0.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 5.96 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.0 p -80.64 141.97 34.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.257 -1.016 . . . . 2.22 108.257 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.75 -179.12 47.09 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.248 -1.93 . . . . 0.81 112.126 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.78 158.03 44.36 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.365 -1.494 . . . . 0.01 109.365 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -148.23 136.52 21.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.129 -1.218 . . . . 0.02 110.333 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 tt -130.58 140.38 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.111 -0.7 . . . . 0.02 109.111 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.79 130.71 53.61 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.238 -0.914 . . . . 0.39 110.171 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -110.9 140.3 45.49 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.577 -0.702 . . . . 0.02 109.622 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -122.71 138.64 54.55 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.282 -0.886 . . . . 0.02 109.591 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -69.42 -27.28 65.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.01 -1.056 . . . . 0.03 111.76 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.12 169.73 8.8 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.896 -1.128 . . . . 0.03 110.127 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -75.44 158.43 32.67 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.571 0.701 . . . . 0.03 110.196 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 m120 66.19 33.38 7.38 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.907 0.861 . . . . 0.74 111.093 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.32 42.14 30.54 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.223 0.535 . . . . 0.02 111.136 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -113.28 165.75 12.12 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.274 -1.01 . . . . 0.02 108.274 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.08 -167.9 34.9 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.872 -1.156 . . . . 0.03 110.576 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -69.17 142.5 54.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.382 -1.069 . . . . 2.76 108.928 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -122.66 151.21 41.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.586 -0.696 . . . . 1.89 110.181 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -136.83 132.77 35.11 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.193 -0.669 . . . . 0.02 109.193 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 6.6 p30 -108.38 135.93 48.87 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.369 -0.975 . . . . 1.12 108.369 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 13.9 t -127.37 137.5 52.79 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.585 -0.697 . . . . 0.02 109.981 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.75 11.03 11.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.673 -0.642 . . . . 0.2 110.808 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.526 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 25.0 p -159.71 173.43 16.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.574 -1.329 . . . . 1.23 109.34 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -63.1 145.54 55.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.428 -1.42 . . . . 0.02 110.801 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.7 m -135.12 119.21 17.55 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.925 -0.769 . . . . 0.02 108.925 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.98 -20.83 51.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.35 -0.844 . . . . 0.24 112.269 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -153.53 106.64 2.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.748 -1.22 . . . . 1.14 110.034 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.64 6.49 39.7 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.4 -0.813 . . . . 6.37 110.401 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.96 -29.32 69.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 3.11 112.063 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.0 m -77.01 -17.23 58.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.389 -1.445 . . . . 0.88 111.126 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -106.57 -21.09 13.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.454 -0.779 . . . . 0.02 110.555 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -149.28 127.57 12.15 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.966 -1.083 . . . . 3.32 109.62 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.8 t -87.47 -12.58 45.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.461 -0.774 . . . . 0.02 111.267 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -172.23 161.75 5.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.02 108.41 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.8 t -143.78 117.6 9.32 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.974 -1.079 . . . . 0.02 109.201 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.54 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.1 m-80 -109.56 0.0 18.96 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.746 -1.222 . . . . 0.03 111.691 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 22.3 m -155.54 153.97 31.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.005 -1.059 . . . . 0.02 108.475 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mt -145.88 146.56 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.011 -1.055 . . . . 0.02 110.848 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -123.19 124.17 42.43 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.808 -1.182 . . . . 0.02 107.808 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.1 t -105.29 113.72 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.829 -1.545 . . . . 0.02 106.829 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -85.14 -34.66 22.09 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.997 -0.681 . . . . 3.81 110.139 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.44 149.2 17.04 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.602 -1.761 . . . . 0.02 110.824 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.78 172.16 48.61 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.332 -1.107 . . . . 0.01 110.332 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -117.79 134.01 55.36 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.39 -1.337 . . . . 1.48 107.39 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -126.29 154.49 43.35 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.555 1.169 . . . . 0.02 112.495 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.0 133.3 53.17 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.57 -2.011 . . . . 0.24 105.57 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.1 141.31 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.544 -0.723 . . . . 0.65 109.154 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -120.16 143.08 48.41 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.128 0.966 . . . . 0.02 109.651 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.02 -34.09 77.6 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.641 -0.708 . . . . 0.02 111.755 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -124.49 157.78 63.98 Favored Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 120.939 -1.101 . . . . 0.02 109.615 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.26 166.56 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.733 1.622 . . . . 0.02 112.704 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 63.52 36.61 11.04 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.344 -0.843 . . . . 0.02 111.118 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.452 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 4.8 m-85 44.98 51.42 8.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.744 0.783 . . . . 3.39 110.691 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 m -125.4 163.22 23.08 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.206 0.527 . . . . 2.33 109.783 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.95 -162.07 31.0 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.599 -1.4 . . . . 0.02 109.599 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 8.3 t-80 -67.4 139.86 57.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.947 -1.325 . . . . 0.02 110.138 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.453 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 20.4 ptm -119.22 137.86 53.36 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.472 0.653 . . . . 5.01 109.978 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 79.8 m-85 -133.92 139.85 46.42 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.465 -0.772 . . . . 0.02 109.744 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.34 132.29 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 N-CA-C 108.523 -0.917 . . . . 1.72 108.523 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.0 mt -122.48 112.6 31.06 Favored Pre-proline 0 N--CA 1.506 2.357 0 O-C-N 121.414 -0.804 . . . . 0.02 110.644 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.45 170.73 18.84 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 119.821 0.972 . . . . 1.47 110.415 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -53.12 140.33 26.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.951 -1.093 . . . . 4.25 110.534 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.49 -178.18 32.25 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.38 -1.39 . . . . 0.02 110.8 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -119.72 131.23 55.33 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.362 -1.081 . . . . 0.96 109.896 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -121.5 97.91 46.6 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 107.726 -1.212 . . . . 0.02 107.726 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 38' ' ' SER . 7.9 Cg_endo -70.64 -3.44 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 120.743 0.962 . . . . 0.02 113.761 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -157.38 154.87 29.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.54 -1.35 . . . . 2.02 108.136 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -59.69 -39.4 84.42 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.531 -0.731 . . . . 0.02 111.766 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -59.89 -24.15 64.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.02 110.474 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -70.43 -18.38 63.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.4 -0.812 . . . . 3.42 108.846 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 2.1 t90 -107.78 10.2 28.82 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.535 -1.283 . . . . 0.02 107.535 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 10.0 mmt 60.63 22.66 12.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 0.02 110.322 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.68 144.88 47.91 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.542 -1.423 . . . . 0.02 109.542 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 mt -79.99 -30.54 39.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -1.175 . . . . 0.98 107.946 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -157.05 -171.49 3.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.43 -1.692 . . . . 0.02 106.43 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -99.03 28.78 4.18 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.645 -1.284 . . . . 0.02 110.815 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -96.65 122.82 40.0 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.826 -1.171 . . . . 3.2 111.146 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -141.39 118.8 11.49 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.551 -1.277 . . . . 2.61 107.551 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.55 -18.96 9.09 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 121.193 -0.942 . . . . 0.02 112.474 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 11.2 t -156.09 156.41 34.28 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 119.763 1.782 . . . . 0.02 111.028 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.6 p -145.85 147.83 32.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.421 -0.799 . . . . 0.02 110.501 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.422 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 49.2 mtp180 -137.14 142.04 42.25 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.511 -0.743 . . . . 0.01 109.111 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.29 131.26 36.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.129 -0.982 . . . . 0.43 109.505 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 t -90.4 124.61 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.561 -0.903 . . . . 1.25 108.561 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -92.91 131.58 37.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.071 . . . . 1.77 108.571 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.32 139.57 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.13 -1.063 . . . . 1.63 108.13 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.5 p -110.8 126.09 54.26 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.674 -0.861 . . . . 1.08 108.674 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.0 t -102.66 -154.8 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.029 -1.841 . . . . 1.26 106.029 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.29 -49.36 0.89 Allowed Glycine 0 N--CA 1.497 2.754 0 O-C-N 120.473 -1.392 . . . . 0.01 111.952 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.66 -99.33 0.13 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.64 -1.743 . . . . 0.01 112.085 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -121.05 120.67 36.03 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.262 -1.14 . . . . 4.43 110.702 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.34 135.75 54.81 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.47 -0.567 . . . . 2.99 109.47 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.484 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 2.7 ttmp? -134.54 130.59 36.81 Favored 'General case' 0 N--CA 1.519 2.981 0 CA-C-O 122.187 0.994 . . . . 6.36 112.936 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -132.44 141.61 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 115.62 -0.718 . . . . 1.09 110.627 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.515 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 pm0 -124.56 140.04 53.31 Favored 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 107.568 -1.271 . . . . 2.05 107.568 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.2 m -123.45 146.96 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 O-C-N 120.664 -1.272 . . . . 1.1 111.236 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 24.0 m-85 -120.17 139.72 52.2 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.035 0.922 . . . . 0.73 110.804 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.6 -32.81 71.75 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.77 -0.65 . . . . 0.02 112.304 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' O ' ' OG ' ' A' ' 128' ' ' SER . 41.0 mmtm -113.89 165.14 12.88 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.866 -1.146 . . . . 3.18 110.059 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.93 163.06 45.11 Favored Glycine 0 N--CA 1.492 2.374 0 CA-C-O 122.034 0.797 . . . . 0.01 111.306 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.22 39.58 28.62 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.567 0.698 . . . . 0.01 111.108 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 52.5 55.69 8.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.57 -0.706 . . . . 0.01 111.036 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -128.75 164.89 22.01 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.943 -1.132 . . . . 3.15 107.943 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.23 -162.67 28.53 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.269 -1.532 . . . . 0.01 109.269 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -75.79 142.17 42.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.93 -1.336 . . . . 0.01 109.211 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.529 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.7 ttp -116.69 143.48 45.58 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.593 0.711 . . . . 0.01 109.543 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -132.25 136.33 46.9 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.252 -1.018 . . . . 2.48 108.252 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -116.49 134.32 54.99 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.619 -0.675 . . . . 0.01 109.791 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 t -149.48 148.35 29.3 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.492 1.139 . . . . 1.69 111.578 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.7 p -115.34 7.46 15.13 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.998 -1.001 . . . . 0.01 109.961 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -122.31 163.42 19.73 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.448 -0.783 . . . . 3.21 111.043 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.29 154.86 41.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.439 -0.788 . . . . 0.01 109.624 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.5 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 59.4 m -128.61 115.94 19.55 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.913 -0.773 . . . . 0.01 108.913 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.09 -30.89 6.57 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 CA-C-N 120.316 1.149 . . . . 0.01 111.56 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.7 p -142.61 108.25 5.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.289 -0.882 . . . . 0.02 109.115 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.5 -39.31 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.773 -0.58 . . . . 1.83 111.062 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 15.0 tpt -66.89 -37.76 85.0 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.035 -1.066 . . . . 1.34 109.856 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.69 -38.66 77.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.504 -1.372 . . . . 2.11 109.887 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -80.41 -47.62 14.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.169 -0.957 . . . . 2.08 112.472 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -111.03 -0.82 16.53 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.283 -0.886 . . . . 0.02 112.728 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 59.79 33.73 21.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.822 -1.174 . . . . 0.02 109.487 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' C ' ' SD ' ' A' ' 118' ' ' MET . 6.3 mt -112.69 135.54 53.31 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 108.737 -0.838 . . . . 0.02 108.737 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -92.37 -23.18 19.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.302 -0.874 . . . . 5.32 110.623 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -148.96 163.44 37.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.077 -1.015 . . . . 0.02 110.121 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.411 HD12 HG21 ' A' ' 126' ' ' ILE . 51.6 mt -131.97 129.45 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.55 -1.278 . . . . 2.17 107.55 178.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -106.65 -13.65 15.23 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.206 -0.934 . . . . 0.02 113.185 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -157.04 155.68 31.59 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.35 -1.468 . . . . 0.01 108.237 177.606 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.4 t -164.28 145.86 8.58 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.482 -1.386 . . . . 1.22 109.567 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.43 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 27.6 mtmt -121.35 112.14 18.21 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.443 1.116 . . . . 1.41 108.905 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.2 t -107.41 122.52 61.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 105.372 -2.085 . . . . 0.01 105.372 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -145.9 67.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 118.153 -1.419 . . . . 1.98 108.133 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.01 108.29 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.563 -1.643 . . . . 0.01 106.563 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.86 -174.53 42.95 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.186 -1.165 . . . . 0.01 110.186 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.72 144.12 40.16 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.472 -1.016 . . . . 2.3 109.036 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -129.82 145.59 51.57 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.366 -0.834 . . . . 0.01 110.294 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.7 mt -117.92 141.86 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.667 -1.234 . . . . 1.69 107.667 178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.58 143.45 44.97 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 107.521 -1.289 . . . . 2.49 107.521 177.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 8.4 m-85 -122.59 144.24 49.24 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.005 -0.739 . . . . 0.02 109.005 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.49 -29.85 62.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.722 -0.611 . . . . 0.02 111.905 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.33 153.63 47.5 Favored Pre-proline 0 N--CA 1.505 2.279 0 O-C-N 120.604 -1.31 . . . . 1.48 109.187 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.9 167.03 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.225 1.284 . . . . 0.02 112.481 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 59.64 31.12 20.72 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.119 -0.946 . . . . 0.75 111.052 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.2 m-85 58.16 51.55 8.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.547 -0.72 . . . . 0.02 111.026 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -125.1 163.73 21.76 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.435 -0.791 . . . . 0.02 109.843 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.65 -165.6 32.34 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.951 -1.26 . . . . 0.02 109.951 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -67.7 141.32 56.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.425 -1.044 . . . . 0.02 108.883 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -118.65 147.95 43.24 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.424 -0.584 . . . . 0.02 109.424 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 2.5 t80 -129.9 143.87 51.03 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.836 -0.802 . . . . 0.01 108.836 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 tt -98.3 122.53 41.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.414 -0.804 . . . . 0.01 109.528 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.0 mt -104.29 135.95 44.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.499 -0.75 . . . . 0.01 109.982 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 154' ' ' LYS . 30.0 t70 -108.61 174.47 5.86 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.221 -1.029 . . . . 2.27 108.221 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -59.38 83.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.883 -1.135 . . . . 1.84 108.439 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 152' ' ' ASP . 66.6 mttm -136.53 172.09 13.53 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.257 -0.902 . . . . 2.28 111.696 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -113.62 110.12 19.7 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.423 -0.955 . . . . 0.01 108.423 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.68 114.61 28.48 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.019 -1.051 . . . . 0.01 109.876 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -93.69 -25.07 17.62 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.072 -1.018 . . . . 0.01 111.668 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -126.2 153.5 74.38 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.855 -1.153 . . . . 2.54 108.987 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.15 -42.7 33.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 119.247 0.767 . . . . 0.7 110.713 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.67 -20.58 21.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.732 -1.23 . . . . 0.86 108.557 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -64.95 -15.81 62.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.978 -1.076 . . . . 0.02 109.383 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.529 ' O ' ' CE2' ' A' ' 149' ' ' TYR . 0.5 OUTLIER -95.46 9.97 38.13 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.971 -1.122 . . . . 0.02 107.971 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.73 11.41 84.55 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.173 -1.489 . . . . 0.02 109.648 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.98 142.43 31.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.453 -1.028 . . . . 0.02 110.266 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.62 -8.21 58.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.758 -0.589 . . . . 0.59 110.022 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.3 p -144.9 150.93 47.88 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.726 -1.234 . . . . 0.87 108.819 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.37 21.58 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.833 1.022 . . . . 0.38 112.397 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.85 124.31 30.19 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.612 1.196 . . . . 0.18 111.631 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.1 mt -147.51 127.23 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.796 -1.557 . . . . 3.99 106.796 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -112.38 -19.08 12.31 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.187 -0.945 . . . . 5.17 112.865 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.6 p -158.37 161.28 37.55 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.147 -2.221 . . . . 0.02 110.271 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.5 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 9.5 p90 -152.55 153.69 33.92 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.168 -0.958 . . . . 2.02 110.496 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 21.5 mtp180 -143.58 151.0 39.66 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.267 -0.896 . . . . 0.01 110.412 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -87.64 142.33 27.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.01 109.188 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.1 mt -92.98 128.24 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.133 -0.979 . . . . 3.04 109.019 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.07 146.58 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.257 -0.902 . . . . 1.89 109.592 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 4.89 109.404 179.948 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.531 -0.544 . . . . 5.28 109.531 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -70.58 -133.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.897 . . . . 5.96 109.294 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.02 141.01 34.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.004 -1.06 . . . . 2.22 108.382 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.83 -179.35 47.02 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.255 -1.926 . . . . 0.81 112.194 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.04 158.31 44.18 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.273 -1.531 . . . . 0.01 109.273 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -149.23 136.91 20.35 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.095 -1.238 . . . . 0.02 110.168 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -130.23 141.14 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.201 -0.666 . . . . 0.02 109.201 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.8 t -121.3 129.92 53.37 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.523 -0.736 . . . . 0.39 110.0 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -110.36 140.23 44.77 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.159 -0.682 . . . . 0.02 109.159 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.9 m-85 -122.67 138.71 54.52 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.105 -0.997 . . . . 0.02 109.512 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.431 ' OE2' ' NH2' ' A' ' 18' ' ' ARG . 78.5 mt-10 -68.93 -27.27 65.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.075 -1.016 . . . . 0.03 111.693 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.31 170.28 8.41 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.902 -1.124 . . . . 0.03 110.034 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -74.93 161.79 29.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.698 0.761 . . . . 0.03 110.149 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 23.4 t30 62.42 35.06 15.1 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.898 0.856 . . . . 0.74 110.594 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.69 43.2 24.32 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.396 -0.82 . . . . 0.02 111.084 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -109.73 165.82 11.39 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.827 -1.175 . . . . 0.02 107.827 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.29 -168.16 34.84 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.83 -1.176 . . . . 0.03 110.663 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.431 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 25.9 ttp180 -69.16 143.5 54.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -1.102 . . . . 2.76 108.962 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.422 ' NH1' ' OD2' ' A' ' 21' ' ' ASP . 5.3 tmm_? -123.54 151.22 43.09 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.541 -0.725 . . . . 1.89 110.353 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -136.6 133.03 35.89 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.252 -0.647 . . . . 0.02 109.252 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.422 ' OD2' ' NH1' ' A' ' 19' ' ' ARG . 50.8 m-20 -109.64 136.32 49.19 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.911 -0.774 . . . . 1.12 108.911 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.1 t -127.83 137.74 52.47 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.659 -0.65 . . . . 0.02 109.704 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -118.61 11.41 12.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.726 -0.609 . . . . 0.2 110.157 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.5 p -159.68 173.7 15.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.848 -1.158 . . . . 1.23 109.066 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.87 145.63 54.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.842 -1.162 . . . . 0.02 110.629 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.591 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 11.6 p -135.04 119.69 18.21 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 109.004 -0.739 . . . . 0.02 109.004 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.39 -20.68 50.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.261 -0.9 . . . . 0.24 112.275 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -152.89 107.12 3.12 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.812 -1.18 . . . . 1.14 110.049 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.591 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.12 5.63 40.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.315 -0.865 . . . . 6.37 110.309 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -61.22 -30.13 70.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 3.11 112.133 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 p -76.69 -17.72 58.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.466 -1.396 . . . . 0.88 111.062 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -106.79 -21.13 13.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.392 -0.817 . . . . 0.02 110.655 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 tp -148.65 126.61 11.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.901 -1.124 . . . . 3.32 109.556 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.2 t -87.01 -12.83 46.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.519 -0.738 . . . . 0.02 111.053 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -172.72 162.16 4.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.858 -1.151 . . . . 0.02 108.403 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.2 p -143.83 116.52 8.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.068 -1.02 . . . . 0.02 108.824 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.59 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -108.38 -0.42 20.64 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.755 -1.216 . . . . 0.03 111.203 -178.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.414 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 13.0 t -155.36 153.46 30.5 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.856 -1.165 . . . . 0.02 107.856 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.414 ' N ' ' HG ' ' A' ' 38' ' ' SER . 8.8 mt -146.83 148.05 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.102 -0.999 . . . . 0.02 110.49 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -123.92 124.72 43.23 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.02 -1.104 . . . . 0.02 108.02 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.3 t -105.3 114.06 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.691 -1.596 . . . . 0.02 106.691 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -85.41 -34.92 21.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.447 -0.783 . . . . 3.81 110.178 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.49 149.03 16.65 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 118.523 -1.799 . . . . 0.02 110.864 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.7 172.32 48.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.197 -1.161 . . . . 0.01 110.197 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.0 m -117.67 134.09 55.26 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.494 -1.299 . . . . 1.48 107.494 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -126.68 154.52 43.97 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.541 1.162 . . . . 0.02 112.192 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.37 134.06 52.29 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 105.502 -2.036 . . . . 0.24 105.502 176.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.07 141.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.56 -0.712 . . . . 0.65 109.292 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -120.3 142.99 48.6 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.062 0.934 . . . . 0.02 109.624 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -65.21 -34.36 78.2 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.491 -0.777 . . . . 0.02 111.904 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -124.44 158.02 63.02 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.091 -1.006 . . . . 0.02 109.495 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.04 166.55 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.642 1.561 . . . . 0.02 112.806 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 63.11 37.17 11.67 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.373 -0.83 . . . . 0.02 111.135 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.3 m-85 45.1 51.69 8.84 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.62 0.724 . . . . 3.39 110.834 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 t -125.89 163.62 22.55 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.12 0.486 . . . . 2.33 109.95 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.52 -161.89 31.44 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.926 -1.27 . . . . 0.02 109.926 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.437 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 8.5 m80 -64.34 138.51 58.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.996 -1.297 . . . . 0.02 110.224 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 58' ' ' MET . 12.3 tmm? -119.12 137.17 53.77 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.519 -0.549 . . . . 5.01 109.519 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.407 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 86.4 m-85 -135.01 139.84 45.18 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.526 -0.733 . . . . 0.02 109.943 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.8 mm -94.37 130.48 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.903 -0.777 . . . . 1.72 108.903 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.558 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.73 110.86 34.89 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.386 -0.821 . . . . 0.02 110.752 -178.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.9 169.23 20.93 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 CA-C-N 119.793 0.962 . . . . 1.47 110.415 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -53.78 140.64 29.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.959 -1.088 . . . . 4.25 110.767 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.04 -177.46 32.27 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.507 -1.33 . . . . 0.02 110.722 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -119.47 131.09 55.54 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.39 -1.065 . . . . 0.96 109.659 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.558 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 78.0 m-85 -120.99 97.85 47.86 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 107.914 -1.143 . . . . 0.02 107.914 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -69.86 -4.52 14.26 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 120.679 0.919 . . . . 0.02 113.686 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -157.47 154.06 28.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.614 -1.304 . . . . 2.02 107.992 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -59.81 -38.03 80.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.379 -0.826 . . . . 0.02 111.871 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -59.79 -24.46 64.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.02 110.446 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -69.75 -19.0 63.55 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.756 0.789 . . . . 3.42 108.894 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.19 10.38 27.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.601 -1.259 . . . . 0.02 107.601 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.2 mmm 60.52 22.55 12.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.597 -0.689 . . . . 0.02 110.381 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.55 144.94 47.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.534 -1.427 . . . . 0.02 109.534 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.5 mt -79.51 -30.73 42.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -1.215 . . . . 0.98 108.013 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -157.42 -171.4 3.58 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.463 -1.68 . . . . 0.02 106.463 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 14.3 p30 -98.6 28.66 4.08 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.692 -1.255 . . . . 0.02 110.64 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -97.83 122.88 41.46 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.875 -1.141 . . . . 3.2 111.435 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.4 mt -142.66 120.06 11.64 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.298 -1.371 . . . . 2.61 107.298 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.46 -17.99 10.75 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 121.251 -0.905 . . . . 0.02 112.295 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.599 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 22.6 t -155.79 156.15 34.27 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 119.591 1.696 . . . . 0.02 110.845 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.599 ' N ' ' HG ' ' A' ' 81' ' ' SER . 49.5 t -145.65 147.92 32.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.02 110.161 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 17.6 mtp180 -136.88 141.73 42.76 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.461 -0.774 . . . . 0.01 109.023 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.38 131.5 36.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.203 -0.936 . . . . 0.43 109.269 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.54 124.34 43.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.816 -0.809 . . . . 1.25 108.816 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -92.47 131.91 37.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.826 -1.171 . . . . 1.77 108.737 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.36 138.5 33.86 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.127 -1.064 . . . . 1.63 108.127 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.4 p -110.67 126.65 54.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.357 -0.839 . . . . 1.08 108.757 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.511 ' HG ' ' H ' ' A' ' 90' ' ' GLY . 13.1 t -103.15 -154.54 0.5 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 106.114 -1.81 . . . . 1.26 106.114 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.511 ' H ' ' HG ' ' A' ' 89' ' ' SER . . . 135.63 -50.31 0.86 Allowed Glycine 0 N--CA 1.498 2.799 0 O-C-N 120.456 -1.403 . . . . 0.01 112.066 178.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.47 -99.77 0.13 Allowed Glycine 0 N--CA 1.487 2.068 0 C-N-CA 118.683 -1.722 . . . . 0.01 112.212 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -120.51 119.54 33.27 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.261 -1.141 . . . . 4.43 110.635 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.8 136.39 55.38 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.302 -0.559 . . . . 2.99 109.588 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -134.85 130.93 36.76 Favored 'General case' 0 N--CA 1.518 2.942 0 CA-C-O 122.182 0.992 . . . . 6.36 112.65 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.5 141.96 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.527 -0.76 . . . . 1.09 110.409 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.5 pm0 -124.68 140.34 53.03 Favored 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 107.573 -1.269 . . . . 2.05 107.573 176.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.87 146.2 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 O-C-N 120.618 -1.301 . . . . 1.1 110.882 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.537 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 25.4 m-85 -119.93 139.96 51.64 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 122.347 1.07 . . . . 0.73 110.799 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.97 -32.26 72.55 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.639 -0.709 . . . . 0.02 111.694 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -114.5 167.31 10.84 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.109 -0.994 . . . . 3.18 110.321 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.45 164.39 52.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 111.147 -0.781 . . . . 0.01 111.147 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 57.82 38.95 27.36 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.554 0.692 . . . . 0.01 111.641 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 52.27 54.58 10.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.41 -0.806 . . . . 0.01 111.241 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 24.7 t30 -129.6 165.21 22.21 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.992 -1.114 . . . . 3.15 107.992 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 90.94 -162.61 28.85 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.975 -1.65 . . . . 0.01 108.975 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -76.22 141.61 41.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.841 -1.388 . . . . 0.01 109.078 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.537 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.4 ttp -116.66 143.54 45.51 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.553 0.692 . . . . 0.01 109.61 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -132.28 136.23 46.79 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -116.02 134.29 55.12 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.748 -0.595 . . . . 0.01 109.754 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -149.34 148.28 29.33 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.626 1.203 . . . . 1.69 111.501 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -115.44 7.38 14.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.872 -1.058 . . . . 0.01 109.938 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -122.38 163.35 19.94 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.391 -0.818 . . . . 3.21 111.307 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -69.69 154.33 42.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.898 . . . . 0.01 109.665 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.425 ' O ' ' OG ' ' A' ' 171' ' ' SER . 40.8 t -126.74 115.56 22.55 Favored Pre-proline 0 N--CA 1.501 2.104 0 N-CA-C 109.192 -0.67 . . . . 0.01 109.192 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.2 -32.63 5.01 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 120.358 1.164 . . . . 0.01 111.418 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 p -142.35 108.42 5.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.294 -0.879 . . . . 0.02 109.125 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.404 HD11 HG21 ' A' ' 117' ' ' ILE . 95.7 mt -64.44 -39.73 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.825 -0.547 . . . . 1.83 111.099 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.7 ttt -66.95 -37.5 84.4 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.107 -1.037 . . . . 1.34 109.853 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.84 -38.57 76.54 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.559 -1.338 . . . . 2.11 109.792 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -80.2 -47.55 14.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 2.08 112.472 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.36 -0.88 16.19 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.334 -0.854 . . . . 0.02 112.727 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.4 m80 60.28 33.77 20.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.808 -1.182 . . . . 0.02 109.48 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.7 mt -112.53 135.16 53.57 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 108.62 -0.882 . . . . 0.02 108.62 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -92.29 -23.23 19.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.354 -0.841 . . . . 5.32 110.565 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -148.97 163.57 37.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.166 -0.959 . . . . 0.02 110.008 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 126' ' ' ILE . 51.2 mt -131.61 129.11 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 107.417 -1.327 . . . . 2.17 107.417 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -107.16 -13.38 15.17 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.192 -0.943 . . . . 0.02 113.246 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.29 153.35 30.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.306 -1.496 . . . . 0.01 108.287 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.4 t -162.34 145.06 11.28 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.326 -1.484 . . . . 1.22 109.737 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.434 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 27.0 ttmt -122.29 111.53 17.03 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.3 1.048 . . . . 1.41 108.892 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.9 t -107.51 122.62 62.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.661 -1.977 . . . . 0.01 105.661 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -146.58 67.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 118.125 -1.43 . . . . 1.98 108.222 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.69 109.04 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.597 -1.631 . . . . 0.01 106.597 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.7 -174.28 39.64 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.711 -1.356 . . . . 0.01 109.711 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -112.4 144.47 41.78 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.372 -1.076 . . . . 2.3 109.349 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -129.89 146.2 51.61 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.43 -0.794 . . . . 0.01 110.392 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.6 mt -118.06 142.12 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 107.668 -1.234 . . . . 1.69 107.668 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.67 143.92 44.27 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 107.736 -1.209 . . . . 2.49 107.736 177.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.8 m-85 -122.53 143.52 49.67 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.966 -0.753 . . . . 0.02 108.966 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -73.02 -29.52 63.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.575 -0.703 . . . . 0.02 112.005 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.58 153.58 47.8 Favored Pre-proline 0 N--CA 1.505 2.323 0 O-C-N 120.614 -1.304 . . . . 1.48 109.198 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.58 167.05 1.57 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.359 1.372 . . . . 0.02 112.606 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 59.56 31.21 20.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.063 -0.971 . . . . 0.75 110.993 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.61 51.32 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.449 -0.782 . . . . 0.02 111.045 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -124.77 163.78 21.39 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.466 -0.771 . . . . 0.02 109.838 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.77 -165.65 32.22 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.873 -1.291 . . . . 0.02 109.873 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -67.53 141.38 56.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.564 -0.962 . . . . 0.02 109.042 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -117.9 148.4 42.18 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.28 -0.637 . . . . 0.02 109.28 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.64 142.92 50.64 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.041 -0.726 . . . . 0.01 109.041 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.412 ' CD2' ' C ' ' A' ' 150' ' ' LEU . 6.0 tt -97.41 121.84 39.78 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.283 -0.886 . . . . 0.01 109.485 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.5 mt -104.98 133.33 49.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.472 -0.767 . . . . 0.01 110.321 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 5.3 p-10 -107.69 173.19 6.43 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.253 -1.017 . . . . 2.27 108.253 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -57.97 84.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.972 -1.08 . . . . 1.84 108.621 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 11.4 tptp -136.34 168.31 19.67 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.327 -0.858 . . . . 2.28 111.068 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 5.3 mp0 -111.09 109.78 20.02 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.325 -0.991 . . . . 0.01 108.325 178.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.37 115.69 30.58 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.087 -1.008 . . . . 0.01 109.904 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -94.05 -25.49 17.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.99 -1.069 . . . . 0.01 111.375 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -125.85 153.92 73.48 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.958 -1.089 . . . . 2.54 109.008 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.03 -42.66 35.02 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 119.144 0.73 . . . . 0.7 110.64 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.73 -20.42 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.638 -1.289 . . . . 0.86 108.433 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -65.41 -15.75 62.92 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.961 -1.087 . . . . 0.02 109.425 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.436 ' O ' ' CE2' ' A' ' 149' ' ' TYR . 0.2 OUTLIER -95.21 9.72 38.69 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.943 -1.132 . . . . 0.02 107.943 178.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.49 11.04 85.49 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.204 -1.474 . . . . 0.02 109.607 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.94 142.26 31.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.382 -1.07 . . . . 0.02 110.204 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.41 -8.49 58.96 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.728 -0.608 . . . . 0.59 109.886 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 16.5 p -144.46 150.78 48.92 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 120.849 -1.157 . . . . 0.87 108.731 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.16 21.55 0.52 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.73 0.953 . . . . 0.38 112.376 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.78 123.98 29.84 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.5 1.143 . . . . 0.18 111.705 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.0 mt -147.07 126.92 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 106.92 -1.511 . . . . 3.99 106.92 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -113.46 -19.22 11.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.142 -0.974 . . . . 5.17 112.853 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.459 ' HG ' ' N ' ' A' ' 172' ' ' PHE . 32.6 t -157.15 159.88 38.22 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 119.142 -2.224 . . . . 0.02 110.376 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.459 ' N ' ' HG ' ' A' ' 171' ' ' SER . 10.9 p90 -152.92 154.08 34.31 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.044 -1.035 . . . . 2.02 110.7 178.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -144.62 151.69 39.38 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.304 -0.872 . . . . 0.01 110.58 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -87.69 142.94 27.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.564 -0.71 . . . . 0.01 109.254 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.2 128.21 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.998 -1.064 . . . . 3.04 109.099 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -136.07 146.46 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.218 -0.927 . . . . 1.89 109.631 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 4.89 109.446 179.903 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 3' ' ' THR . 77.2 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.322 0.582 . . . . 5.28 109.464 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -60.11 -1.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 5.96 109.533 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 1' ' ' SER . 4.8 p -90.67 -139.88 0.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.244 -1.391 . . . . 2.22 107.244 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.463 ' H ' ' HG1' ' A' ' 3' ' ' THR . . . 172.44 -174.91 45.66 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 117.321 -2.371 . . . . 0.81 112.761 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.78 160.71 45.33 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.267 -1.533 . . . . 0.01 109.267 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -147.49 135.98 21.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.133 -1.216 . . . . 0.02 110.039 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.9 tt -130.58 140.09 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.218 -0.66 . . . . 0.02 109.218 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t -121.65 130.28 53.37 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.291 -0.88 . . . . 0.39 110.077 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -110.24 139.62 45.22 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.652 -0.655 . . . . 0.02 109.397 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.3 m-85 -121.42 138.03 54.45 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.209 -0.932 . . . . 0.02 109.698 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.516 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 88.5 mt-10 -69.47 -27.52 65.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.842 -1.162 . . . . 0.03 111.594 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -114.16 169.79 8.76 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.752 -1.217 . . . . 0.03 110.179 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.516 ' NH2' ' OE1' ' A' ' 68' ' ' GLU . 49.9 mtp180 -75.67 158.65 32.09 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.629 0.728 . . . . 0.03 110.121 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 8.2 t-20 65.75 33.71 8.03 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.016 0.912 . . . . 0.74 111.072 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.52 41.74 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.974 -0.557 . . . . 0.02 111.306 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -113.69 165.57 12.4 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.265 -1.013 . . . . 0.02 108.265 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.8 -167.43 34.92 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.887 -1.149 . . . . 0.03 110.711 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -68.24 141.51 55.9 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.554 -0.968 . . . . 2.76 109.046 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -122.52 150.15 42.95 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.572 -0.705 . . . . 1.89 109.87 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -137.21 133.16 34.83 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.205 -0.665 . . . . 0.02 109.205 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -108.74 136.05 48.96 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.748 -0.834 . . . . 1.12 108.748 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 17.1 t -127.64 137.31 52.49 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.572 -0.705 . . . . 0.02 110.02 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 p30 -119.89 11.57 11.85 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.702 -0.624 . . . . 0.2 110.704 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.527 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 32.4 t -159.64 173.22 16.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.709 -1.245 . . . . 1.23 109.262 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -62.8 145.25 55.38 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.489 -1.382 . . . . 0.02 110.611 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 m -135.23 119.48 17.76 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.51 -0.744 . . . . 0.02 109.035 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.66 -20.52 50.07 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.581 -0.699 . . . . 0.24 112.325 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 8.9 p-10 -153.35 106.39 2.95 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.541 -1.349 . . . . 1.14 110.103 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.8 6.59 36.76 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.242 -0.911 . . . . 6.37 110.461 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -60.58 -28.77 68.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.853 . . . . 3.11 111.891 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.9 p -76.69 -16.77 59.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.465 -1.397 . . . . 0.88 111.021 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -105.89 -21.62 13.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.329 -0.857 . . . . 0.02 110.624 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.9 mt -148.66 127.67 12.76 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.093 -1.005 . . . . 3.32 109.309 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -85.9 -11.01 54.31 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.728 -0.607 . . . . 0.02 110.254 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -171.85 161.85 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.144 -1.058 . . . . 0.02 108.144 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 t -143.24 116.41 8.95 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.0 -1.063 . . . . 0.02 108.566 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.682 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.2 OUTLIER -109.77 -0.82 18.28 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 120.789 -1.194 . . . . 0.03 112.049 -177.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 t -154.93 153.69 31.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.014 -1.053 . . . . 0.02 108.3 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -146.17 147.81 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.104 -0.998 . . . . 0.02 110.716 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -124.86 124.86 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.676 -1.231 . . . . 0.02 107.676 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.1 t -105.69 114.13 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.928 -1.508 . . . . 0.02 106.928 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -85.33 -34.49 21.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.548 -0.72 . . . . 3.81 110.216 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.33 148.97 16.65 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.592 -1.766 . . . . 0.02 110.807 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.67 172.31 48.78 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.287 -1.125 . . . . 0.01 110.287 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.9 m -118.12 134.5 54.94 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.505 -1.295 . . . . 1.48 107.505 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -126.73 154.16 44.54 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.516 1.15 . . . . 0.02 112.33 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.57 133.62 52.45 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.29 -2.115 . . . . 0.24 105.29 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -117.32 142.49 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 0.65 109.173 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.513 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 31.9 m-85 -120.62 144.87 47.9 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.262 1.029 . . . . 0.02 110.024 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.21 -33.61 76.16 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.773 -0.649 . . . . 0.02 111.526 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -124.63 157.96 63.75 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 121.065 -1.022 . . . . 0.02 109.551 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.81 166.9 1.22 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.788 1.659 . . . . 0.02 112.794 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 63.58 36.68 10.87 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.344 -0.844 . . . . 0.02 110.968 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.666 ' H ' ' HG ' ' A' ' 81' ' ' SER . 3.6 m-85 45.11 51.48 8.96 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.562 0.696 . . . . 3.39 110.78 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.3 m -125.91 163.53 22.76 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.206 0.526 . . . . 2.33 109.918 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.78 -162.31 31.38 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.738 -1.345 . . . . 0.02 109.738 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.454 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 18.7 m-70 -64.8 138.48 58.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.35 . . . . 0.02 110.04 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.513 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 60.0 ttp -118.3 137.88 52.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.324 0.583 . . . . 5.01 109.514 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.2 m-85 -134.98 139.33 44.81 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.469 -0.769 . . . . 0.02 109.882 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.3 130.53 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.875 -0.787 . . . . 1.72 108.875 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.91 110.6 34.82 Favored Pre-proline 0 N--CA 1.504 2.265 0 O-C-N 121.43 -0.794 . . . . 0.02 110.876 -178.341 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.54 169.39 21.09 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 CA-C-N 119.722 0.936 . . . . 1.47 110.317 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -53.69 140.78 28.35 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.924 -1.11 . . . . 4.25 110.562 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.42 -177.15 32.76 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.47 -1.348 . . . . 0.02 110.634 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -119.41 130.6 55.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.459 -1.024 . . . . 0.96 109.686 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 71.1 m-85 -121.83 95.15 47.96 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.297 -1.001 . . . . 0.02 108.297 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.31 -3.57 10.19 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 120.978 1.118 . . . . 0.02 114.221 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' NH2' ' A' ' 13' ' ' ARG . 38.2 mt-10 -157.96 155.08 28.85 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.479 -1.388 . . . . 2.02 108.311 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -60.08 -38.78 83.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.594 -0.691 . . . . 0.02 112.035 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -59.7 -23.74 63.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.052 -1.03 . . . . 0.02 110.091 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -70.31 -19.11 63.1 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.774 0.797 . . . . 3.42 108.938 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -108.36 10.75 27.5 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.517 -1.29 . . . . 0.02 107.517 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 73' ' ' MET . 2.1 mpt? 59.65 23.88 12.69 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.478 0.656 . . . . 0.02 110.563 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.0 144.86 46.5 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.785 -1.326 . . . . 0.02 109.785 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.13 -30.73 39.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -1.219 . . . . 0.98 107.875 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -157.16 -171.93 3.82 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.413 -1.699 . . . . 0.02 106.413 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.422 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 78.4 m-20 -97.98 27.92 4.25 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.642 -1.286 . . . . 0.02 110.83 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -96.71 122.54 39.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.805 -1.184 . . . . 3.2 111.102 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.0 mt -141.38 118.42 11.24 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.449 -1.315 . . . . 2.61 107.449 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.49 -18.27 9.79 Favored Glycine 0 N--CA 1.501 2.997 0 O-C-N 120.992 -1.067 . . . . 0.02 112.463 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.666 ' HG ' ' H ' ' A' ' 54' ' ' PHE . 32.8 p -156.25 156.01 33.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.352 -1.675 . . . . 0.02 110.351 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.0 m -145.14 148.28 33.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.749 -0.594 . . . . 0.02 109.923 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -137.15 141.75 42.22 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.456 -0.778 . . . . 0.01 109.304 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.16 132.24 36.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.106 -0.996 . . . . 0.43 109.434 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.87 124.48 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.69 -0.856 . . . . 1.25 108.69 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -90.72 133.2 35.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.868 -1.145 . . . . 1.77 108.287 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.17 139.18 36.21 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.851 -0.796 . . . . 1.63 108.851 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 p -110.58 123.78 50.62 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.072 -1.085 . . . . 1.08 108.072 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.4 p -114.99 132.46 56.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.746 -1.221 . . . . 1.26 107.818 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.73 -47.98 0.01 OUTLIER Glycine 0 N--CA 1.503 3.1 0 C-N-CA 117.704 -2.189 . . . . 0.01 113.44 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.16 -103.39 0.17 Allowed Glycine 0 N--CA 1.488 2.129 0 CA-C-N 120.045 1.923 . . . . 0.01 110.927 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -119.13 118.2 30.73 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.16 -1.2 . . . . 4.43 110.179 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.0 135.92 55.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.769 -0.582 . . . . 2.99 109.491 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -134.86 130.06 35.39 Favored 'General case' 0 N--CA 1.519 2.977 0 O-C-N 121.128 -0.982 . . . . 6.36 112.997 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -131.72 142.39 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-O 121.591 0.71 . . . . 1.09 110.318 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.494 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 2.0 pt20 -124.78 139.27 54.0 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.679 -1.23 . . . . 2.05 107.679 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.65 146.54 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.584 0 O-C-N 120.655 -1.278 . . . . 1.1 110.96 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -121.34 140.96 51.41 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 122.084 0.945 . . . . 0.73 111.482 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -69.09 -33.42 73.49 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.774 -0.648 . . . . 0.02 112.391 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.484 ' O ' ' OG ' ' A' ' 128' ' ' SER . 0.8 OUTLIER -113.67 165.33 12.63 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.815 -1.178 . . . . 3.18 109.584 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.97 163.43 44.78 Favored Glycine 0 N--CA 1.492 2.376 0 CA-C-O 122.07 0.817 . . . . 0.01 111.266 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.7 t0 57.65 39.96 27.01 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.599 0.714 . . . . 0.01 111.077 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.46 55.01 9.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.632 -0.668 . . . . 0.01 111.002 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -127.07 165.72 18.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.219 -1.03 . . . . 3.15 108.219 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.65 -163.0 29.47 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.14 -1.584 . . . . 0.01 109.14 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.492 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 58.7 tt0 -75.2 142.18 43.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.942 -1.328 . . . . 0.01 108.841 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' A' ' 107' ' ' MET . 9.7 tmm? -116.46 143.28 45.78 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.566 0.698 . . . . 0.01 109.433 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.492 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 55.1 m-85 -132.17 136.04 46.79 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.349 -0.982 . . . . 2.48 108.349 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -117.01 134.07 55.21 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.697 -0.627 . . . . 0.01 109.844 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.49 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -149.83 149.1 29.99 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.42 1.105 . . . . 1.69 111.313 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -115.19 7.75 15.39 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.132 -0.94 . . . . 0.01 110.321 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.49 ' H ' ' HG1' ' A' ' 110' ' ' THR . 62.9 mm-40 -121.67 163.28 19.27 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.406 -0.809 . . . . 3.21 111.255 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.21 154.84 41.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.01 109.539 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 35.1 t -126.64 114.53 22.76 Favored Pre-proline 0 N--CA 1.499 2.013 0 N-CA-C 109.049 -0.722 . . . . 0.01 109.049 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.37 -33.57 4.14 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 120.274 1.134 . . . . 0.01 111.218 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 p -141.15 107.15 5.17 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.662 -0.866 . . . . 0.02 108.662 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.82 -39.52 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.721 -0.612 . . . . 1.83 111.23 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.6 ttt -66.77 -37.65 85.01 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.002 -1.079 . . . . 1.34 109.727 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.72 -38.55 76.95 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.58 -1.325 . . . . 2.11 109.693 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -80.18 -47.47 14.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 2.08 112.359 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -111.02 -1.1 16.43 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.413 -0.804 . . . . 0.02 112.84 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 m80 59.97 33.23 21.4 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.621 -1.299 . . . . 0.02 109.503 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.1 mt -111.63 135.02 52.79 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.805 -0.813 . . . . 0.02 108.805 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -93.65 -24.01 18.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.284 -0.885 . . . . 5.32 110.688 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -148.42 162.55 39.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.259 -0.9 . . . . 0.02 109.791 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.434 ' C ' ' HD1' ' A' ' 127' ' ' HIS . 54.5 mt -133.18 130.2 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 107.64 -1.244 . . . . 2.17 107.64 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.434 ' HD1' ' C ' ' A' ' 126' ' ' ILE . 0.7 OUTLIER -106.52 -13.72 15.25 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 113.524 0.935 . . . . 0.02 113.524 -176.346 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -157.45 156.37 32.02 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.256 -1.527 . . . . 0.01 108.396 177.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.4 t -162.11 146.81 12.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.478 -1.389 . . . . 1.22 109.93 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -120.03 108.54 14.42 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.137 0.97 . . . . 1.41 108.445 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 t -107.09 120.35 58.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 105.795 -1.928 . . . . 0.01 105.795 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 t -146.63 68.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 118.043 -1.463 . . . . 1.98 108.304 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.6 108.3 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.505 -1.665 . . . . 0.01 106.505 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.24 -174.31 44.51 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.737 -1.345 . . . . 0.01 109.737 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 m -111.92 145.69 39.11 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.369 -1.077 . . . . 2.3 109.088 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -131.32 145.29 51.8 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.552 -0.718 . . . . 0.01 110.741 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.2 mt -117.7 142.01 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 107.421 -1.325 . . . . 1.69 107.421 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -115.12 143.9 44.49 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 107.499 -1.297 . . . . 2.49 107.499 177.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 18.0 m-85 -122.42 144.67 48.9 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.948 -0.76 . . . . 0.02 108.948 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.01 -30.0 62.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.02 112.06 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.17 153.96 47.32 Favored Pre-proline 0 N--CA 1.506 2.351 0 O-C-N 120.593 -1.317 . . . . 1.48 109.292 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.71 166.27 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.192 1.262 . . . . 0.02 112.615 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 59.84 31.31 20.7 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.149 -0.932 . . . . 0.75 111.186 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 57.74 51.94 8.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.02 110.926 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -125.09 163.67 21.89 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.486 -0.759 . . . . 0.02 109.747 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.51 -165.37 32.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.751 -1.34 . . . . 0.02 109.751 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -67.97 141.72 56.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.629 -0.924 . . . . 0.02 108.949 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.464 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.2 mp0 -118.51 148.41 42.65 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.463 -0.569 . . . . 0.02 109.463 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.516 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.7 t80 -129.33 142.9 50.7 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.013 -0.736 . . . . 0.01 109.013 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.75 121.8 39.0 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.293 -0.88 . . . . 0.01 109.345 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 17.4 mt -104.66 133.51 49.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.506 -0.746 . . . . 0.01 110.225 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 154' ' ' LYS . 21.1 t0 -108.83 175.39 5.48 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.341 -0.985 . . . . 2.27 108.341 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.402 ' H ' ' CG ' ' A' ' 152' ' ' ASP . 86.9 mttt -57.41 84.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.84 -1.162 . . . . 1.84 108.626 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 152' ' ' ASP . 35.4 mttp -137.73 168.42 19.72 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.191 0.996 . . . . 2.28 111.647 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -113.33 109.82 19.34 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.26 -1.015 . . . . 0.01 108.26 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -99.77 115.87 30.54 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.022 -1.049 . . . . 0.01 109.931 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -93.52 -25.4 17.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.079 -1.013 . . . . 0.01 111.433 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -125.89 153.42 73.56 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 120.786 -1.196 . . . . 2.54 108.613 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.16 -41.7 41.14 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 CA-C-N 119.281 0.779 . . . . 0.7 110.584 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.58 -20.58 21.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.769 -1.207 . . . . 0.86 108.586 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.49 -15.77 62.99 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.029 -1.044 . . . . 0.02 109.625 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.516 ' O ' ' CE2' ' A' ' 149' ' ' TYR . 0.3 OUTLIER -95.34 9.87 38.31 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 107.919 -1.141 . . . . 0.02 107.919 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.38 10.8 85.48 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.205 -1.474 . . . . 0.02 109.588 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.76 142.43 31.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.469 -1.018 . . . . 0.02 110.282 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.63 -8.59 58.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.728 -0.608 . . . . 0.59 110.007 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.3 p -144.68 150.99 48.85 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.737 -1.227 . . . . 0.87 108.789 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.97 21.72 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 120.899 1.066 . . . . 0.38 112.331 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.19 123.89 29.99 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.623 1.201 . . . . 0.18 111.563 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.0 mt -146.66 126.75 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 106.765 -1.569 . . . . 3.99 106.765 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -113.17 -20.34 11.48 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.112 -0.993 . . . . 5.17 112.835 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.1 p -157.76 160.13 37.53 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.172 -2.205 . . . . 0.02 110.233 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -153.04 154.9 35.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.184 -0.948 . . . . 2.02 110.683 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -145.03 151.63 38.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.263 -0.898 . . . . 0.01 110.539 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -87.73 142.08 28.1 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.524 -0.735 . . . . 0.01 109.406 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.3 mt -92.2 128.17 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.137 -0.977 . . . . 3.04 109.241 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.7 t -136.35 146.83 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.151 -0.968 . . . . 1.89 109.487 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 4.89 109.441 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.275 -1.53 . . . . 0.01 109.275 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -148.45 136.78 21.24 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.128 -1.219 . . . . 0.02 110.337 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.73 140.94 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.17 -0.678 . . . . 0.02 109.17 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -121.5 130.25 53.43 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.396 -0.815 . . . . 0.39 110.089 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 m-85 -110.18 140.14 44.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.598 -0.689 . . . . 0.02 109.27 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.54 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.0 m-85 -122.04 138.21 54.52 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.155 -0.965 . . . . 0.02 109.58 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -69.62 -27.37 65.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 0.03 111.788 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.0 m-20 -113.89 169.44 8.99 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.85 -1.156 . . . . 0.03 110.091 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.15 158.3 33.26 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.606 0.717 . . . . 0.03 110.095 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m-20 66.05 35.07 6.52 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.745 0.784 . . . . 0.74 110.76 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.5 p90 49.82 44.31 25.01 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.606 -0.724 . . . . 0.02 111.19 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -112.71 166.05 11.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.95 -167.58 34.8 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 120.736 -1.228 . . . . 0.03 110.415 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -69.36 142.68 53.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -1.024 . . . . 2.76 109.036 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -122.06 150.13 42.56 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.521 -0.737 . . . . 1.89 110.065 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -135.93 132.88 37.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.749 -0.594 . . . . 0.02 109.516 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -110.25 135.96 50.19 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.398 -0.814 . . . . 1.12 109.118 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 43.6 t -128.43 138.49 52.34 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.524 -0.735 . . . . 0.02 109.411 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 34.2 p-10 -119.16 11.88 12.48 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.624 -0.672 . . . . 0.2 110.392 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 4.3 p -159.42 173.45 16.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.765 -1.209 . . . . 1.23 109.05 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 13.2 p-10 -63.15 145.98 54.32 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.693 -1.254 . . . . 0.02 110.612 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.561 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 45.0 t -134.95 118.54 16.98 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.144 -0.687 . . . . 0.02 109.144 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.4 -21.62 52.87 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.53 -0.731 . . . . 0.24 111.605 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -154.49 105.06 2.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.845 -1.159 . . . . 1.14 109.506 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.4 OUTLIER -101.84 8.88 41.16 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.427 -0.796 . . . . 6.37 109.875 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.46 -28.55 68.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.435 -0.79 . . . . 3.11 112.033 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 m -76.83 -17.32 59.07 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.35 -1.469 . . . . 0.88 111.235 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 27.8 m-85 -107.22 -20.48 13.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.381 -0.824 . . . . 0.02 110.393 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tp -148.93 127.15 12.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.026 -1.046 . . . . 3.32 109.51 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.8 p -87.1 -12.26 47.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.558 -0.714 . . . . 0.02 111.329 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -172.02 161.98 5.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.807 -1.183 . . . . 0.02 108.283 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.8 t -143.52 116.61 8.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.96 -1.088 . . . . 0.02 108.984 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -109.7 0.5 18.98 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.792 -1.193 . . . . 0.03 111.714 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 m -156.09 153.84 30.01 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.276 -1.009 . . . . 0.02 108.276 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mt -146.24 146.9 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.946 -1.096 . . . . 0.02 110.715 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -123.79 124.62 43.08 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.485 -1.302 . . . . 0.02 107.485 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.21 114.39 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.843 -1.54 . . . . 0.02 106.843 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -84.94 -34.85 22.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.565 -0.71 . . . . 3.81 109.906 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.61 149.34 17.22 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.497 -1.811 . . . . 0.02 110.976 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.1 171.84 48.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.386 -1.086 . . . . 0.01 110.386 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.1 m -118.02 134.03 55.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.554 -1.276 . . . . 1.48 107.554 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.1 m95 -128.27 155.69 44.19 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 122.636 1.208 . . . . 0.02 112.27 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.83 134.0 52.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.493 -2.04 . . . . 0.24 105.493 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.408 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.6 m -117.08 142.45 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.936 -0.764 . . . . 0.65 108.936 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -120.83 144.98 48.07 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.386 1.089 . . . . 0.02 110.092 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -66.17 -34.0 77.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.721 -0.672 . . . . 0.02 111.472 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -124.44 157.9 63.44 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 121.097 -1.002 . . . . 0.02 109.449 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.56 166.47 1.25 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.766 1.644 . . . . 0.02 112.783 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 m-20 63.71 36.36 10.75 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.366 -0.834 . . . . 0.02 111.15 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 5.1 m-85 45.67 51.74 9.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.567 0.699 . . . . 3.39 110.732 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 p -126.23 163.74 22.51 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.203 0.525 . . . . 2.33 109.993 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.38 -161.56 31.39 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.748 -1.341 . . . . 0.02 109.748 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -64.54 138.79 58.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.936 -1.332 . . . . 0.02 110.042 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 21.2 ptm -119.61 137.49 53.83 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.208 0.528 . . . . 5.01 109.736 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.58 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 95.1 m-85 -134.61 139.67 45.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.434 -0.791 . . . . 0.02 110.127 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 mm -93.79 130.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.736 -0.838 . . . . 1.72 108.736 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.483 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -120.91 110.48 34.91 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.425 -0.797 . . . . 0.02 110.63 -178.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -78.09 169.76 19.85 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 119.767 0.953 . . . . 1.47 110.17 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -53.55 140.84 27.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.818 -1.176 . . . . 4.25 110.496 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.55 -177.37 32.74 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.462 -1.352 . . . . 0.02 110.611 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -119.3 130.42 55.38 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.402 -1.058 . . . . 0.96 109.708 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.483 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 32.1 m-85 -122.94 91.92 49.49 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.296 -1.002 . . . . 0.02 108.296 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -65.95 -2.83 7.28 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.115 1.21 . . . . 0.02 113.739 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -156.93 151.05 24.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.335 -1.478 . . . . 2.02 107.88 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -59.59 -38.94 82.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.662 -0.649 . . . . 0.02 112.538 -176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -60.36 -23.47 64.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.026 -1.046 . . . . 0.02 111.079 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -73.13 -15.54 61.47 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.79 -1.164 . . . . 3.42 108.752 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.58 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -107.63 9.35 29.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.3 -1.37 . . . . 0.02 107.3 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.0 mtm 62.11 22.91 13.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.685 -0.635 . . . . 0.02 110.923 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.21 145.05 46.85 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.748 -1.341 . . . . 0.02 109.748 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.76 -31.7 35.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -1.209 . . . . 0.98 107.949 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -157.28 -172.27 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.467 -1.679 . . . . 0.02 106.467 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.29 27.65 4.55 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.768 -1.208 . . . . 0.02 110.654 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -96.34 122.52 39.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.881 -1.137 . . . . 3.2 110.864 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 79' ' ' LEU . 83.5 mt -142.44 119.06 11.04 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.771 -1.196 . . . . 2.61 107.771 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.1 -18.28 10.03 Favored Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.138 -0.976 . . . . 0.02 112.511 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.5 p -156.12 156.52 34.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.255 -1.732 . . . . 0.02 110.394 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.4 m -145.47 148.23 33.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.719 -0.613 . . . . 0.02 109.841 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.44 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 54.6 mtm180 -137.39 141.97 41.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.331 -0.855 . . . . 0.01 109.311 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 132.79 36.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.213 -0.93 . . . . 0.43 109.496 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.74 124.03 42.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.242 -1.021 . . . . 1.25 108.242 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -91.31 134.57 34.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.823 -1.173 . . . . 1.77 108.507 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.61 135.41 40.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.841 -1.17 . . . . 1.63 107.841 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.7 p -109.37 127.63 54.5 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.763 -0.828 . . . . 1.08 108.763 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -105.19 -153.78 0.5 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 106.314 -1.736 . . . . 1.26 106.314 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.59 -50.63 0.86 Allowed Glycine 0 N--CA 1.499 2.849 0 O-C-N 120.528 -1.358 . . . . 0.01 111.846 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.73 -100.73 0.15 Allowed Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.867 -1.635 . . . . 0.01 111.402 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -119.61 118.11 30.12 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.185 -1.185 . . . . 4.43 110.243 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.493 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.19 136.69 56.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.385 -0.598 . . . . 2.99 109.385 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -134.38 130.4 36.83 Favored 'General case' 0 N--CA 1.519 2.988 0 O-C-N 121.06 -1.025 . . . . 6.36 113.048 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.17 143.49 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 115.63 -0.713 . . . . 1.09 110.591 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.413 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.9 pt20 -124.89 139.71 53.58 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.771 -1.196 . . . . 2.05 107.771 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.22 145.69 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 120.652 -1.28 . . . . 1.1 111.189 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 27.8 m-85 -120.4 140.19 51.71 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.956 0.884 . . . . 0.73 110.847 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -68.55 -32.41 72.32 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.784 -0.644 . . . . 0.02 112.178 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -114.82 165.74 12.51 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.956 -1.09 . . . . 3.18 110.212 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.18 163.41 45.44 Favored Glycine 0 N--CA 1.492 2.38 0 CA-C-O 121.958 0.755 . . . . 0.01 111.278 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 57.15 39.17 29.13 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.578 0.704 . . . . 0.01 111.026 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 52.66 55.91 8.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.624 -0.672 . . . . 0.01 111.112 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -128.42 164.87 21.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.281 -1.007 . . . . 3.15 108.281 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.65 -163.05 28.25 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.092 -1.603 . . . . 0.01 109.092 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -75.62 142.04 42.72 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.878 -1.366 . . . . 0.01 108.959 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 33.9 ttp -116.73 143.27 45.85 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.538 0.685 . . . . 0.01 109.533 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.98 136.41 47.28 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.173 -1.047 . . . . 2.48 108.173 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -115.96 134.09 55.34 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.715 -0.616 . . . . 0.01 109.7 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.1 t -149.31 147.93 28.93 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.515 1.15 . . . . 1.69 111.474 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -114.54 7.63 16.19 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.894 -1.048 . . . . 0.01 109.875 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -121.96 163.56 19.11 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.393 -0.817 . . . . 3.21 111.008 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.4 154.82 41.43 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.358 -0.839 . . . . 0.01 109.379 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.8 t -126.64 114.98 22.77 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.911 -0.774 . . . . 0.01 108.911 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.23 -32.59 5.01 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 120.323 1.151 . . . . 0.01 111.447 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 m -142.31 108.26 5.18 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.847 0.832 . . . . 0.02 108.947 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.42 HD12 ' O ' ' A' ' 169' ' ' ILE . 95.9 mt -64.29 -39.9 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.776 -0.577 . . . . 1.83 110.97 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 32.7 ttp -66.89 -37.4 84.31 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.026 -1.069 . . . . 1.34 109.812 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -70.22 -38.62 75.29 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.524 -1.36 . . . . 2.11 109.761 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.14 -47.49 14.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.253 -0.904 . . . . 2.08 112.203 -176.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -110.82 -0.44 16.93 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.378 -0.826 . . . . 0.02 112.699 -176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 59.93 33.2 21.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.659 -1.276 . . . . 0.02 109.595 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mt -112.69 135.85 52.95 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 108.764 -0.828 . . . . 0.02 108.764 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -91.73 -22.89 19.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -0.822 . . . . 5.32 110.358 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -149.36 164.03 36.07 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.09 -1.006 . . . . 0.02 110.019 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.8 mt -131.7 129.57 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.375 -1.343 . . . . 2.17 107.375 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -107.77 -12.92 15.12 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.134 -0.979 . . . . 0.02 113.18 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.6 OUTLIER -153.52 151.35 29.71 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.489 -1.382 . . . . 0.01 108.278 178.321 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 13.7 t -160.92 145.03 13.6 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.261 -1.524 . . . . 1.22 109.935 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -121.8 110.22 15.64 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.43 1.109 . . . . 1.41 109.156 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 t -107.55 120.34 58.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 105.851 -1.907 . . . . 0.01 105.851 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.0 t -146.27 68.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 118.453 -1.299 . . . . 1.98 108.369 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 172.65 107.22 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.443 -1.688 . . . . 0.01 106.443 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.66 -174.07 43.1 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.554 -1.418 . . . . 0.01 109.554 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.2 m -111.41 144.3 40.84 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.387 -1.066 . . . . 2.3 109.216 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.493 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 63.1 m95 -129.15 146.03 51.18 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.643 -0.66 . . . . 0.01 110.377 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.1 mt -117.36 141.71 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 107.642 -1.244 . . . . 1.69 107.642 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -113.97 143.42 44.76 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 107.453 -1.314 . . . . 2.49 107.453 177.604 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 16.0 m-85 -122.77 144.17 49.35 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.291 -0.633 . . . . 0.02 109.291 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.5 -29.86 62.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.737 -0.602 . . . . 0.02 111.964 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.47 153.87 47.69 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 120.679 -1.263 . . . . 1.48 109.26 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -54.48 166.13 1.98 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.229 1.286 . . . . 0.02 112.658 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.573 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 1.7 t30 59.79 31.76 20.97 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.145 -0.934 . . . . 0.75 111.136 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.504 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.8 m-85 57.43 51.45 9.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.54 -0.725 . . . . 0.02 110.827 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -124.55 163.43 21.93 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.541 -0.724 . . . . 0.02 109.659 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.45 -165.34 32.42 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.83 -1.308 . . . . 0.02 109.83 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -67.89 141.48 56.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.991 . . . . 0.02 109.011 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -118.87 149.01 42.27 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.284 -0.635 . . . . 0.02 109.284 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.68 142.4 51.03 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.181 -0.674 . . . . 0.01 109.181 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.827 ' N ' HD12 ' A' ' 150' ' ' LEU . 3.4 mp -95.43 121.11 36.76 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.462 -0.774 . . . . 0.01 109.336 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.669 HD22 ' NE1' ' A' ' 162' ' ' TRP . 18.5 mt -105.42 135.25 47.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.44 -0.788 . . . . 0.01 110.674 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 154' ' ' LYS . 2.8 m-20 -110.31 175.63 5.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.187 -1.042 . . . . 2.27 108.187 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -57.85 84.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.905 -1.122 . . . . 1.84 108.638 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 152' ' ' ASP . 73.6 tttt -137.14 165.38 26.21 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.256 -0.903 . . . . 2.28 111.654 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 6.7 pt-20 -111.8 113.66 26.15 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.061 -1.088 . . . . 0.01 108.061 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.44 115.28 30.25 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.933 -1.104 . . . . 0.01 110.29 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.445 ' O ' ' OG ' ' A' ' 128' ' ' SER . 3.7 ptp180 -92.18 -25.82 18.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.01 111.347 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -125.67 153.17 72.97 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 121.017 -1.052 . . . . 2.54 108.643 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -60.7 -42.08 41.85 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 CA-C-N 119.27 0.775 . . . . 0.7 110.524 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.1 t -60.38 -20.43 20.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.745 -1.222 . . . . 0.86 108.612 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -65.91 -16.19 63.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.989 -1.069 . . . . 0.02 109.605 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.669 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.73 9.3 39.48 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.763 -1.199 . . . . 0.02 107.763 179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.15 10.32 86.32 Favored Glycine 0 N--CA 1.486 2.024 0 C-N-CA 119.214 -1.47 . . . . 0.02 109.617 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.5 142.03 31.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.45 -1.03 . . . . 0.02 110.091 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.1 -8.33 59.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.677 -0.64 . . . . 0.59 109.828 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.5 p -144.66 150.86 48.47 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.857 -1.152 . . . . 0.87 108.702 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.83 21.03 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 120.816 1.011 . . . . 0.38 112.355 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.87 124.13 30.03 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.464 1.126 . . . . 0.18 111.708 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.42 ' O ' HD12 ' A' ' 117' ' ' ILE . 16.4 mt -146.47 126.9 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 106.78 -1.563 . . . . 3.99 106.78 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -112.02 -20.53 11.93 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.098 -1.001 . . . . 5.17 112.783 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.6 p -158.0 160.63 37.68 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 119.269 -2.144 . . . . 0.02 110.141 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -152.48 154.03 34.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.129 -0.982 . . . . 2.02 110.26 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.504 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -144.51 151.97 39.9 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.195 -0.941 . . . . 0.01 110.449 -179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -88.24 143.02 27.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.496 -0.753 . . . . 0.01 109.412 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -93.25 128.66 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.17 -0.956 . . . . 3.04 109.053 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.8 t -136.0 146.4 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.224 -0.923 . . . . 1.89 109.384 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 4.89 109.517 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.642 -1.383 . . . . 0.01 109.642 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -152.83 138.29 17.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.264 -1.139 . . . . 0.02 109.586 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -130.31 140.87 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.373 -0.603 . . . . 0.02 109.373 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -121.13 129.95 53.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.469 -0.77 . . . . 0.39 110.143 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -109.02 139.32 44.05 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.549 -0.719 . . . . 0.02 109.147 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.3 m-85 -121.98 137.73 54.69 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.361 -0.837 . . . . 0.02 109.276 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.78 -27.4 64.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.013 -1.054 . . . . 0.03 111.88 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.9 m-20 -114.2 170.2 8.46 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.87 -1.144 . . . . 0.03 110.366 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -75.25 157.91 33.72 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.599 0.714 . . . . 0.03 110.136 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 10.4 t30 65.85 35.11 6.85 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.803 0.811 . . . . 0.74 110.8 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.96 44.83 25.5 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.487 -0.779 . . . . 0.02 111.368 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -112.28 165.87 11.79 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.032 -1.099 . . . . 0.02 108.032 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -167.88 34.44 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 120.847 -1.158 . . . . 0.03 110.619 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -69.19 143.1 54.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -1.04 . . . . 2.76 108.922 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -123.22 149.92 44.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.518 -0.739 . . . . 1.89 110.211 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -136.25 133.4 36.96 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 109.317 -0.623 . . . . 0.02 109.317 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.0 136.16 48.99 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.688 -0.856 . . . . 1.12 108.688 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.429 ' SG ' ' CE2' ' A' ' 29' ' ' PHE . 1.9 m -126.94 137.31 53.1 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.637 -0.664 . . . . 0.02 109.541 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -118.95 10.74 12.31 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.572 -0.705 . . . . 0.2 110.233 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.407 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 14.9 t -159.61 173.19 16.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.79 -1.194 . . . . 1.23 109.063 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.407 ' OD1' ' SG ' ' A' ' 24' ' ' CYS . 5.5 p-10 -63.22 146.28 53.72 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.683 -1.26 . . . . 0.02 110.721 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.88 119.22 17.81 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.061 -0.718 . . . . 0.02 109.061 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -20.84 51.33 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.504 -0.748 . . . . 0.24 112.037 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -153.73 106.02 2.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.729 -1.232 . . . . 1.14 109.762 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.429 ' CE2' ' SG ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -102.66 6.7 39.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.353 -0.842 . . . . 6.37 110.399 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -61.17 -29.5 69.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 3.11 111.898 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.4 t -77.06 -17.56 58.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.505 -1.372 . . . . 0.88 110.948 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -106.14 -21.42 13.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.388 -0.82 . . . . 0.02 110.624 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.13 127.39 12.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.145 -0.972 . . . . 3.32 109.472 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.6 t -87.29 -12.48 46.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.516 -0.74 . . . . 0.02 110.976 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -172.56 161.99 5.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.847 -1.158 . . . . 0.02 108.378 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.464 ' SG ' HD12 ' A' ' 79' ' ' LEU . 3.1 p -142.63 115.04 8.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.99 -1.069 . . . . 0.02 108.735 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -107.04 -2.71 20.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.836 -1.165 . . . . 0.03 111.289 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -152.96 153.65 33.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.118 -1.067 . . . . 0.02 108.118 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.7 mt -146.83 147.44 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.045 -1.034 . . . . 0.02 110.438 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -124.91 125.66 44.29 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.899 -1.148 . . . . 0.02 107.899 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.6 114.11 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 106.773 -1.566 . . . . 0.02 106.773 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.94 -34.61 22.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.609 -0.682 . . . . 3.81 110.184 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.24 149.99 18.24 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 118.358 -1.877 . . . . 0.02 110.758 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.12 172.42 49.11 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.174 -1.171 . . . . 0.01 110.174 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 m -118.35 134.19 55.26 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.484 -1.302 . . . . 1.48 107.484 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -126.38 154.86 43.0 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.626 1.203 . . . . 0.02 112.326 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.72 133.99 52.51 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.189 -2.152 . . . . 0.24 105.189 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.458 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.7 m -117.22 142.63 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.514 -0.741 . . . . 0.65 109.319 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -120.88 143.19 49.05 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 122.053 0.93 . . . . 0.02 109.535 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.08 -33.62 76.47 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.498 -0.774 . . . . 0.02 111.641 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -124.46 157.7 64.19 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 121.098 -1.001 . . . . 0.02 109.467 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.13 166.94 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.656 1.57 . . . . 0.02 112.726 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.07 36.5 12.24 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.331 -0.849 . . . . 0.02 111.108 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 45.56 51.54 9.84 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.601 0.715 . . . . 3.39 110.864 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 p -125.78 163.55 22.62 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.384 0.612 . . . . 2.33 109.904 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.49 -161.45 31.17 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.799 -1.32 . . . . 0.02 109.799 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -65.3 139.35 58.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.027 -1.278 . . . . 0.02 110.163 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 18.4 ptm -118.91 137.05 53.73 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.245 0.545 . . . . 5.01 109.61 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.442 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.9 m-85 -134.19 138.82 45.4 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.459 -0.776 . . . . 0.02 109.925 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.7 mm -95.2 130.62 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.49 -0.756 . . . . 1.72 109.031 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.475 HD22 ' CE1' ' A' ' 66' ' ' TYR . 7.4 mt -121.44 111.2 33.49 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 121.326 -0.859 . . . . 0.02 110.653 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -77.66 169.77 20.29 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 CA-C-N 119.85 0.982 . . . . 1.47 110.415 177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -53.53 141.26 25.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.902 -1.124 . . . . 4.25 110.603 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.45 -177.4 31.83 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.502 -1.333 . . . . 0.02 110.693 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -118.45 130.42 55.95 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.354 -1.086 . . . . 0.96 109.787 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' CE1' HD22 ' A' ' 61' ' ' LEU . 90.0 m-85 -120.37 97.05 49.08 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 107.861 -1.163 . . . . 0.02 107.861 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -69.48 -4.49 13.94 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 120.752 0.968 . . . . 0.02 113.583 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -157.27 154.53 29.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.623 -1.298 . . . . 2.02 108.144 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -59.95 -38.6 82.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.408 -0.808 . . . . 0.02 111.773 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -59.82 -24.44 64.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.02 110.226 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -70.09 -18.72 63.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.41 -0.806 . . . . 3.42 108.879 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.46 10.12 27.42 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.628 -1.249 . . . . 0.02 107.628 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.9 mmt 60.81 22.32 12.37 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.48 0.657 . . . . 0.02 110.598 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.43 144.17 45.8 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.367 -1.493 . . . . 0.02 109.367 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.1 tp -78.93 -30.93 44.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.553 -1.276 . . . . 0.98 107.553 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -157.42 -171.82 3.74 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.544 -1.651 . . . . 0.02 106.544 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -98.25 28.63 3.96 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.603 -1.31 . . . . 0.02 110.775 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -97.82 122.72 41.26 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.933 -1.105 . . . . 3.2 111.324 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.464 HD12 ' SG ' ' A' ' 36' ' ' CYS . 54.4 mt -142.36 119.51 11.43 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.317 -1.364 . . . . 2.61 107.317 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.99 -18.55 10.41 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 121.282 -0.886 . . . . 0.02 112.065 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 p -155.45 155.63 33.86 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 119.531 1.666 . . . . 0.02 110.695 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.5 p -145.17 147.82 32.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.403 -0.811 . . . . 0.02 110.283 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -137.17 141.87 42.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.442 -0.786 . . . . 0.01 109.109 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.58 132.36 37.11 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.203 -0.935 . . . . 0.43 109.28 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.3 123.95 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.653 -0.869 . . . . 1.25 108.653 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -92.01 132.34 36.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.956 -1.09 . . . . 1.77 108.552 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.484 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -96.83 138.12 34.87 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.139 -1.06 . . . . 1.63 108.139 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.9 p -110.21 126.38 54.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 1.08 108.682 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.2 t -102.85 -155.1 0.51 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.205 -1.776 . . . . 1.26 106.205 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.59 -50.41 0.84 Allowed Glycine 0 N--CA 1.497 2.743 0 O-C-N 120.521 -1.362 . . . . 0.01 111.986 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.6 -99.77 0.13 Allowed Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.816 -1.659 . . . . 0.01 111.709 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -119.34 119.45 34.01 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.117 -1.225 . . . . 4.43 110.311 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.515 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.35 137.32 56.82 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.344 -0.613 . . . . 2.99 109.344 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 7.5 ttpm? -136.45 130.7 33.03 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-O 122.273 1.035 . . . . 6.36 113.015 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 tt -131.72 141.51 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 115.397 -0.82 . . . . 1.09 110.286 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 6.3 pt20 -124.33 140.2 53.18 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 107.597 -1.26 . . . . 2.05 107.597 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 m -124.24 146.29 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.685 -1.259 . . . . 1.1 111.189 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 26.2 m-85 -120.4 140.24 51.64 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 122.224 1.011 . . . . 0.73 110.745 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.84 -32.44 72.97 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.709 -0.678 . . . . 0.02 111.907 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -114.47 165.7 12.47 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 120.948 -1.095 . . . . 3.18 110.446 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.9 163.69 47.24 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 111.038 -0.825 . . . . 0.01 111.038 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 57.62 38.86 27.88 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.578 0.704 . . . . 0.01 110.946 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 52.44 56.91 7.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.537 -0.727 . . . . 0.01 111.035 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -129.48 165.34 21.82 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.166 -1.05 . . . . 3.15 108.166 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.4 -162.77 28.38 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.13 -1.588 . . . . 0.01 109.13 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -75.81 142.0 42.37 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.016 -1.285 . . . . 0.01 108.76 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.7 ttp -116.55 143.05 46.09 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.513 0.673 . . . . 0.01 109.563 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -131.89 135.91 47.01 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.198 -1.038 . . . . 2.48 108.198 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -116.52 134.37 54.92 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.722 -0.611 . . . . 0.01 109.669 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t -149.23 148.02 29.09 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.528 1.156 . . . . 1.69 111.367 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 p -114.95 7.67 15.67 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.949 -1.023 . . . . 0.01 109.934 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.449 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 21.8 mp0 -122.03 163.78 18.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.408 -0.808 . . . . 3.21 111.181 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.59 153.89 42.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.384 -0.823 . . . . 0.01 109.46 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 46.0 t -126.98 114.95 22.03 Favored Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 108.971 -0.752 . . . . 0.01 108.971 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -75.1 -32.94 4.86 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 120.387 1.174 . . . . 0.01 111.612 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -142.05 108.49 5.3 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.834 0.826 . . . . 0.02 109.198 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 169' ' ' ILE . 96.4 mt -64.36 -39.75 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.844 -0.535 . . . . 1.83 111.02 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.6 ttt -66.57 -38.17 86.5 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.169 -1.012 . . . . 1.34 109.865 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.62 -38.46 77.23 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.506 -1.371 . . . . 2.11 109.858 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -80.78 -47.25 14.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.29 -0.881 . . . . 2.08 112.462 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -111.21 -0.78 16.36 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.252 -0.905 . . . . 0.02 112.719 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 59.88 33.43 21.57 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.812 -1.18 . . . . 0.02 109.384 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.27 135.7 52.61 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 108.699 -0.852 . . . . 0.02 108.699 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -92.66 -23.43 18.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 5.32 110.65 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -149.11 163.66 36.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.084 -1.01 . . . . 0.02 110.095 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.2 mt -131.63 129.4 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 107.348 -1.353 . . . . 2.17 107.348 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -107.18 -13.32 15.18 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.144 -0.973 . . . . 0.02 113.06 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.38 153.06 29.85 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.277 -1.514 . . . . 0.01 108.255 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 6.8 t -162.86 143.81 9.75 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.375 -1.453 . . . . 1.22 109.665 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -122.37 112.87 18.62 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.001 0.905 . . . . 1.41 108.77 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 t -109.03 123.4 64.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.061 -1.829 . . . . 0.01 106.061 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -146.41 66.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 C-N-CA 117.951 -1.5 . . . . 1.98 109.061 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.402 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.1 tp10 176.28 108.72 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.32 -1.733 . . . . 0.01 106.32 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.678 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 70.99 -174.44 40.39 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.476 -1.45 . . . . 0.01 109.476 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -112.05 146.57 37.7 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.423 -1.045 . . . . 2.3 109.43 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.515 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 61.1 m95 -130.35 146.19 51.89 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.502 -0.749 . . . . 0.01 110.284 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mt -117.13 141.56 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 107.566 -1.272 . . . . 1.69 107.566 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.33 143.79 44.32 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.688 -1.227 . . . . 2.49 107.688 177.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 7.5 m-85 -122.58 144.7 48.94 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.994 -0.743 . . . . 0.02 108.994 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 76.5 tt0 -74.06 -29.78 62.06 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.669 -0.644 . . . . 0.02 112.08 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.5 mt -115.24 153.5 47.39 Favored Pre-proline 0 N--CA 1.506 2.369 0 O-C-N 120.676 -1.265 . . . . 1.48 109.208 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.41 167.08 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.129 1.219 . . . . 0.02 112.565 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 59.31 31.08 20.88 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.065 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.76 51.12 9.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 0.02 111.124 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -123.99 163.33 21.6 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.569 -0.707 . . . . 0.02 109.528 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.2 -165.79 31.74 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.873 -1.291 . . . . 0.02 109.873 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -68.2 142.28 55.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.477 -1.014 . . . . 0.02 109.03 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -118.01 148.46 42.21 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.451 -0.574 . . . . 0.02 109.451 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.463 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -128.64 142.73 50.94 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.563 -0.71 . . . . 0.01 109.113 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.64 119.8 34.77 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.48 -0.763 . . . . 0.01 109.465 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 162' ' ' TRP . 19.5 mt -106.21 131.95 52.84 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.422 -0.798 . . . . 0.01 110.363 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 154' ' ' LYS . 11.9 p-10 -109.84 176.77 4.94 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.454 -0.943 . . . . 2.27 108.454 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.678 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 48.7 mttm -55.54 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.066 -1.021 . . . . 1.84 108.489 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 152' ' ' ASP . 53.4 mmtt -136.74 166.86 22.6 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.189 -0.945 . . . . 2.28 111.593 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 15.0 mp0 -113.82 106.4 14.42 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.76 -1.2 . . . . 0.01 107.76 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.56 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 90.9 m-85 -99.03 114.16 26.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.965 -1.085 . . . . 0.01 110.201 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -92.41 -25.67 18.37 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.19 -0.943 . . . . 0.01 111.144 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -125.18 153.88 71.74 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.079 -1.013 . . . . 2.54 108.392 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -61.3 -41.43 42.04 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 120.442 0.761 . . . . 0.7 110.651 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.33 -20.1 21.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.657 -1.277 . . . . 0.86 108.769 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -65.57 -16.11 63.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.025 -1.047 . . . . 0.02 109.758 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.56 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 1.1 m0 -96.11 10.88 36.2 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.999 -1.112 . . . . 0.02 107.999 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.57 11.34 85.56 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.414 -1.374 . . . . 0.02 110.159 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.73 141.94 31.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.293 -1.122 . . . . 0.02 110.209 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.29 -8.22 59.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.613 -0.679 . . . . 0.59 109.817 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.4 p -144.31 150.87 49.78 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.806 -1.184 . . . . 0.87 108.728 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.6 20.85 0.5 Allowed 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 120.701 0.934 . . . . 0.38 112.341 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.28 122.14 27.56 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.467 1.127 . . . . 0.18 111.45 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.433 ' O ' HD12 ' A' ' 117' ' ' ILE . 9.8 mm -142.74 125.39 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.009 -1.848 . . . . 3.99 106.009 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.526 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 12.3 mp0 -112.33 -20.82 11.69 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.088 -1.008 . . . . 5.17 112.615 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.5 p -157.41 160.92 38.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.384 -2.072 . . . . 0.02 109.954 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -153.53 154.59 34.6 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.182 -0.949 . . . . 2.02 110.578 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -144.46 151.39 39.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.35 -0.843 . . . . 0.01 110.442 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -87.66 142.64 27.68 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.054 -0.721 . . . . 0.01 109.054 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.8 mt -93.12 128.45 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.037 -1.039 . . . . 3.04 109.206 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 44.9 t -136.07 146.71 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.294 -0.879 . . . . 1.89 109.564 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.86 . . . . 4.89 109.483 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.39 -1.484 . . . . 0.01 109.39 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -152.83 138.28 17.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.245 -1.15 . . . . 0.02 109.841 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -130.32 141.03 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.475 -0.565 . . . . 0.02 109.475 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.422 ' OG ' ' NE ' ' A' ' 19' ' ' ARG . 1.6 t -122.26 130.76 53.47 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.308 -0.87 . . . . 0.39 110.091 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.0 OUTLIER -111.11 140.71 45.43 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.768 -0.582 . . . . 0.02 109.444 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.4 m-85 -121.85 138.45 54.38 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.353 -0.842 . . . . 0.02 109.573 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -68.86 -27.4 65.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.99 -1.069 . . . . 0.03 111.504 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.7 m-20 -114.53 170.72 8.1 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.858 -1.151 . . . . 0.03 110.009 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -75.81 162.06 28.49 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.705 0.764 . . . . 0.03 110.313 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.9 t30 62.46 33.28 16.25 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.113 0.959 . . . . 0.74 110.742 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.1 40.29 31.81 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.733 -0.667 . . . . 0.02 110.834 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -109.97 165.42 11.74 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.196 -1.038 . . . . 0.02 108.196 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.54 -168.04 34.38 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.888 -1.149 . . . . 0.03 110.557 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -68.83 143.53 54.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -1.058 . . . . 2.76 108.887 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.533 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 51.4 ttt180 -122.03 149.95 42.78 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.62 -0.675 . . . . 1.89 109.916 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.24 134.5 34.51 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.637 -0.664 . . . . 0.02 109.466 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.31 136.92 48.75 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.385 -0.822 . . . . 1.12 109.384 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.7 t -127.99 138.3 52.55 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.594 -0.691 . . . . 0.02 109.488 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -118.74 11.98 12.87 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.59 -0.694 . . . . 0.2 110.554 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.2 t -159.46 173.84 15.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.706 -1.246 . . . . 1.23 109.091 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 17.8 p30 -63.11 146.67 52.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.747 -1.221 . . . . 0.02 110.527 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.4 m -133.7 117.64 17.21 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.127 -0.694 . . . . 0.02 109.127 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.75 -23.21 45.53 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.284 -0.885 . . . . 0.24 111.471 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -151.77 103.77 2.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.974 -1.079 . . . . 1.14 109.056 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.16 6.81 33.39 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.588 0.709 . . . . 6.37 110.231 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -59.93 -27.63 66.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 3.11 111.691 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.4 p -76.6 -16.08 59.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.611 -1.306 . . . . 0.88 110.803 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.57 -21.96 12.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.44 -0.787 . . . . 0.02 110.422 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tp -149.08 127.33 12.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.04 -1.037 . . . . 3.32 109.436 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.2 t -87.02 -12.16 48.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.64 -0.662 . . . . 0.02 111.051 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.717 HH21 HD22 ' A' ' 37' ' ' ASN . 14.9 ptm180 -172.84 162.13 4.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.93 -1.106 . . . . 0.02 108.417 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -142.7 115.79 8.87 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.047 -1.033 . . . . 0.02 108.649 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.717 HD22 HH21 ' A' ' 35' ' ' ARG . 4.0 m120 -107.71 -1.0 21.43 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.803 -1.186 . . . . 0.03 110.987 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -155.52 152.88 29.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.6 mt -145.33 148.46 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.091 -1.006 . . . . 0.02 109.887 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -124.46 124.55 42.56 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.5 -1.296 . . . . 0.02 107.5 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -105.03 113.87 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.704 -1.591 . . . . 0.02 106.704 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -83.81 -34.83 24.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.576 -0.703 . . . . 3.81 109.971 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 151.27 20.64 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 118.392 -1.861 . . . . 0.02 110.535 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.79 171.89 48.61 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.318 -1.113 . . . . 0.01 110.318 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.9 m -117.76 133.74 55.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.429 -1.323 . . . . 1.48 107.429 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -126.21 154.23 43.59 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.6 1.19 . . . . 0.02 112.16 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.03 133.72 52.61 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.419 -2.067 . . . . 0.24 105.419 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.3 m -117.62 142.87 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.569 -0.707 . . . . 0.65 109.249 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -120.62 144.87 47.91 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.112 0.958 . . . . 0.02 109.997 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.472 ' OE2' ' NH2' ' A' ' 78' ' ' ARG . 33.5 tt0 -66.16 -33.69 76.34 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.875 -0.602 . . . . 0.02 111.582 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' A' ' 51' ' ' ARG . 0.4 OUTLIER -124.64 157.88 64.07 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.006 -1.059 . . . . 0.02 109.486 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.09 166.44 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.637 1.558 . . . . 0.02 112.763 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m120 63.67 36.39 10.84 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.36 -0.836 . . . . 0.02 111.153 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 8.0 m-85 45.29 51.51 9.32 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.654 0.74 . . . . 3.39 110.812 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -125.75 163.44 22.84 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.143 0.497 . . . . 2.33 109.882 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.83 31.38 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.46 ' CD2' ' CD1' ' A' ' 75' ' ' LEU . 21.2 m80 -64.35 138.48 58.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.981 -1.305 . . . . 0.02 109.989 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.8 ppp? -119.37 137.45 53.72 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.283 0.564 . . . . 5.01 109.58 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.594 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.7 m-85 -134.99 139.95 45.29 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.492 -0.755 . . . . 0.02 110.238 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.7 mm -94.16 130.45 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 108.656 -0.868 . . . . 1.72 108.656 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.03 110.32 36.53 Favored Pre-proline 0 N--CA 1.505 2.324 0 O-C-N 121.439 -0.788 . . . . 0.02 110.597 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.69 168.65 22.13 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 CA-C-N 119.935 1.012 . . . . 1.47 110.311 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -53.75 140.79 28.67 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.84 -1.163 . . . . 4.25 110.524 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.77 32.68 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.489 -1.338 . . . . 0.02 110.598 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -118.76 130.09 55.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.251 -1.146 . . . . 0.96 109.622 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.574 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 71.8 m-85 -121.1 98.91 46.88 Favored Pre-proline 0 N--CA 1.492 1.667 0 N-CA-C 107.852 -1.166 . . . . 0.02 107.852 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -71.3 -3.73 13.53 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 120.637 0.892 . . . . 0.02 113.836 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -157.52 155.04 29.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.64 -1.288 . . . . 2.02 108.274 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -59.85 -39.08 84.0 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.62 -0.675 . . . . 0.02 111.787 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -59.94 -23.99 64.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.917 . . . . 0.02 110.256 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -70.32 -18.75 63.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.791 0.805 . . . . 3.42 108.921 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.594 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -108.4 10.53 27.46 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.455 -1.313 . . . . 0.02 107.455 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.0 mtt 61.34 22.56 12.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.619 -0.676 . . . . 0.02 110.714 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.14 144.55 46.92 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.648 -1.381 . . . . 0.02 109.648 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.46 ' CD1' ' CD2' ' A' ' 57' ' ' HIS . 23.3 mt -79.71 -30.75 41.06 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.725 -1.213 . . . . 0.98 107.725 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -157.38 -171.52 3.63 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.374 -1.713 . . . . 0.02 106.374 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -98.93 28.3 4.45 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.607 -1.308 . . . . 0.02 110.72 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.472 ' NH2' ' OE2' ' A' ' 50' ' ' GLU . 80.1 mtm180 -96.44 122.56 39.47 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.916 -1.115 . . . . 3.2 111.011 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.435 HD21 ' CH2' ' A' ' 72' ' ' TRP . 82.5 mt -142.71 119.49 11.18 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.791 -1.189 . . . . 2.61 107.791 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.4 -17.79 10.32 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 121.167 -0.958 . . . . 0.02 112.416 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 92.9 p -156.19 156.15 33.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.165 -1.786 . . . . 0.02 110.495 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.8 p -145.26 148.43 33.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.693 -0.629 . . . . 0.02 109.706 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.465 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.9 mtp180 -137.06 141.42 42.42 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.286 -0.884 . . . . 0.01 109.281 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.67 133.03 37.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.843 . . . . 0.43 109.387 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 t -91.72 124.66 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.02 -0.733 . . . . 1.25 109.02 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -91.09 132.11 36.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.852 -1.155 . . . . 1.77 108.202 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -99.09 140.23 33.56 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.775 -0.824 . . . . 1.63 108.775 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.5 m -111.01 123.51 50.34 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.097 -1.075 . . . . 1.08 108.097 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.8 p -114.62 131.96 56.53 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.611 -1.255 . . . . 1.26 107.611 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.9 -48.76 0.01 OUTLIER Glycine 0 N--CA 1.502 3.078 0 C-N-CA 117.698 -2.191 . . . . 0.01 113.329 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.44 -103.79 0.17 Allowed Glycine 0 N--CA 1.485 1.956 0 CA-C-N 119.95 1.875 . . . . 0.01 110.939 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -119.17 118.94 32.7 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.244 -1.15 . . . . 4.43 110.229 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.45 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.39 135.11 53.85 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.234 -0.586 . . . . 2.99 109.532 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -133.73 129.98 37.46 Favored 'General case' 0 N--CA 1.52 3.042 0 CA-C-O 122.224 1.011 . . . . 6.36 113.067 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -130.07 141.26 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-N 115.511 -0.768 . . . . 1.09 110.406 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.472 ' HG2' ' H ' ' A' ' 130' ' ' LYS . 0.8 OUTLIER -123.64 138.74 54.48 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 107.637 -1.245 . . . . 2.05 107.637 177.033 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 m -123.98 145.62 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 O-C-N 120.664 -1.272 . . . . 1.1 111.032 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -120.27 139.61 52.44 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.958 0.885 . . . . 0.73 110.652 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 3.9 tm-20 -69.16 -33.04 72.78 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.766 -0.652 . . . . 0.02 112.073 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.457 ' O ' ' OG ' ' A' ' 128' ' ' SER . 49.4 mttp -114.22 165.57 12.54 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.902 -1.124 . . . . 3.18 110.229 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.38 163.07 46.43 Favored Glycine 0 N--CA 1.492 2.375 0 CA-C-O 122.007 0.781 . . . . 0.01 111.308 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.59 39.51 27.58 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.532 0.682 . . . . 0.01 111.102 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 52.29 56.04 8.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.727 -0.608 . . . . 0.01 111.003 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -129.08 164.87 22.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.001 -1.111 . . . . 3.15 108.001 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.38 -162.64 28.32 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.081 -1.607 . . . . 0.01 109.081 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -75.51 141.79 42.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.919 -1.342 . . . . 0.01 109.126 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 107' ' ' MET . 9.7 tmm? -116.08 142.79 46.34 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.448 0.642 . . . . 0.01 109.546 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -132.08 135.65 46.61 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.166 -1.05 . . . . 2.48 108.166 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.72 133.93 55.42 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.754 -0.592 . . . . 0.01 109.808 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -148.95 148.25 29.57 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.511 1.148 . . . . 1.69 111.365 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.2 p -114.62 7.84 16.14 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.99 -1.005 . . . . 0.01 109.936 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.82 163.48 19.09 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.429 -0.794 . . . . 3.21 111.183 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.04 154.34 42.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.357 -0.839 . . . . 0.01 109.436 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.423 ' O ' ' OG ' ' A' ' 171' ' ' SER . 51.0 t -126.98 114.6 22.02 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 108.806 -0.812 . . . . 0.01 108.806 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.58 -31.97 5.1 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 120.241 1.122 . . . . 0.01 111.51 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.4 t -142.48 107.67 4.98 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.825 0.822 . . . . 0.02 108.992 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 169' ' ' ILE . 96.7 mt -63.84 -39.31 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.843 -0.535 . . . . 1.83 111.141 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 42.7 ttp -67.37 -37.54 83.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.202 -0.999 . . . . 1.34 110.014 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -69.88 -38.98 76.53 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.504 -1.372 . . . . 2.11 109.852 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -79.82 -47.08 15.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.233 -0.917 . . . . 2.08 112.455 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -110.76 -0.13 17.14 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.365 -0.834 . . . . 0.02 112.655 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 m80 59.33 33.06 22.33 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.738 -1.226 . . . . 0.02 109.272 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.27 135.59 52.76 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 108.652 -0.869 . . . . 0.02 108.652 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -92.56 -23.48 19.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 5.32 110.501 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -149.51 163.78 36.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.207 -0.933 . . . . 0.02 110.028 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.1 mt -131.79 129.68 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 107.427 -1.324 . . . . 2.17 107.427 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -106.07 -13.89 15.32 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.105 -0.997 . . . . 0.02 113.098 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 2.2 p -157.63 156.29 31.57 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.486 -1.384 . . . . 0.01 108.242 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.581 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 18.4 p -164.0 146.91 9.52 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.446 -1.409 . . . . 1.22 109.663 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.472 ' H ' ' HG2' ' A' ' 96' ' ' GLN . 31.7 tttt -121.51 111.48 17.31 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.153 0.977 . . . . 1.41 108.532 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.51 122.9 64.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.054 -1.832 . . . . 0.01 106.054 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.98 69.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 118.12 -1.432 . . . . 1.98 108.391 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.37 108.32 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 106.852 -1.536 . . . . 0.01 106.852 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.68 -174.27 45.95 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.876 -1.29 . . . . 0.01 109.876 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.481 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.7 m -110.47 145.6 37.39 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.364 -1.08 . . . . 2.3 108.901 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.45 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.8 m95 -131.54 145.35 51.69 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.48 -0.762 . . . . 0.01 110.58 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.8 141.88 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 107.519 -1.289 . . . . 1.69 107.519 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.18 143.62 44.52 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 107.657 -1.238 . . . . 2.49 107.657 177.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.1 m-85 -121.51 143.9 49.01 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.79 -0.819 . . . . 0.02 108.79 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.432 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 3.0 tm-20 -73.86 -29.9 62.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.705 -0.622 . . . . 0.02 111.525 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.42 152.84 47.42 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 120.666 -1.272 . . . . 1.48 108.989 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.07 170.61 0.47 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.213 1.276 . . . . 0.02 112.502 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 2.9 m-20 57.93 31.13 20.17 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.18 -0.918 . . . . 0.75 110.996 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 56.54 47.64 18.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.608 -0.682 . . . . 0.02 110.501 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -120.93 163.46 18.2 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.578 -0.702 . . . . 0.02 109.848 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.39 -165.77 31.49 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.971 -1.251 . . . . 0.02 109.971 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -68.06 142.57 55.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.551 -0.97 . . . . 0.02 109.14 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -118.26 148.43 42.43 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.43 -0.582 . . . . 0.02 109.43 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -129.41 142.43 50.8 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.602 ' C ' HD23 ' A' ' 150' ' ' LEU . 5.7 tt -97.41 121.33 39.18 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.384 -0.823 . . . . 0.01 109.333 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.685 HD13 ' HE1' ' A' ' 162' ' ' TRP . 17.0 mt -107.06 138.01 44.04 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.563 -0.711 . . . . 0.01 110.957 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 154' ' ' LYS . 31.8 t70 -110.21 168.98 9.04 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.174 -1.047 . . . . 2.27 108.174 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -53.02 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.845 -1.159 . . . . 1.84 108.834 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 152' ' ' ASP . 92.6 mttt -136.57 168.53 19.31 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.114 0.959 . . . . 2.28 111.584 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -113.1 109.03 18.13 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.152 -1.055 . . . . 0.01 108.152 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.55 114.45 28.1 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.11 -0.994 . . . . 0.01 110.253 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -92.48 -25.99 18.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.199 -0.938 . . . . 0.01 111.319 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -125.75 152.96 73.1 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 120.956 -1.09 . . . . 2.54 108.583 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -60.27 -42.2 44.26 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 CA-C-N 119.377 0.813 . . . . 0.7 110.408 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.7 t -60.28 -21.24 22.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.625 -1.297 . . . . 0.86 108.443 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 43.1 t0 -66.24 -16.04 63.68 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.143 -1.023 . . . . 0.02 109.255 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.685 ' HE1' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -92.97 7.33 44.46 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.892 -1.151 . . . . 0.02 107.892 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.4 9.42 85.89 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.417 -1.473 . . . . 0.02 109.417 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.3 142.43 30.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.63 -0.923 . . . . 0.02 110.142 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.26 -8.23 59.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.708 -0.62 . . . . 0.59 109.553 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.0 t -144.41 151.15 50.27 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.969 -1.082 . . . . 0.87 108.289 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.55 22.11 0.46 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 120.774 0.982 . . . . 0.38 112.369 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.73 122.23 28.36 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.488 1.137 . . . . 0.18 111.79 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 117' ' ' ILE . 9.5 mm -142.15 125.67 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 106.004 -1.85 . . . . 3.99 106.004 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 13.5 mp0 -112.66 -22.14 10.9 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.958 -1.089 . . . . 5.17 112.852 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 34.1 t -156.45 159.65 38.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.327 -2.108 . . . . 0.02 110.044 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.404 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.3 p90 -152.85 153.97 34.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.031 -1.043 . . . . 2.02 110.778 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -145.52 152.05 39.13 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.226 -0.921 . . . . 0.01 110.458 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -88.04 142.82 27.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.6 -0.688 . . . . 0.01 109.397 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.28 128.62 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.215 -0.928 . . . . 3.04 108.999 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.01 146.35 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.244 -0.91 . . . . 1.89 109.545 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 4.89 109.654 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 109.412 -1.475 . . . . 0.01 109.412 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -153.85 138.48 16.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.239 -1.154 . . . . 0.02 109.605 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -130.06 140.54 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 109.473 -0.566 . . . . 0.02 109.473 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.2 130.14 53.55 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.482 -0.761 . . . . 0.39 109.993 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -110.32 140.27 44.67 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.645 -0.659 . . . . 0.02 109.384 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.5 m-85 -121.93 138.14 54.52 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.162 -0.961 . . . . 0.02 109.617 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -69.51 -27.6 65.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.054 . . . . 0.03 111.814 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 12.4 t70 -113.93 169.86 8.7 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.829 -1.169 . . . . 0.03 110.115 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.451 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 24.8 mtp180 -75.36 158.12 33.24 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.542 0.687 . . . . 0.03 110.13 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.7 m120 66.23 35.01 6.22 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.774 0.797 . . . . 0.74 110.905 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.3 p90 49.85 44.65 25.16 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.688 0.756 . . . . 0.02 111.316 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -112.86 165.89 11.9 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.064 -1.088 . . . . 0.02 108.064 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.9 -167.47 34.79 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.808 -1.187 . . . . 0.03 110.684 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -68.69 141.92 55.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.515 -0.991 . . . . 2.76 109.152 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -122.95 150.16 43.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.535 -0.728 . . . . 1.89 110.212 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -136.62 133.47 36.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.776 -0.577 . . . . 0.02 109.473 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -109.48 135.91 49.74 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.882 -0.785 . . . . 1.12 108.882 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 45.9 t -127.85 138.43 52.69 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.582 -0.699 . . . . 0.02 109.778 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 14.8 p30 -119.2 11.66 12.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.572 -0.705 . . . . 0.2 110.372 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 21.3 p -159.58 173.58 15.91 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.797 -1.189 . . . . 1.23 109.097 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 9.0 p30 -62.91 145.92 54.09 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.766 -1.208 . . . . 0.02 110.748 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.562 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 19.4 t -134.54 118.68 17.55 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.096 -0.705 . . . . 0.02 109.096 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.19 -21.79 53.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.85 . . . . 0.24 111.697 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -153.82 105.86 2.81 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.893 -1.129 . . . . 1.14 109.82 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.562 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -102.69 8.07 39.64 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.267 -0.896 . . . . 6.37 110.272 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -60.14 -27.69 67.27 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -0.83 . . . . 3.11 111.829 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.0 p -76.32 -16.82 59.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.512 -1.368 . . . . 0.88 111.153 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -106.81 -21.07 13.14 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.287 -0.883 . . . . 0.02 110.644 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 mt -148.77 127.81 12.77 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.959 -1.088 . . . . 3.32 109.399 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.0 t -86.77 -11.8 49.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.647 -0.658 . . . . 0.02 110.582 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -172.03 161.8 5.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.012 -1.055 . . . . 0.02 108.265 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.444 ' SG ' HD12 ' A' ' 79' ' ' LEU . 4.1 p -143.79 116.38 8.65 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.044 -1.035 . . . . 0.02 108.835 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.579 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 2.0 m120 -108.11 -0.77 20.9 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.708 -1.245 . . . . 0.03 111.645 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -154.88 154.04 32.06 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.727 -1.212 . . . . 0.02 107.727 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.2 mt -146.89 147.65 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.902 -1.124 . . . . 0.02 110.728 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.525 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 29.2 ttp180 -123.88 124.69 43.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.119 -1.067 . . . . 0.02 108.119 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.67 113.94 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 106.681 -1.6 . . . . 0.02 106.681 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 69.6 mm-40 -84.75 -34.72 22.79 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.18 -0.608 . . . . 3.81 110.414 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.49 150.55 19.34 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.633 -1.746 . . . . 0.02 110.591 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.74 172.13 48.82 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.25 -1.14 . . . . 0.01 110.25 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 m -118.25 133.86 55.52 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.573 -1.269 . . . . 1.48 107.573 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -126.23 154.61 43.08 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.849 1.309 . . . . 0.02 112.235 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.22 133.76 52.62 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.292 -2.114 . . . . 0.24 105.292 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.447 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.5 m -115.88 141.52 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.467 -0.771 . . . . 0.65 109.241 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -120.21 142.59 48.86 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.028 0.918 . . . . 0.02 109.467 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' ND1' ' A' ' 57' ' ' HIS . 35.6 tt0 -65.54 -33.66 76.43 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.62 -0.718 . . . . 0.02 111.915 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 51' ' ' ARG . 0.6 OUTLIER -124.43 157.59 64.45 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 120.926 -1.109 . . . . 0.02 109.383 -178.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.03 166.08 1.06 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.667 1.578 . . . . 0.02 112.728 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 m120 63.66 36.77 10.6 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.362 -0.835 . . . . 0.02 111.12 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.487 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.4 m-85 45.06 51.32 8.94 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.636 0.732 . . . . 3.39 110.747 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 97.1 p -125.54 163.41 22.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.275 0.559 . . . . 2.33 109.837 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.4 -161.41 31.26 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.756 -1.338 . . . . 0.02 109.756 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.516 ' ND1' ' OE1' ' A' ' 50' ' ' GLU . 7.2 m170 -64.43 138.54 58.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.006 -1.291 . . . . 0.02 110.259 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.1 ppp? -119.27 137.44 53.67 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.294 0.569 . . . . 5.01 109.5 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 88.3 m-85 -135.32 139.68 44.51 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.421 -0.799 . . . . 0.02 109.821 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.7 mm -94.27 130.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.831 -0.803 . . . . 1.72 108.831 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.6 110.75 35.2 Favored Pre-proline 0 N--CA 1.506 2.332 0 O-C-N 121.349 -0.844 . . . . 0.02 110.675 -178.411 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -78.11 169.42 20.37 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 119.869 0.989 . . . . 1.47 110.442 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.53 141.6 24.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.934 -1.104 . . . . 4.25 110.607 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.06 -178.0 31.19 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 119.608 -1.282 . . . . 0.02 110.967 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -119.83 131.4 55.28 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.601 -0.94 . . . . 0.96 109.712 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 50.2 m-85 -121.8 94.84 48.16 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.974 -1.121 . . . . 0.02 107.974 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.84 -4.31 11.03 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 120.908 1.072 . . . . 0.02 113.678 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -157.16 153.96 28.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.611 -1.305 . . . . 2.02 108.143 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -59.53 -38.94 82.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.526 -0.734 . . . . 0.02 111.98 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -59.87 -23.95 63.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.107 -0.995 . . . . 0.02 110.475 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -70.59 -18.69 62.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.883 -0.784 . . . . 3.42 108.883 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.565 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.7 t90 -108.1 10.59 28.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.528 -1.286 . . . . 0.02 107.528 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 73' ' ' MET . 1.5 mpt? 59.34 22.85 11.26 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.502 0.668 . . . . 0.02 110.456 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.34 144.72 45.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.34 -1.504 . . . . 0.02 109.34 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.9 tp -79.31 -30.52 42.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.026 -1.279 . . . . 0.98 107.745 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -157.35 -171.81 3.75 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.475 -1.676 . . . . 0.02 106.475 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.579 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 78.5 m-20 -98.15 28.21 4.16 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.708 -1.245 . . . . 0.02 110.718 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -98.27 123.35 42.31 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.08 -1.013 . . . . 3.2 111.598 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 79' ' ' LEU . 53.6 mt -142.64 120.07 11.66 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.26 -1.385 . . . . 2.61 107.26 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.67 -18.04 10.55 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 121.208 -0.932 . . . . 0.02 112.392 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.487 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 39.6 t -155.63 156.27 34.72 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-N 119.722 1.761 . . . . 0.02 110.816 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.0 p -145.49 147.63 32.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.553 -0.717 . . . . 0.02 110.178 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.413 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.5 mtp180 -136.88 141.72 42.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.542 -0.724 . . . . 0.01 109.116 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 132.71 37.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.074 -1.016 . . . . 0.43 109.254 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -91.35 124.58 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.922 -0.77 . . . . 1.25 108.922 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -91.98 130.9 37.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.817 -1.177 . . . . 1.77 108.402 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mt -96.11 138.84 33.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.92 -1.141 . . . . 1.63 107.92 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.0 t -110.41 126.05 53.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.375 -0.828 . . . . 1.08 108.774 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.7 t -102.37 -154.79 0.5 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 106.109 -1.812 . . . . 1.26 106.109 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.69 -50.66 0.84 Allowed Glycine 0 N--CA 1.497 2.746 0 O-C-N 120.486 -1.383 . . . . 0.01 111.977 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.18 -99.59 0.13 Allowed Glycine 0 N--CA 1.488 2.154 0 C-N-CA 118.662 -1.732 . . . . 0.01 112.172 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -120.08 119.89 34.66 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.298 -1.119 . . . . 4.43 110.707 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.494 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.16 137.95 57.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.835 -0.541 . . . . 2.99 109.559 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.408 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 19.7 ttpp -136.88 130.16 31.29 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 120.915 -1.115 . . . . 6.36 112.973 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.53 141.79 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.535 -0.757 . . . . 1.09 110.35 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 1.3 pt20 -124.69 139.77 53.55 Favored 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 107.666 -1.235 . . . . 2.05 107.666 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.49 146.08 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 O-C-N 120.586 -1.321 . . . . 1.1 111.123 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -120.48 139.99 52.07 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 122.259 1.028 . . . . 0.73 110.855 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -68.08 -32.35 72.62 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.731 -0.668 . . . . 0.02 111.73 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -114.26 167.38 10.75 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.032 -1.042 . . . . 3.18 110.347 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.36 163.81 52.72 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.857 -0.897 . . . . 0.01 110.857 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 58.05 38.29 26.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.986 -0.714 . . . . 0.01 111.618 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 14.9 m-85 52.63 54.76 10.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.417 -0.802 . . . . 0.01 111.234 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -128.1 164.87 21.48 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.957 -1.127 . . . . 3.15 107.957 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.3 -162.21 29.39 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.146 -1.582 . . . . 0.01 109.146 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -75.93 141.37 42.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.817 -1.402 . . . . 0.01 109.179 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.1 tmm? -116.38 143.13 45.95 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.519 0.676 . . . . 0.01 109.566 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -132.23 135.9 46.62 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.315 -0.994 . . . . 2.48 108.315 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -117.01 134.15 55.11 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.68 -0.638 . . . . 0.01 109.715 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -149.11 148.8 30.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.87 -1.144 . . . . 1.69 111.318 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 p -114.88 7.79 15.79 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.1 -0.955 . . . . 0.01 109.829 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -122.26 163.12 20.2 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.614 -0.679 . . . . 3.21 111.227 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.88 155.78 40.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.405 -0.809 . . . . 0.01 109.823 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.494 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 63.3 m -129.55 116.72 18.46 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 109.043 -0.725 . . . . 0.01 109.043 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.83 -30.74 7.16 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.343 1.158 . . . . 0.01 111.49 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.6 m -142.83 108.68 5.15 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.856 0.836 . . . . 0.02 109.195 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 169' ' ' ILE . 94.3 mt -63.98 -39.96 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.873 -0.517 . . . . 1.83 111.057 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.7 ttp -66.38 -37.89 86.3 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.198 -1.001 . . . . 1.34 109.808 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.77 -38.42 76.71 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.537 -1.352 . . . . 2.11 109.696 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.568 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 43.1 tt0 -80.11 -47.64 14.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.91 . . . . 2.08 112.415 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.568 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 80.6 m-85 -111.06 -0.41 16.64 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.354 -0.841 . . . . 0.02 112.848 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 m80 59.68 33.61 21.95 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.799 -1.188 . . . . 0.02 109.463 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 mt -112.46 135.35 53.26 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.579 -0.897 . . . . 0.02 108.579 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -92.68 -23.18 19.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -0.901 . . . . 5.32 110.557 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -148.93 163.37 37.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.163 -0.96 . . . . 0.02 109.949 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.8 mt -131.56 129.33 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 107.523 -1.288 . . . . 2.17 107.523 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -107.11 -13.11 15.25 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.177 -0.952 . . . . 0.02 112.971 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.518 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.88 153.5 29.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.339 -1.476 . . . . 0.01 108.297 178.001 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.1 t -163.36 145.43 9.82 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.317 -1.49 . . . . 1.22 109.757 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -122.45 112.73 18.42 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.248 1.023 . . . . 1.41 109.061 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.63 122.63 63.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 105.924 -1.88 . . . . 0.01 105.924 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 t -146.02 64.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 117.974 -1.491 . . . . 1.98 108.971 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.2 tp10 176.14 108.83 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.641 -1.615 . . . . 0.01 106.641 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.687 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 72.55 -173.1 47.38 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.115 -1.194 . . . . 0.01 110.115 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.25 142.94 42.8 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.318 -1.107 . . . . 2.3 109.043 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.494 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 64.0 m95 -129.42 145.17 51.45 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.458 -0.776 . . . . 0.01 109.849 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.9 mt -118.46 142.78 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.892 -1.151 . . . . 1.69 107.892 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.84 144.14 43.99 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 107.542 -1.281 . . . . 2.49 107.542 177.193 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 8.0 m-85 -123.11 145.2 48.77 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.069 -0.715 . . . . 0.02 109.069 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -73.72 -30.06 62.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.628 -0.67 . . . . 0.02 112.043 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.33 153.83 47.51 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 120.644 -1.285 . . . . 1.48 109.031 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.35 166.52 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.236 1.291 . . . . 0.02 112.742 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 59.23 31.86 21.54 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.185 -0.916 . . . . 0.75 111.063 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.404 ' CE1' ' CG ' ' A' ' 173' ' ' ARG . 2.0 m-85 57.42 52.42 8.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.02 111.294 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -124.88 163.19 22.76 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.424 -0.797 . . . . 0.02 109.706 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.46 -165.29 32.38 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.835 -1.306 . . . . 0.02 109.835 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -67.99 141.47 56.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.531 -0.982 . . . . 0.02 108.863 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -118.2 148.37 42.44 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.379 -0.6 . . . . 0.02 109.379 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.49 142.76 50.7 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.804 -0.813 . . . . 0.01 108.804 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 151' ' ' LEU . 1.1 tt -98.18 122.26 41.11 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.268 -0.895 . . . . 0.01 109.245 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.591 ' N ' HD23 ' A' ' 150' ' ' LEU . 18.6 mt -105.14 134.21 48.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.435 -0.791 . . . . 0.01 110.141 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 2.6 m-20 -108.35 176.95 4.94 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.504 -0.925 . . . . 2.27 108.504 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.687 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 45.0 mttm -57.73 83.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 1.84 108.456 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 55.3 mmtt -136.51 167.7 20.86 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.971 0.891 . . . . 2.28 111.659 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -112.92 107.33 15.86 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.7 -1.222 . . . . 0.01 107.7 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.585 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 93.1 m-85 -99.09 115.09 28.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.175 -0.953 . . . . 0.01 110.383 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -93.14 -25.21 17.97 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.263 -0.898 . . . . 0.01 111.356 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -125.87 153.81 73.53 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.047 -1.033 . . . . 2.54 108.701 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.38 -42.04 37.12 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 120.436 0.757 . . . . 0.7 110.645 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.04 -20.12 21.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.666 -1.271 . . . . 0.86 108.869 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -65.34 -15.83 62.96 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.926 -1.109 . . . . 0.02 109.705 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.585 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 1.7 m0 -96.85 11.22 36.55 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.73 85.26 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.489 -1.338 . . . . 0.02 110.249 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.7 141.79 32.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.3 -1.118 . . . . 0.02 110.243 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.34 -8.7 58.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.718 -0.614 . . . . 0.59 109.95 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 t -144.22 150.64 49.27 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.934 -1.104 . . . . 0.87 108.651 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.63 21.21 0.49 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 120.717 0.945 . . . . 0.38 112.484 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.64 121.94 27.48 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.466 1.127 . . . . 0.18 111.393 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.401 ' O ' HD12 ' A' ' 117' ' ' ILE . 9.2 mm -143.48 125.66 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 106.048 -1.834 . . . . 3.99 106.048 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -110.94 -20.1 12.56 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.983 -1.073 . . . . 5.17 112.716 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.7 p -158.46 161.97 37.48 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 119.558 -1.964 . . . . 0.02 110.075 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.494 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 8.9 p90 -152.48 153.13 32.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 2.02 110.278 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.404 ' CG ' ' CE1' ' A' ' 144' ' ' TYR . 7.2 mmm180 -143.0 150.08 39.14 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.63 0.729 . . . . 0.01 110.035 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -87.79 142.71 27.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.538 -0.727 . . . . 0.01 109.319 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.1 mt -92.59 128.03 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.065 -1.022 . . . . 3.04 109.021 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.07 146.39 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.247 -0.908 . . . . 1.89 109.546 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 4.89 109.402 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.493 -1.443 . . . . 0.01 109.493 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' NZ ' ' CB ' ' A' ' 6' ' ' LYS . 5.5 ttpm? -152.3 137.61 17.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.18 -1.188 . . . . 0.02 109.978 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.6 139.95 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.302 -0.629 . . . . 0.02 109.302 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -121.04 130.41 53.77 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.484 -0.76 . . . . 0.39 110.183 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.8 m-85 -110.63 140.15 45.23 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.603 -0.686 . . . . 0.02 109.498 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.3 m-85 -122.98 138.7 54.62 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.182 -0.949 . . . . 0.02 109.921 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 41.9 mm-40 -68.54 -28.13 66.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.047 . . . . 0.03 111.742 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -114.49 170.01 8.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.917 -1.114 . . . . 0.03 110.214 -179.514 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -75.5 158.54 32.43 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.574 0.702 . . . . 0.03 110.051 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.604 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.4 m120 66.06 35.02 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.919 0.866 . . . . 0.74 110.88 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.604 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.9 p90 49.93 44.67 25.4 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.502 -0.772 . . . . 0.02 111.47 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -112.26 166.16 11.53 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.005 -1.109 . . . . 0.02 108.005 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.28 -167.81 36.19 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.792 -1.194 . . . . 0.03 110.478 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -68.43 142.5 55.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.41 -1.053 . . . . 2.76 109.142 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -121.99 149.5 43.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.596 -0.69 . . . . 1.89 110.115 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -135.81 132.24 36.43 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.372 -0.603 . . . . 0.02 109.372 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.07 135.83 49.59 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.859 -0.793 . . . . 1.12 108.859 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 48.2 t -127.34 138.02 52.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.603 -0.686 . . . . 0.02 109.704 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.485 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 23.4 t0 -119.37 11.31 12.17 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.622 -0.674 . . . . 0.2 110.552 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.7 m -158.99 173.51 16.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.791 -1.193 . . . . 1.23 109.002 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.06 146.27 53.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.74 -1.225 . . . . 0.02 110.706 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.548 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 12.2 t -134.52 118.46 17.33 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.018 -0.734 . . . . 0.02 109.018 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.18 -21.44 53.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.814 . . . . 0.24 111.682 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -154.51 106.17 2.71 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.876 -1.14 . . . . 1.14 109.727 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.548 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.83 8.2 41.41 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.336 -0.853 . . . . 6.37 110.105 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -60.45 -28.66 68.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 3.11 112.046 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 p -76.22 -17.7 59.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.404 -1.435 . . . . 0.88 111.176 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -106.94 -21.08 13.13 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.309 -0.869 . . . . 0.02 110.268 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -147.32 126.42 12.91 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.217 -0.927 . . . . 3.32 108.909 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t -86.65 -11.33 51.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.658 -0.652 . . . . 0.02 110.374 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 33.2 ttt180 -171.47 161.67 6.38 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.057 -1.09 . . . . 0.02 108.057 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -144.15 116.59 8.57 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.764 -1.21 . . . . 0.02 108.886 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 -110.12 0.19 18.21 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.767 -1.208 . . . . 0.03 112.132 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.4 t -155.64 153.75 30.54 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.047 -1.094 . . . . 0.02 108.047 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.47 146.81 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.274 1.035 . . . . 0.02 111.049 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -122.86 123.93 42.11 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.535 -1.283 . . . . 0.02 107.535 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.1 t -105.25 113.87 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.777 -1.564 . . . . 0.02 106.777 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -84.66 -35.43 22.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.69 -0.631 . . . . 3.81 110.174 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.54 150.96 20.63 Favored Glycine 0 N--CA 1.487 2.086 0 C-N-CA 118.447 -1.835 . . . . 0.02 110.701 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.7 172.06 48.74 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.347 -1.101 . . . . 0.01 110.347 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.9 m -117.55 133.67 55.71 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.552 -1.277 . . . . 1.48 107.552 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -126.29 154.57 43.24 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.724 1.249 . . . . 0.02 112.223 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.3 133.79 52.61 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.337 -2.097 . . . . 0.24 105.337 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.92 141.16 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.519 -0.738 . . . . 0.65 109.34 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.538 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 27.5 m-85 -120.08 142.62 48.71 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.064 0.935 . . . . 0.02 109.556 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.41 -33.93 77.11 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.526 -0.761 . . . . 0.02 111.855 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -124.85 157.86 64.79 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.92 -1.113 . . . . 0.02 109.58 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.38 166.96 0.96 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.633 1.556 . . . . 0.02 112.824 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 63.28 36.52 11.71 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.258 -0.883 . . . . 0.02 111.084 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.7 m-85 45.31 51.48 9.36 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.71 0.767 . . . . 3.39 110.788 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 p -125.94 163.6 22.62 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.287 0.565 . . . . 2.33 109.954 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.64 -161.79 31.21 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.788 -1.325 . . . . 0.02 109.788 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -64.57 138.62 58.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.257 . . . . 0.02 110.299 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.538 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 47.5 ttp -119.43 137.01 54.04 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.229 0.538 . . . . 5.01 109.635 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.495 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 84.4 m-85 -135.0 140.15 45.43 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.483 -0.761 . . . . 0.02 109.862 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -94.49 130.58 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.773 -0.825 . . . . 1.72 108.773 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.548 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -121.08 111.07 34.16 Favored Pre-proline 0 N--CA 1.506 2.372 0 O-C-N 121.37 -0.832 . . . . 0.02 110.744 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -77.86 169.44 20.63 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 CA-C-N 119.81 0.968 . . . . 1.47 110.557 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -53.6 141.04 26.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.95 -1.094 . . . . 4.25 110.618 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.91 -177.39 32.21 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.447 -1.359 . . . . 0.02 110.834 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -119.41 131.02 55.58 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.516 -0.99 . . . . 0.96 109.668 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.548 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 74.9 m-85 -121.54 97.42 46.93 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.814 -1.18 . . . . 0.02 107.814 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -69.93 -3.62 12.5 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 120.76 0.973 . . . . 0.02 113.766 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -157.28 154.17 28.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.523 -1.36 . . . . 2.02 108.043 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -59.83 -38.72 82.85 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.617 -0.677 . . . . 0.02 111.755 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.62 -24.65 65.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -0.967 . . . . 0.02 110.258 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -68.54 -17.9 64.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.276 -0.89 . . . . 3.42 109.067 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.562 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.5 11.66 26.68 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.754 -1.202 . . . . 0.02 107.754 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 mtp 60.91 22.2 12.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.491 -0.756 . . . . 0.02 110.313 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.14 144.9 46.79 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.615 -1.394 . . . . 0.02 109.615 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.86 -30.63 40.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.134 -1.215 . . . . 0.98 107.843 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -156.96 -171.66 3.74 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.478 -1.675 . . . . 0.02 106.478 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -98.54 28.06 4.42 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.752 -1.218 . . . . 0.02 110.671 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -96.61 122.92 40.06 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.816 -1.178 . . . . 3.2 111.229 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.491 HD21 ' CH2' ' A' ' 72' ' ' TRP . 78.8 mt -142.5 119.88 11.62 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.931 -1.137 . . . . 2.61 107.931 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.86 -18.37 8.94 Favored Glycine 0 N--CA 1.5 2.911 0 O-C-N 121.193 -0.942 . . . . 0.02 112.627 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.442 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 13.2 t -155.75 156.19 34.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.038 -1.86 . . . . 0.02 111.091 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.1 p -146.04 147.99 32.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.514 -0.741 . . . . 0.02 110.335 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.422 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 47.8 mtm180 -136.97 142.02 42.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.482 -0.761 . . . . 0.01 109.13 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.7 131.97 36.82 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.128 -0.983 . . . . 0.43 109.307 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 t -90.66 124.63 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.882 -0.784 . . . . 1.25 108.882 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -92.33 131.35 37.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.893 -1.129 . . . . 1.77 108.583 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -96.4 139.08 33.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.158 -1.053 . . . . 1.63 108.158 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.1 t -110.83 126.61 54.83 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 1.08 108.906 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 m -103.02 -154.62 0.5 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.207 -1.775 . . . . 1.26 106.207 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.43 -50.68 0.83 Allowed Glycine 0 N--CA 1.498 2.774 0 O-C-N 120.454 -1.404 . . . . 0.01 112.213 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.53 -99.75 0.13 Allowed Glycine 0 N--CA 1.487 2.088 0 C-N-CA 118.79 -1.671 . . . . 0.01 112.076 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -119.99 119.59 33.88 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.142 -1.211 . . . . 4.43 110.642 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.405 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.26 135.56 54.62 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.253 -0.579 . . . . 2.99 109.541 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.588 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 52.5 tttp -135.33 131.23 36.18 Favored 'General case' 0 N--CA 1.519 2.985 0 CA-C-O 122.136 0.969 . . . . 6.36 113.066 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.39 142.78 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.737 0.779 . . . . 1.09 110.642 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.495 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.0 pt20 -124.68 139.76 53.56 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 107.581 -1.266 . . . . 2.05 107.581 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.33 146.29 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 O-C-N 120.596 -1.315 . . . . 1.1 111.182 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 24.9 m-85 -120.42 139.79 52.31 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.97 0.89 . . . . 0.73 110.769 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -68.02 -32.49 72.91 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.694 -0.684 . . . . 0.02 112.145 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -114.85 166.24 11.99 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.054 -1.029 . . . . 3.18 110.403 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.48 163.58 46.11 Favored Glycine 0 N--CA 1.492 2.382 0 CA-C-O 122.072 0.818 . . . . 0.01 111.243 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.3 m-20 57.15 39.33 29.02 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.636 0.732 . . . . 0.01 111.071 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 52.38 56.39 7.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.555 -0.715 . . . . 0.01 110.971 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -129.5 165.57 21.38 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.02 -1.104 . . . . 3.15 108.02 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.3 -162.91 28.6 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.222 -1.551 . . . . 0.01 109.222 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -76.04 142.14 41.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.927 -1.337 . . . . 0.01 108.947 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.54 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.4 ttp -116.64 143.34 45.75 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.626 0.727 . . . . 0.01 109.694 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -131.74 136.22 47.43 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.138 -1.06 . . . . 2.48 108.138 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.588 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 44.7 tt0 -115.89 134.05 55.39 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.695 -0.628 . . . . 0.01 109.62 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.57 148.7 28.99 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.519 1.152 . . . . 1.69 111.525 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.8 p -115.24 8.14 15.43 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.863 -1.062 . . . . 0.01 110.295 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -121.97 163.26 19.64 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.359 -0.838 . . . . 3.21 111.308 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.01 155.05 41.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.501 -0.749 . . . . 0.01 109.414 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 32.8 m -128.87 116.93 19.25 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.589 -0.694 . . . . 0.01 109.156 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -74.96 -31.47 6.26 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 CA-C-N 120.386 1.173 . . . . 0.01 111.424 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.0 t -142.65 108.76 5.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.361 -0.837 . . . . 0.02 109.298 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 169' ' ' ILE . 81.9 mt -63.63 -39.51 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.795 -0.565 . . . . 1.83 110.731 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.81 -37.77 85.17 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.265 -0.974 . . . . 1.34 109.936 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -69.76 -38.65 76.83 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.595 -1.316 . . . . 2.11 109.778 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -79.93 -47.4 15.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.228 -0.92 . . . . 2.08 112.456 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -111.03 -0.29 16.7 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.396 -0.815 . . . . 0.02 112.662 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.488 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.7 m-70 59.77 33.14 21.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.79 -1.194 . . . . 0.02 109.464 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 mt -112.33 135.59 52.83 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.684 -0.858 . . . . 0.02 108.684 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -91.7 -22.83 20.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 5.32 110.473 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -149.44 164.06 36.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.152 -0.968 . . . . 0.02 109.858 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.54 129.27 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 107.289 -1.374 . . . . 2.17 107.289 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -107.71 -13.52 15.01 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.243 -0.911 . . . . 0.02 113.184 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -154.5 152.1 29.71 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.47 -1.394 . . . . 0.01 108.19 178.234 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.6 t -161.52 145.14 12.68 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.286 -1.509 . . . . 1.22 109.849 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -119.56 108.53 14.61 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.155 0.979 . . . . 1.41 108.486 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 t -107.5 120.49 58.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 105.797 -1.927 . . . . 0.01 105.797 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.41 68.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 C-N-CA 118.199 -1.401 . . . . 1.98 108.384 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.64 108.18 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.501 -1.666 . . . . 0.01 106.501 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.87 -174.03 43.8 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.899 -1.28 . . . . 0.01 109.899 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.512 ' CG2' HD21 ' A' ' 150' ' ' LEU . 7.5 m -111.69 145.51 39.14 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.335 -1.097 . . . . 2.3 109.191 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.405 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 75.3 m95 -130.6 146.27 52.07 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.492 -0.755 . . . . 0.01 110.492 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.6 mt -118.46 142.17 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 107.83 -1.174 . . . . 1.69 107.83 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -115.06 144.41 43.68 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 107.647 -1.242 . . . . 2.49 107.647 177.409 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.4 m-85 -122.42 145.08 48.62 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.657 -0.868 . . . . 0.02 108.657 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.29 -29.47 61.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.685 -0.634 . . . . 0.02 112.137 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.24 153.79 47.39 Favored Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 120.703 -1.248 . . . . 1.48 109.216 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.37 166.67 1.64 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.132 1.221 . . . . 0.02 112.47 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.4 m120 59.72 31.15 20.69 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.172 -0.922 . . . . 0.75 111.127 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 57.85 51.47 9.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.576 -0.703 . . . . 0.02 111.083 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -124.83 163.63 21.75 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.496 -0.753 . . . . 0.02 109.908 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.03 -165.51 31.79 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.91 -1.276 . . . . 0.02 109.91 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -67.67 141.66 56.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.435 -1.038 . . . . 0.02 108.846 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -117.98 148.18 42.46 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.375 -0.602 . . . . 0.02 109.375 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.456 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.5 t80 -129.69 143.72 50.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.057 -0.72 . . . . 0.01 109.057 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.593 ' C ' HD23 ' A' ' 150' ' ' LEU . 6.1 tt -98.11 121.46 40.06 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.183 -0.948 . . . . 0.01 109.294 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.554 ' N ' HD23 ' A' ' 150' ' ' LEU . 18.4 mt -105.35 136.43 44.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.01 110.319 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 154' ' ' LYS . 52.4 m-20 -108.19 171.29 7.49 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.702 -0.851 . . . . 2.27 108.702 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -57.69 83.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 1.84 108.748 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 152' ' ' ASP . 5.2 tptm -138.08 168.51 19.58 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.166 -0.959 . . . . 2.28 111.356 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -110.18 110.6 21.51 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.081 -1.081 . . . . 0.01 108.081 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.616 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 97.2 m-85 -100.44 116.35 32.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.134 -0.979 . . . . 0.01 110.089 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 7.5 ptp180 -92.05 -26.19 18.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.305 -0.872 . . . . 0.01 111.579 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -125.42 155.53 71.63 Favored Pre-proline 0 N--CA 1.504 2.245 0 O-C-N 120.741 -1.225 . . . . 2.54 107.866 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -62.79 -40.58 35.22 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.554 0.836 . . . . 0.7 110.473 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.75 -20.3 21.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.823 -1.173 . . . . 0.86 108.931 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 161' ' ' ASP . 4.9 m-20 -65.46 -16.02 63.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.953 -1.092 . . . . 0.02 109.804 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.616 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 2.7 m0 -96.72 10.83 37.57 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.164 -1.05 . . . . 0.02 108.164 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.64 12.08 84.73 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.271 -1.442 . . . . 0.02 109.959 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.42 142.01 32.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.467 -1.019 . . . . 0.02 110.159 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.59 -8.4 58.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.747 -0.596 . . . . 0.59 110.098 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 25.1 p -144.53 150.67 48.29 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.754 -1.216 . . . . 0.87 108.813 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.1 21.35 0.52 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 120.741 0.961 . . . . 0.38 112.19 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.667 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -82.69 123.98 29.79 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.595 1.188 . . . . 0.18 111.57 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 168' ' ' ALA . 10.3 mm -143.63 124.69 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.463 -1.68 . . . . 3.99 106.463 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -110.33 -22.02 11.92 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.95 -1.094 . . . . 5.17 112.369 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.6 p -157.4 160.17 38.13 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 119.501 -2.0 . . . . 0.02 109.856 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.439 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 23.5 p90 -153.61 155.26 35.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.08 -1.013 . . . . 2.02 110.696 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -145.42 151.95 39.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.239 -0.913 . . . . 0.01 110.62 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 11.8 ptm180 -87.85 143.16 27.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.648 -0.658 . . . . 0.01 109.357 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.1 mt -93.42 128.6 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.071 -1.018 . . . . 3.04 108.882 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.95 146.66 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.314 -0.866 . . . . 1.89 109.525 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 4.89 109.493 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 110.495 -1.042 . . . . 0.01 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -153.23 138.6 17.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.483 -1.01 . . . . 0.02 109.603 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tt -130.05 140.56 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.186 0.517 . . . . 0.02 109.632 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -121.84 130.25 53.24 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.332 -0.855 . . . . 0.39 110.247 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.7 m-85 -111.19 140.39 45.79 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.501 -0.75 . . . . 0.02 109.75 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.2 m-85 -122.33 138.54 54.48 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.121 -0.987 . . . . 0.02 109.88 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -69.35 -27.5 65.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.03 111.865 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' O ' ' OG ' ' A' ' 38' ' ' SER . 17.2 t70 -113.82 169.43 9.0 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.818 -1.176 . . . . 0.03 110.23 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -75.6 158.32 32.61 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.695 0.76 . . . . 0.03 110.101 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 66.36 33.31 7.08 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.025 0.917 . . . . 0.74 110.956 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 55.23 41.54 31.32 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.023 -0.535 . . . . 0.02 111.273 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -112.37 165.45 12.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.122 -1.066 . . . . 0.02 108.122 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.13 -167.7 34.64 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.888 -1.148 . . . . 0.03 110.289 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -69.1 143.65 54.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.328 -1.101 . . . . 2.76 109.109 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -120.52 150.05 41.45 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.473 0.654 . . . . 1.89 109.719 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -136.36 131.59 34.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.642 -0.661 . . . . 0.02 109.549 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -109.42 134.91 51.27 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.403 -0.811 . . . . 1.12 108.907 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.2 t -127.35 137.55 52.81 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.126 -0.694 . . . . 0.02 109.126 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.95 11.87 12.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.583 -0.698 . . . . 0.2 110.552 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 p -159.93 173.59 15.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.75 -1.219 . . . . 1.23 109.303 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -63.55 146.41 53.74 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.84 -1.163 . . . . 0.02 110.842 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.43 116.92 16.61 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.922 -0.77 . . . . 0.02 108.922 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.13 -22.23 49.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.206 -0.934 . . . . 0.24 111.373 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 28.2 p-10 -149.58 103.18 3.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.194 -1.039 . . . . 1.14 108.194 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 51.3 t80 -105.01 3.46 30.61 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.188 0.994 . . . . 6.37 110.866 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -61.13 -25.46 67.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 3.11 112.232 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 t -77.53 -15.01 59.52 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.366 -1.459 . . . . 0.88 111.342 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -105.31 -20.17 13.58 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.199 -0.938 . . . . 0.02 110.442 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 3.3 tp -151.29 131.84 13.89 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.07 -1.019 . . . . 3.32 109.64 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.9 m -86.8 -11.89 49.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.66 -0.65 . . . . 0.02 111.021 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -172.91 162.12 4.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.787 -1.196 . . . . 0.02 108.575 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' HD12 ' A' ' 79' ' ' LEU . 1.8 p -143.29 116.68 9.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.177 -0.952 . . . . 0.02 108.681 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -108.65 -0.64 20.06 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.65 -1.281 . . . . 0.03 111.474 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 2.8 p -155.43 153.61 30.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.597 -1.26 . . . . 0.02 107.597 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -147.03 148.56 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.187 -0.946 . . . . 0.02 110.619 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.506 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 60.7 ttt180 -125.41 125.48 43.46 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.94 -1.133 . . . . 0.02 107.94 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 t -105.29 114.79 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.71 -1.589 . . . . 0.02 106.71 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 53.8 mm-40 -84.56 -34.53 23.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.491 -0.756 . . . . 3.81 109.991 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.23 151.29 20.44 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 118.451 -1.833 . . . . 0.02 110.807 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.93 171.45 48.26 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.227 -1.149 . . . . 0.01 110.227 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -118.05 133.73 55.64 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.403 -1.332 . . . . 1.48 107.403 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 39.7 m95 -126.96 154.82 44.06 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.622 1.201 . . . . 0.02 112.19 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.17 133.8 52.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.423 -2.066 . . . . 0.24 105.423 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.446 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.6 m -115.95 141.3 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.623 -0.673 . . . . 0.65 109.227 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -120.43 143.0 48.71 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.999 0.904 . . . . 0.02 109.651 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.22 -34.39 78.26 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.599 -0.728 . . . . 0.02 111.826 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -124.84 158.27 63.27 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 120.893 -1.129 . . . . 0.02 109.36 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.54 166.77 1.12 Allowed 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.724 1.616 . . . . 0.02 112.867 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 63.08 37.31 11.66 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.21 -0.905 . . . . 0.02 111.143 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.435 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.0 m-85 44.9 51.92 8.35 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.664 0.745 . . . . 3.39 110.79 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.4 m -125.87 163.5 22.79 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.259 0.552 . . . . 2.33 109.898 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.28 -161.72 31.63 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.842 -1.303 . . . . 0.02 109.842 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 13.0 m170 -64.86 138.46 58.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.061 -1.258 . . . . 0.02 110.227 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.2 ptm -119.23 136.84 54.02 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.24 0.543 . . . . 5.01 109.567 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.441 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 93.8 m-85 -134.48 139.68 45.66 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.551 -0.718 . . . . 0.02 109.937 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.2 mm -94.43 130.5 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.932 -0.766 . . . . 1.72 108.932 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.559 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.56 110.69 35.31 Favored Pre-proline 0 N--CA 1.505 2.314 0 O-C-N 121.409 -0.807 . . . . 0.02 110.781 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -78.14 169.21 20.68 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 CA-C-N 119.898 0.999 . . . . 1.47 110.531 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -54.77 140.23 36.84 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.92 -1.112 . . . . 4.25 110.716 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.81 -176.97 33.16 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.506 -1.331 . . . . 0.02 110.517 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -119.29 130.7 55.53 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.287 -1.125 . . . . 0.96 109.853 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.559 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 83.3 m-85 -121.07 96.98 48.26 Favored Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 107.991 -1.114 . . . . 0.02 107.991 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.17 -4.14 13.04 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.76 0.973 . . . . 0.02 113.621 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -157.45 154.62 29.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.705 -1.247 . . . . 2.02 108.114 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -59.61 -39.05 82.98 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.448 -0.783 . . . . 0.02 111.868 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -59.99 -23.76 63.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.061 -1.025 . . . . 0.02 110.44 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -70.74 -18.55 62.78 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.777 0.798 . . . . 3.42 108.918 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.55 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.11 10.18 28.13 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.421 -1.325 . . . . 0.02 107.421 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 mtt 60.83 22.39 12.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.563 -0.711 . . . . 0.02 110.464 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.08 144.76 46.72 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.512 -1.435 . . . . 0.02 109.512 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.9 tp -79.55 -31.08 41.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -1.19 . . . . 0.98 107.888 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -157.48 -171.93 3.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.553 -1.647 . . . . 0.02 106.553 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.05 28.31 4.06 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.658 -1.276 . . . . 0.02 110.596 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -97.74 122.75 41.21 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.978 -1.076 . . . . 3.2 111.201 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 79' ' ' LEU . 56.9 mt -142.09 119.91 11.92 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.444 -1.317 . . . . 2.61 107.444 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.79 -18.59 9.9 Favored Glycine 0 N--CA 1.498 2.823 0 O-C-N 121.233 -0.917 . . . . 0.02 112.231 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.435 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 17.2 t -155.68 155.97 34.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.112 -1.817 . . . . 0.02 110.68 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.8 p -145.95 148.1 32.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.446 -0.784 . . . . 0.02 110.254 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.417 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 22.2 mtp180 -137.67 142.35 41.13 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.504 -0.747 . . . . 0.01 109.111 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.14 131.75 36.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.207 -0.933 . . . . 0.43 109.478 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -90.49 124.83 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.698 -0.852 . . . . 1.25 108.698 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -91.26 132.25 36.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.969 -1.082 . . . . 1.77 108.319 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mt -99.14 140.47 33.25 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.708 -0.849 . . . . 1.63 108.708 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.6 p -111.18 123.5 50.32 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.096 -1.076 . . . . 1.08 108.096 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 t -114.8 132.62 56.41 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.766 -1.209 . . . . 1.26 107.806 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.48 -47.9 0.01 OUTLIER Glycine 0 N--CA 1.503 3.124 0 C-N-CA 117.754 -2.165 . . . . 0.01 113.465 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.9 -103.38 0.17 Allowed Glycine 0 N--CA 1.486 2.03 0 CA-C-N 120.005 1.902 . . . . 0.01 110.908 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -118.92 118.12 30.66 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.178 -1.19 . . . . 4.43 110.021 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.45 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -65.98 135.02 54.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 120.132 -0.627 . . . . 2.99 109.528 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -134.12 130.57 37.57 Favored 'General case' 0 N--CA 1.517 2.905 0 CA-C-O 122.175 0.988 . . . . 6.36 113.115 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -130.46 141.23 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 115.51 -0.768 . . . . 1.09 110.276 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.467 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 10.9 pt20 -124.09 137.73 54.53 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 107.501 -1.296 . . . . 2.05 107.501 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.4 m -123.69 146.6 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.602 0 O-C-N 120.489 -1.382 . . . . 1.1 111.406 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.52 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 64.6 m-85 -119.4 139.17 52.45 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.137 0.97 . . . . 0.73 110.709 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.37 -32.09 71.93 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 115.853 -0.612 . . . . 0.02 111.797 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -114.78 167.52 10.7 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.964 -1.085 . . . . 3.18 110.485 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.27 164.18 52.39 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 111.057 -0.817 . . . . 0.01 111.057 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 t70 57.6 38.36 27.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.968 -0.725 . . . . 0.01 111.479 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.433 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 14.7 m-85 53.09 54.88 9.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.01 111.352 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -129.13 165.02 22.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.253 -1.018 . . . . 3.15 108.253 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.15 -163.21 28.97 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.24 -1.544 . . . . 0.01 109.24 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.428 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 55.0 tt0 -75.86 142.95 42.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.925 -1.338 . . . . 0.01 109.314 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.52 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.9 ttp -117.4 143.35 46.09 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.505 0.669 . . . . 0.01 109.754 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.428 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 54.2 m-85 -131.91 136.31 47.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.222 -1.029 . . . . 2.48 108.222 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -116.7 134.65 54.55 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.737 -0.602 . . . . 0.01 109.849 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -149.54 147.87 28.69 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.39 1.091 . . . . 1.69 111.272 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.6 p -114.3 7.94 16.58 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.049 -0.978 . . . . 0.01 109.996 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -122.18 163.44 19.54 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.439 -0.788 . . . . 3.21 111.186 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 6.7 p30 -69.19 154.81 41.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.01 109.396 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.403 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 51.2 t -126.64 115.18 22.78 Favored Pre-proline 0 N--CA 1.499 2.025 0 N-CA-C 109.009 -0.737 . . . . 0.01 109.009 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -75.41 -32.41 4.96 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 CA-C-N 120.302 1.143 . . . . 0.01 111.406 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -142.45 107.79 5.02 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.842 0.829 . . . . 0.02 108.995 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.43 -39.43 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.791 -0.568 . . . . 1.83 111.061 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.9 ttt -66.78 -37.21 84.13 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.04 -1.064 . . . . 1.34 109.873 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -70.16 -38.7 75.5 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.673 -1.267 . . . . 2.11 109.871 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -80.14 -47.45 14.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.283 -0.886 . . . . 2.08 112.469 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -110.56 -0.42 17.32 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.337 -0.852 . . . . 0.02 112.675 -176.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.574 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.2 m-70 59.78 32.64 21.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.836 -1.165 . . . . 0.02 109.504 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.2 135.75 52.47 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 108.756 -0.831 . . . . 0.02 108.756 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -92.11 -22.92 19.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 5.32 110.425 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -149.55 163.62 37.35 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.132 -0.98 . . . . 0.02 110.134 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.0 mt -131.76 129.48 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 107.125 -1.435 . . . . 2.17 107.125 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.0 -13.07 15.28 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.193 -0.942 . . . . 0.02 113.015 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.433 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -155.82 153.97 30.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.483 -1.386 . . . . 0.01 108.146 177.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 5.0 t -163.07 145.62 10.36 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.181 -1.574 . . . . 1.22 109.683 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -122.29 110.49 15.75 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.423 1.106 . . . . 1.41 108.767 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.81 122.86 64.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.127 -1.805 . . . . 0.01 106.127 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t -146.63 69.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 118.051 -1.46 . . . . 1.98 108.405 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.1 108.94 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.862 -1.533 . . . . 0.01 106.862 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.88 -174.63 46.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.003 -1.239 . . . . 0.01 110.003 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.451 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.1 m -111.33 144.98 39.64 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.528 -0.984 . . . . 2.3 109.234 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.45 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.2 m95 -131.62 146.84 52.4 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.436 -0.79 . . . . 0.01 110.907 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.4 mt -118.76 141.28 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 107.279 -1.378 . . . . 1.69 107.279 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.68 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.6 142.38 46.04 Favored 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 107.549 -1.278 . . . . 2.49 107.549 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 16.7 m-85 -122.94 145.14 48.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.452 -0.78 . . . . 0.02 109.213 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -74.69 -29.7 61.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.643 -0.66 . . . . 0.02 112.08 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.29 153.41 47.45 Favored Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 120.639 -1.288 . . . . 1.48 109.074 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -54.24 166.85 1.47 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.315 1.344 . . . . 0.02 112.41 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 2.8 m-20 59.43 31.24 20.92 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.062 -0.972 . . . . 0.75 111.081 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.3 m-85 58.1 51.38 8.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.548 -0.72 . . . . 0.02 110.981 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.93 164.01 21.02 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.47 -0.769 . . . . 0.02 109.896 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.37 -165.41 32.57 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.975 -1.25 . . . . 0.02 109.975 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -67.73 141.6 56.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.549 -0.971 . . . . 0.02 108.78 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.1 mp0 -118.52 148.46 42.61 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.219 0.533 . . . . 0.02 109.606 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.95 142.19 51.32 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.61 -0.885 . . . . 0.01 108.61 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 151' ' ' LEU . 4.9 tt -96.28 119.79 35.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.117 -0.99 . . . . 0.01 108.678 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.779 HD13 ' CZ2' ' A' ' 162' ' ' TRP . 1.8 mt -104.29 135.23 46.14 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.527 -0.733 . . . . 0.01 109.985 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 154' ' ' LYS . 1.9 m-20 -110.91 172.8 6.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.356 -0.84 . . . . 2.27 108.867 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -55.04 85.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.161 -0.962 . . . . 1.84 108.635 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 152' ' ' ASP . 19.5 mmtp -137.16 166.48 23.62 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 2.28 111.594 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 6.6 mp0 -112.35 107.47 16.31 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.51 -1.293 . . . . 0.01 107.51 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.625 ' CE2' ' NE1' ' A' ' 162' ' ' TRP . 94.2 m-85 -99.54 113.42 25.81 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.0 -1.063 . . . . 0.01 110.581 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -91.62 -28.18 17.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.329 -0.857 . . . . 0.01 111.392 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 158' ' ' LYS . 8.0 mtmp? -126.46 151.42 72.71 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 120.819 -1.175 . . . . 2.54 108.384 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -58.62 -45.62 28.69 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.352 0.804 . . . . 0.7 111.346 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 160' ' ' VAL . 11.3 t -61.21 -22.56 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.726 -1.234 . . . . 0.86 109.696 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -65.57 -15.69 62.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.723 -1.236 . . . . 0.02 109.928 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.779 ' CZ2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -97.46 11.36 37.02 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.618 -0.882 . . . . 0.02 108.618 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.95 9.27 87.05 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.555 -1.307 . . . . 0.02 110.421 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.2 142.34 30.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.396 -1.061 . . . . 0.02 110.075 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.36 -9.69 57.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.752 -0.592 . . . . 0.59 110.168 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 42.1 m -146.08 150.76 43.0 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 120.648 -1.283 . . . . 0.87 108.928 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.59 21.74 0.55 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.903 1.069 . . . . 0.38 112.397 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.93 125.56 31.52 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.556 1.169 . . . . 0.18 112.063 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.68 HG23 ' CD1' ' A' ' 138' ' ' PHE . 22.0 mt -145.94 125.74 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.778 -1.564 . . . . 3.99 106.778 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -112.16 -21.78 11.3 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.969 -1.082 . . . . 5.17 112.823 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 p -157.16 159.9 38.23 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.427 -2.046 . . . . 0.02 109.749 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.403 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.1 p90 -152.63 154.2 34.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.93 -1.106 . . . . 2.02 110.71 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 25.0 mtp180 -144.17 150.9 38.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.381 -0.824 . . . . 0.01 110.29 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.4 ' H ' ' HG2' ' A' ' 174' ' ' ARG . 33.5 ptt180 -88.07 142.36 27.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.726 . . . . 0.01 109.313 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.73 128.5 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.106 -0.996 . . . . 3.04 109.051 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.9 t -136.39 146.87 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.152 -0.967 . . . . 1.89 109.676 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 4.89 109.417 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.441 -1.064 . . . . 0.01 110.441 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -152.65 139.12 18.6 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.365 -1.079 . . . . 0.02 109.887 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 tt -130.63 139.6 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.691 -0.631 . . . . 0.02 109.412 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -121.28 130.31 53.59 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.545 -0.722 . . . . 0.39 109.938 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.5 m-85 -110.49 139.65 45.52 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.652 -0.655 . . . . 0.02 109.578 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.9 m-85 -121.41 137.88 54.51 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.237 -0.914 . . . . 0.02 109.531 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.56 -27.42 65.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.843 -1.16 . . . . 0.03 111.731 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -113.78 169.73 8.77 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.821 -1.174 . . . . 0.03 110.114 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -75.7 158.06 32.81 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.63 0.729 . . . . 0.03 110.13 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.411 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 1.8 m-20 66.44 33.34 6.91 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.96 0.886 . . . . 0.74 111.046 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.411 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.69 41.66 30.19 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.271 0.557 . . . . 0.02 111.259 177.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -113.31 165.51 12.36 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.376 -0.972 . . . . 0.02 108.376 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.25 -167.62 34.39 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.898 -1.144 . . . . 0.03 110.554 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -69.02 142.68 54.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.46 -1.023 . . . . 2.76 108.941 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -122.53 150.24 42.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.587 -0.695 . . . . 1.89 110.079 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -136.43 133.08 36.26 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.131 -0.692 . . . . 0.02 109.131 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -109.45 135.79 49.9 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.507 -0.923 . . . . 1.12 108.507 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.6 t -127.82 138.04 52.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.635 -0.665 . . . . 0.02 109.348 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -118.45 12.32 13.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.654 -0.654 . . . . 0.2 110.128 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.6 t -159.81 173.77 15.48 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.888 -1.133 . . . . 1.23 109.164 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -62.79 146.09 53.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.807 -1.183 . . . . 0.02 110.708 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.1 m -133.36 117.33 17.16 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.84 -0.8 . . . . 0.02 108.84 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.79 -20.91 48.66 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.271 -0.893 . . . . 0.24 111.758 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -151.82 105.36 3.11 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.804 -1.185 . . . . 1.14 109.342 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.15 5.82 42.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.402 -0.811 . . . . 6.37 110.291 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -62.75 -29.36 70.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.373 -0.83 . . . . 3.11 112.708 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.6 p -77.49 -18.66 56.87 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.198 -1.564 . . . . 0.88 111.605 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -107.33 -19.29 13.63 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.315 -0.866 . . . . 0.02 110.089 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -148.94 127.08 12.04 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.046 . . . . 3.32 109.258 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 p -87.72 -12.45 45.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.453 -0.779 . . . . 0.02 111.389 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -171.49 160.84 6.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.793 -1.192 . . . . 0.02 108.446 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.78 116.35 8.64 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.031 -1.043 . . . . 0.02 108.97 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 -109.83 0.49 18.78 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.856 -1.153 . . . . 0.03 111.987 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 t -156.2 154.45 30.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.325 -0.991 . . . . 0.02 108.325 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mt -146.57 146.95 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.02 -1.05 . . . . 0.02 111.001 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -122.84 124.07 42.45 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.487 -1.301 . . . . 0.02 107.487 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.35 114.15 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.774 -1.565 . . . . 0.02 106.774 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -84.16 -34.05 24.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.574 -0.704 . . . . 3.81 110.552 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.22 150.74 19.87 Favored Glycine 0 N--CA 1.484 1.897 0 C-N-CA 118.977 -1.583 . . . . 0.02 110.775 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.4 172.22 48.81 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 119.988 -1.101 . . . . 0.01 110.488 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -118.16 134.47 54.98 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.631 -1.248 . . . . 1.48 107.631 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -127.29 154.52 44.81 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 122.508 1.147 . . . . 0.02 112.112 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.38 134.45 51.81 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 105.625 -1.991 . . . . 0.24 105.625 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.94 142.1 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -0.762 . . . . 0.65 109.316 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -121.08 143.61 48.99 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.032 0.92 . . . . 0.02 109.688 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.13 -34.04 77.46 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.604 -0.725 . . . . 0.02 111.791 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -124.43 157.78 63.8 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 121.001 -1.062 . . . . 0.02 109.51 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.38 166.87 0.99 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.613 1.542 . . . . 0.02 112.814 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 63.65 36.73 10.64 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.243 -0.89 . . . . 0.02 111.039 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 45.03 51.46 8.8 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.667 0.746 . . . . 3.39 110.617 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.7 m -125.9 163.65 22.49 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.184 0.516 . . . . 2.33 109.898 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.65 -161.95 31.32 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.821 -1.311 . . . . 0.02 109.821 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -64.9 138.78 58.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.999 -1.295 . . . . 0.02 110.103 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.7 ppp? -119.89 137.6 53.92 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.773 -0.579 . . . . 5.01 109.817 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.559 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 85.4 m-85 -134.87 140.19 45.6 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.408 -0.808 . . . . 0.02 109.944 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mm -95.18 130.72 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.972 -0.751 . . . . 1.72 108.972 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.4 mt -121.86 111.66 32.52 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.374 -0.829 . . . . 0.02 110.802 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.67 170.35 19.29 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 119.859 0.985 . . . . 1.47 110.329 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -52.59 141.01 21.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.904 -1.123 . . . . 4.25 110.357 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.19 -177.54 32.35 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.41 -1.376 . . . . 0.02 110.785 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -120.1 131.33 55.02 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.408 -1.054 . . . . 0.96 109.878 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -122.21 94.79 47.74 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.931 -1.137 . . . . 0.02 107.931 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.88 -3.98 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.078 1.185 . . . . 0.02 113.855 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -157.58 154.55 28.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.608 -1.308 . . . . 2.02 108.213 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -59.49 -39.35 83.46 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.409 -0.807 . . . . 0.02 111.935 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -60.04 -24.02 64.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.081 -1.012 . . . . 0.02 110.573 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -70.37 -18.32 63.05 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.936 0.874 . . . . 3.42 108.828 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.559 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.1 t90 -107.49 11.17 29.06 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.324 -1.362 . . . . 0.02 107.324 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.1 mmt 60.41 22.28 11.87 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.51 0.671 . . . . 0.02 110.286 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.49 144.26 45.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.505 -1.438 . . . . 0.02 109.505 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.5 tp -79.13 -30.18 43.57 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.699 -1.223 . . . . 0.98 107.699 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.415 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 15.0 t-20 -157.2 -171.9 3.8 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.47 -1.678 . . . . 0.02 106.47 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.415 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 84.4 m-20 -98.81 28.21 4.45 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.789 -1.195 . . . . 0.02 110.639 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -96.52 123.05 40.06 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.971 -1.081 . . . . 3.2 111.1 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.541 HD21 ' CH2' ' A' ' 72' ' ' TRP . 81.2 mt -141.57 119.28 11.76 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.772 -1.196 . . . . 2.61 107.772 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.51 -18.94 9.14 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 121.144 -0.973 . . . . 0.02 112.389 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 p -156.08 156.2 33.93 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 119.738 1.769 . . . . 0.02 110.793 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.78 147.95 32.43 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.471 -0.768 . . . . 0.02 110.327 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -137.38 142.16 41.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.423 -0.798 . . . . 0.01 109.267 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.29 132.46 36.47 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.145 -0.972 . . . . 0.43 109.583 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.16 124.89 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.806 -0.813 . . . . 1.25 108.806 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 86' ' ' HIS . 1.6 m80 -91.11 132.81 35.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.919 -1.113 . . . . 1.77 108.424 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 mt -99.36 139.61 34.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.838 -0.801 . . . . 1.63 108.838 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.6 t -110.85 123.79 50.79 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.969 -1.123 . . . . 1.08 107.969 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.9 p -114.79 132.1 56.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.654 -1.279 . . . . 1.26 107.689 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.76 -48.97 0.01 OUTLIER Glycine 0 N--CA 1.503 3.129 0 C-N-CA 117.652 -2.214 . . . . 0.01 113.299 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.17 -103.93 0.17 Allowed Glycine 0 N--CA 1.488 2.105 0 CA-C-N 119.82 1.81 . . . . 0.01 110.963 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -118.99 118.41 31.41 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.244 -1.15 . . . . 4.43 110.184 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.453 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -65.87 135.07 54.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.811 -0.556 . . . . 2.99 109.527 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -133.68 129.97 37.54 Favored 'General case' 0 N--CA 1.519 2.994 0 CA-C-O 122.187 0.994 . . . . 6.36 113.055 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -131.84 141.46 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 115.505 -0.77 . . . . 1.09 110.248 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.438 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.3 pt20 -124.41 139.53 53.81 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 107.399 -1.334 . . . . 2.05 107.399 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.76 145.84 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 120.657 -1.277 . . . . 1.1 110.917 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -120.42 139.67 52.48 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.084 0.945 . . . . 0.73 110.929 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -68.31 -32.24 72.24 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.712 -0.676 . . . . 0.02 111.895 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -114.68 167.7 10.53 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.976 -1.077 . . . . 3.18 110.181 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.36 163.7 52.79 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.741 -0.943 . . . . 0.01 110.741 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 58.12 37.79 26.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.821 -0.811 . . . . 0.01 111.604 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.527 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 28.6 m-85 53.33 54.69 9.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.01 111.253 177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -128.15 164.3 22.78 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.079 -1.082 . . . . 3.15 108.079 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.32 -162.4 29.49 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.913 -1.675 . . . . 0.01 108.913 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -75.82 141.67 42.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.958 -1.319 . . . . 0.01 109.28 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.1 tmm? -116.54 143.23 45.86 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.518 0.675 . . . . 0.01 109.304 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -132.48 136.36 46.64 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.337 -0.986 . . . . 2.48 108.337 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -116.38 134.23 55.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.704 -0.622 . . . . 0.01 109.814 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.9 t -149.35 147.57 28.48 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.901 -1.125 . . . . 1.69 111.336 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.9 p -115.03 7.61 15.54 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.996 -1.002 . . . . 0.01 110.19 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -121.77 163.22 19.47 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.411 -0.806 . . . . 3.21 111.109 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -69.44 154.78 41.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.351 -0.843 . . . . 0.01 109.491 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.608 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 20.5 p -126.53 119.77 23.11 Favored Pre-proline 0 N--CA 1.502 2.126 0 N-CA-C 109.22 -0.659 . . . . 0.01 109.22 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -77.01 -33.11 2.88 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 120.341 1.158 . . . . 0.01 110.638 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 t -143.24 108.8 5.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.438 -0.789 . . . . 0.02 109.103 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.99 -39.31 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.731 -0.606 . . . . 1.83 110.823 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.7 ttp -67.18 -36.74 82.43 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.174 -1.01 . . . . 1.34 109.881 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.95 -38.79 76.23 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.575 -1.328 . . . . 2.11 109.668 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.567 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 42.4 tt0 -80.34 -46.6 15.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.345 -0.847 . . . . 2.08 112.509 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.567 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 53.1 m-85 -110.29 -0.45 17.7 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.281 -0.887 . . . . 0.02 112.623 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.7 m80 59.65 33.01 21.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.738 -1.226 . . . . 0.02 109.495 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.0 mt -112.45 135.71 52.83 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 108.71 -0.848 . . . . 0.02 108.71 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -92.4 -22.9 19.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 5.32 110.581 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -149.02 163.33 37.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.184 -0.948 . . . . 0.02 109.947 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.6 mt -131.75 129.19 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.452 -1.314 . . . . 2.17 107.452 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -106.81 -13.4 15.26 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.2 -0.938 . . . . 0.02 113.172 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.32 153.58 30.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.333 -1.479 . . . . 0.01 108.186 178.195 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 8.6 t -160.52 147.01 15.42 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.318 -1.489 . . . . 1.22 109.904 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -121.79 108.28 13.31 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.029 0.919 . . . . 1.41 108.623 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.15 121.06 60.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.068 -1.827 . . . . 0.01 106.068 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t -146.83 69.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 118.182 -1.407 . . . . 1.98 108.42 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.66 109.04 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.634 -1.617 . . . . 0.01 106.634 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.35 -174.1 45.2 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.819 -1.312 . . . . 0.01 109.819 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.458 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.5 m -111.4 143.62 41.93 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.526 -0.984 . . . . 2.3 109.147 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.453 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 72.5 m95 -129.92 144.97 51.6 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.403 -0.811 . . . . 0.01 110.481 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.7 mt -117.61 141.36 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.504 -1.295 . . . . 1.69 107.504 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.31 143.55 44.69 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 107.528 -1.286 . . . . 2.49 107.528 177.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 9.4 m-85 -122.46 144.88 48.78 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.903 -0.777 . . . . 0.02 108.903 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -74.33 -29.82 61.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.729 -0.607 . . . . 0.02 112.119 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.56 153.54 47.78 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 120.805 -1.184 . . . . 1.48 109.083 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.23 166.86 1.46 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.232 1.288 . . . . 0.02 112.7 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 59.54 30.9 20.58 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.235 -0.893 . . . . 0.75 111.029 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.77 51.57 9.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.574 -0.704 . . . . 0.02 110.924 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -124.58 163.66 21.47 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.55 -0.719 . . . . 0.02 109.732 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.52 -165.17 32.22 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.843 -1.303 . . . . 0.02 109.843 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -67.92 141.77 56.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.607 -0.937 . . . . 0.02 108.921 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -118.26 149.03 41.81 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.155 -0.683 . . . . 0.02 109.155 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -129.5 142.54 50.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.486 -0.759 . . . . 0.01 109.049 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.557 ' C ' HD23 ' A' ' 150' ' ' LEU . 5.8 tt -96.96 121.45 38.85 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.217 -0.927 . . . . 0.01 109.079 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.644 HD22 ' NE1' ' A' ' 162' ' ' TRP . 18.8 mt -105.8 135.32 47.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.545 -0.722 . . . . 0.01 110.71 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 154' ' ' LYS . 29.4 t70 -108.68 172.71 6.68 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.015 -1.106 . . . . 2.27 108.015 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -57.08 85.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.964 -1.085 . . . . 1.84 108.483 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 152' ' ' ASP . 52.2 tttp -135.79 167.04 21.9 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.303 1.049 . . . . 2.28 111.428 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.414 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 29.5 mt-10 -110.92 108.29 18.02 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.209 -1.034 . . . . 0.01 108.209 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.83 114.36 26.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.063 -1.023 . . . . 0.01 110.272 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -91.46 -27.12 18.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.101 -0.999 . . . . 0.01 111.506 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -125.82 153.77 73.39 Favored Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.027 -1.046 . . . . 2.54 108.692 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.58 -42.91 36.25 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 CA-C-N 119.171 0.74 . . . . 0.7 110.745 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.9 t -60.63 -20.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.648 -1.282 . . . . 0.86 108.642 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -65.44 -15.96 63.16 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.908 -1.12 . . . . 0.02 109.432 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.644 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -95.17 9.76 38.45 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.939 -1.134 . . . . 0.02 107.939 178.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.87 10.48 86.1 Favored Glycine 0 N--CA 1.485 1.963 0 C-N-CA 119.3 -1.429 . . . . 0.02 109.813 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.41 142.23 31.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.547 -0.972 . . . . 0.02 110.164 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.63 -8.37 58.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.682 -0.636 . . . . 0.59 109.783 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 t -144.66 150.71 47.94 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.758 -1.214 . . . . 0.87 108.696 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.84 21.54 0.5 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 120.735 0.957 . . . . 0.38 112.322 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.15 123.76 29.85 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.508 1.147 . . . . 0.18 111.649 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.6 mt -146.4 126.77 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.663 -1.606 . . . . 3.99 106.663 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -112.45 -20.15 11.88 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.04 -1.038 . . . . 5.17 112.982 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 11.9 p -157.69 160.83 38.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 119.353 -2.092 . . . . 0.02 110.19 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.608 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 5.2 p90 -152.46 154.28 35.22 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.149 -0.969 . . . . 2.02 110.784 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -144.79 151.85 39.45 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.105 -0.997 . . . . 0.01 110.708 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -88.21 143.75 26.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.68 -0.638 . . . . 0.01 109.33 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.17 129.26 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.137 -0.977 . . . . 3.04 109.083 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.5 t -136.14 146.57 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.269 -0.895 . . . . 1.89 109.62 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.295 -0.878 . . . . 4.89 109.434 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 110.406 -1.078 . . . . 0.01 110.406 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -152.57 138.56 18.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.421 -1.047 . . . . 0.02 109.879 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.05 139.24 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.215 -0.661 . . . . 0.02 109.215 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -121.85 130.94 53.77 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.459 -0.776 . . . . 0.39 109.861 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 m-85 -110.89 140.41 45.39 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.656 -0.653 . . . . 0.02 109.633 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 4.8 m-85 -122.07 138.41 54.45 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.317 -0.865 . . . . 0.02 109.402 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -69.27 -27.43 65.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.144 . . . . 0.03 111.869 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -114.08 169.97 8.62 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.852 -1.155 . . . . 0.03 110.257 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -75.41 158.48 32.64 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.535 0.684 . . . . 0.03 109.986 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.1 t30 65.7 35.05 7.14 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.891 0.853 . . . . 0.74 110.75 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.4 p90 50.03 44.78 25.7 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.681 0.753 . . . . 0.02 111.342 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -112.16 165.73 11.89 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.986 -1.116 . . . . 0.02 107.986 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.21 -167.74 34.57 Favored Glycine 0 N--CA 1.494 2.567 0 C-N-CA 119.87 -1.157 . . . . 0.03 110.559 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -68.95 143.18 54.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -1.108 . . . . 2.76 108.861 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.515 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 50.1 ttt180 -122.19 149.26 43.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.564 -0.71 . . . . 1.89 110.225 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -135.91 132.2 36.18 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.18 -0.674 . . . . 0.02 109.18 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -109.65 136.57 48.81 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.396 -0.815 . . . . 1.12 108.928 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 t -128.03 137.85 52.35 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.553 -0.717 . . . . 0.02 109.593 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.39 11.85 13.15 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.661 -0.649 . . . . 0.2 110.139 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 36.7 t -159.53 174.15 15.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.896 -1.128 . . . . 1.23 108.913 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.404 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -62.85 145.86 54.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.63 -1.294 . . . . 0.02 110.599 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.519 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 12.7 p -134.93 119.36 17.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.5 -0.75 . . . . 0.02 109.152 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.0 -21.08 47.53 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.289 -0.882 . . . . 0.24 112.376 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -152.41 107.02 3.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.67 -1.269 . . . . 1.14 110.14 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.48 5.95 39.79 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.375 -0.828 . . . . 6.37 110.442 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -61.42 -30.25 70.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 3.11 112.186 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.7 t -76.94 -17.31 58.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.389 -1.444 . . . . 0.88 111.124 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -106.99 -20.84 13.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.403 -0.811 . . . . 0.02 110.755 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.07 127.2 12.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.979 -1.076 . . . . 3.32 109.663 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 t -87.01 -12.39 47.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.57 -0.706 . . . . 0.02 111.032 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -172.8 161.72 4.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.781 -1.199 . . . . 0.02 108.467 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.445 ' SG ' HD12 ' A' ' 79' ' ' LEU . 3.4 p -143.49 116.55 8.9 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.1 -1.0 . . . . 0.02 108.876 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -108.28 -0.04 21.04 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.813 -1.179 . . . . 0.03 111.287 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 t -156.46 154.34 30.26 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.965 -1.124 . . . . 0.02 107.965 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 39' ' ' ILE . 9.0 mt -146.96 148.13 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.057 -1.027 . . . . 0.02 110.554 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -123.54 124.81 43.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.2 -1.037 . . . . 0.02 108.2 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.66 114.31 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 106.768 -1.567 . . . . 0.02 106.768 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -83.99 -34.1 24.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.717 -0.614 . . . . 3.81 110.629 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.54 151.19 20.58 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.019 -1.563 . . . . 0.02 110.688 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.09 172.41 49.12 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.934 -1.127 . . . . 0.01 110.496 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -118.15 133.98 55.42 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.548 -1.278 . . . . 1.48 107.548 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -126.36 154.74 43.13 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.685 -1.26 . . . . 0.02 112.196 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.61 133.93 52.53 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.543 -2.021 . . . . 0.24 105.543 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.465 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.5 m -116.86 142.6 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.565 -0.709 . . . . 0.65 109.451 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -120.7 142.74 49.21 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.053 0.93 . . . . 0.02 109.596 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.433 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 38.0 tt0 -65.11 -33.54 76.27 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.593 -0.73 . . . . 0.02 111.786 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -124.45 157.71 64.1 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 120.988 -1.07 . . . . 0.02 109.444 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.23 166.63 0.99 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.61 1.54 . . . . 0.02 112.71 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m120 63.44 36.42 11.39 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 115.355 -0.839 . . . . 0.02 111.016 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.527 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.3 m-85 45.37 51.41 9.53 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.528 0.68 . . . . 3.39 110.742 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 p -125.75 163.7 22.27 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.27 0.557 . . . . 2.33 109.948 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.46 -161.54 31.26 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.882 -1.287 . . . . 0.02 109.882 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 13.8 m80 -64.25 138.79 58.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.045 -1.268 . . . . 0.02 110.161 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.1 ppp? -119.09 137.17 53.75 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.397 0.618 . . . . 5.01 109.65 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 88.3 m-85 -135.27 139.29 44.29 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.419 -0.801 . . . . 0.02 109.765 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 mm -96.25 131.03 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.715 -0.846 . . . . 1.72 108.715 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.478 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.9 mt -121.69 111.9 32.67 Favored Pre-proline 0 N--CA 1.505 2.305 0 O-C-N 121.344 -0.848 . . . . 0.02 110.757 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.46 170.1 19.93 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 119.892 0.997 . . . . 1.47 110.325 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -52.63 141.09 21.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.991 -1.068 . . . . 4.25 110.42 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.71 -177.9 31.76 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.437 -1.363 . . . . 0.02 110.782 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -120.04 131.57 55.16 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.401 -1.058 . . . . 0.96 109.659 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CE1' HD22 ' A' ' 61' ' ' LEU . 92.6 m-85 -121.32 97.95 47.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.941 -1.133 . . . . 0.02 107.941 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -70.17 -3.88 13.18 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.678 0.919 . . . . 0.02 113.6 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -157.39 154.2 28.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.549 -1.344 . . . . 2.02 107.989 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -59.83 -38.49 82.2 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.432 -0.792 . . . . 0.02 111.872 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -59.71 -24.38 63.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.051 . . . . 0.02 110.433 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -70.22 -18.81 63.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.863 0.84 . . . . 3.42 108.978 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.55 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.6 t90 -108.25 10.08 27.87 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.493 -1.299 . . . . 0.02 107.493 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.3 mtm 60.84 21.84 11.95 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.484 0.659 . . . . 0.02 110.535 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.61 144.3 46.06 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.388 -1.485 . . . . 0.02 109.388 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 mt -78.84 -30.57 45.27 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.687 -1.227 . . . . 0.98 107.687 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -157.32 -171.31 3.56 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.335 -1.728 . . . . 0.02 106.335 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -98.32 29.06 3.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.639 -1.288 . . . . 0.02 110.595 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -97.94 122.65 41.31 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.899 -1.126 . . . . 3.2 111.448 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.465 HD22 ' HB ' ' A' ' 48' ' ' VAL . 57.1 mt -142.76 119.78 11.36 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.45 -1.315 . . . . 2.61 107.45 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.94 -17.89 10.53 Favored Glycine 0 N--CA 1.497 2.762 0 O-C-N 121.296 -0.878 . . . . 0.02 112.25 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 31.2 t -155.17 155.83 34.64 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.189 -1.771 . . . . 0.02 110.856 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 47.8 t -145.42 148.17 33.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.463 -0.773 . . . . 0.02 110.233 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -137.52 141.67 41.44 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.482 -0.761 . . . . 0.01 109.038 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.06 133.73 36.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.43 109.405 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 t -91.92 124.58 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.98 -0.748 . . . . 1.25 108.98 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -92.75 131.96 37.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.958 -1.089 . . . . 1.77 108.507 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.15 138.8 33.23 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.134 -1.061 . . . . 1.63 108.134 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 t -110.84 126.67 54.9 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.758 -0.83 . . . . 1.08 108.758 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.4 m -103.22 -154.49 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.23 -1.767 . . . . 1.26 106.23 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.06 -50.55 0.84 Allowed Glycine 0 N--CA 1.497 2.723 0 O-C-N 120.527 -1.358 . . . . 0.01 112.09 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.67 -100.2 0.14 Allowed Glycine 0 N--CA 1.487 2.076 0 C-N-CA 118.76 -1.686 . . . . 0.01 111.995 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -120.03 119.73 34.23 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.164 -1.198 . . . . 4.43 110.523 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.455 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.44 136.45 55.74 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.177 -0.609 . . . . 2.99 109.463 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -134.7 130.57 36.49 Favored 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 122.163 0.982 . . . . 6.36 112.942 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -132.08 142.07 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.675 0.75 . . . . 1.09 110.532 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.425 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.9 pt20 -124.82 139.83 53.48 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 107.686 -1.228 . . . . 2.05 107.686 176.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -124.07 145.71 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.495 0 O-C-N 120.607 -1.308 . . . . 1.1 111.121 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -120.47 140.17 51.8 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 122.081 0.943 . . . . 0.73 110.852 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -68.66 -32.58 72.51 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.652 -0.704 . . . . 0.02 111.929 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -114.57 165.47 12.73 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.978 -1.076 . . . . 3.18 110.228 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 163.39 45.42 Favored Glycine 0 N--CA 1.494 2.532 0 CA-C-O 122.022 0.79 . . . . 0.01 111.264 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 t70 57.01 39.4 29.37 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.595 0.712 . . . . 0.01 111.1 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 52.15 56.2 8.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.509 -0.744 . . . . 0.01 111.03 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -129.23 165.03 22.17 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.839 -1.171 . . . . 3.15 107.839 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.07 -162.78 28.8 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 108.963 -1.655 . . . . 0.01 108.963 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -75.33 141.24 43.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.775 -1.426 . . . . 0.01 109.001 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.1 tmm? -116.3 143.37 45.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.604 0.716 . . . . 0.01 109.526 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -132.41 136.65 46.92 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.309 -0.997 . . . . 2.48 108.309 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -116.21 134.42 54.94 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.632 -0.668 . . . . 0.01 109.635 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -149.68 148.08 28.85 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.532 1.158 . . . . 1.69 111.437 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 p -115.09 7.88 15.55 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.936 -1.029 . . . . 0.01 109.985 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -122.16 163.26 19.85 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.437 -0.79 . . . . 3.21 111.236 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.55 154.31 42.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.01 109.471 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.429 ' O ' ' OG ' ' A' ' 171' ' ' SER . 44.2 t -127.07 115.99 21.9 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 109.096 -0.705 . . . . 0.01 109.096 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.45 -32.95 4.51 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.324 1.151 . . . . 0.01 111.604 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.7 m -142.07 108.59 5.32 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.379 -0.826 . . . . 0.02 109.237 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 169' ' ' ILE . 95.9 mt -64.37 -40.02 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.787 -0.571 . . . . 1.83 111.019 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.0 ttp -66.76 -37.6 84.94 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.021 -1.071 . . . . 1.34 109.76 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -69.81 -38.53 76.62 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.538 -1.351 . . . . 2.11 109.817 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.526 ' OE1' ' CG ' ' A' ' 121' ' ' PHE . 7.9 tm0? -80.49 -47.61 14.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.281 -0.887 . . . . 2.08 112.282 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.526 ' CG ' ' OE1' ' A' ' 120' ' ' GLN . 92.1 m-85 -110.72 -0.85 16.93 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.389 -0.819 . . . . 0.02 112.748 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.9 m80 60.1 33.24 21.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.748 -1.22 . . . . 0.02 109.483 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 mt -112.42 135.67 52.84 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.802 -0.814 . . . . 0.02 108.802 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -92.3 -23.14 19.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.313 -0.867 . . . . 5.32 110.365 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -148.92 163.57 37.08 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.151 -0.968 . . . . 0.02 109.957 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.2 mt -131.6 129.43 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 107.473 -1.306 . . . . 2.17 107.473 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -107.82 -13.26 15.04 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.25 -0.906 . . . . 0.02 113.171 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.5 OUTLIER -153.87 152.1 30.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.355 -1.466 . . . . 0.01 108.206 178.342 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.2 t -160.72 145.04 13.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.29 -1.506 . . . . 1.22 109.651 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -120.86 108.82 14.38 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.099 0.952 . . . . 1.41 108.714 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.12 120.68 59.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 105.771 -1.937 . . . . 0.01 105.771 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 t -146.43 68.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 118.209 -1.397 . . . . 1.98 108.341 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.62 108.75 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.563 -1.643 . . . . 0.01 106.563 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.89 -174.16 40.52 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.693 -1.363 . . . . 0.01 109.693 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 m -111.62 144.88 40.16 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.37 -1.076 . . . . 2.3 109.12 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.455 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 71.5 m95 -129.69 146.47 51.46 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.537 -0.727 . . . . 0.01 110.263 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.2 mt -118.0 141.3 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.583 -1.266 . . . . 1.69 107.583 177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.1 143.66 44.43 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.77 -1.196 . . . . 2.49 107.77 177.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.5 m-85 -122.63 143.75 49.56 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.535 -0.728 . . . . 0.02 109.052 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -73.21 -29.61 62.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.514 -0.741 . . . . 0.02 111.98 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.31 153.54 47.48 Favored Pre-proline 0 N--CA 1.505 2.318 0 O-C-N 120.69 -1.256 . . . . 1.48 109.112 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.46 167.24 1.44 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.376 1.384 . . . . 0.02 112.565 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.34 31.14 20.91 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.246 -0.888 . . . . 0.75 111.058 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.65 51.65 9.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.641 -0.662 . . . . 0.02 110.943 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -125.02 163.8 21.55 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.567 -0.708 . . . . 0.02 109.809 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.83 -165.55 32.07 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.878 -1.289 . . . . 0.02 109.878 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -67.7 141.77 56.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.555 -0.968 . . . . 0.02 108.784 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -118.15 148.75 42.03 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.308 -0.627 . . . . 0.02 109.308 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.95 142.45 50.93 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.477 -0.764 . . . . 0.01 109.007 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.37 121.37 38.1 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.302 -0.874 . . . . 0.01 109.297 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.658 HD22 ' NE1' ' A' ' 162' ' ' TRP . 18.1 mt -105.27 136.62 44.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.37 -0.831 . . . . 0.01 110.616 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 154' ' ' LYS . 48.1 t0 -109.88 171.99 7.12 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.127 -1.064 . . . . 2.27 108.127 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -57.87 84.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.994 -1.066 . . . . 1.84 108.796 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 152' ' ' ASP . 53.8 mttm -136.19 168.78 18.76 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.245 -0.909 . . . . 2.28 111.62 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -112.88 110.61 20.8 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.001 -1.111 . . . . 0.01 108.001 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -100.72 116.52 32.81 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.069 -1.019 . . . . 0.01 110.171 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.457 ' O ' ' OG ' ' A' ' 128' ' ' SER . 25.4 ptt180 -92.44 -25.21 18.57 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.251 -0.906 . . . . 0.01 111.525 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -126.32 153.38 74.68 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 120.845 -1.159 . . . . 2.54 108.658 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -60.71 -42.19 40.98 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 119.265 0.773 . . . . 0.7 110.446 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.36 -20.43 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.696 -1.253 . . . . 0.86 108.571 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -65.75 -16.46 63.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.92 -1.113 . . . . 0.02 109.561 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.658 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -94.88 9.76 37.96 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.873 -1.158 . . . . 0.02 107.873 179.053 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.64 10.73 85.76 Favored Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.341 -1.409 . . . . 0.02 109.761 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.06 142.23 31.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.463 -1.022 . . . . 0.02 110.194 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.38 -8.23 59.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.773 -0.579 . . . . 0.59 109.856 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.4 m -144.68 150.91 48.55 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 120.88 -1.137 . . . . 0.87 108.708 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.19 21.67 0.52 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.708 0.939 . . . . 0.38 112.233 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.02 123.91 29.91 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.455 1.122 . . . . 0.18 111.702 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.422 ' O ' HD12 ' A' ' 117' ' ' ILE . 17.5 mt -146.47 126.24 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.799 -1.556 . . . . 3.99 106.799 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -112.24 -19.87 12.08 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.074 -1.016 . . . . 5.17 112.896 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 28.4 t -157.29 160.0 38.14 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 119.174 -2.204 . . . . 0.02 110.357 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -153.01 154.25 34.56 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 2.02 110.589 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -144.44 151.19 38.86 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.169 -0.957 . . . . 0.01 110.566 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -87.95 143.46 27.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.409 -0.807 . . . . 0.01 109.232 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.0 mt -93.73 128.65 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.052 -1.03 . . . . 3.04 109.221 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.86 146.69 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.42 -0.8 . . . . 1.89 109.535 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 4.89 109.528 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 110.42 -1.072 . . . . 0.01 110.42 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -152.62 137.44 17.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.586 -0.949 . . . . 0.02 109.488 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.2 tt -130.27 141.12 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.223 0.535 . . . . 0.02 109.828 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t -121.75 130.27 53.3 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.39 -0.819 . . . . 0.39 109.972 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 m-85 -110.25 139.6 45.25 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.543 -0.723 . . . . 0.02 109.378 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.2 m-85 -121.76 137.94 54.57 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.282 -0.886 . . . . 0.02 109.557 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -69.58 -27.53 65.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -0.999 . . . . 0.03 111.733 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.4 170.68 8.12 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.848 -1.158 . . . . 0.03 110.087 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -74.93 161.16 29.76 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.749 0.785 . . . . 0.03 110.26 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 12.9 t-20 62.4 35.06 15.14 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.894 0.854 . . . . 0.74 110.551 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 19.6 p90 49.41 43.39 23.42 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.381 -0.827 . . . . 0.02 110.906 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -109.39 165.48 11.61 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.698 -1.223 . . . . 0.02 107.698 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.8 -167.61 33.62 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.785 -1.198 . . . . 0.03 110.63 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -69.47 143.81 53.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.361 -1.082 . . . . 2.76 109.032 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -122.96 150.51 42.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.63 -0.669 . . . . 1.89 110.164 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -137.18 134.05 35.89 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.367 -0.605 . . . . 0.02 109.367 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -109.53 135.57 50.31 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.961 -0.755 . . . . 1.12 108.961 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.7 t -127.73 137.65 52.52 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.588 -0.695 . . . . 0.02 109.327 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -118.84 11.99 12.79 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.64 -0.662 . . . . 0.2 110.377 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 46.3 t -159.85 173.62 15.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.77 -1.206 . . . . 1.23 109.186 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.562 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.9 p30 -63.35 146.26 53.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.794 -1.191 . . . . 0.02 110.829 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.6 m -134.01 117.48 16.73 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.691 -0.855 . . . . 0.02 108.691 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.484 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.19 -20.46 55.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.466 -0.771 . . . . 0.24 111.793 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.57 105.87 3.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.901 -1.124 . . . . 1.14 109.25 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.68 5.23 43.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 6.37 110.243 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -62.15 -29.6 70.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.448 -0.782 . . . . 3.11 112.495 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -77.34 -18.59 57.29 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.224 -1.548 . . . . 0.88 111.687 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -106.43 -19.96 13.52 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.305 -0.872 . . . . 0.02 110.423 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -149.05 127.44 12.23 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.019 -1.051 . . . . 3.32 109.457 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -87.27 -12.97 45.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.549 -0.72 . . . . 0.02 111.004 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -172.8 162.08 4.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.02 108.477 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.4 p -142.61 115.21 8.57 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.021 -1.05 . . . . 0.02 108.851 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -106.8 -2.77 21.11 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.737 -1.227 . . . . 0.03 111.44 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 t -152.98 153.51 33.09 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.884 -1.154 . . . . 0.02 107.884 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 39' ' ' ILE . 9.7 mt -147.01 147.35 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.858 -1.151 . . . . 0.02 110.725 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -125.12 125.55 43.92 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.972 -1.122 . . . . 0.02 107.972 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -105.9 114.95 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.643 -1.614 . . . . 0.02 106.643 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -85.57 -34.31 21.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 3.81 109.968 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.37 150.52 19.33 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.512 -1.804 . . . . 0.02 110.696 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.68 171.78 48.34 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.486 -1.046 . . . . 0.01 110.486 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.5 m -118.16 133.35 55.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.579 -1.267 . . . . 1.48 107.579 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 43.8 m95 -126.3 154.68 43.11 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.812 -1.18 . . . . 0.02 112.14 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.24 133.96 52.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.253 -2.129 . . . . 0.24 105.253 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.486 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.3 m -119.21 144.0 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.656 -0.653 . . . . 0.65 109.405 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.555 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 43.6 m-85 -120.93 145.15 48.0 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.095 0.95 . . . . 0.02 109.887 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -66.97 -33.35 75.38 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.975 -0.557 . . . . 0.02 111.914 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -123.7 158.2 60.24 Favored Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 120.978 -1.076 . . . . 0.02 109.598 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.36 164.98 1.69 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.591 1.527 . . . . 0.02 112.764 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m120 64.07 37.17 9.3 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.452 -0.795 . . . . 0.02 111.189 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 44.88 51.26 8.64 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.559 0.695 . . . . 3.39 110.738 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.5 t -125.93 163.59 22.63 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.179 0.514 . . . . 2.33 109.745 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.92 -161.74 30.8 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.877 -1.289 . . . . 0.02 109.877 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -65.84 140.6 58.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.081 -1.246 . . . . 0.02 110.348 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.555 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 52.4 ttp -118.65 138.3 52.7 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.639 -0.663 . . . . 5.01 109.956 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 48.3 m-85 -134.45 137.39 43.93 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.409 -0.807 . . . . 0.02 109.748 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.0 mm -95.28 131.25 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.579 -0.897 . . . . 1.72 108.579 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.501 HD22 ' CE1' ' A' ' 66' ' ' TYR . 6.9 mt -120.5 111.52 34.78 Favored Pre-proline 0 N--CA 1.504 2.266 0 O-C-N 121.31 -0.869 . . . . 0.02 110.985 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.02 168.97 21.22 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 119.853 0.983 . . . . 1.47 110.117 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -53.67 140.7 28.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.774 -1.204 . . . . 4.25 110.502 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.37 -177.21 32.67 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.586 -1.293 . . . . 0.02 110.636 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -118.95 130.63 55.81 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.352 -1.087 . . . . 0.96 109.808 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.501 ' CE1' HD22 ' A' ' 61' ' ' LEU . 87.6 m-85 -120.64 97.11 48.73 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.004 -1.11 . . . . 0.02 108.004 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.45 -3.94 12.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 120.708 0.939 . . . . 0.02 113.52 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -157.38 153.96 28.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.651 -1.28 . . . . 2.02 107.988 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -59.76 -38.17 81.07 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.456 -0.777 . . . . 0.02 111.787 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -60.78 -23.85 65.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.061 -1.025 . . . . 0.02 110.433 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -70.1 -18.28 63.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.339 -0.851 . . . . 3.42 108.89 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.546 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.55 10.46 27.15 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.482 -1.303 . . . . 0.02 107.482 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.1 mtt 61.13 21.55 11.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.621 -0.674 . . . . 0.02 110.539 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.45 144.49 45.63 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.307 -1.517 . . . . 0.02 109.307 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.45 -31.1 42.45 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.743 -1.206 . . . . 0.98 107.743 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -157.48 -172.21 3.89 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.443 -1.688 . . . . 0.02 106.443 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 3.7 p-10 -98.1 28.49 3.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.708 -1.245 . . . . 0.02 110.672 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 78' ' ' ARG . 26.5 ttm-85 -97.84 122.48 41.0 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.851 -1.156 . . . . 3.2 111.142 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.486 HD22 ' HB ' ' A' ' 48' ' ' VAL . 54.5 mt -142.34 120.13 11.91 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.652 -1.24 . . . . 2.61 107.652 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.32 -18.1 10.72 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 121.309 -0.87 . . . . 0.02 112.183 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.6 m -155.67 155.67 33.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.212 -1.758 . . . . 0.02 110.505 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.4 p -145.23 147.67 32.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.807 -0.558 . . . . 0.02 109.74 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -137.64 142.09 41.19 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.39 -0.819 . . . . 0.01 109.159 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.94 133.13 36.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.13 -0.981 . . . . 0.43 109.391 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.03 124.41 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.89 -0.781 . . . . 1.25 108.89 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -92.4 131.54 37.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.859 -1.15 . . . . 1.77 108.582 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.55 138.98 33.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.183 -1.043 . . . . 1.63 108.183 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.8 p -111.05 126.56 54.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.351 -0.843 . . . . 1.08 108.878 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.2 t -103.32 -154.33 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.184 -1.784 . . . . 1.26 106.184 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.19 -50.96 0.83 Allowed Glycine 0 N--CA 1.499 2.88 0 O-C-N 120.49 -1.381 . . . . 0.01 112.214 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.74 -100.14 0.14 Allowed Glycine 0 N--CA 1.487 2.091 0 C-N-CA 118.845 -1.645 . . . . 0.01 111.905 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -120.26 119.53 33.46 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.23 -1.159 . . . . 4.43 110.386 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.458 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.61 136.93 56.31 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.226 -0.59 . . . . 2.99 109.586 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -136.01 131.16 34.64 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-O 122.205 1.003 . . . . 6.36 112.93 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.1 143.35 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-N 115.584 -0.734 . . . . 1.09 110.365 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.438 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 1.3 pt20 -124.8 139.52 53.76 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 107.493 -1.299 . . . . 2.05 107.493 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.0 m -123.99 145.86 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.548 -1.345 . . . . 1.1 110.971 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -120.68 140.16 52.0 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.302 1.049 . . . . 0.73 110.876 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.2 tm-20 -68.36 -32.54 72.69 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.587 -0.733 . . . . 0.02 111.81 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -114.0 167.46 10.64 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.043 -1.035 . . . . 3.18 110.306 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.24 163.52 52.67 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.815 -0.914 . . . . 0.01 110.815 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 58.2 38.51 26.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.98 -0.718 . . . . 0.01 111.567 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 52.16 55.41 9.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.01 111.245 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -128.51 164.53 22.59 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.93 -1.137 . . . . 3.15 107.93 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.67 -162.39 29.05 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.013 -1.635 . . . . 0.01 109.013 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -75.54 141.18 43.04 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.842 -1.387 . . . . 0.01 109.154 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 107' ' ' MET . 0.8 OUTLIER -116.26 143.07 46.0 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.48 0.657 . . . . 0.01 109.42 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -132.36 136.16 46.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.22 -1.03 . . . . 2.48 108.22 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.482 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.2 tm-20 -116.4 134.1 55.26 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.735 -0.603 . . . . 0.01 109.5 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.482 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 11.9 t -149.3 148.04 29.07 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.491 1.138 . . . . 1.69 111.216 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.5 p -115.09 7.56 15.46 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.017 -0.992 . . . . 0.01 109.924 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -121.97 163.31 19.55 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.504 -0.747 . . . . 3.21 111.194 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -70.25 155.05 41.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.833 . . . . 0.01 109.78 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.402 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 34.9 t -126.49 115.17 23.09 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 121.532 -0.73 . . . . 0.01 109.195 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.05 -33.13 4.76 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 120.339 1.157 . . . . 0.01 111.113 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.8 t -141.8 107.67 5.15 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.968 0.889 . . . . 0.02 108.832 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.09 -39.93 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.585 -0.697 . . . . 1.83 111.176 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.8 ttt -66.39 -37.47 85.31 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.078 -1.049 . . . . 1.34 109.593 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.59 -38.46 77.35 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.572 -1.33 . . . . 2.11 109.709 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -80.44 -47.24 14.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -0.906 . . . . 2.08 112.476 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -111.41 -0.7 16.2 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.235 -0.915 . . . . 0.02 112.653 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.7 m80 60.08 33.41 21.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.755 -1.216 . . . . 0.02 109.648 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.42 135.51 53.03 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.793 -0.817 . . . . 0.02 108.793 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -92.71 -23.16 19.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.334 -0.854 . . . . 5.32 110.766 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -148.91 163.42 37.49 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.226 -0.922 . . . . 0.02 109.965 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.2 mt -131.97 129.72 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 107.576 -1.268 . . . . 2.17 107.576 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -107.72 -13.53 15.0 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.21 -0.931 . . . . 0.02 113.243 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.95 153.52 31.18 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.277 -1.515 . . . . 0.01 108.24 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 7.4 t -161.35 147.39 14.24 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.286 -1.509 . . . . 1.22 109.9 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -121.76 108.66 13.77 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.989 0.9 . . . . 1.41 108.627 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 t -107.59 120.41 58.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 105.941 -1.874 . . . . 0.01 105.941 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 t -146.49 68.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 118.189 -1.404 . . . . 1.98 108.454 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.39 108.75 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 106.715 -1.587 . . . . 0.01 106.715 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.21 -173.27 43.1 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.978 -1.249 . . . . 0.01 109.978 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.479 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.2 m -112.02 143.73 42.54 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.283 -1.128 . . . . 2.3 109.221 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.458 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 72.6 m95 -129.69 145.72 51.51 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.461 -0.774 . . . . 0.01 110.336 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.0 mt -117.8 141.35 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 107.708 -1.219 . . . . 1.69 107.708 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.783 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.54 141.45 47.14 Favored 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 107.019 -1.474 . . . . 2.49 107.019 178.037 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 7.7 m-85 -122.73 145.71 48.16 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.437 -0.789 . . . . 0.02 109.197 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -74.12 -29.92 62.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.02 112.007 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.68 153.18 47.91 Favored Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 120.753 -1.217 . . . . 1.48 109.118 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.419 ' O ' ' NH1' ' A' ' 145' ' ' ARG . 1.2 Cg_endo -54.24 166.72 1.54 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.25 1.3 . . . . 0.02 112.791 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 58.67 32.15 21.87 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.205 -0.907 . . . . 0.75 111.099 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 144' ' ' TYR . 1.0 OUTLIER 57.51 52.25 8.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.564 -0.71 . . . . 0.02 111.473 178.186 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.464 ' HG3' HH11 ' A' ' 145' ' ' ARG . 10.8 mtm-85 -124.5 163.14 22.49 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.52 -0.737 . . . . 0.02 109.597 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.2 -164.95 32.48 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.923 -1.271 . . . . 0.02 109.923 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -68.04 141.13 56.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.583 -0.951 . . . . 0.02 108.862 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -118.32 148.42 42.49 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.361 0.601 . . . . 0.02 109.438 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.5 141.97 51.22 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.465 -0.772 . . . . 0.01 108.977 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.584 ' C ' HD23 ' A' ' 150' ' ' LEU . 6.0 tt -97.15 121.57 39.18 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.263 -0.898 . . . . 0.01 109.288 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.673 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.1 mt -105.22 133.91 49.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.426 -0.797 . . . . 0.01 110.536 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 32.2 t70 -109.41 175.76 5.33 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.346 -0.983 . . . . 2.27 108.346 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.18 84.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.974 -1.079 . . . . 1.84 108.528 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 48.6 tttp -136.61 165.45 25.85 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.343 -0.848 . . . . 2.28 111.461 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.484 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 27.1 mt-10 -111.1 108.4 18.09 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.033 -1.099 . . . . 0.01 108.033 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -98.93 114.82 27.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.002 -1.061 . . . . 0.01 110.241 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -93.26 -26.05 17.51 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.145 -0.972 . . . . 0.01 111.34 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -125.56 153.75 72.7 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 120.94 -1.1 . . . . 2.54 108.738 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.67 -43.35 32.79 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 119.145 0.73 . . . . 0.7 110.724 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.34 -20.72 21.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.728 -1.233 . . . . 0.86 108.632 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -65.67 -16.2 63.51 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.044 -1.035 . . . . 0.02 109.568 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.673 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.91 9.76 38.06 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.026 -1.101 . . . . 0.02 108.026 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.02 10.43 86.26 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.259 -1.448 . . . . 0.02 109.693 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.56 142.22 31.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.482 -1.011 . . . . 0.02 110.145 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.46 -8.48 58.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.7 -0.625 . . . . 0.59 109.819 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 32.2 m -144.5 151.05 49.66 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.888 -1.133 . . . . 0.87 108.602 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.8 21.3 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 120.786 0.991 . . . . 0.38 112.294 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.06 122.69 28.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.525 1.155 . . . . 0.18 111.476 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.783 HG23 ' CD1' ' A' ' 138' ' ' PHE . 56.4 mt -145.76 125.35 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.183 -1.784 . . . . 3.99 106.183 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -111.65 -19.34 12.52 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.024 -1.048 . . . . 5.17 113.094 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.2 t -157.05 160.49 38.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.328 -2.108 . . . . 0.02 110.2 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.402 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 11.6 p90 -151.55 152.25 32.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.116 -0.99 . . . . 2.02 110.272 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.419 ' CG ' ' CE1' ' A' ' 144' ' ' TYR . 7.1 mmm180 -143.34 149.81 38.29 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.388 -0.82 . . . . 0.01 110.033 -178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -88.56 143.46 26.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.464 -0.772 . . . . 0.01 109.566 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.11 128.25 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.136 -0.977 . . . . 3.04 109.123 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.9 t -136.01 146.48 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.223 -0.923 . . . . 1.89 109.496 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 4.89 109.508 179.995 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.429 -1.468 . . . . 0.01 109.429 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -151.28 138.2 19.02 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.214 -1.168 . . . . 0.02 110.355 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 tt -130.13 138.33 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.055 -0.72 . . . . 0.02 109.055 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 t -120.72 130.59 54.13 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.468 -0.77 . . . . 0.39 110.058 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.6 m-85 -110.86 140.09 45.62 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.695 -0.628 . . . . 0.02 109.548 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.8 m-85 -122.51 138.61 54.51 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.219 -0.926 . . . . 0.02 109.362 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.41 -27.13 65.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.126 -0.984 . . . . 0.03 111.781 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -114.18 169.88 8.7 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.926 -1.109 . . . . 0.03 110.15 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -75.61 158.25 32.68 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.626 0.727 . . . . 0.03 110.074 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 66.22 33.18 7.46 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.899 0.857 . . . . 0.74 111.029 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.47 41.58 30.74 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.235 0.541 . . . . 0.02 111.212 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -113.02 166.09 11.74 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.321 -0.992 . . . . 0.02 108.321 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.48 -167.71 35.75 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.965 -1.112 . . . . 0.03 110.446 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -68.71 142.15 55.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.229 -1.159 . . . . 2.76 108.771 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -122.75 149.37 44.19 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.653 -0.654 . . . . 1.89 110.013 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -135.93 133.02 37.19 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.685 -0.634 . . . . 0.02 109.656 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 2.2 p-10 -109.64 136.46 48.96 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.526 -0.733 . . . . 1.12 109.07 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 54.1 t -128.2 138.08 52.31 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.554 -0.716 . . . . 0.02 109.618 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -119.24 11.14 12.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.62 -0.675 . . . . 0.2 110.645 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 30.4 p -159.27 173.67 15.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.779 -1.201 . . . . 1.23 109.124 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.69 145.73 53.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.612 -1.305 . . . . 0.02 110.694 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.561 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 21.6 t -134.6 118.42 17.21 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.09 -0.708 . . . . 0.02 109.09 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.23 -20.95 54.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.373 -0.829 . . . . 0.24 111.444 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -155.31 105.68 2.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.797 -1.189 . . . . 1.14 109.707 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.63 8.81 41.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.388 -0.82 . . . . 6.37 109.922 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -60.55 -29.13 68.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -0.841 . . . . 3.11 111.978 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.8 m -76.45 -17.61 59.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.466 -1.396 . . . . 0.88 111.347 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -107.32 -20.24 13.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.374 -0.829 . . . . 0.02 110.539 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 tp -148.83 127.02 12.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.89 -1.131 . . . . 3.32 109.631 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.9 t -87.14 -12.58 46.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.615 -0.678 . . . . 0.02 111.37 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -171.82 161.91 6.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.73 -1.231 . . . . 0.02 108.364 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.91 116.62 8.71 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.972 -1.08 . . . . 0.02 109.043 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 1.9 m120 -109.41 0.41 19.37 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.671 -1.268 . . . . 0.03 111.862 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.1 t -156.39 154.38 30.41 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.274 -1.01 . . . . 0.02 108.274 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -146.14 146.91 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 122.328 1.061 . . . . 0.02 111.092 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -122.77 124.24 42.89 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.706 -1.22 . . . . 0.02 107.706 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -106.67 114.33 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 106.716 -1.587 . . . . 0.02 106.716 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.26 -34.38 23.84 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.348 -0.541 . . . . 3.81 110.554 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.19 149.99 18.26 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.102 -1.523 . . . . 0.02 110.682 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.31 172.54 49.13 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.374 -1.09 . . . . 0.01 110.374 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -118.24 134.05 55.36 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 107.81 -1.181 . . . . 1.48 107.81 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -126.47 154.89 43.11 Favored 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 122.587 1.184 . . . . 0.02 112.274 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.08 52.27 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.681 -1.97 . . . . 0.24 105.681 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.36 141.64 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -0.758 . . . . 0.65 109.298 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -120.52 143.07 48.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.158 0.98 . . . . 0.02 109.536 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CD ' HH21 ' A' ' 78' ' ' ARG . 31.2 tt0 -65.35 -34.07 77.46 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.52 -0.764 . . . . 0.02 111.794 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -124.65 157.95 63.86 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.095 -1.003 . . . . 0.02 109.323 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.56 167.05 1.03 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.67 1.58 . . . . 0.02 112.623 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.1 t30 62.82 36.44 13.04 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.238 -0.892 . . . . 0.02 111.007 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 45.21 51.53 9.13 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.728 0.775 . . . . 3.39 110.72 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -125.37 163.26 22.98 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.234 0.54 . . . . 2.33 109.818 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.32 -161.34 31.31 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.426 ' ND1' ' OE1' ' A' ' 50' ' ' GLU . 10.9 m80 -65.35 138.54 58.23 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.89 -1.359 . . . . 0.02 110.251 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -119.58 137.16 54.02 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.773 -0.579 . . . . 5.01 109.505 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.4 m-85 -134.75 140.38 45.88 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.437 -0.789 . . . . 0.02 109.978 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.8 mm -94.49 130.74 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.863 -0.791 . . . . 1.72 108.863 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -121.22 110.95 34.02 Favored Pre-proline 0 N--CA 1.505 2.287 0 O-C-N 121.353 -0.842 . . . . 0.02 110.702 -178.458 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.67 169.79 20.25 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 CA-C-N 119.819 0.971 . . . . 1.47 110.423 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -53.19 141.7 22.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.023 -1.048 . . . . 4.25 110.413 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.92 -177.83 31.17 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.41 -1.376 . . . . 0.02 111.012 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -119.55 131.32 55.5 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.453 -1.028 . . . . 0.96 109.749 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 53.3 m-85 -122.42 96.03 46.37 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 107.823 -1.176 . . . . 0.02 107.823 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.52 -3.43 11.05 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.831 1.021 . . . . 0.02 113.876 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -157.39 154.22 28.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.548 -1.345 . . . . 2.02 108.098 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -59.7 -38.98 83.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.02 112.016 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -60.16 -23.76 64.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.149 -0.969 . . . . 0.02 110.417 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -70.18 -18.26 63.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 3.42 108.755 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.552 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.0 OUTLIER -108.26 10.78 27.69 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.56 -1.274 . . . . 0.02 107.56 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.6 mtt 61.65 22.73 13.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.02 110.546 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.12 144.57 48.64 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.81 -1.316 . . . . 0.02 109.81 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 75' ' ' LEU . 9.3 mp -80.05 -30.28 39.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -1.219 . . . . 0.98 107.88 177.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -157.03 -171.48 3.66 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.666 -1.605 . . . . 0.02 106.666 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.498 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 65.9 m-20 -98.66 28.34 4.3 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.64 -1.288 . . . . 0.02 110.847 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.5 HH21 ' CD ' ' A' ' 50' ' ' GLU . 27.7 mtm-85 -96.77 122.82 40.13 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.833 -1.167 . . . . 3.2 111.351 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.491 HD21 ' CH2' ' A' ' 72' ' ' TRP . 80.3 mt -142.05 119.3 11.47 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 107.618 -1.253 . . . . 2.61 107.618 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.86 -18.53 9.32 Favored Glycine 0 N--CA 1.499 2.889 0 O-C-N 121.12 -0.988 . . . . 0.02 112.638 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 p -156.16 156.69 34.66 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 119.628 1.714 . . . . 0.02 110.841 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 57.0 m -145.91 148.42 32.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.366 -0.834 . . . . 0.02 110.361 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -137.05 141.89 42.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.435 -0.791 . . . . 0.01 109.284 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 132.18 36.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.048 -1.033 . . . . 0.43 109.443 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 t -91.49 124.58 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.874 -0.787 . . . . 1.25 108.874 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -92.58 131.3 37.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.942 -1.099 . . . . 1.77 108.569 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mt -95.87 139.69 31.72 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.233 -1.025 . . . . 1.63 108.233 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.6 t -110.89 126.12 54.36 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.643 -0.873 . . . . 1.08 108.643 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.0 m -102.58 -154.91 0.5 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.069 -1.826 . . . . 1.26 106.069 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.23 -51.01 0.82 Allowed Glycine 0 N--CA 1.498 2.778 0 O-C-N 120.522 -1.361 . . . . 0.01 112.029 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.56 -99.85 0.13 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 118.683 -1.722 . . . . 0.01 112.121 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -120.17 120.37 35.97 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.202 -1.175 . . . . 4.43 110.723 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.486 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.2 137.58 57.09 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.362 -0.607 . . . . 2.99 109.362 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 32.6 ttmt -136.53 130.44 32.46 Favored 'General case' 0 N--CA 1.516 2.856 0 CA-C-O 122.155 0.979 . . . . 6.36 113.031 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -131.81 141.37 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-N 115.51 -0.768 . . . . 1.09 110.524 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 pt20 -124.45 139.78 53.57 Favored 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 107.485 -1.302 . . . . 2.05 107.485 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.83 146.07 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 O-C-N 120.734 -1.229 . . . . 1.1 111.038 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -120.73 139.96 52.34 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.046 0.927 . . . . 0.73 110.817 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -68.6 -32.47 72.38 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.688 -0.687 . . . . 0.02 112.025 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -114.27 165.35 12.78 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.855 -1.153 . . . . 3.18 110.087 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.29 163.41 45.75 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.973 -0.851 . . . . 0.01 110.973 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 57.29 38.86 28.8 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.541 0.686 . . . . 0.01 111.069 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 52.65 56.23 7.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.534 -0.729 . . . . 0.01 111.087 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -128.59 164.93 21.78 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.998 -1.112 . . . . 3.15 107.998 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.93 -162.6 28.86 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.04 -1.624 . . . . 0.01 109.04 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -75.34 141.57 43.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.839 -1.389 . . . . 0.01 108.963 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' A' ' 107' ' ' MET . 9.3 tmm? -116.33 142.94 46.18 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.482 0.658 . . . . 0.01 109.431 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -132.44 136.55 46.81 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.348 -0.982 . . . . 2.48 108.348 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -116.35 134.15 55.22 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.713 -0.617 . . . . 0.01 109.615 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -149.1 147.92 29.07 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.522 1.153 . . . . 1.69 111.358 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.4 p -114.53 7.66 16.2 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.972 -1.013 . . . . 0.01 109.901 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -122.14 163.34 19.68 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.443 -0.786 . . . . 3.21 111.264 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 4.9 p30 -69.57 154.6 41.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.01 109.568 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.5 t -126.79 115.33 22.45 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.487 -0.758 . . . . 0.01 108.976 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.03 -32.69 5.14 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 120.4 1.179 . . . . 0.01 111.346 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.0 m -142.12 108.38 5.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.368 -0.833 . . . . 0.02 109.203 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.22 -39.66 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.769 -0.582 . . . . 1.83 111.03 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.3 ttt -67.04 -37.79 84.72 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.141 -1.024 . . . . 1.34 109.835 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -69.59 -38.5 77.34 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.622 -1.299 . . . . 2.11 109.724 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -80.62 -47.4 14.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -0.919 . . . . 2.08 112.531 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -111.0 -0.72 16.58 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.291 -0.881 . . . . 0.02 112.727 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.3 m170 59.96 33.51 21.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.738 -1.226 . . . . 0.02 109.436 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.53 135.38 53.31 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.73 -0.841 . . . . 0.02 108.73 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -92.42 -23.03 19.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.288 -0.883 . . . . 5.32 110.605 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -148.8 163.64 36.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.163 -0.96 . . . . 0.02 109.934 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -131.57 129.46 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 107.454 -1.313 . . . . 2.17 107.454 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -107.86 -13.21 15.04 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.216 -0.927 . . . . 0.02 113.142 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -154.1 152.11 30.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.432 -1.418 . . . . 0.01 108.251 178.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 7.3 t -161.77 145.12 12.25 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.212 -1.555 . . . . 1.22 109.56 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -122.02 111.03 16.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.191 0.996 . . . . 1.41 108.861 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.14 121.96 63.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 105.733 -1.951 . . . . 0.01 105.733 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.7 t -146.27 64.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 117.996 -1.482 . . . . 1.98 108.955 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.2 tp10 176.67 109.67 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.485 -1.672 . . . . 0.01 106.485 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.16 -173.41 45.71 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.214 -1.154 . . . . 0.01 110.214 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.42 142.95 41.43 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.491 -1.006 . . . . 2.3 108.93 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.486 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 68.0 m95 -129.2 145.21 51.37 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.513 -0.742 . . . . 0.01 109.958 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.0 mt -118.2 142.09 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 107.743 -1.206 . . . . 1.69 107.743 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.2 143.25 45.13 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 107.515 -1.291 . . . . 2.49 107.515 177.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -122.56 143.65 49.6 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.107 -0.701 . . . . 0.02 109.107 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.45 -29.95 62.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.614 -0.679 . . . . 0.02 112.19 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.26 153.58 47.42 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 120.674 -1.266 . . . . 1.48 109.128 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.35 166.59 1.67 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.237 1.291 . . . . 0.02 112.492 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 59.67 31.54 20.95 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.166 -0.925 . . . . 0.75 111.127 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.482 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.8 m-85 57.62 51.51 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.513 -0.742 . . . . 0.02 111.066 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -124.97 163.81 21.49 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.484 -0.76 . . . . 0.02 109.886 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.68 -165.36 32.14 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.838 -1.305 . . . . 0.02 109.838 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -67.71 141.41 56.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.979 . . . . 0.02 108.81 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.63 148.37 42.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.246 -0.65 . . . . 0.02 109.246 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.442 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.04 143.07 50.75 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.808 -0.812 . . . . 0.01 108.808 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 151' ' ' LEU . 1.3 tt -97.51 121.99 40.05 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.385 -0.822 . . . . 0.01 109.127 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.642 HD22 ' NE1' ' A' ' 162' ' ' TRP . 16.9 mt -104.3 135.63 45.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.01 110.311 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 154' ' ' LYS . 13.2 m-20 -108.05 173.36 6.36 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -58.68 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.992 -1.068 . . . . 1.84 108.614 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 152' ' ' ASP . 40.8 tttm -137.04 168.75 19.0 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.362 -0.836 . . . . 2.28 111.483 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 1.6 pm0 -112.61 111.37 22.13 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.213 -1.032 . . . . 0.01 108.213 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -100.68 116.03 31.62 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.053 -1.029 . . . . 0.01 110.059 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.448 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.9 ptm180 -92.78 -25.6 18.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.101 -0.999 . . . . 0.01 111.49 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -125.96 153.08 73.73 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.78 -1.2 . . . . 2.54 108.716 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.72 -42.2 40.75 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 119.271 0.775 . . . . 0.7 110.62 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.78 -20.22 21.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.706 -1.246 . . . . 0.86 108.508 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -65.65 -16.16 63.47 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.941 -1.099 . . . . 0.02 109.494 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.642 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -95.11 9.68 38.67 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.881 -1.155 . . . . 0.02 107.881 178.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.53 11.07 85.5 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 119.295 -1.431 . . . . 0.02 109.659 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.96 142.24 31.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.44 -1.035 . . . . 0.02 110.174 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.44 -8.28 59.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.736 -0.603 . . . . 0.59 109.987 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.0 p -144.48 150.85 49.05 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.709 -1.244 . . . . 0.87 108.771 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -76.05 21.31 0.52 Allowed 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 120.818 1.012 . . . . 0.38 112.248 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.63 123.99 29.76 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.572 1.177 . . . . 0.18 111.739 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.2 mt -147.05 126.71 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 106.925 -1.509 . . . . 3.99 106.925 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -112.66 -19.52 12.02 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.132 -0.98 . . . . 5.17 112.826 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.1 p -158.4 161.44 37.53 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 119.242 -2.161 . . . . 0.02 110.216 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -153.03 154.6 35.24 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.182 -0.948 . . . . 2.02 110.576 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.482 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 25.5 mtp180 -143.84 150.54 38.63 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.086 -1.009 . . . . 0.01 110.314 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -87.74 142.72 27.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.622 -0.674 . . . . 0.01 109.268 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.5 mt -93.14 128.19 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.089 -1.007 . . . . 3.04 109.033 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.4 m -135.89 146.31 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.116 -0.99 . . . . 1.89 109.558 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 4.89 109.389 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 110.322 -1.111 . . . . 0.01 110.322 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -152.37 138.59 18.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.354 -1.086 . . . . 0.02 109.769 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.4 139.52 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.194 -0.669 . . . . 0.02 109.194 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 t -122.08 130.96 53.72 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.464 -0.773 . . . . 0.39 110.301 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 m-85 -111.16 140.31 45.81 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.617 -0.677 . . . . 0.02 109.623 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.7 m-85 -121.8 138.54 54.33 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.296 -0.877 . . . . 0.02 109.368 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -68.99 -27.33 65.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.905 -1.122 . . . . 0.03 111.767 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -114.47 170.35 8.37 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.864 -1.147 . . . . 0.03 110.111 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -74.99 161.59 29.33 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.673 0.749 . . . . 0.03 110.137 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.608 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 t30 62.42 34.97 15.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.907 0.86 . . . . 0.74 110.634 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.608 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 19.5 p90 49.68 43.31 24.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.307 -0.861 . . . . 0.02 111.057 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -109.43 165.71 11.43 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.73 -1.211 . . . . 0.02 107.73 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.41 -167.86 34.4 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 120.775 -1.203 . . . . 0.03 110.688 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -68.84 143.66 54.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.382 -1.069 . . . . 2.76 108.883 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.532 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 48.9 ttt180 -122.1 149.94 42.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.615 -0.678 . . . . 1.89 110.039 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -136.91 132.63 34.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.653 -0.654 . . . . 0.02 109.303 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -109.75 136.14 49.55 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.435 -0.79 . . . . 1.12 109.046 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.1 t -127.86 137.71 52.43 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.522 -0.736 . . . . 0.02 109.42 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.488 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -118.41 11.98 13.18 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.2 110.15 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 29.3 m -159.17 173.77 15.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.849 -1.157 . . . . 1.23 108.826 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 33.4 p30 -62.87 145.8 54.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.856 -1.152 . . . . 0.02 110.324 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 10.8 p -134.89 119.2 17.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.497 -0.752 . . . . 0.02 109.16 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.2 -20.97 47.02 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.257 -0.902 . . . . 0.24 112.297 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.48 106.28 3.1 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.702 -1.249 . . . . 1.14 110.175 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.507 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.1 6.46 40.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.341 -0.849 . . . . 6.37 110.046 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -61.21 -30.37 70.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 3.11 112.097 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.1 m -77.1 -17.52 58.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.308 -1.495 . . . . 0.88 110.965 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -106.66 -21.19 13.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.453 -0.78 . . . . 0.02 110.64 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -149.01 127.18 12.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.98 -1.075 . . . . 3.32 109.599 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.9 t -86.66 -12.2 49.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.531 -0.731 . . . . 0.02 111.176 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -172.0 161.73 5.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.867 -1.146 . . . . 0.02 108.357 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.5 t -143.19 116.59 9.07 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.914 -1.116 . . . . 0.02 108.936 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -109.33 0.29 19.43 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.831 -1.168 . . . . 0.03 111.608 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.1 t -156.92 154.72 30.2 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.508 -0.923 . . . . 0.02 108.508 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.1 147.0 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 122.232 1.015 . . . . 0.02 110.79 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -122.21 123.67 42.03 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.847 -1.168 . . . . 0.02 107.847 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 t -106.52 113.75 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 106.746 -1.576 . . . . 0.02 106.746 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -83.95 -34.12 24.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.17 -0.612 . . . . 3.81 110.412 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.94 150.63 19.76 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 119.052 -1.546 . . . . 0.02 110.525 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.32 172.08 48.72 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.871 -1.157 . . . . 0.01 110.502 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.7 m -118.48 134.72 54.85 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.69 -1.226 . . . . 1.48 107.69 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.0 m95 -127.58 155.01 44.51 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.601 1.191 . . . . 0.02 112.118 -176.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.38 134.26 52.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 105.518 -2.03 . . . . 0.24 105.518 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.02 143.48 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.523 -0.736 . . . . 0.65 109.374 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -120.69 144.67 48.09 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.165 0.983 . . . . 0.02 110.06 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' OE2' ' ND1' ' A' ' 57' ' ' HIS . 21.0 tt0 -65.95 -33.09 75.02 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.798 -0.637 . . . . 0.02 111.505 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -124.62 158.1 63.25 Favored Pre-proline 0 N--CA 1.503 2.219 0 O-C-N 120.993 -1.067 . . . . 0.02 109.419 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.61 166.68 1.19 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.692 1.595 . . . . 0.02 112.772 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.5 m-20 63.31 36.62 11.57 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.464 -0.789 . . . . 0.02 110.934 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.46 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 6.5 m-85 45.23 51.74 9.05 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.612 0.72 . . . . 3.39 110.749 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -125.99 163.61 22.63 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.208 0.528 . . . . 2.33 109.883 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.7 -161.9 31.21 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.705 -1.358 . . . . 0.02 109.705 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.457 ' ND1' ' OE2' ' A' ' 50' ' ' GLU . 14.0 m80 -64.34 138.87 58.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.922 -1.34 . . . . 0.02 110.122 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -118.77 137.16 53.56 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.337 0.589 . . . . 5.01 109.609 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.587 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.5 m-85 -134.73 139.34 45.11 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.459 -0.776 . . . . 0.02 109.912 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.7 mm -95.51 130.97 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.11 -0.7 . . . . 1.72 109.11 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.493 HD22 ' CE1' ' A' ' 66' ' ' TYR . 13.5 mt -122.33 112.01 31.59 Favored Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.261 -0.9 . . . . 0.02 110.835 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.38 170.84 18.7 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 119.754 0.948 . . . . 1.47 110.03 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -52.28 140.79 20.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 4.25 110.243 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.39 -177.46 32.55 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.4 -1.381 . . . . 0.02 110.769 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -121.02 131.94 54.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.381 -1.07 . . . . 0.96 109.878 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CE1' HD22 ' A' ' 61' ' ' LEU . 96.6 m-85 -122.27 97.79 44.89 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 107.768 -1.197 . . . . 0.02 107.768 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.08 -2.23 10.78 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.79 0.994 . . . . 0.02 113.694 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -157.32 153.94 28.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.734 -1.228 . . . . 2.02 108.156 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -59.96 -39.68 86.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.478 -0.764 . . . . 0.02 111.778 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -59.73 -23.88 63.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.02 110.35 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -70.87 -18.49 62.69 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.926 0.869 . . . . 3.42 108.937 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.587 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.72 10.08 28.97 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.376 -1.342 . . . . 0.02 107.376 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.6 mtt 61.04 22.4 12.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.593 -0.692 . . . . 0.02 110.518 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.93 144.45 46.56 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.571 -1.412 . . . . 0.02 109.571 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -79.42 -30.8 42.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.699 -1.222 . . . . 0.98 107.699 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 11.7 p-10 -157.03 -171.65 3.72 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.35 -1.722 . . . . 0.02 106.35 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -98.61 28.74 4.04 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.652 -1.28 . . . . 0.02 110.591 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HG3' HH11 ' A' ' 78' ' ' ARG . 25.5 ttm-85 -96.77 122.23 39.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.817 -1.177 . . . . 3.2 111.005 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.509 HD21 ' CH2' ' A' ' 72' ' ' TRP . 78.4 mt -141.9 119.37 11.62 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.606 -1.257 . . . . 2.61 107.606 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.4 -18.34 9.78 Favored Glycine 0 N--CA 1.501 3.026 0 O-C-N 121.129 -0.982 . . . . 0.02 112.579 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.1 p -156.48 156.81 34.37 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 119.502 1.651 . . . . 0.02 110.451 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.4 m -145.38 148.26 33.17 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.623 -0.673 . . . . 0.02 109.846 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.46 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 51.1 mtp180 -137.48 141.98 41.52 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.193 -0.942 . . . . 0.01 109.283 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 133.18 36.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.237 -0.915 . . . . 0.43 109.679 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.74 123.66 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.112 -1.07 . . . . 1.25 108.112 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -94.92 133.29 38.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.131 . . . . 1.77 108.956 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.57 134.14 37.44 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.714 -1.217 . . . . 1.63 107.714 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m -106.79 130.27 54.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.501 -0.749 . . . . 1.08 109.988 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.4 p -115.3 100.53 8.19 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 102.749 -3.056 . . . . 1.26 102.749 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -119.74 -60.84 0.26 Allowed Glycine 0 N--CA 1.51 3.623 0 N-CA-C 110.069 -1.212 . . . . 0.01 110.069 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.13 -107.82 1.32 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.353 -1.499 . . . . 0.01 109.353 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -120.55 -141.01 0.34 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.679 -0.895 . . . . 4.43 109.213 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -126.5 119.73 27.91 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.23 -1.026 . . . . 2.99 108.23 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -144.1 121.98 12.0 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.416 -1.427 . . . . 6.36 113.28 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.3 tt -130.71 138.09 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.435 0.636 . . . . 1.09 109.681 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.483 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.6 pt20 -123.84 138.76 54.44 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.418 -1.327 . . . . 2.05 107.418 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.61 146.21 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.687 -1.258 . . . . 1.1 110.658 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -119.77 141.7 49.23 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.215 1.007 . . . . 0.73 111.385 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.32 -33.02 72.5 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.783 -0.644 . . . . 0.02 111.358 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.8 mmmt -114.38 167.91 10.31 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.122 -0.986 . . . . 3.18 109.66 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.68 168.89 45.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 111.169 -0.772 . . . . 0.01 111.169 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 53.53 39.51 30.14 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.511 0.672 . . . . 0.01 111.598 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 52.48 48.45 22.56 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.707 -0.621 . . . . 0.01 110.934 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -121.67 164.22 17.7 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.332 -0.988 . . . . 3.15 108.332 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.69 -163.09 29.48 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.042 -1.623 . . . . 0.01 109.042 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.5 141.58 43.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.798 -1.413 . . . . 0.01 109.199 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.458 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.6 tmm? -116.24 143.79 45.06 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.479 0.657 . . . . 0.01 109.595 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.44 136.44 46.73 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.387 -0.968 . . . . 2.48 108.387 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -117.36 133.94 55.4 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.576 -0.703 . . . . 0.01 109.771 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 t -149.58 149.2 30.33 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.481 1.134 . . . . 1.69 111.329 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.7 p -114.74 7.96 16.01 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.057 -0.974 . . . . 0.01 110.334 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 23.9 mp0 -121.62 163.16 19.41 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.345 -0.847 . . . . 3.21 111.018 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.6 p30 -69.46 154.91 41.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.479 -0.763 . . . . 0.01 109.451 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.4 t -127.31 115.17 21.5 Favored Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 109.13 -0.692 . . . . 0.01 109.13 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.4 -31.44 5.72 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 120.295 1.141 . . . . 0.01 111.429 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.3 m -142.46 107.86 5.03 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.385 -0.822 . . . . 0.02 108.989 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.07 -39.92 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.783 -0.573 . . . . 1.83 111.066 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.44 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 15.1 tpt -66.43 -37.4 85.11 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.167 -1.013 . . . . 1.34 109.766 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -70.15 -38.42 75.47 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.584 -1.322 . . . . 2.11 109.791 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -80.56 -47.4 14.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.179 -0.951 . . . . 2.08 112.354 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -111.04 -0.81 16.52 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.329 -0.857 . . . . 0.02 112.852 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.3 m80 59.6 33.53 22.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.732 -1.23 . . . . 0.02 109.525 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.44 ' C ' ' SD ' ' A' ' 118' ' ' MET . 6.4 mt -112.4 135.45 53.08 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 108.703 -0.851 . . . . 0.02 108.703 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -92.12 -23.01 19.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 5.32 110.633 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -149.15 163.6 37.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.078 -1.014 . . . . 0.02 110.101 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.5 mt -132.25 129.55 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 107.475 -1.305 . . . . 2.17 107.475 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -107.65 -12.12 15.31 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.159 -0.963 . . . . 0.02 113.13 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -156.7 154.12 29.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.467 -1.396 . . . . 0.01 107.759 178.121 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.9 t -161.48 146.0 13.24 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.877 -1.139 . . . . 1.22 109.639 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -121.86 109.56 14.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.374 1.083 . . . . 1.41 108.949 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.53 122.18 64.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 106.408 -1.701 . . . . 0.01 106.408 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.63 68.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 118.639 -1.225 . . . . 1.98 107.802 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 174.13 105.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.705 -1.591 . . . . 0.01 106.705 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.11 -177.07 46.04 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.548 -1.421 . . . . 0.01 109.548 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.8 m -109.55 143.73 38.82 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.442 -1.034 . . . . 2.3 108.659 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -128.56 145.34 51.16 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.474 -0.767 . . . . 0.01 110.49 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.4 mt -116.56 140.29 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 107.504 -1.295 . . . . 1.69 107.504 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.602 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -112.89 141.7 46.42 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 107.577 -1.268 . . . . 2.49 107.577 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 15.3 m-85 -121.99 143.54 49.42 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.008 -0.738 . . . . 0.02 109.008 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 140' ' ' GLU . 3.2 tm-20 -73.32 -29.74 62.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.02 112.001 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -114.76 153.92 46.86 Favored Pre-proline 0 N--CA 1.508 2.457 0 O-C-N 120.593 -1.317 . . . . 1.48 109.332 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.47 166.27 1.91 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.13 1.22 . . . . 0.02 112.44 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 59.97 31.1 20.51 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.178 -0.919 . . . . 0.75 111.138 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 58.0 51.53 8.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.553 -0.717 . . . . 0.02 111.044 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -124.95 163.69 21.74 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.551 -0.718 . . . . 0.02 109.76 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.93 -165.28 31.76 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.804 -1.318 . . . . 0.02 109.804 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -67.86 141.97 56.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -1.004 . . . . 0.02 108.831 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.462 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.3 mp0 -118.57 149.42 41.37 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.509 -0.552 . . . . 0.02 109.509 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.49 141.89 51.25 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.536 -0.727 . . . . 0.01 109.263 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.7 tp -94.61 119.91 34.01 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.826 -0.805 . . . . 0.01 108.826 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.633 HD22 ' NE1' ' A' ' 162' ' ' TRP . 19.7 mt -106.67 136.22 46.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.44 -0.788 . . . . 0.01 110.781 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 154' ' ' LYS . 16.3 t0 -110.42 171.35 7.51 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.21 -1.033 . . . . 2.27 108.21 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 pttm -55.74 86.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.0 -1.063 . . . . 1.84 108.605 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 152' ' ' ASP . 56.0 mttp -136.27 168.6 19.11 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.096 -1.003 . . . . 2.28 111.423 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 18.9 mp0 -112.99 109.7 19.28 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.129 -1.063 . . . . 0.01 108.129 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -101.05 115.05 29.57 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.019 -1.05 . . . . 0.01 110.448 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -92.19 -25.65 18.57 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.083 -1.011 . . . . 0.01 111.324 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -126.2 153.53 74.36 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.797 -1.189 . . . . 2.54 108.54 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.04 -42.61 35.33 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 CA-C-N 119.313 0.791 . . . . 0.7 110.644 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.6 t -60.24 -20.71 20.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.637 -1.29 . . . . 0.86 108.669 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -65.87 -15.95 63.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.888 -1.132 . . . . 0.02 109.609 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.633 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.83 9.55 38.69 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.08 10.56 86.2 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.349 -1.405 . . . . 0.02 109.784 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.54 142.13 31.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.455 -1.027 . . . . 0.02 110.194 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.62 -8.41 58.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.66 -0.65 . . . . 0.59 109.767 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.9 p -144.49 150.98 49.52 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.947 -1.095 . . . . 0.87 108.544 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -76.15 21.56 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.738 0.958 . . . . 0.38 112.4 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.14 123.89 29.97 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.592 1.187 . . . . 0.18 111.92 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.602 HG23 ' CD1' ' A' ' 138' ' ' PHE . 26.0 mt -146.08 125.22 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 106.38 -1.711 . . . . 3.99 106.38 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -111.21 -20.26 12.39 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.154 -0.966 . . . . 5.17 112.988 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.7 p -157.89 160.17 37.36 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 119.423 -2.048 . . . . 0.02 109.871 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -152.81 154.59 35.47 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.095 -1.003 . . . . 2.02 110.426 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -144.33 151.63 39.61 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.25 -0.906 . . . . 0.01 110.712 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -88.27 144.88 26.16 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.168 -0.679 . . . . 0.01 109.168 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -95.63 128.58 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.165 -0.959 . . . . 3.04 109.403 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 177' ' ' GLU . 17.4 m -136.81 146.6 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.229 -0.92 . . . . 1.89 109.304 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 176' ' ' VAL . 16.1 pt-20 . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.891 -0.506 . . . . 4.89 110.808 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.107 -1.597 . . . . 0.01 109.107 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -149.06 136.99 20.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.015 -1.285 . . . . 0.02 110.255 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 tt -130.43 140.67 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.136 -0.69 . . . . 0.02 109.136 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 t -121.47 130.23 53.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.427 -0.795 . . . . 0.39 110.146 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.51 140.42 44.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.647 -0.658 . . . . 0.02 109.361 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -121.92 138.26 54.48 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.189 -0.944 . . . . 0.02 109.493 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -69.47 -27.42 65.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.892 -1.13 . . . . 0.03 111.672 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -113.89 169.86 8.69 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.801 -1.187 . . . . 0.03 110.241 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -75.62 158.42 32.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.509 0.671 . . . . 0.03 110.174 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 43.8 t30 65.78 35.37 6.83 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.883 0.849 . . . . 0.74 110.759 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.602 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.99 44.62 25.57 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.682 0.754 . . . . 0.02 111.26 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -112.58 165.67 12.04 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.975 -1.12 . . . . 0.02 107.975 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.09 -167.57 34.57 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.789 -1.196 . . . . 0.03 110.563 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -69.14 142.64 54.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -1.06 . . . . 2.76 109.073 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -122.3 150.13 42.77 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.455 -0.778 . . . . 1.89 110.152 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -136.53 133.12 36.14 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.665 -0.647 . . . . 0.02 109.351 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -109.37 135.74 49.93 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.772 -0.825 . . . . 1.12 108.772 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -127.44 138.02 52.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.588 -0.695 . . . . 0.02 109.516 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -118.81 12.14 12.86 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.598 -0.689 . . . . 0.2 110.305 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 39.0 t -159.94 173.79 15.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.771 -1.206 . . . . 1.23 109.079 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.423 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 4.9 p-10 -63.29 146.36 53.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.805 -1.184 . . . . 0.02 110.652 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.9 m -133.45 117.34 17.09 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.725 -0.843 . . . . 0.02 108.725 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.3 -20.26 55.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.477 -0.764 . . . . 0.24 111.806 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 25.4 p-10 -152.85 106.28 3.04 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.887 -1.133 . . . . 1.14 109.287 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.76 5.21 41.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.473 -0.767 . . . . 6.37 110.427 -178.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -62.46 -29.42 70.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 3.11 112.65 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -77.05 -18.42 58.09 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.159 -1.588 . . . . 0.88 111.797 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -107.25 -19.52 13.57 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.313 -0.867 . . . . 0.02 110.438 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.4 tp -148.73 126.91 12.1 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.927 -1.108 . . . . 3.32 109.467 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 t -87.43 -13.07 44.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.538 -0.726 . . . . 0.02 111.362 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -172.55 161.73 5.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.819 -1.176 . . . . 0.02 108.5 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.463 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.6 p -143.86 116.59 8.72 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.194 -0.941 . . . . 0.02 108.85 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -108.38 -0.06 20.85 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.744 -1.223 . . . . 0.03 111.314 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 t -155.9 153.85 30.31 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.723 -1.214 . . . . 0.02 107.723 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 39' ' ' ILE . 9.1 mt -146.81 147.97 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.253 1.025 . . . . 0.02 110.727 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -123.49 125.04 44.2 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.95 -1.13 . . . . 0.02 107.95 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.59 114.02 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 106.663 -1.606 . . . . 0.02 106.663 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -85.36 -34.72 21.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.628 -0.67 . . . . 3.81 110.277 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.31 148.9 16.52 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.52 -1.8 . . . . 0.02 110.72 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.89 172.33 48.7 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.284 -1.126 . . . . 0.01 110.284 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.3 m -118.58 134.95 54.71 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.529 -1.285 . . . . 1.48 107.529 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -127.17 154.28 44.99 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.703 1.239 . . . . 0.02 112.305 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.95 134.28 51.82 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 105.176 -2.157 . . . . 0.24 105.176 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.487 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.2 m -119.16 144.32 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.578 -0.701 . . . . 0.65 109.512 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -120.78 144.68 48.17 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.083 0.944 . . . . 0.02 109.976 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.61 -33.45 75.69 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.833 -0.621 . . . . 0.02 111.925 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -123.75 158.12 60.63 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.069 -1.019 . . . . 0.02 109.521 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -52.9 164.7 1.48 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.503 1.468 . . . . 0.02 112.669 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 64.1 37.29 9.15 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.722 0.772 . . . . 0.02 111.299 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 45.1 51.6 8.87 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.689 0.757 . . . . 3.39 110.764 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -125.92 163.59 22.63 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.185 0.517 . . . . 2.33 109.811 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.71 -161.72 31.06 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.563 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -64.46 139.43 58.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.997 -1.296 . . . . 0.02 110.275 -178.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.3 ppp? -119.0 137.16 53.72 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.769 -0.582 . . . . 5.01 109.663 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.8 m-85 -134.92 139.32 44.87 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.434 -0.791 . . . . 0.02 110.197 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.6 mm -94.21 130.56 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.953 -0.758 . . . . 1.72 108.953 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.521 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.0 mt -120.95 111.13 34.35 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 121.251 -0.905 . . . . 0.02 110.887 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.15 169.86 19.62 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 CA-C-N 119.742 0.943 . . . . 1.47 110.184 177.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -52.94 141.03 23.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.894 -1.129 . . . . 4.25 110.388 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.82 -177.59 32.02 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.551 -1.309 . . . . 0.02 110.929 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -120.06 131.39 55.08 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.56 -0.964 . . . . 0.96 109.91 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CE1' HD22 ' A' ' 61' ' ' LEU . 86.7 m-85 -121.94 92.93 48.81 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 107.928 -1.138 . . . . 0.02 107.928 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.85 -4.13 6.83 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.003 1.135 . . . . 0.02 113.863 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -157.62 154.85 29.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.621 -1.299 . . . . 2.02 108.201 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -59.5 -39.37 83.59 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.445 -0.784 . . . . 0.02 112.092 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -59.81 -23.97 63.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.02 110.366 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.71 -18.68 62.81 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.75 0.785 . . . . 3.42 109.013 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.1 t90 -107.92 9.91 28.58 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.439 -1.319 . . . . 0.02 107.439 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.3 mtt 60.79 22.25 12.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.572 -0.705 . . . . 0.02 110.485 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.25 144.4 45.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.344 -1.502 . . . . 0.02 109.344 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.2 tp -78.74 -31.06 46.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.492 -1.299 . . . . 0.98 107.492 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.481 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 55.6 t30 -157.07 -171.16 3.53 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.389 -1.708 . . . . 0.02 106.389 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.481 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 2.9 p-10 -98.6 28.76 4.03 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.59 -1.319 . . . . 0.02 110.468 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -97.95 123.02 41.75 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.953 -1.092 . . . . 3.2 111.175 -178.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.487 HD22 ' HB ' ' A' ' 48' ' ' VAL . 52.8 mt -142.79 119.97 11.48 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.404 -1.332 . . . . 2.61 107.404 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.15 -17.91 11.04 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 121.123 -0.986 . . . . 0.02 112.17 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.5 m -155.77 155.99 34.03 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.271 -1.723 . . . . 0.02 110.598 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.7 m -145.17 147.77 32.84 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.304 0.573 . . . . 0.02 109.58 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -137.44 142.15 41.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.416 -0.802 . . . . 0.01 109.173 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.31 132.97 36.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.212 -0.93 . . . . 0.43 109.314 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -89.68 123.79 42.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.282 -1.006 . . . . 1.25 108.282 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -91.19 131.5 36.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.751 -1.218 . . . . 1.77 108.004 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -96.77 137.48 35.79 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.005 -1.109 . . . . 1.63 108.005 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.2 t -109.91 126.58 54.02 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.479 -0.934 . . . . 1.08 108.479 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 t -103.15 -154.87 0.51 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.046 -1.835 . . . . 1.26 106.046 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.9 -49.62 0.89 Allowed Glycine 0 N--CA 1.497 2.734 0 O-C-N 120.658 -1.276 . . . . 0.01 111.812 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.85 -99.21 0.12 Allowed Glycine 0 N--CA 1.487 2.069 0 C-N-CA 118.77 -1.681 . . . . 0.01 111.897 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -120.91 119.92 34.02 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.279 -1.13 . . . . 4.43 110.619 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.492 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.49 137.09 56.57 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.325 -0.62 . . . . 2.99 109.325 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -134.79 130.96 36.91 Favored 'General case' 0 N--CA 1.518 2.957 0 CA-C-O 122.195 0.997 . . . . 6.36 112.996 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -131.71 142.38 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 115.598 -0.728 . . . . 1.09 110.2 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.419 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.7 pt20 -124.22 139.67 53.7 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.818 -1.179 . . . . 2.05 107.818 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.5 m -123.59 144.71 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 O-C-N 120.73 -1.231 . . . . 1.1 110.942 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -120.55 140.43 51.51 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.155 0.978 . . . . 0.73 111.13 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.46 ' OE2' ' CD2' ' A' ' 123' ' ' LEU . 7.2 tp10 -68.38 -33.4 74.18 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.934 -0.576 . . . . 0.02 111.474 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -114.84 168.59 9.77 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.933 -1.104 . . . . 3.18 110.168 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.01 169.16 46.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.916 -0.873 . . . . 0.01 110.916 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 53.34 39.19 29.46 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.58 0.705 . . . . 0.01 111.686 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 52.69 48.21 23.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.56 -0.712 . . . . 0.01 111.075 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -121.01 164.21 17.09 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.384 -0.969 . . . . 3.15 108.384 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.69 -162.91 29.37 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.97 -1.652 . . . . 0.01 108.97 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -75.94 141.69 42.2 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.945 -1.327 . . . . 0.01 109.214 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.2 tmm? -116.09 143.4 45.52 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.596 0.712 . . . . 0.01 109.465 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -132.56 136.13 46.39 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.278 -1.008 . . . . 2.48 108.278 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.467 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.9 tm-20 -116.63 134.16 55.15 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.639 -0.663 . . . . 0.01 109.576 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.467 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 8.8 t -148.88 148.35 29.76 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.383 1.087 . . . . 1.69 111.302 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.2 p -115.01 7.67 15.59 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.213 -0.903 . . . . 0.01 110.051 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -122.09 163.2 19.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.401 -0.812 . . . . 3.21 111.24 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -69.7 154.75 41.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.01 109.419 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.497 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 53.1 m -127.78 115.53 20.79 Favored Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 109.049 -0.723 . . . . 0.01 109.049 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.43 -32.5 4.87 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 CA-C-N 120.198 1.107 . . . . 0.01 111.308 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 t -141.83 107.37 5.06 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.833 0.825 . . . . 0.02 108.888 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.4 mt -64.83 -39.17 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.864 -0.523 . . . . 1.83 111.036 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 37.1 ttp -67.41 -37.39 83.01 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.148 -1.021 . . . . 1.34 109.79 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.73 -38.72 76.98 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.588 -1.32 . . . . 2.11 109.709 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -79.42 -46.84 16.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.346 -0.846 . . . . 2.08 112.317 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.81 0.45 17.28 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.384 -0.822 . . . . 0.02 112.769 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 59.82 33.07 21.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.68 -1.262 . . . . 0.02 109.39 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.46 ' CD2' ' OE2' ' A' ' 99' ' ' GLU . 10.6 mt -111.89 135.08 52.98 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.64 -0.874 . . . . 0.02 108.64 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -92.58 -23.76 18.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 5.32 110.409 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -148.89 162.96 38.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.146 -0.971 . . . . 0.02 110.023 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.6 mt -131.96 129.44 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.223 -1.399 . . . . 2.17 107.223 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -105.54 -12.32 16.02 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.087 -1.008 . . . . 0.02 112.64 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -155.05 153.15 30.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.524 -1.36 . . . . 0.01 108.156 178.06 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 12.8 t -160.63 144.45 13.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.446 -1.408 . . . . 1.22 109.775 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -122.07 113.4 19.48 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.267 1.032 . . . . 1.41 109.457 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.06 120.23 60.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 105.554 -2.017 . . . . 0.01 105.554 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -145.76 67.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 118.34 -1.344 . . . . 1.98 108.398 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 172.14 108.32 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.586 -1.635 . . . . 0.01 106.586 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.38 -172.56 47.65 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.999 -1.24 . . . . 0.01 109.999 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -110.93 144.22 40.35 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.483 -1.01 . . . . 2.3 108.845 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.492 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.4 m95 -131.32 147.2 52.55 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.446 -0.784 . . . . 0.01 110.641 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.4 mt -119.1 140.29 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 107.956 -1.128 . . . . 1.69 107.956 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.721 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -112.81 141.73 46.28 Favored 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 107.408 -1.331 . . . . 2.49 107.408 177.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 12.9 m-85 -122.46 145.04 48.67 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.55 -0.719 . . . . 0.02 109.264 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -74.55 -30.29 61.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.579 -0.701 . . . . 0.02 112.275 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -114.89 153.79 46.99 Favored Pre-proline 0 N--CA 1.506 2.362 0 O-C-N 120.622 -1.299 . . . . 1.48 109.139 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.51 166.34 1.89 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 120.991 1.127 . . . . 0.02 112.462 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 59.79 31.21 20.68 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.221 -0.9 . . . . 0.75 111.253 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.497 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 58.38 51.97 7.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.02 111.13 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -124.91 163.34 22.46 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.666 -0.646 . . . . 0.02 109.937 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.65 -165.61 32.35 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.159 -1.177 . . . . 0.02 110.159 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -67.85 141.62 56.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.614 -0.933 . . . . 0.02 108.957 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.11 149.07 41.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.582 -0.525 . . . . 0.02 109.582 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.67 141.43 51.61 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 109.125 -0.695 . . . . 0.01 109.125 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.25 120.87 36.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.334 -0.854 . . . . 0.01 109.282 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.671 ' CD2' ' HE1' ' A' ' 162' ' ' TRP . 6.7 mt -104.3 135.14 46.31 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.344 -0.848 . . . . 0.01 110.321 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 154' ' ' LYS . 38.9 t70 -110.78 178.23 4.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.399 -1.334 . . . . 2.27 107.399 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -59.3 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.747 -1.221 . . . . 1.84 108.519 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 152' ' ' ASP . 68.4 tttt -134.95 163.12 30.56 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 122.106 0.955 . . . . 2.28 111.957 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.406 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 2.7 pt-20 -113.87 112.03 22.7 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.07 -1.085 . . . . 0.01 108.07 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.63 114.92 29.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.023 -1.048 . . . . 0.01 110.18 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.456 ' O ' ' OG ' ' A' ' 128' ' ' SER . 23.5 ptt180 -96.74 -27.12 14.9 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.497 -0.752 . . . . 0.01 112.063 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -125.65 151.33 70.45 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 120.766 -1.209 . . . . 2.54 108.98 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -57.97 -48.8 14.82 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 CA-C-N 119.234 0.762 . . . . 0.7 110.759 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.68 -23.67 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.86 -1.15 . . . . 0.86 109.152 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.61 -15.86 63.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.755 -1.216 . . . . 0.02 109.305 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.671 ' HE1' ' CD2' ' A' ' 151' ' ' LEU . 2.7 t90 -94.78 6.54 48.65 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.607 -0.886 . . . . 0.02 108.607 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 74.79 8.29 81.81 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.565 -1.303 . . . . 0.02 109.917 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.22 143.32 29.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.62 -0.929 . . . . 0.02 110.074 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.13 -9.22 58.76 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.675 -0.641 . . . . 0.59 109.671 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.1 p -147.24 150.9 39.34 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.756 -1.215 . . . . 0.87 108.015 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -75.7 25.48 0.4 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 120.777 0.985 . . . . 0.38 112.464 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.888 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.85 124.4 30.92 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.644 1.211 . . . . 0.18 112.534 -177.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.888 HD13 ' O ' ' A' ' 168' ' ' ALA . 6.4 mm -142.19 127.82 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 106.382 -1.71 . . . . 3.99 106.382 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -113.65 -23.7 9.59 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.784 -1.198 . . . . 5.17 112.846 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.9 p -157.31 160.26 38.37 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 119.503 -1.998 . . . . 0.02 109.839 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.497 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 11.8 p90 -153.44 153.98 33.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.983 -1.073 . . . . 2.02 110.601 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.497 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 18.9 mtp180 -143.23 151.14 40.25 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.161 -0.962 . . . . 0.01 110.4 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 174' ' ' ARG . 28.9 ptt180 -87.56 141.83 28.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.991 -0.744 . . . . 0.01 108.991 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.0 mt -93.25 128.31 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.005 -1.059 . . . . 3.04 109.078 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.1 t -136.27 146.52 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.254 -0.903 . . . . 1.89 109.553 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 4.89 109.452 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.292 -1.523 . . . . 0.01 109.292 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -147.76 136.69 22.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.012 -1.287 . . . . 0.02 110.641 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 tt -130.78 139.52 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 109.115 -0.698 . . . . 0.02 109.115 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -121.22 130.33 53.64 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.465 -0.772 . . . . 0.39 109.766 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.05 139.77 44.81 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.983 -0.747 . . . . 0.02 108.983 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.6 m-85 -122.16 138.37 54.49 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.213 -0.929 . . . . 0.02 109.545 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.472 ' HG3' HD11 ' A' ' 33' ' ' LEU . 88.7 mt-10 -69.57 -27.76 65.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.03 111.652 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.2 m-20 -114.36 169.7 8.85 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.808 -1.182 . . . . 0.03 110.237 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.563 ' CG ' HH11 ' A' ' 13' ' ' ARG . 3.5 mtt-85 -74.88 157.81 34.43 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.703 0.763 . . . . 0.03 110.078 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 66.26 33.49 7.16 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.958 0.885 . . . . 0.74 111.14 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.25 42.32 30.53 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.212 0.53 . . . . 0.02 111.266 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -113.74 166.0 11.98 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.288 -1.005 . . . . 0.02 108.288 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.95 -167.25 36.2 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.841 -1.171 . . . . 0.03 110.702 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.05 141.59 54.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.976 . . . . 2.76 109.313 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -120.27 148.81 43.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.523 -0.736 . . . . 1.89 110.149 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -132.68 127.39 34.72 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.488 -0.93 . . . . 0.02 108.488 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.62 136.16 51.23 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.414 -0.804 . . . . 1.12 109.565 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -130.52 138.18 50.09 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.502 0.668 . . . . 0.02 109.55 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -117.56 11.16 13.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.737 -0.602 . . . . 0.2 109.655 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.9 p -158.31 173.83 16.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.144 -0.972 . . . . 1.23 108.585 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.62 145.19 55.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.636 -1.29 . . . . 0.02 110.372 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 22.0 p -132.99 117.32 17.49 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.407 -0.96 . . . . 0.02 108.407 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.83 -23.5 52.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.24 110.743 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 31.1 p-10 -154.83 101.44 2.29 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.615 -0.883 . . . . 1.14 108.615 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 22.2 p90 -107.08 10.06 30.3 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 122.089 0.947 . . . . 6.37 110.273 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HE ' ' CA ' ' A' ' 80' ' ' GLY . 29.4 mmt180 -59.2 -23.19 62.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.544 -0.722 . . . . 3.11 110.676 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -75.23 -16.32 60.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.726 -1.233 . . . . 0.88 110.354 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -103.08 -21.43 13.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.382 -0.824 . . . . 0.02 109.277 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.472 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.3 tp -150.27 129.46 12.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.309 -0.869 . . . . 3.32 109.081 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t -85.5 -10.58 55.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.76 -0.588 . . . . 0.02 110.769 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -170.56 161.97 7.88 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.896 -1.15 . . . . 0.02 107.896 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.32 115.89 8.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.817 -1.177 . . . . 0.02 109.087 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -109.56 0.79 19.33 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.81 -1.181 . . . . 0.03 111.595 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -156.33 154.51 30.71 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.24 -1.022 . . . . 0.02 108.24 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.9 146.72 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.031 -1.043 . . . . 0.02 110.879 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -123.04 124.04 42.23 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.886 -1.153 . . . . 0.02 107.886 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.0 t -106.45 113.91 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 106.751 -1.574 . . . . 0.02 106.751 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 32.1 tp10 -84.27 -34.52 23.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.633 . . . . 3.81 110.435 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.51 149.32 17.24 Favored Glycine 0 N--CA 1.485 1.948 0 C-N-CA 119.029 -1.558 . . . . 0.02 110.525 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.73 172.41 48.83 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.255 -1.138 . . . . 0.01 110.255 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -118.3 134.77 54.75 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.489 -1.3 . . . . 1.48 107.489 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -127.17 154.68 44.48 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.755 -1.216 . . . . 0.02 112.443 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.37 134.1 52.24 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.349 -2.093 . . . . 0.24 105.349 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.489 ' HB ' HD22 ' A' ' 79' ' ' LEU . 36.0 m -118.35 143.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.479 -0.763 . . . . 0.65 109.351 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -120.84 144.42 48.36 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.37 1.081 . . . . 0.02 110.073 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.86 -33.42 75.8 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.665 -0.698 . . . . 0.02 111.47 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -124.38 157.81 63.54 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.034 -1.041 . . . . 0.02 109.491 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.27 166.45 1.08 Allowed 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.702 1.601 . . . . 0.02 112.728 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 t30 63.28 36.65 11.63 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.383 -0.826 . . . . 0.02 111.127 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 45.31 51.22 9.53 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.634 0.73 . . . . 3.39 110.769 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.2 p -125.49 163.28 23.0 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.186 0.517 . . . . 2.33 109.862 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.67 -161.74 31.14 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.722 -1.351 . . . . 0.02 109.722 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -64.32 138.58 58.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.33 . . . . 0.02 110.124 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -119.16 137.29 53.71 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.818 -0.551 . . . . 5.01 109.578 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.615 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 79.4 m-85 -134.76 139.98 45.57 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.5 -0.75 . . . . 0.02 110.067 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.8 mm -95.18 130.43 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.907 -0.775 . . . . 1.72 108.907 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.488 HD22 ' CE1' ' A' ' 66' ' ' TYR . 13.8 mt -122.54 111.72 31.39 Favored Pre-proline 0 N--CA 1.507 2.39 0 O-C-N 121.338 -0.852 . . . . 0.02 110.654 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.99 170.65 19.39 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 CA-C-N 119.863 0.987 . . . . 1.47 110.13 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 58.1 tt0 -52.16 140.47 20.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.963 -1.086 . . . . 4.25 110.092 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.59 -177.75 32.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.366 -1.397 . . . . 0.02 110.84 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -120.75 131.62 54.6 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.454 -1.027 . . . . 0.96 110.043 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.488 ' CE1' HD22 ' A' ' 61' ' ' LEU . 97.1 m-85 -122.24 95.84 46.83 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.1 Cg_endo -67.79 -3.16 9.88 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.945 1.096 . . . . 0.02 114.125 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 67.6 mt-10 -157.54 154.96 29.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.551 -1.343 . . . . 2.02 108.313 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -60.02 -39.28 85.31 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.498 -0.751 . . . . 0.02 111.734 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -59.56 -24.13 63.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.033 . . . . 0.02 110.202 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -70.49 -18.97 62.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.935 0.874 . . . . 3.42 108.904 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.615 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.3 t90 -108.01 9.78 28.44 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.537 -1.283 . . . . 0.02 107.537 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 mmt 60.97 22.61 12.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.02 110.59 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.16 145.44 46.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.505 -1.438 . . . . 0.02 109.505 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.539 ' O ' HD23 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -79.88 -31.28 40.33 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.601 -1.259 . . . . 0.98 107.601 177.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -156.92 -171.44 3.65 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.448 -1.686 . . . . 0.02 106.448 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 16.5 p-10 -97.98 28.14 4.12 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.634 -1.291 . . . . 0.02 110.661 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' A' ' 78' ' ' ARG . 2.5 mtt-85 -96.42 121.93 38.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.009 -1.057 . . . . 3.2 110.563 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.501 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 24.9 mt -144.82 121.4 11.1 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.629 -1.248 . . . . 2.61 107.629 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.425 ' CA ' ' HE ' ' A' ' 30' ' ' ARG . . . -112.12 -16.4 9.08 Favored Glycine 0 N--CA 1.508 3.471 0 O-C-N 121.218 -0.926 . . . . 0.02 113.495 -177.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.6 p -155.51 156.87 35.97 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.244 -1.739 . . . . 0.02 110.69 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.2 p -145.73 148.32 32.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.695 -0.628 . . . . 0.02 109.903 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -137.23 141.71 42.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.365 -0.834 . . . . 0.01 109.181 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 132.11 36.48 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.166 -0.959 . . . . 0.43 109.436 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -90.06 124.12 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.302 -0.999 . . . . 1.25 108.302 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.432 ' C ' HD23 ' A' ' 87' ' ' LEU . 61.2 m80 -92.4 131.98 37.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.819 -1.176 . . . . 1.77 108.408 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.561 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -96.39 138.25 34.25 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.082 -1.081 . . . . 1.63 108.082 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 m -109.72 126.74 54.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.671 -0.862 . . . . 1.08 108.671 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.9 t -103.65 -154.94 0.51 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.07 -1.826 . . . . 1.26 106.07 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.89 -49.87 0.88 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 120.552 -1.343 . . . . 0.01 111.879 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.26 -99.7 0.13 Allowed Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.825 -1.655 . . . . 0.01 111.924 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.4 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 38.5 tt0 -120.37 119.5 33.28 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.294 -1.121 . . . . 4.43 110.523 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.515 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.71 136.68 55.87 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.501 -0.555 . . . . 2.99 109.501 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -134.39 130.19 36.5 Favored 'General case' 0 N--CA 1.517 2.912 0 CA-C-O 122.11 0.957 . . . . 6.36 113.029 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.43 141.76 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-N 115.637 -0.711 . . . . 1.09 110.211 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.428 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 2.6 pt20 -124.95 139.7 53.59 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 107.526 -1.287 . . . . 2.05 107.526 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.07 146.85 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 120.646 -1.284 . . . . 1.1 111.08 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -120.84 140.29 51.97 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.256 1.027 . . . . 0.73 111.117 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -67.94 -32.19 72.46 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.644 -0.707 . . . . 0.02 111.934 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -114.76 165.61 12.64 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.078 -1.014 . . . . 3.18 110.43 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.26 163.12 46.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 111.069 -0.812 . . . . 0.01 111.069 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 57.65 39.06 27.8 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.608 0.718 . . . . 0.01 111.004 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 33.2 m-85 52.31 56.33 7.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 0.01 111.052 177.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -128.62 164.92 21.84 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.034 -1.098 . . . . 3.15 108.034 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.39 -162.82 28.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.077 -1.609 . . . . 0.01 109.077 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -75.07 141.81 43.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.874 -1.368 . . . . 0.01 108.864 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.9 tmm? -116.18 143.0 46.08 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.472 0.653 . . . . 0.01 109.451 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -132.07 136.22 47.03 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.206 -1.035 . . . . 2.48 108.206 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -116.76 134.48 54.74 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.711 -0.618 . . . . 0.01 109.756 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -149.7 148.55 29.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.941 -1.099 . . . . 1.69 111.337 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -114.48 7.95 16.35 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.106 -0.952 . . . . 0.01 109.695 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -122.27 163.41 19.71 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.545 -0.722 . . . . 3.21 111.152 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -69.62 154.83 41.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.802 . . . . 0.01 109.591 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.401 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 47.5 t -125.92 114.28 24.39 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.947 -0.76 . . . . 0.01 108.947 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -76.0 -33.64 3.52 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 CA-C-N 120.3 1.143 . . . . 0.01 111.557 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t -141.69 107.2 5.05 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.328 -0.858 . . . . 0.02 108.692 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.21 -39.41 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.715 -0.615 . . . . 1.83 111.198 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.2 ttp -66.26 -38.13 87.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.944 -1.102 . . . . 1.34 109.574 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -69.95 -38.73 76.22 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.63 -1.294 . . . . 2.11 109.74 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.47 -47.95 13.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.188 -0.945 . . . . 2.08 112.207 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.457 ' C ' ' ND1' ' A' ' 122' ' ' HIS . 94.8 m-85 -111.35 -1.06 16.13 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.474 -0.766 . . . . 0.02 112.884 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.457 ' ND1' ' C ' ' A' ' 121' ' ' PHE . 5.0 m80 60.26 33.7 20.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.716 -1.24 . . . . 0.02 109.707 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.44 135.63 52.91 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.784 -0.821 . . . . 0.02 108.784 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -92.83 -23.69 18.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.334 -0.854 . . . . 5.32 110.788 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -149.21 163.69 36.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.016 -1.053 . . . . 0.02 110.121 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.2 mt -131.56 129.43 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 107.443 -1.317 . . . . 2.17 107.443 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -107.77 -13.17 15.07 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.123 -0.986 . . . . 0.02 113.033 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.471 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.54 153.08 29.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.412 -1.43 . . . . 0.01 108.261 177.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.9 t -163.53 143.96 8.82 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.287 -1.508 . . . . 1.22 109.697 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -121.82 113.31 19.49 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.062 0.934 . . . . 1.41 108.841 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.96 123.23 63.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 105.694 -1.965 . . . . 0.01 105.694 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.5 t -146.31 68.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 118.186 -1.406 . . . . 1.98 108.271 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER 172.51 107.87 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.537 -1.653 . . . . 0.01 106.537 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.53 -174.1 42.64 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.623 -1.391 . . . . 0.01 109.623 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 m -111.81 143.66 42.38 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.411 -1.053 . . . . 2.3 109.214 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.515 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 61.6 m95 -128.92 146.17 51.02 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.444 -0.785 . . . . 0.01 110.424 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.11 141.15 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.398 -1.334 . . . . 1.69 107.398 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.506 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.14 143.16 45.26 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 107.329 -1.359 . . . . 2.49 107.329 177.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.42 144.64 49.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.623 -0.673 . . . . 0.02 109.297 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 -30.06 63.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.638 -0.664 . . . . 0.02 112.124 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.5 153.64 47.71 Favored Pre-proline 0 N--CA 1.506 2.356 0 O-C-N 120.637 -1.289 . . . . 1.48 109.223 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.72 166.93 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.344 1.362 . . . . 0.02 112.678 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 59.46 31.36 20.99 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.188 -0.915 . . . . 0.75 111.114 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.466 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.2 m-85 57.73 51.52 9.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.55 -0.719 . . . . 0.02 110.961 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -124.7 163.54 21.83 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.487 -0.758 . . . . 0.02 109.857 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.51 -165.28 32.3 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.711 -1.356 . . . . 0.02 109.711 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -67.89 141.3 56.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.437 -1.037 . . . . 0.02 108.894 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -118.22 148.52 42.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.06 -0.718 . . . . 0.02 109.06 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -128.83 142.84 50.84 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.574 -0.704 . . . . 0.01 109.18 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.12 120.0 34.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.367 -0.833 . . . . 0.01 109.492 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.547 HD22 ' CD1' ' A' ' 162' ' ' TRP . 20.0 mt -106.12 133.08 51.4 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.36 -0.837 . . . . 0.01 110.297 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 154' ' ' LYS . 4.4 m-20 -108.79 174.63 5.79 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.356 -0.979 . . . . 2.27 108.356 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -57.12 84.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.077 -1.014 . . . . 1.84 108.627 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 152' ' ' ASP . 90.8 mttt -137.76 169.37 17.9 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 122.0 0.905 . . . . 2.28 111.603 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.39 110.59 20.89 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.389 -0.967 . . . . 0.01 108.389 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.57 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 90.7 m-85 -101.73 114.36 28.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.1 -1.0 . . . . 0.01 109.827 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -91.64 -25.84 18.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.096 -1.003 . . . . 0.01 111.222 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -125.44 154.09 72.43 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.061 -1.024 . . . . 2.54 108.525 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.27 -41.16 44.15 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 120.44 0.76 . . . . 0.7 110.539 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.95 -20.07 21.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.906 -1.121 . . . . 0.86 108.841 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -65.48 -16.17 63.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.003 -1.061 . . . . 0.02 109.787 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.57 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 2.0 m0 -96.94 11.0 37.54 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.065 -1.087 . . . . 0.02 108.065 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.59 11.78 85.14 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.414 -1.374 . . . . 0.02 110.336 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.9 141.83 32.19 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.178 -1.19 . . . . 0.02 110.096 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -8.29 58.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.791 -0.568 . . . . 0.59 109.917 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.6 m -144.37 151.04 50.1 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 120.845 -1.159 . . . . 0.87 108.791 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.43 21.25 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 120.694 0.929 . . . . 0.38 112.368 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.489 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -83.82 122.4 28.64 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.357 1.075 . . . . 0.18 111.602 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.489 HD12 ' C ' ' A' ' 168' ' ' ALA . 3.6 mp -149.01 125.94 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.425 -1.694 . . . . 3.99 106.425 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -111.07 -16.44 13.48 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.176 -0.953 . . . . 5.17 113.23 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 86.4 p -158.46 161.14 37.42 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 119.181 -2.199 . . . . 0.02 110.075 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.2 p90 -152.78 155.25 36.79 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.076 -1.015 . . . . 2.02 110.358 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.466 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 22.9 mtp180 -143.54 150.41 38.85 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.158 -0.964 . . . . 0.01 110.293 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -87.35 142.73 27.66 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.072 -0.714 . . . . 0.01 109.072 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.4 mt -93.66 127.9 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.033 -1.042 . . . . 3.04 109.279 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.7 t -136.01 146.5 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.346 -0.846 . . . . 1.89 109.549 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 4.89 109.477 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 109.21 -1.556 . . . . 0.01 109.21 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -148.25 136.31 21.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.898 -1.354 . . . . 0.02 110.29 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 tt -130.38 140.08 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.098 -0.705 . . . . 0.02 109.098 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -121.38 130.46 53.62 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.363 -0.836 . . . . 0.39 110.071 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -110.06 139.7 44.9 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.657 -0.652 . . . . 0.02 109.316 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.543 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.4 m-85 -122.28 138.28 54.56 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.293 -0.879 . . . . 0.02 109.483 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -69.36 -27.3 65.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.956 -1.09 . . . . 0.03 111.875 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -113.92 169.66 8.84 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.796 -1.19 . . . . 0.03 110.143 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.39 158.38 32.81 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.549 0.69 . . . . 0.03 109.647 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.4 m120 66.24 35.05 6.19 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.719 0.771 . . . . 0.74 110.933 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.81 44.89 25.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.669 0.747 . . . . 0.02 111.403 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -112.64 165.84 11.89 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.008 -1.108 . . . . 0.02 108.008 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -167.87 34.44 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.766 -1.207 . . . . 0.03 110.532 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.789 ' HE ' ' H ' ' A' ' 19' ' ' ARG . 9.3 tpm_? -69.33 142.96 53.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -1.088 . . . . 2.76 108.922 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.789 ' H ' ' HE ' ' A' ' 18' ' ' ARG . 18.7 ttm180 -122.44 150.1 42.95 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.38 -0.825 . . . . 1.89 110.331 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -135.9 132.5 36.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.155 -0.683 . . . . 0.02 109.155 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 14.6 p-10 -108.52 136.23 48.48 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.589 -0.893 . . . . 1.12 108.589 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 15.9 t -127.68 137.77 52.6 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.666 -0.646 . . . . 0.02 110.035 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -119.9 11.05 11.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.2 110.754 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.532 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 16.0 t -159.73 173.77 15.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.633 -1.292 . . . . 1.23 109.26 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 19.5 p-10 -63.41 145.8 54.86 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.416 -1.428 . . . . 0.02 110.931 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.9 m -135.22 119.19 17.41 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.886 -0.783 . . . . 0.02 108.886 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.482 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.79 -20.02 54.0 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.526 -0.734 . . . . 0.24 112.24 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -154.16 106.68 2.82 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.705 -1.247 . . . . 1.14 109.931 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.95 6.63 39.05 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.425 -0.797 . . . . 6.37 110.202 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -61.12 -29.69 69.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 3.11 112.052 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -76.96 -17.41 58.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.405 -1.434 . . . . 0.88 111.005 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -106.34 -21.17 13.17 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.413 -0.804 . . . . 0.02 110.621 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -149.33 127.47 12.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.092 -1.005 . . . . 3.32 109.653 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.5 p -87.2 -12.39 46.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.618 -0.676 . . . . 0.02 111.083 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -172.28 161.94 5.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.743 -1.223 . . . . 0.02 108.479 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 t -143.73 117.06 9.04 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.001 -1.062 . . . . 0.02 109.002 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -109.64 0.12 18.9 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.708 -1.245 . . . . 0.03 111.754 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 18.3 m -155.74 154.05 30.86 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.273 -1.01 . . . . 0.02 108.273 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -145.86 146.31 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 122.32 1.057 . . . . 0.02 110.818 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -122.77 123.68 41.61 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.594 -1.262 . . . . 0.02 107.594 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.1 t -105.64 113.63 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.87 -1.53 . . . . 0.02 106.87 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -85.13 -34.53 22.14 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.133 -0.627 . . . . 3.81 110.07 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.4 149.15 16.96 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.599 -1.763 . . . . 0.02 110.751 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.59 172.19 48.71 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.243 -1.143 . . . . 0.01 110.243 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.5 m -118.3 134.65 54.86 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.644 -1.243 . . . . 1.48 107.644 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -127.06 154.56 44.52 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 122.624 1.202 . . . . 0.02 112.345 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.34 133.77 52.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 105.453 -2.055 . . . . 0.24 105.453 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.1 144.19 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.519 -0.738 . . . . 0.65 109.323 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -120.65 144.95 47.9 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.157 0.979 . . . . 0.02 109.978 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -66.77 -33.8 76.43 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.943 -0.571 . . . . 0.02 111.957 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -123.09 158.27 58.27 Favored Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 121.111 -0.993 . . . . 0.02 109.509 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -53.1 164.64 1.64 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.524 1.482 . . . . 0.02 112.636 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 64.0 37.06 9.55 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.8 0.809 . . . . 0.02 111.363 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.453 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 11.2 m-85 45.54 51.39 9.91 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.681 0.753 . . . . 3.39 110.91 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 t -125.67 163.43 22.81 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.168 0.509 . . . . 2.33 109.827 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.72 -161.69 31.03 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.764 -1.334 . . . . 0.02 109.764 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -64.68 139.17 58.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.932 -1.334 . . . . 0.02 110.216 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.0 ppp? -119.6 138.12 53.43 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.725 -0.609 . . . . 5.01 109.475 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.599 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 63.8 m-85 -135.32 139.93 44.7 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.461 -0.774 . . . . 0.02 110.084 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.1 mm -93.76 130.18 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.311 -0.996 . . . . 1.72 108.311 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -121.48 111.1 33.47 Favored Pre-proline 0 N--CA 1.506 2.337 0 O-C-N 121.291 -0.881 . . . . 0.02 111.008 -178.312 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.04 169.79 19.85 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.738 0.942 . . . . 1.47 110.542 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -53.03 141.25 22.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.972 -1.08 . . . . 4.25 110.695 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.71 -177.76 31.84 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.47 -1.347 . . . . 0.02 110.955 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -119.68 131.29 55.38 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.367 -1.078 . . . . 0.96 109.782 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 78.8 m-85 -121.93 98.59 44.93 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.034 -1.099 . . . . 0.02 108.034 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.425 ' O ' ' OG ' ' A' ' 38' ' ' SER . 9.8 Cg_endo -71.12 -3.25 12.51 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.82 1.013 . . . . 0.02 113.919 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -157.51 154.54 28.82 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.672 -1.267 . . . . 2.02 108.221 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -59.69 -39.32 84.19 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.462 -0.774 . . . . 0.02 111.886 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -59.85 -23.82 63.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.02 110.303 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -70.49 -18.7 62.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.301 -0.874 . . . . 3.42 108.972 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.599 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -108.22 10.6 27.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.391 -1.337 . . . . 0.02 107.391 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.3 mmt 60.55 22.45 12.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.02 110.401 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.02 145.08 46.41 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.449 -1.46 . . . . 0.02 109.449 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -79.94 -30.53 39.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -1.174 . . . . 0.98 107.9 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.435 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 9.2 t-20 -157.16 -171.64 3.71 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.558 -1.645 . . . . 0.02 106.558 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.435 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 1.6 p30 -98.81 28.67 4.17 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.606 -1.309 . . . . 0.02 110.791 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -96.99 123.14 40.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.862 -1.149 . . . . 3.2 111.074 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.487 HD21 ' CH2' ' A' ' 72' ' ' TRP . 85.5 mt -141.78 119.1 11.47 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.472 -1.307 . . . . 2.61 107.472 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.96 -18.49 9.89 Favored Glycine 0 N--CA 1.502 3.062 0 O-C-N 121.008 -1.058 . . . . 0.02 112.537 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.1 m -156.11 156.52 34.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.303 -1.704 . . . . 0.02 110.387 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.0 m -144.83 147.63 33.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.801 -0.562 . . . . 0.02 109.754 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.453 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 46.6 mtp180 -137.32 141.77 41.86 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.451 -0.781 . . . . 0.01 109.162 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.86 132.13 36.7 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.26 -0.9 . . . . 0.43 109.313 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -90.76 124.4 43.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.634 -0.876 . . . . 1.25 108.634 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -92.13 131.67 37.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.844 -1.16 . . . . 1.77 108.645 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.45 138.83 33.46 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.142 -1.058 . . . . 1.63 108.142 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.1 p -110.73 126.42 54.54 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.783 -0.821 . . . . 1.08 108.783 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.4 p -103.17 -154.99 0.51 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.089 -1.819 . . . . 1.26 106.089 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.7 -49.61 0.88 Allowed Glycine 0 N--CA 1.498 2.814 0 O-C-N 120.482 -1.386 . . . . 0.01 112.069 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.58 -99.7 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 118.758 -1.687 . . . . 0.01 112.091 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -120.76 120.02 34.43 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.204 -1.174 . . . . 4.43 110.601 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.65 135.46 54.12 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.332 -0.547 . . . . 2.99 109.612 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -133.57 130.19 38.07 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 121.103 -0.998 . . . . 6.36 112.924 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 tt -131.75 141.3 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 115.538 -0.756 . . . . 1.09 110.535 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.1 pt20 -124.44 139.19 54.12 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 107.56 -1.274 . . . . 2.05 107.56 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.13 146.64 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 120.644 -1.285 . . . . 1.1 110.942 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -119.34 139.31 52.16 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.897 0.855 . . . . 0.73 110.65 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.5 -32.47 72.47 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.694 -0.684 . . . . 0.02 111.86 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.476 ' O ' ' OG ' ' A' ' 128' ' ' SER . 14.6 mtpp -114.67 168.32 9.98 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.04 -1.038 . . . . 3.18 109.753 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.38 168.83 44.99 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.67 -0.776 . . . . 0.01 111.201 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.45 39.6 30.17 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.667 0.746 . . . . 0.01 111.611 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 52.68 48.8 21.72 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.58 -0.7 . . . . 0.01 111.027 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -121.79 164.35 17.61 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.378 -0.971 . . . . 3.15 108.378 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.63 -163.38 28.47 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.389 -1.484 . . . . 0.01 109.389 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -76.01 142.57 41.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.93 -1.335 . . . . 0.01 109.143 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.458 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.2 tmm? -116.47 143.38 45.65 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.5 0.667 . . . . 0.01 109.771 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.08 136.11 46.94 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.265 -1.013 . . . . 2.48 108.265 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -116.77 134.33 54.92 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.748 -0.595 . . . . 0.01 109.856 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -149.5 148.78 29.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.885 -1.134 . . . . 1.69 111.195 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.5 p -114.87 7.86 15.82 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.103 -0.953 . . . . 0.01 109.685 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -122.15 163.59 19.26 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.536 -0.727 . . . . 3.21 111.031 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 1.5 p30 -69.2 154.36 42.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.456 -0.777 . . . . 0.01 109.535 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.7 t -125.8 115.03 24.61 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 108.966 -0.753 . . . . 0.01 108.966 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -75.66 -33.47 3.95 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 CA-C-N 120.404 1.18 . . . . 0.01 111.687 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.4 p -141.91 108.06 5.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.325 -0.859 . . . . 0.02 109.071 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.68 -40.06 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.753 -0.592 . . . . 1.83 110.993 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.4 ttt -66.69 -37.45 84.77 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.005 -1.078 . . . . 1.34 109.749 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -69.74 -38.5 76.87 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.474 -1.391 . . . . 2.11 109.819 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.31 -47.54 14.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.277 -0.889 . . . . 2.08 112.493 -177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.51 -1.36 15.88 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.269 -0.895 . . . . 0.02 112.747 -176.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 61.25 34.01 18.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.789 -1.194 . . . . 0.02 109.697 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.1 mt -113.78 136.52 52.77 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.498 -0.751 . . . . 0.02 109.351 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -91.26 -22.49 20.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.873 . . . . 5.32 111.074 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -148.54 163.94 35.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.907 -1.121 . . . . 0.02 110.254 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mm -127.87 125.5 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.163 -1.421 . . . . 2.17 107.163 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -106.15 -15.41 14.88 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.865 -1.147 . . . . 0.02 113.201 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 1.2 p -157.03 155.51 31.33 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.278 -1.513 . . . . 0.01 107.942 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.6 t -163.15 146.49 10.67 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.442 -1.411 . . . . 1.22 109.737 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.77 111.49 17.22 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.432 1.11 . . . . 1.41 108.601 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.7 t -109.16 122.67 64.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 105.584 -2.006 . . . . 0.01 105.584 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.3 t -146.43 67.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 118.128 -1.429 . . . . 1.98 108.06 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.95 108.83 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.534 -1.654 . . . . 0.01 106.534 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.82 -174.3 40.05 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.659 -1.376 . . . . 0.01 109.659 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 m -112.2 145.1 40.47 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.331 -1.1 . . . . 2.3 109.522 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.496 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 62.8 m95 -130.03 145.87 51.68 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.535 -0.728 . . . . 0.01 110.379 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mt -116.96 141.45 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 107.639 -1.245 . . . . 1.69 107.639 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -112.36 141.76 45.7 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 107.198 -1.408 . . . . 2.49 107.198 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -122.06 143.78 49.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.09 -0.707 . . . . 0.02 109.09 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.34 -30.3 61.96 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.729 -0.607 . . . . 0.02 111.908 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.53 153.45 47.74 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.667 -1.271 . . . . 1.48 109.018 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.45 167.11 1.47 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.243 1.295 . . . . 0.02 112.665 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 m120 59.21 31.03 20.89 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.141 -0.936 . . . . 0.75 111.079 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.494 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.6 m-85 57.72 52.07 8.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.633 -0.667 . . . . 0.02 111.048 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -125.07 163.72 21.78 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.495 -0.753 . . . . 0.02 109.69 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.17 -165.5 32.89 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -67.81 141.22 56.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.448 -1.031 . . . . 0.02 108.92 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.64 148.48 42.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.25 -0.648 . . . . 0.02 109.25 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.52 142.72 50.98 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.959 -0.756 . . . . 0.01 108.959 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.0 tt -96.69 121.3 38.39 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.277 -0.89 . . . . 0.01 109.131 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.652 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.9 mt -106.11 135.05 48.26 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.369 -0.832 . . . . 0.01 110.261 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 154' ' ' LYS . 22.8 t70 -108.25 174.82 5.71 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.339 -0.985 . . . . 2.27 108.339 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.455 ' N ' ' CG ' ' A' ' 152' ' ' ASP . 13.2 pttp -58.72 83.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.921 -1.112 . . . . 1.84 108.598 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 152' ' ' ASP . 55.0 mmtt -136.47 170.74 15.55 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.215 -0.928 . . . . 2.28 111.518 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.465 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 14.5 mp0 -113.24 109.49 18.84 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.282 -1.007 . . . . 0.01 108.282 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -100.1 114.77 28.36 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.031 -1.043 . . . . 0.01 110.112 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -93.31 -25.85 17.56 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.156 -0.965 . . . . 0.01 111.643 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -125.75 153.32 73.18 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 120.762 -1.211 . . . . 2.54 108.682 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -61.04 -43.02 32.35 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 120.431 0.754 . . . . 0.7 110.77 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.7 t -60.73 -20.52 21.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.64 -1.288 . . . . 0.86 108.619 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -65.14 -15.99 63.02 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.068 -1.02 . . . . 0.02 109.416 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.652 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -94.85 9.87 37.51 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.945 -1.132 . . . . 0.02 107.945 178.677 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.09 11.27 84.95 Favored Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.18 -1.486 . . . . 0.02 109.627 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.59 142.33 31.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.557 -0.966 . . . . 0.02 110.181 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.79 -8.61 58.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.775 -0.578 . . . . 0.59 109.885 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 58.7 m -144.19 150.59 49.22 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 120.862 -1.149 . . . . 0.87 108.687 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -76.09 21.17 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 120.781 0.987 . . . . 0.38 112.541 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 123.23 28.73 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.653 1.216 . . . . 0.18 111.437 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.527 HG23 ' CD1' ' A' ' 138' ' ' PHE . 17.4 mt -147.25 124.51 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.316 -1.735 . . . . 3.99 106.316 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -114.01 -17.79 11.88 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.178 -0.951 . . . . 5.17 113.022 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.0 t -157.6 160.27 37.93 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.354 -2.091 . . . . 0.02 110.144 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -153.4 154.55 34.68 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.009 -1.057 . . . . 2.02 110.611 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.494 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 21.8 mtp180 -143.53 150.81 39.45 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 0.01 110.356 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -87.94 142.77 27.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.01 109.173 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.96 128.21 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.121 -0.987 . . . . 3.04 109.081 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.9 146.46 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.293 -0.88 . . . . 1.89 109.708 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 4.89 109.353 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.144 -1.583 . . . . 0.01 109.144 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.514 ' NZ ' ' CB ' ' A' ' 6' ' ' LYS . 5.4 ttpm? -148.8 137.34 21.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.285 . . . . 0.02 110.414 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 tt -130.95 140.52 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 109.206 -0.664 . . . . 0.02 109.206 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -121.41 130.46 53.61 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.403 -0.811 . . . . 0.39 110.054 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.85 140.46 45.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.737 -0.602 . . . . 0.02 109.448 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.3 m-85 -122.24 138.66 54.41 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.184 -0.947 . . . . 0.02 109.603 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.49 -27.27 65.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.08 . . . . 0.03 111.805 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -114.32 170.28 8.42 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.816 -1.178 . . . . 0.03 110.263 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -75.64 158.48 32.34 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.662 0.744 . . . . 0.03 110.18 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 65.99 33.15 7.93 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.006 0.908 . . . . 0.74 111.142 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.22 41.94 30.95 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.923 -0.58 . . . . 0.02 111.21 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -113.16 165.83 12.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.278 -1.008 . . . . 0.02 108.278 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.67 -167.67 35.38 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.882 -1.152 . . . . 0.03 110.464 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -68.97 142.0 54.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -1.096 . . . . 2.76 108.838 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -122.69 151.0 41.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.532 -0.73 . . . . 1.89 109.999 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -137.52 133.87 35.04 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.756 -0.59 . . . . 0.02 109.746 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -109.44 136.08 49.43 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.973 -0.751 . . . . 1.12 108.973 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.0 t -127.63 138.32 52.81 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.577 -0.702 . . . . 0.02 109.535 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 13.1 t70 -119.2 12.19 12.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.619 -0.676 . . . . 0.2 110.494 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.8 p -159.65 173.4 16.15 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.898 -1.126 . . . . 1.23 109.197 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -62.64 146.09 52.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.776 -1.203 . . . . 0.02 110.586 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.7 m -133.73 117.33 16.82 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.801 -0.814 . . . . 0.02 108.801 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.32 52.01 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.314 -0.866 . . . . 0.24 111.641 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -151.06 105.69 3.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.88 -1.137 . . . . 1.14 109.215 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.0 4.85 42.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 6.37 110.097 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -62.1 -29.47 70.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 3.11 112.635 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 m -77.21 -18.22 57.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.152 -1.592 . . . . 0.88 111.647 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -106.95 -19.8 13.52 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.418 -0.801 . . . . 0.02 110.51 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -148.98 127.09 12.02 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.032 -1.042 . . . . 3.32 109.55 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 p -87.44 -13.15 44.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.02 111.301 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -172.38 161.84 5.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.788 -1.195 . . . . 0.02 108.45 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.443 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.6 p -143.35 116.24 8.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.117 -0.989 . . . . 0.02 108.851 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -108.1 -0.73 20.95 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.829 -1.169 . . . . 0.03 111.228 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 19.3 m -155.23 153.68 31.04 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.829 -1.174 . . . . 0.02 107.829 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.89 147.53 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 122.158 0.98 . . . . 0.02 110.551 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -123.58 124.96 43.98 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.952 -1.129 . . . . 0.02 107.952 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.27 113.79 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.672 -1.603 . . . . 0.02 106.672 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -84.76 -35.06 22.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.6 -0.687 . . . . 3.81 110.001 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.65 149.45 17.42 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.598 -1.763 . . . . 0.02 110.778 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.75 172.1 48.57 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.237 -1.145 . . . . 0.01 110.237 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -118.48 134.36 55.13 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.592 -1.262 . . . . 1.48 107.592 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -127.03 154.31 44.81 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.704 1.24 . . . . 0.02 112.484 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.88 134.11 52.0 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 105.194 -2.15 . . . . 0.24 105.194 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.6 m -116.38 141.95 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.65 109.453 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -120.48 143.13 48.69 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.192 0.996 . . . . 0.02 109.649 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.84 -34.1 77.37 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.511 -0.768 . . . . 0.02 111.897 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -124.51 157.96 63.43 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.017 -1.052 . . . . 0.02 109.472 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.39 166.4 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.587 1.525 . . . . 0.02 112.769 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.461 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 63.55 36.59 10.99 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.242 -0.89 . . . . 0.02 111.116 178.268 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.514 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 6.0 m-85 45.56 51.6 9.81 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.603 0.716 . . . . 3.39 110.679 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.8 m -126.1 163.62 22.68 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.291 0.567 . . . . 2.33 109.77 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.66 31.27 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -64.78 139.21 58.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.036 -1.273 . . . . 0.02 110.268 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 19.9 ptm -119.54 136.96 54.13 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.178 0.513 . . . . 5.01 109.722 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.444 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 93.4 m-85 -134.41 139.51 45.62 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.47 -0.768 . . . . 0.02 109.954 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 mm -94.1 130.34 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.924 -0.769 . . . . 1.72 108.924 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.546 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.55 110.69 35.32 Favored Pre-proline 0 N--CA 1.505 2.308 0 O-C-N 121.39 -0.819 . . . . 0.02 110.877 -178.521 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.99 169.32 20.69 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 119.823 0.972 . . . . 1.47 110.388 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -53.97 141.25 28.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.882 -1.136 . . . . 4.25 110.728 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.72 -177.64 31.91 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.509 -1.329 . . . . 0.02 110.748 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -119.42 131.38 55.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.388 -1.066 . . . . 0.96 109.887 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 73.5 m-85 -121.67 98.09 46.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.051 -1.092 . . . . 0.02 108.051 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.423 ' O ' ' OG ' ' A' ' 38' ' ' SER . 7.3 Cg_endo -70.61 -3.82 13.36 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 120.787 0.991 . . . . 0.02 113.576 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -157.33 154.54 29.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.489 -1.382 . . . . 2.02 107.966 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -59.85 -39.07 83.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.434 -0.792 . . . . 0.02 111.722 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -59.75 -24.39 64.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.02 110.496 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -69.95 -18.89 63.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 3.42 109.247 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.554 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.12 10.61 28.02 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.637 -1.245 . . . . 0.02 107.637 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 mtt 60.67 21.97 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.555 0.693 . . . . 0.02 110.359 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.02 144.28 44.98 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.332 -1.507 . . . . 0.02 109.332 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.2 tp -78.64 -30.46 46.38 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.502 -1.296 . . . . 0.98 107.502 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -157.66 -171.39 3.54 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.326 -1.731 . . . . 0.02 106.326 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -98.93 28.56 4.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.62 -1.3 . . . . 0.02 110.433 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -97.84 123.3 41.74 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.026 -1.046 . . . . 3.2 111.36 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.466 HD22 ' HB ' ' A' ' 48' ' ' VAL . 57.1 mt -142.5 119.6 11.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.259 -1.385 . . . . 2.61 107.259 177.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.98 -18.07 10.98 Favored Glycine 0 N--CA 1.497 2.703 0 O-C-N 121.249 -0.907 . . . . 0.02 111.949 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.514 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 15.8 t -155.67 155.29 32.95 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.321 -1.693 . . . . 0.02 110.826 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 30.0 p -146.02 148.2 32.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.02 110.19 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.445 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 49.0 mtp180 -137.43 142.05 41.62 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.88 -0.785 . . . . 0.01 108.88 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.65 133.06 37.27 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.175 -0.953 . . . . 0.43 109.276 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.18 123.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.351 -0.981 . . . . 1.25 108.351 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -91.47 131.75 36.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.678 -1.264 . . . . 1.77 107.958 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.434 ' N ' HD23 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -96.52 137.28 35.83 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.145 -1.057 . . . . 1.63 108.145 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 t -109.7 126.47 53.73 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.454 -0.943 . . . . 1.08 108.454 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.3 m -103.47 -154.48 0.5 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.211 -1.774 . . . . 1.26 106.211 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.36 -50.12 0.88 Allowed Glycine 0 N--CA 1.497 2.748 0 O-C-N 120.692 -1.255 . . . . 0.01 111.676 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.87 -99.41 0.13 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.74 -1.695 . . . . 0.01 112.001 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.42 119.2 32.34 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.311 -1.111 . . . . 4.43 110.457 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.601 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.79 137.52 56.68 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.765 -0.584 . . . . 2.99 109.472 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -134.55 131.51 38.03 Favored 'General case' 0 N--CA 1.519 2.994 0 O-C-N 121.083 -1.011 . . . . 6.36 113.19 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 tt -131.83 141.96 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 115.525 -0.761 . . . . 1.09 110.237 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.532 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 2.3 pm0 -125.11 140.34 52.97 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 107.743 -1.206 . . . . 2.05 107.743 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.3 145.79 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 O-C-N 120.603 -1.31 . . . . 1.1 111.038 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 27.6 m-85 -119.79 140.05 51.37 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.218 1.009 . . . . 0.73 110.959 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.27 -32.97 73.51 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.801 -0.636 . . . . 0.02 111.48 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -115.02 168.91 9.5 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.213 -0.929 . . . . 3.18 109.953 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.25 169.03 47.31 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 111.011 -0.836 . . . . 0.01 111.011 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.7 t0 53.55 39.11 29.61 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.66 0.743 . . . . 0.01 111.594 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 52.53 48.41 22.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.553 -0.717 . . . . 0.01 110.828 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 24.2 t30 -121.53 164.36 17.35 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.307 -0.997 . . . . 3.15 108.307 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 90.68 -163.13 29.52 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.118 -1.593 . . . . 0.01 109.118 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -75.48 141.82 43.03 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.839 -1.389 . . . . 0.01 109.222 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 41.3 ttp -116.39 143.39 45.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.613 0.721 . . . . 0.01 109.528 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -132.52 136.18 46.46 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.34 -0.985 . . . . 2.48 108.34 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -117.0 134.72 54.38 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.702 -0.624 . . . . 0.01 109.642 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -149.49 148.55 29.54 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.419 1.104 . . . . 1.69 111.353 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 p -115.6 6.91 14.68 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.045 -0.98 . . . . 0.01 110.015 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.56 163.34 19.05 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.505 -0.747 . . . . 3.21 111.107 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -68.31 152.59 45.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.01 109.822 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.1 t -126.52 113.79 23.02 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.901 -0.777 . . . . 0.01 108.901 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -76.1 -33.27 3.66 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 CA-C-N 120.19 1.103 . . . . 0.01 111.658 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.4 p -140.91 106.84 5.16 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.056 0.931 . . . . 0.02 108.645 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.44 -39.36 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.772 -0.58 . . . . 1.83 111.186 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.0 ttt -67.26 -37.24 83.15 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.024 -1.07 . . . . 1.34 109.578 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -69.6 -38.39 77.28 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.64 -1.288 . . . . 2.11 109.858 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.17 -46.51 16.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 2.08 112.265 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -110.11 -0.14 18.09 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.317 -0.864 . . . . 0.02 112.694 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 59.81 33.26 21.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.653 -1.279 . . . . 0.02 109.379 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.76 135.64 53.27 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 108.676 -0.861 . . . . 0.02 108.676 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -92.34 -23.19 19.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 5.32 110.46 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -149.16 163.32 37.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.163 -0.961 . . . . 0.02 110.073 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.4 mt -132.06 129.66 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 107.189 -1.412 . . . . 2.17 107.189 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -105.75 -12.31 15.94 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.381 -0.928 . . . . 0.02 112.59 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.18 152.8 29.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.368 -1.458 . . . . 0.01 108.11 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 12.8 t -162.88 141.86 8.7 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.556 -1.34 . . . . 1.22 109.465 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.405 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 30.5 ttpt -124.04 114.47 19.78 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.643 1.211 . . . . 1.41 109.656 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.39 123.75 61.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 105.614 -1.995 . . . . 0.01 105.614 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.5 HG13 ' NZ ' ' A' ' 153' ' ' LYS . 59.0 t -147.65 71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 C-N-CA 118.404 -1.318 . . . . 1.98 108.205 175.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 171.35 108.29 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.427 -1.694 . . . . 0.01 106.427 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.75 -172.31 46.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.563 -1.415 . . . . 0.01 109.563 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -110.25 140.89 43.94 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.555 -0.968 . . . . 2.3 108.877 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.601 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 70.5 m95 -129.85 146.69 51.57 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.443 -0.786 . . . . 0.01 110.442 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 137' ' ' ILE . 61.1 mt -118.36 139.86 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 107.816 -1.179 . . . . 1.69 107.816 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.671 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.04 141.96 46.26 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.103 -1.443 . . . . 2.49 107.103 178.057 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 6.7 m-85 -122.55 144.39 49.12 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.593 -0.692 . . . . 0.02 109.155 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -73.92 -30.12 62.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.586 -0.696 . . . . 0.02 112.407 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.3 mt -115.05 153.56 47.17 Favored Pre-proline 0 N--CA 1.506 2.349 0 O-C-N 120.773 -1.204 . . . . 1.48 109.085 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.3 166.67 1.6 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.117 1.211 . . . . 0.02 112.522 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 59.54 30.76 20.43 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.225 -0.898 . . . . 0.75 111.114 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.56 52.21 7.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.424 -0.798 . . . . 0.02 111.272 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -125.78 163.84 21.98 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.532 -0.73 . . . . 0.02 109.959 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.67 -165.56 32.29 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.078 -1.209 . . . . 0.02 110.078 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -68.1 141.69 56.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.543 -0.975 . . . . 0.02 108.941 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -118.15 149.92 40.24 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 116.044 -0.526 . . . . 0.02 109.676 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.56 140.82 51.87 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.221 -0.659 . . . . 0.01 109.221 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.5 tp -95.13 121.69 37.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.414 -0.804 . . . . 0.01 109.191 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.63 ' CD2' ' HE1' ' A' ' 162' ' ' TRP . 5.8 mt -104.62 113.98 27.91 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.384 -0.823 . . . . 0.01 109.677 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 152' ' ' ASP . 5.3 m-20 -113.9 89.83 3.19 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 108.702 -0.851 . . . . 2.27 108.702 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.5 ' NZ ' HG13 ' A' ' 132' ' ' VAL . 51.8 tttp 49.37 78.86 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.99 -1.069 . . . . 1.84 108.267 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -131.45 144.4 51.14 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.468 -0.77 . . . . 2.28 111.902 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -112.98 99.79 8.13 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.329 -1.36 . . . . 0.01 107.329 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -98.06 116.72 30.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.096 -1.003 . . . . 0.01 110.853 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -97.72 -27.3 14.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.434 -0.791 . . . . 0.01 110.734 -178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -125.72 152.44 72.28 Favored Pre-proline 0 N--CA 1.502 2.137 0 N-CA-C 108.527 -0.916 . . . . 2.54 108.527 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -57.87 -47.49 20.6 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 CA-C-N 119.313 0.79 . . . . 0.7 110.889 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.58 -23.57 29.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.829 -1.17 . . . . 0.86 109.435 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 11.9 t0 -66.8 -16.22 64.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.777 -1.202 . . . . 0.02 109.492 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.63 ' HE1' ' CD2' ' A' ' 151' ' ' LEU . 2.2 t90 -95.06 7.83 44.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.529 -0.915 . . . . 0.02 108.529 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.98 8.18 84.67 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.904 -1.278 . . . . 0.02 109.904 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.27 142.84 30.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.552 -0.97 . . . . 0.02 110.035 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.31 -8.97 58.85 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.728 -0.608 . . . . 0.59 109.635 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.7 t -146.46 151.38 43.33 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.825 -1.172 . . . . 0.87 108.113 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.22 24.85 0.39 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.768 0.979 . . . . 0.38 112.344 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.485 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -85.27 123.01 30.27 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.87 -1.144 . . . . 0.18 112.803 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.671 HG23 ' CD1' ' A' ' 138' ' ' PHE . 4.6 mp -146.84 126.92 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.429 -1.693 . . . . 3.99 106.429 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -112.16 -17.88 12.7 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.917 -1.114 . . . . 5.17 113.605 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.8 p -157.79 160.82 38.2 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 119.18 -2.2 . . . . 0.02 110.263 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -153.2 153.74 33.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.054 -1.029 . . . . 2.02 110.766 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -144.72 152.16 39.97 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.205 -0.934 . . . . 0.01 110.908 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -88.31 141.82 28.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.118 -0.697 . . . . 0.01 109.118 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.0 mt -94.42 129.41 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.215 -0.928 . . . . 3.04 109.105 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.29 147.22 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.186 -0.946 . . . . 1.89 109.681 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 4.89 109.366 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.425 -1.47 . . . . 0.01 109.425 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -147.67 136.03 21.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.093 -1.239 . . . . 0.02 110.267 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -130.38 140.32 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.211 -0.663 . . . . 0.02 109.211 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.95 130.9 53.7 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.429 -0.795 . . . . 0.39 110.191 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.9 m-85 -110.98 140.62 45.34 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.546 -0.721 . . . . 0.02 109.487 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -121.89 138.1 54.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.365 -0.834 . . . . 0.02 109.49 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.43 -27.25 65.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.957 -1.09 . . . . 0.03 111.681 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -113.88 169.63 8.85 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.927 -1.108 . . . . 0.03 110.212 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.51 ' NH2' ' OE2' ' A' ' 68' ' ' GLU . 21.8 mtp180 -75.91 158.43 32.05 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.614 0.721 . . . . 0.03 110.159 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 66.39 33.26 7.06 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.05 0.928 . . . . 0.74 111.082 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 55.58 41.8 30.27 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.932 -0.576 . . . . 0.02 111.39 177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -113.44 165.72 12.19 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.357 -0.979 . . . . 0.02 108.357 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.18 -167.94 34.81 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.851 -1.166 . . . . 0.03 110.536 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -69.03 142.84 54.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.443 -1.034 . . . . 2.76 108.955 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -122.2 149.96 42.93 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.614 -0.679 . . . . 1.89 110.053 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -136.59 133.02 35.91 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.329 -0.619 . . . . 0.02 109.329 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -109.22 136.79 48.12 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.761 -0.829 . . . . 1.12 108.761 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 16.0 t -128.21 138.44 52.46 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.556 -0.715 . . . . 0.02 109.891 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -119.74 11.53 11.95 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.647 -0.658 . . . . 0.2 110.776 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.525 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 26.7 p -159.7 173.48 15.99 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.562 -1.336 . . . . 1.23 109.418 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.09 145.89 54.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.404 -1.435 . . . . 0.02 110.688 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.9 m -135.1 119.57 18.01 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.037 -0.727 . . . . 0.02 109.037 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.25 -20.33 55.33 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.425 -0.797 . . . . 0.24 111.918 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -153.96 106.62 2.86 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.838 -1.163 . . . . 1.14 109.792 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.77 5.65 38.93 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.378 -0.826 . . . . 6.37 110.289 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -60.5 -29.21 68.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 3.11 111.976 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 p -76.86 -16.78 59.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.417 -1.427 . . . . 0.88 111.039 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -106.13 -21.63 13.07 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.326 -0.859 . . . . 0.02 110.684 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 tp -149.44 127.67 12.09 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.988 -1.07 . . . . 3.32 109.534 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -87.63 -12.41 45.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.562 -0.711 . . . . 0.02 110.966 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -171.82 160.85 5.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.854 -1.154 . . . . 0.02 108.541 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.454 ' SG ' HD12 ' A' ' 79' ' ' LEU . 1.8 p -143.38 116.1 8.71 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.975 -1.078 . . . . 0.02 108.846 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -108.6 -0.91 19.98 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.811 -1.18 . . . . 0.03 111.363 -178.331 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 21.1 m -154.73 153.64 31.6 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mt -146.67 147.41 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.296 1.046 . . . . 0.02 110.735 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -123.75 124.53 42.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.052 -1.092 . . . . 0.02 108.052 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 t -105.28 113.88 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.654 -1.609 . . . . 0.02 106.654 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -85.52 -34.9 21.44 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.079 -0.649 . . . . 3.81 110.212 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.56 149.11 16.78 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 118.481 -1.819 . . . . 0.02 110.773 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.75 172.18 48.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.08 -1.208 . . . . 0.01 110.08 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.8 m -118.26 134.37 55.08 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.422 -1.325 . . . . 1.48 107.422 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -126.78 154.49 44.19 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.694 1.235 . . . . 0.02 112.411 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.25 133.97 52.36 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 105.18 -2.155 . . . . 0.24 105.18 176.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.445 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.1 m -116.38 142.01 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.494 -0.754 . . . . 0.65 109.268 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -120.85 143.06 49.09 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.104 0.954 . . . . 0.02 109.607 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.88 -33.82 76.93 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.527 -0.761 . . . . 0.02 111.76 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -124.76 158.01 63.98 Favored Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 120.971 -1.081 . . . . 0.02 109.366 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.29 167.14 0.87 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.548 1.499 . . . . 0.02 112.76 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.471 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.2 OUTLIER 63.2 36.58 11.88 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.245 -0.888 . . . . 0.02 111.11 178.275 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.412 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 4.1 m-85 45.1 51.59 8.89 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.626 0.727 . . . . 3.39 110.677 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.7 p -125.69 163.33 23.04 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.227 0.537 . . . . 2.33 109.966 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.51 -161.59 31.23 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.58 -1.408 . . . . 0.02 109.58 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -65.27 138.9 58.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.962 -1.317 . . . . 0.02 110.153 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.2 ptm -118.86 137.31 53.52 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.314 0.578 . . . . 5.01 109.717 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.426 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 97.3 m-85 -134.27 139.34 45.67 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.52 -0.738 . . . . 0.02 109.818 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.9 mm -94.54 130.5 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.906 -0.775 . . . . 1.72 108.906 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.78 110.84 34.83 Favored Pre-proline 0 N--CA 1.506 2.359 0 O-C-N 121.417 -0.802 . . . . 0.02 110.784 -178.311 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -78.06 169.61 20.14 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.855 0.984 . . . . 1.47 110.438 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -53.71 141.18 27.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.966 -1.084 . . . . 4.25 110.589 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.66 -177.61 31.88 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.485 -1.341 . . . . 0.02 110.94 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -119.91 131.38 55.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.377 -1.073 . . . . 0.96 109.785 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 76.3 m-85 -121.29 97.74 47.24 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 107.959 -1.126 . . . . 0.02 107.959 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.43 ' O ' ' OG ' ' A' ' 38' ' ' SER . 4.8 Cg_endo -69.38 -4.46 13.82 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 120.731 0.954 . . . . 0.02 113.754 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.51 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 74.6 mt-10 -157.53 154.66 28.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.693 -1.255 . . . . 2.02 107.97 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -59.45 -38.69 81.4 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.473 -0.767 . . . . 0.02 111.978 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -60.36 -23.98 64.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 0.02 110.554 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -70.04 -18.78 63.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.38 -0.825 . . . . 3.42 108.951 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.552 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.69 10.4 26.88 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.562 -1.273 . . . . 0.02 107.562 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 mtt 60.94 22.32 12.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.735 . . . . 0.02 110.457 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.36 144.48 45.46 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.389 -1.484 . . . . 0.02 109.389 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.09 -31.2 44.25 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.494 -1.299 . . . . 0.98 107.494 177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -157.18 -171.82 3.77 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.383 -1.71 . . . . 0.02 106.383 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 92.9 m-20 -98.5 28.1 4.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.784 -1.198 . . . . 0.02 110.718 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -97.64 123.17 41.44 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.085 -1.009 . . . . 3.2 111.422 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.454 HD12 ' SG ' ' A' ' 36' ' ' CYS . 60.0 mt -142.01 119.56 11.7 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.221 -1.4 . . . . 2.61 107.221 177.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.22 -18.31 10.55 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.229 -0.92 . . . . 0.02 112.14 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 p -155.84 156.01 33.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.371 -1.664 . . . . 0.02 110.583 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.2 p -145.72 148.15 32.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.497 -0.752 . . . . 0.02 110.08 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.412 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 54.3 mtp180 -137.4 142.03 41.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.383 -0.823 . . . . 0.01 109.075 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.8 132.38 36.86 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.259 -0.901 . . . . 0.43 109.394 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 t -89.52 123.75 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.43 -0.952 . . . . 1.25 108.43 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -91.84 131.87 36.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.925 -1.109 . . . . 1.77 108.267 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.47 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -96.99 138.02 35.17 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.16 -1.052 . . . . 1.63 108.16 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 m -110.01 126.79 54.33 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.665 -0.865 . . . . 1.08 108.665 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.4 m -103.34 -154.39 0.5 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.196 -1.779 . . . . 1.26 106.196 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.42 -49.91 0.87 Allowed Glycine 0 N--CA 1.497 2.701 0 O-C-N 120.517 -1.364 . . . . 0.01 111.891 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.28 -99.86 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 118.723 -1.703 . . . . 0.01 111.822 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -119.67 119.35 33.44 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.258 -1.142 . . . . 4.43 110.465 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.425 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.12 135.59 54.78 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.304 -0.628 . . . . 2.99 109.304 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -134.69 131.06 37.23 Favored 'General case' 0 N--CA 1.519 3.021 0 O-C-N 121.024 -1.047 . . . . 6.36 113.079 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 tt -131.83 142.04 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 115.467 -0.788 . . . . 1.09 110.384 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.53 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.4 pt20 -124.32 138.44 54.38 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 107.285 -1.376 . . . . 2.05 107.285 176.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -124.55 147.23 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 120.586 -1.321 . . . . 1.1 111.188 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -119.86 141.51 49.49 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 122.385 1.088 . . . . 0.73 111.582 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -69.54 -33.18 72.42 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.738 -0.664 . . . . 0.02 111.135 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 12.0 mptt -113.84 167.73 10.39 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.185 -0.947 . . . . 3.18 109.545 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.38 169.69 46.55 Favored Glycine 0 N--CA 1.492 2.404 0 CA-C-O 122.033 0.796 . . . . 0.01 111.318 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 53.26 40.09 30.75 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.632 0.73 . . . . 0.01 111.605 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 52.58 47.73 24.07 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.523 -0.735 . . . . 0.01 110.785 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -121.47 165.28 15.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.12 -1.066 . . . . 3.15 108.12 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.27 -162.93 29.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.168 -1.573 . . . . 0.01 109.168 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -76.14 141.87 41.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.903 -1.351 . . . . 0.01 108.967 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.456 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.0 tmm? -116.08 143.28 45.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.497 0.665 . . . . 0.01 109.595 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -132.28 136.4 46.91 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.421 -0.955 . . . . 2.48 108.421 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -116.78 134.19 55.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.703 -0.623 . . . . 0.01 109.871 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.2 t -149.13 148.54 29.77 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 122.466 1.126 . . . . 1.69 111.444 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -114.74 7.64 15.93 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.062 -0.972 . . . . 0.01 110.1 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.89 163.35 19.39 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.43 -0.794 . . . . 3.21 111.28 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 154.41 42.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.01 109.379 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 35.0 t -125.8 114.5 24.64 Favored Pre-proline 0 N--CA 1.5 2.025 0 N-CA-C 109.19 -0.671 . . . . 0.01 109.19 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -75.59 -33.81 3.78 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 CA-C-N 120.225 1.116 . . . . 0.01 111.488 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 55.0 m -141.46 107.55 5.2 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.921 0.867 . . . . 0.02 108.84 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.7 mt -65.01 -39.04 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.748 -0.595 . . . . 1.83 111.182 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.6 ttt -66.88 -37.36 84.25 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.936 -1.105 . . . . 1.34 109.577 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -69.81 -38.56 76.64 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.59 -1.319 . . . . 2.11 109.752 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -80.16 -47.58 14.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.314 -0.866 . . . . 2.08 112.491 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.43 -0.65 16.2 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.389 -0.82 . . . . 0.02 112.724 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m170 59.71 33.63 21.9 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.76 -1.213 . . . . 0.02 109.5 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 mt -112.3 135.28 53.17 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.637 -0.875 . . . . 0.02 108.637 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -92.45 -23.44 19.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 5.32 110.664 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -149.34 163.63 37.16 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.218 -0.926 . . . . 0.02 110.12 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.5 mt -131.89 129.48 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.237 -1.394 . . . . 2.17 107.237 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -106.32 -12.49 15.67 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.109 -0.994 . . . . 0.02 113.068 -176.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 1.5 p -158.9 156.23 29.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.636 -1.29 . . . . 0.01 107.519 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 3.3 t -163.18 147.18 10.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.939 -1.1 . . . . 1.22 109.541 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.75 108.93 15.01 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.132 0.968 . . . . 1.41 108.767 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.49 121.6 61.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 105.886 -1.894 . . . . 0.01 105.886 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.1 t -147.24 69.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 118.072 -1.451 . . . . 1.98 108.289 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.68 107.56 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.238 -1.764 . . . . 0.01 106.238 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.19 -176.46 40.95 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.604 -1.399 . . . . 0.01 109.604 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.6 m -110.74 146.83 35.63 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.413 -1.051 . . . . 2.3 109.103 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.425 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 67.4 m95 -131.54 149.11 52.64 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.491 -0.756 . . . . 0.01 110.693 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 58.8 mt -118.8 140.61 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.66 -1.237 . . . . 1.69 107.66 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.724 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.14 141.44 46.93 Favored 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 107.314 -1.365 . . . . 2.49 107.314 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 7.4 m-85 -122.64 145.46 48.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.408 -0.807 . . . . 0.02 109.325 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.79 -30.03 61.3 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.561 -0.712 . . . . 0.02 112.187 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.45 153.33 47.64 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 120.684 -1.26 . . . . 1.48 109.068 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.13 167.06 1.33 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.27 1.313 . . . . 0.02 112.478 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.2 t30 59.22 31.11 20.95 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.051 -0.977 . . . . 0.75 111.027 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.57 51.32 9.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.563 -0.711 . . . . 0.02 111.06 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -124.12 163.31 21.76 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.533 -0.729 . . . . 0.02 109.726 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.53 -165.13 32.18 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.889 -1.284 . . . . 0.02 109.889 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -67.84 141.62 56.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.453 -1.028 . . . . 0.02 108.877 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -117.63 149.09 41.27 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.195 -0.669 . . . . 0.02 109.195 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -128.47 141.85 51.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.5 -0.75 . . . . 0.01 109.346 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.12 118.14 31.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.258 -0.901 . . . . 0.01 108.821 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.766 HD13 ' CZ2' ' A' ' 162' ' ' TRP . 0.8 OUTLIER -106.58 135.55 47.9 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.454 -0.778 . . . . 0.01 109.519 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 154' ' ' LYS . 14.4 p30 -109.62 172.73 6.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.234 -0.917 . . . . 2.27 109.157 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -56.53 83.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.14 -0.975 . . . . 1.84 108.738 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 152' ' ' ASP . 51.3 tttm -136.3 166.46 23.39 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.192 -0.942 . . . . 2.28 111.332 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 1.4 pm0 -110.04 108.48 18.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.805 -1.183 . . . . 0.01 107.805 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.608 ' CE2' ' NE1' ' A' ' 162' ' ' TRP . 94.4 m-85 -99.08 114.27 26.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.026 -1.046 . . . . 0.01 110.314 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -91.98 -27.82 17.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.443 -0.786 . . . . 0.01 111.208 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -126.26 152.23 73.4 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 120.96 -1.088 . . . . 2.54 108.228 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -59.72 -44.25 32.66 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 CA-C-N 119.283 0.78 . . . . 0.7 111.185 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.3 t -61.09 -21.62 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.789 -1.194 . . . . 0.86 109.509 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -65.92 -15.84 63.32 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.748 -1.22 . . . . 0.02 110.057 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.766 ' CZ2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -97.39 11.22 37.4 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.548 -0.908 . . . . 0.02 108.548 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.2 10.0 86.54 Favored Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.633 -1.27 . . . . 0.02 110.346 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.71 142.39 31.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.281 -1.129 . . . . 0.02 110.146 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.2 -9.47 57.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.688 -0.633 . . . . 0.59 110.314 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -145.51 150.49 44.13 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.703 -1.248 . . . . 0.87 108.957 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -76.19 21.23 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 120.888 1.059 . . . . 0.38 112.47 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.6 124.66 30.36 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.454 1.121 . . . . 0.18 111.762 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.724 HG23 ' CD1' ' A' ' 138' ' ' PHE . 42.3 mt -145.71 125.91 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.526 -1.657 . . . . 3.99 106.526 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -112.06 -20.7 11.86 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.008 -1.057 . . . . 5.17 112.584 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.2 t -156.5 159.67 38.82 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 119.546 -1.971 . . . . 0.02 109.725 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -153.13 154.02 33.97 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.008 -1.058 . . . . 2.02 110.649 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -144.52 151.61 39.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.156 -0.965 . . . . 0.01 110.558 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -87.59 142.33 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.952 -0.759 . . . . 0.01 108.952 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.9 mt -93.93 128.8 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.145 -0.972 . . . . 3.04 109.004 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.28 146.9 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.208 -0.932 . . . . 1.89 109.46 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 4.89 109.502 179.876 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.106 -1.598 . . . . 0.01 109.106 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -148.46 136.03 20.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.071 -1.252 . . . . 0.02 110.209 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -130.35 140.59 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.198 -0.668 . . . . 0.02 109.198 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 t -120.86 129.82 53.68 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.544 -0.722 . . . . 0.39 109.908 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 m-85 -109.81 139.47 44.85 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.61 -0.681 . . . . 0.02 109.239 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.515 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.5 m-85 -121.56 137.9 54.54 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.209 -0.932 . . . . 0.02 109.416 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.508 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 81.3 mt-10 -69.8 -27.34 64.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.074 -1.016 . . . . 0.03 111.756 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.48 170.66 8.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.843 -1.161 . . . . 0.03 109.95 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.457 ' CZ ' ' OE1' ' A' ' 68' ' ' GLU . 37.4 mtp180 -75.02 161.25 29.62 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.699 0.761 . . . . 0.03 110.245 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.2 m120 62.68 35.03 14.38 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.937 0.875 . . . . 0.74 110.565 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.6 p90 49.49 43.4 23.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.365 -0.834 . . . . 0.02 110.932 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -109.54 165.61 11.53 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.877 -1.157 . . . . 0.02 107.877 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.73 -167.83 33.92 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 120.748 -1.22 . . . . 0.03 110.733 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -69.37 143.71 53.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -1.059 . . . . 2.76 109.071 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -122.85 150.2 43.18 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.529 -0.732 . . . . 1.89 110.24 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -136.05 133.28 37.24 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.245 -0.65 . . . . 0.02 109.245 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -109.22 135.61 50.05 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.708 -0.849 . . . . 1.12 108.708 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.3 t -127.85 138.11 52.58 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.649 -0.657 . . . . 0.02 109.411 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 24.5 p-10 -118.89 12.1 12.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.747 -0.596 . . . . 0.2 110.166 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.8 p -160.18 173.67 15.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.864 -1.148 . . . . 1.23 109.083 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.18 146.07 54.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.838 -1.164 . . . . 0.02 110.657 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 29' ' ' PHE . 5.5 t -133.75 117.92 17.48 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.767 -0.827 . . . . 0.02 108.767 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.53 -21.25 49.07 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.299 -0.876 . . . . 0.24 111.865 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.99 105.79 3.29 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.784 -1.197 . . . . 1.14 109.496 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.581 ' CD2' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -101.32 5.33 42.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.459 -0.776 . . . . 6.37 110.351 -178.387 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -62.48 -29.78 70.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 3.11 112.669 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.6 p -77.11 -19.04 57.5 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.152 -1.592 . . . . 0.88 111.806 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -106.99 -19.49 13.61 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.303 -0.873 . . . . 0.02 110.152 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -148.73 126.97 12.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.994 -1.066 . . . . 3.32 109.39 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 m -87.43 -12.5 45.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.53 -0.732 . . . . 0.02 111.174 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -172.61 162.0 5.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.807 -1.183 . . . . 0.02 108.43 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.9 p -142.77 115.2 8.5 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.992 -1.068 . . . . 0.02 108.791 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 11' ' ' GLU . 10.5 m-80 -107.87 -1.97 20.28 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.858 -1.152 . . . . 0.03 111.441 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.02 153.63 33.3 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 39' ' ' ILE . 9.7 mt -147.23 147.64 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.041 -1.037 . . . . 0.02 110.653 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -125.33 125.94 44.28 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.868 -1.16 . . . . 0.02 107.868 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.5 t -105.39 114.24 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 106.828 -1.545 . . . . 0.02 106.828 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -85.37 -34.83 21.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 3.81 110.131 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.7 149.07 16.6 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 118.38 -1.867 . . . . 0.02 110.797 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.86 172.42 48.78 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.144 -1.182 . . . . 0.01 110.144 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -118.34 134.48 55.01 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.572 -1.27 . . . . 1.48 107.572 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -126.77 154.04 44.76 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.595 1.188 . . . . 0.02 112.382 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.69 133.53 52.66 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.094 -2.187 . . . . 0.24 105.094 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.9 m -117.75 143.28 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.546 -0.721 . . . . 0.65 109.279 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.544 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 33.1 m-85 -120.72 145.1 47.84 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.197 0.999 . . . . 0.02 109.917 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.97 -33.66 76.32 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.76 -0.654 . . . . 0.02 111.436 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -124.71 158.01 63.83 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.122 -0.986 . . . . 0.02 109.484 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.7 167.16 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.747 1.631 . . . . 0.02 112.716 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.0 t30 63.29 36.55 11.66 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.309 -0.859 . . . . 0.02 111.015 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.433 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 7.2 m-85 45.59 51.49 9.92 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.619 0.723 . . . . 3.39 110.936 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -126.13 163.63 22.68 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.223 0.535 . . . . 2.33 110.014 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.85 -161.87 30.99 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.895 -1.282 . . . . 0.02 109.895 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -65.16 139.5 58.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.966 -1.314 . . . . 0.02 110.134 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.544 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 49.2 ttp -118.35 137.34 53.16 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.292 0.568 . . . . 5.01 109.827 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.564 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.6 m-85 -134.75 138.81 44.66 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.467 -0.77 . . . . 0.02 109.911 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.2 mm -94.55 130.89 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.003 -0.74 . . . . 1.72 109.003 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -120.36 110.76 35.58 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.396 -0.815 . . . . 0.02 110.631 -178.508 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -78.25 169.2 20.57 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.876 0.992 . . . . 1.47 110.275 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -53.79 140.64 29.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.831 -1.168 . . . . 4.25 110.558 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.17 -177.56 32.32 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.635 -1.269 . . . . 0.02 110.61 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -118.58 130.41 55.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.454 -1.027 . . . . 0.96 109.735 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 53.2 m-85 -120.61 97.25 48.72 Favored Pre-proline 0 N--CA 1.494 1.763 0 N-CA-C 107.994 -1.113 . . . . 0.02 107.994 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -69.73 -3.72 12.55 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.69 0.926 . . . . 0.02 113.656 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.457 ' OE1' ' CZ ' ' A' ' 13' ' ' ARG . 40.6 mt-10 -157.49 154.17 28.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.579 -1.326 . . . . 2.02 108.138 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -59.63 -38.82 82.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.485 -0.759 . . . . 0.02 111.768 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -60.26 -23.92 64.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.105 -0.997 . . . . 0.02 110.283 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -70.15 -18.58 63.22 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.812 0.815 . . . . 3.42 108.842 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.564 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -108.13 11.13 27.8 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.378 -1.342 . . . . 0.02 107.378 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' A' ' 73' ' ' MET . 1.2 mpt? 59.04 22.61 10.66 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.66 0.743 . . . . 0.02 110.435 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.48 145.16 45.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.409 -1.476 . . . . 0.02 109.409 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.38 -31.6 42.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.122 -1.222 . . . . 0.98 107.751 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -157.07 -171.88 3.81 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.501 -1.666 . . . . 0.02 106.501 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -98.05 28.26 4.08 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.738 -1.226 . . . . 0.02 110.612 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -97.7 122.72 41.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.921 -1.112 . . . . 3.2 111.225 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.473 HD12 ' SG ' ' A' ' 36' ' ' CYS . 61.1 mt -142.24 119.25 11.31 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.372 -1.344 . . . . 2.61 107.372 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.79 -18.22 10.99 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.272 -0.893 . . . . 0.02 112.18 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 76.9 p -155.68 155.62 33.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.335 -1.685 . . . . 0.02 110.169 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.4 p -145.27 148.03 33.02 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.712 -0.618 . . . . 0.02 109.669 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 66.5 mtm180 -137.4 142.2 41.69 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.474 -0.766 . . . . 0.01 109.17 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.97 133.15 36.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.227 -0.92 . . . . 0.43 109.413 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.33 123.91 42.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.593 -0.892 . . . . 1.25 108.593 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -91.75 131.67 36.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.731 -1.231 . . . . 1.77 108.147 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mt -97.12 138.57 34.44 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.194 -1.039 . . . . 1.63 108.194 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.1 m -110.43 126.33 54.2 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.652 -0.87 . . . . 1.08 108.652 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 t -102.96 -154.82 0.5 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.011 -1.848 . . . . 1.26 106.011 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.48 -49.27 0.89 Allowed Glycine 0 N--CA 1.496 2.694 0 O-C-N 120.472 -1.392 . . . . 0.01 111.847 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.08 -99.24 0.12 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 118.77 -1.681 . . . . 0.01 111.897 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -120.59 120.26 35.28 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.321 -1.105 . . . . 4.43 110.595 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.478 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.28 135.83 54.98 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.365 -0.606 . . . . 2.99 109.365 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.511 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 2.4 ttmp? -134.5 130.67 37.03 Favored 'General case' 0 N--CA 1.518 2.974 0 CA-C-O 122.258 1.028 . . . . 6.36 113.074 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 tt -131.62 142.2 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.5 -0.773 . . . . 1.09 110.143 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.426 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.5 pt20 -124.53 139.74 53.6 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.611 -1.255 . . . . 2.05 107.611 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.16 145.83 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 120.68 -1.262 . . . . 1.1 111.2 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.525 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 76.1 m-85 -120.2 139.91 51.94 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.045 0.926 . . . . 0.73 110.758 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.31 -32.11 72.01 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.836 -0.62 . . . . 0.02 111.791 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -114.6 167.73 10.49 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.064 -1.022 . . . . 3.18 110.352 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.53 164.35 52.79 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 111.071 -0.812 . . . . 0.01 111.071 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 57.74 38.77 27.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 122.02 -0.694 . . . . 0.01 111.595 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 52.29 54.95 9.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.519 -0.738 . . . . 0.01 111.208 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -128.97 165.46 21.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.041 -1.096 . . . . 3.15 108.041 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.06 -162.99 30.21 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.014 -1.634 . . . . 0.01 109.014 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -75.73 141.6 42.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.879 -1.366 . . . . 0.01 109.193 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.525 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 51.1 ttp -116.48 143.09 46.02 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.645 0.736 . . . . 0.01 109.548 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -131.91 136.13 47.16 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 2.48 108.21 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.406 ' OE2' ' N ' ' A' ' 110' ' ' THR . 3.0 tm-20 -116.71 133.76 55.63 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.658 -0.651 . . . . 0.01 109.687 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.406 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 0.1 OUTLIER -149.09 148.31 29.53 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.429 1.109 . . . . 1.69 111.088 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -115.23 7.62 15.31 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.96 -1.018 . . . . 0.01 110.152 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -122.07 163.59 19.17 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.373 -0.83 . . . . 3.21 111.214 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.56 154.85 41.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.333 -0.855 . . . . 0.01 109.309 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.604 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 20.3 p -127.32 119.79 22.03 Favored Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 109.24 -0.652 . . . . 0.01 109.24 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -76.72 -33.39 3.01 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 120.198 1.107 . . . . 0.01 110.995 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.0 m -143.45 109.05 5.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.443 -0.786 . . . . 0.02 109.304 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.5 mt -64.04 -39.48 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.83 -0.544 . . . . 1.83 110.79 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.1 ttt -66.64 -37.27 84.47 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.102 -1.039 . . . . 1.34 109.79 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -69.98 -38.61 76.09 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.543 -1.348 . . . . 2.11 109.707 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -80.23 -47.06 15.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.356 -0.84 . . . . 2.08 112.39 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -110.69 -0.62 17.06 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.376 -0.827 . . . . 0.02 112.678 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.598 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.1 m-70 59.92 33.3 21.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.749 -1.219 . . . . 0.02 109.483 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.6 135.82 52.87 Favored 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 108.761 -0.829 . . . . 0.02 108.761 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -92.72 -23.15 19.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 5.32 110.6 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -148.89 163.32 37.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.048 -1.033 . . . . 0.02 110.082 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.0 mt -131.87 129.49 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 107.345 -1.354 . . . . 2.17 107.345 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -107.09 -13.15 15.24 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.183 -0.948 . . . . 0.02 113.073 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.21 153.64 31.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.36 -1.462 . . . . 0.01 108.189 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.6 t -160.88 146.14 14.32 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.218 -1.551 . . . . 1.22 109.963 -178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -121.82 109.08 14.23 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.143 0.973 . . . . 1.41 108.827 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.9 120.74 59.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.002 -1.851 . . . . 0.01 106.002 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -146.59 69.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 118.326 -1.35 . . . . 1.98 108.437 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.57 108.05 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.48 -1.674 . . . . 0.01 106.48 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.696 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 71.07 -172.84 43.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.658 -1.377 . . . . 0.01 109.658 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.24 146.05 37.64 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.466 -1.02 . . . . 2.3 108.93 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.478 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 68.6 m95 -131.35 145.23 51.76 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.441 -0.787 . . . . 0.01 110.389 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mt -117.69 140.94 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.806 -1.183 . . . . 1.69 107.806 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.27 143.63 44.54 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.58 -1.267 . . . . 2.49 107.58 177.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 11.2 m-85 -122.69 144.04 49.4 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.168 -0.678 . . . . 0.02 109.168 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -73.53 -29.72 62.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.654 -0.654 . . . . 0.02 112.088 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.88 153.78 48.19 Favored Pre-proline 0 N--CA 1.506 2.353 0 O-C-N 120.584 -1.322 . . . . 1.48 109.205 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.49 166.73 1.68 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.248 1.299 . . . . 0.02 112.686 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.3 t30 59.39 31.54 21.16 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.13 -0.941 . . . . 0.75 111.076 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.41 51.38 9.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.515 -0.741 . . . . 0.02 110.962 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -124.44 163.49 21.69 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.493 -0.754 . . . . 0.02 109.77 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.58 -165.44 32.31 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.755 -1.338 . . . . 0.02 109.755 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -67.97 141.76 56.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -1.059 . . . . 0.02 108.952 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.448 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.5 mp0 -118.5 149.07 41.91 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.109 -0.7 . . . . 0.02 109.109 -178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.37 142.33 51.15 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.576 -0.703 . . . . 0.01 109.121 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.11 120.68 35.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.505 -0.747 . . . . 0.01 109.27 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.659 HD22 ' NE1' ' A' ' 162' ' ' TRP . 19.0 mt -105.61 133.91 49.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.01 110.727 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 1.2 m-20 -110.31 176.43 5.05 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.183 -1.043 . . . . 2.27 108.183 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.696 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 37.7 mttm -56.66 85.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.985 -1.072 . . . . 1.84 108.571 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 44.8 mttp -136.47 165.13 26.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.233 -0.917 . . . . 2.28 111.778 -178.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -113.27 109.1 18.19 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.951 -1.129 . . . . 0.01 107.951 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -99.67 114.64 27.86 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.139 -0.975 . . . . 0.01 110.219 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -92.17 -25.86 18.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.17 -0.956 . . . . 0.01 111.151 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -125.47 153.65 72.47 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 121.169 -0.957 . . . . 2.54 108.526 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.67 -42.09 42.01 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 CA-C-N 119.227 0.76 . . . . 0.7 110.628 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.56 -20.38 20.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.731 -1.23 . . . . 0.86 108.535 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 37.5 t0 -65.74 -16.25 63.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.986 -1.071 . . . . 0.02 109.531 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.659 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.86 9.59 38.58 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.847 -1.168 . . . . 0.02 107.847 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.99 10.62 86.16 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.308 -1.425 . . . . 0.02 109.716 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.91 142.11 31.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.491 -1.005 . . . . 0.02 110.162 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.08 -8.13 58.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.711 -0.618 . . . . 0.59 109.847 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 t -143.77 148.6 43.41 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.85 -1.156 . . . . 0.87 108.535 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -74.77 21.57 0.42 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 CA-C-N 119.842 0.979 . . . . 0.38 112.231 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.02 123.77 29.78 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.538 1.161 . . . . 0.18 111.781 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.407 ' CD1' ' CZ3' ' A' ' 162' ' ' TRP . 17.8 mt -146.59 126.63 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.773 -1.566 . . . . 3.99 106.773 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -112.36 -19.62 12.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.071 -1.018 . . . . 5.17 112.909 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 9.6 p -157.85 159.88 37.12 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 119.238 -2.164 . . . . 0.02 110.154 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.604 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 6.1 p90 -152.19 154.68 36.29 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.09 -1.006 . . . . 2.02 110.477 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -144.71 151.79 39.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.192 -0.943 . . . . 0.01 110.586 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -87.77 142.57 27.71 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.018 -0.734 . . . . 0.01 109.018 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.6 mt -93.63 128.88 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.091 -1.006 . . . . 3.04 109.14 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.27 146.88 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.194 -0.941 . . . . 1.89 109.54 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.359 -0.838 . . . . 4.89 109.435 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.365 -1.494 . . . . 0.01 109.365 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -148.23 136.52 21.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.129 -1.218 . . . . 0.02 110.333 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 tt -130.58 140.38 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.111 -0.7 . . . . 0.02 109.111 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.79 130.71 53.61 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.238 -0.914 . . . . 0.39 110.171 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -110.9 140.3 45.49 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.577 -0.702 . . . . 0.02 109.622 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -122.71 138.64 54.55 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.282 -0.886 . . . . 0.02 109.591 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -69.42 -27.28 65.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.01 -1.056 . . . . 0.03 111.76 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.12 169.73 8.8 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.896 -1.128 . . . . 0.03 110.127 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -75.44 158.43 32.67 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.571 0.701 . . . . 0.03 110.196 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 m120 66.19 33.38 7.38 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.907 0.861 . . . . 0.74 111.093 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.32 42.14 30.54 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.223 0.535 . . . . 0.02 111.136 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -113.28 165.75 12.12 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.274 -1.01 . . . . 0.02 108.274 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.08 -167.9 34.9 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.872 -1.156 . . . . 0.03 110.576 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -69.17 142.5 54.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.382 -1.069 . . . . 2.76 108.928 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -122.66 151.21 41.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.586 -0.696 . . . . 1.89 110.181 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -136.83 132.77 35.11 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.193 -0.669 . . . . 0.02 109.193 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 6.6 p30 -108.38 135.93 48.87 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.369 -0.975 . . . . 1.12 108.369 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 13.9 t -127.37 137.5 52.79 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.585 -0.697 . . . . 0.02 109.981 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.75 11.03 11.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.673 -0.642 . . . . 0.2 110.808 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.526 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 25.0 p -159.71 173.43 16.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.574 -1.329 . . . . 1.23 109.34 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -63.1 145.54 55.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.428 -1.42 . . . . 0.02 110.801 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.7 m -135.12 119.21 17.55 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.925 -0.769 . . . . 0.02 108.925 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.98 -20.83 51.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.35 -0.844 . . . . 0.24 112.269 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -153.53 106.64 2.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.748 -1.22 . . . . 1.14 110.034 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.64 6.49 39.7 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.4 -0.813 . . . . 6.37 110.401 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.96 -29.32 69.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 3.11 112.063 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.0 m -77.01 -17.23 58.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.389 -1.445 . . . . 0.88 111.126 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -106.57 -21.09 13.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.454 -0.779 . . . . 0.02 110.555 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -149.28 127.57 12.15 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.966 -1.083 . . . . 3.32 109.62 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.8 t -87.47 -12.58 45.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.461 -0.774 . . . . 0.02 111.267 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -172.23 161.75 5.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.02 108.41 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.8 t -143.78 117.6 9.32 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.974 -1.079 . . . . 0.02 109.201 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -109.56 0.0 18.96 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.746 -1.222 . . . . 0.03 111.691 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 22.3 m -155.54 153.97 31.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.005 -1.059 . . . . 0.02 108.475 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 39' ' ' ILE . 12.8 mt -145.88 146.56 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.011 -1.055 . . . . 0.02 110.848 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -123.19 124.17 42.43 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.808 -1.182 . . . . 0.02 107.808 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.1 t -105.29 113.72 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.829 -1.545 . . . . 0.02 106.829 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -85.14 -34.66 22.09 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.997 -0.681 . . . . 3.81 110.139 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.44 149.2 17.04 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.602 -1.761 . . . . 0.02 110.824 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.78 172.16 48.61 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.332 -1.107 . . . . 0.01 110.332 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -117.79 134.01 55.36 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.39 -1.337 . . . . 1.48 107.39 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -126.29 154.49 43.35 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.555 1.169 . . . . 0.02 112.495 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.0 133.3 53.17 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.57 -2.011 . . . . 0.24 105.57 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.1 141.31 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.544 -0.723 . . . . 0.65 109.154 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -120.16 143.08 48.41 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.128 0.966 . . . . 0.02 109.651 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.02 -34.09 77.6 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.641 -0.708 . . . . 0.02 111.755 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -124.49 157.78 63.98 Favored Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 120.939 -1.101 . . . . 0.02 109.615 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.26 166.56 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.733 1.622 . . . . 0.02 112.704 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 63.52 36.61 11.04 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.344 -0.843 . . . . 0.02 111.118 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.451 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.8 m-85 44.98 51.42 8.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.744 0.783 . . . . 3.39 110.691 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 m -125.4 163.22 23.08 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.206 0.527 . . . . 2.33 109.783 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.95 -162.07 31.0 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.599 -1.4 . . . . 0.02 109.599 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 8.3 t-80 -67.4 139.86 57.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.947 -1.325 . . . . 0.02 110.138 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 20.4 ptm -119.22 137.86 53.36 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.472 0.653 . . . . 5.01 109.978 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 79.8 m-85 -133.92 139.85 46.42 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.465 -0.772 . . . . 0.02 109.744 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.34 132.29 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 N-CA-C 108.523 -0.917 . . . . 1.72 108.523 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.446 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.0 mt -122.48 112.6 31.06 Favored Pre-proline 0 N--CA 1.506 2.357 0 O-C-N 121.414 -0.804 . . . . 0.02 110.644 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.45 170.73 18.84 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 119.821 0.972 . . . . 1.47 110.415 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -53.12 140.33 26.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.951 -1.093 . . . . 4.25 110.534 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.49 -178.18 32.25 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.38 -1.39 . . . . 0.02 110.8 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -119.72 131.23 55.33 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.362 -1.081 . . . . 0.96 109.896 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.446 ' CE1' HD22 ' A' ' 61' ' ' LEU . 95.4 m-85 -121.5 97.91 46.6 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 107.726 -1.212 . . . . 0.02 107.726 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 38' ' ' SER . 7.9 Cg_endo -70.64 -3.44 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 120.743 0.962 . . . . 0.02 113.761 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -157.38 154.87 29.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.54 -1.35 . . . . 2.02 108.136 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -59.69 -39.4 84.42 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.531 -0.731 . . . . 0.02 111.766 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -59.89 -24.15 64.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.02 110.474 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -70.43 -18.38 63.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.4 -0.812 . . . . 3.42 108.846 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 2.1 t90 -107.78 10.2 28.82 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.535 -1.283 . . . . 0.02 107.535 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 10.0 mmt 60.63 22.66 12.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 0.02 110.322 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.68 144.88 47.91 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.542 -1.423 . . . . 0.02 109.542 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 mt -79.99 -30.54 39.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -1.175 . . . . 0.98 107.946 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -157.05 -171.49 3.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.43 -1.692 . . . . 0.02 106.43 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -99.03 28.78 4.18 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.645 -1.284 . . . . 0.02 110.815 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -96.65 122.82 40.0 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.826 -1.171 . . . . 3.2 111.146 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.51 HD21 ' CH2' ' A' ' 72' ' ' TRP . 80.8 mt -141.39 118.8 11.49 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.551 -1.277 . . . . 2.61 107.551 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.55 -18.96 9.09 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 121.193 -0.942 . . . . 0.02 112.474 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.451 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 11.2 t -156.09 156.41 34.28 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 119.763 1.782 . . . . 0.02 111.028 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.6 p -145.85 147.83 32.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.421 -0.799 . . . . 0.02 110.501 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.422 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 49.2 mtp180 -137.14 142.04 42.25 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.511 -0.743 . . . . 0.01 109.111 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.29 131.26 36.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.129 -0.982 . . . . 0.43 109.505 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 t -90.4 124.61 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.561 -0.903 . . . . 1.25 108.561 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -92.91 131.58 37.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.071 . . . . 1.77 108.571 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.32 139.57 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.13 -1.063 . . . . 1.63 108.13 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.5 p -110.8 126.09 54.26 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.674 -0.861 . . . . 1.08 108.674 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.0 t -102.66 -154.8 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.029 -1.841 . . . . 1.26 106.029 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.29 -49.36 0.89 Allowed Glycine 0 N--CA 1.497 2.754 0 O-C-N 120.473 -1.392 . . . . 0.01 111.952 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.66 -99.33 0.13 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.64 -1.743 . . . . 0.01 112.085 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -121.05 120.67 36.03 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.262 -1.14 . . . . 4.43 110.702 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.478 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.34 135.75 54.81 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.47 -0.567 . . . . 2.99 109.47 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.484 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 2.7 ttmp? -134.54 130.59 36.81 Favored 'General case' 0 N--CA 1.519 2.981 0 CA-C-O 122.187 0.994 . . . . 6.36 112.936 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -132.44 141.61 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 115.62 -0.718 . . . . 1.09 110.627 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.508 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 pm0 -124.56 140.04 53.31 Favored 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 107.568 -1.271 . . . . 2.05 107.568 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.2 m -123.45 146.96 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 O-C-N 120.664 -1.272 . . . . 1.1 111.236 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 24.0 m-85 -120.17 139.72 52.2 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.035 0.922 . . . . 0.73 110.804 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.6 -32.81 71.75 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.77 -0.65 . . . . 0.02 112.304 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' O ' ' OG ' ' A' ' 128' ' ' SER . 41.0 mmtm -113.89 165.14 12.88 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.866 -1.146 . . . . 3.18 110.059 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.93 163.06 45.11 Favored Glycine 0 N--CA 1.492 2.374 0 CA-C-O 122.034 0.797 . . . . 0.01 111.306 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.22 39.58 28.62 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.567 0.698 . . . . 0.01 111.108 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 52.5 55.69 8.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.57 -0.706 . . . . 0.01 111.036 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -128.75 164.89 22.01 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.943 -1.132 . . . . 3.15 107.943 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.23 -162.67 28.53 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.269 -1.532 . . . . 0.01 109.269 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -75.79 142.17 42.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.93 -1.336 . . . . 0.01 109.211 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.529 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.7 ttp -116.69 143.48 45.58 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.593 0.711 . . . . 0.01 109.543 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -132.25 136.33 46.9 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.252 -1.018 . . . . 2.48 108.252 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -116.49 134.32 54.99 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.619 -0.675 . . . . 0.01 109.791 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 t -149.48 148.35 29.3 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.492 1.139 . . . . 1.69 111.578 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.7 p -115.34 7.46 15.13 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.998 -1.001 . . . . 0.01 109.961 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -122.31 163.42 19.73 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.448 -0.783 . . . . 3.21 111.043 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.29 154.86 41.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.439 -0.788 . . . . 0.01 109.624 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.5 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 59.4 m -128.61 115.94 19.55 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.913 -0.773 . . . . 0.01 108.913 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.09 -30.89 6.57 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 CA-C-N 120.316 1.149 . . . . 0.01 111.56 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.7 p -142.61 108.25 5.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.289 -0.882 . . . . 0.02 109.115 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.5 -39.31 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.773 -0.58 . . . . 1.83 111.062 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 15.0 tpt -66.89 -37.76 85.0 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.035 -1.066 . . . . 1.34 109.856 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.69 -38.66 77.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.504 -1.372 . . . . 2.11 109.887 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -80.41 -47.62 14.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.169 -0.957 . . . . 2.08 112.472 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -111.03 -0.82 16.53 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.283 -0.886 . . . . 0.02 112.728 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 59.79 33.73 21.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.822 -1.174 . . . . 0.02 109.487 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' C ' ' SD ' ' A' ' 118' ' ' MET . 6.3 mt -112.69 135.54 53.31 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 108.737 -0.838 . . . . 0.02 108.737 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -92.37 -23.18 19.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.302 -0.874 . . . . 5.32 110.623 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -148.96 163.44 37.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.077 -1.015 . . . . 0.02 110.121 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.6 mt -131.97 129.45 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.55 -1.278 . . . . 2.17 107.55 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -106.65 -13.65 15.23 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.206 -0.934 . . . . 0.02 113.185 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -157.04 155.68 31.59 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.35 -1.468 . . . . 0.01 108.237 177.606 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.4 t -164.28 145.86 8.58 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.482 -1.386 . . . . 1.22 109.567 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.43 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 27.6 mtmt -121.35 112.14 18.21 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.443 1.116 . . . . 1.41 108.905 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.2 t -107.41 122.52 61.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 105.372 -2.085 . . . . 0.01 105.372 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -145.9 67.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 118.153 -1.419 . . . . 1.98 108.133 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.01 108.29 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.563 -1.643 . . . . 0.01 106.563 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.86 -174.53 42.95 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.186 -1.165 . . . . 0.01 110.186 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.72 144.12 40.16 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.472 -1.016 . . . . 2.3 109.036 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.478 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 65.6 m95 -129.82 145.59 51.57 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.366 -0.834 . . . . 0.01 110.294 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.7 mt -117.92 141.86 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.667 -1.234 . . . . 1.69 107.667 178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.58 143.45 44.97 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 107.521 -1.289 . . . . 2.49 107.521 177.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 8.4 m-85 -122.59 144.24 49.24 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.005 -0.739 . . . . 0.02 109.005 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.49 -29.85 62.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.722 -0.611 . . . . 0.02 111.905 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.33 153.63 47.5 Favored Pre-proline 0 N--CA 1.505 2.279 0 O-C-N 120.604 -1.31 . . . . 1.48 109.187 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.9 167.03 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.225 1.284 . . . . 0.02 112.481 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 59.64 31.12 20.72 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.119 -0.946 . . . . 0.75 111.052 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.2 m-85 58.16 51.55 8.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.547 -0.72 . . . . 0.02 111.026 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -125.1 163.73 21.76 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.435 -0.791 . . . . 0.02 109.843 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.65 -165.6 32.34 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.951 -1.26 . . . . 0.02 109.951 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -67.7 141.32 56.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.425 -1.044 . . . . 0.02 108.883 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -118.65 147.95 43.24 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.424 -0.584 . . . . 0.02 109.424 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 2.5 t80 -129.9 143.87 51.03 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.836 -0.802 . . . . 0.01 108.836 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.612 HD23 ' N ' ' A' ' 151' ' ' LEU . 1.7 tt -98.3 122.53 41.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.414 -0.804 . . . . 0.01 109.528 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.612 ' N ' HD23 ' A' ' 150' ' ' LEU . 17.0 mt -104.29 135.95 44.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.499 -0.75 . . . . 0.01 109.982 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 154' ' ' LYS . 30.0 t70 -108.61 174.47 5.86 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.221 -1.029 . . . . 2.27 108.221 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -59.38 83.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.883 -1.135 . . . . 1.84 108.439 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 152' ' ' ASP . 66.6 mttm -136.53 172.09 13.53 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.257 -0.902 . . . . 2.28 111.696 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -113.62 110.12 19.7 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.423 -0.955 . . . . 0.01 108.423 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.68 114.61 28.48 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.019 -1.051 . . . . 0.01 109.876 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -93.69 -25.07 17.62 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.072 -1.018 . . . . 0.01 111.668 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -126.2 153.5 74.38 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.855 -1.153 . . . . 2.54 108.987 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.15 -42.7 33.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 119.247 0.767 . . . . 0.7 110.713 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.67 -20.58 21.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.732 -1.23 . . . . 0.86 108.557 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -64.95 -15.81 62.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.978 -1.076 . . . . 0.02 109.383 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.612 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -95.46 9.97 38.13 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.971 -1.122 . . . . 0.02 107.971 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.73 11.41 84.55 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.173 -1.489 . . . . 0.02 109.648 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.98 142.43 31.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.453 -1.028 . . . . 0.02 110.266 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.62 -8.21 58.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.758 -0.589 . . . . 0.59 110.022 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.3 p -144.9 150.93 47.88 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.726 -1.234 . . . . 0.87 108.819 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.37 21.58 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.833 1.022 . . . . 0.38 112.397 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.85 124.31 30.19 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.612 1.196 . . . . 0.18 111.631 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.1 mt -147.51 127.23 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.796 -1.557 . . . . 3.99 106.796 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -112.38 -19.08 12.31 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.187 -0.945 . . . . 5.17 112.865 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.6 p -158.37 161.28 37.55 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.147 -2.221 . . . . 0.02 110.271 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.5 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 9.5 p90 -152.55 153.69 33.92 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.168 -0.958 . . . . 2.02 110.496 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 21.5 mtp180 -143.58 151.0 39.66 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.267 -0.896 . . . . 0.01 110.412 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -87.64 142.33 27.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.01 109.188 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.1 mt -92.98 128.24 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.133 -0.979 . . . . 3.04 109.019 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.07 146.58 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.257 -0.902 . . . . 1.89 109.592 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 4.89 109.404 179.948 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.273 -1.531 . . . . 0.01 109.273 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -149.23 136.91 20.35 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.095 -1.238 . . . . 0.02 110.168 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -130.23 141.14 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.201 -0.666 . . . . 0.02 109.201 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.8 t -121.3 129.92 53.37 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.523 -0.736 . . . . 0.39 110.0 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -110.36 140.23 44.77 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.159 -0.682 . . . . 0.02 109.159 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.9 m-85 -122.67 138.71 54.52 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.105 -0.997 . . . . 0.02 109.512 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.431 ' OE2' ' NH2' ' A' ' 18' ' ' ARG . 78.5 mt-10 -68.93 -27.27 65.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.075 -1.016 . . . . 0.03 111.693 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.31 170.28 8.41 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.902 -1.124 . . . . 0.03 110.034 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -74.93 161.79 29.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.698 0.761 . . . . 0.03 110.149 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 23.4 t30 62.42 35.06 15.1 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.898 0.856 . . . . 0.74 110.594 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.69 43.2 24.32 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.396 -0.82 . . . . 0.02 111.084 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -109.73 165.82 11.39 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.827 -1.175 . . . . 0.02 107.827 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.29 -168.16 34.84 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.83 -1.176 . . . . 0.03 110.663 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.431 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 25.9 ttp180 -69.16 143.5 54.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -1.102 . . . . 2.76 108.962 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.422 ' NH1' ' OD2' ' A' ' 21' ' ' ASP . 5.3 tmm_? -123.54 151.22 43.09 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.541 -0.725 . . . . 1.89 110.353 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -136.6 133.03 35.89 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.252 -0.647 . . . . 0.02 109.252 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.422 ' OD2' ' NH1' ' A' ' 19' ' ' ARG . 50.8 m-20 -109.64 136.32 49.19 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.911 -0.774 . . . . 1.12 108.911 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.1 t -127.83 137.74 52.47 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.659 -0.65 . . . . 0.02 109.704 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -118.61 11.41 12.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.726 -0.609 . . . . 0.2 110.157 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.5 p -159.68 173.7 15.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.848 -1.158 . . . . 1.23 109.066 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.87 145.63 54.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.842 -1.162 . . . . 0.02 110.629 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.591 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 11.6 p -135.04 119.69 18.21 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 109.004 -0.739 . . . . 0.02 109.004 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.39 -20.68 50.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.261 -0.9 . . . . 0.24 112.275 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -152.89 107.12 3.12 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.812 -1.18 . . . . 1.14 110.049 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.591 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.12 5.63 40.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.315 -0.865 . . . . 6.37 110.309 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -61.22 -30.13 70.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 3.11 112.133 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 p -76.69 -17.72 58.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.466 -1.396 . . . . 0.88 111.062 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -106.79 -21.13 13.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.392 -0.817 . . . . 0.02 110.655 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 tp -148.65 126.61 11.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.901 -1.124 . . . . 3.32 109.556 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.2 t -87.01 -12.83 46.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.519 -0.738 . . . . 0.02 111.053 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -172.72 162.16 4.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.858 -1.151 . . . . 0.02 108.403 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.452 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.2 p -143.83 116.52 8.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.068 -1.02 . . . . 0.02 108.824 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -108.38 -0.42 20.64 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.755 -1.216 . . . . 0.03 111.203 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 t -155.36 153.46 30.5 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.856 -1.165 . . . . 0.02 107.856 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.8 mt -146.83 148.05 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.102 -0.999 . . . . 0.02 110.49 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -123.92 124.72 43.23 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.02 -1.104 . . . . 0.02 108.02 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.3 t -105.3 114.06 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.691 -1.596 . . . . 0.02 106.691 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -85.41 -34.92 21.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.447 -0.783 . . . . 3.81 110.178 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.49 149.03 16.65 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 118.523 -1.799 . . . . 0.02 110.864 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.7 172.32 48.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.197 -1.161 . . . . 0.01 110.197 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.0 m -117.67 134.09 55.26 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.494 -1.299 . . . . 1.48 107.494 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -126.68 154.52 43.97 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.541 1.162 . . . . 0.02 112.192 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.37 134.06 52.29 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 105.502 -2.036 . . . . 0.24 105.502 176.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.9 m -116.07 141.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.56 -0.712 . . . . 0.65 109.292 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -120.3 142.99 48.6 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.062 0.934 . . . . 0.02 109.624 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -65.21 -34.36 78.2 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.491 -0.777 . . . . 0.02 111.904 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -124.44 158.02 63.02 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.091 -1.006 . . . . 0.02 109.495 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.04 166.55 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.642 1.561 . . . . 0.02 112.806 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 63.11 37.17 11.67 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.373 -0.83 . . . . 0.02 111.135 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.3 m-85 45.1 51.69 8.84 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.62 0.724 . . . . 3.39 110.834 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 t -125.89 163.62 22.55 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.12 0.486 . . . . 2.33 109.95 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.52 -161.89 31.44 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.926 -1.27 . . . . 0.02 109.926 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -64.34 138.51 58.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.996 -1.297 . . . . 0.02 110.224 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 58' ' ' MET . 12.3 tmm? -119.12 137.17 53.77 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.519 -0.549 . . . . 5.01 109.519 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 86.4 m-85 -135.01 139.84 45.18 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.526 -0.733 . . . . 0.02 109.943 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.8 mm -94.37 130.48 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.903 -0.777 . . . . 1.72 108.903 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.558 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.73 110.86 34.89 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.386 -0.821 . . . . 0.02 110.752 -178.513 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.9 169.23 20.93 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 CA-C-N 119.793 0.962 . . . . 1.47 110.415 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -53.78 140.64 29.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.959 -1.088 . . . . 4.25 110.767 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.04 -177.46 32.27 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.507 -1.33 . . . . 0.02 110.722 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -119.47 131.09 55.54 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.39 -1.065 . . . . 0.96 109.659 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.558 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 78.0 m-85 -120.99 97.85 47.86 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 107.914 -1.143 . . . . 0.02 107.914 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -69.86 -4.52 14.26 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 120.679 0.919 . . . . 0.02 113.686 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -157.47 154.06 28.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.614 -1.304 . . . . 2.02 107.992 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -59.81 -38.03 80.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.379 -0.826 . . . . 0.02 111.871 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -59.79 -24.46 64.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.02 110.446 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -69.75 -19.0 63.55 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.756 0.789 . . . . 3.42 108.894 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.19 10.38 27.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.601 -1.259 . . . . 0.02 107.601 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.2 mmm 60.52 22.55 12.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.597 -0.689 . . . . 0.02 110.381 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.55 144.94 47.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.534 -1.427 . . . . 0.02 109.534 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.5 mt -79.51 -30.73 42.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -1.215 . . . . 0.98 108.013 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -157.42 -171.4 3.58 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.463 -1.68 . . . . 0.02 106.463 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 14.3 p30 -98.6 28.66 4.08 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.692 -1.255 . . . . 0.02 110.64 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -97.83 122.88 41.46 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.875 -1.141 . . . . 3.2 111.435 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.452 HD12 ' SG ' ' A' ' 36' ' ' CYS . 57.4 mt -142.66 120.06 11.64 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.298 -1.371 . . . . 2.61 107.298 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.46 -17.99 10.75 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 121.251 -0.905 . . . . 0.02 112.295 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 22.6 t -155.79 156.15 34.27 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 119.591 1.696 . . . . 0.02 110.845 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.5 t -145.65 147.92 32.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.02 110.161 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 17.6 mtp180 -136.88 141.73 42.76 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.461 -0.774 . . . . 0.01 109.023 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.38 131.5 36.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.203 -0.936 . . . . 0.43 109.269 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.54 124.34 43.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.816 -0.809 . . . . 1.25 108.816 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -92.47 131.91 37.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.826 -1.171 . . . . 1.77 108.737 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.36 138.5 33.86 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.127 -1.064 . . . . 1.63 108.127 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.4 p -110.67 126.65 54.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.357 -0.839 . . . . 1.08 108.757 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 t -103.15 -154.54 0.5 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 106.114 -1.81 . . . . 1.26 106.114 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.63 -50.31 0.86 Allowed Glycine 0 N--CA 1.498 2.799 0 O-C-N 120.456 -1.403 . . . . 0.01 112.066 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.47 -99.77 0.13 Allowed Glycine 0 N--CA 1.487 2.068 0 C-N-CA 118.683 -1.722 . . . . 0.01 112.212 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -120.51 119.54 33.27 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.261 -1.141 . . . . 4.43 110.635 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.507 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.8 136.39 55.38 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.302 -0.559 . . . . 2.99 109.588 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -134.85 130.93 36.76 Favored 'General case' 0 N--CA 1.518 2.942 0 CA-C-O 122.182 0.992 . . . . 6.36 112.65 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.5 141.96 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.527 -0.76 . . . . 1.09 110.409 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 3.5 pm0 -124.68 140.34 53.03 Favored 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 107.573 -1.269 . . . . 2.05 107.573 176.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.87 146.2 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 O-C-N 120.618 -1.301 . . . . 1.1 110.882 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.537 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 25.4 m-85 -119.93 139.96 51.64 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 122.347 1.07 . . . . 0.73 110.799 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.97 -32.26 72.55 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.639 -0.709 . . . . 0.02 111.694 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -114.5 167.31 10.84 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.109 -0.994 . . . . 3.18 110.321 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.45 164.39 52.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 111.147 -0.781 . . . . 0.01 111.147 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 57.82 38.95 27.36 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.554 0.692 . . . . 0.01 111.641 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 52.27 54.58 10.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.41 -0.806 . . . . 0.01 111.241 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 24.7 t30 -129.6 165.21 22.21 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.992 -1.114 . . . . 3.15 107.992 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 90.94 -162.61 28.85 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.975 -1.65 . . . . 0.01 108.975 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -76.22 141.61 41.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.841 -1.388 . . . . 0.01 109.078 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.537 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.4 ttp -116.66 143.54 45.51 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.553 0.692 . . . . 0.01 109.61 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -132.28 136.23 46.79 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -116.02 134.29 55.12 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.748 -0.595 . . . . 0.01 109.754 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -149.34 148.28 29.33 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.626 1.203 . . . . 1.69 111.501 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -115.44 7.38 14.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.872 -1.058 . . . . 0.01 109.938 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -122.38 163.35 19.94 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.391 -0.818 . . . . 3.21 111.307 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -69.69 154.33 42.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.898 . . . . 0.01 109.665 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.425 ' O ' ' OG ' ' A' ' 171' ' ' SER . 40.8 t -126.74 115.56 22.55 Favored Pre-proline 0 N--CA 1.501 2.104 0 N-CA-C 109.192 -0.67 . . . . 0.01 109.192 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.2 -32.63 5.01 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 120.358 1.164 . . . . 0.01 111.418 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 p -142.35 108.42 5.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.294 -0.879 . . . . 0.02 109.125 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.44 -39.73 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.825 -0.547 . . . . 1.83 111.099 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.7 ttt -66.95 -37.5 84.4 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.107 -1.037 . . . . 1.34 109.853 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.84 -38.57 76.54 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.559 -1.338 . . . . 2.11 109.792 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -80.2 -47.55 14.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 2.08 112.472 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.36 -0.88 16.19 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.334 -0.854 . . . . 0.02 112.727 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.4 m80 60.28 33.77 20.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.808 -1.182 . . . . 0.02 109.48 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.7 mt -112.53 135.16 53.57 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 108.62 -0.882 . . . . 0.02 108.62 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -92.29 -23.23 19.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.354 -0.841 . . . . 5.32 110.565 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -148.97 163.57 37.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.166 -0.959 . . . . 0.02 110.008 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.2 mt -131.61 129.11 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 107.417 -1.327 . . . . 2.17 107.417 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -107.16 -13.38 15.17 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.192 -0.943 . . . . 0.02 113.246 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.29 153.35 30.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.306 -1.496 . . . . 0.01 108.287 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.4 t -162.34 145.06 11.28 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.326 -1.484 . . . . 1.22 109.737 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.434 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 27.0 ttmt -122.29 111.53 17.03 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.3 1.048 . . . . 1.41 108.892 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.9 t -107.51 122.62 62.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.661 -1.977 . . . . 0.01 105.661 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -146.58 67.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 118.125 -1.43 . . . . 1.98 108.222 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.69 109.04 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.597 -1.631 . . . . 0.01 106.597 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.7 -174.28 39.64 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.711 -1.356 . . . . 0.01 109.711 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.506 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.3 m -112.4 144.47 41.78 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.372 -1.076 . . . . 2.3 109.349 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.507 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.4 m95 -129.89 146.2 51.61 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.43 -0.794 . . . . 0.01 110.392 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.6 mt -118.06 142.12 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 107.668 -1.234 . . . . 1.69 107.668 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.67 143.92 44.27 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 107.736 -1.209 . . . . 2.49 107.736 177.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.8 m-85 -122.53 143.52 49.67 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.966 -0.753 . . . . 0.02 108.966 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -73.02 -29.52 63.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.575 -0.703 . . . . 0.02 112.005 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.58 153.58 47.8 Favored Pre-proline 0 N--CA 1.505 2.323 0 O-C-N 120.614 -1.304 . . . . 1.48 109.198 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.58 167.05 1.57 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.359 1.372 . . . . 0.02 112.606 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 59.56 31.21 20.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.063 -0.971 . . . . 0.75 110.993 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.61 51.32 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.449 -0.782 . . . . 0.02 111.045 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -124.77 163.78 21.39 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.466 -0.771 . . . . 0.02 109.838 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.77 -165.65 32.22 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.873 -1.291 . . . . 0.02 109.873 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -67.53 141.38 56.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.564 -0.962 . . . . 0.02 109.042 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -117.9 148.4 42.18 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.28 -0.637 . . . . 0.02 109.28 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.64 142.92 50.64 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.041 -0.726 . . . . 0.01 109.041 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.636 ' C ' HD23 ' A' ' 150' ' ' LEU . 6.0 tt -97.41 121.84 39.78 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.283 -0.886 . . . . 0.01 109.485 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.656 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.5 mt -104.98 133.33 49.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.472 -0.767 . . . . 0.01 110.321 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 5.3 p-10 -107.69 173.19 6.43 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.253 -1.017 . . . . 2.27 108.253 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -57.97 84.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.972 -1.08 . . . . 1.84 108.621 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 11.4 tptp -136.34 168.31 19.67 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.327 -0.858 . . . . 2.28 111.068 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 5.3 mp0 -111.09 109.78 20.02 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.325 -0.991 . . . . 0.01 108.325 178.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.37 115.69 30.58 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.087 -1.008 . . . . 0.01 109.904 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -94.05 -25.49 17.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.99 -1.069 . . . . 0.01 111.375 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -125.85 153.92 73.48 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.958 -1.089 . . . . 2.54 109.008 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.03 -42.66 35.02 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 119.144 0.73 . . . . 0.7 110.64 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.73 -20.42 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.638 -1.289 . . . . 0.86 108.433 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -65.41 -15.75 62.92 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.961 -1.087 . . . . 0.02 109.425 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.656 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -95.21 9.72 38.69 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.943 -1.132 . . . . 0.02 107.943 178.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.49 11.04 85.49 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.204 -1.474 . . . . 0.02 109.607 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.94 142.26 31.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.382 -1.07 . . . . 0.02 110.204 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.41 -8.49 58.96 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.728 -0.608 . . . . 0.59 109.886 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 16.5 p -144.46 150.78 48.92 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 120.849 -1.157 . . . . 0.87 108.731 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.16 21.55 0.52 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.73 0.953 . . . . 0.38 112.376 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.78 123.98 29.84 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.5 1.143 . . . . 0.18 111.705 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.0 mt -147.07 126.92 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 106.92 -1.511 . . . . 3.99 106.92 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -113.46 -19.22 11.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.142 -0.974 . . . . 5.17 112.853 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 32.6 t -157.15 159.88 38.22 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 119.142 -2.224 . . . . 0.02 110.376 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -152.92 154.08 34.31 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.044 -1.035 . . . . 2.02 110.7 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -144.62 151.69 39.38 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.304 -0.872 . . . . 0.01 110.58 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -87.69 142.94 27.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.564 -0.71 . . . . 0.01 109.254 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.2 128.21 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.998 -1.064 . . . . 3.04 109.099 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -136.07 146.46 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.218 -0.927 . . . . 1.89 109.631 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 4.89 109.446 179.903 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.267 -1.533 . . . . 0.01 109.267 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -147.49 135.98 21.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.133 -1.216 . . . . 0.02 110.039 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.9 tt -130.58 140.09 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.218 -0.66 . . . . 0.02 109.218 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t -121.65 130.28 53.37 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.291 -0.88 . . . . 0.39 110.077 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -110.24 139.62 45.22 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.652 -0.655 . . . . 0.02 109.397 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.3 m-85 -121.42 138.03 54.45 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.209 -0.932 . . . . 0.02 109.698 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -69.47 -27.52 65.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.842 -1.162 . . . . 0.03 111.594 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -114.16 169.79 8.76 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.752 -1.217 . . . . 0.03 110.179 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.516 ' NH2' ' OE1' ' A' ' 68' ' ' GLU . 49.9 mtp180 -75.67 158.65 32.09 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.629 0.728 . . . . 0.03 110.121 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.41 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 8.2 t-20 65.75 33.71 8.03 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.016 0.912 . . . . 0.74 111.072 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.52 41.74 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.974 -0.557 . . . . 0.02 111.306 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -113.69 165.57 12.4 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.265 -1.013 . . . . 0.02 108.265 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.8 -167.43 34.92 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.887 -1.149 . . . . 0.03 110.711 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -68.24 141.51 55.9 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.554 -0.968 . . . . 2.76 109.046 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -122.52 150.15 42.95 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.572 -0.705 . . . . 1.89 109.87 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -137.21 133.16 34.83 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.205 -0.665 . . . . 0.02 109.205 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -108.74 136.05 48.96 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.748 -0.834 . . . . 1.12 108.748 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 17.1 t -127.64 137.31 52.49 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.572 -0.705 . . . . 0.02 110.02 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 p30 -119.89 11.57 11.85 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.702 -0.624 . . . . 0.2 110.704 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.527 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 32.4 t -159.64 173.22 16.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.709 -1.245 . . . . 1.23 109.262 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -62.8 145.25 55.38 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.489 -1.382 . . . . 0.02 110.611 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 m -135.23 119.48 17.76 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.51 -0.744 . . . . 0.02 109.035 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.66 -20.52 50.07 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.581 -0.699 . . . . 0.24 112.325 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 8.9 p-10 -153.35 106.39 2.95 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.541 -1.349 . . . . 1.14 110.103 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.8 6.59 36.76 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.242 -0.911 . . . . 6.37 110.461 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -60.58 -28.77 68.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.853 . . . . 3.11 111.891 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.9 p -76.69 -16.77 59.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.465 -1.397 . . . . 0.88 111.021 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -105.89 -21.62 13.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.329 -0.857 . . . . 0.02 110.624 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.9 mt -148.66 127.67 12.76 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.093 -1.005 . . . . 3.32 109.309 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -85.9 -11.01 54.31 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.728 -0.607 . . . . 0.02 110.254 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -171.85 161.85 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.144 -1.058 . . . . 0.02 108.144 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 t -143.24 116.41 8.95 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.0 -1.063 . . . . 0.02 108.566 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.582 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 1.7 m120 -109.77 -0.82 18.28 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 120.789 -1.194 . . . . 0.03 112.049 -177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 t -154.93 153.69 31.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.014 -1.053 . . . . 0.02 108.3 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 39' ' ' ILE . 11.9 mt -146.17 147.81 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.104 -0.998 . . . . 0.02 110.716 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -124.86 124.86 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.676 -1.231 . . . . 0.02 107.676 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.1 t -105.69 114.13 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.928 -1.508 . . . . 0.02 106.928 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -85.33 -34.49 21.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.548 -0.72 . . . . 3.81 110.216 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.33 148.97 16.65 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.592 -1.766 . . . . 0.02 110.807 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.67 172.31 48.78 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.287 -1.125 . . . . 0.01 110.287 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.9 m -118.12 134.5 54.94 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.505 -1.295 . . . . 1.48 107.505 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -126.73 154.16 44.54 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.516 1.15 . . . . 0.02 112.33 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.57 133.62 52.45 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.29 -2.115 . . . . 0.24 105.29 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -117.32 142.49 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 0.65 109.173 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.513 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 31.9 m-85 -120.62 144.87 47.9 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.262 1.029 . . . . 0.02 110.024 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.21 -33.61 76.16 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.773 -0.649 . . . . 0.02 111.526 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -124.63 157.96 63.75 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 121.065 -1.022 . . . . 0.02 109.551 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.81 166.9 1.22 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.788 1.659 . . . . 0.02 112.794 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 63.58 36.68 10.87 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.344 -0.844 . . . . 0.02 110.968 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 45.11 51.48 8.96 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.562 0.696 . . . . 3.39 110.78 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.3 m -125.91 163.53 22.76 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.206 0.526 . . . . 2.33 109.918 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.78 -162.31 31.38 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.738 -1.345 . . . . 0.02 109.738 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -64.8 138.48 58.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.35 . . . . 0.02 110.04 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.513 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 60.0 ttp -118.3 137.88 52.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.324 0.583 . . . . 5.01 109.514 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.606 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.2 m-85 -134.98 139.33 44.81 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.469 -0.769 . . . . 0.02 109.882 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.3 130.53 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.875 -0.787 . . . . 1.72 108.875 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.91 110.6 34.82 Favored Pre-proline 0 N--CA 1.504 2.265 0 O-C-N 121.43 -0.794 . . . . 0.02 110.876 -178.341 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.54 169.39 21.09 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 CA-C-N 119.722 0.936 . . . . 1.47 110.317 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -53.69 140.78 28.35 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.924 -1.11 . . . . 4.25 110.562 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.42 -177.15 32.76 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.47 -1.348 . . . . 0.02 110.634 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -119.41 130.6 55.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.459 -1.024 . . . . 0.96 109.686 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 71.1 m-85 -121.83 95.15 47.96 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.297 -1.001 . . . . 0.02 108.297 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.31 -3.57 10.19 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 120.978 1.118 . . . . 0.02 114.221 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' NH2' ' A' ' 13' ' ' ARG . 38.2 mt-10 -157.96 155.08 28.85 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.479 -1.388 . . . . 2.02 108.311 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -60.08 -38.78 83.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.594 -0.691 . . . . 0.02 112.035 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -59.7 -23.74 63.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.052 -1.03 . . . . 0.02 110.091 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -70.31 -19.11 63.1 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.774 0.797 . . . . 3.42 108.938 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.606 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -108.36 10.75 27.5 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.517 -1.29 . . . . 0.02 107.517 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 73' ' ' MET . 2.1 mpt? 59.65 23.88 12.69 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.478 0.656 . . . . 0.02 110.563 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.0 144.86 46.5 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.785 -1.326 . . . . 0.02 109.785 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.13 -30.73 39.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -1.219 . . . . 0.98 107.875 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -157.16 -171.93 3.82 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.413 -1.699 . . . . 0.02 106.413 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.582 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 78.4 m-20 -97.98 27.92 4.25 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.642 -1.286 . . . . 0.02 110.83 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -96.71 122.54 39.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.805 -1.184 . . . . 3.2 111.102 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.528 HD21 ' CH2' ' A' ' 72' ' ' TRP . 86.0 mt -141.38 118.42 11.24 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.449 -1.315 . . . . 2.61 107.449 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.49 -18.27 9.79 Favored Glycine 0 N--CA 1.501 2.997 0 O-C-N 120.992 -1.067 . . . . 0.02 112.463 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.8 p -156.25 156.01 33.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.352 -1.675 . . . . 0.02 110.351 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.0 m -145.14 148.28 33.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.749 -0.594 . . . . 0.02 109.923 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -137.15 141.75 42.22 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.456 -0.778 . . . . 0.01 109.304 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.16 132.24 36.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.106 -0.996 . . . . 0.43 109.434 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.87 124.48 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.69 -0.856 . . . . 1.25 108.69 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -90.72 133.2 35.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.868 -1.145 . . . . 1.77 108.287 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.17 139.18 36.21 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.851 -0.796 . . . . 1.63 108.851 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 p -110.58 123.78 50.62 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.072 -1.085 . . . . 1.08 108.072 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.4 p -114.99 132.46 56.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.746 -1.221 . . . . 1.26 107.818 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.73 -47.98 0.01 OUTLIER Glycine 0 N--CA 1.503 3.1 0 C-N-CA 117.704 -2.189 . . . . 0.01 113.44 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.16 -103.39 0.17 Allowed Glycine 0 N--CA 1.488 2.129 0 CA-C-N 120.045 1.923 . . . . 0.01 110.927 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -119.13 118.2 30.73 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.16 -1.2 . . . . 4.43 110.179 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.0 135.92 55.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.769 -0.582 . . . . 2.99 109.491 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -134.86 130.06 35.39 Favored 'General case' 0 N--CA 1.519 2.977 0 O-C-N 121.128 -0.982 . . . . 6.36 112.997 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -131.72 142.39 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-O 121.591 0.71 . . . . 1.09 110.318 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.494 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 2.0 pt20 -124.78 139.27 54.0 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.679 -1.23 . . . . 2.05 107.679 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.65 146.54 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.584 0 O-C-N 120.655 -1.278 . . . . 1.1 110.96 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -121.34 140.96 51.41 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 122.084 0.945 . . . . 0.73 111.482 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -69.09 -33.42 73.49 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.774 -0.648 . . . . 0.02 112.391 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.484 ' O ' ' OG ' ' A' ' 128' ' ' SER . 0.8 OUTLIER -113.67 165.33 12.63 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.815 -1.178 . . . . 3.18 109.584 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.97 163.43 44.78 Favored Glycine 0 N--CA 1.492 2.376 0 CA-C-O 122.07 0.817 . . . . 0.01 111.266 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.7 t0 57.65 39.96 27.01 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.599 0.714 . . . . 0.01 111.077 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.46 55.01 9.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.632 -0.668 . . . . 0.01 111.002 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -127.07 165.72 18.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.219 -1.03 . . . . 3.15 108.219 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.65 -163.0 29.47 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.14 -1.584 . . . . 0.01 109.14 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -75.2 142.18 43.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.942 -1.328 . . . . 0.01 108.841 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' A' ' 107' ' ' MET . 9.7 tmm? -116.46 143.28 45.78 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.566 0.698 . . . . 0.01 109.433 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -132.17 136.04 46.79 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.349 -0.982 . . . . 2.48 108.349 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -117.01 134.07 55.21 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.697 -0.627 . . . . 0.01 109.844 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.83 149.1 29.99 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.42 1.105 . . . . 1.69 111.313 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -115.19 7.75 15.39 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.132 -0.94 . . . . 0.01 110.321 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -121.67 163.28 19.27 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.406 -0.809 . . . . 3.21 111.255 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.21 154.84 41.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.01 109.539 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 35.1 t -126.64 114.53 22.76 Favored Pre-proline 0 N--CA 1.499 2.013 0 N-CA-C 109.049 -0.722 . . . . 0.01 109.049 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.37 -33.57 4.14 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 120.274 1.134 . . . . 0.01 111.218 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 p -141.15 107.15 5.17 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.662 -0.866 . . . . 0.02 108.662 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.82 -39.52 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.721 -0.612 . . . . 1.83 111.23 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.6 ttt -66.77 -37.65 85.01 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.002 -1.079 . . . . 1.34 109.727 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.72 -38.55 76.95 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.58 -1.325 . . . . 2.11 109.693 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -80.18 -47.47 14.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 2.08 112.359 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -111.02 -1.1 16.43 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.413 -0.804 . . . . 0.02 112.84 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 m80 59.97 33.23 21.4 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.621 -1.299 . . . . 0.02 109.503 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.1 mt -111.63 135.02 52.79 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.805 -0.813 . . . . 0.02 108.805 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -93.65 -24.01 18.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.284 -0.885 . . . . 5.32 110.688 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -148.42 162.55 39.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.259 -0.9 . . . . 0.02 109.791 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.5 mt -133.18 130.2 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 107.64 -1.244 . . . . 2.17 107.64 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.52 -13.72 15.25 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 113.524 0.935 . . . . 0.02 113.524 -176.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -157.45 156.37 32.02 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.256 -1.527 . . . . 0.01 108.396 177.743 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.4 t -162.11 146.81 12.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.478 -1.389 . . . . 1.22 109.93 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -120.03 108.54 14.42 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.137 0.97 . . . . 1.41 108.445 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 t -107.09 120.35 58.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 105.795 -1.928 . . . . 0.01 105.795 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 t -146.63 68.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 118.043 -1.463 . . . . 1.98 108.304 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.6 108.3 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.505 -1.665 . . . . 0.01 106.505 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.24 -174.31 44.51 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.737 -1.345 . . . . 0.01 109.737 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.48 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.7 m -111.92 145.69 39.11 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.369 -1.077 . . . . 2.3 109.088 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.419 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 76.8 m95 -131.32 145.29 51.8 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.552 -0.718 . . . . 0.01 110.741 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.2 mt -117.7 142.01 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 107.421 -1.325 . . . . 1.69 107.421 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -115.12 143.9 44.49 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 107.499 -1.297 . . . . 2.49 107.499 177.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 18.0 m-85 -122.42 144.67 48.9 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.948 -0.76 . . . . 0.02 108.948 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.01 -30.0 62.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.02 112.06 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.17 153.96 47.32 Favored Pre-proline 0 N--CA 1.506 2.351 0 O-C-N 120.593 -1.317 . . . . 1.48 109.292 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.71 166.27 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.192 1.262 . . . . 0.02 112.615 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 59.84 31.31 20.7 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.149 -0.932 . . . . 0.75 111.186 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 57.74 51.94 8.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.02 110.926 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -125.09 163.67 21.89 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.486 -0.759 . . . . 0.02 109.747 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.51 -165.37 32.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.751 -1.34 . . . . 0.02 109.751 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -67.97 141.72 56.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.629 -0.924 . . . . 0.02 108.949 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.464 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.2 mp0 -118.51 148.41 42.65 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.463 -0.569 . . . . 0.02 109.463 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.516 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.7 t80 -129.33 142.9 50.7 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.013 -0.736 . . . . 0.01 109.013 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.576 ' C ' HD23 ' A' ' 150' ' ' LEU . 5.8 tt -96.75 121.8 39.0 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.293 -0.88 . . . . 0.01 109.345 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.654 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.4 mt -104.66 133.51 49.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.506 -0.746 . . . . 0.01 110.225 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 154' ' ' LYS . 21.1 t0 -108.83 175.39 5.48 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.341 -0.985 . . . . 2.27 108.341 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -57.41 84.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.84 -1.162 . . . . 1.84 108.626 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 152' ' ' ASP . 35.4 mttp -137.73 168.42 19.72 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.191 0.996 . . . . 2.28 111.647 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -113.33 109.82 19.34 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.26 -1.015 . . . . 0.01 108.26 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -99.77 115.87 30.54 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.022 -1.049 . . . . 0.01 109.931 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -93.52 -25.4 17.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.079 -1.013 . . . . 0.01 111.433 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -125.89 153.42 73.56 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 120.786 -1.196 . . . . 2.54 108.613 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.16 -41.7 41.14 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 CA-C-N 119.281 0.779 . . . . 0.7 110.584 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.58 -20.58 21.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.769 -1.207 . . . . 0.86 108.586 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.49 -15.77 62.99 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.029 -1.044 . . . . 0.02 109.625 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.654 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -95.34 9.87 38.31 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 107.919 -1.141 . . . . 0.02 107.919 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.38 10.8 85.48 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.205 -1.474 . . . . 0.02 109.588 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.76 142.43 31.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.469 -1.018 . . . . 0.02 110.282 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.63 -8.59 58.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.728 -0.608 . . . . 0.59 110.007 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.3 p -144.68 150.99 48.85 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.737 -1.227 . . . . 0.87 108.789 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.97 21.72 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 120.899 1.066 . . . . 0.38 112.331 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.19 123.89 29.99 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.623 1.201 . . . . 0.18 111.563 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.0 mt -146.66 126.75 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 106.765 -1.569 . . . . 3.99 106.765 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -113.17 -20.34 11.48 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.112 -0.993 . . . . 5.17 112.835 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.1 p -157.76 160.13 37.53 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.172 -2.205 . . . . 0.02 110.233 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -153.04 154.9 35.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.184 -0.948 . . . . 2.02 110.683 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -145.03 151.63 38.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.263 -0.898 . . . . 0.01 110.539 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -87.73 142.08 28.1 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.524 -0.735 . . . . 0.01 109.406 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.3 mt -92.2 128.17 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.137 -0.977 . . . . 3.04 109.241 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.7 t -136.35 146.83 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.151 -0.968 . . . . 1.89 109.487 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 4.89 109.441 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.405 -0.591 . . . . 5.28 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -76.3 64.31 2.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 5.96 109.528 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.6 m -80.91 143.1 32.92 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.32 -0.993 . . . . 2.22 108.32 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.39 -179.72 47.29 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 118.332 -1.889 . . . . 0.81 112.082 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.71 157.7 44.11 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.275 -1.53 . . . . 0.01 109.275 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -148.45 136.78 21.24 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.128 -1.219 . . . . 0.02 110.337 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.73 140.94 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.17 -0.678 . . . . 0.02 109.17 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -121.5 130.25 53.43 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.396 -0.815 . . . . 0.39 110.089 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 m-85 -110.18 140.14 44.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.598 -0.689 . . . . 0.02 109.27 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.54 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.0 m-85 -122.04 138.21 54.52 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.155 -0.965 . . . . 0.02 109.58 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -69.62 -27.37 65.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 0.03 111.788 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.0 m-20 -113.89 169.44 8.99 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.85 -1.156 . . . . 0.03 110.091 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.15 158.3 33.26 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.606 0.717 . . . . 0.03 110.095 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m-20 66.05 35.07 6.52 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.745 0.784 . . . . 0.74 110.76 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.5 p90 49.82 44.31 25.01 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.606 -0.724 . . . . 0.02 111.19 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -112.71 166.05 11.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.95 -167.58 34.8 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 120.736 -1.228 . . . . 0.03 110.415 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -69.36 142.68 53.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -1.024 . . . . 2.76 109.036 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -122.06 150.13 42.56 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.521 -0.737 . . . . 1.89 110.065 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -135.93 132.88 37.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.749 -0.594 . . . . 0.02 109.516 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -110.25 135.96 50.19 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.398 -0.814 . . . . 1.12 109.118 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 43.6 t -128.43 138.49 52.34 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.524 -0.735 . . . . 0.02 109.411 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 34.2 p-10 -119.16 11.88 12.48 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.624 -0.672 . . . . 0.2 110.392 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 4.3 p -159.42 173.45 16.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.765 -1.209 . . . . 1.23 109.05 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 13.2 p-10 -63.15 145.98 54.32 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.693 -1.254 . . . . 0.02 110.612 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.561 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 45.0 t -134.95 118.54 16.98 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.144 -0.687 . . . . 0.02 109.144 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.4 -21.62 52.87 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.53 -0.731 . . . . 0.24 111.605 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -154.49 105.06 2.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.845 -1.159 . . . . 1.14 109.506 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.4 OUTLIER -101.84 8.88 41.16 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.427 -0.796 . . . . 6.37 109.875 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.46 -28.55 68.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.435 -0.79 . . . . 3.11 112.033 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 m -76.83 -17.32 59.07 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.35 -1.469 . . . . 0.88 111.235 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 27.8 m-85 -107.22 -20.48 13.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.381 -0.824 . . . . 0.02 110.393 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tp -148.93 127.15 12.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.026 -1.046 . . . . 3.32 109.51 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.8 p -87.1 -12.26 47.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.558 -0.714 . . . . 0.02 111.329 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -172.02 161.98 5.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.807 -1.183 . . . . 0.02 108.283 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.8 t -143.52 116.61 8.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.96 -1.088 . . . . 0.02 108.984 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -109.7 0.5 18.98 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.792 -1.193 . . . . 0.03 111.714 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 m -156.09 153.84 30.01 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.276 -1.009 . . . . 0.02 108.276 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mt -146.24 146.9 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.946 -1.096 . . . . 0.02 110.715 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -123.79 124.62 43.08 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.485 -1.302 . . . . 0.02 107.485 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.21 114.39 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.843 -1.54 . . . . 0.02 106.843 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -84.94 -34.85 22.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.565 -0.71 . . . . 3.81 109.906 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.61 149.34 17.22 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.497 -1.811 . . . . 0.02 110.976 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.1 171.84 48.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.386 -1.086 . . . . 0.01 110.386 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.1 m -118.02 134.03 55.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.554 -1.276 . . . . 1.48 107.554 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.1 m95 -128.27 155.69 44.19 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 122.636 1.208 . . . . 0.02 112.27 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.83 134.0 52.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.493 -2.04 . . . . 0.24 105.493 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.408 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.6 m -117.08 142.45 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.936 -0.764 . . . . 0.65 108.936 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -120.83 144.98 48.07 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.386 1.089 . . . . 0.02 110.092 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -66.17 -34.0 77.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.721 -0.672 . . . . 0.02 111.472 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -124.44 157.9 63.44 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 121.097 -1.002 . . . . 0.02 109.449 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.56 166.47 1.25 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.766 1.644 . . . . 0.02 112.783 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 m-20 63.71 36.36 10.75 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.366 -0.834 . . . . 0.02 111.15 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 5.1 m-85 45.67 51.74 9.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.567 0.699 . . . . 3.39 110.732 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 p -126.23 163.74 22.51 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.203 0.525 . . . . 2.33 109.993 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.38 -161.56 31.39 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.748 -1.341 . . . . 0.02 109.748 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -64.54 138.79 58.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.936 -1.332 . . . . 0.02 110.042 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 21.2 ptm -119.61 137.49 53.83 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.208 0.528 . . . . 5.01 109.736 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.58 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 95.1 m-85 -134.61 139.67 45.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.434 -0.791 . . . . 0.02 110.127 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 mm -93.79 130.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.736 -0.838 . . . . 1.72 108.736 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.483 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -120.91 110.48 34.91 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.425 -0.797 . . . . 0.02 110.63 -178.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -78.09 169.76 19.85 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 119.767 0.953 . . . . 1.47 110.17 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -53.55 140.84 27.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.818 -1.176 . . . . 4.25 110.496 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.55 -177.37 32.74 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.462 -1.352 . . . . 0.02 110.611 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -119.3 130.42 55.38 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.402 -1.058 . . . . 0.96 109.708 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.483 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 32.1 m-85 -122.94 91.92 49.49 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.296 -1.002 . . . . 0.02 108.296 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -65.95 -2.83 7.28 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.115 1.21 . . . . 0.02 113.739 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -156.93 151.05 24.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.335 -1.478 . . . . 2.02 107.88 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -59.59 -38.94 82.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.662 -0.649 . . . . 0.02 112.538 -176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -60.36 -23.47 64.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.026 -1.046 . . . . 0.02 111.079 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -73.13 -15.54 61.47 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.79 -1.164 . . . . 3.42 108.752 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.58 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -107.63 9.35 29.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.3 -1.37 . . . . 0.02 107.3 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.0 mtm 62.11 22.91 13.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.685 -0.635 . . . . 0.02 110.923 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.21 145.05 46.85 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.748 -1.341 . . . . 0.02 109.748 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.76 -31.7 35.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -1.209 . . . . 0.98 107.949 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -157.28 -172.27 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.467 -1.679 . . . . 0.02 106.467 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.29 27.65 4.55 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.768 -1.208 . . . . 0.02 110.654 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -96.34 122.52 39.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.881 -1.137 . . . . 3.2 110.864 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 79' ' ' LEU . 83.5 mt -142.44 119.06 11.04 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.771 -1.196 . . . . 2.61 107.771 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.1 -18.28 10.03 Favored Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.138 -0.976 . . . . 0.02 112.511 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.5 p -156.12 156.52 34.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.255 -1.732 . . . . 0.02 110.394 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.4 m -145.47 148.23 33.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.719 -0.613 . . . . 0.02 109.841 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.44 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 54.6 mtm180 -137.39 141.97 41.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.331 -0.855 . . . . 0.01 109.311 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 132.79 36.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.213 -0.93 . . . . 0.43 109.496 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.74 124.03 42.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.242 -1.021 . . . . 1.25 108.242 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -91.31 134.57 34.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.823 -1.173 . . . . 1.77 108.507 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.61 135.41 40.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.841 -1.17 . . . . 1.63 107.841 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.7 p -109.37 127.63 54.5 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.763 -0.828 . . . . 1.08 108.763 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -105.19 -153.78 0.5 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 106.314 -1.736 . . . . 1.26 106.314 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.59 -50.63 0.86 Allowed Glycine 0 N--CA 1.499 2.849 0 O-C-N 120.528 -1.358 . . . . 0.01 111.846 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.73 -100.73 0.15 Allowed Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.867 -1.635 . . . . 0.01 111.402 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -119.61 118.11 30.12 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.185 -1.185 . . . . 4.43 110.243 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.493 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.19 136.69 56.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.385 -0.598 . . . . 2.99 109.385 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -134.38 130.4 36.83 Favored 'General case' 0 N--CA 1.519 2.988 0 O-C-N 121.06 -1.025 . . . . 6.36 113.048 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.17 143.49 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 115.63 -0.713 . . . . 1.09 110.591 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.413 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.9 pt20 -124.89 139.71 53.58 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.771 -1.196 . . . . 2.05 107.771 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.22 145.69 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 120.652 -1.28 . . . . 1.1 111.189 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 27.8 m-85 -120.4 140.19 51.71 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.956 0.884 . . . . 0.73 110.847 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -68.55 -32.41 72.32 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.784 -0.644 . . . . 0.02 112.178 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -114.82 165.74 12.51 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.956 -1.09 . . . . 3.18 110.212 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.18 163.41 45.44 Favored Glycine 0 N--CA 1.492 2.38 0 CA-C-O 121.958 0.755 . . . . 0.01 111.278 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 57.15 39.17 29.13 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.578 0.704 . . . . 0.01 111.026 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 52.66 55.91 8.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.624 -0.672 . . . . 0.01 111.112 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -128.42 164.87 21.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.281 -1.007 . . . . 3.15 108.281 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.65 -163.05 28.25 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.092 -1.603 . . . . 0.01 109.092 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -75.62 142.04 42.72 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.878 -1.366 . . . . 0.01 108.959 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 33.9 ttp -116.73 143.27 45.85 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.538 0.685 . . . . 0.01 109.533 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.98 136.41 47.28 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.173 -1.047 . . . . 2.48 108.173 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -115.96 134.09 55.34 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.715 -0.616 . . . . 0.01 109.7 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.1 t -149.31 147.93 28.93 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.515 1.15 . . . . 1.69 111.474 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -114.54 7.63 16.19 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.894 -1.048 . . . . 0.01 109.875 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -121.96 163.56 19.11 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.393 -0.817 . . . . 3.21 111.008 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.4 154.82 41.43 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.358 -0.839 . . . . 0.01 109.379 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.8 t -126.64 114.98 22.77 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.911 -0.774 . . . . 0.01 108.911 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.23 -32.59 5.01 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 120.323 1.151 . . . . 0.01 111.447 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 m -142.31 108.26 5.18 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.847 0.832 . . . . 0.02 108.947 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.42 HD12 ' O ' ' A' ' 169' ' ' ILE . 95.9 mt -64.29 -39.9 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.776 -0.577 . . . . 1.83 110.97 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 32.7 ttp -66.89 -37.4 84.31 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.026 -1.069 . . . . 1.34 109.812 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -70.22 -38.62 75.29 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.524 -1.36 . . . . 2.11 109.761 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.14 -47.49 14.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.253 -0.904 . . . . 2.08 112.203 -176.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -110.82 -0.44 16.93 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.378 -0.826 . . . . 0.02 112.699 -176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 59.93 33.2 21.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.659 -1.276 . . . . 0.02 109.595 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mt -112.69 135.85 52.95 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 108.764 -0.828 . . . . 0.02 108.764 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -91.73 -22.89 19.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -0.822 . . . . 5.32 110.358 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -149.36 164.03 36.07 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.09 -1.006 . . . . 0.02 110.019 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.8 mt -131.7 129.57 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.375 -1.343 . . . . 2.17 107.375 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -107.77 -12.92 15.12 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.134 -0.979 . . . . 0.02 113.18 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.6 OUTLIER -153.52 151.35 29.71 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.489 -1.382 . . . . 0.01 108.278 178.321 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 13.7 t -160.92 145.03 13.6 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.261 -1.524 . . . . 1.22 109.935 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -121.8 110.22 15.64 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.43 1.109 . . . . 1.41 109.156 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 t -107.55 120.34 58.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 105.851 -1.907 . . . . 0.01 105.851 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.0 t -146.27 68.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 118.453 -1.299 . . . . 1.98 108.369 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 172.65 107.22 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.443 -1.688 . . . . 0.01 106.443 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.66 -174.07 43.1 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.554 -1.418 . . . . 0.01 109.554 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.2 m -111.41 144.3 40.84 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.387 -1.066 . . . . 2.3 109.216 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.493 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 63.1 m95 -129.15 146.03 51.18 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.643 -0.66 . . . . 0.01 110.377 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.1 mt -117.36 141.71 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 107.642 -1.244 . . . . 1.69 107.642 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -113.97 143.42 44.76 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 107.453 -1.314 . . . . 2.49 107.453 177.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 16.0 m-85 -122.77 144.17 49.35 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.291 -0.633 . . . . 0.02 109.291 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.5 -29.86 62.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.737 -0.602 . . . . 0.02 111.964 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.47 153.87 47.69 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 120.679 -1.263 . . . . 1.48 109.26 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -54.48 166.13 1.98 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.229 1.286 . . . . 0.02 112.658 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.573 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 1.7 t30 59.79 31.76 20.97 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.145 -0.934 . . . . 0.75 111.136 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.504 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.8 m-85 57.43 51.45 9.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.54 -0.725 . . . . 0.02 110.827 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -124.55 163.43 21.93 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.541 -0.724 . . . . 0.02 109.659 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.45 -165.34 32.42 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.83 -1.308 . . . . 0.02 109.83 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -67.89 141.48 56.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.991 . . . . 0.02 109.011 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -118.87 149.01 42.27 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.284 -0.635 . . . . 0.02 109.284 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.68 142.4 51.03 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.181 -0.674 . . . . 0.01 109.181 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.827 ' N ' HD12 ' A' ' 150' ' ' LEU . 3.4 mp -95.43 121.11 36.76 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.462 -0.774 . . . . 0.01 109.336 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.669 HD22 ' NE1' ' A' ' 162' ' ' TRP . 18.5 mt -105.42 135.25 47.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.44 -0.788 . . . . 0.01 110.674 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 154' ' ' LYS . 2.8 m-20 -110.31 175.63 5.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.187 -1.042 . . . . 2.27 108.187 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -57.85 84.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.905 -1.122 . . . . 1.84 108.638 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 152' ' ' ASP . 73.6 tttt -137.14 165.38 26.21 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.256 -0.903 . . . . 2.28 111.654 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 6.7 pt-20 -111.8 113.66 26.15 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.061 -1.088 . . . . 0.01 108.061 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.44 115.28 30.25 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.933 -1.104 . . . . 0.01 110.29 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.445 ' O ' ' OG ' ' A' ' 128' ' ' SER . 3.7 ptp180 -92.18 -25.82 18.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.01 111.347 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -125.67 153.17 72.97 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 121.017 -1.052 . . . . 2.54 108.643 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -60.7 -42.08 41.85 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 CA-C-N 119.27 0.775 . . . . 0.7 110.524 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.1 t -60.38 -20.43 20.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.745 -1.222 . . . . 0.86 108.612 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -65.91 -16.19 63.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.989 -1.069 . . . . 0.02 109.605 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.669 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.73 9.3 39.48 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.763 -1.199 . . . . 0.02 107.763 179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.15 10.32 86.32 Favored Glycine 0 N--CA 1.486 2.024 0 C-N-CA 119.214 -1.47 . . . . 0.02 109.617 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.5 142.03 31.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.45 -1.03 . . . . 0.02 110.091 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.1 -8.33 59.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.677 -0.64 . . . . 0.59 109.828 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.5 p -144.66 150.86 48.47 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.857 -1.152 . . . . 0.87 108.702 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.83 21.03 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 120.816 1.011 . . . . 0.38 112.355 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.87 124.13 30.03 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.464 1.126 . . . . 0.18 111.708 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.42 ' O ' HD12 ' A' ' 117' ' ' ILE . 16.4 mt -146.47 126.9 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 106.78 -1.563 . . . . 3.99 106.78 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -112.02 -20.53 11.93 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.098 -1.001 . . . . 5.17 112.783 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.6 p -158.0 160.63 37.68 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 119.269 -2.144 . . . . 0.02 110.141 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -152.48 154.03 34.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.129 -0.982 . . . . 2.02 110.26 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.504 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -144.51 151.97 39.9 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.195 -0.941 . . . . 0.01 110.449 -179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -88.24 143.02 27.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.496 -0.753 . . . . 0.01 109.412 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -93.25 128.66 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.17 -0.956 . . . . 3.04 109.053 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.8 t -136.0 146.4 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.224 -0.923 . . . . 1.89 109.384 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 4.89 109.517 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.581 -0.525 . . . . 5.28 109.581 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.91 -86.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 5.96 109.329 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 t -170.49 169.09 7.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.832 -1.167 . . . . 2.22 109.053 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.08 117.34 3.62 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 106.939 -2.465 . . . . 0.81 106.939 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.08 145.38 33.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.642 -1.383 . . . . 0.01 109.642 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -152.83 138.29 17.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.264 -1.139 . . . . 0.02 109.586 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -130.31 140.87 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.373 -0.603 . . . . 0.02 109.373 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -121.13 129.95 53.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.469 -0.77 . . . . 0.39 110.143 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -109.02 139.32 44.05 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.549 -0.719 . . . . 0.02 109.147 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.3 m-85 -121.98 137.73 54.69 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.361 -0.837 . . . . 0.02 109.276 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.78 -27.4 64.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.013 -1.054 . . . . 0.03 111.88 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.9 m-20 -114.2 170.2 8.46 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.87 -1.144 . . . . 0.03 110.366 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -75.25 157.91 33.72 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.599 0.714 . . . . 0.03 110.136 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 10.4 t30 65.85 35.11 6.85 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.803 0.811 . . . . 0.74 110.8 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.96 44.83 25.5 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.487 -0.779 . . . . 0.02 111.368 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -112.28 165.87 11.79 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.032 -1.099 . . . . 0.02 108.032 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -167.88 34.44 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 120.847 -1.158 . . . . 0.03 110.619 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -69.19 143.1 54.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -1.04 . . . . 2.76 108.922 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -123.22 149.92 44.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.518 -0.739 . . . . 1.89 110.211 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -136.25 133.4 36.96 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 109.317 -0.623 . . . . 0.02 109.317 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.0 136.16 48.99 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.688 -0.856 . . . . 1.12 108.688 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.429 ' SG ' ' CE2' ' A' ' 29' ' ' PHE . 1.9 m -126.94 137.31 53.1 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.637 -0.664 . . . . 0.02 109.541 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -118.95 10.74 12.31 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.572 -0.705 . . . . 0.2 110.233 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.407 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 14.9 t -159.61 173.19 16.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.79 -1.194 . . . . 1.23 109.063 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.407 ' OD1' ' SG ' ' A' ' 24' ' ' CYS . 5.5 p-10 -63.22 146.28 53.72 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.683 -1.26 . . . . 0.02 110.721 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.88 119.22 17.81 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.061 -0.718 . . . . 0.02 109.061 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -20.84 51.33 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.504 -0.748 . . . . 0.24 112.037 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -153.73 106.02 2.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.729 -1.232 . . . . 1.14 109.762 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.429 ' CE2' ' SG ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -102.66 6.7 39.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.353 -0.842 . . . . 6.37 110.399 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -61.17 -29.5 69.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 3.11 111.898 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.4 t -77.06 -17.56 58.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.505 -1.372 . . . . 0.88 110.948 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -106.14 -21.42 13.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.388 -0.82 . . . . 0.02 110.624 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.13 127.39 12.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.145 -0.972 . . . . 3.32 109.472 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.6 t -87.29 -12.48 46.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.516 -0.74 . . . . 0.02 110.976 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -172.56 161.99 5.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.847 -1.158 . . . . 0.02 108.378 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.464 ' SG ' HD12 ' A' ' 79' ' ' LEU . 3.1 p -142.63 115.04 8.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.99 -1.069 . . . . 0.02 108.735 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -107.04 -2.71 20.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.836 -1.165 . . . . 0.03 111.289 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -152.96 153.65 33.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.118 -1.067 . . . . 0.02 108.118 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.7 mt -146.83 147.44 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.045 -1.034 . . . . 0.02 110.438 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -124.91 125.66 44.29 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.899 -1.148 . . . . 0.02 107.899 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.6 114.11 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 106.773 -1.566 . . . . 0.02 106.773 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.94 -34.61 22.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.609 -0.682 . . . . 3.81 110.184 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.24 149.99 18.24 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 118.358 -1.877 . . . . 0.02 110.758 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.12 172.42 49.11 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.174 -1.171 . . . . 0.01 110.174 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 m -118.35 134.19 55.26 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.484 -1.302 . . . . 1.48 107.484 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -126.38 154.86 43.0 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.626 1.203 . . . . 0.02 112.326 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.72 133.99 52.51 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.189 -2.152 . . . . 0.24 105.189 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.458 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.7 m -117.22 142.63 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.514 -0.741 . . . . 0.65 109.319 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -120.88 143.19 49.05 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 122.053 0.93 . . . . 0.02 109.535 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.08 -33.62 76.47 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.498 -0.774 . . . . 0.02 111.641 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -124.46 157.7 64.19 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 121.098 -1.001 . . . . 0.02 109.467 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.13 166.94 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.656 1.57 . . . . 0.02 112.726 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.07 36.5 12.24 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.331 -0.849 . . . . 0.02 111.108 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 45.56 51.54 9.84 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.601 0.715 . . . . 3.39 110.864 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 p -125.78 163.55 22.62 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.384 0.612 . . . . 2.33 109.904 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.49 -161.45 31.17 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.799 -1.32 . . . . 0.02 109.799 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -65.3 139.35 58.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.027 -1.278 . . . . 0.02 110.163 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 18.4 ptm -118.91 137.05 53.73 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.245 0.545 . . . . 5.01 109.61 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.442 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.9 m-85 -134.19 138.82 45.4 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.459 -0.776 . . . . 0.02 109.925 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.7 mm -95.2 130.62 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.49 -0.756 . . . . 1.72 109.031 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.475 HD22 ' CE1' ' A' ' 66' ' ' TYR . 7.4 mt -121.44 111.2 33.49 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 121.326 -0.859 . . . . 0.02 110.653 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -77.66 169.77 20.29 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 CA-C-N 119.85 0.982 . . . . 1.47 110.415 177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -53.53 141.26 25.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.902 -1.124 . . . . 4.25 110.603 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.45 -177.4 31.83 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.502 -1.333 . . . . 0.02 110.693 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -118.45 130.42 55.95 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.354 -1.086 . . . . 0.96 109.787 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' CE1' HD22 ' A' ' 61' ' ' LEU . 90.0 m-85 -120.37 97.05 49.08 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 107.861 -1.163 . . . . 0.02 107.861 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -69.48 -4.49 13.94 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 120.752 0.968 . . . . 0.02 113.583 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -157.27 154.53 29.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.623 -1.298 . . . . 2.02 108.144 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -59.95 -38.6 82.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.408 -0.808 . . . . 0.02 111.773 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -59.82 -24.44 64.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.02 110.226 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -70.09 -18.72 63.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.41 -0.806 . . . . 3.42 108.879 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.46 10.12 27.42 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.628 -1.249 . . . . 0.02 107.628 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.9 mmt 60.81 22.32 12.37 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.48 0.657 . . . . 0.02 110.598 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.43 144.17 45.8 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.367 -1.493 . . . . 0.02 109.367 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.1 tp -78.93 -30.93 44.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.553 -1.276 . . . . 0.98 107.553 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -157.42 -171.82 3.74 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.544 -1.651 . . . . 0.02 106.544 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -98.25 28.63 3.96 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.603 -1.31 . . . . 0.02 110.775 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -97.82 122.72 41.26 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.933 -1.105 . . . . 3.2 111.324 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.464 HD12 ' SG ' ' A' ' 36' ' ' CYS . 54.4 mt -142.36 119.51 11.43 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.317 -1.364 . . . . 2.61 107.317 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.99 -18.55 10.41 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 121.282 -0.886 . . . . 0.02 112.065 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 p -155.45 155.63 33.86 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 119.531 1.666 . . . . 0.02 110.695 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.5 p -145.17 147.82 32.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.403 -0.811 . . . . 0.02 110.283 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -137.17 141.87 42.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.442 -0.786 . . . . 0.01 109.109 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.58 132.36 37.11 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.203 -0.935 . . . . 0.43 109.28 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.3 123.95 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.653 -0.869 . . . . 1.25 108.653 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -92.01 132.34 36.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.956 -1.09 . . . . 1.77 108.552 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.484 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -96.83 138.12 34.87 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.139 -1.06 . . . . 1.63 108.139 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.9 p -110.21 126.38 54.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 1.08 108.682 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.2 t -102.85 -155.1 0.51 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.205 -1.776 . . . . 1.26 106.205 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.59 -50.41 0.84 Allowed Glycine 0 N--CA 1.497 2.743 0 O-C-N 120.521 -1.362 . . . . 0.01 111.986 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.6 -99.77 0.13 Allowed Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.816 -1.659 . . . . 0.01 111.709 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -119.34 119.45 34.01 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.117 -1.225 . . . . 4.43 110.311 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.515 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.35 137.32 56.82 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.344 -0.613 . . . . 2.99 109.344 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 7.5 ttpm? -136.45 130.7 33.03 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-O 122.273 1.035 . . . . 6.36 113.015 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 tt -131.72 141.51 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 115.397 -0.82 . . . . 1.09 110.286 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 6.3 pt20 -124.33 140.2 53.18 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 107.597 -1.26 . . . . 2.05 107.597 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 m -124.24 146.29 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.685 -1.259 . . . . 1.1 111.189 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 26.2 m-85 -120.4 140.24 51.64 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 122.224 1.011 . . . . 0.73 110.745 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.84 -32.44 72.97 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.709 -0.678 . . . . 0.02 111.907 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -114.47 165.7 12.47 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 120.948 -1.095 . . . . 3.18 110.446 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.9 163.69 47.24 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 111.038 -0.825 . . . . 0.01 111.038 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 57.62 38.86 27.88 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.578 0.704 . . . . 0.01 110.946 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 52.44 56.91 7.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.537 -0.727 . . . . 0.01 111.035 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -129.48 165.34 21.82 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.166 -1.05 . . . . 3.15 108.166 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.4 -162.77 28.38 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.13 -1.588 . . . . 0.01 109.13 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -75.81 142.0 42.37 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.016 -1.285 . . . . 0.01 108.76 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.7 ttp -116.55 143.05 46.09 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.513 0.673 . . . . 0.01 109.563 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -131.89 135.91 47.01 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.198 -1.038 . . . . 2.48 108.198 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -116.52 134.37 54.92 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.722 -0.611 . . . . 0.01 109.669 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t -149.23 148.02 29.09 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.528 1.156 . . . . 1.69 111.367 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 p -114.95 7.67 15.67 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.949 -1.023 . . . . 0.01 109.934 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.449 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 21.8 mp0 -122.03 163.78 18.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.408 -0.808 . . . . 3.21 111.181 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.59 153.89 42.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.384 -0.823 . . . . 0.01 109.46 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 46.0 t -126.98 114.95 22.03 Favored Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 108.971 -0.752 . . . . 0.01 108.971 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -75.1 -32.94 4.86 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 120.387 1.174 . . . . 0.01 111.612 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -142.05 108.49 5.3 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.834 0.826 . . . . 0.02 109.198 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 169' ' ' ILE . 96.4 mt -64.36 -39.75 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.844 -0.535 . . . . 1.83 111.02 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.6 ttt -66.57 -38.17 86.5 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.169 -1.012 . . . . 1.34 109.865 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.62 -38.46 77.23 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.506 -1.371 . . . . 2.11 109.858 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -80.78 -47.25 14.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.29 -0.881 . . . . 2.08 112.462 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -111.21 -0.78 16.36 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.252 -0.905 . . . . 0.02 112.719 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 59.88 33.43 21.57 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.812 -1.18 . . . . 0.02 109.384 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.27 135.7 52.61 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 108.699 -0.852 . . . . 0.02 108.699 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -92.66 -23.43 18.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 5.32 110.65 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -149.11 163.66 36.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.084 -1.01 . . . . 0.02 110.095 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.2 mt -131.63 129.4 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 107.348 -1.353 . . . . 2.17 107.348 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -107.18 -13.32 15.18 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.144 -0.973 . . . . 0.02 113.06 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.38 153.06 29.85 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.277 -1.514 . . . . 0.01 108.255 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 6.8 t -162.86 143.81 9.75 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.375 -1.453 . . . . 1.22 109.665 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -122.37 112.87 18.62 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.001 0.905 . . . . 1.41 108.77 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 t -109.03 123.4 64.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.061 -1.829 . . . . 0.01 106.061 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -146.41 66.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 C-N-CA 117.951 -1.5 . . . . 1.98 109.061 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.402 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.1 tp10 176.28 108.72 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.32 -1.733 . . . . 0.01 106.32 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.678 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 70.99 -174.44 40.39 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.476 -1.45 . . . . 0.01 109.476 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -112.05 146.57 37.7 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.423 -1.045 . . . . 2.3 109.43 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.515 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 61.1 m95 -130.35 146.19 51.89 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.502 -0.749 . . . . 0.01 110.284 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mt -117.13 141.56 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 107.566 -1.272 . . . . 1.69 107.566 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.33 143.79 44.32 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.688 -1.227 . . . . 2.49 107.688 177.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 7.5 m-85 -122.58 144.7 48.94 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.994 -0.743 . . . . 0.02 108.994 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 76.5 tt0 -74.06 -29.78 62.06 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.669 -0.644 . . . . 0.02 112.08 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.5 mt -115.24 153.5 47.39 Favored Pre-proline 0 N--CA 1.506 2.369 0 O-C-N 120.676 -1.265 . . . . 1.48 109.208 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.41 167.08 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.129 1.219 . . . . 0.02 112.565 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 59.31 31.08 20.88 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.065 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.76 51.12 9.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 0.02 111.124 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -123.99 163.33 21.6 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.569 -0.707 . . . . 0.02 109.528 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.2 -165.79 31.74 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.873 -1.291 . . . . 0.02 109.873 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -68.2 142.28 55.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.477 -1.014 . . . . 0.02 109.03 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -118.01 148.46 42.21 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.451 -0.574 . . . . 0.02 109.451 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.463 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -128.64 142.73 50.94 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.563 -0.71 . . . . 0.01 109.113 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.64 119.8 34.77 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.48 -0.763 . . . . 0.01 109.465 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 162' ' ' TRP . 19.5 mt -106.21 131.95 52.84 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.422 -0.798 . . . . 0.01 110.363 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 154' ' ' LYS . 11.9 p-10 -109.84 176.77 4.94 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.454 -0.943 . . . . 2.27 108.454 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.678 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 48.7 mttm -55.54 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.066 -1.021 . . . . 1.84 108.489 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 152' ' ' ASP . 53.4 mmtt -136.74 166.86 22.6 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.189 -0.945 . . . . 2.28 111.593 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 15.0 mp0 -113.82 106.4 14.42 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.76 -1.2 . . . . 0.01 107.76 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.56 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 90.9 m-85 -99.03 114.16 26.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.965 -1.085 . . . . 0.01 110.201 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -92.41 -25.67 18.37 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.19 -0.943 . . . . 0.01 111.144 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -125.18 153.88 71.74 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.079 -1.013 . . . . 2.54 108.392 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -61.3 -41.43 42.04 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 120.442 0.761 . . . . 0.7 110.651 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.33 -20.1 21.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.657 -1.277 . . . . 0.86 108.769 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -65.57 -16.11 63.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.025 -1.047 . . . . 0.02 109.758 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.56 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 1.1 m0 -96.11 10.88 36.2 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.999 -1.112 . . . . 0.02 107.999 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.57 11.34 85.56 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.414 -1.374 . . . . 0.02 110.159 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.73 141.94 31.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.293 -1.122 . . . . 0.02 110.209 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.29 -8.22 59.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.613 -0.679 . . . . 0.59 109.817 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.4 p -144.31 150.87 49.78 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.806 -1.184 . . . . 0.87 108.728 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.6 20.85 0.5 Allowed 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 120.701 0.934 . . . . 0.38 112.341 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.28 122.14 27.56 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.467 1.127 . . . . 0.18 111.45 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.433 ' O ' HD12 ' A' ' 117' ' ' ILE . 9.8 mm -142.74 125.39 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.009 -1.848 . . . . 3.99 106.009 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.526 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 12.3 mp0 -112.33 -20.82 11.69 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.088 -1.008 . . . . 5.17 112.615 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.5 p -157.41 160.92 38.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.384 -2.072 . . . . 0.02 109.954 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -153.53 154.59 34.6 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.182 -0.949 . . . . 2.02 110.578 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -144.46 151.39 39.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.35 -0.843 . . . . 0.01 110.442 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -87.66 142.64 27.68 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.054 -0.721 . . . . 0.01 109.054 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.8 mt -93.12 128.45 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.037 -1.039 . . . . 3.04 109.206 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 44.9 t -136.07 146.71 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.294 -0.879 . . . . 1.89 109.564 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.86 . . . . 4.89 109.483 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.353 -0.61 . . . . 5.28 109.353 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -151.66 -35.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 5.96 109.442 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 m -55.22 -54.13 47.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.607 -1.308 . . . . 2.22 110.615 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.85 117.77 3.86 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 107.038 -2.425 . . . . 0.81 107.038 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.58 145.27 33.97 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.39 -1.484 . . . . 0.01 109.39 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -152.83 138.28 17.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.245 -1.15 . . . . 0.02 109.841 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -130.32 141.03 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.475 -0.565 . . . . 0.02 109.475 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.422 ' OG ' ' NE ' ' A' ' 19' ' ' ARG . 1.6 t -122.26 130.76 53.47 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.308 -0.87 . . . . 0.39 110.091 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.0 OUTLIER -111.11 140.71 45.43 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.768 -0.582 . . . . 0.02 109.444 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.4 m-85 -121.85 138.45 54.38 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.353 -0.842 . . . . 0.02 109.573 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -68.86 -27.4 65.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.99 -1.069 . . . . 0.03 111.504 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.7 m-20 -114.53 170.72 8.1 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.858 -1.151 . . . . 0.03 110.009 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -75.81 162.06 28.49 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.705 0.764 . . . . 0.03 110.313 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.9 t30 62.46 33.28 16.25 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.113 0.959 . . . . 0.74 110.742 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.1 40.29 31.81 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.733 -0.667 . . . . 0.02 110.834 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -109.97 165.42 11.74 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.196 -1.038 . . . . 0.02 108.196 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.54 -168.04 34.38 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.888 -1.149 . . . . 0.03 110.557 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -68.83 143.53 54.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -1.058 . . . . 2.76 108.887 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.533 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 51.4 ttt180 -122.03 149.95 42.78 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.62 -0.675 . . . . 1.89 109.916 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.24 134.5 34.51 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.637 -0.664 . . . . 0.02 109.466 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.31 136.92 48.75 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.385 -0.822 . . . . 1.12 109.384 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.7 t -127.99 138.3 52.55 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.594 -0.691 . . . . 0.02 109.488 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -118.74 11.98 12.87 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.59 -0.694 . . . . 0.2 110.554 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.2 t -159.46 173.84 15.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.706 -1.246 . . . . 1.23 109.091 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 17.8 p30 -63.11 146.67 52.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.747 -1.221 . . . . 0.02 110.527 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.4 m -133.7 117.64 17.21 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.127 -0.694 . . . . 0.02 109.127 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.75 -23.21 45.53 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.284 -0.885 . . . . 0.24 111.471 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -151.77 103.77 2.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.974 -1.079 . . . . 1.14 109.056 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.16 6.81 33.39 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.588 0.709 . . . . 6.37 110.231 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -59.93 -27.63 66.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 3.11 111.691 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.4 p -76.6 -16.08 59.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.611 -1.306 . . . . 0.88 110.803 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.57 -21.96 12.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.44 -0.787 . . . . 0.02 110.422 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tp -149.08 127.33 12.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.04 -1.037 . . . . 3.32 109.436 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.2 t -87.02 -12.16 48.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.64 -0.662 . . . . 0.02 111.051 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.717 HH21 HD22 ' A' ' 37' ' ' ASN . 14.9 ptm180 -172.84 162.13 4.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.93 -1.106 . . . . 0.02 108.417 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -142.7 115.79 8.87 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.047 -1.033 . . . . 0.02 108.649 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.717 HD22 HH21 ' A' ' 35' ' ' ARG . 4.0 m120 -107.71 -1.0 21.43 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.803 -1.186 . . . . 0.03 110.987 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -155.52 152.88 29.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.6 mt -145.33 148.46 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.091 -1.006 . . . . 0.02 109.887 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -124.46 124.55 42.56 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.5 -1.296 . . . . 0.02 107.5 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -105.03 113.87 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.704 -1.591 . . . . 0.02 106.704 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -83.81 -34.83 24.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.576 -0.703 . . . . 3.81 109.971 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 151.27 20.64 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 118.392 -1.861 . . . . 0.02 110.535 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.79 171.89 48.61 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.318 -1.113 . . . . 0.01 110.318 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.9 m -117.76 133.74 55.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.429 -1.323 . . . . 1.48 107.429 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -126.21 154.23 43.59 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.6 1.19 . . . . 0.02 112.16 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.03 133.72 52.61 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.419 -2.067 . . . . 0.24 105.419 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.3 m -117.62 142.87 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.569 -0.707 . . . . 0.65 109.249 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -120.62 144.87 47.91 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.112 0.958 . . . . 0.02 109.997 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.472 ' OE2' ' NH2' ' A' ' 78' ' ' ARG . 33.5 tt0 -66.16 -33.69 76.34 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.875 -0.602 . . . . 0.02 111.582 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' A' ' 51' ' ' ARG . 0.4 OUTLIER -124.64 157.88 64.07 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.006 -1.059 . . . . 0.02 109.486 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.09 166.44 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.637 1.558 . . . . 0.02 112.763 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m120 63.67 36.39 10.84 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.36 -0.836 . . . . 0.02 111.153 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 8.0 m-85 45.29 51.51 9.32 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.654 0.74 . . . . 3.39 110.812 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -125.75 163.44 22.84 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.143 0.497 . . . . 2.33 109.882 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.83 31.38 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.46 ' CD2' ' CD1' ' A' ' 75' ' ' LEU . 21.2 m80 -64.35 138.48 58.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.981 -1.305 . . . . 0.02 109.989 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.8 ppp? -119.37 137.45 53.72 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.283 0.564 . . . . 5.01 109.58 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.594 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.7 m-85 -134.99 139.95 45.29 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.492 -0.755 . . . . 0.02 110.238 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.7 mm -94.16 130.45 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 108.656 -0.868 . . . . 1.72 108.656 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.03 110.32 36.53 Favored Pre-proline 0 N--CA 1.505 2.324 0 O-C-N 121.439 -0.788 . . . . 0.02 110.597 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.69 168.65 22.13 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 CA-C-N 119.935 1.012 . . . . 1.47 110.311 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -53.75 140.79 28.67 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.84 -1.163 . . . . 4.25 110.524 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.77 32.68 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.489 -1.338 . . . . 0.02 110.598 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -118.76 130.09 55.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.251 -1.146 . . . . 0.96 109.622 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.574 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 71.8 m-85 -121.1 98.91 46.88 Favored Pre-proline 0 N--CA 1.492 1.667 0 N-CA-C 107.852 -1.166 . . . . 0.02 107.852 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -71.3 -3.73 13.53 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 120.637 0.892 . . . . 0.02 113.836 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -157.52 155.04 29.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.64 -1.288 . . . . 2.02 108.274 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -59.85 -39.08 84.0 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.62 -0.675 . . . . 0.02 111.787 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -59.94 -23.99 64.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.917 . . . . 0.02 110.256 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -70.32 -18.75 63.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.791 0.805 . . . . 3.42 108.921 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.594 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -108.4 10.53 27.46 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.455 -1.313 . . . . 0.02 107.455 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.0 mtt 61.34 22.56 12.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.619 -0.676 . . . . 0.02 110.714 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.14 144.55 46.92 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.648 -1.381 . . . . 0.02 109.648 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.46 ' CD1' ' CD2' ' A' ' 57' ' ' HIS . 23.3 mt -79.71 -30.75 41.06 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.725 -1.213 . . . . 0.98 107.725 177.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -157.38 -171.52 3.63 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.374 -1.713 . . . . 0.02 106.374 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -98.93 28.3 4.45 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.607 -1.308 . . . . 0.02 110.72 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' NH2' ' OE2' ' A' ' 50' ' ' GLU . 80.1 mtm180 -96.44 122.56 39.47 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.916 -1.115 . . . . 3.2 111.011 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.435 HD21 ' CH2' ' A' ' 72' ' ' TRP . 82.5 mt -142.71 119.49 11.18 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.791 -1.189 . . . . 2.61 107.791 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.4 -17.79 10.32 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 121.167 -0.958 . . . . 0.02 112.416 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 92.9 p -156.19 156.15 33.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.165 -1.786 . . . . 0.02 110.495 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.8 p -145.26 148.43 33.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.693 -0.629 . . . . 0.02 109.706 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.465 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.9 mtp180 -137.06 141.42 42.42 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.286 -0.884 . . . . 0.01 109.281 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.67 133.03 37.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.843 . . . . 0.43 109.387 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 t -91.72 124.66 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.02 -0.733 . . . . 1.25 109.02 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -91.09 132.11 36.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.852 -1.155 . . . . 1.77 108.202 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -99.09 140.23 33.56 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.775 -0.824 . . . . 1.63 108.775 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.5 m -111.01 123.51 50.34 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.097 -1.075 . . . . 1.08 108.097 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.8 p -114.62 131.96 56.53 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.611 -1.255 . . . . 1.26 107.611 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.9 -48.76 0.01 OUTLIER Glycine 0 N--CA 1.502 3.078 0 C-N-CA 117.698 -2.191 . . . . 0.01 113.329 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.44 -103.79 0.17 Allowed Glycine 0 N--CA 1.485 1.956 0 CA-C-N 119.95 1.875 . . . . 0.01 110.939 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -119.17 118.94 32.7 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.244 -1.15 . . . . 4.43 110.229 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.45 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.39 135.11 53.85 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.234 -0.586 . . . . 2.99 109.532 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -133.73 129.98 37.46 Favored 'General case' 0 N--CA 1.52 3.042 0 CA-C-O 122.224 1.011 . . . . 6.36 113.067 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -130.07 141.26 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-N 115.511 -0.768 . . . . 1.09 110.406 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.472 ' HG2' ' H ' ' A' ' 130' ' ' LYS . 0.8 OUTLIER -123.64 138.74 54.48 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 107.637 -1.245 . . . . 2.05 107.637 177.033 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 m -123.98 145.62 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 O-C-N 120.664 -1.272 . . . . 1.1 111.032 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -120.27 139.61 52.44 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.958 0.885 . . . . 0.73 110.652 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 3.9 tm-20 -69.16 -33.04 72.78 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.766 -0.652 . . . . 0.02 112.073 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.457 ' O ' ' OG ' ' A' ' 128' ' ' SER . 49.4 mttp -114.22 165.57 12.54 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.902 -1.124 . . . . 3.18 110.229 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.38 163.07 46.43 Favored Glycine 0 N--CA 1.492 2.375 0 CA-C-O 122.007 0.781 . . . . 0.01 111.308 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.59 39.51 27.58 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.532 0.682 . . . . 0.01 111.102 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 52.29 56.04 8.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.727 -0.608 . . . . 0.01 111.003 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -129.08 164.87 22.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.001 -1.111 . . . . 3.15 108.001 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.38 -162.64 28.32 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.081 -1.607 . . . . 0.01 109.081 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -75.51 141.79 42.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.919 -1.342 . . . . 0.01 109.126 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 107' ' ' MET . 9.7 tmm? -116.08 142.79 46.34 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.448 0.642 . . . . 0.01 109.546 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -132.08 135.65 46.61 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.166 -1.05 . . . . 2.48 108.166 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.72 133.93 55.42 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.754 -0.592 . . . . 0.01 109.808 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -148.95 148.25 29.57 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.511 1.148 . . . . 1.69 111.365 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.2 p -114.62 7.84 16.14 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.99 -1.005 . . . . 0.01 109.936 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.82 163.48 19.09 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.429 -0.794 . . . . 3.21 111.183 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.04 154.34 42.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.357 -0.839 . . . . 0.01 109.436 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.423 ' O ' ' OG ' ' A' ' 171' ' ' SER . 51.0 t -126.98 114.6 22.02 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 108.806 -0.812 . . . . 0.01 108.806 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.58 -31.97 5.1 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 120.241 1.122 . . . . 0.01 111.51 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.4 t -142.48 107.67 4.98 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.825 0.822 . . . . 0.02 108.992 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 169' ' ' ILE . 96.7 mt -63.84 -39.31 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.843 -0.535 . . . . 1.83 111.141 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 42.7 ttp -67.37 -37.54 83.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.202 -0.999 . . . . 1.34 110.014 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -69.88 -38.98 76.53 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.504 -1.372 . . . . 2.11 109.852 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -79.82 -47.08 15.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.233 -0.917 . . . . 2.08 112.455 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -110.76 -0.13 17.14 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.365 -0.834 . . . . 0.02 112.655 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 m80 59.33 33.06 22.33 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.738 -1.226 . . . . 0.02 109.272 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.27 135.59 52.76 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 108.652 -0.869 . . . . 0.02 108.652 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -92.56 -23.48 19.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 5.32 110.501 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -149.51 163.78 36.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.207 -0.933 . . . . 0.02 110.028 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.1 mt -131.79 129.68 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 107.427 -1.324 . . . . 2.17 107.427 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -106.07 -13.89 15.32 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.105 -0.997 . . . . 0.02 113.098 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 2.2 p -157.63 156.29 31.57 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.486 -1.384 . . . . 0.01 108.242 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.581 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 18.4 p -164.0 146.91 9.52 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.446 -1.409 . . . . 1.22 109.663 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.472 ' H ' ' HG2' ' A' ' 96' ' ' GLN . 31.7 tttt -121.51 111.48 17.31 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.153 0.977 . . . . 1.41 108.532 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.51 122.9 64.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.054 -1.832 . . . . 0.01 106.054 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.98 69.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 118.12 -1.432 . . . . 1.98 108.391 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.37 108.32 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 106.852 -1.536 . . . . 0.01 106.852 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.68 -174.27 45.95 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.876 -1.29 . . . . 0.01 109.876 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.481 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.7 m -110.47 145.6 37.39 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.364 -1.08 . . . . 2.3 108.901 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.45 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.8 m95 -131.54 145.35 51.69 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.48 -0.762 . . . . 0.01 110.58 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.8 141.88 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 107.519 -1.289 . . . . 1.69 107.519 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.18 143.62 44.52 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 107.657 -1.238 . . . . 2.49 107.657 177.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.1 m-85 -121.51 143.9 49.01 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.79 -0.819 . . . . 0.02 108.79 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.432 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 3.0 tm-20 -73.86 -29.9 62.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.705 -0.622 . . . . 0.02 111.525 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.42 152.84 47.42 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 120.666 -1.272 . . . . 1.48 108.989 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.07 170.61 0.47 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.213 1.276 . . . . 0.02 112.502 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 2.9 m-20 57.93 31.13 20.17 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.18 -0.918 . . . . 0.75 110.996 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 56.54 47.64 18.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.608 -0.682 . . . . 0.02 110.501 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -120.93 163.46 18.2 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.578 -0.702 . . . . 0.02 109.848 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.39 -165.77 31.49 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.971 -1.251 . . . . 0.02 109.971 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -68.06 142.57 55.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.551 -0.97 . . . . 0.02 109.14 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -118.26 148.43 42.43 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.43 -0.582 . . . . 0.02 109.43 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -129.41 142.43 50.8 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.602 ' C ' HD23 ' A' ' 150' ' ' LEU . 5.7 tt -97.41 121.33 39.18 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.384 -0.823 . . . . 0.01 109.333 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.685 HD13 ' HE1' ' A' ' 162' ' ' TRP . 17.0 mt -107.06 138.01 44.04 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.563 -0.711 . . . . 0.01 110.957 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 154' ' ' LYS . 31.8 t70 -110.21 168.98 9.04 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.174 -1.047 . . . . 2.27 108.174 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -53.02 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.845 -1.159 . . . . 1.84 108.834 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 152' ' ' ASP . 92.6 mttt -136.57 168.53 19.31 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.114 0.959 . . . . 2.28 111.584 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -113.1 109.03 18.13 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.152 -1.055 . . . . 0.01 108.152 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.55 114.45 28.1 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.11 -0.994 . . . . 0.01 110.253 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -92.48 -25.99 18.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.199 -0.938 . . . . 0.01 111.319 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -125.75 152.96 73.1 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 120.956 -1.09 . . . . 2.54 108.583 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -60.27 -42.2 44.26 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 CA-C-N 119.377 0.813 . . . . 0.7 110.408 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.7 t -60.28 -21.24 22.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.625 -1.297 . . . . 0.86 108.443 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 43.1 t0 -66.24 -16.04 63.68 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.143 -1.023 . . . . 0.02 109.255 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.685 ' HE1' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -92.97 7.33 44.46 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.892 -1.151 . . . . 0.02 107.892 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.4 9.42 85.89 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.417 -1.473 . . . . 0.02 109.417 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.3 142.43 30.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.63 -0.923 . . . . 0.02 110.142 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.26 -8.23 59.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.708 -0.62 . . . . 0.59 109.553 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.0 t -144.41 151.15 50.27 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.969 -1.082 . . . . 0.87 108.289 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.55 22.11 0.46 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 120.774 0.982 . . . . 0.38 112.369 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.73 122.23 28.36 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.488 1.137 . . . . 0.18 111.79 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 117' ' ' ILE . 9.5 mm -142.15 125.67 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 106.004 -1.85 . . . . 3.99 106.004 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 13.5 mp0 -112.66 -22.14 10.9 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.958 -1.089 . . . . 5.17 112.852 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 34.1 t -156.45 159.65 38.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.327 -2.108 . . . . 0.02 110.044 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.404 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.3 p90 -152.85 153.97 34.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.031 -1.043 . . . . 2.02 110.778 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -145.52 152.05 39.13 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.226 -0.921 . . . . 0.01 110.458 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -88.04 142.82 27.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.6 -0.688 . . . . 0.01 109.397 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.28 128.62 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.215 -0.928 . . . . 3.04 108.999 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.01 146.35 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.244 -0.91 . . . . 1.89 109.545 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 4.89 109.654 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 85.0 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.413 -0.588 . . . . 5.28 109.413 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 11.3 mptt -78.89 52.4 1.24 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.15 -0.969 . . . . 5.96 109.282 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.472 ' H ' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -54.38 -49.39 69.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.118 -0.989 . . . . 2.22 110.718 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.93 119.05 4.2 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 107.122 -2.391 . . . . 0.81 107.122 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.05 145.97 34.27 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.412 -1.475 . . . . 0.01 109.412 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -153.85 138.48 16.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.239 -1.154 . . . . 0.02 109.605 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -130.06 140.54 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 109.473 -0.566 . . . . 0.02 109.473 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.2 130.14 53.55 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.482 -0.761 . . . . 0.39 109.993 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -110.32 140.27 44.67 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.645 -0.659 . . . . 0.02 109.384 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.5 m-85 -121.93 138.14 54.52 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.162 -0.961 . . . . 0.02 109.617 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -69.51 -27.6 65.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.054 . . . . 0.03 111.814 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 12.4 t70 -113.93 169.86 8.7 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.829 -1.169 . . . . 0.03 110.115 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 24.8 mtp180 -75.36 158.12 33.24 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.542 0.687 . . . . 0.03 110.13 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.7 m120 66.23 35.01 6.22 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.774 0.797 . . . . 0.74 110.905 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.3 p90 49.85 44.65 25.16 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.688 0.756 . . . . 0.02 111.316 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -112.86 165.89 11.9 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.064 -1.088 . . . . 0.02 108.064 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.9 -167.47 34.79 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.808 -1.187 . . . . 0.03 110.684 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -68.69 141.92 55.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.515 -0.991 . . . . 2.76 109.152 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -122.95 150.16 43.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.535 -0.728 . . . . 1.89 110.212 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -136.62 133.47 36.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.776 -0.577 . . . . 0.02 109.473 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -109.48 135.91 49.74 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.882 -0.785 . . . . 1.12 108.882 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 45.9 t -127.85 138.43 52.69 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.582 -0.699 . . . . 0.02 109.778 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 14.8 p30 -119.2 11.66 12.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.572 -0.705 . . . . 0.2 110.372 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 21.3 p -159.58 173.58 15.91 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.797 -1.189 . . . . 1.23 109.097 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 9.0 p30 -62.91 145.92 54.09 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.766 -1.208 . . . . 0.02 110.748 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.562 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 19.4 t -134.54 118.68 17.55 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.096 -0.705 . . . . 0.02 109.096 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.19 -21.79 53.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.85 . . . . 0.24 111.697 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -153.82 105.86 2.81 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.893 -1.129 . . . . 1.14 109.82 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.562 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -102.69 8.07 39.64 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.267 -0.896 . . . . 6.37 110.272 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -60.14 -27.69 67.27 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -0.83 . . . . 3.11 111.829 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.0 p -76.32 -16.82 59.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.512 -1.368 . . . . 0.88 111.153 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -106.81 -21.07 13.14 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.287 -0.883 . . . . 0.02 110.644 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 mt -148.77 127.81 12.77 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.959 -1.088 . . . . 3.32 109.399 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.0 t -86.77 -11.8 49.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.647 -0.658 . . . . 0.02 110.582 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -172.03 161.8 5.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.012 -1.055 . . . . 0.02 108.265 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.444 ' SG ' HD12 ' A' ' 79' ' ' LEU . 4.1 p -143.79 116.38 8.65 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.044 -1.035 . . . . 0.02 108.835 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.579 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 2.0 m120 -108.11 -0.77 20.9 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.708 -1.245 . . . . 0.03 111.645 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -154.88 154.04 32.06 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.727 -1.212 . . . . 0.02 107.727 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.2 mt -146.89 147.65 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.902 -1.124 . . . . 0.02 110.728 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.525 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 29.2 ttp180 -123.88 124.69 43.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.119 -1.067 . . . . 0.02 108.119 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.67 113.94 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 106.681 -1.6 . . . . 0.02 106.681 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 69.6 mm-40 -84.75 -34.72 22.79 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.18 -0.608 . . . . 3.81 110.414 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.49 150.55 19.34 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.633 -1.746 . . . . 0.02 110.591 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.74 172.13 48.82 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.25 -1.14 . . . . 0.01 110.25 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 m -118.25 133.86 55.52 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.573 -1.269 . . . . 1.48 107.573 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -126.23 154.61 43.08 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.849 1.309 . . . . 0.02 112.235 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.22 133.76 52.62 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.292 -2.114 . . . . 0.24 105.292 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.447 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.5 m -115.88 141.52 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.467 -0.771 . . . . 0.65 109.241 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -120.21 142.59 48.86 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.028 0.918 . . . . 0.02 109.467 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' ND1' ' A' ' 57' ' ' HIS . 35.6 tt0 -65.54 -33.66 76.43 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.62 -0.718 . . . . 0.02 111.915 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 51' ' ' ARG . 0.6 OUTLIER -124.43 157.59 64.45 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 120.926 -1.109 . . . . 0.02 109.383 -178.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.03 166.08 1.06 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.667 1.578 . . . . 0.02 112.728 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 m120 63.66 36.77 10.6 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.362 -0.835 . . . . 0.02 111.12 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.4 m-85 45.06 51.32 8.94 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.636 0.732 . . . . 3.39 110.747 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 97.1 p -125.54 163.41 22.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.275 0.559 . . . . 2.33 109.837 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.4 -161.41 31.26 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.756 -1.338 . . . . 0.02 109.756 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.516 ' ND1' ' OE1' ' A' ' 50' ' ' GLU . 7.2 m170 -64.43 138.54 58.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.006 -1.291 . . . . 0.02 110.259 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.1 ppp? -119.27 137.44 53.67 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.294 0.569 . . . . 5.01 109.5 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 88.3 m-85 -135.32 139.68 44.51 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.421 -0.799 . . . . 0.02 109.821 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.7 mm -94.27 130.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.831 -0.803 . . . . 1.72 108.831 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.6 110.75 35.2 Favored Pre-proline 0 N--CA 1.506 2.332 0 O-C-N 121.349 -0.844 . . . . 0.02 110.675 -178.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -78.11 169.42 20.37 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 119.869 0.989 . . . . 1.47 110.442 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.53 141.6 24.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.934 -1.104 . . . . 4.25 110.607 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.06 -178.0 31.19 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 119.608 -1.282 . . . . 0.02 110.967 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -119.83 131.4 55.28 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.601 -0.94 . . . . 0.96 109.712 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 50.2 m-85 -121.8 94.84 48.16 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.974 -1.121 . . . . 0.02 107.974 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.84 -4.31 11.03 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 120.908 1.072 . . . . 0.02 113.678 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -157.16 153.96 28.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.611 -1.305 . . . . 2.02 108.143 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -59.53 -38.94 82.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.526 -0.734 . . . . 0.02 111.98 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -59.87 -23.95 63.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.107 -0.995 . . . . 0.02 110.475 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -70.59 -18.69 62.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.883 -0.784 . . . . 3.42 108.883 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.565 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.7 t90 -108.1 10.59 28.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.528 -1.286 . . . . 0.02 107.528 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 73' ' ' MET . 1.5 mpt? 59.34 22.85 11.26 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.502 0.668 . . . . 0.02 110.456 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.34 144.72 45.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.34 -1.504 . . . . 0.02 109.34 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.9 tp -79.31 -30.52 42.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.026 -1.279 . . . . 0.98 107.745 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -157.35 -171.81 3.75 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.475 -1.676 . . . . 0.02 106.475 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.579 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 78.5 m-20 -98.15 28.21 4.16 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.708 -1.245 . . . . 0.02 110.718 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -98.27 123.35 42.31 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.08 -1.013 . . . . 3.2 111.598 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 79' ' ' LEU . 53.6 mt -142.64 120.07 11.66 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.26 -1.385 . . . . 2.61 107.26 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.67 -18.04 10.55 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 121.208 -0.932 . . . . 0.02 112.392 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.487 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 39.6 t -155.63 156.27 34.72 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-N 119.722 1.761 . . . . 0.02 110.816 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.0 p -145.49 147.63 32.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.553 -0.717 . . . . 0.02 110.178 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.413 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.5 mtp180 -136.88 141.72 42.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.542 -0.724 . . . . 0.01 109.116 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 132.71 37.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.074 -1.016 . . . . 0.43 109.254 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -91.35 124.58 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.922 -0.77 . . . . 1.25 108.922 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -91.98 130.9 37.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.817 -1.177 . . . . 1.77 108.402 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mt -96.11 138.84 33.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.92 -1.141 . . . . 1.63 107.92 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.0 t -110.41 126.05 53.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.375 -0.828 . . . . 1.08 108.774 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.7 t -102.37 -154.79 0.5 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 106.109 -1.812 . . . . 1.26 106.109 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.69 -50.66 0.84 Allowed Glycine 0 N--CA 1.497 2.746 0 O-C-N 120.486 -1.383 . . . . 0.01 111.977 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.18 -99.59 0.13 Allowed Glycine 0 N--CA 1.488 2.154 0 C-N-CA 118.662 -1.732 . . . . 0.01 112.172 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -120.08 119.89 34.66 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.298 -1.119 . . . . 4.43 110.707 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.494 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.16 137.95 57.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.835 -0.541 . . . . 2.99 109.559 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.408 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 19.7 ttpp -136.88 130.16 31.29 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 120.915 -1.115 . . . . 6.36 112.973 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.53 141.79 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.535 -0.757 . . . . 1.09 110.35 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 1.3 pt20 -124.69 139.77 53.55 Favored 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 107.666 -1.235 . . . . 2.05 107.666 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.49 146.08 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 O-C-N 120.586 -1.321 . . . . 1.1 111.123 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -120.48 139.99 52.07 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 122.259 1.028 . . . . 0.73 110.855 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -68.08 -32.35 72.62 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.731 -0.668 . . . . 0.02 111.73 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -114.26 167.38 10.75 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.032 -1.042 . . . . 3.18 110.347 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.36 163.81 52.72 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.857 -0.897 . . . . 0.01 110.857 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 58.05 38.29 26.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.986 -0.714 . . . . 0.01 111.618 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 14.9 m-85 52.63 54.76 10.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.417 -0.802 . . . . 0.01 111.234 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -128.1 164.87 21.48 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.957 -1.127 . . . . 3.15 107.957 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.3 -162.21 29.39 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.146 -1.582 . . . . 0.01 109.146 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -75.93 141.37 42.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.817 -1.402 . . . . 0.01 109.179 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.1 tmm? -116.38 143.13 45.95 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.519 0.676 . . . . 0.01 109.566 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -132.23 135.9 46.62 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.315 -0.994 . . . . 2.48 108.315 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -117.01 134.15 55.11 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.68 -0.638 . . . . 0.01 109.715 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -149.11 148.8 30.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.87 -1.144 . . . . 1.69 111.318 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 p -114.88 7.79 15.79 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.1 -0.955 . . . . 0.01 109.829 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -122.26 163.12 20.2 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.614 -0.679 . . . . 3.21 111.227 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.88 155.78 40.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.405 -0.809 . . . . 0.01 109.823 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.494 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 63.3 m -129.55 116.72 18.46 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 109.043 -0.725 . . . . 0.01 109.043 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.83 -30.74 7.16 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.343 1.158 . . . . 0.01 111.49 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.6 m -142.83 108.68 5.15 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.856 0.836 . . . . 0.02 109.195 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 169' ' ' ILE . 94.3 mt -63.98 -39.96 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.873 -0.517 . . . . 1.83 111.057 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.7 ttp -66.38 -37.89 86.3 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.198 -1.001 . . . . 1.34 109.808 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.77 -38.42 76.71 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.537 -1.352 . . . . 2.11 109.696 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.568 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 43.1 tt0 -80.11 -47.64 14.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.91 . . . . 2.08 112.415 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.568 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 80.6 m-85 -111.06 -0.41 16.64 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.354 -0.841 . . . . 0.02 112.848 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 m80 59.68 33.61 21.95 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.799 -1.188 . . . . 0.02 109.463 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 mt -112.46 135.35 53.26 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.579 -0.897 . . . . 0.02 108.579 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -92.68 -23.18 19.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -0.901 . . . . 5.32 110.557 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -148.93 163.37 37.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.163 -0.96 . . . . 0.02 109.949 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.8 mt -131.56 129.33 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 107.523 -1.288 . . . . 2.17 107.523 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -107.11 -13.11 15.25 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.177 -0.952 . . . . 0.02 112.971 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.518 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.88 153.5 29.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.339 -1.476 . . . . 0.01 108.297 178.001 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.1 t -163.36 145.43 9.82 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.317 -1.49 . . . . 1.22 109.757 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -122.45 112.73 18.42 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.248 1.023 . . . . 1.41 109.061 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.63 122.63 63.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 105.924 -1.88 . . . . 0.01 105.924 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 t -146.02 64.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 117.974 -1.491 . . . . 1.98 108.971 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.2 tp10 176.14 108.83 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.641 -1.615 . . . . 0.01 106.641 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.687 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 72.55 -173.1 47.38 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.115 -1.194 . . . . 0.01 110.115 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.25 142.94 42.8 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.318 -1.107 . . . . 2.3 109.043 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.494 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 64.0 m95 -129.42 145.17 51.45 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.458 -0.776 . . . . 0.01 109.849 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.9 mt -118.46 142.78 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.892 -1.151 . . . . 1.69 107.892 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.84 144.14 43.99 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 107.542 -1.281 . . . . 2.49 107.542 177.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 8.0 m-85 -123.11 145.2 48.77 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.069 -0.715 . . . . 0.02 109.069 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -73.72 -30.06 62.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.628 -0.67 . . . . 0.02 112.043 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.33 153.83 47.51 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 120.644 -1.285 . . . . 1.48 109.031 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.35 166.52 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.236 1.291 . . . . 0.02 112.742 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 59.23 31.86 21.54 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.185 -0.916 . . . . 0.75 111.063 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.404 ' CE1' ' CG ' ' A' ' 173' ' ' ARG . 2.0 m-85 57.42 52.42 8.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.02 111.294 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -124.88 163.19 22.76 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.424 -0.797 . . . . 0.02 109.706 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.46 -165.29 32.38 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.835 -1.306 . . . . 0.02 109.835 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -67.99 141.47 56.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.531 -0.982 . . . . 0.02 108.863 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -118.2 148.37 42.44 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.379 -0.6 . . . . 0.02 109.379 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.49 142.76 50.7 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.804 -0.813 . . . . 0.01 108.804 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 151' ' ' LEU . 1.1 tt -98.18 122.26 41.11 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.268 -0.895 . . . . 0.01 109.245 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.591 ' N ' HD23 ' A' ' 150' ' ' LEU . 18.6 mt -105.14 134.21 48.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.435 -0.791 . . . . 0.01 110.141 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 2.6 m-20 -108.35 176.95 4.94 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.504 -0.925 . . . . 2.27 108.504 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.687 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 45.0 mttm -57.73 83.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 1.84 108.456 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 55.3 mmtt -136.51 167.7 20.86 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.971 0.891 . . . . 2.28 111.659 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -112.92 107.33 15.86 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.7 -1.222 . . . . 0.01 107.7 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.585 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 93.1 m-85 -99.09 115.09 28.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.175 -0.953 . . . . 0.01 110.383 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -93.14 -25.21 17.97 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.263 -0.898 . . . . 0.01 111.356 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -125.87 153.81 73.53 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.047 -1.033 . . . . 2.54 108.701 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.38 -42.04 37.12 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 120.436 0.757 . . . . 0.7 110.645 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.04 -20.12 21.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.666 -1.271 . . . . 0.86 108.869 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -65.34 -15.83 62.96 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.926 -1.109 . . . . 0.02 109.705 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.585 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 1.7 m0 -96.85 11.22 36.55 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.73 85.26 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.489 -1.338 . . . . 0.02 110.249 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.7 141.79 32.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.3 -1.118 . . . . 0.02 110.243 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.34 -8.7 58.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.718 -0.614 . . . . 0.59 109.95 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 t -144.22 150.64 49.27 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.934 -1.104 . . . . 0.87 108.651 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.63 21.21 0.49 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 120.717 0.945 . . . . 0.38 112.484 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.64 121.94 27.48 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.466 1.127 . . . . 0.18 111.393 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.401 ' O ' HD12 ' A' ' 117' ' ' ILE . 9.2 mm -143.48 125.66 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 106.048 -1.834 . . . . 3.99 106.048 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -110.94 -20.1 12.56 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.983 -1.073 . . . . 5.17 112.716 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.7 p -158.46 161.97 37.48 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 119.558 -1.964 . . . . 0.02 110.075 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.494 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 8.9 p90 -152.48 153.13 32.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 2.02 110.278 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.404 ' CG ' ' CE1' ' A' ' 144' ' ' TYR . 7.2 mmm180 -143.0 150.08 39.14 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.63 0.729 . . . . 0.01 110.035 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -87.79 142.71 27.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.538 -0.727 . . . . 0.01 109.319 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.1 mt -92.59 128.03 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.065 -1.022 . . . . 3.04 109.021 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.07 146.39 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.247 -0.908 . . . . 1.89 109.546 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 4.89 109.402 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.458 -0.571 . . . . 5.28 109.458 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -78.32 96.87 5.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 5.96 109.498 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.3 p -97.81 40.52 1.16 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.023 -1.048 . . . . 2.22 111.915 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.51 115.18 2.95 Favored Glycine 0 N--CA 1.502 3.071 0 N-CA-C 107.371 -2.292 . . . . 0.81 107.371 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.77 146.39 35.27 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.493 -1.443 . . . . 0.01 109.493 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' NZ ' ' CB ' ' A' ' 6' ' ' LYS . 5.5 ttpm? -152.3 137.61 17.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.18 -1.188 . . . . 0.02 109.978 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.6 139.95 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.302 -0.629 . . . . 0.02 109.302 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -121.04 130.41 53.77 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.484 -0.76 . . . . 0.39 110.183 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.8 m-85 -110.63 140.15 45.23 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.603 -0.686 . . . . 0.02 109.498 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.562 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.3 m-85 -122.98 138.7 54.62 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.182 -0.949 . . . . 0.02 109.921 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 41.9 mm-40 -68.54 -28.13 66.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.047 . . . . 0.03 111.742 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -114.49 170.01 8.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.917 -1.114 . . . . 0.03 110.214 -179.514 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -75.5 158.54 32.43 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.574 0.702 . . . . 0.03 110.051 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.604 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.4 m120 66.06 35.02 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.919 0.866 . . . . 0.74 110.88 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.604 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.9 p90 49.93 44.67 25.4 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.502 -0.772 . . . . 0.02 111.47 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -112.26 166.16 11.53 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.005 -1.109 . . . . 0.02 108.005 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.28 -167.81 36.19 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.792 -1.194 . . . . 0.03 110.478 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -68.43 142.5 55.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.41 -1.053 . . . . 2.76 109.142 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -121.99 149.5 43.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.596 -0.69 . . . . 1.89 110.115 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -135.81 132.24 36.43 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.372 -0.603 . . . . 0.02 109.372 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.07 135.83 49.59 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.859 -0.793 . . . . 1.12 108.859 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 48.2 t -127.34 138.02 52.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.603 -0.686 . . . . 0.02 109.704 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.485 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 23.4 t0 -119.37 11.31 12.17 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.622 -0.674 . . . . 0.2 110.552 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.7 m -158.99 173.51 16.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.791 -1.193 . . . . 1.23 109.002 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.06 146.27 53.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.74 -1.225 . . . . 0.02 110.706 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.548 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 12.2 t -134.52 118.46 17.33 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.018 -0.734 . . . . 0.02 109.018 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.18 -21.44 53.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.814 . . . . 0.24 111.682 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -154.51 106.17 2.71 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.876 -1.14 . . . . 1.14 109.727 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.548 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.83 8.2 41.41 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.336 -0.853 . . . . 6.37 110.105 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -60.45 -28.66 68.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 3.11 112.046 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 p -76.22 -17.7 59.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.404 -1.435 . . . . 0.88 111.176 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -106.94 -21.08 13.13 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.309 -0.869 . . . . 0.02 110.268 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -147.32 126.42 12.91 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.217 -0.927 . . . . 3.32 108.909 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t -86.65 -11.33 51.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.658 -0.652 . . . . 0.02 110.374 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 33.2 ttt180 -171.47 161.67 6.38 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.057 -1.09 . . . . 0.02 108.057 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -144.15 116.59 8.57 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.764 -1.21 . . . . 0.02 108.886 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 -110.12 0.19 18.21 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.767 -1.208 . . . . 0.03 112.132 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.4 t -155.64 153.75 30.54 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.047 -1.094 . . . . 0.02 108.047 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.47 146.81 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.274 1.035 . . . . 0.02 111.049 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -122.86 123.93 42.11 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.535 -1.283 . . . . 0.02 107.535 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.1 t -105.25 113.87 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.777 -1.564 . . . . 0.02 106.777 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -84.66 -35.43 22.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.69 -0.631 . . . . 3.81 110.174 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.54 150.96 20.63 Favored Glycine 0 N--CA 1.487 2.086 0 C-N-CA 118.447 -1.835 . . . . 0.02 110.701 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.7 172.06 48.74 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.347 -1.101 . . . . 0.01 110.347 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.9 m -117.55 133.67 55.71 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.552 -1.277 . . . . 1.48 107.552 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -126.29 154.57 43.24 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.724 1.249 . . . . 0.02 112.223 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.3 133.79 52.61 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.337 -2.097 . . . . 0.24 105.337 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.92 141.16 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.519 -0.738 . . . . 0.65 109.34 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.538 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 27.5 m-85 -120.08 142.62 48.71 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.064 0.935 . . . . 0.02 109.556 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.41 -33.93 77.11 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.526 -0.761 . . . . 0.02 111.855 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -124.85 157.86 64.79 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.92 -1.113 . . . . 0.02 109.58 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.38 166.96 0.96 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.633 1.556 . . . . 0.02 112.824 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 63.28 36.52 11.71 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.258 -0.883 . . . . 0.02 111.084 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.7 m-85 45.31 51.48 9.36 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.71 0.767 . . . . 3.39 110.788 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 p -125.94 163.6 22.62 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.287 0.565 . . . . 2.33 109.954 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.64 -161.79 31.21 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.788 -1.325 . . . . 0.02 109.788 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -64.57 138.62 58.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.257 . . . . 0.02 110.299 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.538 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 47.5 ttp -119.43 137.01 54.04 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.229 0.538 . . . . 5.01 109.635 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.495 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 84.4 m-85 -135.0 140.15 45.43 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.483 -0.761 . . . . 0.02 109.862 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -94.49 130.58 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.773 -0.825 . . . . 1.72 108.773 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.548 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -121.08 111.07 34.16 Favored Pre-proline 0 N--CA 1.506 2.372 0 O-C-N 121.37 -0.832 . . . . 0.02 110.744 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -77.86 169.44 20.63 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 CA-C-N 119.81 0.968 . . . . 1.47 110.557 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -53.6 141.04 26.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.95 -1.094 . . . . 4.25 110.618 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.91 -177.39 32.21 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.447 -1.359 . . . . 0.02 110.834 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -119.41 131.02 55.58 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.516 -0.99 . . . . 0.96 109.668 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.548 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 74.9 m-85 -121.54 97.42 46.93 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.814 -1.18 . . . . 0.02 107.814 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -69.93 -3.62 12.5 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 120.76 0.973 . . . . 0.02 113.766 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -157.28 154.17 28.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.523 -1.36 . . . . 2.02 108.043 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -59.83 -38.72 82.85 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.617 -0.677 . . . . 0.02 111.755 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.62 -24.65 65.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -0.967 . . . . 0.02 110.258 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -68.54 -17.9 64.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.276 -0.89 . . . . 3.42 109.067 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.562 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.5 11.66 26.68 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.754 -1.202 . . . . 0.02 107.754 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 mtp 60.91 22.2 12.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.491 -0.756 . . . . 0.02 110.313 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.14 144.9 46.79 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.615 -1.394 . . . . 0.02 109.615 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.86 -30.63 40.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.134 -1.215 . . . . 0.98 107.843 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -156.96 -171.66 3.74 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.478 -1.675 . . . . 0.02 106.478 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -98.54 28.06 4.42 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.752 -1.218 . . . . 0.02 110.671 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -96.61 122.92 40.06 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.816 -1.178 . . . . 3.2 111.229 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.491 HD21 ' CH2' ' A' ' 72' ' ' TRP . 78.8 mt -142.5 119.88 11.62 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.931 -1.137 . . . . 2.61 107.931 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.86 -18.37 8.94 Favored Glycine 0 N--CA 1.5 2.911 0 O-C-N 121.193 -0.942 . . . . 0.02 112.627 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.442 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 13.2 t -155.75 156.19 34.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.038 -1.86 . . . . 0.02 111.091 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.1 p -146.04 147.99 32.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.514 -0.741 . . . . 0.02 110.335 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.422 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 47.8 mtm180 -136.97 142.02 42.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.482 -0.761 . . . . 0.01 109.13 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.7 131.97 36.82 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.128 -0.983 . . . . 0.43 109.307 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 t -90.66 124.63 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.882 -0.784 . . . . 1.25 108.882 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -92.33 131.35 37.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.893 -1.129 . . . . 1.77 108.583 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -96.4 139.08 33.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.158 -1.053 . . . . 1.63 108.158 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.1 t -110.83 126.61 54.83 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 1.08 108.906 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 m -103.02 -154.62 0.5 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.207 -1.775 . . . . 1.26 106.207 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.43 -50.68 0.83 Allowed Glycine 0 N--CA 1.498 2.774 0 O-C-N 120.454 -1.404 . . . . 0.01 112.213 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.53 -99.75 0.13 Allowed Glycine 0 N--CA 1.487 2.088 0 C-N-CA 118.79 -1.671 . . . . 0.01 112.076 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -119.99 119.59 33.88 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.142 -1.211 . . . . 4.43 110.642 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.405 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.26 135.56 54.62 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.253 -0.579 . . . . 2.99 109.541 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.588 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 52.5 tttp -135.33 131.23 36.18 Favored 'General case' 0 N--CA 1.519 2.985 0 CA-C-O 122.136 0.969 . . . . 6.36 113.066 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.39 142.78 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.737 0.779 . . . . 1.09 110.642 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.495 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.0 pt20 -124.68 139.76 53.56 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 107.581 -1.266 . . . . 2.05 107.581 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.33 146.29 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 O-C-N 120.596 -1.315 . . . . 1.1 111.182 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 24.9 m-85 -120.42 139.79 52.31 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.97 0.89 . . . . 0.73 110.769 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -68.02 -32.49 72.91 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.694 -0.684 . . . . 0.02 112.145 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -114.85 166.24 11.99 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.054 -1.029 . . . . 3.18 110.403 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.48 163.58 46.11 Favored Glycine 0 N--CA 1.492 2.382 0 CA-C-O 122.072 0.818 . . . . 0.01 111.243 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.3 m-20 57.15 39.33 29.02 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.636 0.732 . . . . 0.01 111.071 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 52.38 56.39 7.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.555 -0.715 . . . . 0.01 110.971 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -129.5 165.57 21.38 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.02 -1.104 . . . . 3.15 108.02 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.3 -162.91 28.6 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.222 -1.551 . . . . 0.01 109.222 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -76.04 142.14 41.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.927 -1.337 . . . . 0.01 108.947 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.54 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.4 ttp -116.64 143.34 45.75 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.626 0.727 . . . . 0.01 109.694 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -131.74 136.22 47.43 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.138 -1.06 . . . . 2.48 108.138 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.588 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 44.7 tt0 -115.89 134.05 55.39 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.695 -0.628 . . . . 0.01 109.62 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.57 148.7 28.99 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.519 1.152 . . . . 1.69 111.525 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.8 p -115.24 8.14 15.43 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.863 -1.062 . . . . 0.01 110.295 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -121.97 163.26 19.64 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.359 -0.838 . . . . 3.21 111.308 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.01 155.05 41.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.501 -0.749 . . . . 0.01 109.414 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 32.8 m -128.87 116.93 19.25 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.589 -0.694 . . . . 0.01 109.156 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -74.96 -31.47 6.26 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 CA-C-N 120.386 1.173 . . . . 0.01 111.424 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.0 t -142.65 108.76 5.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.361 -0.837 . . . . 0.02 109.298 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 169' ' ' ILE . 81.9 mt -63.63 -39.51 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.795 -0.565 . . . . 1.83 110.731 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.81 -37.77 85.17 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.265 -0.974 . . . . 1.34 109.936 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -69.76 -38.65 76.83 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.595 -1.316 . . . . 2.11 109.778 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -79.93 -47.4 15.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.228 -0.92 . . . . 2.08 112.456 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -111.03 -0.29 16.7 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.396 -0.815 . . . . 0.02 112.662 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.488 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.7 m-70 59.77 33.14 21.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.79 -1.194 . . . . 0.02 109.464 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 mt -112.33 135.59 52.83 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.684 -0.858 . . . . 0.02 108.684 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -91.7 -22.83 20.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 5.32 110.473 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -149.44 164.06 36.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.152 -0.968 . . . . 0.02 109.858 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.54 129.27 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 107.289 -1.374 . . . . 2.17 107.289 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -107.71 -13.52 15.01 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.243 -0.911 . . . . 0.02 113.184 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -154.5 152.1 29.71 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.47 -1.394 . . . . 0.01 108.19 178.234 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.6 t -161.52 145.14 12.68 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.286 -1.509 . . . . 1.22 109.849 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -119.56 108.53 14.61 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.155 0.979 . . . . 1.41 108.486 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 t -107.5 120.49 58.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 105.797 -1.927 . . . . 0.01 105.797 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.41 68.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 C-N-CA 118.199 -1.401 . . . . 1.98 108.384 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.64 108.18 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.501 -1.666 . . . . 0.01 106.501 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.87 -174.03 43.8 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.899 -1.28 . . . . 0.01 109.899 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.512 ' CG2' HD21 ' A' ' 150' ' ' LEU . 7.5 m -111.69 145.51 39.14 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.335 -1.097 . . . . 2.3 109.191 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.405 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 75.3 m95 -130.6 146.27 52.07 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.492 -0.755 . . . . 0.01 110.492 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.6 mt -118.46 142.17 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 107.83 -1.174 . . . . 1.69 107.83 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -115.06 144.41 43.68 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 107.647 -1.242 . . . . 2.49 107.647 177.409 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.4 m-85 -122.42 145.08 48.62 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.657 -0.868 . . . . 0.02 108.657 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.29 -29.47 61.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.685 -0.634 . . . . 0.02 112.137 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.24 153.79 47.39 Favored Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 120.703 -1.248 . . . . 1.48 109.216 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.37 166.67 1.64 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.132 1.221 . . . . 0.02 112.47 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.4 m120 59.72 31.15 20.69 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.172 -0.922 . . . . 0.75 111.127 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 57.85 51.47 9.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.576 -0.703 . . . . 0.02 111.083 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -124.83 163.63 21.75 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.496 -0.753 . . . . 0.02 109.908 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.03 -165.51 31.79 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.91 -1.276 . . . . 0.02 109.91 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -67.67 141.66 56.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.435 -1.038 . . . . 0.02 108.846 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -117.98 148.18 42.46 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.375 -0.602 . . . . 0.02 109.375 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.456 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.5 t80 -129.69 143.72 50.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.057 -0.72 . . . . 0.01 109.057 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.593 ' C ' HD23 ' A' ' 150' ' ' LEU . 6.1 tt -98.11 121.46 40.06 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.183 -0.948 . . . . 0.01 109.294 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.554 ' N ' HD23 ' A' ' 150' ' ' LEU . 18.4 mt -105.35 136.43 44.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.01 110.319 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 154' ' ' LYS . 52.4 m-20 -108.19 171.29 7.49 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.702 -0.851 . . . . 2.27 108.702 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -57.69 83.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 1.84 108.748 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 152' ' ' ASP . 5.2 tptm -138.08 168.51 19.58 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.166 -0.959 . . . . 2.28 111.356 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -110.18 110.6 21.51 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.081 -1.081 . . . . 0.01 108.081 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.616 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 97.2 m-85 -100.44 116.35 32.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.134 -0.979 . . . . 0.01 110.089 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 7.5 ptp180 -92.05 -26.19 18.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.305 -0.872 . . . . 0.01 111.579 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -125.42 155.53 71.63 Favored Pre-proline 0 N--CA 1.504 2.245 0 O-C-N 120.741 -1.225 . . . . 2.54 107.866 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -62.79 -40.58 35.22 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.554 0.836 . . . . 0.7 110.473 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.75 -20.3 21.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.823 -1.173 . . . . 0.86 108.931 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 161' ' ' ASP . 4.9 m-20 -65.46 -16.02 63.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.953 -1.092 . . . . 0.02 109.804 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.616 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 2.7 m0 -96.72 10.83 37.57 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.164 -1.05 . . . . 0.02 108.164 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.64 12.08 84.73 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.271 -1.442 . . . . 0.02 109.959 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.42 142.01 32.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.467 -1.019 . . . . 0.02 110.159 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.59 -8.4 58.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.747 -0.596 . . . . 0.59 110.098 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 25.1 p -144.53 150.67 48.29 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.754 -1.216 . . . . 0.87 108.813 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.1 21.35 0.52 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 120.741 0.961 . . . . 0.38 112.19 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.667 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -82.69 123.98 29.79 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.595 1.188 . . . . 0.18 111.57 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 168' ' ' ALA . 10.3 mm -143.63 124.69 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.463 -1.68 . . . . 3.99 106.463 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -110.33 -22.02 11.92 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.95 -1.094 . . . . 5.17 112.369 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.6 p -157.4 160.17 38.13 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 119.501 -2.0 . . . . 0.02 109.856 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.439 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 23.5 p90 -153.61 155.26 35.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.08 -1.013 . . . . 2.02 110.696 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -145.42 151.95 39.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.239 -0.913 . . . . 0.01 110.62 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 11.8 ptm180 -87.85 143.16 27.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.648 -0.658 . . . . 0.01 109.357 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.1 mt -93.42 128.6 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.071 -1.018 . . . . 3.04 108.882 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.95 146.66 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.314 -0.866 . . . . 1.89 109.525 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 4.89 109.493 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.538 -0.541 . . . . 5.28 109.538 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -74.85 -134.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.837 . . . . 5.96 109.283 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.9 m -98.91 110.76 23.32 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.531 -1.655 . . . . 2.22 106.531 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.4 94.99 0.1 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 106.626 -2.589 . . . . 0.81 106.626 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.78 147.62 33.99 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.495 -1.042 . . . . 0.01 110.495 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -153.23 138.6 17.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.483 -1.01 . . . . 0.02 109.603 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tt -130.05 140.56 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.186 0.517 . . . . 0.02 109.632 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -121.84 130.25 53.24 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.332 -0.855 . . . . 0.39 110.247 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.7 m-85 -111.19 140.39 45.79 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.501 -0.75 . . . . 0.02 109.75 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.2 m-85 -122.33 138.54 54.48 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.121 -0.987 . . . . 0.02 109.88 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -69.35 -27.5 65.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.03 111.865 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' O ' ' OG ' ' A' ' 38' ' ' SER . 17.2 t70 -113.82 169.43 9.0 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.818 -1.176 . . . . 0.03 110.23 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -75.6 158.32 32.61 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.695 0.76 . . . . 0.03 110.101 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 66.36 33.31 7.08 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.025 0.917 . . . . 0.74 110.956 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 55.23 41.54 31.32 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.023 -0.535 . . . . 0.02 111.273 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -112.37 165.45 12.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.122 -1.066 . . . . 0.02 108.122 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.13 -167.7 34.64 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.888 -1.148 . . . . 0.03 110.289 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -69.1 143.65 54.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.328 -1.101 . . . . 2.76 109.109 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -120.52 150.05 41.45 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.473 0.654 . . . . 1.89 109.719 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -136.36 131.59 34.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.642 -0.661 . . . . 0.02 109.549 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -109.42 134.91 51.27 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.403 -0.811 . . . . 1.12 108.907 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.2 t -127.35 137.55 52.81 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.126 -0.694 . . . . 0.02 109.126 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.95 11.87 12.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.583 -0.698 . . . . 0.2 110.552 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 p -159.93 173.59 15.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.75 -1.219 . . . . 1.23 109.303 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -63.55 146.41 53.74 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.84 -1.163 . . . . 0.02 110.842 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.43 116.92 16.61 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.922 -0.77 . . . . 0.02 108.922 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.13 -22.23 49.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.206 -0.934 . . . . 0.24 111.373 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 28.2 p-10 -149.58 103.18 3.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.194 -1.039 . . . . 1.14 108.194 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 51.3 t80 -105.01 3.46 30.61 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.188 0.994 . . . . 6.37 110.866 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -61.13 -25.46 67.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 3.11 112.232 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 t -77.53 -15.01 59.52 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.366 -1.459 . . . . 0.88 111.342 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -105.31 -20.17 13.58 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.199 -0.938 . . . . 0.02 110.442 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 3.3 tp -151.29 131.84 13.89 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.07 -1.019 . . . . 3.32 109.64 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.9 m -86.8 -11.89 49.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.66 -0.65 . . . . 0.02 111.021 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -172.91 162.12 4.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.787 -1.196 . . . . 0.02 108.575 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' HD12 ' A' ' 79' ' ' LEU . 1.8 p -143.29 116.68 9.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.177 -0.952 . . . . 0.02 108.681 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -108.65 -0.64 20.06 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.65 -1.281 . . . . 0.03 111.474 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 2.8 p -155.43 153.61 30.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.597 -1.26 . . . . 0.02 107.597 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -147.03 148.56 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.187 -0.946 . . . . 0.02 110.619 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.506 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 60.7 ttt180 -125.41 125.48 43.46 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.94 -1.133 . . . . 0.02 107.94 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 t -105.29 114.79 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.71 -1.589 . . . . 0.02 106.71 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 53.8 mm-40 -84.56 -34.53 23.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.491 -0.756 . . . . 3.81 109.991 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.23 151.29 20.44 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 118.451 -1.833 . . . . 0.02 110.807 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.93 171.45 48.26 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.227 -1.149 . . . . 0.01 110.227 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -118.05 133.73 55.64 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.403 -1.332 . . . . 1.48 107.403 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 39.7 m95 -126.96 154.82 44.06 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.622 1.201 . . . . 0.02 112.19 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.17 133.8 52.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.423 -2.066 . . . . 0.24 105.423 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.446 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.6 m -115.95 141.3 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.623 -0.673 . . . . 0.65 109.227 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -120.43 143.0 48.71 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.999 0.904 . . . . 0.02 109.651 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.22 -34.39 78.26 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.599 -0.728 . . . . 0.02 111.826 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -124.84 158.27 63.27 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 120.893 -1.129 . . . . 0.02 109.36 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.54 166.77 1.12 Allowed 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.724 1.616 . . . . 0.02 112.867 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 63.08 37.31 11.66 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.21 -0.905 . . . . 0.02 111.143 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.435 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.0 m-85 44.9 51.92 8.35 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.664 0.745 . . . . 3.39 110.79 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.4 m -125.87 163.5 22.79 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.259 0.552 . . . . 2.33 109.898 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.28 -161.72 31.63 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.842 -1.303 . . . . 0.02 109.842 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 13.0 m170 -64.86 138.46 58.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.061 -1.258 . . . . 0.02 110.227 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.2 ptm -119.23 136.84 54.02 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.24 0.543 . . . . 5.01 109.567 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.441 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 93.8 m-85 -134.48 139.68 45.66 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.551 -0.718 . . . . 0.02 109.937 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.2 mm -94.43 130.5 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.932 -0.766 . . . . 1.72 108.932 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.559 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.56 110.69 35.31 Favored Pre-proline 0 N--CA 1.505 2.314 0 O-C-N 121.409 -0.807 . . . . 0.02 110.781 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -78.14 169.21 20.68 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 CA-C-N 119.898 0.999 . . . . 1.47 110.531 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -54.77 140.23 36.84 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.92 -1.112 . . . . 4.25 110.716 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.81 -176.97 33.16 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.506 -1.331 . . . . 0.02 110.517 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -119.29 130.7 55.53 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.287 -1.125 . . . . 0.96 109.853 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.559 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 83.3 m-85 -121.07 96.98 48.26 Favored Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 107.991 -1.114 . . . . 0.02 107.991 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.17 -4.14 13.04 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.76 0.973 . . . . 0.02 113.621 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -157.45 154.62 29.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.705 -1.247 . . . . 2.02 108.114 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -59.61 -39.05 82.98 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.448 -0.783 . . . . 0.02 111.868 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -59.99 -23.76 63.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.061 -1.025 . . . . 0.02 110.44 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -70.74 -18.55 62.78 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.777 0.798 . . . . 3.42 108.918 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.55 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.11 10.18 28.13 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.421 -1.325 . . . . 0.02 107.421 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 mtt 60.83 22.39 12.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.563 -0.711 . . . . 0.02 110.464 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.08 144.76 46.72 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.512 -1.435 . . . . 0.02 109.512 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.9 tp -79.55 -31.08 41.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -1.19 . . . . 0.98 107.888 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -157.48 -171.93 3.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.553 -1.647 . . . . 0.02 106.553 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.05 28.31 4.06 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.658 -1.276 . . . . 0.02 110.596 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -97.74 122.75 41.21 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.978 -1.076 . . . . 3.2 111.201 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 79' ' ' LEU . 56.9 mt -142.09 119.91 11.92 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.444 -1.317 . . . . 2.61 107.444 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.79 -18.59 9.9 Favored Glycine 0 N--CA 1.498 2.823 0 O-C-N 121.233 -0.917 . . . . 0.02 112.231 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.435 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 17.2 t -155.68 155.97 34.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.112 -1.817 . . . . 0.02 110.68 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.8 p -145.95 148.1 32.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.446 -0.784 . . . . 0.02 110.254 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.417 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 22.2 mtp180 -137.67 142.35 41.13 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.504 -0.747 . . . . 0.01 109.111 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.14 131.75 36.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.207 -0.933 . . . . 0.43 109.478 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -90.49 124.83 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.698 -0.852 . . . . 1.25 108.698 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -91.26 132.25 36.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.969 -1.082 . . . . 1.77 108.319 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mt -99.14 140.47 33.25 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.708 -0.849 . . . . 1.63 108.708 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.6 p -111.18 123.5 50.32 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.096 -1.076 . . . . 1.08 108.096 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 t -114.8 132.62 56.41 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.766 -1.209 . . . . 1.26 107.806 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.48 -47.9 0.01 OUTLIER Glycine 0 N--CA 1.503 3.124 0 C-N-CA 117.754 -2.165 . . . . 0.01 113.465 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.9 -103.38 0.17 Allowed Glycine 0 N--CA 1.486 2.03 0 CA-C-N 120.005 1.902 . . . . 0.01 110.908 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -118.92 118.12 30.66 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.178 -1.19 . . . . 4.43 110.021 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.45 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -65.98 135.02 54.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 120.132 -0.627 . . . . 2.99 109.528 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -134.12 130.57 37.57 Favored 'General case' 0 N--CA 1.517 2.905 0 CA-C-O 122.175 0.988 . . . . 6.36 113.115 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -130.46 141.23 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 115.51 -0.768 . . . . 1.09 110.276 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.467 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 10.9 pt20 -124.09 137.73 54.53 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 107.501 -1.296 . . . . 2.05 107.501 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.4 m -123.69 146.6 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.602 0 O-C-N 120.489 -1.382 . . . . 1.1 111.406 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.52 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 64.6 m-85 -119.4 139.17 52.45 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.137 0.97 . . . . 0.73 110.709 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.37 -32.09 71.93 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 115.853 -0.612 . . . . 0.02 111.797 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -114.78 167.52 10.7 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.964 -1.085 . . . . 3.18 110.485 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.27 164.18 52.39 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 111.057 -0.817 . . . . 0.01 111.057 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 t70 57.6 38.36 27.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.968 -0.725 . . . . 0.01 111.479 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.433 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 14.7 m-85 53.09 54.88 9.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.01 111.352 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -129.13 165.02 22.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.253 -1.018 . . . . 3.15 108.253 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.15 -163.21 28.97 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.24 -1.544 . . . . 0.01 109.24 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.428 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 55.0 tt0 -75.86 142.95 42.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.925 -1.338 . . . . 0.01 109.314 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.52 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.9 ttp -117.4 143.35 46.09 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.505 0.669 . . . . 0.01 109.754 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.428 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 54.2 m-85 -131.91 136.31 47.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.222 -1.029 . . . . 2.48 108.222 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -116.7 134.65 54.55 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.737 -0.602 . . . . 0.01 109.849 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -149.54 147.87 28.69 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.39 1.091 . . . . 1.69 111.272 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.6 p -114.3 7.94 16.58 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.049 -0.978 . . . . 0.01 109.996 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -122.18 163.44 19.54 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.439 -0.788 . . . . 3.21 111.186 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 6.7 p30 -69.19 154.81 41.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.01 109.396 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.403 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 51.2 t -126.64 115.18 22.78 Favored Pre-proline 0 N--CA 1.499 2.025 0 N-CA-C 109.009 -0.737 . . . . 0.01 109.009 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -75.41 -32.41 4.96 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 CA-C-N 120.302 1.143 . . . . 0.01 111.406 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -142.45 107.79 5.02 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.842 0.829 . . . . 0.02 108.995 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.43 -39.43 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.791 -0.568 . . . . 1.83 111.061 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.9 ttt -66.78 -37.21 84.13 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.04 -1.064 . . . . 1.34 109.873 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -70.16 -38.7 75.5 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.673 -1.267 . . . . 2.11 109.871 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -80.14 -47.45 14.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.283 -0.886 . . . . 2.08 112.469 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -110.56 -0.42 17.32 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.337 -0.852 . . . . 0.02 112.675 -176.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.574 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.2 m-70 59.78 32.64 21.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.836 -1.165 . . . . 0.02 109.504 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.2 135.75 52.47 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 108.756 -0.831 . . . . 0.02 108.756 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -92.11 -22.92 19.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 5.32 110.425 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -149.55 163.62 37.35 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.132 -0.98 . . . . 0.02 110.134 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.0 mt -131.76 129.48 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 107.125 -1.435 . . . . 2.17 107.125 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.0 -13.07 15.28 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.193 -0.942 . . . . 0.02 113.015 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.433 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -155.82 153.97 30.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.483 -1.386 . . . . 0.01 108.146 177.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 5.0 t -163.07 145.62 10.36 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.181 -1.574 . . . . 1.22 109.683 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -122.29 110.49 15.75 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.423 1.106 . . . . 1.41 108.767 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.81 122.86 64.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.127 -1.805 . . . . 0.01 106.127 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t -146.63 69.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 118.051 -1.46 . . . . 1.98 108.405 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.1 108.94 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.862 -1.533 . . . . 0.01 106.862 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.88 -174.63 46.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.003 -1.239 . . . . 0.01 110.003 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.451 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.1 m -111.33 144.98 39.64 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.528 -0.984 . . . . 2.3 109.234 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.45 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.2 m95 -131.62 146.84 52.4 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.436 -0.79 . . . . 0.01 110.907 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.4 mt -118.76 141.28 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 107.279 -1.378 . . . . 1.69 107.279 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.68 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.6 142.38 46.04 Favored 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 107.549 -1.278 . . . . 2.49 107.549 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 16.7 m-85 -122.94 145.14 48.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.452 -0.78 . . . . 0.02 109.213 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -74.69 -29.7 61.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.643 -0.66 . . . . 0.02 112.08 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.29 153.41 47.45 Favored Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 120.639 -1.288 . . . . 1.48 109.074 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -54.24 166.85 1.47 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.315 1.344 . . . . 0.02 112.41 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 2.8 m-20 59.43 31.24 20.92 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.062 -0.972 . . . . 0.75 111.081 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.3 m-85 58.1 51.38 8.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.548 -0.72 . . . . 0.02 110.981 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.93 164.01 21.02 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.47 -0.769 . . . . 0.02 109.896 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.37 -165.41 32.57 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.975 -1.25 . . . . 0.02 109.975 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -67.73 141.6 56.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.549 -0.971 . . . . 0.02 108.78 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.1 mp0 -118.52 148.46 42.61 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.219 0.533 . . . . 0.02 109.606 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.95 142.19 51.32 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.61 -0.885 . . . . 0.01 108.61 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 151' ' ' LEU . 4.9 tt -96.28 119.79 35.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.117 -0.99 . . . . 0.01 108.678 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.779 HD13 ' CZ2' ' A' ' 162' ' ' TRP . 1.8 mt -104.29 135.23 46.14 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.527 -0.733 . . . . 0.01 109.985 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 154' ' ' LYS . 1.9 m-20 -110.91 172.8 6.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.356 -0.84 . . . . 2.27 108.867 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -55.04 85.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.161 -0.962 . . . . 1.84 108.635 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 152' ' ' ASP . 19.5 mmtp -137.16 166.48 23.62 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 2.28 111.594 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 6.6 mp0 -112.35 107.47 16.31 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.51 -1.293 . . . . 0.01 107.51 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.625 ' CE2' ' NE1' ' A' ' 162' ' ' TRP . 94.2 m-85 -99.54 113.42 25.81 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.0 -1.063 . . . . 0.01 110.581 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -91.62 -28.18 17.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.329 -0.857 . . . . 0.01 111.392 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 158' ' ' LYS . 8.0 mtmp? -126.46 151.42 72.71 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 120.819 -1.175 . . . . 2.54 108.384 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -58.62 -45.62 28.69 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.352 0.804 . . . . 0.7 111.346 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 160' ' ' VAL . 11.3 t -61.21 -22.56 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.726 -1.234 . . . . 0.86 109.696 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -65.57 -15.69 62.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.723 -1.236 . . . . 0.02 109.928 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.779 ' CZ2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -97.46 11.36 37.02 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.618 -0.882 . . . . 0.02 108.618 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.95 9.27 87.05 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.555 -1.307 . . . . 0.02 110.421 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.2 142.34 30.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.396 -1.061 . . . . 0.02 110.075 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.36 -9.69 57.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.752 -0.592 . . . . 0.59 110.168 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 42.1 m -146.08 150.76 43.0 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 120.648 -1.283 . . . . 0.87 108.928 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.59 21.74 0.55 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.903 1.069 . . . . 0.38 112.397 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.93 125.56 31.52 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.556 1.169 . . . . 0.18 112.063 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.68 HG23 ' CD1' ' A' ' 138' ' ' PHE . 22.0 mt -145.94 125.74 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.778 -1.564 . . . . 3.99 106.778 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -112.16 -21.78 11.3 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.969 -1.082 . . . . 5.17 112.823 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 p -157.16 159.9 38.23 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.427 -2.046 . . . . 0.02 109.749 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.403 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.1 p90 -152.63 154.2 34.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.93 -1.106 . . . . 2.02 110.71 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 25.0 mtp180 -144.17 150.9 38.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.381 -0.824 . . . . 0.01 110.29 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.4 ' H ' ' HG2' ' A' ' 174' ' ' ARG . 33.5 ptt180 -88.07 142.36 27.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.726 . . . . 0.01 109.313 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.73 128.5 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.106 -0.996 . . . . 3.04 109.051 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.9 t -136.39 146.87 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.152 -0.967 . . . . 1.89 109.676 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 4.89 109.417 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.532 -0.544 . . . . 5.28 109.532 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -80.5 -12.05 59.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 5.96 109.714 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.1 m -100.45 110.87 23.08 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.872 -1.529 . . . . 2.22 106.872 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.17 93.89 0.09 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 106.671 -2.572 . . . . 0.81 106.671 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.07 148.01 34.06 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.441 -1.064 . . . . 0.01 110.441 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -152.65 139.12 18.6 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.365 -1.079 . . . . 0.02 109.887 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 tt -130.63 139.6 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.691 -0.631 . . . . 0.02 109.412 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -121.28 130.31 53.59 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.545 -0.722 . . . . 0.39 109.938 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.5 m-85 -110.49 139.65 45.52 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.652 -0.655 . . . . 0.02 109.578 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.9 m-85 -121.41 137.88 54.51 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.237 -0.914 . . . . 0.02 109.531 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.56 -27.42 65.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.843 -1.16 . . . . 0.03 111.731 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -113.78 169.73 8.77 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.821 -1.174 . . . . 0.03 110.114 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -75.7 158.06 32.81 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.63 0.729 . . . . 0.03 110.13 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.411 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 1.8 m-20 66.44 33.34 6.91 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.96 0.886 . . . . 0.74 111.046 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.411 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.69 41.66 30.19 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.271 0.557 . . . . 0.02 111.259 177.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -113.31 165.51 12.36 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.376 -0.972 . . . . 0.02 108.376 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.25 -167.62 34.39 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.898 -1.144 . . . . 0.03 110.554 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -69.02 142.68 54.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.46 -1.023 . . . . 2.76 108.941 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -122.53 150.24 42.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.587 -0.695 . . . . 1.89 110.079 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -136.43 133.08 36.26 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.131 -0.692 . . . . 0.02 109.131 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -109.45 135.79 49.9 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.507 -0.923 . . . . 1.12 108.507 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.6 t -127.82 138.04 52.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.635 -0.665 . . . . 0.02 109.348 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -118.45 12.32 13.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.654 -0.654 . . . . 0.2 110.128 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.6 t -159.81 173.77 15.48 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.888 -1.133 . . . . 1.23 109.164 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -62.79 146.09 53.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.807 -1.183 . . . . 0.02 110.708 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.1 m -133.36 117.33 17.16 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.84 -0.8 . . . . 0.02 108.84 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.79 -20.91 48.66 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.271 -0.893 . . . . 0.24 111.758 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -151.82 105.36 3.11 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.804 -1.185 . . . . 1.14 109.342 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.15 5.82 42.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.402 -0.811 . . . . 6.37 110.291 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -62.75 -29.36 70.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.373 -0.83 . . . . 3.11 112.708 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.6 p -77.49 -18.66 56.87 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.198 -1.564 . . . . 0.88 111.605 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -107.33 -19.29 13.63 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.315 -0.866 . . . . 0.02 110.089 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -148.94 127.08 12.04 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.046 . . . . 3.32 109.258 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 p -87.72 -12.45 45.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.453 -0.779 . . . . 0.02 111.389 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -171.49 160.84 6.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.793 -1.192 . . . . 0.02 108.446 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.78 116.35 8.64 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.031 -1.043 . . . . 0.02 108.97 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 -109.83 0.49 18.78 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.856 -1.153 . . . . 0.03 111.987 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 t -156.2 154.45 30.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.325 -0.991 . . . . 0.02 108.325 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mt -146.57 146.95 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.02 -1.05 . . . . 0.02 111.001 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -122.84 124.07 42.45 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.487 -1.301 . . . . 0.02 107.487 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.35 114.15 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.774 -1.565 . . . . 0.02 106.774 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -84.16 -34.05 24.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.574 -0.704 . . . . 3.81 110.552 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.22 150.74 19.87 Favored Glycine 0 N--CA 1.484 1.897 0 C-N-CA 118.977 -1.583 . . . . 0.02 110.775 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.4 172.22 48.81 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 119.988 -1.101 . . . . 0.01 110.488 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -118.16 134.47 54.98 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.631 -1.248 . . . . 1.48 107.631 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -127.29 154.52 44.81 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 122.508 1.147 . . . . 0.02 112.112 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.38 134.45 51.81 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 105.625 -1.991 . . . . 0.24 105.625 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.94 142.1 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -0.762 . . . . 0.65 109.316 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -121.08 143.61 48.99 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.032 0.92 . . . . 0.02 109.688 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -65.13 -34.04 77.46 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.604 -0.725 . . . . 0.02 111.791 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -124.43 157.78 63.8 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 121.001 -1.062 . . . . 0.02 109.51 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.38 166.87 0.99 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.613 1.542 . . . . 0.02 112.814 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 63.65 36.73 10.64 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.243 -0.89 . . . . 0.02 111.039 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 45.03 51.46 8.8 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.667 0.746 . . . . 3.39 110.617 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.7 m -125.9 163.65 22.49 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.184 0.516 . . . . 2.33 109.898 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.65 -161.95 31.32 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.821 -1.311 . . . . 0.02 109.821 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -64.9 138.78 58.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.999 -1.295 . . . . 0.02 110.103 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 58' ' ' MET . 2.7 ppp? -119.89 137.6 53.92 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.773 -0.579 . . . . 5.01 109.817 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.559 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 85.4 m-85 -134.87 140.19 45.6 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.408 -0.808 . . . . 0.02 109.944 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mm -95.18 130.72 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.972 -0.751 . . . . 1.72 108.972 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.4 mt -121.86 111.66 32.52 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.374 -0.829 . . . . 0.02 110.802 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.67 170.35 19.29 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 119.859 0.985 . . . . 1.47 110.329 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -52.59 141.01 21.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.904 -1.123 . . . . 4.25 110.357 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.19 -177.54 32.35 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.41 -1.376 . . . . 0.02 110.785 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -120.1 131.33 55.02 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.408 -1.054 . . . . 0.96 109.878 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -122.21 94.79 47.74 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.931 -1.137 . . . . 0.02 107.931 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.88 -3.98 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.078 1.185 . . . . 0.02 113.855 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -157.58 154.55 28.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.608 -1.308 . . . . 2.02 108.213 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -59.49 -39.35 83.46 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.409 -0.807 . . . . 0.02 111.935 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -60.04 -24.02 64.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.081 -1.012 . . . . 0.02 110.573 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -70.37 -18.32 63.05 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.936 0.874 . . . . 3.42 108.828 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.559 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.1 t90 -107.49 11.17 29.06 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.324 -1.362 . . . . 0.02 107.324 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.1 mmt 60.41 22.28 11.87 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.51 0.671 . . . . 0.02 110.286 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.49 144.26 45.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.505 -1.438 . . . . 0.02 109.505 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.5 tp -79.13 -30.18 43.57 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.699 -1.223 . . . . 0.98 107.699 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.415 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 15.0 t-20 -157.2 -171.9 3.8 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.47 -1.678 . . . . 0.02 106.47 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.415 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 84.4 m-20 -98.81 28.21 4.45 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.789 -1.195 . . . . 0.02 110.639 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -96.52 123.05 40.06 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.971 -1.081 . . . . 3.2 111.1 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.541 HD21 ' CH2' ' A' ' 72' ' ' TRP . 81.2 mt -141.57 119.28 11.76 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.772 -1.196 . . . . 2.61 107.772 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.51 -18.94 9.14 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 121.144 -0.973 . . . . 0.02 112.389 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 p -156.08 156.2 33.93 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 119.738 1.769 . . . . 0.02 110.793 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.78 147.95 32.43 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.471 -0.768 . . . . 0.02 110.327 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -137.38 142.16 41.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.423 -0.798 . . . . 0.01 109.267 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.29 132.46 36.47 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.145 -0.972 . . . . 0.43 109.583 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.16 124.89 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.806 -0.813 . . . . 1.25 108.806 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 86' ' ' HIS . 1.6 m80 -91.11 132.81 35.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.919 -1.113 . . . . 1.77 108.424 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 mt -99.36 139.61 34.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.838 -0.801 . . . . 1.63 108.838 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.6 t -110.85 123.79 50.79 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.969 -1.123 . . . . 1.08 107.969 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.9 p -114.79 132.1 56.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.654 -1.279 . . . . 1.26 107.689 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.76 -48.97 0.01 OUTLIER Glycine 0 N--CA 1.503 3.129 0 C-N-CA 117.652 -2.214 . . . . 0.01 113.299 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.17 -103.93 0.17 Allowed Glycine 0 N--CA 1.488 2.105 0 CA-C-N 119.82 1.81 . . . . 0.01 110.963 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -118.99 118.41 31.41 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.244 -1.15 . . . . 4.43 110.184 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.453 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -65.87 135.07 54.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.811 -0.556 . . . . 2.99 109.527 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -133.68 129.97 37.54 Favored 'General case' 0 N--CA 1.519 2.994 0 CA-C-O 122.187 0.994 . . . . 6.36 113.055 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -131.84 141.46 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 115.505 -0.77 . . . . 1.09 110.248 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.438 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.3 pt20 -124.41 139.53 53.81 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 107.399 -1.334 . . . . 2.05 107.399 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.76 145.84 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 120.657 -1.277 . . . . 1.1 110.917 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -120.42 139.67 52.48 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.084 0.945 . . . . 0.73 110.929 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -68.31 -32.24 72.24 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.712 -0.676 . . . . 0.02 111.895 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -114.68 167.7 10.53 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.976 -1.077 . . . . 3.18 110.181 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.36 163.7 52.79 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.741 -0.943 . . . . 0.01 110.741 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 58.12 37.79 26.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.821 -0.811 . . . . 0.01 111.604 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.527 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 28.6 m-85 53.33 54.69 9.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.01 111.253 177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -128.15 164.3 22.78 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.079 -1.082 . . . . 3.15 108.079 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.32 -162.4 29.49 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.913 -1.675 . . . . 0.01 108.913 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -75.82 141.67 42.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.958 -1.319 . . . . 0.01 109.28 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.1 tmm? -116.54 143.23 45.86 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.518 0.675 . . . . 0.01 109.304 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -132.48 136.36 46.64 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.337 -0.986 . . . . 2.48 108.337 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -116.38 134.23 55.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.704 -0.622 . . . . 0.01 109.814 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.9 t -149.35 147.57 28.48 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.901 -1.125 . . . . 1.69 111.336 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.9 p -115.03 7.61 15.54 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.996 -1.002 . . . . 0.01 110.19 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -121.77 163.22 19.47 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.411 -0.806 . . . . 3.21 111.109 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -69.44 154.78 41.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.351 -0.843 . . . . 0.01 109.491 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.608 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 20.5 p -126.53 119.77 23.11 Favored Pre-proline 0 N--CA 1.502 2.126 0 N-CA-C 109.22 -0.659 . . . . 0.01 109.22 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -77.01 -33.11 2.88 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 120.341 1.158 . . . . 0.01 110.638 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 t -143.24 108.8 5.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.438 -0.789 . . . . 0.02 109.103 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.99 -39.31 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.731 -0.606 . . . . 1.83 110.823 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.7 ttp -67.18 -36.74 82.43 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.174 -1.01 . . . . 1.34 109.881 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.95 -38.79 76.23 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.575 -1.328 . . . . 2.11 109.668 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.567 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 42.4 tt0 -80.34 -46.6 15.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.345 -0.847 . . . . 2.08 112.509 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.567 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 53.1 m-85 -110.29 -0.45 17.7 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.281 -0.887 . . . . 0.02 112.623 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.7 m80 59.65 33.01 21.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.738 -1.226 . . . . 0.02 109.495 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.0 mt -112.45 135.71 52.83 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 108.71 -0.848 . . . . 0.02 108.71 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -92.4 -22.9 19.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 5.32 110.581 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -149.02 163.33 37.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.184 -0.948 . . . . 0.02 109.947 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.6 mt -131.75 129.19 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.452 -1.314 . . . . 2.17 107.452 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -106.81 -13.4 15.26 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.2 -0.938 . . . . 0.02 113.172 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.32 153.58 30.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.333 -1.479 . . . . 0.01 108.186 178.195 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 8.6 t -160.52 147.01 15.42 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.318 -1.489 . . . . 1.22 109.904 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -121.79 108.28 13.31 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.029 0.919 . . . . 1.41 108.623 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.15 121.06 60.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.068 -1.827 . . . . 0.01 106.068 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t -146.83 69.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 118.182 -1.407 . . . . 1.98 108.42 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.66 109.04 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.634 -1.617 . . . . 0.01 106.634 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.35 -174.1 45.2 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.819 -1.312 . . . . 0.01 109.819 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.458 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.5 m -111.4 143.62 41.93 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.526 -0.984 . . . . 2.3 109.147 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.453 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 72.5 m95 -129.92 144.97 51.6 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.403 -0.811 . . . . 0.01 110.481 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.7 mt -117.61 141.36 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.504 -1.295 . . . . 1.69 107.504 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.31 143.55 44.69 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 107.528 -1.286 . . . . 2.49 107.528 177.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 9.4 m-85 -122.46 144.88 48.78 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.903 -0.777 . . . . 0.02 108.903 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -74.33 -29.82 61.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.729 -0.607 . . . . 0.02 112.119 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.56 153.54 47.78 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 120.805 -1.184 . . . . 1.48 109.083 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.23 166.86 1.46 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.232 1.288 . . . . 0.02 112.7 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 59.54 30.9 20.58 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.235 -0.893 . . . . 0.75 111.029 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.77 51.57 9.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.574 -0.704 . . . . 0.02 110.924 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -124.58 163.66 21.47 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.55 -0.719 . . . . 0.02 109.732 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.52 -165.17 32.22 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.843 -1.303 . . . . 0.02 109.843 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -67.92 141.77 56.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.607 -0.937 . . . . 0.02 108.921 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -118.26 149.03 41.81 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.155 -0.683 . . . . 0.02 109.155 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -129.5 142.54 50.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.486 -0.759 . . . . 0.01 109.049 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.557 ' C ' HD23 ' A' ' 150' ' ' LEU . 5.8 tt -96.96 121.45 38.85 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.217 -0.927 . . . . 0.01 109.079 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.644 HD22 ' NE1' ' A' ' 162' ' ' TRP . 18.8 mt -105.8 135.32 47.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.545 -0.722 . . . . 0.01 110.71 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 154' ' ' LYS . 29.4 t70 -108.68 172.71 6.68 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.015 -1.106 . . . . 2.27 108.015 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -57.08 85.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.964 -1.085 . . . . 1.84 108.483 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 152' ' ' ASP . 52.2 tttp -135.79 167.04 21.9 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.303 1.049 . . . . 2.28 111.428 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.414 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 29.5 mt-10 -110.92 108.29 18.02 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.209 -1.034 . . . . 0.01 108.209 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.83 114.36 26.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.063 -1.023 . . . . 0.01 110.272 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -91.46 -27.12 18.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.101 -0.999 . . . . 0.01 111.506 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -125.82 153.77 73.39 Favored Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.027 -1.046 . . . . 2.54 108.692 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.58 -42.91 36.25 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 CA-C-N 119.171 0.74 . . . . 0.7 110.745 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.9 t -60.63 -20.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.648 -1.282 . . . . 0.86 108.642 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -65.44 -15.96 63.16 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.908 -1.12 . . . . 0.02 109.432 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.644 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -95.17 9.76 38.45 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.939 -1.134 . . . . 0.02 107.939 178.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.87 10.48 86.1 Favored Glycine 0 N--CA 1.485 1.963 0 C-N-CA 119.3 -1.429 . . . . 0.02 109.813 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.41 142.23 31.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.547 -0.972 . . . . 0.02 110.164 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.63 -8.37 58.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.682 -0.636 . . . . 0.59 109.783 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 t -144.66 150.71 47.94 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.758 -1.214 . . . . 0.87 108.696 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.84 21.54 0.5 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 120.735 0.957 . . . . 0.38 112.322 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.15 123.76 29.85 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.508 1.147 . . . . 0.18 111.649 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.6 mt -146.4 126.77 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.663 -1.606 . . . . 3.99 106.663 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -112.45 -20.15 11.88 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.04 -1.038 . . . . 5.17 112.982 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 11.9 p -157.69 160.83 38.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 119.353 -2.092 . . . . 0.02 110.19 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.608 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 5.2 p90 -152.46 154.28 35.22 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.149 -0.969 . . . . 2.02 110.784 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -144.79 151.85 39.45 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.105 -0.997 . . . . 0.01 110.708 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -88.21 143.75 26.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.68 -0.638 . . . . 0.01 109.33 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.17 129.26 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.137 -0.977 . . . . 3.04 109.083 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.5 t -136.14 146.57 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.269 -0.895 . . . . 1.89 109.62 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.295 -0.878 . . . . 4.89 109.434 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' LYS . 38.8 m . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.543 -0.54 . . . . 5.28 109.543 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 1' ' ' SER . 44.8 mttp 54.69 103.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 5.96 109.433 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.0 m -99.74 113.31 25.7 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 106.461 -1.681 . . . . 2.22 106.461 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.52 95.33 0.1 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 106.477 -2.649 . . . . 0.81 106.477 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.21 147.93 33.74 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.406 -1.078 . . . . 0.01 110.406 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -152.57 138.56 18.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.421 -1.047 . . . . 0.02 109.879 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.05 139.24 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.215 -0.661 . . . . 0.02 109.215 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -121.85 130.94 53.77 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.459 -0.776 . . . . 0.39 109.861 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 m-85 -110.89 140.41 45.39 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.656 -0.653 . . . . 0.02 109.633 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 4.8 m-85 -122.07 138.41 54.45 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.317 -0.865 . . . . 0.02 109.402 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -69.27 -27.43 65.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.144 . . . . 0.03 111.869 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -114.08 169.97 8.62 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.852 -1.155 . . . . 0.03 110.257 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -75.41 158.48 32.64 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.535 0.684 . . . . 0.03 109.986 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.1 t30 65.7 35.05 7.14 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.891 0.853 . . . . 0.74 110.75 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.4 p90 50.03 44.78 25.7 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.681 0.753 . . . . 0.02 111.342 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -112.16 165.73 11.89 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.986 -1.116 . . . . 0.02 107.986 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.21 -167.74 34.57 Favored Glycine 0 N--CA 1.494 2.567 0 C-N-CA 119.87 -1.157 . . . . 0.03 110.559 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -68.95 143.18 54.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -1.108 . . . . 2.76 108.861 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 50.1 ttt180 -122.19 149.26 43.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.564 -0.71 . . . . 1.89 110.225 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -135.91 132.2 36.18 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.18 -0.674 . . . . 0.02 109.18 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -109.65 136.57 48.81 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.396 -0.815 . . . . 1.12 108.928 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 t -128.03 137.85 52.35 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.553 -0.717 . . . . 0.02 109.593 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.39 11.85 13.15 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.661 -0.649 . . . . 0.2 110.139 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 36.7 t -159.53 174.15 15.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.896 -1.128 . . . . 1.23 108.913 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.404 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -62.85 145.86 54.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.63 -1.294 . . . . 0.02 110.599 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.519 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 12.7 p -134.93 119.36 17.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.5 -0.75 . . . . 0.02 109.152 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.0 -21.08 47.53 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.289 -0.882 . . . . 0.24 112.376 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -152.41 107.02 3.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.67 -1.269 . . . . 1.14 110.14 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.48 5.95 39.79 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.375 -0.828 . . . . 6.37 110.442 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -61.42 -30.25 70.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 3.11 112.186 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.7 t -76.94 -17.31 58.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.389 -1.444 . . . . 0.88 111.124 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -106.99 -20.84 13.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.403 -0.811 . . . . 0.02 110.755 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.07 127.2 12.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.979 -1.076 . . . . 3.32 109.663 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 t -87.01 -12.39 47.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.57 -0.706 . . . . 0.02 111.032 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -172.8 161.72 4.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.781 -1.199 . . . . 0.02 108.467 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.445 ' SG ' HD12 ' A' ' 79' ' ' LEU . 3.4 p -143.49 116.55 8.9 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.1 -1.0 . . . . 0.02 108.876 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -108.28 -0.04 21.04 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.813 -1.179 . . . . 0.03 111.287 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 t -156.46 154.34 30.26 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.965 -1.124 . . . . 0.02 107.965 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 39' ' ' ILE . 9.0 mt -146.96 148.13 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.057 -1.027 . . . . 0.02 110.554 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -123.54 124.81 43.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.2 -1.037 . . . . 0.02 108.2 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.66 114.31 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 106.768 -1.567 . . . . 0.02 106.768 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -83.99 -34.1 24.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.717 -0.614 . . . . 3.81 110.629 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.54 151.19 20.58 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.019 -1.563 . . . . 0.02 110.688 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.09 172.41 49.12 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.934 -1.127 . . . . 0.01 110.496 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -118.15 133.98 55.42 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.548 -1.278 . . . . 1.48 107.548 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -126.36 154.74 43.13 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.685 -1.26 . . . . 0.02 112.196 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.61 133.93 52.53 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.543 -2.021 . . . . 0.24 105.543 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.465 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.5 m -116.86 142.6 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.565 -0.709 . . . . 0.65 109.451 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -120.7 142.74 49.21 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.053 0.93 . . . . 0.02 109.596 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.433 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 38.0 tt0 -65.11 -33.54 76.27 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.593 -0.73 . . . . 0.02 111.786 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -124.45 157.71 64.1 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 120.988 -1.07 . . . . 0.02 109.444 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.23 166.63 0.99 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.61 1.54 . . . . 0.02 112.71 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m120 63.44 36.42 11.39 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 115.355 -0.839 . . . . 0.02 111.016 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.527 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.3 m-85 45.37 51.41 9.53 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.528 0.68 . . . . 3.39 110.742 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 p -125.75 163.7 22.27 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.27 0.557 . . . . 2.33 109.948 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.46 -161.54 31.26 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.882 -1.287 . . . . 0.02 109.882 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 13.8 m80 -64.25 138.79 58.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.045 -1.268 . . . . 0.02 110.161 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.1 ppp? -119.09 137.17 53.75 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.397 0.618 . . . . 5.01 109.65 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 88.3 m-85 -135.27 139.29 44.29 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.419 -0.801 . . . . 0.02 109.765 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 mm -96.25 131.03 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.715 -0.846 . . . . 1.72 108.715 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.478 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.9 mt -121.69 111.9 32.67 Favored Pre-proline 0 N--CA 1.505 2.305 0 O-C-N 121.344 -0.848 . . . . 0.02 110.757 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.46 170.1 19.93 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 119.892 0.997 . . . . 1.47 110.325 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -52.63 141.09 21.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.991 -1.068 . . . . 4.25 110.42 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.71 -177.9 31.76 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.437 -1.363 . . . . 0.02 110.782 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -120.04 131.57 55.16 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.401 -1.058 . . . . 0.96 109.659 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CE1' HD22 ' A' ' 61' ' ' LEU . 92.6 m-85 -121.32 97.95 47.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.941 -1.133 . . . . 0.02 107.941 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -70.17 -3.88 13.18 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.678 0.919 . . . . 0.02 113.6 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -157.39 154.2 28.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.549 -1.344 . . . . 2.02 107.989 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -59.83 -38.49 82.2 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.432 -0.792 . . . . 0.02 111.872 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -59.71 -24.38 63.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.051 . . . . 0.02 110.433 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -70.22 -18.81 63.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.863 0.84 . . . . 3.42 108.978 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.55 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.6 t90 -108.25 10.08 27.87 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.493 -1.299 . . . . 0.02 107.493 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.3 mtm 60.84 21.84 11.95 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.484 0.659 . . . . 0.02 110.535 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.61 144.3 46.06 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.388 -1.485 . . . . 0.02 109.388 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 mt -78.84 -30.57 45.27 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.687 -1.227 . . . . 0.98 107.687 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -157.32 -171.31 3.56 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.335 -1.728 . . . . 0.02 106.335 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -98.32 29.06 3.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.639 -1.288 . . . . 0.02 110.595 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -97.94 122.65 41.31 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.899 -1.126 . . . . 3.2 111.448 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.465 HD22 ' HB ' ' A' ' 48' ' ' VAL . 57.1 mt -142.76 119.78 11.36 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.45 -1.315 . . . . 2.61 107.45 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.94 -17.89 10.53 Favored Glycine 0 N--CA 1.497 2.762 0 O-C-N 121.296 -0.878 . . . . 0.02 112.25 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 31.2 t -155.17 155.83 34.64 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.189 -1.771 . . . . 0.02 110.856 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 47.8 t -145.42 148.17 33.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.463 -0.773 . . . . 0.02 110.233 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -137.52 141.67 41.44 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.482 -0.761 . . . . 0.01 109.038 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.06 133.73 36.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.43 109.405 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 t -91.92 124.58 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.98 -0.748 . . . . 1.25 108.98 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -92.75 131.96 37.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.958 -1.089 . . . . 1.77 108.507 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.15 138.8 33.23 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.134 -1.061 . . . . 1.63 108.134 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 t -110.84 126.67 54.9 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.758 -0.83 . . . . 1.08 108.758 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.4 m -103.22 -154.49 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.23 -1.767 . . . . 1.26 106.23 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.06 -50.55 0.84 Allowed Glycine 0 N--CA 1.497 2.723 0 O-C-N 120.527 -1.358 . . . . 0.01 112.09 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.67 -100.2 0.14 Allowed Glycine 0 N--CA 1.487 2.076 0 C-N-CA 118.76 -1.686 . . . . 0.01 111.995 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -120.03 119.73 34.23 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.164 -1.198 . . . . 4.43 110.523 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.455 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.44 136.45 55.74 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.177 -0.609 . . . . 2.99 109.463 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -134.7 130.57 36.49 Favored 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 122.163 0.982 . . . . 6.36 112.942 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -132.08 142.07 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.675 0.75 . . . . 1.09 110.532 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.425 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.9 pt20 -124.82 139.83 53.48 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 107.686 -1.228 . . . . 2.05 107.686 176.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -124.07 145.71 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.495 0 O-C-N 120.607 -1.308 . . . . 1.1 111.121 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -120.47 140.17 51.8 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 122.081 0.943 . . . . 0.73 110.852 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -68.66 -32.58 72.51 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.652 -0.704 . . . . 0.02 111.929 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -114.57 165.47 12.73 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.978 -1.076 . . . . 3.18 110.228 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 163.39 45.42 Favored Glycine 0 N--CA 1.494 2.532 0 CA-C-O 122.022 0.79 . . . . 0.01 111.264 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 t70 57.01 39.4 29.37 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.595 0.712 . . . . 0.01 111.1 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 52.15 56.2 8.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.509 -0.744 . . . . 0.01 111.03 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -129.23 165.03 22.17 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.839 -1.171 . . . . 3.15 107.839 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.07 -162.78 28.8 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 108.963 -1.655 . . . . 0.01 108.963 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -75.33 141.24 43.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.775 -1.426 . . . . 0.01 109.001 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.1 tmm? -116.3 143.37 45.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.604 0.716 . . . . 0.01 109.526 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -132.41 136.65 46.92 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.309 -0.997 . . . . 2.48 108.309 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -116.21 134.42 54.94 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.632 -0.668 . . . . 0.01 109.635 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -149.68 148.08 28.85 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.532 1.158 . . . . 1.69 111.437 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 p -115.09 7.88 15.55 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.936 -1.029 . . . . 0.01 109.985 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -122.16 163.26 19.85 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.437 -0.79 . . . . 3.21 111.236 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.55 154.31 42.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.01 109.471 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.429 ' O ' ' OG ' ' A' ' 171' ' ' SER . 44.2 t -127.07 115.99 21.9 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 109.096 -0.705 . . . . 0.01 109.096 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.45 -32.95 4.51 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.324 1.151 . . . . 0.01 111.604 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.7 m -142.07 108.59 5.32 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.379 -0.826 . . . . 0.02 109.237 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 169' ' ' ILE . 95.9 mt -64.37 -40.02 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.787 -0.571 . . . . 1.83 111.019 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.0 ttp -66.76 -37.6 84.94 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.021 -1.071 . . . . 1.34 109.76 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -69.81 -38.53 76.62 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.538 -1.351 . . . . 2.11 109.817 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.526 ' OE1' ' CG ' ' A' ' 121' ' ' PHE . 7.9 tm0? -80.49 -47.61 14.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.281 -0.887 . . . . 2.08 112.282 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.526 ' CG ' ' OE1' ' A' ' 120' ' ' GLN . 92.1 m-85 -110.72 -0.85 16.93 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.389 -0.819 . . . . 0.02 112.748 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.9 m80 60.1 33.24 21.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.748 -1.22 . . . . 0.02 109.483 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 mt -112.42 135.67 52.84 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.802 -0.814 . . . . 0.02 108.802 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -92.3 -23.14 19.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.313 -0.867 . . . . 5.32 110.365 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -148.92 163.57 37.08 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.151 -0.968 . . . . 0.02 109.957 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.2 mt -131.6 129.43 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 107.473 -1.306 . . . . 2.17 107.473 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -107.82 -13.26 15.04 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.25 -0.906 . . . . 0.02 113.171 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.5 OUTLIER -153.87 152.1 30.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.355 -1.466 . . . . 0.01 108.206 178.342 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.2 t -160.72 145.04 13.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.29 -1.506 . . . . 1.22 109.651 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -120.86 108.82 14.38 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.099 0.952 . . . . 1.41 108.714 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.12 120.68 59.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 105.771 -1.937 . . . . 0.01 105.771 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 t -146.43 68.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 118.209 -1.397 . . . . 1.98 108.341 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.62 108.75 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.563 -1.643 . . . . 0.01 106.563 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.89 -174.16 40.52 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.693 -1.363 . . . . 0.01 109.693 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 m -111.62 144.88 40.16 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.37 -1.076 . . . . 2.3 109.12 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.455 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 71.5 m95 -129.69 146.47 51.46 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.537 -0.727 . . . . 0.01 110.263 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.2 mt -118.0 141.3 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.583 -1.266 . . . . 1.69 107.583 177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.1 143.66 44.43 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.77 -1.196 . . . . 2.49 107.77 177.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.502 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.5 m-85 -122.63 143.75 49.56 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.535 -0.728 . . . . 0.02 109.052 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -73.21 -29.61 62.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.514 -0.741 . . . . 0.02 111.98 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.31 153.54 47.48 Favored Pre-proline 0 N--CA 1.505 2.318 0 O-C-N 120.69 -1.256 . . . . 1.48 109.112 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.46 167.24 1.44 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.376 1.384 . . . . 0.02 112.565 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.34 31.14 20.91 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.246 -0.888 . . . . 0.75 111.058 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.65 51.65 9.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.641 -0.662 . . . . 0.02 110.943 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -125.02 163.8 21.55 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.567 -0.708 . . . . 0.02 109.809 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.83 -165.55 32.07 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.878 -1.289 . . . . 0.02 109.878 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -67.7 141.77 56.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.555 -0.968 . . . . 0.02 108.784 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -118.15 148.75 42.03 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.308 -0.627 . . . . 0.02 109.308 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.95 142.45 50.93 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.477 -0.764 . . . . 0.01 109.007 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.37 121.37 38.1 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.302 -0.874 . . . . 0.01 109.297 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.658 HD22 ' NE1' ' A' ' 162' ' ' TRP . 18.1 mt -105.27 136.62 44.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.37 -0.831 . . . . 0.01 110.616 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 154' ' ' LYS . 48.1 t0 -109.88 171.99 7.12 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.127 -1.064 . . . . 2.27 108.127 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -57.87 84.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.994 -1.066 . . . . 1.84 108.796 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 152' ' ' ASP . 53.8 mttm -136.19 168.78 18.76 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.245 -0.909 . . . . 2.28 111.62 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -112.88 110.61 20.8 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.001 -1.111 . . . . 0.01 108.001 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -100.72 116.52 32.81 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.069 -1.019 . . . . 0.01 110.171 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.457 ' O ' ' OG ' ' A' ' 128' ' ' SER . 25.4 ptt180 -92.44 -25.21 18.57 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.251 -0.906 . . . . 0.01 111.525 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -126.32 153.38 74.68 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 120.845 -1.159 . . . . 2.54 108.658 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -60.71 -42.19 40.98 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 119.265 0.773 . . . . 0.7 110.446 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.36 -20.43 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.696 -1.253 . . . . 0.86 108.571 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -65.75 -16.46 63.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.92 -1.113 . . . . 0.02 109.561 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.658 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -94.88 9.76 37.96 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.873 -1.158 . . . . 0.02 107.873 179.053 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.64 10.73 85.76 Favored Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.341 -1.409 . . . . 0.02 109.761 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.06 142.23 31.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.463 -1.022 . . . . 0.02 110.194 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.38 -8.23 59.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.773 -0.579 . . . . 0.59 109.856 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.4 m -144.68 150.91 48.55 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 120.88 -1.137 . . . . 0.87 108.708 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.19 21.67 0.52 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.708 0.939 . . . . 0.38 112.233 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.02 123.91 29.91 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.455 1.122 . . . . 0.18 111.702 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.422 ' O ' HD12 ' A' ' 117' ' ' ILE . 17.5 mt -146.47 126.24 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.799 -1.556 . . . . 3.99 106.799 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -112.24 -19.87 12.08 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.074 -1.016 . . . . 5.17 112.896 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 28.4 t -157.29 160.0 38.14 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 119.174 -2.204 . . . . 0.02 110.357 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -153.01 154.25 34.56 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 2.02 110.589 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -144.44 151.19 38.86 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.169 -0.957 . . . . 0.01 110.566 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -87.95 143.46 27.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.409 -0.807 . . . . 0.01 109.232 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.0 mt -93.73 128.65 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.052 -1.03 . . . . 3.04 109.221 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.86 146.69 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.42 -0.8 . . . . 1.89 109.535 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 4.89 109.528 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.42 -0.585 . . . . 5.28 109.42 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -66.43 -134.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 5.96 109.206 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.6 p -99.5 111.6 23.93 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.754 -1.573 . . . . 2.22 106.754 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.29 95.53 0.1 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 106.565 -2.614 . . . . 0.81 106.565 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.68 147.47 33.93 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.42 -1.072 . . . . 0.01 110.42 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -152.62 137.44 17.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.586 -0.949 . . . . 0.02 109.488 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.2 tt -130.27 141.12 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.223 0.535 . . . . 0.02 109.828 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t -121.75 130.27 53.3 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.39 -0.819 . . . . 0.39 109.972 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 m-85 -110.25 139.6 45.25 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.543 -0.723 . . . . 0.02 109.378 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.2 m-85 -121.76 137.94 54.57 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.282 -0.886 . . . . 0.02 109.557 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -69.58 -27.53 65.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -0.999 . . . . 0.03 111.733 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.4 170.68 8.12 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.848 -1.158 . . . . 0.03 110.087 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -74.93 161.16 29.76 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.749 0.785 . . . . 0.03 110.26 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 12.9 t-20 62.4 35.06 15.14 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.894 0.854 . . . . 0.74 110.551 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 19.6 p90 49.41 43.39 23.42 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.381 -0.827 . . . . 0.02 110.906 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -109.39 165.48 11.61 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.698 -1.223 . . . . 0.02 107.698 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.8 -167.61 33.62 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.785 -1.198 . . . . 0.03 110.63 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -69.47 143.81 53.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.361 -1.082 . . . . 2.76 109.032 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -122.96 150.51 42.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.63 -0.669 . . . . 1.89 110.164 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -137.18 134.05 35.89 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.367 -0.605 . . . . 0.02 109.367 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -109.53 135.57 50.31 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.961 -0.755 . . . . 1.12 108.961 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.7 t -127.73 137.65 52.52 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.588 -0.695 . . . . 0.02 109.327 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -118.84 11.99 12.79 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.64 -0.662 . . . . 0.2 110.377 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 46.3 t -159.85 173.62 15.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.77 -1.206 . . . . 1.23 109.186 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.562 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.9 p30 -63.35 146.26 53.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.794 -1.191 . . . . 0.02 110.829 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.6 m -134.01 117.48 16.73 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.691 -0.855 . . . . 0.02 108.691 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.484 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.19 -20.46 55.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.466 -0.771 . . . . 0.24 111.793 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.57 105.87 3.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.901 -1.124 . . . . 1.14 109.25 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.68 5.23 43.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 6.37 110.243 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -62.15 -29.6 70.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.448 -0.782 . . . . 3.11 112.495 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -77.34 -18.59 57.29 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.224 -1.548 . . . . 0.88 111.687 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -106.43 -19.96 13.52 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.305 -0.872 . . . . 0.02 110.423 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -149.05 127.44 12.23 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.019 -1.051 . . . . 3.32 109.457 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -87.27 -12.97 45.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.549 -0.72 . . . . 0.02 111.004 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -172.8 162.08 4.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.02 108.477 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.4 p -142.61 115.21 8.57 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.021 -1.05 . . . . 0.02 108.851 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -106.8 -2.77 21.11 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.737 -1.227 . . . . 0.03 111.44 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 t -152.98 153.51 33.09 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.884 -1.154 . . . . 0.02 107.884 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 39' ' ' ILE . 9.7 mt -147.01 147.35 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.858 -1.151 . . . . 0.02 110.725 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -125.12 125.55 43.92 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.972 -1.122 . . . . 0.02 107.972 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -105.9 114.95 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.643 -1.614 . . . . 0.02 106.643 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -85.57 -34.31 21.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 3.81 109.968 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.37 150.52 19.33 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.512 -1.804 . . . . 0.02 110.696 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.68 171.78 48.34 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.486 -1.046 . . . . 0.01 110.486 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.5 m -118.16 133.35 55.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.579 -1.267 . . . . 1.48 107.579 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 43.8 m95 -126.3 154.68 43.11 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.812 -1.18 . . . . 0.02 112.14 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.24 133.96 52.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.253 -2.129 . . . . 0.24 105.253 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.486 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.3 m -119.21 144.0 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.656 -0.653 . . . . 0.65 109.405 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.555 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 43.6 m-85 -120.93 145.15 48.0 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.095 0.95 . . . . 0.02 109.887 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -66.97 -33.35 75.38 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.975 -0.557 . . . . 0.02 111.914 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -123.7 158.2 60.24 Favored Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 120.978 -1.076 . . . . 0.02 109.598 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.36 164.98 1.69 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.591 1.527 . . . . 0.02 112.764 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m120 64.07 37.17 9.3 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.452 -0.795 . . . . 0.02 111.189 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 44.88 51.26 8.64 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.559 0.695 . . . . 3.39 110.738 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.5 t -125.93 163.59 22.63 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.179 0.514 . . . . 2.33 109.745 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.92 -161.74 30.8 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.877 -1.289 . . . . 0.02 109.877 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -65.84 140.6 58.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.081 -1.246 . . . . 0.02 110.348 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.555 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 52.4 ttp -118.65 138.3 52.7 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.639 -0.663 . . . . 5.01 109.956 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 48.3 m-85 -134.45 137.39 43.93 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.409 -0.807 . . . . 0.02 109.748 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.0 mm -95.28 131.25 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.579 -0.897 . . . . 1.72 108.579 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.501 HD22 ' CE1' ' A' ' 66' ' ' TYR . 6.9 mt -120.5 111.52 34.78 Favored Pre-proline 0 N--CA 1.504 2.266 0 O-C-N 121.31 -0.869 . . . . 0.02 110.985 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.02 168.97 21.22 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 119.853 0.983 . . . . 1.47 110.117 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -53.67 140.7 28.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.774 -1.204 . . . . 4.25 110.502 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.37 -177.21 32.67 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.586 -1.293 . . . . 0.02 110.636 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -118.95 130.63 55.81 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.352 -1.087 . . . . 0.96 109.808 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.501 ' CE1' HD22 ' A' ' 61' ' ' LEU . 87.6 m-85 -120.64 97.11 48.73 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.004 -1.11 . . . . 0.02 108.004 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.45 -3.94 12.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 120.708 0.939 . . . . 0.02 113.52 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -157.38 153.96 28.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.651 -1.28 . . . . 2.02 107.988 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -59.76 -38.17 81.07 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.456 -0.777 . . . . 0.02 111.787 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -60.78 -23.85 65.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.061 -1.025 . . . . 0.02 110.433 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -70.1 -18.28 63.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.339 -0.851 . . . . 3.42 108.89 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.546 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.55 10.46 27.15 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.482 -1.303 . . . . 0.02 107.482 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.1 mtt 61.13 21.55 11.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.621 -0.674 . . . . 0.02 110.539 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.45 144.49 45.63 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.307 -1.517 . . . . 0.02 109.307 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.45 -31.1 42.45 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.743 -1.206 . . . . 0.98 107.743 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -157.48 -172.21 3.89 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.443 -1.688 . . . . 0.02 106.443 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 3.7 p-10 -98.1 28.49 3.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.708 -1.245 . . . . 0.02 110.672 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.42 ' HG3' HH11 ' A' ' 78' ' ' ARG . 26.5 ttm-85 -97.84 122.48 41.0 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.851 -1.156 . . . . 3.2 111.142 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.486 HD22 ' HB ' ' A' ' 48' ' ' VAL . 54.5 mt -142.34 120.13 11.91 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.652 -1.24 . . . . 2.61 107.652 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.32 -18.1 10.72 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 121.309 -0.87 . . . . 0.02 112.183 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.6 m -155.67 155.67 33.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.212 -1.758 . . . . 0.02 110.505 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.4 p -145.23 147.67 32.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.807 -0.558 . . . . 0.02 109.74 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -137.64 142.09 41.19 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.39 -0.819 . . . . 0.01 109.159 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.94 133.13 36.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.13 -0.981 . . . . 0.43 109.391 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.03 124.41 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.89 -0.781 . . . . 1.25 108.89 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -92.4 131.54 37.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.859 -1.15 . . . . 1.77 108.582 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.55 138.98 33.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.183 -1.043 . . . . 1.63 108.183 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.8 p -111.05 126.56 54.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.351 -0.843 . . . . 1.08 108.878 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.2 t -103.32 -154.33 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.184 -1.784 . . . . 1.26 106.184 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.19 -50.96 0.83 Allowed Glycine 0 N--CA 1.499 2.88 0 O-C-N 120.49 -1.381 . . . . 0.01 112.214 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.74 -100.14 0.14 Allowed Glycine 0 N--CA 1.487 2.091 0 C-N-CA 118.845 -1.645 . . . . 0.01 111.905 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -120.26 119.53 33.46 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.23 -1.159 . . . . 4.43 110.386 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.458 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.61 136.93 56.31 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.226 -0.59 . . . . 2.99 109.586 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -136.01 131.16 34.64 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-O 122.205 1.003 . . . . 6.36 112.93 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.1 143.35 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-N 115.584 -0.734 . . . . 1.09 110.365 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.438 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 1.3 pt20 -124.8 139.52 53.76 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 107.493 -1.299 . . . . 2.05 107.493 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.0 m -123.99 145.86 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.548 -1.345 . . . . 1.1 110.971 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -120.68 140.16 52.0 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.302 1.049 . . . . 0.73 110.876 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.2 tm-20 -68.36 -32.54 72.69 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.587 -0.733 . . . . 0.02 111.81 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -114.0 167.46 10.64 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.043 -1.035 . . . . 3.18 110.306 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.24 163.52 52.67 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.815 -0.914 . . . . 0.01 110.815 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 58.2 38.51 26.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.98 -0.718 . . . . 0.01 111.567 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 52.16 55.41 9.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.01 111.245 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -128.51 164.53 22.59 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.93 -1.137 . . . . 3.15 107.93 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.67 -162.39 29.05 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.013 -1.635 . . . . 0.01 109.013 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -75.54 141.18 43.04 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.842 -1.387 . . . . 0.01 109.154 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 107' ' ' MET . 0.8 OUTLIER -116.26 143.07 46.0 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.48 0.657 . . . . 0.01 109.42 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -132.36 136.16 46.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.22 -1.03 . . . . 2.48 108.22 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.482 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.2 tm-20 -116.4 134.1 55.26 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.735 -0.603 . . . . 0.01 109.5 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.482 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 11.9 t -149.3 148.04 29.07 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.491 1.138 . . . . 1.69 111.216 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.5 p -115.09 7.56 15.46 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.017 -0.992 . . . . 0.01 109.924 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -121.97 163.31 19.55 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.504 -0.747 . . . . 3.21 111.194 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -70.25 155.05 41.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.833 . . . . 0.01 109.78 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.402 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 34.9 t -126.49 115.17 23.09 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 121.532 -0.73 . . . . 0.01 109.195 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.05 -33.13 4.76 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 120.339 1.157 . . . . 0.01 111.113 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.8 t -141.8 107.67 5.15 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.968 0.889 . . . . 0.02 108.832 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.09 -39.93 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.585 -0.697 . . . . 1.83 111.176 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.8 ttt -66.39 -37.47 85.31 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.078 -1.049 . . . . 1.34 109.593 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.59 -38.46 77.35 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.572 -1.33 . . . . 2.11 109.709 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -80.44 -47.24 14.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -0.906 . . . . 2.08 112.476 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -111.41 -0.7 16.2 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.235 -0.915 . . . . 0.02 112.653 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.7 m80 60.08 33.41 21.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.755 -1.216 . . . . 0.02 109.648 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.42 135.51 53.03 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.793 -0.817 . . . . 0.02 108.793 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -92.71 -23.16 19.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.334 -0.854 . . . . 5.32 110.766 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -148.91 163.42 37.49 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.226 -0.922 . . . . 0.02 109.965 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.2 mt -131.97 129.72 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 107.576 -1.268 . . . . 2.17 107.576 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -107.72 -13.53 15.0 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.21 -0.931 . . . . 0.02 113.243 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.95 153.52 31.18 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.277 -1.515 . . . . 0.01 108.24 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 7.4 t -161.35 147.39 14.24 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.286 -1.509 . . . . 1.22 109.9 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -121.76 108.66 13.77 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.989 0.9 . . . . 1.41 108.627 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 t -107.59 120.41 58.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 105.941 -1.874 . . . . 0.01 105.941 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 t -146.49 68.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 118.189 -1.404 . . . . 1.98 108.454 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.39 108.75 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 106.715 -1.587 . . . . 0.01 106.715 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.21 -173.27 43.1 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.978 -1.249 . . . . 0.01 109.978 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.479 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.2 m -112.02 143.73 42.54 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.283 -1.128 . . . . 2.3 109.221 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.458 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 72.6 m95 -129.69 145.72 51.51 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.461 -0.774 . . . . 0.01 110.336 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.0 mt -117.8 141.35 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 107.708 -1.219 . . . . 1.69 107.708 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.783 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.54 141.45 47.14 Favored 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 107.019 -1.474 . . . . 2.49 107.019 178.037 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 7.7 m-85 -122.73 145.71 48.16 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.437 -0.789 . . . . 0.02 109.197 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -74.12 -29.92 62.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.02 112.007 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.68 153.18 47.91 Favored Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 120.753 -1.217 . . . . 1.48 109.118 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.419 ' O ' ' NH1' ' A' ' 145' ' ' ARG . 1.2 Cg_endo -54.24 166.72 1.54 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.25 1.3 . . . . 0.02 112.791 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 58.67 32.15 21.87 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.205 -0.907 . . . . 0.75 111.099 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 144' ' ' TYR . 1.0 OUTLIER 57.51 52.25 8.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.564 -0.71 . . . . 0.02 111.473 178.186 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.464 ' HG3' HH11 ' A' ' 145' ' ' ARG . 10.8 mtm-85 -124.5 163.14 22.49 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.52 -0.737 . . . . 0.02 109.597 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.2 -164.95 32.48 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.923 -1.271 . . . . 0.02 109.923 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -68.04 141.13 56.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.583 -0.951 . . . . 0.02 108.862 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -118.32 148.42 42.49 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.361 0.601 . . . . 0.02 109.438 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.5 141.97 51.22 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.465 -0.772 . . . . 0.01 108.977 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.584 ' C ' HD23 ' A' ' 150' ' ' LEU . 6.0 tt -97.15 121.57 39.18 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.263 -0.898 . . . . 0.01 109.288 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.673 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.1 mt -105.22 133.91 49.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.426 -0.797 . . . . 0.01 110.536 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 32.2 t70 -109.41 175.76 5.33 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.346 -0.983 . . . . 2.27 108.346 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.18 84.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.974 -1.079 . . . . 1.84 108.528 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 48.6 tttp -136.61 165.45 25.85 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.343 -0.848 . . . . 2.28 111.461 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.484 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 27.1 mt-10 -111.1 108.4 18.09 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.033 -1.099 . . . . 0.01 108.033 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -98.93 114.82 27.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.002 -1.061 . . . . 0.01 110.241 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -93.26 -26.05 17.51 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.145 -0.972 . . . . 0.01 111.34 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -125.56 153.75 72.7 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 120.94 -1.1 . . . . 2.54 108.738 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.67 -43.35 32.79 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 119.145 0.73 . . . . 0.7 110.724 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.34 -20.72 21.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.728 -1.233 . . . . 0.86 108.632 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -65.67 -16.2 63.51 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.044 -1.035 . . . . 0.02 109.568 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.673 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.91 9.76 38.06 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.026 -1.101 . . . . 0.02 108.026 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.02 10.43 86.26 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.259 -1.448 . . . . 0.02 109.693 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.56 142.22 31.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.482 -1.011 . . . . 0.02 110.145 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.46 -8.48 58.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.7 -0.625 . . . . 0.59 109.819 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 32.2 m -144.5 151.05 49.66 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.888 -1.133 . . . . 0.87 108.602 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.8 21.3 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 120.786 0.991 . . . . 0.38 112.294 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.06 122.69 28.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.525 1.155 . . . . 0.18 111.476 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.783 HG23 ' CD1' ' A' ' 138' ' ' PHE . 56.4 mt -145.76 125.35 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.183 -1.784 . . . . 3.99 106.183 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -111.65 -19.34 12.52 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.024 -1.048 . . . . 5.17 113.094 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.2 t -157.05 160.49 38.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.328 -2.108 . . . . 0.02 110.2 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.402 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 11.6 p90 -151.55 152.25 32.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.116 -0.99 . . . . 2.02 110.272 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.419 ' CG ' ' CE1' ' A' ' 144' ' ' TYR . 7.1 mmm180 -143.34 149.81 38.29 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.388 -0.82 . . . . 0.01 110.033 -178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -88.56 143.46 26.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.464 -0.772 . . . . 0.01 109.566 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.11 128.25 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.136 -0.977 . . . . 3.04 109.123 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.9 t -136.01 146.48 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.223 -0.923 . . . . 1.89 109.496 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 4.89 109.508 179.995 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' LYS . 70.5 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.505 -0.554 . . . . 5.28 109.505 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 1' ' ' SER . 76.6 mttt 52.4 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 5.96 109.456 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -98.03 40.71 1.16 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.034 -1.041 . . . . 2.22 111.923 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.45 115.36 3.01 Favored Glycine 0 N--CA 1.503 3.139 0 N-CA-C 107.4 -2.28 . . . . 0.81 107.4 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.19 146.37 34.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.429 -1.468 . . . . 0.01 109.429 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -151.28 138.2 19.02 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.214 -1.168 . . . . 0.02 110.355 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 tt -130.13 138.33 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.055 -0.72 . . . . 0.02 109.055 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 t -120.72 130.59 54.13 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.468 -0.77 . . . . 0.39 110.058 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.6 m-85 -110.86 140.09 45.62 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.695 -0.628 . . . . 0.02 109.548 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.8 m-85 -122.51 138.61 54.51 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.219 -0.926 . . . . 0.02 109.362 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.41 -27.13 65.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.126 -0.984 . . . . 0.03 111.781 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -114.18 169.88 8.7 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.926 -1.109 . . . . 0.03 110.15 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -75.61 158.25 32.68 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.626 0.727 . . . . 0.03 110.074 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 66.22 33.18 7.46 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.899 0.857 . . . . 0.74 111.029 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.47 41.58 30.74 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.235 0.541 . . . . 0.02 111.212 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -113.02 166.09 11.74 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.321 -0.992 . . . . 0.02 108.321 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.48 -167.71 35.75 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.965 -1.112 . . . . 0.03 110.446 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -68.71 142.15 55.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.229 -1.159 . . . . 2.76 108.771 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -122.75 149.37 44.19 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.653 -0.654 . . . . 1.89 110.013 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -135.93 133.02 37.19 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.685 -0.634 . . . . 0.02 109.656 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 2.2 p-10 -109.64 136.46 48.96 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.526 -0.733 . . . . 1.12 109.07 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 54.1 t -128.2 138.08 52.31 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.554 -0.716 . . . . 0.02 109.618 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -119.24 11.14 12.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.62 -0.675 . . . . 0.2 110.645 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 30.4 p -159.27 173.67 15.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.779 -1.201 . . . . 1.23 109.124 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.69 145.73 53.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.612 -1.305 . . . . 0.02 110.694 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.561 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 21.6 t -134.6 118.42 17.21 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.09 -0.708 . . . . 0.02 109.09 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.23 -20.95 54.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.373 -0.829 . . . . 0.24 111.444 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -155.31 105.68 2.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.797 -1.189 . . . . 1.14 109.707 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.63 8.81 41.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.388 -0.82 . . . . 6.37 109.922 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -60.55 -29.13 68.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -0.841 . . . . 3.11 111.978 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.8 m -76.45 -17.61 59.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.466 -1.396 . . . . 0.88 111.347 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -107.32 -20.24 13.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.374 -0.829 . . . . 0.02 110.539 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 tp -148.83 127.02 12.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.89 -1.131 . . . . 3.32 109.631 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.9 t -87.14 -12.58 46.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.615 -0.678 . . . . 0.02 111.37 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -171.82 161.91 6.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.73 -1.231 . . . . 0.02 108.364 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.91 116.62 8.71 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.972 -1.08 . . . . 0.02 109.043 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 1.9 m120 -109.41 0.41 19.37 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.671 -1.268 . . . . 0.03 111.862 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.1 t -156.39 154.38 30.41 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.274 -1.01 . . . . 0.02 108.274 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -146.14 146.91 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 122.328 1.061 . . . . 0.02 111.092 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -122.77 124.24 42.89 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.706 -1.22 . . . . 0.02 107.706 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -106.67 114.33 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 106.716 -1.587 . . . . 0.02 106.716 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.26 -34.38 23.84 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.348 -0.541 . . . . 3.81 110.554 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.19 149.99 18.26 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.102 -1.523 . . . . 0.02 110.682 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.31 172.54 49.13 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.374 -1.09 . . . . 0.01 110.374 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -118.24 134.05 55.36 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 107.81 -1.181 . . . . 1.48 107.81 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -126.47 154.89 43.11 Favored 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 122.587 1.184 . . . . 0.02 112.274 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.08 52.27 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.681 -1.97 . . . . 0.24 105.681 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.36 141.64 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -0.758 . . . . 0.65 109.298 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -120.52 143.07 48.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.158 0.98 . . . . 0.02 109.536 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CD ' HH21 ' A' ' 78' ' ' ARG . 31.2 tt0 -65.35 -34.07 77.46 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.52 -0.764 . . . . 0.02 111.794 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -124.65 157.95 63.86 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.095 -1.003 . . . . 0.02 109.323 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.56 167.05 1.03 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.67 1.58 . . . . 0.02 112.623 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.1 t30 62.82 36.44 13.04 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.238 -0.892 . . . . 0.02 111.007 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 45.21 51.53 9.13 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.728 0.775 . . . . 3.39 110.72 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -125.37 163.26 22.98 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.234 0.54 . . . . 2.33 109.818 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.32 -161.34 31.31 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.426 ' ND1' ' OE1' ' A' ' 50' ' ' GLU . 10.9 m80 -65.35 138.54 58.23 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.89 -1.359 . . . . 0.02 110.251 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -119.58 137.16 54.02 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.773 -0.579 . . . . 5.01 109.505 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.4 m-85 -134.75 140.38 45.88 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.437 -0.789 . . . . 0.02 109.978 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.8 mm -94.49 130.74 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.863 -0.791 . . . . 1.72 108.863 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -121.22 110.95 34.02 Favored Pre-proline 0 N--CA 1.505 2.287 0 O-C-N 121.353 -0.842 . . . . 0.02 110.702 -178.458 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.67 169.79 20.25 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 CA-C-N 119.819 0.971 . . . . 1.47 110.423 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -53.19 141.7 22.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.023 -1.048 . . . . 4.25 110.413 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.92 -177.83 31.17 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.41 -1.376 . . . . 0.02 111.012 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -119.55 131.32 55.5 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.453 -1.028 . . . . 0.96 109.749 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 53.3 m-85 -122.42 96.03 46.37 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 107.823 -1.176 . . . . 0.02 107.823 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.52 -3.43 11.05 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.831 1.021 . . . . 0.02 113.876 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -157.39 154.22 28.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.548 -1.345 . . . . 2.02 108.098 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -59.7 -38.98 83.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.02 112.016 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -60.16 -23.76 64.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.149 -0.969 . . . . 0.02 110.417 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -70.18 -18.26 63.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 3.42 108.755 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.552 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.0 OUTLIER -108.26 10.78 27.69 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.56 -1.274 . . . . 0.02 107.56 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.6 mtt 61.65 22.73 13.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.02 110.546 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.12 144.57 48.64 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.81 -1.316 . . . . 0.02 109.81 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 75' ' ' LEU . 9.3 mp -80.05 -30.28 39.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -1.219 . . . . 0.98 107.88 177.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -157.03 -171.48 3.66 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.666 -1.605 . . . . 0.02 106.666 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.498 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 65.9 m-20 -98.66 28.34 4.3 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.64 -1.288 . . . . 0.02 110.847 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.5 HH21 ' CD ' ' A' ' 50' ' ' GLU . 27.7 mtm-85 -96.77 122.82 40.13 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.833 -1.167 . . . . 3.2 111.351 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.491 HD21 ' CH2' ' A' ' 72' ' ' TRP . 80.3 mt -142.05 119.3 11.47 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 107.618 -1.253 . . . . 2.61 107.618 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.86 -18.53 9.32 Favored Glycine 0 N--CA 1.499 2.889 0 O-C-N 121.12 -0.988 . . . . 0.02 112.638 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 p -156.16 156.69 34.66 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 119.628 1.714 . . . . 0.02 110.841 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 57.0 m -145.91 148.42 32.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.366 -0.834 . . . . 0.02 110.361 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -137.05 141.89 42.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.435 -0.791 . . . . 0.01 109.284 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 132.18 36.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.048 -1.033 . . . . 0.43 109.443 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 t -91.49 124.58 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.874 -0.787 . . . . 1.25 108.874 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -92.58 131.3 37.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.942 -1.099 . . . . 1.77 108.569 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mt -95.87 139.69 31.72 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.233 -1.025 . . . . 1.63 108.233 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.6 t -110.89 126.12 54.36 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.643 -0.873 . . . . 1.08 108.643 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.0 m -102.58 -154.91 0.5 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.069 -1.826 . . . . 1.26 106.069 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.23 -51.01 0.82 Allowed Glycine 0 N--CA 1.498 2.778 0 O-C-N 120.522 -1.361 . . . . 0.01 112.029 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.56 -99.85 0.13 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 118.683 -1.722 . . . . 0.01 112.121 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -120.17 120.37 35.97 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.202 -1.175 . . . . 4.43 110.723 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.486 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.2 137.58 57.09 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.362 -0.607 . . . . 2.99 109.362 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 32.6 ttmt -136.53 130.44 32.46 Favored 'General case' 0 N--CA 1.516 2.856 0 CA-C-O 122.155 0.979 . . . . 6.36 113.031 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -131.81 141.37 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-N 115.51 -0.768 . . . . 1.09 110.524 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 pt20 -124.45 139.78 53.57 Favored 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 107.485 -1.302 . . . . 2.05 107.485 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.83 146.07 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 O-C-N 120.734 -1.229 . . . . 1.1 111.038 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -120.73 139.96 52.34 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.046 0.927 . . . . 0.73 110.817 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -68.6 -32.47 72.38 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.688 -0.687 . . . . 0.02 112.025 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -114.27 165.35 12.78 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.855 -1.153 . . . . 3.18 110.087 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.29 163.41 45.75 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.973 -0.851 . . . . 0.01 110.973 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 57.29 38.86 28.8 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.541 0.686 . . . . 0.01 111.069 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 52.65 56.23 7.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.534 -0.729 . . . . 0.01 111.087 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -128.59 164.93 21.78 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.998 -1.112 . . . . 3.15 107.998 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.93 -162.6 28.86 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.04 -1.624 . . . . 0.01 109.04 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -75.34 141.57 43.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.839 -1.389 . . . . 0.01 108.963 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' A' ' 107' ' ' MET . 9.3 tmm? -116.33 142.94 46.18 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.482 0.658 . . . . 0.01 109.431 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -132.44 136.55 46.81 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.348 -0.982 . . . . 2.48 108.348 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -116.35 134.15 55.22 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.713 -0.617 . . . . 0.01 109.615 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -149.1 147.92 29.07 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.522 1.153 . . . . 1.69 111.358 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.4 p -114.53 7.66 16.2 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.972 -1.013 . . . . 0.01 109.901 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -122.14 163.34 19.68 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.443 -0.786 . . . . 3.21 111.264 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 4.9 p30 -69.57 154.6 41.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.01 109.568 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.5 t -126.79 115.33 22.45 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.487 -0.758 . . . . 0.01 108.976 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.03 -32.69 5.14 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 120.4 1.179 . . . . 0.01 111.346 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.0 m -142.12 108.38 5.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.368 -0.833 . . . . 0.02 109.203 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.22 -39.66 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.769 -0.582 . . . . 1.83 111.03 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.3 ttt -67.04 -37.79 84.72 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.141 -1.024 . . . . 1.34 109.835 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -69.59 -38.5 77.34 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.622 -1.299 . . . . 2.11 109.724 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -80.62 -47.4 14.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -0.919 . . . . 2.08 112.531 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -111.0 -0.72 16.58 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.291 -0.881 . . . . 0.02 112.727 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.3 m170 59.96 33.51 21.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.738 -1.226 . . . . 0.02 109.436 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.53 135.38 53.31 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.73 -0.841 . . . . 0.02 108.73 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -92.42 -23.03 19.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.288 -0.883 . . . . 5.32 110.605 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -148.8 163.64 36.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.163 -0.96 . . . . 0.02 109.934 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -131.57 129.46 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 107.454 -1.313 . . . . 2.17 107.454 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -107.86 -13.21 15.04 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.216 -0.927 . . . . 0.02 113.142 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -154.1 152.11 30.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.432 -1.418 . . . . 0.01 108.251 178.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 7.3 t -161.77 145.12 12.25 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.212 -1.555 . . . . 1.22 109.56 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -122.02 111.03 16.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.191 0.996 . . . . 1.41 108.861 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.14 121.96 63.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 105.733 -1.951 . . . . 0.01 105.733 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.7 t -146.27 64.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 117.996 -1.482 . . . . 1.98 108.955 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.2 tp10 176.67 109.67 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.485 -1.672 . . . . 0.01 106.485 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.16 -173.41 45.71 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.214 -1.154 . . . . 0.01 110.214 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.42 142.95 41.43 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.491 -1.006 . . . . 2.3 108.93 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.486 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 68.0 m95 -129.2 145.21 51.37 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.513 -0.742 . . . . 0.01 109.958 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.0 mt -118.2 142.09 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 107.743 -1.206 . . . . 1.69 107.743 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.2 143.25 45.13 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 107.515 -1.291 . . . . 2.49 107.515 177.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -122.56 143.65 49.6 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.107 -0.701 . . . . 0.02 109.107 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.45 -29.95 62.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.614 -0.679 . . . . 0.02 112.19 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.26 153.58 47.42 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 120.674 -1.266 . . . . 1.48 109.128 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.35 166.59 1.67 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.237 1.291 . . . . 0.02 112.492 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 59.67 31.54 20.95 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.166 -0.925 . . . . 0.75 111.127 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.482 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.8 m-85 57.62 51.51 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.513 -0.742 . . . . 0.02 111.066 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -124.97 163.81 21.49 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.484 -0.76 . . . . 0.02 109.886 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.68 -165.36 32.14 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.838 -1.305 . . . . 0.02 109.838 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -67.71 141.41 56.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.979 . . . . 0.02 108.81 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.63 148.37 42.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.246 -0.65 . . . . 0.02 109.246 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.442 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.04 143.07 50.75 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.808 -0.812 . . . . 0.01 108.808 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 151' ' ' LEU . 1.3 tt -97.51 121.99 40.05 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.385 -0.822 . . . . 0.01 109.127 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.642 HD22 ' NE1' ' A' ' 162' ' ' TRP . 16.9 mt -104.3 135.63 45.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.01 110.311 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 154' ' ' LYS . 13.2 m-20 -108.05 173.36 6.36 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -58.68 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.992 -1.068 . . . . 1.84 108.614 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 152' ' ' ASP . 40.8 tttm -137.04 168.75 19.0 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.362 -0.836 . . . . 2.28 111.483 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 1.6 pm0 -112.61 111.37 22.13 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.213 -1.032 . . . . 0.01 108.213 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -100.68 116.03 31.62 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.053 -1.029 . . . . 0.01 110.059 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.448 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.9 ptm180 -92.78 -25.6 18.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.101 -0.999 . . . . 0.01 111.49 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -125.96 153.08 73.73 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.78 -1.2 . . . . 2.54 108.716 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.72 -42.2 40.75 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 119.271 0.775 . . . . 0.7 110.62 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.78 -20.22 21.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.706 -1.246 . . . . 0.86 108.508 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -65.65 -16.16 63.47 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.941 -1.099 . . . . 0.02 109.494 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.642 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -95.11 9.68 38.67 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.881 -1.155 . . . . 0.02 107.881 178.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.53 11.07 85.5 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 119.295 -1.431 . . . . 0.02 109.659 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.96 142.24 31.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.44 -1.035 . . . . 0.02 110.174 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.44 -8.28 59.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.736 -0.603 . . . . 0.59 109.987 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.0 p -144.48 150.85 49.05 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.709 -1.244 . . . . 0.87 108.771 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -76.05 21.31 0.52 Allowed 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 120.818 1.012 . . . . 0.38 112.248 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.63 123.99 29.76 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.572 1.177 . . . . 0.18 111.739 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.2 mt -147.05 126.71 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 106.925 -1.509 . . . . 3.99 106.925 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -112.66 -19.52 12.02 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.132 -0.98 . . . . 5.17 112.826 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.1 p -158.4 161.44 37.53 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 119.242 -2.161 . . . . 0.02 110.216 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -153.03 154.6 35.24 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.182 -0.948 . . . . 2.02 110.576 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.482 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 25.5 mtp180 -143.84 150.54 38.63 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.086 -1.009 . . . . 0.01 110.314 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -87.74 142.72 27.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.622 -0.674 . . . . 0.01 109.268 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.5 mt -93.14 128.19 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.089 -1.007 . . . . 3.04 109.033 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.4 m -135.89 146.31 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.116 -0.99 . . . . 1.89 109.558 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 4.89 109.389 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.475 -0.565 . . . . 5.28 109.475 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.499 ' NZ ' ' CB ' ' A' ' 2' ' ' LYS . 8.9 mtmp? -61.6 103.17 0.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 5.96 109.517 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.2 m -99.07 112.11 24.33 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.288 -1.745 . . . . 2.22 106.288 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.47 95.24 0.1 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 106.57 -2.612 . . . . 0.81 106.57 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.91 147.9 34.14 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.322 -1.111 . . . . 0.01 110.322 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -152.37 138.59 18.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.354 -1.086 . . . . 0.02 109.769 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.4 139.52 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.194 -0.669 . . . . 0.02 109.194 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 t -122.08 130.96 53.72 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.464 -0.773 . . . . 0.39 110.301 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 m-85 -111.16 140.31 45.81 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.617 -0.677 . . . . 0.02 109.623 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.7 m-85 -121.8 138.54 54.33 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.296 -0.877 . . . . 0.02 109.368 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -68.99 -27.33 65.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.905 -1.122 . . . . 0.03 111.767 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -114.47 170.35 8.37 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.864 -1.147 . . . . 0.03 110.111 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -74.99 161.59 29.33 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.673 0.749 . . . . 0.03 110.137 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.608 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 58.6 t30 62.42 34.97 15.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.907 0.86 . . . . 0.74 110.634 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.608 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 19.5 p90 49.68 43.31 24.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.307 -0.861 . . . . 0.02 111.057 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -109.43 165.71 11.43 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.73 -1.211 . . . . 0.02 107.73 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.41 -167.86 34.4 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 120.775 -1.203 . . . . 0.03 110.688 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -68.84 143.66 54.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.382 -1.069 . . . . 2.76 108.883 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 48.9 ttt180 -122.1 149.94 42.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.615 -0.678 . . . . 1.89 110.039 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -136.91 132.63 34.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.653 -0.654 . . . . 0.02 109.303 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -109.75 136.14 49.55 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.435 -0.79 . . . . 1.12 109.046 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.1 t -127.86 137.71 52.43 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.522 -0.736 . . . . 0.02 109.42 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.488 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -118.41 11.98 13.18 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.2 110.15 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 29.3 m -159.17 173.77 15.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.849 -1.157 . . . . 1.23 108.826 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 33.4 p30 -62.87 145.8 54.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.856 -1.152 . . . . 0.02 110.324 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 10.8 p -134.89 119.2 17.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.497 -0.752 . . . . 0.02 109.16 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.2 -20.97 47.02 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.257 -0.902 . . . . 0.24 112.297 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.48 106.28 3.1 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.702 -1.249 . . . . 1.14 110.175 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.507 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.1 6.46 40.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.341 -0.849 . . . . 6.37 110.046 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -61.21 -30.37 70.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 3.11 112.097 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.1 m -77.1 -17.52 58.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.308 -1.495 . . . . 0.88 110.965 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -106.66 -21.19 13.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.453 -0.78 . . . . 0.02 110.64 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -149.01 127.18 12.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.98 -1.075 . . . . 3.32 109.599 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.9 t -86.66 -12.2 49.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.531 -0.731 . . . . 0.02 111.176 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -172.0 161.73 5.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.867 -1.146 . . . . 0.02 108.357 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.5 t -143.19 116.59 9.07 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.914 -1.116 . . . . 0.02 108.936 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -109.33 0.29 19.43 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.831 -1.168 . . . . 0.03 111.608 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.1 t -156.92 154.72 30.2 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.508 -0.923 . . . . 0.02 108.508 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.1 147.0 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 122.232 1.015 . . . . 0.02 110.79 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -122.21 123.67 42.03 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.847 -1.168 . . . . 0.02 107.847 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 t -106.52 113.75 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 106.746 -1.576 . . . . 0.02 106.746 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -83.95 -34.12 24.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.17 -0.612 . . . . 3.81 110.412 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.94 150.63 19.76 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 119.052 -1.546 . . . . 0.02 110.525 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.32 172.08 48.72 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.871 -1.157 . . . . 0.01 110.502 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.7 m -118.48 134.72 54.85 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.69 -1.226 . . . . 1.48 107.69 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.0 m95 -127.58 155.01 44.51 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.601 1.191 . . . . 0.02 112.118 -176.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.38 134.26 52.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 105.518 -2.03 . . . . 0.24 105.518 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.02 143.48 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.523 -0.736 . . . . 0.65 109.374 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -120.69 144.67 48.09 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.165 0.983 . . . . 0.02 110.06 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' OE2' ' ND1' ' A' ' 57' ' ' HIS . 21.0 tt0 -65.95 -33.09 75.02 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.798 -0.637 . . . . 0.02 111.505 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -124.62 158.1 63.25 Favored Pre-proline 0 N--CA 1.503 2.219 0 O-C-N 120.993 -1.067 . . . . 0.02 109.419 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.61 166.68 1.19 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.692 1.595 . . . . 0.02 112.772 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.5 m-20 63.31 36.62 11.57 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.464 -0.789 . . . . 0.02 110.934 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.46 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 6.5 m-85 45.23 51.74 9.05 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.612 0.72 . . . . 3.39 110.749 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -125.99 163.61 22.63 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.208 0.528 . . . . 2.33 109.883 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.7 -161.9 31.21 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.705 -1.358 . . . . 0.02 109.705 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.457 ' ND1' ' OE2' ' A' ' 50' ' ' GLU . 14.0 m80 -64.34 138.87 58.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.922 -1.34 . . . . 0.02 110.122 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -118.77 137.16 53.56 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.337 0.589 . . . . 5.01 109.609 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.587 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.5 m-85 -134.73 139.34 45.11 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.459 -0.776 . . . . 0.02 109.912 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.7 mm -95.51 130.97 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.11 -0.7 . . . . 1.72 109.11 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.493 HD22 ' CE1' ' A' ' 66' ' ' TYR . 13.5 mt -122.33 112.01 31.59 Favored Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.261 -0.9 . . . . 0.02 110.835 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.38 170.84 18.7 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 119.754 0.948 . . . . 1.47 110.03 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -52.28 140.79 20.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 4.25 110.243 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.39 -177.46 32.55 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.4 -1.381 . . . . 0.02 110.769 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -121.02 131.94 54.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.381 -1.07 . . . . 0.96 109.878 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CE1' HD22 ' A' ' 61' ' ' LEU . 96.6 m-85 -122.27 97.79 44.89 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 107.768 -1.197 . . . . 0.02 107.768 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.08 -2.23 10.78 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.79 0.994 . . . . 0.02 113.694 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -157.32 153.94 28.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.734 -1.228 . . . . 2.02 108.156 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -59.96 -39.68 86.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.478 -0.764 . . . . 0.02 111.778 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -59.73 -23.88 63.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.02 110.35 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -70.87 -18.49 62.69 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.926 0.869 . . . . 3.42 108.937 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.587 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.72 10.08 28.97 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.376 -1.342 . . . . 0.02 107.376 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.6 mtt 61.04 22.4 12.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.593 -0.692 . . . . 0.02 110.518 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.93 144.45 46.56 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.571 -1.412 . . . . 0.02 109.571 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -79.42 -30.8 42.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.699 -1.222 . . . . 0.98 107.699 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 11.7 p-10 -157.03 -171.65 3.72 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.35 -1.722 . . . . 0.02 106.35 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -98.61 28.74 4.04 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.652 -1.28 . . . . 0.02 110.591 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HG3' HH11 ' A' ' 78' ' ' ARG . 25.5 ttm-85 -96.77 122.23 39.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.817 -1.177 . . . . 3.2 111.005 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.509 HD21 ' CH2' ' A' ' 72' ' ' TRP . 78.4 mt -141.9 119.37 11.62 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.606 -1.257 . . . . 2.61 107.606 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.4 -18.34 9.78 Favored Glycine 0 N--CA 1.501 3.026 0 O-C-N 121.129 -0.982 . . . . 0.02 112.579 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.1 p -156.48 156.81 34.37 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 119.502 1.651 . . . . 0.02 110.451 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.4 m -145.38 148.26 33.17 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.623 -0.673 . . . . 0.02 109.846 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.46 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 51.1 mtp180 -137.48 141.98 41.52 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.193 -0.942 . . . . 0.01 109.283 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 133.18 36.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.237 -0.915 . . . . 0.43 109.679 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.74 123.66 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.112 -1.07 . . . . 1.25 108.112 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -94.92 133.29 38.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.131 . . . . 1.77 108.956 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.57 134.14 37.44 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.714 -1.217 . . . . 1.63 107.714 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m -106.79 130.27 54.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.501 -0.749 . . . . 1.08 109.988 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.4 p -115.3 100.53 8.19 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 102.749 -3.056 . . . . 1.26 102.749 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -119.74 -60.84 0.26 Allowed Glycine 0 N--CA 1.51 3.623 0 N-CA-C 110.069 -1.212 . . . . 0.01 110.069 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.13 -107.82 1.32 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.353 -1.499 . . . . 0.01 109.353 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -120.55 -141.01 0.34 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.679 -0.895 . . . . 4.43 109.213 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -126.5 119.73 27.91 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.23 -1.026 . . . . 2.99 108.23 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -144.1 121.98 12.0 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.416 -1.427 . . . . 6.36 113.28 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.3 tt -130.71 138.09 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.435 0.636 . . . . 1.09 109.681 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.483 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.6 pt20 -123.84 138.76 54.44 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.418 -1.327 . . . . 2.05 107.418 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.61 146.21 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.687 -1.258 . . . . 1.1 110.658 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -119.77 141.7 49.23 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.215 1.007 . . . . 0.73 111.385 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.32 -33.02 72.5 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.783 -0.644 . . . . 0.02 111.358 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.8 mmmt -114.38 167.91 10.31 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.122 -0.986 . . . . 3.18 109.66 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.68 168.89 45.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 111.169 -0.772 . . . . 0.01 111.169 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 53.53 39.51 30.14 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.511 0.672 . . . . 0.01 111.598 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 52.48 48.45 22.56 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.707 -0.621 . . . . 0.01 110.934 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -121.67 164.22 17.7 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.332 -0.988 . . . . 3.15 108.332 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.69 -163.09 29.48 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.042 -1.623 . . . . 0.01 109.042 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.5 141.58 43.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.798 -1.413 . . . . 0.01 109.199 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.458 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.6 tmm? -116.24 143.79 45.06 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.479 0.657 . . . . 0.01 109.595 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.44 136.44 46.73 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.387 -0.968 . . . . 2.48 108.387 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -117.36 133.94 55.4 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.576 -0.703 . . . . 0.01 109.771 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 t -149.58 149.2 30.33 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.481 1.134 . . . . 1.69 111.329 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.7 p -114.74 7.96 16.01 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.057 -0.974 . . . . 0.01 110.334 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 23.9 mp0 -121.62 163.16 19.41 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.345 -0.847 . . . . 3.21 111.018 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.6 p30 -69.46 154.91 41.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.479 -0.763 . . . . 0.01 109.451 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.4 t -127.31 115.17 21.5 Favored Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 109.13 -0.692 . . . . 0.01 109.13 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.4 -31.44 5.72 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 120.295 1.141 . . . . 0.01 111.429 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.3 m -142.46 107.86 5.03 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.385 -0.822 . . . . 0.02 108.989 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.07 -39.92 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.783 -0.573 . . . . 1.83 111.066 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.44 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 15.1 tpt -66.43 -37.4 85.11 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.167 -1.013 . . . . 1.34 109.766 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -70.15 -38.42 75.47 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.584 -1.322 . . . . 2.11 109.791 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -80.56 -47.4 14.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.179 -0.951 . . . . 2.08 112.354 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -111.04 -0.81 16.52 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.329 -0.857 . . . . 0.02 112.852 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.3 m80 59.6 33.53 22.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.732 -1.23 . . . . 0.02 109.525 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.44 ' C ' ' SD ' ' A' ' 118' ' ' MET . 6.4 mt -112.4 135.45 53.08 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 108.703 -0.851 . . . . 0.02 108.703 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -92.12 -23.01 19.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 5.32 110.633 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -149.15 163.6 37.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.078 -1.014 . . . . 0.02 110.101 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.5 mt -132.25 129.55 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 107.475 -1.305 . . . . 2.17 107.475 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -107.65 -12.12 15.31 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.159 -0.963 . . . . 0.02 113.13 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -156.7 154.12 29.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.467 -1.396 . . . . 0.01 107.759 178.121 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.9 t -161.48 146.0 13.24 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.877 -1.139 . . . . 1.22 109.639 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -121.86 109.56 14.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.374 1.083 . . . . 1.41 108.949 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.53 122.18 64.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 106.408 -1.701 . . . . 0.01 106.408 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.63 68.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 118.639 -1.225 . . . . 1.98 107.802 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 174.13 105.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.705 -1.591 . . . . 0.01 106.705 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.11 -177.07 46.04 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.548 -1.421 . . . . 0.01 109.548 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.8 m -109.55 143.73 38.82 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.442 -1.034 . . . . 2.3 108.659 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -128.56 145.34 51.16 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.474 -0.767 . . . . 0.01 110.49 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.4 mt -116.56 140.29 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 107.504 -1.295 . . . . 1.69 107.504 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.602 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -112.89 141.7 46.42 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 107.577 -1.268 . . . . 2.49 107.577 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 15.3 m-85 -121.99 143.54 49.42 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.008 -0.738 . . . . 0.02 109.008 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 140' ' ' GLU . 3.2 tm-20 -73.32 -29.74 62.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.02 112.001 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -114.76 153.92 46.86 Favored Pre-proline 0 N--CA 1.508 2.457 0 O-C-N 120.593 -1.317 . . . . 1.48 109.332 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.47 166.27 1.91 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.13 1.22 . . . . 0.02 112.44 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 59.97 31.1 20.51 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.178 -0.919 . . . . 0.75 111.138 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 58.0 51.53 8.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.553 -0.717 . . . . 0.02 111.044 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -124.95 163.69 21.74 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.551 -0.718 . . . . 0.02 109.76 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.93 -165.28 31.76 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.804 -1.318 . . . . 0.02 109.804 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -67.86 141.97 56.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -1.004 . . . . 0.02 108.831 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.462 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.3 mp0 -118.57 149.42 41.37 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.509 -0.552 . . . . 0.02 109.509 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.49 141.89 51.25 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.536 -0.727 . . . . 0.01 109.263 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.7 tp -94.61 119.91 34.01 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.826 -0.805 . . . . 0.01 108.826 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.633 HD22 ' NE1' ' A' ' 162' ' ' TRP . 19.7 mt -106.67 136.22 46.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.44 -0.788 . . . . 0.01 110.781 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 154' ' ' LYS . 16.3 t0 -110.42 171.35 7.51 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.21 -1.033 . . . . 2.27 108.21 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 pttm -55.74 86.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.0 -1.063 . . . . 1.84 108.605 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 152' ' ' ASP . 56.0 mttp -136.27 168.6 19.11 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.096 -1.003 . . . . 2.28 111.423 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 18.9 mp0 -112.99 109.7 19.28 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.129 -1.063 . . . . 0.01 108.129 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -101.05 115.05 29.57 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.019 -1.05 . . . . 0.01 110.448 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -92.19 -25.65 18.57 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.083 -1.011 . . . . 0.01 111.324 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -126.2 153.53 74.36 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.797 -1.189 . . . . 2.54 108.54 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.04 -42.61 35.33 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 CA-C-N 119.313 0.791 . . . . 0.7 110.644 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.6 t -60.24 -20.71 20.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.637 -1.29 . . . . 0.86 108.669 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -65.87 -15.95 63.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.888 -1.132 . . . . 0.02 109.609 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.633 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.83 9.55 38.69 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.08 10.56 86.2 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.349 -1.405 . . . . 0.02 109.784 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.54 142.13 31.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.455 -1.027 . . . . 0.02 110.194 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.62 -8.41 58.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.66 -0.65 . . . . 0.59 109.767 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.9 p -144.49 150.98 49.52 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.947 -1.095 . . . . 0.87 108.544 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -76.15 21.56 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.738 0.958 . . . . 0.38 112.4 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.14 123.89 29.97 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.592 1.187 . . . . 0.18 111.92 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.602 HG23 ' CD1' ' A' ' 138' ' ' PHE . 26.0 mt -146.08 125.22 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 106.38 -1.711 . . . . 3.99 106.38 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -111.21 -20.26 12.39 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.154 -0.966 . . . . 5.17 112.988 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.7 p -157.89 160.17 37.36 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 119.423 -2.048 . . . . 0.02 109.871 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -152.81 154.59 35.47 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.095 -1.003 . . . . 2.02 110.426 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -144.33 151.63 39.61 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.25 -0.906 . . . . 0.01 110.712 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -88.27 144.88 26.16 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.168 -0.679 . . . . 0.01 109.168 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -95.63 128.58 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.165 -0.959 . . . . 3.04 109.403 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 177' ' ' GLU . 17.4 m -136.81 146.6 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.229 -0.92 . . . . 1.89 109.304 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 176' ' ' VAL . 16.1 pt-20 . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.891 -0.506 . . . . 4.89 110.808 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.0 t . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.419 -0.586 . . . . 5.28 109.419 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -70.7 62.91 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 5.96 109.424 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 4' ' ' GLY . 50.2 m -173.88 158.39 3.19 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.824 -1.173 . . . . 2.22 108.265 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.492 ' N ' HG22 ' A' ' 3' ' ' THR . . . 178.79 177.76 47.62 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 118.619 -1.753 . . . . 0.81 111.806 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.47 156.9 43.58 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.107 -1.597 . . . . 0.01 109.107 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -149.06 136.99 20.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.015 -1.285 . . . . 0.02 110.255 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 tt -130.43 140.67 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.136 -0.69 . . . . 0.02 109.136 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 t -121.47 130.23 53.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.427 -0.795 . . . . 0.39 110.146 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.51 140.42 44.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.647 -0.658 . . . . 0.02 109.361 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -121.92 138.26 54.48 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.189 -0.944 . . . . 0.02 109.493 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -69.47 -27.42 65.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.892 -1.13 . . . . 0.03 111.672 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -113.89 169.86 8.69 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.801 -1.187 . . . . 0.03 110.241 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -75.62 158.42 32.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.509 0.671 . . . . 0.03 110.174 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 43.8 t30 65.78 35.37 6.83 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.883 0.849 . . . . 0.74 110.759 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.602 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.99 44.62 25.57 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.682 0.754 . . . . 0.02 111.26 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -112.58 165.67 12.04 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.975 -1.12 . . . . 0.02 107.975 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.09 -167.57 34.57 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.789 -1.196 . . . . 0.03 110.563 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -69.14 142.64 54.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -1.06 . . . . 2.76 109.073 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -122.3 150.13 42.77 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.455 -0.778 . . . . 1.89 110.152 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -136.53 133.12 36.14 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.665 -0.647 . . . . 0.02 109.351 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -109.37 135.74 49.93 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.772 -0.825 . . . . 1.12 108.772 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -127.44 138.02 52.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.588 -0.695 . . . . 0.02 109.516 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -118.81 12.14 12.86 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.598 -0.689 . . . . 0.2 110.305 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 39.0 t -159.94 173.79 15.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.771 -1.206 . . . . 1.23 109.079 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 4.9 p-10 -63.29 146.36 53.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.805 -1.184 . . . . 0.02 110.652 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.9 m -133.45 117.34 17.09 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.725 -0.843 . . . . 0.02 108.725 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.3 -20.26 55.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.477 -0.764 . . . . 0.24 111.806 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 25.4 p-10 -152.85 106.28 3.04 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.887 -1.133 . . . . 1.14 109.287 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.76 5.21 41.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.473 -0.767 . . . . 6.37 110.427 -178.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -62.46 -29.42 70.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 3.11 112.65 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -77.05 -18.42 58.09 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.159 -1.588 . . . . 0.88 111.797 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -107.25 -19.52 13.57 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.313 -0.867 . . . . 0.02 110.438 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.4 tp -148.73 126.91 12.1 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.927 -1.108 . . . . 3.32 109.467 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 t -87.43 -13.07 44.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.538 -0.726 . . . . 0.02 111.362 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -172.55 161.73 5.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.819 -1.176 . . . . 0.02 108.5 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.463 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.6 p -143.86 116.59 8.72 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.194 -0.941 . . . . 0.02 108.85 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -108.38 -0.06 20.85 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.744 -1.223 . . . . 0.03 111.314 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 t -155.9 153.85 30.31 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.723 -1.214 . . . . 0.02 107.723 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 39' ' ' ILE . 9.1 mt -146.81 147.97 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.253 1.025 . . . . 0.02 110.727 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -123.49 125.04 44.2 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.95 -1.13 . . . . 0.02 107.95 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.59 114.02 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 106.663 -1.606 . . . . 0.02 106.663 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -85.36 -34.72 21.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.628 -0.67 . . . . 3.81 110.277 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.31 148.9 16.52 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.52 -1.8 . . . . 0.02 110.72 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.89 172.33 48.7 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.284 -1.126 . . . . 0.01 110.284 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.3 m -118.58 134.95 54.71 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.529 -1.285 . . . . 1.48 107.529 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -127.17 154.28 44.99 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.703 1.239 . . . . 0.02 112.305 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.95 134.28 51.82 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 105.176 -2.157 . . . . 0.24 105.176 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.487 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.2 m -119.16 144.32 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.578 -0.701 . . . . 0.65 109.512 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -120.78 144.68 48.17 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.083 0.944 . . . . 0.02 109.976 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.61 -33.45 75.69 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.833 -0.621 . . . . 0.02 111.925 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -123.75 158.12 60.63 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.069 -1.019 . . . . 0.02 109.521 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -52.9 164.7 1.48 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.503 1.468 . . . . 0.02 112.669 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 64.1 37.29 9.15 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.722 0.772 . . . . 0.02 111.299 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 45.1 51.6 8.87 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.689 0.757 . . . . 3.39 110.764 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -125.92 163.59 22.63 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.185 0.517 . . . . 2.33 109.811 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.71 -161.72 31.06 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.563 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -64.46 139.43 58.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.997 -1.296 . . . . 0.02 110.275 -178.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.3 ppp? -119.0 137.16 53.72 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.769 -0.582 . . . . 5.01 109.663 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.8 m-85 -134.92 139.32 44.87 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.434 -0.791 . . . . 0.02 110.197 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.6 mm -94.21 130.56 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.953 -0.758 . . . . 1.72 108.953 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.521 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.0 mt -120.95 111.13 34.35 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 121.251 -0.905 . . . . 0.02 110.887 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.15 169.86 19.62 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 CA-C-N 119.742 0.943 . . . . 1.47 110.184 177.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -52.94 141.03 23.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.894 -1.129 . . . . 4.25 110.388 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.82 -177.59 32.02 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.551 -1.309 . . . . 0.02 110.929 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -120.06 131.39 55.08 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.56 -0.964 . . . . 0.96 109.91 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CE1' HD22 ' A' ' 61' ' ' LEU . 86.7 m-85 -121.94 92.93 48.81 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 107.928 -1.138 . . . . 0.02 107.928 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.85 -4.13 6.83 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.003 1.135 . . . . 0.02 113.863 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -157.62 154.85 29.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.621 -1.299 . . . . 2.02 108.201 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -59.5 -39.37 83.59 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.445 -0.784 . . . . 0.02 112.092 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -59.81 -23.97 63.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.02 110.366 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.71 -18.68 62.81 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.75 0.785 . . . . 3.42 109.013 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.1 t90 -107.92 9.91 28.58 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.439 -1.319 . . . . 0.02 107.439 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.3 mtt 60.79 22.25 12.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.572 -0.705 . . . . 0.02 110.485 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.25 144.4 45.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.344 -1.502 . . . . 0.02 109.344 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.2 tp -78.74 -31.06 46.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.492 -1.299 . . . . 0.98 107.492 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.481 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 55.6 t30 -157.07 -171.16 3.53 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.389 -1.708 . . . . 0.02 106.389 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.481 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 2.9 p-10 -98.6 28.76 4.03 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.59 -1.319 . . . . 0.02 110.468 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -97.95 123.02 41.75 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.953 -1.092 . . . . 3.2 111.175 -178.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.487 HD22 ' HB ' ' A' ' 48' ' ' VAL . 52.8 mt -142.79 119.97 11.48 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.404 -1.332 . . . . 2.61 107.404 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.15 -17.91 11.04 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 121.123 -0.986 . . . . 0.02 112.17 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.5 m -155.77 155.99 34.03 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.271 -1.723 . . . . 0.02 110.598 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.7 m -145.17 147.77 32.84 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.304 0.573 . . . . 0.02 109.58 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -137.44 142.15 41.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.416 -0.802 . . . . 0.01 109.173 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.31 132.97 36.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.212 -0.93 . . . . 0.43 109.314 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -89.68 123.79 42.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.282 -1.006 . . . . 1.25 108.282 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -91.19 131.5 36.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.751 -1.218 . . . . 1.77 108.004 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -96.77 137.48 35.79 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.005 -1.109 . . . . 1.63 108.005 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.2 t -109.91 126.58 54.02 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.479 -0.934 . . . . 1.08 108.479 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 t -103.15 -154.87 0.51 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.046 -1.835 . . . . 1.26 106.046 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.9 -49.62 0.89 Allowed Glycine 0 N--CA 1.497 2.734 0 O-C-N 120.658 -1.276 . . . . 0.01 111.812 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.85 -99.21 0.12 Allowed Glycine 0 N--CA 1.487 2.069 0 C-N-CA 118.77 -1.681 . . . . 0.01 111.897 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -120.91 119.92 34.02 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.279 -1.13 . . . . 4.43 110.619 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.492 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.49 137.09 56.57 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.325 -0.62 . . . . 2.99 109.325 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -134.79 130.96 36.91 Favored 'General case' 0 N--CA 1.518 2.957 0 CA-C-O 122.195 0.997 . . . . 6.36 112.996 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -131.71 142.38 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 115.598 -0.728 . . . . 1.09 110.2 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.419 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.7 pt20 -124.22 139.67 53.7 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.818 -1.179 . . . . 2.05 107.818 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.5 m -123.59 144.71 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 O-C-N 120.73 -1.231 . . . . 1.1 110.942 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -120.55 140.43 51.51 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.155 0.978 . . . . 0.73 111.13 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.46 ' OE2' ' CD2' ' A' ' 123' ' ' LEU . 7.2 tp10 -68.38 -33.4 74.18 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.934 -0.576 . . . . 0.02 111.474 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -114.84 168.59 9.77 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.933 -1.104 . . . . 3.18 110.168 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.01 169.16 46.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.916 -0.873 . . . . 0.01 110.916 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 53.34 39.19 29.46 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.58 0.705 . . . . 0.01 111.686 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 52.69 48.21 23.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.56 -0.712 . . . . 0.01 111.075 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -121.01 164.21 17.09 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.384 -0.969 . . . . 3.15 108.384 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.69 -162.91 29.37 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.97 -1.652 . . . . 0.01 108.97 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -75.94 141.69 42.2 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.945 -1.327 . . . . 0.01 109.214 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.2 tmm? -116.09 143.4 45.52 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.596 0.712 . . . . 0.01 109.465 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -132.56 136.13 46.39 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.278 -1.008 . . . . 2.48 108.278 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.467 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.9 tm-20 -116.63 134.16 55.15 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.639 -0.663 . . . . 0.01 109.576 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.467 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 8.8 t -148.88 148.35 29.76 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.383 1.087 . . . . 1.69 111.302 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.2 p -115.01 7.67 15.59 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.213 -0.903 . . . . 0.01 110.051 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -122.09 163.2 19.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.401 -0.812 . . . . 3.21 111.24 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -69.7 154.75 41.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.01 109.419 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.497 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 53.1 m -127.78 115.53 20.79 Favored Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 109.049 -0.723 . . . . 0.01 109.049 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.43 -32.5 4.87 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 CA-C-N 120.198 1.107 . . . . 0.01 111.308 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 t -141.83 107.37 5.06 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.833 0.825 . . . . 0.02 108.888 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.4 mt -64.83 -39.17 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.864 -0.523 . . . . 1.83 111.036 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 37.1 ttp -67.41 -37.39 83.01 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.148 -1.021 . . . . 1.34 109.79 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.73 -38.72 76.98 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.588 -1.32 . . . . 2.11 109.709 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -79.42 -46.84 16.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.346 -0.846 . . . . 2.08 112.317 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.81 0.45 17.28 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.384 -0.822 . . . . 0.02 112.769 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 59.82 33.07 21.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.68 -1.262 . . . . 0.02 109.39 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.46 ' CD2' ' OE2' ' A' ' 99' ' ' GLU . 10.6 mt -111.89 135.08 52.98 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.64 -0.874 . . . . 0.02 108.64 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -92.58 -23.76 18.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 5.32 110.409 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -148.89 162.96 38.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.146 -0.971 . . . . 0.02 110.023 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.6 mt -131.96 129.44 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.223 -1.399 . . . . 2.17 107.223 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -105.54 -12.32 16.02 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.087 -1.008 . . . . 0.02 112.64 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -155.05 153.15 30.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.524 -1.36 . . . . 0.01 108.156 178.06 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 12.8 t -160.63 144.45 13.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.446 -1.408 . . . . 1.22 109.775 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -122.07 113.4 19.48 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.267 1.032 . . . . 1.41 109.457 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.06 120.23 60.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 105.554 -2.017 . . . . 0.01 105.554 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -145.76 67.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 118.34 -1.344 . . . . 1.98 108.398 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 172.14 108.32 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.586 -1.635 . . . . 0.01 106.586 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.38 -172.56 47.65 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.999 -1.24 . . . . 0.01 109.999 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -110.93 144.22 40.35 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.483 -1.01 . . . . 2.3 108.845 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.492 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.4 m95 -131.32 147.2 52.55 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.446 -0.784 . . . . 0.01 110.641 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.4 mt -119.1 140.29 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 107.956 -1.128 . . . . 1.69 107.956 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.721 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -112.81 141.73 46.28 Favored 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 107.408 -1.331 . . . . 2.49 107.408 177.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 12.9 m-85 -122.46 145.04 48.67 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.55 -0.719 . . . . 0.02 109.264 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -74.55 -30.29 61.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.579 -0.701 . . . . 0.02 112.275 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -114.89 153.79 46.99 Favored Pre-proline 0 N--CA 1.506 2.362 0 O-C-N 120.622 -1.299 . . . . 1.48 109.139 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.51 166.34 1.89 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 120.991 1.127 . . . . 0.02 112.462 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 59.79 31.21 20.68 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.221 -0.9 . . . . 0.75 111.253 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.497 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 58.38 51.97 7.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.02 111.13 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -124.91 163.34 22.46 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.666 -0.646 . . . . 0.02 109.937 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.65 -165.61 32.35 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.159 -1.177 . . . . 0.02 110.159 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -67.85 141.62 56.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.614 -0.933 . . . . 0.02 108.957 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.11 149.07 41.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.582 -0.525 . . . . 0.02 109.582 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.67 141.43 51.61 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 109.125 -0.695 . . . . 0.01 109.125 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.25 120.87 36.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.334 -0.854 . . . . 0.01 109.282 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.671 ' CD2' ' HE1' ' A' ' 162' ' ' TRP . 6.7 mt -104.3 135.14 46.31 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.344 -0.848 . . . . 0.01 110.321 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 154' ' ' LYS . 38.9 t70 -110.78 178.23 4.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.399 -1.334 . . . . 2.27 107.399 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -59.3 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.747 -1.221 . . . . 1.84 108.519 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 152' ' ' ASP . 68.4 tttt -134.95 163.12 30.56 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 122.106 0.955 . . . . 2.28 111.957 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.406 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 2.7 pt-20 -113.87 112.03 22.7 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.07 -1.085 . . . . 0.01 108.07 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.63 114.92 29.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.023 -1.048 . . . . 0.01 110.18 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.456 ' O ' ' OG ' ' A' ' 128' ' ' SER . 23.5 ptt180 -96.74 -27.12 14.9 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.497 -0.752 . . . . 0.01 112.063 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -125.65 151.33 70.45 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 120.766 -1.209 . . . . 2.54 108.98 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -57.97 -48.8 14.82 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 CA-C-N 119.234 0.762 . . . . 0.7 110.759 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.68 -23.67 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.86 -1.15 . . . . 0.86 109.152 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.61 -15.86 63.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.755 -1.216 . . . . 0.02 109.305 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.671 ' HE1' ' CD2' ' A' ' 151' ' ' LEU . 2.7 t90 -94.78 6.54 48.65 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.607 -0.886 . . . . 0.02 108.607 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 74.79 8.29 81.81 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.565 -1.303 . . . . 0.02 109.917 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.22 143.32 29.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.62 -0.929 . . . . 0.02 110.074 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.13 -9.22 58.76 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.675 -0.641 . . . . 0.59 109.671 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.1 p -147.24 150.9 39.34 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.756 -1.215 . . . . 0.87 108.015 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -75.7 25.48 0.4 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 120.777 0.985 . . . . 0.38 112.464 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.888 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.85 124.4 30.92 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.644 1.211 . . . . 0.18 112.534 -177.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.888 HD13 ' O ' ' A' ' 168' ' ' ALA . 6.4 mm -142.19 127.82 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 106.382 -1.71 . . . . 3.99 106.382 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -113.65 -23.7 9.59 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.784 -1.198 . . . . 5.17 112.846 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.9 p -157.31 160.26 38.37 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 119.503 -1.998 . . . . 0.02 109.839 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.497 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 11.8 p90 -153.44 153.98 33.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.983 -1.073 . . . . 2.02 110.601 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.497 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 18.9 mtp180 -143.23 151.14 40.25 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.161 -0.962 . . . . 0.01 110.4 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 174' ' ' ARG . 28.9 ptt180 -87.56 141.83 28.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.991 -0.744 . . . . 0.01 108.991 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.0 mt -93.25 128.31 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.005 -1.059 . . . . 3.04 109.078 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.1 t -136.27 146.52 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.254 -0.903 . . . . 1.89 109.553 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 4.89 109.452 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.495 -0.557 . . . . 5.28 109.495 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.07 166.99 6.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 5.96 109.429 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -81.13 141.8 33.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 2.22 108.415 178.331 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.54 -179.51 47.52 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 118.317 -1.897 . . . . 0.81 112.005 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.78 157.92 44.24 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.292 -1.523 . . . . 0.01 109.292 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -147.76 136.69 22.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.012 -1.287 . . . . 0.02 110.641 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 tt -130.78 139.52 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 109.115 -0.698 . . . . 0.02 109.115 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -121.22 130.33 53.64 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.465 -0.772 . . . . 0.39 109.766 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.05 139.77 44.81 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.983 -0.747 . . . . 0.02 108.983 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.6 m-85 -122.16 138.37 54.49 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.213 -0.929 . . . . 0.02 109.545 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' HG3' HD11 ' A' ' 33' ' ' LEU . 88.7 mt-10 -69.57 -27.76 65.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.03 111.652 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.2 m-20 -114.36 169.7 8.85 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.808 -1.182 . . . . 0.03 110.237 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.563 ' CG ' HH11 ' A' ' 13' ' ' ARG . 3.5 mtt-85 -74.88 157.81 34.43 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.703 0.763 . . . . 0.03 110.078 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 66.26 33.49 7.16 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.958 0.885 . . . . 0.74 111.14 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.25 42.32 30.53 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.212 0.53 . . . . 0.02 111.266 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -113.74 166.0 11.98 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.288 -1.005 . . . . 0.02 108.288 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.95 -167.25 36.2 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.841 -1.171 . . . . 0.03 110.702 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.05 141.59 54.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.976 . . . . 2.76 109.313 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -120.27 148.81 43.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.523 -0.736 . . . . 1.89 110.149 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -132.68 127.39 34.72 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.488 -0.93 . . . . 0.02 108.488 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.62 136.16 51.23 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.414 -0.804 . . . . 1.12 109.565 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -130.52 138.18 50.09 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.502 0.668 . . . . 0.02 109.55 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -117.56 11.16 13.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.737 -0.602 . . . . 0.2 109.655 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.9 p -158.31 173.83 16.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.144 -0.972 . . . . 1.23 108.585 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.62 145.19 55.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.636 -1.29 . . . . 0.02 110.372 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 26' ' ' CYS . 22.0 p -132.99 117.32 17.49 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.407 -0.96 . . . . 0.02 108.407 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.83 -23.5 52.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.24 110.743 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 31.1 p-10 -154.83 101.44 2.29 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.615 -0.883 . . . . 1.14 108.615 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 22.2 p90 -107.08 10.06 30.3 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 122.089 0.947 . . . . 6.37 110.273 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HE ' ' CA ' ' A' ' 80' ' ' GLY . 29.4 mmt180 -59.2 -23.19 62.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.544 -0.722 . . . . 3.11 110.676 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -75.23 -16.32 60.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.726 -1.233 . . . . 0.88 110.354 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -103.08 -21.43 13.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.382 -0.824 . . . . 0.02 109.277 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.472 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.3 tp -150.27 129.46 12.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.309 -0.869 . . . . 3.32 109.081 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t -85.5 -10.58 55.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.76 -0.588 . . . . 0.02 110.769 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -170.56 161.97 7.88 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.896 -1.15 . . . . 0.02 107.896 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.32 115.89 8.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.817 -1.177 . . . . 0.02 109.087 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -109.56 0.79 19.33 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.81 -1.181 . . . . 0.03 111.595 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -156.33 154.51 30.71 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.24 -1.022 . . . . 0.02 108.24 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.9 146.72 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.031 -1.043 . . . . 0.02 110.879 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -123.04 124.04 42.23 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.886 -1.153 . . . . 0.02 107.886 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.0 t -106.45 113.91 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 106.751 -1.574 . . . . 0.02 106.751 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 32.1 tp10 -84.27 -34.52 23.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.633 . . . . 3.81 110.435 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.51 149.32 17.24 Favored Glycine 0 N--CA 1.485 1.948 0 C-N-CA 119.029 -1.558 . . . . 0.02 110.525 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.73 172.41 48.83 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.255 -1.138 . . . . 0.01 110.255 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -118.3 134.77 54.75 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.489 -1.3 . . . . 1.48 107.489 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -127.17 154.68 44.48 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.755 -1.216 . . . . 0.02 112.443 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.37 134.1 52.24 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.349 -2.093 . . . . 0.24 105.349 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.489 ' HB ' HD22 ' A' ' 79' ' ' LEU . 36.0 m -118.35 143.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.479 -0.763 . . . . 0.65 109.351 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -120.84 144.42 48.36 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.37 1.081 . . . . 0.02 110.073 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.86 -33.42 75.8 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.665 -0.698 . . . . 0.02 111.47 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -124.38 157.81 63.54 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.034 -1.041 . . . . 0.02 109.491 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.27 166.45 1.08 Allowed 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.702 1.601 . . . . 0.02 112.728 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 t30 63.28 36.65 11.63 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.383 -0.826 . . . . 0.02 111.127 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 45.31 51.22 9.53 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.634 0.73 . . . . 3.39 110.769 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.2 p -125.49 163.28 23.0 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.186 0.517 . . . . 2.33 109.862 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.67 -161.74 31.14 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.722 -1.351 . . . . 0.02 109.722 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -64.32 138.58 58.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.33 . . . . 0.02 110.124 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -119.16 137.29 53.71 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.818 -0.551 . . . . 5.01 109.578 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.615 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 79.4 m-85 -134.76 139.98 45.57 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.5 -0.75 . . . . 0.02 110.067 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.8 mm -95.18 130.43 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.907 -0.775 . . . . 1.72 108.907 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.488 HD22 ' CE1' ' A' ' 66' ' ' TYR . 13.8 mt -122.54 111.72 31.39 Favored Pre-proline 0 N--CA 1.507 2.39 0 O-C-N 121.338 -0.852 . . . . 0.02 110.654 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.99 170.65 19.39 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 CA-C-N 119.863 0.987 . . . . 1.47 110.13 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 58.1 tt0 -52.16 140.47 20.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.963 -1.086 . . . . 4.25 110.092 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.59 -177.75 32.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.366 -1.397 . . . . 0.02 110.84 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -120.75 131.62 54.6 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.454 -1.027 . . . . 0.96 110.043 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.488 ' CE1' HD22 ' A' ' 61' ' ' LEU . 97.1 m-85 -122.24 95.84 46.83 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.1 Cg_endo -67.79 -3.16 9.88 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.945 1.096 . . . . 0.02 114.125 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 67.6 mt-10 -157.54 154.96 29.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.551 -1.343 . . . . 2.02 108.313 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -60.02 -39.28 85.31 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.498 -0.751 . . . . 0.02 111.734 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -59.56 -24.13 63.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.033 . . . . 0.02 110.202 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -70.49 -18.97 62.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.935 0.874 . . . . 3.42 108.904 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.615 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.3 t90 -108.01 9.78 28.44 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.537 -1.283 . . . . 0.02 107.537 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 mmt 60.97 22.61 12.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.02 110.59 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.16 145.44 46.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.505 -1.438 . . . . 0.02 109.505 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.539 ' O ' HD23 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -79.88 -31.28 40.33 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.601 -1.259 . . . . 0.98 107.601 177.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -156.92 -171.44 3.65 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.448 -1.686 . . . . 0.02 106.448 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 16.5 p-10 -97.98 28.14 4.12 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.634 -1.291 . . . . 0.02 110.661 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' A' ' 78' ' ' ARG . 2.5 mtt-85 -96.42 121.93 38.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.009 -1.057 . . . . 3.2 110.563 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.501 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 24.9 mt -144.82 121.4 11.1 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.629 -1.248 . . . . 2.61 107.629 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.425 ' CA ' ' HE ' ' A' ' 30' ' ' ARG . . . -112.12 -16.4 9.08 Favored Glycine 0 N--CA 1.508 3.471 0 O-C-N 121.218 -0.926 . . . . 0.02 113.495 -177.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.6 p -155.51 156.87 35.97 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.244 -1.739 . . . . 0.02 110.69 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.2 p -145.73 148.32 32.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.695 -0.628 . . . . 0.02 109.903 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -137.23 141.71 42.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.365 -0.834 . . . . 0.01 109.181 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 132.11 36.48 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.166 -0.959 . . . . 0.43 109.436 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -90.06 124.12 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.302 -0.999 . . . . 1.25 108.302 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.432 ' C ' HD23 ' A' ' 87' ' ' LEU . 61.2 m80 -92.4 131.98 37.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.819 -1.176 . . . . 1.77 108.408 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.561 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -96.39 138.25 34.25 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.082 -1.081 . . . . 1.63 108.082 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 m -109.72 126.74 54.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.671 -0.862 . . . . 1.08 108.671 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.9 t -103.65 -154.94 0.51 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.07 -1.826 . . . . 1.26 106.07 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.89 -49.87 0.88 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 120.552 -1.343 . . . . 0.01 111.879 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.26 -99.7 0.13 Allowed Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.825 -1.655 . . . . 0.01 111.924 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.4 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 38.5 tt0 -120.37 119.5 33.28 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.294 -1.121 . . . . 4.43 110.523 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.515 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.71 136.68 55.87 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.501 -0.555 . . . . 2.99 109.501 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -134.39 130.19 36.5 Favored 'General case' 0 N--CA 1.517 2.912 0 CA-C-O 122.11 0.957 . . . . 6.36 113.029 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.43 141.76 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-N 115.637 -0.711 . . . . 1.09 110.211 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.428 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 2.6 pt20 -124.95 139.7 53.59 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 107.526 -1.287 . . . . 2.05 107.526 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.07 146.85 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 120.646 -1.284 . . . . 1.1 111.08 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -120.84 140.29 51.97 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.256 1.027 . . . . 0.73 111.117 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -67.94 -32.19 72.46 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.644 -0.707 . . . . 0.02 111.934 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -114.76 165.61 12.64 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.078 -1.014 . . . . 3.18 110.43 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.26 163.12 46.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 111.069 -0.812 . . . . 0.01 111.069 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 57.65 39.06 27.8 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.608 0.718 . . . . 0.01 111.004 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 33.2 m-85 52.31 56.33 7.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 0.01 111.052 177.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -128.62 164.92 21.84 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.034 -1.098 . . . . 3.15 108.034 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.39 -162.82 28.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.077 -1.609 . . . . 0.01 109.077 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -75.07 141.81 43.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.874 -1.368 . . . . 0.01 108.864 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.9 tmm? -116.18 143.0 46.08 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.472 0.653 . . . . 0.01 109.451 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -132.07 136.22 47.03 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.206 -1.035 . . . . 2.48 108.206 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -116.76 134.48 54.74 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.711 -0.618 . . . . 0.01 109.756 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -149.7 148.55 29.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.941 -1.099 . . . . 1.69 111.337 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -114.48 7.95 16.35 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.106 -0.952 . . . . 0.01 109.695 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -122.27 163.41 19.71 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.545 -0.722 . . . . 3.21 111.152 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -69.62 154.83 41.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.802 . . . . 0.01 109.591 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.401 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 47.5 t -125.92 114.28 24.39 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.947 -0.76 . . . . 0.01 108.947 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -76.0 -33.64 3.52 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 CA-C-N 120.3 1.143 . . . . 0.01 111.557 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t -141.69 107.2 5.05 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.328 -0.858 . . . . 0.02 108.692 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.21 -39.41 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.715 -0.615 . . . . 1.83 111.198 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.2 ttp -66.26 -38.13 87.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.944 -1.102 . . . . 1.34 109.574 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -69.95 -38.73 76.22 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.63 -1.294 . . . . 2.11 109.74 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.47 -47.95 13.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.188 -0.945 . . . . 2.08 112.207 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.457 ' C ' ' ND1' ' A' ' 122' ' ' HIS . 94.8 m-85 -111.35 -1.06 16.13 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.474 -0.766 . . . . 0.02 112.884 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.457 ' ND1' ' C ' ' A' ' 121' ' ' PHE . 5.0 m80 60.26 33.7 20.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.716 -1.24 . . . . 0.02 109.707 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.44 135.63 52.91 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.784 -0.821 . . . . 0.02 108.784 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -92.83 -23.69 18.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.334 -0.854 . . . . 5.32 110.788 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -149.21 163.69 36.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.016 -1.053 . . . . 0.02 110.121 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.2 mt -131.56 129.43 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 107.443 -1.317 . . . . 2.17 107.443 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -107.77 -13.17 15.07 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.123 -0.986 . . . . 0.02 113.033 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.471 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.54 153.08 29.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.412 -1.43 . . . . 0.01 108.261 177.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.9 t -163.53 143.96 8.82 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.287 -1.508 . . . . 1.22 109.697 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -121.82 113.31 19.49 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.062 0.934 . . . . 1.41 108.841 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.96 123.23 63.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 105.694 -1.965 . . . . 0.01 105.694 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.5 t -146.31 68.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 118.186 -1.406 . . . . 1.98 108.271 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER 172.51 107.87 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.537 -1.653 . . . . 0.01 106.537 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.53 -174.1 42.64 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.623 -1.391 . . . . 0.01 109.623 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 m -111.81 143.66 42.38 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.411 -1.053 . . . . 2.3 109.214 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.515 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 61.6 m95 -128.92 146.17 51.02 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.444 -0.785 . . . . 0.01 110.424 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.11 141.15 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.398 -1.334 . . . . 1.69 107.398 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.506 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.14 143.16 45.26 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 107.329 -1.359 . . . . 2.49 107.329 177.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.42 144.64 49.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.623 -0.673 . . . . 0.02 109.297 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 -30.06 63.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.638 -0.664 . . . . 0.02 112.124 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.5 153.64 47.71 Favored Pre-proline 0 N--CA 1.506 2.356 0 O-C-N 120.637 -1.289 . . . . 1.48 109.223 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.72 166.93 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.344 1.362 . . . . 0.02 112.678 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 59.46 31.36 20.99 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.188 -0.915 . . . . 0.75 111.114 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.466 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.2 m-85 57.73 51.52 9.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.55 -0.719 . . . . 0.02 110.961 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -124.7 163.54 21.83 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.487 -0.758 . . . . 0.02 109.857 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.51 -165.28 32.3 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.711 -1.356 . . . . 0.02 109.711 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -67.89 141.3 56.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.437 -1.037 . . . . 0.02 108.894 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -118.22 148.52 42.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.06 -0.718 . . . . 0.02 109.06 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -128.83 142.84 50.84 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.574 -0.704 . . . . 0.01 109.18 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.12 120.0 34.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.367 -0.833 . . . . 0.01 109.492 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.547 HD22 ' CD1' ' A' ' 162' ' ' TRP . 20.0 mt -106.12 133.08 51.4 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.36 -0.837 . . . . 0.01 110.297 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 154' ' ' LYS . 4.4 m-20 -108.79 174.63 5.79 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.356 -0.979 . . . . 2.27 108.356 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -57.12 84.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.077 -1.014 . . . . 1.84 108.627 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 152' ' ' ASP . 90.8 mttt -137.76 169.37 17.9 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 122.0 0.905 . . . . 2.28 111.603 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.39 110.59 20.89 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.389 -0.967 . . . . 0.01 108.389 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.57 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 90.7 m-85 -101.73 114.36 28.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.1 -1.0 . . . . 0.01 109.827 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -91.64 -25.84 18.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.096 -1.003 . . . . 0.01 111.222 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -125.44 154.09 72.43 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.061 -1.024 . . . . 2.54 108.525 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.27 -41.16 44.15 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 120.44 0.76 . . . . 0.7 110.539 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.95 -20.07 21.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.906 -1.121 . . . . 0.86 108.841 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -65.48 -16.17 63.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.003 -1.061 . . . . 0.02 109.787 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.57 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 2.0 m0 -96.94 11.0 37.54 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.065 -1.087 . . . . 0.02 108.065 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.59 11.78 85.14 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.414 -1.374 . . . . 0.02 110.336 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.9 141.83 32.19 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.178 -1.19 . . . . 0.02 110.096 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -8.29 58.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.791 -0.568 . . . . 0.59 109.917 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.6 m -144.37 151.04 50.1 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 120.845 -1.159 . . . . 0.87 108.791 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.43 21.25 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 120.694 0.929 . . . . 0.38 112.368 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.489 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -83.82 122.4 28.64 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.357 1.075 . . . . 0.18 111.602 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.489 HD12 ' C ' ' A' ' 168' ' ' ALA . 3.6 mp -149.01 125.94 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.425 -1.694 . . . . 3.99 106.425 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -111.07 -16.44 13.48 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.176 -0.953 . . . . 5.17 113.23 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 86.4 p -158.46 161.14 37.42 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 119.181 -2.199 . . . . 0.02 110.075 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.2 p90 -152.78 155.25 36.79 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.076 -1.015 . . . . 2.02 110.358 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.466 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 22.9 mtp180 -143.54 150.41 38.85 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.158 -0.964 . . . . 0.01 110.293 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -87.35 142.73 27.66 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.072 -0.714 . . . . 0.01 109.072 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.4 mt -93.66 127.9 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.033 -1.042 . . . . 3.04 109.279 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.7 t -136.01 146.5 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.346 -0.846 . . . . 1.89 109.549 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 4.89 109.477 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.281 0.563 . . . . 5.28 109.496 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -57.82 156.35 8.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.216 -0.927 . . . . 5.96 109.482 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 t -174.78 158.25 2.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.347 -1.47 . . . . 2.22 108.63 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.31 178.54 47.8 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 118.717 -1.706 . . . . 0.81 111.637 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.57 157.1 43.66 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.21 -1.556 . . . . 0.01 109.21 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -148.25 136.31 21.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.898 -1.354 . . . . 0.02 110.29 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 tt -130.38 140.08 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.098 -0.705 . . . . 0.02 109.098 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -121.38 130.46 53.62 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.363 -0.836 . . . . 0.39 110.071 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -110.06 139.7 44.9 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.657 -0.652 . . . . 0.02 109.316 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.543 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.4 m-85 -122.28 138.28 54.56 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.293 -0.879 . . . . 0.02 109.483 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -69.36 -27.3 65.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.956 -1.09 . . . . 0.03 111.875 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -113.92 169.66 8.84 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.796 -1.19 . . . . 0.03 110.143 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.39 158.38 32.81 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.549 0.69 . . . . 0.03 109.647 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.4 m120 66.24 35.05 6.19 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.719 0.771 . . . . 0.74 110.933 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.81 44.89 25.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.669 0.747 . . . . 0.02 111.403 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -112.64 165.84 11.89 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.008 -1.108 . . . . 0.02 108.008 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -167.87 34.44 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.766 -1.207 . . . . 0.03 110.532 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.789 ' HE ' ' H ' ' A' ' 19' ' ' ARG . 9.3 tpm_? -69.33 142.96 53.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -1.088 . . . . 2.76 108.922 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.789 ' H ' ' HE ' ' A' ' 18' ' ' ARG . 18.7 ttm180 -122.44 150.1 42.95 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.38 -0.825 . . . . 1.89 110.331 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -135.9 132.5 36.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.155 -0.683 . . . . 0.02 109.155 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 14.6 p-10 -108.52 136.23 48.48 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.589 -0.893 . . . . 1.12 108.589 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 15.9 t -127.68 137.77 52.6 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.666 -0.646 . . . . 0.02 110.035 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -119.9 11.05 11.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.2 110.754 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.532 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 16.0 t -159.73 173.77 15.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.633 -1.292 . . . . 1.23 109.26 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 19.5 p-10 -63.41 145.8 54.86 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.416 -1.428 . . . . 0.02 110.931 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.9 m -135.22 119.19 17.41 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.886 -0.783 . . . . 0.02 108.886 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.482 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.79 -20.02 54.0 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.526 -0.734 . . . . 0.24 112.24 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -154.16 106.68 2.82 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.705 -1.247 . . . . 1.14 109.931 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.95 6.63 39.05 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.425 -0.797 . . . . 6.37 110.202 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -61.12 -29.69 69.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 3.11 112.052 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -76.96 -17.41 58.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.405 -1.434 . . . . 0.88 111.005 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -106.34 -21.17 13.17 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.413 -0.804 . . . . 0.02 110.621 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -149.33 127.47 12.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.092 -1.005 . . . . 3.32 109.653 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.5 p -87.2 -12.39 46.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.618 -0.676 . . . . 0.02 111.083 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -172.28 161.94 5.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.743 -1.223 . . . . 0.02 108.479 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 t -143.73 117.06 9.04 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.001 -1.062 . . . . 0.02 109.002 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -109.64 0.12 18.9 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.708 -1.245 . . . . 0.03 111.754 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 18.3 m -155.74 154.05 30.86 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.273 -1.01 . . . . 0.02 108.273 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -145.86 146.31 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 122.32 1.057 . . . . 0.02 110.818 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -122.77 123.68 41.61 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.594 -1.262 . . . . 0.02 107.594 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.1 t -105.64 113.63 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.87 -1.53 . . . . 0.02 106.87 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -85.13 -34.53 22.14 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.133 -0.627 . . . . 3.81 110.07 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.4 149.15 16.96 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.599 -1.763 . . . . 0.02 110.751 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.59 172.19 48.71 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.243 -1.143 . . . . 0.01 110.243 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.5 m -118.3 134.65 54.86 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.644 -1.243 . . . . 1.48 107.644 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -127.06 154.56 44.52 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 122.624 1.202 . . . . 0.02 112.345 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.34 133.77 52.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 105.453 -2.055 . . . . 0.24 105.453 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.1 144.19 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.519 -0.738 . . . . 0.65 109.323 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -120.65 144.95 47.9 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.157 0.979 . . . . 0.02 109.978 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -66.77 -33.8 76.43 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.943 -0.571 . . . . 0.02 111.957 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -123.09 158.27 58.27 Favored Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 121.111 -0.993 . . . . 0.02 109.509 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -53.1 164.64 1.64 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.524 1.482 . . . . 0.02 112.636 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 64.0 37.06 9.55 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.8 0.809 . . . . 0.02 111.363 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.453 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 11.2 m-85 45.54 51.39 9.91 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.681 0.753 . . . . 3.39 110.91 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 t -125.67 163.43 22.81 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.168 0.509 . . . . 2.33 109.827 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.72 -161.69 31.03 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.764 -1.334 . . . . 0.02 109.764 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -64.68 139.17 58.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.932 -1.334 . . . . 0.02 110.216 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 58' ' ' MET . 3.0 ppp? -119.6 138.12 53.43 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.725 -0.609 . . . . 5.01 109.475 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.599 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 63.8 m-85 -135.32 139.93 44.7 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.461 -0.774 . . . . 0.02 110.084 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.1 mm -93.76 130.18 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.311 -0.996 . . . . 1.72 108.311 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -121.48 111.1 33.47 Favored Pre-proline 0 N--CA 1.506 2.337 0 O-C-N 121.291 -0.881 . . . . 0.02 111.008 -178.312 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.04 169.79 19.85 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.738 0.942 . . . . 1.47 110.542 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -53.03 141.25 22.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.972 -1.08 . . . . 4.25 110.695 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.71 -177.76 31.84 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.47 -1.347 . . . . 0.02 110.955 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -119.68 131.29 55.38 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.367 -1.078 . . . . 0.96 109.782 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 78.8 m-85 -121.93 98.59 44.93 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.034 -1.099 . . . . 0.02 108.034 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.425 ' O ' ' OG ' ' A' ' 38' ' ' SER . 9.8 Cg_endo -71.12 -3.25 12.51 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.82 1.013 . . . . 0.02 113.919 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -157.51 154.54 28.82 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.672 -1.267 . . . . 2.02 108.221 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -59.69 -39.32 84.19 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.462 -0.774 . . . . 0.02 111.886 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -59.85 -23.82 63.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.02 110.303 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -70.49 -18.7 62.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.301 -0.874 . . . . 3.42 108.972 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.599 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -108.22 10.6 27.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.391 -1.337 . . . . 0.02 107.391 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.3 mmt 60.55 22.45 12.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.02 110.401 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.02 145.08 46.41 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.449 -1.46 . . . . 0.02 109.449 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -79.94 -30.53 39.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -1.174 . . . . 0.98 107.9 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.435 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 9.2 t-20 -157.16 -171.64 3.71 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.558 -1.645 . . . . 0.02 106.558 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.435 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 1.6 p30 -98.81 28.67 4.17 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.606 -1.309 . . . . 0.02 110.791 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -96.99 123.14 40.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.862 -1.149 . . . . 3.2 111.074 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.487 HD21 ' CH2' ' A' ' 72' ' ' TRP . 85.5 mt -141.78 119.1 11.47 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.472 -1.307 . . . . 2.61 107.472 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.96 -18.49 9.89 Favored Glycine 0 N--CA 1.502 3.062 0 O-C-N 121.008 -1.058 . . . . 0.02 112.537 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.1 m -156.11 156.52 34.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.303 -1.704 . . . . 0.02 110.387 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.0 m -144.83 147.63 33.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.801 -0.562 . . . . 0.02 109.754 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.453 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 46.6 mtp180 -137.32 141.77 41.86 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.451 -0.781 . . . . 0.01 109.162 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.86 132.13 36.7 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.26 -0.9 . . . . 0.43 109.313 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -90.76 124.4 43.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.634 -0.876 . . . . 1.25 108.634 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -92.13 131.67 37.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.844 -1.16 . . . . 1.77 108.645 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.45 138.83 33.46 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.142 -1.058 . . . . 1.63 108.142 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.1 p -110.73 126.42 54.54 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.783 -0.821 . . . . 1.08 108.783 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.4 p -103.17 -154.99 0.51 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.089 -1.819 . . . . 1.26 106.089 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.7 -49.61 0.88 Allowed Glycine 0 N--CA 1.498 2.814 0 O-C-N 120.482 -1.386 . . . . 0.01 112.069 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.58 -99.7 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 118.758 -1.687 . . . . 0.01 112.091 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -120.76 120.02 34.43 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.204 -1.174 . . . . 4.43 110.601 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.65 135.46 54.12 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.332 -0.547 . . . . 2.99 109.612 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -133.57 130.19 38.07 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 121.103 -0.998 . . . . 6.36 112.924 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 tt -131.75 141.3 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 115.538 -0.756 . . . . 1.09 110.535 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.1 pt20 -124.44 139.19 54.12 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 107.56 -1.274 . . . . 2.05 107.56 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.13 146.64 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 120.644 -1.285 . . . . 1.1 110.942 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -119.34 139.31 52.16 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.897 0.855 . . . . 0.73 110.65 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.5 -32.47 72.47 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.694 -0.684 . . . . 0.02 111.86 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.476 ' O ' ' OG ' ' A' ' 128' ' ' SER . 14.6 mtpp -114.67 168.32 9.98 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.04 -1.038 . . . . 3.18 109.753 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.38 168.83 44.99 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.67 -0.776 . . . . 0.01 111.201 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.45 39.6 30.17 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.667 0.746 . . . . 0.01 111.611 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 52.68 48.8 21.72 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.58 -0.7 . . . . 0.01 111.027 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -121.79 164.35 17.61 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.378 -0.971 . . . . 3.15 108.378 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.63 -163.38 28.47 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.389 -1.484 . . . . 0.01 109.389 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -76.01 142.57 41.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.93 -1.335 . . . . 0.01 109.143 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.458 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.2 tmm? -116.47 143.38 45.65 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.5 0.667 . . . . 0.01 109.771 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.08 136.11 46.94 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.265 -1.013 . . . . 2.48 108.265 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -116.77 134.33 54.92 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.748 -0.595 . . . . 0.01 109.856 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -149.5 148.78 29.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.885 -1.134 . . . . 1.69 111.195 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.5 p -114.87 7.86 15.82 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.103 -0.953 . . . . 0.01 109.685 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -122.15 163.59 19.26 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.536 -0.727 . . . . 3.21 111.031 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 1.5 p30 -69.2 154.36 42.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.456 -0.777 . . . . 0.01 109.535 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.7 t -125.8 115.03 24.61 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 108.966 -0.753 . . . . 0.01 108.966 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -75.66 -33.47 3.95 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 CA-C-N 120.404 1.18 . . . . 0.01 111.687 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.4 p -141.91 108.06 5.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.325 -0.859 . . . . 0.02 109.071 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.68 -40.06 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.753 -0.592 . . . . 1.83 110.993 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.4 ttt -66.69 -37.45 84.77 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.005 -1.078 . . . . 1.34 109.749 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -69.74 -38.5 76.87 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.474 -1.391 . . . . 2.11 109.819 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.31 -47.54 14.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.277 -0.889 . . . . 2.08 112.493 -177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.51 -1.36 15.88 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.269 -0.895 . . . . 0.02 112.747 -176.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 61.25 34.01 18.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.789 -1.194 . . . . 0.02 109.697 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.1 mt -113.78 136.52 52.77 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.498 -0.751 . . . . 0.02 109.351 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -91.26 -22.49 20.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.873 . . . . 5.32 111.074 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -148.54 163.94 35.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.907 -1.121 . . . . 0.02 110.254 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mm -127.87 125.5 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.163 -1.421 . . . . 2.17 107.163 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -106.15 -15.41 14.88 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.865 -1.147 . . . . 0.02 113.201 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 1.2 p -157.03 155.51 31.33 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.278 -1.513 . . . . 0.01 107.942 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.6 t -163.15 146.49 10.67 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.442 -1.411 . . . . 1.22 109.737 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.77 111.49 17.22 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.432 1.11 . . . . 1.41 108.601 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.7 t -109.16 122.67 64.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 105.584 -2.006 . . . . 0.01 105.584 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.3 t -146.43 67.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 118.128 -1.429 . . . . 1.98 108.06 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.95 108.83 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.534 -1.654 . . . . 0.01 106.534 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.82 -174.3 40.05 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.659 -1.376 . . . . 0.01 109.659 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 m -112.2 145.1 40.47 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.331 -1.1 . . . . 2.3 109.522 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.496 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 62.8 m95 -130.03 145.87 51.68 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.535 -0.728 . . . . 0.01 110.379 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mt -116.96 141.45 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 107.639 -1.245 . . . . 1.69 107.639 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -112.36 141.76 45.7 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 107.198 -1.408 . . . . 2.49 107.198 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -122.06 143.78 49.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.09 -0.707 . . . . 0.02 109.09 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.34 -30.3 61.96 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.729 -0.607 . . . . 0.02 111.908 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.53 153.45 47.74 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.667 -1.271 . . . . 1.48 109.018 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.45 167.11 1.47 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.243 1.295 . . . . 0.02 112.665 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 m120 59.21 31.03 20.89 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.141 -0.936 . . . . 0.75 111.079 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.494 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.6 m-85 57.72 52.07 8.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.633 -0.667 . . . . 0.02 111.048 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -125.07 163.72 21.78 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.495 -0.753 . . . . 0.02 109.69 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.17 -165.5 32.89 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -67.81 141.22 56.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.448 -1.031 . . . . 0.02 108.92 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.64 148.48 42.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.25 -0.648 . . . . 0.02 109.25 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.52 142.72 50.98 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.959 -0.756 . . . . 0.01 108.959 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.0 tt -96.69 121.3 38.39 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.277 -0.89 . . . . 0.01 109.131 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.652 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.9 mt -106.11 135.05 48.26 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.369 -0.832 . . . . 0.01 110.261 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 154' ' ' LYS . 22.8 t70 -108.25 174.82 5.71 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.339 -0.985 . . . . 2.27 108.339 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' N ' ' CG ' ' A' ' 152' ' ' ASP . 13.2 pttp -58.72 83.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.921 -1.112 . . . . 1.84 108.598 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 152' ' ' ASP . 55.0 mmtt -136.47 170.74 15.55 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.215 -0.928 . . . . 2.28 111.518 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.465 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 14.5 mp0 -113.24 109.49 18.84 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.282 -1.007 . . . . 0.01 108.282 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -100.1 114.77 28.36 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.031 -1.043 . . . . 0.01 110.112 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -93.31 -25.85 17.56 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.156 -0.965 . . . . 0.01 111.643 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -125.75 153.32 73.18 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 120.762 -1.211 . . . . 2.54 108.682 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -61.04 -43.02 32.35 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 120.431 0.754 . . . . 0.7 110.77 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.7 t -60.73 -20.52 21.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.64 -1.288 . . . . 0.86 108.619 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -65.14 -15.99 63.02 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.068 -1.02 . . . . 0.02 109.416 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.652 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -94.85 9.87 37.51 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.945 -1.132 . . . . 0.02 107.945 178.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.09 11.27 84.95 Favored Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.18 -1.486 . . . . 0.02 109.627 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.59 142.33 31.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.557 -0.966 . . . . 0.02 110.181 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.79 -8.61 58.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.775 -0.578 . . . . 0.59 109.885 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 58.7 m -144.19 150.59 49.22 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 120.862 -1.149 . . . . 0.87 108.687 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -76.09 21.17 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 120.781 0.987 . . . . 0.38 112.541 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 123.23 28.73 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.653 1.216 . . . . 0.18 111.437 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.527 HG23 ' CD1' ' A' ' 138' ' ' PHE . 17.4 mt -147.25 124.51 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.316 -1.735 . . . . 3.99 106.316 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -114.01 -17.79 11.88 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.178 -0.951 . . . . 5.17 113.022 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.0 t -157.6 160.27 37.93 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.354 -2.091 . . . . 0.02 110.144 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -153.4 154.55 34.68 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.009 -1.057 . . . . 2.02 110.611 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.494 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 21.8 mtp180 -143.53 150.81 39.45 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 0.01 110.356 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -87.94 142.77 27.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.01 109.173 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.96 128.21 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.121 -0.987 . . . . 3.04 109.081 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.9 146.46 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.293 -0.88 . . . . 1.89 109.708 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 4.89 109.353 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.482 -0.562 . . . . 5.28 109.482 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.453 ' O ' ' OG1' ' A' ' 3' ' ' THR . 59.0 mttm -72.41 -39.32 68.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 5.96 109.188 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 4' ' ' GLY . 55.2 m -173.31 156.39 3.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.48 -1.388 . . . . 2.22 108.212 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 3' ' ' THR . . . 178.9 177.67 47.65 Favored Glycine 0 N--CA 1.491 2.3 0 C-N-CA 118.651 -1.738 . . . . 0.81 111.791 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.14 156.47 43.62 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.144 -1.583 . . . . 0.01 109.144 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.514 ' NZ ' ' CB ' ' A' ' 6' ' ' LYS . 5.4 ttpm? -148.8 137.34 21.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.285 . . . . 0.02 110.414 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 tt -130.95 140.52 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 109.206 -0.664 . . . . 0.02 109.206 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -121.41 130.46 53.61 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.403 -0.811 . . . . 0.39 110.054 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.85 140.46 45.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.737 -0.602 . . . . 0.02 109.448 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.3 m-85 -122.24 138.66 54.41 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.184 -0.947 . . . . 0.02 109.603 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.49 -27.27 65.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.08 . . . . 0.03 111.805 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -114.32 170.28 8.42 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.816 -1.178 . . . . 0.03 110.263 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -75.64 158.48 32.34 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.662 0.744 . . . . 0.03 110.18 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 65.99 33.15 7.93 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.006 0.908 . . . . 0.74 111.142 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.22 41.94 30.95 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.923 -0.58 . . . . 0.02 111.21 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -113.16 165.83 12.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.278 -1.008 . . . . 0.02 108.278 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.67 -167.67 35.38 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.882 -1.152 . . . . 0.03 110.464 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -68.97 142.0 54.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -1.096 . . . . 2.76 108.838 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -122.69 151.0 41.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.532 -0.73 . . . . 1.89 109.999 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -137.52 133.87 35.04 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.756 -0.59 . . . . 0.02 109.746 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -109.44 136.08 49.43 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.973 -0.751 . . . . 1.12 108.973 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.0 t -127.63 138.32 52.81 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.577 -0.702 . . . . 0.02 109.535 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 13.1 t70 -119.2 12.19 12.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.619 -0.676 . . . . 0.2 110.494 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.8 p -159.65 173.4 16.15 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.898 -1.126 . . . . 1.23 109.197 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -62.64 146.09 52.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.776 -1.203 . . . . 0.02 110.586 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.7 m -133.73 117.33 16.82 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.801 -0.814 . . . . 0.02 108.801 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.32 52.01 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.314 -0.866 . . . . 0.24 111.641 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -151.06 105.69 3.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.88 -1.137 . . . . 1.14 109.215 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.0 4.85 42.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 6.37 110.097 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -62.1 -29.47 70.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 3.11 112.635 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 m -77.21 -18.22 57.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.152 -1.592 . . . . 0.88 111.647 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -106.95 -19.8 13.52 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.418 -0.801 . . . . 0.02 110.51 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -148.98 127.09 12.02 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.032 -1.042 . . . . 3.32 109.55 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 p -87.44 -13.15 44.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.02 111.301 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -172.38 161.84 5.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.788 -1.195 . . . . 0.02 108.45 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.443 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.6 p -143.35 116.24 8.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.117 -0.989 . . . . 0.02 108.851 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -108.1 -0.73 20.95 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.829 -1.169 . . . . 0.03 111.228 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 19.3 m -155.23 153.68 31.04 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.829 -1.174 . . . . 0.02 107.829 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.89 147.53 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 122.158 0.98 . . . . 0.02 110.551 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -123.58 124.96 43.98 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.952 -1.129 . . . . 0.02 107.952 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.27 113.79 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.672 -1.603 . . . . 0.02 106.672 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -84.76 -35.06 22.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.6 -0.687 . . . . 3.81 110.001 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.65 149.45 17.42 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.598 -1.763 . . . . 0.02 110.778 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.75 172.1 48.57 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.237 -1.145 . . . . 0.01 110.237 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -118.48 134.36 55.13 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.592 -1.262 . . . . 1.48 107.592 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -127.03 154.31 44.81 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.704 1.24 . . . . 0.02 112.484 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.88 134.11 52.0 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 105.194 -2.15 . . . . 0.24 105.194 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.6 m -116.38 141.95 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.65 109.453 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -120.48 143.13 48.69 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.192 0.996 . . . . 0.02 109.649 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.84 -34.1 77.37 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.511 -0.768 . . . . 0.02 111.897 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -124.51 157.96 63.43 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.017 -1.052 . . . . 0.02 109.472 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.39 166.4 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.587 1.525 . . . . 0.02 112.769 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.461 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 63.55 36.59 10.99 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.242 -0.89 . . . . 0.02 111.116 178.268 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.514 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 6.0 m-85 45.56 51.6 9.81 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.603 0.716 . . . . 3.39 110.679 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.8 m -126.1 163.62 22.68 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.291 0.567 . . . . 2.33 109.77 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.66 31.27 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -64.78 139.21 58.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.036 -1.273 . . . . 0.02 110.268 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 19.9 ptm -119.54 136.96 54.13 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.178 0.513 . . . . 5.01 109.722 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.444 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 93.4 m-85 -134.41 139.51 45.62 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.47 -0.768 . . . . 0.02 109.954 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 mm -94.1 130.34 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.924 -0.769 . . . . 1.72 108.924 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.546 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.55 110.69 35.32 Favored Pre-proline 0 N--CA 1.505 2.308 0 O-C-N 121.39 -0.819 . . . . 0.02 110.877 -178.521 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.99 169.32 20.69 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 119.823 0.972 . . . . 1.47 110.388 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -53.97 141.25 28.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.882 -1.136 . . . . 4.25 110.728 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.72 -177.64 31.91 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.509 -1.329 . . . . 0.02 110.748 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -119.42 131.38 55.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.388 -1.066 . . . . 0.96 109.887 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 73.5 m-85 -121.67 98.09 46.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.051 -1.092 . . . . 0.02 108.051 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.423 ' O ' ' OG ' ' A' ' 38' ' ' SER . 7.3 Cg_endo -70.61 -3.82 13.36 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 120.787 0.991 . . . . 0.02 113.576 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -157.33 154.54 29.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.489 -1.382 . . . . 2.02 107.966 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -59.85 -39.07 83.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.434 -0.792 . . . . 0.02 111.722 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -59.75 -24.39 64.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.02 110.496 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -69.95 -18.89 63.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 3.42 109.247 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.554 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.12 10.61 28.02 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.637 -1.245 . . . . 0.02 107.637 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 mtt 60.67 21.97 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.555 0.693 . . . . 0.02 110.359 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.02 144.28 44.98 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.332 -1.507 . . . . 0.02 109.332 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.2 tp -78.64 -30.46 46.38 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.502 -1.296 . . . . 0.98 107.502 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -157.66 -171.39 3.54 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.326 -1.731 . . . . 0.02 106.326 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -98.93 28.56 4.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.62 -1.3 . . . . 0.02 110.433 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -97.84 123.3 41.74 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.026 -1.046 . . . . 3.2 111.36 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.466 HD22 ' HB ' ' A' ' 48' ' ' VAL . 57.1 mt -142.5 119.6 11.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.259 -1.385 . . . . 2.61 107.259 177.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.98 -18.07 10.98 Favored Glycine 0 N--CA 1.497 2.703 0 O-C-N 121.249 -0.907 . . . . 0.02 111.949 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.514 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 15.8 t -155.67 155.29 32.95 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.321 -1.693 . . . . 0.02 110.826 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 30.0 p -146.02 148.2 32.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.02 110.19 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.445 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 49.0 mtp180 -137.43 142.05 41.62 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.88 -0.785 . . . . 0.01 108.88 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.65 133.06 37.27 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.175 -0.953 . . . . 0.43 109.276 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.18 123.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.351 -0.981 . . . . 1.25 108.351 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -91.47 131.75 36.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.678 -1.264 . . . . 1.77 107.958 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.434 ' N ' HD23 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -96.52 137.28 35.83 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.145 -1.057 . . . . 1.63 108.145 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 t -109.7 126.47 53.73 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.454 -0.943 . . . . 1.08 108.454 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.3 m -103.47 -154.48 0.5 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.211 -1.774 . . . . 1.26 106.211 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.36 -50.12 0.88 Allowed Glycine 0 N--CA 1.497 2.748 0 O-C-N 120.692 -1.255 . . . . 0.01 111.676 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.87 -99.41 0.13 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.74 -1.695 . . . . 0.01 112.001 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.42 119.2 32.34 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.311 -1.111 . . . . 4.43 110.457 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.601 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.79 137.52 56.68 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.765 -0.584 . . . . 2.99 109.472 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -134.55 131.51 38.03 Favored 'General case' 0 N--CA 1.519 2.994 0 O-C-N 121.083 -1.011 . . . . 6.36 113.19 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 tt -131.83 141.96 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 115.525 -0.761 . . . . 1.09 110.237 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.532 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 2.3 pm0 -125.11 140.34 52.97 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 107.743 -1.206 . . . . 2.05 107.743 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.3 145.79 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 O-C-N 120.603 -1.31 . . . . 1.1 111.038 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 27.6 m-85 -119.79 140.05 51.37 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.218 1.009 . . . . 0.73 110.959 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.27 -32.97 73.51 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.801 -0.636 . . . . 0.02 111.48 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -115.02 168.91 9.5 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.213 -0.929 . . . . 3.18 109.953 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.25 169.03 47.31 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 111.011 -0.836 . . . . 0.01 111.011 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.7 t0 53.55 39.11 29.61 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.66 0.743 . . . . 0.01 111.594 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 52.53 48.41 22.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.553 -0.717 . . . . 0.01 110.828 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 24.2 t30 -121.53 164.36 17.35 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.307 -0.997 . . . . 3.15 108.307 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 90.68 -163.13 29.52 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.118 -1.593 . . . . 0.01 109.118 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -75.48 141.82 43.03 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.839 -1.389 . . . . 0.01 109.222 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 41.3 ttp -116.39 143.39 45.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.613 0.721 . . . . 0.01 109.528 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -132.52 136.18 46.46 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.34 -0.985 . . . . 2.48 108.34 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -117.0 134.72 54.38 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.702 -0.624 . . . . 0.01 109.642 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -149.49 148.55 29.54 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.419 1.104 . . . . 1.69 111.353 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 p -115.6 6.91 14.68 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.045 -0.98 . . . . 0.01 110.015 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.56 163.34 19.05 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.505 -0.747 . . . . 3.21 111.107 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -68.31 152.59 45.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.01 109.822 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.1 t -126.52 113.79 23.02 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.901 -0.777 . . . . 0.01 108.901 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -76.1 -33.27 3.66 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 CA-C-N 120.19 1.103 . . . . 0.01 111.658 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.4 p -140.91 106.84 5.16 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.056 0.931 . . . . 0.02 108.645 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.44 -39.36 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.772 -0.58 . . . . 1.83 111.186 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.0 ttt -67.26 -37.24 83.15 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.024 -1.07 . . . . 1.34 109.578 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -69.6 -38.39 77.28 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.64 -1.288 . . . . 2.11 109.858 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.17 -46.51 16.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 2.08 112.265 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -110.11 -0.14 18.09 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.317 -0.864 . . . . 0.02 112.694 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 59.81 33.26 21.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.653 -1.279 . . . . 0.02 109.379 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.76 135.64 53.27 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 108.676 -0.861 . . . . 0.02 108.676 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -92.34 -23.19 19.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 5.32 110.46 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -149.16 163.32 37.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.163 -0.961 . . . . 0.02 110.073 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.4 mt -132.06 129.66 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 107.189 -1.412 . . . . 2.17 107.189 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -105.75 -12.31 15.94 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.381 -0.928 . . . . 0.02 112.59 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.18 152.8 29.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.368 -1.458 . . . . 0.01 108.11 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 12.8 t -162.88 141.86 8.7 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.556 -1.34 . . . . 1.22 109.465 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.405 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 30.5 ttpt -124.04 114.47 19.78 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.643 1.211 . . . . 1.41 109.656 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.39 123.75 61.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 105.614 -1.995 . . . . 0.01 105.614 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.5 HG13 ' NZ ' ' A' ' 153' ' ' LYS . 59.0 t -147.65 71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 C-N-CA 118.404 -1.318 . . . . 1.98 108.205 175.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 171.35 108.29 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.427 -1.694 . . . . 0.01 106.427 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.75 -172.31 46.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.563 -1.415 . . . . 0.01 109.563 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -110.25 140.89 43.94 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.555 -0.968 . . . . 2.3 108.877 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.601 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 70.5 m95 -129.85 146.69 51.57 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.443 -0.786 . . . . 0.01 110.442 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 137' ' ' ILE . 61.1 mt -118.36 139.86 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 107.816 -1.179 . . . . 1.69 107.816 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.671 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.04 141.96 46.26 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.103 -1.443 . . . . 2.49 107.103 178.057 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 6.7 m-85 -122.55 144.39 49.12 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.593 -0.692 . . . . 0.02 109.155 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -73.92 -30.12 62.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.586 -0.696 . . . . 0.02 112.407 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.3 mt -115.05 153.56 47.17 Favored Pre-proline 0 N--CA 1.506 2.349 0 O-C-N 120.773 -1.204 . . . . 1.48 109.085 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.3 166.67 1.6 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.117 1.211 . . . . 0.02 112.522 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 59.54 30.76 20.43 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.225 -0.898 . . . . 0.75 111.114 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.56 52.21 7.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.424 -0.798 . . . . 0.02 111.272 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -125.78 163.84 21.98 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.532 -0.73 . . . . 0.02 109.959 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.67 -165.56 32.29 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.078 -1.209 . . . . 0.02 110.078 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -68.1 141.69 56.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.543 -0.975 . . . . 0.02 108.941 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -118.15 149.92 40.24 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 116.044 -0.526 . . . . 0.02 109.676 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.56 140.82 51.87 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.221 -0.659 . . . . 0.01 109.221 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.5 tp -95.13 121.69 37.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.414 -0.804 . . . . 0.01 109.191 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.63 ' CD2' ' HE1' ' A' ' 162' ' ' TRP . 5.8 mt -104.62 113.98 27.91 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.384 -0.823 . . . . 0.01 109.677 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 152' ' ' ASP . 5.3 m-20 -113.9 89.83 3.19 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 108.702 -0.851 . . . . 2.27 108.702 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.5 ' NZ ' HG13 ' A' ' 132' ' ' VAL . 51.8 tttp 49.37 78.86 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.99 -1.069 . . . . 1.84 108.267 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -131.45 144.4 51.14 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.468 -0.77 . . . . 2.28 111.902 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -112.98 99.79 8.13 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.329 -1.36 . . . . 0.01 107.329 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -98.06 116.72 30.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.096 -1.003 . . . . 0.01 110.853 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -97.72 -27.3 14.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.434 -0.791 . . . . 0.01 110.734 -178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -125.72 152.44 72.28 Favored Pre-proline 0 N--CA 1.502 2.137 0 N-CA-C 108.527 -0.916 . . . . 2.54 108.527 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -57.87 -47.49 20.6 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 CA-C-N 119.313 0.79 . . . . 0.7 110.889 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.58 -23.57 29.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.829 -1.17 . . . . 0.86 109.435 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 11.9 t0 -66.8 -16.22 64.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.777 -1.202 . . . . 0.02 109.492 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.63 ' HE1' ' CD2' ' A' ' 151' ' ' LEU . 2.2 t90 -95.06 7.83 44.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.529 -0.915 . . . . 0.02 108.529 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.98 8.18 84.67 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.904 -1.278 . . . . 0.02 109.904 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.27 142.84 30.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.552 -0.97 . . . . 0.02 110.035 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.31 -8.97 58.85 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.728 -0.608 . . . . 0.59 109.635 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.7 t -146.46 151.38 43.33 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.825 -1.172 . . . . 0.87 108.113 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.22 24.85 0.39 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.768 0.979 . . . . 0.38 112.344 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.485 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -85.27 123.01 30.27 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.87 -1.144 . . . . 0.18 112.803 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.671 HG23 ' CD1' ' A' ' 138' ' ' PHE . 4.6 mp -146.84 126.92 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.429 -1.693 . . . . 3.99 106.429 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -112.16 -17.88 12.7 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.917 -1.114 . . . . 5.17 113.605 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.8 p -157.79 160.82 38.2 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 119.18 -2.2 . . . . 0.02 110.263 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -153.2 153.74 33.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.054 -1.029 . . . . 2.02 110.766 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -144.72 152.16 39.97 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.205 -0.934 . . . . 0.01 110.908 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -88.31 141.82 28.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.118 -0.697 . . . . 0.01 109.118 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.0 mt -94.42 129.41 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.215 -0.928 . . . . 3.04 109.105 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.29 147.22 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.186 -0.946 . . . . 1.89 109.681 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 4.89 109.366 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.388 -0.597 . . . . 5.28 109.388 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -55.35 116.69 2.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 5.96 109.463 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 p -89.9 -139.74 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.367 -1.346 . . . . 2.22 107.367 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.67 -174.95 45.81 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 117.421 -2.323 . . . . 0.81 112.9 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.88 160.36 44.77 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.425 -1.47 . . . . 0.01 109.425 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -147.67 136.03 21.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.093 -1.239 . . . . 0.02 110.267 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -130.38 140.32 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.211 -0.663 . . . . 0.02 109.211 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.95 130.9 53.7 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.429 -0.795 . . . . 0.39 110.191 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.9 m-85 -110.98 140.62 45.34 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.546 -0.721 . . . . 0.02 109.487 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -121.89 138.1 54.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.365 -0.834 . . . . 0.02 109.49 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.43 -27.25 65.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.957 -1.09 . . . . 0.03 111.681 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -113.88 169.63 8.85 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.927 -1.108 . . . . 0.03 110.212 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.51 ' NH2' ' OE2' ' A' ' 68' ' ' GLU . 21.8 mtp180 -75.91 158.43 32.05 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.614 0.721 . . . . 0.03 110.159 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 66.39 33.26 7.06 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.05 0.928 . . . . 0.74 111.082 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 55.58 41.8 30.27 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.932 -0.576 . . . . 0.02 111.39 177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -113.44 165.72 12.19 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.357 -0.979 . . . . 0.02 108.357 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.18 -167.94 34.81 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.851 -1.166 . . . . 0.03 110.536 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -69.03 142.84 54.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.443 -1.034 . . . . 2.76 108.955 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -122.2 149.96 42.93 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.614 -0.679 . . . . 1.89 110.053 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -136.59 133.02 35.91 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.329 -0.619 . . . . 0.02 109.329 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -109.22 136.79 48.12 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.761 -0.829 . . . . 1.12 108.761 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 16.0 t -128.21 138.44 52.46 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.556 -0.715 . . . . 0.02 109.891 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -119.74 11.53 11.95 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.647 -0.658 . . . . 0.2 110.776 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.525 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 26.7 p -159.7 173.48 15.99 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.562 -1.336 . . . . 1.23 109.418 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.09 145.89 54.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.404 -1.435 . . . . 0.02 110.688 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.9 m -135.1 119.57 18.01 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.037 -0.727 . . . . 0.02 109.037 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.25 -20.33 55.33 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.425 -0.797 . . . . 0.24 111.918 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -153.96 106.62 2.86 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.838 -1.163 . . . . 1.14 109.792 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.77 5.65 38.93 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.378 -0.826 . . . . 6.37 110.289 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -60.5 -29.21 68.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 3.11 111.976 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 p -76.86 -16.78 59.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.417 -1.427 . . . . 0.88 111.039 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -106.13 -21.63 13.07 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.326 -0.859 . . . . 0.02 110.684 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 tp -149.44 127.67 12.09 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.988 -1.07 . . . . 3.32 109.534 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -87.63 -12.41 45.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.562 -0.711 . . . . 0.02 110.966 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -171.82 160.85 5.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.854 -1.154 . . . . 0.02 108.541 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.454 ' SG ' HD12 ' A' ' 79' ' ' LEU . 1.8 p -143.38 116.1 8.71 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.975 -1.078 . . . . 0.02 108.846 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -108.6 -0.91 19.98 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.811 -1.18 . . . . 0.03 111.363 -178.331 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 21.1 m -154.73 153.64 31.6 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mt -146.67 147.41 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.296 1.046 . . . . 0.02 110.735 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -123.75 124.53 42.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.052 -1.092 . . . . 0.02 108.052 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 t -105.28 113.88 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.654 -1.609 . . . . 0.02 106.654 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -85.52 -34.9 21.44 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.079 -0.649 . . . . 3.81 110.212 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.56 149.11 16.78 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 118.481 -1.819 . . . . 0.02 110.773 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.75 172.18 48.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.08 -1.208 . . . . 0.01 110.08 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.8 m -118.26 134.37 55.08 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.422 -1.325 . . . . 1.48 107.422 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -126.78 154.49 44.19 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.694 1.235 . . . . 0.02 112.411 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.25 133.97 52.36 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 105.18 -2.155 . . . . 0.24 105.18 176.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.445 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.1 m -116.38 142.01 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.494 -0.754 . . . . 0.65 109.268 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -120.85 143.06 49.09 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.104 0.954 . . . . 0.02 109.607 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.88 -33.82 76.93 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.527 -0.761 . . . . 0.02 111.76 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -124.76 158.01 63.98 Favored Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 120.971 -1.081 . . . . 0.02 109.366 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.29 167.14 0.87 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.548 1.499 . . . . 0.02 112.76 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.471 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.2 OUTLIER 63.2 36.58 11.88 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.245 -0.888 . . . . 0.02 111.11 178.275 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.412 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 4.1 m-85 45.1 51.59 8.89 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.626 0.727 . . . . 3.39 110.677 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.7 p -125.69 163.33 23.04 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.227 0.537 . . . . 2.33 109.966 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.51 -161.59 31.23 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.58 -1.408 . . . . 0.02 109.58 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -65.27 138.9 58.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.962 -1.317 . . . . 0.02 110.153 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.2 ptm -118.86 137.31 53.52 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.314 0.578 . . . . 5.01 109.717 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.426 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 97.3 m-85 -134.27 139.34 45.67 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.52 -0.738 . . . . 0.02 109.818 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.9 mm -94.54 130.5 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.906 -0.775 . . . . 1.72 108.906 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.78 110.84 34.83 Favored Pre-proline 0 N--CA 1.506 2.359 0 O-C-N 121.417 -0.802 . . . . 0.02 110.784 -178.311 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -78.06 169.61 20.14 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.855 0.984 . . . . 1.47 110.438 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -53.71 141.18 27.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.966 -1.084 . . . . 4.25 110.589 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.66 -177.61 31.88 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.485 -1.341 . . . . 0.02 110.94 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -119.91 131.38 55.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.377 -1.073 . . . . 0.96 109.785 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 76.3 m-85 -121.29 97.74 47.24 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 107.959 -1.126 . . . . 0.02 107.959 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.43 ' O ' ' OG ' ' A' ' 38' ' ' SER . 4.8 Cg_endo -69.38 -4.46 13.82 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 120.731 0.954 . . . . 0.02 113.754 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.51 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 74.6 mt-10 -157.53 154.66 28.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.693 -1.255 . . . . 2.02 107.97 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -59.45 -38.69 81.4 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.473 -0.767 . . . . 0.02 111.978 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -60.36 -23.98 64.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 0.02 110.554 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -70.04 -18.78 63.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.38 -0.825 . . . . 3.42 108.951 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.552 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.69 10.4 26.88 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.562 -1.273 . . . . 0.02 107.562 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 mtt 60.94 22.32 12.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.735 . . . . 0.02 110.457 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.36 144.48 45.46 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.389 -1.484 . . . . 0.02 109.389 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.09 -31.2 44.25 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.494 -1.299 . . . . 0.98 107.494 177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -157.18 -171.82 3.77 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.383 -1.71 . . . . 0.02 106.383 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 92.9 m-20 -98.5 28.1 4.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.784 -1.198 . . . . 0.02 110.718 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -97.64 123.17 41.44 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.085 -1.009 . . . . 3.2 111.422 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.454 HD12 ' SG ' ' A' ' 36' ' ' CYS . 60.0 mt -142.01 119.56 11.7 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.221 -1.4 . . . . 2.61 107.221 177.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.22 -18.31 10.55 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.229 -0.92 . . . . 0.02 112.14 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 p -155.84 156.01 33.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.371 -1.664 . . . . 0.02 110.583 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.2 p -145.72 148.15 32.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.497 -0.752 . . . . 0.02 110.08 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.412 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 54.3 mtp180 -137.4 142.03 41.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.383 -0.823 . . . . 0.01 109.075 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.8 132.38 36.86 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.259 -0.901 . . . . 0.43 109.394 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 t -89.52 123.75 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.43 -0.952 . . . . 1.25 108.43 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -91.84 131.87 36.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.925 -1.109 . . . . 1.77 108.267 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.47 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -96.99 138.02 35.17 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.16 -1.052 . . . . 1.63 108.16 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 m -110.01 126.79 54.33 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.665 -0.865 . . . . 1.08 108.665 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.4 m -103.34 -154.39 0.5 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.196 -1.779 . . . . 1.26 106.196 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.42 -49.91 0.87 Allowed Glycine 0 N--CA 1.497 2.701 0 O-C-N 120.517 -1.364 . . . . 0.01 111.891 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.28 -99.86 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 118.723 -1.703 . . . . 0.01 111.822 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -119.67 119.35 33.44 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.258 -1.142 . . . . 4.43 110.465 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.425 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.12 135.59 54.78 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.304 -0.628 . . . . 2.99 109.304 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -134.69 131.06 37.23 Favored 'General case' 0 N--CA 1.519 3.021 0 O-C-N 121.024 -1.047 . . . . 6.36 113.079 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 tt -131.83 142.04 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 115.467 -0.788 . . . . 1.09 110.384 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.53 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.4 pt20 -124.32 138.44 54.38 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 107.285 -1.376 . . . . 2.05 107.285 176.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -124.55 147.23 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 120.586 -1.321 . . . . 1.1 111.188 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -119.86 141.51 49.49 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 122.385 1.088 . . . . 0.73 111.582 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -69.54 -33.18 72.42 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.738 -0.664 . . . . 0.02 111.135 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 12.0 mptt -113.84 167.73 10.39 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.185 -0.947 . . . . 3.18 109.545 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.38 169.69 46.55 Favored Glycine 0 N--CA 1.492 2.404 0 CA-C-O 122.033 0.796 . . . . 0.01 111.318 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 53.26 40.09 30.75 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.632 0.73 . . . . 0.01 111.605 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 52.58 47.73 24.07 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.523 -0.735 . . . . 0.01 110.785 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -121.47 165.28 15.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.12 -1.066 . . . . 3.15 108.12 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.27 -162.93 29.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.168 -1.573 . . . . 0.01 109.168 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -76.14 141.87 41.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.903 -1.351 . . . . 0.01 108.967 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.456 ' SD ' ' C ' ' A' ' 107' ' ' MET . 11.0 tmm? -116.08 143.28 45.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.497 0.665 . . . . 0.01 109.595 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -132.28 136.4 46.91 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.421 -0.955 . . . . 2.48 108.421 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -116.78 134.19 55.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.703 -0.623 . . . . 0.01 109.871 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.2 t -149.13 148.54 29.77 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 122.466 1.126 . . . . 1.69 111.444 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -114.74 7.64 15.93 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.062 -0.972 . . . . 0.01 110.1 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.89 163.35 19.39 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.43 -0.794 . . . . 3.21 111.28 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 154.41 42.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.01 109.379 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 35.0 t -125.8 114.5 24.64 Favored Pre-proline 0 N--CA 1.5 2.025 0 N-CA-C 109.19 -0.671 . . . . 0.01 109.19 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -75.59 -33.81 3.78 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 CA-C-N 120.225 1.116 . . . . 0.01 111.488 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 55.0 m -141.46 107.55 5.2 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.921 0.867 . . . . 0.02 108.84 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.7 mt -65.01 -39.04 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.748 -0.595 . . . . 1.83 111.182 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.6 ttt -66.88 -37.36 84.25 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.936 -1.105 . . . . 1.34 109.577 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -69.81 -38.56 76.64 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.59 -1.319 . . . . 2.11 109.752 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -80.16 -47.58 14.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.314 -0.866 . . . . 2.08 112.491 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.43 -0.65 16.2 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.389 -0.82 . . . . 0.02 112.724 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m170 59.71 33.63 21.9 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.76 -1.213 . . . . 0.02 109.5 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 mt -112.3 135.28 53.17 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.637 -0.875 . . . . 0.02 108.637 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -92.45 -23.44 19.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 5.32 110.664 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -149.34 163.63 37.16 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.218 -0.926 . . . . 0.02 110.12 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.5 mt -131.89 129.48 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.237 -1.394 . . . . 2.17 107.237 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -106.32 -12.49 15.67 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.109 -0.994 . . . . 0.02 113.068 -176.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 1.5 p -158.9 156.23 29.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.636 -1.29 . . . . 0.01 107.519 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 3.3 t -163.18 147.18 10.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.939 -1.1 . . . . 1.22 109.541 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.75 108.93 15.01 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.132 0.968 . . . . 1.41 108.767 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.49 121.6 61.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 105.886 -1.894 . . . . 0.01 105.886 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.1 t -147.24 69.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 118.072 -1.451 . . . . 1.98 108.289 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.68 107.56 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.238 -1.764 . . . . 0.01 106.238 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.19 -176.46 40.95 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.604 -1.399 . . . . 0.01 109.604 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.6 m -110.74 146.83 35.63 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.413 -1.051 . . . . 2.3 109.103 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.425 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 67.4 m95 -131.54 149.11 52.64 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.491 -0.756 . . . . 0.01 110.693 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 58.8 mt -118.8 140.61 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.66 -1.237 . . . . 1.69 107.66 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.724 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.14 141.44 46.93 Favored 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 107.314 -1.365 . . . . 2.49 107.314 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 7.4 m-85 -122.64 145.46 48.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.408 -0.807 . . . . 0.02 109.325 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.79 -30.03 61.3 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.561 -0.712 . . . . 0.02 112.187 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.45 153.33 47.64 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 120.684 -1.26 . . . . 1.48 109.068 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.13 167.06 1.33 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.27 1.313 . . . . 0.02 112.478 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.2 t30 59.22 31.11 20.95 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.051 -0.977 . . . . 0.75 111.027 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.57 51.32 9.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.563 -0.711 . . . . 0.02 111.06 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -124.12 163.31 21.76 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.533 -0.729 . . . . 0.02 109.726 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.53 -165.13 32.18 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.889 -1.284 . . . . 0.02 109.889 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -67.84 141.62 56.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.453 -1.028 . . . . 0.02 108.877 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -117.63 149.09 41.27 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.195 -0.669 . . . . 0.02 109.195 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -128.47 141.85 51.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.5 -0.75 . . . . 0.01 109.346 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.12 118.14 31.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.258 -0.901 . . . . 0.01 108.821 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.766 HD13 ' CZ2' ' A' ' 162' ' ' TRP . 0.8 OUTLIER -106.58 135.55 47.9 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.454 -0.778 . . . . 0.01 109.519 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 154' ' ' LYS . 14.4 p30 -109.62 172.73 6.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.234 -0.917 . . . . 2.27 109.157 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -56.53 83.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.14 -0.975 . . . . 1.84 108.738 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 152' ' ' ASP . 51.3 tttm -136.3 166.46 23.39 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.192 -0.942 . . . . 2.28 111.332 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 1.4 pm0 -110.04 108.48 18.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.805 -1.183 . . . . 0.01 107.805 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.608 ' CE2' ' NE1' ' A' ' 162' ' ' TRP . 94.4 m-85 -99.08 114.27 26.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.026 -1.046 . . . . 0.01 110.314 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -91.98 -27.82 17.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.443 -0.786 . . . . 0.01 111.208 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -126.26 152.23 73.4 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 120.96 -1.088 . . . . 2.54 108.228 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -59.72 -44.25 32.66 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 CA-C-N 119.283 0.78 . . . . 0.7 111.185 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.3 t -61.09 -21.62 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.789 -1.194 . . . . 0.86 109.509 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -65.92 -15.84 63.32 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.748 -1.22 . . . . 0.02 110.057 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.766 ' CZ2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -97.39 11.22 37.4 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.548 -0.908 . . . . 0.02 108.548 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.2 10.0 86.54 Favored Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.633 -1.27 . . . . 0.02 110.346 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.71 142.39 31.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.281 -1.129 . . . . 0.02 110.146 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.2 -9.47 57.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.688 -0.633 . . . . 0.59 110.314 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -145.51 150.49 44.13 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.703 -1.248 . . . . 0.87 108.957 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -76.19 21.23 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 120.888 1.059 . . . . 0.38 112.47 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.6 124.66 30.36 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.454 1.121 . . . . 0.18 111.762 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.724 HG23 ' CD1' ' A' ' 138' ' ' PHE . 42.3 mt -145.71 125.91 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.526 -1.657 . . . . 3.99 106.526 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -112.06 -20.7 11.86 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.008 -1.057 . . . . 5.17 112.584 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.2 t -156.5 159.67 38.82 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 119.546 -1.971 . . . . 0.02 109.725 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -153.13 154.02 33.97 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.008 -1.058 . . . . 2.02 110.649 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -144.52 151.61 39.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.156 -0.965 . . . . 0.01 110.558 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -87.59 142.33 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.952 -0.759 . . . . 0.01 108.952 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.9 mt -93.93 128.8 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.145 -0.972 . . . . 3.04 109.004 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.28 146.9 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.208 -0.932 . . . . 1.89 109.46 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 4.89 109.502 179.876 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.313 0.578 . . . . 5.28 109.528 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -68.4 -112.48 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 5.96 109.518 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -175.4 158.82 2.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.242 -1.536 . . . . 2.22 108.653 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.38 178.47 47.8 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.819 -1.658 . . . . 0.81 111.658 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.82 156.08 43.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.106 -1.598 . . . . 0.01 109.106 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -148.46 136.03 20.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.071 -1.252 . . . . 0.02 110.209 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -130.35 140.59 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.198 -0.668 . . . . 0.02 109.198 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 t -120.86 129.82 53.68 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.544 -0.722 . . . . 0.39 109.908 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 m-85 -109.81 139.47 44.85 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.61 -0.681 . . . . 0.02 109.239 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.515 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.5 m-85 -121.56 137.9 54.54 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.209 -0.932 . . . . 0.02 109.416 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.508 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 81.3 mt-10 -69.8 -27.34 64.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.074 -1.016 . . . . 0.03 111.756 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.48 170.66 8.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.843 -1.161 . . . . 0.03 109.95 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.457 ' CZ ' ' OE1' ' A' ' 68' ' ' GLU . 37.4 mtp180 -75.02 161.25 29.62 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.699 0.761 . . . . 0.03 110.245 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.2 m120 62.68 35.03 14.38 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.937 0.875 . . . . 0.74 110.565 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.6 p90 49.49 43.4 23.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.365 -0.834 . . . . 0.02 110.932 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -109.54 165.61 11.53 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.877 -1.157 . . . . 0.02 107.877 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.73 -167.83 33.92 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 120.748 -1.22 . . . . 0.03 110.733 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -69.37 143.71 53.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -1.059 . . . . 2.76 109.071 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -122.85 150.2 43.18 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.529 -0.732 . . . . 1.89 110.24 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -136.05 133.28 37.24 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.245 -0.65 . . . . 0.02 109.245 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -109.22 135.61 50.05 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.708 -0.849 . . . . 1.12 108.708 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.3 t -127.85 138.11 52.58 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.649 -0.657 . . . . 0.02 109.411 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 24.5 p-10 -118.89 12.1 12.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.747 -0.596 . . . . 0.2 110.166 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.8 p -160.18 173.67 15.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.864 -1.148 . . . . 1.23 109.083 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.18 146.07 54.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.838 -1.164 . . . . 0.02 110.657 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 29' ' ' PHE . 5.5 t -133.75 117.92 17.48 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.767 -0.827 . . . . 0.02 108.767 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.53 -21.25 49.07 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.299 -0.876 . . . . 0.24 111.865 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.99 105.79 3.29 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.784 -1.197 . . . . 1.14 109.496 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.581 ' CD2' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -101.32 5.33 42.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.459 -0.776 . . . . 6.37 110.351 -178.387 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -62.48 -29.78 70.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 3.11 112.669 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.6 p -77.11 -19.04 57.5 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.152 -1.592 . . . . 0.88 111.806 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -106.99 -19.49 13.61 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.303 -0.873 . . . . 0.02 110.152 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -148.73 126.97 12.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.994 -1.066 . . . . 3.32 109.39 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 m -87.43 -12.5 45.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.53 -0.732 . . . . 0.02 111.174 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -172.61 162.0 5.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.807 -1.183 . . . . 0.02 108.43 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.9 p -142.77 115.2 8.5 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.992 -1.068 . . . . 0.02 108.791 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 11' ' ' GLU . 10.5 m-80 -107.87 -1.97 20.28 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.858 -1.152 . . . . 0.03 111.441 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.02 153.63 33.3 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 39' ' ' ILE . 9.7 mt -147.23 147.64 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.041 -1.037 . . . . 0.02 110.653 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -125.33 125.94 44.28 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.868 -1.16 . . . . 0.02 107.868 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.5 t -105.39 114.24 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 106.828 -1.545 . . . . 0.02 106.828 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -85.37 -34.83 21.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 3.81 110.131 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.7 149.07 16.6 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 118.38 -1.867 . . . . 0.02 110.797 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.86 172.42 48.78 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.144 -1.182 . . . . 0.01 110.144 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -118.34 134.48 55.01 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.572 -1.27 . . . . 1.48 107.572 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -126.77 154.04 44.76 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.595 1.188 . . . . 0.02 112.382 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.69 133.53 52.66 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.094 -2.187 . . . . 0.24 105.094 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.9 m -117.75 143.28 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.546 -0.721 . . . . 0.65 109.279 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.544 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 33.1 m-85 -120.72 145.1 47.84 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.197 0.999 . . . . 0.02 109.917 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.97 -33.66 76.32 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.76 -0.654 . . . . 0.02 111.436 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -124.71 158.01 63.83 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.122 -0.986 . . . . 0.02 109.484 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.7 167.16 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.747 1.631 . . . . 0.02 112.716 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.0 t30 63.29 36.55 11.66 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.309 -0.859 . . . . 0.02 111.015 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.433 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 7.2 m-85 45.59 51.49 9.92 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.619 0.723 . . . . 3.39 110.936 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -126.13 163.63 22.68 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.223 0.535 . . . . 2.33 110.014 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.85 -161.87 30.99 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.895 -1.282 . . . . 0.02 109.895 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -65.16 139.5 58.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.966 -1.314 . . . . 0.02 110.134 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.544 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 49.2 ttp -118.35 137.34 53.16 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.292 0.568 . . . . 5.01 109.827 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.564 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.6 m-85 -134.75 138.81 44.66 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.467 -0.77 . . . . 0.02 109.911 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.2 mm -94.55 130.89 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.003 -0.74 . . . . 1.72 109.003 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -120.36 110.76 35.58 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.396 -0.815 . . . . 0.02 110.631 -178.508 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -78.25 169.2 20.57 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.876 0.992 . . . . 1.47 110.275 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -53.79 140.64 29.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.831 -1.168 . . . . 4.25 110.558 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.17 -177.56 32.32 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.635 -1.269 . . . . 0.02 110.61 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -118.58 130.41 55.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.454 -1.027 . . . . 0.96 109.735 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 53.2 m-85 -120.61 97.25 48.72 Favored Pre-proline 0 N--CA 1.494 1.763 0 N-CA-C 107.994 -1.113 . . . . 0.02 107.994 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -69.73 -3.72 12.55 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.69 0.926 . . . . 0.02 113.656 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.457 ' OE1' ' CZ ' ' A' ' 13' ' ' ARG . 40.6 mt-10 -157.49 154.17 28.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.579 -1.326 . . . . 2.02 108.138 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -59.63 -38.82 82.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.485 -0.759 . . . . 0.02 111.768 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -60.26 -23.92 64.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.105 -0.997 . . . . 0.02 110.283 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -70.15 -18.58 63.22 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.812 0.815 . . . . 3.42 108.842 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.564 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -108.13 11.13 27.8 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.378 -1.342 . . . . 0.02 107.378 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' A' ' 73' ' ' MET . 1.2 mpt? 59.04 22.61 10.66 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.66 0.743 . . . . 0.02 110.435 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.48 145.16 45.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.409 -1.476 . . . . 0.02 109.409 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.38 -31.6 42.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.122 -1.222 . . . . 0.98 107.751 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -157.07 -171.88 3.81 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.501 -1.666 . . . . 0.02 106.501 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -98.05 28.26 4.08 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.738 -1.226 . . . . 0.02 110.612 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -97.7 122.72 41.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.921 -1.112 . . . . 3.2 111.225 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.473 HD12 ' SG ' ' A' ' 36' ' ' CYS . 61.1 mt -142.24 119.25 11.31 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.372 -1.344 . . . . 2.61 107.372 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.79 -18.22 10.99 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.272 -0.893 . . . . 0.02 112.18 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 76.9 p -155.68 155.62 33.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.335 -1.685 . . . . 0.02 110.169 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.4 p -145.27 148.03 33.02 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.712 -0.618 . . . . 0.02 109.669 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 66.5 mtm180 -137.4 142.2 41.69 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.474 -0.766 . . . . 0.01 109.17 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.97 133.15 36.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.227 -0.92 . . . . 0.43 109.413 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.33 123.91 42.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.593 -0.892 . . . . 1.25 108.593 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -91.75 131.67 36.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.731 -1.231 . . . . 1.77 108.147 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mt -97.12 138.57 34.44 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.194 -1.039 . . . . 1.63 108.194 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.1 m -110.43 126.33 54.2 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.652 -0.87 . . . . 1.08 108.652 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 t -102.96 -154.82 0.5 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.011 -1.848 . . . . 1.26 106.011 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.48 -49.27 0.89 Allowed Glycine 0 N--CA 1.496 2.694 0 O-C-N 120.472 -1.392 . . . . 0.01 111.847 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.08 -99.24 0.12 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 118.77 -1.681 . . . . 0.01 111.897 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -120.59 120.26 35.28 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.321 -1.105 . . . . 4.43 110.595 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.478 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.28 135.83 54.98 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.365 -0.606 . . . . 2.99 109.365 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.511 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 2.4 ttmp? -134.5 130.67 37.03 Favored 'General case' 0 N--CA 1.518 2.974 0 CA-C-O 122.258 1.028 . . . . 6.36 113.074 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 tt -131.62 142.2 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.5 -0.773 . . . . 1.09 110.143 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.426 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.5 pt20 -124.53 139.74 53.6 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.611 -1.255 . . . . 2.05 107.611 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.16 145.83 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 120.68 -1.262 . . . . 1.1 111.2 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.525 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 76.1 m-85 -120.2 139.91 51.94 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.045 0.926 . . . . 0.73 110.758 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.31 -32.11 72.01 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.836 -0.62 . . . . 0.02 111.791 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -114.6 167.73 10.49 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.064 -1.022 . . . . 3.18 110.352 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.53 164.35 52.79 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 111.071 -0.812 . . . . 0.01 111.071 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 57.74 38.77 27.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 122.02 -0.694 . . . . 0.01 111.595 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 52.29 54.95 9.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.519 -0.738 . . . . 0.01 111.208 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -128.97 165.46 21.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.041 -1.096 . . . . 3.15 108.041 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.06 -162.99 30.21 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.014 -1.634 . . . . 0.01 109.014 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -75.73 141.6 42.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.879 -1.366 . . . . 0.01 109.193 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.525 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 51.1 ttp -116.48 143.09 46.02 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.645 0.736 . . . . 0.01 109.548 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -131.91 136.13 47.16 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 2.48 108.21 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.406 ' OE2' ' N ' ' A' ' 110' ' ' THR . 3.0 tm-20 -116.71 133.76 55.63 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.658 -0.651 . . . . 0.01 109.687 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.406 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 0.1 OUTLIER -149.09 148.31 29.53 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.429 1.109 . . . . 1.69 111.088 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -115.23 7.62 15.31 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.96 -1.018 . . . . 0.01 110.152 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -122.07 163.59 19.17 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.373 -0.83 . . . . 3.21 111.214 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.56 154.85 41.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.333 -0.855 . . . . 0.01 109.309 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.604 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 20.3 p -127.32 119.79 22.03 Favored Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 109.24 -0.652 . . . . 0.01 109.24 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -76.72 -33.39 3.01 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 120.198 1.107 . . . . 0.01 110.995 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.0 m -143.45 109.05 5.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.443 -0.786 . . . . 0.02 109.304 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.5 mt -64.04 -39.48 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.83 -0.544 . . . . 1.83 110.79 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.1 ttt -66.64 -37.27 84.47 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.102 -1.039 . . . . 1.34 109.79 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -69.98 -38.61 76.09 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.543 -1.348 . . . . 2.11 109.707 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -80.23 -47.06 15.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.356 -0.84 . . . . 2.08 112.39 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -110.69 -0.62 17.06 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.376 -0.827 . . . . 0.02 112.678 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.598 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.1 m-70 59.92 33.3 21.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.749 -1.219 . . . . 0.02 109.483 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.6 135.82 52.87 Favored 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 108.761 -0.829 . . . . 0.02 108.761 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -92.72 -23.15 19.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 5.32 110.6 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -148.89 163.32 37.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.048 -1.033 . . . . 0.02 110.082 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.0 mt -131.87 129.49 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 107.345 -1.354 . . . . 2.17 107.345 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -107.09 -13.15 15.24 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.183 -0.948 . . . . 0.02 113.073 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.21 153.64 31.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.36 -1.462 . . . . 0.01 108.189 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.6 t -160.88 146.14 14.32 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.218 -1.551 . . . . 1.22 109.963 -178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -121.82 109.08 14.23 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.143 0.973 . . . . 1.41 108.827 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.9 120.74 59.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.002 -1.851 . . . . 0.01 106.002 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -146.59 69.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 118.326 -1.35 . . . . 1.98 108.437 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.57 108.05 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.48 -1.674 . . . . 0.01 106.48 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.696 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 71.07 -172.84 43.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.658 -1.377 . . . . 0.01 109.658 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.24 146.05 37.64 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.466 -1.02 . . . . 2.3 108.93 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.478 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 68.6 m95 -131.35 145.23 51.76 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.441 -0.787 . . . . 0.01 110.389 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mt -117.69 140.94 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.806 -1.183 . . . . 1.69 107.806 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.27 143.63 44.54 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.58 -1.267 . . . . 2.49 107.58 177.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 11.2 m-85 -122.69 144.04 49.4 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.168 -0.678 . . . . 0.02 109.168 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -73.53 -29.72 62.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.654 -0.654 . . . . 0.02 112.088 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.88 153.78 48.19 Favored Pre-proline 0 N--CA 1.506 2.353 0 O-C-N 120.584 -1.322 . . . . 1.48 109.205 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.49 166.73 1.68 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.248 1.299 . . . . 0.02 112.686 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.3 t30 59.39 31.54 21.16 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.13 -0.941 . . . . 0.75 111.076 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.41 51.38 9.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.515 -0.741 . . . . 0.02 110.962 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -124.44 163.49 21.69 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.493 -0.754 . . . . 0.02 109.77 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.58 -165.44 32.31 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.755 -1.338 . . . . 0.02 109.755 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -67.97 141.76 56.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -1.059 . . . . 0.02 108.952 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.448 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.5 mp0 -118.5 149.07 41.91 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.109 -0.7 . . . . 0.02 109.109 -178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.37 142.33 51.15 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.576 -0.703 . . . . 0.01 109.121 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.11 120.68 35.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.505 -0.747 . . . . 0.01 109.27 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.659 HD22 ' NE1' ' A' ' 162' ' ' TRP . 19.0 mt -105.61 133.91 49.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.01 110.727 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 1.2 m-20 -110.31 176.43 5.05 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.183 -1.043 . . . . 2.27 108.183 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.696 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 37.7 mttm -56.66 85.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.985 -1.072 . . . . 1.84 108.571 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 44.8 mttp -136.47 165.13 26.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.233 -0.917 . . . . 2.28 111.778 -178.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -113.27 109.1 18.19 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.951 -1.129 . . . . 0.01 107.951 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -99.67 114.64 27.86 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.139 -0.975 . . . . 0.01 110.219 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -92.17 -25.86 18.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.17 -0.956 . . . . 0.01 111.151 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -125.47 153.65 72.47 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 121.169 -0.957 . . . . 2.54 108.526 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.67 -42.09 42.01 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 CA-C-N 119.227 0.76 . . . . 0.7 110.628 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.56 -20.38 20.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.731 -1.23 . . . . 0.86 108.535 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 37.5 t0 -65.74 -16.25 63.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.986 -1.071 . . . . 0.02 109.531 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.659 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.86 9.59 38.58 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.847 -1.168 . . . . 0.02 107.847 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.99 10.62 86.16 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.308 -1.425 . . . . 0.02 109.716 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.91 142.11 31.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.491 -1.005 . . . . 0.02 110.162 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.08 -8.13 58.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.711 -0.618 . . . . 0.59 109.847 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 t -143.77 148.6 43.41 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.85 -1.156 . . . . 0.87 108.535 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -74.77 21.57 0.42 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 CA-C-N 119.842 0.979 . . . . 0.38 112.231 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.02 123.77 29.78 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.538 1.161 . . . . 0.18 111.781 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.407 ' CD1' ' CZ3' ' A' ' 162' ' ' TRP . 17.8 mt -146.59 126.63 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.773 -1.566 . . . . 3.99 106.773 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -112.36 -19.62 12.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.071 -1.018 . . . . 5.17 112.909 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 9.6 p -157.85 159.88 37.12 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 119.238 -2.164 . . . . 0.02 110.154 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.604 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 6.1 p90 -152.19 154.68 36.29 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.09 -1.006 . . . . 2.02 110.477 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -144.71 151.79 39.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.192 -0.943 . . . . 0.01 110.586 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -87.77 142.57 27.71 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.018 -0.734 . . . . 0.01 109.018 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.6 mt -93.63 128.88 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.091 -1.006 . . . . 3.04 109.14 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.27 146.88 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.194 -0.941 . . . . 1.89 109.54 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.359 -0.838 . . . . 4.89 109.435 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.507 -0.553 . . . . 5.28 109.507 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -52.78 166.36 0.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 5.96 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.0 p -80.64 141.97 34.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.257 -1.016 . . . . 2.22 108.257 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.75 -179.12 47.09 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.248 -1.93 . . . . 0.81 112.126 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.78 158.03 44.36 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.365 -1.494 . . . . 0.01 109.365 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -148.23 136.52 21.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.129 -1.218 . . . . 0.02 110.333 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 tt -130.58 140.38 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.111 -0.7 . . . . 0.02 109.111 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.79 130.71 53.61 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.238 -0.914 . . . . 0.39 110.171 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -110.9 140.3 45.49 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.577 -0.702 . . . . 0.02 109.622 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.7 m-85 -122.71 138.64 54.55 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.282 -0.886 . . . . 0.02 109.591 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -69.42 -27.28 65.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.01 -1.056 . . . . 0.03 111.76 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.12 169.73 8.8 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.896 -1.128 . . . . 0.03 110.127 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -75.44 158.43 32.67 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.571 0.701 . . . . 0.03 110.196 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 m120 66.19 33.38 7.38 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.907 0.861 . . . . 0.74 111.093 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.32 42.14 30.54 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.223 0.535 . . . . 0.02 111.136 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -113.28 165.75 12.12 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.274 -1.01 . . . . 0.02 108.274 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.08 -167.9 34.9 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.872 -1.156 . . . . 0.03 110.576 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -69.17 142.5 54.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.382 -1.069 . . . . 2.76 108.928 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -122.66 151.21 41.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.586 -0.696 . . . . 1.89 110.181 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -136.83 132.77 35.11 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.193 -0.669 . . . . 0.02 109.193 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 6.6 p30 -108.38 135.93 48.87 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.369 -0.975 . . . . 1.12 108.369 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 13.9 t -127.37 137.5 52.79 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.585 -0.697 . . . . 0.02 109.981 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.75 11.03 11.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.673 -0.642 . . . . 0.2 110.808 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.526 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 25.0 p -159.71 173.43 16.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.574 -1.329 . . . . 1.23 109.34 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -63.1 145.54 55.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.428 -1.42 . . . . 0.02 110.801 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.7 m -135.12 119.21 17.55 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.925 -0.769 . . . . 0.02 108.925 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.98 -20.83 51.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.35 -0.844 . . . . 0.24 112.269 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -153.53 106.64 2.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.748 -1.22 . . . . 1.14 110.034 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.64 6.49 39.7 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.4 -0.813 . . . . 6.37 110.401 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.96 -29.32 69.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 3.11 112.063 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.0 m -77.01 -17.23 58.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.389 -1.445 . . . . 0.88 111.126 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -106.57 -21.09 13.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.454 -0.779 . . . . 0.02 110.555 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -149.28 127.57 12.15 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.966 -1.083 . . . . 3.32 109.62 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.8 t -87.47 -12.58 45.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.461 -0.774 . . . . 0.02 111.267 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -172.23 161.75 5.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.02 108.41 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.8 t -143.78 117.6 9.32 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.974 -1.079 . . . . 0.02 109.201 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -109.56 0.0 18.96 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.746 -1.222 . . . . 0.03 111.691 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 22.3 m -155.54 153.97 31.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.005 -1.059 . . . . 0.02 108.475 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 39' ' ' ILE . 12.8 mt -145.88 146.56 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.011 -1.055 . . . . 0.02 110.848 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -123.19 124.17 42.43 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.808 -1.182 . . . . 0.02 107.808 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.1 t -105.29 113.72 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.829 -1.545 . . . . 0.02 106.829 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -85.14 -34.66 22.09 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.997 -0.681 . . . . 3.81 110.139 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.44 149.2 17.04 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.602 -1.761 . . . . 0.02 110.824 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.78 172.16 48.61 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.332 -1.107 . . . . 0.01 110.332 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -117.79 134.01 55.36 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.39 -1.337 . . . . 1.48 107.39 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -126.29 154.49 43.35 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.555 1.169 . . . . 0.02 112.495 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.0 133.3 53.17 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.57 -2.011 . . . . 0.24 105.57 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.1 141.31 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.544 -0.723 . . . . 0.65 109.154 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -120.16 143.08 48.41 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.128 0.966 . . . . 0.02 109.651 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.02 -34.09 77.6 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.641 -0.708 . . . . 0.02 111.755 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -124.49 157.78 63.98 Favored Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 120.939 -1.101 . . . . 0.02 109.615 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.26 166.56 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.733 1.622 . . . . 0.02 112.704 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 63.52 36.61 11.04 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.344 -0.843 . . . . 0.02 111.118 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.451 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.8 m-85 44.98 51.42 8.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.744 0.783 . . . . 3.39 110.691 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 m -125.4 163.22 23.08 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.206 0.527 . . . . 2.33 109.783 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.95 -162.07 31.0 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.599 -1.4 . . . . 0.02 109.599 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 8.3 t-80 -67.4 139.86 57.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.947 -1.325 . . . . 0.02 110.138 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 20.4 ptm -119.22 137.86 53.36 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.472 0.653 . . . . 5.01 109.978 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 79.8 m-85 -133.92 139.85 46.42 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.465 -0.772 . . . . 0.02 109.744 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.34 132.29 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 N-CA-C 108.523 -0.917 . . . . 1.72 108.523 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.446 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.0 mt -122.48 112.6 31.06 Favored Pre-proline 0 N--CA 1.506 2.357 0 O-C-N 121.414 -0.804 . . . . 0.02 110.644 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.45 170.73 18.84 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 119.821 0.972 . . . . 1.47 110.415 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -53.12 140.33 26.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.951 -1.093 . . . . 4.25 110.534 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.49 -178.18 32.25 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.38 -1.39 . . . . 0.02 110.8 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -119.72 131.23 55.33 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.362 -1.081 . . . . 0.96 109.896 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.446 ' CE1' HD22 ' A' ' 61' ' ' LEU . 95.4 m-85 -121.5 97.91 46.6 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 107.726 -1.212 . . . . 0.02 107.726 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 38' ' ' SER . 7.9 Cg_endo -70.64 -3.44 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 120.743 0.962 . . . . 0.02 113.761 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -157.38 154.87 29.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.54 -1.35 . . . . 2.02 108.136 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -59.69 -39.4 84.42 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.531 -0.731 . . . . 0.02 111.766 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -59.89 -24.15 64.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.02 110.474 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -70.43 -18.38 63.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.4 -0.812 . . . . 3.42 108.846 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 2.1 t90 -107.78 10.2 28.82 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.535 -1.283 . . . . 0.02 107.535 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 10.0 mmt 60.63 22.66 12.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 0.02 110.322 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.68 144.88 47.91 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.542 -1.423 . . . . 0.02 109.542 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 mt -79.99 -30.54 39.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -1.175 . . . . 0.98 107.946 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -157.05 -171.49 3.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.43 -1.692 . . . . 0.02 106.43 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -99.03 28.78 4.18 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.645 -1.284 . . . . 0.02 110.815 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -96.65 122.82 40.0 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.826 -1.171 . . . . 3.2 111.146 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.51 HD21 ' CH2' ' A' ' 72' ' ' TRP . 80.8 mt -141.39 118.8 11.49 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.551 -1.277 . . . . 2.61 107.551 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.55 -18.96 9.09 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 121.193 -0.942 . . . . 0.02 112.474 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.451 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 11.2 t -156.09 156.41 34.28 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 119.763 1.782 . . . . 0.02 111.028 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.6 p -145.85 147.83 32.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.421 -0.799 . . . . 0.02 110.501 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.422 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 49.2 mtp180 -137.14 142.04 42.25 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.511 -0.743 . . . . 0.01 109.111 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.29 131.26 36.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.129 -0.982 . . . . 0.43 109.505 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 t -90.4 124.61 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.561 -0.903 . . . . 1.25 108.561 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -92.91 131.58 37.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.071 . . . . 1.77 108.571 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.32 139.57 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.13 -1.063 . . . . 1.63 108.13 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.5 p -110.8 126.09 54.26 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.674 -0.861 . . . . 1.08 108.674 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.0 t -102.66 -154.8 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.029 -1.841 . . . . 1.26 106.029 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.29 -49.36 0.89 Allowed Glycine 0 N--CA 1.497 2.754 0 O-C-N 120.473 -1.392 . . . . 0.01 111.952 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.66 -99.33 0.13 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.64 -1.743 . . . . 0.01 112.085 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -121.05 120.67 36.03 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.262 -1.14 . . . . 4.43 110.702 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.478 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.34 135.75 54.81 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.47 -0.567 . . . . 2.99 109.47 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.484 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 2.7 ttmp? -134.54 130.59 36.81 Favored 'General case' 0 N--CA 1.519 2.981 0 CA-C-O 122.187 0.994 . . . . 6.36 112.936 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -132.44 141.61 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 115.62 -0.718 . . . . 1.09 110.627 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.508 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 pm0 -124.56 140.04 53.31 Favored 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 107.568 -1.271 . . . . 2.05 107.568 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.2 m -123.45 146.96 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 O-C-N 120.664 -1.272 . . . . 1.1 111.236 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 24.0 m-85 -120.17 139.72 52.2 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.035 0.922 . . . . 0.73 110.804 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.6 -32.81 71.75 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.77 -0.65 . . . . 0.02 112.304 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' O ' ' OG ' ' A' ' 128' ' ' SER . 41.0 mmtm -113.89 165.14 12.88 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.866 -1.146 . . . . 3.18 110.059 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.93 163.06 45.11 Favored Glycine 0 N--CA 1.492 2.374 0 CA-C-O 122.034 0.797 . . . . 0.01 111.306 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.22 39.58 28.62 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.567 0.698 . . . . 0.01 111.108 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 52.5 55.69 8.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.57 -0.706 . . . . 0.01 111.036 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -128.75 164.89 22.01 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.943 -1.132 . . . . 3.15 107.943 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.23 -162.67 28.53 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.269 -1.532 . . . . 0.01 109.269 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -75.79 142.17 42.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.93 -1.336 . . . . 0.01 109.211 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.529 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.7 ttp -116.69 143.48 45.58 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.593 0.711 . . . . 0.01 109.543 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -132.25 136.33 46.9 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.252 -1.018 . . . . 2.48 108.252 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -116.49 134.32 54.99 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.619 -0.675 . . . . 0.01 109.791 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 t -149.48 148.35 29.3 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.492 1.139 . . . . 1.69 111.578 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.7 p -115.34 7.46 15.13 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.998 -1.001 . . . . 0.01 109.961 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -122.31 163.42 19.73 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.448 -0.783 . . . . 3.21 111.043 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.29 154.86 41.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.439 -0.788 . . . . 0.01 109.624 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.5 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 59.4 m -128.61 115.94 19.55 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.913 -0.773 . . . . 0.01 108.913 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.09 -30.89 6.57 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 CA-C-N 120.316 1.149 . . . . 0.01 111.56 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.7 p -142.61 108.25 5.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.289 -0.882 . . . . 0.02 109.115 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.5 -39.31 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.773 -0.58 . . . . 1.83 111.062 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 15.0 tpt -66.89 -37.76 85.0 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.035 -1.066 . . . . 1.34 109.856 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.69 -38.66 77.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.504 -1.372 . . . . 2.11 109.887 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -80.41 -47.62 14.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.169 -0.957 . . . . 2.08 112.472 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -111.03 -0.82 16.53 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.283 -0.886 . . . . 0.02 112.728 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 59.79 33.73 21.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.822 -1.174 . . . . 0.02 109.487 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' C ' ' SD ' ' A' ' 118' ' ' MET . 6.3 mt -112.69 135.54 53.31 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 108.737 -0.838 . . . . 0.02 108.737 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -92.37 -23.18 19.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.302 -0.874 . . . . 5.32 110.623 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -148.96 163.44 37.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.077 -1.015 . . . . 0.02 110.121 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.6 mt -131.97 129.45 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.55 -1.278 . . . . 2.17 107.55 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -106.65 -13.65 15.23 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.206 -0.934 . . . . 0.02 113.185 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -157.04 155.68 31.59 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.35 -1.468 . . . . 0.01 108.237 177.606 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.4 t -164.28 145.86 8.58 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.482 -1.386 . . . . 1.22 109.567 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.43 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 27.6 mtmt -121.35 112.14 18.21 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.443 1.116 . . . . 1.41 108.905 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.2 t -107.41 122.52 61.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 105.372 -2.085 . . . . 0.01 105.372 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -145.9 67.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 118.153 -1.419 . . . . 1.98 108.133 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.01 108.29 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.563 -1.643 . . . . 0.01 106.563 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.86 -174.53 42.95 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.186 -1.165 . . . . 0.01 110.186 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.72 144.12 40.16 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.472 -1.016 . . . . 2.3 109.036 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.478 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 65.6 m95 -129.82 145.59 51.57 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.366 -0.834 . . . . 0.01 110.294 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.7 mt -117.92 141.86 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.667 -1.234 . . . . 1.69 107.667 178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.58 143.45 44.97 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 107.521 -1.289 . . . . 2.49 107.521 177.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 8.4 m-85 -122.59 144.24 49.24 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.005 -0.739 . . . . 0.02 109.005 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.49 -29.85 62.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.722 -0.611 . . . . 0.02 111.905 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.33 153.63 47.5 Favored Pre-proline 0 N--CA 1.505 2.279 0 O-C-N 120.604 -1.31 . . . . 1.48 109.187 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.9 167.03 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.225 1.284 . . . . 0.02 112.481 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 59.64 31.12 20.72 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.119 -0.946 . . . . 0.75 111.052 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.2 m-85 58.16 51.55 8.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.547 -0.72 . . . . 0.02 111.026 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -125.1 163.73 21.76 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.435 -0.791 . . . . 0.02 109.843 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.65 -165.6 32.34 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.951 -1.26 . . . . 0.02 109.951 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -67.7 141.32 56.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.425 -1.044 . . . . 0.02 108.883 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -118.65 147.95 43.24 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.424 -0.584 . . . . 0.02 109.424 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 2.5 t80 -129.9 143.87 51.03 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.836 -0.802 . . . . 0.01 108.836 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.612 HD23 ' N ' ' A' ' 151' ' ' LEU . 1.7 tt -98.3 122.53 41.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.414 -0.804 . . . . 0.01 109.528 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.612 ' N ' HD23 ' A' ' 150' ' ' LEU . 17.0 mt -104.29 135.95 44.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.499 -0.75 . . . . 0.01 109.982 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 154' ' ' LYS . 30.0 t70 -108.61 174.47 5.86 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.221 -1.029 . . . . 2.27 108.221 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -59.38 83.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.883 -1.135 . . . . 1.84 108.439 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 152' ' ' ASP . 66.6 mttm -136.53 172.09 13.53 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.257 -0.902 . . . . 2.28 111.696 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -113.62 110.12 19.7 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.423 -0.955 . . . . 0.01 108.423 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.68 114.61 28.48 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.019 -1.051 . . . . 0.01 109.876 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -93.69 -25.07 17.62 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.072 -1.018 . . . . 0.01 111.668 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -126.2 153.5 74.38 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.855 -1.153 . . . . 2.54 108.987 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.15 -42.7 33.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 119.247 0.767 . . . . 0.7 110.713 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.67 -20.58 21.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.732 -1.23 . . . . 0.86 108.557 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -64.95 -15.81 62.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.978 -1.076 . . . . 0.02 109.383 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.612 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -95.46 9.97 38.13 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.971 -1.122 . . . . 0.02 107.971 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.73 11.41 84.55 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.173 -1.489 . . . . 0.02 109.648 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.98 142.43 31.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.453 -1.028 . . . . 0.02 110.266 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.62 -8.21 58.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.758 -0.589 . . . . 0.59 110.022 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.3 p -144.9 150.93 47.88 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.726 -1.234 . . . . 0.87 108.819 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.37 21.58 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.833 1.022 . . . . 0.38 112.397 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.85 124.31 30.19 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.612 1.196 . . . . 0.18 111.631 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.1 mt -147.51 127.23 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.796 -1.557 . . . . 3.99 106.796 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -112.38 -19.08 12.31 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.187 -0.945 . . . . 5.17 112.865 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.6 p -158.37 161.28 37.55 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.147 -2.221 . . . . 0.02 110.271 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.5 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 9.5 p90 -152.55 153.69 33.92 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.168 -0.958 . . . . 2.02 110.496 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 21.5 mtp180 -143.58 151.0 39.66 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.267 -0.896 . . . . 0.01 110.412 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -87.64 142.33 27.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.01 109.188 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.1 mt -92.98 128.24 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.133 -0.979 . . . . 3.04 109.019 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.07 146.58 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.257 -0.902 . . . . 1.89 109.592 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 4.89 109.404 179.948 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.531 -0.544 . . . . 5.28 109.531 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -70.58 -133.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.897 . . . . 5.96 109.294 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -81.02 141.01 34.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.004 -1.06 . . . . 2.22 108.382 178.43 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.83 -179.35 47.02 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.255 -1.926 . . . . 0.81 112.194 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.04 158.31 44.18 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.273 -1.531 . . . . 0.01 109.273 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -149.23 136.91 20.35 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.095 -1.238 . . . . 0.02 110.168 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -130.23 141.14 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.201 -0.666 . . . . 0.02 109.201 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.8 t -121.3 129.92 53.37 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.523 -0.736 . . . . 0.39 110.0 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -110.36 140.23 44.77 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.159 -0.682 . . . . 0.02 109.159 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 6.9 m-85 -122.67 138.71 54.52 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.105 -0.997 . . . . 0.02 109.512 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.431 ' OE2' ' NH2' ' A' ' 18' ' ' ARG . 78.5 mt-10 -68.93 -27.27 65.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.075 -1.016 . . . . 0.03 111.693 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.31 170.28 8.41 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.902 -1.124 . . . . 0.03 110.034 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -74.93 161.79 29.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.698 0.761 . . . . 0.03 110.149 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 23.4 t30 62.42 35.06 15.1 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.898 0.856 . . . . 0.74 110.594 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.69 43.2 24.32 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.396 -0.82 . . . . 0.02 111.084 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -109.73 165.82 11.39 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.827 -1.175 . . . . 0.02 107.827 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.29 -168.16 34.84 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.83 -1.176 . . . . 0.03 110.663 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.431 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 25.9 ttp180 -69.16 143.5 54.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -1.102 . . . . 2.76 108.962 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.422 ' NH1' ' OD2' ' A' ' 21' ' ' ASP . 5.3 tmm_? -123.54 151.22 43.09 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.541 -0.725 . . . . 1.89 110.353 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -136.6 133.03 35.89 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.252 -0.647 . . . . 0.02 109.252 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.422 ' OD2' ' NH1' ' A' ' 19' ' ' ARG . 50.8 m-20 -109.64 136.32 49.19 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.911 -0.774 . . . . 1.12 108.911 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.1 t -127.83 137.74 52.47 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.659 -0.65 . . . . 0.02 109.704 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -118.61 11.41 12.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.726 -0.609 . . . . 0.2 110.157 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.5 p -159.68 173.7 15.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.848 -1.158 . . . . 1.23 109.066 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.87 145.63 54.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.842 -1.162 . . . . 0.02 110.629 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.591 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 11.6 p -135.04 119.69 18.21 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 109.004 -0.739 . . . . 0.02 109.004 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.39 -20.68 50.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.261 -0.9 . . . . 0.24 112.275 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -152.89 107.12 3.12 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.812 -1.18 . . . . 1.14 110.049 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.591 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.12 5.63 40.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.315 -0.865 . . . . 6.37 110.309 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -61.22 -30.13 70.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 3.11 112.133 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 p -76.69 -17.72 58.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.466 -1.396 . . . . 0.88 111.062 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -106.79 -21.13 13.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.392 -0.817 . . . . 0.02 110.655 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 tp -148.65 126.61 11.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.901 -1.124 . . . . 3.32 109.556 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.2 t -87.01 -12.83 46.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.519 -0.738 . . . . 0.02 111.053 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -172.72 162.16 4.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.858 -1.151 . . . . 0.02 108.403 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.452 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.2 p -143.83 116.52 8.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.068 -1.02 . . . . 0.02 108.824 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -108.38 -0.42 20.64 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.755 -1.216 . . . . 0.03 111.203 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 t -155.36 153.46 30.5 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.856 -1.165 . . . . 0.02 107.856 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.8 mt -146.83 148.05 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.102 -0.999 . . . . 0.02 110.49 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -123.92 124.72 43.23 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.02 -1.104 . . . . 0.02 108.02 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.3 t -105.3 114.06 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.691 -1.596 . . . . 0.02 106.691 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -85.41 -34.92 21.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.447 -0.783 . . . . 3.81 110.178 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.49 149.03 16.65 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 118.523 -1.799 . . . . 0.02 110.864 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.7 172.32 48.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.197 -1.161 . . . . 0.01 110.197 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.0 m -117.67 134.09 55.26 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.494 -1.299 . . . . 1.48 107.494 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -126.68 154.52 43.97 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.541 1.162 . . . . 0.02 112.192 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.37 134.06 52.29 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 105.502 -2.036 . . . . 0.24 105.502 176.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.9 m -116.07 141.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.56 -0.712 . . . . 0.65 109.292 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -120.3 142.99 48.6 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.062 0.934 . . . . 0.02 109.624 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -65.21 -34.36 78.2 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.491 -0.777 . . . . 0.02 111.904 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -124.44 158.02 63.02 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.091 -1.006 . . . . 0.02 109.495 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.04 166.55 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.642 1.561 . . . . 0.02 112.806 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 63.11 37.17 11.67 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.373 -0.83 . . . . 0.02 111.135 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.3 m-85 45.1 51.69 8.84 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.62 0.724 . . . . 3.39 110.834 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 t -125.89 163.62 22.55 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.12 0.486 . . . . 2.33 109.95 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.52 -161.89 31.44 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.926 -1.27 . . . . 0.02 109.926 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -64.34 138.51 58.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.996 -1.297 . . . . 0.02 110.224 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 58' ' ' MET . 12.3 tmm? -119.12 137.17 53.77 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.519 -0.549 . . . . 5.01 109.519 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 86.4 m-85 -135.01 139.84 45.18 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.526 -0.733 . . . . 0.02 109.943 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.8 mm -94.37 130.48 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.903 -0.777 . . . . 1.72 108.903 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.558 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.73 110.86 34.89 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.386 -0.821 . . . . 0.02 110.752 -178.513 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.9 169.23 20.93 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 CA-C-N 119.793 0.962 . . . . 1.47 110.415 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -53.78 140.64 29.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.959 -1.088 . . . . 4.25 110.767 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.04 -177.46 32.27 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.507 -1.33 . . . . 0.02 110.722 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -119.47 131.09 55.54 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.39 -1.065 . . . . 0.96 109.659 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.558 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 78.0 m-85 -120.99 97.85 47.86 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 107.914 -1.143 . . . . 0.02 107.914 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -69.86 -4.52 14.26 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 120.679 0.919 . . . . 0.02 113.686 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -157.47 154.06 28.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.614 -1.304 . . . . 2.02 107.992 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -59.81 -38.03 80.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.379 -0.826 . . . . 0.02 111.871 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -59.79 -24.46 64.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.02 110.446 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -69.75 -19.0 63.55 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.756 0.789 . . . . 3.42 108.894 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.19 10.38 27.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.601 -1.259 . . . . 0.02 107.601 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.2 mmm 60.52 22.55 12.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.597 -0.689 . . . . 0.02 110.381 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.55 144.94 47.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.534 -1.427 . . . . 0.02 109.534 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.5 mt -79.51 -30.73 42.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -1.215 . . . . 0.98 108.013 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -157.42 -171.4 3.58 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.463 -1.68 . . . . 0.02 106.463 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 14.3 p30 -98.6 28.66 4.08 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.692 -1.255 . . . . 0.02 110.64 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -97.83 122.88 41.46 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.875 -1.141 . . . . 3.2 111.435 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.452 HD12 ' SG ' ' A' ' 36' ' ' CYS . 57.4 mt -142.66 120.06 11.64 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.298 -1.371 . . . . 2.61 107.298 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.46 -17.99 10.75 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 121.251 -0.905 . . . . 0.02 112.295 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 22.6 t -155.79 156.15 34.27 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 119.591 1.696 . . . . 0.02 110.845 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.5 t -145.65 147.92 32.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.02 110.161 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 17.6 mtp180 -136.88 141.73 42.76 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.461 -0.774 . . . . 0.01 109.023 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.38 131.5 36.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.203 -0.936 . . . . 0.43 109.269 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.54 124.34 43.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.816 -0.809 . . . . 1.25 108.816 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -92.47 131.91 37.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.826 -1.171 . . . . 1.77 108.737 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.36 138.5 33.86 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.127 -1.064 . . . . 1.63 108.127 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.4 p -110.67 126.65 54.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.357 -0.839 . . . . 1.08 108.757 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 t -103.15 -154.54 0.5 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 106.114 -1.81 . . . . 1.26 106.114 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.63 -50.31 0.86 Allowed Glycine 0 N--CA 1.498 2.799 0 O-C-N 120.456 -1.403 . . . . 0.01 112.066 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.47 -99.77 0.13 Allowed Glycine 0 N--CA 1.487 2.068 0 C-N-CA 118.683 -1.722 . . . . 0.01 112.212 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -120.51 119.54 33.27 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.261 -1.141 . . . . 4.43 110.635 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.507 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.8 136.39 55.38 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.302 -0.559 . . . . 2.99 109.588 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -134.85 130.93 36.76 Favored 'General case' 0 N--CA 1.518 2.942 0 CA-C-O 122.182 0.992 . . . . 6.36 112.65 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.5 141.96 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.527 -0.76 . . . . 1.09 110.409 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 3.5 pm0 -124.68 140.34 53.03 Favored 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 107.573 -1.269 . . . . 2.05 107.573 176.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.87 146.2 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 O-C-N 120.618 -1.301 . . . . 1.1 110.882 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.537 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 25.4 m-85 -119.93 139.96 51.64 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 122.347 1.07 . . . . 0.73 110.799 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.97 -32.26 72.55 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.639 -0.709 . . . . 0.02 111.694 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -114.5 167.31 10.84 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.109 -0.994 . . . . 3.18 110.321 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.45 164.39 52.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 111.147 -0.781 . . . . 0.01 111.147 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 57.82 38.95 27.36 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.554 0.692 . . . . 0.01 111.641 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 52.27 54.58 10.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.41 -0.806 . . . . 0.01 111.241 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 24.7 t30 -129.6 165.21 22.21 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.992 -1.114 . . . . 3.15 107.992 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 90.94 -162.61 28.85 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.975 -1.65 . . . . 0.01 108.975 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -76.22 141.61 41.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.841 -1.388 . . . . 0.01 109.078 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.537 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.4 ttp -116.66 143.54 45.51 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.553 0.692 . . . . 0.01 109.61 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -132.28 136.23 46.79 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -116.02 134.29 55.12 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.748 -0.595 . . . . 0.01 109.754 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -149.34 148.28 29.33 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.626 1.203 . . . . 1.69 111.501 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -115.44 7.38 14.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.872 -1.058 . . . . 0.01 109.938 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -122.38 163.35 19.94 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.391 -0.818 . . . . 3.21 111.307 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -69.69 154.33 42.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.898 . . . . 0.01 109.665 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.425 ' O ' ' OG ' ' A' ' 171' ' ' SER . 40.8 t -126.74 115.56 22.55 Favored Pre-proline 0 N--CA 1.501 2.104 0 N-CA-C 109.192 -0.67 . . . . 0.01 109.192 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.2 -32.63 5.01 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 120.358 1.164 . . . . 0.01 111.418 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 p -142.35 108.42 5.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.294 -0.879 . . . . 0.02 109.125 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.44 -39.73 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.825 -0.547 . . . . 1.83 111.099 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.7 ttt -66.95 -37.5 84.4 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.107 -1.037 . . . . 1.34 109.853 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.84 -38.57 76.54 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.559 -1.338 . . . . 2.11 109.792 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -80.2 -47.55 14.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 2.08 112.472 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.36 -0.88 16.19 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.334 -0.854 . . . . 0.02 112.727 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.4 m80 60.28 33.77 20.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.808 -1.182 . . . . 0.02 109.48 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.7 mt -112.53 135.16 53.57 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 108.62 -0.882 . . . . 0.02 108.62 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -92.29 -23.23 19.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.354 -0.841 . . . . 5.32 110.565 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -148.97 163.57 37.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.166 -0.959 . . . . 0.02 110.008 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.2 mt -131.61 129.11 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 107.417 -1.327 . . . . 2.17 107.417 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -107.16 -13.38 15.17 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.192 -0.943 . . . . 0.02 113.246 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.29 153.35 30.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.306 -1.496 . . . . 0.01 108.287 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.4 t -162.34 145.06 11.28 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.326 -1.484 . . . . 1.22 109.737 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.434 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 27.0 ttmt -122.29 111.53 17.03 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.3 1.048 . . . . 1.41 108.892 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.9 t -107.51 122.62 62.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.661 -1.977 . . . . 0.01 105.661 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -146.58 67.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 118.125 -1.43 . . . . 1.98 108.222 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.69 109.04 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.597 -1.631 . . . . 0.01 106.597 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.7 -174.28 39.64 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.711 -1.356 . . . . 0.01 109.711 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.506 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.3 m -112.4 144.47 41.78 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.372 -1.076 . . . . 2.3 109.349 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.507 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.4 m95 -129.89 146.2 51.61 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.43 -0.794 . . . . 0.01 110.392 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.6 mt -118.06 142.12 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 107.668 -1.234 . . . . 1.69 107.668 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.67 143.92 44.27 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 107.736 -1.209 . . . . 2.49 107.736 177.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 10.8 m-85 -122.53 143.52 49.67 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.966 -0.753 . . . . 0.02 108.966 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -73.02 -29.52 63.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.575 -0.703 . . . . 0.02 112.005 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.58 153.58 47.8 Favored Pre-proline 0 N--CA 1.505 2.323 0 O-C-N 120.614 -1.304 . . . . 1.48 109.198 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.58 167.05 1.57 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.359 1.372 . . . . 0.02 112.606 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 59.56 31.21 20.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.063 -0.971 . . . . 0.75 110.993 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.61 51.32 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.449 -0.782 . . . . 0.02 111.045 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -124.77 163.78 21.39 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.466 -0.771 . . . . 0.02 109.838 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.77 -165.65 32.22 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.873 -1.291 . . . . 0.02 109.873 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -67.53 141.38 56.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.564 -0.962 . . . . 0.02 109.042 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -117.9 148.4 42.18 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.28 -0.637 . . . . 0.02 109.28 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.64 142.92 50.64 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.041 -0.726 . . . . 0.01 109.041 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.636 ' C ' HD23 ' A' ' 150' ' ' LEU . 6.0 tt -97.41 121.84 39.78 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.283 -0.886 . . . . 0.01 109.485 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.656 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.5 mt -104.98 133.33 49.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.472 -0.767 . . . . 0.01 110.321 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 5.3 p-10 -107.69 173.19 6.43 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.253 -1.017 . . . . 2.27 108.253 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -57.97 84.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.972 -1.08 . . . . 1.84 108.621 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 11.4 tptp -136.34 168.31 19.67 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.327 -0.858 . . . . 2.28 111.068 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 5.3 mp0 -111.09 109.78 20.02 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.325 -0.991 . . . . 0.01 108.325 178.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.37 115.69 30.58 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.087 -1.008 . . . . 0.01 109.904 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -94.05 -25.49 17.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.99 -1.069 . . . . 0.01 111.375 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -125.85 153.92 73.48 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.958 -1.089 . . . . 2.54 109.008 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.03 -42.66 35.02 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 119.144 0.73 . . . . 0.7 110.64 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.73 -20.42 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.638 -1.289 . . . . 0.86 108.433 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -65.41 -15.75 62.92 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.961 -1.087 . . . . 0.02 109.425 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.656 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -95.21 9.72 38.69 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.943 -1.132 . . . . 0.02 107.943 178.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.49 11.04 85.49 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.204 -1.474 . . . . 0.02 109.607 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.94 142.26 31.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.382 -1.07 . . . . 0.02 110.204 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.41 -8.49 58.96 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.728 -0.608 . . . . 0.59 109.886 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 16.5 p -144.46 150.78 48.92 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 120.849 -1.157 . . . . 0.87 108.731 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.16 21.55 0.52 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.73 0.953 . . . . 0.38 112.376 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.78 123.98 29.84 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.5 1.143 . . . . 0.18 111.705 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.0 mt -147.07 126.92 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 106.92 -1.511 . . . . 3.99 106.92 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -113.46 -19.22 11.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.142 -0.974 . . . . 5.17 112.853 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 32.6 t -157.15 159.88 38.22 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 119.142 -2.224 . . . . 0.02 110.376 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -152.92 154.08 34.31 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.044 -1.035 . . . . 2.02 110.7 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -144.62 151.69 39.38 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.304 -0.872 . . . . 0.01 110.58 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -87.69 142.94 27.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.564 -0.71 . . . . 0.01 109.254 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.2 128.21 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.998 -1.064 . . . . 3.04 109.099 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -136.07 146.46 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.218 -0.927 . . . . 1.89 109.631 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 4.89 109.446 179.903 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 3' ' ' THR . 77.2 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.322 0.582 . . . . 5.28 109.464 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.416 ' N ' ' OG ' ' A' ' 1' ' ' SER . 88.4 mttt -60.11 -1.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 5.96 109.533 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 1' ' ' SER . 4.8 p -90.67 -139.88 0.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.244 -1.391 . . . . 2.22 107.244 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.44 -174.91 45.66 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 117.321 -2.371 . . . . 0.81 112.761 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.78 160.71 45.33 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.267 -1.533 . . . . 0.01 109.267 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -147.49 135.98 21.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.133 -1.216 . . . . 0.02 110.039 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.9 tt -130.58 140.09 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.218 -0.66 . . . . 0.02 109.218 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t -121.65 130.28 53.37 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.291 -0.88 . . . . 0.39 110.077 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -110.24 139.62 45.22 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.652 -0.655 . . . . 0.02 109.397 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.3 m-85 -121.42 138.03 54.45 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.209 -0.932 . . . . 0.02 109.698 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -69.47 -27.52 65.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.842 -1.162 . . . . 0.03 111.594 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -114.16 169.79 8.76 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.752 -1.217 . . . . 0.03 110.179 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.516 ' NH2' ' OE1' ' A' ' 68' ' ' GLU . 49.9 mtp180 -75.67 158.65 32.09 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.629 0.728 . . . . 0.03 110.121 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 8.2 t-20 65.75 33.71 8.03 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.016 0.912 . . . . 0.74 111.072 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.52 41.74 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.974 -0.557 . . . . 0.02 111.306 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -113.69 165.57 12.4 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.265 -1.013 . . . . 0.02 108.265 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.8 -167.43 34.92 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.887 -1.149 . . . . 0.03 110.711 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -68.24 141.51 55.9 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.554 -0.968 . . . . 2.76 109.046 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -122.52 150.15 42.95 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.572 -0.705 . . . . 1.89 109.87 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -137.21 133.16 34.83 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.205 -0.665 . . . . 0.02 109.205 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -108.74 136.05 48.96 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.748 -0.834 . . . . 1.12 108.748 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 17.1 t -127.64 137.31 52.49 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.572 -0.705 . . . . 0.02 110.02 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 p30 -119.89 11.57 11.85 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.702 -0.624 . . . . 0.2 110.704 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.527 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 32.4 t -159.64 173.22 16.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.709 -1.245 . . . . 1.23 109.262 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -62.8 145.25 55.38 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.489 -1.382 . . . . 0.02 110.611 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 m -135.23 119.48 17.76 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.51 -0.744 . . . . 0.02 109.035 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.66 -20.52 50.07 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.581 -0.699 . . . . 0.24 112.325 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 8.9 p-10 -153.35 106.39 2.95 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.541 -1.349 . . . . 1.14 110.103 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.8 6.59 36.76 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.242 -0.911 . . . . 6.37 110.461 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -60.58 -28.77 68.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.853 . . . . 3.11 111.891 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.9 p -76.69 -16.77 59.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.465 -1.397 . . . . 0.88 111.021 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -105.89 -21.62 13.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.329 -0.857 . . . . 0.02 110.624 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.9 mt -148.66 127.67 12.76 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.093 -1.005 . . . . 3.32 109.309 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -85.9 -11.01 54.31 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.728 -0.607 . . . . 0.02 110.254 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -171.85 161.85 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.144 -1.058 . . . . 0.02 108.144 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 t -143.24 116.41 8.95 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.0 -1.063 . . . . 0.02 108.566 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.582 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 1.7 m120 -109.77 -0.82 18.28 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 120.789 -1.194 . . . . 0.03 112.049 -177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 t -154.93 153.69 31.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.014 -1.053 . . . . 0.02 108.3 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 39' ' ' ILE . 11.9 mt -146.17 147.81 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.104 -0.998 . . . . 0.02 110.716 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -124.86 124.86 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.676 -1.231 . . . . 0.02 107.676 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.1 t -105.69 114.13 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.928 -1.508 . . . . 0.02 106.928 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -85.33 -34.49 21.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.548 -0.72 . . . . 3.81 110.216 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.33 148.97 16.65 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.592 -1.766 . . . . 0.02 110.807 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.67 172.31 48.78 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.287 -1.125 . . . . 0.01 110.287 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.9 m -118.12 134.5 54.94 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.505 -1.295 . . . . 1.48 107.505 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -126.73 154.16 44.54 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.516 1.15 . . . . 0.02 112.33 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.57 133.62 52.45 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.29 -2.115 . . . . 0.24 105.29 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -117.32 142.49 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 0.65 109.173 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.513 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 31.9 m-85 -120.62 144.87 47.9 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.262 1.029 . . . . 0.02 110.024 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.21 -33.61 76.16 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.773 -0.649 . . . . 0.02 111.526 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -124.63 157.96 63.75 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 121.065 -1.022 . . . . 0.02 109.551 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.81 166.9 1.22 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.788 1.659 . . . . 0.02 112.794 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 63.58 36.68 10.87 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.344 -0.844 . . . . 0.02 110.968 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 45.11 51.48 8.96 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.562 0.696 . . . . 3.39 110.78 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.3 m -125.91 163.53 22.76 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.206 0.526 . . . . 2.33 109.918 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.78 -162.31 31.38 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.738 -1.345 . . . . 0.02 109.738 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -64.8 138.48 58.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.35 . . . . 0.02 110.04 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.513 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 60.0 ttp -118.3 137.88 52.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.324 0.583 . . . . 5.01 109.514 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.606 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.2 m-85 -134.98 139.33 44.81 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.469 -0.769 . . . . 0.02 109.882 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.3 130.53 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.875 -0.787 . . . . 1.72 108.875 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.91 110.6 34.82 Favored Pre-proline 0 N--CA 1.504 2.265 0 O-C-N 121.43 -0.794 . . . . 0.02 110.876 -178.341 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.54 169.39 21.09 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 CA-C-N 119.722 0.936 . . . . 1.47 110.317 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -53.69 140.78 28.35 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.924 -1.11 . . . . 4.25 110.562 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.42 -177.15 32.76 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.47 -1.348 . . . . 0.02 110.634 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -119.41 130.6 55.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.459 -1.024 . . . . 0.96 109.686 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 71.1 m-85 -121.83 95.15 47.96 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.297 -1.001 . . . . 0.02 108.297 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.31 -3.57 10.19 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 120.978 1.118 . . . . 0.02 114.221 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' NH2' ' A' ' 13' ' ' ARG . 38.2 mt-10 -157.96 155.08 28.85 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.479 -1.388 . . . . 2.02 108.311 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -60.08 -38.78 83.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.594 -0.691 . . . . 0.02 112.035 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -59.7 -23.74 63.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.052 -1.03 . . . . 0.02 110.091 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -70.31 -19.11 63.1 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.774 0.797 . . . . 3.42 108.938 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.606 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -108.36 10.75 27.5 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.517 -1.29 . . . . 0.02 107.517 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 73' ' ' MET . 2.1 mpt? 59.65 23.88 12.69 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.478 0.656 . . . . 0.02 110.563 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.0 144.86 46.5 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.785 -1.326 . . . . 0.02 109.785 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.13 -30.73 39.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -1.219 . . . . 0.98 107.875 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -157.16 -171.93 3.82 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.413 -1.699 . . . . 0.02 106.413 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.582 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 78.4 m-20 -97.98 27.92 4.25 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.642 -1.286 . . . . 0.02 110.83 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -96.71 122.54 39.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.805 -1.184 . . . . 3.2 111.102 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.528 HD21 ' CH2' ' A' ' 72' ' ' TRP . 86.0 mt -141.38 118.42 11.24 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.449 -1.315 . . . . 2.61 107.449 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.49 -18.27 9.79 Favored Glycine 0 N--CA 1.501 2.997 0 O-C-N 120.992 -1.067 . . . . 0.02 112.463 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.8 p -156.25 156.01 33.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.352 -1.675 . . . . 0.02 110.351 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.0 m -145.14 148.28 33.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.749 -0.594 . . . . 0.02 109.923 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -137.15 141.75 42.22 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.456 -0.778 . . . . 0.01 109.304 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.16 132.24 36.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.106 -0.996 . . . . 0.43 109.434 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.87 124.48 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.69 -0.856 . . . . 1.25 108.69 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -90.72 133.2 35.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.868 -1.145 . . . . 1.77 108.287 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.17 139.18 36.21 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.851 -0.796 . . . . 1.63 108.851 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 p -110.58 123.78 50.62 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.072 -1.085 . . . . 1.08 108.072 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.4 p -114.99 132.46 56.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.746 -1.221 . . . . 1.26 107.818 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.73 -47.98 0.01 OUTLIER Glycine 0 N--CA 1.503 3.1 0 C-N-CA 117.704 -2.189 . . . . 0.01 113.44 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.16 -103.39 0.17 Allowed Glycine 0 N--CA 1.488 2.129 0 CA-C-N 120.045 1.923 . . . . 0.01 110.927 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -119.13 118.2 30.73 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.16 -1.2 . . . . 4.43 110.179 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.0 135.92 55.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.769 -0.582 . . . . 2.99 109.491 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -134.86 130.06 35.39 Favored 'General case' 0 N--CA 1.519 2.977 0 O-C-N 121.128 -0.982 . . . . 6.36 112.997 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -131.72 142.39 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-O 121.591 0.71 . . . . 1.09 110.318 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.494 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 2.0 pt20 -124.78 139.27 54.0 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.679 -1.23 . . . . 2.05 107.679 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.65 146.54 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.584 0 O-C-N 120.655 -1.278 . . . . 1.1 110.96 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -121.34 140.96 51.41 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 122.084 0.945 . . . . 0.73 111.482 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -69.09 -33.42 73.49 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.774 -0.648 . . . . 0.02 112.391 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.484 ' O ' ' OG ' ' A' ' 128' ' ' SER . 0.8 OUTLIER -113.67 165.33 12.63 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.815 -1.178 . . . . 3.18 109.584 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.97 163.43 44.78 Favored Glycine 0 N--CA 1.492 2.376 0 CA-C-O 122.07 0.817 . . . . 0.01 111.266 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.7 t0 57.65 39.96 27.01 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.599 0.714 . . . . 0.01 111.077 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.46 55.01 9.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.632 -0.668 . . . . 0.01 111.002 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -127.07 165.72 18.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.219 -1.03 . . . . 3.15 108.219 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.65 -163.0 29.47 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.14 -1.584 . . . . 0.01 109.14 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -75.2 142.18 43.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.942 -1.328 . . . . 0.01 108.841 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' A' ' 107' ' ' MET . 9.7 tmm? -116.46 143.28 45.78 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.566 0.698 . . . . 0.01 109.433 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -132.17 136.04 46.79 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.349 -0.982 . . . . 2.48 108.349 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -117.01 134.07 55.21 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.697 -0.627 . . . . 0.01 109.844 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.83 149.1 29.99 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.42 1.105 . . . . 1.69 111.313 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -115.19 7.75 15.39 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.132 -0.94 . . . . 0.01 110.321 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -121.67 163.28 19.27 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.406 -0.809 . . . . 3.21 111.255 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.21 154.84 41.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.01 109.539 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 35.1 t -126.64 114.53 22.76 Favored Pre-proline 0 N--CA 1.499 2.013 0 N-CA-C 109.049 -0.722 . . . . 0.01 109.049 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.37 -33.57 4.14 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 120.274 1.134 . . . . 0.01 111.218 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 p -141.15 107.15 5.17 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.662 -0.866 . . . . 0.02 108.662 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.82 -39.52 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.721 -0.612 . . . . 1.83 111.23 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.6 ttt -66.77 -37.65 85.01 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.002 -1.079 . . . . 1.34 109.727 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.72 -38.55 76.95 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.58 -1.325 . . . . 2.11 109.693 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -80.18 -47.47 14.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 2.08 112.359 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -111.02 -1.1 16.43 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.413 -0.804 . . . . 0.02 112.84 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 m80 59.97 33.23 21.4 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.621 -1.299 . . . . 0.02 109.503 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.1 mt -111.63 135.02 52.79 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.805 -0.813 . . . . 0.02 108.805 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -93.65 -24.01 18.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.284 -0.885 . . . . 5.32 110.688 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -148.42 162.55 39.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.259 -0.9 . . . . 0.02 109.791 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.5 mt -133.18 130.2 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 107.64 -1.244 . . . . 2.17 107.64 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.52 -13.72 15.25 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 113.524 0.935 . . . . 0.02 113.524 -176.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -157.45 156.37 32.02 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.256 -1.527 . . . . 0.01 108.396 177.743 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.4 t -162.11 146.81 12.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.478 -1.389 . . . . 1.22 109.93 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -120.03 108.54 14.42 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.137 0.97 . . . . 1.41 108.445 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 t -107.09 120.35 58.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 105.795 -1.928 . . . . 0.01 105.795 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 t -146.63 68.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 118.043 -1.463 . . . . 1.98 108.304 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.6 108.3 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.505 -1.665 . . . . 0.01 106.505 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.24 -174.31 44.51 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.737 -1.345 . . . . 0.01 109.737 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.48 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.7 m -111.92 145.69 39.11 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.369 -1.077 . . . . 2.3 109.088 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.419 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 76.8 m95 -131.32 145.29 51.8 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.552 -0.718 . . . . 0.01 110.741 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.2 mt -117.7 142.01 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 107.421 -1.325 . . . . 1.69 107.421 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -115.12 143.9 44.49 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 107.499 -1.297 . . . . 2.49 107.499 177.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 18.0 m-85 -122.42 144.67 48.9 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.948 -0.76 . . . . 0.02 108.948 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.01 -30.0 62.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.02 112.06 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.17 153.96 47.32 Favored Pre-proline 0 N--CA 1.506 2.351 0 O-C-N 120.593 -1.317 . . . . 1.48 109.292 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.71 166.27 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.192 1.262 . . . . 0.02 112.615 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 59.84 31.31 20.7 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.149 -0.932 . . . . 0.75 111.186 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 57.74 51.94 8.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.02 110.926 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -125.09 163.67 21.89 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.486 -0.759 . . . . 0.02 109.747 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.51 -165.37 32.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.751 -1.34 . . . . 0.02 109.751 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -67.97 141.72 56.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.629 -0.924 . . . . 0.02 108.949 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.464 ' N ' ' CD ' ' A' ' 148' ' ' GLN . 3.2 mp0 -118.51 148.41 42.65 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.463 -0.569 . . . . 0.02 109.463 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.516 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.7 t80 -129.33 142.9 50.7 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.013 -0.736 . . . . 0.01 109.013 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.576 ' C ' HD23 ' A' ' 150' ' ' LEU . 5.8 tt -96.75 121.8 39.0 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.293 -0.88 . . . . 0.01 109.345 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.654 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.4 mt -104.66 133.51 49.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.506 -0.746 . . . . 0.01 110.225 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 154' ' ' LYS . 21.1 t0 -108.83 175.39 5.48 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.341 -0.985 . . . . 2.27 108.341 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -57.41 84.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.84 -1.162 . . . . 1.84 108.626 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 152' ' ' ASP . 35.4 mttp -137.73 168.42 19.72 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.191 0.996 . . . . 2.28 111.647 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -113.33 109.82 19.34 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.26 -1.015 . . . . 0.01 108.26 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -99.77 115.87 30.54 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.022 -1.049 . . . . 0.01 109.931 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -93.52 -25.4 17.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.079 -1.013 . . . . 0.01 111.433 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -125.89 153.42 73.56 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 120.786 -1.196 . . . . 2.54 108.613 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.16 -41.7 41.14 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 CA-C-N 119.281 0.779 . . . . 0.7 110.584 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.58 -20.58 21.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.769 -1.207 . . . . 0.86 108.586 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.49 -15.77 62.99 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.029 -1.044 . . . . 0.02 109.625 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.654 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -95.34 9.87 38.31 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 107.919 -1.141 . . . . 0.02 107.919 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.38 10.8 85.48 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.205 -1.474 . . . . 0.02 109.588 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.76 142.43 31.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.469 -1.018 . . . . 0.02 110.282 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.63 -8.59 58.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.728 -0.608 . . . . 0.59 110.007 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.3 p -144.68 150.99 48.85 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.737 -1.227 . . . . 0.87 108.789 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.97 21.72 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 120.899 1.066 . . . . 0.38 112.331 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.19 123.89 29.99 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.623 1.201 . . . . 0.18 111.563 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.0 mt -146.66 126.75 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 106.765 -1.569 . . . . 3.99 106.765 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -113.17 -20.34 11.48 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.112 -0.993 . . . . 5.17 112.835 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.1 p -157.76 160.13 37.53 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.172 -2.205 . . . . 0.02 110.233 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -153.04 154.9 35.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.184 -0.948 . . . . 2.02 110.683 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -145.03 151.63 38.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.263 -0.898 . . . . 0.01 110.539 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -87.73 142.08 28.1 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.524 -0.735 . . . . 0.01 109.406 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.3 mt -92.2 128.17 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.137 -0.977 . . . . 3.04 109.241 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.7 t -136.35 146.83 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.151 -0.968 . . . . 1.89 109.487 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 4.89 109.441 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.275 -1.53 . . . . 0.01 109.275 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -148.45 136.78 21.24 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.128 -1.219 . . . . 0.02 110.337 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.73 140.94 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.17 -0.678 . . . . 0.02 109.17 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -121.5 130.25 53.43 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.396 -0.815 . . . . 0.39000000000000001 110.089 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 m-85 -110.18 140.14 44.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.598 -0.689 . . . . 0.02 109.27 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.0 m-85 -122.04 138.21 54.52 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.155 -0.965 . . . . 0.02 109.58 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -69.62 -27.37 65.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 0.029999999999999999 111.788 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.0 m-20 -113.89 169.44 8.99 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.85 -1.156 . . . . 0.029999999999999999 110.091 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.15 158.3 33.26 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.606 0.717 . . . . 0.029999999999999999 110.095 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 0.8 OUTLIER 66.05 35.07 6.52 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.745 0.784 . . . . 0.73999999999999999 110.76 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.5 p90 49.82 44.31 25.01 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.606 -0.724 . . . . 0.02 111.19 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -112.71 166.05 11.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.95 -167.58 34.8 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 120.736 -1.228 . . . . 0.029999999999999999 110.415 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -69.36 142.68 53.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -1.024 . . . . 2.7599999999999998 109.036 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -122.06 150.13 42.56 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.521 -0.737 . . . . 1.8899999999999999 110.065 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -135.93 132.88 37.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.749 -0.594 . . . . 0.02 109.516 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -110.25 135.96 50.19 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.398 -0.814 . . . . 1.1200000000000001 109.118 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 43.6 t -128.43 138.49 52.34 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.524 -0.735 . . . . 0.02 109.411 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 34.2 p-10 -119.16 11.88 12.48 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.624 -0.672 . . . . 0.20000000000000001 110.392 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 4.3 p -159.42 173.45 16.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.765 -1.209 . . . . 1.23 109.05 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 13.2 p-10 -63.15 145.98 54.32 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.693 -1.254 . . . . 0.02 110.612 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.561 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 45.0 t -134.95 118.54 16.98 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.144 -0.687 . . . . 0.02 109.144 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.4 -21.62 52.87 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.53 -0.731 . . . . 0.23999999999999999 111.605 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -154.49 105.06 2.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.845 -1.159 . . . . 1.1399999999999999 109.506 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.4 OUTLIER -101.84 8.88 41.16 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.427 -0.796 . . . . 6.3700000000000001 109.875 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.46 -28.55 68.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.435 -0.79 . . . . 3.1099999999999999 112.033 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 m -76.83 -17.32 59.07 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.35 -1.469 . . . . 0.88 111.235 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 27.8 m-85 -107.22 -20.48 13.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.381 -0.824 . . . . 0.02 110.393 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tp -148.93 127.15 12.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.026 -1.046 . . . . 3.3199999999999998 109.51 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.8 p -87.1 -12.26 47.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.558 -0.714 . . . . 0.02 111.329 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -172.02 161.98 5.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.807 -1.183 . . . . 0.02 108.283 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.8 t -143.52 116.61 8.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.96 -1.088 . . . . 0.02 108.984 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.534 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -109.7 0.5 18.98 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.792 -1.193 . . . . 0.029999999999999999 111.714 -178.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 m -156.09 153.84 30.01 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.276 -1.009 . . . . 0.02 108.276 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mt -146.24 146.9 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.946 -1.096 . . . . 0.02 110.715 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -123.79 124.62 43.08 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.485 -1.302 . . . . 0.02 107.485 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.21 114.39 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.843 -1.54 . . . . 0.02 106.843 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -84.94 -34.85 22.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.565 -0.71 . . . . 3.8100000000000001 109.906 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.61 149.34 17.22 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.497 -1.811 . . . . 0.02 110.976 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.1 171.84 48.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.386 -1.086 . . . . 0.01 110.386 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.1 m -118.02 134.03 55.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.554 -1.276 . . . . 1.48 107.554 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.1 m95 -128.27 155.69 44.19 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 122.636 1.208 . . . . 0.02 112.27 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.83 134.0 52.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.493 -2.04 . . . . 0.23999999999999999 105.493 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.408 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.6 m -117.08 142.45 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.936 -0.764 . . . . 0.65000000000000002 108.936 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -120.83 144.98 48.07 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.386 1.089 . . . . 0.02 110.092 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -66.17 -34.0 77.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.721 -0.672 . . . . 0.02 111.472 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -124.44 157.9 63.44 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 121.097 -1.002 . . . . 0.02 109.449 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.56 166.47 1.25 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.766 1.644 . . . . 0.02 112.783 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 m-20 63.71 36.36 10.75 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.366 -0.834 . . . . 0.02 111.15 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 5.1 m-85 45.67 51.74 9.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.567 0.699 . . . . 3.3900000000000001 110.732 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 p -126.23 163.74 22.51 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.203 0.525 . . . . 2.3300000000000001 109.993 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.38 -161.56 31.39 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.748 -1.341 . . . . 0.02 109.748 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -64.54 138.79 58.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.936 -1.332 . . . . 0.02 110.042 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 21.2 ptm -119.61 137.49 53.83 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.208 0.528 . . . . 5.0099999999999998 109.736 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.58 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 95.1 m-85 -134.61 139.67 45.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.434 -0.791 . . . . 0.02 110.127 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 mm -93.79 130.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.736 -0.838 . . . . 1.72 108.736 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.483 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -120.91 110.48 34.91 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.425 -0.797 . . . . 0.02 110.63 -178.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -78.09 169.76 19.85 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 119.767 0.953 . . . . 1.47 110.17 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -53.55 140.84 27.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.818 -1.176 . . . . 4.25 110.496 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.55 -177.37 32.74 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.462 -1.352 . . . . 0.02 110.611 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -119.3 130.42 55.38 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.402 -1.058 . . . . 0.95999999999999996 109.708 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.483 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 32.1 m-85 -122.94 91.92 49.49 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.296 -1.002 . . . . 0.02 108.296 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -65.95 -2.83 7.28 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.115 1.21 . . . . 0.02 113.739 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -156.93 151.05 24.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.335 -1.478 . . . . 2.02 107.88 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -59.59 -38.94 82.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.662 -0.649 . . . . 0.02 112.538 -176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -60.36 -23.47 64.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.026 -1.046 . . . . 0.02 111.079 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -73.13 -15.54 61.47 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.79 -1.164 . . . . 3.4199999999999999 108.752 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.58 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -107.63 9.35 29.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.3 -1.37 . . . . 0.02 107.3 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.0 mtm 62.11 22.91 13.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.685 -0.635 . . . . 0.02 110.923 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.21 145.05 46.85 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.748 -1.341 . . . . 0.02 109.748 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.76 -31.7 35.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -1.209 . . . . 0.97999999999999998 107.949 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.721 HD22 ' H ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -157.28 -172.27 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.467 -1.679 . . . . 0.02 106.467 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.29 27.65 4.55 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.768 -1.208 . . . . 0.02 110.654 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.721 ' H ' HD22 ' A' ' 76' ' ' ASN . 68.7 mtm180 -96.34 122.52 39.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.881 -1.137 . . . . 3.2000000000000002 110.864 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 79' ' ' LEU . 83.5 mt -142.44 119.06 11.04 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.771 -1.196 . . . . 2.6099999999999999 107.771 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.1 -18.28 10.03 Favored Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.138 -0.976 . . . . 0.02 112.511 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.5 p -156.12 156.52 34.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.255 -1.732 . . . . 0.02 110.394 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.4 m -145.47 148.23 33.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.719 -0.613 . . . . 0.02 109.841 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.44 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 54.6 mtm180 -137.39 141.97 41.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.331 -0.855 . . . . 0.01 109.311 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 132.79 36.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.213 -0.93 . . . . 0.42999999999999999 109.496 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.74 124.03 42.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.242 -1.021 . . . . 1.25 108.242 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -91.31 134.57 34.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.823 -1.173 . . . . 1.77 108.507 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.61 135.41 40.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.841 -1.17 . . . . 1.6299999999999999 107.841 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.7 p -109.37 127.63 54.5 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.763 -0.828 . . . . 1.0800000000000001 108.763 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -105.19 -153.78 0.5 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 106.314 -1.736 . . . . 1.26 106.314 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.59 -50.63 0.86 Allowed Glycine 0 N--CA 1.499 2.849 0 O-C-N 120.528 -1.358 . . . . 0.01 111.846 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.73 -100.73 0.15 Allowed Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.867 -1.635 . . . . 0.01 111.402 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -119.61 118.11 30.12 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.185 -1.185 . . . . 4.4299999999999997 110.243 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.493 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.19 136.69 56.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.385 -0.598 . . . . 2.9900000000000002 109.385 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -134.38 130.4 36.83 Favored 'General case' 0 N--CA 1.519 2.988 0 O-C-N 121.06 -1.025 . . . . 6.3600000000000003 113.048 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.17 143.49 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 115.63 -0.713 . . . . 1.0900000000000001 110.591 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.413 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.9 pt20 -124.89 139.71 53.58 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.771 -1.196 . . . . 2.0499999999999998 107.771 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.22 145.69 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 120.652 -1.28 . . . . 1.1000000000000001 111.189 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 27.8 m-85 -120.4 140.19 51.71 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.956 0.884 . . . . 0.72999999999999998 110.847 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -68.55 -32.41 72.32 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.784 -0.644 . . . . 0.02 112.178 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -114.82 165.74 12.51 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.956 -1.09 . . . . 3.1800000000000002 110.212 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.18 163.41 45.44 Favored Glycine 0 N--CA 1.492 2.38 0 CA-C-O 121.958 0.755 . . . . 0.01 111.278 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 57.15 39.17 29.13 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.578 0.704 . . . . 0.01 111.026 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 52.66 55.91 8.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.624 -0.672 . . . . 0.01 111.112 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -128.42 164.87 21.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.281 -1.007 . . . . 3.1499999999999999 108.281 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.65 -163.05 28.25 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.092 -1.603 . . . . 0.01 109.092 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -75.62 142.04 42.72 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.878 -1.366 . . . . 0.01 108.959 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 33.9 ttp -116.73 143.27 45.85 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.538 0.685 . . . . 0.01 109.533 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.98 136.41 47.28 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.173 -1.047 . . . . 2.48 108.173 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -115.96 134.09 55.34 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.715 -0.616 . . . . 0.01 109.7 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.1 t -149.31 147.93 28.93 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.515 1.15 . . . . 1.6899999999999999 111.474 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -114.54 7.63 16.19 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.894 -1.048 . . . . 0.01 109.875 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -121.96 163.56 19.11 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.393 -0.817 . . . . 3.21 111.008 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.4 154.82 41.43 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.358 -0.839 . . . . 0.01 109.379 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.8 t -126.64 114.98 22.77 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.911 -0.774 . . . . 0.01 108.911 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.23 -32.59 5.01 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 120.323 1.151 . . . . 0.01 111.447 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 m -142.31 108.26 5.18 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.847 0.832 . . . . 0.02 108.947 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.42 HD12 ' O ' ' A' ' 169' ' ' ILE . 95.9 mt -64.29 -39.9 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.776 -0.577 . . . . 1.8300000000000001 110.97 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 32.7 ttp -66.89 -37.4 84.31 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.026 -1.069 . . . . 1.3400000000000001 109.812 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -70.22 -38.62 75.29 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.524 -1.36 . . . . 2.1099999999999999 109.761 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.51 ' NE2' ' CE1' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -80.14 -47.49 14.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.253 -0.904 . . . . 2.0800000000000001 112.203 -176.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.51 ' CE1' ' NE2' ' A' ' 120' ' ' GLN . 92.1 m-85 -110.82 -0.44 16.93 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.378 -0.826 . . . . 0.02 112.699 -176.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 59.93 33.2 21.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.659 -1.276 . . . . 0.02 109.595 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mt -112.69 135.85 52.95 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 108.764 -0.828 . . . . 0.02 108.764 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -91.73 -22.89 19.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -0.822 . . . . 5.3200000000000003 110.358 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -149.36 164.03 36.07 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.09 -1.006 . . . . 0.02 110.019 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.8 mt -131.7 129.57 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.375 -1.343 . . . . 2.1699999999999999 107.375 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -107.77 -12.92 15.12 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.134 -0.979 . . . . 0.02 113.18 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.6 OUTLIER -153.52 151.35 29.71 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.489 -1.382 . . . . 0.01 108.278 178.321 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 13.7 t -160.92 145.03 13.6 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.261 -1.524 . . . . 1.22 109.935 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -121.8 110.22 15.64 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.43 1.109 . . . . 1.4099999999999999 109.156 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 t -107.55 120.34 58.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 105.851 -1.907 . . . . 0.01 105.851 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.0 t -146.27 68.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 118.453 -1.299 . . . . 1.98 108.369 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 172.65 107.22 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.443 -1.688 . . . . 0.01 106.443 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.66 -174.07 43.1 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.554 -1.418 . . . . 0.01 109.554 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.2 m -111.41 144.3 40.84 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.387 -1.066 . . . . 2.2999999999999998 109.216 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.493 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 63.1 m95 -129.15 146.03 51.18 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.643 -0.66 . . . . 0.01 110.377 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.1 mt -117.36 141.71 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 107.642 -1.244 . . . . 1.6899999999999999 107.642 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -113.97 143.42 44.76 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 107.453 -1.314 . . . . 2.4900000000000002 107.453 177.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 16.0 m-85 -122.77 144.17 49.35 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.291 -0.633 . . . . 0.02 109.291 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.5 -29.86 62.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.737 -0.602 . . . . 0.02 111.964 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.47 153.87 47.69 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 120.679 -1.263 . . . . 1.48 109.26 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -54.48 166.13 1.98 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.229 1.286 . . . . 0.02 112.658 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 15.3 t-20 59.79 31.76 20.97 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.145 -0.934 . . . . 0.75 111.136 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.504 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.8 m-85 57.43 51.45 9.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.54 -0.725 . . . . 0.02 110.827 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -124.55 163.43 21.93 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.541 -0.724 . . . . 0.02 109.659 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.45 -165.34 32.42 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.83 -1.308 . . . . 0.02 109.83 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -67.89 141.48 56.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.991 . . . . 0.02 109.011 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.718 ' NE2' ' H ' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -118.87 149.01 42.27 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.284 -0.635 . . . . 0.02 109.284 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.68 142.4 51.03 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.181 -0.674 . . . . 0.01 109.181 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.827 ' N ' HD12 ' A' ' 150' ' ' LEU . 3.4 mp -95.43 121.11 36.76 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.462 -0.774 . . . . 0.01 109.336 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.669 HD22 ' NE1' ' A' ' 162' ' ' TRP . 18.5 mt -105.42 135.25 47.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.44 -0.788 . . . . 0.01 110.674 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 154' ' ' LYS . 2.8 m-20 -110.31 175.63 5.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.187 -1.042 . . . . 2.27 108.187 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -57.85 84.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.905 -1.122 . . . . 1.8400000000000001 108.638 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 152' ' ' ASP . 73.6 tttt -137.14 165.38 26.21 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.256 -0.903 . . . . 2.2799999999999998 111.654 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 6.7 pt-20 -111.8 113.66 26.15 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.061 -1.088 . . . . 0.01 108.061 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.44 115.28 30.25 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.933 -1.104 . . . . 0.01 110.29 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.445 ' O ' ' OG ' ' A' ' 128' ' ' SER . 3.7 ptp180 -92.18 -25.82 18.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.01 111.347 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -125.67 153.17 72.97 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 121.017 -1.052 . . . . 2.54 108.643 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -60.7 -42.08 41.85 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 CA-C-N 119.27 0.775 . . . . 0.69999999999999996 110.524 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.1 t -60.38 -20.43 20.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.745 -1.222 . . . . 0.85999999999999999 108.612 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -65.91 -16.19 63.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.989 -1.069 . . . . 0.02 109.605 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.669 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.73 9.3 39.48 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.763 -1.199 . . . . 0.02 107.763 179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.15 10.32 86.32 Favored Glycine 0 N--CA 1.486 2.024 0 C-N-CA 119.214 -1.47 . . . . 0.02 109.617 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.5 142.03 31.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.45 -1.03 . . . . 0.02 110.091 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.1 -8.33 59.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.677 -0.64 . . . . 0.58999999999999997 109.828 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.5 p -144.66 150.86 48.47 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.857 -1.152 . . . . 0.87 108.702 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.83 21.03 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 120.816 1.011 . . . . 0.38 112.355 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.87 124.13 30.03 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.464 1.126 . . . . 0.17999999999999999 111.708 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.42 ' O ' HD12 ' A' ' 117' ' ' ILE . 16.4 mt -146.47 126.9 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 106.78 -1.563 . . . . 3.9900000000000002 106.78 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -112.02 -20.53 11.93 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.098 -1.001 . . . . 5.1699999999999999 112.783 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.6 p -158.0 160.63 37.68 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 119.269 -2.144 . . . . 0.02 110.141 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -152.48 154.03 34.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.129 -0.982 . . . . 2.02 110.26 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.504 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -144.51 151.97 39.9 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.195 -0.941 . . . . 0.01 110.449 -179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -88.24 143.02 27.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.496 -0.753 . . . . 0.01 109.412 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -93.25 128.66 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.17 -0.956 . . . . 3.04 109.053 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.8 t -136.0 146.4 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.224 -0.923 . . . . 1.8899999999999999 109.384 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 4.8899999999999997 109.517 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.642 -1.383 . . . . 0.01 109.642 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -152.83 138.29 17.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.264 -1.139 . . . . 0.02 109.586 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -130.31 140.87 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.373 -0.603 . . . . 0.02 109.373 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -121.13 129.95 53.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.469 -0.77 . . . . 0.39000000000000001 110.143 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -109.02 139.32 44.05 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.549 -0.719 . . . . 0.02 109.147 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.3 m-85 -121.98 137.73 54.69 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.361 -0.837 . . . . 0.02 109.276 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.78 -27.4 64.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.013 -1.054 . . . . 0.029999999999999999 111.88 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.9 m-20 -114.2 170.2 8.46 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.87 -1.144 . . . . 0.029999999999999999 110.366 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -75.25 157.91 33.72 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.599 0.714 . . . . 0.029999999999999999 110.136 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 10.4 t30 65.85 35.11 6.85 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.803 0.811 . . . . 0.73999999999999999 110.8 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.96 44.83 25.5 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.487 -0.779 . . . . 0.02 111.368 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -112.28 165.87 11.79 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.032 -1.099 . . . . 0.02 108.032 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -167.88 34.44 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 120.847 -1.158 . . . . 0.029999999999999999 110.619 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -69.19 143.1 54.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -1.04 . . . . 2.7599999999999998 108.922 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -123.22 149.92 44.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.518 -0.739 . . . . 1.8899999999999999 110.211 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -136.25 133.4 36.96 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 109.317 -0.623 . . . . 0.02 109.317 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.0 136.16 48.99 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.688 -0.856 . . . . 1.1200000000000001 108.688 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.429 ' SG ' ' CE2' ' A' ' 29' ' ' PHE . 1.9 m -126.94 137.31 53.1 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.637 -0.664 . . . . 0.02 109.541 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -118.95 10.74 12.31 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.572 -0.705 . . . . 0.20000000000000001 110.233 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.407 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 14.9 t -159.61 173.19 16.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.79 -1.194 . . . . 1.23 109.063 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.407 ' OD1' ' SG ' ' A' ' 24' ' ' CYS . 5.5 p-10 -63.22 146.28 53.72 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.683 -1.26 . . . . 0.02 110.721 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.88 119.22 17.81 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.061 -0.718 . . . . 0.02 109.061 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -20.84 51.33 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.504 -0.748 . . . . 0.23999999999999999 112.037 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -153.73 106.02 2.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.729 -1.232 . . . . 1.1399999999999999 109.762 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.429 ' CE2' ' SG ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -102.66 6.7 39.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.353 -0.842 . . . . 6.3700000000000001 110.399 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -61.17 -29.5 69.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 3.1099999999999999 111.898 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.4 t -77.06 -17.56 58.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.505 -1.372 . . . . 0.88 110.948 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -106.14 -21.42 13.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.388 -0.82 . . . . 0.02 110.624 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.13 127.39 12.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.145 -0.972 . . . . 3.3199999999999998 109.472 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.6 t -87.29 -12.48 46.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.516 -0.74 . . . . 0.02 110.976 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -172.56 161.99 5.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.847 -1.158 . . . . 0.02 108.378 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.464 ' SG ' HD12 ' A' ' 79' ' ' LEU . 3.1 p -142.63 115.04 8.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.99 -1.069 . . . . 0.02 108.735 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -107.04 -2.71 20.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.836 -1.165 . . . . 0.029999999999999999 111.289 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -152.96 153.65 33.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.118 -1.067 . . . . 0.02 108.118 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.7 mt -146.83 147.44 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.045 -1.034 . . . . 0.02 110.438 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -124.91 125.66 44.29 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.899 -1.148 . . . . 0.02 107.899 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.6 114.11 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 106.773 -1.566 . . . . 0.02 106.773 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.94 -34.61 22.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.609 -0.682 . . . . 3.8100000000000001 110.184 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.24 149.99 18.24 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 118.358 -1.877 . . . . 0.02 110.758 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.12 172.42 49.11 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.174 -1.171 . . . . 0.01 110.174 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 m -118.35 134.19 55.26 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.484 -1.302 . . . . 1.48 107.484 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -126.38 154.86 43.0 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.626 1.203 . . . . 0.02 112.326 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.72 133.99 52.51 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.189 -2.152 . . . . 0.23999999999999999 105.189 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.458 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.7 m -117.22 142.63 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.514 -0.741 . . . . 0.65000000000000002 109.319 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -120.88 143.19 49.05 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 122.053 0.93 . . . . 0.02 109.535 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.08 -33.62 76.47 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.498 -0.774 . . . . 0.02 111.641 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -124.46 157.7 64.19 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 121.098 -1.001 . . . . 0.02 109.467 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.13 166.94 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.656 1.57 . . . . 0.02 112.726 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.07 36.5 12.24 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.331 -0.849 . . . . 0.02 111.108 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 45.56 51.54 9.84 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.601 0.715 . . . . 3.3900000000000001 110.864 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 p -125.78 163.55 22.62 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.384 0.612 . . . . 2.3300000000000001 109.904 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.49 -161.45 31.17 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.799 -1.32 . . . . 0.02 109.799 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.427 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 24.0 m-70 -65.3 139.35 58.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.027 -1.278 . . . . 0.02 110.163 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 18.4 ptm -118.91 137.05 53.73 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.245 0.545 . . . . 5.0099999999999998 109.61 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.442 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.9 m-85 -134.19 138.82 45.4 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.459 -0.776 . . . . 0.02 109.925 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.7 mm -95.2 130.62 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.49 -0.756 . . . . 1.72 109.031 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.475 HD22 ' CE1' ' A' ' 66' ' ' TYR . 7.4 mt -121.44 111.2 33.49 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 121.326 -0.859 . . . . 0.02 110.653 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -77.66 169.77 20.29 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 CA-C-N 119.85 0.982 . . . . 1.47 110.415 177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -53.53 141.26 25.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.902 -1.124 . . . . 4.25 110.603 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.45 -177.4 31.83 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.502 -1.333 . . . . 0.02 110.693 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -118.45 130.42 55.95 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.354 -1.086 . . . . 0.95999999999999996 109.787 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' CE1' HD22 ' A' ' 61' ' ' LEU . 90.0 m-85 -120.37 97.05 49.08 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 107.861 -1.163 . . . . 0.02 107.861 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -69.48 -4.49 13.94 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 120.752 0.968 . . . . 0.02 113.583 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -157.27 154.53 29.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.623 -1.298 . . . . 2.02 108.144 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -59.95 -38.6 82.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.408 -0.808 . . . . 0.02 111.773 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -59.82 -24.44 64.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.02 110.226 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -70.09 -18.72 63.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.41 -0.806 . . . . 3.4199999999999999 108.879 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.46 10.12 27.42 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.628 -1.249 . . . . 0.02 107.628 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.9 mmt 60.81 22.32 12.37 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.48 0.657 . . . . 0.02 110.598 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.43 144.17 45.8 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.367 -1.493 . . . . 0.02 109.367 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.1 tp -78.93 -30.93 44.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.553 -1.276 . . . . 0.97999999999999998 107.553 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -157.42 -171.82 3.74 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.544 -1.651 . . . . 0.02 106.544 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -98.25 28.63 3.96 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.603 -1.31 . . . . 0.02 110.775 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -97.82 122.72 41.26 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.933 -1.105 . . . . 3.2000000000000002 111.324 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.464 HD12 ' SG ' ' A' ' 36' ' ' CYS . 54.4 mt -142.36 119.51 11.43 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.317 -1.364 . . . . 2.6099999999999999 107.317 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.99 -18.55 10.41 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 121.282 -0.886 . . . . 0.02 112.065 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 p -155.45 155.63 33.86 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 119.531 1.666 . . . . 0.02 110.695 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.5 p -145.17 147.82 32.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.403 -0.811 . . . . 0.02 110.283 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -137.17 141.87 42.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.442 -0.786 . . . . 0.01 109.109 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.58 132.36 37.11 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.203 -0.935 . . . . 0.42999999999999999 109.28 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.3 123.95 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.653 -0.869 . . . . 1.25 108.653 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -92.01 132.34 36.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.956 -1.09 . . . . 1.77 108.552 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.8 OUTLIER -96.83 138.12 34.87 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.139 -1.06 . . . . 1.6299999999999999 108.139 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.9 p -110.21 126.38 54.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 1.0800000000000001 108.682 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.2 t -102.85 -155.1 0.51 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.205 -1.776 . . . . 1.26 106.205 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.59 -50.41 0.84 Allowed Glycine 0 N--CA 1.497 2.743 0 O-C-N 120.521 -1.362 . . . . 0.01 111.986 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.6 -99.77 0.13 Allowed Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.816 -1.659 . . . . 0.01 111.709 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -119.34 119.45 34.01 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.117 -1.225 . . . . 4.4299999999999997 110.311 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.515 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.35 137.32 56.82 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.344 -0.613 . . . . 2.9900000000000002 109.344 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 7.5 ttpm? -136.45 130.7 33.03 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-O 122.273 1.035 . . . . 6.3600000000000003 113.015 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 tt -131.72 141.51 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 115.397 -0.82 . . . . 1.0900000000000001 110.286 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 6.3 pt20 -124.33 140.2 53.18 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 107.597 -1.26 . . . . 2.0499999999999998 107.597 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 m -124.24 146.29 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.685 -1.259 . . . . 1.1000000000000001 111.189 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 26.2 m-85 -120.4 140.24 51.64 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 122.224 1.011 . . . . 0.72999999999999998 110.745 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.84 -32.44 72.97 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.709 -0.678 . . . . 0.02 111.907 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -114.47 165.7 12.47 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 120.948 -1.095 . . . . 3.1800000000000002 110.446 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.9 163.69 47.24 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 111.038 -0.825 . . . . 0.01 111.038 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 57.62 38.86 27.88 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.578 0.704 . . . . 0.01 110.946 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 52.44 56.91 7.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.537 -0.727 . . . . 0.01 111.035 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -129.48 165.34 21.82 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.166 -1.05 . . . . 3.1499999999999999 108.166 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.4 -162.77 28.38 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.13 -1.588 . . . . 0.01 109.13 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.471 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 54.6 tt0 -75.81 142.0 42.37 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.016 -1.285 . . . . 0.01 108.76 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.7 ttp -116.55 143.05 46.09 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.513 0.673 . . . . 0.01 109.563 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.471 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 55.9 m-85 -131.89 135.91 47.01 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.198 -1.038 . . . . 2.48 108.198 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -116.52 134.37 54.92 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.722 -0.611 . . . . 0.01 109.669 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t -149.23 148.02 29.09 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.528 1.156 . . . . 1.6899999999999999 111.367 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 p -114.95 7.67 15.67 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.949 -1.023 . . . . 0.01 109.934 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.449 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 21.8 mp0 -122.03 163.78 18.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.408 -0.808 . . . . 3.21 111.181 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.59 153.89 42.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.384 -0.823 . . . . 0.01 109.46 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 46.0 t -126.98 114.95 22.03 Favored Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 108.971 -0.752 . . . . 0.01 108.971 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -75.1 -32.94 4.86 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 120.387 1.174 . . . . 0.01 111.612 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -142.05 108.49 5.3 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.834 0.826 . . . . 0.02 109.198 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 169' ' ' ILE . 96.4 mt -64.36 -39.75 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.844 -0.535 . . . . 1.8300000000000001 111.02 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.6 ttt -66.57 -38.17 86.5 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.169 -1.012 . . . . 1.3400000000000001 109.865 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.62 -38.46 77.23 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.506 -1.371 . . . . 2.1099999999999999 109.858 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -80.78 -47.25 14.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.29 -0.881 . . . . 2.0800000000000001 112.462 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -111.21 -0.78 16.36 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.252 -0.905 . . . . 0.02 112.719 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 59.88 33.43 21.57 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.812 -1.18 . . . . 0.02 109.384 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.27 135.7 52.61 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 108.699 -0.852 . . . . 0.02 108.699 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -92.66 -23.43 18.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 5.3200000000000003 110.65 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -149.11 163.66 36.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.084 -1.01 . . . . 0.02 110.095 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.2 mt -131.63 129.4 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 107.348 -1.353 . . . . 2.1699999999999999 107.348 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -107.18 -13.32 15.18 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.144 -0.973 . . . . 0.02 113.06 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.38 153.06 29.85 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.277 -1.514 . . . . 0.01 108.255 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 6.8 t -162.86 143.81 9.75 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.375 -1.453 . . . . 1.22 109.665 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -122.37 112.87 18.62 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.001 0.905 . . . . 1.4099999999999999 108.77 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 t -109.03 123.4 64.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.061 -1.829 . . . . 0.01 106.061 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -146.41 66.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 C-N-CA 117.951 -1.5 . . . . 1.98 109.061 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.402 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.1 tp10 176.28 108.72 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.32 -1.733 . . . . 0.01 106.32 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.678 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 70.99 -174.44 40.39 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.476 -1.45 . . . . 0.01 109.476 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -112.05 146.57 37.7 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.423 -1.045 . . . . 2.2999999999999998 109.43 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.515 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 61.1 m95 -130.35 146.19 51.89 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.502 -0.749 . . . . 0.01 110.284 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mt -117.13 141.56 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 107.566 -1.272 . . . . 1.6899999999999999 107.566 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.33 143.79 44.32 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.688 -1.227 . . . . 2.4900000000000002 107.688 177.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 7.5 m-85 -122.58 144.7 48.94 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.994 -0.743 . . . . 0.02 108.994 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 76.5 tt0 -74.06 -29.78 62.06 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.669 -0.644 . . . . 0.02 112.08 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.5 mt -115.24 153.5 47.39 Favored Pre-proline 0 N--CA 1.506 2.369 0 O-C-N 120.676 -1.265 . . . . 1.48 109.208 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.41 167.08 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.129 1.219 . . . . 0.02 112.565 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 59.31 31.08 20.88 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.065 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.76 51.12 9.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 0.02 111.124 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -123.99 163.33 21.6 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.569 -0.707 . . . . 0.02 109.528 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.2 -165.79 31.74 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.873 -1.291 . . . . 0.02 109.873 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -68.2 142.28 55.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.477 -1.014 . . . . 0.02 109.03 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -118.01 148.46 42.21 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.451 -0.574 . . . . 0.02 109.451 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.463 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -128.64 142.73 50.94 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.563 -0.71 . . . . 0.01 109.113 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.64 119.8 34.77 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.48 -0.763 . . . . 0.01 109.465 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 162' ' ' TRP . 19.5 mt -106.21 131.95 52.84 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.422 -0.798 . . . . 0.01 110.363 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 154' ' ' LYS . 11.9 p-10 -109.84 176.77 4.94 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.454 -0.943 . . . . 2.27 108.454 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.678 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 48.7 mttm -55.54 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.066 -1.021 . . . . 1.8400000000000001 108.489 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 152' ' ' ASP . 53.4 mmtt -136.74 166.86 22.6 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.189 -0.945 . . . . 2.2799999999999998 111.593 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 15.0 mp0 -113.82 106.4 14.42 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.76 -1.2 . . . . 0.01 107.76 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.56 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 90.9 m-85 -99.03 114.16 26.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.965 -1.085 . . . . 0.01 110.201 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -92.41 -25.67 18.37 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.19 -0.943 . . . . 0.01 111.144 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -125.18 153.88 71.74 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.079 -1.013 . . . . 2.54 108.392 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -61.3 -41.43 42.04 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 120.442 0.761 . . . . 0.69999999999999996 110.651 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.33 -20.1 21.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.657 -1.277 . . . . 0.85999999999999999 108.769 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -65.57 -16.11 63.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.025 -1.047 . . . . 0.02 109.758 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.56 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 1.1 m0 -96.11 10.88 36.2 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.999 -1.112 . . . . 0.02 107.999 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.57 11.34 85.56 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.414 -1.374 . . . . 0.02 110.159 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.73 141.94 31.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.293 -1.122 . . . . 0.02 110.209 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.29 -8.22 59.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.613 -0.679 . . . . 0.58999999999999997 109.817 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.4 p -144.31 150.87 49.78 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.806 -1.184 . . . . 0.87 108.728 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.6 20.85 0.5 Allowed 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 120.701 0.934 . . . . 0.38 112.341 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.28 122.14 27.56 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.467 1.127 . . . . 0.17999999999999999 111.45 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.433 ' O ' HD12 ' A' ' 117' ' ' ILE . 9.8 mm -142.74 125.39 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.009 -1.848 . . . . 3.9900000000000002 106.009 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 12.3 mp0 -112.33 -20.82 11.69 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.088 -1.008 . . . . 5.1699999999999999 112.615 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.5 p -157.41 160.92 38.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.384 -2.072 . . . . 0.02 109.954 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -153.53 154.59 34.6 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.182 -0.949 . . . . 2.02 110.578 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -144.46 151.39 39.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.35 -0.843 . . . . 0.01 110.442 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -87.66 142.64 27.68 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.054 -0.721 . . . . 0.01 109.054 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.8 mt -93.12 128.45 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.037 -1.039 . . . . 3.04 109.206 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 44.9 t -136.07 146.71 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.294 -0.879 . . . . 1.8899999999999999 109.564 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.86 . . . . 4.8899999999999997 109.483 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.39 -1.484 . . . . 0.01 109.39 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -152.83 138.28 17.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.245 -1.15 . . . . 0.02 109.841 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -130.32 141.03 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.475 -0.565 . . . . 0.02 109.475 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.422 ' OG ' ' NE ' ' A' ' 19' ' ' ARG . 1.6 t -122.26 130.76 53.47 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.308 -0.87 . . . . 0.39000000000000001 110.091 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.0 OUTLIER -111.11 140.71 45.43 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.768 -0.582 . . . . 0.02 109.444 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.4 m-85 -121.85 138.45 54.38 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.353 -0.842 . . . . 0.02 109.573 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -68.86 -27.4 65.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.99 -1.069 . . . . 0.029999999999999999 111.504 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.7 m-20 -114.53 170.72 8.1 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.858 -1.151 . . . . 0.029999999999999999 110.009 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -75.81 162.06 28.49 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.705 0.764 . . . . 0.029999999999999999 110.313 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.9 t30 62.46 33.28 16.25 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.113 0.959 . . . . 0.73999999999999999 110.742 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.1 40.29 31.81 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.733 -0.667 . . . . 0.02 110.834 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -109.97 165.42 11.74 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.196 -1.038 . . . . 0.02 108.196 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.54 -168.04 34.38 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.888 -1.149 . . . . 0.029999999999999999 110.557 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -68.83 143.53 54.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -1.058 . . . . 2.7599999999999998 108.887 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.533 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 51.4 ttt180 -122.03 149.95 42.78 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.62 -0.675 . . . . 1.8899999999999999 109.916 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.24 134.5 34.51 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.637 -0.664 . . . . 0.02 109.466 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.31 136.92 48.75 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.385 -0.822 . . . . 1.1200000000000001 109.384 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.7 t -127.99 138.3 52.55 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.594 -0.691 . . . . 0.02 109.488 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -118.74 11.98 12.87 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.59 -0.694 . . . . 0.20000000000000001 110.554 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.2 t -159.46 173.84 15.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.706 -1.246 . . . . 1.23 109.091 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 17.8 p30 -63.11 146.67 52.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.747 -1.221 . . . . 0.02 110.527 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.4 m -133.7 117.64 17.21 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.127 -0.694 . . . . 0.02 109.127 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.75 -23.21 45.53 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.284 -0.885 . . . . 0.23999999999999999 111.471 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -151.77 103.77 2.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.974 -1.079 . . . . 1.1399999999999999 109.056 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.16 6.81 33.39 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.588 0.709 . . . . 6.3700000000000001 110.231 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -59.93 -27.63 66.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 3.1099999999999999 111.691 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.4 p -76.6 -16.08 59.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.611 -1.306 . . . . 0.88 110.803 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.57 -21.96 12.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.44 -0.787 . . . . 0.02 110.422 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tp -149.08 127.33 12.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.04 -1.037 . . . . 3.3199999999999998 109.436 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.2 t -87.02 -12.16 48.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.64 -0.662 . . . . 0.02 111.051 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.52 ' HE ' HD21 ' A' ' 37' ' ' ASN . 14.9 ptm180 -172.84 162.13 4.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.93 -1.106 . . . . 0.02 108.417 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -142.7 115.79 8.87 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.047 -1.033 . . . . 0.02 108.649 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.52 HD21 ' HE ' ' A' ' 35' ' ' ARG . 1.6 m-80 -107.71 -1.0 21.43 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.803 -1.186 . . . . 0.029999999999999999 110.987 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -155.52 152.88 29.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.6 mt -145.33 148.46 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.091 -1.006 . . . . 0.02 109.887 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -124.46 124.55 42.56 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.5 -1.296 . . . . 0.02 107.5 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -105.03 113.87 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.704 -1.591 . . . . 0.02 106.704 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -83.81 -34.83 24.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.576 -0.703 . . . . 3.8100000000000001 109.971 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 151.27 20.64 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 118.392 -1.861 . . . . 0.02 110.535 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.79 171.89 48.61 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.318 -1.113 . . . . 0.01 110.318 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.9 m -117.76 133.74 55.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.429 -1.323 . . . . 1.48 107.429 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -126.21 154.23 43.59 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.6 1.19 . . . . 0.02 112.16 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.03 133.72 52.61 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.419 -2.067 . . . . 0.23999999999999999 105.419 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.3 m -117.62 142.87 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.569 -0.707 . . . . 0.65000000000000002 109.249 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -120.62 144.87 47.91 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.112 0.958 . . . . 0.02 109.997 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.472 ' OE2' ' NH2' ' A' ' 78' ' ' ARG . 33.5 tt0 -66.16 -33.69 76.34 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.875 -0.602 . . . . 0.02 111.582 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' A' ' 51' ' ' ARG . 0.4 OUTLIER -124.64 157.88 64.07 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.006 -1.059 . . . . 0.02 109.486 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.09 166.44 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.637 1.558 . . . . 0.02 112.763 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m120 63.67 36.39 10.84 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.36 -0.836 . . . . 0.02 111.153 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 8.0 m-85 45.29 51.51 9.32 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.654 0.74 . . . . 3.3900000000000001 110.812 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -125.75 163.44 22.84 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.143 0.497 . . . . 2.3300000000000001 109.882 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.83 31.38 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.513 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 21.1 m-70 -64.35 138.48 58.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.981 -1.305 . . . . 0.02 109.989 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.498 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.8 ppp? -119.37 137.45 53.72 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.283 0.564 . . . . 5.0099999999999998 109.58 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.594 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.7 m-85 -134.99 139.95 45.29 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.492 -0.755 . . . . 0.02 110.238 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.7 mm -94.16 130.45 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 108.656 -0.868 . . . . 1.72 108.656 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.03 110.32 36.53 Favored Pre-proline 0 N--CA 1.505 2.324 0 O-C-N 121.439 -0.788 . . . . 0.02 110.597 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.69 168.65 22.13 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 CA-C-N 119.935 1.012 . . . . 1.47 110.311 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -53.75 140.79 28.67 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.84 -1.163 . . . . 4.25 110.524 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.77 32.68 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.489 -1.338 . . . . 0.02 110.598 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -118.76 130.09 55.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.251 -1.146 . . . . 0.95999999999999996 109.622 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.574 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 71.8 m-85 -121.1 98.91 46.88 Favored Pre-proline 0 N--CA 1.492 1.667 0 N-CA-C 107.852 -1.166 . . . . 0.02 107.852 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -71.3 -3.73 13.53 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 120.637 0.892 . . . . 0.02 113.836 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -157.52 155.04 29.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.64 -1.288 . . . . 2.02 108.274 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -59.85 -39.08 84.0 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.62 -0.675 . . . . 0.02 111.787 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -59.94 -23.99 64.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.917 . . . . 0.02 110.256 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -70.32 -18.75 63.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.791 0.805 . . . . 3.4199999999999999 108.921 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.594 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -108.4 10.53 27.46 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.455 -1.313 . . . . 0.02 107.455 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.0 mtt 61.34 22.56 12.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.619 -0.676 . . . . 0.02 110.714 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.14 144.55 46.92 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.648 -1.381 . . . . 0.02 109.648 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.71 -30.75 41.06 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.725 -1.213 . . . . 0.97999999999999998 107.725 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -157.38 -171.52 3.63 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.374 -1.713 . . . . 0.02 106.374 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -98.93 28.3 4.45 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.607 -1.308 . . . . 0.02 110.72 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.472 ' NH2' ' OE2' ' A' ' 50' ' ' GLU . 80.1 mtm180 -96.44 122.56 39.47 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.916 -1.115 . . . . 3.2000000000000002 111.011 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.435 HD21 ' CH2' ' A' ' 72' ' ' TRP . 82.5 mt -142.71 119.49 11.18 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.791 -1.189 . . . . 2.6099999999999999 107.791 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.4 -17.79 10.32 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 121.167 -0.958 . . . . 0.02 112.416 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 92.9 p -156.19 156.15 33.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.165 -1.786 . . . . 0.02 110.495 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.8 p -145.26 148.43 33.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.693 -0.629 . . . . 0.02 109.706 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.465 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.9 mtp180 -137.06 141.42 42.42 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.286 -0.884 . . . . 0.01 109.281 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.67 133.03 37.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.843 . . . . 0.42999999999999999 109.387 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 t -91.72 124.66 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.02 -0.733 . . . . 1.25 109.02 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -91.09 132.11 36.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.852 -1.155 . . . . 1.77 108.202 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -99.09 140.23 33.56 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.775 -0.824 . . . . 1.6299999999999999 108.775 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.5 m -111.01 123.51 50.34 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.097 -1.075 . . . . 1.0800000000000001 108.097 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.8 p -114.62 131.96 56.53 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.611 -1.255 . . . . 1.26 107.611 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.9 -48.76 0.01 OUTLIER Glycine 0 N--CA 1.502 3.078 0 C-N-CA 117.698 -2.191 . . . . 0.01 113.329 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.44 -103.79 0.17 Allowed Glycine 0 N--CA 1.485 1.956 0 CA-C-N 119.95 1.875 . . . . 0.01 110.939 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.44 HE22 HH12 ' A' ' 174' ' ' ARG . 64.5 tp60 -119.17 118.94 32.7 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.244 -1.15 . . . . 4.4299999999999997 110.229 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.45 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.39 135.11 53.85 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.234 -0.586 . . . . 2.9900000000000002 109.532 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -133.73 129.98 37.46 Favored 'General case' 0 N--CA 1.52 3.042 0 CA-C-O 122.224 1.011 . . . . 6.3600000000000003 113.067 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -130.07 141.26 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-N 115.511 -0.768 . . . . 1.0900000000000001 110.406 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.472 ' HG2' ' H ' ' A' ' 130' ' ' LYS . 0.8 OUTLIER -123.64 138.74 54.48 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 107.637 -1.245 . . . . 2.0499999999999998 107.637 177.033 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 m -123.98 145.62 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 O-C-N 120.664 -1.272 . . . . 1.1000000000000001 111.032 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -120.27 139.61 52.44 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.958 0.885 . . . . 0.72999999999999998 110.652 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 3.9 tm-20 -69.16 -33.04 72.78 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.766 -0.652 . . . . 0.02 112.073 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.457 ' O ' ' OG ' ' A' ' 128' ' ' SER . 49.4 mttp -114.22 165.57 12.54 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.902 -1.124 . . . . 3.1800000000000002 110.229 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.38 163.07 46.43 Favored Glycine 0 N--CA 1.492 2.375 0 CA-C-O 122.007 0.781 . . . . 0.01 111.308 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.59 39.51 27.58 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.532 0.682 . . . . 0.01 111.102 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 52.29 56.04 8.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.727 -0.608 . . . . 0.01 111.003 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.623 ' ND2' ' H ' ' A' ' 105' ' ' GLY . 4.9 t-20 -129.08 164.87 22.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.001 -1.111 . . . . 3.1499999999999999 108.001 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.623 ' H ' ' ND2' ' A' ' 104' ' ' ASN . . . 91.38 -162.64 28.32 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.081 -1.607 . . . . 0.01 109.081 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -75.51 141.79 42.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.919 -1.342 . . . . 0.01 109.126 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 107' ' ' MET . 9.7 tmm? -116.08 142.79 46.34 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.448 0.642 . . . . 0.01 109.546 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -132.08 135.65 46.61 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.166 -1.05 . . . . 2.48 108.166 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.72 133.93 55.42 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.754 -0.592 . . . . 0.01 109.808 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -148.95 148.25 29.57 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.511 1.148 . . . . 1.6899999999999999 111.365 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.2 p -114.62 7.84 16.14 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.99 -1.005 . . . . 0.01 109.936 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.82 163.48 19.09 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.429 -0.794 . . . . 3.21 111.183 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.04 154.34 42.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.357 -0.839 . . . . 0.01 109.436 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.463 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 51.0 t -126.98 114.6 22.02 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 108.806 -0.812 . . . . 0.01 108.806 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.58 -31.97 5.1 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 120.241 1.122 . . . . 0.01 111.51 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.4 t -142.48 107.67 4.98 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.825 0.822 . . . . 0.02 108.992 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 169' ' ' ILE . 96.7 mt -63.84 -39.31 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.843 -0.535 . . . . 1.8300000000000001 111.141 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 42.7 ttp -67.37 -37.54 83.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.202 -0.999 . . . . 1.3400000000000001 110.014 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -69.88 -38.98 76.53 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.504 -1.372 . . . . 2.1099999999999999 109.852 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.463 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.9 tt0 -79.82 -47.08 15.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.233 -0.917 . . . . 2.0800000000000001 112.455 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -110.76 -0.13 17.14 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.365 -0.834 . . . . 0.02 112.655 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 m80 59.33 33.06 22.33 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.738 -1.226 . . . . 0.02 109.272 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.27 135.59 52.76 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 108.652 -0.869 . . . . 0.02 108.652 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -92.56 -23.48 19.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 5.3200000000000003 110.501 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -149.51 163.78 36.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.207 -0.933 . . . . 0.02 110.028 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.1 mt -131.79 129.68 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 107.427 -1.324 . . . . 2.1699999999999999 107.427 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -106.07 -13.89 15.32 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.105 -0.997 . . . . 0.02 113.098 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 2.2 p -157.63 156.29 31.57 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.486 -1.384 . . . . 0.01 108.242 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.581 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 18.4 p -164.0 146.91 9.52 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.446 -1.409 . . . . 1.22 109.663 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.472 ' H ' ' HG2' ' A' ' 96' ' ' GLN . 31.7 tttt -121.51 111.48 17.31 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.153 0.977 . . . . 1.4099999999999999 108.532 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.51 122.9 64.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.054 -1.832 . . . . 0.01 106.054 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.98 69.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 118.12 -1.432 . . . . 1.98 108.391 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.37 108.32 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 106.852 -1.536 . . . . 0.01 106.852 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.68 -174.27 45.95 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.876 -1.29 . . . . 0.01 109.876 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.481 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.7 m -110.47 145.6 37.39 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.364 -1.08 . . . . 2.2999999999999998 108.901 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.45 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.8 m95 -131.54 145.35 51.69 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.48 -0.762 . . . . 0.01 110.58 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.8 141.88 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 107.519 -1.289 . . . . 1.6899999999999999 107.519 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.18 143.62 44.52 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 107.657 -1.238 . . . . 2.4900000000000002 107.657 177.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.1 m-85 -121.51 143.9 49.01 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.79 -0.819 . . . . 0.02 108.79 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.432 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 3.0 tm-20 -73.86 -29.9 62.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.705 -0.622 . . . . 0.02 111.525 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.42 152.84 47.42 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 120.666 -1.272 . . . . 1.48 108.989 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.07 170.61 0.47 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.213 1.276 . . . . 0.02 112.502 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.644 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER 57.93 31.13 20.17 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.18 -0.918 . . . . 0.75 110.996 178.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 56.54 47.64 18.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.608 -0.682 . . . . 0.02 110.501 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -120.93 163.46 18.2 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.578 -0.702 . . . . 0.02 109.848 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.39 -165.77 31.49 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.971 -1.251 . . . . 0.02 109.971 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -68.06 142.57 55.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.551 -0.97 . . . . 0.02 109.14 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -118.26 148.43 42.43 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.43 -0.582 . . . . 0.02 109.43 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -129.41 142.43 50.8 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 150' ' ' LEU . 5.7 tt -97.41 121.33 39.18 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.384 -0.823 . . . . 0.01 109.333 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.685 HD13 ' HE1' ' A' ' 162' ' ' TRP . 17.0 mt -107.06 138.01 44.04 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.563 -0.711 . . . . 0.01 110.957 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 154' ' ' LYS . 31.8 t70 -110.21 168.98 9.04 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.174 -1.047 . . . . 2.27 108.174 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -53.02 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.845 -1.159 . . . . 1.8400000000000001 108.834 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 152' ' ' ASP . 92.6 mttt -136.57 168.53 19.31 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.114 0.959 . . . . 2.2799999999999998 111.584 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -113.1 109.03 18.13 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.152 -1.055 . . . . 0.01 108.152 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.55 114.45 28.1 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.11 -0.994 . . . . 0.01 110.253 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -92.48 -25.99 18.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.199 -0.938 . . . . 0.01 111.319 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -125.75 152.96 73.1 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 120.956 -1.09 . . . . 2.54 108.583 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -60.27 -42.2 44.26 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 CA-C-N 119.377 0.813 . . . . 0.69999999999999996 110.408 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.7 t -60.28 -21.24 22.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.625 -1.297 . . . . 0.85999999999999999 108.443 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 43.1 t0 -66.24 -16.04 63.68 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.143 -1.023 . . . . 0.02 109.255 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.685 ' HE1' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -92.97 7.33 44.46 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.892 -1.151 . . . . 0.02 107.892 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.4 9.42 85.89 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.417 -1.473 . . . . 0.02 109.417 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.3 142.43 30.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.63 -0.923 . . . . 0.02 110.142 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.26 -8.23 59.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.708 -0.62 . . . . 0.58999999999999997 109.553 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.0 t -144.41 151.15 50.27 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.969 -1.082 . . . . 0.87 108.289 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.55 22.11 0.46 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 120.774 0.982 . . . . 0.38 112.369 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.73 122.23 28.36 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.488 1.137 . . . . 0.17999999999999999 111.79 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 117' ' ' ILE . 9.5 mm -142.15 125.67 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 106.004 -1.85 . . . . 3.9900000000000002 106.004 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 13.5 mp0 -112.66 -22.14 10.9 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.958 -1.089 . . . . 5.1699999999999999 112.852 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 34.1 t -156.45 159.65 38.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.327 -2.108 . . . . 0.02 110.044 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.404 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.3 p90 -152.85 153.97 34.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.031 -1.043 . . . . 2.02 110.778 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -145.52 152.05 39.13 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.226 -0.921 . . . . 0.01 110.458 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.44 HH12 HE22 ' A' ' 92' ' ' GLN . 32.2 ptt180 -88.04 142.82 27.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.6 -0.688 . . . . 0.01 109.397 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.28 128.62 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.215 -0.928 . . . . 3.04 108.999 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.01 146.35 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.244 -0.91 . . . . 1.8899999999999999 109.545 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 4.8899999999999997 109.654 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 109.412 -1.475 . . . . 0.01 109.412 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -153.85 138.48 16.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.239 -1.154 . . . . 0.02 109.605 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -130.06 140.54 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 109.473 -0.566 . . . . 0.02 109.473 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.2 130.14 53.55 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.482 -0.761 . . . . 0.39000000000000001 109.993 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -110.32 140.27 44.67 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.645 -0.659 . . . . 0.02 109.384 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.542 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.5 m-85 -121.93 138.14 54.52 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.162 -0.961 . . . . 0.02 109.617 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 66.6 mt-10 -69.51 -27.6 65.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.054 . . . . 0.029999999999999999 111.814 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 12.4 t70 -113.93 169.86 8.7 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.829 -1.169 . . . . 0.029999999999999999 110.115 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.451 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 24.8 mtp180 -75.36 158.12 33.24 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.542 0.687 . . . . 0.029999999999999999 110.13 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.7 m120 66.23 35.01 6.22 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.774 0.797 . . . . 0.73999999999999999 110.905 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.3 p90 49.85 44.65 25.16 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.688 0.756 . . . . 0.02 111.316 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -112.86 165.89 11.9 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.064 -1.088 . . . . 0.02 108.064 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.9 -167.47 34.79 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.808 -1.187 . . . . 0.029999999999999999 110.684 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -68.69 141.92 55.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.515 -0.991 . . . . 2.7599999999999998 109.152 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -122.95 150.16 43.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.535 -0.728 . . . . 1.8899999999999999 110.212 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -136.62 133.47 36.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.776 -0.577 . . . . 0.02 109.473 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -109.48 135.91 49.74 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.882 -0.785 . . . . 1.1200000000000001 108.882 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 45.9 t -127.85 138.43 52.69 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.582 -0.699 . . . . 0.02 109.778 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 14.8 p30 -119.2 11.66 12.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.572 -0.705 . . . . 0.20000000000000001 110.372 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 21.3 p -159.58 173.58 15.91 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.797 -1.189 . . . . 1.23 109.097 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 9.0 p30 -62.91 145.92 54.09 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.766 -1.208 . . . . 0.02 110.748 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.562 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 19.4 t -134.54 118.68 17.55 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.096 -0.705 . . . . 0.02 109.096 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.19 -21.79 53.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.85 . . . . 0.23999999999999999 111.697 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -153.82 105.86 2.81 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.893 -1.129 . . . . 1.1399999999999999 109.82 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.562 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -102.69 8.07 39.64 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.267 -0.896 . . . . 6.3700000000000001 110.272 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -60.14 -27.69 67.27 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -0.83 . . . . 3.1099999999999999 111.829 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.0 p -76.32 -16.82 59.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.512 -1.368 . . . . 0.88 111.153 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -106.81 -21.07 13.14 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.287 -0.883 . . . . 0.02 110.644 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 mt -148.77 127.81 12.77 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.959 -1.088 . . . . 3.3199999999999998 109.399 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.0 t -86.77 -11.8 49.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.647 -0.658 . . . . 0.02 110.582 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -172.03 161.8 5.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.012 -1.055 . . . . 0.02 108.265 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.444 ' SG ' HD12 ' A' ' 79' ' ' LEU . 4.1 p -143.79 116.38 8.65 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.044 -1.035 . . . . 0.02 108.835 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.675 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -108.11 -0.77 20.9 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.708 -1.245 . . . . 0.029999999999999999 111.645 -178.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -154.88 154.04 32.06 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.727 -1.212 . . . . 0.02 107.727 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.2 mt -146.89 147.65 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.902 -1.124 . . . . 0.02 110.728 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.525 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 29.2 ttp180 -123.88 124.69 43.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.119 -1.067 . . . . 0.02 108.119 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.67 113.94 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 106.681 -1.6 . . . . 0.02 106.681 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 69.6 mm-40 -84.75 -34.72 22.79 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.18 -0.608 . . . . 3.8100000000000001 110.414 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.49 150.55 19.34 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.633 -1.746 . . . . 0.02 110.591 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.74 172.13 48.82 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.25 -1.14 . . . . 0.01 110.25 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 m -118.25 133.86 55.52 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.573 -1.269 . . . . 1.48 107.573 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -126.23 154.61 43.08 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.849 1.309 . . . . 0.02 112.235 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.22 133.76 52.62 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.292 -2.114 . . . . 0.23999999999999999 105.292 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.447 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.5 m -115.88 141.52 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.467 -0.771 . . . . 0.65000000000000002 109.241 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -120.21 142.59 48.86 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.028 0.918 . . . . 0.02 109.467 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' ND1' ' A' ' 57' ' ' HIS . 35.6 tt0 -65.54 -33.66 76.43 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.62 -0.718 . . . . 0.02 111.915 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 51' ' ' ARG . 0.6 OUTLIER -124.43 157.59 64.45 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 120.926 -1.109 . . . . 0.02 109.383 -178.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.03 166.08 1.06 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.667 1.578 . . . . 0.02 112.728 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 m120 63.66 36.77 10.6 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.362 -0.835 . . . . 0.02 111.12 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.487 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.4 m-85 45.06 51.32 8.94 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.636 0.732 . . . . 3.3900000000000001 110.747 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 97.1 p -125.54 163.41 22.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.275 0.559 . . . . 2.3300000000000001 109.837 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.4 -161.41 31.26 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.756 -1.338 . . . . 0.02 109.756 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.516 ' ND1' ' OE1' ' A' ' 50' ' ' GLU . 7.2 m170 -64.43 138.54 58.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.006 -1.291 . . . . 0.02 110.259 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.503 ' O ' ' SD ' ' A' ' 58' ' ' MET . 3.1 ppp? -119.27 137.44 53.67 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.294 0.569 . . . . 5.0099999999999998 109.5 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 88.3 m-85 -135.32 139.68 44.51 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.421 -0.799 . . . . 0.02 109.821 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.7 mm -94.27 130.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.831 -0.803 . . . . 1.72 108.831 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.6 110.75 35.2 Favored Pre-proline 0 N--CA 1.506 2.332 0 O-C-N 121.349 -0.844 . . . . 0.02 110.675 -178.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -78.11 169.42 20.37 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 119.869 0.989 . . . . 1.47 110.442 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.53 141.6 24.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.934 -1.104 . . . . 4.25 110.607 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.06 -178.0 31.19 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 119.608 -1.282 . . . . 0.02 110.967 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -119.83 131.4 55.28 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.601 -0.94 . . . . 0.95999999999999996 109.712 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 50.2 m-85 -121.8 94.84 48.16 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.974 -1.121 . . . . 0.02 107.974 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.84 -4.31 11.03 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 120.908 1.072 . . . . 0.02 113.678 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -157.16 153.96 28.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.611 -1.305 . . . . 2.02 108.143 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -59.53 -38.94 82.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.526 -0.734 . . . . 0.02 111.98 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -59.87 -23.95 63.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.107 -0.995 . . . . 0.02 110.475 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -70.59 -18.69 62.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.883 -0.784 . . . . 3.4199999999999999 108.883 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.565 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.7 t90 -108.1 10.59 28.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.528 -1.286 . . . . 0.02 107.528 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 73' ' ' MET . 1.5 mpt? 59.34 22.85 11.26 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.502 0.668 . . . . 0.02 110.456 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.34 144.72 45.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.34 -1.504 . . . . 0.02 109.34 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.9 tp -79.31 -30.52 42.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.026 -1.279 . . . . 0.97999999999999998 107.745 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -157.35 -171.81 3.75 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.475 -1.676 . . . . 0.02 106.475 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.425 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 78.5 m-20 -98.15 28.21 4.16 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.708 -1.245 . . . . 0.02 110.718 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -98.27 123.35 42.31 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.08 -1.013 . . . . 3.2000000000000002 111.598 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 79' ' ' LEU . 53.6 mt -142.64 120.07 11.66 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.26 -1.385 . . . . 2.6099999999999999 107.26 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.67 -18.04 10.55 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 121.208 -0.932 . . . . 0.02 112.392 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.487 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 39.6 t -155.63 156.27 34.72 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-N 119.722 1.761 . . . . 0.02 110.816 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.0 p -145.49 147.63 32.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.553 -0.717 . . . . 0.02 110.178 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.413 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.5 mtp180 -136.88 141.72 42.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.542 -0.724 . . . . 0.01 109.116 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 132.71 37.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.074 -1.016 . . . . 0.42999999999999999 109.254 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -91.35 124.58 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.922 -0.77 . . . . 1.25 108.922 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -91.98 130.9 37.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.817 -1.177 . . . . 1.77 108.402 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mt -96.11 138.84 33.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.92 -1.141 . . . . 1.6299999999999999 107.92 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.0 t -110.41 126.05 53.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.375 -0.828 . . . . 1.0800000000000001 108.774 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.7 t -102.37 -154.79 0.5 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 106.109 -1.812 . . . . 1.26 106.109 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.69 -50.66 0.84 Allowed Glycine 0 N--CA 1.497 2.746 0 O-C-N 120.486 -1.383 . . . . 0.01 111.977 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.18 -99.59 0.13 Allowed Glycine 0 N--CA 1.488 2.154 0 C-N-CA 118.662 -1.732 . . . . 0.01 112.172 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -120.08 119.89 34.66 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.298 -1.119 . . . . 4.4299999999999997 110.707 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.494 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.16 137.95 57.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.835 -0.541 . . . . 2.9900000000000002 109.559 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.408 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 19.7 ttpp -136.88 130.16 31.29 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 120.915 -1.115 . . . . 6.3600000000000003 112.973 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.53 141.79 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.535 -0.757 . . . . 1.0900000000000001 110.35 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 1.3 pt20 -124.69 139.77 53.55 Favored 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 107.666 -1.235 . . . . 2.0499999999999998 107.666 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.49 146.08 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 O-C-N 120.586 -1.321 . . . . 1.1000000000000001 111.123 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -120.48 139.99 52.07 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 122.259 1.028 . . . . 0.72999999999999998 110.855 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -68.08 -32.35 72.62 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.731 -0.668 . . . . 0.02 111.73 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -114.26 167.38 10.75 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.032 -1.042 . . . . 3.1800000000000002 110.347 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.36 163.81 52.72 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.857 -0.897 . . . . 0.01 110.857 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 58.05 38.29 26.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.986 -0.714 . . . . 0.01 111.618 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 14.9 m-85 52.63 54.76 10.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.417 -0.802 . . . . 0.01 111.234 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -128.1 164.87 21.48 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.957 -1.127 . . . . 3.1499999999999999 107.957 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.3 -162.21 29.39 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.146 -1.582 . . . . 0.01 109.146 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -75.93 141.37 42.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.817 -1.402 . . . . 0.01 109.179 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.1 tmm? -116.38 143.13 45.95 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.519 0.676 . . . . 0.01 109.566 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -132.23 135.9 46.62 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.315 -0.994 . . . . 2.48 108.315 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -117.01 134.15 55.11 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.68 -0.638 . . . . 0.01 109.715 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -149.11 148.8 30.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.87 -1.144 . . . . 1.6899999999999999 111.318 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 p -114.88 7.79 15.79 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.1 -0.955 . . . . 0.01 109.829 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -122.26 163.12 20.2 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.614 -0.679 . . . . 3.21 111.227 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.88 155.78 40.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.405 -0.809 . . . . 0.01 109.823 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.494 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 63.3 m -129.55 116.72 18.46 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 109.043 -0.725 . . . . 0.01 109.043 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.83 -30.74 7.16 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.343 1.158 . . . . 0.01 111.49 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.6 m -142.83 108.68 5.15 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.856 0.836 . . . . 0.02 109.195 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 169' ' ' ILE . 94.3 mt -63.98 -39.96 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.873 -0.517 . . . . 1.8300000000000001 111.057 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.7 ttp -66.38 -37.89 86.3 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.198 -1.001 . . . . 1.3400000000000001 109.808 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.77 -38.42 76.71 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.537 -1.352 . . . . 2.1099999999999999 109.696 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.427 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 9.2 tt0 -80.11 -47.64 14.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.91 . . . . 2.0800000000000001 112.415 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.427 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 80.6 m-85 -111.06 -0.41 16.64 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.354 -0.841 . . . . 0.02 112.848 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 m80 59.68 33.61 21.95 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.799 -1.188 . . . . 0.02 109.463 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 mt -112.46 135.35 53.26 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.579 -0.897 . . . . 0.02 108.579 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -92.68 -23.18 19.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -0.901 . . . . 5.3200000000000003 110.557 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -148.93 163.37 37.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.163 -0.96 . . . . 0.02 109.949 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.8 mt -131.56 129.33 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 107.523 -1.288 . . . . 2.1699999999999999 107.523 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -107.11 -13.11 15.25 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.177 -0.952 . . . . 0.02 112.971 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.518 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.88 153.5 29.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.339 -1.476 . . . . 0.01 108.297 178.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.1 t -163.36 145.43 9.82 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.317 -1.49 . . . . 1.22 109.757 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -122.45 112.73 18.42 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.248 1.023 . . . . 1.4099999999999999 109.061 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.63 122.63 63.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 105.924 -1.88 . . . . 0.01 105.924 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 t -146.02 64.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 117.974 -1.491 . . . . 1.98 108.971 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.2 tp10 176.14 108.83 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.641 -1.615 . . . . 0.01 106.641 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.687 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 72.55 -173.1 47.38 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.115 -1.194 . . . . 0.01 110.115 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.25 142.94 42.8 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.318 -1.107 . . . . 2.2999999999999998 109.043 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.494 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 64.0 m95 -129.42 145.17 51.45 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.458 -0.776 . . . . 0.01 109.849 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.9 mt -118.46 142.78 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.892 -1.151 . . . . 1.6899999999999999 107.892 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.84 144.14 43.99 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 107.542 -1.281 . . . . 2.4900000000000002 107.542 177.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.0 m-85 -123.11 145.2 48.77 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.069 -0.715 . . . . 0.02 109.069 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -73.72 -30.06 62.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.628 -0.67 . . . . 0.02 112.043 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.33 153.83 47.51 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 120.644 -1.285 . . . . 1.48 109.031 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.35 166.52 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.236 1.291 . . . . 0.02 112.742 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.721 HD22 ' HE ' ' A' ' 145' ' ' ARG . 23.9 t30 59.23 31.86 21.54 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.185 -0.916 . . . . 0.75 111.063 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.404 ' CE1' ' CG ' ' A' ' 173' ' ' ARG . 2.0 m-85 57.42 52.42 8.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.02 111.294 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.721 ' HE ' HD22 ' A' ' 143' ' ' ASN . 94.4 mtt180 -124.88 163.19 22.76 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.424 -0.797 . . . . 0.02 109.706 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.46 -165.29 32.38 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.835 -1.306 . . . . 0.02 109.835 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -67.99 141.47 56.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.531 -0.982 . . . . 0.02 108.863 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -118.2 148.37 42.44 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.379 -0.6 . . . . 0.02 109.379 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.49 142.76 50.7 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.804 -0.813 . . . . 0.01 108.804 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 151' ' ' LEU . 1.1 tt -98.18 122.26 41.11 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.268 -0.895 . . . . 0.01 109.245 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.591 ' N ' HD23 ' A' ' 150' ' ' LEU . 18.6 mt -105.14 134.21 48.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.435 -0.791 . . . . 0.01 110.141 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 2.6 m-20 -108.35 176.95 4.94 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.504 -0.925 . . . . 2.27 108.504 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.687 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 45.0 mttm -57.73 83.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 1.8400000000000001 108.456 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 55.3 mmtt -136.51 167.7 20.86 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.971 0.891 . . . . 2.2799999999999998 111.659 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -112.92 107.33 15.86 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.7 -1.222 . . . . 0.01 107.7 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.585 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 93.1 m-85 -99.09 115.09 28.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.175 -0.953 . . . . 0.01 110.383 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -93.14 -25.21 17.97 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.263 -0.898 . . . . 0.01 111.356 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -125.87 153.81 73.53 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.047 -1.033 . . . . 2.54 108.701 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.38 -42.04 37.12 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 120.436 0.757 . . . . 0.69999999999999996 110.645 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.04 -20.12 21.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.666 -1.271 . . . . 0.85999999999999999 108.869 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -65.34 -15.83 62.96 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.926 -1.109 . . . . 0.02 109.705 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.585 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 1.7 m0 -96.85 11.22 36.55 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.73 85.26 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.489 -1.338 . . . . 0.02 110.249 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.7 141.79 32.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.3 -1.118 . . . . 0.02 110.243 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.34 -8.7 58.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.718 -0.614 . . . . 0.58999999999999997 109.95 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 t -144.22 150.64 49.27 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.934 -1.104 . . . . 0.87 108.651 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.63 21.21 0.49 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 120.717 0.945 . . . . 0.38 112.484 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.64 121.94 27.48 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.466 1.127 . . . . 0.17999999999999999 111.393 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.401 ' O ' HD12 ' A' ' 117' ' ' ILE . 9.2 mm -143.48 125.66 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 106.048 -1.834 . . . . 3.9900000000000002 106.048 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -110.94 -20.1 12.56 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.983 -1.073 . . . . 5.1699999999999999 112.716 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.7 p -158.46 161.97 37.48 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 119.558 -1.964 . . . . 0.02 110.075 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.494 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 8.9 p90 -152.48 153.13 32.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 2.02 110.278 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.404 ' CG ' ' CE1' ' A' ' 144' ' ' TYR . 7.2 mmm180 -143.0 150.08 39.14 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.63 0.729 . . . . 0.01 110.035 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -87.79 142.71 27.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.538 -0.727 . . . . 0.01 109.319 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.1 mt -92.59 128.03 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.065 -1.022 . . . . 3.04 109.021 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.07 146.39 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.247 -0.908 . . . . 1.8899999999999999 109.546 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 4.8899999999999997 109.402 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.493 -1.443 . . . . 0.01 109.493 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 5.5 ttpm? -152.3 137.61 17.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.18 -1.188 . . . . 0.02 109.978 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.6 139.95 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.302 -0.629 . . . . 0.02 109.302 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -121.04 130.41 53.77 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.484 -0.76 . . . . 0.39000000000000001 110.183 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.8 m-85 -110.63 140.15 45.23 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.603 -0.686 . . . . 0.02 109.498 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.562 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.3 m-85 -122.98 138.7 54.62 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.182 -0.949 . . . . 0.02 109.921 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 41.9 mm-40 -68.54 -28.13 66.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.047 . . . . 0.029999999999999999 111.742 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -114.49 170.01 8.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.917 -1.114 . . . . 0.029999999999999999 110.214 -179.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -75.5 158.54 32.43 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.574 0.702 . . . . 0.029999999999999999 110.051 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.604 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.4 m120 66.06 35.02 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.919 0.866 . . . . 0.73999999999999999 110.88 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.604 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.9 p90 49.93 44.67 25.4 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.502 -0.772 . . . . 0.02 111.47 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -112.26 166.16 11.53 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.005 -1.109 . . . . 0.02 108.005 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.28 -167.81 36.19 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.792 -1.194 . . . . 0.029999999999999999 110.478 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -68.43 142.5 55.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.41 -1.053 . . . . 2.7599999999999998 109.142 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -121.99 149.5 43.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.596 -0.69 . . . . 1.8899999999999999 110.115 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -135.81 132.24 36.43 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.372 -0.603 . . . . 0.02 109.372 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.07 135.83 49.59 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.859 -0.793 . . . . 1.1200000000000001 108.859 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 48.2 t -127.34 138.02 52.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.603 -0.686 . . . . 0.02 109.704 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.485 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 23.4 t0 -119.37 11.31 12.17 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.622 -0.674 . . . . 0.20000000000000001 110.552 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.7 m -158.99 173.51 16.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.791 -1.193 . . . . 1.23 109.002 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.06 146.27 53.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.74 -1.225 . . . . 0.02 110.706 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.548 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 12.2 t -134.52 118.46 17.33 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.018 -0.734 . . . . 0.02 109.018 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.18 -21.44 53.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.814 . . . . 0.23999999999999999 111.682 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -154.51 106.17 2.71 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.876 -1.14 . . . . 1.1399999999999999 109.727 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.548 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.83 8.2 41.41 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.336 -0.853 . . . . 6.3700000000000001 110.105 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -60.45 -28.66 68.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 3.1099999999999999 112.046 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 p -76.22 -17.7 59.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.404 -1.435 . . . . 0.88 111.176 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -106.94 -21.08 13.13 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.309 -0.869 . . . . 0.02 110.268 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -147.32 126.42 12.91 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.217 -0.927 . . . . 3.3199999999999998 108.909 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t -86.65 -11.33 51.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.658 -0.652 . . . . 0.02 110.374 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 33.2 ttt180 -171.47 161.67 6.38 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.057 -1.09 . . . . 0.02 108.057 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -144.15 116.59 8.57 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.764 -1.21 . . . . 0.02 108.886 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 -110.12 0.19 18.21 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.767 -1.208 . . . . 0.029999999999999999 112.132 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.4 t -155.64 153.75 30.54 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.047 -1.094 . . . . 0.02 108.047 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.47 146.81 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.274 1.035 . . . . 0.02 111.049 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -122.86 123.93 42.11 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.535 -1.283 . . . . 0.02 107.535 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.1 t -105.25 113.87 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.777 -1.564 . . . . 0.02 106.777 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -84.66 -35.43 22.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.69 -0.631 . . . . 3.8100000000000001 110.174 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.54 150.96 20.63 Favored Glycine 0 N--CA 1.487 2.086 0 C-N-CA 118.447 -1.835 . . . . 0.02 110.701 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.7 172.06 48.74 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.347 -1.101 . . . . 0.01 110.347 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.9 m -117.55 133.67 55.71 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.552 -1.277 . . . . 1.48 107.552 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -126.29 154.57 43.24 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.724 1.249 . . . . 0.02 112.223 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.3 133.79 52.61 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.337 -2.097 . . . . 0.23999999999999999 105.337 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.92 141.16 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.519 -0.738 . . . . 0.65000000000000002 109.34 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.538 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 27.5 m-85 -120.08 142.62 48.71 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.064 0.935 . . . . 0.02 109.556 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.41 -33.93 77.11 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.526 -0.761 . . . . 0.02 111.855 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -124.85 157.86 64.79 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.92 -1.113 . . . . 0.02 109.58 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.38 166.96 0.96 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.633 1.556 . . . . 0.02 112.824 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 63.28 36.52 11.71 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.258 -0.883 . . . . 0.02 111.084 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.7 m-85 45.31 51.48 9.36 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.71 0.767 . . . . 3.3900000000000001 110.788 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 p -125.94 163.6 22.62 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.287 0.565 . . . . 2.3300000000000001 109.954 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.64 -161.79 31.21 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.788 -1.325 . . . . 0.02 109.788 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -64.57 138.62 58.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.257 . . . . 0.02 110.299 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.538 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 47.5 ttp -119.43 137.01 54.04 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.229 0.538 . . . . 5.0099999999999998 109.635 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.495 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 84.4 m-85 -135.0 140.15 45.43 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.483 -0.761 . . . . 0.02 109.862 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -94.49 130.58 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.773 -0.825 . . . . 1.72 108.773 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.548 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -121.08 111.07 34.16 Favored Pre-proline 0 N--CA 1.506 2.372 0 O-C-N 121.37 -0.832 . . . . 0.02 110.744 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -77.86 169.44 20.63 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 CA-C-N 119.81 0.968 . . . . 1.47 110.557 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -53.6 141.04 26.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.95 -1.094 . . . . 4.25 110.618 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.91 -177.39 32.21 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.447 -1.359 . . . . 0.02 110.834 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -119.41 131.02 55.58 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.516 -0.99 . . . . 0.95999999999999996 109.668 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.548 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 74.9 m-85 -121.54 97.42 46.93 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.814 -1.18 . . . . 0.02 107.814 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -69.93 -3.62 12.5 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 120.76 0.973 . . . . 0.02 113.766 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -157.28 154.17 28.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.523 -1.36 . . . . 2.02 108.043 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -59.83 -38.72 82.85 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.617 -0.677 . . . . 0.02 111.755 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.62 -24.65 65.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -0.967 . . . . 0.02 110.258 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -68.54 -17.9 64.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.276 -0.89 . . . . 3.4199999999999999 109.067 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.562 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.5 11.66 26.68 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.754 -1.202 . . . . 0.02 107.754 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 mtp 60.91 22.2 12.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.491 -0.756 . . . . 0.02 110.313 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.14 144.9 46.79 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.615 -1.394 . . . . 0.02 109.615 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.86 -30.63 40.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.134 -1.215 . . . . 0.97999999999999998 107.843 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -156.96 -171.66 3.74 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.478 -1.675 . . . . 0.02 106.478 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -98.54 28.06 4.42 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.752 -1.218 . . . . 0.02 110.671 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -96.61 122.92 40.06 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.816 -1.178 . . . . 3.2000000000000002 111.229 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.491 HD21 ' CH2' ' A' ' 72' ' ' TRP . 78.8 mt -142.5 119.88 11.62 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.931 -1.137 . . . . 2.6099999999999999 107.931 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.86 -18.37 8.94 Favored Glycine 0 N--CA 1.5 2.911 0 O-C-N 121.193 -0.942 . . . . 0.02 112.627 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.442 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 13.2 t -155.75 156.19 34.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.038 -1.86 . . . . 0.02 111.091 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.1 p -146.04 147.99 32.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.514 -0.741 . . . . 0.02 110.335 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.422 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 47.8 mtm180 -136.97 142.02 42.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.482 -0.761 . . . . 0.01 109.13 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.7 131.97 36.82 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.128 -0.983 . . . . 0.42999999999999999 109.307 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 t -90.66 124.63 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.882 -0.784 . . . . 1.25 108.882 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -92.33 131.35 37.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.893 -1.129 . . . . 1.77 108.583 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -96.4 139.08 33.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.158 -1.053 . . . . 1.6299999999999999 108.158 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.1 t -110.83 126.61 54.83 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 1.0800000000000001 108.906 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 m -103.02 -154.62 0.5 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.207 -1.775 . . . . 1.26 106.207 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.43 -50.68 0.83 Allowed Glycine 0 N--CA 1.498 2.774 0 O-C-N 120.454 -1.404 . . . . 0.01 112.213 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.53 -99.75 0.13 Allowed Glycine 0 N--CA 1.487 2.088 0 C-N-CA 118.79 -1.671 . . . . 0.01 112.076 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -119.99 119.59 33.88 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.142 -1.211 . . . . 4.4299999999999997 110.642 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.405 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.26 135.56 54.62 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.253 -0.579 . . . . 2.9900000000000002 109.541 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.588 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 52.5 tttp -135.33 131.23 36.18 Favored 'General case' 0 N--CA 1.519 2.985 0 CA-C-O 122.136 0.969 . . . . 6.3600000000000003 113.066 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.39 142.78 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.737 0.779 . . . . 1.0900000000000001 110.642 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.495 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.0 pt20 -124.68 139.76 53.56 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 107.581 -1.266 . . . . 2.0499999999999998 107.581 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.33 146.29 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 O-C-N 120.596 -1.315 . . . . 1.1000000000000001 111.182 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 24.9 m-85 -120.42 139.79 52.31 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.97 0.89 . . . . 0.72999999999999998 110.769 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -68.02 -32.49 72.91 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.694 -0.684 . . . . 0.02 112.145 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -114.85 166.24 11.99 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.054 -1.029 . . . . 3.1800000000000002 110.403 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.48 163.58 46.11 Favored Glycine 0 N--CA 1.492 2.382 0 CA-C-O 122.072 0.818 . . . . 0.01 111.243 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.3 m-20 57.15 39.33 29.02 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.636 0.732 . . . . 0.01 111.071 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 52.38 56.39 7.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.555 -0.715 . . . . 0.01 110.971 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -129.5 165.57 21.38 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.02 -1.104 . . . . 3.1499999999999999 108.02 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.3 -162.91 28.6 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.222 -1.551 . . . . 0.01 109.222 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -76.04 142.14 41.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.927 -1.337 . . . . 0.01 108.947 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.54 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.4 ttp -116.64 143.34 45.75 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.626 0.727 . . . . 0.01 109.694 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -131.74 136.22 47.43 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.138 -1.06 . . . . 2.48 108.138 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.588 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 44.7 tt0 -115.89 134.05 55.39 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.695 -0.628 . . . . 0.01 109.62 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.57 148.7 28.99 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.519 1.152 . . . . 1.6899999999999999 111.525 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.8 p -115.24 8.14 15.43 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.863 -1.062 . . . . 0.01 110.295 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -121.97 163.26 19.64 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.359 -0.838 . . . . 3.21 111.308 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.01 155.05 41.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.501 -0.749 . . . . 0.01 109.414 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 32.8 m -128.87 116.93 19.25 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.589 -0.694 . . . . 0.01 109.156 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -74.96 -31.47 6.26 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 CA-C-N 120.386 1.173 . . . . 0.01 111.424 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.0 t -142.65 108.76 5.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.361 -0.837 . . . . 0.02 109.298 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 169' ' ' ILE . 81.9 mt -63.63 -39.51 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.795 -0.565 . . . . 1.8300000000000001 110.731 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.81 -37.77 85.17 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.265 -0.974 . . . . 1.3400000000000001 109.936 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -69.76 -38.65 76.83 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.595 -1.316 . . . . 2.1099999999999999 109.778 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -79.93 -47.4 15.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.228 -0.92 . . . . 2.0800000000000001 112.456 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -111.03 -0.29 16.7 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.396 -0.815 . . . . 0.02 112.662 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.488 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.7 m-70 59.77 33.14 21.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.79 -1.194 . . . . 0.02 109.464 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 mt -112.33 135.59 52.83 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.684 -0.858 . . . . 0.02 108.684 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -91.7 -22.83 20.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 5.3200000000000003 110.473 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -149.44 164.06 36.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.152 -0.968 . . . . 0.02 109.858 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.54 129.27 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 107.289 -1.374 . . . . 2.1699999999999999 107.289 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -107.71 -13.52 15.01 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.243 -0.911 . . . . 0.02 113.184 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -154.5 152.1 29.71 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.47 -1.394 . . . . 0.01 108.19 178.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.6 t -161.52 145.14 12.68 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.286 -1.509 . . . . 1.22 109.849 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -119.56 108.53 14.61 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.155 0.979 . . . . 1.4099999999999999 108.486 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 t -107.5 120.49 58.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 105.797 -1.927 . . . . 0.01 105.797 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.41 68.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 C-N-CA 118.199 -1.401 . . . . 1.98 108.384 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.64 108.18 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.501 -1.666 . . . . 0.01 106.501 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.87 -174.03 43.8 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.899 -1.28 . . . . 0.01 109.899 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.512 ' CG2' HD21 ' A' ' 150' ' ' LEU . 7.5 m -111.69 145.51 39.14 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.335 -1.097 . . . . 2.2999999999999998 109.191 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.405 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 75.3 m95 -130.6 146.27 52.07 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.492 -0.755 . . . . 0.01 110.492 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.6 mt -118.46 142.17 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 107.83 -1.174 . . . . 1.6899999999999999 107.83 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -115.06 144.41 43.68 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 107.647 -1.242 . . . . 2.4900000000000002 107.647 177.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.4 m-85 -122.42 145.08 48.62 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.657 -0.868 . . . . 0.02 108.657 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.29 -29.47 61.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.685 -0.634 . . . . 0.02 112.137 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.24 153.79 47.39 Favored Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 120.703 -1.248 . . . . 1.48 109.216 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.37 166.67 1.64 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.132 1.221 . . . . 0.02 112.47 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.4 m120 59.72 31.15 20.69 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.172 -0.922 . . . . 0.75 111.127 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 57.85 51.47 9.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.576 -0.703 . . . . 0.02 111.083 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -124.83 163.63 21.75 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.496 -0.753 . . . . 0.02 109.908 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.03 -165.51 31.79 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.91 -1.276 . . . . 0.02 109.91 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -67.67 141.66 56.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.435 -1.038 . . . . 0.02 108.846 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -117.98 148.18 42.46 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.375 -0.602 . . . . 0.02 109.375 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.456 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.5 t80 -129.69 143.72 50.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.057 -0.72 . . . . 0.01 109.057 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 150' ' ' LEU . 6.1 tt -98.11 121.46 40.06 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.183 -0.948 . . . . 0.01 109.294 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.554 ' N ' HD23 ' A' ' 150' ' ' LEU . 18.4 mt -105.35 136.43 44.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.01 110.319 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 154' ' ' LYS . 52.4 m-20 -108.19 171.29 7.49 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.702 -0.851 . . . . 2.27 108.702 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -57.69 83.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 1.8400000000000001 108.748 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 152' ' ' ASP . 5.2 tptm -138.08 168.51 19.58 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.166 -0.959 . . . . 2.2799999999999998 111.356 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -110.18 110.6 21.51 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.081 -1.081 . . . . 0.01 108.081 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.616 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 97.2 m-85 -100.44 116.35 32.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.134 -0.979 . . . . 0.01 110.089 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 7.5 ptp180 -92.05 -26.19 18.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.305 -0.872 . . . . 0.01 111.579 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -125.42 155.53 71.63 Favored Pre-proline 0 N--CA 1.504 2.245 0 O-C-N 120.741 -1.225 . . . . 2.54 107.866 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -62.79 -40.58 35.22 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.554 0.836 . . . . 0.69999999999999996 110.473 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.75 -20.3 21.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.823 -1.173 . . . . 0.85999999999999999 108.931 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 161' ' ' ASP . 4.9 m-20 -65.46 -16.02 63.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.953 -1.092 . . . . 0.02 109.804 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.616 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 2.7 m0 -96.72 10.83 37.57 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.164 -1.05 . . . . 0.02 108.164 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.64 12.08 84.73 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.271 -1.442 . . . . 0.02 109.959 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.42 142.01 32.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.467 -1.019 . . . . 0.02 110.159 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.59 -8.4 58.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.747 -0.596 . . . . 0.58999999999999997 110.098 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 25.1 p -144.53 150.67 48.29 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.754 -1.216 . . . . 0.87 108.813 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.1 21.35 0.52 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 120.741 0.961 . . . . 0.38 112.19 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.667 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -82.69 123.98 29.79 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.595 1.188 . . . . 0.17999999999999999 111.57 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 168' ' ' ALA . 10.3 mm -143.63 124.69 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.463 -1.68 . . . . 3.9900000000000002 106.463 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -110.33 -22.02 11.92 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.95 -1.094 . . . . 5.1699999999999999 112.369 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.6 p -157.4 160.17 38.13 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 119.501 -2.0 . . . . 0.02 109.856 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.439 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 23.5 p90 -153.61 155.26 35.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.08 -1.013 . . . . 2.02 110.696 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -145.42 151.95 39.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.239 -0.913 . . . . 0.01 110.62 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 11.8 ptm180 -87.85 143.16 27.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.648 -0.658 . . . . 0.01 109.357 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.1 mt -93.42 128.6 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.071 -1.018 . . . . 3.04 108.882 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.95 146.66 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.314 -0.866 . . . . 1.8899999999999999 109.525 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 4.8899999999999997 109.493 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 110.495 -1.042 . . . . 0.01 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -153.23 138.6 17.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.483 -1.01 . . . . 0.02 109.603 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tt -130.05 140.56 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.186 0.517 . . . . 0.02 109.632 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -121.84 130.25 53.24 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.332 -0.855 . . . . 0.39000000000000001 110.247 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.7 m-85 -111.19 140.39 45.79 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.501 -0.75 . . . . 0.02 109.75 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 2.2 m-85 -122.33 138.54 54.48 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.121 -0.987 . . . . 0.02 109.88 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -69.35 -27.5 65.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.029999999999999999 111.865 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' O ' ' OG ' ' A' ' 38' ' ' SER . 17.2 t70 -113.82 169.43 9.0 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.818 -1.176 . . . . 0.029999999999999999 110.23 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -75.6 158.32 32.61 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.695 0.76 . . . . 0.029999999999999999 110.101 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 66.36 33.31 7.08 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.025 0.917 . . . . 0.73999999999999999 110.956 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 55.23 41.54 31.32 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.023 -0.535 . . . . 0.02 111.273 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -112.37 165.45 12.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.122 -1.066 . . . . 0.02 108.122 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.13 -167.7 34.64 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.888 -1.148 . . . . 0.029999999999999999 110.289 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -69.1 143.65 54.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.328 -1.101 . . . . 2.7599999999999998 109.109 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -120.52 150.05 41.45 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.473 0.654 . . . . 1.8899999999999999 109.719 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -136.36 131.59 34.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.642 -0.661 . . . . 0.02 109.549 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -109.42 134.91 51.27 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.403 -0.811 . . . . 1.1200000000000001 108.907 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.2 t -127.35 137.55 52.81 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.126 -0.694 . . . . 0.02 109.126 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.95 11.87 12.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.583 -0.698 . . . . 0.20000000000000001 110.552 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 p -159.93 173.59 15.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.75 -1.219 . . . . 1.23 109.303 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -63.55 146.41 53.74 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.84 -1.163 . . . . 0.02 110.842 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.43 116.92 16.61 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.922 -0.77 . . . . 0.02 108.922 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.13 -22.23 49.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.206 -0.934 . . . . 0.23999999999999999 111.373 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 28.2 p-10 -149.58 103.18 3.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.194 -1.039 . . . . 1.1399999999999999 108.194 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 51.3 t80 -105.01 3.46 30.61 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.188 0.994 . . . . 6.3700000000000001 110.866 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -61.13 -25.46 67.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 3.1099999999999999 112.232 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 t -77.53 -15.01 59.52 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.366 -1.459 . . . . 0.88 111.342 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -105.31 -20.17 13.58 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.199 -0.938 . . . . 0.02 110.442 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 3.3 tp -151.29 131.84 13.89 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.07 -1.019 . . . . 3.3199999999999998 109.64 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.9 m -86.8 -11.89 49.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.66 -0.65 . . . . 0.02 111.021 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -172.91 162.12 4.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.787 -1.196 . . . . 0.02 108.575 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' HD12 ' A' ' 79' ' ' LEU . 1.8 p -143.29 116.68 9.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.177 -0.952 . . . . 0.02 108.681 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -108.65 -0.64 20.06 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.65 -1.281 . . . . 0.029999999999999999 111.474 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 2.8 p -155.43 153.61 30.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.597 -1.26 . . . . 0.02 107.597 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -147.03 148.56 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.187 -0.946 . . . . 0.02 110.619 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.506 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 60.7 ttt180 -125.41 125.48 43.46 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.94 -1.133 . . . . 0.02 107.94 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 t -105.29 114.79 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.71 -1.589 . . . . 0.02 106.71 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 53.8 mm-40 -84.56 -34.53 23.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.491 -0.756 . . . . 3.8100000000000001 109.991 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.23 151.29 20.44 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 118.451 -1.833 . . . . 0.02 110.807 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.93 171.45 48.26 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.227 -1.149 . . . . 0.01 110.227 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -118.05 133.73 55.64 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.403 -1.332 . . . . 1.48 107.403 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 39.7 m95 -126.96 154.82 44.06 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.622 1.201 . . . . 0.02 112.19 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.17 133.8 52.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.423 -2.066 . . . . 0.23999999999999999 105.423 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.446 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.6 m -115.95 141.3 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.623 -0.673 . . . . 0.65000000000000002 109.227 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -120.43 143.0 48.71 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.999 0.904 . . . . 0.02 109.651 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.22 -34.39 78.26 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.599 -0.728 . . . . 0.02 111.826 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -124.84 158.27 63.27 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 120.893 -1.129 . . . . 0.02 109.36 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.54 166.77 1.12 Allowed 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.724 1.616 . . . . 0.02 112.867 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 63.08 37.31 11.66 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.21 -0.905 . . . . 0.02 111.143 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.435 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.0 m-85 44.9 51.92 8.35 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.664 0.745 . . . . 3.3900000000000001 110.79 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.4 m -125.87 163.5 22.79 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.259 0.552 . . . . 2.3300000000000001 109.898 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.28 -161.72 31.63 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.842 -1.303 . . . . 0.02 109.842 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 13.0 m170 -64.86 138.46 58.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.061 -1.258 . . . . 0.02 110.227 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.2 ptm -119.23 136.84 54.02 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.24 0.543 . . . . 5.0099999999999998 109.567 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.441 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 93.8 m-85 -134.48 139.68 45.66 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.551 -0.718 . . . . 0.02 109.937 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.2 mm -94.43 130.5 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.932 -0.766 . . . . 1.72 108.932 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.559 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.56 110.69 35.31 Favored Pre-proline 0 N--CA 1.505 2.314 0 O-C-N 121.409 -0.807 . . . . 0.02 110.781 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -78.14 169.21 20.68 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 CA-C-N 119.898 0.999 . . . . 1.47 110.531 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -54.77 140.23 36.84 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.92 -1.112 . . . . 4.25 110.716 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.81 -176.97 33.16 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.506 -1.331 . . . . 0.02 110.517 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -119.29 130.7 55.53 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.287 -1.125 . . . . 0.95999999999999996 109.853 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.559 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 83.3 m-85 -121.07 96.98 48.26 Favored Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 107.991 -1.114 . . . . 0.02 107.991 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.17 -4.14 13.04 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.76 0.973 . . . . 0.02 113.621 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -157.45 154.62 29.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.705 -1.247 . . . . 2.02 108.114 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -59.61 -39.05 82.98 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.448 -0.783 . . . . 0.02 111.868 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -59.99 -23.76 63.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.061 -1.025 . . . . 0.02 110.44 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -70.74 -18.55 62.78 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.777 0.798 . . . . 3.4199999999999999 108.918 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.55 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.11 10.18 28.13 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.421 -1.325 . . . . 0.02 107.421 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 mtt 60.83 22.39 12.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.563 -0.711 . . . . 0.02 110.464 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.08 144.76 46.72 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.512 -1.435 . . . . 0.02 109.512 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.493 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 11.9 tp -79.55 -31.08 41.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -1.19 . . . . 0.97999999999999998 107.888 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 75' ' ' LEU . 16.2 m-80 -157.48 -171.93 3.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.553 -1.647 . . . . 0.02 106.553 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.05 28.31 4.06 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.658 -1.276 . . . . 0.02 110.596 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -97.74 122.75 41.21 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.978 -1.076 . . . . 3.2000000000000002 111.201 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 79' ' ' LEU . 56.9 mt -142.09 119.91 11.92 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.444 -1.317 . . . . 2.6099999999999999 107.444 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.79 -18.59 9.9 Favored Glycine 0 N--CA 1.498 2.823 0 O-C-N 121.233 -0.917 . . . . 0.02 112.231 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.435 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 17.2 t -155.68 155.97 34.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.112 -1.817 . . . . 0.02 110.68 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.8 p -145.95 148.1 32.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.446 -0.784 . . . . 0.02 110.254 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.417 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 22.2 mtp180 -137.67 142.35 41.13 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.504 -0.747 . . . . 0.01 109.111 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.14 131.75 36.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.207 -0.933 . . . . 0.42999999999999999 109.478 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -90.49 124.83 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.698 -0.852 . . . . 1.25 108.698 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -91.26 132.25 36.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.969 -1.082 . . . . 1.77 108.319 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mt -99.14 140.47 33.25 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.708 -0.849 . . . . 1.6299999999999999 108.708 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.6 p -111.18 123.5 50.32 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.096 -1.076 . . . . 1.0800000000000001 108.096 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 t -114.8 132.62 56.41 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.766 -1.209 . . . . 1.26 107.806 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.48 -47.9 0.01 OUTLIER Glycine 0 N--CA 1.503 3.124 0 C-N-CA 117.754 -2.165 . . . . 0.01 113.465 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.9 -103.38 0.17 Allowed Glycine 0 N--CA 1.486 2.03 0 CA-C-N 120.005 1.902 . . . . 0.01 110.908 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -118.92 118.12 30.66 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.178 -1.19 . . . . 4.4299999999999997 110.021 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.45 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -65.98 135.02 54.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 120.132 -0.627 . . . . 2.9900000000000002 109.528 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -134.12 130.57 37.57 Favored 'General case' 0 N--CA 1.517 2.905 0 CA-C-O 122.175 0.988 . . . . 6.3600000000000003 113.115 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -130.46 141.23 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 115.51 -0.768 . . . . 1.0900000000000001 110.276 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.467 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 10.9 pt20 -124.09 137.73 54.53 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 107.501 -1.296 . . . . 2.0499999999999998 107.501 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.4 m -123.69 146.6 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.602 0 O-C-N 120.489 -1.382 . . . . 1.1000000000000001 111.406 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.52 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 64.6 m-85 -119.4 139.17 52.45 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.137 0.97 . . . . 0.72999999999999998 110.709 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.37 -32.09 71.93 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 115.853 -0.612 . . . . 0.02 111.797 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -114.78 167.52 10.7 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.964 -1.085 . . . . 3.1800000000000002 110.485 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.27 164.18 52.39 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 111.057 -0.817 . . . . 0.01 111.057 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 t70 57.6 38.36 27.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.968 -0.725 . . . . 0.01 111.479 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.433 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 14.7 m-85 53.09 54.88 9.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.01 111.352 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -129.13 165.02 22.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.253 -1.018 . . . . 3.1499999999999999 108.253 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.15 -163.21 28.97 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.24 -1.544 . . . . 0.01 109.24 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.428 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 55.0 tt0 -75.86 142.95 42.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.925 -1.338 . . . . 0.01 109.314 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.52 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.9 ttp -117.4 143.35 46.09 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.505 0.669 . . . . 0.01 109.754 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.428 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 54.2 m-85 -131.91 136.31 47.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.222 -1.029 . . . . 2.48 108.222 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -116.7 134.65 54.55 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.737 -0.602 . . . . 0.01 109.849 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -149.54 147.87 28.69 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.39 1.091 . . . . 1.6899999999999999 111.272 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.6 p -114.3 7.94 16.58 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.049 -0.978 . . . . 0.01 109.996 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -122.18 163.44 19.54 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.439 -0.788 . . . . 3.21 111.186 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 6.7 p30 -69.19 154.81 41.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.01 109.396 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.403 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 51.2 t -126.64 115.18 22.78 Favored Pre-proline 0 N--CA 1.499 2.025 0 N-CA-C 109.009 -0.737 . . . . 0.01 109.009 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -75.41 -32.41 4.96 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 CA-C-N 120.302 1.143 . . . . 0.01 111.406 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -142.45 107.79 5.02 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.842 0.829 . . . . 0.02 108.995 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.43 -39.43 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.791 -0.568 . . . . 1.8300000000000001 111.061 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.9 ttt -66.78 -37.21 84.13 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.04 -1.064 . . . . 1.3400000000000001 109.873 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -70.16 -38.7 75.5 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.673 -1.267 . . . . 2.1099999999999999 109.871 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -80.14 -47.45 14.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.283 -0.886 . . . . 2.0800000000000001 112.469 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -110.56 -0.42 17.32 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.337 -0.852 . . . . 0.02 112.675 -176.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.2 m-70 59.78 32.64 21.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.836 -1.165 . . . . 0.02 109.504 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.2 135.75 52.47 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 108.756 -0.831 . . . . 0.02 108.756 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -92.11 -22.92 19.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 5.3200000000000003 110.425 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -149.55 163.62 37.35 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.132 -0.98 . . . . 0.02 110.134 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.0 mt -131.76 129.48 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 107.125 -1.435 . . . . 2.1699999999999999 107.125 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.0 -13.07 15.28 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.193 -0.942 . . . . 0.02 113.015 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.433 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -155.82 153.97 30.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.483 -1.386 . . . . 0.01 108.146 177.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 5.0 t -163.07 145.62 10.36 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.181 -1.574 . . . . 1.22 109.683 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -122.29 110.49 15.75 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.423 1.106 . . . . 1.4099999999999999 108.767 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.81 122.86 64.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.127 -1.805 . . . . 0.01 106.127 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t -146.63 69.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 118.051 -1.46 . . . . 1.98 108.405 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.1 108.94 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.862 -1.533 . . . . 0.01 106.862 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.88 -174.63 46.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.003 -1.239 . . . . 0.01 110.003 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.451 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.1 m -111.33 144.98 39.64 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.528 -0.984 . . . . 2.2999999999999998 109.234 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.45 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.2 m95 -131.62 146.84 52.4 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.436 -0.79 . . . . 0.01 110.907 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.4 mt -118.76 141.28 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 107.279 -1.378 . . . . 1.6899999999999999 107.279 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.68 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.6 142.38 46.04 Favored 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 107.549 -1.278 . . . . 2.4900000000000002 107.549 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 16.7 m-85 -122.94 145.14 48.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.452 -0.78 . . . . 0.02 109.213 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -74.69 -29.7 61.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.643 -0.66 . . . . 0.02 112.08 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.29 153.41 47.45 Favored Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 120.639 -1.288 . . . . 1.48 109.074 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -54.24 166.85 1.47 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.315 1.344 . . . . 0.02 112.41 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.606 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER 59.43 31.24 20.92 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.062 -0.972 . . . . 0.75 111.081 178.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.3 m-85 58.1 51.38 8.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.548 -0.72 . . . . 0.02 110.981 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.93 164.01 21.02 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.47 -0.769 . . . . 0.02 109.896 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.37 -165.41 32.57 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.975 -1.25 . . . . 0.02 109.975 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -67.73 141.6 56.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.549 -0.971 . . . . 0.02 108.78 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.461 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 3.1 mp0 -118.52 148.46 42.61 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.219 0.533 . . . . 0.02 109.606 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.95 142.19 51.32 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.61 -0.885 . . . . 0.01 108.61 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 151' ' ' LEU . 4.9 tt -96.28 119.79 35.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.117 -0.99 . . . . 0.01 108.678 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.779 HD13 ' CZ2' ' A' ' 162' ' ' TRP . 1.8 mt -104.29 135.23 46.14 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.527 -0.733 . . . . 0.01 109.985 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 154' ' ' LYS . 1.9 m-20 -110.91 172.8 6.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.356 -0.84 . . . . 2.27 108.867 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -55.04 85.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.161 -0.962 . . . . 1.8400000000000001 108.635 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 152' ' ' ASP . 19.5 mmtp -137.16 166.48 23.62 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 2.2799999999999998 111.594 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 6.6 mp0 -112.35 107.47 16.31 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.51 -1.293 . . . . 0.01 107.51 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.625 ' CE2' ' NE1' ' A' ' 162' ' ' TRP . 94.2 m-85 -99.54 113.42 25.81 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.0 -1.063 . . . . 0.01 110.581 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -91.62 -28.18 17.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.329 -0.857 . . . . 0.01 111.392 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 158' ' ' LYS . 8.0 mtmp? -126.46 151.42 72.71 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 120.819 -1.175 . . . . 2.54 108.384 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -58.62 -45.62 28.69 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.352 0.804 . . . . 0.69999999999999996 111.346 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 160' ' ' VAL . 11.3 t -61.21 -22.56 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.726 -1.234 . . . . 0.85999999999999999 109.696 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -65.57 -15.69 62.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.723 -1.236 . . . . 0.02 109.928 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.779 ' CZ2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -97.46 11.36 37.02 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.618 -0.882 . . . . 0.02 108.618 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.95 9.27 87.05 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.555 -1.307 . . . . 0.02 110.421 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.2 142.34 30.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.396 -1.061 . . . . 0.02 110.075 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.36 -9.69 57.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.752 -0.592 . . . . 0.58999999999999997 110.168 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 42.1 m -146.08 150.76 43.0 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 120.648 -1.283 . . . . 0.87 108.928 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.59 21.74 0.55 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.903 1.069 . . . . 0.38 112.397 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.93 125.56 31.52 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.556 1.169 . . . . 0.17999999999999999 112.063 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.68 HG23 ' CD1' ' A' ' 138' ' ' PHE . 22.0 mt -145.94 125.74 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.778 -1.564 . . . . 3.9900000000000002 106.778 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -112.16 -21.78 11.3 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.969 -1.082 . . . . 5.1699999999999999 112.823 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 p -157.16 159.9 38.23 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.427 -2.046 . . . . 0.02 109.749 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.403 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.1 p90 -152.63 154.2 34.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.93 -1.106 . . . . 2.02 110.71 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 25.0 mtp180 -144.17 150.9 38.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.381 -0.824 . . . . 0.01 110.29 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.4 ' H ' ' HG2' ' A' ' 174' ' ' ARG . 33.5 ptt180 -88.07 142.36 27.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.726 . . . . 0.01 109.313 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.73 128.5 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.106 -0.996 . . . . 3.04 109.051 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.9 t -136.39 146.87 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.152 -0.967 . . . . 1.8899999999999999 109.676 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 4.8899999999999997 109.417 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.441 -1.064 . . . . 0.01 110.441 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -152.65 139.12 18.6 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.365 -1.079 . . . . 0.02 109.887 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 tt -130.63 139.6 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.691 -0.631 . . . . 0.02 109.412 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -121.28 130.31 53.59 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.545 -0.722 . . . . 0.39000000000000001 109.938 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.5 m-85 -110.49 139.65 45.52 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.652 -0.655 . . . . 0.02 109.578 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.9 m-85 -121.41 137.88 54.51 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.237 -0.914 . . . . 0.02 109.531 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.56 -27.42 65.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.843 -1.16 . . . . 0.029999999999999999 111.731 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -113.78 169.73 8.77 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.821 -1.174 . . . . 0.029999999999999999 110.114 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -75.7 158.06 32.81 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.63 0.729 . . . . 0.029999999999999999 110.13 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 1.1 m120 66.44 33.34 6.91 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.96 0.886 . . . . 0.73999999999999999 111.046 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.411 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.69 41.66 30.19 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.271 0.557 . . . . 0.02 111.259 177.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -113.31 165.51 12.36 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.376 -0.972 . . . . 0.02 108.376 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.25 -167.62 34.39 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.898 -1.144 . . . . 0.029999999999999999 110.554 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -69.02 142.68 54.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.46 -1.023 . . . . 2.7599999999999998 108.941 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -122.53 150.24 42.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.587 -0.695 . . . . 1.8899999999999999 110.079 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -136.43 133.08 36.26 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.131 -0.692 . . . . 0.02 109.131 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -109.45 135.79 49.9 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.507 -0.923 . . . . 1.1200000000000001 108.507 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.6 t -127.82 138.04 52.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.635 -0.665 . . . . 0.02 109.348 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -118.45 12.32 13.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.654 -0.654 . . . . 0.20000000000000001 110.128 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.6 t -159.81 173.77 15.48 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.888 -1.133 . . . . 1.23 109.164 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -62.79 146.09 53.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.807 -1.183 . . . . 0.02 110.708 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.1 m -133.36 117.33 17.16 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.84 -0.8 . . . . 0.02 108.84 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.79 -20.91 48.66 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.271 -0.893 . . . . 0.23999999999999999 111.758 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -151.82 105.36 3.11 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.804 -1.185 . . . . 1.1399999999999999 109.342 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.15 5.82 42.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.402 -0.811 . . . . 6.3700000000000001 110.291 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -62.75 -29.36 70.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.373 -0.83 . . . . 3.1099999999999999 112.708 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.6 p -77.49 -18.66 56.87 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.198 -1.564 . . . . 0.88 111.605 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -107.33 -19.29 13.63 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.315 -0.866 . . . . 0.02 110.089 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -148.94 127.08 12.04 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.046 . . . . 3.3199999999999998 109.258 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 p -87.72 -12.45 45.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.453 -0.779 . . . . 0.02 111.389 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -171.49 160.84 6.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.793 -1.192 . . . . 0.02 108.446 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.78 116.35 8.64 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.031 -1.043 . . . . 0.02 108.97 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 -109.83 0.49 18.78 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.856 -1.153 . . . . 0.029999999999999999 111.987 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 t -156.2 154.45 30.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.325 -0.991 . . . . 0.02 108.325 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mt -146.57 146.95 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.02 -1.05 . . . . 0.02 111.001 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -122.84 124.07 42.45 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.487 -1.301 . . . . 0.02 107.487 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.35 114.15 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.774 -1.565 . . . . 0.02 106.774 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -84.16 -34.05 24.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.574 -0.704 . . . . 3.8100000000000001 110.552 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.22 150.74 19.87 Favored Glycine 0 N--CA 1.484 1.897 0 C-N-CA 118.977 -1.583 . . . . 0.02 110.775 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.4 172.22 48.81 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 119.988 -1.101 . . . . 0.01 110.488 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -118.16 134.47 54.98 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.631 -1.248 . . . . 1.48 107.631 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -127.29 154.52 44.81 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 122.508 1.147 . . . . 0.02 112.112 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.38 134.45 51.81 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 105.625 -1.991 . . . . 0.23999999999999999 105.625 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.94 142.1 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -0.762 . . . . 0.65000000000000002 109.316 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -121.08 143.61 48.99 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.032 0.92 . . . . 0.02 109.688 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.432 ' OE1' ' CD2' ' A' ' 57' ' ' HIS . 43.5 tt0 -65.13 -34.04 77.46 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.604 -0.725 . . . . 0.02 111.791 -177.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -124.43 157.78 63.8 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 121.001 -1.062 . . . . 0.02 109.51 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.38 166.87 0.99 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.613 1.542 . . . . 0.02 112.814 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 63.65 36.73 10.64 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.243 -0.89 . . . . 0.02 111.039 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 45.03 51.46 8.8 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.667 0.746 . . . . 3.3900000000000001 110.617 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.7 m -125.9 163.65 22.49 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.184 0.516 . . . . 2.3300000000000001 109.898 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.65 -161.95 31.32 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.821 -1.311 . . . . 0.02 109.821 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.432 ' CD2' ' OE1' ' A' ' 50' ' ' GLU . 13.4 m-70 -64.9 138.78 58.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.999 -1.295 . . . . 0.02 110.103 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.498 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.7 ppp? -119.89 137.6 53.92 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.773 -0.579 . . . . 5.0099999999999998 109.817 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.559 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 85.4 m-85 -134.87 140.19 45.6 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.408 -0.808 . . . . 0.02 109.944 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mm -95.18 130.72 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.972 -0.751 . . . . 1.72 108.972 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.4 mt -121.86 111.66 32.52 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.374 -0.829 . . . . 0.02 110.802 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.67 170.35 19.29 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 119.859 0.985 . . . . 1.47 110.329 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -52.59 141.01 21.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.904 -1.123 . . . . 4.25 110.357 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.19 -177.54 32.35 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.41 -1.376 . . . . 0.02 110.785 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -120.1 131.33 55.02 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.408 -1.054 . . . . 0.95999999999999996 109.878 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -122.21 94.79 47.74 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.931 -1.137 . . . . 0.02 107.931 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.88 -3.98 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.078 1.185 . . . . 0.02 113.855 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -157.58 154.55 28.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.608 -1.308 . . . . 2.02 108.213 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -59.49 -39.35 83.46 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.409 -0.807 . . . . 0.02 111.935 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -60.04 -24.02 64.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.081 -1.012 . . . . 0.02 110.573 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -70.37 -18.32 63.05 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.936 0.874 . . . . 3.4199999999999999 108.828 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.559 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.1 t90 -107.49 11.17 29.06 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.324 -1.362 . . . . 0.02 107.324 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.1 mmt 60.41 22.28 11.87 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.51 0.671 . . . . 0.02 110.286 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.49 144.26 45.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.505 -1.438 . . . . 0.02 109.505 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.5 tp -79.13 -30.18 43.57 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.699 -1.223 . . . . 0.97999999999999998 107.699 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.415 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 15.0 t-20 -157.2 -171.9 3.8 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.47 -1.678 . . . . 0.02 106.47 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.415 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 84.4 m-20 -98.81 28.21 4.45 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.789 -1.195 . . . . 0.02 110.639 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -96.52 123.05 40.06 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.971 -1.081 . . . . 3.2000000000000002 111.1 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.541 HD21 ' CH2' ' A' ' 72' ' ' TRP . 81.2 mt -141.57 119.28 11.76 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.772 -1.196 . . . . 2.6099999999999999 107.772 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.51 -18.94 9.14 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 121.144 -0.973 . . . . 0.02 112.389 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 p -156.08 156.2 33.93 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 119.738 1.769 . . . . 0.02 110.793 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.78 147.95 32.43 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.471 -0.768 . . . . 0.02 110.327 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -137.38 142.16 41.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.423 -0.798 . . . . 0.01 109.267 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.29 132.46 36.47 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.145 -0.972 . . . . 0.42999999999999999 109.583 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.16 124.89 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.806 -0.813 . . . . 1.25 108.806 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 86' ' ' HIS . 1.6 m80 -91.11 132.81 35.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.919 -1.113 . . . . 1.77 108.424 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 mt -99.36 139.61 34.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.838 -0.801 . . . . 1.6299999999999999 108.838 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.6 t -110.85 123.79 50.79 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.969 -1.123 . . . . 1.0800000000000001 107.969 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.9 p -114.79 132.1 56.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.654 -1.279 . . . . 1.26 107.689 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.76 -48.97 0.01 OUTLIER Glycine 0 N--CA 1.503 3.129 0 C-N-CA 117.652 -2.214 . . . . 0.01 113.299 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.17 -103.93 0.17 Allowed Glycine 0 N--CA 1.488 2.105 0 CA-C-N 119.82 1.81 . . . . 0.01 110.963 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -118.99 118.41 31.41 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.244 -1.15 . . . . 4.4299999999999997 110.184 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.453 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -65.87 135.07 54.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.811 -0.556 . . . . 2.9900000000000002 109.527 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -133.68 129.97 37.54 Favored 'General case' 0 N--CA 1.519 2.994 0 CA-C-O 122.187 0.994 . . . . 6.3600000000000003 113.055 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -131.84 141.46 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 115.505 -0.77 . . . . 1.0900000000000001 110.248 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.438 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.3 pt20 -124.41 139.53 53.81 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 107.399 -1.334 . . . . 2.0499999999999998 107.399 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.76 145.84 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 120.657 -1.277 . . . . 1.1000000000000001 110.917 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -120.42 139.67 52.48 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.084 0.945 . . . . 0.72999999999999998 110.929 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -68.31 -32.24 72.24 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.712 -0.676 . . . . 0.02 111.895 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -114.68 167.7 10.53 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.976 -1.077 . . . . 3.1800000000000002 110.181 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.36 163.7 52.79 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.741 -0.943 . . . . 0.01 110.741 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 58.12 37.79 26.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.821 -0.811 . . . . 0.01 111.604 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.527 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 28.6 m-85 53.33 54.69 9.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.01 111.253 177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -128.15 164.3 22.78 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.079 -1.082 . . . . 3.1499999999999999 108.079 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.32 -162.4 29.49 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.913 -1.675 . . . . 0.01 108.913 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -75.82 141.67 42.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.958 -1.319 . . . . 0.01 109.28 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.1 tmm? -116.54 143.23 45.86 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.518 0.675 . . . . 0.01 109.304 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -132.48 136.36 46.64 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.337 -0.986 . . . . 2.48 108.337 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -116.38 134.23 55.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.704 -0.622 . . . . 0.01 109.814 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.9 t -149.35 147.57 28.48 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.901 -1.125 . . . . 1.6899999999999999 111.336 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.9 p -115.03 7.61 15.54 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.996 -1.002 . . . . 0.01 110.19 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -121.77 163.22 19.47 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.411 -0.806 . . . . 3.21 111.109 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -69.44 154.78 41.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.351 -0.843 . . . . 0.01 109.491 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.608 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 20.5 p -126.53 119.77 23.11 Favored Pre-proline 0 N--CA 1.502 2.126 0 N-CA-C 109.22 -0.659 . . . . 0.01 109.22 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -77.01 -33.11 2.88 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 120.341 1.158 . . . . 0.01 110.638 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 t -143.24 108.8 5.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.438 -0.789 . . . . 0.02 109.103 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.99 -39.31 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.731 -0.606 . . . . 1.8300000000000001 110.823 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.7 ttp -67.18 -36.74 82.43 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.174 -1.01 . . . . 1.3400000000000001 109.881 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.95 -38.79 76.23 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.575 -1.328 . . . . 2.1099999999999999 109.668 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.415 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 8.3 tt0 -80.34 -46.6 15.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.345 -0.847 . . . . 2.0800000000000001 112.509 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.415 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 53.1 m-85 -110.29 -0.45 17.7 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.281 -0.887 . . . . 0.02 112.623 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.7 m80 59.65 33.01 21.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.738 -1.226 . . . . 0.02 109.495 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.0 mt -112.45 135.71 52.83 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 108.71 -0.848 . . . . 0.02 108.71 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -92.4 -22.9 19.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 5.3200000000000003 110.581 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -149.02 163.33 37.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.184 -0.948 . . . . 0.02 109.947 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.6 mt -131.75 129.19 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.452 -1.314 . . . . 2.1699999999999999 107.452 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -106.81 -13.4 15.26 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.2 -0.938 . . . . 0.02 113.172 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.32 153.58 30.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.333 -1.479 . . . . 0.01 108.186 178.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 8.6 t -160.52 147.01 15.42 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.318 -1.489 . . . . 1.22 109.904 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -121.79 108.28 13.31 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.029 0.919 . . . . 1.4099999999999999 108.623 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.15 121.06 60.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.068 -1.827 . . . . 0.01 106.068 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t -146.83 69.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 118.182 -1.407 . . . . 1.98 108.42 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.66 109.04 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.634 -1.617 . . . . 0.01 106.634 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.35 -174.1 45.2 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.819 -1.312 . . . . 0.01 109.819 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.458 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.5 m -111.4 143.62 41.93 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.526 -0.984 . . . . 2.2999999999999998 109.147 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.453 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 72.5 m95 -129.92 144.97 51.6 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.403 -0.811 . . . . 0.01 110.481 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.7 mt -117.61 141.36 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.504 -1.295 . . . . 1.6899999999999999 107.504 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.31 143.55 44.69 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 107.528 -1.286 . . . . 2.4900000000000002 107.528 177.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.512 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 9.4 m-85 -122.46 144.88 48.78 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.903 -0.777 . . . . 0.02 108.903 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -74.33 -29.82 61.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.729 -0.607 . . . . 0.02 112.119 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.56 153.54 47.78 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 120.805 -1.184 . . . . 1.48 109.083 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.23 166.86 1.46 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.232 1.288 . . . . 0.02 112.7 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 59.54 30.9 20.58 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.235 -0.893 . . . . 0.75 111.029 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.77 51.57 9.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.574 -0.704 . . . . 0.02 110.924 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -124.58 163.66 21.47 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.55 -0.719 . . . . 0.02 109.732 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.52 -165.17 32.22 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.843 -1.303 . . . . 0.02 109.843 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -67.92 141.77 56.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.607 -0.937 . . . . 0.02 108.921 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -118.26 149.03 41.81 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.155 -0.683 . . . . 0.02 109.155 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -129.5 142.54 50.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.486 -0.759 . . . . 0.01 109.049 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.557 HD23 ' C ' ' A' ' 150' ' ' LEU . 5.8 tt -96.96 121.45 38.85 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.217 -0.927 . . . . 0.01 109.079 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.644 HD22 ' NE1' ' A' ' 162' ' ' TRP . 18.8 mt -105.8 135.32 47.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.545 -0.722 . . . . 0.01 110.71 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 154' ' ' LYS . 29.4 t70 -108.68 172.71 6.68 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.015 -1.106 . . . . 2.27 108.015 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -57.08 85.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.964 -1.085 . . . . 1.8400000000000001 108.483 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 152' ' ' ASP . 52.2 tttp -135.79 167.04 21.9 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.303 1.049 . . . . 2.2799999999999998 111.428 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.414 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 29.5 mt-10 -110.92 108.29 18.02 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.209 -1.034 . . . . 0.01 108.209 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.83 114.36 26.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.063 -1.023 . . . . 0.01 110.272 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -91.46 -27.12 18.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.101 -0.999 . . . . 0.01 111.506 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -125.82 153.77 73.39 Favored Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.027 -1.046 . . . . 2.54 108.692 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.58 -42.91 36.25 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 CA-C-N 119.171 0.74 . . . . 0.69999999999999996 110.745 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.9 t -60.63 -20.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.648 -1.282 . . . . 0.85999999999999999 108.642 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -65.44 -15.96 63.16 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.908 -1.12 . . . . 0.02 109.432 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.644 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -95.17 9.76 38.45 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.939 -1.134 . . . . 0.02 107.939 178.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.87 10.48 86.1 Favored Glycine 0 N--CA 1.485 1.963 0 C-N-CA 119.3 -1.429 . . . . 0.02 109.813 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.41 142.23 31.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.547 -0.972 . . . . 0.02 110.164 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.63 -8.37 58.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.682 -0.636 . . . . 0.58999999999999997 109.783 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 t -144.66 150.71 47.94 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.758 -1.214 . . . . 0.87 108.696 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.84 21.54 0.5 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 120.735 0.957 . . . . 0.38 112.322 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.15 123.76 29.85 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.508 1.147 . . . . 0.17999999999999999 111.649 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.6 mt -146.4 126.77 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.663 -1.606 . . . . 3.9900000000000002 106.663 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -112.45 -20.15 11.88 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.04 -1.038 . . . . 5.1699999999999999 112.982 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 11.9 p -157.69 160.83 38.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 119.353 -2.092 . . . . 0.02 110.19 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.608 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 5.2 p90 -152.46 154.28 35.22 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.149 -0.969 . . . . 2.02 110.784 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -144.79 151.85 39.45 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.105 -0.997 . . . . 0.01 110.708 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -88.21 143.75 26.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.68 -0.638 . . . . 0.01 109.33 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.17 129.26 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.137 -0.977 . . . . 3.04 109.083 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.5 t -136.14 146.57 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.269 -0.895 . . . . 1.8899999999999999 109.62 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.295 -0.878 . . . . 4.8899999999999997 109.434 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 110.406 -1.078 . . . . 0.01 110.406 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -152.57 138.56 18.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.421 -1.047 . . . . 0.02 109.879 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.05 139.24 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.215 -0.661 . . . . 0.02 109.215 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -121.85 130.94 53.77 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.459 -0.776 . . . . 0.39000000000000001 109.861 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 m-85 -110.89 140.41 45.39 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.656 -0.653 . . . . 0.02 109.633 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 4.8 m-85 -122.07 138.41 54.45 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.317 -0.865 . . . . 0.02 109.402 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -69.27 -27.43 65.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.144 . . . . 0.029999999999999999 111.869 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -114.08 169.97 8.62 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.852 -1.155 . . . . 0.029999999999999999 110.257 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -75.41 158.48 32.64 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.535 0.684 . . . . 0.029999999999999999 109.986 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.1 t30 65.7 35.05 7.14 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.891 0.853 . . . . 0.73999999999999999 110.75 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.4 p90 50.03 44.78 25.7 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.681 0.753 . . . . 0.02 111.342 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -112.16 165.73 11.89 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.986 -1.116 . . . . 0.02 107.986 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.21 -167.74 34.57 Favored Glycine 0 N--CA 1.494 2.567 0 C-N-CA 119.87 -1.157 . . . . 0.029999999999999999 110.559 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -68.95 143.18 54.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -1.108 . . . . 2.7599999999999998 108.861 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.515 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 50.1 ttt180 -122.19 149.26 43.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.564 -0.71 . . . . 1.8899999999999999 110.225 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -135.91 132.2 36.18 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.18 -0.674 . . . . 0.02 109.18 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -109.65 136.57 48.81 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.396 -0.815 . . . . 1.1200000000000001 108.928 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 t -128.03 137.85 52.35 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.553 -0.717 . . . . 0.02 109.593 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.39 11.85 13.15 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.661 -0.649 . . . . 0.20000000000000001 110.139 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 36.7 t -159.53 174.15 15.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.896 -1.128 . . . . 1.23 108.913 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.404 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -62.85 145.86 54.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.63 -1.294 . . . . 0.02 110.599 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.519 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 12.7 p -134.93 119.36 17.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.5 -0.75 . . . . 0.02 109.152 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.0 -21.08 47.53 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.289 -0.882 . . . . 0.23999999999999999 112.376 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -152.41 107.02 3.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.67 -1.269 . . . . 1.1399999999999999 110.14 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.48 5.95 39.79 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.375 -0.828 . . . . 6.3700000000000001 110.442 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -61.42 -30.25 70.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 3.1099999999999999 112.186 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.7 t -76.94 -17.31 58.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.389 -1.444 . . . . 0.88 111.124 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -106.99 -20.84 13.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.403 -0.811 . . . . 0.02 110.755 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.07 127.2 12.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.979 -1.076 . . . . 3.3199999999999998 109.663 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 t -87.01 -12.39 47.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.57 -0.706 . . . . 0.02 111.032 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -172.8 161.72 4.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.781 -1.199 . . . . 0.02 108.467 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.445 ' SG ' HD12 ' A' ' 79' ' ' LEU . 3.4 p -143.49 116.55 8.9 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.1 -1.0 . . . . 0.02 108.876 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -108.28 -0.04 21.04 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.813 -1.179 . . . . 0.029999999999999999 111.287 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 t -156.46 154.34 30.26 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.965 -1.124 . . . . 0.02 107.965 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 39' ' ' ILE . 9.0 mt -146.96 148.13 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.057 -1.027 . . . . 0.02 110.554 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -123.54 124.81 43.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.2 -1.037 . . . . 0.02 108.2 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.66 114.31 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 106.768 -1.567 . . . . 0.02 106.768 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -83.99 -34.1 24.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.717 -0.614 . . . . 3.8100000000000001 110.629 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.54 151.19 20.58 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.019 -1.563 . . . . 0.02 110.688 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.09 172.41 49.12 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.934 -1.127 . . . . 0.01 110.496 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -118.15 133.98 55.42 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.548 -1.278 . . . . 1.48 107.548 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -126.36 154.74 43.13 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.685 -1.26 . . . . 0.02 112.196 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.61 133.93 52.53 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.543 -2.021 . . . . 0.23999999999999999 105.543 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.465 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.5 m -116.86 142.6 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.565 -0.709 . . . . 0.65000000000000002 109.451 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -120.7 142.74 49.21 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.053 0.93 . . . . 0.02 109.596 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.433 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 38.0 tt0 -65.11 -33.54 76.27 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.593 -0.73 . . . . 0.02 111.786 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -124.45 157.71 64.1 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 120.988 -1.07 . . . . 0.02 109.444 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.23 166.63 0.99 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.61 1.54 . . . . 0.02 112.71 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m120 63.44 36.42 11.39 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 115.355 -0.839 . . . . 0.02 111.016 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.527 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.3 m-85 45.37 51.41 9.53 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.528 0.68 . . . . 3.3900000000000001 110.742 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 p -125.75 163.7 22.27 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.27 0.557 . . . . 2.3300000000000001 109.948 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.46 -161.54 31.26 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.882 -1.287 . . . . 0.02 109.882 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 13.8 m80 -64.25 138.79 58.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.045 -1.268 . . . . 0.02 110.161 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 58' ' ' MET . 3.1 ppp? -119.09 137.17 53.75 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.397 0.618 . . . . 5.0099999999999998 109.65 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 88.3 m-85 -135.27 139.29 44.29 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.419 -0.801 . . . . 0.02 109.765 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 mm -96.25 131.03 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.715 -0.846 . . . . 1.72 108.715 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.478 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.9 mt -121.69 111.9 32.67 Favored Pre-proline 0 N--CA 1.505 2.305 0 O-C-N 121.344 -0.848 . . . . 0.02 110.757 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.46 170.1 19.93 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 119.892 0.997 . . . . 1.47 110.325 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -52.63 141.09 21.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.991 -1.068 . . . . 4.25 110.42 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.71 -177.9 31.76 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.437 -1.363 . . . . 0.02 110.782 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -120.04 131.57 55.16 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.401 -1.058 . . . . 0.95999999999999996 109.659 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CE1' HD22 ' A' ' 61' ' ' LEU . 92.6 m-85 -121.32 97.95 47.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.941 -1.133 . . . . 0.02 107.941 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -70.17 -3.88 13.18 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.678 0.919 . . . . 0.02 113.6 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -157.39 154.2 28.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.549 -1.344 . . . . 2.02 107.989 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -59.83 -38.49 82.2 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.432 -0.792 . . . . 0.02 111.872 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -59.71 -24.38 63.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.051 . . . . 0.02 110.433 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -70.22 -18.81 63.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.863 0.84 . . . . 3.4199999999999999 108.978 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.55 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.6 t90 -108.25 10.08 27.87 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.493 -1.299 . . . . 0.02 107.493 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.3 mtm 60.84 21.84 11.95 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.484 0.659 . . . . 0.02 110.535 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.61 144.3 46.06 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.388 -1.485 . . . . 0.02 109.388 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 mt -78.84 -30.57 45.27 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.687 -1.227 . . . . 0.97999999999999998 107.687 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -157.32 -171.31 3.56 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.335 -1.728 . . . . 0.02 106.335 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -98.32 29.06 3.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.639 -1.288 . . . . 0.02 110.595 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -97.94 122.65 41.31 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.899 -1.126 . . . . 3.2000000000000002 111.448 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.465 HD22 ' HB ' ' A' ' 48' ' ' VAL . 57.1 mt -142.76 119.78 11.36 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.45 -1.315 . . . . 2.6099999999999999 107.45 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.94 -17.89 10.53 Favored Glycine 0 N--CA 1.497 2.762 0 O-C-N 121.296 -0.878 . . . . 0.02 112.25 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 31.2 t -155.17 155.83 34.64 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.189 -1.771 . . . . 0.02 110.856 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 47.8 t -145.42 148.17 33.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.463 -0.773 . . . . 0.02 110.233 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -137.52 141.67 41.44 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.482 -0.761 . . . . 0.01 109.038 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.06 133.73 36.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.42999999999999999 109.405 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 t -91.92 124.58 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.98 -0.748 . . . . 1.25 108.98 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -92.75 131.96 37.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.958 -1.089 . . . . 1.77 108.507 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.15 138.8 33.23 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.134 -1.061 . . . . 1.6299999999999999 108.134 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 t -110.84 126.67 54.9 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.758 -0.83 . . . . 1.0800000000000001 108.758 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.4 m -103.22 -154.49 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.23 -1.767 . . . . 1.26 106.23 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.06 -50.55 0.84 Allowed Glycine 0 N--CA 1.497 2.723 0 O-C-N 120.527 -1.358 . . . . 0.01 112.09 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.67 -100.2 0.14 Allowed Glycine 0 N--CA 1.487 2.076 0 C-N-CA 118.76 -1.686 . . . . 0.01 111.995 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -120.03 119.73 34.23 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.164 -1.198 . . . . 4.4299999999999997 110.523 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.455 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.44 136.45 55.74 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.177 -0.609 . . . . 2.9900000000000002 109.463 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -134.7 130.57 36.49 Favored 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 122.163 0.982 . . . . 6.3600000000000003 112.942 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -132.08 142.07 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.675 0.75 . . . . 1.0900000000000001 110.532 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.425 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.9 pt20 -124.82 139.83 53.48 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 107.686 -1.228 . . . . 2.0499999999999998 107.686 176.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -124.07 145.71 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.495 0 O-C-N 120.607 -1.308 . . . . 1.1000000000000001 111.121 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -120.47 140.17 51.8 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 122.081 0.943 . . . . 0.72999999999999998 110.852 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -68.66 -32.58 72.51 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.652 -0.704 . . . . 0.02 111.929 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -114.57 165.47 12.73 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.978 -1.076 . . . . 3.1800000000000002 110.228 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 163.39 45.42 Favored Glycine 0 N--CA 1.494 2.532 0 CA-C-O 122.022 0.79 . . . . 0.01 111.264 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 t70 57.01 39.4 29.37 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.595 0.712 . . . . 0.01 111.1 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 52.15 56.2 8.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.509 -0.744 . . . . 0.01 111.03 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -129.23 165.03 22.17 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.839 -1.171 . . . . 3.1499999999999999 107.839 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.07 -162.78 28.8 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 108.963 -1.655 . . . . 0.01 108.963 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -75.33 141.24 43.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.775 -1.426 . . . . 0.01 109.001 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 11.1 tmm? -116.3 143.37 45.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.604 0.716 . . . . 0.01 109.526 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -132.41 136.65 46.92 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.309 -0.997 . . . . 2.48 108.309 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -116.21 134.42 54.94 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.632 -0.668 . . . . 0.01 109.635 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -149.68 148.08 28.85 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.532 1.158 . . . . 1.6899999999999999 111.437 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 p -115.09 7.88 15.55 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.936 -1.029 . . . . 0.01 109.985 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -122.16 163.26 19.85 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.437 -0.79 . . . . 3.21 111.236 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.55 154.31 42.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.01 109.471 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.429 ' O ' ' OG ' ' A' ' 171' ' ' SER . 44.2 t -127.07 115.99 21.9 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 109.096 -0.705 . . . . 0.01 109.096 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.45 -32.95 4.51 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.324 1.151 . . . . 0.01 111.604 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.7 m -142.07 108.59 5.32 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.379 -0.826 . . . . 0.02 109.237 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 169' ' ' ILE . 95.9 mt -64.37 -40.02 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.787 -0.571 . . . . 1.8300000000000001 111.019 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.0 ttp -66.76 -37.6 84.94 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.021 -1.071 . . . . 1.3400000000000001 109.76 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -69.81 -38.53 76.62 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.538 -1.351 . . . . 2.1099999999999999 109.817 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.526 ' OE1' ' CG ' ' A' ' 121' ' ' PHE . 7.9 tm0? -80.49 -47.61 14.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.281 -0.887 . . . . 2.0800000000000001 112.282 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.526 ' CG ' ' OE1' ' A' ' 120' ' ' GLN . 92.1 m-85 -110.72 -0.85 16.93 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.389 -0.819 . . . . 0.02 112.748 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.9 m80 60.1 33.24 21.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.748 -1.22 . . . . 0.02 109.483 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 mt -112.42 135.67 52.84 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.802 -0.814 . . . . 0.02 108.802 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -92.3 -23.14 19.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.313 -0.867 . . . . 5.3200000000000003 110.365 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -148.92 163.57 37.08 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.151 -0.968 . . . . 0.02 109.957 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.2 mt -131.6 129.43 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 107.473 -1.306 . . . . 2.1699999999999999 107.473 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -107.82 -13.26 15.04 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.25 -0.906 . . . . 0.02 113.171 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.5 OUTLIER -153.87 152.1 30.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.355 -1.466 . . . . 0.01 108.206 178.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.2 t -160.72 145.04 13.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.29 -1.506 . . . . 1.22 109.651 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -120.86 108.82 14.38 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.099 0.952 . . . . 1.4099999999999999 108.714 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.12 120.68 59.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 105.771 -1.937 . . . . 0.01 105.771 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 t -146.43 68.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 118.209 -1.397 . . . . 1.98 108.341 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.62 108.75 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.563 -1.643 . . . . 0.01 106.563 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.89 -174.16 40.52 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.693 -1.363 . . . . 0.01 109.693 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 m -111.62 144.88 40.16 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.37 -1.076 . . . . 2.2999999999999998 109.12 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.455 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 71.5 m95 -129.69 146.47 51.46 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.537 -0.727 . . . . 0.01 110.263 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.2 mt -118.0 141.3 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.583 -1.266 . . . . 1.6899999999999999 107.583 177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.1 143.66 44.43 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.77 -1.196 . . . . 2.4900000000000002 107.77 177.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.5 m-85 -122.63 143.75 49.56 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.535 -0.728 . . . . 0.02 109.052 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -73.21 -29.61 62.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.514 -0.741 . . . . 0.02 111.98 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.31 153.54 47.48 Favored Pre-proline 0 N--CA 1.505 2.318 0 O-C-N 120.69 -1.256 . . . . 1.48 109.112 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.46 167.24 1.44 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.376 1.384 . . . . 0.02 112.565 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.34 31.14 20.91 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.246 -0.888 . . . . 0.75 111.058 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.65 51.65 9.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.641 -0.662 . . . . 0.02 110.943 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -125.02 163.8 21.55 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.567 -0.708 . . . . 0.02 109.809 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.83 -165.55 32.07 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.878 -1.289 . . . . 0.02 109.878 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -67.7 141.77 56.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.555 -0.968 . . . . 0.02 108.784 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -118.15 148.75 42.03 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.308 -0.627 . . . . 0.02 109.308 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.95 142.45 50.93 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.477 -0.764 . . . . 0.01 109.007 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.37 121.37 38.1 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.302 -0.874 . . . . 0.01 109.297 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.658 HD22 ' NE1' ' A' ' 162' ' ' TRP . 18.1 mt -105.27 136.62 44.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.37 -0.831 . . . . 0.01 110.616 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 154' ' ' LYS . 48.1 t0 -109.88 171.99 7.12 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.127 -1.064 . . . . 2.27 108.127 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -57.87 84.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.994 -1.066 . . . . 1.8400000000000001 108.796 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 152' ' ' ASP . 53.8 mttm -136.19 168.78 18.76 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.245 -0.909 . . . . 2.2799999999999998 111.62 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -112.88 110.61 20.8 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.001 -1.111 . . . . 0.01 108.001 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -100.72 116.52 32.81 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.069 -1.019 . . . . 0.01 110.171 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.457 ' O ' ' OG ' ' A' ' 128' ' ' SER . 25.4 ptt180 -92.44 -25.21 18.57 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.251 -0.906 . . . . 0.01 111.525 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -126.32 153.38 74.68 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 120.845 -1.159 . . . . 2.54 108.658 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -60.71 -42.19 40.98 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 119.265 0.773 . . . . 0.69999999999999996 110.446 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.36 -20.43 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.696 -1.253 . . . . 0.85999999999999999 108.571 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -65.75 -16.46 63.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.92 -1.113 . . . . 0.02 109.561 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.658 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -94.88 9.76 37.96 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.873 -1.158 . . . . 0.02 107.873 179.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.64 10.73 85.76 Favored Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.341 -1.409 . . . . 0.02 109.761 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.06 142.23 31.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.463 -1.022 . . . . 0.02 110.194 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.38 -8.23 59.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.773 -0.579 . . . . 0.58999999999999997 109.856 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.4 m -144.68 150.91 48.55 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 120.88 -1.137 . . . . 0.87 108.708 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.19 21.67 0.52 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.708 0.939 . . . . 0.38 112.233 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.02 123.91 29.91 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.455 1.122 . . . . 0.17999999999999999 111.702 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.422 ' O ' HD12 ' A' ' 117' ' ' ILE . 17.5 mt -146.47 126.24 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.799 -1.556 . . . . 3.9900000000000002 106.799 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -112.24 -19.87 12.08 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.074 -1.016 . . . . 5.1699999999999999 112.896 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 28.4 t -157.29 160.0 38.14 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 119.174 -2.204 . . . . 0.02 110.357 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -153.01 154.25 34.56 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 2.02 110.589 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -144.44 151.19 38.86 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.169 -0.957 . . . . 0.01 110.566 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -87.95 143.46 27.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.409 -0.807 . . . . 0.01 109.232 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.0 mt -93.73 128.65 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.052 -1.03 . . . . 3.04 109.221 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.86 146.69 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.42 -0.8 . . . . 1.8899999999999999 109.535 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 4.8899999999999997 109.528 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 110.42 -1.072 . . . . 0.01 110.42 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -152.62 137.44 17.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.586 -0.949 . . . . 0.02 109.488 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.2 tt -130.27 141.12 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.223 0.535 . . . . 0.02 109.828 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t -121.75 130.27 53.3 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.39 -0.819 . . . . 0.39000000000000001 109.972 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 m-85 -110.25 139.6 45.25 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.543 -0.723 . . . . 0.02 109.378 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.2 m-85 -121.76 137.94 54.57 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.282 -0.886 . . . . 0.02 109.557 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -69.58 -27.53 65.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -0.999 . . . . 0.029999999999999999 111.733 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.4 170.68 8.12 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.848 -1.158 . . . . 0.029999999999999999 110.087 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -74.93 161.16 29.76 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.749 0.785 . . . . 0.029999999999999999 110.26 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 12.9 t-20 62.4 35.06 15.14 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.894 0.854 . . . . 0.73999999999999999 110.551 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 19.6 p90 49.41 43.39 23.42 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.381 -0.827 . . . . 0.02 110.906 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -109.39 165.48 11.61 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.698 -1.223 . . . . 0.02 107.698 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.8 -167.61 33.62 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.785 -1.198 . . . . 0.029999999999999999 110.63 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -69.47 143.81 53.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.361 -1.082 . . . . 2.7599999999999998 109.032 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -122.96 150.51 42.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.63 -0.669 . . . . 1.8899999999999999 110.164 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -137.18 134.05 35.89 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.367 -0.605 . . . . 0.02 109.367 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -109.53 135.57 50.31 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.961 -0.755 . . . . 1.1200000000000001 108.961 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.7 t -127.73 137.65 52.52 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.588 -0.695 . . . . 0.02 109.327 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -118.84 11.99 12.79 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.64 -0.662 . . . . 0.20000000000000001 110.377 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 46.3 t -159.85 173.62 15.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.77 -1.206 . . . . 1.23 109.186 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.562 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.9 p30 -63.35 146.26 53.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.794 -1.191 . . . . 0.02 110.829 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.6 m -134.01 117.48 16.73 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.691 -0.855 . . . . 0.02 108.691 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.484 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.19 -20.46 55.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.466 -0.771 . . . . 0.23999999999999999 111.793 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.57 105.87 3.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.901 -1.124 . . . . 1.1399999999999999 109.25 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.68 5.23 43.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 6.3700000000000001 110.243 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -62.15 -29.6 70.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.448 -0.782 . . . . 3.1099999999999999 112.495 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -77.34 -18.59 57.29 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.224 -1.548 . . . . 0.88 111.687 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -106.43 -19.96 13.52 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.305 -0.872 . . . . 0.02 110.423 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -149.05 127.44 12.23 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.019 -1.051 . . . . 3.3199999999999998 109.457 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -87.27 -12.97 45.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.549 -0.72 . . . . 0.02 111.004 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -172.8 162.08 4.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.02 108.477 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.4 p -142.61 115.21 8.57 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.021 -1.05 . . . . 0.02 108.851 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.453 ' N ' HD22 ' A' ' 37' ' ' ASN . 1.7 m-80 -106.8 -2.77 21.11 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.737 -1.227 . . . . 0.029999999999999999 111.44 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 t -152.98 153.51 33.09 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.884 -1.154 . . . . 0.02 107.884 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 39' ' ' ILE . 9.7 mt -147.01 147.35 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.858 -1.151 . . . . 0.02 110.725 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -125.12 125.55 43.92 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.972 -1.122 . . . . 0.02 107.972 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -105.9 114.95 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.643 -1.614 . . . . 0.02 106.643 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -85.57 -34.31 21.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 3.8100000000000001 109.968 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.37 150.52 19.33 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.512 -1.804 . . . . 0.02 110.696 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.68 171.78 48.34 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.486 -1.046 . . . . 0.01 110.486 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.5 m -118.16 133.35 55.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.579 -1.267 . . . . 1.48 107.579 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.411 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 43.8 m95 -126.3 154.68 43.11 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.812 -1.18 . . . . 0.02 112.14 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.24 133.96 52.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.253 -2.129 . . . . 0.23999999999999999 105.253 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.486 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.3 m -119.21 144.0 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.656 -0.653 . . . . 0.65000000000000002 109.405 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.555 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 43.6 m-85 -120.93 145.15 48.0 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.095 0.95 . . . . 0.02 109.887 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -66.97 -33.35 75.38 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.975 -0.557 . . . . 0.02 111.914 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -123.7 158.2 60.24 Favored Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 120.978 -1.076 . . . . 0.02 109.598 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.36 164.98 1.69 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.591 1.527 . . . . 0.02 112.764 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 64.07 37.17 9.3 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.452 -0.795 . . . . 0.02 111.189 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 44.88 51.26 8.64 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.559 0.695 . . . . 3.3900000000000001 110.738 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.5 t -125.93 163.59 22.63 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.179 0.514 . . . . 2.3300000000000001 109.745 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.92 -161.74 30.8 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.877 -1.289 . . . . 0.02 109.877 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -65.84 140.6 58.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.081 -1.246 . . . . 0.02 110.348 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.555 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 52.4 ttp -118.65 138.3 52.7 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.639 -0.663 . . . . 5.0099999999999998 109.956 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 48.3 m-85 -134.45 137.39 43.93 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.409 -0.807 . . . . 0.02 109.748 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.0 mm -95.28 131.25 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.579 -0.897 . . . . 1.72 108.579 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.501 HD22 ' CE1' ' A' ' 66' ' ' TYR . 6.9 mt -120.5 111.52 34.78 Favored Pre-proline 0 N--CA 1.504 2.266 0 O-C-N 121.31 -0.869 . . . . 0.02 110.985 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.02 168.97 21.22 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 119.853 0.983 . . . . 1.47 110.117 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -53.67 140.7 28.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.774 -1.204 . . . . 4.25 110.502 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.37 -177.21 32.67 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.586 -1.293 . . . . 0.02 110.636 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -118.95 130.63 55.81 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.352 -1.087 . . . . 0.95999999999999996 109.808 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.501 ' CE1' HD22 ' A' ' 61' ' ' LEU . 87.6 m-85 -120.64 97.11 48.73 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.004 -1.11 . . . . 0.02 108.004 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.45 -3.94 12.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 120.708 0.939 . . . . 0.02 113.52 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -157.38 153.96 28.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.651 -1.28 . . . . 2.02 107.988 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -59.76 -38.17 81.07 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.456 -0.777 . . . . 0.02 111.787 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -60.78 -23.85 65.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.061 -1.025 . . . . 0.02 110.433 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -70.1 -18.28 63.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.339 -0.851 . . . . 3.4199999999999999 108.89 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.546 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.55 10.46 27.15 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.482 -1.303 . . . . 0.02 107.482 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.1 mtt 61.13 21.55 11.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.621 -0.674 . . . . 0.02 110.539 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.45 144.49 45.63 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.307 -1.517 . . . . 0.02 109.307 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.45 -31.1 42.45 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.743 -1.206 . . . . 0.97999999999999998 107.743 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -157.48 -172.21 3.89 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.443 -1.688 . . . . 0.02 106.443 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 3.7 p-10 -98.1 28.49 3.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.708 -1.245 . . . . 0.02 110.672 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 78' ' ' ARG . 26.5 ttm-85 -97.84 122.48 41.0 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.851 -1.156 . . . . 3.2000000000000002 111.142 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.486 HD22 ' HB ' ' A' ' 48' ' ' VAL . 54.5 mt -142.34 120.13 11.91 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.652 -1.24 . . . . 2.6099999999999999 107.652 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.32 -18.1 10.72 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 121.309 -0.87 . . . . 0.02 112.183 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.6 m -155.67 155.67 33.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.212 -1.758 . . . . 0.02 110.505 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.4 p -145.23 147.67 32.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.807 -0.558 . . . . 0.02 109.74 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -137.64 142.09 41.19 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.39 -0.819 . . . . 0.01 109.159 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.94 133.13 36.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.13 -0.981 . . . . 0.42999999999999999 109.391 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.03 124.41 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.89 -0.781 . . . . 1.25 108.89 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -92.4 131.54 37.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.859 -1.15 . . . . 1.77 108.582 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.55 138.98 33.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.183 -1.043 . . . . 1.6299999999999999 108.183 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.8 p -111.05 126.56 54.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.351 -0.843 . . . . 1.0800000000000001 108.878 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.2 t -103.32 -154.33 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.184 -1.784 . . . . 1.26 106.184 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.19 -50.96 0.83 Allowed Glycine 0 N--CA 1.499 2.88 0 O-C-N 120.49 -1.381 . . . . 0.01 112.214 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.74 -100.14 0.14 Allowed Glycine 0 N--CA 1.487 2.091 0 C-N-CA 118.845 -1.645 . . . . 0.01 111.905 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -120.26 119.53 33.46 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.23 -1.159 . . . . 4.4299999999999997 110.386 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.458 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.61 136.93 56.31 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.226 -0.59 . . . . 2.9900000000000002 109.586 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -136.01 131.16 34.64 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-O 122.205 1.003 . . . . 6.3600000000000003 112.93 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.1 143.35 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-N 115.584 -0.734 . . . . 1.0900000000000001 110.365 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.438 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 1.3 pt20 -124.8 139.52 53.76 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 107.493 -1.299 . . . . 2.0499999999999998 107.493 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.0 m -123.99 145.86 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.548 -1.345 . . . . 1.1000000000000001 110.971 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -120.68 140.16 52.0 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.302 1.049 . . . . 0.72999999999999998 110.876 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.2 tm-20 -68.36 -32.54 72.69 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.587 -0.733 . . . . 0.02 111.81 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -114.0 167.46 10.64 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.043 -1.035 . . . . 3.1800000000000002 110.306 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.24 163.52 52.67 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.815 -0.914 . . . . 0.01 110.815 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 58.2 38.51 26.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.98 -0.718 . . . . 0.01 111.567 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 52.16 55.41 9.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.01 111.245 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -128.51 164.53 22.59 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.93 -1.137 . . . . 3.1499999999999999 107.93 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.67 -162.39 29.05 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.013 -1.635 . . . . 0.01 109.013 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -75.54 141.18 43.04 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.842 -1.387 . . . . 0.01 109.154 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 107' ' ' MET . 0.8 OUTLIER -116.26 143.07 46.0 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.48 0.657 . . . . 0.01 109.42 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -132.36 136.16 46.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.22 -1.03 . . . . 2.48 108.22 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.482 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.2 tm-20 -116.4 134.1 55.26 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.735 -0.603 . . . . 0.01 109.5 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.482 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 11.9 t -149.3 148.04 29.07 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.491 1.138 . . . . 1.6899999999999999 111.216 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.5 p -115.09 7.56 15.46 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.017 -0.992 . . . . 0.01 109.924 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -121.97 163.31 19.55 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.504 -0.747 . . . . 3.21 111.194 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -70.25 155.05 41.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.833 . . . . 0.01 109.78 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.402 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 34.9 t -126.49 115.17 23.09 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 121.532 -0.73 . . . . 0.01 109.195 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.05 -33.13 4.76 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 120.339 1.157 . . . . 0.01 111.113 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.8 t -141.8 107.67 5.15 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.968 0.889 . . . . 0.02 108.832 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.09 -39.93 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.585 -0.697 . . . . 1.8300000000000001 111.176 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.8 ttt -66.39 -37.47 85.31 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.078 -1.049 . . . . 1.3400000000000001 109.593 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.59 -38.46 77.35 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.572 -1.33 . . . . 2.1099999999999999 109.709 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -80.44 -47.24 14.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -0.906 . . . . 2.0800000000000001 112.476 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -111.41 -0.7 16.2 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.235 -0.915 . . . . 0.02 112.653 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 60.08 33.41 21.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.755 -1.216 . . . . 0.02 109.648 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.42 135.51 53.03 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.793 -0.817 . . . . 0.02 108.793 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -92.71 -23.16 19.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.334 -0.854 . . . . 5.3200000000000003 110.766 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -148.91 163.42 37.49 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.226 -0.922 . . . . 0.02 109.965 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.2 mt -131.97 129.72 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 107.576 -1.268 . . . . 2.1699999999999999 107.576 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -107.72 -13.53 15.0 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.21 -0.931 . . . . 0.02 113.243 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.95 153.52 31.18 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.277 -1.515 . . . . 0.01 108.24 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 7.4 t -161.35 147.39 14.24 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.286 -1.509 . . . . 1.22 109.9 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -121.76 108.66 13.77 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.989 0.9 . . . . 1.4099999999999999 108.627 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 t -107.59 120.41 58.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 105.941 -1.874 . . . . 0.01 105.941 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 t -146.49 68.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 118.189 -1.404 . . . . 1.98 108.454 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.39 108.75 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 106.715 -1.587 . . . . 0.01 106.715 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.21 -173.27 43.1 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.978 -1.249 . . . . 0.01 109.978 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.479 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.2 m -112.02 143.73 42.54 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.283 -1.128 . . . . 2.2999999999999998 109.221 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.458 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 72.6 m95 -129.69 145.72 51.51 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.461 -0.774 . . . . 0.01 110.336 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.0 mt -117.8 141.35 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 107.708 -1.219 . . . . 1.6899999999999999 107.708 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.783 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.54 141.45 47.14 Favored 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 107.019 -1.474 . . . . 2.4900000000000002 107.019 178.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 7.7 m-85 -122.73 145.71 48.16 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.437 -0.789 . . . . 0.02 109.197 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -74.12 -29.92 62.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.02 112.007 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.68 153.18 47.91 Favored Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 120.753 -1.217 . . . . 1.48 109.118 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.419 ' O ' ' NH1' ' A' ' 145' ' ' ARG . 1.2 Cg_endo -54.24 166.72 1.54 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.25 1.3 . . . . 0.02 112.791 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.2 t30 58.67 32.15 21.87 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.205 -0.907 . . . . 0.75 111.099 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 144' ' ' TYR . 1.0 OUTLIER 57.51 52.25 8.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.564 -0.71 . . . . 0.02 111.473 178.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.464 HH11 ' HG3' ' A' ' 145' ' ' ARG . 10.8 mtm-85 -124.5 163.14 22.49 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.52 -0.737 . . . . 0.02 109.597 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.2 -164.95 32.48 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.923 -1.271 . . . . 0.02 109.923 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -68.04 141.13 56.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.583 -0.951 . . . . 0.02 108.862 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -118.32 148.42 42.49 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.361 0.601 . . . . 0.02 109.438 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.5 141.97 51.22 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.465 -0.772 . . . . 0.01 108.977 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.584 HD23 ' C ' ' A' ' 150' ' ' LEU . 6.0 tt -97.15 121.57 39.18 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.263 -0.898 . . . . 0.01 109.288 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.673 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.1 mt -105.22 133.91 49.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.426 -0.797 . . . . 0.01 110.536 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 32.2 t70 -109.41 175.76 5.33 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.346 -0.983 . . . . 2.27 108.346 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.18 84.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.974 -1.079 . . . . 1.8400000000000001 108.528 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 48.6 tttp -136.61 165.45 25.85 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.343 -0.848 . . . . 2.2799999999999998 111.461 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.484 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 27.1 mt-10 -111.1 108.4 18.09 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.033 -1.099 . . . . 0.01 108.033 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -98.93 114.82 27.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.002 -1.061 . . . . 0.01 110.241 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -93.26 -26.05 17.51 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.145 -0.972 . . . . 0.01 111.34 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -125.56 153.75 72.7 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 120.94 -1.1 . . . . 2.54 108.738 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.67 -43.35 32.79 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 119.145 0.73 . . . . 0.69999999999999996 110.724 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.34 -20.72 21.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.728 -1.233 . . . . 0.85999999999999999 108.632 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -65.67 -16.2 63.51 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.044 -1.035 . . . . 0.02 109.568 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.673 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.91 9.76 38.06 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.026 -1.101 . . . . 0.02 108.026 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.02 10.43 86.26 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.259 -1.448 . . . . 0.02 109.693 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.56 142.22 31.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.482 -1.011 . . . . 0.02 110.145 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.46 -8.48 58.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.7 -0.625 . . . . 0.58999999999999997 109.819 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 32.2 m -144.5 151.05 49.66 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.888 -1.133 . . . . 0.87 108.602 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.8 21.3 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 120.786 0.991 . . . . 0.38 112.294 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.06 122.69 28.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.525 1.155 . . . . 0.17999999999999999 111.476 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.783 HG23 ' CD1' ' A' ' 138' ' ' PHE . 56.4 mt -145.76 125.35 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.183 -1.784 . . . . 3.9900000000000002 106.183 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -111.65 -19.34 12.52 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.024 -1.048 . . . . 5.1699999999999999 113.094 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.2 t -157.05 160.49 38.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.328 -2.108 . . . . 0.02 110.2 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.402 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 11.6 p90 -151.55 152.25 32.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.116 -0.99 . . . . 2.02 110.272 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.419 ' CG ' ' CE1' ' A' ' 144' ' ' TYR . 7.1 mmm180 -143.34 149.81 38.29 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.388 -0.82 . . . . 0.01 110.033 -178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -88.56 143.46 26.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.464 -0.772 . . . . 0.01 109.566 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.11 128.25 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.136 -0.977 . . . . 3.04 109.123 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.9 t -136.01 146.48 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.223 -0.923 . . . . 1.8899999999999999 109.496 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 4.8899999999999997 109.508 179.995 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.429 -1.468 . . . . 0.01 109.429 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -151.28 138.2 19.02 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.214 -1.168 . . . . 0.02 110.355 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 tt -130.13 138.33 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.055 -0.72 . . . . 0.02 109.055 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 t -120.72 130.59 54.13 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.468 -0.77 . . . . 0.39000000000000001 110.058 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.6 m-85 -110.86 140.09 45.62 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.695 -0.628 . . . . 0.02 109.548 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.8 m-85 -122.51 138.61 54.51 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.219 -0.926 . . . . 0.02 109.362 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.41 -27.13 65.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.126 -0.984 . . . . 0.029999999999999999 111.781 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -114.18 169.88 8.7 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.926 -1.109 . . . . 0.029999999999999999 110.15 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -75.61 158.25 32.68 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.626 0.727 . . . . 0.029999999999999999 110.074 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 66.22 33.18 7.46 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.899 0.857 . . . . 0.73999999999999999 111.029 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.47 41.58 30.74 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.235 0.541 . . . . 0.02 111.212 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -113.02 166.09 11.74 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.321 -0.992 . . . . 0.02 108.321 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.48 -167.71 35.75 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.965 -1.112 . . . . 0.029999999999999999 110.446 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -68.71 142.15 55.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.229 -1.159 . . . . 2.7599999999999998 108.771 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -122.75 149.37 44.19 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.653 -0.654 . . . . 1.8899999999999999 110.013 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -135.93 133.02 37.19 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.685 -0.634 . . . . 0.02 109.656 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 2.2 p-10 -109.64 136.46 48.96 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.526 -0.733 . . . . 1.1200000000000001 109.07 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 54.1 t -128.2 138.08 52.31 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.554 -0.716 . . . . 0.02 109.618 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -119.24 11.14 12.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.62 -0.675 . . . . 0.20000000000000001 110.645 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 30.4 p -159.27 173.67 15.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.779 -1.201 . . . . 1.23 109.124 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.69 145.73 53.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.612 -1.305 . . . . 0.02 110.694 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.561 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 21.6 t -134.6 118.42 17.21 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.09 -0.708 . . . . 0.02 109.09 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.23 -20.95 54.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.373 -0.829 . . . . 0.23999999999999999 111.444 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -155.31 105.68 2.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.797 -1.189 . . . . 1.1399999999999999 109.707 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.63 8.81 41.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.388 -0.82 . . . . 6.3700000000000001 109.922 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -60.55 -29.13 68.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -0.841 . . . . 3.1099999999999999 111.978 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.8 m -76.45 -17.61 59.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.466 -1.396 . . . . 0.88 111.347 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -107.32 -20.24 13.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.374 -0.829 . . . . 0.02 110.539 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 tp -148.83 127.02 12.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.89 -1.131 . . . . 3.3199999999999998 109.631 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.9 t -87.14 -12.58 46.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.615 -0.678 . . . . 0.02 111.37 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -171.82 161.91 6.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.73 -1.231 . . . . 0.02 108.364 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.91 116.62 8.71 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.972 -1.08 . . . . 0.02 109.043 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 1.9 m120 -109.41 0.41 19.37 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.671 -1.268 . . . . 0.029999999999999999 111.862 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.1 t -156.39 154.38 30.41 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.274 -1.01 . . . . 0.02 108.274 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -146.14 146.91 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 122.328 1.061 . . . . 0.02 111.092 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -122.77 124.24 42.89 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.706 -1.22 . . . . 0.02 107.706 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -106.67 114.33 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 106.716 -1.587 . . . . 0.02 106.716 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.26 -34.38 23.84 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.348 -0.541 . . . . 3.8100000000000001 110.554 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.19 149.99 18.26 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.102 -1.523 . . . . 0.02 110.682 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.31 172.54 49.13 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.374 -1.09 . . . . 0.01 110.374 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -118.24 134.05 55.36 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 107.81 -1.181 . . . . 1.48 107.81 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -126.47 154.89 43.11 Favored 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 122.587 1.184 . . . . 0.02 112.274 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.08 52.27 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.681 -1.97 . . . . 0.23999999999999999 105.681 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.36 141.64 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -0.758 . . . . 0.65000000000000002 109.298 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -120.52 143.07 48.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.158 0.98 . . . . 0.02 109.536 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CD ' HH21 ' A' ' 78' ' ' ARG . 31.2 tt0 -65.35 -34.07 77.46 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.52 -0.764 . . . . 0.02 111.794 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -124.65 157.95 63.86 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.095 -1.003 . . . . 0.02 109.323 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.56 167.05 1.03 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.67 1.58 . . . . 0.02 112.623 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.1 t30 62.82 36.44 13.04 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.238 -0.892 . . . . 0.02 111.007 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 45.21 51.53 9.13 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.728 0.775 . . . . 3.3900000000000001 110.72 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -125.37 163.26 22.98 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.234 0.54 . . . . 2.3300000000000001 109.818 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.32 -161.34 31.31 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.426 ' ND1' ' OE1' ' A' ' 50' ' ' GLU . 10.9 m80 -65.35 138.54 58.23 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.89 -1.359 . . . . 0.02 110.251 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -119.58 137.16 54.02 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.773 -0.579 . . . . 5.0099999999999998 109.505 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.4 m-85 -134.75 140.38 45.88 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.437 -0.789 . . . . 0.02 109.978 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.8 mm -94.49 130.74 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.863 -0.791 . . . . 1.72 108.863 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -121.22 110.95 34.02 Favored Pre-proline 0 N--CA 1.505 2.287 0 O-C-N 121.353 -0.842 . . . . 0.02 110.702 -178.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.67 169.79 20.25 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 CA-C-N 119.819 0.971 . . . . 1.47 110.423 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -53.19 141.7 22.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.023 -1.048 . . . . 4.25 110.413 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.92 -177.83 31.17 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.41 -1.376 . . . . 0.02 111.012 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -119.55 131.32 55.5 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.453 -1.028 . . . . 0.95999999999999996 109.749 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 53.3 m-85 -122.42 96.03 46.37 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 107.823 -1.176 . . . . 0.02 107.823 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.52 -3.43 11.05 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.831 1.021 . . . . 0.02 113.876 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -157.39 154.22 28.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.548 -1.345 . . . . 2.02 108.098 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -59.7 -38.98 83.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.02 112.016 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -60.16 -23.76 64.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.149 -0.969 . . . . 0.02 110.417 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -70.18 -18.26 63.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 3.4199999999999999 108.755 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.552 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.0 OUTLIER -108.26 10.78 27.69 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.56 -1.274 . . . . 0.02 107.56 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.6 mtt 61.65 22.73 13.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.02 110.546 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.12 144.57 48.64 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.81 -1.316 . . . . 0.02 109.81 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 75' ' ' LEU . 9.3 mp -80.05 -30.28 39.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -1.219 . . . . 0.97999999999999998 107.88 177.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -157.03 -171.48 3.66 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.666 -1.605 . . . . 0.02 106.666 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.498 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 65.9 m-20 -98.66 28.34 4.3 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.64 -1.288 . . . . 0.02 110.847 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.5 HH21 ' CD ' ' A' ' 50' ' ' GLU . 27.7 mtm-85 -96.77 122.82 40.13 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.833 -1.167 . . . . 3.2000000000000002 111.351 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.491 HD21 ' CH2' ' A' ' 72' ' ' TRP . 80.3 mt -142.05 119.3 11.47 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 107.618 -1.253 . . . . 2.6099999999999999 107.618 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.86 -18.53 9.32 Favored Glycine 0 N--CA 1.499 2.889 0 O-C-N 121.12 -0.988 . . . . 0.02 112.638 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 p -156.16 156.69 34.66 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 119.628 1.714 . . . . 0.02 110.841 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 57.0 m -145.91 148.42 32.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.366 -0.834 . . . . 0.02 110.361 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -137.05 141.89 42.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.435 -0.791 . . . . 0.01 109.284 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 132.18 36.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.048 -1.033 . . . . 0.42999999999999999 109.443 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 t -91.49 124.58 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.874 -0.787 . . . . 1.25 108.874 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -92.58 131.3 37.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.942 -1.099 . . . . 1.77 108.569 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mt -95.87 139.69 31.72 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.233 -1.025 . . . . 1.6299999999999999 108.233 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.6 t -110.89 126.12 54.36 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.643 -0.873 . . . . 1.0800000000000001 108.643 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.0 m -102.58 -154.91 0.5 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.069 -1.826 . . . . 1.26 106.069 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.23 -51.01 0.82 Allowed Glycine 0 N--CA 1.498 2.778 0 O-C-N 120.522 -1.361 . . . . 0.01 112.029 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.56 -99.85 0.13 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 118.683 -1.722 . . . . 0.01 112.121 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -120.17 120.37 35.97 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.202 -1.175 . . . . 4.4299999999999997 110.723 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.486 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.2 137.58 57.09 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.362 -0.607 . . . . 2.9900000000000002 109.362 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 32.6 ttmt -136.53 130.44 32.46 Favored 'General case' 0 N--CA 1.516 2.856 0 CA-C-O 122.155 0.979 . . . . 6.3600000000000003 113.031 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -131.81 141.37 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-N 115.51 -0.768 . . . . 1.0900000000000001 110.524 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 pt20 -124.45 139.78 53.57 Favored 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 107.485 -1.302 . . . . 2.0499999999999998 107.485 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.83 146.07 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 O-C-N 120.734 -1.229 . . . . 1.1000000000000001 111.038 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -120.73 139.96 52.34 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.046 0.927 . . . . 0.72999999999999998 110.817 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -68.6 -32.47 72.38 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.688 -0.687 . . . . 0.02 112.025 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -114.27 165.35 12.78 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.855 -1.153 . . . . 3.1800000000000002 110.087 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.29 163.41 45.75 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.973 -0.851 . . . . 0.01 110.973 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.428 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 9.5 m-20 57.29 38.86 28.8 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.541 0.686 . . . . 0.01 111.069 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.484 ' C ' HD22 ' A' ' 104' ' ' ASN . 19.8 m-85 52.65 56.23 7.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.534 -0.729 . . . . 0.01 111.087 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.484 HD22 ' C ' ' A' ' 103' ' ' PHE . 1.8 m-80 -128.59 164.93 21.78 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.998 -1.112 . . . . 3.1499999999999999 107.998 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.93 -162.6 28.86 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.04 -1.624 . . . . 0.01 109.04 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -75.34 141.57 43.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.839 -1.389 . . . . 0.01 108.963 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 107' ' ' MET . 9.3 tmm? -116.33 142.94 46.18 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.482 0.658 . . . . 0.01 109.431 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -132.44 136.55 46.81 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.348 -0.982 . . . . 2.48 108.348 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -116.35 134.15 55.22 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.713 -0.617 . . . . 0.01 109.615 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -149.1 147.92 29.07 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.522 1.153 . . . . 1.6899999999999999 111.358 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.4 p -114.53 7.66 16.2 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.972 -1.013 . . . . 0.01 109.901 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -122.14 163.34 19.68 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.443 -0.786 . . . . 3.21 111.264 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 4.9 p30 -69.57 154.6 41.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.01 109.568 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.5 t -126.79 115.33 22.45 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.487 -0.758 . . . . 0.01 108.976 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.03 -32.69 5.14 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 120.4 1.179 . . . . 0.01 111.346 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.0 m -142.12 108.38 5.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.368 -0.833 . . . . 0.02 109.203 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.22 -39.66 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.769 -0.582 . . . . 1.8300000000000001 111.03 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.3 ttt -67.04 -37.79 84.72 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.141 -1.024 . . . . 1.3400000000000001 109.835 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -69.59 -38.5 77.34 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.622 -1.299 . . . . 2.1099999999999999 109.724 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -80.62 -47.4 14.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -0.919 . . . . 2.0800000000000001 112.531 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -111.0 -0.72 16.58 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.291 -0.881 . . . . 0.02 112.727 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.3 m170 59.96 33.51 21.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.738 -1.226 . . . . 0.02 109.436 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.53 135.38 53.31 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.73 -0.841 . . . . 0.02 108.73 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -92.42 -23.03 19.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.288 -0.883 . . . . 5.3200000000000003 110.605 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -148.8 163.64 36.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.163 -0.96 . . . . 0.02 109.934 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -131.57 129.46 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 107.454 -1.313 . . . . 2.1699999999999999 107.454 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -107.86 -13.21 15.04 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.216 -0.927 . . . . 0.02 113.142 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -154.1 152.11 30.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.432 -1.418 . . . . 0.01 108.251 178.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 7.3 t -161.77 145.12 12.25 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.212 -1.555 . . . . 1.22 109.56 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -122.02 111.03 16.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.191 0.996 . . . . 1.4099999999999999 108.861 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.14 121.96 63.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 105.733 -1.951 . . . . 0.01 105.733 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.7 t -146.27 64.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 117.996 -1.482 . . . . 1.98 108.955 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.2 tp10 176.67 109.67 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.485 -1.672 . . . . 0.01 106.485 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.16 -173.41 45.71 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.214 -1.154 . . . . 0.01 110.214 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.42 142.95 41.43 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.491 -1.006 . . . . 2.2999999999999998 108.93 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.486 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 68.0 m95 -129.2 145.21 51.37 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.513 -0.742 . . . . 0.01 109.958 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.0 mt -118.2 142.09 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 107.743 -1.206 . . . . 1.6899999999999999 107.743 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.2 143.25 45.13 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 107.515 -1.291 . . . . 2.4900000000000002 107.515 177.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -122.56 143.65 49.6 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.107 -0.701 . . . . 0.02 109.107 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.45 -29.95 62.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.614 -0.679 . . . . 0.02 112.19 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.26 153.58 47.42 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 120.674 -1.266 . . . . 1.48 109.128 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.35 166.59 1.67 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.237 1.291 . . . . 0.02 112.492 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 59.67 31.54 20.95 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.166 -0.925 . . . . 0.75 111.127 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.482 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.8 m-85 57.62 51.51 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.513 -0.742 . . . . 0.02 111.066 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -124.97 163.81 21.49 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.484 -0.76 . . . . 0.02 109.886 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.68 -165.36 32.14 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.838 -1.305 . . . . 0.02 109.838 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -67.71 141.41 56.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.979 . . . . 0.02 108.81 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.63 148.37 42.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.246 -0.65 . . . . 0.02 109.246 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.442 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.04 143.07 50.75 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.808 -0.812 . . . . 0.01 108.808 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 151' ' ' LEU . 1.3 tt -97.51 121.99 40.05 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.385 -0.822 . . . . 0.01 109.127 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.642 HD22 ' NE1' ' A' ' 162' ' ' TRP . 16.9 mt -104.3 135.63 45.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.01 110.311 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 154' ' ' LYS . 13.2 m-20 -108.05 173.36 6.36 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -58.68 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.992 -1.068 . . . . 1.8400000000000001 108.614 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 152' ' ' ASP . 40.8 tttm -137.04 168.75 19.0 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.362 -0.836 . . . . 2.2799999999999998 111.483 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 1.6 pm0 -112.61 111.37 22.13 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.213 -1.032 . . . . 0.01 108.213 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -100.68 116.03 31.62 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.053 -1.029 . . . . 0.01 110.059 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.448 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.9 ptm180 -92.78 -25.6 18.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.101 -0.999 . . . . 0.01 111.49 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -125.96 153.08 73.73 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.78 -1.2 . . . . 2.54 108.716 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.72 -42.2 40.75 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 119.271 0.775 . . . . 0.69999999999999996 110.62 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.78 -20.22 21.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.706 -1.246 . . . . 0.85999999999999999 108.508 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -65.65 -16.16 63.47 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.941 -1.099 . . . . 0.02 109.494 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.642 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -95.11 9.68 38.67 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.881 -1.155 . . . . 0.02 107.881 178.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.53 11.07 85.5 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 119.295 -1.431 . . . . 0.02 109.659 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.96 142.24 31.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.44 -1.035 . . . . 0.02 110.174 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.44 -8.28 59.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.736 -0.603 . . . . 0.58999999999999997 109.987 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.0 p -144.48 150.85 49.05 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.709 -1.244 . . . . 0.87 108.771 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -76.05 21.31 0.52 Allowed 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 120.818 1.012 . . . . 0.38 112.248 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.63 123.99 29.76 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.572 1.177 . . . . 0.17999999999999999 111.739 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.2 mt -147.05 126.71 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 106.925 -1.509 . . . . 3.9900000000000002 106.925 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -112.66 -19.52 12.02 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.132 -0.98 . . . . 5.1699999999999999 112.826 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.1 p -158.4 161.44 37.53 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 119.242 -2.161 . . . . 0.02 110.216 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -153.03 154.6 35.24 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.182 -0.948 . . . . 2.02 110.576 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.482 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 25.5 mtp180 -143.84 150.54 38.63 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.086 -1.009 . . . . 0.01 110.314 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -87.74 142.72 27.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.622 -0.674 . . . . 0.01 109.268 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.5 mt -93.14 128.19 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.089 -1.007 . . . . 3.04 109.033 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.4 m -135.89 146.31 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.116 -0.99 . . . . 1.8899999999999999 109.558 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 4.8899999999999997 109.389 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 110.322 -1.111 . . . . 0.01 110.322 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -152.37 138.59 18.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.354 -1.086 . . . . 0.02 109.769 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.4 139.52 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.194 -0.669 . . . . 0.02 109.194 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 t -122.08 130.96 53.72 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.464 -0.773 . . . . 0.39000000000000001 110.301 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 m-85 -111.16 140.31 45.81 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.617 -0.677 . . . . 0.02 109.623 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.7 m-85 -121.8 138.54 54.33 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.296 -0.877 . . . . 0.02 109.368 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -68.99 -27.33 65.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.905 -1.122 . . . . 0.029999999999999999 111.767 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -114.47 170.35 8.37 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.864 -1.147 . . . . 0.029999999999999999 110.111 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -74.99 161.59 29.33 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.673 0.749 . . . . 0.029999999999999999 110.137 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.608 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 6.0 t-20 62.42 34.97 15.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.907 0.86 . . . . 0.73999999999999999 110.634 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.608 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 19.5 p90 49.68 43.31 24.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.307 -0.861 . . . . 0.02 111.057 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -109.43 165.71 11.43 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.73 -1.211 . . . . 0.02 107.73 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.41 -167.86 34.4 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 120.775 -1.203 . . . . 0.029999999999999999 110.688 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -68.84 143.66 54.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.382 -1.069 . . . . 2.7599999999999998 108.883 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.532 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 48.9 ttt180 -122.1 149.94 42.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.615 -0.678 . . . . 1.8899999999999999 110.039 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -136.91 132.63 34.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.653 -0.654 . . . . 0.02 109.303 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -109.75 136.14 49.55 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.435 -0.79 . . . . 1.1200000000000001 109.046 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.1 t -127.86 137.71 52.43 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.522 -0.736 . . . . 0.02 109.42 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.488 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -118.41 11.98 13.18 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.20000000000000001 110.15 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 29.3 m -159.17 173.77 15.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.849 -1.157 . . . . 1.23 108.826 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 33.4 p30 -62.87 145.8 54.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.856 -1.152 . . . . 0.02 110.324 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.525 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 10.8 p -134.89 119.2 17.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.497 -0.752 . . . . 0.02 109.16 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.2 -20.97 47.02 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.257 -0.902 . . . . 0.23999999999999999 112.297 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.48 106.28 3.1 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.702 -1.249 . . . . 1.1399999999999999 110.175 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.507 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.1 6.46 40.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.341 -0.849 . . . . 6.3700000000000001 110.046 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -61.21 -30.37 70.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 3.1099999999999999 112.097 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.1 m -77.1 -17.52 58.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.308 -1.495 . . . . 0.88 110.965 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -106.66 -21.19 13.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.453 -0.78 . . . . 0.02 110.64 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -149.01 127.18 12.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.98 -1.075 . . . . 3.3199999999999998 109.599 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.9 t -86.66 -12.2 49.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.531 -0.731 . . . . 0.02 111.176 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -172.0 161.73 5.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.867 -1.146 . . . . 0.02 108.357 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.5 t -143.19 116.59 9.07 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.914 -1.116 . . . . 0.02 108.936 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -109.33 0.29 19.43 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.831 -1.168 . . . . 0.029999999999999999 111.608 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.1 t -156.92 154.72 30.2 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.508 -0.923 . . . . 0.02 108.508 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.1 147.0 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 122.232 1.015 . . . . 0.02 110.79 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -122.21 123.67 42.03 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.847 -1.168 . . . . 0.02 107.847 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 t -106.52 113.75 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 106.746 -1.576 . . . . 0.02 106.746 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -83.95 -34.12 24.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.17 -0.612 . . . . 3.8100000000000001 110.412 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.94 150.63 19.76 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 119.052 -1.546 . . . . 0.02 110.525 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.32 172.08 48.72 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.871 -1.157 . . . . 0.01 110.502 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.7 m -118.48 134.72 54.85 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.69 -1.226 . . . . 1.48 107.69 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.0 m95 -127.58 155.01 44.51 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.601 1.191 . . . . 0.02 112.118 -176.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.38 134.26 52.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 105.518 -2.03 . . . . 0.23999999999999999 105.518 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.02 143.48 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.523 -0.736 . . . . 0.65000000000000002 109.374 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -120.69 144.67 48.09 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.165 0.983 . . . . 0.02 110.06 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' OE2' ' ND1' ' A' ' 57' ' ' HIS . 21.0 tt0 -65.95 -33.09 75.02 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.798 -0.637 . . . . 0.02 111.505 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -124.62 158.1 63.25 Favored Pre-proline 0 N--CA 1.503 2.219 0 O-C-N 120.993 -1.067 . . . . 0.02 109.419 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.61 166.68 1.19 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.692 1.595 . . . . 0.02 112.772 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 63.31 36.62 11.57 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.464 -0.789 . . . . 0.02 110.934 178.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.46 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 6.5 m-85 45.23 51.74 9.05 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.612 0.72 . . . . 3.3900000000000001 110.749 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -125.99 163.61 22.63 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.208 0.528 . . . . 2.3300000000000001 109.883 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.7 -161.9 31.21 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.705 -1.358 . . . . 0.02 109.705 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.457 ' ND1' ' OE2' ' A' ' 50' ' ' GLU . 14.0 m80 -64.34 138.87 58.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.922 -1.34 . . . . 0.02 110.122 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -118.77 137.16 53.56 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.337 0.589 . . . . 5.0099999999999998 109.609 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.587 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.5 m-85 -134.73 139.34 45.11 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.459 -0.776 . . . . 0.02 109.912 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.7 mm -95.51 130.97 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.11 -0.7 . . . . 1.72 109.11 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.493 HD22 ' CE1' ' A' ' 66' ' ' TYR . 13.5 mt -122.33 112.01 31.59 Favored Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.261 -0.9 . . . . 0.02 110.835 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.38 170.84 18.7 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 119.754 0.948 . . . . 1.47 110.03 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -52.28 140.79 20.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 4.25 110.243 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.39 -177.46 32.55 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.4 -1.381 . . . . 0.02 110.769 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -121.02 131.94 54.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.381 -1.07 . . . . 0.95999999999999996 109.878 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CE1' HD22 ' A' ' 61' ' ' LEU . 96.6 m-85 -122.27 97.79 44.89 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 107.768 -1.197 . . . . 0.02 107.768 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.08 -2.23 10.78 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.79 0.994 . . . . 0.02 113.694 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -157.32 153.94 28.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.734 -1.228 . . . . 2.02 108.156 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -59.96 -39.68 86.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.478 -0.764 . . . . 0.02 111.778 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -59.73 -23.88 63.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.02 110.35 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -70.87 -18.49 62.69 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.926 0.869 . . . . 3.4199999999999999 108.937 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.587 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.72 10.08 28.97 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.376 -1.342 . . . . 0.02 107.376 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.6 mtt 61.04 22.4 12.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.593 -0.692 . . . . 0.02 110.518 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.93 144.45 46.56 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.571 -1.412 . . . . 0.02 109.571 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -79.42 -30.8 42.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.699 -1.222 . . . . 0.97999999999999998 107.699 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 11.7 p-10 -157.03 -171.65 3.72 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.35 -1.722 . . . . 0.02 106.35 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -98.61 28.74 4.04 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.652 -1.28 . . . . 0.02 110.591 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' A' ' 78' ' ' ARG . 25.5 ttm-85 -96.77 122.23 39.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.817 -1.177 . . . . 3.2000000000000002 111.005 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.509 HD21 ' CH2' ' A' ' 72' ' ' TRP . 78.4 mt -141.9 119.37 11.62 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.606 -1.257 . . . . 2.6099999999999999 107.606 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.4 -18.34 9.78 Favored Glycine 0 N--CA 1.501 3.026 0 O-C-N 121.129 -0.982 . . . . 0.02 112.579 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.1 p -156.48 156.81 34.37 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 119.502 1.651 . . . . 0.02 110.451 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.4 m -145.38 148.26 33.17 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.623 -0.673 . . . . 0.02 109.846 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.46 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 51.1 mtp180 -137.48 141.98 41.52 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.193 -0.942 . . . . 0.01 109.283 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 133.18 36.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.237 -0.915 . . . . 0.42999999999999999 109.679 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.74 123.66 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.112 -1.07 . . . . 1.25 108.112 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -94.92 133.29 38.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.131 . . . . 1.77 108.956 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.57 134.14 37.44 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.714 -1.217 . . . . 1.6299999999999999 107.714 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m -106.79 130.27 54.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.501 -0.749 . . . . 1.0800000000000001 109.988 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.4 p -115.3 100.53 8.19 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 102.749 -3.056 . . . . 1.26 102.749 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -119.74 -60.84 0.26 Allowed Glycine 0 N--CA 1.51 3.623 0 N-CA-C 110.069 -1.212 . . . . 0.01 110.069 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.13 -107.82 1.32 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.353 -1.499 . . . . 0.01 109.353 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -120.55 -141.01 0.34 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.679 -0.895 . . . . 4.4299999999999997 109.213 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -126.5 119.73 27.91 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.23 -1.026 . . . . 2.9900000000000002 108.23 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -144.1 121.98 12.0 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.416 -1.427 . . . . 6.3600000000000003 113.28 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.3 tt -130.71 138.09 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.435 0.636 . . . . 1.0900000000000001 109.681 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.483 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.6 pt20 -123.84 138.76 54.44 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.418 -1.327 . . . . 2.0499999999999998 107.418 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.61 146.21 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.687 -1.258 . . . . 1.1000000000000001 110.658 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -119.77 141.7 49.23 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.215 1.007 . . . . 0.72999999999999998 111.385 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.32 -33.02 72.5 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.783 -0.644 . . . . 0.02 111.358 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.8 mmmt -114.38 167.91 10.31 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.122 -0.986 . . . . 3.1800000000000002 109.66 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.68 168.89 45.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 111.169 -0.772 . . . . 0.01 111.169 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 53.53 39.51 30.14 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.511 0.672 . . . . 0.01 111.598 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 52.48 48.45 22.56 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.707 -0.621 . . . . 0.01 110.934 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -121.67 164.22 17.7 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.332 -0.988 . . . . 3.1499999999999999 108.332 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.69 -163.09 29.48 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.042 -1.623 . . . . 0.01 109.042 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.5 141.58 43.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.798 -1.413 . . . . 0.01 109.199 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.458 ' C ' ' SD ' ' A' ' 107' ' ' MET . 11.6 tmm? -116.24 143.79 45.06 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.479 0.657 . . . . 0.01 109.595 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.44 136.44 46.73 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.387 -0.968 . . . . 2.48 108.387 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -117.36 133.94 55.4 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.576 -0.703 . . . . 0.01 109.771 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 t -149.58 149.2 30.33 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.481 1.134 . . . . 1.6899999999999999 111.329 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.7 p -114.74 7.96 16.01 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.057 -0.974 . . . . 0.01 110.334 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 23.9 mp0 -121.62 163.16 19.41 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.345 -0.847 . . . . 3.21 111.018 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.6 p30 -69.46 154.91 41.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.479 -0.763 . . . . 0.01 109.451 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.4 t -127.31 115.17 21.5 Favored Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 109.13 -0.692 . . . . 0.01 109.13 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.4 -31.44 5.72 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 120.295 1.141 . . . . 0.01 111.429 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.3 m -142.46 107.86 5.03 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.385 -0.822 . . . . 0.02 108.989 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.07 -39.92 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.783 -0.573 . . . . 1.8300000000000001 111.066 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.44 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 15.1 tpt -66.43 -37.4 85.11 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.167 -1.013 . . . . 1.3400000000000001 109.766 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -70.15 -38.42 75.47 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.584 -1.322 . . . . 2.1099999999999999 109.791 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -80.56 -47.4 14.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.179 -0.951 . . . . 2.0800000000000001 112.354 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -111.04 -0.81 16.52 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.329 -0.857 . . . . 0.02 112.852 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.3 m80 59.6 33.53 22.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.732 -1.23 . . . . 0.02 109.525 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.44 ' C ' ' SD ' ' A' ' 118' ' ' MET . 6.4 mt -112.4 135.45 53.08 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 108.703 -0.851 . . . . 0.02 108.703 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -92.12 -23.01 19.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 5.3200000000000003 110.633 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -149.15 163.6 37.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.078 -1.014 . . . . 0.02 110.101 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.5 mt -132.25 129.55 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 107.475 -1.305 . . . . 2.1699999999999999 107.475 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -107.65 -12.12 15.31 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.159 -0.963 . . . . 0.02 113.13 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -156.7 154.12 29.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.467 -1.396 . . . . 0.01 107.759 178.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.9 t -161.48 146.0 13.24 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.877 -1.139 . . . . 1.22 109.639 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -121.86 109.56 14.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.374 1.083 . . . . 1.4099999999999999 108.949 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.53 122.18 64.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 106.408 -1.701 . . . . 0.01 106.408 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.63 68.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 118.639 -1.225 . . . . 1.98 107.802 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 174.13 105.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.705 -1.591 . . . . 0.01 106.705 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.11 -177.07 46.04 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.548 -1.421 . . . . 0.01 109.548 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.8 m -109.55 143.73 38.82 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.442 -1.034 . . . . 2.2999999999999998 108.659 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -128.56 145.34 51.16 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.474 -0.767 . . . . 0.01 110.49 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.4 mt -116.56 140.29 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 107.504 -1.295 . . . . 1.6899999999999999 107.504 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.602 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -112.89 141.7 46.42 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 107.577 -1.268 . . . . 2.4900000000000002 107.577 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.3 m-85 -121.99 143.54 49.42 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.008 -0.738 . . . . 0.02 109.008 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 140' ' ' GLU . 3.2 tm-20 -73.32 -29.74 62.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.02 112.001 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -114.76 153.92 46.86 Favored Pre-proline 0 N--CA 1.508 2.457 0 O-C-N 120.593 -1.317 . . . . 1.48 109.332 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.47 166.27 1.91 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.13 1.22 . . . . 0.02 112.44 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 59.97 31.1 20.51 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.178 -0.919 . . . . 0.75 111.138 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 58.0 51.53 8.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.553 -0.717 . . . . 0.02 111.044 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -124.95 163.69 21.74 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.551 -0.718 . . . . 0.02 109.76 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.93 -165.28 31.76 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.804 -1.318 . . . . 0.02 109.804 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -67.86 141.97 56.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -1.004 . . . . 0.02 108.831 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.462 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 3.3 mp0 -118.57 149.42 41.37 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.509 -0.552 . . . . 0.02 109.509 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.49 141.89 51.25 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.536 -0.727 . . . . 0.01 109.263 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.7 tp -94.61 119.91 34.01 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.826 -0.805 . . . . 0.01 108.826 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.633 HD22 ' NE1' ' A' ' 162' ' ' TRP . 19.7 mt -106.67 136.22 46.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.44 -0.788 . . . . 0.01 110.781 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 154' ' ' LYS . 16.3 t0 -110.42 171.35 7.51 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.21 -1.033 . . . . 2.27 108.21 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 pttm -55.74 86.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.0 -1.063 . . . . 1.8400000000000001 108.605 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 152' ' ' ASP . 56.0 mttp -136.27 168.6 19.11 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.096 -1.003 . . . . 2.2799999999999998 111.423 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 18.9 mp0 -112.99 109.7 19.28 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.129 -1.063 . . . . 0.01 108.129 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -101.05 115.05 29.57 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.019 -1.05 . . . . 0.01 110.448 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -92.19 -25.65 18.57 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.083 -1.011 . . . . 0.01 111.324 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -126.2 153.53 74.36 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.797 -1.189 . . . . 2.54 108.54 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.04 -42.61 35.33 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 CA-C-N 119.313 0.791 . . . . 0.69999999999999996 110.644 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.6 t -60.24 -20.71 20.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.637 -1.29 . . . . 0.85999999999999999 108.669 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -65.87 -15.95 63.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.888 -1.132 . . . . 0.02 109.609 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.633 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.83 9.55 38.69 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.08 10.56 86.2 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.349 -1.405 . . . . 0.02 109.784 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.54 142.13 31.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.455 -1.027 . . . . 0.02 110.194 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.62 -8.41 58.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.66 -0.65 . . . . 0.58999999999999997 109.767 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.9 p -144.49 150.98 49.52 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.947 -1.095 . . . . 0.87 108.544 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -76.15 21.56 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.738 0.958 . . . . 0.38 112.4 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.14 123.89 29.97 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.592 1.187 . . . . 0.17999999999999999 111.92 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.602 HG23 ' CD1' ' A' ' 138' ' ' PHE . 26.0 mt -146.08 125.22 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 106.38 -1.711 . . . . 3.9900000000000002 106.38 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -111.21 -20.26 12.39 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.154 -0.966 . . . . 5.1699999999999999 112.988 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.7 p -157.89 160.17 37.36 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 119.423 -2.048 . . . . 0.02 109.871 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -152.81 154.59 35.47 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.095 -1.003 . . . . 2.02 110.426 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -144.33 151.63 39.61 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.25 -0.906 . . . . 0.01 110.712 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -88.27 144.88 26.16 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.168 -0.679 . . . . 0.01 109.168 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -95.63 128.58 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.165 -0.959 . . . . 3.04 109.403 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 177' ' ' GLU . 17.4 m -136.81 146.6 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.229 -0.92 . . . . 1.8899999999999999 109.304 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 176' ' ' VAL . 16.1 pt-20 . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.891 -0.506 . . . . 4.8899999999999997 110.808 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.107 -1.597 . . . . 0.01 109.107 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -149.06 136.99 20.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.015 -1.285 . . . . 0.02 110.255 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 tt -130.43 140.67 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.136 -0.69 . . . . 0.02 109.136 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 t -121.47 130.23 53.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.427 -0.795 . . . . 0.39000000000000001 110.146 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.51 140.42 44.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.647 -0.658 . . . . 0.02 109.361 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.7 m-85 -121.92 138.26 54.48 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.189 -0.944 . . . . 0.02 109.493 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -69.47 -27.42 65.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.892 -1.13 . . . . 0.029999999999999999 111.672 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -113.89 169.86 8.69 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.801 -1.187 . . . . 0.029999999999999999 110.241 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -75.62 158.42 32.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.509 0.671 . . . . 0.029999999999999999 110.174 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 43.8 t30 65.78 35.37 6.83 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.883 0.849 . . . . 0.73999999999999999 110.759 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.602 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.99 44.62 25.57 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.682 0.754 . . . . 0.02 111.26 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -112.58 165.67 12.04 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.975 -1.12 . . . . 0.02 107.975 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.09 -167.57 34.57 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.789 -1.196 . . . . 0.029999999999999999 110.563 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -69.14 142.64 54.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -1.06 . . . . 2.7599999999999998 109.073 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -122.3 150.13 42.77 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.455 -0.778 . . . . 1.8899999999999999 110.152 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -136.53 133.12 36.14 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.665 -0.647 . . . . 0.02 109.351 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -109.37 135.74 49.93 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.772 -0.825 . . . . 1.1200000000000001 108.772 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -127.44 138.02 52.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.588 -0.695 . . . . 0.02 109.516 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -118.81 12.14 12.86 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.598 -0.689 . . . . 0.20000000000000001 110.305 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 39.0 t -159.94 173.79 15.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.771 -1.206 . . . . 1.23 109.079 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.423 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 4.9 p-10 -63.29 146.36 53.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.805 -1.184 . . . . 0.02 110.652 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.9 m -133.45 117.34 17.09 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.725 -0.843 . . . . 0.02 108.725 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.3 -20.26 55.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.477 -0.764 . . . . 0.23999999999999999 111.806 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 25.4 p-10 -152.85 106.28 3.04 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.887 -1.133 . . . . 1.1399999999999999 109.287 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.76 5.21 41.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.473 -0.767 . . . . 6.3700000000000001 110.427 -178.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -62.46 -29.42 70.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 3.1099999999999999 112.65 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -77.05 -18.42 58.09 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.159 -1.588 . . . . 0.88 111.797 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -107.25 -19.52 13.57 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.313 -0.867 . . . . 0.02 110.438 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.4 tp -148.73 126.91 12.1 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.927 -1.108 . . . . 3.3199999999999998 109.467 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 t -87.43 -13.07 44.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.538 -0.726 . . . . 0.02 111.362 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -172.55 161.73 5.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.819 -1.176 . . . . 0.02 108.5 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.463 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.6 p -143.86 116.59 8.72 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.194 -0.941 . . . . 0.02 108.85 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.581 ' N ' HD22 ' A' ' 37' ' ' ASN . 1.0 OUTLIER -108.38 -0.06 20.85 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.744 -1.223 . . . . 0.029999999999999999 111.314 -178.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 t -155.9 153.85 30.31 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.723 -1.214 . . . . 0.02 107.723 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 39' ' ' ILE . 9.1 mt -146.81 147.97 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.253 1.025 . . . . 0.02 110.727 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -123.49 125.04 44.2 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.95 -1.13 . . . . 0.02 107.95 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.59 114.02 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 106.663 -1.606 . . . . 0.02 106.663 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -85.36 -34.72 21.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.628 -0.67 . . . . 3.8100000000000001 110.277 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.31 148.9 16.52 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.52 -1.8 . . . . 0.02 110.72 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.89 172.33 48.7 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.284 -1.126 . . . . 0.01 110.284 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.3 m -118.58 134.95 54.71 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.529 -1.285 . . . . 1.48 107.529 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -127.17 154.28 44.99 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.703 1.239 . . . . 0.02 112.305 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.95 134.28 51.82 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 105.176 -2.157 . . . . 0.23999999999999999 105.176 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.487 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.2 m -119.16 144.32 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.578 -0.701 . . . . 0.65000000000000002 109.512 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -120.78 144.68 48.17 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.083 0.944 . . . . 0.02 109.976 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.61 -33.45 75.69 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.833 -0.621 . . . . 0.02 111.925 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -123.75 158.12 60.63 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.069 -1.019 . . . . 0.02 109.521 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -52.9 164.7 1.48 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.503 1.468 . . . . 0.02 112.669 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 64.1 37.29 9.15 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.722 0.772 . . . . 0.02 111.299 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 45.1 51.6 8.87 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.689 0.757 . . . . 3.3900000000000001 110.764 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -125.92 163.59 22.63 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.185 0.517 . . . . 2.3300000000000001 109.811 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.71 -161.72 31.06 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.563 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -64.46 139.43 58.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.997 -1.296 . . . . 0.02 110.275 -178.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 58' ' ' MET . 3.3 ppp? -119.0 137.16 53.72 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.769 -0.582 . . . . 5.0099999999999998 109.663 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.8 m-85 -134.92 139.32 44.87 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.434 -0.791 . . . . 0.02 110.197 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.6 mm -94.21 130.56 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.953 -0.758 . . . . 1.72 108.953 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.521 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.0 mt -120.95 111.13 34.35 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 121.251 -0.905 . . . . 0.02 110.887 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.15 169.86 19.62 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 CA-C-N 119.742 0.943 . . . . 1.47 110.184 177.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -52.94 141.03 23.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.894 -1.129 . . . . 4.25 110.388 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.82 -177.59 32.02 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.551 -1.309 . . . . 0.02 110.929 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -120.06 131.39 55.08 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.56 -0.964 . . . . 0.95999999999999996 109.91 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CE1' HD22 ' A' ' 61' ' ' LEU . 86.7 m-85 -121.94 92.93 48.81 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 107.928 -1.138 . . . . 0.02 107.928 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.85 -4.13 6.83 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.003 1.135 . . . . 0.02 113.863 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -157.62 154.85 29.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.621 -1.299 . . . . 2.02 108.201 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -59.5 -39.37 83.59 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.445 -0.784 . . . . 0.02 112.092 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -59.81 -23.97 63.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.02 110.366 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.71 -18.68 62.81 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.75 0.785 . . . . 3.4199999999999999 109.013 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.1 t90 -107.92 9.91 28.58 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.439 -1.319 . . . . 0.02 107.439 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.3 mtt 60.79 22.25 12.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.572 -0.705 . . . . 0.02 110.485 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.25 144.4 45.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.344 -1.502 . . . . 0.02 109.344 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.2 tp -78.74 -31.06 46.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.492 -1.299 . . . . 0.97999999999999998 107.492 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.481 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 55.6 t30 -157.07 -171.16 3.53 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.389 -1.708 . . . . 0.02 106.389 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.481 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 2.9 p-10 -98.6 28.76 4.03 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.59 -1.319 . . . . 0.02 110.468 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.593 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -97.95 123.02 41.75 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.953 -1.092 . . . . 3.2000000000000002 111.175 -178.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.487 HD22 ' HB ' ' A' ' 48' ' ' VAL . 52.8 mt -142.79 119.97 11.48 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.404 -1.332 . . . . 2.6099999999999999 107.404 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.15 -17.91 11.04 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 121.123 -0.986 . . . . 0.02 112.17 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.5 m -155.77 155.99 34.03 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.271 -1.723 . . . . 0.02 110.598 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.7 m -145.17 147.77 32.84 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.304 0.573 . . . . 0.02 109.58 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -137.44 142.15 41.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.416 -0.802 . . . . 0.01 109.173 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.31 132.97 36.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.212 -0.93 . . . . 0.42999999999999999 109.314 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -89.68 123.79 42.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.282 -1.006 . . . . 1.25 108.282 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -91.19 131.5 36.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.751 -1.218 . . . . 1.77 108.004 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -96.77 137.48 35.79 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.005 -1.109 . . . . 1.6299999999999999 108.005 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.2 t -109.91 126.58 54.02 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.479 -0.934 . . . . 1.0800000000000001 108.479 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 t -103.15 -154.87 0.51 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.046 -1.835 . . . . 1.26 106.046 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.9 -49.62 0.89 Allowed Glycine 0 N--CA 1.497 2.734 0 O-C-N 120.658 -1.276 . . . . 0.01 111.812 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.85 -99.21 0.12 Allowed Glycine 0 N--CA 1.487 2.069 0 C-N-CA 118.77 -1.681 . . . . 0.01 111.897 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -120.91 119.92 34.02 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.279 -1.13 . . . . 4.4299999999999997 110.619 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.492 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.49 137.09 56.57 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.325 -0.62 . . . . 2.9900000000000002 109.325 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -134.79 130.96 36.91 Favored 'General case' 0 N--CA 1.518 2.957 0 CA-C-O 122.195 0.997 . . . . 6.3600000000000003 112.996 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -131.71 142.38 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 115.598 -0.728 . . . . 1.0900000000000001 110.2 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.419 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.7 pt20 -124.22 139.67 53.7 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.818 -1.179 . . . . 2.0499999999999998 107.818 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.5 m -123.59 144.71 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 O-C-N 120.73 -1.231 . . . . 1.1000000000000001 110.942 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -120.55 140.43 51.51 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.155 0.978 . . . . 0.72999999999999998 111.13 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.46 ' OE2' ' CD2' ' A' ' 123' ' ' LEU . 7.2 tp10 -68.38 -33.4 74.18 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.934 -0.576 . . . . 0.02 111.474 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -114.84 168.59 9.77 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.933 -1.104 . . . . 3.1800000000000002 110.168 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.01 169.16 46.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.916 -0.873 . . . . 0.01 110.916 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 53.34 39.19 29.46 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.58 0.705 . . . . 0.01 111.686 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.435 ' C ' HD22 ' A' ' 104' ' ' ASN . 11.7 m-85 52.69 48.21 23.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.56 -0.712 . . . . 0.01 111.075 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.435 HD22 ' C ' ' A' ' 103' ' ' PHE . 4.0 m120 -121.01 164.21 17.09 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.384 -0.969 . . . . 3.1499999999999999 108.384 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.69 -162.91 29.37 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.97 -1.652 . . . . 0.01 108.97 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.482 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 56.6 tt0 -75.94 141.69 42.2 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.945 -1.327 . . . . 0.01 109.214 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 107' ' ' MET . 11.2 tmm? -116.09 143.4 45.52 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.596 0.712 . . . . 0.01 109.465 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.482 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 54.6 m-85 -132.56 136.13 46.39 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.278 -1.008 . . . . 2.48 108.278 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.467 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.9 tm-20 -116.63 134.16 55.15 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.639 -0.663 . . . . 0.01 109.576 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.467 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 8.8 t -148.88 148.35 29.76 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.383 1.087 . . . . 1.6899999999999999 111.302 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.2 p -115.01 7.67 15.59 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.213 -0.903 . . . . 0.01 110.051 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -122.09 163.2 19.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.401 -0.812 . . . . 3.21 111.24 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -69.7 154.75 41.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.01 109.419 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.497 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 53.1 m -127.78 115.53 20.79 Favored Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 109.049 -0.723 . . . . 0.01 109.049 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.43 -32.5 4.87 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 CA-C-N 120.198 1.107 . . . . 0.01 111.308 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 t -141.83 107.37 5.06 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.833 0.825 . . . . 0.02 108.888 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.4 mt -64.83 -39.17 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.864 -0.523 . . . . 1.8300000000000001 111.036 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 37.1 ttp -67.41 -37.39 83.01 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.148 -1.021 . . . . 1.3400000000000001 109.79 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.73 -38.72 76.98 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.588 -1.32 . . . . 2.1099999999999999 109.709 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -79.42 -46.84 16.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.346 -0.846 . . . . 2.0800000000000001 112.317 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.81 0.45 17.28 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.384 -0.822 . . . . 0.02 112.769 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 59.82 33.07 21.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.68 -1.262 . . . . 0.02 109.39 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.46 ' CD2' ' OE2' ' A' ' 99' ' ' GLU . 10.6 mt -111.89 135.08 52.98 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.64 -0.874 . . . . 0.02 108.64 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -92.58 -23.76 18.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 5.3200000000000003 110.409 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -148.89 162.96 38.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.146 -0.971 . . . . 0.02 110.023 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.6 mt -131.96 129.44 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.223 -1.399 . . . . 2.1699999999999999 107.223 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -105.54 -12.32 16.02 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.087 -1.008 . . . . 0.02 112.64 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -155.05 153.15 30.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.524 -1.36 . . . . 0.01 108.156 178.06 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 12.8 t -160.63 144.45 13.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.446 -1.408 . . . . 1.22 109.775 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -122.07 113.4 19.48 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.267 1.032 . . . . 1.4099999999999999 109.457 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.06 120.23 60.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 105.554 -2.017 . . . . 0.01 105.554 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -145.76 67.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 118.34 -1.344 . . . . 1.98 108.398 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 172.14 108.32 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.586 -1.635 . . . . 0.01 106.586 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.38 -172.56 47.65 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.999 -1.24 . . . . 0.01 109.999 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -110.93 144.22 40.35 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.483 -1.01 . . . . 2.2999999999999998 108.845 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.492 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.4 m95 -131.32 147.2 52.55 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.446 -0.784 . . . . 0.01 110.641 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.4 mt -119.1 140.29 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 107.956 -1.128 . . . . 1.6899999999999999 107.956 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.721 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -112.81 141.73 46.28 Favored 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 107.408 -1.331 . . . . 2.4900000000000002 107.408 177.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 12.9 m-85 -122.46 145.04 48.67 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.55 -0.719 . . . . 0.02 109.264 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -74.55 -30.29 61.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.579 -0.701 . . . . 0.02 112.275 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -114.89 153.79 46.99 Favored Pre-proline 0 N--CA 1.506 2.362 0 O-C-N 120.622 -1.299 . . . . 1.48 109.139 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.51 166.34 1.89 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 120.991 1.127 . . . . 0.02 112.462 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 59.79 31.21 20.68 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.221 -0.9 . . . . 0.75 111.253 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.497 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 58.38 51.97 7.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.02 111.13 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -124.91 163.34 22.46 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.666 -0.646 . . . . 0.02 109.937 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.65 -165.61 32.35 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.159 -1.177 . . . . 0.02 110.159 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -67.85 141.62 56.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.614 -0.933 . . . . 0.02 108.957 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.11 149.07 41.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.582 -0.525 . . . . 0.02 109.582 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.67 141.43 51.61 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 109.125 -0.695 . . . . 0.01 109.125 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.25 120.87 36.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.334 -0.854 . . . . 0.01 109.282 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.671 ' CD2' ' HE1' ' A' ' 162' ' ' TRP . 6.7 mt -104.3 135.14 46.31 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.344 -0.848 . . . . 0.01 110.321 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 154' ' ' LYS . 38.9 t70 -110.78 178.23 4.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.399 -1.334 . . . . 2.27 107.399 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -59.3 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.747 -1.221 . . . . 1.8400000000000001 108.519 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 152' ' ' ASP . 68.4 tttt -134.95 163.12 30.56 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 122.106 0.955 . . . . 2.2799999999999998 111.957 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.406 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 2.7 pt-20 -113.87 112.03 22.7 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.07 -1.085 . . . . 0.01 108.07 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.63 114.92 29.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.023 -1.048 . . . . 0.01 110.18 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.456 ' O ' ' OG ' ' A' ' 128' ' ' SER . 23.5 ptt180 -96.74 -27.12 14.9 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.497 -0.752 . . . . 0.01 112.063 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -125.65 151.33 70.45 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 120.766 -1.209 . . . . 2.54 108.98 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -57.97 -48.8 14.82 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 CA-C-N 119.234 0.762 . . . . 0.69999999999999996 110.759 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.68 -23.67 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.86 -1.15 . . . . 0.85999999999999999 109.152 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.61 -15.86 63.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.755 -1.216 . . . . 0.02 109.305 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.671 ' HE1' ' CD2' ' A' ' 151' ' ' LEU . 2.7 t90 -94.78 6.54 48.65 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.607 -0.886 . . . . 0.02 108.607 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 74.79 8.29 81.81 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.565 -1.303 . . . . 0.02 109.917 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.22 143.32 29.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.62 -0.929 . . . . 0.02 110.074 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.13 -9.22 58.76 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.675 -0.641 . . . . 0.58999999999999997 109.671 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.1 p -147.24 150.9 39.34 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.756 -1.215 . . . . 0.87 108.015 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -75.7 25.48 0.4 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 120.777 0.985 . . . . 0.38 112.464 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.888 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.85 124.4 30.92 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.644 1.211 . . . . 0.17999999999999999 112.534 -177.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.888 HD13 ' O ' ' A' ' 168' ' ' ALA . 6.4 mm -142.19 127.82 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 106.382 -1.71 . . . . 3.9900000000000002 106.382 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -113.65 -23.7 9.59 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.784 -1.198 . . . . 5.1699999999999999 112.846 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.9 p -157.31 160.26 38.37 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 119.503 -1.998 . . . . 0.02 109.839 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.497 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 11.8 p90 -153.44 153.98 33.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.983 -1.073 . . . . 2.02 110.601 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.497 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 18.9 mtp180 -143.23 151.14 40.25 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.161 -0.962 . . . . 0.01 110.4 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 174' ' ' ARG . 28.9 ptt180 -87.56 141.83 28.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.991 -0.744 . . . . 0.01 108.991 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.0 mt -93.25 128.31 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.005 -1.059 . . . . 3.04 109.078 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.1 t -136.27 146.52 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.254 -0.903 . . . . 1.8899999999999999 109.553 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 4.8899999999999997 109.452 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.292 -1.523 . . . . 0.01 109.292 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -147.76 136.69 22.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.012 -1.287 . . . . 0.02 110.641 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 tt -130.78 139.52 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 109.115 -0.698 . . . . 0.02 109.115 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -121.22 130.33 53.64 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.465 -0.772 . . . . 0.39000000000000001 109.766 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.05 139.77 44.81 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.983 -0.747 . . . . 0.02 108.983 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.6 m-85 -122.16 138.37 54.49 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.213 -0.929 . . . . 0.02 109.545 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.472 ' HG3' HD11 ' A' ' 33' ' ' LEU . 88.7 mt-10 -69.57 -27.76 65.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.029999999999999999 111.652 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.2 m-20 -114.36 169.7 8.85 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.808 -1.182 . . . . 0.029999999999999999 110.237 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.712 HH12 HD22 ' A' ' 37' ' ' ASN . 3.5 mtt-85 -74.88 157.81 34.43 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.703 0.763 . . . . 0.029999999999999999 110.078 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 66.26 33.49 7.16 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.958 0.885 . . . . 0.73999999999999999 111.14 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.25 42.32 30.53 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.212 0.53 . . . . 0.02 111.266 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -113.74 166.0 11.98 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.288 -1.005 . . . . 0.02 108.288 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.95 -167.25 36.2 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.841 -1.171 . . . . 0.029999999999999999 110.702 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.05 141.59 54.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.976 . . . . 2.7599999999999998 109.313 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -120.27 148.81 43.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.523 -0.736 . . . . 1.8899999999999999 110.149 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -132.68 127.39 34.72 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.488 -0.93 . . . . 0.02 108.488 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.62 136.16 51.23 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.414 -0.804 . . . . 1.1200000000000001 109.565 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -130.52 138.18 50.09 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.502 0.668 . . . . 0.02 109.55 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -117.56 11.16 13.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.737 -0.602 . . . . 0.20000000000000001 109.655 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.9 p -158.31 173.83 16.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.144 -0.972 . . . . 1.23 108.585 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.62 145.19 55.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.636 -1.29 . . . . 0.02 110.372 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 22.0 p -132.99 117.32 17.49 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.407 -0.96 . . . . 0.02 108.407 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.83 -23.5 52.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.23999999999999999 110.743 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 31.1 p-10 -154.83 101.44 2.29 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.615 -0.883 . . . . 1.1399999999999999 108.615 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 22.2 p90 -107.08 10.06 30.3 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 122.089 0.947 . . . . 6.3700000000000001 110.273 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HE ' ' CA ' ' A' ' 80' ' ' GLY . 29.4 mmt180 -59.2 -23.19 62.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.544 -0.722 . . . . 3.1099999999999999 110.676 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -75.23 -16.32 60.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.726 -1.233 . . . . 0.88 110.354 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -103.08 -21.43 13.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.382 -0.824 . . . . 0.02 109.277 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.472 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.3 tp -150.27 129.46 12.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.309 -0.869 . . . . 3.3199999999999998 109.081 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t -85.5 -10.58 55.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.76 -0.588 . . . . 0.02 110.769 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -170.56 161.97 7.88 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.896 -1.15 . . . . 0.02 107.896 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.32 115.89 8.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.817 -1.177 . . . . 0.02 109.087 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.712 HD22 HH12 ' A' ' 13' ' ' ARG . 4.4 m120 -109.56 0.79 19.33 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.81 -1.181 . . . . 0.029999999999999999 111.595 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -156.33 154.51 30.71 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.24 -1.022 . . . . 0.02 108.24 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.9 146.72 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.031 -1.043 . . . . 0.02 110.879 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -123.04 124.04 42.23 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.886 -1.153 . . . . 0.02 107.886 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.0 t -106.45 113.91 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 106.751 -1.574 . . . . 0.02 106.751 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 32.1 tp10 -84.27 -34.52 23.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.633 . . . . 3.8100000000000001 110.435 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.51 149.32 17.24 Favored Glycine 0 N--CA 1.485 1.948 0 C-N-CA 119.029 -1.558 . . . . 0.02 110.525 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.73 172.41 48.83 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.255 -1.138 . . . . 0.01 110.255 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -118.3 134.77 54.75 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.489 -1.3 . . . . 1.48 107.489 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -127.17 154.68 44.48 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.755 -1.216 . . . . 0.02 112.443 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.37 134.1 52.24 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.349 -2.093 . . . . 0.23999999999999999 105.349 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.489 ' HB ' HD22 ' A' ' 79' ' ' LEU . 36.0 m -118.35 143.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.479 -0.763 . . . . 0.65000000000000002 109.351 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -120.84 144.42 48.36 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.37 1.081 . . . . 0.02 110.073 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.86 -33.42 75.8 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.665 -0.698 . . . . 0.02 111.47 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -124.38 157.81 63.54 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.034 -1.041 . . . . 0.02 109.491 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.27 166.45 1.08 Allowed 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.702 1.601 . . . . 0.02 112.728 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 t30 63.28 36.65 11.63 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.383 -0.826 . . . . 0.02 111.127 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 45.31 51.22 9.53 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.634 0.73 . . . . 3.3900000000000001 110.769 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.2 p -125.49 163.28 23.0 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.186 0.517 . . . . 2.3300000000000001 109.862 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.67 -161.74 31.14 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.722 -1.351 . . . . 0.02 109.722 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -64.32 138.58 58.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.33 . . . . 0.02 110.124 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -119.16 137.29 53.71 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.818 -0.551 . . . . 5.0099999999999998 109.578 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.615 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 79.4 m-85 -134.76 139.98 45.57 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.5 -0.75 . . . . 0.02 110.067 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.8 mm -95.18 130.43 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.907 -0.775 . . . . 1.72 108.907 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.488 HD22 ' CE1' ' A' ' 66' ' ' TYR . 13.8 mt -122.54 111.72 31.39 Favored Pre-proline 0 N--CA 1.507 2.39 0 O-C-N 121.338 -0.852 . . . . 0.02 110.654 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.99 170.65 19.39 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 CA-C-N 119.863 0.987 . . . . 1.47 110.13 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 58.1 tt0 -52.16 140.47 20.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.963 -1.086 . . . . 4.25 110.092 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.59 -177.75 32.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.366 -1.397 . . . . 0.02 110.84 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -120.75 131.62 54.6 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.454 -1.027 . . . . 0.95999999999999996 110.043 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.488 ' CE1' HD22 ' A' ' 61' ' ' LEU . 97.1 m-85 -122.24 95.84 46.83 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.1 Cg_endo -67.79 -3.16 9.88 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.945 1.096 . . . . 0.02 114.125 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 67.6 mt-10 -157.54 154.96 29.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.551 -1.343 . . . . 2.02 108.313 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -60.02 -39.28 85.31 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.498 -0.751 . . . . 0.02 111.734 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -59.56 -24.13 63.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.033 . . . . 0.02 110.202 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -70.49 -18.97 62.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.935 0.874 . . . . 3.4199999999999999 108.904 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.615 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.3 t90 -108.01 9.78 28.44 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.537 -1.283 . . . . 0.02 107.537 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 mmt 60.97 22.61 12.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.02 110.59 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.16 145.44 46.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.505 -1.438 . . . . 0.02 109.505 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -79.88 -31.28 40.33 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.601 -1.259 . . . . 0.97999999999999998 107.601 177.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -156.92 -171.44 3.65 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.448 -1.686 . . . . 0.02 106.448 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 16.5 p-10 -97.98 28.14 4.12 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.634 -1.291 . . . . 0.02 110.661 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.582 HH11 ' CG ' ' A' ' 78' ' ' ARG . 2.5 mtt-85 -96.42 121.93 38.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.009 -1.057 . . . . 3.2000000000000002 110.563 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.501 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 24.9 mt -144.82 121.4 11.1 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.629 -1.248 . . . . 2.6099999999999999 107.629 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.425 ' CA ' ' HE ' ' A' ' 30' ' ' ARG . . . -112.12 -16.4 9.08 Favored Glycine 0 N--CA 1.508 3.471 0 O-C-N 121.218 -0.926 . . . . 0.02 113.495 -177.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.6 p -155.51 156.87 35.97 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.244 -1.739 . . . . 0.02 110.69 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.2 p -145.73 148.32 32.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.695 -0.628 . . . . 0.02 109.903 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -137.23 141.71 42.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.365 -0.834 . . . . 0.01 109.181 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 132.11 36.48 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.166 -0.959 . . . . 0.42999999999999999 109.436 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -90.06 124.12 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.302 -0.999 . . . . 1.25 108.302 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.432 ' C ' HD23 ' A' ' 87' ' ' LEU . 61.2 m80 -92.4 131.98 37.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.819 -1.176 . . . . 1.77 108.408 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -96.39 138.25 34.25 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.082 -1.081 . . . . 1.6299999999999999 108.082 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 m -109.72 126.74 54.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.671 -0.862 . . . . 1.0800000000000001 108.671 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.9 t -103.65 -154.94 0.51 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.07 -1.826 . . . . 1.26 106.07 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.89 -49.87 0.88 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 120.552 -1.343 . . . . 0.01 111.879 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.26 -99.7 0.13 Allowed Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.825 -1.655 . . . . 0.01 111.924 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.4 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 38.5 tt0 -120.37 119.5 33.28 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.294 -1.121 . . . . 4.4299999999999997 110.523 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.515 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.71 136.68 55.87 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.501 -0.555 . . . . 2.9900000000000002 109.501 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -134.39 130.19 36.5 Favored 'General case' 0 N--CA 1.517 2.912 0 CA-C-O 122.11 0.957 . . . . 6.3600000000000003 113.029 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.43 141.76 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-N 115.637 -0.711 . . . . 1.0900000000000001 110.211 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.428 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.4 pt20 -124.95 139.7 53.59 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 107.526 -1.287 . . . . 2.0499999999999998 107.526 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.07 146.85 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 120.646 -1.284 . . . . 1.1000000000000001 111.08 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -120.84 140.29 51.97 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.256 1.027 . . . . 0.72999999999999998 111.117 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -67.94 -32.19 72.46 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.644 -0.707 . . . . 0.02 111.934 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -114.76 165.61 12.64 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.078 -1.014 . . . . 3.1800000000000002 110.43 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.26 163.12 46.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 111.069 -0.812 . . . . 0.01 111.069 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 57.65 39.06 27.8 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.608 0.718 . . . . 0.01 111.004 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 33.2 m-85 52.31 56.33 7.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 0.01 111.052 177.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -128.62 164.92 21.84 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.034 -1.098 . . . . 3.1499999999999999 108.034 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.39 -162.82 28.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.077 -1.609 . . . . 0.01 109.077 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -75.07 141.81 43.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.874 -1.368 . . . . 0.01 108.864 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.9 tmm? -116.18 143.0 46.08 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.472 0.653 . . . . 0.01 109.451 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -132.07 136.22 47.03 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.206 -1.035 . . . . 2.48 108.206 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -116.76 134.48 54.74 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.711 -0.618 . . . . 0.01 109.756 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -149.7 148.55 29.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.941 -1.099 . . . . 1.6899999999999999 111.337 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -114.48 7.95 16.35 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.106 -0.952 . . . . 0.01 109.695 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -122.27 163.41 19.71 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.545 -0.722 . . . . 3.21 111.152 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -69.62 154.83 41.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.802 . . . . 0.01 109.591 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.401 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 47.5 t -125.92 114.28 24.39 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.947 -0.76 . . . . 0.01 108.947 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -76.0 -33.64 3.52 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 CA-C-N 120.3 1.143 . . . . 0.01 111.557 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t -141.69 107.2 5.05 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.328 -0.858 . . . . 0.02 108.692 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.21 -39.41 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.715 -0.615 . . . . 1.8300000000000001 111.198 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.2 ttp -66.26 -38.13 87.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.944 -1.102 . . . . 1.3400000000000001 109.574 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -69.95 -38.73 76.22 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.63 -1.294 . . . . 2.1099999999999999 109.74 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.496 ' NE2' ' CE1' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -80.47 -47.95 13.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.188 -0.945 . . . . 2.0800000000000001 112.207 -176.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.496 ' CE1' ' NE2' ' A' ' 120' ' ' GLN . 94.8 m-85 -111.35 -1.06 16.13 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.474 -0.766 . . . . 0.02 112.884 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.457 ' ND1' ' C ' ' A' ' 121' ' ' PHE . 5.0 m80 60.26 33.7 20.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.716 -1.24 . . . . 0.02 109.707 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.44 135.63 52.91 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.784 -0.821 . . . . 0.02 108.784 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -92.83 -23.69 18.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.334 -0.854 . . . . 5.3200000000000003 110.788 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -149.21 163.69 36.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.016 -1.053 . . . . 0.02 110.121 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.2 mt -131.56 129.43 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 107.443 -1.317 . . . . 2.1699999999999999 107.443 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -107.77 -13.17 15.07 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.123 -0.986 . . . . 0.02 113.033 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.471 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.54 153.08 29.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.412 -1.43 . . . . 0.01 108.261 177.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.9 t -163.53 143.96 8.82 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.287 -1.508 . . . . 1.22 109.697 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -121.82 113.31 19.49 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.062 0.934 . . . . 1.4099999999999999 108.841 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.96 123.23 63.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 105.694 -1.965 . . . . 0.01 105.694 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.5 t -146.31 68.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 118.186 -1.406 . . . . 1.98 108.271 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER 172.51 107.87 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.537 -1.653 . . . . 0.01 106.537 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.53 -174.1 42.64 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.623 -1.391 . . . . 0.01 109.623 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 m -111.81 143.66 42.38 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.411 -1.053 . . . . 2.2999999999999998 109.214 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.515 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 61.6 m95 -128.92 146.17 51.02 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.444 -0.785 . . . . 0.01 110.424 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.11 141.15 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.398 -1.334 . . . . 1.6899999999999999 107.398 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.506 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.14 143.16 45.26 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 107.329 -1.359 . . . . 2.4900000000000002 107.329 177.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.42 144.64 49.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.623 -0.673 . . . . 0.02 109.297 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 -30.06 63.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.638 -0.664 . . . . 0.02 112.124 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.5 153.64 47.71 Favored Pre-proline 0 N--CA 1.506 2.356 0 O-C-N 120.637 -1.289 . . . . 1.48 109.223 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.72 166.93 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.344 1.362 . . . . 0.02 112.678 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.8 m120 59.46 31.36 20.99 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.188 -0.915 . . . . 0.75 111.114 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.466 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.2 m-85 57.73 51.52 9.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.55 -0.719 . . . . 0.02 110.961 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -124.7 163.54 21.83 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.487 -0.758 . . . . 0.02 109.857 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.51 -165.28 32.3 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.711 -1.356 . . . . 0.02 109.711 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -67.89 141.3 56.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.437 -1.037 . . . . 0.02 108.894 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -118.22 148.52 42.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.06 -0.718 . . . . 0.02 109.06 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -128.83 142.84 50.84 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.574 -0.704 . . . . 0.01 109.18 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.12 120.0 34.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.367 -0.833 . . . . 0.01 109.492 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.547 HD22 ' CD1' ' A' ' 162' ' ' TRP . 20.0 mt -106.12 133.08 51.4 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.36 -0.837 . . . . 0.01 110.297 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 154' ' ' LYS . 4.4 m-20 -108.79 174.63 5.79 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.356 -0.979 . . . . 2.27 108.356 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -57.12 84.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.077 -1.014 . . . . 1.8400000000000001 108.627 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 152' ' ' ASP . 90.8 mttt -137.76 169.37 17.9 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 122.0 0.905 . . . . 2.2799999999999998 111.603 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.39 110.59 20.89 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.389 -0.967 . . . . 0.01 108.389 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.57 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 90.7 m-85 -101.73 114.36 28.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.1 -1.0 . . . . 0.01 109.827 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -91.64 -25.84 18.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.096 -1.003 . . . . 0.01 111.222 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -125.44 154.09 72.43 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.061 -1.024 . . . . 2.54 108.525 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.27 -41.16 44.15 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 120.44 0.76 . . . . 0.69999999999999996 110.539 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.95 -20.07 21.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.906 -1.121 . . . . 0.85999999999999999 108.841 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -65.48 -16.17 63.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.003 -1.061 . . . . 0.02 109.787 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.57 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 2.0 m0 -96.94 11.0 37.54 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.065 -1.087 . . . . 0.02 108.065 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.59 11.78 85.14 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.414 -1.374 . . . . 0.02 110.336 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.9 141.83 32.19 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.178 -1.19 . . . . 0.02 110.096 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -8.29 58.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.791 -0.568 . . . . 0.58999999999999997 109.917 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.6 m -144.37 151.04 50.1 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 120.845 -1.159 . . . . 0.87 108.791 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.43 21.25 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 120.694 0.929 . . . . 0.38 112.368 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.489 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -83.82 122.4 28.64 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.357 1.075 . . . . 0.17999999999999999 111.602 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.489 HD12 ' C ' ' A' ' 168' ' ' ALA . 3.6 mp -149.01 125.94 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.425 -1.694 . . . . 3.9900000000000002 106.425 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -111.07 -16.44 13.48 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.176 -0.953 . . . . 5.1699999999999999 113.23 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 86.4 p -158.46 161.14 37.42 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 119.181 -2.199 . . . . 0.02 110.075 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.2 p90 -152.78 155.25 36.79 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.076 -1.015 . . . . 2.02 110.358 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.466 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 22.9 mtp180 -143.54 150.41 38.85 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.158 -0.964 . . . . 0.01 110.293 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -87.35 142.73 27.66 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.072 -0.714 . . . . 0.01 109.072 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.4 mt -93.66 127.9 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.033 -1.042 . . . . 3.04 109.279 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.7 t -136.01 146.5 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.346 -0.846 . . . . 1.8899999999999999 109.549 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 4.8899999999999997 109.477 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 109.21 -1.556 . . . . 0.01 109.21 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -148.25 136.31 21.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.898 -1.354 . . . . 0.02 110.29 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 tt -130.38 140.08 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.098 -0.705 . . . . 0.02 109.098 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -121.38 130.46 53.62 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.363 -0.836 . . . . 0.39000000000000001 110.071 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -110.06 139.7 44.9 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.657 -0.652 . . . . 0.02 109.316 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.543 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.4 m-85 -122.28 138.28 54.56 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.293 -0.879 . . . . 0.02 109.483 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -69.36 -27.3 65.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.956 -1.09 . . . . 0.029999999999999999 111.875 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -113.92 169.66 8.84 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.796 -1.19 . . . . 0.029999999999999999 110.143 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.39 158.38 32.81 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.549 0.69 . . . . 0.029999999999999999 109.647 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.4 m120 66.24 35.05 6.19 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.719 0.771 . . . . 0.73999999999999999 110.933 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.81 44.89 25.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.669 0.747 . . . . 0.02 111.403 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -112.64 165.84 11.89 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.008 -1.108 . . . . 0.02 108.008 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -167.87 34.44 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.766 -1.207 . . . . 0.029999999999999999 110.532 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.789 ' HE ' ' H ' ' A' ' 19' ' ' ARG . 9.3 tpm_? -69.33 142.96 53.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -1.088 . . . . 2.7599999999999998 108.922 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.789 ' H ' ' HE ' ' A' ' 18' ' ' ARG . 18.7 ttm180 -122.44 150.1 42.95 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.38 -0.825 . . . . 1.8899999999999999 110.331 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -135.9 132.5 36.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.155 -0.683 . . . . 0.02 109.155 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 14.6 p-10 -108.52 136.23 48.48 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.589 -0.893 . . . . 1.1200000000000001 108.589 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 15.9 t -127.68 137.77 52.6 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.666 -0.646 . . . . 0.02 110.035 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -119.9 11.05 11.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.20000000000000001 110.754 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.532 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 16.0 t -159.73 173.77 15.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.633 -1.292 . . . . 1.23 109.26 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 19.5 p-10 -63.41 145.8 54.86 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.416 -1.428 . . . . 0.02 110.931 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.9 m -135.22 119.19 17.41 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.886 -0.783 . . . . 0.02 108.886 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.482 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.79 -20.02 54.0 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.526 -0.734 . . . . 0.23999999999999999 112.24 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -154.16 106.68 2.82 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.705 -1.247 . . . . 1.1399999999999999 109.931 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.95 6.63 39.05 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.425 -0.797 . . . . 6.3700000000000001 110.202 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -61.12 -29.69 69.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 3.1099999999999999 112.052 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -76.96 -17.41 58.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.405 -1.434 . . . . 0.88 111.005 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -106.34 -21.17 13.17 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.413 -0.804 . . . . 0.02 110.621 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -149.33 127.47 12.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.092 -1.005 . . . . 3.3199999999999998 109.653 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.5 p -87.2 -12.39 46.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.618 -0.676 . . . . 0.02 111.083 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -172.28 161.94 5.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.743 -1.223 . . . . 0.02 108.479 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 t -143.73 117.06 9.04 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.001 -1.062 . . . . 0.02 109.002 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -109.64 0.12 18.9 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.708 -1.245 . . . . 0.029999999999999999 111.754 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 18.3 m -155.74 154.05 30.86 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.273 -1.01 . . . . 0.02 108.273 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -145.86 146.31 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 122.32 1.057 . . . . 0.02 110.818 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -122.77 123.68 41.61 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.594 -1.262 . . . . 0.02 107.594 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.1 t -105.64 113.63 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.87 -1.53 . . . . 0.02 106.87 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -85.13 -34.53 22.14 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.133 -0.627 . . . . 3.8100000000000001 110.07 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.4 149.15 16.96 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.599 -1.763 . . . . 0.02 110.751 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.59 172.19 48.71 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.243 -1.143 . . . . 0.01 110.243 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.5 m -118.3 134.65 54.86 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.644 -1.243 . . . . 1.48 107.644 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -127.06 154.56 44.52 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 122.624 1.202 . . . . 0.02 112.345 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.34 133.77 52.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 105.453 -2.055 . . . . 0.23999999999999999 105.453 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.1 144.19 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.519 -0.738 . . . . 0.65000000000000002 109.323 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -120.65 144.95 47.9 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.157 0.979 . . . . 0.02 109.978 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -66.77 -33.8 76.43 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.943 -0.571 . . . . 0.02 111.957 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -123.09 158.27 58.27 Favored Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 121.111 -0.993 . . . . 0.02 109.509 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -53.1 164.64 1.64 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.524 1.482 . . . . 0.02 112.636 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 64.0 37.06 9.55 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.8 0.809 . . . . 0.02 111.363 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.453 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 11.2 m-85 45.54 51.39 9.91 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.681 0.753 . . . . 3.3900000000000001 110.91 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 t -125.67 163.43 22.81 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.168 0.509 . . . . 2.3300000000000001 109.827 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.72 -161.69 31.03 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.764 -1.334 . . . . 0.02 109.764 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -64.68 139.17 58.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.932 -1.334 . . . . 0.02 110.216 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 58' ' ' MET . 3.0 ppp? -119.6 138.12 53.43 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.725 -0.609 . . . . 5.0099999999999998 109.475 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.599 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 63.8 m-85 -135.32 139.93 44.7 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.461 -0.774 . . . . 0.02 110.084 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.1 mm -93.76 130.18 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.311 -0.996 . . . . 1.72 108.311 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -121.48 111.1 33.47 Favored Pre-proline 0 N--CA 1.506 2.337 0 O-C-N 121.291 -0.881 . . . . 0.02 111.008 -178.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.04 169.79 19.85 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.738 0.942 . . . . 1.47 110.542 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -53.03 141.25 22.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.972 -1.08 . . . . 4.25 110.695 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.71 -177.76 31.84 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.47 -1.347 . . . . 0.02 110.955 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -119.68 131.29 55.38 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.367 -1.078 . . . . 0.95999999999999996 109.782 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 78.8 m-85 -121.93 98.59 44.93 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.034 -1.099 . . . . 0.02 108.034 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.425 ' O ' ' OG ' ' A' ' 38' ' ' SER . 9.8 Cg_endo -71.12 -3.25 12.51 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.82 1.013 . . . . 0.02 113.919 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -157.51 154.54 28.82 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.672 -1.267 . . . . 2.02 108.221 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -59.69 -39.32 84.19 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.462 -0.774 . . . . 0.02 111.886 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -59.85 -23.82 63.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.02 110.303 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -70.49 -18.7 62.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.301 -0.874 . . . . 3.4199999999999999 108.972 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.599 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -108.22 10.6 27.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.391 -1.337 . . . . 0.02 107.391 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.3 mmt 60.55 22.45 12.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.02 110.401 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.02 145.08 46.41 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.449 -1.46 . . . . 0.02 109.449 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -79.94 -30.53 39.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -1.174 . . . . 0.97999999999999998 107.9 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.435 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 60.4 t30 -157.16 -171.64 3.71 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.558 -1.645 . . . . 0.02 106.558 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.435 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 1.6 p30 -98.81 28.67 4.17 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.606 -1.309 . . . . 0.02 110.791 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -96.99 123.14 40.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.862 -1.149 . . . . 3.2000000000000002 111.074 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.487 HD21 ' CH2' ' A' ' 72' ' ' TRP . 85.5 mt -141.78 119.1 11.47 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.472 -1.307 . . . . 2.6099999999999999 107.472 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.96 -18.49 9.89 Favored Glycine 0 N--CA 1.502 3.062 0 O-C-N 121.008 -1.058 . . . . 0.02 112.537 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.1 m -156.11 156.52 34.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.303 -1.704 . . . . 0.02 110.387 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.0 m -144.83 147.63 33.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.801 -0.562 . . . . 0.02 109.754 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.453 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 46.6 mtp180 -137.32 141.77 41.86 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.451 -0.781 . . . . 0.01 109.162 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.86 132.13 36.7 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.26 -0.9 . . . . 0.42999999999999999 109.313 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -90.76 124.4 43.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.634 -0.876 . . . . 1.25 108.634 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -92.13 131.67 37.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.844 -1.16 . . . . 1.77 108.645 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.45 138.83 33.46 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.142 -1.058 . . . . 1.6299999999999999 108.142 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.1 p -110.73 126.42 54.54 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.783 -0.821 . . . . 1.0800000000000001 108.783 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.4 p -103.17 -154.99 0.51 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.089 -1.819 . . . . 1.26 106.089 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.7 -49.61 0.88 Allowed Glycine 0 N--CA 1.498 2.814 0 O-C-N 120.482 -1.386 . . . . 0.01 112.069 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.58 -99.7 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 118.758 -1.687 . . . . 0.01 112.091 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -120.76 120.02 34.43 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.204 -1.174 . . . . 4.4299999999999997 110.601 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.65 135.46 54.12 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.332 -0.547 . . . . 2.9900000000000002 109.612 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -133.57 130.19 38.07 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 121.103 -0.998 . . . . 6.3600000000000003 112.924 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 tt -131.75 141.3 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 115.538 -0.756 . . . . 1.0900000000000001 110.535 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.1 pt20 -124.44 139.19 54.12 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 107.56 -1.274 . . . . 2.0499999999999998 107.56 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.13 146.64 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 120.644 -1.285 . . . . 1.1000000000000001 110.942 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -119.34 139.31 52.16 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.897 0.855 . . . . 0.72999999999999998 110.65 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.5 -32.47 72.47 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.694 -0.684 . . . . 0.02 111.86 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.476 ' O ' ' OG ' ' A' ' 128' ' ' SER . 14.6 mtpp -114.67 168.32 9.98 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.04 -1.038 . . . . 3.1800000000000002 109.753 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.38 168.83 44.99 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.67 -0.776 . . . . 0.01 111.201 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.45 39.6 30.17 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.667 0.746 . . . . 0.01 111.611 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 52.68 48.8 21.72 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.58 -0.7 . . . . 0.01 111.027 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -121.79 164.35 17.61 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.378 -0.971 . . . . 3.1499999999999999 108.378 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.63 -163.38 28.47 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.389 -1.484 . . . . 0.01 109.389 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -76.01 142.57 41.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.93 -1.335 . . . . 0.01 109.143 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.458 ' C ' ' SD ' ' A' ' 107' ' ' MET . 11.2 tmm? -116.47 143.38 45.65 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.5 0.667 . . . . 0.01 109.771 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.08 136.11 46.94 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.265 -1.013 . . . . 2.48 108.265 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -116.77 134.33 54.92 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.748 -0.595 . . . . 0.01 109.856 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -149.5 148.78 29.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.885 -1.134 . . . . 1.6899999999999999 111.195 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.5 p -114.87 7.86 15.82 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.103 -0.953 . . . . 0.01 109.685 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -122.15 163.59 19.26 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.536 -0.727 . . . . 3.21 111.031 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 1.5 p30 -69.2 154.36 42.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.456 -0.777 . . . . 0.01 109.535 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.7 t -125.8 115.03 24.61 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 108.966 -0.753 . . . . 0.01 108.966 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -75.66 -33.47 3.95 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 CA-C-N 120.404 1.18 . . . . 0.01 111.687 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.4 p -141.91 108.06 5.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.325 -0.859 . . . . 0.02 109.071 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.68 -40.06 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.753 -0.592 . . . . 1.8300000000000001 110.993 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.4 ttt -66.69 -37.45 84.77 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.005 -1.078 . . . . 1.3400000000000001 109.749 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -69.74 -38.5 76.87 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.474 -1.391 . . . . 2.1099999999999999 109.819 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.31 -47.54 14.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.277 -0.889 . . . . 2.0800000000000001 112.493 -177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.51 -1.36 15.88 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.269 -0.895 . . . . 0.02 112.747 -176.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 61.25 34.01 18.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.789 -1.194 . . . . 0.02 109.697 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.1 mt -113.78 136.52 52.77 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.498 -0.751 . . . . 0.02 109.351 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -91.26 -22.49 20.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.873 . . . . 5.3200000000000003 111.074 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -148.54 163.94 35.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.907 -1.121 . . . . 0.02 110.254 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mm -127.87 125.5 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.163 -1.421 . . . . 2.1699999999999999 107.163 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -106.15 -15.41 14.88 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.865 -1.147 . . . . 0.02 113.201 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 1.2 p -157.03 155.51 31.33 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.278 -1.513 . . . . 0.01 107.942 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.6 t -163.15 146.49 10.67 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.442 -1.411 . . . . 1.22 109.737 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.77 111.49 17.22 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.432 1.11 . . . . 1.4099999999999999 108.601 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.7 t -109.16 122.67 64.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 105.584 -2.006 . . . . 0.01 105.584 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.3 t -146.43 67.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 118.128 -1.429 . . . . 1.98 108.06 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.95 108.83 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.534 -1.654 . . . . 0.01 106.534 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.82 -174.3 40.05 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.659 -1.376 . . . . 0.01 109.659 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 m -112.2 145.1 40.47 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.331 -1.1 . . . . 2.2999999999999998 109.522 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.496 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 62.8 m95 -130.03 145.87 51.68 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.535 -0.728 . . . . 0.01 110.379 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mt -116.96 141.45 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 107.639 -1.245 . . . . 1.6899999999999999 107.639 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -112.36 141.76 45.7 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 107.198 -1.408 . . . . 2.4900000000000002 107.198 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -122.06 143.78 49.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.09 -0.707 . . . . 0.02 109.09 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.34 -30.3 61.96 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.729 -0.607 . . . . 0.02 111.908 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.53 153.45 47.74 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.667 -1.271 . . . . 1.48 109.018 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.45 167.11 1.47 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.243 1.295 . . . . 0.02 112.665 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 m120 59.21 31.03 20.89 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.141 -0.936 . . . . 0.75 111.079 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.494 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.6 m-85 57.72 52.07 8.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.633 -0.667 . . . . 0.02 111.048 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -125.07 163.72 21.78 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.495 -0.753 . . . . 0.02 109.69 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.17 -165.5 32.89 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -67.81 141.22 56.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.448 -1.031 . . . . 0.02 108.92 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.64 148.48 42.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.25 -0.648 . . . . 0.02 109.25 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.52 142.72 50.98 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.959 -0.756 . . . . 0.01 108.959 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.0 tt -96.69 121.3 38.39 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.277 -0.89 . . . . 0.01 109.131 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.652 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.9 mt -106.11 135.05 48.26 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.369 -0.832 . . . . 0.01 110.261 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 154' ' ' LYS . 22.8 t70 -108.25 174.82 5.71 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.339 -0.985 . . . . 2.27 108.339 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.455 ' N ' ' CG ' ' A' ' 152' ' ' ASP . 13.2 pttp -58.72 83.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.921 -1.112 . . . . 1.8400000000000001 108.598 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 152' ' ' ASP . 55.0 mmtt -136.47 170.74 15.55 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.215 -0.928 . . . . 2.2799999999999998 111.518 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.465 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 14.5 mp0 -113.24 109.49 18.84 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.282 -1.007 . . . . 0.01 108.282 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -100.1 114.77 28.36 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.031 -1.043 . . . . 0.01 110.112 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -93.31 -25.85 17.56 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.156 -0.965 . . . . 0.01 111.643 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -125.75 153.32 73.18 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 120.762 -1.211 . . . . 2.54 108.682 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -61.04 -43.02 32.35 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 120.431 0.754 . . . . 0.69999999999999996 110.77 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.7 t -60.73 -20.52 21.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.64 -1.288 . . . . 0.85999999999999999 108.619 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -65.14 -15.99 63.02 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.068 -1.02 . . . . 0.02 109.416 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.652 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -94.85 9.87 37.51 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.945 -1.132 . . . . 0.02 107.945 178.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.09 11.27 84.95 Favored Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.18 -1.486 . . . . 0.02 109.627 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.59 142.33 31.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.557 -0.966 . . . . 0.02 110.181 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.79 -8.61 58.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.775 -0.578 . . . . 0.58999999999999997 109.885 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 58.7 m -144.19 150.59 49.22 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 120.862 -1.149 . . . . 0.87 108.687 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -76.09 21.17 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 120.781 0.987 . . . . 0.38 112.541 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 123.23 28.73 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.653 1.216 . . . . 0.17999999999999999 111.437 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.527 HG23 ' CD1' ' A' ' 138' ' ' PHE . 17.4 mt -147.25 124.51 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.316 -1.735 . . . . 3.9900000000000002 106.316 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -114.01 -17.79 11.88 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.178 -0.951 . . . . 5.1699999999999999 113.022 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.0 t -157.6 160.27 37.93 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.354 -2.091 . . . . 0.02 110.144 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -153.4 154.55 34.68 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.009 -1.057 . . . . 2.02 110.611 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.494 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 21.8 mtp180 -143.53 150.81 39.45 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 0.01 110.356 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -87.94 142.77 27.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.01 109.173 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.96 128.21 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.121 -0.987 . . . . 3.04 109.081 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.9 146.46 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.293 -0.88 . . . . 1.8899999999999999 109.708 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 4.8899999999999997 109.353 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.144 -1.583 . . . . 0.01 109.144 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.514 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 5.4 ttpm? -148.8 137.34 21.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.285 . . . . 0.02 110.414 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 tt -130.95 140.52 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 109.206 -0.664 . . . . 0.02 109.206 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -121.41 130.46 53.61 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.403 -0.811 . . . . 0.39000000000000001 110.054 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.85 140.46 45.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.737 -0.602 . . . . 0.02 109.448 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.545 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.3 m-85 -122.24 138.66 54.41 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.184 -0.947 . . . . 0.02 109.603 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.49 -27.27 65.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.08 . . . . 0.029999999999999999 111.805 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -114.32 170.28 8.42 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.816 -1.178 . . . . 0.029999999999999999 110.263 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -75.64 158.48 32.34 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.662 0.744 . . . . 0.029999999999999999 110.18 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 65.99 33.15 7.93 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.006 0.908 . . . . 0.73999999999999999 111.142 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.22 41.94 30.95 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.923 -0.58 . . . . 0.02 111.21 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -113.16 165.83 12.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.278 -1.008 . . . . 0.02 108.278 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.67 -167.67 35.38 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.882 -1.152 . . . . 0.029999999999999999 110.464 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -68.97 142.0 54.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -1.096 . . . . 2.7599999999999998 108.838 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -122.69 151.0 41.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.532 -0.73 . . . . 1.8899999999999999 109.999 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -137.52 133.87 35.04 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.756 -0.59 . . . . 0.02 109.746 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -109.44 136.08 49.43 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.973 -0.751 . . . . 1.1200000000000001 108.973 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.0 t -127.63 138.32 52.81 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.577 -0.702 . . . . 0.02 109.535 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 13.1 t70 -119.2 12.19 12.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.619 -0.676 . . . . 0.20000000000000001 110.494 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.8 p -159.65 173.4 16.15 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.898 -1.126 . . . . 1.23 109.197 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -62.64 146.09 52.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.776 -1.203 . . . . 0.02 110.586 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.7 m -133.73 117.33 16.82 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.801 -0.814 . . . . 0.02 108.801 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.32 52.01 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.314 -0.866 . . . . 0.23999999999999999 111.641 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -151.06 105.69 3.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.88 -1.137 . . . . 1.1399999999999999 109.215 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.0 4.85 42.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 6.3700000000000001 110.097 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -62.1 -29.47 70.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 3.1099999999999999 112.635 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 m -77.21 -18.22 57.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.152 -1.592 . . . . 0.88 111.647 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -106.95 -19.8 13.52 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.418 -0.801 . . . . 0.02 110.51 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -148.98 127.09 12.02 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.032 -1.042 . . . . 3.3199999999999998 109.55 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 p -87.44 -13.15 44.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.02 111.301 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -172.38 161.84 5.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.788 -1.195 . . . . 0.02 108.45 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.443 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.6 p -143.35 116.24 8.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.117 -0.989 . . . . 0.02 108.851 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -108.1 -0.73 20.95 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.829 -1.169 . . . . 0.029999999999999999 111.228 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 19.3 m -155.23 153.68 31.04 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.829 -1.174 . . . . 0.02 107.829 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.89 147.53 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 122.158 0.98 . . . . 0.02 110.551 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -123.58 124.96 43.98 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.952 -1.129 . . . . 0.02 107.952 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.27 113.79 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.672 -1.603 . . . . 0.02 106.672 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -84.76 -35.06 22.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.6 -0.687 . . . . 3.8100000000000001 110.001 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.65 149.45 17.42 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.598 -1.763 . . . . 0.02 110.778 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.75 172.1 48.57 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.237 -1.145 . . . . 0.01 110.237 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -118.48 134.36 55.13 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.592 -1.262 . . . . 1.48 107.592 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -127.03 154.31 44.81 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.704 1.24 . . . . 0.02 112.484 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.88 134.11 52.0 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 105.194 -2.15 . . . . 0.23999999999999999 105.194 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.6 m -116.38 141.95 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.65000000000000002 109.453 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -120.48 143.13 48.69 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.192 0.996 . . . . 0.02 109.649 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.84 -34.1 77.37 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.511 -0.768 . . . . 0.02 111.897 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -124.51 157.96 63.43 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.017 -1.052 . . . . 0.02 109.472 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.39 166.4 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.587 1.525 . . . . 0.02 112.769 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.55 36.59 10.99 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.242 -0.89 . . . . 0.02 111.116 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.514 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 6.0 m-85 45.56 51.6 9.81 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.603 0.716 . . . . 3.3900000000000001 110.679 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.8 m -126.1 163.62 22.68 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.291 0.567 . . . . 2.3300000000000001 109.77 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.66 31.27 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -64.78 139.21 58.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.036 -1.273 . . . . 0.02 110.268 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 19.9 ptm -119.54 136.96 54.13 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.178 0.513 . . . . 5.0099999999999998 109.722 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.444 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 93.4 m-85 -134.41 139.51 45.62 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.47 -0.768 . . . . 0.02 109.954 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 mm -94.1 130.34 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.924 -0.769 . . . . 1.72 108.924 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.546 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.55 110.69 35.32 Favored Pre-proline 0 N--CA 1.505 2.308 0 O-C-N 121.39 -0.819 . . . . 0.02 110.877 -178.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.99 169.32 20.69 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 119.823 0.972 . . . . 1.47 110.388 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -53.97 141.25 28.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.882 -1.136 . . . . 4.25 110.728 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.72 -177.64 31.91 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.509 -1.329 . . . . 0.02 110.748 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -119.42 131.38 55.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.388 -1.066 . . . . 0.95999999999999996 109.887 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 73.5 m-85 -121.67 98.09 46.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.051 -1.092 . . . . 0.02 108.051 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.423 ' O ' ' OG ' ' A' ' 38' ' ' SER . 7.3 Cg_endo -70.61 -3.82 13.36 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 120.787 0.991 . . . . 0.02 113.576 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -157.33 154.54 29.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.489 -1.382 . . . . 2.02 107.966 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -59.85 -39.07 83.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.434 -0.792 . . . . 0.02 111.722 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -59.75 -24.39 64.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.02 110.496 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -69.95 -18.89 63.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 3.4199999999999999 109.247 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.554 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.12 10.61 28.02 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.637 -1.245 . . . . 0.02 107.637 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 mtt 60.67 21.97 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.555 0.693 . . . . 0.02 110.359 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.02 144.28 44.98 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.332 -1.507 . . . . 0.02 109.332 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.2 tp -78.64 -30.46 46.38 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.502 -1.296 . . . . 0.97999999999999998 107.502 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -157.66 -171.39 3.54 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.326 -1.731 . . . . 0.02 106.326 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -98.93 28.56 4.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.62 -1.3 . . . . 0.02 110.433 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -97.84 123.3 41.74 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.026 -1.046 . . . . 3.2000000000000002 111.36 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.466 HD22 ' HB ' ' A' ' 48' ' ' VAL . 57.1 mt -142.5 119.6 11.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.259 -1.385 . . . . 2.6099999999999999 107.259 177.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.98 -18.07 10.98 Favored Glycine 0 N--CA 1.497 2.703 0 O-C-N 121.249 -0.907 . . . . 0.02 111.949 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.514 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 15.8 t -155.67 155.29 32.95 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.321 -1.693 . . . . 0.02 110.826 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 30.0 p -146.02 148.2 32.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.02 110.19 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.445 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 49.0 mtp180 -137.43 142.05 41.62 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.88 -0.785 . . . . 0.01 108.88 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.65 133.06 37.27 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.175 -0.953 . . . . 0.42999999999999999 109.276 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.18 123.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.351 -0.981 . . . . 1.25 108.351 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -91.47 131.75 36.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.678 -1.264 . . . . 1.77 107.958 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -96.52 137.28 35.83 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.145 -1.057 . . . . 1.6299999999999999 108.145 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 t -109.7 126.47 53.73 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.454 -0.943 . . . . 1.0800000000000001 108.454 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.3 m -103.47 -154.48 0.5 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.211 -1.774 . . . . 1.26 106.211 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.36 -50.12 0.88 Allowed Glycine 0 N--CA 1.497 2.748 0 O-C-N 120.692 -1.255 . . . . 0.01 111.676 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.87 -99.41 0.13 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.74 -1.695 . . . . 0.01 112.001 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.42 119.2 32.34 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.311 -1.111 . . . . 4.4299999999999997 110.457 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.601 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.79 137.52 56.68 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.765 -0.584 . . . . 2.9900000000000002 109.472 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -134.55 131.51 38.03 Favored 'General case' 0 N--CA 1.519 2.994 0 O-C-N 121.083 -1.011 . . . . 6.3600000000000003 113.19 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 tt -131.83 141.96 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 115.525 -0.761 . . . . 1.0900000000000001 110.237 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.532 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 2.3 pm0 -125.11 140.34 52.97 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 107.743 -1.206 . . . . 2.0499999999999998 107.743 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.3 145.79 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 O-C-N 120.603 -1.31 . . . . 1.1000000000000001 111.038 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 27.6 m-85 -119.79 140.05 51.37 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.218 1.009 . . . . 0.72999999999999998 110.959 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.27 -32.97 73.51 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.801 -0.636 . . . . 0.02 111.48 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -115.02 168.91 9.5 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.213 -0.929 . . . . 3.1800000000000002 109.953 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.25 169.03 47.31 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 111.011 -0.836 . . . . 0.01 111.011 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.7 t0 53.55 39.11 29.61 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.66 0.743 . . . . 0.01 111.594 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 52.53 48.41 22.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.553 -0.717 . . . . 0.01 110.828 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 24.2 t30 -121.53 164.36 17.35 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.307 -0.997 . . . . 3.1499999999999999 108.307 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 90.68 -163.13 29.52 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.118 -1.593 . . . . 0.01 109.118 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -75.48 141.82 43.03 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.839 -1.389 . . . . 0.01 109.222 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 41.3 ttp -116.39 143.39 45.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.613 0.721 . . . . 0.01 109.528 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -132.52 136.18 46.46 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.34 -0.985 . . . . 2.48 108.34 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -117.0 134.72 54.38 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.702 -0.624 . . . . 0.01 109.642 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -149.49 148.55 29.54 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.419 1.104 . . . . 1.6899999999999999 111.353 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 p -115.6 6.91 14.68 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.045 -0.98 . . . . 0.01 110.015 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.56 163.34 19.05 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.505 -0.747 . . . . 3.21 111.107 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -68.31 152.59 45.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.01 109.822 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.1 t -126.52 113.79 23.02 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.901 -0.777 . . . . 0.01 108.901 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -76.1 -33.27 3.66 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 CA-C-N 120.19 1.103 . . . . 0.01 111.658 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.4 p -140.91 106.84 5.16 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.056 0.931 . . . . 0.02 108.645 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.44 -39.36 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.772 -0.58 . . . . 1.8300000000000001 111.186 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.0 ttt -67.26 -37.24 83.15 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.024 -1.07 . . . . 1.3400000000000001 109.578 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -69.6 -38.39 77.28 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.64 -1.288 . . . . 2.1099999999999999 109.858 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.17 -46.51 16.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 2.0800000000000001 112.265 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -110.11 -0.14 18.09 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.317 -0.864 . . . . 0.02 112.694 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 59.81 33.26 21.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.653 -1.279 . . . . 0.02 109.379 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.76 135.64 53.27 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 108.676 -0.861 . . . . 0.02 108.676 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -92.34 -23.19 19.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 5.3200000000000003 110.46 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -149.16 163.32 37.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.163 -0.961 . . . . 0.02 110.073 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.4 mt -132.06 129.66 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 107.189 -1.412 . . . . 2.1699999999999999 107.189 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -105.75 -12.31 15.94 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.381 -0.928 . . . . 0.02 112.59 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.18 152.8 29.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.368 -1.458 . . . . 0.01 108.11 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 12.8 t -162.88 141.86 8.7 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.556 -1.34 . . . . 1.22 109.465 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.405 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 30.5 ttpt -124.04 114.47 19.78 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.643 1.211 . . . . 1.4099999999999999 109.656 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.39 123.75 61.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 105.614 -1.995 . . . . 0.01 105.614 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.5 HG13 ' NZ ' ' A' ' 153' ' ' LYS . 59.0 t -147.65 71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 C-N-CA 118.404 -1.318 . . . . 1.98 108.205 175.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 171.35 108.29 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.427 -1.694 . . . . 0.01 106.427 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.75 -172.31 46.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.563 -1.415 . . . . 0.01 109.563 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -110.25 140.89 43.94 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.555 -0.968 . . . . 2.2999999999999998 108.877 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.601 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 70.5 m95 -129.85 146.69 51.57 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.443 -0.786 . . . . 0.01 110.442 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 137' ' ' ILE . 61.1 mt -118.36 139.86 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 107.816 -1.179 . . . . 1.6899999999999999 107.816 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.671 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.04 141.96 46.26 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.103 -1.443 . . . . 2.4900000000000002 107.103 178.057 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 6.7 m-85 -122.55 144.39 49.12 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.593 -0.692 . . . . 0.02 109.155 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -73.92 -30.12 62.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.586 -0.696 . . . . 0.02 112.407 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.3 mt -115.05 153.56 47.17 Favored Pre-proline 0 N--CA 1.506 2.349 0 O-C-N 120.773 -1.204 . . . . 1.48 109.085 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.3 166.67 1.6 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.117 1.211 . . . . 0.02 112.522 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 59.54 30.76 20.43 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.225 -0.898 . . . . 0.75 111.114 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.56 52.21 7.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.424 -0.798 . . . . 0.02 111.272 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -125.78 163.84 21.98 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.532 -0.73 . . . . 0.02 109.959 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.67 -165.56 32.29 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.078 -1.209 . . . . 0.02 110.078 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -68.1 141.69 56.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.543 -0.975 . . . . 0.02 108.941 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -118.15 149.92 40.24 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 116.044 -0.526 . . . . 0.02 109.676 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.56 140.82 51.87 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.221 -0.659 . . . . 0.01 109.221 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.5 tp -95.13 121.69 37.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.414 -0.804 . . . . 0.01 109.191 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.63 ' CD2' ' HE1' ' A' ' 162' ' ' TRP . 5.8 mt -104.62 113.98 27.91 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.384 -0.823 . . . . 0.01 109.677 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 152' ' ' ASP . 5.3 m-20 -113.9 89.83 3.19 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 108.702 -0.851 . . . . 2.27 108.702 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.5 ' NZ ' HG13 ' A' ' 132' ' ' VAL . 51.8 tttp 49.37 78.86 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.99 -1.069 . . . . 1.8400000000000001 108.267 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -131.45 144.4 51.14 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.468 -0.77 . . . . 2.2799999999999998 111.902 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -112.98 99.79 8.13 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.329 -1.36 . . . . 0.01 107.329 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -98.06 116.72 30.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.096 -1.003 . . . . 0.01 110.853 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -97.72 -27.3 14.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.434 -0.791 . . . . 0.01 110.734 -178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -125.72 152.44 72.28 Favored Pre-proline 0 N--CA 1.502 2.137 0 N-CA-C 108.527 -0.916 . . . . 2.54 108.527 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -57.87 -47.49 20.6 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 CA-C-N 119.313 0.79 . . . . 0.69999999999999996 110.889 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.58 -23.57 29.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.829 -1.17 . . . . 0.85999999999999999 109.435 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 11.9 t0 -66.8 -16.22 64.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.777 -1.202 . . . . 0.02 109.492 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.63 ' HE1' ' CD2' ' A' ' 151' ' ' LEU . 2.2 t90 -95.06 7.83 44.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.529 -0.915 . . . . 0.02 108.529 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.98 8.18 84.67 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.904 -1.278 . . . . 0.02 109.904 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.27 142.84 30.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.552 -0.97 . . . . 0.02 110.035 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.31 -8.97 58.85 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.728 -0.608 . . . . 0.58999999999999997 109.635 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.7 t -146.46 151.38 43.33 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.825 -1.172 . . . . 0.87 108.113 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.22 24.85 0.39 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.768 0.979 . . . . 0.38 112.344 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.485 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -85.27 123.01 30.27 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.87 -1.144 . . . . 0.17999999999999999 112.803 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.671 HG23 ' CD1' ' A' ' 138' ' ' PHE . 4.6 mp -146.84 126.92 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.429 -1.693 . . . . 3.9900000000000002 106.429 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -112.16 -17.88 12.7 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.917 -1.114 . . . . 5.1699999999999999 113.605 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.8 p -157.79 160.82 38.2 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 119.18 -2.2 . . . . 0.02 110.263 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -153.2 153.74 33.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.054 -1.029 . . . . 2.02 110.766 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -144.72 152.16 39.97 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.205 -0.934 . . . . 0.01 110.908 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -88.31 141.82 28.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.118 -0.697 . . . . 0.01 109.118 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.0 mt -94.42 129.41 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.215 -0.928 . . . . 3.04 109.105 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.29 147.22 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.186 -0.946 . . . . 1.8899999999999999 109.681 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 4.8899999999999997 109.366 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.425 -1.47 . . . . 0.01 109.425 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -147.67 136.03 21.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.093 -1.239 . . . . 0.02 110.267 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -130.38 140.32 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.211 -0.663 . . . . 0.02 109.211 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.95 130.9 53.7 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.429 -0.795 . . . . 0.39000000000000001 110.191 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.9 m-85 -110.98 140.62 45.34 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.546 -0.721 . . . . 0.02 109.487 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.7 m-85 -121.89 138.1 54.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.365 -0.834 . . . . 0.02 109.49 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.43 -27.25 65.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.957 -1.09 . . . . 0.029999999999999999 111.681 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -113.88 169.63 8.85 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.927 -1.108 . . . . 0.029999999999999999 110.212 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.51 ' NH2' ' OE2' ' A' ' 68' ' ' GLU . 21.8 mtp180 -75.91 158.43 32.05 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.614 0.721 . . . . 0.029999999999999999 110.159 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 66.39 33.26 7.06 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.05 0.928 . . . . 0.73999999999999999 111.082 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 55.58 41.8 30.27 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.932 -0.576 . . . . 0.02 111.39 177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -113.44 165.72 12.19 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.357 -0.979 . . . . 0.02 108.357 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.18 -167.94 34.81 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.851 -1.166 . . . . 0.029999999999999999 110.536 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -69.03 142.84 54.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.443 -1.034 . . . . 2.7599999999999998 108.955 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -122.2 149.96 42.93 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.614 -0.679 . . . . 1.8899999999999999 110.053 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -136.59 133.02 35.91 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.329 -0.619 . . . . 0.02 109.329 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -109.22 136.79 48.12 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.761 -0.829 . . . . 1.1200000000000001 108.761 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 16.0 t -128.21 138.44 52.46 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.556 -0.715 . . . . 0.02 109.891 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -119.74 11.53 11.95 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.647 -0.658 . . . . 0.20000000000000001 110.776 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.525 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 26.7 p -159.7 173.48 15.99 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.562 -1.336 . . . . 1.23 109.418 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.09 145.89 54.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.404 -1.435 . . . . 0.02 110.688 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.9 m -135.1 119.57 18.01 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.037 -0.727 . . . . 0.02 109.037 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.25 -20.33 55.33 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.425 -0.797 . . . . 0.23999999999999999 111.918 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -153.96 106.62 2.86 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.838 -1.163 . . . . 1.1399999999999999 109.792 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.77 5.65 38.93 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.378 -0.826 . . . . 6.3700000000000001 110.289 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -60.5 -29.21 68.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 3.1099999999999999 111.976 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 p -76.86 -16.78 59.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.417 -1.427 . . . . 0.88 111.039 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -106.13 -21.63 13.07 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.326 -0.859 . . . . 0.02 110.684 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 tp -149.44 127.67 12.09 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.988 -1.07 . . . . 3.3199999999999998 109.534 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -87.63 -12.41 45.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.562 -0.711 . . . . 0.02 110.966 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -171.82 160.85 5.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.854 -1.154 . . . . 0.02 108.541 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.454 ' SG ' HD12 ' A' ' 79' ' ' LEU . 1.8 p -143.38 116.1 8.71 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.975 -1.078 . . . . 0.02 108.846 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -108.6 -0.91 19.98 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.811 -1.18 . . . . 0.029999999999999999 111.363 -178.331 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 21.1 m -154.73 153.64 31.6 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mt -146.67 147.41 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.296 1.046 . . . . 0.02 110.735 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -123.75 124.53 42.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.052 -1.092 . . . . 0.02 108.052 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 t -105.28 113.88 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.654 -1.609 . . . . 0.02 106.654 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -85.52 -34.9 21.44 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.079 -0.649 . . . . 3.8100000000000001 110.212 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.56 149.11 16.78 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 118.481 -1.819 . . . . 0.02 110.773 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.75 172.18 48.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.08 -1.208 . . . . 0.01 110.08 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.8 m -118.26 134.37 55.08 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.422 -1.325 . . . . 1.48 107.422 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -126.78 154.49 44.19 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.694 1.235 . . . . 0.02 112.411 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.25 133.97 52.36 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 105.18 -2.155 . . . . 0.23999999999999999 105.18 176.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.445 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.1 m -116.38 142.01 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.494 -0.754 . . . . 0.65000000000000002 109.268 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -120.85 143.06 49.09 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.104 0.954 . . . . 0.02 109.607 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.88 -33.82 76.93 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.527 -0.761 . . . . 0.02 111.76 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -124.76 158.01 63.98 Favored Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 120.971 -1.081 . . . . 0.02 109.366 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.29 167.14 0.87 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.548 1.499 . . . . 0.02 112.76 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 63.2 36.58 11.88 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.245 -0.888 . . . . 0.02 111.11 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.412 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 4.1 m-85 45.1 51.59 8.89 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.626 0.727 . . . . 3.3900000000000001 110.677 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.7 p -125.69 163.33 23.04 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.227 0.537 . . . . 2.3300000000000001 109.966 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.51 -161.59 31.23 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.58 -1.408 . . . . 0.02 109.58 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -65.27 138.9 58.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.962 -1.317 . . . . 0.02 110.153 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.2 ptm -118.86 137.31 53.52 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.314 0.578 . . . . 5.0099999999999998 109.717 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.426 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 97.3 m-85 -134.27 139.34 45.67 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.52 -0.738 . . . . 0.02 109.818 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.9 mm -94.54 130.5 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.906 -0.775 . . . . 1.72 108.906 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.78 110.84 34.83 Favored Pre-proline 0 N--CA 1.506 2.359 0 O-C-N 121.417 -0.802 . . . . 0.02 110.784 -178.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -78.06 169.61 20.14 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.855 0.984 . . . . 1.47 110.438 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -53.71 141.18 27.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.966 -1.084 . . . . 4.25 110.589 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.66 -177.61 31.88 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.485 -1.341 . . . . 0.02 110.94 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -119.91 131.38 55.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.377 -1.073 . . . . 0.95999999999999996 109.785 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 76.3 m-85 -121.29 97.74 47.24 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 107.959 -1.126 . . . . 0.02 107.959 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.43 ' O ' ' OG ' ' A' ' 38' ' ' SER . 4.8 Cg_endo -69.38 -4.46 13.82 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 120.731 0.954 . . . . 0.02 113.754 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.51 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 74.6 mt-10 -157.53 154.66 28.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.693 -1.255 . . . . 2.02 107.97 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -59.45 -38.69 81.4 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.473 -0.767 . . . . 0.02 111.978 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -60.36 -23.98 64.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 0.02 110.554 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -70.04 -18.78 63.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.38 -0.825 . . . . 3.4199999999999999 108.951 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.552 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.69 10.4 26.88 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.562 -1.273 . . . . 0.02 107.562 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 mtt 60.94 22.32 12.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.735 . . . . 0.02 110.457 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.36 144.48 45.46 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.389 -1.484 . . . . 0.02 109.389 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.09 -31.2 44.25 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.494 -1.299 . . . . 0.97999999999999998 107.494 177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -157.18 -171.82 3.77 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.383 -1.71 . . . . 0.02 106.383 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 92.9 m-20 -98.5 28.1 4.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.784 -1.198 . . . . 0.02 110.718 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -97.64 123.17 41.44 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.085 -1.009 . . . . 3.2000000000000002 111.422 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.454 HD12 ' SG ' ' A' ' 36' ' ' CYS . 60.0 mt -142.01 119.56 11.7 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.221 -1.4 . . . . 2.6099999999999999 107.221 177.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.22 -18.31 10.55 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.229 -0.92 . . . . 0.02 112.14 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 p -155.84 156.01 33.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.371 -1.664 . . . . 0.02 110.583 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.2 p -145.72 148.15 32.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.497 -0.752 . . . . 0.02 110.08 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.412 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 54.3 mtp180 -137.4 142.03 41.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.383 -0.823 . . . . 0.01 109.075 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.8 132.38 36.86 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.259 -0.901 . . . . 0.42999999999999999 109.394 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 t -89.52 123.75 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.43 -0.952 . . . . 1.25 108.43 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -91.84 131.87 36.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.925 -1.109 . . . . 1.77 108.267 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -96.99 138.02 35.17 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.16 -1.052 . . . . 1.6299999999999999 108.16 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 m -110.01 126.79 54.33 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.665 -0.865 . . . . 1.0800000000000001 108.665 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.4 m -103.34 -154.39 0.5 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.196 -1.779 . . . . 1.26 106.196 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.42 -49.91 0.87 Allowed Glycine 0 N--CA 1.497 2.701 0 O-C-N 120.517 -1.364 . . . . 0.01 111.891 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.28 -99.86 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 118.723 -1.703 . . . . 0.01 111.822 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -119.67 119.35 33.44 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.258 -1.142 . . . . 4.4299999999999997 110.465 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.425 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.12 135.59 54.78 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.304 -0.628 . . . . 2.9900000000000002 109.304 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -134.69 131.06 37.23 Favored 'General case' 0 N--CA 1.519 3.021 0 O-C-N 121.024 -1.047 . . . . 6.3600000000000003 113.079 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 tt -131.83 142.04 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 115.467 -0.788 . . . . 1.0900000000000001 110.384 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.53 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.4 pt20 -124.32 138.44 54.38 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 107.285 -1.376 . . . . 2.0499999999999998 107.285 176.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -124.55 147.23 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 120.586 -1.321 . . . . 1.1000000000000001 111.188 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -119.86 141.51 49.49 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 122.385 1.088 . . . . 0.72999999999999998 111.582 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -69.54 -33.18 72.42 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.738 -0.664 . . . . 0.02 111.135 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 12.0 mptt -113.84 167.73 10.39 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.185 -0.947 . . . . 3.1800000000000002 109.545 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.38 169.69 46.55 Favored Glycine 0 N--CA 1.492 2.404 0 CA-C-O 122.033 0.796 . . . . 0.01 111.318 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 53.26 40.09 30.75 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.632 0.73 . . . . 0.01 111.605 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 52.58 47.73 24.07 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.523 -0.735 . . . . 0.01 110.785 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -121.47 165.28 15.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.12 -1.066 . . . . 3.1499999999999999 108.12 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.27 -162.93 29.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.168 -1.573 . . . . 0.01 109.168 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -76.14 141.87 41.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.903 -1.351 . . . . 0.01 108.967 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 107' ' ' MET . 11.0 tmm? -116.08 143.28 45.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.497 0.665 . . . . 0.01 109.595 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -132.28 136.4 46.91 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.421 -0.955 . . . . 2.48 108.421 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -116.78 134.19 55.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.703 -0.623 . . . . 0.01 109.871 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.2 t -149.13 148.54 29.77 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 122.466 1.126 . . . . 1.6899999999999999 111.444 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -114.74 7.64 15.93 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.062 -0.972 . . . . 0.01 110.1 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.89 163.35 19.39 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.43 -0.794 . . . . 3.21 111.28 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 154.41 42.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.01 109.379 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 35.0 t -125.8 114.5 24.64 Favored Pre-proline 0 N--CA 1.5 2.025 0 N-CA-C 109.19 -0.671 . . . . 0.01 109.19 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -75.59 -33.81 3.78 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 CA-C-N 120.225 1.116 . . . . 0.01 111.488 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 55.0 m -141.46 107.55 5.2 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.921 0.867 . . . . 0.02 108.84 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.7 mt -65.01 -39.04 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.748 -0.595 . . . . 1.8300000000000001 111.182 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.6 ttt -66.88 -37.36 84.25 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.936 -1.105 . . . . 1.3400000000000001 109.577 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -69.81 -38.56 76.64 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.59 -1.319 . . . . 2.1099999999999999 109.752 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -80.16 -47.58 14.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.314 -0.866 . . . . 2.0800000000000001 112.491 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.43 -0.65 16.2 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.389 -0.82 . . . . 0.02 112.724 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m170 59.71 33.63 21.9 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.76 -1.213 . . . . 0.02 109.5 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 mt -112.3 135.28 53.17 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.637 -0.875 . . . . 0.02 108.637 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -92.45 -23.44 19.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 5.3200000000000003 110.664 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -149.34 163.63 37.16 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.218 -0.926 . . . . 0.02 110.12 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.5 mt -131.89 129.48 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.237 -1.394 . . . . 2.1699999999999999 107.237 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -106.32 -12.49 15.67 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.109 -0.994 . . . . 0.02 113.068 -176.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 1.5 p -158.9 156.23 29.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.636 -1.29 . . . . 0.01 107.519 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 3.3 t -163.18 147.18 10.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.939 -1.1 . . . . 1.22 109.541 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.75 108.93 15.01 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.132 0.968 . . . . 1.4099999999999999 108.767 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.49 121.6 61.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 105.886 -1.894 . . . . 0.01 105.886 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.1 t -147.24 69.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 118.072 -1.451 . . . . 1.98 108.289 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.68 107.56 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.238 -1.764 . . . . 0.01 106.238 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.19 -176.46 40.95 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.604 -1.399 . . . . 0.01 109.604 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.6 m -110.74 146.83 35.63 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.413 -1.051 . . . . 2.2999999999999998 109.103 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.425 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 67.4 m95 -131.54 149.11 52.64 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.491 -0.756 . . . . 0.01 110.693 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 58.8 mt -118.8 140.61 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.66 -1.237 . . . . 1.6899999999999999 107.66 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.724 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.14 141.44 46.93 Favored 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 107.314 -1.365 . . . . 2.4900000000000002 107.314 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 7.4 m-85 -122.64 145.46 48.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.408 -0.807 . . . . 0.02 109.325 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.79 -30.03 61.3 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.561 -0.712 . . . . 0.02 112.187 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.45 153.33 47.64 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 120.684 -1.26 . . . . 1.48 109.068 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.13 167.06 1.33 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.27 1.313 . . . . 0.02 112.478 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.2 t30 59.22 31.11 20.95 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.051 -0.977 . . . . 0.75 111.027 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.57 51.32 9.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.563 -0.711 . . . . 0.02 111.06 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -124.12 163.31 21.76 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.533 -0.729 . . . . 0.02 109.726 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.53 -165.13 32.18 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.889 -1.284 . . . . 0.02 109.889 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -67.84 141.62 56.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.453 -1.028 . . . . 0.02 108.877 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -117.63 149.09 41.27 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.195 -0.669 . . . . 0.02 109.195 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -128.47 141.85 51.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.5 -0.75 . . . . 0.01 109.346 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.12 118.14 31.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.258 -0.901 . . . . 0.01 108.821 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.766 HD13 ' CZ2' ' A' ' 162' ' ' TRP . 0.8 OUTLIER -106.58 135.55 47.9 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.454 -0.778 . . . . 0.01 109.519 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 154' ' ' LYS . 14.4 p30 -109.62 172.73 6.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.234 -0.917 . . . . 2.27 109.157 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -56.53 83.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.14 -0.975 . . . . 1.8400000000000001 108.738 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 152' ' ' ASP . 51.3 tttm -136.3 166.46 23.39 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.192 -0.942 . . . . 2.2799999999999998 111.332 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 1.4 pm0 -110.04 108.48 18.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.805 -1.183 . . . . 0.01 107.805 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.608 ' CE2' ' NE1' ' A' ' 162' ' ' TRP . 94.4 m-85 -99.08 114.27 26.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.026 -1.046 . . . . 0.01 110.314 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -91.98 -27.82 17.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.443 -0.786 . . . . 0.01 111.208 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -126.26 152.23 73.4 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 120.96 -1.088 . . . . 2.54 108.228 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -59.72 -44.25 32.66 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 CA-C-N 119.283 0.78 . . . . 0.69999999999999996 111.185 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.3 t -61.09 -21.62 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.789 -1.194 . . . . 0.85999999999999999 109.509 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -65.92 -15.84 63.32 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.748 -1.22 . . . . 0.02 110.057 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.766 ' CZ2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -97.39 11.22 37.4 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.548 -0.908 . . . . 0.02 108.548 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.2 10.0 86.54 Favored Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.633 -1.27 . . . . 0.02 110.346 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.71 142.39 31.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.281 -1.129 . . . . 0.02 110.146 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.2 -9.47 57.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.688 -0.633 . . . . 0.58999999999999997 110.314 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -145.51 150.49 44.13 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.703 -1.248 . . . . 0.87 108.957 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -76.19 21.23 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 120.888 1.059 . . . . 0.38 112.47 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.6 124.66 30.36 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.454 1.121 . . . . 0.17999999999999999 111.762 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.724 HG23 ' CD1' ' A' ' 138' ' ' PHE . 42.3 mt -145.71 125.91 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.526 -1.657 . . . . 3.9900000000000002 106.526 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -112.06 -20.7 11.86 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.008 -1.057 . . . . 5.1699999999999999 112.584 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.2 t -156.5 159.67 38.82 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 119.546 -1.971 . . . . 0.02 109.725 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -153.13 154.02 33.97 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.008 -1.058 . . . . 2.02 110.649 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -144.52 151.61 39.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.156 -0.965 . . . . 0.01 110.558 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -87.59 142.33 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.952 -0.759 . . . . 0.01 108.952 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.9 mt -93.93 128.8 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.145 -0.972 . . . . 3.04 109.004 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.28 146.9 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.208 -0.932 . . . . 1.8899999999999999 109.46 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 4.8899999999999997 109.502 179.876 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.106 -1.598 . . . . 0.01 109.106 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -148.46 136.03 20.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.071 -1.252 . . . . 0.02 110.209 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -130.35 140.59 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.198 -0.668 . . . . 0.02 109.198 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 t -120.86 129.82 53.68 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.544 -0.722 . . . . 0.39000000000000001 109.908 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 m-85 -109.81 139.47 44.85 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.61 -0.681 . . . . 0.02 109.239 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.5 m-85 -121.56 137.9 54.54 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.209 -0.932 . . . . 0.02 109.416 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.8 -27.34 64.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.074 -1.016 . . . . 0.029999999999999999 111.756 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.48 170.66 8.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.843 -1.161 . . . . 0.029999999999999999 109.95 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.457 ' CZ ' ' OE1' ' A' ' 68' ' ' GLU . 37.4 mtp180 -75.02 161.25 29.62 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.699 0.761 . . . . 0.029999999999999999 110.245 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.2 m120 62.68 35.03 14.38 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.937 0.875 . . . . 0.73999999999999999 110.565 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.6 p90 49.49 43.4 23.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.365 -0.834 . . . . 0.02 110.932 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -109.54 165.61 11.53 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.877 -1.157 . . . . 0.02 107.877 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.73 -167.83 33.92 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 120.748 -1.22 . . . . 0.029999999999999999 110.733 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -69.37 143.71 53.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -1.059 . . . . 2.7599999999999998 109.071 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -122.85 150.2 43.18 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.529 -0.732 . . . . 1.8899999999999999 110.24 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -136.05 133.28 37.24 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.245 -0.65 . . . . 0.02 109.245 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -109.22 135.61 50.05 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.708 -0.849 . . . . 1.1200000000000001 108.708 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.3 t -127.85 138.11 52.58 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.649 -0.657 . . . . 0.02 109.411 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 24.5 p-10 -118.89 12.1 12.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.747 -0.596 . . . . 0.20000000000000001 110.166 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.8 p -160.18 173.67 15.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.864 -1.148 . . . . 1.23 109.083 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.18 146.07 54.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.838 -1.164 . . . . 0.02 110.657 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 29' ' ' PHE . 5.5 t -133.75 117.92 17.48 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.767 -0.827 . . . . 0.02 108.767 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.53 -21.25 49.07 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.299 -0.876 . . . . 0.23999999999999999 111.865 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.99 105.79 3.29 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.784 -1.197 . . . . 1.1399999999999999 109.496 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.581 ' CD2' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -101.32 5.33 42.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.459 -0.776 . . . . 6.3700000000000001 110.351 -178.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -62.48 -29.78 70.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 3.1099999999999999 112.669 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.6 p -77.11 -19.04 57.5 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.152 -1.592 . . . . 0.88 111.806 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -106.99 -19.49 13.61 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.303 -0.873 . . . . 0.02 110.152 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -148.73 126.97 12.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.994 -1.066 . . . . 3.3199999999999998 109.39 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 m -87.43 -12.5 45.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.53 -0.732 . . . . 0.02 111.174 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -172.61 162.0 5.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.807 -1.183 . . . . 0.02 108.43 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.9 p -142.77 115.2 8.5 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.992 -1.068 . . . . 0.02 108.791 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -107.87 -1.97 20.28 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.858 -1.152 . . . . 0.029999999999999999 111.441 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.02 153.63 33.3 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 39' ' ' ILE . 9.7 mt -147.23 147.64 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.041 -1.037 . . . . 0.02 110.653 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -125.33 125.94 44.28 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.868 -1.16 . . . . 0.02 107.868 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.5 t -105.39 114.24 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 106.828 -1.545 . . . . 0.02 106.828 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -85.37 -34.83 21.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 3.8100000000000001 110.131 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.7 149.07 16.6 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 118.38 -1.867 . . . . 0.02 110.797 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.86 172.42 48.78 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.144 -1.182 . . . . 0.01 110.144 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -118.34 134.48 55.01 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.572 -1.27 . . . . 1.48 107.572 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -126.77 154.04 44.76 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.595 1.188 . . . . 0.02 112.382 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.69 133.53 52.66 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.094 -2.187 . . . . 0.23999999999999999 105.094 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.9 m -117.75 143.28 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.546 -0.721 . . . . 0.65000000000000002 109.279 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.544 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 33.1 m-85 -120.72 145.1 47.84 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.197 0.999 . . . . 0.02 109.917 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.97 -33.66 76.32 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.76 -0.654 . . . . 0.02 111.436 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -124.71 158.01 63.83 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.122 -0.986 . . . . 0.02 109.484 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.7 167.16 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.747 1.631 . . . . 0.02 112.716 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.0 t30 63.29 36.55 11.66 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.309 -0.859 . . . . 0.02 111.015 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.433 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 7.2 m-85 45.59 51.49 9.92 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.619 0.723 . . . . 3.3900000000000001 110.936 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -126.13 163.63 22.68 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.223 0.535 . . . . 2.3300000000000001 110.014 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.85 -161.87 30.99 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.895 -1.282 . . . . 0.02 109.895 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -65.16 139.5 58.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.966 -1.314 . . . . 0.02 110.134 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.544 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 49.2 ttp -118.35 137.34 53.16 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.292 0.568 . . . . 5.0099999999999998 109.827 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.564 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.6 m-85 -134.75 138.81 44.66 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.467 -0.77 . . . . 0.02 109.911 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.2 mm -94.55 130.89 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.003 -0.74 . . . . 1.72 109.003 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -120.36 110.76 35.58 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.396 -0.815 . . . . 0.02 110.631 -178.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -78.25 169.2 20.57 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.876 0.992 . . . . 1.47 110.275 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -53.79 140.64 29.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.831 -1.168 . . . . 4.25 110.558 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.17 -177.56 32.32 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.635 -1.269 . . . . 0.02 110.61 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -118.58 130.41 55.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.454 -1.027 . . . . 0.95999999999999996 109.735 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 53.2 m-85 -120.61 97.25 48.72 Favored Pre-proline 0 N--CA 1.494 1.763 0 N-CA-C 107.994 -1.113 . . . . 0.02 107.994 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -69.73 -3.72 12.55 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.69 0.926 . . . . 0.02 113.656 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.457 ' OE1' ' CZ ' ' A' ' 13' ' ' ARG . 40.6 mt-10 -157.49 154.17 28.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.579 -1.326 . . . . 2.02 108.138 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -59.63 -38.82 82.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.485 -0.759 . . . . 0.02 111.768 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -60.26 -23.92 64.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.105 -0.997 . . . . 0.02 110.283 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -70.15 -18.58 63.22 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.812 0.815 . . . . 3.4199999999999999 108.842 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.564 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -108.13 11.13 27.8 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.378 -1.342 . . . . 0.02 107.378 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' A' ' 73' ' ' MET . 1.2 mpt? 59.04 22.61 10.66 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.66 0.743 . . . . 0.02 110.435 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.48 145.16 45.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.409 -1.476 . . . . 0.02 109.409 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.38 -31.6 42.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.122 -1.222 . . . . 0.97999999999999998 107.751 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -157.07 -171.88 3.81 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.501 -1.666 . . . . 0.02 106.501 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -98.05 28.26 4.08 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.738 -1.226 . . . . 0.02 110.612 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -97.7 122.72 41.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.921 -1.112 . . . . 3.2000000000000002 111.225 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.473 HD12 ' SG ' ' A' ' 36' ' ' CYS . 61.1 mt -142.24 119.25 11.31 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.372 -1.344 . . . . 2.6099999999999999 107.372 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.79 -18.22 10.99 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.272 -0.893 . . . . 0.02 112.18 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 76.9 p -155.68 155.62 33.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.335 -1.685 . . . . 0.02 110.169 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.4 p -145.27 148.03 33.02 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.712 -0.618 . . . . 0.02 109.669 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 66.5 mtm180 -137.4 142.2 41.69 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.474 -0.766 . . . . 0.01 109.17 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.97 133.15 36.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.227 -0.92 . . . . 0.42999999999999999 109.413 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.33 123.91 42.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.593 -0.892 . . . . 1.25 108.593 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -91.75 131.67 36.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.731 -1.231 . . . . 1.77 108.147 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mt -97.12 138.57 34.44 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.194 -1.039 . . . . 1.6299999999999999 108.194 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.1 m -110.43 126.33 54.2 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.652 -0.87 . . . . 1.0800000000000001 108.652 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 t -102.96 -154.82 0.5 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.011 -1.848 . . . . 1.26 106.011 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.48 -49.27 0.89 Allowed Glycine 0 N--CA 1.496 2.694 0 O-C-N 120.472 -1.392 . . . . 0.01 111.847 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.08 -99.24 0.12 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 118.77 -1.681 . . . . 0.01 111.897 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -120.59 120.26 35.28 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.321 -1.105 . . . . 4.4299999999999997 110.595 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.478 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.28 135.83 54.98 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.365 -0.606 . . . . 2.9900000000000002 109.365 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.511 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 2.4 ttmp? -134.5 130.67 37.03 Favored 'General case' 0 N--CA 1.518 2.974 0 CA-C-O 122.258 1.028 . . . . 6.3600000000000003 113.074 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 tt -131.62 142.2 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.5 -0.773 . . . . 1.0900000000000001 110.143 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.426 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.5 pt20 -124.53 139.74 53.6 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.611 -1.255 . . . . 2.0499999999999998 107.611 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.16 145.83 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 120.68 -1.262 . . . . 1.1000000000000001 111.2 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.525 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 76.1 m-85 -120.2 139.91 51.94 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.045 0.926 . . . . 0.72999999999999998 110.758 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.31 -32.11 72.01 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.836 -0.62 . . . . 0.02 111.791 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -114.6 167.73 10.49 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.064 -1.022 . . . . 3.1800000000000002 110.352 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.53 164.35 52.79 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 111.071 -0.812 . . . . 0.01 111.071 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 57.74 38.77 27.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 122.02 -0.694 . . . . 0.01 111.595 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 52.29 54.95 9.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.519 -0.738 . . . . 0.01 111.208 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -128.97 165.46 21.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.041 -1.096 . . . . 3.1499999999999999 108.041 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.06 -162.99 30.21 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.014 -1.634 . . . . 0.01 109.014 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -75.73 141.6 42.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.879 -1.366 . . . . 0.01 109.193 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.525 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 51.1 ttp -116.48 143.09 46.02 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.645 0.736 . . . . 0.01 109.548 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -131.91 136.13 47.16 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 2.48 108.21 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.406 ' OE2' ' N ' ' A' ' 110' ' ' THR . 3.0 tm-20 -116.71 133.76 55.63 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.658 -0.651 . . . . 0.01 109.687 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.406 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 0.1 OUTLIER -149.09 148.31 29.53 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.429 1.109 . . . . 1.6899999999999999 111.088 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -115.23 7.62 15.31 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.96 -1.018 . . . . 0.01 110.152 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -122.07 163.59 19.17 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.373 -0.83 . . . . 3.21 111.214 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.56 154.85 41.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.333 -0.855 . . . . 0.01 109.309 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.604 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 20.3 p -127.32 119.79 22.03 Favored Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 109.24 -0.652 . . . . 0.01 109.24 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -76.72 -33.39 3.01 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 120.198 1.107 . . . . 0.01 110.995 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.0 m -143.45 109.05 5.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.443 -0.786 . . . . 0.02 109.304 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.5 mt -64.04 -39.48 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.83 -0.544 . . . . 1.8300000000000001 110.79 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.1 ttt -66.64 -37.27 84.47 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.102 -1.039 . . . . 1.3400000000000001 109.79 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -69.98 -38.61 76.09 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.543 -1.348 . . . . 2.1099999999999999 109.707 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -80.23 -47.06 15.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.356 -0.84 . . . . 2.0800000000000001 112.39 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -110.69 -0.62 17.06 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.376 -0.827 . . . . 0.02 112.678 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.598 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.1 m-70 59.92 33.3 21.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.749 -1.219 . . . . 0.02 109.483 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.6 135.82 52.87 Favored 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 108.761 -0.829 . . . . 0.02 108.761 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -92.72 -23.15 19.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 5.3200000000000003 110.6 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -148.89 163.32 37.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.048 -1.033 . . . . 0.02 110.082 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.0 mt -131.87 129.49 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 107.345 -1.354 . . . . 2.1699999999999999 107.345 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -107.09 -13.15 15.24 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.183 -0.948 . . . . 0.02 113.073 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.21 153.64 31.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.36 -1.462 . . . . 0.01 108.189 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.6 t -160.88 146.14 14.32 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.218 -1.551 . . . . 1.22 109.963 -178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -121.82 109.08 14.23 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.143 0.973 . . . . 1.4099999999999999 108.827 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.9 120.74 59.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.002 -1.851 . . . . 0.01 106.002 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -146.59 69.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 118.326 -1.35 . . . . 1.98 108.437 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.57 108.05 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.48 -1.674 . . . . 0.01 106.48 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.696 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 71.07 -172.84 43.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.658 -1.377 . . . . 0.01 109.658 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.24 146.05 37.64 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.466 -1.02 . . . . 2.2999999999999998 108.93 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.478 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 68.6 m95 -131.35 145.23 51.76 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.441 -0.787 . . . . 0.01 110.389 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mt -117.69 140.94 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.806 -1.183 . . . . 1.6899999999999999 107.806 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.27 143.63 44.54 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.58 -1.267 . . . . 2.4900000000000002 107.58 177.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 11.2 m-85 -122.69 144.04 49.4 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.168 -0.678 . . . . 0.02 109.168 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -73.53 -29.72 62.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.654 -0.654 . . . . 0.02 112.088 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.88 153.78 48.19 Favored Pre-proline 0 N--CA 1.506 2.353 0 O-C-N 120.584 -1.322 . . . . 1.48 109.205 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.49 166.73 1.68 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.248 1.299 . . . . 0.02 112.686 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.3 t30 59.39 31.54 21.16 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.13 -0.941 . . . . 0.75 111.076 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.41 51.38 9.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.515 -0.741 . . . . 0.02 110.962 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -124.44 163.49 21.69 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.493 -0.754 . . . . 0.02 109.77 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' A' ' 148' ' ' GLN . . . 89.58 -165.44 32.31 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.755 -1.338 . . . . 0.02 109.755 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -67.97 141.76 56.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -1.059 . . . . 0.02 108.952 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.448 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -118.5 149.07 41.91 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.109 -0.7 . . . . 0.02 109.109 -178.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.37 142.33 51.15 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.576 -0.703 . . . . 0.01 109.121 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.11 120.68 35.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.505 -0.747 . . . . 0.01 109.27 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.659 HD22 ' NE1' ' A' ' 162' ' ' TRP . 19.0 mt -105.61 133.91 49.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.01 110.727 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 1.2 m-20 -110.31 176.43 5.05 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.183 -1.043 . . . . 2.27 108.183 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.696 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 37.7 mttm -56.66 85.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.985 -1.072 . . . . 1.8400000000000001 108.571 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 44.8 mttp -136.47 165.13 26.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.233 -0.917 . . . . 2.2799999999999998 111.778 -178.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -113.27 109.1 18.19 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.951 -1.129 . . . . 0.01 107.951 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -99.67 114.64 27.86 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.139 -0.975 . . . . 0.01 110.219 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -92.17 -25.86 18.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.17 -0.956 . . . . 0.01 111.151 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -125.47 153.65 72.47 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 121.169 -0.957 . . . . 2.54 108.526 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.67 -42.09 42.01 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 CA-C-N 119.227 0.76 . . . . 0.69999999999999996 110.628 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.56 -20.38 20.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.731 -1.23 . . . . 0.85999999999999999 108.535 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 37.5 t0 -65.74 -16.25 63.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.986 -1.071 . . . . 0.02 109.531 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.659 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.86 9.59 38.58 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.847 -1.168 . . . . 0.02 107.847 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.99 10.62 86.16 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.308 -1.425 . . . . 0.02 109.716 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.91 142.11 31.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.491 -1.005 . . . . 0.02 110.162 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.08 -8.13 58.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.711 -0.618 . . . . 0.58999999999999997 109.847 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 t -143.77 148.6 43.41 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.85 -1.156 . . . . 0.87 108.535 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -74.77 21.57 0.42 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 CA-C-N 119.842 0.979 . . . . 0.38 112.231 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.02 123.77 29.78 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.538 1.161 . . . . 0.17999999999999999 111.781 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.407 ' CD1' ' CZ3' ' A' ' 162' ' ' TRP . 17.8 mt -146.59 126.63 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.773 -1.566 . . . . 3.9900000000000002 106.773 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -112.36 -19.62 12.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.071 -1.018 . . . . 5.1699999999999999 112.909 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 9.6 p -157.85 159.88 37.12 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 119.238 -2.164 . . . . 0.02 110.154 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.604 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 6.1 p90 -152.19 154.68 36.29 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.09 -1.006 . . . . 2.02 110.477 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -144.71 151.79 39.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.192 -0.943 . . . . 0.01 110.586 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -87.77 142.57 27.71 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.018 -0.734 . . . . 0.01 109.018 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.6 mt -93.63 128.88 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.091 -1.006 . . . . 3.04 109.14 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.27 146.88 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.194 -0.941 . . . . 1.8899999999999999 109.54 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.359 -0.838 . . . . 4.8899999999999997 109.435 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.365 -1.494 . . . . 0.01 109.365 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -148.23 136.52 21.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.129 -1.218 . . . . 0.02 110.333 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 tt -130.58 140.38 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.111 -0.7 . . . . 0.02 109.111 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.79 130.71 53.61 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.238 -0.914 . . . . 0.39000000000000001 110.171 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -110.9 140.3 45.49 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.577 -0.702 . . . . 0.02 109.622 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.547 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.7 m-85 -122.71 138.64 54.55 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.282 -0.886 . . . . 0.02 109.591 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -69.42 -27.28 65.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.01 -1.056 . . . . 0.029999999999999999 111.76 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.12 169.73 8.8 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.896 -1.128 . . . . 0.029999999999999999 110.127 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -75.44 158.43 32.67 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.571 0.701 . . . . 0.029999999999999999 110.196 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 m120 66.19 33.38 7.38 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.907 0.861 . . . . 0.73999999999999999 111.093 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.32 42.14 30.54 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.223 0.535 . . . . 0.02 111.136 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -113.28 165.75 12.12 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.274 -1.01 . . . . 0.02 108.274 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.08 -167.9 34.9 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.872 -1.156 . . . . 0.029999999999999999 110.576 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -69.17 142.5 54.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.382 -1.069 . . . . 2.7599999999999998 108.928 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -122.66 151.21 41.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.586 -0.696 . . . . 1.8899999999999999 110.181 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -136.83 132.77 35.11 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.193 -0.669 . . . . 0.02 109.193 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 6.6 p30 -108.38 135.93 48.87 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.369 -0.975 . . . . 1.1200000000000001 108.369 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 13.9 t -127.37 137.5 52.79 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.585 -0.697 . . . . 0.02 109.981 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.75 11.03 11.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.673 -0.642 . . . . 0.20000000000000001 110.808 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.526 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 25.0 p -159.71 173.43 16.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.574 -1.329 . . . . 1.23 109.34 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -63.1 145.54 55.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.428 -1.42 . . . . 0.02 110.801 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.7 m -135.12 119.21 17.55 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.925 -0.769 . . . . 0.02 108.925 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.98 -20.83 51.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.35 -0.844 . . . . 0.23999999999999999 112.269 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -153.53 106.64 2.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.748 -1.22 . . . . 1.1399999999999999 110.034 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.64 6.49 39.7 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.4 -0.813 . . . . 6.3700000000000001 110.401 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.96 -29.32 69.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 3.1099999999999999 112.063 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.0 m -77.01 -17.23 58.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.389 -1.445 . . . . 0.88 111.126 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -106.57 -21.09 13.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.454 -0.779 . . . . 0.02 110.555 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -149.28 127.57 12.15 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.966 -1.083 . . . . 3.3199999999999998 109.62 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.8 t -87.47 -12.58 45.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.461 -0.774 . . . . 0.02 111.267 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -172.23 161.75 5.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.02 108.41 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.8 t -143.78 117.6 9.32 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.974 -1.079 . . . . 0.02 109.201 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.57 ' N ' HD22 ' A' ' 37' ' ' ASN . 1.1 m-80 -109.56 0.0 18.96 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.746 -1.222 . . . . 0.029999999999999999 111.691 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 22.3 m -155.54 153.97 31.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.005 -1.059 . . . . 0.02 108.475 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 39' ' ' ILE . 12.8 mt -145.88 146.56 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.011 -1.055 . . . . 0.02 110.848 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -123.19 124.17 42.43 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.808 -1.182 . . . . 0.02 107.808 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.1 t -105.29 113.72 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.829 -1.545 . . . . 0.02 106.829 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -85.14 -34.66 22.09 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.997 -0.681 . . . . 3.8100000000000001 110.139 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.44 149.2 17.04 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.602 -1.761 . . . . 0.02 110.824 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.78 172.16 48.61 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.332 -1.107 . . . . 0.01 110.332 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -117.79 134.01 55.36 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.39 -1.337 . . . . 1.48 107.39 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -126.29 154.49 43.35 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.555 1.169 . . . . 0.02 112.495 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.0 133.3 53.17 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.57 -2.011 . . . . 0.23999999999999999 105.57 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.1 141.31 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.544 -0.723 . . . . 0.65000000000000002 109.154 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -120.16 143.08 48.41 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.128 0.966 . . . . 0.02 109.651 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.02 -34.09 77.6 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.641 -0.708 . . . . 0.02 111.755 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -124.49 157.78 63.98 Favored Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 120.939 -1.101 . . . . 0.02 109.615 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.26 166.56 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.733 1.622 . . . . 0.02 112.704 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 63.52 36.61 11.04 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.344 -0.843 . . . . 0.02 111.118 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.451 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.8 m-85 44.98 51.42 8.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.744 0.783 . . . . 3.3900000000000001 110.691 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 m -125.4 163.22 23.08 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.206 0.527 . . . . 2.3300000000000001 109.783 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.95 -162.07 31.0 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.599 -1.4 . . . . 0.02 109.599 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 8.3 t-80 -67.4 139.86 57.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.947 -1.325 . . . . 0.02 110.138 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 20.4 ptm -119.22 137.86 53.36 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.472 0.653 . . . . 5.0099999999999998 109.978 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 79.8 m-85 -133.92 139.85 46.42 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.465 -0.772 . . . . 0.02 109.744 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.34 132.29 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 N-CA-C 108.523 -0.917 . . . . 1.72 108.523 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.446 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.0 mt -122.48 112.6 31.06 Favored Pre-proline 0 N--CA 1.506 2.357 0 O-C-N 121.414 -0.804 . . . . 0.02 110.644 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.45 170.73 18.84 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 119.821 0.972 . . . . 1.47 110.415 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -53.12 140.33 26.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.951 -1.093 . . . . 4.25 110.534 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.49 -178.18 32.25 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.38 -1.39 . . . . 0.02 110.8 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -119.72 131.23 55.33 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.362 -1.081 . . . . 0.95999999999999996 109.896 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.446 ' CE1' HD22 ' A' ' 61' ' ' LEU . 95.4 m-85 -121.5 97.91 46.6 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 107.726 -1.212 . . . . 0.02 107.726 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 38' ' ' SER . 7.9 Cg_endo -70.64 -3.44 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 120.743 0.962 . . . . 0.02 113.761 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -157.38 154.87 29.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.54 -1.35 . . . . 2.02 108.136 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -59.69 -39.4 84.42 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.531 -0.731 . . . . 0.02 111.766 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -59.89 -24.15 64.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.02 110.474 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -70.43 -18.38 63.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.4 -0.812 . . . . 3.4199999999999999 108.846 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 2.1 t90 -107.78 10.2 28.82 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.535 -1.283 . . . . 0.02 107.535 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 10.0 mmt 60.63 22.66 12.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 0.02 110.322 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.68 144.88 47.91 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.542 -1.423 . . . . 0.02 109.542 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 mt -79.99 -30.54 39.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -1.175 . . . . 0.97999999999999998 107.946 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -157.05 -171.49 3.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.43 -1.692 . . . . 0.02 106.43 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -99.03 28.78 4.18 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.645 -1.284 . . . . 0.02 110.815 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -96.65 122.82 40.0 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.826 -1.171 . . . . 3.2000000000000002 111.146 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.51 HD21 ' CH2' ' A' ' 72' ' ' TRP . 80.8 mt -141.39 118.8 11.49 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.551 -1.277 . . . . 2.6099999999999999 107.551 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.55 -18.96 9.09 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 121.193 -0.942 . . . . 0.02 112.474 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.451 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 11.2 t -156.09 156.41 34.28 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 119.763 1.782 . . . . 0.02 111.028 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.6 p -145.85 147.83 32.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.421 -0.799 . . . . 0.02 110.501 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.422 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 49.2 mtp180 -137.14 142.04 42.25 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.511 -0.743 . . . . 0.01 109.111 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.29 131.26 36.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.129 -0.982 . . . . 0.42999999999999999 109.505 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 t -90.4 124.61 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.561 -0.903 . . . . 1.25 108.561 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -92.91 131.58 37.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.071 . . . . 1.77 108.571 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.32 139.57 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.13 -1.063 . . . . 1.6299999999999999 108.13 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.5 p -110.8 126.09 54.26 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.674 -0.861 . . . . 1.0800000000000001 108.674 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.0 t -102.66 -154.8 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.029 -1.841 . . . . 1.26 106.029 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.29 -49.36 0.89 Allowed Glycine 0 N--CA 1.497 2.754 0 O-C-N 120.473 -1.392 . . . . 0.01 111.952 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.66 -99.33 0.13 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.64 -1.743 . . . . 0.01 112.085 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -121.05 120.67 36.03 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.262 -1.14 . . . . 4.4299999999999997 110.702 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.478 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.34 135.75 54.81 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.47 -0.567 . . . . 2.9900000000000002 109.47 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.484 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 2.7 ttmp? -134.54 130.59 36.81 Favored 'General case' 0 N--CA 1.519 2.981 0 CA-C-O 122.187 0.994 . . . . 6.3600000000000003 112.936 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -132.44 141.61 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 115.62 -0.718 . . . . 1.0900000000000001 110.627 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.508 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 pm0 -124.56 140.04 53.31 Favored 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 107.568 -1.271 . . . . 2.0499999999999998 107.568 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.2 m -123.45 146.96 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 O-C-N 120.664 -1.272 . . . . 1.1000000000000001 111.236 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 24.0 m-85 -120.17 139.72 52.2 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.035 0.922 . . . . 0.72999999999999998 110.804 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.6 -32.81 71.75 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.77 -0.65 . . . . 0.02 112.304 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.487 ' O ' ' OG ' ' A' ' 128' ' ' SER . 41.0 mmtm -113.89 165.14 12.88 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.866 -1.146 . . . . 3.1800000000000002 110.059 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.93 163.06 45.11 Favored Glycine 0 N--CA 1.492 2.374 0 CA-C-O 122.034 0.797 . . . . 0.01 111.306 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.22 39.58 28.62 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.567 0.698 . . . . 0.01 111.108 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 52.5 55.69 8.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.57 -0.706 . . . . 0.01 111.036 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -128.75 164.89 22.01 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.943 -1.132 . . . . 3.1499999999999999 107.943 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.23 -162.67 28.53 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.269 -1.532 . . . . 0.01 109.269 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -75.79 142.17 42.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.93 -1.336 . . . . 0.01 109.211 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.529 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.7 ttp -116.69 143.48 45.58 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.593 0.711 . . . . 0.01 109.543 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -132.25 136.33 46.9 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.252 -1.018 . . . . 2.48 108.252 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -116.49 134.32 54.99 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.619 -0.675 . . . . 0.01 109.791 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 t -149.48 148.35 29.3 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.492 1.139 . . . . 1.6899999999999999 111.578 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.7 p -115.34 7.46 15.13 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.998 -1.001 . . . . 0.01 109.961 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -122.31 163.42 19.73 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.448 -0.783 . . . . 3.21 111.043 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.29 154.86 41.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.439 -0.788 . . . . 0.01 109.624 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.5 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 59.4 m -128.61 115.94 19.55 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.913 -0.773 . . . . 0.01 108.913 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.09 -30.89 6.57 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 CA-C-N 120.316 1.149 . . . . 0.01 111.56 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.7 p -142.61 108.25 5.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.289 -0.882 . . . . 0.02 109.115 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.5 -39.31 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.773 -0.58 . . . . 1.8300000000000001 111.062 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 15.0 tpt -66.89 -37.76 85.0 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.035 -1.066 . . . . 1.3400000000000001 109.856 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.69 -38.66 77.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.504 -1.372 . . . . 2.1099999999999999 109.887 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -80.41 -47.62 14.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.169 -0.957 . . . . 2.0800000000000001 112.472 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -111.03 -0.82 16.53 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.283 -0.886 . . . . 0.02 112.728 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 59.79 33.73 21.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.822 -1.174 . . . . 0.02 109.487 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' C ' ' SD ' ' A' ' 118' ' ' MET . 6.3 mt -112.69 135.54 53.31 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 108.737 -0.838 . . . . 0.02 108.737 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -92.37 -23.18 19.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.302 -0.874 . . . . 5.3200000000000003 110.623 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -148.96 163.44 37.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.077 -1.015 . . . . 0.02 110.121 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.6 mt -131.97 129.45 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.55 -1.278 . . . . 2.1699999999999999 107.55 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -106.65 -13.65 15.23 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.206 -0.934 . . . . 0.02 113.185 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -157.04 155.68 31.59 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.35 -1.468 . . . . 0.01 108.237 177.606 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.4 t -164.28 145.86 8.58 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.482 -1.386 . . . . 1.22 109.567 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.43 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 27.6 mtmt -121.35 112.14 18.21 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.443 1.116 . . . . 1.4099999999999999 108.905 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.2 t -107.41 122.52 61.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 105.372 -2.085 . . . . 0.01 105.372 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -145.9 67.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 118.153 -1.419 . . . . 1.98 108.133 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.01 108.29 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.563 -1.643 . . . . 0.01 106.563 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.86 -174.53 42.95 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.186 -1.165 . . . . 0.01 110.186 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.72 144.12 40.16 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.472 -1.016 . . . . 2.2999999999999998 109.036 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.478 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 65.6 m95 -129.82 145.59 51.57 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.366 -0.834 . . . . 0.01 110.294 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.7 mt -117.92 141.86 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.667 -1.234 . . . . 1.6899999999999999 107.667 178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.58 143.45 44.97 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 107.521 -1.289 . . . . 2.4900000000000002 107.521 177.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.4 m-85 -122.59 144.24 49.24 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.005 -0.739 . . . . 0.02 109.005 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.49 -29.85 62.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.722 -0.611 . . . . 0.02 111.905 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.33 153.63 47.5 Favored Pre-proline 0 N--CA 1.505 2.279 0 O-C-N 120.604 -1.31 . . . . 1.48 109.187 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.9 167.03 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.225 1.284 . . . . 0.02 112.481 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 59.64 31.12 20.72 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.119 -0.946 . . . . 0.75 111.052 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.2 m-85 58.16 51.55 8.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.547 -0.72 . . . . 0.02 111.026 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -125.1 163.73 21.76 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.435 -0.791 . . . . 0.02 109.843 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.65 -165.6 32.34 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.951 -1.26 . . . . 0.02 109.951 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -67.7 141.32 56.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.425 -1.044 . . . . 0.02 108.883 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -118.65 147.95 43.24 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.424 -0.584 . . . . 0.02 109.424 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 2.5 t80 -129.9 143.87 51.03 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.836 -0.802 . . . . 0.01 108.836 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.612 HD23 ' N ' ' A' ' 151' ' ' LEU . 1.7 tt -98.3 122.53 41.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.414 -0.804 . . . . 0.01 109.528 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.612 ' N ' HD23 ' A' ' 150' ' ' LEU . 17.0 mt -104.29 135.95 44.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.499 -0.75 . . . . 0.01 109.982 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 154' ' ' LYS . 30.0 t70 -108.61 174.47 5.86 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.221 -1.029 . . . . 2.27 108.221 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -59.38 83.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.883 -1.135 . . . . 1.8400000000000001 108.439 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 152' ' ' ASP . 66.6 mttm -136.53 172.09 13.53 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.257 -0.902 . . . . 2.2799999999999998 111.696 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -113.62 110.12 19.7 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.423 -0.955 . . . . 0.01 108.423 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.68 114.61 28.48 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.019 -1.051 . . . . 0.01 109.876 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -93.69 -25.07 17.62 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.072 -1.018 . . . . 0.01 111.668 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -126.2 153.5 74.38 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.855 -1.153 . . . . 2.54 108.987 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.15 -42.7 33.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 119.247 0.767 . . . . 0.69999999999999996 110.713 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.67 -20.58 21.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.732 -1.23 . . . . 0.85999999999999999 108.557 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -64.95 -15.81 62.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.978 -1.076 . . . . 0.02 109.383 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.612 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -95.46 9.97 38.13 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.971 -1.122 . . . . 0.02 107.971 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.73 11.41 84.55 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.173 -1.489 . . . . 0.02 109.648 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.98 142.43 31.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.453 -1.028 . . . . 0.02 110.266 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.62 -8.21 58.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.758 -0.589 . . . . 0.58999999999999997 110.022 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.3 p -144.9 150.93 47.88 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.726 -1.234 . . . . 0.87 108.819 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.37 21.58 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.833 1.022 . . . . 0.38 112.397 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.85 124.31 30.19 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.612 1.196 . . . . 0.17999999999999999 111.631 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.1 mt -147.51 127.23 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.796 -1.557 . . . . 3.9900000000000002 106.796 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -112.38 -19.08 12.31 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.187 -0.945 . . . . 5.1699999999999999 112.865 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.6 p -158.37 161.28 37.55 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.147 -2.221 . . . . 0.02 110.271 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.5 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 9.5 p90 -152.55 153.69 33.92 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.168 -0.958 . . . . 2.02 110.496 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 21.5 mtp180 -143.58 151.0 39.66 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.267 -0.896 . . . . 0.01 110.412 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -87.64 142.33 27.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.01 109.188 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.1 mt -92.98 128.24 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.133 -0.979 . . . . 3.04 109.019 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.07 146.58 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.257 -0.902 . . . . 1.8899999999999999 109.592 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 4.8899999999999997 109.404 179.948 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.273 -1.531 . . . . 0.01 109.273 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -149.23 136.91 20.35 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.095 -1.238 . . . . 0.02 110.168 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -130.23 141.14 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.201 -0.666 . . . . 0.02 109.201 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.8 t -121.3 129.92 53.37 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.523 -0.736 . . . . 0.39000000000000001 110.0 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -110.36 140.23 44.77 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.159 -0.682 . . . . 0.02 109.159 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.9 m-85 -122.67 138.71 54.52 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.105 -0.997 . . . . 0.02 109.512 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.431 ' OE2' ' NH2' ' A' ' 18' ' ' ARG . 78.5 mt-10 -68.93 -27.27 65.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.075 -1.016 . . . . 0.029999999999999999 111.693 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.31 170.28 8.41 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.902 -1.124 . . . . 0.029999999999999999 110.034 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -74.93 161.79 29.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.698 0.761 . . . . 0.029999999999999999 110.149 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 23.4 t30 62.42 35.06 15.1 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.898 0.856 . . . . 0.73999999999999999 110.594 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.69 43.2 24.32 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.396 -0.82 . . . . 0.02 111.084 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -109.73 165.82 11.39 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.827 -1.175 . . . . 0.02 107.827 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.29 -168.16 34.84 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.83 -1.176 . . . . 0.029999999999999999 110.663 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.431 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 25.9 ttp180 -69.16 143.5 54.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -1.102 . . . . 2.7599999999999998 108.962 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.422 ' NH1' ' OD2' ' A' ' 21' ' ' ASP . 5.3 tmm_? -123.54 151.22 43.09 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.541 -0.725 . . . . 1.8899999999999999 110.353 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -136.6 133.03 35.89 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.252 -0.647 . . . . 0.02 109.252 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.422 ' OD2' ' NH1' ' A' ' 19' ' ' ARG . 50.8 m-20 -109.64 136.32 49.19 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.911 -0.774 . . . . 1.1200000000000001 108.911 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.1 t -127.83 137.74 52.47 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.659 -0.65 . . . . 0.02 109.704 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -118.61 11.41 12.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.726 -0.609 . . . . 0.20000000000000001 110.157 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.5 p -159.68 173.7 15.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.848 -1.158 . . . . 1.23 109.066 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.87 145.63 54.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.842 -1.162 . . . . 0.02 110.629 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.591 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 11.6 p -135.04 119.69 18.21 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 109.004 -0.739 . . . . 0.02 109.004 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.39 -20.68 50.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.261 -0.9 . . . . 0.23999999999999999 112.275 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -152.89 107.12 3.12 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.812 -1.18 . . . . 1.1399999999999999 110.049 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.591 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.12 5.63 40.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.315 -0.865 . . . . 6.3700000000000001 110.309 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -61.22 -30.13 70.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 3.1099999999999999 112.133 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 p -76.69 -17.72 58.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.466 -1.396 . . . . 0.88 111.062 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -106.79 -21.13 13.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.392 -0.817 . . . . 0.02 110.655 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 tp -148.65 126.61 11.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.901 -1.124 . . . . 3.3199999999999998 109.556 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.2 t -87.01 -12.83 46.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.519 -0.738 . . . . 0.02 111.053 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -172.72 162.16 4.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.858 -1.151 . . . . 0.02 108.403 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.452 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.2 p -143.83 116.52 8.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.068 -1.02 . . . . 0.02 108.824 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.619 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -108.38 -0.42 20.64 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.755 -1.216 . . . . 0.029999999999999999 111.203 -178.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 t -155.36 153.46 30.5 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.856 -1.165 . . . . 0.02 107.856 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.8 mt -146.83 148.05 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.102 -0.999 . . . . 0.02 110.49 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -123.92 124.72 43.23 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.02 -1.104 . . . . 0.02 108.02 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.3 t -105.3 114.06 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.691 -1.596 . . . . 0.02 106.691 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -85.41 -34.92 21.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.447 -0.783 . . . . 3.8100000000000001 110.178 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.49 149.03 16.65 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 118.523 -1.799 . . . . 0.02 110.864 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.7 172.32 48.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.197 -1.161 . . . . 0.01 110.197 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.0 m -117.67 134.09 55.26 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.494 -1.299 . . . . 1.48 107.494 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -126.68 154.52 43.97 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.541 1.162 . . . . 0.02 112.192 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.37 134.06 52.29 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 105.502 -2.036 . . . . 0.23999999999999999 105.502 176.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.9 m -116.07 141.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.56 -0.712 . . . . 0.65000000000000002 109.292 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -120.3 142.99 48.6 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.062 0.934 . . . . 0.02 109.624 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -65.21 -34.36 78.2 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.491 -0.777 . . . . 0.02 111.904 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -124.44 158.02 63.02 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.091 -1.006 . . . . 0.02 109.495 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.04 166.55 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.642 1.561 . . . . 0.02 112.806 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 63.11 37.17 11.67 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.373 -0.83 . . . . 0.02 111.135 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.3 m-85 45.1 51.69 8.84 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.62 0.724 . . . . 3.3900000000000001 110.834 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 t -125.89 163.62 22.55 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.12 0.486 . . . . 2.3300000000000001 109.95 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.52 -161.89 31.44 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.926 -1.27 . . . . 0.02 109.926 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -64.34 138.51 58.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.996 -1.297 . . . . 0.02 110.224 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 58' ' ' MET . 12.3 tmm? -119.12 137.17 53.77 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.519 -0.549 . . . . 5.0099999999999998 109.519 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 86.4 m-85 -135.01 139.84 45.18 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.526 -0.733 . . . . 0.02 109.943 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.8 mm -94.37 130.48 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.903 -0.777 . . . . 1.72 108.903 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.558 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.73 110.86 34.89 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.386 -0.821 . . . . 0.02 110.752 -178.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.9 169.23 20.93 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 CA-C-N 119.793 0.962 . . . . 1.47 110.415 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -53.78 140.64 29.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.959 -1.088 . . . . 4.25 110.767 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.04 -177.46 32.27 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.507 -1.33 . . . . 0.02 110.722 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -119.47 131.09 55.54 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.39 -1.065 . . . . 0.95999999999999996 109.659 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.558 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 78.0 m-85 -120.99 97.85 47.86 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 107.914 -1.143 . . . . 0.02 107.914 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -69.86 -4.52 14.26 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 120.679 0.919 . . . . 0.02 113.686 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -157.47 154.06 28.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.614 -1.304 . . . . 2.02 107.992 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -59.81 -38.03 80.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.379 -0.826 . . . . 0.02 111.871 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -59.79 -24.46 64.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.02 110.446 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -69.75 -19.0 63.55 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.756 0.789 . . . . 3.4199999999999999 108.894 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.19 10.38 27.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.601 -1.259 . . . . 0.02 107.601 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.2 mmm 60.52 22.55 12.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.597 -0.689 . . . . 0.02 110.381 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.55 144.94 47.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.534 -1.427 . . . . 0.02 109.534 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.5 mt -79.51 -30.73 42.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -1.215 . . . . 0.97999999999999998 108.013 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -157.42 -171.4 3.58 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.463 -1.68 . . . . 0.02 106.463 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 14.3 p30 -98.6 28.66 4.08 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.692 -1.255 . . . . 0.02 110.64 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -97.83 122.88 41.46 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.875 -1.141 . . . . 3.2000000000000002 111.435 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.452 HD12 ' SG ' ' A' ' 36' ' ' CYS . 57.4 mt -142.66 120.06 11.64 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.298 -1.371 . . . . 2.6099999999999999 107.298 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.46 -17.99 10.75 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 121.251 -0.905 . . . . 0.02 112.295 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 22.6 t -155.79 156.15 34.27 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 119.591 1.696 . . . . 0.02 110.845 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.5 t -145.65 147.92 32.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.02 110.161 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 17.6 mtp180 -136.88 141.73 42.76 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.461 -0.774 . . . . 0.01 109.023 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.38 131.5 36.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.203 -0.936 . . . . 0.42999999999999999 109.269 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.54 124.34 43.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.816 -0.809 . . . . 1.25 108.816 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -92.47 131.91 37.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.826 -1.171 . . . . 1.77 108.737 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.36 138.5 33.86 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.127 -1.064 . . . . 1.6299999999999999 108.127 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.4 p -110.67 126.65 54.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.357 -0.839 . . . . 1.0800000000000001 108.757 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 t -103.15 -154.54 0.5 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 106.114 -1.81 . . . . 1.26 106.114 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.63 -50.31 0.86 Allowed Glycine 0 N--CA 1.498 2.799 0 O-C-N 120.456 -1.403 . . . . 0.01 112.066 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.47 -99.77 0.13 Allowed Glycine 0 N--CA 1.487 2.068 0 C-N-CA 118.683 -1.722 . . . . 0.01 112.212 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -120.51 119.54 33.27 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.261 -1.141 . . . . 4.4299999999999997 110.635 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.507 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.8 136.39 55.38 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.302 -0.559 . . . . 2.9900000000000002 109.588 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -134.85 130.93 36.76 Favored 'General case' 0 N--CA 1.518 2.942 0 CA-C-O 122.182 0.992 . . . . 6.3600000000000003 112.65 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.5 141.96 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.527 -0.76 . . . . 1.0900000000000001 110.409 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 3.5 pm0 -124.68 140.34 53.03 Favored 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 107.573 -1.269 . . . . 2.0499999999999998 107.573 176.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.87 146.2 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 O-C-N 120.618 -1.301 . . . . 1.1000000000000001 110.882 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.537 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 25.4 m-85 -119.93 139.96 51.64 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 122.347 1.07 . . . . 0.72999999999999998 110.799 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.97 -32.26 72.55 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.639 -0.709 . . . . 0.02 111.694 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -114.5 167.31 10.84 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.109 -0.994 . . . . 3.1800000000000002 110.321 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.45 164.39 52.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 111.147 -0.781 . . . . 0.01 111.147 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 57.82 38.95 27.36 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.554 0.692 . . . . 0.01 111.641 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 52.27 54.58 10.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.41 -0.806 . . . . 0.01 111.241 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 24.7 t30 -129.6 165.21 22.21 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.992 -1.114 . . . . 3.1499999999999999 107.992 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 90.94 -162.61 28.85 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.975 -1.65 . . . . 0.01 108.975 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -76.22 141.61 41.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.841 -1.388 . . . . 0.01 109.078 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.537 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.4 ttp -116.66 143.54 45.51 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.553 0.692 . . . . 0.01 109.61 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -132.28 136.23 46.79 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -116.02 134.29 55.12 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.748 -0.595 . . . . 0.01 109.754 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -149.34 148.28 29.33 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.626 1.203 . . . . 1.6899999999999999 111.501 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -115.44 7.38 14.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.872 -1.058 . . . . 0.01 109.938 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -122.38 163.35 19.94 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.391 -0.818 . . . . 3.21 111.307 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -69.69 154.33 42.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.898 . . . . 0.01 109.665 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.425 ' O ' ' OG ' ' A' ' 171' ' ' SER . 40.8 t -126.74 115.56 22.55 Favored Pre-proline 0 N--CA 1.501 2.104 0 N-CA-C 109.192 -0.67 . . . . 0.01 109.192 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.2 -32.63 5.01 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 120.358 1.164 . . . . 0.01 111.418 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 p -142.35 108.42 5.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.294 -0.879 . . . . 0.02 109.125 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.44 -39.73 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.825 -0.547 . . . . 1.8300000000000001 111.099 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.7 ttt -66.95 -37.5 84.4 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.107 -1.037 . . . . 1.3400000000000001 109.853 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.84 -38.57 76.54 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.559 -1.338 . . . . 2.1099999999999999 109.792 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -80.2 -47.55 14.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 2.0800000000000001 112.472 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.36 -0.88 16.19 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.334 -0.854 . . . . 0.02 112.727 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.4 m80 60.28 33.77 20.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.808 -1.182 . . . . 0.02 109.48 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.7 mt -112.53 135.16 53.57 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 108.62 -0.882 . . . . 0.02 108.62 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -92.29 -23.23 19.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.354 -0.841 . . . . 5.3200000000000003 110.565 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -148.97 163.57 37.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.166 -0.959 . . . . 0.02 110.008 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.2 mt -131.61 129.11 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 107.417 -1.327 . . . . 2.1699999999999999 107.417 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -107.16 -13.38 15.17 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.192 -0.943 . . . . 0.02 113.246 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.29 153.35 30.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.306 -1.496 . . . . 0.01 108.287 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.4 t -162.34 145.06 11.28 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.326 -1.484 . . . . 1.22 109.737 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.434 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 27.0 ttmt -122.29 111.53 17.03 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.3 1.048 . . . . 1.4099999999999999 108.892 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.9 t -107.51 122.62 62.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.661 -1.977 . . . . 0.01 105.661 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -146.58 67.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 118.125 -1.43 . . . . 1.98 108.222 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.69 109.04 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.597 -1.631 . . . . 0.01 106.597 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.7 -174.28 39.64 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.711 -1.356 . . . . 0.01 109.711 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.506 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.3 m -112.4 144.47 41.78 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.372 -1.076 . . . . 2.2999999999999998 109.349 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.507 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.4 m95 -129.89 146.2 51.61 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.43 -0.794 . . . . 0.01 110.392 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.6 mt -118.06 142.12 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 107.668 -1.234 . . . . 1.6899999999999999 107.668 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.67 143.92 44.27 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 107.736 -1.209 . . . . 2.4900000000000002 107.736 177.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.8 m-85 -122.53 143.52 49.67 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.966 -0.753 . . . . 0.02 108.966 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -73.02 -29.52 63.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.575 -0.703 . . . . 0.02 112.005 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.58 153.58 47.8 Favored Pre-proline 0 N--CA 1.505 2.323 0 O-C-N 120.614 -1.304 . . . . 1.48 109.198 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.58 167.05 1.57 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.359 1.372 . . . . 0.02 112.606 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 59.56 31.21 20.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.063 -0.971 . . . . 0.75 110.993 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.61 51.32 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.449 -0.782 . . . . 0.02 111.045 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -124.77 163.78 21.39 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.466 -0.771 . . . . 0.02 109.838 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.77 -165.65 32.22 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.873 -1.291 . . . . 0.02 109.873 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -67.53 141.38 56.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.564 -0.962 . . . . 0.02 109.042 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -117.9 148.4 42.18 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.28 -0.637 . . . . 0.02 109.28 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.64 142.92 50.64 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.041 -0.726 . . . . 0.01 109.041 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.636 HD23 ' C ' ' A' ' 150' ' ' LEU . 6.0 tt -97.41 121.84 39.78 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.283 -0.886 . . . . 0.01 109.485 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.656 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.5 mt -104.98 133.33 49.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.472 -0.767 . . . . 0.01 110.321 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 5.3 p-10 -107.69 173.19 6.43 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.253 -1.017 . . . . 2.27 108.253 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -57.97 84.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.972 -1.08 . . . . 1.8400000000000001 108.621 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 11.4 tptp -136.34 168.31 19.67 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.327 -0.858 . . . . 2.2799999999999998 111.068 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 5.3 mp0 -111.09 109.78 20.02 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.325 -0.991 . . . . 0.01 108.325 178.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.37 115.69 30.58 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.087 -1.008 . . . . 0.01 109.904 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -94.05 -25.49 17.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.99 -1.069 . . . . 0.01 111.375 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -125.85 153.92 73.48 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.958 -1.089 . . . . 2.54 109.008 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.03 -42.66 35.02 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 119.144 0.73 . . . . 0.69999999999999996 110.64 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.73 -20.42 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.638 -1.289 . . . . 0.85999999999999999 108.433 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -65.41 -15.75 62.92 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.961 -1.087 . . . . 0.02 109.425 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.656 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -95.21 9.72 38.69 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.943 -1.132 . . . . 0.02 107.943 178.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.49 11.04 85.49 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.204 -1.474 . . . . 0.02 109.607 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.94 142.26 31.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.382 -1.07 . . . . 0.02 110.204 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.41 -8.49 58.96 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.728 -0.608 . . . . 0.58999999999999997 109.886 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 16.5 p -144.46 150.78 48.92 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 120.849 -1.157 . . . . 0.87 108.731 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.16 21.55 0.52 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.73 0.953 . . . . 0.38 112.376 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.78 123.98 29.84 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.5 1.143 . . . . 0.17999999999999999 111.705 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.0 mt -147.07 126.92 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 106.92 -1.511 . . . . 3.9900000000000002 106.92 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -113.46 -19.22 11.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.142 -0.974 . . . . 5.1699999999999999 112.853 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 32.6 t -157.15 159.88 38.22 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 119.142 -2.224 . . . . 0.02 110.376 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -152.92 154.08 34.31 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.044 -1.035 . . . . 2.02 110.7 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -144.62 151.69 39.38 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.304 -0.872 . . . . 0.01 110.58 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -87.69 142.94 27.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.564 -0.71 . . . . 0.01 109.254 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.2 128.21 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.998 -1.064 . . . . 3.04 109.099 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -136.07 146.46 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.218 -0.927 . . . . 1.8899999999999999 109.631 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 4.8899999999999997 109.446 179.903 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.267 -1.533 . . . . 0.01 109.267 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -147.49 135.98 21.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.133 -1.216 . . . . 0.02 110.039 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.9 tt -130.58 140.09 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.218 -0.66 . . . . 0.02 109.218 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t -121.65 130.28 53.37 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.291 -0.88 . . . . 0.39000000000000001 110.077 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -110.24 139.62 45.22 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.652 -0.655 . . . . 0.02 109.397 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.3 m-85 -121.42 138.03 54.45 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.209 -0.932 . . . . 0.02 109.698 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.516 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 88.5 mt-10 -69.47 -27.52 65.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.842 -1.162 . . . . 0.029999999999999999 111.594 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -114.16 169.79 8.76 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.752 -1.217 . . . . 0.029999999999999999 110.179 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.516 ' NH2' ' OE1' ' A' ' 68' ' ' GLU . 49.9 mtp180 -75.67 158.65 32.09 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.629 0.728 . . . . 0.029999999999999999 110.121 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.41 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 8.2 t-20 65.75 33.71 8.03 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.016 0.912 . . . . 0.73999999999999999 111.072 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.52 41.74 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.974 -0.557 . . . . 0.02 111.306 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -113.69 165.57 12.4 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.265 -1.013 . . . . 0.02 108.265 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.8 -167.43 34.92 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.887 -1.149 . . . . 0.029999999999999999 110.711 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -68.24 141.51 55.9 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.554 -0.968 . . . . 2.7599999999999998 109.046 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -122.52 150.15 42.95 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.572 -0.705 . . . . 1.8899999999999999 109.87 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -137.21 133.16 34.83 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.205 -0.665 . . . . 0.02 109.205 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -108.74 136.05 48.96 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.748 -0.834 . . . . 1.1200000000000001 108.748 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 17.1 t -127.64 137.31 52.49 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.572 -0.705 . . . . 0.02 110.02 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 p30 -119.89 11.57 11.85 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.702 -0.624 . . . . 0.20000000000000001 110.704 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.527 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 32.4 t -159.64 173.22 16.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.709 -1.245 . . . . 1.23 109.262 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -62.8 145.25 55.38 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.489 -1.382 . . . . 0.02 110.611 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 m -135.23 119.48 17.76 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.51 -0.744 . . . . 0.02 109.035 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.66 -20.52 50.07 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.581 -0.699 . . . . 0.23999999999999999 112.325 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 8.9 p-10 -153.35 106.39 2.95 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.541 -1.349 . . . . 1.1399999999999999 110.103 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.8 6.59 36.76 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.242 -0.911 . . . . 6.3700000000000001 110.461 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -60.58 -28.77 68.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.853 . . . . 3.1099999999999999 111.891 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.9 p -76.69 -16.77 59.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.465 -1.397 . . . . 0.88 111.021 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -105.89 -21.62 13.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.329 -0.857 . . . . 0.02 110.624 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.9 mt -148.66 127.67 12.76 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.093 -1.005 . . . . 3.3199999999999998 109.309 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -85.9 -11.01 54.31 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.728 -0.607 . . . . 0.02 110.254 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -171.85 161.85 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.144 -1.058 . . . . 0.02 108.144 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 t -143.24 116.41 8.95 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.0 -1.063 . . . . 0.02 108.566 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.706 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.2 OUTLIER -109.77 -0.82 18.28 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 120.789 -1.194 . . . . 0.029999999999999999 112.049 -177.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 t -154.93 153.69 31.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.014 -1.053 . . . . 0.02 108.3 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 39' ' ' ILE . 11.9 mt -146.17 147.81 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.104 -0.998 . . . . 0.02 110.716 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -124.86 124.86 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.676 -1.231 . . . . 0.02 107.676 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.1 t -105.69 114.13 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.928 -1.508 . . . . 0.02 106.928 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -85.33 -34.49 21.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.548 -0.72 . . . . 3.8100000000000001 110.216 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.33 148.97 16.65 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.592 -1.766 . . . . 0.02 110.807 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.67 172.31 48.78 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.287 -1.125 . . . . 0.01 110.287 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.9 m -118.12 134.5 54.94 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.505 -1.295 . . . . 1.48 107.505 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -126.73 154.16 44.54 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.516 1.15 . . . . 0.02 112.33 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.57 133.62 52.45 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.29 -2.115 . . . . 0.23999999999999999 105.29 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -117.32 142.49 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 0.65000000000000002 109.173 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.513 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 31.9 m-85 -120.62 144.87 47.9 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.262 1.029 . . . . 0.02 110.024 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.21 -33.61 76.16 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.773 -0.649 . . . . 0.02 111.526 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -124.63 157.96 63.75 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 121.065 -1.022 . . . . 0.02 109.551 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.81 166.9 1.22 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.788 1.659 . . . . 0.02 112.794 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 63.58 36.68 10.87 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.344 -0.844 . . . . 0.02 110.968 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 45.11 51.48 8.96 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.562 0.696 . . . . 3.3900000000000001 110.78 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.3 m -125.91 163.53 22.76 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.206 0.526 . . . . 2.3300000000000001 109.918 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.78 -162.31 31.38 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.738 -1.345 . . . . 0.02 109.738 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.514 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 18.7 m-70 -64.8 138.48 58.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.35 . . . . 0.02 110.04 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.513 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 60.0 ttp -118.3 137.88 52.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.324 0.583 . . . . 5.0099999999999998 109.514 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.606 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.2 m-85 -134.98 139.33 44.81 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.469 -0.769 . . . . 0.02 109.882 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.3 130.53 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.875 -0.787 . . . . 1.72 108.875 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.91 110.6 34.82 Favored Pre-proline 0 N--CA 1.504 2.265 0 O-C-N 121.43 -0.794 . . . . 0.02 110.876 -178.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.54 169.39 21.09 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 CA-C-N 119.722 0.936 . . . . 1.47 110.317 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -53.69 140.78 28.35 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.924 -1.11 . . . . 4.25 110.562 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.42 -177.15 32.76 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.47 -1.348 . . . . 0.02 110.634 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -119.41 130.6 55.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.459 -1.024 . . . . 0.95999999999999996 109.686 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 71.1 m-85 -121.83 95.15 47.96 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.297 -1.001 . . . . 0.02 108.297 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.31 -3.57 10.19 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 120.978 1.118 . . . . 0.02 114.221 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' NH2' ' A' ' 13' ' ' ARG . 38.2 mt-10 -157.96 155.08 28.85 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.479 -1.388 . . . . 2.02 108.311 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -60.08 -38.78 83.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.594 -0.691 . . . . 0.02 112.035 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -59.7 -23.74 63.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.052 -1.03 . . . . 0.02 110.091 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -70.31 -19.11 63.1 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.774 0.797 . . . . 3.4199999999999999 108.938 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.606 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -108.36 10.75 27.5 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.517 -1.29 . . . . 0.02 107.517 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 73' ' ' MET . 2.1 mpt? 59.65 23.88 12.69 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.478 0.656 . . . . 0.02 110.563 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.0 144.86 46.5 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.785 -1.326 . . . . 0.02 109.785 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.13 -30.73 39.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -1.219 . . . . 0.97999999999999998 107.875 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -157.16 -171.93 3.82 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.413 -1.699 . . . . 0.02 106.413 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.422 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 78.4 m-20 -97.98 27.92 4.25 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.642 -1.286 . . . . 0.02 110.83 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -96.71 122.54 39.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.805 -1.184 . . . . 3.2000000000000002 111.102 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.528 HD21 ' CH2' ' A' ' 72' ' ' TRP . 86.0 mt -141.38 118.42 11.24 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.449 -1.315 . . . . 2.6099999999999999 107.449 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.49 -18.27 9.79 Favored Glycine 0 N--CA 1.501 2.997 0 O-C-N 120.992 -1.067 . . . . 0.02 112.463 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.8 p -156.25 156.01 33.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.352 -1.675 . . . . 0.02 110.351 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.0 m -145.14 148.28 33.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.749 -0.594 . . . . 0.02 109.923 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -137.15 141.75 42.22 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.456 -0.778 . . . . 0.01 109.304 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.16 132.24 36.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.106 -0.996 . . . . 0.42999999999999999 109.434 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.87 124.48 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.69 -0.856 . . . . 1.25 108.69 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -90.72 133.2 35.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.868 -1.145 . . . . 1.77 108.287 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.17 139.18 36.21 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.851 -0.796 . . . . 1.6299999999999999 108.851 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 p -110.58 123.78 50.62 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.072 -1.085 . . . . 1.0800000000000001 108.072 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.4 p -114.99 132.46 56.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.746 -1.221 . . . . 1.26 107.818 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.73 -47.98 0.01 OUTLIER Glycine 0 N--CA 1.503 3.1 0 C-N-CA 117.704 -2.189 . . . . 0.01 113.44 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.16 -103.39 0.17 Allowed Glycine 0 N--CA 1.488 2.129 0 CA-C-N 120.045 1.923 . . . . 0.01 110.927 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -119.13 118.2 30.73 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.16 -1.2 . . . . 4.4299999999999997 110.179 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.0 135.92 55.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.769 -0.582 . . . . 2.9900000000000002 109.491 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -134.86 130.06 35.39 Favored 'General case' 0 N--CA 1.519 2.977 0 O-C-N 121.128 -0.982 . . . . 6.3600000000000003 112.997 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -131.72 142.39 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-O 121.591 0.71 . . . . 1.0900000000000001 110.318 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.494 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 2.0 pt20 -124.78 139.27 54.0 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.679 -1.23 . . . . 2.0499999999999998 107.679 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.65 146.54 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.584 0 O-C-N 120.655 -1.278 . . . . 1.1000000000000001 110.96 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -121.34 140.96 51.41 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 122.084 0.945 . . . . 0.72999999999999998 111.482 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -69.09 -33.42 73.49 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.774 -0.648 . . . . 0.02 112.391 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.484 ' O ' ' OG ' ' A' ' 128' ' ' SER . 0.8 OUTLIER -113.67 165.33 12.63 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.815 -1.178 . . . . 3.1800000000000002 109.584 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.97 163.43 44.78 Favored Glycine 0 N--CA 1.492 2.376 0 CA-C-O 122.07 0.817 . . . . 0.01 111.266 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.7 t0 57.65 39.96 27.01 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.599 0.714 . . . . 0.01 111.077 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.46 55.01 9.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.632 -0.668 . . . . 0.01 111.002 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -127.07 165.72 18.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.219 -1.03 . . . . 3.1499999999999999 108.219 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.65 -163.0 29.47 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.14 -1.584 . . . . 0.01 109.14 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.492 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 58.7 tt0 -75.2 142.18 43.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.942 -1.328 . . . . 0.01 108.841 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 107' ' ' MET . 9.7 tmm? -116.46 143.28 45.78 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.566 0.698 . . . . 0.01 109.433 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.492 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 55.1 m-85 -132.17 136.04 46.79 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.349 -0.982 . . . . 2.48 108.349 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -117.01 134.07 55.21 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.697 -0.627 . . . . 0.01 109.844 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.83 149.1 29.99 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.42 1.105 . . . . 1.6899999999999999 111.313 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -115.19 7.75 15.39 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.132 -0.94 . . . . 0.01 110.321 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -121.67 163.28 19.27 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.406 -0.809 . . . . 3.21 111.255 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.21 154.84 41.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.01 109.539 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 35.1 t -126.64 114.53 22.76 Favored Pre-proline 0 N--CA 1.499 2.013 0 N-CA-C 109.049 -0.722 . . . . 0.01 109.049 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.37 -33.57 4.14 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 120.274 1.134 . . . . 0.01 111.218 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 p -141.15 107.15 5.17 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.662 -0.866 . . . . 0.02 108.662 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.82 -39.52 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.721 -0.612 . . . . 1.8300000000000001 111.23 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.6 ttt -66.77 -37.65 85.01 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.002 -1.079 . . . . 1.3400000000000001 109.727 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.72 -38.55 76.95 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.58 -1.325 . . . . 2.1099999999999999 109.693 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -80.18 -47.47 14.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 2.0800000000000001 112.359 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -111.02 -1.1 16.43 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.413 -0.804 . . . . 0.02 112.84 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 m80 59.97 33.23 21.4 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.621 -1.299 . . . . 0.02 109.503 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.1 mt -111.63 135.02 52.79 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.805 -0.813 . . . . 0.02 108.805 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -93.65 -24.01 18.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.284 -0.885 . . . . 5.3200000000000003 110.688 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -148.42 162.55 39.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.259 -0.9 . . . . 0.02 109.791 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.5 mt -133.18 130.2 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 107.64 -1.244 . . . . 2.1699999999999999 107.64 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.52 -13.72 15.25 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 113.524 0.935 . . . . 0.02 113.524 -176.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -157.45 156.37 32.02 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.256 -1.527 . . . . 0.01 108.396 177.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.4 t -162.11 146.81 12.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.478 -1.389 . . . . 1.22 109.93 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -120.03 108.54 14.42 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.137 0.97 . . . . 1.4099999999999999 108.445 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 t -107.09 120.35 58.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 105.795 -1.928 . . . . 0.01 105.795 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 t -146.63 68.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 118.043 -1.463 . . . . 1.98 108.304 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.6 108.3 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.505 -1.665 . . . . 0.01 106.505 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.24 -174.31 44.51 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.737 -1.345 . . . . 0.01 109.737 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.48 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.7 m -111.92 145.69 39.11 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.369 -1.077 . . . . 2.2999999999999998 109.088 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.419 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 76.8 m95 -131.32 145.29 51.8 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.552 -0.718 . . . . 0.01 110.741 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.2 mt -117.7 142.01 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 107.421 -1.325 . . . . 1.6899999999999999 107.421 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -115.12 143.9 44.49 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 107.499 -1.297 . . . . 2.4900000000000002 107.499 177.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 18.0 m-85 -122.42 144.67 48.9 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.948 -0.76 . . . . 0.02 108.948 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.01 -30.0 62.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.02 112.06 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.17 153.96 47.32 Favored Pre-proline 0 N--CA 1.506 2.351 0 O-C-N 120.593 -1.317 . . . . 1.48 109.292 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.71 166.27 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.192 1.262 . . . . 0.02 112.615 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 59.84 31.31 20.7 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.149 -0.932 . . . . 0.75 111.186 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 57.74 51.94 8.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.02 110.926 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -125.09 163.67 21.89 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.486 -0.759 . . . . 0.02 109.747 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.51 -165.37 32.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.751 -1.34 . . . . 0.02 109.751 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -67.97 141.72 56.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.629 -0.924 . . . . 0.02 108.949 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.464 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 3.2 mp0 -118.51 148.41 42.65 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.463 -0.569 . . . . 0.02 109.463 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.516 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.7 t80 -129.33 142.9 50.7 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.013 -0.736 . . . . 0.01 109.013 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 150' ' ' LEU . 5.8 tt -96.75 121.8 39.0 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.293 -0.88 . . . . 0.01 109.345 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.654 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.4 mt -104.66 133.51 49.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.506 -0.746 . . . . 0.01 110.225 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 154' ' ' LYS . 21.1 t0 -108.83 175.39 5.48 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.341 -0.985 . . . . 2.27 108.341 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -57.41 84.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.84 -1.162 . . . . 1.8400000000000001 108.626 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 152' ' ' ASP . 35.4 mttp -137.73 168.42 19.72 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.191 0.996 . . . . 2.2799999999999998 111.647 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -113.33 109.82 19.34 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.26 -1.015 . . . . 0.01 108.26 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -99.77 115.87 30.54 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.022 -1.049 . . . . 0.01 109.931 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -93.52 -25.4 17.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.079 -1.013 . . . . 0.01 111.433 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -125.89 153.42 73.56 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 120.786 -1.196 . . . . 2.54 108.613 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.16 -41.7 41.14 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 CA-C-N 119.281 0.779 . . . . 0.69999999999999996 110.584 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.58 -20.58 21.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.769 -1.207 . . . . 0.85999999999999999 108.586 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.49 -15.77 62.99 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.029 -1.044 . . . . 0.02 109.625 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.654 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -95.34 9.87 38.31 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 107.919 -1.141 . . . . 0.02 107.919 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.38 10.8 85.48 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.205 -1.474 . . . . 0.02 109.588 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.76 142.43 31.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.469 -1.018 . . . . 0.02 110.282 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.63 -8.59 58.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.728 -0.608 . . . . 0.58999999999999997 110.007 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.3 p -144.68 150.99 48.85 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.737 -1.227 . . . . 0.87 108.789 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.97 21.72 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 120.899 1.066 . . . . 0.38 112.331 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.19 123.89 29.99 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.623 1.201 . . . . 0.17999999999999999 111.563 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.0 mt -146.66 126.75 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 106.765 -1.569 . . . . 3.9900000000000002 106.765 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -113.17 -20.34 11.48 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.112 -0.993 . . . . 5.1699999999999999 112.835 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.1 p -157.76 160.13 37.53 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.172 -2.205 . . . . 0.02 110.233 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -153.04 154.9 35.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.184 -0.948 . . . . 2.02 110.683 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -145.03 151.63 38.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.263 -0.898 . . . . 0.01 110.539 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -87.73 142.08 28.1 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.524 -0.735 . . . . 0.01 109.406 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.3 mt -92.2 128.17 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.137 -0.977 . . . . 3.04 109.241 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.7 t -136.35 146.83 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.151 -0.968 . . . . 1.8899999999999999 109.487 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 4.8899999999999997 109.441 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.405 -0.591 . . . . 5.2800000000000002 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -76.3 64.31 2.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 5.96 109.528 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.6 m -80.91 143.1 32.92 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.32 -0.993 . . . . 2.2200000000000002 108.32 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.39 -179.72 47.29 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 118.332 -1.889 . . . . 0.81000000000000005 112.082 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.71 157.7 44.11 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.275 -1.53 . . . . 0.01 109.275 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -148.45 136.78 21.24 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.128 -1.219 . . . . 0.02 110.337 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.73 140.94 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 109.17 -0.678 . . . . 0.02 109.17 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -121.5 130.25 53.43 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.396 -0.815 . . . . 0.39000000000000001 110.089 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.1 m-85 -110.18 140.14 44.6 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.598 -0.689 . . . . 0.02 109.27 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.0 m-85 -122.04 138.21 54.52 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.155 -0.965 . . . . 0.02 109.58 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -69.62 -27.37 65.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 0.029999999999999999 111.788 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 3.0 m-20 -113.89 169.44 8.99 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.85 -1.156 . . . . 0.029999999999999999 110.091 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -75.15 158.3 33.26 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.606 0.717 . . . . 0.029999999999999999 110.095 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 0.8 OUTLIER 66.05 35.07 6.52 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.745 0.784 . . . . 0.73999999999999999 110.76 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.5 p90 49.82 44.31 25.01 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.606 -0.724 . . . . 0.02 111.19 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -112.71 166.05 11.72 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.95 -167.58 34.8 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 120.736 -1.228 . . . . 0.029999999999999999 110.415 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -69.36 142.68 53.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -1.024 . . . . 2.7599999999999998 109.036 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -122.06 150.13 42.56 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.521 -0.737 . . . . 1.8899999999999999 110.065 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -135.93 132.88 37.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.749 -0.594 . . . . 0.02 109.516 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -110.25 135.96 50.19 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.398 -0.814 . . . . 1.1200000000000001 109.118 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.489 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 43.6 t -128.43 138.49 52.34 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.524 -0.735 . . . . 0.02 109.411 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 34.2 p-10 -119.16 11.88 12.48 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.624 -0.672 . . . . 0.20000000000000001 110.392 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 4.3 p -159.42 173.45 16.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.765 -1.209 . . . . 1.23 109.05 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 13.2 p-10 -63.15 145.98 54.32 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.693 -1.254 . . . . 0.02 110.612 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.561 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 45.0 t -134.95 118.54 16.98 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.144 -0.687 . . . . 0.02 109.144 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.4 -21.62 52.87 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.53 -0.731 . . . . 0.23999999999999999 111.605 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -154.49 105.06 2.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.845 -1.159 . . . . 1.1399999999999999 109.506 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.4 OUTLIER -101.84 8.88 41.16 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.427 -0.796 . . . . 6.3700000000000001 109.875 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.46 -28.55 68.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.435 -0.79 . . . . 3.1099999999999999 112.033 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.7 m -76.83 -17.32 59.07 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.35 -1.469 . . . . 0.88 111.235 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 27.8 m-85 -107.22 -20.48 13.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.381 -0.824 . . . . 0.02 110.393 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tp -148.93 127.15 12.11 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.026 -1.046 . . . . 3.3199999999999998 109.51 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.8 p -87.1 -12.26 47.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.558 -0.714 . . . . 0.02 111.329 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -172.02 161.98 5.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.807 -1.183 . . . . 0.02 108.283 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.8 t -143.52 116.61 8.91 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.96 -1.088 . . . . 0.02 108.984 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.534 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -109.7 0.5 18.98 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.792 -1.193 . . . . 0.029999999999999999 111.714 -178.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 m -156.09 153.84 30.01 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.276 -1.009 . . . . 0.02 108.276 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.8 mt -146.24 146.9 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.946 -1.096 . . . . 0.02 110.715 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -123.79 124.62 43.08 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.485 -1.302 . . . . 0.02 107.485 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.21 114.39 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.843 -1.54 . . . . 0.02 106.843 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -84.94 -34.85 22.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.565 -0.71 . . . . 3.8100000000000001 109.906 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.61 149.34 17.22 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.497 -1.811 . . . . 0.02 110.976 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.1 171.84 48.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 110.386 -1.086 . . . . 0.01 110.386 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.1 m -118.02 134.03 55.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.554 -1.276 . . . . 1.48 107.554 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.1 m95 -128.27 155.69 44.19 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 122.636 1.208 . . . . 0.02 112.27 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.83 134.0 52.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.493 -2.04 . . . . 0.23999999999999999 105.493 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.408 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.6 m -117.08 142.45 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.936 -0.764 . . . . 0.65000000000000002 108.936 179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -120.83 144.98 48.07 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.386 1.089 . . . . 0.02 110.092 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -66.17 -34.0 77.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.721 -0.672 . . . . 0.02 111.472 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -124.44 157.9 63.44 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 121.097 -1.002 . . . . 0.02 109.449 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.56 166.47 1.25 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.766 1.644 . . . . 0.02 112.783 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 m-20 63.71 36.36 10.75 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.366 -0.834 . . . . 0.02 111.15 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 5.1 m-85 45.67 51.74 9.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.567 0.699 . . . . 3.3900000000000001 110.732 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 p -126.23 163.74 22.51 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.203 0.525 . . . . 2.3300000000000001 109.993 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.38 -161.56 31.39 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.748 -1.341 . . . . 0.02 109.748 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -64.54 138.79 58.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.936 -1.332 . . . . 0.02 110.042 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 21.2 ptm -119.61 137.49 53.83 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.208 0.528 . . . . 5.0099999999999998 109.736 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.58 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 95.1 m-85 -134.61 139.67 45.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.434 -0.791 . . . . 0.02 110.127 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 mm -93.79 130.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 108.736 -0.838 . . . . 1.72 108.736 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.483 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -120.91 110.48 34.91 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.425 -0.797 . . . . 0.02 110.63 -178.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -78.09 169.76 19.85 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 119.767 0.953 . . . . 1.47 110.17 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -53.55 140.84 27.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.818 -1.176 . . . . 4.25 110.496 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.55 -177.37 32.74 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.462 -1.352 . . . . 0.02 110.611 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -119.3 130.42 55.38 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.402 -1.058 . . . . 0.95999999999999996 109.708 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.483 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 32.1 m-85 -122.94 91.92 49.49 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 108.296 -1.002 . . . . 0.02 108.296 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -65.95 -2.83 7.28 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.115 1.21 . . . . 0.02 113.739 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -156.93 151.05 24.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.335 -1.478 . . . . 2.02 107.88 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -59.59 -38.94 82.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.662 -0.649 . . . . 0.02 112.538 -176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -60.36 -23.47 64.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.026 -1.046 . . . . 0.02 111.079 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -73.13 -15.54 61.47 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.79 -1.164 . . . . 3.4199999999999999 108.752 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.58 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -107.63 9.35 29.33 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.3 -1.37 . . . . 0.02 107.3 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.0 mtm 62.11 22.91 13.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.685 -0.635 . . . . 0.02 110.923 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.21 145.05 46.85 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.748 -1.341 . . . . 0.02 109.748 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.76 -31.7 35.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -1.209 . . . . 0.97999999999999998 107.949 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.721 HD22 ' H ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -157.28 -172.27 3.94 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.467 -1.679 . . . . 0.02 106.467 178.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.29 27.65 4.55 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.768 -1.208 . . . . 0.02 110.654 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.721 ' H ' HD22 ' A' ' 76' ' ' ASN . 68.7 mtm180 -96.34 122.52 39.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.881 -1.137 . . . . 3.2000000000000002 110.864 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 79' ' ' LEU . 83.5 mt -142.44 119.06 11.04 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.771 -1.196 . . . . 2.6099999999999999 107.771 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.1 -18.28 10.03 Favored Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.138 -0.976 . . . . 0.02 112.511 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.5 p -156.12 156.52 34.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.255 -1.732 . . . . 0.02 110.394 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 56.4 m -145.47 148.23 33.04 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.719 -0.613 . . . . 0.02 109.841 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.44 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 54.6 mtm180 -137.39 141.97 41.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.331 -0.855 . . . . 0.01 109.311 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.21 132.79 36.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.213 -0.93 . . . . 0.42999999999999999 109.496 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.74 124.03 42.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.242 -1.021 . . . . 1.25 108.242 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -91.31 134.57 34.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.823 -1.173 . . . . 1.77 108.507 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.61 135.41 40.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.841 -1.17 . . . . 1.6299999999999999 107.841 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.7 p -109.37 127.63 54.5 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.763 -0.828 . . . . 1.0800000000000001 108.763 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -105.19 -153.78 0.5 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 106.314 -1.736 . . . . 1.26 106.314 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.59 -50.63 0.86 Allowed Glycine 0 N--CA 1.499 2.849 0 O-C-N 120.528 -1.358 . . . . 0.01 111.846 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.73 -100.73 0.15 Allowed Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.867 -1.635 . . . . 0.01 111.402 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -119.61 118.11 30.12 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.185 -1.185 . . . . 4.4299999999999997 110.243 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.493 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.19 136.69 56.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.385 -0.598 . . . . 2.9900000000000002 109.385 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -134.38 130.4 36.83 Favored 'General case' 0 N--CA 1.519 2.988 0 O-C-N 121.06 -1.025 . . . . 6.3600000000000003 113.048 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.17 143.49 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 115.63 -0.713 . . . . 1.0900000000000001 110.591 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.413 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.9 pt20 -124.89 139.71 53.58 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.771 -1.196 . . . . 2.0499999999999998 107.771 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -124.22 145.69 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 120.652 -1.28 . . . . 1.1000000000000001 111.189 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.577 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 27.8 m-85 -120.4 140.19 51.71 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.956 0.884 . . . . 0.72999999999999998 110.847 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -68.55 -32.41 72.32 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.784 -0.644 . . . . 0.02 112.178 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -114.82 165.74 12.51 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.956 -1.09 . . . . 3.1800000000000002 110.212 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.18 163.41 45.44 Favored Glycine 0 N--CA 1.492 2.38 0 CA-C-O 121.958 0.755 . . . . 0.01 111.278 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 57.15 39.17 29.13 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.578 0.704 . . . . 0.01 111.026 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 52.66 55.91 8.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.624 -0.672 . . . . 0.01 111.112 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -128.42 164.87 21.77 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.281 -1.007 . . . . 3.1499999999999999 108.281 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.65 -163.05 28.25 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.092 -1.603 . . . . 0.01 109.092 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -75.62 142.04 42.72 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.878 -1.366 . . . . 0.01 108.959 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.577 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 33.9 ttp -116.73 143.27 45.85 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.538 0.685 . . . . 0.01 109.533 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.98 136.41 47.28 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.173 -1.047 . . . . 2.48 108.173 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -115.96 134.09 55.34 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.715 -0.616 . . . . 0.01 109.7 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.1 t -149.31 147.93 28.93 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.515 1.15 . . . . 1.6899999999999999 111.474 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -114.54 7.63 16.19 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.894 -1.048 . . . . 0.01 109.875 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -121.96 163.56 19.11 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.393 -0.817 . . . . 3.21 111.008 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.4 154.82 41.43 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.358 -0.839 . . . . 0.01 109.379 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.8 t -126.64 114.98 22.77 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.911 -0.774 . . . . 0.01 108.911 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.23 -32.59 5.01 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 120.323 1.151 . . . . 0.01 111.447 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 m -142.31 108.26 5.18 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.847 0.832 . . . . 0.02 108.947 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.42 HD12 ' O ' ' A' ' 169' ' ' ILE . 95.9 mt -64.29 -39.9 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.776 -0.577 . . . . 1.8300000000000001 110.97 -178.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 32.7 ttp -66.89 -37.4 84.31 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.026 -1.069 . . . . 1.3400000000000001 109.812 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -70.22 -38.62 75.29 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.524 -1.36 . . . . 2.1099999999999999 109.761 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.51 ' NE2' ' CE1' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -80.14 -47.49 14.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.253 -0.904 . . . . 2.0800000000000001 112.203 -176.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.51 ' CE1' ' NE2' ' A' ' 120' ' ' GLN . 92.1 m-85 -110.82 -0.44 16.93 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.378 -0.826 . . . . 0.02 112.699 -176.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 59.93 33.2 21.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.659 -1.276 . . . . 0.02 109.595 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.2 mt -112.69 135.85 52.95 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 108.764 -0.828 . . . . 0.02 108.764 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -91.73 -22.89 19.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -0.822 . . . . 5.3200000000000003 110.358 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -149.36 164.03 36.07 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.09 -1.006 . . . . 0.02 110.019 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.8 mt -131.7 129.57 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.375 -1.343 . . . . 2.1699999999999999 107.375 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -107.77 -12.92 15.12 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.134 -0.979 . . . . 0.02 113.18 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.6 OUTLIER -153.52 151.35 29.71 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.489 -1.382 . . . . 0.01 108.278 178.321 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 13.7 t -160.92 145.03 13.6 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.261 -1.524 . . . . 1.22 109.935 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -121.8 110.22 15.64 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.43 1.109 . . . . 1.4099999999999999 109.156 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 t -107.55 120.34 58.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 105.851 -1.907 . . . . 0.01 105.851 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.0 t -146.27 68.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 118.453 -1.299 . . . . 1.98 108.369 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 172.65 107.22 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.443 -1.688 . . . . 0.01 106.443 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.66 -174.07 43.1 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.554 -1.418 . . . . 0.01 109.554 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.2 m -111.41 144.3 40.84 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.387 -1.066 . . . . 2.2999999999999998 109.216 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.493 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 63.1 m95 -129.15 146.03 51.18 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.643 -0.66 . . . . 0.01 110.377 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.1 mt -117.36 141.71 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 107.642 -1.244 . . . . 1.6899999999999999 107.642 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -113.97 143.42 44.76 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 107.453 -1.314 . . . . 2.4900000000000002 107.453 177.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 16.0 m-85 -122.77 144.17 49.35 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.291 -0.633 . . . . 0.02 109.291 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.5 -29.86 62.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.737 -0.602 . . . . 0.02 111.964 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.9 mt -115.47 153.87 47.69 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 120.679 -1.263 . . . . 1.48 109.26 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -54.48 166.13 1.98 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.229 1.286 . . . . 0.02 112.658 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 15.3 t-20 59.79 31.76 20.97 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.145 -0.934 . . . . 0.75 111.136 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.504 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.8 m-85 57.43 51.45 9.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.54 -0.725 . . . . 0.02 110.827 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -124.55 163.43 21.93 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.541 -0.724 . . . . 0.02 109.659 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.45 -165.34 32.42 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.83 -1.308 . . . . 0.02 109.83 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -67.89 141.48 56.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.991 . . . . 0.02 109.011 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.718 ' NE2' ' H ' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -118.87 149.01 42.27 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.284 -0.635 . . . . 0.02 109.284 -178.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.68 142.4 51.03 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.181 -0.674 . . . . 0.01 109.181 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.827 ' N ' HD12 ' A' ' 150' ' ' LEU . 3.4 mp -95.43 121.11 36.76 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.462 -0.774 . . . . 0.01 109.336 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.669 HD22 ' NE1' ' A' ' 162' ' ' TRP . 18.5 mt -105.42 135.25 47.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.44 -0.788 . . . . 0.01 110.674 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 154' ' ' LYS . 2.8 m-20 -110.31 175.63 5.36 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.187 -1.042 . . . . 2.27 108.187 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -57.85 84.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.905 -1.122 . . . . 1.8400000000000001 108.638 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 152' ' ' ASP . 73.6 tttt -137.14 165.38 26.21 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.256 -0.903 . . . . 2.2799999999999998 111.654 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 6.7 pt-20 -111.8 113.66 26.15 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.061 -1.088 . . . . 0.01 108.061 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -102.44 115.28 30.25 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.933 -1.104 . . . . 0.01 110.29 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.445 ' O ' ' OG ' ' A' ' 128' ' ' SER . 3.7 ptp180 -92.18 -25.82 18.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.01 111.347 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -125.67 153.17 72.97 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 121.017 -1.052 . . . . 2.54 108.643 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -60.7 -42.08 41.85 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 CA-C-N 119.27 0.775 . . . . 0.69999999999999996 110.524 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.1 t -60.38 -20.43 20.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.745 -1.222 . . . . 0.85999999999999999 108.612 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -65.91 -16.19 63.63 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.989 -1.069 . . . . 0.02 109.605 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.669 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.73 9.3 39.48 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.763 -1.199 . . . . 0.02 107.763 179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.15 10.32 86.32 Favored Glycine 0 N--CA 1.486 2.024 0 C-N-CA 119.214 -1.47 . . . . 0.02 109.617 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.5 142.03 31.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.45 -1.03 . . . . 0.02 110.091 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.1 -8.33 59.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.677 -0.64 . . . . 0.58999999999999997 109.828 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.5 p -144.66 150.86 48.47 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.857 -1.152 . . . . 0.87 108.702 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.83 21.03 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 120.816 1.011 . . . . 0.38 112.355 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.87 124.13 30.03 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.464 1.126 . . . . 0.17999999999999999 111.708 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.42 ' O ' HD12 ' A' ' 117' ' ' ILE . 16.4 mt -146.47 126.9 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 106.78 -1.563 . . . . 3.9900000000000002 106.78 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -112.02 -20.53 11.93 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.098 -1.001 . . . . 5.1699999999999999 112.783 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.6 p -158.0 160.63 37.68 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 119.269 -2.144 . . . . 0.02 110.141 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -152.48 154.03 34.69 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.129 -0.982 . . . . 2.02 110.26 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.504 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -144.51 151.97 39.9 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.195 -0.941 . . . . 0.01 110.449 -179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -88.24 143.02 27.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.496 -0.753 . . . . 0.01 109.412 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -93.25 128.66 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.17 -0.956 . . . . 3.04 109.053 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.8 t -136.0 146.4 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.224 -0.923 . . . . 1.8899999999999999 109.384 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 4.8899999999999997 109.517 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.581 -0.525 . . . . 5.2800000000000002 109.581 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.91 -86.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 5.96 109.329 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.2 t -170.49 169.09 7.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.832 -1.167 . . . . 2.2200000000000002 109.053 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.08 117.34 3.62 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 106.939 -2.465 . . . . 0.81000000000000005 106.939 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.08 145.38 33.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.642 -1.383 . . . . 0.01 109.642 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -152.83 138.29 17.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.264 -1.139 . . . . 0.02 109.586 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -130.31 140.87 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 109.373 -0.603 . . . . 0.02 109.373 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 m -121.13 129.95 53.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.469 -0.77 . . . . 0.39000000000000001 110.143 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -109.02 139.32 44.05 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.549 -0.719 . . . . 0.02 109.147 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.3 m-85 -121.98 137.73 54.69 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.361 -0.837 . . . . 0.02 109.276 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.78 -27.4 64.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.013 -1.054 . . . . 0.029999999999999999 111.88 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.9 m-20 -114.2 170.2 8.46 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.87 -1.144 . . . . 0.029999999999999999 110.366 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -75.25 157.91 33.72 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.599 0.714 . . . . 0.029999999999999999 110.136 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 10.4 t30 65.85 35.11 6.85 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.803 0.811 . . . . 0.73999999999999999 110.8 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.96 44.83 25.5 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.487 -0.779 . . . . 0.02 111.368 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -112.28 165.87 11.79 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.032 -1.099 . . . . 0.02 108.032 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -167.88 34.44 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 120.847 -1.158 . . . . 0.029999999999999999 110.619 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -69.19 143.1 54.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -1.04 . . . . 2.7599999999999998 108.922 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -123.22 149.92 44.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.518 -0.739 . . . . 1.8899999999999999 110.211 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -136.25 133.4 36.96 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 109.317 -0.623 . . . . 0.02 109.317 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.0 136.16 48.99 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.688 -0.856 . . . . 1.1200000000000001 108.688 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.429 ' SG ' ' CE2' ' A' ' 29' ' ' PHE . 1.9 m -126.94 137.31 53.1 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.637 -0.664 . . . . 0.02 109.541 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -118.95 10.74 12.31 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.572 -0.705 . . . . 0.20000000000000001 110.233 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.407 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 14.9 t -159.61 173.19 16.48 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.79 -1.194 . . . . 1.23 109.063 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.407 ' OD1' ' SG ' ' A' ' 24' ' ' CYS . 5.5 p-10 -63.22 146.28 53.72 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.683 -1.26 . . . . 0.02 110.721 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.88 119.22 17.81 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 109.061 -0.718 . . . . 0.02 109.061 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.12 -20.84 51.33 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.504 -0.748 . . . . 0.23999999999999999 112.037 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -153.73 106.02 2.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.729 -1.232 . . . . 1.1399999999999999 109.762 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.429 ' CE2' ' SG ' ' A' ' 22' ' ' CYS . 0.1 OUTLIER -102.66 6.7 39.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.353 -0.842 . . . . 6.3700000000000001 110.399 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -61.17 -29.5 69.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 3.1099999999999999 111.898 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.4 t -77.06 -17.56 58.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.505 -1.372 . . . . 0.88 110.948 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -106.14 -21.42 13.13 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.388 -0.82 . . . . 0.02 110.624 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.13 127.39 12.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.145 -0.972 . . . . 3.3199999999999998 109.472 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.6 t -87.29 -12.48 46.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.516 -0.74 . . . . 0.02 110.976 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -172.56 161.99 5.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.847 -1.158 . . . . 0.02 108.378 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.464 ' SG ' HD12 ' A' ' 79' ' ' LEU . 3.1 p -142.63 115.04 8.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.99 -1.069 . . . . 0.02 108.735 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -107.04 -2.71 20.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.836 -1.165 . . . . 0.029999999999999999 111.289 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -152.96 153.65 33.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.118 -1.067 . . . . 0.02 108.118 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.7 mt -146.83 147.44 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.045 -1.034 . . . . 0.02 110.438 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -124.91 125.66 44.29 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.899 -1.148 . . . . 0.02 107.899 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -105.6 114.11 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 106.773 -1.566 . . . . 0.02 106.773 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -84.94 -34.61 22.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.609 -0.682 . . . . 3.8100000000000001 110.184 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.24 149.99 18.24 Favored Glycine 0 N--CA 1.489 2.185 0 C-N-CA 118.358 -1.877 . . . . 0.02 110.758 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.12 172.42 49.11 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.174 -1.171 . . . . 0.01 110.174 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.7 m -118.35 134.19 55.26 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.484 -1.302 . . . . 1.48 107.484 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -126.38 154.86 43.0 Favored 'General case' 0 N--CA 1.503 2.197 0 CA-C-O 122.626 1.203 . . . . 0.02 112.326 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.72 133.99 52.51 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.189 -2.152 . . . . 0.23999999999999999 105.189 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.458 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.7 m -117.22 142.63 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.514 -0.741 . . . . 0.65000000000000002 109.319 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -120.88 143.19 49.05 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 122.053 0.93 . . . . 0.02 109.535 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.08 -33.62 76.47 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 115.498 -0.774 . . . . 0.02 111.641 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -124.46 157.7 64.19 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 121.098 -1.001 . . . . 0.02 109.467 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.13 166.94 0.83 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.656 1.57 . . . . 0.02 112.726 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 63.07 36.5 12.24 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.331 -0.849 . . . . 0.02 111.108 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 45.56 51.54 9.84 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.601 0.715 . . . . 3.3900000000000001 110.864 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 p -125.78 163.55 22.62 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.384 0.612 . . . . 2.3300000000000001 109.904 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.49 -161.45 31.17 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.799 -1.32 . . . . 0.02 109.799 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.427 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 24.0 m-70 -65.3 139.35 58.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.027 -1.278 . . . . 0.02 110.163 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 18.4 ptm -118.91 137.05 53.73 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.245 0.545 . . . . 5.0099999999999998 109.61 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.442 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 96.9 m-85 -134.19 138.82 45.4 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.459 -0.776 . . . . 0.02 109.925 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.7 mm -95.2 130.62 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.49 -0.756 . . . . 1.72 109.031 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.475 HD22 ' CE1' ' A' ' 66' ' ' TYR . 7.4 mt -121.44 111.2 33.49 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 121.326 -0.859 . . . . 0.02 110.653 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -77.66 169.77 20.29 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 CA-C-N 119.85 0.982 . . . . 1.47 110.415 177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -53.53 141.26 25.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.902 -1.124 . . . . 4.25 110.603 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.45 -177.4 31.83 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.502 -1.333 . . . . 0.02 110.693 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -118.45 130.42 55.95 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.354 -1.086 . . . . 0.95999999999999996 109.787 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' CE1' HD22 ' A' ' 61' ' ' LEU . 90.0 m-85 -120.37 97.05 49.08 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 107.861 -1.163 . . . . 0.02 107.861 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -69.48 -4.49 13.94 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 120.752 0.968 . . . . 0.02 113.583 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -157.27 154.53 29.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.623 -1.298 . . . . 2.02 108.144 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -59.95 -38.6 82.91 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.408 -0.808 . . . . 0.02 111.773 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -59.82 -24.44 64.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.02 110.226 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -70.09 -18.72 63.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.41 -0.806 . . . . 3.4199999999999999 108.879 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.46 10.12 27.42 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.628 -1.249 . . . . 0.02 107.628 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.9 mmt 60.81 22.32 12.37 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.48 0.657 . . . . 0.02 110.598 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.43 144.17 45.8 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.367 -1.493 . . . . 0.02 109.367 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.1 tp -78.93 -30.93 44.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.553 -1.276 . . . . 0.97999999999999998 107.553 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -157.42 -171.82 3.74 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 106.544 -1.651 . . . . 0.02 106.544 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -98.25 28.63 3.96 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.603 -1.31 . . . . 0.02 110.775 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -97.82 122.72 41.26 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.933 -1.105 . . . . 3.2000000000000002 111.324 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.464 HD12 ' SG ' ' A' ' 36' ' ' CYS . 54.4 mt -142.36 119.51 11.43 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.317 -1.364 . . . . 2.6099999999999999 107.317 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.99 -18.55 10.41 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 121.282 -0.886 . . . . 0.02 112.065 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 p -155.45 155.63 33.86 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 119.531 1.666 . . . . 0.02 110.695 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.5 p -145.17 147.82 32.89 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.403 -0.811 . . . . 0.02 110.283 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -137.17 141.87 42.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.442 -0.786 . . . . 0.01 109.109 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.58 132.36 37.11 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.203 -0.935 . . . . 0.42999999999999999 109.28 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.3 123.95 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.653 -0.869 . . . . 1.25 108.653 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -92.01 132.34 36.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.956 -1.09 . . . . 1.77 108.552 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.8 OUTLIER -96.83 138.12 34.87 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.139 -1.06 . . . . 1.6299999999999999 108.139 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.9 p -110.21 126.38 54.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 1.0800000000000001 108.682 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.2 t -102.85 -155.1 0.51 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.205 -1.776 . . . . 1.26 106.205 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.59 -50.41 0.84 Allowed Glycine 0 N--CA 1.497 2.743 0 O-C-N 120.521 -1.362 . . . . 0.01 111.986 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.6 -99.77 0.13 Allowed Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.816 -1.659 . . . . 0.01 111.709 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -119.34 119.45 34.01 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.117 -1.225 . . . . 4.4299999999999997 110.311 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.515 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.35 137.32 56.82 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.344 -0.613 . . . . 2.9900000000000002 109.344 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 7.5 ttpm? -136.45 130.7 33.03 Favored 'General case' 0 N--CA 1.515 2.795 0 CA-C-O 122.273 1.035 . . . . 6.3600000000000003 113.015 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 tt -131.72 141.51 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 115.397 -0.82 . . . . 1.0900000000000001 110.286 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 6.3 pt20 -124.33 140.2 53.18 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 107.597 -1.26 . . . . 2.0499999999999998 107.597 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 m -124.24 146.29 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 120.685 -1.259 . . . . 1.1000000000000001 111.189 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 26.2 m-85 -120.4 140.24 51.64 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 122.224 1.011 . . . . 0.72999999999999998 110.745 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -67.84 -32.44 72.97 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.709 -0.678 . . . . 0.02 111.907 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -114.47 165.7 12.47 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 120.948 -1.095 . . . . 3.1800000000000002 110.446 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.9 163.69 47.24 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 111.038 -0.825 . . . . 0.01 111.038 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 57.62 38.86 27.88 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.578 0.704 . . . . 0.01 110.946 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 52.44 56.91 7.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.537 -0.727 . . . . 0.01 111.035 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -129.48 165.34 21.82 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.166 -1.05 . . . . 3.1499999999999999 108.166 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.4 -162.77 28.38 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.13 -1.588 . . . . 0.01 109.13 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.471 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 54.6 tt0 -75.81 142.0 42.37 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.016 -1.285 . . . . 0.01 108.76 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.7 ttp -116.55 143.05 46.09 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.513 0.673 . . . . 0.01 109.563 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.471 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 55.9 m-85 -131.89 135.91 47.01 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.198 -1.038 . . . . 2.48 108.198 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -116.52 134.37 54.92 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.722 -0.611 . . . . 0.01 109.669 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.4 t -149.23 148.02 29.09 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.528 1.156 . . . . 1.6899999999999999 111.367 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 p -114.95 7.67 15.67 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.949 -1.023 . . . . 0.01 109.934 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.449 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 21.8 mp0 -122.03 163.78 18.8 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.408 -0.808 . . . . 3.21 111.181 -177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.59 153.89 42.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.384 -0.823 . . . . 0.01 109.46 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 46.0 t -126.98 114.95 22.03 Favored Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 108.971 -0.752 . . . . 0.01 108.971 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -75.1 -32.94 4.86 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 120.387 1.174 . . . . 0.01 111.612 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -142.05 108.49 5.3 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.834 0.826 . . . . 0.02 109.198 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 169' ' ' ILE . 96.4 mt -64.36 -39.75 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.844 -0.535 . . . . 1.8300000000000001 111.02 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.6 ttt -66.57 -38.17 86.5 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.169 -1.012 . . . . 1.3400000000000001 109.865 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -69.62 -38.46 77.23 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.506 -1.371 . . . . 2.1099999999999999 109.858 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -80.78 -47.25 14.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.29 -0.881 . . . . 2.0800000000000001 112.462 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -111.21 -0.78 16.36 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.252 -0.905 . . . . 0.02 112.719 -176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 59.88 33.43 21.57 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.812 -1.18 . . . . 0.02 109.384 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.27 135.7 52.61 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 108.699 -0.852 . . . . 0.02 108.699 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -92.66 -23.43 18.98 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.37 -0.831 . . . . 5.3200000000000003 110.65 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -149.11 163.66 36.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.084 -1.01 . . . . 0.02 110.095 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 48.2 mt -131.63 129.4 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 107.348 -1.353 . . . . 2.1699999999999999 107.348 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -107.18 -13.32 15.18 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.144 -0.973 . . . . 0.02 113.06 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.38 153.06 29.85 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.277 -1.514 . . . . 0.01 108.255 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 6.8 t -162.86 143.81 9.75 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.375 -1.453 . . . . 1.22 109.665 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -122.37 112.87 18.62 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.001 0.905 . . . . 1.4099999999999999 108.77 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 t -109.03 123.4 64.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.061 -1.829 . . . . 0.01 106.061 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -146.41 66.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 C-N-CA 117.951 -1.5 . . . . 1.98 109.061 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.402 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.1 tp10 176.28 108.72 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 106.32 -1.733 . . . . 0.01 106.32 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.678 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 70.99 -174.44 40.39 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.476 -1.45 . . . . 0.01 109.476 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -112.05 146.57 37.7 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.423 -1.045 . . . . 2.2999999999999998 109.43 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.515 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 61.1 m95 -130.35 146.19 51.89 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.502 -0.749 . . . . 0.01 110.284 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mt -117.13 141.56 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 107.566 -1.272 . . . . 1.6899999999999999 107.566 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.33 143.79 44.32 Favored 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 107.688 -1.227 . . . . 2.4900000000000002 107.688 177.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 7.5 m-85 -122.58 144.7 48.94 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.994 -0.743 . . . . 0.02 108.994 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 76.5 tt0 -74.06 -29.78 62.06 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.669 -0.644 . . . . 0.02 112.08 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.5 mt -115.24 153.5 47.39 Favored Pre-proline 0 N--CA 1.506 2.369 0 O-C-N 120.676 -1.265 . . . . 1.48 109.208 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.41 167.08 1.46 Allowed 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.129 1.219 . . . . 0.02 112.565 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 59.31 31.08 20.88 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.065 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.76 51.12 9.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 0.02 111.124 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -123.99 163.33 21.6 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.569 -0.707 . . . . 0.02 109.528 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.2 -165.79 31.74 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.873 -1.291 . . . . 0.02 109.873 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -68.2 142.28 55.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.477 -1.014 . . . . 0.02 109.03 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -118.01 148.46 42.21 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.451 -0.574 . . . . 0.02 109.451 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.463 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -128.64 142.73 50.94 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.563 -0.71 . . . . 0.01 109.113 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.64 119.8 34.77 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.48 -0.763 . . . . 0.01 109.465 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.551 HD22 ' CD1' ' A' ' 162' ' ' TRP . 19.5 mt -106.21 131.95 52.84 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.422 -0.798 . . . . 0.01 110.363 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 154' ' ' LYS . 11.9 p-10 -109.84 176.77 4.94 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.454 -0.943 . . . . 2.27 108.454 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.678 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 48.7 mttm -55.54 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.066 -1.021 . . . . 1.8400000000000001 108.489 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 152' ' ' ASP . 53.4 mmtt -136.74 166.86 22.6 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.189 -0.945 . . . . 2.2799999999999998 111.593 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 15.0 mp0 -113.82 106.4 14.42 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.76 -1.2 . . . . 0.01 107.76 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.56 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 90.9 m-85 -99.03 114.16 26.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.965 -1.085 . . . . 0.01 110.201 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -92.41 -25.67 18.37 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.19 -0.943 . . . . 0.01 111.144 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -125.18 153.88 71.74 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.079 -1.013 . . . . 2.54 108.392 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -61.3 -41.43 42.04 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 120.442 0.761 . . . . 0.69999999999999996 110.651 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.33 -20.1 21.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.657 -1.277 . . . . 0.85999999999999999 108.769 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -65.57 -16.11 63.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.025 -1.047 . . . . 0.02 109.758 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.56 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 1.1 m0 -96.11 10.88 36.2 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.999 -1.112 . . . . 0.02 107.999 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.57 11.34 85.56 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.414 -1.374 . . . . 0.02 110.159 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.73 141.94 31.87 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.293 -1.122 . . . . 0.02 110.209 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.29 -8.22 59.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.613 -0.679 . . . . 0.58999999999999997 109.817 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.4 p -144.31 150.87 49.78 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 120.806 -1.184 . . . . 0.87 108.728 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.6 20.85 0.5 Allowed 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 120.701 0.934 . . . . 0.38 112.341 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.28 122.14 27.56 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.467 1.127 . . . . 0.17999999999999999 111.45 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.433 ' O ' HD12 ' A' ' 117' ' ' ILE . 9.8 mm -142.74 125.39 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.009 -1.848 . . . . 3.9900000000000002 106.009 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 12.3 mp0 -112.33 -20.82 11.69 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.088 -1.008 . . . . 5.1699999999999999 112.615 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.5 p -157.41 160.92 38.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 119.384 -2.072 . . . . 0.02 109.954 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -153.53 154.59 34.6 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.182 -0.949 . . . . 2.02 110.578 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -144.46 151.39 39.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.35 -0.843 . . . . 0.01 110.442 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -87.66 142.64 27.68 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.054 -0.721 . . . . 0.01 109.054 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.8 mt -93.12 128.45 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.037 -1.039 . . . . 3.04 109.206 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 44.9 t -136.07 146.71 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.294 -0.879 . . . . 1.8899999999999999 109.564 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.86 . . . . 4.8899999999999997 109.483 179.896 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.353 -0.61 . . . . 5.2800000000000002 109.353 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -151.66 -35.71 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.216 -0.927 . . . . 5.96 109.442 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 m -55.22 -54.13 47.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.607 -1.308 . . . . 2.2200000000000002 110.615 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.85 117.77 3.86 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 107.038 -2.425 . . . . 0.81000000000000005 107.038 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.58 145.27 33.97 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.39 -1.484 . . . . 0.01 109.39 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -152.83 138.28 17.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.245 -1.15 . . . . 0.02 109.841 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 tt -130.32 141.03 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.475 -0.565 . . . . 0.02 109.475 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.422 ' OG ' ' NE ' ' A' ' 19' ' ' ARG . 1.6 t -122.26 130.76 53.47 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.308 -0.87 . . . . 0.39000000000000001 110.091 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.0 OUTLIER -111.11 140.71 45.43 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.768 -0.582 . . . . 0.02 109.444 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.4 m-85 -121.85 138.45 54.38 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.353 -0.842 . . . . 0.02 109.573 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -68.86 -27.4 65.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.99 -1.069 . . . . 0.029999999999999999 111.504 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.7 m-20 -114.53 170.72 8.1 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.858 -1.151 . . . . 0.029999999999999999 110.009 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -75.81 162.06 28.49 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.705 0.764 . . . . 0.029999999999999999 110.313 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.9 t30 62.46 33.28 16.25 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.113 0.959 . . . . 0.73999999999999999 110.742 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.1 40.29 31.81 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.733 -0.667 . . . . 0.02 110.834 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -109.97 165.42 11.74 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.196 -1.038 . . . . 0.02 108.196 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.54 -168.04 34.38 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.888 -1.149 . . . . 0.029999999999999999 110.557 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -68.83 143.53 54.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -1.058 . . . . 2.7599999999999998 108.887 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.533 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 51.4 ttt180 -122.03 149.95 42.78 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.62 -0.675 . . . . 1.8899999999999999 109.916 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.24 134.5 34.51 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.637 -0.664 . . . . 0.02 109.466 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.31 136.92 48.75 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.385 -0.822 . . . . 1.1200000000000001 109.384 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.7 t -127.99 138.3 52.55 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.594 -0.691 . . . . 0.02 109.488 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -118.74 11.98 12.87 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.59 -0.694 . . . . 0.20000000000000001 110.554 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.2 t -159.46 173.84 15.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.706 -1.246 . . . . 1.23 109.091 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 25' ' ' ASP . 17.8 p30 -63.11 146.67 52.78 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.747 -1.221 . . . . 0.02 110.527 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.4 m -133.7 117.64 17.21 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.127 -0.694 . . . . 0.02 109.127 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.75 -23.21 45.53 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.284 -0.885 . . . . 0.23999999999999999 111.471 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -151.77 103.77 2.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.974 -1.079 . . . . 1.1399999999999999 109.056 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.16 6.81 33.39 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.588 0.709 . . . . 6.3700000000000001 110.231 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -59.93 -27.63 66.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 3.1099999999999999 111.691 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 81.4 p -76.6 -16.08 59.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.611 -1.306 . . . . 0.88 110.803 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -106.57 -21.96 12.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.44 -0.787 . . . . 0.02 110.422 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tp -149.08 127.33 12.12 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.04 -1.037 . . . . 3.3199999999999998 109.436 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.2 t -87.02 -12.16 48.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.64 -0.662 . . . . 0.02 111.051 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.52 ' HE ' HD21 ' A' ' 37' ' ' ASN . 14.9 ptm180 -172.84 162.13 4.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.93 -1.106 . . . . 0.02 108.417 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -142.7 115.79 8.87 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.047 -1.033 . . . . 0.02 108.649 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.52 HD21 ' HE ' ' A' ' 35' ' ' ARG . 1.6 m-80 -107.71 -1.0 21.43 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.803 -1.186 . . . . 0.029999999999999999 110.987 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -155.52 152.88 29.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.672 -1.233 . . . . 0.02 107.672 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.6 mt -145.33 148.46 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.091 -1.006 . . . . 0.02 109.887 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -124.46 124.55 42.56 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.5 -1.296 . . . . 0.02 107.5 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.8 t -105.03 113.87 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 106.704 -1.591 . . . . 0.02 106.704 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -83.81 -34.83 24.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.576 -0.703 . . . . 3.8100000000000001 109.971 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 151.27 20.64 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 118.392 -1.861 . . . . 0.02 110.535 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.79 171.89 48.61 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.318 -1.113 . . . . 0.01 110.318 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.9 m -117.76 133.74 55.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.429 -1.323 . . . . 1.48 107.429 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -126.21 154.23 43.59 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.6 1.19 . . . . 0.02 112.16 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.03 133.72 52.61 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.419 -2.067 . . . . 0.23999999999999999 105.419 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.407 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.3 m -117.62 142.87 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.569 -0.707 . . . . 0.65000000000000002 109.249 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -120.62 144.87 47.91 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.112 0.958 . . . . 0.02 109.997 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.472 ' OE2' ' NH2' ' A' ' 78' ' ' ARG . 33.5 tt0 -66.16 -33.69 76.34 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.875 -0.602 . . . . 0.02 111.582 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' A' ' 51' ' ' ARG . 0.4 OUTLIER -124.64 157.88 64.07 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.006 -1.059 . . . . 0.02 109.486 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.09 166.44 0.98 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.637 1.558 . . . . 0.02 112.763 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m120 63.67 36.39 10.84 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.36 -0.836 . . . . 0.02 111.153 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 8.0 m-85 45.29 51.51 9.32 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.654 0.74 . . . . 3.3900000000000001 110.812 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -125.75 163.44 22.84 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.143 0.497 . . . . 2.3300000000000001 109.882 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.83 31.38 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.513 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 21.1 m-70 -64.35 138.48 58.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.981 -1.305 . . . . 0.02 109.989 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.498 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.8 ppp? -119.37 137.45 53.72 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.283 0.564 . . . . 5.0099999999999998 109.58 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.594 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.7 m-85 -134.99 139.95 45.29 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.492 -0.755 . . . . 0.02 110.238 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.7 mm -94.16 130.45 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 108.656 -0.868 . . . . 1.72 108.656 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.03 110.32 36.53 Favored Pre-proline 0 N--CA 1.505 2.324 0 O-C-N 121.439 -0.788 . . . . 0.02 110.597 -178.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.69 168.65 22.13 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 CA-C-N 119.935 1.012 . . . . 1.47 110.311 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -53.75 140.79 28.67 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.84 -1.163 . . . . 4.25 110.524 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.77 32.68 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.489 -1.338 . . . . 0.02 110.598 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -118.76 130.09 55.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.251 -1.146 . . . . 0.95999999999999996 109.622 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.574 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 71.8 m-85 -121.1 98.91 46.88 Favored Pre-proline 0 N--CA 1.492 1.667 0 N-CA-C 107.852 -1.166 . . . . 0.02 107.852 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -71.3 -3.73 13.53 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 120.637 0.892 . . . . 0.02 113.836 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -157.52 155.04 29.6 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.64 -1.288 . . . . 2.02 108.274 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -59.85 -39.08 84.0 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.62 -0.675 . . . . 0.02 111.787 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -59.94 -23.99 64.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.917 . . . . 0.02 110.256 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -70.32 -18.75 63.09 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.791 0.805 . . . . 3.4199999999999999 108.921 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.594 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -108.4 10.53 27.46 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.455 -1.313 . . . . 0.02 107.455 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.0 mtt 61.34 22.56 12.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.619 -0.676 . . . . 0.02 110.714 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.14 144.55 46.92 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.648 -1.381 . . . . 0.02 109.648 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.71 -30.75 41.06 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.725 -1.213 . . . . 0.97999999999999998 107.725 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -157.38 -171.52 3.63 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.374 -1.713 . . . . 0.02 106.374 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -98.93 28.3 4.45 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.607 -1.308 . . . . 0.02 110.72 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' NH2' ' OE2' ' A' ' 50' ' ' GLU . 80.1 mtm180 -96.44 122.56 39.47 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.916 -1.115 . . . . 3.2000000000000002 111.011 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.435 HD21 ' CH2' ' A' ' 72' ' ' TRP . 82.5 mt -142.71 119.49 11.18 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.791 -1.189 . . . . 2.6099999999999999 107.791 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.4 -17.79 10.32 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 121.167 -0.958 . . . . 0.02 112.416 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 92.9 p -156.19 156.15 33.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.165 -1.786 . . . . 0.02 110.495 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.8 p -145.26 148.43 33.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.693 -0.629 . . . . 0.02 109.706 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.465 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.9 mtp180 -137.06 141.42 42.42 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.286 -0.884 . . . . 0.01 109.281 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.67 133.03 37.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.352 -0.843 . . . . 0.42999999999999999 109.387 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 t -91.72 124.66 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.02 -0.733 . . . . 1.25 109.02 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -91.09 132.11 36.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.852 -1.155 . . . . 1.77 108.202 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -99.09 140.23 33.56 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.775 -0.824 . . . . 1.6299999999999999 108.775 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.5 m -111.01 123.51 50.34 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.097 -1.075 . . . . 1.0800000000000001 108.097 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.8 p -114.62 131.96 56.53 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.611 -1.255 . . . . 1.26 107.611 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.9 -48.76 0.01 OUTLIER Glycine 0 N--CA 1.502 3.078 0 C-N-CA 117.698 -2.191 . . . . 0.01 113.329 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.44 -103.79 0.17 Allowed Glycine 0 N--CA 1.485 1.956 0 CA-C-N 119.95 1.875 . . . . 0.01 110.939 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.44 HE22 HH12 ' A' ' 174' ' ' ARG . 64.5 tp60 -119.17 118.94 32.7 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.244 -1.15 . . . . 4.4299999999999997 110.229 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.45 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.39 135.11 53.85 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.234 -0.586 . . . . 2.9900000000000002 109.532 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -133.73 129.98 37.46 Favored 'General case' 0 N--CA 1.52 3.042 0 CA-C-O 122.224 1.011 . . . . 6.3600000000000003 113.067 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -130.07 141.26 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-N 115.511 -0.768 . . . . 1.0900000000000001 110.406 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.472 ' HG2' ' H ' ' A' ' 130' ' ' LYS . 0.8 OUTLIER -123.64 138.74 54.48 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 107.637 -1.245 . . . . 2.0499999999999998 107.637 177.033 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 m -123.98 145.62 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 O-C-N 120.664 -1.272 . . . . 1.1000000000000001 111.032 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -120.27 139.61 52.44 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.958 0.885 . . . . 0.72999999999999998 110.652 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 3.9 tm-20 -69.16 -33.04 72.78 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.766 -0.652 . . . . 0.02 112.073 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.457 ' O ' ' OG ' ' A' ' 128' ' ' SER . 49.4 mttp -114.22 165.57 12.54 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.902 -1.124 . . . . 3.1800000000000002 110.229 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.38 163.07 46.43 Favored Glycine 0 N--CA 1.492 2.375 0 CA-C-O 122.007 0.781 . . . . 0.01 111.308 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.59 39.51 27.58 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.532 0.682 . . . . 0.01 111.102 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 52.29 56.04 8.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.727 -0.608 . . . . 0.01 111.003 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.623 ' ND2' ' H ' ' A' ' 105' ' ' GLY . 4.9 t-20 -129.08 164.87 22.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.001 -1.111 . . . . 3.1499999999999999 108.001 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.623 ' H ' ' ND2' ' A' ' 104' ' ' ASN . . . 91.38 -162.64 28.32 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.081 -1.607 . . . . 0.01 109.081 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -75.51 141.79 42.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.919 -1.342 . . . . 0.01 109.126 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 107' ' ' MET . 9.7 tmm? -116.08 142.79 46.34 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.448 0.642 . . . . 0.01 109.546 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -132.08 135.65 46.61 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.166 -1.05 . . . . 2.48 108.166 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -116.72 133.93 55.42 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.754 -0.592 . . . . 0.01 109.808 -178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -148.95 148.25 29.57 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.511 1.148 . . . . 1.6899999999999999 111.365 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.2 p -114.62 7.84 16.14 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.99 -1.005 . . . . 0.01 109.936 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -121.82 163.48 19.09 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.429 -0.794 . . . . 3.21 111.183 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.04 154.34 42.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.357 -0.839 . . . . 0.01 109.436 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.463 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 51.0 t -126.98 114.6 22.02 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 108.806 -0.812 . . . . 0.01 108.806 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.58 -31.97 5.1 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 CA-C-N 120.241 1.122 . . . . 0.01 111.51 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.4 t -142.48 107.67 4.98 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.825 0.822 . . . . 0.02 108.992 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 169' ' ' ILE . 96.7 mt -63.84 -39.31 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.843 -0.535 . . . . 1.8300000000000001 111.141 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 42.7 ttp -67.37 -37.54 83.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.202 -0.999 . . . . 1.3400000000000001 110.014 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -69.88 -38.98 76.53 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.504 -1.372 . . . . 2.1099999999999999 109.852 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.463 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.9 tt0 -79.82 -47.08 15.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.233 -0.917 . . . . 2.0800000000000001 112.455 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -110.76 -0.13 17.14 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.365 -0.834 . . . . 0.02 112.655 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.7 m80 59.33 33.06 22.33 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.738 -1.226 . . . . 0.02 109.272 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.27 135.59 52.76 Favored 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 108.652 -0.869 . . . . 0.02 108.652 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -92.56 -23.48 19.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 5.3200000000000003 110.501 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -149.51 163.78 36.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.207 -0.933 . . . . 0.02 110.028 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.1 mt -131.79 129.68 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 107.427 -1.324 . . . . 2.1699999999999999 107.427 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -106.07 -13.89 15.32 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.105 -0.997 . . . . 0.02 113.098 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 2.2 p -157.63 156.29 31.57 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.486 -1.384 . . . . 0.01 108.242 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.581 ' SG ' ' CZ2' ' A' ' 162' ' ' TRP . 18.4 p -164.0 146.91 9.52 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.446 -1.409 . . . . 1.22 109.663 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.472 ' H ' ' HG2' ' A' ' 96' ' ' GLN . 31.7 tttt -121.51 111.48 17.31 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.153 0.977 . . . . 1.4099999999999999 108.532 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.51 122.9 64.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.054 -1.832 . . . . 0.01 106.054 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.98 69.89 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 118.12 -1.432 . . . . 1.98 108.391 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.37 108.32 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 106.852 -1.536 . . . . 0.01 106.852 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.68 -174.27 45.95 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.876 -1.29 . . . . 0.01 109.876 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.481 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.7 m -110.47 145.6 37.39 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.364 -1.08 . . . . 2.2999999999999998 108.901 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.45 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.8 m95 -131.54 145.35 51.69 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.48 -0.762 . . . . 0.01 110.58 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.3 mt -117.8 141.88 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 107.519 -1.289 . . . . 1.6899999999999999 107.519 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.18 143.62 44.52 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 107.657 -1.238 . . . . 2.4900000000000002 107.657 177.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.1 m-85 -121.51 143.9 49.01 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.79 -0.819 . . . . 0.02 108.79 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.432 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 3.0 tm-20 -73.86 -29.9 62.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.705 -0.622 . . . . 0.02 111.525 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.42 152.84 47.42 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 120.666 -1.272 . . . . 1.48 108.989 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.07 170.61 0.47 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.213 1.276 . . . . 0.02 112.502 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.644 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER 57.93 31.13 20.17 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.18 -0.918 . . . . 0.75 110.996 178.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 56.54 47.64 18.25 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.608 -0.682 . . . . 0.02 110.501 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -120.93 163.46 18.2 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.578 -0.702 . . . . 0.02 109.848 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.39 -165.77 31.49 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.971 -1.251 . . . . 0.02 109.971 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -68.06 142.57 55.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.551 -0.97 . . . . 0.02 109.14 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -118.26 148.43 42.43 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.43 -0.582 . . . . 0.02 109.43 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -129.41 142.43 50.8 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 150' ' ' LEU . 5.7 tt -97.41 121.33 39.18 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.384 -0.823 . . . . 0.01 109.333 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.685 HD13 ' HE1' ' A' ' 162' ' ' TRP . 17.0 mt -107.06 138.01 44.04 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.563 -0.711 . . . . 0.01 110.957 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 154' ' ' LYS . 31.8 t70 -110.21 168.98 9.04 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.174 -1.047 . . . . 2.27 108.174 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -53.02 88.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.845 -1.159 . . . . 1.8400000000000001 108.834 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 152' ' ' ASP . 92.6 mttt -136.57 168.53 19.31 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.114 0.959 . . . . 2.2799999999999998 111.584 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -113.1 109.03 18.13 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.152 -1.055 . . . . 0.01 108.152 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.55 114.45 28.1 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.11 -0.994 . . . . 0.01 110.253 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -92.48 -25.99 18.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.199 -0.938 . . . . 0.01 111.319 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -125.75 152.96 73.1 Favored Pre-proline 0 N--CA 1.501 2.1 0 O-C-N 120.956 -1.09 . . . . 2.54 108.583 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -60.27 -42.2 44.26 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 CA-C-N 119.377 0.813 . . . . 0.69999999999999996 110.408 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 23.7 t -60.28 -21.24 22.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.625 -1.297 . . . . 0.85999999999999999 108.443 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 43.1 t0 -66.24 -16.04 63.68 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.143 -1.023 . . . . 0.02 109.255 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.685 ' HE1' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -92.97 7.33 44.46 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.892 -1.151 . . . . 0.02 107.892 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.4 9.42 85.89 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.417 -1.473 . . . . 0.02 109.417 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.3 142.43 30.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.63 -0.923 . . . . 0.02 110.142 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.26 -8.23 59.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.708 -0.62 . . . . 0.58999999999999997 109.553 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.0 t -144.41 151.15 50.27 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.969 -1.082 . . . . 0.87 108.289 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.55 22.11 0.46 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 120.774 0.982 . . . . 0.38 112.369 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.73 122.23 28.36 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.488 1.137 . . . . 0.17999999999999999 111.79 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 117' ' ' ILE . 9.5 mm -142.15 125.67 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 106.004 -1.85 . . . . 3.9900000000000002 106.004 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 13.5 mp0 -112.66 -22.14 10.9 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.958 -1.089 . . . . 5.1699999999999999 112.852 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 34.1 t -156.45 159.65 38.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.327 -2.108 . . . . 0.02 110.044 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.404 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.3 p90 -152.85 153.97 34.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.031 -1.043 . . . . 2.02 110.778 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -145.52 152.05 39.13 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.226 -0.921 . . . . 0.01 110.458 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.44 HH12 HE22 ' A' ' 92' ' ' GLN . 32.2 ptt180 -88.04 142.82 27.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.6 -0.688 . . . . 0.01 109.397 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.28 128.62 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.215 -0.928 . . . . 3.04 108.999 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.01 146.35 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.244 -0.91 . . . . 1.8899999999999999 109.545 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.325 -0.86 . . . . 4.8899999999999997 109.654 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 85.0 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.413 -0.588 . . . . 5.2800000000000002 109.413 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.499 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 11.3 mptt -78.89 52.4 1.24 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.15 -0.969 . . . . 5.96 109.282 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.472 ' H ' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -54.38 -49.39 69.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.118 -0.989 . . . . 2.2200000000000002 110.718 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.93 119.05 4.2 Favored Glycine 0 N--CA 1.5 2.921 0 N-CA-C 107.122 -2.391 . . . . 0.81000000000000005 107.122 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.05 145.97 34.27 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.412 -1.475 . . . . 0.01 109.412 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -153.85 138.48 16.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.239 -1.154 . . . . 0.02 109.605 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -130.06 140.54 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 109.473 -0.566 . . . . 0.02 109.473 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.2 130.14 53.55 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.482 -0.761 . . . . 0.39000000000000001 109.993 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -110.32 140.27 44.67 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.645 -0.659 . . . . 0.02 109.384 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.542 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.5 m-85 -121.93 138.14 54.52 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.162 -0.961 . . . . 0.02 109.617 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 66.6 mt-10 -69.51 -27.6 65.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.054 . . . . 0.029999999999999999 111.814 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 12.4 t70 -113.93 169.86 8.7 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.829 -1.169 . . . . 0.029999999999999999 110.115 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 24.8 mtp180 -75.36 158.12 33.24 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.542 0.687 . . . . 0.029999999999999999 110.13 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.7 m120 66.23 35.01 6.22 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.774 0.797 . . . . 0.73999999999999999 110.905 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.3 p90 49.85 44.65 25.16 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.688 0.756 . . . . 0.02 111.316 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -112.86 165.89 11.9 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.064 -1.088 . . . . 0.02 108.064 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.9 -167.47 34.79 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.808 -1.187 . . . . 0.029999999999999999 110.684 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -68.69 141.92 55.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.515 -0.991 . . . . 2.7599999999999998 109.152 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -122.95 150.16 43.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.535 -0.728 . . . . 1.8899999999999999 110.212 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -136.62 133.47 36.33 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.776 -0.577 . . . . 0.02 109.473 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -109.48 135.91 49.74 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.882 -0.785 . . . . 1.1200000000000001 108.882 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 45.9 t -127.85 138.43 52.69 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.582 -0.699 . . . . 0.02 109.778 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 14.8 p30 -119.2 11.66 12.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.572 -0.705 . . . . 0.20000000000000001 110.372 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 21.3 p -159.58 173.58 15.91 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.797 -1.189 . . . . 1.23 109.097 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 9.0 p30 -62.91 145.92 54.09 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.766 -1.208 . . . . 0.02 110.748 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.562 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 19.4 t -134.54 118.68 17.55 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.096 -0.705 . . . . 0.02 109.096 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.19 -21.79 53.4 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.85 . . . . 0.23999999999999999 111.697 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -153.82 105.86 2.81 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.893 -1.129 . . . . 1.1399999999999999 109.82 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.562 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -102.69 8.07 39.64 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.267 -0.896 . . . . 6.3700000000000001 110.272 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -60.14 -27.69 67.27 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.372 -0.83 . . . . 3.1099999999999999 111.829 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.0 p -76.32 -16.82 59.68 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.512 -1.368 . . . . 0.88 111.153 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -106.81 -21.07 13.14 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.287 -0.883 . . . . 0.02 110.644 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 mt -148.77 127.81 12.77 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.959 -1.088 . . . . 3.3199999999999998 109.399 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.0 t -86.77 -11.8 49.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.647 -0.658 . . . . 0.02 110.582 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -172.03 161.8 5.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.012 -1.055 . . . . 0.02 108.265 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.444 ' SG ' HD12 ' A' ' 79' ' ' LEU . 4.1 p -143.79 116.38 8.65 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.044 -1.035 . . . . 0.02 108.835 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.675 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -108.11 -0.77 20.9 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.708 -1.245 . . . . 0.029999999999999999 111.645 -178.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 t -154.88 154.04 32.06 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.727 -1.212 . . . . 0.02 107.727 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.2 mt -146.89 147.65 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.902 -1.124 . . . . 0.02 110.728 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.525 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 29.2 ttp180 -123.88 124.69 43.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.119 -1.067 . . . . 0.02 108.119 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.67 113.94 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 106.681 -1.6 . . . . 0.02 106.681 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 69.6 mm-40 -84.75 -34.72 22.79 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.18 -0.608 . . . . 3.8100000000000001 110.414 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.49 150.55 19.34 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 118.633 -1.746 . . . . 0.02 110.591 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.74 172.13 48.82 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.25 -1.14 . . . . 0.01 110.25 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 m -118.25 133.86 55.52 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.573 -1.269 . . . . 1.48 107.573 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -126.23 154.61 43.08 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.849 1.309 . . . . 0.02 112.235 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.22 133.76 52.62 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 105.292 -2.114 . . . . 0.23999999999999999 105.292 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.447 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.5 m -115.88 141.52 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.467 -0.771 . . . . 0.65000000000000002 109.241 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -120.21 142.59 48.86 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 122.028 0.918 . . . . 0.02 109.467 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' ND1' ' A' ' 57' ' ' HIS . 35.6 tt0 -65.54 -33.66 76.43 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.62 -0.718 . . . . 0.02 111.915 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 51' ' ' ARG . 0.6 OUTLIER -124.43 157.59 64.45 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 120.926 -1.109 . . . . 0.02 109.383 -178.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.03 166.08 1.06 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.667 1.578 . . . . 0.02 112.728 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 m120 63.66 36.77 10.6 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.362 -0.835 . . . . 0.02 111.12 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.4 m-85 45.06 51.32 8.94 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.636 0.732 . . . . 3.3900000000000001 110.747 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 97.1 p -125.54 163.41 22.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.275 0.559 . . . . 2.3300000000000001 109.837 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.4 -161.41 31.26 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.756 -1.338 . . . . 0.02 109.756 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.516 ' ND1' ' OE1' ' A' ' 50' ' ' GLU . 7.2 m170 -64.43 138.54 58.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.006 -1.291 . . . . 0.02 110.259 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.503 ' O ' ' SD ' ' A' ' 58' ' ' MET . 3.1 ppp? -119.27 137.44 53.67 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.294 0.569 . . . . 5.0099999999999998 109.5 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 88.3 m-85 -135.32 139.68 44.51 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.421 -0.799 . . . . 0.02 109.821 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.7 mm -94.27 130.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.831 -0.803 . . . . 1.72 108.831 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.6 110.75 35.2 Favored Pre-proline 0 N--CA 1.506 2.332 0 O-C-N 121.349 -0.844 . . . . 0.02 110.675 -178.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -78.11 169.42 20.37 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 119.869 0.989 . . . . 1.47 110.442 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.53 141.6 24.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.934 -1.104 . . . . 4.25 110.607 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.06 -178.0 31.19 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 119.608 -1.282 . . . . 0.02 110.967 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -119.83 131.4 55.28 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.601 -0.94 . . . . 0.95999999999999996 109.712 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 50.2 m-85 -121.8 94.84 48.16 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.974 -1.121 . . . . 0.02 107.974 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.84 -4.31 11.03 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 120.908 1.072 . . . . 0.02 113.678 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -157.16 153.96 28.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.611 -1.305 . . . . 2.02 108.143 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -59.53 -38.94 82.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.526 -0.734 . . . . 0.02 111.98 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -59.87 -23.95 63.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.107 -0.995 . . . . 0.02 110.475 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -70.59 -18.69 62.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.883 -0.784 . . . . 3.4199999999999999 108.883 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.565 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.7 t90 -108.1 10.59 28.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.528 -1.286 . . . . 0.02 107.528 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 73' ' ' MET . 1.5 mpt? 59.34 22.85 11.26 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.502 0.668 . . . . 0.02 110.456 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.34 144.72 45.26 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.34 -1.504 . . . . 0.02 109.34 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.9 tp -79.31 -30.52 42.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.026 -1.279 . . . . 0.97999999999999998 107.745 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -157.35 -171.81 3.75 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.475 -1.676 . . . . 0.02 106.475 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 78.5 m-20 -98.15 28.21 4.16 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.708 -1.245 . . . . 0.02 110.718 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -98.27 123.35 42.31 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.08 -1.013 . . . . 3.2000000000000002 111.598 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 79' ' ' LEU . 53.6 mt -142.64 120.07 11.66 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.26 -1.385 . . . . 2.6099999999999999 107.26 177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.67 -18.04 10.55 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 121.208 -0.932 . . . . 0.02 112.392 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.487 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 39.6 t -155.63 156.27 34.72 Favored 'General case' 0 N--CA 1.503 2.204 0 CA-C-N 119.722 1.761 . . . . 0.02 110.816 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.0 p -145.49 147.63 32.36 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.553 -0.717 . . . . 0.02 110.178 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.413 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 50.5 mtp180 -136.88 141.72 42.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.542 -0.724 . . . . 0.01 109.116 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 132.71 37.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.074 -1.016 . . . . 0.42999999999999999 109.254 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -91.35 124.58 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.922 -0.77 . . . . 1.25 108.922 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -91.98 130.9 37.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.817 -1.177 . . . . 1.77 108.402 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mt -96.11 138.84 33.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.92 -1.141 . . . . 1.6299999999999999 107.92 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.0 t -110.41 126.05 53.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.375 -0.828 . . . . 1.0800000000000001 108.774 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.7 t -102.37 -154.79 0.5 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 106.109 -1.812 . . . . 1.26 106.109 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.69 -50.66 0.84 Allowed Glycine 0 N--CA 1.497 2.746 0 O-C-N 120.486 -1.383 . . . . 0.01 111.977 178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.18 -99.59 0.13 Allowed Glycine 0 N--CA 1.488 2.154 0 C-N-CA 118.662 -1.732 . . . . 0.01 112.172 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -120.08 119.89 34.66 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.298 -1.119 . . . . 4.4299999999999997 110.707 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.494 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.16 137.95 57.37 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.835 -0.541 . . . . 2.9900000000000002 109.559 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.408 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 19.7 ttpp -136.88 130.16 31.29 Favored 'General case' 0 N--CA 1.515 2.818 0 O-C-N 120.915 -1.115 . . . . 6.3600000000000003 112.973 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.53 141.79 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.535 -0.757 . . . . 1.0900000000000001 110.35 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 1.3 pt20 -124.69 139.77 53.55 Favored 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 107.666 -1.235 . . . . 2.0499999999999998 107.666 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.49 146.08 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 O-C-N 120.586 -1.321 . . . . 1.1000000000000001 111.123 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -120.48 139.99 52.07 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 122.259 1.028 . . . . 0.72999999999999998 110.855 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -68.08 -32.35 72.62 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.731 -0.668 . . . . 0.02 111.73 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -114.26 167.38 10.75 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.032 -1.042 . . . . 3.1800000000000002 110.347 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.36 163.81 52.72 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.857 -0.897 . . . . 0.01 110.857 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 58.05 38.29 26.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.986 -0.714 . . . . 0.01 111.618 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.518 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 14.9 m-85 52.63 54.76 10.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.417 -0.802 . . . . 0.01 111.234 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -128.1 164.87 21.48 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.957 -1.127 . . . . 3.1499999999999999 107.957 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.3 -162.21 29.39 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.146 -1.582 . . . . 0.01 109.146 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -75.93 141.37 42.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.817 -1.402 . . . . 0.01 109.179 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.1 tmm? -116.38 143.13 45.95 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.519 0.676 . . . . 0.01 109.566 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -132.23 135.9 46.62 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.315 -0.994 . . . . 2.48 108.315 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -117.01 134.15 55.11 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.68 -0.638 . . . . 0.01 109.715 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -149.11 148.8 30.11 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.87 -1.144 . . . . 1.6899999999999999 111.318 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.2 p -114.88 7.79 15.79 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.1 -0.955 . . . . 0.01 109.829 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -122.26 163.12 20.2 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.614 -0.679 . . . . 3.21 111.227 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.88 155.78 40.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.405 -0.809 . . . . 0.01 109.823 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.494 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 63.3 m -129.55 116.72 18.46 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 109.043 -0.725 . . . . 0.01 109.043 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.83 -30.74 7.16 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.343 1.158 . . . . 0.01 111.49 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.6 m -142.83 108.68 5.15 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.856 0.836 . . . . 0.02 109.195 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 169' ' ' ILE . 94.3 mt -63.98 -39.96 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.873 -0.517 . . . . 1.8300000000000001 111.057 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.7 ttp -66.38 -37.89 86.3 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.198 -1.001 . . . . 1.3400000000000001 109.808 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.77 -38.42 76.71 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.537 -1.352 . . . . 2.1099999999999999 109.696 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.427 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 9.2 tt0 -80.11 -47.64 14.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.91 . . . . 2.0800000000000001 112.415 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.427 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 80.6 m-85 -111.06 -0.41 16.64 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.354 -0.841 . . . . 0.02 112.848 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 m80 59.68 33.61 21.95 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.799 -1.188 . . . . 0.02 109.463 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 mt -112.46 135.35 53.26 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.579 -0.897 . . . . 0.02 108.579 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -92.68 -23.18 19.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -0.901 . . . . 5.3200000000000003 110.557 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -148.93 163.37 37.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.163 -0.96 . . . . 0.02 109.949 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.8 mt -131.56 129.33 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 107.523 -1.288 . . . . 2.1699999999999999 107.523 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -107.11 -13.11 15.25 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.177 -0.952 . . . . 0.02 112.971 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.518 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.88 153.5 29.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.339 -1.476 . . . . 0.01 108.297 178.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.1 t -163.36 145.43 9.82 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.317 -1.49 . . . . 1.22 109.757 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.4 mtpt -122.45 112.73 18.42 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.248 1.023 . . . . 1.4099999999999999 109.061 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.63 122.63 63.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 105.924 -1.88 . . . . 0.01 105.924 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 t -146.02 64.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 117.974 -1.491 . . . . 1.98 108.971 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.2 tp10 176.14 108.83 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.641 -1.615 . . . . 0.01 106.641 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.687 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 72.55 -173.1 47.38 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.115 -1.194 . . . . 0.01 110.115 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -111.25 142.94 42.8 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.318 -1.107 . . . . 2.2999999999999998 109.043 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.494 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 64.0 m95 -129.42 145.17 51.45 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.458 -0.776 . . . . 0.01 109.849 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.9 mt -118.46 142.78 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.892 -1.151 . . . . 1.6899999999999999 107.892 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.522 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.84 144.14 43.99 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 107.542 -1.281 . . . . 2.4900000000000002 107.542 177.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.0 m-85 -123.11 145.2 48.77 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.069 -0.715 . . . . 0.02 109.069 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -73.72 -30.06 62.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.628 -0.67 . . . . 0.02 112.043 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 mt -115.33 153.83 47.51 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 120.644 -1.285 . . . . 1.48 109.031 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.35 166.52 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.236 1.291 . . . . 0.02 112.742 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.721 HD22 ' HE ' ' A' ' 145' ' ' ARG . 23.9 t30 59.23 31.86 21.54 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.185 -0.916 . . . . 0.75 111.063 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.404 ' CE1' ' CG ' ' A' ' 173' ' ' ARG . 2.0 m-85 57.42 52.42 8.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.54 -0.725 . . . . 0.02 111.294 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.721 ' HE ' HD22 ' A' ' 143' ' ' ASN . 94.4 mtt180 -124.88 163.19 22.76 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.424 -0.797 . . . . 0.02 109.706 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.46 -165.29 32.38 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.835 -1.306 . . . . 0.02 109.835 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -67.99 141.47 56.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.531 -0.982 . . . . 0.02 108.863 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -118.2 148.37 42.44 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.379 -0.6 . . . . 0.02 109.379 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.49 142.76 50.7 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.804 -0.813 . . . . 0.01 108.804 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 151' ' ' LEU . 1.1 tt -98.18 122.26 41.11 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.268 -0.895 . . . . 0.01 109.245 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.591 ' N ' HD23 ' A' ' 150' ' ' LEU . 18.6 mt -105.14 134.21 48.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.435 -0.791 . . . . 0.01 110.141 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 2.6 m-20 -108.35 176.95 4.94 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.504 -0.925 . . . . 2.27 108.504 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.687 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 45.0 mttm -57.73 83.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 1.8400000000000001 108.456 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 55.3 mmtt -136.51 167.7 20.86 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.971 0.891 . . . . 2.2799999999999998 111.659 -178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -112.92 107.33 15.86 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.7 -1.222 . . . . 0.01 107.7 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.585 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 93.1 m-85 -99.09 115.09 28.21 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.175 -0.953 . . . . 0.01 110.383 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -93.14 -25.21 17.97 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.263 -0.898 . . . . 0.01 111.356 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -125.87 153.81 73.53 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.047 -1.033 . . . . 2.54 108.701 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.38 -42.04 37.12 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 120.436 0.757 . . . . 0.69999999999999996 110.645 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.04 -20.12 21.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.666 -1.271 . . . . 0.85999999999999999 108.869 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -65.34 -15.83 62.96 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.926 -1.109 . . . . 0.02 109.705 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.585 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 1.7 m0 -96.85 11.22 36.55 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.73 85.26 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.489 -1.338 . . . . 0.02 110.249 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.7 141.79 32.04 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.3 -1.118 . . . . 0.02 110.243 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.34 -8.7 58.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.718 -0.614 . . . . 0.58999999999999997 109.95 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 t -144.22 150.64 49.27 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.934 -1.104 . . . . 0.87 108.651 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.63 21.21 0.49 Allowed 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 120.717 0.945 . . . . 0.38 112.484 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.64 121.94 27.48 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.466 1.127 . . . . 0.17999999999999999 111.393 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.401 ' O ' HD12 ' A' ' 117' ' ' ILE . 9.2 mm -143.48 125.66 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 106.048 -1.834 . . . . 3.9900000000000002 106.048 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -110.94 -20.1 12.56 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.983 -1.073 . . . . 5.1699999999999999 112.716 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.7 p -158.46 161.97 37.48 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 119.558 -1.964 . . . . 0.02 110.075 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.494 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 8.9 p90 -152.48 153.13 32.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 2.02 110.278 177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.404 ' CG ' ' CE1' ' A' ' 144' ' ' TYR . 7.2 mmm180 -143.0 150.08 39.14 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.63 0.729 . . . . 0.01 110.035 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -87.79 142.71 27.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.538 -0.727 . . . . 0.01 109.319 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.1 mt -92.59 128.03 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.065 -1.022 . . . . 3.04 109.021 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.6 p -136.07 146.39 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.247 -0.908 . . . . 1.8899999999999999 109.546 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 4.8899999999999997 109.402 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.458 -0.571 . . . . 5.2800000000000002 109.458 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -78.32 96.87 5.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 5.96 109.498 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 39.3 p -97.81 40.52 1.16 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.023 -1.048 . . . . 2.2200000000000002 111.915 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.51 115.18 2.95 Favored Glycine 0 N--CA 1.502 3.071 0 N-CA-C 107.371 -2.292 . . . . 0.81000000000000005 107.371 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.77 146.39 35.27 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.493 -1.443 . . . . 0.01 109.493 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 5.5 ttpm? -152.3 137.61 17.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.18 -1.188 . . . . 0.02 109.978 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 tt -129.6 139.95 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 109.302 -0.629 . . . . 0.02 109.302 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -121.04 130.41 53.77 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.484 -0.76 . . . . 0.39000000000000001 110.183 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.8 m-85 -110.63 140.15 45.23 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.603 -0.686 . . . . 0.02 109.498 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.562 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.3 m-85 -122.98 138.7 54.62 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.182 -0.949 . . . . 0.02 109.921 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 35' ' ' ARG . 41.9 mm-40 -68.54 -28.13 66.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.024 -1.047 . . . . 0.029999999999999999 111.742 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -114.49 170.01 8.63 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.917 -1.114 . . . . 0.029999999999999999 110.214 -179.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -75.5 158.54 32.43 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.574 0.702 . . . . 0.029999999999999999 110.051 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.604 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.4 m120 66.06 35.02 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.919 0.866 . . . . 0.73999999999999999 110.88 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.604 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.9 p90 49.93 44.67 25.4 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.502 -0.772 . . . . 0.02 111.47 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -112.26 166.16 11.53 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.005 -1.109 . . . . 0.02 108.005 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.28 -167.81 36.19 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.792 -1.194 . . . . 0.029999999999999999 110.478 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ttp180 -68.43 142.5 55.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.41 -1.053 . . . . 2.7599999999999998 109.142 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -121.99 149.5 43.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.596 -0.69 . . . . 1.8899999999999999 110.115 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -135.81 132.24 36.43 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 109.372 -0.603 . . . . 0.02 109.372 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.07 135.83 49.59 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.859 -0.793 . . . . 1.1200000000000001 108.859 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.5 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 48.2 t -127.34 138.02 52.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.603 -0.686 . . . . 0.02 109.704 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.485 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 23.4 t0 -119.37 11.31 12.17 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.622 -0.674 . . . . 0.20000000000000001 110.552 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.5 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.7 m -158.99 173.51 16.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.791 -1.193 . . . . 1.23 109.002 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.06 146.27 53.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.74 -1.225 . . . . 0.02 110.706 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.548 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 12.2 t -134.52 118.46 17.33 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.018 -0.734 . . . . 0.02 109.018 178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.18 -21.44 53.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.814 . . . . 0.23999999999999999 111.682 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -154.51 106.17 2.71 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.876 -1.14 . . . . 1.1399999999999999 109.727 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.548 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.83 8.2 41.41 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.336 -0.853 . . . . 6.3700000000000001 110.105 -179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.2 mtm180 -60.45 -28.66 68.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.883 . . . . 3.1099999999999999 112.046 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.9 p -76.22 -17.7 59.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.404 -1.435 . . . . 0.88 111.176 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -106.94 -21.08 13.13 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.309 -0.869 . . . . 0.02 110.268 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -147.32 126.42 12.91 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.217 -0.927 . . . . 3.3199999999999998 108.909 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t -86.65 -11.33 51.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.658 -0.652 . . . . 0.02 110.374 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 33.2 ttt180 -171.47 161.67 6.38 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.057 -1.09 . . . . 0.02 108.057 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.0 t -144.15 116.59 8.57 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.764 -1.21 . . . . 0.02 108.886 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 -110.12 0.19 18.21 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.767 -1.208 . . . . 0.029999999999999999 112.132 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.4 t -155.64 153.75 30.54 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.047 -1.094 . . . . 0.02 108.047 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.47 146.81 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.274 1.035 . . . . 0.02 111.049 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -122.86 123.93 42.11 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.535 -1.283 . . . . 0.02 107.535 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.1 t -105.25 113.87 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.777 -1.564 . . . . 0.02 106.777 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -84.66 -35.43 22.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.69 -0.631 . . . . 3.8100000000000001 110.174 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.54 150.96 20.63 Favored Glycine 0 N--CA 1.487 2.086 0 C-N-CA 118.447 -1.835 . . . . 0.02 110.701 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.7 172.06 48.74 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.347 -1.101 . . . . 0.01 110.347 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.9 m -117.55 133.67 55.71 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.552 -1.277 . . . . 1.48 107.552 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -126.29 154.57 43.24 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.724 1.249 . . . . 0.02 112.223 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.3 133.79 52.61 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.337 -2.097 . . . . 0.23999999999999999 105.337 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -115.92 141.16 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.519 -0.738 . . . . 0.65000000000000002 109.34 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.538 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 27.5 m-85 -120.08 142.62 48.71 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.064 0.935 . . . . 0.02 109.556 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.41 -33.93 77.11 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.526 -0.761 . . . . 0.02 111.855 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -124.85 157.86 64.79 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.92 -1.113 . . . . 0.02 109.58 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.38 166.96 0.96 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.633 1.556 . . . . 0.02 112.824 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 63.28 36.52 11.71 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.258 -0.883 . . . . 0.02 111.084 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.7 m-85 45.31 51.48 9.36 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.71 0.767 . . . . 3.3900000000000001 110.788 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 p -125.94 163.6 22.62 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.287 0.565 . . . . 2.3300000000000001 109.954 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.64 -161.79 31.21 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.788 -1.325 . . . . 0.02 109.788 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -64.57 138.62 58.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.063 -1.257 . . . . 0.02 110.299 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.538 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 47.5 ttp -119.43 137.01 54.04 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.229 0.538 . . . . 5.0099999999999998 109.635 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.495 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 84.4 m-85 -135.0 140.15 45.43 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.483 -0.761 . . . . 0.02 109.862 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -94.49 130.58 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 108.773 -0.825 . . . . 1.72 108.773 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.548 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -121.08 111.07 34.16 Favored Pre-proline 0 N--CA 1.506 2.372 0 O-C-N 121.37 -0.832 . . . . 0.02 110.744 -178.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -77.86 169.44 20.63 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 CA-C-N 119.81 0.968 . . . . 1.47 110.557 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -53.6 141.04 26.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.95 -1.094 . . . . 4.25 110.618 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.91 -177.39 32.21 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.447 -1.359 . . . . 0.02 110.834 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -119.41 131.02 55.58 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.516 -0.99 . . . . 0.95999999999999996 109.668 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.548 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 74.9 m-85 -121.54 97.42 46.93 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.814 -1.18 . . . . 0.02 107.814 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -69.93 -3.62 12.5 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 120.76 0.973 . . . . 0.02 113.766 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -157.28 154.17 28.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.523 -1.36 . . . . 2.02 108.043 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -59.83 -38.72 82.85 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.617 -0.677 . . . . 0.02 111.755 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.62 -24.65 65.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -0.967 . . . . 0.02 110.258 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -68.54 -17.9 64.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.276 -0.89 . . . . 3.4199999999999999 109.067 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.562 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.5 11.66 26.68 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.754 -1.202 . . . . 0.02 107.754 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 mtp 60.91 22.2 12.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.491 -0.756 . . . . 0.02 110.313 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.14 144.9 46.79 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.615 -1.394 . . . . 0.02 109.615 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 14.0 mt -79.86 -30.63 40.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.134 -1.215 . . . . 0.97999999999999998 107.843 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -156.96 -171.66 3.74 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.478 -1.675 . . . . 0.02 106.478 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -98.54 28.06 4.42 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.752 -1.218 . . . . 0.02 110.671 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -96.61 122.92 40.06 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.816 -1.178 . . . . 3.2000000000000002 111.229 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.491 HD21 ' CH2' ' A' ' 72' ' ' TRP . 78.8 mt -142.5 119.88 11.62 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.931 -1.137 . . . . 2.6099999999999999 107.931 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.86 -18.37 8.94 Favored Glycine 0 N--CA 1.5 2.911 0 O-C-N 121.193 -0.942 . . . . 0.02 112.627 -177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.442 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 13.2 t -155.75 156.19 34.4 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.038 -1.86 . . . . 0.02 111.091 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.1 p -146.04 147.99 32.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.514 -0.741 . . . . 0.02 110.335 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.422 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 47.8 mtm180 -136.97 142.02 42.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.482 -0.761 . . . . 0.01 109.13 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.7 131.97 36.82 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.128 -0.983 . . . . 0.42999999999999999 109.307 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 t -90.66 124.63 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.882 -0.784 . . . . 1.25 108.882 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -92.33 131.35 37.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.893 -1.129 . . . . 1.77 108.583 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mt -96.4 139.08 33.04 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.158 -1.053 . . . . 1.6299999999999999 108.158 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.1 t -110.83 126.61 54.83 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.351 -0.843 . . . . 1.0800000000000001 108.906 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 m -103.02 -154.62 0.5 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.207 -1.775 . . . . 1.26 106.207 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.43 -50.68 0.83 Allowed Glycine 0 N--CA 1.498 2.774 0 O-C-N 120.454 -1.404 . . . . 0.01 112.213 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.53 -99.75 0.13 Allowed Glycine 0 N--CA 1.487 2.088 0 C-N-CA 118.79 -1.671 . . . . 0.01 112.076 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -119.99 119.59 33.88 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.142 -1.211 . . . . 4.4299999999999997 110.642 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.405 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.26 135.56 54.62 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.253 -0.579 . . . . 2.9900000000000002 109.541 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.588 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 52.5 tttp -135.33 131.23 36.18 Favored 'General case' 0 N--CA 1.519 2.985 0 CA-C-O 122.136 0.969 . . . . 6.3600000000000003 113.066 -177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.39 142.78 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.737 0.779 . . . . 1.0900000000000001 110.642 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.495 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.0 pt20 -124.68 139.76 53.56 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 107.581 -1.266 . . . . 2.0499999999999998 107.581 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.33 146.29 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 O-C-N 120.596 -1.315 . . . . 1.1000000000000001 111.182 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 24.9 m-85 -120.42 139.79 52.31 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.97 0.89 . . . . 0.72999999999999998 110.769 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -68.02 -32.49 72.91 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.694 -0.684 . . . . 0.02 112.145 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -114.85 166.24 11.99 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.054 -1.029 . . . . 3.1800000000000002 110.403 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.48 163.58 46.11 Favored Glycine 0 N--CA 1.492 2.382 0 CA-C-O 122.072 0.818 . . . . 0.01 111.243 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.3 m-20 57.15 39.33 29.02 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.636 0.732 . . . . 0.01 111.071 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 52.38 56.39 7.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.555 -0.715 . . . . 0.01 110.971 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -129.5 165.57 21.38 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.02 -1.104 . . . . 3.1499999999999999 108.02 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.3 -162.91 28.6 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.222 -1.551 . . . . 0.01 109.222 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -76.04 142.14 41.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.927 -1.337 . . . . 0.01 108.947 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.54 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.4 ttp -116.64 143.34 45.75 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.626 0.727 . . . . 0.01 109.694 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -131.74 136.22 47.43 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.138 -1.06 . . . . 2.48 108.138 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.588 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 44.7 tt0 -115.89 134.05 55.39 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.695 -0.628 . . . . 0.01 109.62 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.57 148.7 28.99 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.519 1.152 . . . . 1.6899999999999999 111.525 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.8 p -115.24 8.14 15.43 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.863 -1.062 . . . . 0.01 110.295 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -121.97 163.26 19.64 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.359 -0.838 . . . . 3.21 111.308 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.01 155.05 41.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.501 -0.749 . . . . 0.01 109.414 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 32.8 m -128.87 116.93 19.25 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.589 -0.694 . . . . 0.01 109.156 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -74.96 -31.47 6.26 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 CA-C-N 120.386 1.173 . . . . 0.01 111.424 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.0 t -142.65 108.76 5.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.361 -0.837 . . . . 0.02 109.298 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 169' ' ' ILE . 81.9 mt -63.63 -39.51 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.795 -0.565 . . . . 1.8300000000000001 110.731 -178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.9 ttt -66.81 -37.77 85.17 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.265 -0.974 . . . . 1.3400000000000001 109.936 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -69.76 -38.65 76.83 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.595 -1.316 . . . . 2.1099999999999999 109.778 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -79.93 -47.4 15.09 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.228 -0.92 . . . . 2.0800000000000001 112.456 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -111.03 -0.29 16.7 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.396 -0.815 . . . . 0.02 112.662 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.488 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.7 m-70 59.77 33.14 21.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.79 -1.194 . . . . 0.02 109.464 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 mt -112.33 135.59 52.83 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.684 -0.858 . . . . 0.02 108.684 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -91.7 -22.83 20.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.246 -0.909 . . . . 5.3200000000000003 110.473 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -149.44 164.06 36.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.152 -0.968 . . . . 0.02 109.858 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.54 129.27 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 107.289 -1.374 . . . . 2.1699999999999999 107.289 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -107.71 -13.52 15.01 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.243 -0.911 . . . . 0.02 113.184 -176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -154.5 152.1 29.71 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.47 -1.394 . . . . 0.01 108.19 178.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.6 t -161.52 145.14 12.68 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.286 -1.509 . . . . 1.22 109.849 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -119.56 108.53 14.61 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.155 0.979 . . . . 1.4099999999999999 108.486 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 t -107.5 120.49 58.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 105.797 -1.927 . . . . 0.01 105.797 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.41 68.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 C-N-CA 118.199 -1.401 . . . . 1.98 108.384 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.64 108.18 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.501 -1.666 . . . . 0.01 106.501 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.87 -174.03 43.8 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.899 -1.28 . . . . 0.01 109.899 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.512 ' CG2' HD21 ' A' ' 150' ' ' LEU . 7.5 m -111.69 145.51 39.14 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.335 -1.097 . . . . 2.2999999999999998 109.191 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.405 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 75.3 m95 -130.6 146.27 52.07 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.492 -0.755 . . . . 0.01 110.492 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.6 mt -118.46 142.17 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 107.83 -1.174 . . . . 1.6899999999999999 107.83 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -115.06 144.41 43.68 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 107.647 -1.242 . . . . 2.4900000000000002 107.647 177.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.4 m-85 -122.42 145.08 48.62 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.657 -0.868 . . . . 0.02 108.657 179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.29 -29.47 61.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.685 -0.634 . . . . 0.02 112.137 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.24 153.79 47.39 Favored Pre-proline 0 N--CA 1.505 2.312 0 O-C-N 120.703 -1.248 . . . . 1.48 109.216 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.37 166.67 1.64 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.132 1.221 . . . . 0.02 112.47 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.4 m120 59.72 31.15 20.69 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.172 -0.922 . . . . 0.75 111.127 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 57.85 51.47 9.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.576 -0.703 . . . . 0.02 111.083 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -124.83 163.63 21.75 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.496 -0.753 . . . . 0.02 109.908 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.03 -165.51 31.79 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.91 -1.276 . . . . 0.02 109.91 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -67.67 141.66 56.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.435 -1.038 . . . . 0.02 108.846 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -117.98 148.18 42.46 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.375 -0.602 . . . . 0.02 109.375 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.456 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.5 t80 -129.69 143.72 50.95 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 109.057 -0.72 . . . . 0.01 109.057 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 150' ' ' LEU . 6.1 tt -98.11 121.46 40.06 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.183 -0.948 . . . . 0.01 109.294 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.554 ' N ' HD23 ' A' ' 150' ' ' LEU . 18.4 mt -105.35 136.43 44.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.01 110.319 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 154' ' ' LYS . 52.4 m-20 -108.19 171.29 7.49 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.702 -0.851 . . . . 2.27 108.702 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -57.69 83.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.055 -1.028 . . . . 1.8400000000000001 108.748 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 152' ' ' ASP . 5.2 tptm -138.08 168.51 19.58 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.166 -0.959 . . . . 2.2799999999999998 111.356 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -110.18 110.6 21.51 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.081 -1.081 . . . . 0.01 108.081 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.616 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 97.2 m-85 -100.44 116.35 32.18 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.134 -0.979 . . . . 0.01 110.089 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 7.5 ptp180 -92.05 -26.19 18.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.305 -0.872 . . . . 0.01 111.579 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -125.42 155.53 71.63 Favored Pre-proline 0 N--CA 1.504 2.245 0 O-C-N 120.741 -1.225 . . . . 2.54 107.866 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -62.79 -40.58 35.22 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.554 0.836 . . . . 0.69999999999999996 110.473 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.75 -20.3 21.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.823 -1.173 . . . . 0.85999999999999999 108.931 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 161' ' ' ASP . 4.9 m-20 -65.46 -16.02 63.23 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.953 -1.092 . . . . 0.02 109.804 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.616 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 2.7 m0 -96.72 10.83 37.57 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.164 -1.05 . . . . 0.02 108.164 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.64 12.08 84.73 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.271 -1.442 . . . . 0.02 109.959 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.42 142.01 32.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.467 -1.019 . . . . 0.02 110.159 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.59 -8.4 58.91 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.747 -0.596 . . . . 0.58999999999999997 110.098 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 25.1 p -144.53 150.67 48.29 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.754 -1.216 . . . . 0.87 108.813 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.1 21.35 0.52 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 120.741 0.961 . . . . 0.38 112.19 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.667 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -82.69 123.98 29.79 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.595 1.188 . . . . 0.17999999999999999 111.57 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 168' ' ' ALA . 10.3 mm -143.63 124.69 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 106.463 -1.68 . . . . 3.9900000000000002 106.463 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -110.33 -22.02 11.92 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.95 -1.094 . . . . 5.1699999999999999 112.369 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 6.6 p -157.4 160.17 38.13 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 119.501 -2.0 . . . . 0.02 109.856 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.439 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 23.5 p90 -153.61 155.26 35.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.08 -1.013 . . . . 2.02 110.696 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -145.42 151.95 39.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.239 -0.913 . . . . 0.01 110.62 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 11.8 ptm180 -87.85 143.16 27.28 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.648 -0.658 . . . . 0.01 109.357 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.1 mt -93.42 128.6 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.071 -1.018 . . . . 3.04 108.882 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.95 146.66 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.314 -0.866 . . . . 1.8899999999999999 109.525 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 4.8899999999999997 109.493 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.538 -0.541 . . . . 5.2800000000000002 109.538 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -74.85 -134.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.36 -0.837 . . . . 5.96 109.283 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.9 m -98.91 110.76 23.32 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.531 -1.655 . . . . 2.2200000000000002 106.531 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.4 94.99 0.1 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 106.626 -2.589 . . . . 0.81000000000000005 106.626 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.78 147.62 33.99 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.495 -1.042 . . . . 0.01 110.495 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -153.23 138.6 17.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.483 -1.01 . . . . 0.02 109.603 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tt -130.05 140.56 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.186 0.517 . . . . 0.02 109.632 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -121.84 130.25 53.24 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.332 -0.855 . . . . 0.39000000000000001 110.247 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.7 m-85 -111.19 140.39 45.79 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.501 -0.75 . . . . 0.02 109.75 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 2.2 m-85 -122.33 138.54 54.48 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.121 -0.987 . . . . 0.02 109.88 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -69.35 -27.5 65.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.029999999999999999 111.865 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' O ' ' OG ' ' A' ' 38' ' ' SER . 17.2 t70 -113.82 169.43 9.0 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.818 -1.176 . . . . 0.029999999999999999 110.23 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -75.6 158.32 32.61 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.695 0.76 . . . . 0.029999999999999999 110.101 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 66.36 33.31 7.08 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.025 0.917 . . . . 0.73999999999999999 110.956 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 55.23 41.54 31.32 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.023 -0.535 . . . . 0.02 111.273 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -112.37 165.45 12.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.122 -1.066 . . . . 0.02 108.122 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.13 -167.7 34.64 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.888 -1.148 . . . . 0.029999999999999999 110.289 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -69.1 143.65 54.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.328 -1.101 . . . . 2.7599999999999998 109.109 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -120.52 150.05 41.45 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.473 0.654 . . . . 1.8899999999999999 109.719 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -136.36 131.59 34.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.642 -0.661 . . . . 0.02 109.549 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -109.42 134.91 51.27 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.403 -0.811 . . . . 1.1200000000000001 108.907 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.2 t -127.35 137.55 52.81 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.126 -0.694 . . . . 0.02 109.126 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.95 11.87 12.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.583 -0.698 . . . . 0.20000000000000001 110.552 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 p -159.93 173.59 15.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.75 -1.219 . . . . 1.23 109.303 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -63.55 146.41 53.74 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.84 -1.163 . . . . 0.02 110.842 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.43 116.92 16.61 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.922 -0.77 . . . . 0.02 108.922 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.13 -22.23 49.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.206 -0.934 . . . . 0.23999999999999999 111.373 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 28.2 p-10 -149.58 103.18 3.24 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.194 -1.039 . . . . 1.1399999999999999 108.194 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 51.3 t80 -105.01 3.46 30.61 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.188 0.994 . . . . 6.3700000000000001 110.866 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -61.13 -25.46 67.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.212 -0.93 . . . . 3.1099999999999999 112.232 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.8 t -77.53 -15.01 59.52 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.366 -1.459 . . . . 0.88 111.342 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -105.31 -20.17 13.58 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.199 -0.938 . . . . 0.02 110.442 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 29' ' ' PHE . 3.3 tp -151.29 131.84 13.89 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.07 -1.019 . . . . 3.3199999999999998 109.64 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.9 m -86.8 -11.89 49.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.66 -0.65 . . . . 0.02 111.021 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -172.91 162.12 4.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.787 -1.196 . . . . 0.02 108.575 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' HD12 ' A' ' 79' ' ' LEU . 1.8 p -143.29 116.68 9.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.177 -0.952 . . . . 0.02 108.681 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -108.65 -0.64 20.06 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.65 -1.281 . . . . 0.029999999999999999 111.474 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 2.8 p -155.43 153.61 30.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.597 -1.26 . . . . 0.02 107.597 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -147.03 148.56 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.187 -0.946 . . . . 0.02 110.619 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.506 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 60.7 ttt180 -125.41 125.48 43.46 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.94 -1.133 . . . . 0.02 107.94 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 t -105.29 114.79 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.71 -1.589 . . . . 0.02 106.71 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 53.8 mm-40 -84.56 -34.53 23.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.491 -0.756 . . . . 3.8100000000000001 109.991 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.23 151.29 20.44 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 118.451 -1.833 . . . . 0.02 110.807 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.93 171.45 48.26 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.227 -1.149 . . . . 0.01 110.227 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.4 m -118.05 133.73 55.64 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.403 -1.332 . . . . 1.48 107.403 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 39.7 m95 -126.96 154.82 44.06 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.622 1.201 . . . . 0.02 112.19 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.17 133.8 52.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 105.423 -2.066 . . . . 0.23999999999999999 105.423 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.446 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.6 m -115.95 141.3 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.623 -0.673 . . . . 0.65000000000000002 109.227 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -120.43 143.0 48.71 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.999 0.904 . . . . 0.02 109.651 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -65.22 -34.39 78.26 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.599 -0.728 . . . . 0.02 111.826 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -124.84 158.27 63.27 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 120.893 -1.129 . . . . 0.02 109.36 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.54 166.77 1.12 Allowed 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.724 1.616 . . . . 0.02 112.867 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 63.08 37.31 11.66 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.21 -0.905 . . . . 0.02 111.143 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.435 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.0 m-85 44.9 51.92 8.35 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.664 0.745 . . . . 3.3900000000000001 110.79 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.4 m -125.87 163.5 22.79 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 121.259 0.552 . . . . 2.3300000000000001 109.898 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.28 -161.72 31.63 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.842 -1.303 . . . . 0.02 109.842 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 13.0 m170 -64.86 138.46 58.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.061 -1.258 . . . . 0.02 110.227 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 14.2 ptm -119.23 136.84 54.02 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.24 0.543 . . . . 5.0099999999999998 109.567 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.441 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 93.8 m-85 -134.48 139.68 45.66 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.551 -0.718 . . . . 0.02 109.937 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.2 mm -94.43 130.5 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.932 -0.766 . . . . 1.72 108.932 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.559 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.56 110.69 35.31 Favored Pre-proline 0 N--CA 1.505 2.314 0 O-C-N 121.409 -0.807 . . . . 0.02 110.781 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -78.14 169.21 20.68 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 CA-C-N 119.898 0.999 . . . . 1.47 110.531 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -54.77 140.23 36.84 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.92 -1.112 . . . . 4.25 110.716 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.81 -176.97 33.16 Favored Glycine 0 N--CA 1.496 2.687 0 C-N-CA 119.506 -1.331 . . . . 0.02 110.517 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -119.29 130.7 55.53 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.287 -1.125 . . . . 0.95999999999999996 109.853 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.559 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 83.3 m-85 -121.07 96.98 48.26 Favored Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 107.991 -1.114 . . . . 0.02 107.991 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.17 -4.14 13.04 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.76 0.973 . . . . 0.02 113.621 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -157.45 154.62 29.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.705 -1.247 . . . . 2.02 108.114 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -59.61 -39.05 82.98 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.448 -0.783 . . . . 0.02 111.868 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -59.99 -23.76 63.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.061 -1.025 . . . . 0.02 110.44 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -70.74 -18.55 62.78 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.777 0.798 . . . . 3.4199999999999999 108.918 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.55 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.3 t90 -108.11 10.18 28.13 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.421 -1.325 . . . . 0.02 107.421 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 mtt 60.83 22.39 12.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.563 -0.711 . . . . 0.02 110.464 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.08 144.76 46.72 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.512 -1.435 . . . . 0.02 109.512 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.493 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 11.9 tp -79.55 -31.08 41.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -1.19 . . . . 0.97999999999999998 107.888 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 75' ' ' LEU . 16.2 m-80 -157.48 -171.93 3.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.553 -1.647 . . . . 0.02 106.553 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.05 28.31 4.06 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.658 -1.276 . . . . 0.02 110.596 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -97.74 122.75 41.21 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.978 -1.076 . . . . 3.2000000000000002 111.201 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 79' ' ' LEU . 56.9 mt -142.09 119.91 11.92 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.444 -1.317 . . . . 2.6099999999999999 107.444 177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.79 -18.59 9.9 Favored Glycine 0 N--CA 1.498 2.823 0 O-C-N 121.233 -0.917 . . . . 0.02 112.231 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.435 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 17.2 t -155.68 155.97 34.13 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.112 -1.817 . . . . 0.02 110.68 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.8 p -145.95 148.1 32.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.446 -0.784 . . . . 0.02 110.254 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.417 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 22.2 mtp180 -137.67 142.35 41.13 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.504 -0.747 . . . . 0.01 109.111 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.14 131.75 36.33 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.207 -0.933 . . . . 0.42999999999999999 109.478 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -90.49 124.83 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.698 -0.852 . . . . 1.25 108.698 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -91.26 132.25 36.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.969 -1.082 . . . . 1.77 108.319 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mt -99.14 140.47 33.25 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.708 -0.849 . . . . 1.6299999999999999 108.708 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.6 p -111.18 123.5 50.32 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.096 -1.076 . . . . 1.0800000000000001 108.096 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 t -114.8 132.62 56.41 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.766 -1.209 . . . . 1.26 107.806 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.48 -47.9 0.01 OUTLIER Glycine 0 N--CA 1.503 3.124 0 C-N-CA 117.754 -2.165 . . . . 0.01 113.465 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.9 -103.38 0.17 Allowed Glycine 0 N--CA 1.486 2.03 0 CA-C-N 120.005 1.902 . . . . 0.01 110.908 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -118.92 118.12 30.66 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.178 -1.19 . . . . 4.4299999999999997 110.021 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.45 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -65.98 135.02 54.14 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 120.132 -0.627 . . . . 2.9900000000000002 109.528 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -134.12 130.57 37.57 Favored 'General case' 0 N--CA 1.517 2.905 0 CA-C-O 122.175 0.988 . . . . 6.3600000000000003 113.115 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -130.46 141.23 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-N 115.51 -0.768 . . . . 1.0900000000000001 110.276 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.467 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 10.9 pt20 -124.09 137.73 54.53 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 107.501 -1.296 . . . . 2.0499999999999998 107.501 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.4 m -123.69 146.6 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.602 0 O-C-N 120.489 -1.382 . . . . 1.1000000000000001 111.406 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.52 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 64.6 m-85 -119.4 139.17 52.45 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.137 0.97 . . . . 0.72999999999999998 110.709 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.37 -32.09 71.93 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 115.853 -0.612 . . . . 0.02 111.797 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -114.78 167.52 10.7 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.964 -1.085 . . . . 3.1800000000000002 110.485 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.27 164.18 52.39 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 111.057 -0.817 . . . . 0.01 111.057 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.9 t70 57.6 38.36 27.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.968 -0.725 . . . . 0.01 111.479 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.433 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 14.7 m-85 53.09 54.88 9.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.01 111.352 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -129.13 165.02 22.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.253 -1.018 . . . . 3.1499999999999999 108.253 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.15 -163.21 28.97 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.24 -1.544 . . . . 0.01 109.24 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.428 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 55.0 tt0 -75.86 142.95 42.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.925 -1.338 . . . . 0.01 109.314 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.52 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.9 ttp -117.4 143.35 46.09 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.505 0.669 . . . . 0.01 109.754 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.428 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 54.2 m-85 -131.91 136.31 47.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.222 -1.029 . . . . 2.48 108.222 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -116.7 134.65 54.55 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.737 -0.602 . . . . 0.01 109.849 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -149.54 147.87 28.69 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.39 1.091 . . . . 1.6899999999999999 111.272 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.6 p -114.3 7.94 16.58 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.049 -0.978 . . . . 0.01 109.996 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -122.18 163.44 19.54 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.439 -0.788 . . . . 3.21 111.186 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 6.7 p30 -69.19 154.81 41.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.01 109.396 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.403 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 51.2 t -126.64 115.18 22.78 Favored Pre-proline 0 N--CA 1.499 2.025 0 N-CA-C 109.009 -0.737 . . . . 0.01 109.009 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -75.41 -32.41 4.96 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 CA-C-N 120.302 1.143 . . . . 0.01 111.406 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -142.45 107.79 5.02 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.842 0.829 . . . . 0.02 108.995 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.43 -39.43 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.791 -0.568 . . . . 1.8300000000000001 111.061 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.9 ttt -66.78 -37.21 84.13 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.04 -1.064 . . . . 1.3400000000000001 109.873 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -70.16 -38.7 75.5 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.673 -1.267 . . . . 2.1099999999999999 109.871 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -80.14 -47.45 14.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.283 -0.886 . . . . 2.0800000000000001 112.469 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -110.56 -0.42 17.32 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.337 -0.852 . . . . 0.02 112.675 -176.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.2 m-70 59.78 32.64 21.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.836 -1.165 . . . . 0.02 109.504 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.2 135.75 52.47 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 108.756 -0.831 . . . . 0.02 108.756 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -92.11 -22.92 19.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 5.3200000000000003 110.425 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -149.55 163.62 37.35 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.132 -0.98 . . . . 0.02 110.134 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.0 mt -131.76 129.48 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 107.125 -1.435 . . . . 2.1699999999999999 107.125 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.0 -13.07 15.28 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.193 -0.942 . . . . 0.02 113.015 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.433 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -155.82 153.97 30.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.483 -1.386 . . . . 0.01 108.146 177.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 5.0 t -163.07 145.62 10.36 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.181 -1.574 . . . . 1.22 109.683 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -122.29 110.49 15.75 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.423 1.106 . . . . 1.4099999999999999 108.767 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.81 122.86 64.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.127 -1.805 . . . . 0.01 106.127 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t -146.63 69.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 118.051 -1.46 . . . . 1.98 108.405 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.1 108.94 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.862 -1.533 . . . . 0.01 106.862 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.88 -174.63 46.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.003 -1.239 . . . . 0.01 110.003 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.451 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.1 m -111.33 144.98 39.64 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.528 -0.984 . . . . 2.2999999999999998 109.234 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.45 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.2 m95 -131.62 146.84 52.4 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.436 -0.79 . . . . 0.01 110.907 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.4 mt -118.76 141.28 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 107.279 -1.378 . . . . 1.6899999999999999 107.279 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.68 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.6 142.38 46.04 Favored 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 107.549 -1.278 . . . . 2.4900000000000002 107.549 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 16.7 m-85 -122.94 145.14 48.73 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.452 -0.78 . . . . 0.02 109.213 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -74.69 -29.7 61.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.643 -0.66 . . . . 0.02 112.08 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.29 153.41 47.45 Favored Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 120.639 -1.288 . . . . 1.48 109.074 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -54.24 166.85 1.47 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.315 1.344 . . . . 0.02 112.41 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.606 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER 59.43 31.24 20.92 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.062 -0.972 . . . . 0.75 111.081 178.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.3 m-85 58.1 51.38 8.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.548 -0.72 . . . . 0.02 110.981 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.93 164.01 21.02 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.47 -0.769 . . . . 0.02 109.896 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.37 -165.41 32.57 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.975 -1.25 . . . . 0.02 109.975 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -67.73 141.6 56.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.549 -0.971 . . . . 0.02 108.78 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.461 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 3.1 mp0 -118.52 148.46 42.61 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.219 0.533 . . . . 0.02 109.606 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.95 142.19 51.32 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 108.61 -0.885 . . . . 0.01 108.61 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 151' ' ' LEU . 4.9 tt -96.28 119.79 35.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.117 -0.99 . . . . 0.01 108.678 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.779 HD13 ' CZ2' ' A' ' 162' ' ' TRP . 1.8 mt -104.29 135.23 46.14 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.527 -0.733 . . . . 0.01 109.985 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 154' ' ' LYS . 1.9 m-20 -110.91 172.8 6.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.356 -0.84 . . . . 2.27 108.867 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -55.04 85.43 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.161 -0.962 . . . . 1.8400000000000001 108.635 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 152' ' ' ASP . 19.5 mmtp -137.16 166.48 23.62 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.199 -0.938 . . . . 2.2799999999999998 111.594 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 6.6 mp0 -112.35 107.47 16.31 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.51 -1.293 . . . . 0.01 107.51 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.625 ' CE2' ' NE1' ' A' ' 162' ' ' TRP . 94.2 m-85 -99.54 113.42 25.81 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.0 -1.063 . . . . 0.01 110.581 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -91.62 -28.18 17.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.329 -0.857 . . . . 0.01 111.392 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 158' ' ' LYS . 8.0 mtmp? -126.46 151.42 72.71 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 120.819 -1.175 . . . . 2.54 108.384 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -58.62 -45.62 28.69 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.352 0.804 . . . . 0.69999999999999996 111.346 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 160' ' ' VAL . 11.3 t -61.21 -22.56 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.726 -1.234 . . . . 0.85999999999999999 109.696 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -65.57 -15.69 62.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.723 -1.236 . . . . 0.02 109.928 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.779 ' CZ2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -97.46 11.36 37.02 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 108.618 -0.882 . . . . 0.02 108.618 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.95 9.27 87.05 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.555 -1.307 . . . . 0.02 110.421 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.2 142.34 30.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.396 -1.061 . . . . 0.02 110.075 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.36 -9.69 57.28 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.752 -0.592 . . . . 0.58999999999999997 110.168 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 42.1 m -146.08 150.76 43.0 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 120.648 -1.283 . . . . 0.87 108.928 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.59 21.74 0.55 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.903 1.069 . . . . 0.38 112.397 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.93 125.56 31.52 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.556 1.169 . . . . 0.17999999999999999 112.063 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.68 HG23 ' CD1' ' A' ' 138' ' ' PHE . 22.0 mt -145.94 125.74 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.778 -1.564 . . . . 3.9900000000000002 106.778 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -112.16 -21.78 11.3 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.969 -1.082 . . . . 5.1699999999999999 112.823 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.4 p -157.16 159.9 38.23 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.427 -2.046 . . . . 0.02 109.749 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.403 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.1 p90 -152.63 154.2 34.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.93 -1.106 . . . . 2.02 110.71 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 25.0 mtp180 -144.17 150.9 38.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.381 -0.824 . . . . 0.01 110.29 -178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.4 ' H ' ' HG2' ' A' ' 174' ' ' ARG . 33.5 ptt180 -88.07 142.36 27.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.726 . . . . 0.01 109.313 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.73 128.5 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.106 -0.996 . . . . 3.04 109.051 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.9 t -136.39 146.87 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.152 -0.967 . . . . 1.8899999999999999 109.676 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.396 -0.815 . . . . 4.8899999999999997 109.417 179.867 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.532 -0.544 . . . . 5.2800000000000002 109.532 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -80.5 -12.05 59.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 5.96 109.714 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.1 m -100.45 110.87 23.08 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.872 -1.529 . . . . 2.2200000000000002 106.872 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.17 93.89 0.09 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 106.671 -2.572 . . . . 0.81000000000000005 106.671 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.07 148.01 34.06 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.441 -1.064 . . . . 0.01 110.441 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -152.65 139.12 18.6 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.365 -1.079 . . . . 0.02 109.887 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 tt -130.63 139.6 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.691 -0.631 . . . . 0.02 109.412 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -121.28 130.31 53.59 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.545 -0.722 . . . . 0.39000000000000001 109.938 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.5 m-85 -110.49 139.65 45.52 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.652 -0.655 . . . . 0.02 109.578 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.9 m-85 -121.41 137.88 54.51 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.237 -0.914 . . . . 0.02 109.531 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -69.56 -27.42 65.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.843 -1.16 . . . . 0.029999999999999999 111.731 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -113.78 169.73 8.77 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.821 -1.174 . . . . 0.029999999999999999 110.114 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -75.7 158.06 32.81 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.63 0.729 . . . . 0.029999999999999999 110.13 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 1.1 m120 66.44 33.34 6.91 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.96 0.886 . . . . 0.73999999999999999 111.046 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.411 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.69 41.66 30.19 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.271 0.557 . . . . 0.02 111.259 177.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -113.31 165.51 12.36 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.376 -0.972 . . . . 0.02 108.376 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.25 -167.62 34.39 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.898 -1.144 . . . . 0.029999999999999999 110.554 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -69.02 142.68 54.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.46 -1.023 . . . . 2.7599999999999998 108.941 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -122.53 150.24 42.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.587 -0.695 . . . . 1.8899999999999999 110.079 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -136.43 133.08 36.26 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.131 -0.692 . . . . 0.02 109.131 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -109.45 135.79 49.9 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.507 -0.923 . . . . 1.1200000000000001 108.507 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.6 t -127.82 138.04 52.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.635 -0.665 . . . . 0.02 109.348 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -118.45 12.32 13.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.654 -0.654 . . . . 0.20000000000000001 110.128 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.6 t -159.81 173.77 15.48 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.888 -1.133 . . . . 1.23 109.164 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -62.79 146.09 53.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.807 -1.183 . . . . 0.02 110.708 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.1 m -133.36 117.33 17.16 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.84 -0.8 . . . . 0.02 108.84 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.79 -20.91 48.66 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.271 -0.893 . . . . 0.23999999999999999 111.758 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -151.82 105.36 3.11 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.804 -1.185 . . . . 1.1399999999999999 109.342 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.15 5.82 42.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.402 -0.811 . . . . 6.3700000000000001 110.291 -178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -62.75 -29.36 70.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.373 -0.83 . . . . 3.1099999999999999 112.708 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 96.6 p -77.49 -18.66 56.87 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.198 -1.564 . . . . 0.88 111.605 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -107.33 -19.29 13.63 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.315 -0.866 . . . . 0.02 110.089 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -148.94 127.08 12.04 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.046 . . . . 3.3199999999999998 109.258 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 p -87.72 -12.45 45.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.453 -0.779 . . . . 0.02 111.389 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -171.49 160.84 6.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.793 -1.192 . . . . 0.02 108.446 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.78 116.35 8.64 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.031 -1.043 . . . . 0.02 108.97 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.501 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 -109.83 0.49 18.78 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.856 -1.153 . . . . 0.029999999999999999 111.987 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.5 t -156.2 154.45 30.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.325 -0.991 . . . . 0.02 108.325 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mt -146.57 146.95 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.02 -1.05 . . . . 0.02 111.001 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -122.84 124.07 42.45 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.487 -1.301 . . . . 0.02 107.487 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.35 114.15 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.774 -1.565 . . . . 0.02 106.774 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -84.16 -34.05 24.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.574 -0.704 . . . . 3.8100000000000001 110.552 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.22 150.74 19.87 Favored Glycine 0 N--CA 1.484 1.897 0 C-N-CA 118.977 -1.583 . . . . 0.02 110.775 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.4 172.22 48.81 Favored Glycine 0 N--CA 1.494 2.504 0 C-N-CA 119.988 -1.101 . . . . 0.01 110.488 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -118.16 134.47 54.98 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.631 -1.248 . . . . 1.48 107.631 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -127.29 154.52 44.81 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 122.508 1.147 . . . . 0.02 112.112 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.38 134.45 51.81 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 105.625 -1.991 . . . . 0.23999999999999999 105.625 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.94 142.1 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -0.762 . . . . 0.65000000000000002 109.316 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -121.08 143.61 48.99 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.032 0.92 . . . . 0.02 109.688 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' OE1' ' CD2' ' A' ' 57' ' ' HIS . 43.5 tt0 -65.13 -34.04 77.46 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.604 -0.725 . . . . 0.02 111.791 -177.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -124.43 157.78 63.8 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 121.001 -1.062 . . . . 0.02 109.51 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.38 166.87 0.99 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.613 1.542 . . . . 0.02 112.814 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 63.65 36.73 10.64 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.243 -0.89 . . . . 0.02 111.039 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 45.03 51.46 8.8 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.667 0.746 . . . . 3.3900000000000001 110.617 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.7 m -125.9 163.65 22.49 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.184 0.516 . . . . 2.3300000000000001 109.898 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.65 -161.95 31.32 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.821 -1.311 . . . . 0.02 109.821 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.432 ' CD2' ' OE1' ' A' ' 50' ' ' GLU . 13.4 m-70 -64.9 138.78 58.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.999 -1.295 . . . . 0.02 110.103 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.498 ' O ' ' SD ' ' A' ' 58' ' ' MET . 2.7 ppp? -119.89 137.6 53.92 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.773 -0.579 . . . . 5.0099999999999998 109.817 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.559 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 85.4 m-85 -134.87 140.19 45.6 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.408 -0.808 . . . . 0.02 109.944 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mm -95.18 130.72 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.972 -0.751 . . . . 1.72 108.972 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.4 mt -121.86 111.66 32.52 Favored Pre-proline 0 N--CA 1.504 2.258 0 O-C-N 121.374 -0.829 . . . . 0.02 110.802 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.67 170.35 19.29 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 CA-C-N 119.859 0.985 . . . . 1.47 110.329 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -52.59 141.01 21.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.904 -1.123 . . . . 4.25 110.357 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.19 -177.54 32.35 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.41 -1.376 . . . . 0.02 110.785 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -120.1 131.33 55.02 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.408 -1.054 . . . . 0.95999999999999996 109.878 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -122.21 94.79 47.74 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 107.931 -1.137 . . . . 0.02 107.931 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.88 -3.98 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.078 1.185 . . . . 0.02 113.855 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -157.58 154.55 28.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.608 -1.308 . . . . 2.02 108.213 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -59.49 -39.35 83.46 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.409 -0.807 . . . . 0.02 111.935 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -60.04 -24.02 64.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.081 -1.012 . . . . 0.02 110.573 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -70.37 -18.32 63.05 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.936 0.874 . . . . 3.4199999999999999 108.828 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.559 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.1 t90 -107.49 11.17 29.06 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.324 -1.362 . . . . 0.02 107.324 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.1 mmt 60.41 22.28 11.87 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.51 0.671 . . . . 0.02 110.286 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.49 144.26 45.87 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.505 -1.438 . . . . 0.02 109.505 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.5 tp -79.13 -30.18 43.57 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.699 -1.223 . . . . 0.97999999999999998 107.699 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.415 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 15.0 t-20 -157.2 -171.9 3.8 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.47 -1.678 . . . . 0.02 106.47 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.415 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 84.4 m-20 -98.81 28.21 4.45 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.789 -1.195 . . . . 0.02 110.639 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -96.52 123.05 40.06 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.971 -1.081 . . . . 3.2000000000000002 111.1 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.541 HD21 ' CH2' ' A' ' 72' ' ' TRP . 81.2 mt -141.57 119.28 11.76 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.772 -1.196 . . . . 2.6099999999999999 107.772 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.51 -18.94 9.14 Favored Glycine 0 N--CA 1.5 2.932 0 O-C-N 121.144 -0.973 . . . . 0.02 112.389 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 p -156.08 156.2 33.93 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 119.738 1.769 . . . . 0.02 110.793 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.78 147.95 32.43 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.471 -0.768 . . . . 0.02 110.327 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -137.38 142.16 41.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.423 -0.798 . . . . 0.01 109.267 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.29 132.46 36.47 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.145 -0.972 . . . . 0.42999999999999999 109.583 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.16 124.89 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.806 -0.813 . . . . 1.25 108.806 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 86' ' ' HIS . 1.6 m80 -91.11 132.81 35.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.919 -1.113 . . . . 1.77 108.424 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 mt -99.36 139.61 34.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.838 -0.801 . . . . 1.6299999999999999 108.838 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.6 t -110.85 123.79 50.79 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.969 -1.123 . . . . 1.0800000000000001 107.969 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.9 p -114.79 132.1 56.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.654 -1.279 . . . . 1.26 107.689 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.76 -48.97 0.01 OUTLIER Glycine 0 N--CA 1.503 3.129 0 C-N-CA 117.652 -2.214 . . . . 0.01 113.299 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.17 -103.93 0.17 Allowed Glycine 0 N--CA 1.488 2.105 0 CA-C-N 119.82 1.81 . . . . 0.01 110.963 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -118.99 118.41 31.41 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.244 -1.15 . . . . 4.4299999999999997 110.184 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.453 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -65.87 135.07 54.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.811 -0.556 . . . . 2.9900000000000002 109.527 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -133.68 129.97 37.54 Favored 'General case' 0 N--CA 1.519 2.994 0 CA-C-O 122.187 0.994 . . . . 6.3600000000000003 113.055 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -131.84 141.46 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 115.505 -0.77 . . . . 1.0900000000000001 110.248 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.438 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.3 pt20 -124.41 139.53 53.81 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 107.399 -1.334 . . . . 2.0499999999999998 107.399 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.76 145.84 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 120.657 -1.277 . . . . 1.1000000000000001 110.917 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -120.42 139.67 52.48 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.084 0.945 . . . . 0.72999999999999998 110.929 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -68.31 -32.24 72.24 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.712 -0.676 . . . . 0.02 111.895 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -114.68 167.7 10.53 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.976 -1.077 . . . . 3.1800000000000002 110.181 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.36 163.7 52.79 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.741 -0.943 . . . . 0.01 110.741 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 58.12 37.79 26.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.821 -0.811 . . . . 0.01 111.604 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.527 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 28.6 m-85 53.33 54.69 9.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -0.798 . . . . 0.01 111.253 177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -128.15 164.3 22.78 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.079 -1.082 . . . . 3.1499999999999999 108.079 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.32 -162.4 29.49 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.913 -1.675 . . . . 0.01 108.913 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -75.82 141.67 42.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.958 -1.319 . . . . 0.01 109.28 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.1 tmm? -116.54 143.23 45.86 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.518 0.675 . . . . 0.01 109.304 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -132.48 136.36 46.64 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.337 -0.986 . . . . 2.48 108.337 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -116.38 134.23 55.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.704 -0.622 . . . . 0.01 109.814 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.9 t -149.35 147.57 28.48 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.901 -1.125 . . . . 1.6899999999999999 111.336 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.9 p -115.03 7.61 15.54 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.996 -1.002 . . . . 0.01 110.19 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -121.77 163.22 19.47 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.411 -0.806 . . . . 3.21 111.109 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -69.44 154.78 41.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.351 -0.843 . . . . 0.01 109.491 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.608 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 20.5 p -126.53 119.77 23.11 Favored Pre-proline 0 N--CA 1.502 2.126 0 N-CA-C 109.22 -0.659 . . . . 0.01 109.22 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -77.01 -33.11 2.88 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 120.341 1.158 . . . . 0.01 110.638 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 t -143.24 108.8 5.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.438 -0.789 . . . . 0.02 109.103 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.4 mt -63.99 -39.31 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.731 -0.606 . . . . 1.8300000000000001 110.823 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.7 ttp -67.18 -36.74 82.43 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.174 -1.01 . . . . 1.3400000000000001 109.881 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.95 -38.79 76.23 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.575 -1.328 . . . . 2.1099999999999999 109.668 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.415 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 8.3 tt0 -80.34 -46.6 15.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.345 -0.847 . . . . 2.0800000000000001 112.509 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.415 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 53.1 m-85 -110.29 -0.45 17.7 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.281 -0.887 . . . . 0.02 112.623 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.7 m80 59.65 33.01 21.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.738 -1.226 . . . . 0.02 109.495 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.0 mt -112.45 135.71 52.83 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 108.71 -0.848 . . . . 0.02 108.71 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -92.4 -22.9 19.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 5.3200000000000003 110.581 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -149.02 163.33 37.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.184 -0.948 . . . . 0.02 109.947 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 53.6 mt -131.75 129.19 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.452 -1.314 . . . . 2.1699999999999999 107.452 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -106.81 -13.4 15.26 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.2 -0.938 . . . . 0.02 113.172 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.32 153.58 30.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.333 -1.479 . . . . 0.01 108.186 178.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 8.6 t -160.52 147.01 15.42 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.318 -1.489 . . . . 1.22 109.904 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -121.79 108.28 13.31 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.029 0.919 . . . . 1.4099999999999999 108.623 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.15 121.06 60.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 106.068 -1.827 . . . . 0.01 106.068 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t -146.83 69.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 118.182 -1.407 . . . . 1.98 108.42 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.66 109.04 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.634 -1.617 . . . . 0.01 106.634 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.35 -174.1 45.2 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.819 -1.312 . . . . 0.01 109.819 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.458 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.5 m -111.4 143.62 41.93 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.526 -0.984 . . . . 2.2999999999999998 109.147 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.453 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 72.5 m95 -129.92 144.97 51.6 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.403 -0.811 . . . . 0.01 110.481 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.7 mt -117.61 141.36 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.504 -1.295 . . . . 1.6899999999999999 107.504 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.31 143.55 44.69 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 107.528 -1.286 . . . . 2.4900000000000002 107.528 177.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.512 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 9.4 m-85 -122.46 144.88 48.78 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.903 -0.777 . . . . 0.02 108.903 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -74.33 -29.82 61.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.729 -0.607 . . . . 0.02 112.119 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.56 153.54 47.78 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 120.805 -1.184 . . . . 1.48 109.083 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.23 166.86 1.46 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.232 1.288 . . . . 0.02 112.7 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 59.54 30.9 20.58 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.235 -0.893 . . . . 0.75 111.029 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.77 51.57 9.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.574 -0.704 . . . . 0.02 110.924 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -124.58 163.66 21.47 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.55 -0.719 . . . . 0.02 109.732 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.52 -165.17 32.22 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.843 -1.303 . . . . 0.02 109.843 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -67.92 141.77 56.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.607 -0.937 . . . . 0.02 108.921 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -118.26 149.03 41.81 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.155 -0.683 . . . . 0.02 109.155 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -129.5 142.54 50.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.486 -0.759 . . . . 0.01 109.049 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.557 HD23 ' C ' ' A' ' 150' ' ' LEU . 5.8 tt -96.96 121.45 38.85 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.217 -0.927 . . . . 0.01 109.079 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.644 HD22 ' NE1' ' A' ' 162' ' ' TRP . 18.8 mt -105.8 135.32 47.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.545 -0.722 . . . . 0.01 110.71 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 154' ' ' LYS . 29.4 t70 -108.68 172.71 6.68 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.015 -1.106 . . . . 2.27 108.015 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -57.08 85.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.964 -1.085 . . . . 1.8400000000000001 108.483 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 152' ' ' ASP . 52.2 tttp -135.79 167.04 21.9 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.303 1.049 . . . . 2.2799999999999998 111.428 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.414 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 29.5 mt-10 -110.92 108.29 18.02 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.209 -1.034 . . . . 0.01 108.209 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.83 114.36 26.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.063 -1.023 . . . . 0.01 110.272 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -91.46 -27.12 18.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.101 -0.999 . . . . 0.01 111.506 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -125.82 153.77 73.39 Favored Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.027 -1.046 . . . . 2.54 108.692 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -60.58 -42.91 36.25 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 CA-C-N 119.171 0.74 . . . . 0.69999999999999996 110.745 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 20.9 t -60.63 -20.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.648 -1.282 . . . . 0.85999999999999999 108.642 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -65.44 -15.96 63.16 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.908 -1.12 . . . . 0.02 109.432 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.644 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -95.17 9.76 38.45 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.939 -1.134 . . . . 0.02 107.939 178.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.87 10.48 86.1 Favored Glycine 0 N--CA 1.485 1.963 0 C-N-CA 119.3 -1.429 . . . . 0.02 109.813 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.41 142.23 31.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.547 -0.972 . . . . 0.02 110.164 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.63 -8.37 58.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.682 -0.636 . . . . 0.58999999999999997 109.783 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.5 t -144.66 150.71 47.94 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.758 -1.214 . . . . 0.87 108.696 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.84 21.54 0.5 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 120.735 0.957 . . . . 0.38 112.322 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.15 123.76 29.85 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.508 1.147 . . . . 0.17999999999999999 111.649 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.6 mt -146.4 126.77 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.663 -1.606 . . . . 3.9900000000000002 106.663 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -112.45 -20.15 11.88 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.04 -1.038 . . . . 5.1699999999999999 112.982 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 11.9 p -157.69 160.83 38.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 119.353 -2.092 . . . . 0.02 110.19 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.608 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 5.2 p90 -152.46 154.28 35.22 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.149 -0.969 . . . . 2.02 110.784 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -144.79 151.85 39.45 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.105 -0.997 . . . . 0.01 110.708 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -88.21 143.75 26.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.68 -0.638 . . . . 0.01 109.33 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.17 129.26 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.137 -0.977 . . . . 3.04 109.083 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.5 t -136.14 146.57 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.269 -0.895 . . . . 1.8899999999999999 109.62 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.295 -0.878 . . . . 4.8899999999999997 109.434 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' LYS . 38.8 m . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.543 -0.54 . . . . 5.2800000000000002 109.543 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 1' ' ' SER . 44.8 mttp 54.69 103.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 5.96 109.433 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.0 m -99.74 113.31 25.7 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 106.461 -1.681 . . . . 2.2200000000000002 106.461 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.52 95.33 0.1 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 106.477 -2.649 . . . . 0.81000000000000005 106.477 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.21 147.93 33.74 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.406 -1.078 . . . . 0.01 110.406 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -152.57 138.56 18.14 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.421 -1.047 . . . . 0.02 109.879 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.05 139.24 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.215 -0.661 . . . . 0.02 109.215 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -121.85 130.94 53.77 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.459 -0.776 . . . . 0.39000000000000001 109.861 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.6 m-85 -110.89 140.41 45.39 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.656 -0.653 . . . . 0.02 109.633 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 4.8 m-85 -122.07 138.41 54.45 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.317 -0.865 . . . . 0.02 109.402 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -69.27 -27.43 65.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.144 . . . . 0.029999999999999999 111.869 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -114.08 169.97 8.62 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.852 -1.155 . . . . 0.029999999999999999 110.257 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -75.41 158.48 32.64 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.535 0.684 . . . . 0.029999999999999999 109.986 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.1 t30 65.7 35.05 7.14 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.891 0.853 . . . . 0.73999999999999999 110.75 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.4 p90 50.03 44.78 25.7 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.681 0.753 . . . . 0.02 111.342 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -112.16 165.73 11.89 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.986 -1.116 . . . . 0.02 107.986 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.21 -167.74 34.57 Favored Glycine 0 N--CA 1.494 2.567 0 C-N-CA 119.87 -1.157 . . . . 0.029999999999999999 110.559 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -68.95 143.18 54.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.317 -1.108 . . . . 2.7599999999999998 108.861 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 50.1 ttt180 -122.19 149.26 43.89 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.564 -0.71 . . . . 1.8899999999999999 110.225 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -135.91 132.2 36.18 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.18 -0.674 . . . . 0.02 109.18 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -109.65 136.57 48.81 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.396 -0.815 . . . . 1.1200000000000001 108.928 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 t -128.03 137.85 52.35 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.553 -0.717 . . . . 0.02 109.593 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.39 11.85 13.15 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.661 -0.649 . . . . 0.20000000000000001 110.139 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 36.7 t -159.53 174.15 15.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.896 -1.128 . . . . 1.23 108.913 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.404 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -62.85 145.86 54.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.63 -1.294 . . . . 0.02 110.599 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.519 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 12.7 p -134.93 119.36 17.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.5 -0.75 . . . . 0.02 109.152 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.0 -21.08 47.53 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.289 -0.882 . . . . 0.23999999999999999 112.376 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -152.41 107.02 3.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.67 -1.269 . . . . 1.1399999999999999 110.14 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.48 5.95 39.79 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.375 -0.828 . . . . 6.3700000000000001 110.442 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -61.42 -30.25 70.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.291 -0.881 . . . . 3.1099999999999999 112.186 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.7 t -76.94 -17.31 58.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.389 -1.444 . . . . 0.88 111.124 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -106.99 -20.84 13.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.403 -0.811 . . . . 0.02 110.755 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.07 127.2 12.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.979 -1.076 . . . . 3.3199999999999998 109.663 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 t -87.01 -12.39 47.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.57 -0.706 . . . . 0.02 111.032 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -172.8 161.72 4.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.781 -1.199 . . . . 0.02 108.467 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.445 ' SG ' HD12 ' A' ' 79' ' ' LEU . 3.4 p -143.49 116.55 8.9 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.1 -1.0 . . . . 0.02 108.876 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -108.28 -0.04 21.04 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.813 -1.179 . . . . 0.029999999999999999 111.287 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 t -156.46 154.34 30.26 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.965 -1.124 . . . . 0.02 107.965 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 39' ' ' ILE . 9.0 mt -146.96 148.13 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.057 -1.027 . . . . 0.02 110.554 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -123.54 124.81 43.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.2 -1.037 . . . . 0.02 108.2 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.5 t -106.66 114.31 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 106.768 -1.567 . . . . 0.02 106.768 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -83.99 -34.1 24.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.717 -0.614 . . . . 3.8100000000000001 110.629 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.54 151.19 20.58 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 119.019 -1.563 . . . . 0.02 110.688 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.09 172.41 49.12 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.934 -1.127 . . . . 0.01 110.496 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -118.15 133.98 55.42 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.548 -1.278 . . . . 1.48 107.548 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -126.36 154.74 43.13 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.685 -1.26 . . . . 0.02 112.196 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.61 133.93 52.53 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.543 -2.021 . . . . 0.23999999999999999 105.543 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.465 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.5 m -116.86 142.6 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.565 -0.709 . . . . 0.65000000000000002 109.451 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -120.7 142.74 49.21 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.053 0.93 . . . . 0.02 109.596 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.433 ' OE1' ' CE1' ' A' ' 57' ' ' HIS . 38.0 tt0 -65.11 -33.54 76.27 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.593 -0.73 . . . . 0.02 111.786 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -124.45 157.71 64.1 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 120.988 -1.07 . . . . 0.02 109.444 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.23 166.63 0.99 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.61 1.54 . . . . 0.02 112.71 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m120 63.44 36.42 11.39 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 115.355 -0.839 . . . . 0.02 111.016 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.527 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.3 m-85 45.37 51.41 9.53 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.528 0.68 . . . . 3.3900000000000001 110.742 178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 p -125.75 163.7 22.27 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.27 0.557 . . . . 2.3300000000000001 109.948 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.46 -161.54 31.26 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.882 -1.287 . . . . 0.02 109.882 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 13.8 m80 -64.25 138.79 58.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.045 -1.268 . . . . 0.02 110.161 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 58' ' ' MET . 3.1 ppp? -119.09 137.17 53.75 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.397 0.618 . . . . 5.0099999999999998 109.65 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 88.3 m-85 -135.27 139.29 44.29 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.419 -0.801 . . . . 0.02 109.765 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 mm -96.25 131.03 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.715 -0.846 . . . . 1.72 108.715 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.478 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.9 mt -121.69 111.9 32.67 Favored Pre-proline 0 N--CA 1.505 2.305 0 O-C-N 121.344 -0.848 . . . . 0.02 110.757 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -77.46 170.1 19.93 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 119.892 0.997 . . . . 1.47 110.325 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -52.63 141.09 21.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.991 -1.068 . . . . 4.25 110.42 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.71 -177.9 31.76 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.437 -1.363 . . . . 0.02 110.782 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -120.04 131.57 55.16 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.401 -1.058 . . . . 0.95999999999999996 109.659 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CE1' HD22 ' A' ' 61' ' ' LEU . 92.6 m-85 -121.32 97.95 47.0 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.941 -1.133 . . . . 0.02 107.941 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -70.17 -3.88 13.18 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.678 0.919 . . . . 0.02 113.6 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -157.39 154.2 28.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.549 -1.344 . . . . 2.02 107.989 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -59.83 -38.49 82.2 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.432 -0.792 . . . . 0.02 111.872 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -59.71 -24.38 63.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.051 . . . . 0.02 110.433 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -70.22 -18.81 63.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.863 0.84 . . . . 3.4199999999999999 108.978 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.55 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.6 t90 -108.25 10.08 27.87 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.493 -1.299 . . . . 0.02 107.493 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.3 mtm 60.84 21.84 11.95 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.484 0.659 . . . . 0.02 110.535 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.61 144.3 46.06 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.388 -1.485 . . . . 0.02 109.388 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 mt -78.84 -30.57 45.27 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.687 -1.227 . . . . 0.97999999999999998 107.687 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -157.32 -171.31 3.56 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.335 -1.728 . . . . 0.02 106.335 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -98.32 29.06 3.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.639 -1.288 . . . . 0.02 110.595 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -97.94 122.65 41.31 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.899 -1.126 . . . . 3.2000000000000002 111.448 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.465 HD22 ' HB ' ' A' ' 48' ' ' VAL . 57.1 mt -142.76 119.78 11.36 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.45 -1.315 . . . . 2.6099999999999999 107.45 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.94 -17.89 10.53 Favored Glycine 0 N--CA 1.497 2.762 0 O-C-N 121.296 -0.878 . . . . 0.02 112.25 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 31.2 t -155.17 155.83 34.64 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.189 -1.771 . . . . 0.02 110.856 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 47.8 t -145.42 148.17 33.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.463 -0.773 . . . . 0.02 110.233 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -137.52 141.67 41.44 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.482 -0.761 . . . . 0.01 109.038 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.06 133.73 36.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.42999999999999999 109.405 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 t -91.92 124.58 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 108.98 -0.748 . . . . 1.25 108.98 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -92.75 131.96 37.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.958 -1.089 . . . . 1.77 108.507 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.15 138.8 33.23 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.134 -1.061 . . . . 1.6299999999999999 108.134 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 t -110.84 126.67 54.9 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.758 -0.83 . . . . 1.0800000000000001 108.758 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.4 m -103.22 -154.49 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.23 -1.767 . . . . 1.26 106.23 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.06 -50.55 0.84 Allowed Glycine 0 N--CA 1.497 2.723 0 O-C-N 120.527 -1.358 . . . . 0.01 112.09 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.67 -100.2 0.14 Allowed Glycine 0 N--CA 1.487 2.076 0 C-N-CA 118.76 -1.686 . . . . 0.01 111.995 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -120.03 119.73 34.23 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.164 -1.198 . . . . 4.4299999999999997 110.523 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.455 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.44 136.45 55.74 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.177 -0.609 . . . . 2.9900000000000002 109.463 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -134.7 130.57 36.49 Favored 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 122.163 0.982 . . . . 6.3600000000000003 112.942 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -132.08 142.07 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.675 0.75 . . . . 1.0900000000000001 110.532 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.425 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.9 pt20 -124.82 139.83 53.48 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 107.686 -1.228 . . . . 2.0499999999999998 107.686 176.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 m -124.07 145.71 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.495 0 O-C-N 120.607 -1.308 . . . . 1.1000000000000001 111.121 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -120.47 140.17 51.8 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 122.081 0.943 . . . . 0.72999999999999998 110.852 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -68.66 -32.58 72.51 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.652 -0.704 . . . . 0.02 111.929 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -114.57 165.47 12.73 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.978 -1.076 . . . . 3.1800000000000002 110.228 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 163.39 45.42 Favored Glycine 0 N--CA 1.494 2.532 0 CA-C-O 122.022 0.79 . . . . 0.01 111.264 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 t70 57.01 39.4 29.37 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.595 0.712 . . . . 0.01 111.1 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 52.15 56.2 8.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.509 -0.744 . . . . 0.01 111.03 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -129.23 165.03 22.17 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.839 -1.171 . . . . 3.1499999999999999 107.839 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.07 -162.78 28.8 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 108.963 -1.655 . . . . 0.01 108.963 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -75.33 141.24 43.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.775 -1.426 . . . . 0.01 109.001 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 11.1 tmm? -116.3 143.37 45.62 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.604 0.716 . . . . 0.01 109.526 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -132.41 136.65 46.92 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.309 -0.997 . . . . 2.48 108.309 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -116.21 134.42 54.94 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.632 -0.668 . . . . 0.01 109.635 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -149.68 148.08 28.85 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.532 1.158 . . . . 1.6899999999999999 111.437 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 p -115.09 7.88 15.55 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.936 -1.029 . . . . 0.01 109.985 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -122.16 163.26 19.85 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.437 -0.79 . . . . 3.21 111.236 -177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.55 154.31 42.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.439 -0.788 . . . . 0.01 109.471 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.429 ' O ' ' OG ' ' A' ' 171' ' ' SER . 44.2 t -127.07 115.99 21.9 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 109.096 -0.705 . . . . 0.01 109.096 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.45 -32.95 4.51 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 120.324 1.151 . . . . 0.01 111.604 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.7 m -142.07 108.59 5.32 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.379 -0.826 . . . . 0.02 109.237 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 169' ' ' ILE . 95.9 mt -64.37 -40.02 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.787 -0.571 . . . . 1.8300000000000001 111.019 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.0 ttp -66.76 -37.6 84.94 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.021 -1.071 . . . . 1.3400000000000001 109.76 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -69.81 -38.53 76.62 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.538 -1.351 . . . . 2.1099999999999999 109.817 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.526 ' OE1' ' CG ' ' A' ' 121' ' ' PHE . 7.9 tm0? -80.49 -47.61 14.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.281 -0.887 . . . . 2.0800000000000001 112.282 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.526 ' CG ' ' OE1' ' A' ' 120' ' ' GLN . 92.1 m-85 -110.72 -0.85 16.93 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.389 -0.819 . . . . 0.02 112.748 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.9 m80 60.1 33.24 21.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.748 -1.22 . . . . 0.02 109.483 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.8 mt -112.42 135.67 52.84 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.802 -0.814 . . . . 0.02 108.802 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -92.3 -23.14 19.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.313 -0.867 . . . . 5.3200000000000003 110.365 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -148.92 163.57 37.08 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.151 -0.968 . . . . 0.02 109.957 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.2 mt -131.6 129.43 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 N-CA-C 107.473 -1.306 . . . . 2.1699999999999999 107.473 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -107.82 -13.26 15.04 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.25 -0.906 . . . . 0.02 113.171 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.5 OUTLIER -153.87 152.1 30.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.355 -1.466 . . . . 0.01 108.206 178.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.2 t -160.72 145.04 13.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.29 -1.506 . . . . 1.22 109.651 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -120.86 108.82 14.38 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 122.099 0.952 . . . . 1.4099999999999999 108.714 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -108.12 120.68 59.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 105.771 -1.937 . . . . 0.01 105.771 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.8 t -146.43 68.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 118.209 -1.397 . . . . 1.98 108.341 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.62 108.75 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 106.563 -1.643 . . . . 0.01 106.563 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.89 -174.16 40.52 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.693 -1.363 . . . . 0.01 109.693 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.7 m -111.62 144.88 40.16 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.37 -1.076 . . . . 2.2999999999999998 109.12 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.455 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 71.5 m95 -129.69 146.47 51.46 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.537 -0.727 . . . . 0.01 110.263 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.2 mt -118.0 141.3 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.583 -1.266 . . . . 1.6899999999999999 107.583 177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.1 143.66 44.43 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.77 -1.196 . . . . 2.4900000000000002 107.77 177.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.502 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.5 m-85 -122.63 143.75 49.56 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.535 -0.728 . . . . 0.02 109.052 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -73.21 -29.61 62.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.514 -0.741 . . . . 0.02 111.98 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.31 153.54 47.48 Favored Pre-proline 0 N--CA 1.505 2.318 0 O-C-N 120.69 -1.256 . . . . 1.48 109.112 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.46 167.24 1.44 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.376 1.384 . . . . 0.02 112.565 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.34 31.14 20.91 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.246 -0.888 . . . . 0.75 111.058 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.65 51.65 9.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.641 -0.662 . . . . 0.02 110.943 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -125.02 163.8 21.55 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.567 -0.708 . . . . 0.02 109.809 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.83 -165.55 32.07 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.878 -1.289 . . . . 0.02 109.878 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -67.7 141.77 56.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.555 -0.968 . . . . 0.02 108.784 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -118.15 148.75 42.03 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.308 -0.627 . . . . 0.02 109.308 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.95 142.45 50.93 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.477 -0.764 . . . . 0.01 109.007 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.37 121.37 38.1 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.302 -0.874 . . . . 0.01 109.297 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.658 HD22 ' NE1' ' A' ' 162' ' ' TRP . 18.1 mt -105.27 136.62 44.46 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.37 -0.831 . . . . 0.01 110.616 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 154' ' ' LYS . 48.1 t0 -109.88 171.99 7.12 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.127 -1.064 . . . . 2.27 108.127 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -57.87 84.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.994 -1.066 . . . . 1.8400000000000001 108.796 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 152' ' ' ASP . 53.8 mttm -136.19 168.78 18.76 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.245 -0.909 . . . . 2.2799999999999998 111.62 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -112.88 110.61 20.8 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.001 -1.111 . . . . 0.01 108.001 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -100.72 116.52 32.81 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.069 -1.019 . . . . 0.01 110.171 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.457 ' O ' ' OG ' ' A' ' 128' ' ' SER . 25.4 ptt180 -92.44 -25.21 18.57 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.251 -0.906 . . . . 0.01 111.525 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -126.32 153.38 74.68 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 120.845 -1.159 . . . . 2.54 108.658 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -60.71 -42.19 40.98 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 119.265 0.773 . . . . 0.69999999999999996 110.446 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 87.4 t -60.36 -20.43 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.696 -1.253 . . . . 0.85999999999999999 108.571 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -65.75 -16.46 63.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.92 -1.113 . . . . 0.02 109.561 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.658 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -94.88 9.76 37.96 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 107.873 -1.158 . . . . 0.02 107.873 179.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.64 10.73 85.76 Favored Glycine 0 N--CA 1.485 1.964 0 C-N-CA 119.341 -1.409 . . . . 0.02 109.761 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.06 142.23 31.82 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.463 -1.022 . . . . 0.02 110.194 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.38 -8.23 59.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.773 -0.579 . . . . 0.58999999999999997 109.856 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 33.4 m -144.68 150.91 48.55 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 120.88 -1.137 . . . . 0.87 108.708 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.19 21.67 0.52 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.708 0.939 . . . . 0.38 112.233 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.02 123.91 29.91 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.455 1.122 . . . . 0.17999999999999999 111.702 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.422 ' O ' HD12 ' A' ' 117' ' ' ILE . 17.5 mt -146.47 126.24 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.799 -1.556 . . . . 3.9900000000000002 106.799 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -112.24 -19.87 12.08 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.074 -1.016 . . . . 5.1699999999999999 112.896 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 28.4 t -157.29 160.0 38.14 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 119.174 -2.204 . . . . 0.02 110.357 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -153.01 154.25 34.56 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 2.02 110.589 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -144.44 151.19 38.86 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.169 -0.957 . . . . 0.01 110.566 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -87.95 143.46 27.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.409 -0.807 . . . . 0.01 109.232 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.0 mt -93.73 128.65 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.052 -1.03 . . . . 3.04 109.221 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -135.86 146.69 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.42 -0.8 . . . . 1.8899999999999999 109.535 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 4.8899999999999997 109.528 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.42 -0.585 . . . . 5.2800000000000002 109.42 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -66.43 -134.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 5.96 109.206 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.6 p -99.5 111.6 23.93 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.754 -1.573 . . . . 2.2200000000000002 106.754 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.29 95.53 0.1 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 106.565 -2.614 . . . . 0.81000000000000005 106.565 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.68 147.47 33.93 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.42 -1.072 . . . . 0.01 110.42 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -152.62 137.44 17.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.586 -0.949 . . . . 0.02 109.488 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.2 tt -130.27 141.12 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.223 0.535 . . . . 0.02 109.828 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t -121.75 130.27 53.3 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.39 -0.819 . . . . 0.39000000000000001 109.972 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.3 m-85 -110.25 139.6 45.25 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.543 -0.723 . . . . 0.02 109.378 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.2 m-85 -121.76 137.94 54.57 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.282 -0.886 . . . . 0.02 109.557 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -69.58 -27.53 65.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -0.999 . . . . 0.029999999999999999 111.733 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.1 m-20 -114.4 170.68 8.12 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.848 -1.158 . . . . 0.029999999999999999 110.087 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -74.93 161.16 29.76 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.749 0.785 . . . . 0.029999999999999999 110.26 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 12.9 t-20 62.4 35.06 15.14 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.894 0.854 . . . . 0.73999999999999999 110.551 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 19.6 p90 49.41 43.39 23.42 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.381 -0.827 . . . . 0.02 110.906 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -109.39 165.48 11.61 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.698 -1.223 . . . . 0.02 107.698 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.8 -167.61 33.62 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.785 -1.198 . . . . 0.029999999999999999 110.63 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -69.47 143.81 53.42 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.361 -1.082 . . . . 2.7599999999999998 109.032 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -122.96 150.51 42.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.63 -0.669 . . . . 1.8899999999999999 110.164 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -137.18 134.05 35.89 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.367 -0.605 . . . . 0.02 109.367 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -109.53 135.57 50.31 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.961 -0.755 . . . . 1.1200000000000001 108.961 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.7 t -127.73 137.65 52.52 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.588 -0.695 . . . . 0.02 109.327 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -118.84 11.99 12.79 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.64 -0.662 . . . . 0.20000000000000001 110.377 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.562 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 46.3 t -159.85 173.62 15.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.77 -1.206 . . . . 1.23 109.186 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.562 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.9 p30 -63.35 146.26 53.87 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.794 -1.191 . . . . 0.02 110.829 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.6 m -134.01 117.48 16.73 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.691 -0.855 . . . . 0.02 108.691 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.484 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.19 -20.46 55.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.466 -0.771 . . . . 0.23999999999999999 111.793 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.57 105.87 3.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.901 -1.124 . . . . 1.1399999999999999 109.25 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.68 5.23 43.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 6.3700000000000001 110.243 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -62.15 -29.6 70.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.448 -0.782 . . . . 3.1099999999999999 112.495 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -77.34 -18.59 57.29 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.224 -1.548 . . . . 0.88 111.687 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -106.43 -19.96 13.52 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.305 -0.872 . . . . 0.02 110.423 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -149.05 127.44 12.23 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.019 -1.051 . . . . 3.3199999999999998 109.457 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -87.27 -12.97 45.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.549 -0.72 . . . . 0.02 111.004 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -172.8 162.08 4.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.02 108.477 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.4 p -142.61 115.21 8.57 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.021 -1.05 . . . . 0.02 108.851 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.453 ' N ' HD22 ' A' ' 37' ' ' ASN . 1.7 m-80 -106.8 -2.77 21.11 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.737 -1.227 . . . . 0.029999999999999999 111.44 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 t -152.98 153.51 33.09 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.884 -1.154 . . . . 0.02 107.884 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 39' ' ' ILE . 9.7 mt -147.01 147.35 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.858 -1.151 . . . . 0.02 110.725 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -125.12 125.55 43.92 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.972 -1.122 . . . . 0.02 107.972 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 t -105.9 114.95 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.643 -1.614 . . . . 0.02 106.643 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -85.57 -34.31 21.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 3.8100000000000001 109.968 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.37 150.52 19.33 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.512 -1.804 . . . . 0.02 110.696 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.68 171.78 48.34 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.486 -1.046 . . . . 0.01 110.486 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.5 m -118.16 133.35 55.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.579 -1.267 . . . . 1.48 107.579 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.411 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 43.8 m95 -126.3 154.68 43.11 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.812 -1.18 . . . . 0.02 112.14 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.24 133.96 52.37 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 105.253 -2.129 . . . . 0.23999999999999999 105.253 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.486 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.3 m -119.21 144.0 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.656 -0.653 . . . . 0.65000000000000002 109.405 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.555 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 43.6 m-85 -120.93 145.15 48.0 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.095 0.95 . . . . 0.02 109.887 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -66.97 -33.35 75.38 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.975 -0.557 . . . . 0.02 111.914 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -123.7 158.2 60.24 Favored Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 120.978 -1.076 . . . . 0.02 109.598 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -53.36 164.98 1.69 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.591 1.527 . . . . 0.02 112.764 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 64.07 37.17 9.3 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.452 -0.795 . . . . 0.02 111.189 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 44.88 51.26 8.64 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.559 0.695 . . . . 3.3900000000000001 110.738 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.5 t -125.93 163.59 22.63 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.179 0.514 . . . . 2.3300000000000001 109.745 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.92 -161.74 30.8 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.877 -1.289 . . . . 0.02 109.877 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -65.84 140.6 58.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.081 -1.246 . . . . 0.02 110.348 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.555 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 52.4 ttp -118.65 138.3 52.7 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.639 -0.663 . . . . 5.0099999999999998 109.956 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 48.3 m-85 -134.45 137.39 43.93 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.409 -0.807 . . . . 0.02 109.748 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.0 mm -95.28 131.25 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.579 -0.897 . . . . 1.72 108.579 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.501 HD22 ' CE1' ' A' ' 66' ' ' TYR . 6.9 mt -120.5 111.52 34.78 Favored Pre-proline 0 N--CA 1.504 2.266 0 O-C-N 121.31 -0.869 . . . . 0.02 110.985 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.02 168.97 21.22 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 119.853 0.983 . . . . 1.47 110.117 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -53.67 140.7 28.43 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.774 -1.204 . . . . 4.25 110.502 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.37 -177.21 32.67 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.586 -1.293 . . . . 0.02 110.636 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -118.95 130.63 55.81 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.352 -1.087 . . . . 0.95999999999999996 109.808 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.501 ' CE1' HD22 ' A' ' 61' ' ' LEU . 87.6 m-85 -120.64 97.11 48.73 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.004 -1.11 . . . . 0.02 108.004 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.45 -3.94 12.82 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 120.708 0.939 . . . . 0.02 113.52 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -157.38 153.96 28.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.651 -1.28 . . . . 2.02 107.988 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -59.76 -38.17 81.07 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.456 -0.777 . . . . 0.02 111.787 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -60.78 -23.85 65.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.061 -1.025 . . . . 0.02 110.433 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -70.1 -18.28 63.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.339 -0.851 . . . . 3.4199999999999999 108.89 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.546 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.1 t90 -108.55 10.46 27.15 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.482 -1.303 . . . . 0.02 107.482 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.1 mtt 61.13 21.55 11.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.621 -0.674 . . . . 0.02 110.539 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.45 144.49 45.63 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.307 -1.517 . . . . 0.02 109.307 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.45 -31.1 42.45 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.743 -1.206 . . . . 0.97999999999999998 107.743 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -157.48 -172.21 3.89 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.443 -1.688 . . . . 0.02 106.443 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 3.7 p-10 -98.1 28.49 3.98 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.708 -1.245 . . . . 0.02 110.672 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 78' ' ' ARG . 26.5 ttm-85 -97.84 122.48 41.0 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.851 -1.156 . . . . 3.2000000000000002 111.142 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.486 HD22 ' HB ' ' A' ' 48' ' ' VAL . 54.5 mt -142.34 120.13 11.91 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 107.652 -1.24 . . . . 2.6099999999999999 107.652 177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.32 -18.1 10.72 Favored Glycine 0 N--CA 1.499 2.878 0 O-C-N 121.309 -0.87 . . . . 0.02 112.183 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.6 m -155.67 155.67 33.61 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.212 -1.758 . . . . 0.02 110.505 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.4 p -145.23 147.67 32.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.807 -0.558 . . . . 0.02 109.74 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -137.64 142.09 41.19 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.39 -0.819 . . . . 0.01 109.159 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.94 133.13 36.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.13 -0.981 . . . . 0.42999999999999999 109.391 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.03 124.41 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.89 -0.781 . . . . 1.25 108.89 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -92.4 131.54 37.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.859 -1.15 . . . . 1.77 108.582 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.55 138.98 33.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.183 -1.043 . . . . 1.6299999999999999 108.183 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.8 p -111.05 126.56 54.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.351 -0.843 . . . . 1.0800000000000001 108.878 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.2 t -103.32 -154.33 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.184 -1.784 . . . . 1.26 106.184 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.19 -50.96 0.83 Allowed Glycine 0 N--CA 1.499 2.88 0 O-C-N 120.49 -1.381 . . . . 0.01 112.214 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.74 -100.14 0.14 Allowed Glycine 0 N--CA 1.487 2.091 0 C-N-CA 118.845 -1.645 . . . . 0.01 111.905 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -120.26 119.53 33.46 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.23 -1.159 . . . . 4.4299999999999997 110.386 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.458 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.61 136.93 56.31 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.226 -0.59 . . . . 2.9900000000000002 109.586 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -136.01 131.16 34.64 Favored 'General case' 0 N--CA 1.516 2.858 0 CA-C-O 122.205 1.003 . . . . 6.3600000000000003 112.93 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -132.1 143.35 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-N 115.584 -0.734 . . . . 1.0900000000000001 110.365 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.438 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 1.3 pt20 -124.8 139.52 53.76 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 107.493 -1.299 . . . . 2.0499999999999998 107.493 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.0 m -123.99 145.86 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.548 -1.345 . . . . 1.1000000000000001 110.971 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -120.68 140.16 52.0 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 122.302 1.049 . . . . 0.72999999999999998 110.876 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.2 tm-20 -68.36 -32.54 72.69 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.587 -0.733 . . . . 0.02 111.81 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -114.0 167.46 10.64 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.043 -1.035 . . . . 3.1800000000000002 110.306 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.24 163.52 52.67 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.815 -0.914 . . . . 0.01 110.815 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 58.2 38.51 26.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.98 -0.718 . . . . 0.01 111.567 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 52.16 55.41 9.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.491 -0.756 . . . . 0.01 111.245 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -128.51 164.53 22.59 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.93 -1.137 . . . . 3.1499999999999999 107.93 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.67 -162.39 29.05 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.013 -1.635 . . . . 0.01 109.013 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -75.54 141.18 43.04 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.842 -1.387 . . . . 0.01 109.154 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 107' ' ' MET . 0.8 OUTLIER -116.26 143.07 46.0 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.48 0.657 . . . . 0.01 109.42 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -132.36 136.16 46.64 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.22 -1.03 . . . . 2.48 108.22 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.482 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.2 tm-20 -116.4 134.1 55.26 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.735 -0.603 . . . . 0.01 109.5 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.482 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 11.9 t -149.3 148.04 29.07 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.491 1.138 . . . . 1.6899999999999999 111.216 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.5 p -115.09 7.56 15.46 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 115.017 -0.992 . . . . 0.01 109.924 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -121.97 163.31 19.55 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.504 -0.747 . . . . 3.21 111.194 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -70.25 155.05 41.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.833 . . . . 0.01 109.78 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.402 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 34.9 t -126.49 115.17 23.09 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 121.532 -0.73 . . . . 0.01 109.195 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.05 -33.13 4.76 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 120.339 1.157 . . . . 0.01 111.113 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.8 t -141.8 107.67 5.15 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.968 0.889 . . . . 0.02 108.832 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.09 -39.93 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.585 -0.697 . . . . 1.8300000000000001 111.176 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.8 ttt -66.39 -37.47 85.31 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.078 -1.049 . . . . 1.3400000000000001 109.593 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.59 -38.46 77.35 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.572 -1.33 . . . . 2.1099999999999999 109.709 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -80.44 -47.24 14.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -0.906 . . . . 2.0800000000000001 112.476 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -111.41 -0.7 16.2 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.235 -0.915 . . . . 0.02 112.653 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 60.08 33.41 21.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.755 -1.216 . . . . 0.02 109.648 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.42 135.51 53.03 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.793 -0.817 . . . . 0.02 108.793 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -92.71 -23.16 19.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.334 -0.854 . . . . 5.3200000000000003 110.766 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -148.91 163.42 37.49 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.226 -0.922 . . . . 0.02 109.965 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 59.2 mt -131.97 129.72 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 107.576 -1.268 . . . . 2.1699999999999999 107.576 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -107.72 -13.53 15.0 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.21 -0.931 . . . . 0.02 113.243 -176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.95 153.52 31.18 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.277 -1.515 . . . . 0.01 108.24 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 7.4 t -161.35 147.39 14.24 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.286 -1.509 . . . . 1.22 109.9 -178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -121.76 108.66 13.77 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.989 0.9 . . . . 1.4099999999999999 108.627 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 t -107.59 120.41 58.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 105.941 -1.874 . . . . 0.01 105.941 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 t -146.49 68.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 118.189 -1.404 . . . . 1.98 108.454 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.39 108.75 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 106.715 -1.587 . . . . 0.01 106.715 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.21 -173.27 43.1 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.978 -1.249 . . . . 0.01 109.978 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.479 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.2 m -112.02 143.73 42.54 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.283 -1.128 . . . . 2.2999999999999998 109.221 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.458 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 72.6 m95 -129.69 145.72 51.51 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.461 -0.774 . . . . 0.01 110.336 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.0 mt -117.8 141.35 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 107.708 -1.219 . . . . 1.6899999999999999 107.708 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.783 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.54 141.45 47.14 Favored 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 107.019 -1.474 . . . . 2.4900000000000002 107.019 178.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 7.7 m-85 -122.73 145.71 48.16 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.437 -0.789 . . . . 0.02 109.197 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -74.12 -29.92 62.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.605 -0.684 . . . . 0.02 112.007 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.68 153.18 47.91 Favored Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 120.753 -1.217 . . . . 1.48 109.118 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.419 ' O ' ' NH1' ' A' ' 145' ' ' ARG . 1.2 Cg_endo -54.24 166.72 1.54 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.25 1.3 . . . . 0.02 112.791 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 14.2 t30 58.67 32.15 21.87 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.205 -0.907 . . . . 0.75 111.099 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 144' ' ' TYR . 1.0 OUTLIER 57.51 52.25 8.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.564 -0.71 . . . . 0.02 111.473 178.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.464 HH11 ' HG3' ' A' ' 145' ' ' ARG . 10.8 mtm-85 -124.5 163.14 22.49 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.52 -0.737 . . . . 0.02 109.597 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.2 -164.95 32.48 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.923 -1.271 . . . . 0.02 109.923 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -68.04 141.13 56.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.583 -0.951 . . . . 0.02 108.862 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -118.32 148.42 42.49 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.361 0.601 . . . . 0.02 109.438 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.5 141.97 51.22 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.465 -0.772 . . . . 0.01 108.977 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.584 HD23 ' C ' ' A' ' 150' ' ' LEU . 6.0 tt -97.15 121.57 39.18 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.263 -0.898 . . . . 0.01 109.288 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.673 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.1 mt -105.22 133.91 49.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.426 -0.797 . . . . 0.01 110.536 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 32.2 t70 -109.41 175.76 5.33 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.346 -0.983 . . . . 2.27 108.346 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -57.18 84.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.974 -1.079 . . . . 1.8400000000000001 108.528 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 48.6 tttp -136.61 165.45 25.85 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.343 -0.848 . . . . 2.2799999999999998 111.461 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.484 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 27.1 mt-10 -111.1 108.4 18.09 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.033 -1.099 . . . . 0.01 108.033 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -98.93 114.82 27.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.002 -1.061 . . . . 0.01 110.241 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -93.26 -26.05 17.51 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.145 -0.972 . . . . 0.01 111.34 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -125.56 153.75 72.7 Favored Pre-proline 0 N--CA 1.502 2.147 0 O-C-N 120.94 -1.1 . . . . 2.54 108.738 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.67 -43.35 32.79 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 119.145 0.73 . . . . 0.69999999999999996 110.724 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.34 -20.72 21.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.728 -1.233 . . . . 0.85999999999999999 108.632 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -65.67 -16.2 63.51 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.044 -1.035 . . . . 0.02 109.568 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.673 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.91 9.76 38.06 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.026 -1.101 . . . . 0.02 108.026 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.02 10.43 86.26 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.259 -1.448 . . . . 0.02 109.693 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.56 142.22 31.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.482 -1.011 . . . . 0.02 110.145 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.46 -8.48 58.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.7 -0.625 . . . . 0.58999999999999997 109.819 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 32.2 m -144.5 151.05 49.66 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 120.888 -1.133 . . . . 0.87 108.602 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.8 21.3 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 120.786 0.991 . . . . 0.38 112.294 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.06 122.69 28.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.525 1.155 . . . . 0.17999999999999999 111.476 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.783 HG23 ' CD1' ' A' ' 138' ' ' PHE . 56.4 mt -145.76 125.35 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.183 -1.784 . . . . 3.9900000000000002 106.183 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -111.65 -19.34 12.52 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.024 -1.048 . . . . 5.1699999999999999 113.094 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.2 t -157.05 160.49 38.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.328 -2.108 . . . . 0.02 110.2 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.402 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 11.6 p90 -151.55 152.25 32.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.116 -0.99 . . . . 2.02 110.272 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.419 ' CG ' ' CE1' ' A' ' 144' ' ' TYR . 7.1 mmm180 -143.34 149.81 38.29 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.388 -0.82 . . . . 0.01 110.033 -178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -88.56 143.46 26.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.464 -0.772 . . . . 0.01 109.566 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.11 128.25 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.136 -0.977 . . . . 3.04 109.123 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.9 t -136.01 146.48 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.223 -0.923 . . . . 1.8899999999999999 109.496 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 4.8899999999999997 109.508 179.995 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' LYS . 70.5 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.505 -0.554 . . . . 5.2800000000000002 109.505 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 1' ' ' SER . 76.6 mttt 52.4 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 5.96 109.456 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 p -98.03 40.71 1.16 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.034 -1.041 . . . . 2.2200000000000002 111.923 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.45 115.36 3.01 Favored Glycine 0 N--CA 1.503 3.139 0 N-CA-C 107.4 -2.28 . . . . 0.81000000000000005 107.4 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.19 146.37 34.64 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.429 -1.468 . . . . 0.01 109.429 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -151.28 138.2 19.02 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.214 -1.168 . . . . 0.02 110.355 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 tt -130.13 138.33 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.055 -0.72 . . . . 0.02 109.055 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 t -120.72 130.59 54.13 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.468 -0.77 . . . . 0.39000000000000001 110.058 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.6 m-85 -110.86 140.09 45.62 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.695 -0.628 . . . . 0.02 109.548 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.8 m-85 -122.51 138.61 54.51 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.219 -0.926 . . . . 0.02 109.362 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.41 -27.13 65.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.126 -0.984 . . . . 0.029999999999999999 111.781 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -114.18 169.88 8.7 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.926 -1.109 . . . . 0.029999999999999999 110.15 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -75.61 158.25 32.68 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.626 0.727 . . . . 0.029999999999999999 110.074 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 66.22 33.18 7.46 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.899 0.857 . . . . 0.73999999999999999 111.029 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.47 41.58 30.74 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.235 0.541 . . . . 0.02 111.212 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -113.02 166.09 11.74 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.321 -0.992 . . . . 0.02 108.321 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.48 -167.71 35.75 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.965 -1.112 . . . . 0.029999999999999999 110.446 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -68.71 142.15 55.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.229 -1.159 . . . . 2.7599999999999998 108.771 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -122.75 149.37 44.19 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.653 -0.654 . . . . 1.8899999999999999 110.013 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -135.93 133.02 37.19 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.685 -0.634 . . . . 0.02 109.656 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 2.2 p-10 -109.64 136.46 48.96 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.526 -0.733 . . . . 1.1200000000000001 109.07 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 54.1 t -128.2 138.08 52.31 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.554 -0.716 . . . . 0.02 109.618 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -119.24 11.14 12.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.62 -0.675 . . . . 0.20000000000000001 110.645 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 30.4 p -159.27 173.67 15.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.779 -1.201 . . . . 1.23 109.124 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.69 145.73 53.97 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.612 -1.305 . . . . 0.02 110.694 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.561 ' CB ' ' CE2' ' A' ' 29' ' ' PHE . 21.6 t -134.6 118.42 17.21 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.09 -0.708 . . . . 0.02 109.09 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.23 -20.95 54.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.373 -0.829 . . . . 0.23999999999999999 111.444 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -155.31 105.68 2.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.797 -1.189 . . . . 1.1399999999999999 109.707 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.561 ' CE2' ' CB ' ' A' ' 26' ' ' CYS . 0.5 OUTLIER -101.63 8.81 41.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.388 -0.82 . . . . 6.3700000000000001 109.922 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -60.55 -29.13 68.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.354 -0.841 . . . . 3.1099999999999999 111.978 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.8 m -76.45 -17.61 59.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.466 -1.396 . . . . 0.88 111.347 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -107.32 -20.24 13.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.374 -0.829 . . . . 0.02 110.539 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 tp -148.83 127.02 12.1 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.89 -1.131 . . . . 3.3199999999999998 109.631 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.9 t -87.14 -12.58 46.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.615 -0.678 . . . . 0.02 111.37 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -171.82 161.91 6.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.73 -1.231 . . . . 0.02 108.364 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.91 116.62 8.71 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.972 -1.08 . . . . 0.02 109.043 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' ND2' ' OD2' ' A' ' 77' ' ' ASP . 1.9 m120 -109.41 0.41 19.37 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.671 -1.268 . . . . 0.029999999999999999 111.862 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.1 t -156.39 154.38 30.41 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.274 -1.01 . . . . 0.02 108.274 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.9 mt -146.14 146.91 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 122.328 1.061 . . . . 0.02 111.092 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -122.77 124.24 42.89 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.706 -1.22 . . . . 0.02 107.706 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -106.67 114.33 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 106.716 -1.587 . . . . 0.02 106.716 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -84.26 -34.38 23.84 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.348 -0.541 . . . . 3.8100000000000001 110.554 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.19 149.99 18.26 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.102 -1.523 . . . . 0.02 110.682 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.31 172.54 49.13 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.374 -1.09 . . . . 0.01 110.374 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.4 m -118.24 134.05 55.36 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 107.81 -1.181 . . . . 1.48 107.81 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -126.47 154.89 43.11 Favored 'General case' 0 N--CA 1.504 2.275 0 CA-C-O 122.587 1.184 . . . . 0.02 112.274 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.39 134.08 52.27 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.681 -1.97 . . . . 0.23999999999999999 105.681 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.36 141.64 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -0.758 . . . . 0.65000000000000002 109.298 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -120.52 143.07 48.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.158 0.98 . . . . 0.02 109.536 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CD ' HH21 ' A' ' 78' ' ' ARG . 31.2 tt0 -65.35 -34.07 77.46 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.52 -0.764 . . . . 0.02 111.794 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -124.65 157.95 63.86 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.095 -1.003 . . . . 0.02 109.323 -178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.56 167.05 1.03 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.67 1.58 . . . . 0.02 112.623 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.1 t30 62.82 36.44 13.04 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.238 -0.892 . . . . 0.02 111.007 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 45.21 51.53 9.13 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.728 0.775 . . . . 3.3900000000000001 110.72 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -125.37 163.26 22.98 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.234 0.54 . . . . 2.3300000000000001 109.818 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.32 -161.34 31.31 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.426 ' ND1' ' OE1' ' A' ' 50' ' ' GLU . 10.9 m80 -65.35 138.54 58.23 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.89 -1.359 . . . . 0.02 110.251 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -119.58 137.16 54.02 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.773 -0.579 . . . . 5.0099999999999998 109.505 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.4 m-85 -134.75 140.38 45.88 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.437 -0.789 . . . . 0.02 109.978 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.8 mm -94.49 130.74 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.863 -0.791 . . . . 1.72 108.863 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -121.22 110.95 34.02 Favored Pre-proline 0 N--CA 1.505 2.287 0 O-C-N 121.353 -0.842 . . . . 0.02 110.702 -178.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -77.67 169.79 20.25 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 CA-C-N 119.819 0.971 . . . . 1.47 110.423 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -53.19 141.7 22.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.023 -1.048 . . . . 4.25 110.413 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.92 -177.83 31.17 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.41 -1.376 . . . . 0.02 111.012 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -119.55 131.32 55.5 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.453 -1.028 . . . . 0.95999999999999996 109.749 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 53.3 m-85 -122.42 96.03 46.37 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 107.823 -1.176 . . . . 0.02 107.823 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.52 -3.43 11.05 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.831 1.021 . . . . 0.02 113.876 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -157.39 154.22 28.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.548 -1.345 . . . . 2.02 108.098 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -59.7 -38.98 83.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.02 112.016 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -60.16 -23.76 64.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.149 -0.969 . . . . 0.02 110.417 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -70.18 -18.26 63.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 3.4199999999999999 108.755 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.552 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.0 OUTLIER -108.26 10.78 27.69 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.56 -1.274 . . . . 0.02 107.56 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.6 mtt 61.65 22.73 13.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.592 -0.692 . . . . 0.02 110.546 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.12 144.57 48.64 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.81 -1.316 . . . . 0.02 109.81 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 75' ' ' LEU . 9.3 mp -80.05 -30.28 39.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -1.219 . . . . 0.97999999999999998 107.88 177.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -157.03 -171.48 3.66 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.666 -1.605 . . . . 0.02 106.666 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.498 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 65.9 m-20 -98.66 28.34 4.3 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.64 -1.288 . . . . 0.02 110.847 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.5 HH21 ' CD ' ' A' ' 50' ' ' GLU . 27.7 mtm-85 -96.77 122.82 40.13 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.833 -1.167 . . . . 3.2000000000000002 111.351 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.491 HD21 ' CH2' ' A' ' 72' ' ' TRP . 80.3 mt -142.05 119.3 11.47 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 107.618 -1.253 . . . . 2.6099999999999999 107.618 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.86 -18.53 9.32 Favored Glycine 0 N--CA 1.499 2.889 0 O-C-N 121.12 -0.988 . . . . 0.02 112.638 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.4 p -156.16 156.69 34.66 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 119.628 1.714 . . . . 0.02 110.841 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 57.0 m -145.91 148.42 32.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.366 -0.834 . . . . 0.02 110.361 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.4 mtp180 -137.05 141.89 42.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.435 -0.791 . . . . 0.01 109.284 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.76 132.18 36.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.048 -1.033 . . . . 0.42999999999999999 109.443 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 t -91.49 124.58 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.874 -0.787 . . . . 1.25 108.874 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -92.58 131.3 37.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.942 -1.099 . . . . 1.77 108.569 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mt -95.87 139.69 31.72 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.233 -1.025 . . . . 1.6299999999999999 108.233 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.6 t -110.89 126.12 54.36 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.643 -0.873 . . . . 1.0800000000000001 108.643 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.0 m -102.58 -154.91 0.5 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.069 -1.826 . . . . 1.26 106.069 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.23 -51.01 0.82 Allowed Glycine 0 N--CA 1.498 2.778 0 O-C-N 120.522 -1.361 . . . . 0.01 112.029 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.56 -99.85 0.13 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 118.683 -1.722 . . . . 0.01 112.121 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -120.17 120.37 35.97 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.202 -1.175 . . . . 4.4299999999999997 110.723 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.486 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.2 137.58 57.09 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.362 -0.607 . . . . 2.9900000000000002 109.362 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 133' ' ' GLU . 32.6 ttmt -136.53 130.44 32.46 Favored 'General case' 0 N--CA 1.516 2.856 0 CA-C-O 122.155 0.979 . . . . 6.3600000000000003 113.031 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -131.81 141.37 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-N 115.51 -0.768 . . . . 1.0900000000000001 110.524 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 pt20 -124.45 139.78 53.57 Favored 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 107.485 -1.302 . . . . 2.0499999999999998 107.485 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.83 146.07 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 O-C-N 120.734 -1.229 . . . . 1.1000000000000001 111.038 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -120.73 139.96 52.34 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.046 0.927 . . . . 0.72999999999999998 110.817 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -68.6 -32.47 72.38 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.688 -0.687 . . . . 0.02 112.025 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -114.27 165.35 12.78 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.855 -1.153 . . . . 3.1800000000000002 110.087 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.29 163.41 45.75 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.973 -0.851 . . . . 0.01 110.973 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.428 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 9.5 m-20 57.29 38.86 28.8 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.541 0.686 . . . . 0.01 111.069 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.484 ' C ' HD22 ' A' ' 104' ' ' ASN . 19.8 m-85 52.65 56.23 7.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.534 -0.729 . . . . 0.01 111.087 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.484 HD22 ' C ' ' A' ' 103' ' ' PHE . 1.8 m-80 -128.59 164.93 21.78 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.998 -1.112 . . . . 3.1499999999999999 107.998 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.93 -162.6 28.86 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.04 -1.624 . . . . 0.01 109.04 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -75.34 141.57 43.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.839 -1.389 . . . . 0.01 108.963 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 107' ' ' MET . 9.3 tmm? -116.33 142.94 46.18 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.482 0.658 . . . . 0.01 109.431 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -132.44 136.55 46.81 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.348 -0.982 . . . . 2.48 108.348 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -116.35 134.15 55.22 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.713 -0.617 . . . . 0.01 109.615 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -149.1 147.92 29.07 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.522 1.153 . . . . 1.6899999999999999 111.358 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.4 p -114.53 7.66 16.2 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.972 -1.013 . . . . 0.01 109.901 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -122.14 163.34 19.68 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.443 -0.786 . . . . 3.21 111.264 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 113' ' ' ASP . 4.9 p30 -69.57 154.6 41.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.01 109.568 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.5 t -126.79 115.33 22.45 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.487 -0.758 . . . . 0.01 108.976 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.03 -32.69 5.14 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 120.4 1.179 . . . . 0.01 111.346 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.0 m -142.12 108.38 5.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.368 -0.833 . . . . 0.02 109.203 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.22 -39.66 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.769 -0.582 . . . . 1.8300000000000001 111.03 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.3 ttt -67.04 -37.79 84.72 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.141 -1.024 . . . . 1.3400000000000001 109.835 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -69.59 -38.5 77.34 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.622 -1.299 . . . . 2.1099999999999999 109.724 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -80.62 -47.4 14.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.229 -0.919 . . . . 2.0800000000000001 112.531 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -111.0 -0.72 16.58 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.291 -0.881 . . . . 0.02 112.727 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.3 m170 59.96 33.51 21.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.738 -1.226 . . . . 0.02 109.436 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.53 135.38 53.31 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.73 -0.841 . . . . 0.02 108.73 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -92.42 -23.03 19.31 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.288 -0.883 . . . . 5.3200000000000003 110.605 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -148.8 163.64 36.77 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.163 -0.96 . . . . 0.02 109.934 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 55.4 mt -131.57 129.46 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 N-CA-C 107.454 -1.313 . . . . 2.1699999999999999 107.454 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -107.86 -13.21 15.04 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.216 -0.927 . . . . 0.02 113.142 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -154.1 152.11 30.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.432 -1.418 . . . . 0.01 108.251 178.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 7.3 t -161.77 145.12 12.25 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.212 -1.555 . . . . 1.22 109.56 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -122.02 111.03 16.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.191 0.996 . . . . 1.4099999999999999 108.861 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.14 121.96 63.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 105.733 -1.951 . . . . 0.01 105.733 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.7 t -146.27 64.94 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 117.996 -1.482 . . . . 1.98 108.955 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 94' ' ' LYS . 1.2 tp10 176.67 109.67 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.485 -1.672 . . . . 0.01 106.485 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.16 -173.41 45.71 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.214 -1.154 . . . . 0.01 110.214 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.42 142.95 41.43 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.491 -1.006 . . . . 2.2999999999999998 108.93 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.486 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 68.0 m95 -129.2 145.21 51.37 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.513 -0.742 . . . . 0.01 109.958 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.0 mt -118.2 142.09 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 107.743 -1.206 . . . . 1.6899999999999999 107.743 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.2 143.25 45.13 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 107.515 -1.291 . . . . 2.4900000000000002 107.515 177.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -122.56 143.65 49.6 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.107 -0.701 . . . . 0.02 109.107 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.45 -29.95 62.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.614 -0.679 . . . . 0.02 112.19 -176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.26 153.58 47.42 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 120.674 -1.266 . . . . 1.48 109.128 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.35 166.59 1.67 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.237 1.291 . . . . 0.02 112.492 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 59.67 31.54 20.95 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.166 -0.925 . . . . 0.75 111.127 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.482 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.8 m-85 57.62 51.51 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.513 -0.742 . . . . 0.02 111.066 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -124.97 163.81 21.49 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.484 -0.76 . . . . 0.02 109.886 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.68 -165.36 32.14 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.838 -1.305 . . . . 0.02 109.838 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -67.71 141.41 56.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.979 . . . . 0.02 108.81 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.63 148.37 42.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.246 -0.65 . . . . 0.02 109.246 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.442 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.04 143.07 50.75 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.808 -0.812 . . . . 0.01 108.808 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 151' ' ' LEU . 1.3 tt -97.51 121.99 40.05 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.385 -0.822 . . . . 0.01 109.127 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.642 HD22 ' NE1' ' A' ' 162' ' ' TRP . 16.9 mt -104.3 135.63 45.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.01 110.311 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 154' ' ' LYS . 13.2 m-20 -108.05 173.36 6.36 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.024 -1.102 . . . . 2.27 108.024 178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -58.68 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.992 -1.068 . . . . 1.8400000000000001 108.614 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 152' ' ' ASP . 40.8 tttm -137.04 168.75 19.0 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.362 -0.836 . . . . 2.2799999999999998 111.483 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 1.6 pm0 -112.61 111.37 22.13 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.213 -1.032 . . . . 0.01 108.213 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -100.68 116.03 31.62 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.053 -1.029 . . . . 0.01 110.059 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.448 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.9 ptm180 -92.78 -25.6 18.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.101 -0.999 . . . . 0.01 111.49 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -125.96 153.08 73.73 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.78 -1.2 . . . . 2.54 108.716 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.72 -42.2 40.75 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 119.271 0.775 . . . . 0.69999999999999996 110.62 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.78 -20.22 21.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.706 -1.246 . . . . 0.85999999999999999 108.508 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -65.65 -16.16 63.47 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.941 -1.099 . . . . 0.02 109.494 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.642 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -95.11 9.68 38.67 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.881 -1.155 . . . . 0.02 107.881 178.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.53 11.07 85.5 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 119.295 -1.431 . . . . 0.02 109.659 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.96 142.24 31.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.44 -1.035 . . . . 0.02 110.174 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.44 -8.28 59.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.736 -0.603 . . . . 0.58999999999999997 109.987 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.0 p -144.48 150.85 49.05 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.709 -1.244 . . . . 0.87 108.771 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -76.05 21.31 0.52 Allowed 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 120.818 1.012 . . . . 0.38 112.248 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.63 123.99 29.76 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.572 1.177 . . . . 0.17999999999999999 111.739 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.2 mt -147.05 126.71 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 106.925 -1.509 . . . . 3.9900000000000002 106.925 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -112.66 -19.52 12.02 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.132 -0.98 . . . . 5.1699999999999999 112.826 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.1 p -158.4 161.44 37.53 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 119.242 -2.161 . . . . 0.02 110.216 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -153.03 154.6 35.24 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.182 -0.948 . . . . 2.02 110.576 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.482 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 25.5 mtp180 -143.84 150.54 38.63 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.086 -1.009 . . . . 0.01 110.314 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -87.74 142.72 27.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.622 -0.674 . . . . 0.01 109.268 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.5 mt -93.14 128.19 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.089 -1.007 . . . . 3.04 109.033 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.4 m -135.89 146.31 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.116 -0.99 . . . . 1.8899999999999999 109.558 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 4.8899999999999997 109.389 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.475 -0.565 . . . . 5.2800000000000002 109.475 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.499 ' CB ' ' NZ ' ' A' ' 2' ' ' LYS . 8.9 mtmp? -61.6 103.17 0.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 5.96 109.517 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.2 m -99.07 112.11 24.33 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.288 -1.745 . . . . 2.2200000000000002 106.288 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.47 95.24 0.1 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 106.57 -2.612 . . . . 0.81000000000000005 106.57 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.91 147.9 34.14 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.322 -1.111 . . . . 0.01 110.322 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -152.37 138.59 18.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.354 -1.086 . . . . 0.02 109.769 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.4 139.52 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.194 -0.669 . . . . 0.02 109.194 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 t -122.08 130.96 53.72 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.464 -0.773 . . . . 0.39000000000000001 110.301 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.1 m-85 -111.16 140.31 45.81 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.617 -0.677 . . . . 0.02 109.623 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.7 m-85 -121.8 138.54 54.33 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.296 -0.877 . . . . 0.02 109.368 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -68.99 -27.33 65.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.905 -1.122 . . . . 0.029999999999999999 111.767 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -114.47 170.35 8.37 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.864 -1.147 . . . . 0.029999999999999999 110.111 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -74.99 161.59 29.33 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.673 0.749 . . . . 0.029999999999999999 110.137 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.608 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 6.0 t-20 62.42 34.97 15.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.907 0.86 . . . . 0.73999999999999999 110.634 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.608 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 19.5 p90 49.68 43.31 24.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.307 -0.861 . . . . 0.02 111.057 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -109.43 165.71 11.43 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.73 -1.211 . . . . 0.02 107.73 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.41 -167.86 34.4 Favored Glycine 0 N--CA 1.495 2.629 0 O-C-N 120.775 -1.203 . . . . 0.029999999999999999 110.688 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -68.84 143.66 54.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.382 -1.069 . . . . 2.7599999999999998 108.883 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' NH2' ' OH ' ' A' ' 10' ' ' TYR . 48.9 ttt180 -122.1 149.94 42.86 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.615 -0.678 . . . . 1.8899999999999999 110.039 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -136.91 132.63 34.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.653 -0.654 . . . . 0.02 109.303 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -109.75 136.14 49.55 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.435 -0.79 . . . . 1.1200000000000001 109.046 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.1 t -127.86 137.71 52.43 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.522 -0.736 . . . . 0.02 109.42 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.488 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 1.4 p30 -118.41 11.98 13.18 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 0.20000000000000001 110.15 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 29.3 m -159.17 173.77 15.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.849 -1.157 . . . . 1.23 108.826 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.405 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 33.4 p30 -62.87 145.8 54.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.856 -1.152 . . . . 0.02 110.324 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.525 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 10.8 p -134.89 119.2 17.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.497 -0.752 . . . . 0.02 109.16 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.2 -20.97 47.02 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.257 -0.902 . . . . 0.23999999999999999 112.297 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.48 106.28 3.1 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.702 -1.249 . . . . 1.1399999999999999 110.175 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.507 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.1 6.46 40.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.341 -0.849 . . . . 6.3700000000000001 110.046 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -61.21 -30.37 70.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 3.1099999999999999 112.097 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.1 m -77.1 -17.52 58.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.308 -1.495 . . . . 0.88 110.965 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -106.66 -21.19 13.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.453 -0.78 . . . . 0.02 110.64 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.0 tp -149.01 127.18 12.06 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.98 -1.075 . . . . 3.3199999999999998 109.599 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.9 t -86.66 -12.2 49.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.531 -0.731 . . . . 0.02 111.176 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -172.0 161.73 5.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.867 -1.146 . . . . 0.02 108.357 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.5 t -143.19 116.59 9.07 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.914 -1.116 . . . . 0.02 108.936 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -109.33 0.29 19.43 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.831 -1.168 . . . . 0.029999999999999999 111.608 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.1 t -156.92 154.72 30.2 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.508 -0.923 . . . . 0.02 108.508 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.1 147.0 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 122.232 1.015 . . . . 0.02 110.79 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -122.21 123.67 42.03 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.847 -1.168 . . . . 0.02 107.847 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 t -106.52 113.75 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 106.746 -1.576 . . . . 0.02 106.746 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -83.95 -34.12 24.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.17 -0.612 . . . . 3.8100000000000001 110.412 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.94 150.63 19.76 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 119.052 -1.546 . . . . 0.02 110.525 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.32 172.08 48.72 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.871 -1.157 . . . . 0.01 110.502 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.7 m -118.48 134.72 54.85 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.69 -1.226 . . . . 1.48 107.69 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.0 m95 -127.58 155.01 44.51 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.601 1.191 . . . . 0.02 112.118 -176.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.38 134.26 52.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 105.518 -2.03 . . . . 0.23999999999999999 105.518 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.02 143.48 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.523 -0.736 . . . . 0.65000000000000002 109.374 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -120.69 144.67 48.09 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.165 0.983 . . . . 0.02 110.06 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' OE2' ' ND1' ' A' ' 57' ' ' HIS . 21.0 tt0 -65.95 -33.09 75.02 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.798 -0.637 . . . . 0.02 111.505 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -124.62 158.1 63.25 Favored Pre-proline 0 N--CA 1.503 2.219 0 O-C-N 120.993 -1.067 . . . . 0.02 109.419 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.61 166.68 1.19 Allowed 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.692 1.595 . . . . 0.02 112.772 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 63.31 36.62 11.57 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 115.464 -0.789 . . . . 0.02 110.934 178.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.46 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 6.5 m-85 45.23 51.74 9.05 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.612 0.72 . . . . 3.3900000000000001 110.749 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.1 t -125.99 163.61 22.63 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.208 0.528 . . . . 2.3300000000000001 109.883 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.7 -161.9 31.21 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.705 -1.358 . . . . 0.02 109.705 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.457 ' ND1' ' OE2' ' A' ' 50' ' ' GLU . 14.0 m80 -64.34 138.87 58.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.922 -1.34 . . . . 0.02 110.122 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -118.77 137.16 53.56 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.337 0.589 . . . . 5.0099999999999998 109.609 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.587 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.5 m-85 -134.73 139.34 45.11 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.459 -0.776 . . . . 0.02 109.912 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.7 mm -95.51 130.97 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.11 -0.7 . . . . 1.72 109.11 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.493 HD22 ' CE1' ' A' ' 66' ' ' TYR . 13.5 mt -122.33 112.01 31.59 Favored Pre-proline 0 N--CA 1.505 2.316 0 O-C-N 121.261 -0.9 . . . . 0.02 110.835 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.38 170.84 18.7 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 119.754 0.948 . . . . 1.47 110.03 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -52.28 140.79 20.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 4.25 110.243 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.39 -177.46 32.55 Favored Glycine 0 N--CA 1.497 2.735 0 C-N-CA 119.4 -1.381 . . . . 0.02 110.769 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -121.02 131.94 54.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.381 -1.07 . . . . 0.95999999999999996 109.878 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CE1' HD22 ' A' ' 61' ' ' LEU . 96.6 m-85 -122.27 97.79 44.89 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 107.768 -1.197 . . . . 0.02 107.768 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.08 -2.23 10.78 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.79 0.994 . . . . 0.02 113.694 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -157.32 153.94 28.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.734 -1.228 . . . . 2.02 108.156 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -59.96 -39.68 86.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.478 -0.764 . . . . 0.02 111.778 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -59.73 -23.88 63.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.046 -1.034 . . . . 0.02 110.35 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -70.87 -18.49 62.69 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.926 0.869 . . . . 3.4199999999999999 108.937 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.587 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.72 10.08 28.97 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.376 -1.342 . . . . 0.02 107.376 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.6 mtt 61.04 22.4 12.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.593 -0.692 . . . . 0.02 110.518 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.93 144.45 46.56 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.571 -1.412 . . . . 0.02 109.571 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -79.42 -30.8 42.49 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.699 -1.222 . . . . 0.97999999999999998 107.699 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 11.7 p-10 -157.03 -171.65 3.72 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.35 -1.722 . . . . 0.02 106.35 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -98.61 28.74 4.04 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.652 -1.28 . . . . 0.02 110.591 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' A' ' 78' ' ' ARG . 25.5 ttm-85 -96.77 122.23 39.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.817 -1.177 . . . . 3.2000000000000002 111.005 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.509 HD21 ' CH2' ' A' ' 72' ' ' TRP . 78.4 mt -141.9 119.37 11.62 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.606 -1.257 . . . . 2.6099999999999999 107.606 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.4 -18.34 9.78 Favored Glycine 0 N--CA 1.501 3.026 0 O-C-N 121.129 -0.982 . . . . 0.02 112.579 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.1 p -156.48 156.81 34.37 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 119.502 1.651 . . . . 0.02 110.451 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.4 m -145.38 148.26 33.17 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.623 -0.673 . . . . 0.02 109.846 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.46 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 51.1 mtp180 -137.48 141.98 41.52 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.193 -0.942 . . . . 0.01 109.283 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 133.18 36.33 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.237 -0.915 . . . . 0.42999999999999999 109.679 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.74 123.66 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.112 -1.07 . . . . 1.25 108.112 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -94.92 133.29 38.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.131 . . . . 1.77 108.956 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.57 134.14 37.44 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.714 -1.217 . . . . 1.6299999999999999 107.714 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.5 m -106.79 130.27 54.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.501 -0.749 . . . . 1.0800000000000001 109.988 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.4 p -115.3 100.53 8.19 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 102.749 -3.056 . . . . 1.26 102.749 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -119.74 -60.84 0.26 Allowed Glycine 0 N--CA 1.51 3.623 0 N-CA-C 110.069 -1.212 . . . . 0.01 110.069 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -129.13 -107.82 1.32 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.353 -1.499 . . . . 0.01 109.353 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -120.55 -141.01 0.34 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.679 -0.895 . . . . 4.4299999999999997 109.213 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -126.5 119.73 27.91 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.23 -1.026 . . . . 2.9900000000000002 108.23 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -144.1 121.98 12.0 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.416 -1.427 . . . . 6.3600000000000003 113.28 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.3 tt -130.71 138.09 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.435 0.636 . . . . 1.0900000000000001 109.681 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.483 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.6 pt20 -123.84 138.76 54.44 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.418 -1.327 . . . . 2.0499999999999998 107.418 177.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 m -124.61 146.21 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.687 -1.258 . . . . 1.1000000000000001 110.658 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -119.77 141.7 49.23 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.215 1.007 . . . . 0.72999999999999998 111.385 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.32 -33.02 72.5 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.783 -0.644 . . . . 0.02 111.358 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.8 mmmt -114.38 167.91 10.31 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.122 -0.986 . . . . 3.1800000000000002 109.66 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.68 168.89 45.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 111.169 -0.772 . . . . 0.01 111.169 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 53.53 39.51 30.14 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.511 0.672 . . . . 0.01 111.598 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 52.48 48.45 22.56 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.707 -0.621 . . . . 0.01 110.934 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -121.67 164.22 17.7 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.332 -0.988 . . . . 3.1499999999999999 108.332 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.69 -163.09 29.48 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.042 -1.623 . . . . 0.01 109.042 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.5 141.58 43.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.798 -1.413 . . . . 0.01 109.199 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.458 ' C ' ' SD ' ' A' ' 107' ' ' MET . 11.6 tmm? -116.24 143.79 45.06 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.479 0.657 . . . . 0.01 109.595 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -132.44 136.44 46.73 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.387 -0.968 . . . . 2.48 108.387 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -117.36 133.94 55.4 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.576 -0.703 . . . . 0.01 109.771 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.4 t -149.58 149.2 30.33 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.481 1.134 . . . . 1.6899999999999999 111.329 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.7 p -114.74 7.96 16.01 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.057 -0.974 . . . . 0.01 110.334 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 23.9 mp0 -121.62 163.16 19.41 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.345 -0.847 . . . . 3.21 111.018 -177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.6 p30 -69.46 154.91 41.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.479 -0.763 . . . . 0.01 109.451 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.4 t -127.31 115.17 21.5 Favored Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 109.13 -0.692 . . . . 0.01 109.13 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.4 -31.44 5.72 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 120.295 1.141 . . . . 0.01 111.429 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.3 m -142.46 107.86 5.03 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.385 -0.822 . . . . 0.02 108.989 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.07 -39.92 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.783 -0.573 . . . . 1.8300000000000001 111.066 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.44 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 15.1 tpt -66.43 -37.4 85.11 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.167 -1.013 . . . . 1.3400000000000001 109.766 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -70.15 -38.42 75.47 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.584 -1.322 . . . . 2.1099999999999999 109.791 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -80.56 -47.4 14.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.179 -0.951 . . . . 2.0800000000000001 112.354 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -111.04 -0.81 16.52 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.329 -0.857 . . . . 0.02 112.852 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.3 m80 59.6 33.53 22.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.732 -1.23 . . . . 0.02 109.525 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.44 ' C ' ' SD ' ' A' ' 118' ' ' MET . 6.4 mt -112.4 135.45 53.08 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 108.703 -0.851 . . . . 0.02 108.703 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -92.12 -23.01 19.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 5.3200000000000003 110.633 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -149.15 163.6 37.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.078 -1.014 . . . . 0.02 110.101 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.5 mt -132.25 129.55 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 107.475 -1.305 . . . . 2.1699999999999999 107.475 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -107.65 -12.12 15.31 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.159 -0.963 . . . . 0.02 113.13 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -156.7 154.12 29.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.467 -1.396 . . . . 0.01 107.759 178.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.9 t -161.48 146.0 13.24 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.877 -1.139 . . . . 1.22 109.639 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -121.86 109.56 14.81 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.374 1.083 . . . . 1.4099999999999999 108.949 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.5 t -110.53 122.18 64.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 106.408 -1.701 . . . . 0.01 106.408 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.6 t -146.63 68.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 118.639 -1.225 . . . . 1.98 107.802 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 174.13 105.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.705 -1.591 . . . . 0.01 106.705 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.11 -177.07 46.04 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.548 -1.421 . . . . 0.01 109.548 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.8 m -109.55 143.73 38.82 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.442 -1.034 . . . . 2.2999999999999998 108.659 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -128.56 145.34 51.16 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.474 -0.767 . . . . 0.01 110.49 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 18.4 mt -116.56 140.29 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 107.504 -1.295 . . . . 1.6899999999999999 107.504 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.602 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -112.89 141.7 46.42 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 107.577 -1.268 . . . . 2.4900000000000002 107.577 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.3 m-85 -121.99 143.54 49.42 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.008 -0.738 . . . . 0.02 109.008 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.416 ' OE2' ' O ' ' A' ' 140' ' ' GLU . 3.2 tm-20 -73.32 -29.74 62.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.02 112.001 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -114.76 153.92 46.86 Favored Pre-proline 0 N--CA 1.508 2.457 0 O-C-N 120.593 -1.317 . . . . 1.48 109.332 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.47 166.27 1.91 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.13 1.22 . . . . 0.02 112.44 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 59.97 31.1 20.51 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.178 -0.919 . . . . 0.75 111.138 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 58.0 51.53 8.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.553 -0.717 . . . . 0.02 111.044 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -124.95 163.69 21.74 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.551 -0.718 . . . . 0.02 109.76 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.93 -165.28 31.76 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.804 -1.318 . . . . 0.02 109.804 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -67.86 141.97 56.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.493 -1.004 . . . . 0.02 108.831 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.462 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 3.3 mp0 -118.57 149.42 41.37 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.509 -0.552 . . . . 0.02 109.509 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.49 141.89 51.25 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.536 -0.727 . . . . 0.01 109.263 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.7 tp -94.61 119.91 34.01 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.826 -0.805 . . . . 0.01 108.826 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.633 HD22 ' NE1' ' A' ' 162' ' ' TRP . 19.7 mt -106.67 136.22 46.85 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.44 -0.788 . . . . 0.01 110.781 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 154' ' ' LYS . 16.3 t0 -110.42 171.35 7.51 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.21 -1.033 . . . . 2.27 108.21 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.9 pttm -55.74 86.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.0 -1.063 . . . . 1.8400000000000001 108.605 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 152' ' ' ASP . 56.0 mttp -136.27 168.6 19.11 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.096 -1.003 . . . . 2.2799999999999998 111.423 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 18.9 mp0 -112.99 109.7 19.28 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.129 -1.063 . . . . 0.01 108.129 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -101.05 115.05 29.57 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.019 -1.05 . . . . 0.01 110.448 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -92.19 -25.65 18.57 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.083 -1.011 . . . . 0.01 111.324 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -126.2 153.53 74.36 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 120.797 -1.189 . . . . 2.54 108.54 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.04 -42.61 35.33 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 CA-C-N 119.313 0.791 . . . . 0.69999999999999996 110.644 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.6 t -60.24 -20.71 20.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.637 -1.29 . . . . 0.85999999999999999 108.669 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -65.87 -15.95 63.4 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.888 -1.132 . . . . 0.02 109.609 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.633 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.83 9.55 38.69 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.08 10.56 86.2 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.349 -1.405 . . . . 0.02 109.784 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.54 142.13 31.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.455 -1.027 . . . . 0.02 110.194 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.62 -8.41 58.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.66 -0.65 . . . . 0.58999999999999997 109.767 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.9 p -144.49 150.98 49.52 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.947 -1.095 . . . . 0.87 108.544 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -76.15 21.56 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.738 0.958 . . . . 0.38 112.4 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.14 123.89 29.97 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.592 1.187 . . . . 0.17999999999999999 111.92 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.602 HG23 ' CD1' ' A' ' 138' ' ' PHE . 26.0 mt -146.08 125.22 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 106.38 -1.711 . . . . 3.9900000000000002 106.38 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -111.21 -20.26 12.39 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.154 -0.966 . . . . 5.1699999999999999 112.988 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.7 p -157.89 160.17 37.36 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 119.423 -2.048 . . . . 0.02 109.871 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -152.81 154.59 35.47 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.095 -1.003 . . . . 2.02 110.426 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -144.33 151.63 39.61 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.25 -0.906 . . . . 0.01 110.712 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -88.27 144.88 26.16 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.168 -0.679 . . . . 0.01 109.168 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.1 mt -95.63 128.58 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.165 -0.959 . . . . 3.04 109.403 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 177' ' ' GLU . 17.4 m -136.81 146.6 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.229 -0.92 . . . . 1.8899999999999999 109.304 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 176' ' ' VAL . 16.1 pt-20 . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.891 -0.506 . . . . 4.8899999999999997 110.808 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.0 t . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.419 -0.586 . . . . 5.2800000000000002 109.419 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -70.7 62.91 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 5.96 109.424 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 4' ' ' GLY . 50.2 m -173.88 158.39 3.19 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.824 -1.173 . . . . 2.2200000000000002 108.265 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.492 ' N ' HG22 ' A' ' 3' ' ' THR . . . 178.79 177.76 47.62 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 118.619 -1.753 . . . . 0.81000000000000005 111.806 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.47 156.9 43.58 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.107 -1.597 . . . . 0.01 109.107 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -149.06 136.99 20.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.015 -1.285 . . . . 0.02 110.255 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 tt -130.43 140.67 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.136 -0.69 . . . . 0.02 109.136 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 t -121.47 130.23 53.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.427 -0.795 . . . . 0.39000000000000001 110.146 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.51 140.42 44.81 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.647 -0.658 . . . . 0.02 109.361 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.7 m-85 -121.92 138.26 54.48 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.189 -0.944 . . . . 0.02 109.493 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -69.47 -27.42 65.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.892 -1.13 . . . . 0.029999999999999999 111.672 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -113.89 169.86 8.69 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.801 -1.187 . . . . 0.029999999999999999 110.241 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -75.62 158.42 32.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.509 0.671 . . . . 0.029999999999999999 110.174 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 43.8 t30 65.78 35.37 6.83 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.883 0.849 . . . . 0.73999999999999999 110.759 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.602 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.99 44.62 25.57 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.682 0.754 . . . . 0.02 111.26 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -112.58 165.67 12.04 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.975 -1.12 . . . . 0.02 107.975 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.09 -167.57 34.57 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.789 -1.196 . . . . 0.029999999999999999 110.563 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -69.14 142.64 54.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.399 -1.06 . . . . 2.7599999999999998 109.073 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -122.3 150.13 42.77 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.455 -0.778 . . . . 1.8899999999999999 110.152 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -136.53 133.12 36.14 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.665 -0.647 . . . . 0.02 109.351 177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -109.37 135.74 49.93 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.772 -0.825 . . . . 1.1200000000000001 108.772 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -127.44 138.02 52.86 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.588 -0.695 . . . . 0.02 109.516 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -118.81 12.14 12.86 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.598 -0.689 . . . . 0.20000000000000001 110.305 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 39.0 t -159.94 173.79 15.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.771 -1.206 . . . . 1.23 109.079 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 4.9 p-10 -63.29 146.36 53.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.805 -1.184 . . . . 0.02 110.652 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.9 m -133.45 117.34 17.09 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.725 -0.843 . . . . 0.02 108.725 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.3 -20.26 55.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.477 -0.764 . . . . 0.23999999999999999 111.806 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 25.4 p-10 -152.85 106.28 3.04 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.887 -1.133 . . . . 1.1399999999999999 109.287 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.76 5.21 41.16 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.473 -0.767 . . . . 6.3700000000000001 110.427 -178.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -62.46 -29.42 70.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 3.1099999999999999 112.65 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -77.05 -18.42 58.09 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.159 -1.588 . . . . 0.88 111.797 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -107.25 -19.52 13.57 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.313 -0.867 . . . . 0.02 110.438 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.4 tp -148.73 126.91 12.1 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.927 -1.108 . . . . 3.3199999999999998 109.467 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 t -87.43 -13.07 44.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.538 -0.726 . . . . 0.02 111.362 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -172.55 161.73 5.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.819 -1.176 . . . . 0.02 108.5 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.463 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.6 p -143.86 116.59 8.72 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.194 -0.941 . . . . 0.02 108.85 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.581 ' N ' HD22 ' A' ' 37' ' ' ASN . 1.0 OUTLIER -108.38 -0.06 20.85 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.744 -1.223 . . . . 0.029999999999999999 111.314 -178.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 t -155.9 153.85 30.31 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.723 -1.214 . . . . 0.02 107.723 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 39' ' ' ILE . 9.1 mt -146.81 147.97 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 122.253 1.025 . . . . 0.02 110.727 -178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -123.49 125.04 44.2 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.95 -1.13 . . . . 0.02 107.95 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -105.59 114.02 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 106.663 -1.606 . . . . 0.02 106.663 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -85.36 -34.72 21.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.628 -0.67 . . . . 3.8100000000000001 110.277 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.31 148.9 16.52 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.52 -1.8 . . . . 0.02 110.72 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.89 172.33 48.7 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.284 -1.126 . . . . 0.01 110.284 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.3 m -118.58 134.95 54.71 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.529 -1.285 . . . . 1.48 107.529 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -127.17 154.28 44.99 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.703 1.239 . . . . 0.02 112.305 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.95 134.28 51.82 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 105.176 -2.157 . . . . 0.23999999999999999 105.176 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.487 ' HB ' HD22 ' A' ' 79' ' ' LEU . 29.2 m -119.16 144.32 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.578 -0.701 . . . . 0.65000000000000002 109.512 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -120.78 144.68 48.17 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.083 0.944 . . . . 0.02 109.976 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -66.61 -33.45 75.69 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.833 -0.621 . . . . 0.02 111.925 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -123.75 158.12 60.63 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.069 -1.019 . . . . 0.02 109.521 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -52.9 164.7 1.48 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.503 1.468 . . . . 0.02 112.669 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 64.1 37.29 9.15 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.722 0.772 . . . . 0.02 111.299 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 45.1 51.6 8.87 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.689 0.757 . . . . 3.3900000000000001 110.764 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 t -125.92 163.59 22.63 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.185 0.517 . . . . 2.3300000000000001 109.811 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.71 -161.72 31.06 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.563 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 0.5 OUTLIER -64.46 139.43 58.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.997 -1.296 . . . . 0.02 110.275 -178.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 58' ' ' MET . 3.3 ppp? -119.0 137.16 53.72 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.769 -0.582 . . . . 5.0099999999999998 109.663 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.507 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.8 m-85 -134.92 139.32 44.87 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.434 -0.791 . . . . 0.02 110.197 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.6 mm -94.21 130.56 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.953 -0.758 . . . . 1.72 108.953 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.521 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.0 mt -120.95 111.13 34.35 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 121.251 -0.905 . . . . 0.02 110.887 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.15 169.86 19.62 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 CA-C-N 119.742 0.943 . . . . 1.47 110.184 177.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -52.94 141.03 23.08 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.894 -1.129 . . . . 4.25 110.388 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.82 -177.59 32.02 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.551 -1.309 . . . . 0.02 110.929 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -120.06 131.39 55.08 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.56 -0.964 . . . . 0.95999999999999996 109.91 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CE1' HD22 ' A' ' 61' ' ' LEU . 86.7 m-85 -121.94 92.93 48.81 Favored Pre-proline 0 N--CA 1.493 1.717 0 N-CA-C 107.928 -1.138 . . . . 0.02 107.928 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.85 -4.13 6.83 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.003 1.135 . . . . 0.02 113.863 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -157.62 154.85 29.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.621 -1.299 . . . . 2.02 108.201 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -59.5 -39.37 83.59 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.445 -0.784 . . . . 0.02 112.092 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -59.81 -23.97 63.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.169 -0.957 . . . . 0.02 110.366 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -70.71 -18.68 62.81 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.75 0.785 . . . . 3.4199999999999999 109.013 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.1 t90 -107.92 9.91 28.58 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.439 -1.319 . . . . 0.02 107.439 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.3 mtt 60.79 22.25 12.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.572 -0.705 . . . . 0.02 110.485 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.25 144.4 45.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.344 -1.502 . . . . 0.02 109.344 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.2 tp -78.74 -31.06 46.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.492 -1.299 . . . . 0.97999999999999998 107.492 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.481 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 55.6 t30 -157.07 -171.16 3.53 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 106.389 -1.708 . . . . 0.02 106.389 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.481 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 2.9 p-10 -98.6 28.76 4.03 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.59 -1.319 . . . . 0.02 110.468 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.593 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -97.95 123.02 41.75 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.953 -1.092 . . . . 3.2000000000000002 111.175 -178.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.487 HD22 ' HB ' ' A' ' 48' ' ' VAL . 52.8 mt -142.79 119.97 11.48 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.404 -1.332 . . . . 2.6099999999999999 107.404 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.15 -17.91 11.04 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 121.123 -0.986 . . . . 0.02 112.17 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.5 m -155.77 155.99 34.03 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.271 -1.723 . . . . 0.02 110.598 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.7 m -145.17 147.77 32.84 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.304 0.573 . . . . 0.02 109.58 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -137.44 142.15 41.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.416 -0.802 . . . . 0.01 109.173 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.31 132.97 36.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.212 -0.93 . . . . 0.42999999999999999 109.314 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -89.68 123.79 42.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.282 -1.006 . . . . 1.25 108.282 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -91.19 131.5 36.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.751 -1.218 . . . . 1.77 108.004 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -96.77 137.48 35.79 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.005 -1.109 . . . . 1.6299999999999999 108.005 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.2 t -109.91 126.58 54.02 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.479 -0.934 . . . . 1.0800000000000001 108.479 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 t -103.15 -154.87 0.51 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.046 -1.835 . . . . 1.26 106.046 177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.9 -49.62 0.89 Allowed Glycine 0 N--CA 1.497 2.734 0 O-C-N 120.658 -1.276 . . . . 0.01 111.812 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.85 -99.21 0.12 Allowed Glycine 0 N--CA 1.487 2.069 0 C-N-CA 118.77 -1.681 . . . . 0.01 111.897 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -120.91 119.92 34.02 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.279 -1.13 . . . . 4.4299999999999997 110.619 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.492 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.49 137.09 56.57 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.325 -0.62 . . . . 2.9900000000000002 109.325 -178.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -134.79 130.96 36.91 Favored 'General case' 0 N--CA 1.518 2.957 0 CA-C-O 122.195 0.997 . . . . 6.3600000000000003 112.996 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.0 tt -131.71 142.38 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 115.598 -0.728 . . . . 1.0900000000000001 110.2 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.419 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.7 pt20 -124.22 139.67 53.7 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.818 -1.179 . . . . 2.0499999999999998 107.818 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.5 m -123.59 144.71 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 O-C-N 120.73 -1.231 . . . . 1.1000000000000001 110.942 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -120.55 140.43 51.51 Favored 'General case' 0 N--CA 1.505 2.28 0 CA-C-O 122.155 0.978 . . . . 0.72999999999999998 111.13 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.46 ' OE2' ' CD2' ' A' ' 123' ' ' LEU . 7.2 tp10 -68.38 -33.4 74.18 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.934 -0.576 . . . . 0.02 111.474 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -114.84 168.59 9.77 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.933 -1.104 . . . . 3.1800000000000002 110.168 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.01 169.16 46.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.916 -0.873 . . . . 0.01 110.916 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 53.34 39.19 29.46 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.58 0.705 . . . . 0.01 111.686 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.435 ' C ' HD22 ' A' ' 104' ' ' ASN . 11.7 m-85 52.69 48.21 23.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.56 -0.712 . . . . 0.01 111.075 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.435 HD22 ' C ' ' A' ' 103' ' ' PHE . 4.0 m120 -121.01 164.21 17.09 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.384 -0.969 . . . . 3.1499999999999999 108.384 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.69 -162.91 29.37 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.97 -1.652 . . . . 0.01 108.97 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.482 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 56.6 tt0 -75.94 141.69 42.2 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.945 -1.327 . . . . 0.01 109.214 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 107' ' ' MET . 11.2 tmm? -116.09 143.4 45.52 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.596 0.712 . . . . 0.01 109.465 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.482 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 54.6 m-85 -132.56 136.13 46.39 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.278 -1.008 . . . . 2.48 108.278 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.467 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.9 tm-20 -116.63 134.16 55.15 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.639 -0.663 . . . . 0.01 109.576 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.467 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 8.8 t -148.88 148.35 29.76 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.383 1.087 . . . . 1.6899999999999999 111.302 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.2 p -115.01 7.67 15.59 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.213 -0.903 . . . . 0.01 110.051 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -122.09 163.2 19.87 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.401 -0.812 . . . . 3.21 111.24 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -69.7 154.75 41.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.01 109.419 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.497 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 53.1 m -127.78 115.53 20.79 Favored Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 109.049 -0.723 . . . . 0.01 109.049 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.43 -32.5 4.87 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 CA-C-N 120.198 1.107 . . . . 0.01 111.308 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 t -141.83 107.37 5.06 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.833 0.825 . . . . 0.02 108.888 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 75.4 mt -64.83 -39.17 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.864 -0.523 . . . . 1.8300000000000001 111.036 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 37.1 ttp -67.41 -37.39 83.01 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.148 -1.021 . . . . 1.3400000000000001 109.79 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -69.73 -38.72 76.98 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.588 -1.32 . . . . 2.1099999999999999 109.709 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -79.42 -46.84 16.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.346 -0.846 . . . . 2.0800000000000001 112.317 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -110.81 0.45 17.28 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.384 -0.822 . . . . 0.02 112.769 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 59.82 33.07 21.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.68 -1.262 . . . . 0.02 109.39 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.46 ' CD2' ' OE2' ' A' ' 99' ' ' GLU . 10.6 mt -111.89 135.08 52.98 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.64 -0.874 . . . . 0.02 108.64 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -92.58 -23.76 18.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 5.3200000000000003 110.409 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -148.89 162.96 38.8 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.146 -0.971 . . . . 0.02 110.023 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.6 mt -131.96 129.44 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.223 -1.399 . . . . 2.1699999999999999 107.223 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -105.54 -12.32 16.02 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.087 -1.008 . . . . 0.02 112.64 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 0.4 OUTLIER -155.05 153.15 30.48 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.524 -1.36 . . . . 0.01 108.156 178.06 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 12.8 t -160.63 144.45 13.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.446 -1.408 . . . . 1.22 109.775 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -122.07 113.4 19.48 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.267 1.032 . . . . 1.4099999999999999 109.457 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.06 120.23 60.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 105.554 -2.017 . . . . 0.01 105.554 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -145.76 67.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 118.34 -1.344 . . . . 1.98 108.398 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 172.14 108.32 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.586 -1.635 . . . . 0.01 106.586 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.38 -172.56 47.65 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.999 -1.24 . . . . 0.01 109.999 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -110.93 144.22 40.35 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.483 -1.01 . . . . 2.2999999999999998 108.845 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.492 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.4 m95 -131.32 147.2 52.55 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.446 -0.784 . . . . 0.01 110.641 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 56.4 mt -119.1 140.29 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 N-CA-C 107.956 -1.128 . . . . 1.6899999999999999 107.956 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.721 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -112.81 141.73 46.28 Favored 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 107.408 -1.331 . . . . 2.4900000000000002 107.408 177.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 12.9 m-85 -122.46 145.04 48.67 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.55 -0.719 . . . . 0.02 109.264 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -74.55 -30.29 61.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.579 -0.701 . . . . 0.02 112.275 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -114.89 153.79 46.99 Favored Pre-proline 0 N--CA 1.506 2.362 0 O-C-N 120.622 -1.299 . . . . 1.48 109.139 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.51 166.34 1.89 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 120.991 1.127 . . . . 0.02 112.462 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 59.79 31.21 20.68 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.221 -0.9 . . . . 0.75 111.253 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.497 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 58.38 51.97 7.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.02 111.13 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -124.91 163.34 22.46 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.666 -0.646 . . . . 0.02 109.937 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.65 -165.61 32.35 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.159 -1.177 . . . . 0.02 110.159 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -67.85 141.62 56.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.614 -0.933 . . . . 0.02 108.957 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.11 149.07 41.64 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.582 -0.525 . . . . 0.02 109.582 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.67 141.43 51.61 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 109.125 -0.695 . . . . 0.01 109.125 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.25 120.87 36.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.334 -0.854 . . . . 0.01 109.282 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.671 ' CD2' ' HE1' ' A' ' 162' ' ' TRP . 6.7 mt -104.3 135.14 46.31 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.344 -0.848 . . . . 0.01 110.321 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 154' ' ' LYS . 38.9 t70 -110.78 178.23 4.42 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.399 -1.334 . . . . 2.27 107.399 177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -59.3 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.747 -1.221 . . . . 1.8400000000000001 108.519 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 152' ' ' ASP . 68.4 tttt -134.95 163.12 30.56 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 122.106 0.955 . . . . 2.2799999999999998 111.957 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.406 ' N ' ' CG ' ' A' ' 154' ' ' LYS . 2.7 pt-20 -113.87 112.03 22.7 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.07 -1.085 . . . . 0.01 108.07 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.63 114.92 29.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.023 -1.048 . . . . 0.01 110.18 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.456 ' O ' ' OG ' ' A' ' 128' ' ' SER . 23.5 ptt180 -96.74 -27.12 14.9 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.497 -0.752 . . . . 0.01 112.063 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -125.65 151.33 70.45 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 120.766 -1.209 . . . . 2.54 108.98 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -57.97 -48.8 14.82 Favored 'Trans proline' 0 N--CA 1.488 1.193 0 CA-C-N 119.234 0.762 . . . . 0.69999999999999996 110.759 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.68 -23.67 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.86 -1.15 . . . . 0.85999999999999999 109.152 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -66.61 -15.86 63.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.755 -1.216 . . . . 0.02 109.305 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.671 ' HE1' ' CD2' ' A' ' 151' ' ' LEU . 2.7 t90 -94.78 6.54 48.65 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.607 -0.886 . . . . 0.02 108.607 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 74.79 8.29 81.81 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.565 -1.303 . . . . 0.02 109.917 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.22 143.32 29.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.62 -0.929 . . . . 0.02 110.074 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.13 -9.22 58.76 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.675 -0.641 . . . . 0.58999999999999997 109.671 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.1 p -147.24 150.9 39.34 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.756 -1.215 . . . . 0.87 108.015 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -75.7 25.48 0.4 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 120.777 0.985 . . . . 0.38 112.464 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.888 ' O ' HD13 ' A' ' 169' ' ' ILE . . . -83.85 124.4 30.92 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.644 1.211 . . . . 0.17999999999999999 112.534 -177.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.888 HD13 ' O ' ' A' ' 168' ' ' ALA . 6.4 mm -142.19 127.82 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 106.382 -1.71 . . . . 3.9900000000000002 106.382 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -113.65 -23.7 9.59 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.784 -1.198 . . . . 5.1699999999999999 112.846 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.9 p -157.31 160.26 38.37 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 119.503 -1.998 . . . . 0.02 109.839 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.497 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 11.8 p90 -153.44 153.98 33.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.983 -1.073 . . . . 2.02 110.601 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.497 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 18.9 mtp180 -143.23 151.14 40.25 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.161 -0.962 . . . . 0.01 110.4 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 174' ' ' ARG . 28.9 ptt180 -87.56 141.83 28.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.991 -0.744 . . . . 0.01 108.991 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.0 mt -93.25 128.31 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.005 -1.059 . . . . 3.04 109.078 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.1 t -136.27 146.52 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.254 -0.903 . . . . 1.8899999999999999 109.553 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 4.8899999999999997 109.452 179.912 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.495 -0.557 . . . . 5.2800000000000002 109.495 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -64.07 166.99 6.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 5.96 109.429 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -81.13 141.8 33.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 2.2200000000000002 108.415 178.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.54 -179.51 47.52 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 118.317 -1.897 . . . . 0.81000000000000005 112.005 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.78 157.92 44.24 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.292 -1.523 . . . . 0.01 109.292 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -147.76 136.69 22.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.012 -1.287 . . . . 0.02 110.641 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 tt -130.78 139.52 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 109.115 -0.698 . . . . 0.02 109.115 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -121.22 130.33 53.64 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.465 -0.772 . . . . 0.39000000000000001 109.766 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.05 139.77 44.81 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.983 -0.747 . . . . 0.02 108.983 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.6 m-85 -122.16 138.37 54.49 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.213 -0.929 . . . . 0.02 109.545 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.472 ' HG3' HD11 ' A' ' 33' ' ' LEU . 88.7 mt-10 -69.57 -27.76 65.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.029999999999999999 111.652 -178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.2 m-20 -114.36 169.7 8.85 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.808 -1.182 . . . . 0.029999999999999999 110.237 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.712 HH12 HD22 ' A' ' 37' ' ' ASN . 3.5 mtt-85 -74.88 157.81 34.43 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.703 0.763 . . . . 0.029999999999999999 110.078 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 66.26 33.49 7.16 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.958 0.885 . . . . 0.73999999999999999 111.14 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 55.25 42.32 30.53 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.212 0.53 . . . . 0.02 111.266 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -113.74 166.0 11.98 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.288 -1.005 . . . . 0.02 108.288 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.95 -167.25 36.2 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.841 -1.171 . . . . 0.029999999999999999 110.702 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -69.05 141.59 54.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.541 -0.976 . . . . 2.7599999999999998 109.313 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -120.27 148.81 43.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.523 -0.736 . . . . 1.8899999999999999 110.149 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -132.68 127.39 34.72 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.488 -0.93 . . . . 0.02 108.488 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.62 136.16 51.23 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.414 -0.804 . . . . 1.1200000000000001 109.565 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -130.52 138.18 50.09 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.502 0.668 . . . . 0.02 109.55 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -117.56 11.16 13.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.737 -0.602 . . . . 0.20000000000000001 109.655 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.9 p -158.31 173.83 16.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.144 -0.972 . . . . 1.23 108.585 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.62 145.19 55.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.636 -1.29 . . . . 0.02 110.372 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 22.0 p -132.99 117.32 17.49 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.407 -0.96 . . . . 0.02 108.407 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.83 -23.5 52.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.23999999999999999 110.743 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 31.1 p-10 -154.83 101.44 2.29 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.615 -0.883 . . . . 1.1399999999999999 108.615 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.501 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 22.2 p90 -107.08 10.06 30.3 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 122.089 0.947 . . . . 6.3700000000000001 110.273 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HE ' ' CA ' ' A' ' 80' ' ' GLY . 29.4 mmt180 -59.2 -23.19 62.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.544 -0.722 . . . . 3.1099999999999999 110.676 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -75.23 -16.32 60.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.726 -1.233 . . . . 0.88 110.354 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -103.08 -21.43 13.91 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.382 -0.824 . . . . 0.02 109.277 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.472 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.3 tp -150.27 129.46 12.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.309 -0.869 . . . . 3.3199999999999998 109.081 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t -85.5 -10.58 55.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.76 -0.588 . . . . 0.02 110.769 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -170.56 161.97 7.88 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.896 -1.15 . . . . 0.02 107.896 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -143.32 115.89 8.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.817 -1.177 . . . . 0.02 109.087 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.712 HD22 HH12 ' A' ' 13' ' ' ARG . 4.4 m120 -109.56 0.79 19.33 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.81 -1.181 . . . . 0.029999999999999999 111.595 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -156.33 154.51 30.71 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.24 -1.022 . . . . 0.02 108.24 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.9 146.72 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.031 -1.043 . . . . 0.02 110.879 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -123.04 124.04 42.23 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.886 -1.153 . . . . 0.02 107.886 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.0 t -106.45 113.91 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 106.751 -1.574 . . . . 0.02 106.751 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.503 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 32.1 tp10 -84.27 -34.52 23.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.633 . . . . 3.8100000000000001 110.435 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.51 149.32 17.24 Favored Glycine 0 N--CA 1.485 1.948 0 C-N-CA 119.029 -1.558 . . . . 0.02 110.525 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.73 172.41 48.83 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.255 -1.138 . . . . 0.01 110.255 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -118.3 134.77 54.75 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 107.489 -1.3 . . . . 1.48 107.489 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -127.17 154.68 44.48 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.755 -1.216 . . . . 0.02 112.443 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.37 134.1 52.24 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.349 -2.093 . . . . 0.23999999999999999 105.349 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.489 ' HB ' HD22 ' A' ' 79' ' ' LEU . 36.0 m -118.35 143.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.479 -0.763 . . . . 0.65000000000000002 109.351 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -120.84 144.42 48.36 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 122.37 1.081 . . . . 0.02 110.073 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.86 -33.42 75.8 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.665 -0.698 . . . . 0.02 111.47 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -124.38 157.81 63.54 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.034 -1.041 . . . . 0.02 109.491 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.27 166.45 1.08 Allowed 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.702 1.601 . . . . 0.02 112.728 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 t30 63.28 36.65 11.63 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.383 -0.826 . . . . 0.02 111.127 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 45.31 51.22 9.53 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.634 0.73 . . . . 3.3900000000000001 110.769 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.2 p -125.49 163.28 23.0 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.186 0.517 . . . . 2.3300000000000001 109.862 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.67 -161.74 31.14 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.722 -1.351 . . . . 0.02 109.722 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -64.32 138.58 58.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.33 . . . . 0.02 110.124 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 15.7 ptm -119.16 137.29 53.71 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.818 -0.551 . . . . 5.0099999999999998 109.578 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.615 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 79.4 m-85 -134.76 139.98 45.57 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.5 -0.75 . . . . 0.02 110.067 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.8 mm -95.18 130.43 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.907 -0.775 . . . . 1.72 108.907 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.488 HD22 ' CE1' ' A' ' 66' ' ' TYR . 13.8 mt -122.54 111.72 31.39 Favored Pre-proline 0 N--CA 1.507 2.39 0 O-C-N 121.338 -0.852 . . . . 0.02 110.654 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.99 170.65 19.39 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 CA-C-N 119.863 0.987 . . . . 1.47 110.13 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 58.1 tt0 -52.16 140.47 20.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.963 -1.086 . . . . 4.25 110.092 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.59 -177.75 32.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.366 -1.397 . . . . 0.02 110.84 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -120.75 131.62 54.6 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.454 -1.027 . . . . 0.95999999999999996 110.043 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.488 ' CE1' HD22 ' A' ' 61' ' ' LEU . 97.1 m-85 -122.24 95.84 46.83 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.1 Cg_endo -67.79 -3.16 9.88 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.945 1.096 . . . . 0.02 114.125 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 67.6 mt-10 -157.54 154.96 29.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.551 -1.343 . . . . 2.02 108.313 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -60.02 -39.28 85.31 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.498 -0.751 . . . . 0.02 111.734 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -59.56 -24.13 63.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.033 . . . . 0.02 110.202 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -70.49 -18.97 62.96 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.935 0.874 . . . . 3.4199999999999999 108.904 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.615 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.3 t90 -108.01 9.78 28.44 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.537 -1.283 . . . . 0.02 107.537 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 mmt 60.97 22.61 12.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.02 110.59 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.16 145.44 46.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.505 -1.438 . . . . 0.02 109.505 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -79.88 -31.28 40.33 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.601 -1.259 . . . . 0.97999999999999998 107.601 177.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -156.92 -171.44 3.65 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.448 -1.686 . . . . 0.02 106.448 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 16.5 p-10 -97.98 28.14 4.12 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.634 -1.291 . . . . 0.02 110.661 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.582 HH11 ' CG ' ' A' ' 78' ' ' ARG . 2.5 mtt-85 -96.42 121.93 38.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.009 -1.057 . . . . 3.2000000000000002 110.563 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.501 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 24.9 mt -144.82 121.4 11.1 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.629 -1.248 . . . . 2.6099999999999999 107.629 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.425 ' CA ' ' HE ' ' A' ' 30' ' ' ARG . . . -112.12 -16.4 9.08 Favored Glycine 0 N--CA 1.508 3.471 0 O-C-N 121.218 -0.926 . . . . 0.02 113.495 -177.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.6 p -155.51 156.87 35.97 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.244 -1.739 . . . . 0.02 110.69 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.2 p -145.73 148.32 32.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.695 -0.628 . . . . 0.02 109.903 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -137.23 141.71 42.05 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.365 -0.834 . . . . 0.01 109.181 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.09 132.11 36.48 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.166 -0.959 . . . . 0.42999999999999999 109.436 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.4 t -90.06 124.12 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.302 -0.999 . . . . 1.25 108.302 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.432 ' C ' HD23 ' A' ' 87' ' ' LEU . 61.2 m80 -92.4 131.98 37.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.819 -1.176 . . . . 1.77 108.408 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -96.39 138.25 34.25 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.082 -1.081 . . . . 1.6299999999999999 108.082 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.8 m -109.72 126.74 54.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.671 -0.862 . . . . 1.0800000000000001 108.671 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.9 t -103.65 -154.94 0.51 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.07 -1.826 . . . . 1.26 106.07 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.89 -49.87 0.88 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 120.552 -1.343 . . . . 0.01 111.879 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.26 -99.7 0.13 Allowed Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.825 -1.655 . . . . 0.01 111.924 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.4 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 38.5 tt0 -120.37 119.5 33.28 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.294 -1.121 . . . . 4.4299999999999997 110.523 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.515 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.71 136.68 55.87 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.501 -0.555 . . . . 2.9900000000000002 109.501 -178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -134.39 130.19 36.5 Favored 'General case' 0 N--CA 1.517 2.912 0 CA-C-O 122.11 0.957 . . . . 6.3600000000000003 113.029 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -131.43 141.76 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-N 115.637 -0.711 . . . . 1.0900000000000001 110.211 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.428 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.4 pt20 -124.95 139.7 53.59 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 107.526 -1.287 . . . . 2.0499999999999998 107.526 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.8 m -124.07 146.85 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 O-C-N 120.646 -1.284 . . . . 1.1000000000000001 111.08 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -120.84 140.29 51.97 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.256 1.027 . . . . 0.72999999999999998 111.117 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -67.94 -32.19 72.46 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.644 -0.707 . . . . 0.02 111.934 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -114.76 165.61 12.64 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.078 -1.014 . . . . 3.1800000000000002 110.43 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.26 163.12 46.03 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 111.069 -0.812 . . . . 0.01 111.069 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 57.65 39.06 27.8 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.608 0.718 . . . . 0.01 111.004 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 33.2 m-85 52.31 56.33 7.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.532 -0.73 . . . . 0.01 111.052 177.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -128.62 164.92 21.84 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.034 -1.098 . . . . 3.1499999999999999 108.034 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.39 -162.82 28.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.077 -1.609 . . . . 0.01 109.077 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -75.07 141.81 43.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.874 -1.368 . . . . 0.01 108.864 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.9 tmm? -116.18 143.0 46.08 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.472 0.653 . . . . 0.01 109.451 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -132.07 136.22 47.03 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.206 -1.035 . . . . 2.48 108.206 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -116.76 134.48 54.74 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.711 -0.618 . . . . 0.01 109.756 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.0 t -149.7 148.55 29.39 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.941 -1.099 . . . . 1.6899999999999999 111.337 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -114.48 7.95 16.35 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.106 -0.952 . . . . 0.01 109.695 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -122.27 163.41 19.71 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.545 -0.722 . . . . 3.21 111.152 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -69.62 154.83 41.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.802 . . . . 0.01 109.591 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.401 ' CB ' ' CZ ' ' A' ' 172' ' ' PHE . 47.5 t -125.92 114.28 24.39 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.947 -0.76 . . . . 0.01 108.947 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -76.0 -33.64 3.52 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 CA-C-N 120.3 1.143 . . . . 0.01 111.557 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.7 t -141.69 107.2 5.05 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.328 -0.858 . . . . 0.02 108.692 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.21 -39.41 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.715 -0.615 . . . . 1.8300000000000001 111.198 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.2 ttp -66.26 -38.13 87.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.944 -1.102 . . . . 1.3400000000000001 109.574 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.5 tt0 -69.95 -38.73 76.22 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.63 -1.294 . . . . 2.1099999999999999 109.74 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.496 ' NE2' ' CE1' ' A' ' 121' ' ' PHE . 0.0 OUTLIER -80.47 -47.95 13.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.188 -0.945 . . . . 2.0800000000000001 112.207 -176.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.496 ' CE1' ' NE2' ' A' ' 120' ' ' GLN . 94.8 m-85 -111.35 -1.06 16.13 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.474 -0.766 . . . . 0.02 112.884 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.457 ' ND1' ' C ' ' A' ' 121' ' ' PHE . 5.0 m80 60.26 33.7 20.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.716 -1.24 . . . . 0.02 109.707 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.5 mt -112.44 135.63 52.91 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 108.784 -0.821 . . . . 0.02 108.784 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -92.83 -23.69 18.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.334 -0.854 . . . . 5.3200000000000003 110.788 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -149.21 163.69 36.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.016 -1.053 . . . . 0.02 110.121 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.2 mt -131.56 129.43 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 107.443 -1.317 . . . . 2.1699999999999999 107.443 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -107.77 -13.17 15.07 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.123 -0.986 . . . . 0.02 113.033 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.471 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -155.54 153.08 29.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.412 -1.43 . . . . 0.01 108.261 177.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.9 t -163.53 143.96 8.82 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.287 -1.508 . . . . 1.22 109.697 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -121.82 113.31 19.49 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.062 0.934 . . . . 1.4099999999999999 108.841 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -107.96 123.23 63.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 105.694 -1.965 . . . . 0.01 105.694 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.5 t -146.31 68.67 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 118.186 -1.406 . . . . 1.98 108.271 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER 172.51 107.87 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.537 -1.653 . . . . 0.01 106.537 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.53 -174.1 42.64 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.623 -1.391 . . . . 0.01 109.623 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 m -111.81 143.66 42.38 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.411 -1.053 . . . . 2.2999999999999998 109.214 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.515 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 61.6 m95 -128.92 146.17 51.02 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.444 -0.785 . . . . 0.01 110.424 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.11 141.15 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.398 -1.334 . . . . 1.6899999999999999 107.398 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.506 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.14 143.16 45.26 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 107.329 -1.359 . . . . 2.4900000000000002 107.329 177.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.42 144.64 49.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.623 -0.673 . . . . 0.02 109.297 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 -30.06 63.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.638 -0.664 . . . . 0.02 112.124 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.5 153.64 47.71 Favored Pre-proline 0 N--CA 1.506 2.356 0 O-C-N 120.637 -1.289 . . . . 1.48 109.223 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -54.72 166.93 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.344 1.362 . . . . 0.02 112.678 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.8 m120 59.46 31.36 20.99 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.188 -0.915 . . . . 0.75 111.114 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.466 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.2 m-85 57.73 51.52 9.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.55 -0.719 . . . . 0.02 110.961 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -124.7 163.54 21.83 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.487 -0.758 . . . . 0.02 109.857 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.51 -165.28 32.3 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.711 -1.356 . . . . 0.02 109.711 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -67.89 141.3 56.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.437 -1.037 . . . . 0.02 108.894 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -118.22 148.52 42.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.06 -0.718 . . . . 0.02 109.06 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -128.83 142.84 50.84 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.574 -0.704 . . . . 0.01 109.18 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tp -95.12 120.0 34.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.367 -0.833 . . . . 0.01 109.492 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.547 HD22 ' CD1' ' A' ' 162' ' ' TRP . 20.0 mt -106.12 133.08 51.4 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.36 -0.837 . . . . 0.01 110.297 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 154' ' ' LYS . 4.4 m-20 -108.79 174.63 5.79 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.356 -0.979 . . . . 2.27 108.356 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -57.12 84.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.077 -1.014 . . . . 1.8400000000000001 108.627 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 152' ' ' ASP . 90.8 mttt -137.76 169.37 17.9 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 122.0 0.905 . . . . 2.2799999999999998 111.603 -178.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.39 110.59 20.89 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.389 -0.967 . . . . 0.01 108.389 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.57 ' CD2' ' NE1' ' A' ' 162' ' ' TRP . 90.7 m-85 -101.73 114.36 28.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.1 -1.0 . . . . 0.01 109.827 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -91.64 -25.84 18.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.096 -1.003 . . . . 0.01 111.222 -177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -125.44 154.09 72.43 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.061 -1.024 . . . . 2.54 108.525 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.27 -41.16 44.15 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 120.44 0.76 . . . . 0.69999999999999996 110.539 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.95 -20.07 21.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 120.906 -1.121 . . . . 0.85999999999999999 108.841 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -65.48 -16.17 63.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.003 -1.061 . . . . 0.02 109.787 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.57 ' NE1' ' CD2' ' A' ' 156' ' ' TYR . 2.0 m0 -96.94 11.0 37.54 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.065 -1.087 . . . . 0.02 108.065 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.59 11.78 85.14 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.414 -1.374 . . . . 0.02 110.336 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.9 141.83 32.19 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.178 -1.19 . . . . 0.02 110.096 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -8.29 58.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.791 -0.568 . . . . 0.58999999999999997 109.917 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.6 m -144.37 151.04 50.1 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 120.845 -1.159 . . . . 0.87 108.791 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.43 21.25 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 120.694 0.929 . . . . 0.38 112.368 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.489 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -83.82 122.4 28.64 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.357 1.075 . . . . 0.17999999999999999 111.602 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.489 HD12 ' C ' ' A' ' 168' ' ' ALA . 3.6 mp -149.01 125.94 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.425 -1.694 . . . . 3.9900000000000002 106.425 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -111.07 -16.44 13.48 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.176 -0.953 . . . . 5.1699999999999999 113.23 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 86.4 p -158.46 161.14 37.42 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 119.181 -2.199 . . . . 0.02 110.075 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CZ ' ' CB ' ' A' ' 114' ' ' CYS . 6.2 p90 -152.78 155.25 36.79 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.076 -1.015 . . . . 2.02 110.358 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.466 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 22.9 mtp180 -143.54 150.41 38.85 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.158 -0.964 . . . . 0.01 110.293 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -87.35 142.73 27.66 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.072 -0.714 . . . . 0.01 109.072 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.4 mt -93.66 127.9 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.033 -1.042 . . . . 3.04 109.279 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.7 t -136.01 146.5 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.346 -0.846 . . . . 1.8899999999999999 109.549 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.313 -0.867 . . . . 4.8899999999999997 109.477 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.281 0.563 . . . . 5.2800000000000002 109.496 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -57.82 156.35 8.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.216 -0.927 . . . . 5.96 109.482 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 t -174.78 158.25 2.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.347 -1.47 . . . . 2.2200000000000002 108.63 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.31 178.54 47.8 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 118.717 -1.706 . . . . 0.81000000000000005 111.637 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.57 157.1 43.66 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.21 -1.556 . . . . 0.01 109.21 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -148.25 136.31 21.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.898 -1.354 . . . . 0.02 110.29 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 tt -130.38 140.08 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.098 -0.705 . . . . 0.02 109.098 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 m -121.38 130.46 53.62 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.363 -0.836 . . . . 0.39000000000000001 110.071 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -110.06 139.7 44.9 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.657 -0.652 . . . . 0.02 109.316 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.543 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.4 m-85 -122.28 138.28 54.56 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.293 -0.879 . . . . 0.02 109.483 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -69.36 -27.3 65.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.956 -1.09 . . . . 0.029999999999999999 111.875 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -113.92 169.66 8.84 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.796 -1.19 . . . . 0.029999999999999999 110.143 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.39 158.38 32.81 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.549 0.69 . . . . 0.029999999999999999 109.647 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.4 m120 66.24 35.05 6.19 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.719 0.771 . . . . 0.73999999999999999 110.933 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.81 44.89 25.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.669 0.747 . . . . 0.02 111.403 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -112.64 165.84 11.89 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.008 -1.108 . . . . 0.02 108.008 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -167.87 34.44 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.766 -1.207 . . . . 0.029999999999999999 110.532 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.789 ' HE ' ' H ' ' A' ' 19' ' ' ARG . 9.3 tpm_? -69.33 142.96 53.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -1.088 . . . . 2.7599999999999998 108.922 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.789 ' H ' ' HE ' ' A' ' 18' ' ' ARG . 18.7 ttm180 -122.44 150.1 42.95 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.38 -0.825 . . . . 1.8899999999999999 110.331 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -135.9 132.5 36.58 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.155 -0.683 . . . . 0.02 109.155 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 14.6 p-10 -108.52 136.23 48.48 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.589 -0.893 . . . . 1.1200000000000001 108.589 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 15.9 t -127.68 137.77 52.6 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.666 -0.646 . . . . 0.02 110.035 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -119.9 11.05 11.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.666 -0.646 . . . . 0.20000000000000001 110.754 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.532 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 16.0 t -159.73 173.77 15.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.633 -1.292 . . . . 1.23 109.26 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 19.5 p-10 -63.41 145.8 54.86 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.416 -1.428 . . . . 0.02 110.931 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.9 m -135.22 119.19 17.41 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.886 -0.783 . . . . 0.02 108.886 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.482 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.79 -20.02 54.0 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.526 -0.734 . . . . 0.23999999999999999 112.24 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -154.16 106.68 2.82 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.705 -1.247 . . . . 1.1399999999999999 109.931 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.95 6.63 39.05 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.425 -0.797 . . . . 6.3700000000000001 110.202 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -61.12 -29.69 69.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 3.1099999999999999 112.052 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -76.96 -17.41 58.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.405 -1.434 . . . . 0.88 111.005 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -106.34 -21.17 13.17 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.413 -0.804 . . . . 0.02 110.621 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -149.33 127.47 12.04 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.092 -1.005 . . . . 3.3199999999999998 109.653 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.5 p -87.2 -12.39 46.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.618 -0.676 . . . . 0.02 111.083 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -172.28 161.94 5.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.743 -1.223 . . . . 0.02 108.479 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 t -143.73 117.06 9.04 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.001 -1.062 . . . . 0.02 109.002 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -109.64 0.12 18.9 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 120.708 -1.245 . . . . 0.029999999999999999 111.754 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 18.3 m -155.74 154.05 30.86 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.273 -1.01 . . . . 0.02 108.273 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -145.86 146.31 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 122.32 1.057 . . . . 0.02 110.818 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -122.77 123.68 41.61 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.594 -1.262 . . . . 0.02 107.594 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.1 t -105.64 113.63 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.87 -1.53 . . . . 0.02 106.87 177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -85.13 -34.53 22.14 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 120.133 -0.627 . . . . 3.8100000000000001 110.07 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.4 149.15 16.96 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.599 -1.763 . . . . 0.02 110.751 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.59 172.19 48.71 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.243 -1.143 . . . . 0.01 110.243 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.5 m -118.3 134.65 54.86 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.644 -1.243 . . . . 1.48 107.644 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -127.06 154.56 44.52 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 122.624 1.202 . . . . 0.02 112.345 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.34 133.77 52.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 105.453 -2.055 . . . . 0.23999999999999999 105.453 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.8 m -119.1 144.19 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.519 -0.738 . . . . 0.65000000000000002 109.323 178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -120.65 144.95 47.9 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 122.157 0.979 . . . . 0.02 109.978 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -66.77 -33.8 76.43 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 115.943 -0.571 . . . . 0.02 111.957 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -123.09 158.27 58.27 Favored Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 121.111 -0.993 . . . . 0.02 109.509 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -53.1 164.64 1.64 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.524 1.482 . . . . 0.02 112.636 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 64.0 37.06 9.55 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.8 0.809 . . . . 0.02 111.363 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.453 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 11.2 m-85 45.54 51.39 9.91 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.681 0.753 . . . . 3.3900000000000001 110.91 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 t -125.67 163.43 22.81 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.168 0.509 . . . . 2.3300000000000001 109.827 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.72 -161.69 31.03 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.764 -1.334 . . . . 0.02 109.764 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -64.68 139.17 58.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.932 -1.334 . . . . 0.02 110.216 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 58' ' ' MET . 3.0 ppp? -119.6 138.12 53.43 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.725 -0.609 . . . . 5.0099999999999998 109.475 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.599 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 63.8 m-85 -135.32 139.93 44.7 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.461 -0.774 . . . . 0.02 110.084 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.1 mm -93.76 130.18 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.311 -0.996 . . . . 1.72 108.311 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -121.48 111.1 33.47 Favored Pre-proline 0 N--CA 1.506 2.337 0 O-C-N 121.291 -0.881 . . . . 0.02 111.008 -178.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -78.04 169.79 19.85 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.738 0.942 . . . . 1.47 110.542 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -53.03 141.25 22.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.972 -1.08 . . . . 4.25 110.695 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.71 -177.76 31.84 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.47 -1.347 . . . . 0.02 110.955 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -119.68 131.29 55.38 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.367 -1.078 . . . . 0.95999999999999996 109.782 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 78.8 m-85 -121.93 98.59 44.93 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.034 -1.099 . . . . 0.02 108.034 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.425 ' O ' ' OG ' ' A' ' 38' ' ' SER . 9.8 Cg_endo -71.12 -3.25 12.51 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 120.82 1.013 . . . . 0.02 113.919 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -157.51 154.54 28.82 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.672 -1.267 . . . . 2.02 108.221 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -59.69 -39.32 84.19 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.462 -0.774 . . . . 0.02 111.886 -177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -59.85 -23.82 63.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.02 110.303 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -70.49 -18.7 62.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.301 -0.874 . . . . 3.4199999999999999 108.972 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.599 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -108.22 10.6 27.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.391 -1.337 . . . . 0.02 107.391 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.3 mmt 60.55 22.45 12.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.54 -0.725 . . . . 0.02 110.401 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.02 145.08 46.41 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.449 -1.46 . . . . 0.02 109.449 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -79.94 -30.53 39.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -1.174 . . . . 0.97999999999999998 107.9 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.435 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 60.4 t30 -157.16 -171.64 3.71 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.558 -1.645 . . . . 0.02 106.558 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.435 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 1.6 p30 -98.81 28.67 4.17 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.606 -1.309 . . . . 0.02 110.791 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -96.99 123.14 40.64 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.862 -1.149 . . . . 3.2000000000000002 111.074 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.487 HD21 ' CH2' ' A' ' 72' ' ' TRP . 85.5 mt -141.78 119.1 11.47 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.472 -1.307 . . . . 2.6099999999999999 107.472 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.96 -18.49 9.89 Favored Glycine 0 N--CA 1.502 3.062 0 O-C-N 121.008 -1.058 . . . . 0.02 112.537 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 14.1 m -156.11 156.52 34.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.303 -1.704 . . . . 0.02 110.387 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.0 m -144.83 147.63 33.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.801 -0.562 . . . . 0.02 109.754 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.453 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 46.6 mtp180 -137.32 141.77 41.86 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.451 -0.781 . . . . 0.01 109.162 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.86 132.13 36.7 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.26 -0.9 . . . . 0.42999999999999999 109.313 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -90.76 124.4 43.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.634 -0.876 . . . . 1.25 108.634 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -92.13 131.67 37.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.844 -1.16 . . . . 1.77 108.645 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.45 138.83 33.46 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.142 -1.058 . . . . 1.6299999999999999 108.142 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.1 p -110.73 126.42 54.54 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.783 -0.821 . . . . 1.0800000000000001 108.783 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.4 p -103.17 -154.99 0.51 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.089 -1.819 . . . . 1.26 106.089 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.7 -49.61 0.88 Allowed Glycine 0 N--CA 1.498 2.814 0 O-C-N 120.482 -1.386 . . . . 0.01 112.069 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.58 -99.7 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 118.758 -1.687 . . . . 0.01 112.091 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -120.76 120.02 34.43 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.204 -1.174 . . . . 4.4299999999999997 110.601 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.496 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.65 135.46 54.12 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.332 -0.547 . . . . 2.9900000000000002 109.612 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -133.57 130.19 38.07 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 121.103 -0.998 . . . . 6.3600000000000003 112.924 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 tt -131.75 141.3 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 115.538 -0.756 . . . . 1.0900000000000001 110.535 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.511 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.1 pt20 -124.44 139.19 54.12 Favored 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 107.56 -1.274 . . . . 2.0499999999999998 107.56 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.13 146.64 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 120.644 -1.285 . . . . 1.1000000000000001 110.942 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -119.34 139.31 52.16 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.897 0.855 . . . . 0.72999999999999998 110.65 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.5 -32.47 72.47 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.694 -0.684 . . . . 0.02 111.86 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.476 ' O ' ' OG ' ' A' ' 128' ' ' SER . 14.6 mtpp -114.67 168.32 9.98 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.04 -1.038 . . . . 3.1800000000000002 109.753 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.38 168.83 44.99 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.67 -0.776 . . . . 0.01 111.201 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.45 39.6 30.17 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.667 0.746 . . . . 0.01 111.611 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 52.68 48.8 21.72 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.58 -0.7 . . . . 0.01 111.027 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -121.79 164.35 17.61 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.378 -0.971 . . . . 3.1499999999999999 108.378 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.63 -163.38 28.47 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.389 -1.484 . . . . 0.01 109.389 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -76.01 142.57 41.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.93 -1.335 . . . . 0.01 109.143 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.458 ' C ' ' SD ' ' A' ' 107' ' ' MET . 11.2 tmm? -116.47 143.38 45.65 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.5 0.667 . . . . 0.01 109.771 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.08 136.11 46.94 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.265 -1.013 . . . . 2.48 108.265 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -116.77 134.33 54.92 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.748 -0.595 . . . . 0.01 109.856 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -149.5 148.78 29.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.885 -1.134 . . . . 1.6899999999999999 111.195 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.5 p -114.87 7.86 15.82 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.103 -0.953 . . . . 0.01 109.685 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -122.15 163.59 19.26 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.536 -0.727 . . . . 3.21 111.031 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 1.5 p30 -69.2 154.36 42.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.456 -0.777 . . . . 0.01 109.535 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.7 t -125.8 115.03 24.61 Favored Pre-proline 0 N--CA 1.501 2.082 0 N-CA-C 108.966 -0.753 . . . . 0.01 108.966 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -75.66 -33.47 3.95 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 CA-C-N 120.404 1.18 . . . . 0.01 111.687 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.4 p -141.91 108.06 5.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.325 -0.859 . . . . 0.02 109.071 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.68 -40.06 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.753 -0.592 . . . . 1.8300000000000001 110.993 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.4 ttt -66.69 -37.45 84.77 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.005 -1.078 . . . . 1.3400000000000001 109.749 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -69.74 -38.5 76.87 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.474 -1.391 . . . . 2.1099999999999999 109.819 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.31 -47.54 14.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.277 -0.889 . . . . 2.0800000000000001 112.493 -177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.51 -1.36 15.88 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.269 -0.895 . . . . 0.02 112.747 -176.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 61.25 34.01 18.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.789 -1.194 . . . . 0.02 109.697 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.1 mt -113.78 136.52 52.77 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.498 -0.751 . . . . 0.02 109.351 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -91.26 -22.49 20.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.873 . . . . 5.3200000000000003 111.074 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -148.54 163.94 35.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.907 -1.121 . . . . 0.02 110.254 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.3 mm -127.87 125.5 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 107.163 -1.421 . . . . 2.1699999999999999 107.163 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -106.15 -15.41 14.88 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.865 -1.147 . . . . 0.02 113.201 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 1.2 p -157.03 155.51 31.33 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.278 -1.513 . . . . 0.01 107.942 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.6 t -163.15 146.49 10.67 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.442 -1.411 . . . . 1.22 109.737 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.77 111.49 17.22 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.432 1.11 . . . . 1.4099999999999999 108.601 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.7 t -109.16 122.67 64.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 105.584 -2.006 . . . . 0.01 105.584 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.3 t -146.43 67.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 118.128 -1.429 . . . . 1.98 108.06 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.95 108.83 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.534 -1.654 . . . . 0.01 106.534 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.82 -174.3 40.05 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.659 -1.376 . . . . 0.01 109.659 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 m -112.2 145.1 40.47 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.331 -1.1 . . . . 2.2999999999999998 109.522 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.496 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 62.8 m95 -130.03 145.87 51.68 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.535 -0.728 . . . . 0.01 110.379 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.9 mt -116.96 141.45 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 107.639 -1.245 . . . . 1.6899999999999999 107.639 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -112.36 141.76 45.7 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 107.198 -1.408 . . . . 2.4900000000000002 107.198 178.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -122.06 143.78 49.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.09 -0.707 . . . . 0.02 109.09 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.34 -30.3 61.96 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.729 -0.607 . . . . 0.02 111.908 -176.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.53 153.45 47.74 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.667 -1.271 . . . . 1.48 109.018 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.45 167.11 1.47 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.243 1.295 . . . . 0.02 112.665 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 m120 59.21 31.03 20.89 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.141 -0.936 . . . . 0.75 111.079 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.494 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.6 m-85 57.72 52.07 8.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.633 -0.667 . . . . 0.02 111.048 178.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -125.07 163.72 21.78 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.495 -0.753 . . . . 0.02 109.69 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.17 -165.5 32.89 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.869 -1.292 . . . . 0.02 109.869 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -67.81 141.22 56.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.448 -1.031 . . . . 0.02 108.92 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.64 148.48 42.67 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.25 -0.648 . . . . 0.02 109.25 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.52 142.72 50.98 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.959 -0.756 . . . . 0.01 108.959 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.0 tt -96.69 121.3 38.39 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.277 -0.89 . . . . 0.01 109.131 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.652 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.9 mt -106.11 135.05 48.26 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.369 -0.832 . . . . 0.01 110.261 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 154' ' ' LYS . 22.8 t70 -108.25 174.82 5.71 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.339 -0.985 . . . . 2.27 108.339 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' N ' ' CG ' ' A' ' 152' ' ' ASP . 13.2 pttp -58.72 83.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.921 -1.112 . . . . 1.8400000000000001 108.598 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 152' ' ' ASP . 55.0 mmtt -136.47 170.74 15.55 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.215 -0.928 . . . . 2.2799999999999998 111.518 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.465 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 14.5 mp0 -113.24 109.49 18.84 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.282 -1.007 . . . . 0.01 108.282 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -100.1 114.77 28.36 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.031 -1.043 . . . . 0.01 110.112 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -93.31 -25.85 17.56 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.156 -0.965 . . . . 0.01 111.643 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -125.75 153.32 73.18 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 120.762 -1.211 . . . . 2.54 108.682 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -61.04 -43.02 32.35 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 120.431 0.754 . . . . 0.69999999999999996 110.77 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.7 t -60.73 -20.52 21.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.64 -1.288 . . . . 0.85999999999999999 108.619 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -65.14 -15.99 63.02 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.068 -1.02 . . . . 0.02 109.416 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.652 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -94.85 9.87 37.51 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.945 -1.132 . . . . 0.02 107.945 178.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.09 11.27 84.95 Favored Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.18 -1.486 . . . . 0.02 109.627 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.59 142.33 31.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.557 -0.966 . . . . 0.02 110.181 -178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.79 -8.61 58.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.775 -0.578 . . . . 0.58999999999999997 109.885 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 58.7 m -144.19 150.59 49.22 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 120.862 -1.149 . . . . 0.87 108.687 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -76.09 21.17 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 120.781 0.987 . . . . 0.38 112.541 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 123.23 28.73 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.653 1.216 . . . . 0.17999999999999999 111.437 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.527 HG23 ' CD1' ' A' ' 138' ' ' PHE . 17.4 mt -147.25 124.51 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.316 -1.735 . . . . 3.9900000000000002 106.316 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -114.01 -17.79 11.88 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.178 -0.951 . . . . 5.1699999999999999 113.022 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.0 t -157.6 160.27 37.93 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 119.354 -2.091 . . . . 0.02 110.144 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -153.4 154.55 34.68 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.009 -1.057 . . . . 2.02 110.611 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.494 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 21.8 mtp180 -143.53 150.81 39.45 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 0.01 110.356 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -87.94 142.77 27.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.714 . . . . 0.01 109.173 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.96 128.21 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.121 -0.987 . . . . 3.04 109.081 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.9 146.46 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.293 -0.88 . . . . 1.8899999999999999 109.708 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.286 -0.884 . . . . 4.8899999999999997 109.353 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.482 -0.562 . . . . 5.2800000000000002 109.482 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.453 ' O ' ' OG1' ' A' ' 3' ' ' THR . 59.0 mttm -72.41 -39.32 68.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 5.96 109.188 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 4' ' ' GLY . 55.2 m -173.31 156.39 3.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.48 -1.388 . . . . 2.2200000000000002 108.212 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 3' ' ' THR . . . 178.9 177.67 47.65 Favored Glycine 0 N--CA 1.491 2.3 0 C-N-CA 118.651 -1.738 . . . . 0.81000000000000005 111.791 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.14 156.47 43.62 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.144 -1.583 . . . . 0.01 109.144 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.514 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 5.4 ttpm? -148.8 137.34 21.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.285 . . . . 0.02 110.414 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 tt -130.95 140.52 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 109.206 -0.664 . . . . 0.02 109.206 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -121.41 130.46 53.61 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.403 -0.811 . . . . 0.39000000000000001 110.054 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 1.6 m-85 -110.85 140.46 45.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.737 -0.602 . . . . 0.02 109.448 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.545 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.3 m-85 -122.24 138.66 54.41 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.184 -0.947 . . . . 0.02 109.603 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.49 -27.27 65.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.08 . . . . 0.029999999999999999 111.805 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -114.32 170.28 8.42 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.816 -1.178 . . . . 0.029999999999999999 110.263 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -75.64 158.48 32.34 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.662 0.744 . . . . 0.029999999999999999 110.18 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 65.99 33.15 7.93 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.006 0.908 . . . . 0.73999999999999999 111.142 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.22 41.94 30.95 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.923 -0.58 . . . . 0.02 111.21 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -113.16 165.83 12.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.278 -1.008 . . . . 0.02 108.278 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.67 -167.67 35.38 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.882 -1.152 . . . . 0.029999999999999999 110.464 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -68.97 142.0 54.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -1.096 . . . . 2.7599999999999998 108.838 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -122.69 151.0 41.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.532 -0.73 . . . . 1.8899999999999999 109.999 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -137.52 133.87 35.04 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.756 -0.59 . . . . 0.02 109.746 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -109.44 136.08 49.43 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.973 -0.751 . . . . 1.1200000000000001 108.973 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.0 t -127.63 138.32 52.81 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.577 -0.702 . . . . 0.02 109.535 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 13.1 t70 -119.2 12.19 12.55 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.619 -0.676 . . . . 0.20000000000000001 110.494 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.8 p -159.65 173.4 16.15 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.898 -1.126 . . . . 1.23 109.197 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -62.64 146.09 52.93 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.776 -1.203 . . . . 0.02 110.586 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.7 m -133.73 117.33 16.82 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.801 -0.814 . . . . 0.02 108.801 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.74 -21.32 52.01 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.314 -0.866 . . . . 0.23999999999999999 111.641 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -151.06 105.69 3.27 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.88 -1.137 . . . . 1.1399999999999999 109.215 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.0 4.85 42.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.55 -0.719 . . . . 6.3700000000000001 110.097 -178.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -62.1 -29.47 70.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.394 -0.816 . . . . 3.1099999999999999 112.635 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 m -77.21 -18.22 57.9 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.152 -1.592 . . . . 0.88 111.647 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -106.95 -19.8 13.52 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.418 -0.801 . . . . 0.02 110.51 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -148.98 127.09 12.02 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.032 -1.042 . . . . 3.3199999999999998 109.55 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 p -87.44 -13.15 44.04 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.641 -0.662 . . . . 0.02 111.301 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -172.38 161.84 5.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.788 -1.195 . . . . 0.02 108.45 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.443 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.6 p -143.35 116.24 8.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.117 -0.989 . . . . 0.02 108.851 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -108.1 -0.73 20.95 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.829 -1.169 . . . . 0.029999999999999999 111.228 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 19.3 m -155.23 153.68 31.04 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.829 -1.174 . . . . 0.02 107.829 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.89 147.53 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 122.158 0.98 . . . . 0.02 110.551 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -123.58 124.96 43.98 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.952 -1.129 . . . . 0.02 107.952 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.4 t -105.27 113.79 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 106.672 -1.603 . . . . 0.02 106.672 177.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -84.76 -35.06 22.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.6 -0.687 . . . . 3.8100000000000001 110.001 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.65 149.45 17.42 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.598 -1.763 . . . . 0.02 110.778 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.75 172.1 48.57 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.237 -1.145 . . . . 0.01 110.237 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 m -118.48 134.36 55.13 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.592 -1.262 . . . . 1.48 107.592 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -127.03 154.31 44.81 Favored 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 122.704 1.24 . . . . 0.02 112.484 -176.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.88 134.11 52.0 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 105.194 -2.15 . . . . 0.23999999999999999 105.194 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.6 m -116.38 141.95 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.65000000000000002 109.453 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -120.48 143.13 48.69 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.192 0.996 . . . . 0.02 109.649 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.84 -34.1 77.37 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.511 -0.768 . . . . 0.02 111.897 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -124.51 157.96 63.43 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.017 -1.052 . . . . 0.02 109.472 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.39 166.4 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.587 1.525 . . . . 0.02 112.769 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.55 36.59 10.99 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.242 -0.89 . . . . 0.02 111.116 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.514 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 6.0 m-85 45.56 51.6 9.81 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.603 0.716 . . . . 3.3900000000000001 110.679 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.8 m -126.1 163.62 22.68 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.291 0.567 . . . . 2.3300000000000001 109.77 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -161.66 31.27 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.718 -1.353 . . . . 0.02 109.718 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -64.78 139.21 58.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.036 -1.273 . . . . 0.02 110.268 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 19.9 ptm -119.54 136.96 54.13 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.178 0.513 . . . . 5.0099999999999998 109.722 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.444 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 93.4 m-85 -134.41 139.51 45.62 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.47 -0.768 . . . . 0.02 109.954 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 mm -94.1 130.34 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.924 -0.769 . . . . 1.72 108.924 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.546 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.55 110.69 35.32 Favored Pre-proline 0 N--CA 1.505 2.308 0 O-C-N 121.39 -0.819 . . . . 0.02 110.877 -178.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.99 169.32 20.69 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 119.823 0.972 . . . . 1.47 110.388 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -53.97 141.25 28.61 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.882 -1.136 . . . . 4.25 110.728 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.72 -177.64 31.91 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.509 -1.329 . . . . 0.02 110.748 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -119.42 131.38 55.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.388 -1.066 . . . . 0.95999999999999996 109.887 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 73.5 m-85 -121.67 98.09 46.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.051 -1.092 . . . . 0.02 108.051 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.423 ' O ' ' OG ' ' A' ' 38' ' ' SER . 7.3 Cg_endo -70.61 -3.82 13.36 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 120.787 0.991 . . . . 0.02 113.576 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -157.33 154.54 29.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.489 -1.382 . . . . 2.02 107.966 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -59.85 -39.07 83.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.434 -0.792 . . . . 0.02 111.722 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -59.75 -24.39 64.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.02 110.496 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -69.95 -18.89 63.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.365 -0.834 . . . . 3.4199999999999999 109.247 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.554 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -108.12 10.61 28.02 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.637 -1.245 . . . . 0.02 107.637 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 mtt 60.67 21.97 11.88 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.555 0.693 . . . . 0.02 110.359 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.02 144.28 44.98 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.332 -1.507 . . . . 0.02 109.332 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.2 tp -78.64 -30.46 46.38 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.502 -1.296 . . . . 0.97999999999999998 107.502 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -157.66 -171.39 3.54 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.326 -1.731 . . . . 0.02 106.326 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -98.93 28.56 4.28 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.62 -1.3 . . . . 0.02 110.433 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -97.84 123.3 41.74 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.026 -1.046 . . . . 3.2000000000000002 111.36 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.466 HD22 ' HB ' ' A' ' 48' ' ' VAL . 57.1 mt -142.5 119.6 11.4 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.259 -1.385 . . . . 2.6099999999999999 107.259 177.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.98 -18.07 10.98 Favored Glycine 0 N--CA 1.497 2.703 0 O-C-N 121.249 -0.907 . . . . 0.02 111.949 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.514 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 15.8 t -155.67 155.29 32.95 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.321 -1.693 . . . . 0.02 110.826 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 30.0 p -146.02 148.2 32.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.493 -0.754 . . . . 0.02 110.19 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.445 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 49.0 mtp180 -137.43 142.05 41.62 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.88 -0.785 . . . . 0.01 108.88 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.65 133.06 37.27 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.175 -0.953 . . . . 0.42999999999999999 109.276 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.18 123.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.351 -0.981 . . . . 1.25 108.351 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -91.47 131.75 36.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.678 -1.264 . . . . 1.77 107.958 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -96.52 137.28 35.83 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.145 -1.057 . . . . 1.6299999999999999 108.145 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 t -109.7 126.47 53.73 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.454 -0.943 . . . . 1.0800000000000001 108.454 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.3 m -103.47 -154.48 0.5 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.211 -1.774 . . . . 1.26 106.211 177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.36 -50.12 0.88 Allowed Glycine 0 N--CA 1.497 2.748 0 O-C-N 120.692 -1.255 . . . . 0.01 111.676 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.87 -99.41 0.13 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 118.74 -1.695 . . . . 0.01 112.001 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.42 119.2 32.34 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.311 -1.111 . . . . 4.4299999999999997 110.457 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.601 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.79 137.52 56.68 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.765 -0.584 . . . . 2.9900000000000002 109.472 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -134.55 131.51 38.03 Favored 'General case' 0 N--CA 1.519 2.994 0 O-C-N 121.083 -1.011 . . . . 6.3600000000000003 113.19 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 tt -131.83 141.96 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 115.525 -0.761 . . . . 1.0900000000000001 110.237 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.532 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 2.3 pm0 -125.11 140.34 52.97 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 107.743 -1.206 . . . . 2.0499999999999998 107.743 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.3 145.79 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 O-C-N 120.603 -1.31 . . . . 1.1000000000000001 111.038 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 27.6 m-85 -119.79 140.05 51.37 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.218 1.009 . . . . 0.72999999999999998 110.959 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.27 -32.97 73.51 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.801 -0.636 . . . . 0.02 111.48 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -115.02 168.91 9.5 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.213 -0.929 . . . . 3.1800000000000002 109.953 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.25 169.03 47.31 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 111.011 -0.836 . . . . 0.01 111.011 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.7 t0 53.55 39.11 29.61 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.66 0.743 . . . . 0.01 111.594 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 52.53 48.41 22.61 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.553 -0.717 . . . . 0.01 110.828 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 24.2 t30 -121.53 164.36 17.35 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.307 -0.997 . . . . 3.1499999999999999 108.307 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 90.68 -163.13 29.52 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.118 -1.593 . . . . 0.01 109.118 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -75.48 141.82 43.03 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.839 -1.389 . . . . 0.01 109.222 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.555 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 41.3 ttp -116.39 143.39 45.61 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.613 0.721 . . . . 0.01 109.528 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -132.52 136.18 46.46 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.34 -0.985 . . . . 2.48 108.34 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -117.0 134.72 54.38 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.702 -0.624 . . . . 0.01 109.642 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -149.49 148.55 29.54 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.419 1.104 . . . . 1.6899999999999999 111.353 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.6 p -115.6 6.91 14.68 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.045 -0.98 . . . . 0.01 110.015 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.56 163.34 19.05 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.505 -0.747 . . . . 3.21 111.107 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -68.31 152.59 45.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.01 109.822 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 41.1 t -126.52 113.79 23.02 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.901 -0.777 . . . . 0.01 108.901 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -76.1 -33.27 3.66 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 CA-C-N 120.19 1.103 . . . . 0.01 111.658 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 16.4 p -140.91 106.84 5.16 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.056 0.931 . . . . 0.02 108.645 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.44 -39.36 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.772 -0.58 . . . . 1.8300000000000001 111.186 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.0 ttt -67.26 -37.24 83.15 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.024 -1.07 . . . . 1.3400000000000001 109.578 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -69.6 -38.39 77.28 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.64 -1.288 . . . . 2.1099999999999999 109.858 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.17 -46.51 16.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.318 -0.864 . . . . 2.0800000000000001 112.265 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -110.11 -0.14 18.09 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.317 -0.864 . . . . 0.02 112.694 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 59.81 33.26 21.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.653 -1.279 . . . . 0.02 109.379 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.76 135.64 53.27 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 108.676 -0.861 . . . . 0.02 108.676 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -92.34 -23.19 19.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 5.3200000000000003 110.46 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -149.16 163.32 37.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.163 -0.961 . . . . 0.02 110.073 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.4 mt -132.06 129.66 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 107.189 -1.412 . . . . 2.1699999999999999 107.189 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -105.75 -12.31 15.94 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.381 -0.928 . . . . 0.02 112.59 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.18 152.8 29.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.368 -1.458 . . . . 0.01 108.11 177.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 12.8 t -162.88 141.86 8.7 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.556 -1.34 . . . . 1.22 109.465 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.405 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 30.5 ttpt -124.04 114.47 19.78 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.643 1.211 . . . . 1.4099999999999999 109.656 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.39 123.75 61.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 105.614 -1.995 . . . . 0.01 105.614 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.5 HG13 ' NZ ' ' A' ' 153' ' ' LYS . 59.0 t -147.65 71.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 C-N-CA 118.404 -1.318 . . . . 1.98 108.205 175.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 171.35 108.29 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 106.427 -1.694 . . . . 0.01 106.427 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.75 -172.31 46.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.563 -1.415 . . . . 0.01 109.563 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.2 p -110.25 140.89 43.94 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.555 -0.968 . . . . 2.2999999999999998 108.877 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.601 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 70.5 m95 -129.85 146.69 51.57 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.443 -0.786 . . . . 0.01 110.442 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 137' ' ' ILE . 61.1 mt -118.36 139.86 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 107.816 -1.179 . . . . 1.6899999999999999 107.816 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.671 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.04 141.96 46.26 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.103 -1.443 . . . . 2.4900000000000002 107.103 178.057 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 6.7 m-85 -122.55 144.39 49.12 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.593 -0.692 . . . . 0.02 109.155 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -73.92 -30.12 62.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.586 -0.696 . . . . 0.02 112.407 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.3 mt -115.05 153.56 47.17 Favored Pre-proline 0 N--CA 1.506 2.349 0 O-C-N 120.773 -1.204 . . . . 1.48 109.085 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.3 166.67 1.6 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.117 1.211 . . . . 0.02 112.522 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 59.54 30.76 20.43 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.225 -0.898 . . . . 0.75 111.114 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.56 52.21 7.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.424 -0.798 . . . . 0.02 111.272 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -125.78 163.84 21.98 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.532 -0.73 . . . . 0.02 109.959 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.67 -165.56 32.29 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.078 -1.209 . . . . 0.02 110.078 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -68.1 141.69 56.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.543 -0.975 . . . . 0.02 108.941 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -118.15 149.92 40.24 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 116.044 -0.526 . . . . 0.02 109.676 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.56 140.82 51.87 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 109.221 -0.659 . . . . 0.01 109.221 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.5 tp -95.13 121.69 37.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.414 -0.804 . . . . 0.01 109.191 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.63 ' CD2' ' HE1' ' A' ' 162' ' ' TRP . 5.8 mt -104.62 113.98 27.91 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.384 -0.823 . . . . 0.01 109.677 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 152' ' ' ASP . 5.3 m-20 -113.9 89.83 3.19 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 108.702 -0.851 . . . . 2.27 108.702 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.5 ' NZ ' HG13 ' A' ' 132' ' ' VAL . 51.8 tttp 49.37 78.86 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.99 -1.069 . . . . 1.8400000000000001 108.267 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -131.45 144.4 51.14 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.468 -0.77 . . . . 2.2799999999999998 111.902 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -112.98 99.79 8.13 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.329 -1.36 . . . . 0.01 107.329 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -98.06 116.72 30.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.096 -1.003 . . . . 0.01 110.853 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -97.72 -27.3 14.41 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.434 -0.791 . . . . 0.01 110.734 -178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -125.72 152.44 72.28 Favored Pre-proline 0 N--CA 1.502 2.137 0 N-CA-C 108.527 -0.916 . . . . 2.54 108.527 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -57.87 -47.49 20.6 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 CA-C-N 119.313 0.79 . . . . 0.69999999999999996 110.889 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.58 -23.57 29.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.829 -1.17 . . . . 0.85999999999999999 109.435 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 11.9 t0 -66.8 -16.22 64.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.777 -1.202 . . . . 0.02 109.492 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.63 ' HE1' ' CD2' ' A' ' 151' ' ' LEU . 2.2 t90 -95.06 7.83 44.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.529 -0.915 . . . . 0.02 108.529 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.98 8.18 84.67 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.904 -1.278 . . . . 0.02 109.904 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.27 142.84 30.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.552 -0.97 . . . . 0.02 110.035 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.31 -8.97 58.85 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.728 -0.608 . . . . 0.58999999999999997 109.635 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.7 t -146.46 151.38 43.33 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.825 -1.172 . . . . 0.87 108.113 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.22 24.85 0.39 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.768 0.979 . . . . 0.38 112.344 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.485 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -85.27 123.01 30.27 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.87 -1.144 . . . . 0.17999999999999999 112.803 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.671 HG23 ' CD1' ' A' ' 138' ' ' PHE . 4.6 mp -146.84 126.92 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 106.429 -1.693 . . . . 3.9900000000000002 106.429 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -112.16 -17.88 12.7 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.917 -1.114 . . . . 5.1699999999999999 113.605 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.8 p -157.79 160.82 38.2 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 119.18 -2.2 . . . . 0.02 110.263 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -153.2 153.74 33.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.054 -1.029 . . . . 2.02 110.766 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -144.72 152.16 39.97 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.205 -0.934 . . . . 0.01 110.908 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -88.31 141.82 28.24 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.118 -0.697 . . . . 0.01 109.118 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.0 mt -94.42 129.41 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.215 -0.928 . . . . 3.04 109.105 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 38.4 t -136.29 147.22 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.186 -0.946 . . . . 1.8899999999999999 109.681 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 4.8899999999999997 109.366 -179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.388 -0.597 . . . . 5.2800000000000002 109.388 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -55.35 116.69 2.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 5.96 109.463 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 p -89.9 -139.74 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.367 -1.346 . . . . 2.2200000000000002 107.367 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.67 -174.95 45.81 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 117.421 -2.323 . . . . 0.81000000000000005 112.9 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.88 160.36 44.77 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.425 -1.47 . . . . 0.01 109.425 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -147.67 136.03 21.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.093 -1.239 . . . . 0.02 110.267 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.5 tt -130.38 140.32 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 109.211 -0.663 . . . . 0.02 109.211 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.95 130.9 53.7 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.429 -0.795 . . . . 0.39000000000000001 110.191 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 4.9 m-85 -110.98 140.62 45.34 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.546 -0.721 . . . . 0.02 109.487 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.7 m-85 -121.89 138.1 54.53 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.365 -0.834 . . . . 0.02 109.49 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.43 -27.25 65.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.957 -1.09 . . . . 0.029999999999999999 111.681 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -113.88 169.63 8.85 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.927 -1.108 . . . . 0.029999999999999999 110.212 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.51 ' NH2' ' OE2' ' A' ' 68' ' ' GLU . 21.8 mtp180 -75.91 158.43 32.05 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.614 0.721 . . . . 0.029999999999999999 110.159 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.8 OUTLIER 66.39 33.26 7.06 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.05 0.928 . . . . 0.73999999999999999 111.082 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 55.58 41.8 30.27 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.932 -0.576 . . . . 0.02 111.39 177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -113.44 165.72 12.19 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.357 -0.979 . . . . 0.02 108.357 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.18 -167.94 34.81 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.851 -1.166 . . . . 0.029999999999999999 110.536 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -69.03 142.84 54.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.443 -1.034 . . . . 2.7599999999999998 108.955 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -122.2 149.96 42.93 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.614 -0.679 . . . . 1.8899999999999999 110.053 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -136.59 133.02 35.91 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.329 -0.619 . . . . 0.02 109.329 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -109.22 136.79 48.12 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.761 -0.829 . . . . 1.1200000000000001 108.761 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 16.0 t -128.21 138.44 52.46 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.556 -0.715 . . . . 0.02 109.891 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -119.74 11.53 11.95 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.647 -0.658 . . . . 0.20000000000000001 110.776 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.525 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 26.7 p -159.7 173.48 15.99 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.562 -1.336 . . . . 1.23 109.418 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.09 145.89 54.46 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.404 -1.435 . . . . 0.02 110.688 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.9 m -135.1 119.57 18.01 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.037 -0.727 . . . . 0.02 109.037 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.25 -20.33 55.33 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.425 -0.797 . . . . 0.23999999999999999 111.918 -177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -153.96 106.62 2.86 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.838 -1.163 . . . . 1.1399999999999999 109.792 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.77 5.65 38.93 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.378 -0.826 . . . . 6.3700000000000001 110.289 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -60.5 -29.21 68.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.367 -0.833 . . . . 3.1099999999999999 111.976 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 p -76.86 -16.78 59.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.417 -1.427 . . . . 0.88 111.039 -178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -106.13 -21.63 13.07 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.326 -0.859 . . . . 0.02 110.684 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.6 tp -149.44 127.67 12.09 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.988 -1.07 . . . . 3.3199999999999998 109.534 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -87.63 -12.41 45.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.562 -0.711 . . . . 0.02 110.966 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -171.82 160.85 5.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.854 -1.154 . . . . 0.02 108.541 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.454 ' SG ' HD12 ' A' ' 79' ' ' LEU . 1.8 p -143.38 116.1 8.71 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.975 -1.078 . . . . 0.02 108.846 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -108.6 -0.91 19.98 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.811 -1.18 . . . . 0.029999999999999999 111.363 -178.331 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 21.1 m -154.73 153.64 31.6 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.882 -1.155 . . . . 0.02 107.882 178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mt -146.67 147.41 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.296 1.046 . . . . 0.02 110.735 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -123.75 124.53 42.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.052 -1.092 . . . . 0.02 108.052 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 t -105.28 113.88 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.654 -1.609 . . . . 0.02 106.654 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -85.52 -34.9 21.44 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.079 -0.649 . . . . 3.8100000000000001 110.212 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.56 149.11 16.78 Favored Glycine 0 N--CA 1.488 2.13 0 C-N-CA 118.481 -1.819 . . . . 0.02 110.773 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.75 172.18 48.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.08 -1.208 . . . . 0.01 110.08 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.8 m -118.26 134.37 55.08 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.422 -1.325 . . . . 1.48 107.422 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -126.78 154.49 44.19 Favored 'General case' 0 N--CA 1.503 2.216 0 CA-C-O 122.694 1.235 . . . . 0.02 112.411 -176.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.25 133.97 52.36 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 105.18 -2.155 . . . . 0.23999999999999999 105.18 176.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.445 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.1 m -116.38 142.01 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.494 -0.754 . . . . 0.65000000000000002 109.268 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -120.85 143.06 49.09 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.104 0.954 . . . . 0.02 109.607 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.88 -33.82 76.93 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.527 -0.761 . . . . 0.02 111.76 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -124.76 158.01 63.98 Favored Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 120.971 -1.081 . . . . 0.02 109.366 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.29 167.14 0.87 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.548 1.499 . . . . 0.02 112.76 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 63.2 36.58 11.88 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.245 -0.888 . . . . 0.02 111.11 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.412 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 4.1 m-85 45.1 51.59 8.89 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.626 0.727 . . . . 3.3900000000000001 110.677 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.7 p -125.69 163.33 23.04 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.227 0.537 . . . . 2.3300000000000001 109.966 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.51 -161.59 31.23 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.58 -1.408 . . . . 0.02 109.58 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -65.27 138.9 58.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.962 -1.317 . . . . 0.02 110.153 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.2 ptm -118.86 137.31 53.52 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.314 0.578 . . . . 5.0099999999999998 109.717 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.426 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 97.3 m-85 -134.27 139.34 45.67 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.52 -0.738 . . . . 0.02 109.818 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.9 mm -94.54 130.5 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.906 -0.775 . . . . 1.72 108.906 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -120.78 110.84 34.83 Favored Pre-proline 0 N--CA 1.506 2.359 0 O-C-N 121.417 -0.802 . . . . 0.02 110.784 -178.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -78.06 169.61 20.14 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 CA-C-N 119.855 0.984 . . . . 1.47 110.438 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -53.71 141.18 27.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.966 -1.084 . . . . 4.25 110.589 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.66 -177.61 31.88 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.485 -1.341 . . . . 0.02 110.94 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -119.91 131.38 55.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.377 -1.073 . . . . 0.95999999999999996 109.785 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 76.3 m-85 -121.29 97.74 47.24 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 107.959 -1.126 . . . . 0.02 107.959 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.43 ' O ' ' OG ' ' A' ' 38' ' ' SER . 4.8 Cg_endo -69.38 -4.46 13.82 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 120.731 0.954 . . . . 0.02 113.754 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.51 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 74.6 mt-10 -157.53 154.66 28.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.693 -1.255 . . . . 2.02 107.97 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -59.45 -38.69 81.4 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.473 -0.767 . . . . 0.02 111.978 -177.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -60.36 -23.98 64.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 0.02 110.554 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -70.04 -18.78 63.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.38 -0.825 . . . . 3.4199999999999999 108.951 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.552 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.69 10.4 26.88 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.562 -1.273 . . . . 0.02 107.562 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 mtt 60.94 22.32 12.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.524 -0.735 . . . . 0.02 110.457 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.36 144.48 45.46 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.389 -1.484 . . . . 0.02 109.389 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.09 -31.2 44.25 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.494 -1.299 . . . . 0.97999999999999998 107.494 177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -157.18 -171.82 3.77 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 106.383 -1.71 . . . . 0.02 106.383 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 92.9 m-20 -98.5 28.1 4.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.784 -1.198 . . . . 0.02 110.718 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -97.64 123.17 41.44 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.085 -1.009 . . . . 3.2000000000000002 111.422 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.454 HD12 ' SG ' ' A' ' 36' ' ' CYS . 60.0 mt -142.01 119.56 11.7 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.221 -1.4 . . . . 2.6099999999999999 107.221 177.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.22 -18.31 10.55 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.229 -0.92 . . . . 0.02 112.14 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.8 p -155.84 156.01 33.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.371 -1.664 . . . . 0.02 110.583 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.2 p -145.72 148.15 32.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.497 -0.752 . . . . 0.02 110.08 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.412 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 54.3 mtp180 -137.4 142.03 41.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.383 -0.823 . . . . 0.01 109.075 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.8 132.38 36.86 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.259 -0.901 . . . . 0.42999999999999999 109.394 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 t -89.52 123.75 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.43 -0.952 . . . . 1.25 108.43 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -91.84 131.87 36.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.925 -1.109 . . . . 1.77 108.267 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -96.99 138.02 35.17 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.16 -1.052 . . . . 1.6299999999999999 108.16 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 m -110.01 126.79 54.33 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.665 -0.865 . . . . 1.0800000000000001 108.665 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.4 m -103.34 -154.39 0.5 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.196 -1.779 . . . . 1.26 106.196 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.42 -49.91 0.87 Allowed Glycine 0 N--CA 1.497 2.701 0 O-C-N 120.517 -1.364 . . . . 0.01 111.891 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.28 -99.86 0.13 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 118.723 -1.703 . . . . 0.01 111.822 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -119.67 119.35 33.44 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.258 -1.142 . . . . 4.4299999999999997 110.465 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.425 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.12 135.59 54.78 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.304 -0.628 . . . . 2.9900000000000002 109.304 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -134.69 131.06 37.23 Favored 'General case' 0 N--CA 1.519 3.021 0 O-C-N 121.024 -1.047 . . . . 6.3600000000000003 113.079 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.7 tt -131.83 142.04 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-N 115.467 -0.788 . . . . 1.0900000000000001 110.384 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.53 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.4 pt20 -124.32 138.44 54.38 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 107.285 -1.376 . . . . 2.0499999999999998 107.285 176.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.8 m -124.55 147.23 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 120.586 -1.321 . . . . 1.1000000000000001 111.188 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -119.86 141.51 49.49 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 122.385 1.088 . . . . 0.72999999999999998 111.582 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -69.54 -33.18 72.42 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.738 -0.664 . . . . 0.02 111.135 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . 12.0 mptt -113.84 167.73 10.39 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.185 -0.947 . . . . 3.1800000000000002 109.545 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.38 169.69 46.55 Favored Glycine 0 N--CA 1.492 2.404 0 CA-C-O 122.033 0.796 . . . . 0.01 111.318 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 53.26 40.09 30.75 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.632 0.73 . . . . 0.01 111.605 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 52.58 47.73 24.07 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.523 -0.735 . . . . 0.01 110.785 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -121.47 165.28 15.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.12 -1.066 . . . . 3.1499999999999999 108.12 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.27 -162.93 29.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.168 -1.573 . . . . 0.01 109.168 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -76.14 141.87 41.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.903 -1.351 . . . . 0.01 108.967 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.456 ' C ' ' SD ' ' A' ' 107' ' ' MET . 11.0 tmm? -116.08 143.28 45.69 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.497 0.665 . . . . 0.01 109.595 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -132.28 136.4 46.91 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.421 -0.955 . . . . 2.48 108.421 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -116.78 134.19 55.09 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.703 -0.623 . . . . 0.01 109.871 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.2 t -149.13 148.54 29.77 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 122.466 1.126 . . . . 1.6899999999999999 111.444 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -114.74 7.64 15.93 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.062 -0.972 . . . . 0.01 110.1 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -121.89 163.35 19.39 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.43 -0.794 . . . . 3.21 111.28 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.91 154.41 42.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -0.752 . . . . 0.01 109.379 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 35.0 t -125.8 114.5 24.64 Favored Pre-proline 0 N--CA 1.5 2.025 0 N-CA-C 109.19 -0.671 . . . . 0.01 109.19 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -75.59 -33.81 3.78 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 CA-C-N 120.225 1.116 . . . . 0.01 111.488 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 55.0 m -141.46 107.55 5.2 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.921 0.867 . . . . 0.02 108.84 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.7 mt -65.01 -39.04 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.748 -0.595 . . . . 1.8300000000000001 111.182 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.6 ttt -66.88 -37.36 84.25 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.936 -1.105 . . . . 1.3400000000000001 109.577 -178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -69.81 -38.56 76.64 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.59 -1.319 . . . . 2.1099999999999999 109.752 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -80.16 -47.58 14.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.314 -0.866 . . . . 2.0800000000000001 112.491 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.43 -0.65 16.2 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.389 -0.82 . . . . 0.02 112.724 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.8 m170 59.71 33.63 21.9 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.76 -1.213 . . . . 0.02 109.5 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 mt -112.3 135.28 53.17 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.637 -0.875 . . . . 0.02 108.637 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -92.45 -23.44 19.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 5.3200000000000003 110.664 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -149.34 163.63 37.16 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.218 -0.926 . . . . 0.02 110.12 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 57.5 mt -131.89 129.48 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.237 -1.394 . . . . 2.1699999999999999 107.237 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -106.32 -12.49 15.67 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 121.109 -0.994 . . . . 0.02 113.068 -176.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 1.5 p -158.9 156.23 29.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.636 -1.29 . . . . 0.01 107.519 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 3.3 t -163.18 147.18 10.95 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.939 -1.1 . . . . 1.22 109.541 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.75 108.93 15.01 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.132 0.968 . . . . 1.4099999999999999 108.767 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -108.49 121.6 61.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 105.886 -1.894 . . . . 0.01 105.886 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.1 t -147.24 69.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 118.072 -1.451 . . . . 1.98 108.289 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.68 107.56 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.238 -1.764 . . . . 0.01 106.238 179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.19 -176.46 40.95 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.604 -1.399 . . . . 0.01 109.604 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.6 m -110.74 146.83 35.63 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.413 -1.051 . . . . 2.2999999999999998 109.103 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.425 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 67.4 m95 -131.54 149.11 52.64 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.491 -0.756 . . . . 0.01 110.693 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 58.8 mt -118.8 140.61 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 107.66 -1.237 . . . . 1.6899999999999999 107.66 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.724 ' CD1' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.14 141.44 46.93 Favored 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 107.314 -1.365 . . . . 2.4900000000000002 107.314 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 7.4 m-85 -122.64 145.46 48.35 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.408 -0.807 . . . . 0.02 109.325 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.79 -30.03 61.3 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.561 -0.712 . . . . 0.02 112.187 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.0 mt -115.45 153.33 47.64 Favored Pre-proline 0 N--CA 1.506 2.344 0 O-C-N 120.684 -1.26 . . . . 1.48 109.068 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.13 167.06 1.33 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.27 1.313 . . . . 0.02 112.478 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.2 t30 59.22 31.11 20.95 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.051 -0.977 . . . . 0.75 111.027 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.57 51.32 9.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.563 -0.711 . . . . 0.02 111.06 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -124.12 163.31 21.76 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.533 -0.729 . . . . 0.02 109.726 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.53 -165.13 32.18 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.889 -1.284 . . . . 0.02 109.889 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -67.84 141.62 56.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.453 -1.028 . . . . 0.02 108.877 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -117.63 149.09 41.27 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.195 -0.669 . . . . 0.02 109.195 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -128.47 141.85 51.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.5 -0.75 . . . . 0.01 109.346 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.12 118.14 31.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.258 -0.901 . . . . 0.01 108.821 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.766 HD13 ' CZ2' ' A' ' 162' ' ' TRP . 0.8 OUTLIER -106.58 135.55 47.9 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.454 -0.778 . . . . 0.01 109.519 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 154' ' ' LYS . 14.4 p30 -109.62 172.73 6.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.234 -0.917 . . . . 2.27 109.157 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -56.53 83.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.14 -0.975 . . . . 1.8400000000000001 108.738 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 152' ' ' ASP . 51.3 tttm -136.3 166.46 23.39 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.192 -0.942 . . . . 2.2799999999999998 111.332 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 155' ' ' GLU . 1.4 pm0 -110.04 108.48 18.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.805 -1.183 . . . . 0.01 107.805 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.608 ' CE2' ' NE1' ' A' ' 162' ' ' TRP . 94.4 m-85 -99.08 114.27 26.9 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.026 -1.046 . . . . 0.01 110.314 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -91.98 -27.82 17.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.443 -0.786 . . . . 0.01 111.208 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -126.26 152.23 73.4 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 120.96 -1.088 . . . . 2.54 108.228 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -59.72 -44.25 32.66 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 CA-C-N 119.283 0.78 . . . . 0.69999999999999996 111.185 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.3 t -61.09 -21.62 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.789 -1.194 . . . . 0.85999999999999999 109.509 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -65.92 -15.84 63.32 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.748 -1.22 . . . . 0.02 110.057 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.766 ' CZ2' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -97.39 11.22 37.4 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.548 -0.908 . . . . 0.02 108.548 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 78.2 10.0 86.54 Favored Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.633 -1.27 . . . . 0.02 110.346 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.71 142.39 31.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.281 -1.129 . . . . 0.02 110.146 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.2 -9.47 57.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.688 -0.633 . . . . 0.58999999999999997 110.314 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -145.51 150.49 44.13 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.703 -1.248 . . . . 0.87 108.957 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -76.19 21.23 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 120.888 1.059 . . . . 0.38 112.47 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.6 124.66 30.36 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.454 1.121 . . . . 0.17999999999999999 111.762 -177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.724 HG23 ' CD1' ' A' ' 138' ' ' PHE . 42.3 mt -145.71 125.91 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 106.526 -1.657 . . . . 3.9900000000000002 106.526 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -112.06 -20.7 11.86 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.008 -1.057 . . . . 5.1699999999999999 112.584 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.2 t -156.5 159.67 38.82 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 119.546 -1.971 . . . . 0.02 109.725 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -153.13 154.02 33.97 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.008 -1.058 . . . . 2.02 110.649 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -144.52 151.61 39.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.156 -0.965 . . . . 0.01 110.558 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -87.59 142.33 27.93 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.952 -0.759 . . . . 0.01 108.952 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.9 mt -93.93 128.8 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.145 -0.972 . . . . 3.04 109.004 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.28 146.9 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.208 -0.932 . . . . 1.8899999999999999 109.46 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 4.8899999999999997 109.502 179.876 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.313 0.578 . . . . 5.2800000000000002 109.528 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -68.4 -112.48 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 5.96 109.518 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -175.4 158.82 2.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.242 -1.536 . . . . 2.2200000000000002 108.653 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.38 178.47 47.8 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.819 -1.658 . . . . 0.81000000000000005 111.658 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.82 156.08 43.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.106 -1.598 . . . . 0.01 109.106 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -148.46 136.03 20.58 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.071 -1.252 . . . . 0.02 110.209 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -130.35 140.59 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.198 -0.668 . . . . 0.02 109.198 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 t -120.86 129.82 53.68 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.544 -0.722 . . . . 0.39000000000000001 109.908 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 2.7 m-85 -109.81 139.47 44.85 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.61 -0.681 . . . . 0.02 109.239 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.5 m-85 -121.56 137.9 54.54 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.209 -0.932 . . . . 0.02 109.416 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -69.8 -27.34 64.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.074 -1.016 . . . . 0.029999999999999999 111.756 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.48 170.66 8.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.843 -1.161 . . . . 0.029999999999999999 109.95 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.457 ' CZ ' ' OE1' ' A' ' 68' ' ' GLU . 37.4 mtp180 -75.02 161.25 29.62 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.699 0.761 . . . . 0.029999999999999999 110.245 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.2 m120 62.68 35.03 14.38 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.937 0.875 . . . . 0.73999999999999999 110.565 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.6 p90 49.49 43.4 23.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.365 -0.834 . . . . 0.02 110.932 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -109.54 165.61 11.53 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.877 -1.157 . . . . 0.02 107.877 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.73 -167.83 33.92 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 120.748 -1.22 . . . . 0.029999999999999999 110.733 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -69.37 143.71 53.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -1.059 . . . . 2.7599999999999998 109.071 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -122.85 150.2 43.18 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.529 -0.732 . . . . 1.8899999999999999 110.24 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -136.05 133.28 37.24 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 109.245 -0.65 . . . . 0.02 109.245 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -109.22 135.61 50.05 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.708 -0.849 . . . . 1.1200000000000001 108.708 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.3 t -127.85 138.11 52.58 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.649 -0.657 . . . . 0.02 109.411 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 24.5 p-10 -118.89 12.1 12.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.747 -0.596 . . . . 0.20000000000000001 110.166 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.8 p -160.18 173.67 15.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.864 -1.148 . . . . 1.23 109.083 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -63.18 146.07 54.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.838 -1.164 . . . . 0.02 110.657 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' ' 29' ' ' PHE . 5.5 t -133.75 117.92 17.48 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.767 -0.827 . . . . 0.02 108.767 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.53 -21.25 49.07 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.299 -0.876 . . . . 0.23999999999999999 111.865 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.99 105.79 3.29 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.784 -1.197 . . . . 1.1399999999999999 109.496 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.581 ' CD2' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -101.32 5.33 42.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.459 -0.776 . . . . 6.3700000000000001 110.351 -178.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -62.48 -29.78 70.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 3.1099999999999999 112.669 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.6 p -77.11 -19.04 57.5 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.152 -1.592 . . . . 0.88 111.806 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -106.99 -19.49 13.61 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.303 -0.873 . . . . 0.02 110.152 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -148.73 126.97 12.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.994 -1.066 . . . . 3.3199999999999998 109.39 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 m -87.43 -12.5 45.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.53 -0.732 . . . . 0.02 111.174 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -172.61 162.0 5.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.807 -1.183 . . . . 0.02 108.43 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.9 p -142.77 115.2 8.5 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.992 -1.068 . . . . 0.02 108.791 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -107.87 -1.97 20.28 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.858 -1.152 . . . . 0.029999999999999999 111.441 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 t -153.02 153.63 33.3 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.932 -1.136 . . . . 0.02 107.932 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 39' ' ' ILE . 9.7 mt -147.23 147.64 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.041 -1.037 . . . . 0.02 110.653 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -125.33 125.94 44.28 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.868 -1.16 . . . . 0.02 107.868 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.5 t -105.39 114.24 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 106.828 -1.545 . . . . 0.02 106.828 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -85.37 -34.83 21.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.499 -0.751 . . . . 3.8100000000000001 110.131 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.7 149.07 16.6 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 118.38 -1.867 . . . . 0.02 110.797 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.86 172.42 48.78 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.144 -1.182 . . . . 0.01 110.144 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 m -118.34 134.48 55.01 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.572 -1.27 . . . . 1.48 107.572 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.7 m95 -126.77 154.04 44.76 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.595 1.188 . . . . 0.02 112.382 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.69 133.53 52.66 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.094 -2.187 . . . . 0.23999999999999999 105.094 176.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.9 m -117.75 143.28 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.546 -0.721 . . . . 0.65000000000000002 109.279 179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.544 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 33.1 m-85 -120.72 145.1 47.84 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 122.197 0.999 . . . . 0.02 109.917 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.97 -33.66 76.32 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.76 -0.654 . . . . 0.02 111.436 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -124.71 158.01 63.83 Favored Pre-proline 0 N--CA 1.505 2.288 0 O-C-N 121.122 -0.986 . . . . 0.02 109.484 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -53.7 167.16 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.747 1.631 . . . . 0.02 112.716 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.0 t30 63.29 36.55 11.66 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.309 -0.859 . . . . 0.02 111.015 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.433 ' CE1' ' CG ' ' A' ' 83' ' ' ARG . 7.2 m-85 45.59 51.49 9.92 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.619 0.723 . . . . 3.3900000000000001 110.936 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -126.13 163.63 22.68 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.223 0.535 . . . . 2.3300000000000001 110.014 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.85 -161.87 30.99 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.895 -1.282 . . . . 0.02 109.895 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -65.16 139.5 58.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.966 -1.314 . . . . 0.02 110.134 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.544 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 49.2 ttp -118.35 137.34 53.16 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.292 0.568 . . . . 5.0099999999999998 109.827 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.564 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.6 m-85 -134.75 138.81 44.66 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.467 -0.77 . . . . 0.02 109.911 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.2 mm -94.55 130.89 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.003 -0.74 . . . . 1.72 109.003 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.522 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -120.36 110.76 35.58 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.396 -0.815 . . . . 0.02 110.631 -178.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -78.25 169.2 20.57 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.876 0.992 . . . . 1.47 110.275 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -53.79 140.64 29.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.831 -1.168 . . . . 4.25 110.558 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.17 -177.56 32.32 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.635 -1.269 . . . . 0.02 110.61 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -118.58 130.41 55.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.454 -1.027 . . . . 0.95999999999999996 109.735 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 53.2 m-85 -120.61 97.25 48.72 Favored Pre-proline 0 N--CA 1.494 1.763 0 N-CA-C 107.994 -1.113 . . . . 0.02 107.994 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -69.73 -3.72 12.55 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.69 0.926 . . . . 0.02 113.656 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.457 ' OE1' ' CZ ' ' A' ' 13' ' ' ARG . 40.6 mt-10 -157.49 154.17 28.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.579 -1.326 . . . . 2.02 108.138 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -59.63 -38.82 82.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.485 -0.759 . . . . 0.02 111.768 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -60.26 -23.92 64.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.105 -0.997 . . . . 0.02 110.283 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -70.15 -18.58 63.22 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.812 0.815 . . . . 3.4199999999999999 108.842 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.564 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -108.13 11.13 27.8 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.378 -1.342 . . . . 0.02 107.378 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' A' ' 73' ' ' MET . 1.2 mpt? 59.04 22.61 10.66 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.66 0.743 . . . . 0.02 110.435 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.48 145.16 45.19 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.409 -1.476 . . . . 0.02 109.409 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.38 -31.6 42.89 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.122 -1.222 . . . . 0.97999999999999998 107.751 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -157.07 -171.88 3.81 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 106.501 -1.666 . . . . 0.02 106.501 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -98.05 28.26 4.08 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.738 -1.226 . . . . 0.02 110.612 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -97.7 122.72 41.12 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.921 -1.112 . . . . 3.2000000000000002 111.225 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.473 HD12 ' SG ' ' A' ' 36' ' ' CYS . 61.1 mt -142.24 119.25 11.31 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.372 -1.344 . . . . 2.6099999999999999 107.372 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.79 -18.22 10.99 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.272 -0.893 . . . . 0.02 112.18 -177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 76.9 p -155.68 155.62 33.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.335 -1.685 . . . . 0.02 110.169 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 20.4 p -145.27 148.03 33.02 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.712 -0.618 . . . . 0.02 109.669 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 66.5 mtm180 -137.4 142.2 41.69 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.474 -0.766 . . . . 0.01 109.17 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.97 133.15 36.88 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.227 -0.92 . . . . 0.42999999999999999 109.413 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 t -90.33 123.91 42.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.593 -0.892 . . . . 1.25 108.593 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -91.75 131.67 36.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.731 -1.231 . . . . 1.77 108.147 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mt -97.12 138.57 34.44 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.194 -1.039 . . . . 1.6299999999999999 108.194 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.1 m -110.43 126.33 54.2 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.652 -0.87 . . . . 1.0800000000000001 108.652 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 t -102.96 -154.82 0.5 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.011 -1.848 . . . . 1.26 106.011 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.48 -49.27 0.89 Allowed Glycine 0 N--CA 1.496 2.694 0 O-C-N 120.472 -1.392 . . . . 0.01 111.847 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.08 -99.24 0.12 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 118.77 -1.681 . . . . 0.01 111.897 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -120.59 120.26 35.28 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.321 -1.105 . . . . 4.4299999999999997 110.595 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.478 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.28 135.83 54.98 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.365 -0.606 . . . . 2.9900000000000002 109.365 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.511 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 2.4 ttmp? -134.5 130.67 37.03 Favored 'General case' 0 N--CA 1.518 2.974 0 CA-C-O 122.258 1.028 . . . . 6.3600000000000003 113.074 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 tt -131.62 142.2 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.5 -0.773 . . . . 1.0900000000000001 110.143 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.426 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 5.5 pt20 -124.53 139.74 53.6 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.611 -1.255 . . . . 2.0499999999999998 107.611 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.16 145.83 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.416 0 O-C-N 120.68 -1.262 . . . . 1.1000000000000001 111.2 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.525 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 76.1 m-85 -120.2 139.91 51.94 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.045 0.926 . . . . 0.72999999999999998 110.758 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.31 -32.11 72.01 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.836 -0.62 . . . . 0.02 111.791 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -114.6 167.73 10.49 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.064 -1.022 . . . . 3.1800000000000002 110.352 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.53 164.35 52.79 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 111.071 -0.812 . . . . 0.01 111.071 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 57.74 38.77 27.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 122.02 -0.694 . . . . 0.01 111.595 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 52.29 54.95 9.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.519 -0.738 . . . . 0.01 111.208 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -128.97 165.46 21.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.041 -1.096 . . . . 3.1499999999999999 108.041 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.06 -162.99 30.21 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.014 -1.634 . . . . 0.01 109.014 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -75.73 141.6 42.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.879 -1.366 . . . . 0.01 109.193 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.525 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 51.1 ttp -116.48 143.09 46.02 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.645 0.736 . . . . 0.01 109.548 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -131.91 136.13 47.16 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.21 -1.033 . . . . 2.48 108.21 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.406 ' OE2' ' N ' ' A' ' 110' ' ' THR . 3.0 tm-20 -116.71 133.76 55.63 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.658 -0.651 . . . . 0.01 109.687 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.406 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 0.1 OUTLIER -149.09 148.31 29.53 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.429 1.109 . . . . 1.6899999999999999 111.088 -179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -115.23 7.62 15.31 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.96 -1.018 . . . . 0.01 110.152 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -122.07 163.59 19.17 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.373 -0.83 . . . . 3.21 111.214 -177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.56 154.85 41.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.333 -0.855 . . . . 0.01 109.309 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.604 ' SG ' ' CE2' ' A' ' 172' ' ' PHE . 20.3 p -127.32 119.79 22.03 Favored Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 109.24 -0.652 . . . . 0.01 109.24 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -76.72 -33.39 3.01 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 120.198 1.107 . . . . 0.01 110.995 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.0 m -143.45 109.05 5.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.443 -0.786 . . . . 0.02 109.304 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.5 mt -64.04 -39.48 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.83 -0.544 . . . . 1.8300000000000001 110.79 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.1 ttt -66.64 -37.27 84.47 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.102 -1.039 . . . . 1.3400000000000001 109.79 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -69.98 -38.61 76.09 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.543 -1.348 . . . . 2.1099999999999999 109.707 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -80.23 -47.06 15.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.356 -0.84 . . . . 2.0800000000000001 112.39 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -110.69 -0.62 17.06 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.376 -0.827 . . . . 0.02 112.678 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.598 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.1 m-70 59.92 33.3 21.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.749 -1.219 . . . . 0.02 109.483 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.2 mt -112.6 135.82 52.87 Favored 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 108.761 -0.829 . . . . 0.02 108.761 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -92.72 -23.15 19.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 5.3200000000000003 110.6 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -148.89 163.32 37.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.048 -1.033 . . . . 0.02 110.082 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 56.0 mt -131.87 129.49 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 107.345 -1.354 . . . . 2.1699999999999999 107.345 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -107.09 -13.15 15.24 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.183 -0.948 . . . . 0.02 113.073 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.21 153.64 31.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.36 -1.462 . . . . 0.01 108.189 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.6 t -160.88 146.14 14.32 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.218 -1.551 . . . . 1.22 109.963 -178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -121.82 109.08 14.23 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.143 0.973 . . . . 1.4099999999999999 108.827 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.9 120.74 59.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.002 -1.851 . . . . 0.01 106.002 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -146.59 69.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 118.326 -1.35 . . . . 1.98 108.437 176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.57 108.05 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.48 -1.674 . . . . 0.01 106.48 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.696 ' H ' ' NZ ' ' A' ' 153' ' ' LYS . . . 71.07 -172.84 43.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.658 -1.377 . . . . 0.01 109.658 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.24 146.05 37.64 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.466 -1.02 . . . . 2.2999999999999998 108.93 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.478 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 68.6 m95 -131.35 145.23 51.76 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.441 -0.787 . . . . 0.01 110.389 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mt -117.69 140.94 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.806 -1.183 . . . . 1.6899999999999999 107.806 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.27 143.63 44.54 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.58 -1.267 . . . . 2.4900000000000002 107.58 177.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 11.2 m-85 -122.69 144.04 49.4 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.168 -0.678 . . . . 0.02 109.168 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -73.53 -29.72 62.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.654 -0.654 . . . . 0.02 112.088 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.88 153.78 48.19 Favored Pre-proline 0 N--CA 1.506 2.353 0 O-C-N 120.584 -1.322 . . . . 1.48 109.205 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.49 166.73 1.68 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.248 1.299 . . . . 0.02 112.686 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.3 t30 59.39 31.54 21.16 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.13 -0.941 . . . . 0.75 111.076 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 57.41 51.38 9.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.515 -0.741 . . . . 0.02 110.962 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -124.44 163.49 21.69 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.493 -0.754 . . . . 0.02 109.77 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.428 ' O ' ' OE1' ' A' ' 148' ' ' GLN . . . 89.58 -165.44 32.31 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.755 -1.338 . . . . 0.02 109.755 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -67.97 141.76 56.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -1.059 . . . . 0.02 108.952 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.448 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -118.5 149.07 41.91 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.109 -0.7 . . . . 0.02 109.109 -178.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -128.37 142.33 51.15 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.576 -0.703 . . . . 0.01 109.121 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.11 120.68 35.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.505 -0.747 . . . . 0.01 109.27 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.659 HD22 ' NE1' ' A' ' 162' ' ' TRP . 19.0 mt -105.61 133.91 49.59 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.01 110.727 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 1.2 m-20 -110.31 176.43 5.05 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.183 -1.043 . . . . 2.27 108.183 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.696 ' NZ ' ' H ' ' A' ' 134' ' ' GLY . 37.7 mttm -56.66 85.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.985 -1.072 . . . . 1.8400000000000001 108.571 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 44.8 mttp -136.47 165.13 26.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.233 -0.917 . . . . 2.2799999999999998 111.778 -178.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -113.27 109.1 18.19 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.951 -1.129 . . . . 0.01 107.951 177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -99.67 114.64 27.86 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.139 -0.975 . . . . 0.01 110.219 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -92.17 -25.86 18.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.17 -0.956 . . . . 0.01 111.151 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -125.47 153.65 72.47 Favored Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 121.169 -0.957 . . . . 2.54 108.526 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.67 -42.09 42.01 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 CA-C-N 119.227 0.76 . . . . 0.69999999999999996 110.628 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.56 -20.38 20.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.731 -1.23 . . . . 0.85999999999999999 108.535 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 37.5 t0 -65.74 -16.25 63.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.986 -1.071 . . . . 0.02 109.531 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.659 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -94.86 9.59 38.58 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.847 -1.168 . . . . 0.02 107.847 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.99 10.62 86.16 Favored Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.308 -1.425 . . . . 0.02 109.716 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.91 142.11 31.83 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.491 -1.005 . . . . 0.02 110.162 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.08 -8.13 58.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.711 -0.618 . . . . 0.58999999999999997 109.847 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 t -143.77 148.6 43.41 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.85 -1.156 . . . . 0.87 108.535 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -74.77 21.57 0.42 Allowed 'Trans proline' 0 N--CA 1.498 1.767 0 CA-C-N 119.842 0.979 . . . . 0.38 112.231 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.02 123.77 29.78 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.538 1.161 . . . . 0.17999999999999999 111.781 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.407 ' CD1' ' CZ3' ' A' ' 162' ' ' TRP . 17.8 mt -146.59 126.63 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.773 -1.566 . . . . 3.9900000000000002 106.773 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -112.36 -19.62 12.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.071 -1.018 . . . . 5.1699999999999999 112.909 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 9.6 p -157.85 159.88 37.12 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 119.238 -2.164 . . . . 0.02 110.154 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.604 ' CE2' ' SG ' ' A' ' 114' ' ' CYS . 6.1 p90 -152.19 154.68 36.29 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.09 -1.006 . . . . 2.02 110.477 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -144.71 151.79 39.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.192 -0.943 . . . . 0.01 110.586 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -87.77 142.57 27.71 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.018 -0.734 . . . . 0.01 109.018 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.6 mt -93.63 128.88 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.091 -1.006 . . . . 3.04 109.14 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.3 m -136.27 146.88 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.194 -0.941 . . . . 1.8899999999999999 109.54 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.359 -0.838 . . . . 4.8899999999999997 109.435 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.507 -0.553 . . . . 5.2800000000000002 109.507 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -52.78 166.36 0.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 5.96 109.481 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.0 p -80.64 141.97 34.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.257 -1.016 . . . . 2.2200000000000002 108.257 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.75 -179.12 47.09 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.248 -1.93 . . . . 0.81000000000000005 112.126 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.78 158.03 44.36 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.365 -1.494 . . . . 0.01 109.365 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -148.23 136.52 21.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.129 -1.218 . . . . 0.02 110.333 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 tt -130.58 140.38 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.111 -0.7 . . . . 0.02 109.111 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -121.79 130.71 53.61 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.238 -0.914 . . . . 0.39000000000000001 110.171 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -110.9 140.3 45.49 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.577 -0.702 . . . . 0.02 109.622 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.547 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.7 m-85 -122.71 138.64 54.55 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.282 -0.886 . . . . 0.02 109.591 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -69.42 -27.28 65.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.01 -1.056 . . . . 0.029999999999999999 111.76 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.12 169.73 8.8 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.896 -1.128 . . . . 0.029999999999999999 110.127 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -75.44 158.43 32.67 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.571 0.701 . . . . 0.029999999999999999 110.196 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 m120 66.19 33.38 7.38 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.907 0.861 . . . . 0.73999999999999999 111.093 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 55.32 42.14 30.54 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.223 0.535 . . . . 0.02 111.136 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -113.28 165.75 12.12 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.274 -1.01 . . . . 0.02 108.274 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.08 -167.9 34.9 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.872 -1.156 . . . . 0.029999999999999999 110.576 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -69.17 142.5 54.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.382 -1.069 . . . . 2.7599999999999998 108.928 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -122.66 151.21 41.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.586 -0.696 . . . . 1.8899999999999999 110.181 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -136.83 132.77 35.11 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.193 -0.669 . . . . 0.02 109.193 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 6.6 p30 -108.38 135.93 48.87 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.369 -0.975 . . . . 1.1200000000000001 108.369 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 13.9 t -127.37 137.5 52.79 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.585 -0.697 . . . . 0.02 109.981 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.75 11.03 11.82 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.673 -0.642 . . . . 0.20000000000000001 110.808 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.526 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 25.0 p -159.71 173.43 16.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.574 -1.329 . . . . 1.23 109.34 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -63.1 145.54 55.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.428 -1.42 . . . . 0.02 110.801 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 2.7 m -135.12 119.21 17.55 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.925 -0.769 . . . . 0.02 108.925 178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.98 -20.83 51.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.35 -0.844 . . . . 0.23999999999999999 112.269 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -153.53 106.64 2.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.748 -1.22 . . . . 1.1399999999999999 110.034 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.64 6.49 39.7 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.4 -0.813 . . . . 6.3700000000000001 110.401 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -60.96 -29.32 69.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.311 -0.868 . . . . 3.1099999999999999 112.063 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.0 m -77.01 -17.23 58.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.389 -1.445 . . . . 0.88 111.126 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -106.57 -21.09 13.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.454 -0.779 . . . . 0.02 110.555 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.3 tp -149.28 127.57 12.15 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.966 -1.083 . . . . 3.3199999999999998 109.62 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.8 t -87.47 -12.58 45.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.461 -0.774 . . . . 0.02 111.267 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -172.23 161.75 5.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.02 108.41 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.8 t -143.78 117.6 9.32 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.974 -1.079 . . . . 0.02 109.201 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.57 ' N ' HD22 ' A' ' 37' ' ' ASN . 1.1 m-80 -109.56 0.0 18.96 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.746 -1.222 . . . . 0.029999999999999999 111.691 -178.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 22.3 m -155.54 153.97 31.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.005 -1.059 . . . . 0.02 108.475 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 39' ' ' ILE . 12.8 mt -145.88 146.56 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.011 -1.055 . . . . 0.02 110.848 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -123.19 124.17 42.43 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.808 -1.182 . . . . 0.02 107.808 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.1 t -105.29 113.72 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.829 -1.545 . . . . 0.02 106.829 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -85.14 -34.66 22.09 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.997 -0.681 . . . . 3.8100000000000001 110.139 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.44 149.2 17.04 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.602 -1.761 . . . . 0.02 110.824 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.78 172.16 48.61 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.332 -1.107 . . . . 0.01 110.332 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 m -117.79 134.01 55.36 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.39 -1.337 . . . . 1.48 107.39 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -126.29 154.49 43.35 Favored 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.555 1.169 . . . . 0.02 112.495 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.0 133.3 53.17 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 105.57 -2.011 . . . . 0.23999999999999999 105.57 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.1 141.31 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.544 -0.723 . . . . 0.65000000000000002 109.154 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -120.16 143.08 48.41 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.128 0.966 . . . . 0.02 109.651 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.02 -34.09 77.6 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.641 -0.708 . . . . 0.02 111.755 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -124.49 157.78 63.98 Favored Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 120.939 -1.101 . . . . 0.02 109.615 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.26 166.56 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.733 1.622 . . . . 0.02 112.704 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 63.52 36.61 11.04 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.344 -0.843 . . . . 0.02 111.118 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.451 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.8 m-85 44.98 51.42 8.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.744 0.783 . . . . 3.3900000000000001 110.691 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 m -125.4 163.22 23.08 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.206 0.527 . . . . 2.3300000000000001 109.783 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.95 -162.07 31.0 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.599 -1.4 . . . . 0.02 109.599 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 8.3 t-80 -67.4 139.86 57.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.947 -1.325 . . . . 0.02 110.138 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 20.4 ptm -119.22 137.86 53.36 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.472 0.653 . . . . 5.0099999999999998 109.978 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 79.8 m-85 -133.92 139.85 46.42 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.465 -0.772 . . . . 0.02 109.744 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.34 132.29 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 N-CA-C 108.523 -0.917 . . . . 1.72 108.523 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.446 HD22 ' CE1' ' A' ' 66' ' ' TYR . 12.0 mt -122.48 112.6 31.06 Favored Pre-proline 0 N--CA 1.506 2.357 0 O-C-N 121.414 -0.804 . . . . 0.02 110.644 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.45 170.73 18.84 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 CA-C-N 119.821 0.972 . . . . 1.47 110.415 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -53.12 140.33 26.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.951 -1.093 . . . . 4.25 110.534 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.49 -178.18 32.25 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.38 -1.39 . . . . 0.02 110.8 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -119.72 131.23 55.33 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.362 -1.081 . . . . 0.95999999999999996 109.896 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.446 ' CE1' HD22 ' A' ' 61' ' ' LEU . 95.4 m-85 -121.5 97.91 46.6 Favored Pre-proline 0 N--CA 1.495 1.818 0 N-CA-C 107.726 -1.212 . . . . 0.02 107.726 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 38' ' ' SER . 7.9 Cg_endo -70.64 -3.44 12.61 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 120.743 0.962 . . . . 0.02 113.761 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -157.38 154.87 29.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.54 -1.35 . . . . 2.02 108.136 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -59.69 -39.4 84.42 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.531 -0.731 . . . . 0.02 111.766 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -59.89 -24.15 64.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.113 -0.992 . . . . 0.02 110.474 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -70.43 -18.38 63.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.4 -0.812 . . . . 3.4199999999999999 108.846 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 2.1 t90 -107.78 10.2 28.82 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.535 -1.283 . . . . 0.02 107.535 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 10.0 mmt 60.63 22.66 12.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 0.02 110.322 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.68 144.88 47.91 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.542 -1.423 . . . . 0.02 109.542 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 mt -79.99 -30.54 39.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -1.175 . . . . 0.97999999999999998 107.946 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -157.05 -171.49 3.66 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.43 -1.692 . . . . 0.02 106.43 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -99.03 28.78 4.18 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.645 -1.284 . . . . 0.02 110.815 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -96.65 122.82 40.0 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.826 -1.171 . . . . 3.2000000000000002 111.146 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.51 HD21 ' CH2' ' A' ' 72' ' ' TRP . 80.8 mt -141.39 118.8 11.49 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.551 -1.277 . . . . 2.6099999999999999 107.551 178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.55 -18.96 9.09 Favored Glycine 0 N--CA 1.497 2.766 0 O-C-N 121.193 -0.942 . . . . 0.02 112.474 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.451 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 11.2 t -156.09 156.41 34.28 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 119.763 1.782 . . . . 0.02 111.028 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.6 p -145.85 147.83 32.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.421 -0.799 . . . . 0.02 110.501 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.422 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 49.2 mtp180 -137.14 142.04 42.25 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.511 -0.743 . . . . 0.01 109.111 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.29 131.26 36.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.129 -0.982 . . . . 0.42999999999999999 109.505 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.0 t -90.4 124.61 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.561 -0.903 . . . . 1.25 108.561 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -92.91 131.58 37.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.071 . . . . 1.77 108.571 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.32 139.57 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.13 -1.063 . . . . 1.6299999999999999 108.13 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.5 p -110.8 126.09 54.26 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.674 -0.861 . . . . 1.0800000000000001 108.674 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.0 t -102.66 -154.8 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.029 -1.841 . . . . 1.26 106.029 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.29 -49.36 0.89 Allowed Glycine 0 N--CA 1.497 2.754 0 O-C-N 120.473 -1.392 . . . . 0.01 111.952 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.66 -99.33 0.13 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.64 -1.743 . . . . 0.01 112.085 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -121.05 120.67 36.03 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.262 -1.14 . . . . 4.4299999999999997 110.702 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.478 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.34 135.75 54.81 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.47 -0.567 . . . . 2.9900000000000002 109.47 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.484 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 2.7 ttmp? -134.54 130.59 36.81 Favored 'General case' 0 N--CA 1.519 2.981 0 CA-C-O 122.187 0.994 . . . . 6.3600000000000003 112.936 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 tt -132.44 141.61 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 115.62 -0.718 . . . . 1.0900000000000001 110.627 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.508 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.1 pm0 -124.56 140.04 53.31 Favored 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 107.568 -1.271 . . . . 2.0499999999999998 107.568 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.2 m -123.45 146.96 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 O-C-N 120.664 -1.272 . . . . 1.1000000000000001 111.236 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.529 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 24.0 m-85 -120.17 139.72 52.2 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.035 0.922 . . . . 0.72999999999999998 110.804 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.6 -32.81 71.75 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.77 -0.65 . . . . 0.02 112.304 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.487 ' O ' ' OG ' ' A' ' 128' ' ' SER . 41.0 mmtm -113.89 165.14 12.88 Favored 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.866 -1.146 . . . . 3.1800000000000002 110.059 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.93 163.06 45.11 Favored Glycine 0 N--CA 1.492 2.374 0 CA-C-O 122.034 0.797 . . . . 0.01 111.306 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 57.22 39.58 28.62 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.567 0.698 . . . . 0.01 111.108 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 52.5 55.69 8.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.57 -0.706 . . . . 0.01 111.036 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -128.75 164.89 22.01 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.943 -1.132 . . . . 3.1499999999999999 107.943 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.23 -162.67 28.53 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.269 -1.532 . . . . 0.01 109.269 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -75.79 142.17 42.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.93 -1.336 . . . . 0.01 109.211 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.529 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.7 ttp -116.69 143.48 45.58 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.593 0.711 . . . . 0.01 109.543 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -132.25 136.33 46.9 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.252 -1.018 . . . . 2.48 108.252 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -116.49 134.32 54.99 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.619 -0.675 . . . . 0.01 109.791 -178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 t -149.48 148.35 29.3 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.492 1.139 . . . . 1.6899999999999999 111.578 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.7 p -115.34 7.46 15.13 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.998 -1.001 . . . . 0.01 109.961 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -122.31 163.42 19.73 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.448 -0.783 . . . . 3.21 111.043 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.29 154.86 41.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.439 -0.788 . . . . 0.01 109.624 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.5 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 59.4 m -128.61 115.94 19.55 Favored Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 108.913 -0.773 . . . . 0.01 108.913 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.09 -30.89 6.57 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 CA-C-N 120.316 1.149 . . . . 0.01 111.56 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.7 p -142.61 108.25 5.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.289 -0.882 . . . . 0.02 109.115 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.5 -39.31 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.773 -0.58 . . . . 1.8300000000000001 111.062 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 15.0 tpt -66.89 -37.76 85.0 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.035 -1.066 . . . . 1.3400000000000001 109.856 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.69 -38.66 77.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.504 -1.372 . . . . 2.1099999999999999 109.887 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -80.41 -47.62 14.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.169 -0.957 . . . . 2.0800000000000001 112.472 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -111.03 -0.82 16.53 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.283 -0.886 . . . . 0.02 112.728 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 59.79 33.73 21.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.822 -1.174 . . . . 0.02 109.487 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' C ' ' SD ' ' A' ' 118' ' ' MET . 6.3 mt -112.69 135.54 53.31 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 108.737 -0.838 . . . . 0.02 108.737 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -92.37 -23.18 19.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.302 -0.874 . . . . 5.3200000000000003 110.623 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -148.96 163.44 37.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.077 -1.015 . . . . 0.02 110.121 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.6 mt -131.97 129.45 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 107.55 -1.278 . . . . 2.1699999999999999 107.55 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -106.65 -13.65 15.23 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.206 -0.934 . . . . 0.02 113.185 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -157.04 155.68 31.59 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.35 -1.468 . . . . 0.01 108.237 177.606 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.4 t -164.28 145.86 8.58 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.482 -1.386 . . . . 1.22 109.567 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.43 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 27.6 mtmt -121.35 112.14 18.21 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.443 1.116 . . . . 1.4099999999999999 108.905 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.2 t -107.41 122.52 61.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 105.372 -2.085 . . . . 0.01 105.372 178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.5 t -145.9 67.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 118.153 -1.419 . . . . 1.98 108.133 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.01 108.29 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.563 -1.643 . . . . 0.01 106.563 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.86 -174.53 42.95 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.186 -1.165 . . . . 0.01 110.186 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.72 144.12 40.16 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.472 -1.016 . . . . 2.2999999999999998 109.036 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.478 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 65.6 m95 -129.82 145.59 51.57 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.366 -0.834 . . . . 0.01 110.294 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.7 mt -117.92 141.86 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.667 -1.234 . . . . 1.6899999999999999 107.667 178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.58 143.45 44.97 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 107.521 -1.289 . . . . 2.4900000000000002 107.521 177.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.4 m-85 -122.59 144.24 49.24 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.005 -0.739 . . . . 0.02 109.005 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.49 -29.85 62.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.722 -0.611 . . . . 0.02 111.905 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.33 153.63 47.5 Favored Pre-proline 0 N--CA 1.505 2.279 0 O-C-N 120.604 -1.31 . . . . 1.48 109.187 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.9 167.03 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.225 1.284 . . . . 0.02 112.481 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 59.64 31.12 20.72 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.119 -0.946 . . . . 0.75 111.052 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.2 m-85 58.16 51.55 8.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.547 -0.72 . . . . 0.02 111.026 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -125.1 163.73 21.76 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.435 -0.791 . . . . 0.02 109.843 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.65 -165.6 32.34 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.951 -1.26 . . . . 0.02 109.951 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -67.7 141.32 56.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.425 -1.044 . . . . 0.02 108.883 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -118.65 147.95 43.24 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.424 -0.584 . . . . 0.02 109.424 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 2.5 t80 -129.9 143.87 51.03 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.836 -0.802 . . . . 0.01 108.836 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.612 HD23 ' N ' ' A' ' 151' ' ' LEU . 1.7 tt -98.3 122.53 41.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.414 -0.804 . . . . 0.01 109.528 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.612 ' N ' HD23 ' A' ' 150' ' ' LEU . 17.0 mt -104.29 135.95 44.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.499 -0.75 . . . . 0.01 109.982 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 154' ' ' LYS . 30.0 t70 -108.61 174.47 5.86 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.221 -1.029 . . . . 2.27 108.221 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -59.38 83.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.883 -1.135 . . . . 1.8400000000000001 108.439 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 152' ' ' ASP . 66.6 mttm -136.53 172.09 13.53 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.257 -0.902 . . . . 2.2799999999999998 111.696 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -113.62 110.12 19.7 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.423 -0.955 . . . . 0.01 108.423 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.68 114.61 28.48 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.019 -1.051 . . . . 0.01 109.876 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -93.69 -25.07 17.62 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.072 -1.018 . . . . 0.01 111.668 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -126.2 153.5 74.38 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.855 -1.153 . . . . 2.54 108.987 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.15 -42.7 33.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 119.247 0.767 . . . . 0.69999999999999996 110.713 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -60.67 -20.58 21.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.732 -1.23 . . . . 0.85999999999999999 108.557 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -64.95 -15.81 62.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.978 -1.076 . . . . 0.02 109.383 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.612 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -95.46 9.97 38.13 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.971 -1.122 . . . . 0.02 107.971 178.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.73 11.41 84.55 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.173 -1.489 . . . . 0.02 109.648 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.98 142.43 31.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.453 -1.028 . . . . 0.02 110.266 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.62 -8.21 58.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.758 -0.589 . . . . 0.58999999999999997 110.022 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.3 p -144.9 150.93 47.88 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.726 -1.234 . . . . 0.87 108.819 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.37 21.58 0.54 Allowed 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 120.833 1.022 . . . . 0.38 112.397 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.85 124.31 30.19 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.612 1.196 . . . . 0.17999999999999999 111.631 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 15.1 mt -147.51 127.23 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.796 -1.557 . . . . 3.9900000000000002 106.796 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -112.38 -19.08 12.31 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.187 -0.945 . . . . 5.1699999999999999 112.865 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.6 p -158.37 161.28 37.55 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.147 -2.221 . . . . 0.02 110.271 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.5 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 9.5 p90 -152.55 153.69 33.92 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.168 -0.958 . . . . 2.02 110.496 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.487 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 21.5 mtp180 -143.58 151.0 39.66 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.267 -0.896 . . . . 0.01 110.412 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -87.64 142.33 27.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.588 -0.695 . . . . 0.01 109.188 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.1 mt -92.98 128.24 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.133 -0.979 . . . . 3.04 109.019 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.07 146.58 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.257 -0.902 . . . . 1.8899999999999999 109.592 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 4.8899999999999997 109.404 179.948 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.531 -0.544 . . . . 5.2800000000000002 109.531 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -70.58 -133.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.897 . . . . 5.96 109.294 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.411 ' H ' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -81.02 141.01 34.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.004 -1.06 . . . . 2.2200000000000002 108.382 178.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.83 -179.35 47.02 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 118.255 -1.926 . . . . 0.81000000000000005 112.194 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.04 158.31 44.18 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.273 -1.531 . . . . 0.01 109.273 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -149.23 136.91 20.35 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.095 -1.238 . . . . 0.02 110.168 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -130.23 141.14 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.201 -0.666 . . . . 0.02 109.201 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.8 t -121.3 129.92 53.37 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.523 -0.736 . . . . 0.39000000000000001 110.0 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.0 m-85 -110.36 140.23 44.77 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.159 -0.682 . . . . 0.02 109.159 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 6.9 m-85 -122.67 138.71 54.52 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.105 -0.997 . . . . 0.02 109.512 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.431 ' OE2' ' NH2' ' A' ' 18' ' ' ARG . 78.5 mt-10 -68.93 -27.27 65.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.075 -1.016 . . . . 0.029999999999999999 111.693 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.31 170.28 8.41 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.902 -1.124 . . . . 0.029999999999999999 110.034 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -74.93 161.79 29.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.698 0.761 . . . . 0.029999999999999999 110.149 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.607 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 23.4 t30 62.42 35.06 15.1 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.898 0.856 . . . . 0.73999999999999999 110.594 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.607 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 18.0 p90 49.69 43.2 24.32 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.396 -0.82 . . . . 0.02 111.084 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -109.73 165.82 11.39 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.827 -1.175 . . . . 0.02 107.827 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.29 -168.16 34.84 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.83 -1.176 . . . . 0.029999999999999999 110.663 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.431 ' NH2' ' OE2' ' A' ' 11' ' ' GLU . 25.9 ttp180 -69.16 143.5 54.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -1.102 . . . . 2.7599999999999998 108.962 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.422 ' NH1' ' OD2' ' A' ' 21' ' ' ASP . 5.3 tmm_? -123.54 151.22 43.09 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.541 -0.725 . . . . 1.8899999999999999 110.353 -178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -136.6 133.03 35.89 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.252 -0.647 . . . . 0.02 109.252 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.422 ' OD2' ' NH1' ' A' ' 19' ' ' ARG . 50.8 m-20 -109.64 136.32 49.19 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.911 -0.774 . . . . 1.1200000000000001 108.911 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.1 t -127.83 137.74 52.47 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.659 -0.65 . . . . 0.02 109.704 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -118.61 11.41 12.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.726 -0.609 . . . . 0.20000000000000001 110.157 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.5 p -159.68 173.7 15.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.848 -1.158 . . . . 1.23 109.066 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.87 145.63 54.66 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.842 -1.162 . . . . 0.02 110.629 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.591 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 11.6 p -135.04 119.69 18.21 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 109.004 -0.739 . . . . 0.02 109.004 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.39 -20.68 50.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.261 -0.9 . . . . 0.23999999999999999 112.275 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -152.89 107.12 3.12 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.812 -1.18 . . . . 1.1399999999999999 110.049 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.591 ' CD1' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -102.12 5.63 40.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.315 -0.865 . . . . 6.3700000000000001 110.309 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -61.22 -30.13 70.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 3.1099999999999999 112.133 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.8 p -76.69 -17.72 58.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.466 -1.396 . . . . 0.88 111.062 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -106.79 -21.13 13.13 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.392 -0.817 . . . . 0.02 110.655 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 tp -148.65 126.61 11.97 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.901 -1.124 . . . . 3.3199999999999998 109.556 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.2 t -87.01 -12.83 46.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.519 -0.738 . . . . 0.02 111.053 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -172.72 162.16 4.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.858 -1.151 . . . . 0.02 108.403 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.452 ' SG ' HD12 ' A' ' 79' ' ' LEU . 2.2 p -143.83 116.52 8.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.068 -1.02 . . . . 0.02 108.824 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.619 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.9 OUTLIER -108.38 -0.42 20.64 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.755 -1.216 . . . . 0.029999999999999999 111.203 -178.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 t -155.36 153.46 30.5 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.856 -1.165 . . . . 0.02 107.856 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.8 mt -146.83 148.05 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.102 -0.999 . . . . 0.02 110.49 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -123.92 124.72 43.23 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.02 -1.104 . . . . 0.02 108.02 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.3 t -105.3 114.06 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.691 -1.596 . . . . 0.02 106.691 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -85.41 -34.92 21.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.447 -0.783 . . . . 3.8100000000000001 110.178 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.49 149.03 16.65 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 118.523 -1.799 . . . . 0.02 110.864 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.7 172.32 48.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.197 -1.161 . . . . 0.01 110.197 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.0 m -117.67 134.09 55.26 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.494 -1.299 . . . . 1.48 107.494 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -126.68 154.52 43.97 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.541 1.162 . . . . 0.02 112.192 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.37 134.06 52.29 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 105.502 -2.036 . . . . 0.23999999999999999 105.502 176.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.9 m -116.07 141.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.56 -0.712 . . . . 0.65000000000000002 109.292 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -120.3 142.99 48.6 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.062 0.934 . . . . 0.02 109.624 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -65.21 -34.36 78.2 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.491 -0.777 . . . . 0.02 111.904 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -124.44 158.02 63.02 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.091 -1.006 . . . . 0.02 109.495 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.04 166.55 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.642 1.561 . . . . 0.02 112.806 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 63.11 37.17 11.67 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.373 -0.83 . . . . 0.02 111.135 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 4.3 m-85 45.1 51.69 8.84 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.62 0.724 . . . . 3.3900000000000001 110.834 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 t -125.89 163.62 22.55 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.12 0.486 . . . . 2.3300000000000001 109.95 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.52 -161.89 31.44 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.926 -1.27 . . . . 0.02 109.926 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -64.34 138.51 58.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.996 -1.297 . . . . 0.02 110.224 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 58' ' ' MET . 12.3 tmm? -119.12 137.17 53.77 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 109.519 -0.549 . . . . 5.0099999999999998 109.519 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.473 ' HB3' ' HE1' ' A' ' 72' ' ' TRP . 86.4 m-85 -135.01 139.84 45.18 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.526 -0.733 . . . . 0.02 109.943 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.8 mm -94.37 130.48 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.903 -0.777 . . . . 1.72 108.903 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.558 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.73 110.86 34.89 Favored Pre-proline 0 N--CA 1.505 2.285 0 O-C-N 121.386 -0.821 . . . . 0.02 110.752 -178.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.9 169.23 20.93 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 CA-C-N 119.793 0.962 . . . . 1.47 110.415 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -53.78 140.64 29.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.959 -1.088 . . . . 4.25 110.767 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.04 -177.46 32.27 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 119.507 -1.33 . . . . 0.02 110.722 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -119.47 131.09 55.54 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.39 -1.065 . . . . 0.95999999999999996 109.659 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.558 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 78.0 m-85 -120.99 97.85 47.86 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 107.914 -1.143 . . . . 0.02 107.914 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -69.86 -4.52 14.26 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 120.679 0.919 . . . . 0.02 113.686 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -157.47 154.06 28.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.614 -1.304 . . . . 2.02 107.992 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -59.81 -38.03 80.83 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.379 -0.826 . . . . 0.02 111.871 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -59.79 -24.46 64.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.02 110.446 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -69.75 -19.0 63.55 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.756 0.789 . . . . 3.4199999999999999 108.894 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.5 t90 -108.19 10.38 27.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.601 -1.259 . . . . 0.02 107.601 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 42.2 mmm 60.52 22.55 12.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.597 -0.689 . . . . 0.02 110.381 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.55 144.94 47.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.534 -1.427 . . . . 0.02 109.534 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.5 mt -79.51 -30.73 42.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -1.215 . . . . 0.97999999999999998 108.013 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -157.42 -171.4 3.58 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.463 -1.68 . . . . 0.02 106.463 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 14.3 p30 -98.6 28.66 4.08 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.692 -1.255 . . . . 0.02 110.64 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -97.83 122.88 41.46 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.875 -1.141 . . . . 3.2000000000000002 111.435 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.452 HD12 ' SG ' ' A' ' 36' ' ' CYS . 57.4 mt -142.66 120.06 11.64 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.298 -1.371 . . . . 2.6099999999999999 107.298 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.46 -17.99 10.75 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 121.251 -0.905 . . . . 0.02 112.295 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 22.6 t -155.79 156.15 34.27 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 119.591 1.696 . . . . 0.02 110.845 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 49.5 t -145.65 147.92 32.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.02 110.161 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 17.6 mtp180 -136.88 141.73 42.76 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.461 -0.774 . . . . 0.01 109.023 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.38 131.5 36.99 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.203 -0.936 . . . . 0.42999999999999999 109.269 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.54 124.34 43.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.816 -0.809 . . . . 1.25 108.816 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -92.47 131.91 37.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.826 -1.171 . . . . 1.77 108.737 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mt -96.36 138.5 33.86 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.127 -1.064 . . . . 1.6299999999999999 108.127 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.4 p -110.67 126.65 54.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.357 -0.839 . . . . 1.0800000000000001 108.757 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 t -103.15 -154.54 0.5 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 106.114 -1.81 . . . . 1.26 106.114 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.63 -50.31 0.86 Allowed Glycine 0 N--CA 1.498 2.799 0 O-C-N 120.456 -1.403 . . . . 0.01 112.066 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.47 -99.77 0.13 Allowed Glycine 0 N--CA 1.487 2.068 0 C-N-CA 118.683 -1.722 . . . . 0.01 112.212 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -120.51 119.54 33.27 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.261 -1.141 . . . . 4.4299999999999997 110.635 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.507 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.8 136.39 55.38 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.302 -0.559 . . . . 2.9900000000000002 109.588 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -134.85 130.93 36.76 Favored 'General case' 0 N--CA 1.518 2.942 0 CA-C-O 122.182 0.992 . . . . 6.3600000000000003 112.65 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.0 tt -132.5 141.96 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.527 -0.76 . . . . 1.0900000000000001 110.409 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.483 ' OE1' ' N ' ' A' ' 96' ' ' GLN . 3.5 pm0 -124.68 140.34 53.03 Favored 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 107.573 -1.269 . . . . 2.0499999999999998 107.573 176.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.87 146.2 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.418 0 O-C-N 120.618 -1.301 . . . . 1.1000000000000001 110.882 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.537 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 25.4 m-85 -119.93 139.96 51.64 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 122.347 1.07 . . . . 0.72999999999999998 110.799 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -67.97 -32.26 72.55 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.639 -0.709 . . . . 0.02 111.694 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -114.5 167.31 10.84 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.109 -0.994 . . . . 3.1800000000000002 110.321 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.45 164.39 52.61 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 111.147 -0.781 . . . . 0.01 111.147 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 57.82 38.95 27.36 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.554 0.692 . . . . 0.01 111.641 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 52.27 54.58 10.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.41 -0.806 . . . . 0.01 111.241 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 105' ' ' GLY . 24.7 t30 -129.6 165.21 22.21 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.992 -1.114 . . . . 3.1499999999999999 107.992 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 104' ' ' ASN . . . 90.94 -162.61 28.85 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.975 -1.65 . . . . 0.01 108.975 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -76.22 141.61 41.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.841 -1.388 . . . . 0.01 109.078 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.537 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 34.4 ttp -116.66 143.54 45.51 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.553 0.692 . . . . 0.01 109.61 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -132.28 136.23 46.79 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -116.02 134.29 55.12 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.748 -0.595 . . . . 0.01 109.754 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -149.34 148.28 29.33 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.626 1.203 . . . . 1.6899999999999999 111.501 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -115.44 7.38 14.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.872 -1.058 . . . . 0.01 109.938 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -122.38 163.35 19.94 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.391 -0.818 . . . . 3.21 111.307 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -69.69 154.33 42.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.898 . . . . 0.01 109.665 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.425 ' O ' ' OG ' ' A' ' 171' ' ' SER . 40.8 t -126.74 115.56 22.55 Favored Pre-proline 0 N--CA 1.501 2.104 0 N-CA-C 109.192 -0.67 . . . . 0.01 109.192 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.2 -32.63 5.01 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 CA-C-N 120.358 1.164 . . . . 0.01 111.418 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 p -142.35 108.42 5.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.294 -0.879 . . . . 0.02 109.125 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.44 -39.73 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.825 -0.547 . . . . 1.8300000000000001 111.099 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.7 ttt -66.95 -37.5 84.4 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.107 -1.037 . . . . 1.3400000000000001 109.853 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.84 -38.57 76.54 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.559 -1.338 . . . . 2.1099999999999999 109.792 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -80.2 -47.55 14.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 2.0800000000000001 112.472 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -111.36 -0.88 16.19 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.334 -0.854 . . . . 0.02 112.727 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.4 m80 60.28 33.77 20.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.808 -1.182 . . . . 0.02 109.48 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.7 mt -112.53 135.16 53.57 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 108.62 -0.882 . . . . 0.02 108.62 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -92.29 -23.23 19.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.354 -0.841 . . . . 5.3200000000000003 110.565 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -148.97 163.57 37.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.166 -0.959 . . . . 0.02 110.008 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.2 mt -131.61 129.11 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 107.417 -1.327 . . . . 2.1699999999999999 107.417 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -107.16 -13.38 15.17 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.192 -0.943 . . . . 0.02 113.246 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.29 153.35 30.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.306 -1.496 . . . . 0.01 108.287 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 9.4 t -162.34 145.06 11.28 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.326 -1.484 . . . . 1.22 109.737 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.434 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 27.0 ttmt -122.29 111.53 17.03 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.3 1.048 . . . . 1.4099999999999999 108.892 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.9 t -107.51 122.62 62.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.661 -1.977 . . . . 0.01 105.661 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 t -146.58 67.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 118.125 -1.43 . . . . 1.98 108.222 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.69 109.04 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.597 -1.631 . . . . 0.01 106.597 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.7 -174.28 39.64 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.711 -1.356 . . . . 0.01 109.711 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.506 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.3 m -112.4 144.47 41.78 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.372 -1.076 . . . . 2.2999999999999998 109.349 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.507 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 69.4 m95 -129.89 146.2 51.61 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.43 -0.794 . . . . 0.01 110.392 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.6 mt -118.06 142.12 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 107.668 -1.234 . . . . 1.6899999999999999 107.668 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.517 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -114.67 143.92 44.27 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 107.736 -1.209 . . . . 2.4900000000000002 107.736 177.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 10.8 m-85 -122.53 143.52 49.67 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.966 -0.753 . . . . 0.02 108.966 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -73.02 -29.52 63.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.575 -0.703 . . . . 0.02 112.005 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -115.58 153.58 47.8 Favored Pre-proline 0 N--CA 1.505 2.323 0 O-C-N 120.614 -1.304 . . . . 1.48 109.198 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.58 167.05 1.57 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.359 1.372 . . . . 0.02 112.606 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 59.56 31.21 20.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.063 -0.971 . . . . 0.75 110.993 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.61 51.32 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.449 -0.782 . . . . 0.02 111.045 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -124.77 163.78 21.39 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.466 -0.771 . . . . 0.02 109.838 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.77 -165.65 32.22 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.873 -1.291 . . . . 0.02 109.873 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -67.53 141.38 56.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.564 -0.962 . . . . 0.02 109.042 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -117.9 148.4 42.18 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.28 -0.637 . . . . 0.02 109.28 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.436 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.6 t80 -129.64 142.92 50.64 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.041 -0.726 . . . . 0.01 109.041 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.636 HD23 ' C ' ' A' ' 150' ' ' LEU . 6.0 tt -97.41 121.84 39.78 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.283 -0.886 . . . . 0.01 109.485 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.656 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.5 mt -104.98 133.33 49.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.472 -0.767 . . . . 0.01 110.321 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 154' ' ' LYS . 5.3 p-10 -107.69 173.19 6.43 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.253 -1.017 . . . . 2.27 108.253 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -57.97 84.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.972 -1.08 . . . . 1.8400000000000001 108.621 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 152' ' ' ASP . 11.4 tptp -136.34 168.31 19.67 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.327 -0.858 . . . . 2.2799999999999998 111.068 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 5.3 mp0 -111.09 109.78 20.02 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.325 -0.991 . . . . 0.01 108.325 178.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.37 115.69 30.58 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.087 -1.008 . . . . 0.01 109.904 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -94.05 -25.49 17.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.99 -1.069 . . . . 0.01 111.375 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -125.85 153.92 73.48 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.958 -1.089 . . . . 2.54 109.008 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.03 -42.66 35.02 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 CA-C-N 119.144 0.73 . . . . 0.69999999999999996 110.64 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 85.7 t -60.73 -20.42 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.638 -1.289 . . . . 0.85999999999999999 108.433 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -65.41 -15.75 62.92 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.961 -1.087 . . . . 0.02 109.425 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.656 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -95.21 9.72 38.69 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.943 -1.132 . . . . 0.02 107.943 178.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.49 11.04 85.49 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.204 -1.474 . . . . 0.02 109.607 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.94 142.26 31.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.382 -1.07 . . . . 0.02 110.204 -178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.41 -8.49 58.96 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.728 -0.608 . . . . 0.58999999999999997 109.886 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 16.5 p -144.46 150.78 48.92 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 120.849 -1.157 . . . . 0.87 108.731 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -76.16 21.55 0.52 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 120.73 0.953 . . . . 0.38 112.376 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.78 123.98 29.84 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.5 1.143 . . . . 0.17999999999999999 111.705 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 16.0 mt -147.07 126.92 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 106.92 -1.511 . . . . 3.9900000000000002 106.92 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -113.46 -19.22 11.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.142 -0.974 . . . . 5.1699999999999999 112.853 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 32.6 t -157.15 159.88 38.22 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 119.142 -2.224 . . . . 0.02 110.376 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -152.92 154.08 34.31 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.044 -1.035 . . . . 2.02 110.7 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -144.62 151.69 39.38 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.304 -0.872 . . . . 0.01 110.58 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -87.69 142.94 27.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.564 -0.71 . . . . 0.01 109.254 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 12.7 mt -93.2 128.21 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.998 -1.064 . . . . 3.04 109.099 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -136.07 146.46 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.218 -0.927 . . . . 1.8899999999999999 109.631 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 4.8899999999999997 109.446 179.903 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 3' ' ' THR . 77.2 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.322 0.582 . . . . 5.2800000000000002 109.464 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.416 ' N ' ' OG ' ' A' ' 1' ' ' SER . 88.4 mttt -60.11 -1.69 0.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 5.96 109.533 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 1' ' ' SER . 4.8 p -90.67 -139.88 0.15 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.244 -1.391 . . . . 2.2200000000000002 107.244 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.44 -174.91 45.66 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 117.321 -2.371 . . . . 0.81000000000000005 112.761 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.78 160.71 45.33 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.267 -1.533 . . . . 0.01 109.267 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -147.49 135.98 21.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.133 -1.216 . . . . 0.02 110.039 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.9 tt -130.58 140.09 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.218 -0.66 . . . . 0.02 109.218 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t -121.65 130.28 53.37 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.291 -0.88 . . . . 0.39000000000000001 110.077 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -110.24 139.62 45.22 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.652 -0.655 . . . . 0.02 109.397 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.3 m-85 -121.42 138.03 54.45 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.209 -0.932 . . . . 0.02 109.698 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.516 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 88.5 mt-10 -69.47 -27.52 65.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.842 -1.162 . . . . 0.029999999999999999 111.594 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -114.16 169.79 8.76 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.752 -1.217 . . . . 0.029999999999999999 110.179 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.516 ' NH2' ' OE1' ' A' ' 68' ' ' GLU . 49.9 mtp180 -75.67 158.65 32.09 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.629 0.728 . . . . 0.029999999999999999 110.121 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 8.2 t-20 65.75 33.71 8.03 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.016 0.912 . . . . 0.73999999999999999 111.072 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.41 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 55.52 41.74 30.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.974 -0.557 . . . . 0.02 111.306 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -113.69 165.57 12.4 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.265 -1.013 . . . . 0.02 108.265 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.8 -167.43 34.92 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.887 -1.149 . . . . 0.029999999999999999 110.711 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -68.24 141.51 55.9 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.554 -0.968 . . . . 2.7599999999999998 109.046 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -122.52 150.15 42.95 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.572 -0.705 . . . . 1.8899999999999999 109.87 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -137.21 133.16 34.83 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.205 -0.665 . . . . 0.02 109.205 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -108.74 136.05 48.96 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.748 -0.834 . . . . 1.1200000000000001 108.748 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 17.1 t -127.64 137.31 52.49 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.572 -0.705 . . . . 0.02 110.02 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 p30 -119.89 11.57 11.85 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.702 -0.624 . . . . 0.20000000000000001 110.704 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.527 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 32.4 t -159.64 173.22 16.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.709 -1.245 . . . . 1.23 109.262 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -62.8 145.25 55.38 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.489 -1.382 . . . . 0.02 110.611 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 m -135.23 119.48 17.76 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.51 -0.744 . . . . 0.02 109.035 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.66 -20.52 50.07 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.581 -0.699 . . . . 0.23999999999999999 112.325 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 8.9 p-10 -153.35 106.39 2.95 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.541 -1.349 . . . . 1.1399999999999999 110.103 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.8 6.59 36.76 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.242 -0.911 . . . . 6.3700000000000001 110.461 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -60.58 -28.77 68.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.336 -0.853 . . . . 3.1099999999999999 111.891 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.9 p -76.69 -16.77 59.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.465 -1.397 . . . . 0.88 111.021 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -105.89 -21.62 13.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.329 -0.857 . . . . 0.02 110.624 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.9 mt -148.66 127.67 12.76 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.093 -1.005 . . . . 3.3199999999999998 109.309 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -85.9 -11.01 54.31 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.728 -0.607 . . . . 0.02 110.254 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -171.85 161.85 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.144 -1.058 . . . . 0.02 108.144 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.3 t -143.24 116.41 8.95 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.0 -1.063 . . . . 0.02 108.566 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.706 ' N ' HD22 ' A' ' 37' ' ' ASN . 0.2 OUTLIER -109.77 -0.82 18.28 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 120.789 -1.194 . . . . 0.029999999999999999 112.049 -177.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 t -154.93 153.69 31.47 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.014 -1.053 . . . . 0.02 108.3 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 39' ' ' ILE . 11.9 mt -146.17 147.81 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.104 -0.998 . . . . 0.02 110.716 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -124.86 124.86 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.676 -1.231 . . . . 0.02 107.676 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.1 t -105.69 114.13 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.928 -1.508 . . . . 0.02 106.928 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -85.33 -34.49 21.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.548 -0.72 . . . . 3.8100000000000001 110.216 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.33 148.97 16.65 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 118.592 -1.766 . . . . 0.02 110.807 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.67 172.31 48.78 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.287 -1.125 . . . . 0.01 110.287 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.9 m -118.12 134.5 54.94 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 107.505 -1.295 . . . . 1.48 107.505 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -126.73 154.16 44.54 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.516 1.15 . . . . 0.02 112.33 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.57 133.62 52.45 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.29 -2.115 . . . . 0.23999999999999999 105.29 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -117.32 142.49 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 0.65000000000000002 109.173 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.513 ' CE2' ' SD ' ' A' ' 58' ' ' MET . 31.9 m-85 -120.62 144.87 47.9 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.262 1.029 . . . . 0.02 110.024 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.21 -33.61 76.16 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.773 -0.649 . . . . 0.02 111.526 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -124.63 157.96 63.75 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 121.065 -1.022 . . . . 0.02 109.551 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.81 166.9 1.22 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.788 1.659 . . . . 0.02 112.794 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 63.58 36.68 10.87 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.344 -0.844 . . . . 0.02 110.968 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 45.11 51.48 8.96 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.562 0.696 . . . . 3.3900000000000001 110.78 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.3 m -125.91 163.53 22.76 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.206 0.526 . . . . 2.3300000000000001 109.918 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.78 -162.31 31.38 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.738 -1.345 . . . . 0.02 109.738 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.514 ' H ' ' CD2' ' A' ' 57' ' ' HIS . 18.7 m-70 -64.8 138.48 58.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.906 -1.35 . . . . 0.02 110.04 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.513 ' SD ' ' CE2' ' A' ' 49' ' ' TYR . 60.0 ttp -118.3 137.88 52.76 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.324 0.583 . . . . 5.0099999999999998 109.514 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.606 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 83.2 m-85 -134.98 139.33 44.81 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.469 -0.769 . . . . 0.02 109.882 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.3 130.53 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.875 -0.787 . . . . 1.72 108.875 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.55 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -120.91 110.6 34.82 Favored Pre-proline 0 N--CA 1.504 2.265 0 O-C-N 121.43 -0.794 . . . . 0.02 110.876 -178.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -77.54 169.39 21.09 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 CA-C-N 119.722 0.936 . . . . 1.47 110.317 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -53.69 140.78 28.35 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.924 -1.11 . . . . 4.25 110.562 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.42 -177.15 32.76 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.47 -1.348 . . . . 0.02 110.634 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -119.41 130.6 55.37 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.459 -1.024 . . . . 0.95999999999999996 109.686 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 71.1 m-85 -121.83 95.15 47.96 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.297 -1.001 . . . . 0.02 108.297 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.31 -3.57 10.19 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 120.978 1.118 . . . . 0.02 114.221 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' NH2' ' A' ' 13' ' ' ARG . 38.2 mt-10 -157.96 155.08 28.85 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.479 -1.388 . . . . 2.02 108.311 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -60.08 -38.78 83.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.594 -0.691 . . . . 0.02 112.035 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -59.7 -23.74 63.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.052 -1.03 . . . . 0.02 110.091 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -70.31 -19.11 63.1 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.774 0.797 . . . . 3.4199999999999999 108.938 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.606 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -108.36 10.75 27.5 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.517 -1.29 . . . . 0.02 107.517 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 73' ' ' MET . 2.1 mpt? 59.65 23.88 12.69 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.478 0.656 . . . . 0.02 110.563 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.0 144.86 46.5 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.785 -1.326 . . . . 0.02 109.785 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.13 -30.73 39.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -1.219 . . . . 0.97999999999999998 107.875 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -157.16 -171.93 3.82 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.413 -1.699 . . . . 0.02 106.413 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.422 ' OD2' ' OD1' ' A' ' 37' ' ' ASN . 78.4 m-20 -97.98 27.92 4.25 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.642 -1.286 . . . . 0.02 110.83 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -96.71 122.54 39.76 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.805 -1.184 . . . . 3.2000000000000002 111.102 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.528 HD21 ' CH2' ' A' ' 72' ' ' TRP . 86.0 mt -141.38 118.42 11.24 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.449 -1.315 . . . . 2.6099999999999999 107.449 178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.49 -18.27 9.79 Favored Glycine 0 N--CA 1.501 2.997 0 O-C-N 120.992 -1.067 . . . . 0.02 112.463 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.8 p -156.25 156.01 33.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.352 -1.675 . . . . 0.02 110.351 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.0 m -145.14 148.28 33.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.749 -0.594 . . . . 0.02 109.923 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -137.15 141.75 42.22 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.456 -0.778 . . . . 0.01 109.304 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.16 132.24 36.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.106 -0.996 . . . . 0.42999999999999999 109.434 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 t -90.87 124.48 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.69 -0.856 . . . . 1.25 108.69 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -90.72 133.2 35.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.868 -1.145 . . . . 1.77 108.287 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.17 139.18 36.21 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.851 -0.796 . . . . 1.6299999999999999 108.851 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 p -110.58 123.78 50.62 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.072 -1.085 . . . . 1.0800000000000001 108.072 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.4 p -114.99 132.46 56.58 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.746 -1.221 . . . . 1.26 107.818 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.73 -47.98 0.01 OUTLIER Glycine 0 N--CA 1.503 3.1 0 C-N-CA 117.704 -2.189 . . . . 0.01 113.44 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.16 -103.39 0.17 Allowed Glycine 0 N--CA 1.488 2.129 0 CA-C-N 120.045 1.923 . . . . 0.01 110.927 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -119.13 118.2 30.73 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.16 -1.2 . . . . 4.4299999999999997 110.179 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB1' ' NE1' ' A' ' 136' ' ' TRP . . . -66.0 135.92 55.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.769 -0.582 . . . . 2.9900000000000002 109.491 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -134.86 130.06 35.39 Favored 'General case' 0 N--CA 1.519 2.977 0 O-C-N 121.128 -0.982 . . . . 6.3600000000000003 112.997 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 tt -131.72 142.39 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-O 121.591 0.71 . . . . 1.0900000000000001 110.318 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.494 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 2.0 pt20 -124.78 139.27 54.0 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 107.679 -1.23 . . . . 2.0499999999999998 107.679 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.65 146.54 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.584 0 O-C-N 120.655 -1.278 . . . . 1.1000000000000001 110.96 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -121.34 140.96 51.41 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-O 122.084 0.945 . . . . 0.72999999999999998 111.482 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -69.09 -33.42 73.49 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.774 -0.648 . . . . 0.02 112.391 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.484 ' O ' ' OG ' ' A' ' 128' ' ' SER . 0.8 OUTLIER -113.67 165.33 12.63 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.815 -1.178 . . . . 3.1800000000000002 109.584 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.97 163.43 44.78 Favored Glycine 0 N--CA 1.492 2.376 0 CA-C-O 122.07 0.817 . . . . 0.01 111.266 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.7 t0 57.65 39.96 27.01 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.599 0.714 . . . . 0.01 111.077 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 52.46 55.01 9.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.632 -0.668 . . . . 0.01 111.002 178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -127.07 165.72 18.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.219 -1.03 . . . . 3.1499999999999999 108.219 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.65 -163.0 29.47 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.14 -1.584 . . . . 0.01 109.14 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.492 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 58.7 tt0 -75.2 142.18 43.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.942 -1.328 . . . . 0.01 108.841 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 107' ' ' MET . 9.7 tmm? -116.46 143.28 45.78 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.566 0.698 . . . . 0.01 109.433 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.492 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 55.1 m-85 -132.17 136.04 46.79 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.349 -0.982 . . . . 2.48 108.349 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -117.01 134.07 55.21 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.697 -0.627 . . . . 0.01 109.844 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.83 149.1 29.99 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.42 1.105 . . . . 1.6899999999999999 111.313 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 17.9 p -115.19 7.75 15.39 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.132 -0.94 . . . . 0.01 110.321 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -121.67 163.28 19.27 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.406 -0.809 . . . . 3.21 111.255 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.21 154.84 41.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.01 109.539 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 35.1 t -126.64 114.53 22.76 Favored Pre-proline 0 N--CA 1.499 2.013 0 N-CA-C 109.049 -0.722 . . . . 0.01 109.049 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.37 -33.57 4.14 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 120.274 1.134 . . . . 0.01 111.218 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 p -141.15 107.15 5.17 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.662 -0.866 . . . . 0.02 108.662 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.82 -39.52 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.721 -0.612 . . . . 1.8300000000000001 111.23 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.6 ttt -66.77 -37.65 85.01 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.002 -1.079 . . . . 1.3400000000000001 109.727 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -69.72 -38.55 76.95 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 120.58 -1.325 . . . . 2.1099999999999999 109.693 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -80.18 -47.47 14.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 2.0800000000000001 112.359 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -111.02 -1.1 16.43 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.413 -0.804 . . . . 0.02 112.84 -175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 m80 59.97 33.23 21.4 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.621 -1.299 . . . . 0.02 109.503 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.1 mt -111.63 135.02 52.79 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.805 -0.813 . . . . 0.02 108.805 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -93.65 -24.01 18.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.284 -0.885 . . . . 5.3200000000000003 110.688 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -148.42 162.55 39.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.259 -0.9 . . . . 0.02 109.791 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 54.5 mt -133.18 130.2 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 107.64 -1.244 . . . . 2.1699999999999999 107.64 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.52 -13.72 15.25 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 113.524 0.935 . . . . 0.02 113.524 -176.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -157.45 156.37 32.02 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.256 -1.527 . . . . 0.01 108.396 177.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.4 t -162.11 146.81 12.6 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.478 -1.389 . . . . 1.22 109.93 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -120.03 108.54 14.42 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.137 0.97 . . . . 1.4099999999999999 108.445 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 t -107.09 120.35 58.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 105.795 -1.928 . . . . 0.01 105.795 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.7 t -146.63 68.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 118.043 -1.463 . . . . 1.98 108.304 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 172.6 108.3 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.505 -1.665 . . . . 0.01 106.505 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.24 -174.31 44.51 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.737 -1.345 . . . . 0.01 109.737 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.48 ' CG2' HD21 ' A' ' 150' ' ' LEU . 6.7 m -111.92 145.69 39.11 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.369 -1.077 . . . . 2.2999999999999998 109.088 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.419 ' NE1' ' HB1' ' A' ' 93' ' ' ALA . 76.8 m95 -131.32 145.29 51.8 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.552 -0.718 . . . . 0.01 110.741 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.2 mt -117.7 142.01 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 107.421 -1.325 . . . . 1.6899999999999999 107.421 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -115.12 143.9 44.49 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 107.499 -1.297 . . . . 2.4900000000000002 107.499 177.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 18.0 m-85 -122.42 144.67 48.9 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.948 -0.76 . . . . 0.02 108.948 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.01 -30.0 62.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.626 -0.671 . . . . 0.02 112.06 -176.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.8 mt -115.17 153.96 47.32 Favored Pre-proline 0 N--CA 1.506 2.351 0 O-C-N 120.593 -1.317 . . . . 1.48 109.292 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.71 166.27 2.05 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.192 1.262 . . . . 0.02 112.615 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 59.84 31.31 20.7 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.149 -0.932 . . . . 0.75 111.186 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 57.74 51.94 8.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.02 110.926 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -125.09 163.67 21.89 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.486 -0.759 . . . . 0.02 109.747 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.51 -165.37 32.37 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.751 -1.34 . . . . 0.02 109.751 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -67.97 141.72 56.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.629 -0.924 . . . . 0.02 108.949 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.464 ' CD ' ' N ' ' A' ' 148' ' ' GLN . 3.2 mp0 -118.51 148.41 42.65 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.463 -0.569 . . . . 0.02 109.463 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.516 ' CE2' ' O ' ' A' ' 162' ' ' TRP . 1.7 t80 -129.33 142.9 50.7 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 109.013 -0.736 . . . . 0.01 109.013 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 150' ' ' LEU . 5.8 tt -96.75 121.8 39.0 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.293 -0.88 . . . . 0.01 109.345 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.654 HD22 ' NE1' ' A' ' 162' ' ' TRP . 17.4 mt -104.66 133.51 49.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.506 -0.746 . . . . 0.01 110.225 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 154' ' ' LYS . 21.1 t0 -108.83 175.39 5.48 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.341 -0.985 . . . . 2.27 108.341 178.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -57.41 84.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.84 -1.162 . . . . 1.8400000000000001 108.626 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' A' ' 152' ' ' ASP . 35.4 mttp -137.73 168.42 19.72 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 122.191 0.996 . . . . 2.2799999999999998 111.647 -178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -113.33 109.82 19.34 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.26 -1.015 . . . . 0.01 108.26 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -99.77 115.87 30.54 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.022 -1.049 . . . . 0.01 109.931 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -93.52 -25.4 17.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.079 -1.013 . . . . 0.01 111.433 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -125.89 153.42 73.56 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 120.786 -1.196 . . . . 2.54 108.613 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -61.16 -41.7 41.14 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 CA-C-N 119.281 0.779 . . . . 0.69999999999999996 110.584 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.58 -20.58 21.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.769 -1.207 . . . . 0.85999999999999999 108.586 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -65.49 -15.77 62.99 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.029 -1.044 . . . . 0.02 109.625 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.654 ' NE1' HD22 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -95.34 9.87 38.31 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 107.919 -1.141 . . . . 0.02 107.919 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.38 10.8 85.48 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.205 -1.474 . . . . 0.02 109.588 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.76 142.43 31.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.469 -1.018 . . . . 0.02 110.282 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.63 -8.59 58.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.728 -0.608 . . . . 0.58999999999999997 110.007 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.3 p -144.68 150.99 48.85 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.737 -1.227 . . . . 0.87 108.789 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.97 21.72 0.5 Allowed 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 120.899 1.066 . . . . 0.38 112.331 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.19 123.89 29.99 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.623 1.201 . . . . 0.17999999999999999 111.563 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 17.0 mt -146.66 126.75 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 106.765 -1.569 . . . . 3.9900000000000002 106.765 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -113.17 -20.34 11.48 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.112 -0.993 . . . . 5.1699999999999999 112.835 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.1 p -157.76 160.13 37.53 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.172 -2.205 . . . . 0.02 110.233 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -153.04 154.9 35.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.184 -0.948 . . . . 2.02 110.683 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -145.03 151.63 38.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.263 -0.898 . . . . 0.01 110.539 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -87.73 142.08 28.1 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.524 -0.735 . . . . 0.01 109.406 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.3 mt -92.2 128.17 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.137 -0.977 . . . . 3.04 109.241 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.7 t -136.35 146.83 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.151 -0.968 . . . . 1.8899999999999999 109.487 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 4.8899999999999997 109.441 179.951 . . . . . . . . 0 0 . 1 stop_ save_